Citrus Sinensis ID: 017021
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 379 | 2.2.26 [Sep-21-2011] | |||||||
| P51567 | 427 | Serine/threonine-protein | yes | no | 0.862 | 0.765 | 0.851 | 1e-170 | |
| P51566 | 467 | Serine/threonine-protein | no | no | 0.868 | 0.704 | 0.793 | 1e-158 | |
| P51568 | 400 | Serine/threonine-protein | no | no | 0.854 | 0.81 | 0.667 | 1e-130 | |
| Q10156 | 690 | Dual specificity protein | yes | no | 0.825 | 0.453 | 0.472 | 1e-86 | |
| O35491 | 499 | Dual specificity protein | yes | no | 0.831 | 0.631 | 0.475 | 2e-83 | |
| P49760 | 499 | Dual specificity protein | yes | no | 0.833 | 0.633 | 0.474 | 2e-83 | |
| P49762 | 832 | Serine/threonine-protein | no | no | 0.839 | 0.382 | 0.456 | 4e-80 | |
| Q9HAZ1 | 481 | Dual specificity protein | no | no | 0.815 | 0.642 | 0.475 | 1e-79 | |
| O35493 | 481 | Dual specificity protein | no | no | 0.815 | 0.642 | 0.466 | 8e-78 | |
| P49759 | 484 | Dual specificity protein | no | no | 0.807 | 0.632 | 0.458 | 3e-77 |
| >sp|P51567|AFC2_ARATH Serine/threonine-protein kinase AFC2 OS=Arabidopsis thaliana GN=AFC2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 599 bits (1545), Expect = e-170, Method: Compositional matrix adjust.
Identities = 280/329 (85%), Positives = 310/329 (94%), Gaps = 2/329 (0%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KI+SKMGEGTFGQVLECWDRERKEMVA+KIVRG+KKYREAAMIEIE+LQQL KHDKGGNR
Sbjct: 99 KIYSKMGEGTFGQVLECWDRERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNR 158
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI QLLEC+AFMHDL
Sbjct: 159 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLR 218
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
MIHTDLKPEN+LLVSS+Y+K+P+YK S +D Y KR+PKSSAIKVIDFGSTTYER D
Sbjct: 219 MIHTDLKPENILLVSSDYVKIPEYKGS-RLQRDVCY-KRVPKSSAIKVIDFGSTTYERQD 276
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
Q YIVSTRHYRAPEVILGLGW+YPCD+WSVGCI+VELCTGEALFQTHENLEHLAMMERVL
Sbjct: 277 QTYIVSTRHYRAPEVILGLGWSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVL 336
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
GP PQ MLK+VDRH+EKYVRRGRLDWP+GA SR+S+K+V+KLPRLQNLIMQHVDHSAG+L
Sbjct: 337 GPFPQQMLKKVDRHSEKYVRRGRLDWPDGATSRDSLKAVLKLPRLQNLIMQHVDHSAGEL 396
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTR 374
+++QGLLR+DP++R+TAREALRHPFF R
Sbjct: 397 INMVQGLLRFDPSERITAREALRHPFFAR 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|P51566|AFC1_ARATH Serine/threonine-protein kinase AFC1 OS=Arabidopsis thaliana GN=AFC1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 558 bits (1439), Expect = e-158, Method: Compositional matrix adjust.
Identities = 262/330 (79%), Positives = 293/330 (88%), Gaps = 1/330 (0%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+I SKMGEGTFGQVLEC+D + KE+VAIK++R I KYREAAMIEI+VLQ+L +HD GG+R
Sbjct: 116 QILSKMGEGTFGQVLECFDNKNKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSR 175
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLG SLYDFLRKN+YRSFPIDLVRE+ RQLLE +A+MHDL
Sbjct: 176 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLR 235
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+IHTDLKPEN+LLVSSEYIK+PDYK KD SYFK +PKSSAIK+IDFGSTT+E D
Sbjct: 236 LIHTDLKPENILLVSSEYIKIPDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 295
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
NYIVSTRHYRAPEVILG+GW YPCD+WS+GCILVELC+GEALFQTHENLEHLAMMERVL
Sbjct: 296 HNYIVSTRHYRAPEVILGVGWNYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVL 355
Query: 286 GPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
GPLP HM+ R DR +EKY RRG +LDWPEGA SR+S+K+V KLPRL NLIMQHVDHSAGD
Sbjct: 356 GPLPPHMVLRADRRSEKYFRRGAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGD 415
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L LLQGLLRYDPT+R AREAL HPFFTR
Sbjct: 416 LIDLLQGLLRYDPTERFKAREALNHPFFTR 445
|
Activator of yeast transcription factor, STE12. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P51568|AFC3_ARATH Serine/threonine-protein kinase AFC3 OS=Arabidopsis thaliana GN=AFC3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 466 bits (1199), Expect = e-130, Method: Compositional matrix adjust.
Identities = 219/328 (66%), Positives = 270/328 (82%), Gaps = 4/328 (1%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KI SKMGEGTFG+VLECWDR+ KE VAIKI+R IKKYR+AAMIEI+VLQ+L K DKG R
Sbjct: 72 KILSKMGEGTFGRVLECWDRDTKEYVAIKIIRSIKKYRDAAMIEIDVLQKLVKSDKGRTR 131
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQ++NWFDYRNHICIVFEKLG SL+DFL++N Y +FP+ LVR+ QLLE +A+MH+L
Sbjct: 132 CVQMKNWFDYRNHICIVFEKLGPSLFDFLKRNKYSAFPLALVRDFGCQLLESVAYMHELQ 191
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
++HTDLKPEN+LLVSSE +K+PD K S + ++F+ +PKSSAIK+IDFGST +
Sbjct: 192 LVHTDLKPENILLVSSENVKLPDNKRS---AANETHFRCLPKSSAIKLIDFGSTVCDNRI 248
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
+ IV TRHYR+PEVILGLGW+Y CD+WS+GCIL ELCTGEALFQTH+NLEHLAMMER L
Sbjct: 249 HHSIVQTRHYRSPEVILGLGWSYQCDLWSIGCILFELCTGEALFQTHDNLEHLAMMERAL 308
Query: 286 GPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
GPLP+HM ++ R AEKY RRG RL+WPEGA SRESI++V +L RL++++ +HVD++
Sbjct: 309 GPLPEHMTRKASRGAEKYFRRGCRLNWPEGANSRESIRAVKRLDRLKDMVSKHVDNTRSR 368
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPFF 372
LL GLL YDP++RLTA EAL HPFF
Sbjct: 369 FADLLYGLLAYDPSERLTANEALDHPFF 396
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q10156|LKH1_SCHPO Dual specificity protein kinase lkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=lkh1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 320 bits (820), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 155/328 (47%), Positives = 227/328 (69%), Gaps = 15/328 (4%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQI 109
+G GTFG+V++C+D+ AIK+ R I KYREA++IE+ VLQ +A D N+C+Q+
Sbjct: 368 LGHGTFGKVIQCYDQSTGRHCAIKVTRAIPKYREASLIELRVLQTIAHSDPTNENKCIQL 427
Query: 110 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 169
R++FDYR HICIV + G S++DFL+ NNY FP+ ++ +++QL + +AF+H L ++HT
Sbjct: 428 RDYFDYRKHICIVTDLFGWSVFDFLKNNNYIPFPLKHIQMLSQQLFKSVAFLHSLGLVHT 487
Query: 170 DLKPENVLLVS--SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 227
DLKPENVLLVS S I++P Y++ Y +++ S I++IDFGS T+E +
Sbjct: 488 DLKPENVLLVSNASRTIRLP-YRN---------YSQKVLNSCEIRLIDFGSATFEDEYHS 537
Query: 228 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 287
+VSTRHYRAPE+ILGLGW+YPCD+WS+GCILVEL TG+ALFQTHE+ EHL MME++LGP
Sbjct: 538 SVVSTRHYRAPEIILGLGWSYPCDVWSIGCILVELFTGQALFQTHEDSEHLCMMEKILGP 597
Query: 288 LPQHMLKRVDRHAEKYVRR-GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346
++M+ R R ++++ + G++ +P ++SI + L L+ + A L
Sbjct: 598 FDRNMISRSSRTSQRFFKSDGKVRYPLSNTPKKSINYLQSLQTLEQIFAVSSPEVAL-LL 656
Query: 347 HLLQGLLRYDPTDRLTAREALRHPFFTR 374
LL+ + YDP R+TA+EAL HPFFT+
Sbjct: 657 DLLKKVFVYDPKRRITAKEALWHPFFTQ 684
|
Protein kinase that may act as a negative regulator of filamentous growth and flocculation. Appears to have a role in normal cell wall and septum formation and in cell seperation. May have antagonistic function in the regulation of beta-glucan distribution between the sites for cell wall and septum assembly. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|O35491|CLK2_MOUSE Dual specificity protein kinase CLK2 OS=Mus musculus GN=Clk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 310 bits (793), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 157/330 (47%), Positives = 221/330 (66%), Gaps = 15/330 (4%)
Query: 46 KIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGG 103
+I S +GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D
Sbjct: 163 EIVSTLGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKEAARLEINVLEKINEKDPDNK 222
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD
Sbjct: 223 NLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHD 282
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ HTDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++
Sbjct: 283 NKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDH 334
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
+ IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER
Sbjct: 335 EHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMER 394
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+LGP+P M+++ + +KY RGRLDW E ++ ++ K P + L + DH
Sbjct: 395 ILGPVPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEDHHQ- 450
Query: 344 DLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
L L++ +L Y+P RLT EAL+HPFF
Sbjct: 451 -LFDLIENMLEYEPAKRLTLGEALQHPFFA 479
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49760|CLK2_HUMAN Dual specificity protein kinase CLK2 OS=Homo sapiens GN=CLK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 309 bits (792), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 157/331 (47%), Positives = 222/331 (67%), Gaps = 15/331 (4%)
Query: 46 KIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGG 103
+I S +GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D
Sbjct: 164 EIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNK 223
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD
Sbjct: 224 NLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHD 283
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ HTDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++
Sbjct: 284 NKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDH 335
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
+ IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER
Sbjct: 336 EHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMER 395
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+LGP+P M+++ + +KY RGRLDW E ++ ++ K P + L + +H
Sbjct: 396 ILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEEHHQ- 451
Query: 344 DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L L++ +L Y+P RLT EAL+HPFF R
Sbjct: 452 -LFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49762|DOA_DROME Serine/threonine-protein kinase Doa OS=Drosophila melanogaster GN=Doa PE=1 SV=2 | Back alignment and function description |
|---|
Score = 298 bits (764), Expect = 4e-80, Method: Compositional matrix adjust.
Identities = 152/333 (45%), Positives = 217/333 (65%), Gaps = 15/333 (4%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KI + +GEGTFG+V++ D ER +A+KI++ ++KYREAA +EI L+++A+ D +
Sbjct: 480 KIMATLGEGTFGRVVKVKDMERDYCMALKIIKNVEKYREAAKLEINALEKIAQKDPHCDH 539
Query: 106 -CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
CV++ +WFDY H+CIVFE LG S++DFLR+NNY +P+D VR +A QL + F+HD
Sbjct: 540 LCVKMIDWFDYHGHMCIVFEMLGLSVFDFLRENNYEPYPLDQVRHMAYQLCYSVKFLHDN 599
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+ HTDLKPEN+L V S+Y ++K + R K++ +++IDFGS T++
Sbjct: 600 RLTHTDLKPENILFVDSDYTSHYNHKINREV--------RRVKNTDVRLIDFGSATFDHE 651
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
+ IVSTRHYRAPEVIL LGW+ PCD+WS+GCIL EL G LFQTH+N EHLAMMER+
Sbjct: 652 HHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCILFELYLGITLFQTHDNREHLAMMERI 711
Query: 285 LGPLPQHMLKR---VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
LG +P M + + KY G+LDW E +++ ++ K P + DH
Sbjct: 712 LGQIPYRMARNHTLYSKTKTKYFYHGKLDWDEKSSAGRYVRDHCK-PLFLCQLSDSEDHC 770
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
+L L++ +L Y+P+ R+T EAL HPFF R
Sbjct: 771 --ELFSLIKKMLEYEPSSRITLGEALHHPFFDR 801
|
Negative regulator of the copia retrotransposon element of the white (w) gene. In the eye, it is required for normal pigmentation, photoreceptor cell development and for organization of interommatidial bristles. Also essential for embryonic segmentation and differentiation of the nervous system. Functions in the control of alternative splicing by phosphorylating the argine/serine-rich splicing factors, SR proteins. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9HAZ1|CLK4_HUMAN Dual specificity protein kinase CLK4 OS=Homo sapiens GN=CLK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 297 bits (760), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 154/324 (47%), Positives = 216/324 (66%), Gaps = 15/324 (4%)
Query: 51 MGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQ 108
+GEG FG+V+EC D M VA+KIV+ + +YREAA EI+VL+ L D RCVQ
Sbjct: 165 LGEGAFGKVVECIDHGMDGMHVAVKIVKNVGRYREAARSEIQVLEHLNSTDPNSVFRCVQ 224
Query: 109 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
+ WFD+ H+CIVFE LG S YDF+++N++ F ID +R++A Q+ + I F+H + H
Sbjct: 225 MLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQIDHIRQMAYQICQSINFLHHNKLTH 284
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 228
TDLKPEN+L V S+Y V Y S + +D +R K++ IKV+DFGS TY+ +
Sbjct: 285 TDLKPENILFVKSDY--VVKYNSKM--KRD----ERTLKNTDIKVVDFGSATYDDEHHST 336
Query: 229 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 288
+VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E G +FQTH++ EHLAMMER+LGP+
Sbjct: 337 LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFQTHDSKEHLAMMERILGPI 396
Query: 289 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348
PQHM+++ + KY +LDW E +++ ++ K L+ ++ H D L L
Sbjct: 397 PQHMIQKTRK--RKYFHHNQLDWDEHSSAGRYVRRRCKP--LKEFMLCH-DEEHEKLFDL 451
Query: 349 LQGLLRYDPTDRLTAREALRHPFF 372
++ +L YDPT R+T EAL+HPFF
Sbjct: 452 VRRMLEYDPTQRITLDEALQHPFF 475
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|O35493|CLK4_MOUSE Dual specificity protein kinase CLK4 OS=Mus musculus GN=Clk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (744), Expect = 8e-78, Method: Compositional matrix adjust.
Identities = 151/324 (46%), Positives = 214/324 (66%), Gaps = 15/324 (4%)
Query: 51 MGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQ 108
+GEG FG+V+EC D + VA+KIV+ + +YREAA EI+VL+ L D RCVQ
Sbjct: 165 LGEGAFGKVVECIDHGMDGLHVAVKIVKNVGRYREAARSEIQVLEHLNSTDPNSVFRCVQ 224
Query: 109 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
+ WFD+ H+CIVFE LG S YDF+++N++ F ID +R++A Q+ + I F+H + H
Sbjct: 225 MLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQIDHIRQMAYQICQSINFLHHNKLTH 284
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 228
TDLKPEN+L V S+Y V Y S + +D +R K++ IKV+DFGS TY+ +
Sbjct: 285 TDLKPENILFVKSDY--VVKYNSKM--KRD----ERTLKNTDIKVVDFGSATYDDEHHST 336
Query: 229 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 288
+VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E G +FQTH++ EHLAMMER+LGP+
Sbjct: 337 LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFQTHDSKEHLAMMERILGPI 396
Query: 289 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348
P HM+++ + KY +LDW E +++ ++ K L+ ++ H D L L
Sbjct: 397 PAHMIQKTRK--RKYFHHNQLDWDEHSSAGRYVRRRCKP--LKEFMLCH-DEEHEKLFDL 451
Query: 349 LQGLLRYDPTDRLTAREALRHPFF 372
++ +L YDP R+T EAL+HPFF
Sbjct: 452 VRRMLEYDPARRITLDEALQHPFF 475
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49759|CLK1_HUMAN Dual specificity protein kinase CLK1 OS=Homo sapiens GN=CLK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 289 bits (739), Expect = 3e-77, Method: Compositional matrix adjust.
Identities = 150/327 (45%), Positives = 211/327 (64%), Gaps = 21/327 (6%)
Query: 51 MGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN-RCVQ 108
+GEG FG+V+EC D + VA+KIV+ + +Y EAA EI+VL+ L D RCVQ
Sbjct: 167 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 226
Query: 109 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
+ WF++ HICIVFE LG S YDF+++N + F +D +R++A Q+ + + F+H + H
Sbjct: 227 MLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTH 286
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS---SAIKVIDFGSTTYERPD 225
TDLKPEN+L V S+Y + + PK KR ++ IKV+DFGS TY+
Sbjct: 287 TDLKPENILFVQSDYTEA-------YNPK----IKRDERTLINPDIKVVDFGSATYDDEH 335
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
+ +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E G +F TH++ EHLAMMER+L
Sbjct: 336 HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 395
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
GPLP+HM+++ + KY RLDW E +++ + K P + ++ Q V+H L
Sbjct: 396 GPLPKHMIQKTRK--RKYFHHDRLDWDEHSSAGRYVSRRCK-PLKEFMLSQDVEHER--L 450
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFF 372
L+Q +L YDP R+T REAL+HPFF
Sbjct: 451 FDLIQKMLEYDPAKRITLREALKHPFF 477
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates: SRSF1, SRSF3 and PTPN1. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells and adenovirus E1A pre-mRNA. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 379 | ||||||
| 255540473 | 435 | afc, putative [Ricinus communis] gi|2235 | 0.881 | 0.767 | 0.922 | 0.0 | |
| 225456860 | 435 | PREDICTED: serine/threonine-protein kina | 0.881 | 0.767 | 0.925 | 0.0 | |
| 224135977 | 427 | predicted protein [Populus trichocarpa] | 0.878 | 0.779 | 0.906 | 0.0 | |
| 7211773 | 437 | protein kinase MK5 [Mesembryanthemum cry | 0.881 | 0.764 | 0.883 | 1e-179 | |
| 224121850 | 422 | predicted protein [Populus trichocarpa] | 0.868 | 0.779 | 0.899 | 1e-178 | |
| 356508738 | 425 | PREDICTED: serine/threonine-protein kina | 0.875 | 0.781 | 0.901 | 1e-178 | |
| 356516617 | 425 | PREDICTED: serine/threonine-protein kina | 0.875 | 0.781 | 0.895 | 1e-178 | |
| 255647343 | 425 | unknown [Glycine max] | 0.875 | 0.781 | 0.895 | 1e-177 | |
| 357461735 | 426 | Serine/threonine protein kinase AFC2 [Me | 0.875 | 0.779 | 0.886 | 1e-177 | |
| 356508740 | 427 | PREDICTED: serine/threonine-protein kina | 0.881 | 0.782 | 0.898 | 1e-177 |
| >gi|255540473|ref|XP_002511301.1| afc, putative [Ricinus communis] gi|223550416|gb|EEF51903.1| afc, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 658 bits (1698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 308/334 (92%), Positives = 322/334 (96%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEI+VLQQL KHDKGGNR
Sbjct: 102 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIDVLQQLGKHDKGGNR 161
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLG SLYDFLRKNNYRSFPIDLVREI RQLLECIAFMHDL
Sbjct: 162 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECIAFMHDLH 221
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+IHTDLKPEN+LLVS +Y+KVPDYK S +PKDSSYFKR+PKSSA+KVIDFGSTTYER D
Sbjct: 222 LIHTDLKPENILLVSPDYVKVPDYKGSTRSPKDSSYFKRVPKSSAVKVIDFGSTTYERQD 281
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
QNYIVSTRHYRAPEVILGLGW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL
Sbjct: 282 QNYIVSTRHYRAPEVILGLGWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 341
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
GPLPQHMLKR+DRHAEKYVRRGRLDWPEGA SRESIK+V+KLPRLQNL+MQHVDHSAGDL
Sbjct: 342 GPLPQHMLKRIDRHAEKYVRRGRLDWPEGATSRESIKAVLKLPRLQNLVMQHVDHSAGDL 401
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 379
HLLQGLLRYDP+DRLTAREALRHPFF RDHLRR
Sbjct: 402 IHLLQGLLRYDPSDRLTAREALRHPFFARDHLRR 435
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456860|ref|XP_002279764.1| PREDICTED: serine/threonine-protein kinase AFC2 [Vitis vinifera] gi|297733679|emb|CBI14926.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 654 bits (1688), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 309/334 (92%), Positives = 321/334 (96%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KI+SKMGEGTFGQVLECWDRERKEMVA+KIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR
Sbjct: 101 KINSKMGEGTFGQVLECWDRERKEMVAVKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 160
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLG SLYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL
Sbjct: 161 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLR 220
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+IHTDLKPEN+LLVS EY+KVPDYK S +PKD SYFKR+PKSSAIKVIDFGSTTYER D
Sbjct: 221 LIHTDLKPENILLVSPEYVKVPDYKVSSRSPKDGSYFKRVPKSSAIKVIDFGSTTYERQD 280
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
QNYIVSTRHYRAPEVILGLGW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL
Sbjct: 281 QNYIVSTRHYRAPEVILGLGWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 340
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
GPLPQHMLKRVDRHAEKYVRRGRLDWPEGA SRESIK+V+KLPRLQNLIMQHVDHSAGDL
Sbjct: 341 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGATSRESIKAVLKLPRLQNLIMQHVDHSAGDL 400
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 379
HLLQGLLRYDP+DRLTA ALRHPFFTRDHLRR
Sbjct: 401 IHLLQGLLRYDPSDRLTALGALRHPFFTRDHLRR 434
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224135977|ref|XP_002322208.1| predicted protein [Populus trichocarpa] gi|222869204|gb|EEF06335.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1669), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 302/333 (90%), Positives = 321/333 (96%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KIH+KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY+EAAMIEIEVLQQL KHDKGGNR
Sbjct: 94 KIHNKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYKEAAMIEIEVLQQLGKHDKGGNR 153
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLG SLYDFLRKNNYRSFPID VREI RQLLEC+AFMHDL
Sbjct: 154 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNNYRSFPIDHVREIGRQLLECVAFMHDLH 213
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
MIHTDLKPEN+LLVSS+Y+KVPDYK+S +PKDSSY+KR+PKSSAIKVIDFGSTTYER D
Sbjct: 214 MIHTDLKPENILLVSSDYVKVPDYKNSTRSPKDSSYYKRVPKSSAIKVIDFGSTTYERQD 273
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
QNYIVSTRHYRAPEVILGLGW+YPCD+WSVGCILVELCTGEALFQTHENLEHLAMMERVL
Sbjct: 274 QNYIVSTRHYRAPEVILGLGWSYPCDVWSVGCILVELCTGEALFQTHENLEHLAMMERVL 333
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
GP+PQ+MLKRVDRHAEK+VRRGRLDWPEGAASRESIK+V+KLPRLQNL+MQHVDHSAGDL
Sbjct: 334 GPMPQNMLKRVDRHAEKFVRRGRLDWPEGAASRESIKAVLKLPRLQNLVMQHVDHSAGDL 393
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 378
HLLQGLLRYDP DRLTAREALRHPFF +DH R
Sbjct: 394 IHLLQGLLRYDPMDRLTAREALRHPFFAKDHRR 426
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7211773|gb|AAF40430.1| protein kinase MK5 [Mesembryanthemum crystallinum] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1632), Expect = e-179, Method: Compositional matrix adjust.
Identities = 295/334 (88%), Positives = 316/334 (94%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KIH KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEI+VLQQL KHDKGG+R
Sbjct: 104 KIHGKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIDVLQQLGKHDKGGSR 163
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNY FPIDLVRE RQLL+C+AFMHDL
Sbjct: 164 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYGPFPIDLVRENGRQLLDCVAFMHDLH 223
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+IHTDLKPENVLLVSS+Y+K+ DYK +PKDSSY+K++PKSSAIKVIDFGSTTYERPD
Sbjct: 224 LIHTDLKPENVLLVSSDYVKIRDYKGFSRSPKDSSYYKKVPKSSAIKVIDFGSTTYERPD 283
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
QNYIVSTRHYRAPEVILGLGW+YPCD+WSVGCILVELC+GEALFQTHENLE LAMMERVL
Sbjct: 284 QNYIVSTRHYRAPEVILGLGWSYPCDVWSVGCILVELCSGEALFQTHENLEDLAMMERVL 343
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI++V KL RLQNL+MQHVDHS GD
Sbjct: 344 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIRAVTKLLRLQNLVMQHVDHSGGDF 403
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 379
HLLQGLLRYDP+DRLTAREA+RHPFFTRD+LRR
Sbjct: 404 IHLLQGLLRYDPSDRLTAREAVRHPFFTRDNLRR 437
|
Source: Mesembryanthemum crystallinum Species: Mesembryanthemum crystallinum Genus: Mesembryanthemum Family: Aizoaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121850|ref|XP_002318688.1| predicted protein [Populus trichocarpa] gi|222859361|gb|EEE96908.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 632 bits (1630), Expect = e-178, Method: Compositional matrix adjust.
Identities = 296/329 (89%), Positives = 312/329 (94%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQ L KHDKG NR
Sbjct: 94 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQNLGKHDKGSNR 153
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLG SLYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL
Sbjct: 154 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLR 213
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
MIHTDLKPEN+LLVSS+Y+KVPDYK+S +PKD SY+KR+PKSSAIKVIDFGSTTYER D
Sbjct: 214 MIHTDLKPENILLVSSDYVKVPDYKNSSRSPKDISYYKRVPKSSAIKVIDFGSTTYERQD 273
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
QNYIVSTRHYRAPEVILGLGW+YPCDIWS GCILVELCTGEALFQTHENLEHLAMMERVL
Sbjct: 274 QNYIVSTRHYRAPEVILGLGWSYPCDIWSAGCILVELCTGEALFQTHENLEHLAMMERVL 333
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
GP+PQH+LKRVDRHA KYVRRGRLDWPEGAASRES+K+V+KLPRLQNL+MQHVD SAGDL
Sbjct: 334 GPMPQHILKRVDRHAGKYVRRGRLDWPEGAASRESMKAVLKLPRLQNLVMQHVDQSAGDL 393
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTR 374
HLLQGLLRYDP DRLTAREALRHPF +
Sbjct: 394 IHLLQGLLRYDPLDRLTAREALRHPFLAK 422
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508738|ref|XP_003523111.1| PREDICTED: serine/threonine-protein kinase AFC2-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1625), Expect = e-178, Method: Compositional matrix adjust.
Identities = 301/334 (90%), Positives = 315/334 (94%), Gaps = 2/334 (0%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL KHDKG NR
Sbjct: 94 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLGKHDKGSNR 153
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLG SLYDFLRKN+YRSFPIDLVREI QLLEC+AFMHDL
Sbjct: 154 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREIGWQLLECVAFMHDLR 213
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
MIHTDLKPEN+LLVS EY+K+PDYKS+ +P SS+FKR+PKSSAIKVIDFGSTTYER D
Sbjct: 214 MIHTDLKPENILLVSPEYLKIPDYKSTTRSP--SSFFKRVPKSSAIKVIDFGSTTYERED 271
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
Q YIVSTRHYRAPEVILGLGW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL
Sbjct: 272 QTYIVSTRHYRAPEVILGLGWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 331
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
GP+PQ MLKRVDRHAEKYVRRGRLDWPEGA SRESIK+VMKLPRLQNLIMQHVDHSAGDL
Sbjct: 332 GPIPQQMLKRVDRHAEKYVRRGRLDWPEGAISRESIKAVMKLPRLQNLIMQHVDHSAGDL 391
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 379
HLLQGLLRYDP +RLTAR+ALRH FF RDHLRR
Sbjct: 392 IHLLQGLLRYDPFERLTARDALRHSFFMRDHLRR 425
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516617|ref|XP_003526990.1| PREDICTED: serine/threonine-protein kinase AFC2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 629 bits (1623), Expect = e-178, Method: Compositional matrix adjust.
Identities = 299/334 (89%), Positives = 315/334 (94%), Gaps = 2/334 (0%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KIH KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAM+EIEVLQQL KHDKG NR
Sbjct: 94 KIHGKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMVEIEVLQQLGKHDKGSNR 153
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLG SLYDFLRKN+YRSFPIDLVREI QLLEC+AFMHDL
Sbjct: 154 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREIGWQLLECVAFMHDLH 213
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
MIHTDLKPEN+LLVS EY+K+PDYKS+ +P SS+FKR+PKSSAIKVIDFGSTTYER D
Sbjct: 214 MIHTDLKPENILLVSPEYLKIPDYKSTTRSP--SSFFKRVPKSSAIKVIDFGSTTYERED 271
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
Q YIVSTRHYRAPEVILGLGW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL
Sbjct: 272 QTYIVSTRHYRAPEVILGLGWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 331
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
GP+PQ MLKRVDRHAEKYVRRGRLDWPEGAASRESIK+VMKLPRLQN+IMQHVDHSAGDL
Sbjct: 332 GPIPQQMLKRVDRHAEKYVRRGRLDWPEGAASRESIKAVMKLPRLQNIIMQHVDHSAGDL 391
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 379
HLLQGLLRYDP +RLTAR+ALRH FFTRD LRR
Sbjct: 392 IHLLQGLLRYDPFERLTARDALRHSFFTRDQLRR 425
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255647343|gb|ACU24138.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 628 bits (1620), Expect = e-177, Method: Compositional matrix adjust.
Identities = 299/334 (89%), Positives = 314/334 (94%), Gaps = 2/334 (0%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KIH KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAM+EIEVLQQL KHDKG NR
Sbjct: 94 KIHGKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMVEIEVLQQLGKHDKGSNR 153
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLG SLYDFLRKN+YRSFPIDLVREI QLLEC+AFMHDL
Sbjct: 154 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREIGWQLLECVAFMHDLH 213
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
MIHTDLKPEN+LLVS EY+K+PDYKS+ +P SS+FKR+PKSSAIKVIDFGSTTYER D
Sbjct: 214 MIHTDLKPENILLVSPEYLKIPDYKSTTRSP--SSFFKRVPKSSAIKVIDFGSTTYERED 271
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
Q YIVSTRHYRAPEVILGLGW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL
Sbjct: 272 QTYIVSTRHYRAPEVILGLGWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 331
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
GP+PQ MLKRVDRHAEKYVRRGRLDWPEGAASRESIK+VMKLPRLQN IMQHVDHSAGDL
Sbjct: 332 GPIPQQMLKRVDRHAEKYVRRGRLDWPEGAASRESIKAVMKLPRLQNTIMQHVDHSAGDL 391
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 379
HLLQGLLRYDP +RLTAR+ALRH FFTRD LRR
Sbjct: 392 IHLLQGLLRYDPFERLTARDALRHSFFTRDQLRR 425
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461735|ref|XP_003601149.1| Serine/threonine protein kinase AFC2 [Medicago truncatula] gi|355490197|gb|AES71400.1| Serine/threonine protein kinase AFC2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1617), Expect = e-177, Method: Compositional matrix adjust.
Identities = 296/334 (88%), Positives = 315/334 (94%), Gaps = 2/334 (0%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++H KMGEGTFGQVLECWDRERKEMVAIK+VR IKKYREAAMIEIE+LQQL KHDKGGNR
Sbjct: 95 RVHGKMGEGTFGQVLECWDRERKEMVAIKVVRAIKKYREAAMIEIEMLQQLGKHDKGGNR 154
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLG SLYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL
Sbjct: 155 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLH 214
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
MIHTDLKPEN+LLVSSEY+K+PDYKSS P S++KR+PKSSAIKVIDFGSTTYER +
Sbjct: 215 MIHTDLKPENILLVSSEYLKIPDYKSSSRAP--CSFYKRVPKSSAIKVIDFGSTTYEREN 272
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
QNYIVSTRHYRAPEVILGLGW+YPCD+WSVGCILVELCTGEALFQTHENLEHLAMMERVL
Sbjct: 273 QNYIVSTRHYRAPEVILGLGWSYPCDVWSVGCILVELCTGEALFQTHENLEHLAMMERVL 332
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
G LPQ +LKRVDRHAEKYVRRGRLDWPEGA SRESIK+VMKLPRLQNLIMQHVDHSAGDL
Sbjct: 333 GLLPQQLLKRVDRHAEKYVRRGRLDWPEGANSRESIKAVMKLPRLQNLIMQHVDHSAGDL 392
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 379
HLLQGLLRYDP +R+TAR+ALRHPFF RDHLRR
Sbjct: 393 IHLLQGLLRYDPFERVTARDALRHPFFMRDHLRR 426
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508740|ref|XP_003523112.1| PREDICTED: serine/threonine-protein kinase AFC2-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1617), Expect = e-177, Method: Compositional matrix adjust.
Identities = 300/334 (89%), Positives = 312/334 (93%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL KHDKG NR
Sbjct: 94 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLGKHDKGSNR 153
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLG SLYDFLRKN+YRSFPIDLVREI QLLEC+AFMHDL
Sbjct: 154 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREIGWQLLECVAFMHDLR 213
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
MIHTDLKPEN+LLVS EY+K+PDYK T SS+FKR+PKSSAIKVIDFGSTTYER D
Sbjct: 214 MIHTDLKPENILLVSPEYLKIPDYKFISTTRSPSSFFKRVPKSSAIKVIDFGSTTYERED 273
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
Q YIVSTRHYRAPEVILGLGW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL
Sbjct: 274 QTYIVSTRHYRAPEVILGLGWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 333
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
GP+PQ MLKRVDRHAEKYVRRGRLDWPEGA SRESIK+VMKLPRLQNLIMQHVDHSAGDL
Sbjct: 334 GPIPQQMLKRVDRHAEKYVRRGRLDWPEGAISRESIKAVMKLPRLQNLIMQHVDHSAGDL 393
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 379
HLLQGLLRYDP +RLTAR+ALRH FF RDHLRR
Sbjct: 394 IHLLQGLLRYDPFERLTARDALRHSFFMRDHLRR 427
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 379 | ||||||
| TAIR|locus:2121984 | 427 | FC2 "FUS3-complementing gene 2 | 0.862 | 0.765 | 0.851 | 7e-157 | |
| TAIR|locus:2084006 | 467 | FC1 "FUS3-complementing gene 1 | 0.868 | 0.704 | 0.793 | 1.5e-145 | |
| TAIR|locus:2125622 | 400 | AME3 [Arabidopsis thaliana (ta | 0.854 | 0.81 | 0.667 | 2.5e-120 | |
| UNIPROTKB|E1B9Q2 | 500 | CLK2 "Uncharacterized protein" | 0.833 | 0.632 | 0.474 | 3.7e-80 | |
| UNIPROTKB|F1P919 | 612 | CLK2 "Uncharacterized protein" | 0.833 | 0.516 | 0.474 | 3.7e-80 | |
| UNIPROTKB|B1AVT0 | 497 | CLK2 "Dual-specificity protein | 0.833 | 0.635 | 0.474 | 3.7e-80 | |
| UNIPROTKB|P49760 | 499 | CLK2 "Dual specificity protein | 0.833 | 0.633 | 0.474 | 3.7e-80 | |
| UNIPROTKB|F1RLJ5 | 500 | CLK2 "Uncharacterized protein" | 0.833 | 0.632 | 0.474 | 3.7e-80 | |
| MGI|MGI:1098669 | 499 | Clk2 "CDC-like kinase 2" [Mus | 0.828 | 0.629 | 0.477 | 4.7e-80 | |
| RGD|1359711 | 500 | Clk2 "CDC-like kinase 2" [Ratt | 0.828 | 0.628 | 0.477 | 6e-80 |
| TAIR|locus:2121984 FC2 "FUS3-complementing gene 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1529 (543.3 bits), Expect = 7.0e-157, P = 7.0e-157
Identities = 280/329 (85%), Positives = 310/329 (94%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KI+SKMGEGTFGQVLECWDRERKEMVA+KIVRG+KKYREAAMIEIE+LQQL KHDKGGNR
Sbjct: 99 KIYSKMGEGTFGQVLECWDRERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNR 158
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI QLLEC+AFMHDL
Sbjct: 159 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLR 218
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
MIHTDLKPEN+LLVSS+Y+K+P+YK S +D Y KR+PKSSAIKVIDFGSTTYER D
Sbjct: 219 MIHTDLKPENILLVSSDYVKIPEYKGS-RLQRDVCY-KRVPKSSAIKVIDFGSTTYERQD 276
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
Q YIVSTRHYRAPEVILGLGW+YPCD+WSVGCI+VELCTGEALFQTHENLEHLAMMERVL
Sbjct: 277 QTYIVSTRHYRAPEVILGLGWSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVL 336
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
GP PQ MLK+VDRH+EKYVRRGRLDWP+GA SR+S+K+V+KLPRLQNLIMQHVDHSAG+L
Sbjct: 337 GPFPQQMLKKVDRHSEKYVRRGRLDWPDGATSRDSLKAVLKLPRLQNLIMQHVDHSAGEL 396
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTR 374
+++QGLLR+DP++R+TAREALRHPFF R
Sbjct: 397 INMVQGLLRFDPSERITAREALRHPFFAR 425
|
|
| TAIR|locus:2084006 FC1 "FUS3-complementing gene 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1422 (505.6 bits), Expect = 1.5e-145, P = 1.5e-145
Identities = 262/330 (79%), Positives = 293/330 (88%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+I SKMGEGTFGQVLEC+D + KE+VAIK++R I KYREAAMIEI+VLQ+L +HD GG+R
Sbjct: 116 QILSKMGEGTFGQVLECFDNKNKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSR 175
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQIRNWFDYRNHICIVFEKLG SLYDFLRKN+YRSFPIDLVRE+ RQLLE +A+MHDL
Sbjct: 176 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLR 235
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+IHTDLKPEN+LLVSSEYIK+PDYK KD SYFK +PKSSAIK+IDFGSTT+E D
Sbjct: 236 LIHTDLKPENILLVSSEYIKIPDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 295
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
NYIVSTRHYRAPEVILG+GW YPCD+WS+GCILVELC+GEALFQTHENLEHLAMMERVL
Sbjct: 296 HNYIVSTRHYRAPEVILGVGWNYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVL 355
Query: 286 GPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
GPLP HM+ R DR +EKY RRG +LDWPEGA SR+S+K+V KLPRL NLIMQHVDHSAGD
Sbjct: 356 GPLPPHMVLRADRRSEKYFRRGAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGD 415
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L LLQGLLRYDPT+R AREAL HPFFTR
Sbjct: 416 LIDLLQGLLRYDPTERFKAREALNHPFFTR 445
|
|
| TAIR|locus:2125622 AME3 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1184 (421.8 bits), Expect = 2.5e-120, P = 2.5e-120
Identities = 219/328 (66%), Positives = 270/328 (82%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
KI SKMGEGTFG+VLECWDR+ KE VAIKI+R IKKYR+AAMIEI+VLQ+L K DKG R
Sbjct: 72 KILSKMGEGTFGRVLECWDRDTKEYVAIKIIRSIKKYRDAAMIEIDVLQKLVKSDKGRTR 131
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
CVQ++NWFDYRNHICIVFEKLG SL+DFL++N Y +FP+ LVR+ QLLE +A+MH+L
Sbjct: 132 CVQMKNWFDYRNHICIVFEKLGPSLFDFLKRNKYSAFPLALVRDFGCQLLESVAYMHELQ 191
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
++HTDLKPEN+LLVSSE +K+PD K S + ++F+ +PKSSAIK+IDFGST +
Sbjct: 192 LVHTDLKPENILLVSSENVKLPDNKRSA---ANETHFRCLPKSSAIKLIDFGSTVCDNRI 248
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
+ IV TRHYR+PEVILGLGW+Y CD+WS+GCIL ELCTGEALFQTH+NLEHLAMMER L
Sbjct: 249 HHSIVQTRHYRSPEVILGLGWSYQCDLWSIGCILFELCTGEALFQTHDNLEHLAMMERAL 308
Query: 286 GPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
GPLP+HM ++ R AEKY RRG RL+WPEGA SRESI++V +L RL++++ +HVD++
Sbjct: 309 GPLPEHMTRKASRGAEKYFRRGCRLNWPEGANSRESIRAVKRLDRLKDMVSKHVDNTRSR 368
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPFF 372
LL GLL YDP++RLTA EAL HPFF
Sbjct: 369 FADLLYGLLAYDPSERLTANEALDHPFF 396
|
|
| UNIPROTKB|E1B9Q2 CLK2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 3.7e-80, P = 3.7e-80
Identities = 157/331 (47%), Positives = 222/331 (67%)
Query: 46 KIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG- 103
+I S +GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D
Sbjct: 164 EIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNK 223
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD
Sbjct: 224 NLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHD 283
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ HTDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++
Sbjct: 284 NKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDH 335
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
+ IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER
Sbjct: 336 EHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMER 395
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+LGP+P M+++ + +KY RGRLDW E ++ ++ K P + L + +H
Sbjct: 396 ILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEEHH-- 450
Query: 344 DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L L++ +L Y+P RLT EAL+HPFF R
Sbjct: 451 QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| UNIPROTKB|F1P919 CLK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 3.7e-80, P = 3.7e-80
Identities = 157/331 (47%), Positives = 222/331 (67%)
Query: 46 KIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG- 103
+I S +GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D
Sbjct: 276 EIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNK 335
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD
Sbjct: 336 NLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHD 395
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ HTDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++
Sbjct: 396 NKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDH 447
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
+ IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER
Sbjct: 448 EHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMER 507
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+LGP+P M+++ + +KY RGRLDW E ++ ++ K P + L + +H
Sbjct: 508 ILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEEHH-- 562
Query: 344 DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L L++ +L Y+P RLT EAL+HPFF R
Sbjct: 563 QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 593
|
|
| UNIPROTKB|B1AVT0 CLK2 "Dual-specificity protein kinase CLK2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 3.7e-80, P = 3.7e-80
Identities = 157/331 (47%), Positives = 222/331 (67%)
Query: 46 KIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG- 103
+I S +GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D
Sbjct: 162 EIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNK 221
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD
Sbjct: 222 NLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHD 281
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ HTDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++
Sbjct: 282 NKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDH 333
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
+ IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER
Sbjct: 334 EHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMER 393
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+LGP+P M+++ + +KY RGRLDW E ++ ++ K P + L + +H
Sbjct: 394 ILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEEHH-- 448
Query: 344 DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L L++ +L Y+P RLT EAL+HPFF R
Sbjct: 449 QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 479
|
|
| UNIPROTKB|P49760 CLK2 "Dual specificity protein kinase CLK2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 3.7e-80, P = 3.7e-80
Identities = 157/331 (47%), Positives = 222/331 (67%)
Query: 46 KIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG- 103
+I S +GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D
Sbjct: 164 EIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNK 223
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD
Sbjct: 224 NLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHD 283
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ HTDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++
Sbjct: 284 NKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDH 335
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
+ IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER
Sbjct: 336 EHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMER 395
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+LGP+P M+++ + +KY RGRLDW E ++ ++ K P + L + +H
Sbjct: 396 ILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEEHH-- 450
Query: 344 DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L L++ +L Y+P RLT EAL+HPFF R
Sbjct: 451 QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| UNIPROTKB|F1RLJ5 CLK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 3.7e-80, P = 3.7e-80
Identities = 157/331 (47%), Positives = 222/331 (67%)
Query: 46 KIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG- 103
+I S +GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D
Sbjct: 164 EIISTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNK 223
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD
Sbjct: 224 NLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHD 283
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ HTDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++
Sbjct: 284 NKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDH 335
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
+ IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER
Sbjct: 336 EHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMER 395
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+LGP+P M+++ + +KY RGRLDW E ++ ++ K P + L + +H
Sbjct: 396 ILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEEHH-- 450
Query: 344 DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L L++ +L Y+P RLT EAL+HPFF R
Sbjct: 451 QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| MGI|MGI:1098669 Clk2 "CDC-like kinase 2" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 804 (288.1 bits), Expect = 4.7e-80, P = 4.7e-80
Identities = 157/329 (47%), Positives = 221/329 (67%)
Query: 46 KIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG- 103
+I S +GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D
Sbjct: 163 EIVSTLGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKEAARLEINVLEKINEKDPDNK 222
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD
Sbjct: 223 NLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHD 282
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ HTDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++
Sbjct: 283 NKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDH 334
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
+ IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER
Sbjct: 335 EHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMER 394
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+LGP+P M+++ + +KY RGRLDW E ++ ++ K P + L + DH
Sbjct: 395 ILGPVPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEDHH-- 449
Query: 344 DLTHLLQGLLRYDPTDRLTAREALRHPFF 372
L L++ +L Y+P RLT EAL+HPFF
Sbjct: 450 QLFDLIENMLEYEPAKRLTLGEALQHPFF 478
|
|
| RGD|1359711 Clk2 "CDC-like kinase 2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 6.0e-80, P = 6.0e-80
Identities = 157/329 (47%), Positives = 221/329 (67%)
Query: 46 KIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG- 103
+I S +GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D
Sbjct: 164 EIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNK 223
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
N CVQ+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD
Sbjct: 224 NLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHD 283
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ HTDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++
Sbjct: 284 NKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDH 335
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
+ IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER
Sbjct: 336 EHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMER 395
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+LGP+P M+++ + +KY RGRLDW E ++ ++ K P + L + DH
Sbjct: 396 ILGPVPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEDHH-- 450
Query: 344 DLTHLLQGLLRYDPTDRLTAREALRHPFF 372
L L++ +L Y+P RLT EAL+HPFF
Sbjct: 451 QLFDLIENMLEYEPAKRLTLGEALQHPFF 479
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| P51567 | AFC2_ARATH | 2, ., 7, ., 1, 2, ., 1 | 0.8510 | 0.8627 | 0.7658 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| estExt_fgenesh4_pg.C_LG_XV0599 | hypothetical protein (428 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 379 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-70 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-64 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-57 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-54 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-49 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-48 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-45 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-42 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-37 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-37 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-35 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-35 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-35 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-35 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-34 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-34 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-34 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-33 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-32 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-31 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-30 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-30 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-29 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-28 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-28 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-28 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-27 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-27 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-26 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-25 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-25 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-24 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-24 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-24 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-24 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-23 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-23 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-23 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-22 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-22 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-21 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-19 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-17 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-16 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-16 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-14 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-14 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-12 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-12 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-12 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-11 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-04 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 0.001 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 0.001 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 0.003 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.003 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 221 bits (565), Expect = 1e-70
Identities = 98/332 (29%), Positives = 147/332 (44%), Gaps = 84/332 (25%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGG 103
+I K+GEG+FG+V D++ ++VAIK+++ IKK RE + EI++L++L KH
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPN-- 58
Query: 104 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
V++ + F+ + + +V E G L+D L+K D R RQ+L + ++H
Sbjct: 59 --IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLH 114
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
++H DLKPEN+LL + +K+ DFG
Sbjct: 115 SKGIVHRDLKPENILLDEDGH---------------------------VKLADFGLARQL 147
Query: 223 RPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
P + V T Y APEV+LG G+ DIWS+G IL EL TG+ F + L +
Sbjct: 148 DPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLL--EL 205
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+++ P P PE S E+
Sbjct: 206 FKKIGKPKPP------------------FPPPEWDISPEAK------------------- 228
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
L++ LL DP RLTA EAL+HPFF
Sbjct: 229 ------DLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 211 bits (538), Expect = 4e-64
Identities = 122/334 (36%), Positives = 184/334 (55%), Gaps = 33/334 (9%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN- 104
KI S +GEGTFG+V+E WDR+RKE A+KIVR + KY A IEI+ ++++ + D
Sbjct: 132 KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRF 191
Query: 105 RCVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKN---NYRSFPIDLVREIARQLLECIAF 160
++I+ +F + H+CIV K G L D++ K+ ++R +I Q + +
Sbjct: 192 PLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLA-----QIIFQTGVALDY 246
Query: 161 MH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
H +L ++HTDLKPEN+L+ +S+ V D ++ P P +++ D G
Sbjct: 247 FHTELHLMHTDLKPENILMETSD--TVVDPVTNRALP---------PDPCRVRICDLGGC 295
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
ER + IVSTRHYR+PEV+LGLGW Y D+WS+GCI+ EL TG+ L+ TH+NLEHL
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355
Query: 280 MMERVLGPLPQHMLKRVDRHAEK--YVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 337
+ME+ LG LP R + Y G+L + + + + ++ +I
Sbjct: 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQL---RPCTDPKHLARIARARPVREVIRDD 412
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
+ L L+ GLL YD RL AR+ HP+
Sbjct: 413 L------LCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 3e-57
Identities = 88/335 (26%), Positives = 146/335 (43%), Gaps = 84/335 (25%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKG 102
++ K+G G+FG V + + ++VA+KI++ K + A EI +L++L H
Sbjct: 2 ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPNI 60
Query: 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
V++ + F+ ++H+ +V E G L+D+L + D ++IA Q+L + ++
Sbjct: 61 ----VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYL 114
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STT 220
H +IH DLKPEN+LL + +K+ DFG +
Sbjct: 115 HSNGIIHRDLKPENILLDENGVVKI---------------------------ADFGLAKK 147
Query: 221 YERPDQNY--IVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277
+ + V T Y APEV+L G G+ D+WS+G IL EL TG+ F L+
Sbjct: 148 LLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQ 207
Query: 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 337
L ++ R+LGP D P+ ++ E
Sbjct: 208 LQLIRRILGPPL------------------EFDEPKWSSGSE------------------ 231
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+ L++ L DP+ R TA E L+HP+F
Sbjct: 232 ------EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 7e-54
Identities = 103/339 (30%), Positives = 160/339 (47%), Gaps = 69/339 (20%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--EAAMI--EIEVLQQLAKHDK 101
K+ ++G+GTFG V ++E E+VAIK + KK+ E M E++ L++L +H
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIK--KMKKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
V+++ F + + VFE + +LY ++ + F ++R I Q+L+ +A +
Sbjct: 60 ----IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--ST 219
H H DLKPEN LLVS + +K+ DFG
Sbjct: 116 HKHGFFHRDLKPEN-LLVSGPEV--------------------------VKIADFGLARE 148
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEH 277
RP VSTR YRAPE++L Y P DIW++GCI+ EL T LF ++
Sbjct: 149 IRSRPPYTDYVSTRWYRAPEILLRSTS-YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ 207
Query: 278 LAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGA--ASRESIKSVMKLPRL-QNL 333
L + VLG P Q DWPEG AS+ + P+
Sbjct: 208 LYKICSVLGTPTKQ-------------------DWPEGYKLASKLGF----RFPQFAPTS 244
Query: 334 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+ Q + +++ + L++ +LR+DP R TA +AL+HP+F
Sbjct: 245 LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 4e-49
Identities = 96/345 (27%), Positives = 155/345 (44%), Gaps = 90/345 (26%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGG 103
K+GEGT+G V + D++ E+VA+K +R GI A+ EI +L++L KH
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS---TALREISLLKEL-KHP--- 58
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
N V++ + + +VFE L +L +L++ I QLL +A+ H
Sbjct: 59 N-IVKLLDVIHTERKLYLVFEYCDMDLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYE 222
++H DLKP+N +L++ + + +K+ DFG + +
Sbjct: 117 HRILHRDLKPQN-ILINRDGV--------------------------LKLADFGLARAFG 149
Query: 223 RPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
P + Y V T YRAPE++LG ++ DIWSVGCI E+ TG+ LF ++ L
Sbjct: 150 IPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF 209
Query: 280 MMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH- 337
+ ++LG P + WP V KLP + +
Sbjct: 210 KIFQILGTPTEE-------------------SWPG----------VTKLPDYKPTFPKFP 240
Query: 338 ----------VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+D D LL +L+Y+P R++A+EAL+HP+F
Sbjct: 241 PKDLEKVLPRLDPEGID---LLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 5e-48
Identities = 99/332 (29%), Positives = 160/332 (48%), Gaps = 58/332 (17%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+GEG +G VL+C ++ E+VAIK + ++ A+ E++VL+QL +H+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHEN---- 61
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V ++ F + + +VFE + +L + L + P D VR QLL+ IA+ H
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY--ER 223
+IH D+KPEN +LVS +S +K+ DFG R
Sbjct: 121 IIHRDIKPEN-ILVS--------------------------ESGVLKLCDFGFARALRAR 153
Query: 224 PDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
P V+TR YRAPE+++G + P D+W++GCI+ EL GE LF +++ L +
Sbjct: 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+++ LGPLP + + R + +PE + ES++ R +
Sbjct: 214 IQKCLGPLPPSHQELFSSNP----RFAGVAFPE-PSQPESLER-----RYPGKV------ 257
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+ L+ LR DP +RLT E L+HP+F
Sbjct: 258 -SSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 3e-45
Identities = 99/339 (29%), Positives = 151/339 (44%), Gaps = 75/339 (22%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKG 102
K+GEGT+G V + D+ E+VAIK ++ GI K A+ EI++L++L H
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPK---TALREIKLLKEL-NHPN- 59
Query: 103 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
+++ + F ++ + +VFE + + LY ++ R P L++ QLL+ +AF H
Sbjct: 60 ---IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH 115
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
++H DLKPEN+L+ +K+ DFG
Sbjct: 116 SHGILHRDLKPENLLI---------------------------NTEGVLKLADFGLARSF 148
Query: 223 RPDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
V TR YRAPE++LG G++ P DIWSVGCI EL + LF ++ L
Sbjct: 149 GSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL 208
Query: 279 AMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGA----ASRESIKSVMKLPRLQNL 333
+ R LG P P+ WP+ + S +P
Sbjct: 209 FKIFRTLGTPDPEV-------------------WPKFTSLARNYKFSFPKKAGMP--LPK 247
Query: 334 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+ + A D LL +L YDP R+TA +AL HP+F
Sbjct: 248 LFPNASPQALD---LLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-43
Identities = 98/344 (28%), Positives = 151/344 (43%), Gaps = 76/344 (22%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKG 102
KI ++GEG G V + DRE E VA+K + R A+ EI+ LQ +H
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHP-- 59
Query: 103 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
V++ + F + + +V E + S L + LR + R P V+ R LL+ +A+MH
Sbjct: 60 --YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
++H DLKP N+L+ + +K+ D+ + + Y +
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ---------------- 160
Query: 221 YERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
V+TR YRAPE++ G + D+W+VGCI EL G LF ++E LA
Sbjct: 161 ---------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA 211
Query: 280 MMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM--- 335
++ R LG P + WP + LP +
Sbjct: 212 IVFRTLGTPNEE-------------------TWPG----------LTSLPDYNKITFPES 242
Query: 336 ------QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
+ ++ + LL+GLL YDP+ RL+A EALRHP+FT
Sbjct: 243 KPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-42
Identities = 73/218 (33%), Positives = 106/218 (48%), Gaps = 39/218 (17%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
GEG FG V D++ + VAIKI++ E + EIE+L++L H V++
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHP----NIVKL 56
Query: 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
F+ NH+ +V E G SL D L++N + D + I Q+LE + ++H +IH
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 228
DLKPEN+LL S +K+ DFG + D++
Sbjct: 116 RDLKPENILLDSDNGK--------------------------VKLADFGLSKLLTSDKSL 149
Query: 229 ---IVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVEL 262
IV T Y APEV+LG G ++ DIWS+G IL EL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 100/342 (29%), Positives = 169/342 (49%), Gaps = 73/342 (21%)
Query: 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIK---------IVRGIKKYREAAMIEIEVLQQ 95
+K+ SK+GEG++G V +C +RE ++VAIK +++ I A+ EI +L+Q
Sbjct: 4 EKL-SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI------ALREIRMLKQ 56
Query: 96 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 155
L KH V + F + + +VFE ++ + L KN R P L+++I Q L
Sbjct: 57 L-KH----PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTL 110
Query: 156 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 215
+ + F H IH D+KPEN+L+ K IK+ D
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILIT---------------------------KQGQIKLCD 143
Query: 216 FG-STTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 271
FG + P +Y V+TR YRAPE+++G + P D+W++GC+ EL TG+ L+
Sbjct: 144 FGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203
Query: 272 HENLEHLAMMERVLGPL-PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 330
+++ L ++ + LG L P+H +++ ++ + + PE +RE ++ K P +
Sbjct: 204 KSDVDQLYLIRKTLGDLIPRH--QQIFS-TNQFFKGLSIPEPE---TREPLE--SKFPNI 255
Query: 331 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+ + L+G L+ DPT+RL+ E L HP+F
Sbjct: 256 SSPALS-----------FLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 7e-37
Identities = 89/336 (26%), Positives = 143/336 (42%), Gaps = 71/336 (21%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMI-EIEVLQQLAKHDKGGN 104
GEG +G V + D VA+K VR GI + + EI +L+QL +
Sbjct: 8 GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP----LSTLREIALLKQLESFEH--P 61
Query: 105 RCVQIR----NWFDYRN-HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
V++ R + +VFE + L +L K P + ++++ RQLL +
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS- 218
F+H ++H DLKP+N+L+ S +K+ D+ + ++ F
Sbjct: 122 FLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA-------------------RIYSFEMA 162
Query: 219 -TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277
T+ +V T YRAPEV+L + P D+WSVGCI EL LF+ +
Sbjct: 163 LTS--------VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ 214
Query: 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRLQNLIMQ 336
L + V+G + +WP + R S S PR +
Sbjct: 215 LDKIFDVIGLPSEE------------------EWPRNVSLPRSSFPS--YTPRSFKSFVP 254
Query: 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+ D LL+ +L ++P R++A EAL+HP+F
Sbjct: 255 EICEEGLD---LLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 88/336 (26%), Positives = 150/336 (44%), Gaps = 66/336 (19%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA------AMIEIEVLQQLAKHDKG 102
K+GEGT+ V + D+E +VAIK ++ ++ A+ EI++LQ+L KH
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPN- 63
Query: 103 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
+ + + F ++++I +VFE + + L ++ + P D ++ L + ++H
Sbjct: 64 ---IIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYMLMTLRGLEYLH 119
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 221
++H DLKP N LL++S+ + +K+ DFG + ++
Sbjct: 120 SNWILHRDLKPNN-LLIASDGV--------------------------LKLADFGLARSF 152
Query: 222 ERPDQNYI--VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
P++ V TR YRAPE++ G + D+WSVGCI EL +++ L
Sbjct: 153 GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL 212
Query: 279 AMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 337
+ LG P + +WP G S P + Q
Sbjct: 213 GKIFEALGTPTEE-------------------NWP-GVTSLPDYVEFKPFPPTP--LKQI 250
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
++ D LLQ LL +P R+TAR+AL HP+F+
Sbjct: 251 FPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 100/335 (29%), Positives = 153/335 (45%), Gaps = 62/335 (18%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHDK 101
KI K+GEGTF +VL+ R+ + AIK K ++ + EI+ L++L+ H
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREIQALRRLSPH-- 57
Query: 102 GGNRCVQIRNWFDYR-NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
N I FD + + +VFE + +LY+ + K R P V+ QLL+ +
Sbjct: 58 -PNILRLIEVLFDRKTGRLALVFELMDMNLYELI-KGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS-- 218
MH + H D+KPEN+L+ K +K+ DFGS
Sbjct: 116 MHRNGIFHRDIKPENILI----------------------------KDDILKLADFGSCR 147
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEH 277
Y +P +STR YRAPE +L G + DIW+VGC+ E+ + LF L+
Sbjct: 148 GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207
Query: 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 337
+A + VLG +LK+ + ++P K L +L + +
Sbjct: 208 IAKIHDVLGTPDAEVLKKFRKSRHM-----NYNFPS--------KKGTGLRKL----LPN 250
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
D LL+ LL YDP +R+TA++ALRHP+F
Sbjct: 251 ASAEGLD---LLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 95/358 (26%), Positives = 149/358 (41%), Gaps = 102/358 (28%)
Query: 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHD 100
+KI ++GEGT+GQV + +++ E+VA+K +R ++ +E A+ EI++LQ+L +H
Sbjct: 2 EKIA-QIGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKL-RHP 58
Query: 101 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLY--------DF---LRKNNYRSFPIDLVRE 149
V++ IV K S+Y D L + F ++
Sbjct: 59 N----IVRL---------KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-FTESQIKC 104
Query: 150 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 209
+QLLE + ++H ++H D+K N+L+ + L
Sbjct: 105 YMKQLLEGLQYLHSNGILHRDIKGSNILI---------NNDGVL---------------- 139
Query: 210 AIKVIDFG-STTYE---RPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 264
K+ DFG + Y D V T YR PE++LG + D+WSVGCIL EL
Sbjct: 140 --KLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197
Query: 265 GEALFQTHENLEHLAMMERVLGP----------LPQHMLKRVDRHAEKYVRRGRLDWPEG 314
G+ +FQ LE L + + G + + Y RR
Sbjct: 198 GKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF--ENLKPKKPYKRR-------- 247
Query: 315 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
RE K ++ D SA D LL LL DP R++A +AL+H +F
Sbjct: 248 --LREFFKHLI-------------DPSALD---LLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 4e-35
Identities = 94/327 (28%), Positives = 158/327 (48%), Gaps = 53/327 (16%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
+GEG +G VL+C +E KE+VAIK + ++ +E + E+++L+ L + + V
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN-----IV 63
Query: 108 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
+++ F R + +VFE + ++ + L + P + VR QL++ I + H ++
Sbjct: 64 ELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIHWCHKNDIV 122
Query: 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 227
H D+KPEN+L+ ++ +K+ D+ F E + N
Sbjct: 123 HRDIKPENLLISHNDVLKLCDF-------------------------GFARNLSEGSNAN 157
Query: 228 YI--VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
Y V+TR YR+PE++LG + D+WSVGCIL EL G+ LF ++ L +++VL
Sbjct: 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
GPLP +K + R L +P ++ L R I+ G L
Sbjct: 218 GPLPAEQMKLFYSNP----RFHGLRFP-------AVNHPQSLERRYLGILS------GVL 260
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFF 372
L++ LL+ +PTDR + L HP F
Sbjct: 261 LDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 94/353 (26%), Positives = 151/353 (42%), Gaps = 81/353 (22%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQLAKHDKG 102
++ +G G +G V D+ VAIK I +A I EI++L+ L +H+
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHE-- 59
Query: 103 GNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR----Q 153
N + + + + N + IV E + + L+ ++ P L + + Q
Sbjct: 60 -N-IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS------PQPLTDDHIQYFLYQ 111
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 213
+L + ++H +IH DLKP N+L+ S+ +K+
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSN---------------------------CDLKI 144
Query: 214 IDFG----STTYERPDQN---YIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG 265
DFG E Y+V TR YRAPE++L +T DIWSVGCI EL T
Sbjct: 145 CDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
Query: 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 325
+ LF + ++ L ++ VLG + LK + +R +KS+
Sbjct: 204 KPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI----------------TSEKARNYLKSLP 247
Query: 326 KLPRLQNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
K P+ + L + A D LL+ +L +DP R+TA EAL HP+ + H
Sbjct: 248 KKPK-KPLSKLFPGASPEAID---LLEKMLVFDPKKRITADEALAHPYLAQLH 296
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 93/353 (26%), Positives = 143/353 (40%), Gaps = 94/353 (26%)
Query: 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 100
+K++ ++GEGT+G V D E+VA+K VR + R+ I EI +L L +H
Sbjct: 10 EKLN-RIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLREITLLLNL-RHP 66
Query: 101 KGGNRCVQIRNWF--DYRNHICIVFE----KLGSSLYDFLRKNNYRSFPIDLVREIARQL 154
V+++ + + I +V E L S L N F V+ + QL
Sbjct: 67 N----IVELKEVVVGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQL 117
Query: 155 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 214
L + ++H+ +IH DLK N+L + +K+
Sbjct: 118 LRGLQYLHENFIIHRDLKVSNLL---------------------------LTDKGCLKIA 150
Query: 215 DFG-STTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ 270
DFG + TY P + V T YRAPE++LG +T D+W+VGCIL EL + L
Sbjct: 151 DFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210
Query: 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 330
+E L ++ ++LG + + WP LP +
Sbjct: 211 GKSEIEQLDLIIQLLGTPNESI------------------WP----------GFSDLPLV 242
Query: 331 QNLIMQHVDHSAGDLTH-----------LLQGLLRYDPTDRLTAREALRHPFF 372
+ ++ +L H LL LL YDP R TA EAL +F
Sbjct: 243 GKFTLPKQPYN--NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 102/350 (29%), Positives = 151/350 (43%), Gaps = 76/350 (21%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEIEVLQQLA 97
+I K+G+G +G V + DR KE+VA+K + + +RE I LQ+L
Sbjct: 10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE-----IMFLQELG 64
Query: 98 KHDKGGNRCVQIRNWFDYRNH--ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 155
H V++ N N I +VFE + + L+ +R N R I QLL
Sbjct: 65 DHPN----IVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED---VHKRYIMYQLL 117
Query: 156 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 215
+ + ++H +IH DLKP N+LL +S +K+ D
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILL-------------------NSDCR--------VKLAD 150
Query: 216 FG--------STTYERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 266
FG E P V+TR YRAPE++LG T D+WSVGCIL E+ G+
Sbjct: 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
Query: 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 326
LF L L + V+GP ++ + P A +S+ S +
Sbjct: 211 PLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS-------------PFAATMLDSLPSRPR 257
Query: 327 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
P + ++ A D LL+ LL ++P RLTA EAL HP+ + H
Sbjct: 258 KPLDE--LLPKASDDALD---LLKKLLVFNPNKRLTAEEALEHPYVAQFH 302
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-33
Identities = 100/335 (29%), Positives = 156/335 (46%), Gaps = 69/335 (20%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGG 103
K+GEGT+G V + ++ E+VA+K +R G+ A+ EI +L++L H
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL-NHPN-- 60
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
V++ + N + +VFE L L F+ + P+ L++ QLL+ +AF H
Sbjct: 61 --IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYE 222
++H DLKP+N LL+++E AIK+ DFG + +
Sbjct: 119 HRVLHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFG 151
Query: 223 RPDQNYI--VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
P + Y V T YRAPE++LG ++ DIWS+GCI E+ T ALF ++ L
Sbjct: 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQH 337
+ R LG P ++ WP + + S K R Q+ ++
Sbjct: 212 RIFRTLGT-PDEVV-----------------WPGVTSLPDYKPSFPKWAR-QDFSKVVPP 252
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+D D LL +L YDP R++A+ AL HPFF
Sbjct: 253 LDEDGRD---LLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-32
Identities = 90/338 (26%), Positives = 149/338 (44%), Gaps = 69/338 (20%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGN 104
+++ EGT+G V D++ E+VA+K ++ ++K +E ++ EI +L +L +H
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLK-MEKEKEGFPITSLREINILLKL-QHPN--- 65
Query: 105 RCVQIRNWF--DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
V ++ + I +V E + L + + + F V+ + QLL +A +H
Sbjct: 66 -IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCLMLQLLSGVAHLH 123
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 221
D ++H DLK N+L + +K+ DFG + Y
Sbjct: 124 DNWILHRDLKTSNLL---------------------------LNNRGILKICDFGLAREY 156
Query: 222 ERPDQNY--IVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
P + Y +V T YRAPE++LG ++ D+WSVGCI EL T + LF ++ L
Sbjct: 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
+ ++LG P EK WP G + K N + +
Sbjct: 217 NKIFKLLG-TPT----------EK-------IWP-GFSELPGAKKKTFTKYPYNQLRKKF 257
Query: 339 DHSAGDLTH----LLQGLLRYDPTDRLTAREALRHPFF 372
L+ LL LL YDP R++A +AL+HP+F
Sbjct: 258 PA--LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 8e-32
Identities = 89/328 (27%), Positives = 150/328 (45%), Gaps = 55/328 (16%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
K+GEGT+ V + +R E+VA+K + + A+ EI ++++L KH+ V
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHEN----IV 61
Query: 108 QIRNWFDYRNHICIVFEKLGSSLYDFLRKN-NYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ + N + +VFE + L ++ + + + V+ QLL+ IAF H+ +
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
+H DLKP+N+L+ +K+ D+ + ++ I V F +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFG--------------LARAFGIPVNTFSNE------- 160
Query: 227 NYIVSTRHYRAPEVILGLGWTYPC--DIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
V T YRAP+V+LG TY DIWSVGCI+ E+ TG LF N + L + R+
Sbjct: 161 ---VVTLWYRAPDVLLG-SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI 216
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
+G + + + E + +P LQ L H+
Sbjct: 217 MGTPTESTWPGISQLPEY-----KPTFPRYPPQ-----------DLQQLF----PHADPL 256
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPFF 372
LL LL+ +P R++A +AL+HP+F
Sbjct: 257 GIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 4e-31
Identities = 87/344 (25%), Positives = 137/344 (39%), Gaps = 71/344 (20%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDK 101
+I K+GEG+FG+V DR+ VA+K++ K E + EI++L L
Sbjct: 3 RILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP-- 57
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR-SFPIDLVREIARQLLECIA 159
V++ ++F + +V E + G SL D L+K + I Q+L +
Sbjct: 58 --PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 160 FMHDLCMIHTDLKPENVLLVSSEY-IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
++H +IH D+KPEN+LL +K+ D+ A + D GS
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDF------------------GLAKLLPDPGS 157
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPC---DIWSVGCILVELCTGEALFQTHENL 275
T+ + V T Y APEV+LGL Y DIWS+G L EL TG F+ +N
Sbjct: 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217
Query: 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335
+ +++ LP L L
Sbjct: 218 SATSQTLKIILELPTPSLA------------------------------------SPLSP 241
Query: 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 379
+ + + + LL+ LL DP +RL++ L H L+
Sbjct: 242 SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285
|
Length = 384 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 98/336 (29%), Positives = 161/336 (47%), Gaps = 70/336 (20%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRC 106
+GEG++G V++C +E ++VAIK K ++ AM EI +L+QL +H+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHEN----L 62
Query: 107 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDL----VREIARQLLECIAFMH 162
V + F + + +VFE + ++ D L K +P L VR+ Q+L I F H
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEK-----YPNGLDESRVRKYLFQILRGIEFCH 117
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 221
+IH D+KPEN+L VS +S +K+ DFG + T
Sbjct: 118 SHNIIHRDIKPENIL-VS--------------------------QSGVVKLCDFGFARTL 150
Query: 222 ERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
P + Y V+TR YRAPE+++G + DIW+VGC++ E+ TGE LF +++ L
Sbjct: 151 AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL 210
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQ 336
+ + LG L + RH E + + + + M+LP ++ + + +
Sbjct: 211 YHIIKCLGNL-------IPRHQEIF-------------QKNPLFAGMRLPEVKEIEPLEK 250
Query: 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+G + L + LR DP DR ++ + L H FF
Sbjct: 251 RFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 65/258 (25%), Positives = 111/258 (43%), Gaps = 54/258 (20%)
Query: 52 GEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108
G G+FG V D++ E++A+K + ++ EA EI +L L +H V+
Sbjct: 9 GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QH----PNIVR 63
Query: 109 IR--NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
+ +N + I E + G SL L+K + P ++R+ RQ+LE +A++H
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
++H D+K N+L+ S +K+ DFG D
Sbjct: 122 IVHRDIKGANILVDSD---------------------------GVVKLADFGCAK-RLGD 153
Query: 226 QNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
T R APEVI G + DIWS+GC ++E+ TG+ + E +A
Sbjct: 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW--SELGNPMA 211
Query: 280 MMERVLG-----PLPQHM 292
+ ++ +P+H+
Sbjct: 212 ALYKIGSSGEPPEIPEHL 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 81/327 (24%), Positives = 134/327 (40%), Gaps = 83/327 (25%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
K+G+G FG+V + + + VAIK+++ K+ +E + EI++L++ KH N V
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KH---PN-IV 60
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+ + ++ + IV E G SL D L K+ ++ + + ++LL+ + ++H +
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYE-RP 224
IH D+K N+LL S +K+IDFG S
Sbjct: 120 IHRDIKAANILLTS---------------------------DGEVKLIDFGLSAQLSDTK 152
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
+N +V T ++ APEVI G + Y DIWS+G +EL G+ + E A+ +
Sbjct: 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY--SELPPMKALFKIA 210
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
P L PE S E
Sbjct: 211 TNGPP------------------GLRNPE-KWSDE------------------------- 226
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPF 371
L+ L+ +P R TA + L+HPF
Sbjct: 227 FKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-30
Identities = 79/333 (23%), Positives = 130/333 (39%), Gaps = 72/333 (21%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNRC 106
+GEG+F V+ ++E + AIKI+ + +E IE EVL +L H G
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH-PG---I 64
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
+++ F ++ V E L ++RK Y S R A ++L + ++H
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+IH DLKPEN+LL +IK+ D+ ++ +SS S + E+
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS------PESNKGDATNIDSQIEKNR 176
Query: 226 QN--YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
+ V T Y +PE++ D+W++GCI+ ++ TG+ F+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR------------- 223
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
G +++ E +P P ++LI
Sbjct: 224 --GSNEYLTFQKI-LKLE-------YSFPPNFP-----------PDAKDLI--------- 253
Query: 344 DLTHLLQGLLRYDPTDRLTA----REALRHPFF 372
+ LL DP DRL E HPFF
Sbjct: 254 ------EKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 95/336 (28%), Positives = 150/336 (44%), Gaps = 71/336 (21%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGG 103
K+GEGT+G V + D+ E+VA+K +R G+ A+ EI +L++L H
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP---STAIREISLLKEL-NHPN-- 59
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
V++ + N + +VFE L L ++ + L++ QLL+ IA+ H
Sbjct: 60 --IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYE 222
++H DLKP+N+L+ + A+K+ DFG + +
Sbjct: 118 HRVLHRDLKPQNLLI---------------------------DREGALKLADFGLARAFG 150
Query: 223 RPDQNYI--VSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHL 278
P + Y V T YRAPE++LG Y P DIWS+GCI E+ LF ++ L
Sbjct: 151 VPVRTYTHEVVTLWYRAPEILLG-SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL 209
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQ 336
+ R LG + + WP G S K Q+L ++
Sbjct: 210 FRIFRTLGTPDEDV------------------WP-GVTSLPDYKPTFPKWARQDLSKVVP 250
Query: 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
++D D LL +L YDP R++A+ AL+HP+F
Sbjct: 251 NLDEDGLD---LLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 96/343 (27%), Positives = 155/343 (45%), Gaps = 68/343 (19%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMI--EIEVLQQLAKHDKG 102
KI +G+G++G V D E VAIK + + ++ +A I EI++L+ L D
Sbjct: 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-- 60
Query: 103 GNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE----IAR 152
V+I++ ++++ I +VFE + S L+ ++ N+ DL E
Sbjct: 61 ---IVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKAND------DLTPEHHQFFLY 110
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
QLL + ++H + H DLKP+N+L + +K+ D+ + D+ +AI
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP--------TAIF 162
Query: 213 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQ 270
D+ V+TR YRAPE+ +T DIWS+GCI E+ TG+ LF
Sbjct: 163 WTDY-------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209
Query: 271 THENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 329
+ L ++ +LG + RV + A +Y+ R P + K P
Sbjct: 210 GKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP--------VPFSQKFPN 261
Query: 330 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
L ++ LL+ LL +DP DR TA EAL P+F
Sbjct: 262 ADPLALR-----------LLERLLAFDPKDRPTAEEALADPYF 293
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 97/342 (28%), Positives = 150/342 (43%), Gaps = 74/342 (21%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGG 103
K+GEGT+G+V + D+ ++VA+K R GI A+ EI +LQ L+
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPP---TALREISLLQMLS-ESIYI 63
Query: 104 NRCVQIRNWFDYRNHICI--VFEKLGSSLYDFL---RKNNYRSFPIDLVREIARQLLECI 158
R + + + + + VFE L S L F+ + R P ++ QLL+ +
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 217
A H ++H DLKP+N+L+ + + +K+ D G
Sbjct: 124 AHCHKHGVMHRDLKPQNLLVDKQKGL--------------------------LKIADLGL 157
Query: 218 STTYERPDQNYI--VSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHE 273
+ P ++Y + T YRAPEV+LG Y P DIWSVGCI E+ + LF
Sbjct: 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLG-STHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216
Query: 274 NLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 332
L+ L + ++LG P Q WP + R+ + P Q+
Sbjct: 217 ELQQLLHIFKLLGTPTEQ-------------------VWPGVSKLRDWHEFPQWKP--QD 255
Query: 333 L--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
L + + D LLQ +LRYDP R++A+ AL HP+F
Sbjct: 256 LSRAVPDLSPEGLD---LLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 95/335 (28%), Positives = 159/335 (47%), Gaps = 68/335 (20%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGG 103
K+GEGT+G V + +++ ++VA+K +R G+ A+ EI +L++L +H
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP---STAIREISLLKEL-QHPN-- 60
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSL---YDFLRKNNYRSFPIDLVREIARQLLECIAF 160
V +++ + + ++FE L L D L K Y +LV+ Q+L+ I F
Sbjct: 61 --IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY--MDAELVKSYLYQILQGILF 116
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
H ++H DLKP+N+L+ + IK+ D+ + ++ I V + T
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFG--------------LARAFGIPVRVY---T 159
Query: 221 YERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
+E V T YRAPEV+LG ++ P DIWS+G I E+ T + LF ++ L
Sbjct: 160 HE-------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF 212
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQH 337
+ R+LG P WP G S K+ + +L +++
Sbjct: 213 RIFRILGT-PTE-----------------DVWP-GVTSLPDYKNTFPKWKKGSLRSAVKN 253
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+D D LL+ +L YDP R++A++AL HP+F
Sbjct: 254 LDEDGLD---LLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 85/333 (25%), Positives = 141/333 (42%), Gaps = 59/333 (17%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD---- 100
+++G G +G V + D VA+K VR ++ + + E+ +L++L D
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVR-VQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 101 -KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
+ + C R D + +VFE + L +L K P + ++++ RQ L +
Sbjct: 65 VRLMDVCATSRT--DRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
F+H C++H DLKPEN+L+ S +K+ D+ + Y +M +
Sbjct: 123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLA------RIYSCQMALTP---------- 166
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
+V T YRAPEV+L + P D+WSVGCI E+ + LF + + L
Sbjct: 167 ---------VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 217
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339
+ ++G P+ DWP S PR + V
Sbjct: 218 KIFDLIGLPPED------------------DWPRDVTLPRGAFS----PRGPRPVQSVVP 255
Query: 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
LL +L ++P R++A AL+HPFF
Sbjct: 256 EIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 93/357 (26%), Positives = 153/357 (42%), Gaps = 73/357 (20%)
Query: 46 KIHSKMGEGTFGQVLECW--DRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKH 99
+I +G GT+G+V + + + + AIK +G K+ +A EI +L++L KH
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KH 61
Query: 100 DKGGNRCVQIRNWF--DYRNHICIVFEKLGSSLYDFL------RKNNYRSFPIDLVREIA 151
+ V + F + ++F+ + +D R+ S P +V+ +
Sbjct: 62 EN----VVSLVEVFLEHADKSVYLLFD---YAEHDLWQIIKFHRQAKRVSIPPSMVKSLL 114
Query: 152 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 211
Q+L + ++H ++H DLKP N+L++ P+ +
Sbjct: 115 WQILNGVHYLHSNWVLHRDLKPANILVMGEG-----------------------PERGVV 151
Query: 212 KVIDFG-STTYERP-----DQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCT 264
K+ D G + + P D + +V T YRAPE++LG +T DIW++GCI EL T
Sbjct: 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
Query: 265 GEALFQTHE------NLEHLAMMER---VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGA 315
E +F+ E N +ER VLG + + + E Y D+
Sbjct: 212 LEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPE-Y-DTLMKDFKTKT 269
Query: 316 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
S+ M+ H + LL+ LL YDPT R+TA EAL HP+F
Sbjct: 270 YPSNSLAKWMEK---------HKKPDSQGF-DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 3e-27
Identities = 81/329 (24%), Positives = 134/329 (40%), Gaps = 88/329 (26%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRCV 107
G+G+FG+VL ++ ++ A+K+++ I K +E E +L ++ H V
Sbjct: 2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHP----FIV 56
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ F + +V E G L+ L K F + R A +++ + ++H L +
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
I+ DLKPEN+LL + +IK+ D+ A ++ GS T
Sbjct: 115 IYRDLKPENILLDADGHIKLTDF------------------GLAKELSSEGSRTNT---- 152
Query: 227 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 286
T Y APEV+LG G+ D WS+G +L E+ TG+ F + E + E++L
Sbjct: 153 --FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKIL- 206
Query: 287 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346
+ L +PE + +
Sbjct: 207 -------------------KDPLRFPEFLSP--------------------------EAR 221
Query: 347 HLLQGLLRYDPTDRLTAREA---LRHPFF 372
L+ GLL+ DPT RL + A HPFF
Sbjct: 222 DLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 8e-27
Identities = 81/328 (24%), Positives = 129/328 (39%), Gaps = 78/328 (23%)
Query: 54 GTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGNRCVQI 109
G +G+V + ++ AIK+++ R+ + E ++L Q V++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-----SPYVVKL 58
Query: 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
F + ++ +V E L G L L N S D+ R +++ + ++H +IH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 228
DLKP+N+L+ S+ ++K+ D+ L S + + + +
Sbjct: 117 RDLKPDNILIDSNGHLKLTDF--GL------SKVGLVRRQINLNDDEKEDKR-------- 160
Query: 229 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 288
IV T Y APEVILG G + D WS+GCIL E G F H E +
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF--HGETP-----EEIF--- 210
Query: 289 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348
Q++L G+++WPE V +LI
Sbjct: 211 -QNILN------------GKIEWPED---------VEVSDEAIDLI-------------- 234
Query: 349 LQGLLRYDPTDRLTAR---EALRHPFFT 373
LL DP RL A+ E HPFF
Sbjct: 235 -SKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-27
Identities = 93/344 (27%), Positives = 148/344 (43%), Gaps = 76/344 (22%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGN 104
++GEGT+GQV + D++ E+VA+K VR + +E A+ EI++L+QL H N
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVR-LDNEKEGFPITAIREIKILRQL-NHRNIVN 70
Query: 105 RC---VQIRNWFDYRNH---ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
++ D++ +VFE + L L ++ F D ++ +QLLE +
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-ESGLVHFSEDHIKSFMKQLLEGL 129
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
+ H +H D+K N+LL + IK+ D+ + + S
Sbjct: 130 NYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES------------------ 171
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPC-DIWSVGCILVELCTGEALFQTHENLEH 277
RP N ++ T YR PE++LG P D+WS GCIL EL T + +FQ ++ L
Sbjct: 172 ----RPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226
Query: 278 LAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--- 333
L ++ R+ G P P WP+ V+KLP +
Sbjct: 227 LELISRLCGSPCPA-------------------VWPD----------VIKLPYFNTMKPK 257
Query: 334 ------IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
+ + LL +L DP+ R TA EAL P+
Sbjct: 258 KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 88/349 (25%), Positives = 148/349 (42%), Gaps = 73/349 (20%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLAKHDKG 102
K +G G +G V D + VAIK I A + E+++L+ KHD
Sbjct: 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDN- 65
Query: 103 GNRCVQIRNWF----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
+ IR+ + +V + + S L+ + + + + +R QLL +
Sbjct: 66 ---IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRGL 120
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVID 215
++H +IH DLKP N+L+ +++ D+ + +P + YF M
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF--M---------- 168
Query: 216 FGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHEN 274
T Y V+TR YRAPE++L L +T D+WSVGCI E+ LF
Sbjct: 169 ---TEY--------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217
Query: 275 LEHLAMMERVLGPLPQHMLK-----RVDRHAEKYVRRGRLDWPE--GAASRESIKSVMKL 327
+ L ++ VLG + +L RV ++ + R+ + W + AS E++
Sbjct: 218 VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALD----- 272
Query: 328 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
LL +L++DP +R+T +AL+HPF + H
Sbjct: 273 --------------------LLSQMLQFDPEERITVEQALQHPFLAQYH 301
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 91/333 (27%), Positives = 154/333 (46%), Gaps = 64/333 (19%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGNR 105
K+GEGT+G V + DR E +A+K +R +++ E A+ EI +L+++ +H
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEM-QHGN---- 62
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V++++ + +VFE L L + + + L++ Q+L IA+ H
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR 122
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP 224
++H DLKP+N+L+ ++A+K+ DFG + + P
Sbjct: 123 VLHRDLKPQNLLIDRR--------------------------TNALKLADFGLARAFGIP 156
Query: 225 DQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
+ + V T YRAPE++LG ++ P DIWSVGCI E+ + LF ++ L +
Sbjct: 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQHVD 339
R+LG + WP G S KS ++L ++ ++
Sbjct: 217 FRILGTPNEET------------------WP-GVTSLPDYKSAFPKWPPKDLATVVPTLE 257
Query: 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+ D LL +LR DP+ R+TAR AL H +F
Sbjct: 258 PAGVD---LLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 97/348 (27%), Positives = 152/348 (43%), Gaps = 86/348 (24%)
Query: 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAK 98
+K+ K+GEGT+G V + +RE E+VA+K VR G+ +A+ EI +L++L K
Sbjct: 3 EKL-EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKEL-K 57
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
H V++ + + +VFE L + N P ++V+ QLL+ +
Sbjct: 58 H----KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP-EIVKSFMFQLLKGL 112
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 217
AF H ++H DLKP+N+L+ K+ +K+ DFG
Sbjct: 113 AFCHSHNVLHRDLKPQNLLI---------------------------NKNGELKLADFGL 145
Query: 218 STTYERPDQNYI--VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT-GEALFQTHE 273
+ + P + Y V T YR P+V+ G ++ D+WS GCI EL G LF ++
Sbjct: 146 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205
Query: 274 NLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 332
+ L + R+LG P + WP V KLP +
Sbjct: 206 VDDQLKRIFRLLGTPTEE-------------------SWP----------GVSKLPDYKP 236
Query: 333 LIMQHVDHSAGDLT--------HLLQGLLRYDPTDRLTAREALRHPFF 372
M S ++ LLQ LL +P R++A EAL+HP+F
Sbjct: 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 84/345 (24%), Positives = 143/345 (41%), Gaps = 62/345 (17%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLA---- 97
+I K+GEGTFG+V + + +VA+K + + ++ A+ EI++L++L
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKIL-MHNEKDGFPITALREIKILKKLKHPNV 69
Query: 98 ---------KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVR 148
+ DK + R + +V + L L + + ++
Sbjct: 70 VPLIDMAVERPDKSKRK----------RGSVYMVTPYMDHDLSGLLENPSVKLTESQ-IK 118
Query: 149 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 208
QLLE I ++H+ ++H D+K N+L+ + +K+ D+ L P D PK
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADF--GLARPYDGP--PPNPKG 174
Query: 209 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEA 267
G R N +V TR YR PE++LG +T DIW +GC+ E+ T
Sbjct: 175 --------GGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225
Query: 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 327
+ Q +++ L ++ ++ G + WP G S + V
Sbjct: 226 ILQGKSDIDQLHLIFKLCGTPTEE------------------TWP-GWRSLPGCEGVHSF 266
Query: 328 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+ + + LL LL DP RLTA +AL HP+F
Sbjct: 267 TNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 82/357 (22%), Positives = 149/357 (41%), Gaps = 82/357 (22%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYRE---------AAMIEIEVLQQ 95
+GEGT+G+V + +D ++VAIK V+ + K R+ + E++++ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 96 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 155
+ + G V + F I +V + + S L + + V+ I Q+L
Sbjct: 77 IKHENIMGLVDVYVEGDF-----INLVMDIMASDLKKVV--DRKIRLTESQVKCILLQIL 129
Query: 156 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIK 212
+ +H +H DL P N+ + S K+ D+ + + P + K +
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 213 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQT 271
+ T + V T YRAPE+++G + + D+WSVGCI EL TG+ LF
Sbjct: 190 M------TSK-------VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236
Query: 272 HENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEG----------AASRES 320
++ L + +LG P +WP+ +
Sbjct: 237 ENEIDQLGRIFELLGTPNED-------------------NWPQAKKLPLYTEFTPRKPKD 277
Query: 321 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377
+K++ +++ D LLQ LL+ +P +R++A+EAL+H +F D L
Sbjct: 278 LKTIFP-------------NASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321
|
Length = 335 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 91/338 (26%), Positives = 149/338 (44%), Gaps = 67/338 (19%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--------EAAMIEIEVLQQLAKHDK- 101
+G G +G V DR VAIK K YR + A E+ +L+ + KH+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLKHM-KHENV 76
Query: 102 -GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
G D + +V +G+ L ++ + D ++ + Q+L+ + +
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKY 133
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+H +IH DLKP N L V+ + +K++DFG
Sbjct: 134 IHAAGIIHRDLKPGN-LAVNED--------------------------CELKILDFGLAR 166
Query: 221 YERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
+ V TR YRAPEVIL + +T DIWSVGCI+ E+ TG+ LF+ H++L+ L
Sbjct: 167 QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLM 226
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339
+ +V G + ++++ S ++ V KLPR + + +
Sbjct: 227 EIMKVTGTPSKEFVQKLQ-------------------SEDAKNYVKKLPRFRKKDFRSLL 267
Query: 340 HSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+A L ++L+ +L D R+TA EAL HP+F H
Sbjct: 268 PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 85/335 (25%), Positives = 144/335 (42%), Gaps = 62/335 (18%)
Query: 49 SKMGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGG 103
+++GEG +G+V + D + VA+K VR ++ E + + E+ VL+ L +
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 104 -----NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
+ C R D + +VFE + L +L K P + ++++ QLL +
Sbjct: 66 VVRLFDVCTVSRT--DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
F+H ++H DLKP+N+L+ SS IK+ D+ + ++ F
Sbjct: 124 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA-------------------RIYSFQM 164
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
+V T YRAPEV+L + P D+WSVGCI E+ + LF+ +++ L
Sbjct: 165 AL------TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 218
Query: 279 AMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 337
+ V+G P + DWP A ++ +
Sbjct: 219 GKILDVIGLPGEE-------------------DWPRDVALPRQAFHSKSAQPIEKFV-TD 258
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+D D LL L ++P R++A AL HP+F
Sbjct: 259 IDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 95/338 (28%), Positives = 142/338 (42%), Gaps = 76/338 (22%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIK-IVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCV 107
+G G +G V D+ E VAIK + R + + + A E+ +L+ + + G V
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 108 QIRNWFDYRNHICIVFEKLGSSLYDF----------LRKNNYRSFPIDLVREIARQLLEC 157
G DF L+K D V+ + Q+L
Sbjct: 83 F-------------TSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+ ++H +IH DLKP N L V+ + +K++DFG
Sbjct: 130 LKYIHSAGIIHRDLKPGN-LAVNED--------------------------CELKILDFG 162
Query: 218 STTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276
+ + V TR YRAPEVIL + + DIWSVGCI+ E+ TG+ LF+ + L+
Sbjct: 163 LARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222
Query: 277 HLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLI 334
L + +V G P P+ + K D+ A+ Y IKS+ K PR + +
Sbjct: 223 QLTQILKVTGVPGPEFVQKLEDKAAKSY-----------------IKSLPKYPRKDFSTL 265
Query: 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
A D LL+ +L D RLTA EAL HP+F
Sbjct: 266 FPKASPQAVD---LLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 79/332 (23%), Positives = 137/332 (41%), Gaps = 93/332 (28%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108
G+G+FG+V + ++ +K + +K RE A+ E+++L++L H N ++
Sbjct: 9 GKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP---N-IIK 63
Query: 109 IRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
F+ + +CIV E G L + +K + FP + + + QL + ++H
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP 224
++H D+KP+N+ L +S + +K+ DFG S
Sbjct: 124 ILHRDIKPQNIFL-TSNGL--------------------------VKLGDFGISKVLSST 156
Query: 225 DQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM-- 280
+V T +Y +PE+ + Y DIWS+GC+L ELCT + F+ ENL LA+
Sbjct: 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE-GENLLELALKI 215
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
++ P+P Y S E L+NL+
Sbjct: 216 LKGQYPPIPSQ-----------Y-------------SSE----------LRNLV------ 235
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
LL+ DP +R + + L+ PF
Sbjct: 236 ---------SSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 84/338 (24%), Positives = 145/338 (42%), Gaps = 72/338 (21%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQLAKHDKGGNR 105
+G G FG V D+ + VAIK + +K + + E+++L+ L +H+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKI--MKPFSTPVLAKRTYRELKLLKHL-RHEN---- 70
Query: 106 CVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+ + + F I V E LG+ L+ L R ++ Q+L + ++H
Sbjct: 71 IISLSDIFISPLEDIYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
++H DLKP N+L+ ++ +K+ DFG + P
Sbjct: 128 GVVHRDLKPSNILI---------------------------NENCDLKICDFGLARIQDP 160
Query: 225 DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
VSTR+YRAPE++L + DIWS GCI E+ G+ LF +++ +++
Sbjct: 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR-----LQNLIMQHV 338
+LG P ++ + S +++ V LP+ ++
Sbjct: 221 LLGTPPDDVINTI-------------------CSENTLRFVQSLPKREPVPFSEKF-KNA 260
Query: 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
D SA D LL+ +L +DP R++A EAL HP+ H
Sbjct: 261 DPSAID---LLEKMLVFDPQKRISAAEALAHPYLAPYH 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 5e-24
Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 41/227 (18%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA---AMIEIEVLQQLAKHDKG 102
++ +G G FG V + + E + VAIK + K EA M EI++L+ L KH
Sbjct: 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KH--- 58
Query: 103 GNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
V+ + + + I+ E SL ++K FP LV Q+L+ +A++
Sbjct: 59 -PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYL 115
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H+ +IH D+K N+L K +K+ DFG T
Sbjct: 116 HEQGVIHRDIKAANIL---------------------------TTKDGVVKLADFGVATK 148
Query: 222 ---ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265
D +V T ++ APEVI G + DIWS+GC ++EL TG
Sbjct: 149 LNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 51/270 (18%)
Query: 114 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 173
D I +V E + S L+ + + D V+ Q+L + ++H ++H D+KP
Sbjct: 74 DPFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKP 131
Query: 174 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI---- 229
N LLV+S + +K+ DFG E PD++
Sbjct: 132 GN-LLVNSNCV--------------------------LKICDFGLARVEEPDESKHMTQE 164
Query: 230 VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 288
V T++YRAPE+++G +T DIWSVGCI EL LFQ ++ L ++ +LG
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224
Query: 289 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348
++ A ++ R K P L L + + HL
Sbjct: 225 SLEAMRSACEGARAHILR----------------GPHKPPSLPVLYT-LSSQATHEAVHL 267
Query: 349 LQGLLRYDPTDRLTAREALRHPFFTRDHLR 378
L +L +DP R++A +AL HP+ LR
Sbjct: 268 LCRMLVFDPDKRISAADALAHPYLDEGRLR 297
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-23
Identities = 85/348 (24%), Positives = 150/348 (43%), Gaps = 83/348 (23%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQLAKHD 100
S +G G +G V +D + VA+K I+ + YRE +L KH
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------RLLKHM 73
Query: 101 KGGN-----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 155
K N + N + +V +G+ L + ++ + D V+ + Q+L
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQIL 130
Query: 156 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 215
+ ++H +IH DLKP N+ + + +K++D
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAV---------------------------NEDCELKILD 163
Query: 216 FGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN 274
FG + + V+TR YRAPE++L + + DIWSVGCI+ EL TG LF ++
Sbjct: 164 FGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223
Query: 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL--QN 332
++ L ++ R++G +LK++ ++R I+S+ ++P++ N
Sbjct: 224 IDQLKLILRLVGTPGAELLKKISSE----------------SARNYIQSLTQMPKMNFAN 267
Query: 333 LIM----QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+ + VD LL+ +L D R+TA +AL H +F + H
Sbjct: 268 VFIGANPLAVD--------LLEKMLVLDSDKRITAAQALAHAYFAQYH 307
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 52/259 (20%)
Query: 50 KMGEGTFGQVLECWDRERKEMVA---IKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRC 106
K+G GTFG+V + + E++A I+I K + E++VL+ L KH
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHP------ 59
Query: 107 VQIRNWFDY------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
N Y R + I E G +L + L + R ++R QLLE +A
Sbjct: 60 ----NLVKYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLA 113
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
++H ++H D+KP N+ L + IK+ D+ + + +T
Sbjct: 114 YLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCA-------------------VKLKNNTT 154
Query: 220 TYERPDQNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTG----EALFQTH 272
T Q+ T Y APEVI G G DIWS+GC+++E+ TG L
Sbjct: 155 TMGEEVQSL-AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF 213
Query: 273 ENLEHLAMMERVLGPLPQH 291
+ + H+ + P+P
Sbjct: 214 QIMFHVGAGHK--PPIPDS 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 88/346 (25%), Positives = 141/346 (40%), Gaps = 85/346 (24%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111
G G +GQV +D + VAIK K R Q A H K R +++
Sbjct: 24 GSGAYGQVCSAFDTKTGRKVAIK-----KLSRPF---------QSAIHAKRTYRELRLLK 69
Query: 112 WFDYRNHIC------------------IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 153
D+ N I +V +G+ L + ++ + D ++ + Q
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC---QKLSDDHIQFLVYQ 126
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 213
+L + ++H +IH DLKP N+ + +K+ D+ + HT
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT------------------ 168
Query: 214 IDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 272
D T Y V+TR YRAPE++L + + DIWSVGCI+ EL TG+ LF
Sbjct: 169 -DDEMTGY--------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219
Query: 273 ENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 331
++++ L + ++G P + + K A Y++ LP++
Sbjct: 220 DHIDQLKRIMNLVGTPDEELLQKISSESARNYIQ--------------------SLPQMP 259
Query: 332 NLIMQHVDHSAG-DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+ V A LL+ +L DP R+TA EAL HP+ H
Sbjct: 260 KKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 4e-23
Identities = 82/349 (23%), Positives = 141/349 (40%), Gaps = 81/349 (23%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHD---- 100
+K+G+GTFG+V + ++ K++VA+K V ++ +E A+ EI++LQ L KH+
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVL-MENEKEGFPITALREIKILQLL-KHENVVN 75
Query: 101 ---------KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA 151
NR Y+ +VFE L L N F + ++++
Sbjct: 76 LIEICRTKATPYNR---------YKGSFYLVFEFCEHDLAGLL-SNKNVKFTLSEIKKVM 125
Query: 152 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 211
+ LL + ++H ++H D+K N+L+ K +
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILIT---------------------------KDGIL 158
Query: 212 KVIDFG-------STTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELC 263
K+ DFG S + V T YR PE++LG + P D+W GCI+ E+
Sbjct: 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218
Query: 264 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 323
T + Q + L ++ ++ G + + VD K +++ P+G + +
Sbjct: 219 TRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD----KLELFKKMELPQGQKRKVKERL 274
Query: 324 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+ L L+ LL DP R+ A AL H FF
Sbjct: 275 KPYVKDPHAL-------------DLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 4e-23
Identities = 88/343 (25%), Positives = 151/343 (44%), Gaps = 77/343 (22%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQLAKHDKG 102
+G G +G V +D ++ VA+K ++ + YRE +L KH K
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYREL---------RLLKHMKH 73
Query: 103 GNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 156
N + + + F + N + +V +G+ L + ++ + + V+ + QLL
Sbjct: 74 EN-VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK---CQKLSDEHVQFLIYQLLR 129
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
+ ++H +IH DLKP NV + + ++++DF
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAV---------------------------NEDCELRILDF 162
Query: 217 GSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 275
G + V+TR YRAPE++L + + DIWSVGCI+ EL G+ALF ++ +
Sbjct: 163 GLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI 222
Query: 276 EHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334
+ L +ME V P P+ + K HA KY++ LP +
Sbjct: 223 DQLKRIMEVVGTPSPEVLKKISSEHARKYIQ--------------------SLPHMPQQD 262
Query: 335 MQHVDHSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
++ + A L LL+ +L D R++A EAL HP+F++ H
Sbjct: 263 LKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-22
Identities = 78/332 (23%), Positives = 125/332 (37%), Gaps = 89/332 (26%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKI--VRGIKKYREAAMIEIEVLQQLAKHDKGGNRC 106
+G+G+ G V + + ++ A+K V G +++R+ + E++ L+ +
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESPY----V 61
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DL 164
V+ F I IV E + G SL D L+K P ++ IARQ+L+ + ++H
Sbjct: 62 VKCYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYER 223
+IH D+KP N+L+ S +K+ DFG S E
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIA---------------------------DFGISKVLEN 152
Query: 224 ---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
+ V T Y +PE I G ++Y DIWS+G L+E G+ F +
Sbjct: 153 TLDQCNTF-VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211
Query: 281 MERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339
M+ + GP P P S E
Sbjct: 212 MQAICDGPPP--------------------SLPAEEFSPE-------------------- 231
Query: 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
+ L+ DP R +A E L+HPF
Sbjct: 232 -----FRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 64/261 (24%), Positives = 113/261 (43%), Gaps = 39/261 (14%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 107
G G FG+V + + A+K V R I + + I E E+L++ H V
Sbjct: 2 GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HP----FIV 56
Query: 108 QIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ F + +I ++ E LG L+ LR F R ++ ++H+ +
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
I+ DLKPEN+LL S+ Y+K+ D+ + K + G T+
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFA-------------------KKLKSGQKTWT---- 151
Query: 227 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 286
T Y APE+IL G+ + D WS+G +L EL TG F ++ + + + +L
Sbjct: 152 --FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE-DDEDPMEIYNDILK 208
Query: 287 PLPQHML-KRVDRHAEKYVRR 306
+ +D+ A+ +++
Sbjct: 209 GNGKLEFPNYIDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-22
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 35/221 (15%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV------RGIKKYREAAMIEIEVLQQLAKHDKGGN 104
+G+G FG+V C+D + +A+K V KK A EI++L+ L +H
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QH----E 64
Query: 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
R VQ + I E + G S+ D L+ Y + + R+ RQ+LE + ++H
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHS 122
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
++H D+K N+L S+ +K+ D+ +S KR+ I S T +
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGAS----------KRL---QTICS----SGTGMK 165
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264
+ T ++ +PEVI G G+ D+WSVGC +VE+ T
Sbjct: 166 S----VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-22
Identities = 94/330 (28%), Positives = 146/330 (44%), Gaps = 60/330 (18%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA----MIEIEVLQQLAKHDKGGNR 105
K+GEGT+ V + + + +VA+K +R ++ E A + E+ +L+ L KH
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNL-KH----AN 64
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + + + +VFE L S L +L N + V+ QLL +++ H
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDSDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
++H DLKP+N+L+ +K+ D+ + K +P + TY
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADF--------GLARAKSVP-----------TKTYSNE- 163
Query: 226 QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
V T YR P+V+LG ++ P D+W VGCIL E+ TG +F E L ++ R+
Sbjct: 164 ----VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL 219
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP--RLQNLIMQHVDHSA 342
LG + WP G S E +S + P R Q LI H
Sbjct: 220 LGTPTEE------------------TWP-GITSNEEFRSYL-FPQYRAQPLI-NHAPRLD 258
Query: 343 GDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
D LL LL Y+ R++A ALRH +F
Sbjct: 259 TDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-22
Identities = 79/331 (23%), Positives = 132/331 (39%), Gaps = 91/331 (27%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMI---EIEVLQQLAKHDKGGN 104
+G G+FG V E + + + A+K V + +EA EI +L +L +H
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPN--- 63
Query: 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
VQ +++ I E + G SL L+K Y SFP ++R RQ+L + ++HD
Sbjct: 64 -IVQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+H D+K N+L+ ++ +K+ D+ + KS
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQ-----VVEFSFAKS--------------- 160
Query: 224 PDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282
+ ++ APEVI G + DIWS+GC ++E+ TG+ + E + + +
Sbjct: 161 -----FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215
Query: 283 R--VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
R L P+P H+ S E ++ I++
Sbjct: 216 RSKELPPIPDHL------------------------SDE----------AKDFILK---- 237
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
L+ DP+ R TA E L HPF
Sbjct: 238 -----------CLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 87/330 (26%), Positives = 149/330 (45%), Gaps = 47/330 (14%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGG 103
+ S +GEG +G V + VAIK + + + + + EI++L++ + G
Sbjct: 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIG 67
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
+ F+ N + IV E + + LY ++ + + D ++ Q+L + ++H
Sbjct: 68 ILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSN---DHIQYFLYQILRGLKYIHS 124
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
++H DLKP N+LL ++ +K+ D+ + + + + T Y
Sbjct: 125 ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL-------------TEY-- 169
Query: 224 PDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282
V+TR YRAPE++L G+T DIWSVGCIL E+ + LF + L L ++
Sbjct: 170 ------VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL 223
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 341
VLG Q L + +R IKS+ P++ N + + D
Sbjct: 224 GVLGTPSQEDLNCI----------------ISLRARNYIKSLPFKPKVPWNKLFPNADPK 267
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
A D LL +L ++P R+T EAL HP+
Sbjct: 268 ALD---LLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 90/346 (26%), Positives = 154/346 (44%), Gaps = 69/346 (19%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA---KHDKG 102
K+ + +G G+FG V E + E VAIK V +Y+ ++ ++ L + D
Sbjct: 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 103 GNRCVQI--RNWFDYRNHICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECI 158
C + +N F + +V E + +++ +++ N + P+ LV+ + QL +
Sbjct: 129 YTECFKKNEKNIF-----LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
A++H + H DLKP+N+L+ P + +K+ DFGS
Sbjct: 184 AYIHSKFICHRDLKPQNLLI--------------------------DPNTHTLKLCDFGS 217
Query: 219 TTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN 274
Q +YI S R YRAPE++LG +T D+WS+GCI+ E+ G +F +
Sbjct: 218 AKNLLAGQRSVSYICS-RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276
Query: 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334
++ L + +VLG + LK ++ P A +K P ++
Sbjct: 277 VDQLVRIIQVLGTPTEDQLKEMN--------------PNYAD--------IKFPDVKPKD 314
Query: 335 MQHV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 378
++ V + D + + L+Y+P RL EAL PFF D LR
Sbjct: 315 LKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF--DDLR 358
|
Length = 440 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 5e-21
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
Q+L I +H +IH DLKP N+++ S D + +K
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKS-----------------DCT----------LK 158
Query: 213 VIDFG-----STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 267
++DFG T++ Y+V TR+YRAPEVILG+G+ DIWSVGCI+ E+ G
Sbjct: 159 ILDFGLARTAGTSFMMTP--YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215
Query: 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR-RGRLDWPEGAASRESIKSVMK 326
LF ++++ + LG + R+ YV R + G + E V+
Sbjct: 216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKY---AGYSFEELFPDVLF 272
Query: 327 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
P ++ H A LL +L DP R++ +AL+HP+
Sbjct: 273 PPDSES----HNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 93/341 (27%), Positives = 151/341 (44%), Gaps = 70/341 (20%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLAKHDKGGNRCV 107
+G G +G V + E E VAIK I +A + EI++L+ L H+ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHEN----VI 67
Query: 108 QIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
I++ + N + IV+E + + L+ +R + ++ D + QLL + ++H
Sbjct: 68 AIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH 125
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--STT 220
++H DLKP N+LL ++ +K+ DFG TT
Sbjct: 126 SANVLHRDLKPSNLLLNAN---------------------------CDLKICDFGLARTT 158
Query: 221 YERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277
E+ D Y+V TR YRAPE++L +T D+WSVGCI EL + LF + +
Sbjct: 159 SEKGDFMTEYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ 217
Query: 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IM 335
L ++ +LG L + +R I+S+ PR Q+ +
Sbjct: 218 LKLITELLGS----------------PSEEDLGFIRNEKARRYIRSLPYTPR-QSFARLF 260
Query: 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
H + A D LL+ +L +DP+ R+T EAL HP+ H
Sbjct: 261 PHANPLAID---LLEKMLVFDPSKRITVEEALAHPYLASLH 298
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-20
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 37/231 (16%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKG 102
K+ K+G+G++G V + + A+K V +K RE A+ EI +L + +
Sbjct: 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN-- 60
Query: 103 GNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNY--RSFPIDLVREIARQLLECIA 159
+ + F N +CIV E L + K + P + I QLL +
Sbjct: 61 ---IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
+H+ ++H DLK N+LLV+++ +K+ D S K + K+ A I
Sbjct: 118 ALHEQKILHRDLKSANILLVANDLVKIGDLGIS----------KVLKKNMAKTQI----- 162
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270
T HY APEV G ++Y DIWS+GC+L E+ T F+
Sbjct: 163 -----------GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 82/337 (24%), Positives = 138/337 (40%), Gaps = 97/337 (28%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108
K+GEG G+V + DR + VAIK +R K+ +E + EI +++ KH
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHP-------N 76
Query: 109 IRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVRE----IARQLLECIAF 160
I +++D + + +V E + G SL D + +N + + + R++L+ + +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQGLEY 131
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--- 217
+H +IH D+K +N+LL KD S +K+ DFG
Sbjct: 132 LHSQNVIHRDIKSDNILL-----------------SKDGS----------VKLADFGFAA 164
Query: 218 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277
T E+ +N +V T ++ APEVI + DIWS+G + +E+ GE
Sbjct: 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE----------- 213
Query: 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 337
P ++ R P A + K +P L+N
Sbjct: 214 -----------PPYL---------------REP-PLRALFLITTK---GIPPLKNP---- 239
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
+ + + L L DP R +A E L+HPF +
Sbjct: 240 -EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 83/348 (23%), Positives = 150/348 (43%), Gaps = 79/348 (22%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMIEIEVLQQLAKHD--------- 100
+G G+ G V D + + VA+K IV + + A+ EI+++++L HD
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVL 71
Query: 101 --KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
G + + + + + + IV E + + L + L + + R QLL +
Sbjct: 72 GPSGSDLTEDVGSLTELNS-VYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGL 127
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
++H ++H DLKP NV + + + + +K+ DFG
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLV--------------------------LKIGDFGL 161
Query: 219 TTYERPD---QNYI---VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 271
P + Y+ + T+ YR+P ++L +T D+W+ GCI E+ TG+ LF
Sbjct: 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221
Query: 272 HENLEHLAMMERVLGPLPQHMLKRVDRHA-----EKYVRRGRLDWPEGAASRESIKSVMK 326
LE M+ +L +P +++ DR+ +VR +G R ++ ++
Sbjct: 222 AHELE---QMQLILESVP--VVREEDRNELLNVIPSFVRN------DGGEPRRPLRDLLP 270
Query: 327 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
V+ A D L+ +L ++P DRLTA EAL HP+ +
Sbjct: 271 ----------GVNPEALD---FLEQILTFNPMDRLTAEEALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 55/233 (23%)
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
Q+L + ++H ++H DLKP N LLV+++ +K
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGN-LLVNAD--------------------------CELK 145
Query: 213 VIDFG-STTY-ERPDQN--YI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 264
+ DFG + + E P +N ++ V+TR YRAPE++L +T D+WSVGCIL EL
Sbjct: 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG 205
Query: 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVRRGRLDWPEGAASRESIKS 323
+ +F+ + ++ L + +VLG + L R+ A+ Y+R L
Sbjct: 206 RKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIR--SLPNIPK--------- 254
Query: 324 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
I + + A D LL+ LL +DPT R++ EAL HP+ H
Sbjct: 255 -KPFES----IFPNANPLALD---LLEKLLAFDPTKRISVEEALEHPYLAIWH 299
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 85/328 (25%), Positives = 141/328 (42%), Gaps = 56/328 (17%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA----MIEIEVLQQLAKHDKGGNR 105
K+GEGT+ V + + +VA+K +R ++ E A + E+ +L+ L KH
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDL-KHAN---- 65
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + + + +VFE L L +L + S + V+ QLL + + H
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
++H DLKP+N+L+ +K+ D+ + ++ +I + TY
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFG--------------LARAKSIP-----TKTYSNE- 164
Query: 226 QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
V T YR P+++LG ++ D+W VGCI E+ TG LF E L + R+
Sbjct: 165 ----VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI 220
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
LG + WP G S E KS + + H D
Sbjct: 221 LGTPTEET------------------WP-GILSNEEFKSYNYPKYRADCLHNHAPRLDSD 261
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPFF 372
LL LL+++ R++A EA++HP+F
Sbjct: 262 GAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 7e-19
Identities = 87/337 (25%), Positives = 140/337 (41%), Gaps = 71/337 (21%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGNR 105
K+GEG++ V + + ++VA+K +R ++ E A+ E +L+ L KH
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLKDL-KH----AN 64
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + + + + +VFE L + L ++ + VR QLL +A+ H
Sbjct: 65 IVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR 123
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-------- 217
++H DLKP+N LL+S + +K+ DFG
Sbjct: 124 VLHRDLKPQN-LLIS--------------------------ERGELKLADFGLARAKSVP 156
Query: 218 STTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN-L 275
S TY N +V T YR P+V+LG ++ D+W VGCI E+ TG LF +
Sbjct: 157 SKTY----SNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211
Query: 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335
+ L + RVLG + V + E P + PRL +
Sbjct: 212 DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINH--------APRLDRIP- 262
Query: 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
L L+Y+P R++A EA++HP+F
Sbjct: 263 --------HGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 32/221 (14%)
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
Q+L I +H +IH DLKP N+++ S +K+ D+ + +++
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG--------------LARTACT- 175
Query: 213 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272
+F T Y V TR+YRAPEVILG+G+ DIWSVGCI+ EL G +FQ
Sbjct: 176 --NFMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225
Query: 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 332
++++ + LG + R+ YV R +P S E + P
Sbjct: 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV-ENRPQYP--GISFEELFPDWIFPSES- 281
Query: 333 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
+ LL +L DP R++ EALRHP+ T
Sbjct: 282 ---ERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 75/340 (22%), Positives = 121/340 (35%), Gaps = 80/340 (23%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAA-MIEIEVLQQLAKHDKGGNRCV 107
G G FG+V D++ ++ A+K++R IK+ + A E ++L
Sbjct: 10 GRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL-------------A 56
Query: 108 QIRN-W-------FDYRNHICIVFEKLGSSLYDFLRK-NNYRSFPIDLVREIARQLLECI 158
+ W F H+ +V E + D + FP + R +L+ +
Sbjct: 57 DADSPWIVKLYYSFQDEEHLYLVMEYMPGG--DLMNLLIRKDVFPEETARFYIAELVLAL 114
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFK--RMPKSSAIKVI 214
+H L IH D+KP+N+L+ + +IK+ D+ ++ KD Y+ V+
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 215 DFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273
+R N V T Y APEV+ G + CD WS+G IL E+ G F
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF---- 230
Query: 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 333
Q ++ ++L
Sbjct: 231 -----------YSDTLQETYNKIINW------------------------------KESL 249
Query: 334 IMQHVDHSAGDLTHLLQGLLRYDPTDRLT-AREALRHPFF 372
+ + L+ LL DP DRL E HPFF
Sbjct: 250 RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-18
Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 36/226 (15%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVR----GIK-KYREAAMI-----EIEVLQQLAKHD 100
+G G+FG V + E++A+K V K R+ +M+ EI +L++L +H+
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66
Query: 101 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
VQ +H+ I E + G S+ L NNY +F LVR RQ+L+ +
Sbjct: 67 N----IVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLN 120
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
++H+ +IH D+K N+L+ + IK+ D+ S K++ +S T
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGIS----------KKLEANSLS-----TKT 165
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265
RP + + + APEV+ +T DIWS+GC++VE+ TG
Sbjct: 166 NGARPS---LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 79/339 (23%), Positives = 130/339 (38%), Gaps = 96/339 (28%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ----LAKHDK 101
+ +G+G+FG+V + D+ ++VAIK++ E A EIE +QQ L++
Sbjct: 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLSQC-- 56
Query: 102 GGNRCVQIRNWF-----DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLL 155
R I ++ + + I+ E G S D L+ + I R++L
Sbjct: 57 ---RSPYITKYYGSFLKGSK--LWIIMEYCGGGSCLDLLK---PGKLDETYIAFILREVL 108
Query: 156 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 215
+ ++H+ IH D+K N+LL +K+ D+ S S+ K
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL-----------TSTMSKRNT 157
Query: 216 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275
F V T + APEVI G+ DIWS+G +EL GE L
Sbjct: 158 F-------------VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP------PL 198
Query: 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335
L M RVL +P++ ++ + K+ + +
Sbjct: 199 SDLHPM-RVLFLIPKNNPPSLEGN--KFSKPFK--------------------------- 228
Query: 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
D L L DP +R +A+E L+H F +
Sbjct: 229 --------DFVSL---CLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
K+GEG++G V + +E ++VAIK+V +++ + + EI +L+Q V+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQ-CDSP----YIVKY 63
Query: 110 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
+ + IV E G S+ D ++ N ++ + + I Q L+ + ++H IH
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIH 122
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 228
D+K N+LL K+ D+ S G T +N
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVS------------------------GQLTDTMAKRNT 158
Query: 229 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266
++ T + APEVI +G+ DIWS+G +E+ G+
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 68/310 (21%), Positives = 109/310 (35%), Gaps = 90/310 (29%)
Query: 67 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126
+ +M+A V +K R MI+ E ++ F ++++ +V E L
Sbjct: 31 KSDMIAKNQVTNVKAERAIMMIQGE-----------SPYVAKLYYSFQSKDYLYLVMEYL 79
Query: 127 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 185
G ++ P D ++ +++ + +H +IH D+KPEN+L+ + ++K
Sbjct: 80 NGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLK 137
Query: 186 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG 245
+ D+ S R E V T Y APE ILG+G
Sbjct: 138 LTDFGLS-----------RN--------------GLENKK---FVGTPDYLAPETILGVG 169
Query: 246 WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR 305
D WS+GC++ E G F P + +
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAET---------------PDAVFDNIL-------- 206
Query: 306 RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA-- 363
R++WPE S P +LI + LL DP RL A
Sbjct: 207 SRRINWPEEVKEFCS-------PEAVDLINR---------------LLCMDPAKRLGANG 244
Query: 364 -REALRHPFF 372
+E HPFF
Sbjct: 245 YQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 44/225 (19%)
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
Q+L I +H +IH DLKP N+++ S +K+ D+ R +S
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 172
Query: 213 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272
F T Y V TR+YRAPEVILG+G+ DIWSVGCI+ E+ + LF
Sbjct: 173 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 273 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 330
+ ++ ++E++ P P+ M K++ YV + P+ A + P+L
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 268
Query: 331 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
+L +H+ A LL +L DP R++ EAL+HP+
Sbjct: 269 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 7e-17
Identities = 85/335 (25%), Positives = 143/335 (42%), Gaps = 67/335 (20%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIV-----RGI--KKYREAAMIEIEVLQQLAKHDKG 102
K+GEG++ V + R ++VA+K++ G+ REA+++ K K
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLL---------KGLKH 62
Query: 103 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
N V + + + + VFE + + L ++ ++ P + VR QLL +A++H
Sbjct: 63 AN-IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYN-VRLFMFQLLRGLAYIH 120
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 221
++H DLKP+N+L+ SY +K+ DFG +
Sbjct: 121 GQHILHRDLKPQNLLI---------------------SYL------GELKLADFGLARAK 153
Query: 222 ERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ-THENLEH 277
P Q Y V T YR P+V+LG ++ DIW GCI +E+ G+ F + E
Sbjct: 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213
Query: 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 337
L + VLG + V + Y L + R K + + P+ ++L Q
Sbjct: 214 LEKIWTVLGVPTEDTWPGVSK-LPNYKPEWFL-PCKPQQLRVVWKRLSRPPKAEDLASQ- 270
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+L P DR++A++AL HP+F
Sbjct: 271 --------------MLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 36/221 (16%)
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
Q+L I +H +IH DLKP N+++ S +K+ D+ R +S
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 179
Query: 213 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272
F T Y V TR+YRAPEVILG+G+ DIWSVGCI+ E+ G LF
Sbjct: 180 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 273 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRL 330
++++ ++E++ P P+ M K++ YV + P+ A S E + + P
Sbjct: 229 DHIDQWNKVIEQLGTPCPEFM-KKLQPTVRTYVE----NRPKYAGYSFEKLFPDVLFPAD 283
Query: 331 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
+H A LL +L D + R++ EAL+HP+
Sbjct: 284 S----EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 88/354 (24%), Positives = 152/354 (42%), Gaps = 75/354 (21%)
Query: 50 KMGEGTFGQVLECWDRERKEM--VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
K+G GT+G V + ++ K+ A+K + G +A EI +L++L K N
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEG-TGISMSACREIALLREL----KHPNVIA 62
Query: 108 QIRNWFDYRNH-ICIVFEKLGSSLYDFLR-----KNNYR--SFPIDLVREIARQLLECIA 159
+ + + + + ++F+ L+ ++ K N + P +V+ + Q+L+ I
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 218
++H ++H DLKP N+L++ P+ +K+ D G +
Sbjct: 123 YLHANWVLHRDLKPANILVMGEG-----------------------PERGRVKIADMGFA 159
Query: 219 TTYERP-----DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 272
+ P D + +V T YRAPE++LG +T DIW++GCI EL T E +F
Sbjct: 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219
Query: 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ- 331
+ E + P H ++DR DW E I+ + + P LQ
Sbjct: 220 Q--------EDIKTSNPFHH-DQLDRIFSVMGFPADKDW-------EDIRKMPEYPTLQK 263
Query: 332 -------------NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+ +H + LLQ LL DPT R+T+ +AL+ P+F
Sbjct: 264 DFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-16
Identities = 82/330 (24%), Positives = 145/330 (43%), Gaps = 60/330 (18%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA----MIEIEVLQQLAKHDKGGNR 105
K+GEGT+ V + + + +VA+K +R ++ E A + E+ +L+ L KH
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDL-KHAN---- 65
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRK-NNYRSFPIDLVREIARQLLECIAFMHDL 164
V + + + +VFE L L ++ N S + V+ Q+L +A+ H
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMS--MHNVKIFLYQILRGLAYCHRR 123
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
++H DLKP+N+L+ +K+ D+ + K +P + TY
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADF--------GLARAKSVP-----------TKTYSNE 164
Query: 225 DQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
V T YR P+V+LG ++ D+W VGCI E+ +G LF + L ++ R
Sbjct: 165 -----VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHSA 342
+LG + WP G +S + K+ P+ + ++ H
Sbjct: 220 LLGTPTEE------------------TWP-GISSNDEFKN-YNFPKYKPQPLINHAPRLD 259
Query: 343 GDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+ LL L+Y+ R++A EA++H +F
Sbjct: 260 TEGIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 9e-16
Identities = 84/328 (25%), Positives = 155/328 (47%), Gaps = 51/328 (15%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE--AAMIEIEVLQQLAKHDKGGNRCV 107
K+GEG++ V + + ++VA+K++R ++ A+ E +L+ L KH V
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHAN----IV 66
Query: 108 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
+ + + + +VFE + + L ++ K+ P + V+ QLL ++++H ++
Sbjct: 67 LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP-ENVKLFLFQLLRGLSYIHQRYIL 125
Query: 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 227
H DLKP+N+L+ + +K+ D+ + ++ ++ S TY
Sbjct: 126 HRDLKPQNLLISDTGELKLADFG--------------LARAKSVP-----SHTYSNE--- 163
Query: 228 YIVSTRHYRAPEVILGLGWTYPC-DIWSVGCILVELCTGEALFQTHENLE-HLAMMERVL 285
V T YR P+V+LG C D+W VGCI VE+ G A F ++++ L + VL
Sbjct: 164 --VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
G + V H+ + + PE R ++ S L + N + +V+H+
Sbjct: 222 GTPNEDTWPGV--HSLPHFK------PE----RFTLYSPKNLRQAWNK-LSYVNHA---- 264
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFT 373
L LL+ P +RL+A+ AL H +F+
Sbjct: 265 EDLASKLLQCFPKNRLSAQAALSHEYFS 292
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 88/349 (25%), Positives = 151/349 (43%), Gaps = 65/349 (18%)
Query: 50 KMGEGTFGQVLECWDRERKEM--VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
K+G GT+G V + ++ K+ A+K + G +A EI +L++L KH +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEG-TGISMSACREIALLREL-KHPN----VI 61
Query: 108 QIRNWF--DYRNHICIVFEKLGSSLYDFLR-----KNNYR--SFPIDLVREIARQLLECI 158
++ F + ++F+ L+ ++ K N + P +V+ + Q+L+ I
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 217
++H ++H DLKP N+L++ P+ +K+ D G
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEG-----------------------PERGRVKIADMGF 158
Query: 218 STTYERP-----DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 271
+ + P D + +V T YRAPE++LG +T DIW++GCI EL T E +F
Sbjct: 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218
Query: 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR-- 329
+ E + P H ++DR DW + E ++MK R
Sbjct: 219 RQ--------EDIKTSNPYHH-DQLDRIFNVMGFPADKDWEDIKKMPEH-STLMKDFRRN 268
Query: 330 ------LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
L + +H HLLQ LL DP R+T+ +A++ P+F
Sbjct: 269 TYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 68/265 (25%), Positives = 120/265 (45%), Gaps = 39/265 (14%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGN 104
+G+G FG+V C+D + +A+K V+ K A EI++L+ L
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE----- 64
Query: 105 RCVQIRNWF-DYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
R VQ D +F + G S+ D L+ +Y + ++ R+ RQ+LE ++++
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQILEGVSYL 122
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H ++H D+K N+L S +K+ D+ +S KR+ + I T
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGAS----------KRL------QTICLSGTGM 166
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
+ + T ++ +PEVI G G+ DIWSVGC +VE+ T + + E + A+
Sbjct: 167 KS-----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--AIF 219
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRR 306
+ P + V H +++R
Sbjct: 220 KIATQPTNPVLPPHVSDHCRDFLKR 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 4e-15
Identities = 74/337 (21%), Positives = 128/337 (37%), Gaps = 93/337 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDK 101
+ +G G+FG+V+ + + A+KI+ I K ++ + E +LQ + +H
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP- 61
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
++ D N + +V E + G L+ LRK+ FP + R A Q++ + +
Sbjct: 62 --FLVNLYGSFQDDSN-LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEY 116
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+H L +++ DLKPEN+LL S Y IK+ DFG
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGY---------------------------IKITDFGFAK 149
Query: 221 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
+ + T Y APE+IL G+ D W++G ++ E+ G F + +
Sbjct: 150 RVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD---NPIQI 206
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
E++L G++ +P
Sbjct: 207 YEKILE--------------------GKVRFP-----------------------SFFS- 222
Query: 341 SAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
D L++ LL+ D T RL + HP+F
Sbjct: 223 --PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 67/268 (25%)
Query: 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 171
F+ + H+C+V E + G L+ N + P+D+ R + + + ++H+ ++H DL
Sbjct: 70 FETKRHLCMVMEYVEGGDCATLLK--NIGALPVDMARMYFAETVLALEYLHNYGIVHRDL 127
Query: 172 KPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 228
KP+N+L+ S +IK+ D+ K L + + Y + K T E D+
Sbjct: 128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD-----------TREFLDKQ- 175
Query: 229 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 288
+ T Y APEVIL G+ P D W++G IL E G F G
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF---------------FGDT 220
Query: 289 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348
P+ + + V ++WPEG + LP D L
Sbjct: 221 PEELFGQ--------VISDDIEWPEGDEA---------LP--------------ADAQDL 249
Query: 349 LQGLLRYDPTDRL---TAREALRHPFFT 373
+ LLR +P +RL A E +H FF
Sbjct: 250 ISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 7e-15
Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 47/269 (17%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGN 104
+G+G FG+V C+D + +A K V+ K A EI++L+ L +H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHE---- 64
Query: 105 RCVQIRNWFDYRNH----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
R VQ R+ + I E + G S+ D L+ Y + + R+ RQ+LE ++
Sbjct: 65 RIVQYYGCL--RDRAEKTLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMS 120
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
++H ++H D+K N+L S+ +K+ D+ +S KR+ + I T
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS----------KRL------QTICMSGT 164
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
+ T ++ +PEVI G G+ D+WS+GC +VE+ T + + +E + +
Sbjct: 165 GIRS-----VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 219
Query: 280 MM--ERVLGPLPQHMLKRVDRHAEKYVRR 306
+ + LP H + HA ++
Sbjct: 220 KIATQPTNPQLPSH----ISEHARDFLGC 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 78/346 (22%), Positives = 129/346 (37%), Gaps = 94/346 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDK 101
+I +++G+G +GQV ++ E+VA+K + + K E + E ++L K +
Sbjct: 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSE- 61
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
V++ F ++ + E + G L NN D R ++ E +
Sbjct: 62 ---WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDA 116
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+H+L IH DLKPEN L+ +S +IK+ DFG +
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKL---------------------------TDFGLSK 149
Query: 221 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF------QTHEN 274
N +V + Y APEV+ G G+ + D WS+GC+L E G F +T EN
Sbjct: 150 GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209
Query: 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334
L++ L P R ++
Sbjct: 210 LKYWKET---------------------------LQRPVYDDPRFNLS------------ 230
Query: 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR-HPFFTRDHLRR 379
D + +T L+ DP+ R + E ++ HPFF
Sbjct: 231 ----DEAWDLITKLIN-----DPSRRFGSLEDIKNHPFFKEVDWNE 267
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 69/335 (20%), Positives = 120/335 (35%), Gaps = 79/335 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR---EAAMIEIEVLQQLAKHDKG 102
++ +G G V E VAIK + ++K + + E++ + Q H
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCN-HPN- 60
Query: 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR-KNNYRSFPIDLVREIARQLLECIAF 160
V+ F + + +V L G SL D ++ ++ + +++L+ + +
Sbjct: 61 ---VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDY--KSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
+H IH D+K N+LL +K+ D+ +SL D + R
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR-------------- 163
Query: 219 TTYERPDQNYIVSTRHYRAPEVI-LGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277
V T + APEV+ G+ + DIWS G +EL TG A + + ++
Sbjct: 164 --------KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK- 214
Query: 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 337
+M + P +KY + R+ I
Sbjct: 215 -VLMLTLQNDPPSL---ETGADYKKY----------SKSFRKMISLC------------- 247
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
L+ DP+ R TA E L+H FF
Sbjct: 248 ---------------LQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 53/236 (22%), Positives = 87/236 (36%), Gaps = 55/236 (23%)
Query: 46 KIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKH 99
+ K+GEG FG+V + ++ VA+K ++ ++ E ++++L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60
Query: 100 D-----KGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 152
G C + + IV E G L D+LRKN + + + A
Sbjct: 61 PNIVKLLGV--CTE-------EEPLMIVMEYMPGGD-LLDYLRKNRPKELSLSDLLSFAL 110
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
Q+ + ++ IH DL N L V + +K
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCL-VGENLV--------------------------VK 143
Query: 213 VIDFGSTTYERPDQNYIVSTRH--YR--APEVILGLGWTYPCDIWSVGCILVELCT 264
+ DFG + D Y V R APE + +T D+WS G +L E+ T
Sbjct: 144 ISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 71/248 (28%), Positives = 106/248 (42%), Gaps = 53/248 (21%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110
+G+GT+G V D + +AIK + + R + E+ L + K N VQ
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIP-ERDSRYVQPLHEEIA--LHSYLKHRN-IVQYL 71
Query: 111 NWFDYRNHICIVFEKL-GSSLYDFLR------KNNYRSFPIDLVREIARQLLECIAFMHD 163
I E++ G SL LR K+N + +Q+LE + ++HD
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE-----QTIIFYTKQILEGLKYLHD 126
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
++H D+K +NVL+ ++Y S +K+ DFG T +R
Sbjct: 127 NQIVHRDIKGDNVLV--------------------NTY------SGVVKISDFG--TSKR 158
Query: 224 -----PDQNYIVSTRHYRAPEVI-LGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE 276
P T Y APEVI G G+ P DIWS+GC +VE+ TG+ F E E
Sbjct: 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF--IELGE 216
Query: 277 HLAMMERV 284
A M +V
Sbjct: 217 PQAAMFKV 224
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 3e-14
Identities = 61/301 (20%), Positives = 106/301 (35%), Gaps = 82/301 (27%)
Query: 46 KIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKH 99
++ K+GEG FG+V + + VA+K ++ ++ RE + E ++++L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SH 60
Query: 100 DK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 152
G C Q + IV E G L DFLRK+ + + ++A
Sbjct: 61 PNIVRLLGV--CTQ-------GEPLYIVTEYMPGGD-LLDFLRKHG-EKLTLKDLLQMAL 109
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
Q+ + + ++ +H DL N L+ + +K+ D
Sbjct: 110 QIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISD------------------------ 145
Query: 213 VIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 267
FG + D Y + APE + +T D+WS G +L E+ T
Sbjct: 146 ---FGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGE 202
Query: 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMK 326
P P + V + + G RL PE + + +M
Sbjct: 203 Q------------------PYPGMSNEEV----LELLEDGYRLPRPENCP--DELYELML 238
Query: 327 L 327
Sbjct: 239 Q 239
|
Length = 258 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 34/237 (14%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ-------LAKHDKGGN 104
G G FG+V ++ + A+K +R ++ M+E E + LA+ D
Sbjct: 10 GRGAFGEVRLVQKKDTGHIYAMKKLR------KSEMLEKEQVAHVRAERDILAEAD--NP 61
Query: 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR-EIARQLLECIAFMH 162
V++ F N++ ++ E L G + L K +F + R IA +L I +H
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETIL-AIDSIH 118
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYK--SSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
L IH D+KP+N+LL + +IK+ D+ + L + +++ + + +DF S
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 221 YERPD--QNY----------IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265
+ + V T Y APEV L G+ CD WS+G I+ E+ G
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-14
Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
K+GEG+FG+ + +E + IK I + K RE + E+ VL + KH
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN---- 60
Query: 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
VQ + F+ ++ IV + G LY + FP D + + Q+ + +HD
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-----ST 219
++H D+K +N+ L K IK+ DFG ++
Sbjct: 121 KILHRDIKSQNIFLT---------------------------KDGTIKLGDFGIARVLNS 153
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270
T E + T +Y +PE+ + DIW++GC+L E+CT + F+
Sbjct: 154 TVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 39/224 (17%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV------RGIKKYREAAMIEIEVLQQLAKHDKGGN 104
+G G FG+V C+D + +A+K V + K A EI++L+ L +HD
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHD---- 64
Query: 105 RCVQ----IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
R VQ +R+ + + I + + G S+ D L+ Y + ++ R RQ+L+ +++
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMP-GGSIKDQLKA--YGALTENVTRRYTRQILQGVSY 121
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+H ++H D+K N+L S+ +K+ D+ +S KR I+ I T
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGAS----------KR------IQTICMSGTG 165
Query: 221 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264
+ + T ++ +PEVI G G+ D+WSV C +VE+ T
Sbjct: 166 IKS-----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 65/245 (26%), Positives = 105/245 (42%), Gaps = 33/245 (13%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIE-VLQQLAKHDKGGNRCVQI 109
+GEG+FG+ L + A+K +R K E VL KH V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN----IVAF 63
Query: 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
+ F+ H+ IV E G L ++ + FP D + + Q+ + +H+ ++H
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 228
D+K +N+ L + +K+ D+ S+ +Y + TY
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY----------------ACTY------- 160
Query: 229 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH--ENLEHLAMMERVLG 286
V T +Y PE+ + + DIWS+GCIL ELCT + FQ + +NL L + +
Sbjct: 161 -VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI-LKVCQGSYK 218
Query: 287 PLPQH 291
PLP H
Sbjct: 219 PLPSH 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 7e-14
Identities = 38/161 (23%), Positives = 81/161 (50%), Gaps = 26/161 (16%)
Query: 138 NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDYKSSLHTP 196
Y +F ++ QLL ++++H+ +IH D+K N+L+ S+ + +++ D+
Sbjct: 96 KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADF------- 148
Query: 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 256
+A ++ G+ E Q ++ T + APEV+ G + CD+WSVG
Sbjct: 149 -----------GAAARLAAKGTGAGEFQGQ--LLGTIAFMAPEVLRGEQYGRSCDVWSVG 195
Query: 257 CILVELCTGEALFQTHENLEHLAMMERVLG-----PLPQHM 292
C+++E+ T + + ++ HLA++ ++ +P+H+
Sbjct: 196 CVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 44/226 (19%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRC 106
++G G G V + R +++A+K +R + ++ + E+++L +C
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH----------KC 56
Query: 107 -----VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
V F I I E + D + K P ++ +IA +L+ + ++
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL 116
Query: 162 H-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
H +IH D+KP N+L+ S IK+ D+ S ++ S A
Sbjct: 117 HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----------GQLVNSLA---------- 156
Query: 221 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266
V T Y APE I G ++ DIWS+G L+EL TG
Sbjct: 157 ------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 9e-14
Identities = 78/340 (22%), Positives = 128/340 (37%), Gaps = 96/340 (28%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMI-----EIEVLQQLAKH 99
+G+GT+G+V + EM+A+K V G R+ M+ EIE L+ L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 100 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
+ VQ + ++ I E + G S+ LR Y F LVR Q+LE +
Sbjct: 69 N-----IVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFTEQVLEGL 121
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
A++H ++H DLK +N+L+ + K+ D+ S +
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS----------------------D 159
Query: 219 TTYERPDQNYIVSTRHYRAPEVI--LGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276
Y+ + + + APEVI G++ DIWS+GC+++E+ G + + E
Sbjct: 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR---RPWSDEE 216
Query: 277 HLAMM-----ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 331
+A M +R P+P + + P
Sbjct: 217 AIAAMFKLGNKRSAPPIPPDVSMNLS--------------PVAL---------------- 246
Query: 332 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
L +P +R TARE L+HPF
Sbjct: 247 ---------------DFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 78/335 (23%), Positives = 125/335 (37%), Gaps = 83/335 (24%)
Query: 47 IHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNR 105
I ++G+G FG+V + +E A KI++ ++ E M+EI++L + KH
Sbjct: 9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPN---- 63
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + + Y N + I+ E D + R +R + RQ+LE + F+H
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+IH DLK N+LL +K+ D+ S
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVS------------------------AKNKSTLQK 159
Query: 226 QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
++ + T ++ APEV+ + Y DIWS+G L+EL E H L + +
Sbjct: 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP---PHHELNPMRV 216
Query: 281 MERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339
+ ++L P LD P +S
Sbjct: 217 LLKILKSEPPT------------------LDQPSKWSS---------------------- 236
Query: 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L+ L DP DR TA E L+HPF +
Sbjct: 237 ----SFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGGN 104
+I ++G+G FG+V + ++E + A K++ + E M+EIE+L
Sbjct: 15 EIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHP----- 69
Query: 105 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
V++ F + + I+ E D + R ++ I RQ+LE + ++H +
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+IH DLK NVLL IK+ D+ S K T +R
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK----------------------TLQRR 167
Query: 225 DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVEL 262
D + T ++ APEV++ + Y DIWS+G L+E+
Sbjct: 168 DS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
+G+G FG+ E +V K V R +K R A+ EI +L L +H +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPN----II 62
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
N F N + I E G +LYD + + + F ++V Q++ ++++H +
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
+H D+K N+ L + IK+ D+ S K M ++
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGIS----KILGSEYSMAET------------------ 160
Query: 227 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264
+V T +Y +PE+ G+ + + DIW++GC+L EL T
Sbjct: 161 --VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 68/332 (20%), Positives = 129/332 (38%), Gaps = 85/332 (25%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYR--EAAMIEIEVLQQLAKHDKGGNRC 106
+G+G FG+V C + +M A K + + +KK + + A+ E ++L++++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + F+ ++ +C+V + G L + FP A Q++ + +H
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+++ DLKPENVLL +++ D ++ G R
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKG-------------------GKKIKGR-- 154
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
T Y APEV+ G + + D +++GC L E+ G + F+ +
Sbjct: 155 ----AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK------------ 198
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
++V++ K R +++ ++ P D + +
Sbjct: 199 --------EKVEKEELK---------------RRTLEMAVEYP----------DKFSPEA 225
Query: 346 THLLQGLLRYDPTDRL-----TAREALRHPFF 372
L + LL+ DP RL +A E HP F
Sbjct: 226 KDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 38/234 (16%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGG 103
++ ++G GT+G V + D E+VAIK+++ ++ + +I EI +L++ +H
Sbjct: 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIK-LEPGDDFEIIQQEISMLKE-CRH---- 59
Query: 104 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
V + R+ + IV E G SL D + + + R+ L+ +A++H
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH 118
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
+ IH D+K N+LL +K+ D+ S ++ KR
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVS--AQLTATIAKR------------------ 158
Query: 223 RPDQNYIVSTRHYRAPEVI---LGLGWTYPCDIWSVGCILVELCTGE-ALFQTH 272
+ T ++ APEV G+ CDIW++G +EL + +F H
Sbjct: 159 ----KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 83/330 (25%), Positives = 131/330 (39%), Gaps = 87/330 (26%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
++G+G+FG+V + D KE+VAIKI+ E A EIE +QQ +
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 110 RNWFDY--RNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDL 164
R + Y + I+ E LG S D L+ P++ + I R++L+ + ++H
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE 120
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
IH D+K NVLL +K+ D+ + G T +
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVA------------------------GQLTDTQI 156
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
+N V T + APEVI + + DIWS+G +EL GE + +L + RV
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP---PNSDLHPM----RV 209
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
L +P++ P L+ Q+ +
Sbjct: 210 LFLIPKN----------------------------------SPPTLEG---QY----SKP 228
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
++ L DP R TA+E L+H F TR
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 35/223 (15%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGGN 104
+I ++G+G FG+V + ++E + A K++ + E M+EI++L +
Sbjct: 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN---- 63
Query: 105 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
V++ + F Y N++ I+ E D + R +R + +Q LE + ++H+
Sbjct: 64 -IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+IH DLK N+L IK+ D+ S + T +R
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----------------------TIQRR 160
Query: 225 DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVEL 262
D + T ++ APEV++ + Y D+WS+G L+E+
Sbjct: 161 DS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 66/250 (26%), Positives = 109/250 (43%), Gaps = 40/250 (16%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ---LAKHDKGGNRCV 107
+G+G +G V C + +++A+K V AA E E LQ+ L K K N
Sbjct: 8 LGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+ D N I I E + G S+ L N + P + + +Q+L+ +A++H+ C+
Sbjct: 67 YLGTCLD-DNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 167 IHTDLKPENVLLVSSEYIKVPDYK-------SSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
+H D+K NV+L+ + IK+ D+ LH S+ K M
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH-SNMLKSMH------------- 169
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
T ++ APEVI G+ DIWS+GC + E+ TG+ + + L +
Sbjct: 170 -----------GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218
Query: 280 MMERVLGPLP 289
+ G +P
Sbjct: 219 YIGAHRGLMP 228
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 63/254 (24%), Positives = 104/254 (40%), Gaps = 74/254 (29%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD----------K 101
GEGT+G+V + ++ ++VAIKI+ I+ E E +L++ + H K
Sbjct: 15 GEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIK 74
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF---LRKNNYRSFPIDLVREIARQLLEC 157
+ W V E G S+ D LRK + + + I R+ L
Sbjct: 75 KNPPGNDDQLWL--------VMELCGGGSVTDLVKGLRKKG-KRLKEEWIAYILRETLRG 125
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+A++H+ +IH D+K +N+LL K++ +K++DFG
Sbjct: 126 LAYLHENKVIHRDIKGQNILLT---------------------------KNAEVKLVDFG 158
Query: 218 ------STTYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVGCILVELCTGE 266
ST R N + T ++ APEVI + D+WS+G +EL G+
Sbjct: 159 VSAQLDSTLGRR---NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
Query: 267 ----------ALFQ 270
ALF+
Sbjct: 216 PPLCDMHPMRALFK 229
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 5e-13
Identities = 56/245 (22%), Positives = 102/245 (41%), Gaps = 44/245 (17%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQLAKHDKG 102
++ +G+G+FG V + + +++ K I G +E + E+ +L++L KH
Sbjct: 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPN- 60
Query: 103 GNRCVQIRNWF-DYRNH-ICIVFEKLG----SSLYDFLRKNNYRSFPIDLVREIARQLLE 156
V+ + D N + IV E + L +K + + + I QLL
Sbjct: 61 ---IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLLL 116
Query: 157 CIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 211
+ H+ ++H DLKP N+ L ++ +K+ D+ + K + S
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA----------KILGHDS-- 164
Query: 212 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271
+ TY V T +Y +PE + + + DIWS+GC++ ELC F
Sbjct: 165 ----SFAKTY--------VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212
Query: 272 HENLE 276
L+
Sbjct: 213 RNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 78/334 (23%), Positives = 126/334 (37%), Gaps = 94/334 (28%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAA--MIEIEVLQQLAKHDKGGNRC 106
+G+GTFG+V+ ++ + A+KI++ I E A + E VLQ +H
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHP----FL 57
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
++ F + +C V E G L+ L + R F D R +++ + ++H
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+++ DLK EN++L +IK+ D+ + K I G+T
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFG--------------LCKEG----ISDGATM----- 152
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 283
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 153 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+ + PR L +
Sbjct: 212 I-----------------------------------------RFPR--TL--------SP 220
Query: 344 DLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
+ LL GLL+ DP RL A+E + H FF
Sbjct: 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 82/332 (24%), Positives = 126/332 (37%), Gaps = 83/332 (25%)
Query: 47 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKG 102
+ ++G+G+FG V D++ +K+++ I E E Q L+K D
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEA-QLLSKLDHP 62
Query: 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLLECIA 159
V+ F R+ CI+ E G L L K+ ++ + V E QLL +
Sbjct: 63 A--IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
+MH ++H DLK +N+ L + +K+ D+ S R+ S D +T
Sbjct: 121 YMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVS-----------RLLMGSC----DLATT 164
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
T +Y +PE + G+ DIWS+GCIL E+C F+ L
Sbjct: 165 ---------FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS--V 213
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339
++ V GP P PE R N IMQ
Sbjct: 214 VLRIVEGPTPS--------------------LPE------------TYSRQLNSIMQS-- 239
Query: 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
+L DP+ R +A E LR+PF
Sbjct: 240 ------------MLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ----LAKHDKGGNR 105
++G+G+FG+V + D +++VAIKI+ E A EIE +QQ L++ D
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDS--PY 63
Query: 106 CVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+ + + I+ E LG S D LR + F I + +++L+ + ++H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI---ATMLKEILKGLDYLHSE 120
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
IH D+K NVLL +K+ D+ + G T +
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVA------------------------GQLTDTQI 156
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266
+N V T + APEVI + DIWS+G +EL GE
Sbjct: 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 64/258 (24%), Positives = 116/258 (44%), Gaps = 39/258 (15%)
Query: 51 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
+G G+FG+V L + E VAIK K ++ + + +++ + CV +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH-PFCVNL 96
Query: 110 RNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
F +++ +V E +G + FLR+N + FP D+ A Q++ ++ L +++
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 228
DLKPEN+LL +IK+ D+ + KV+D + TY
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFA-------------------KVVD--TRTYT------ 187
Query: 229 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-------EALFQTHENLEHLAMM 281
+ T Y APE++L +G D W++G + E+ G E L + LE +
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF 247
Query: 282 ERVLGPLPQHMLKRVDRH 299
+ L +H++K++ H
Sbjct: 248 PKFLDNNCKHLMKKLLSH 265
|
Length = 340 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 43/232 (18%)
Query: 47 IHSKMGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGG 103
I +K+G+G+FG V + + K + A+K + + ++ RE A+ E VL +L
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL------- 56
Query: 104 NRCVQIRNW--FDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
+ IR + F + + IV E L+ L+ R P D V Q+L +A
Sbjct: 57 DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+H ++H D+K N+ L Y V K+ D G
Sbjct: 117 LHSKKILHRDIKSLNLFL--DAYDNV-------------------------KIGDLGVAK 149
Query: 221 YERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269
+ N+ IV T +Y +PE+ + D+W++G +L E CTG+ F
Sbjct: 150 LLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 2e-12
Identities = 54/236 (22%), Positives = 88/236 (37%), Gaps = 56/236 (23%)
Query: 46 KIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKH 99
+ K+GEG FG+V + ++K VA+K ++ ++ E ++++L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60
Query: 100 D-----KGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 152
G C + + IV E + G L +LRKN + DL+ A
Sbjct: 61 PNVVKLLGV--CTE-------EEPLYIVMEYMEGGD-LLSYLRKNRPKLSLSDLL-SFAL 109
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
Q+ + ++ IH DL N L V + +K
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCL-VGENLV--------------------------VK 142
Query: 213 VIDFGSTTYERPDQNYIVSTRH--YR--APEVILGLGWTYPCDIWSVGCILVELCT 264
+ DFG + D Y R APE + +T D+WS G +L E+ T
Sbjct: 143 ISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 45/259 (17%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD---KGGNRCV 107
+G G FG+V + K + A+K +R ++ ++ +V A+ D + N V
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLR-----KKDVLLRNQVAHVKAERDILAEADNEWV 63
Query: 108 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRS-------FPIDLVREIARQLLECIAF 160
+R ++ +++ + F + D++ + S FP DL R +L +
Sbjct: 64 -VRLYYSFQDKDNLYF------VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVES 116
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPD---------------YKSSLHTPKDSSYFKRM 205
+H + IH D+KP+N+L+ +IK+ D Y+S H +DS F
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 206 PKSSA-------IKVIDF-GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 257
A +K ++ + ++R + +V T +Y APEV+L G+T CD WSVG
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 258 ILVELCTGEALFQTHENLE 276
IL E+ G+ F LE
Sbjct: 237 ILYEMLVGQPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 65/262 (24%), Positives = 113/262 (43%), Gaps = 38/262 (14%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
K+GEG+ G V ++ + VA+K + K+ R + V+ + H+ V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN----VVDM 84
Query: 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
N + + + +V E L G +L D + + + + +L ++++H+ +IH
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIATVCLSVLRALSYLHNQGVIH 141
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 228
D+K +++LL S IK+ D+ K E P +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSK------------------------EVPKRKS 177
Query: 229 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 288
+V T ++ APEVI L + DIWS+G +++E+ GE + N L M R+ L
Sbjct: 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP---PYFNEPPLQAMRRIRDNL 234
Query: 289 PQHMLKRVDRHAEKYVRRGRLD 310
P + D H V RG LD
Sbjct: 235 PPRV---KDSHKVSSVLRGFLD 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 34/204 (16%)
Query: 138 NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHT 195
Y +F D+ R + + I +H L IH D+KP+N+L+ +IK+ D+ S H
Sbjct: 94 KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153
Query: 196 PKDSSYFKRMPKSSAIK---------VIDFGSTTYERPDQ------------NYIVSTRH 234
DS+Y++++ + + K +D + T DQ V T
Sbjct: 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213
Query: 235 YRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF---QTHENL-------EHLAMMERV 284
Y APE+ L G+ CD WS+G I+ E G F +HE E L + +
Sbjct: 214 YIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI 273
Query: 285 -LGPLPQHMLKRVDRHAEKYVRRG 307
L + +++R+ +AE + RG
Sbjct: 274 HLSVEAEDLIRRLITNAENRLGRG 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 3e-12
Identities = 65/230 (28%), Positives = 99/230 (43%), Gaps = 55/230 (23%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ----LAKHDKG--- 102
K+G+G+FG+V + D +++VAIKI+ E A EIE +QQ L++ D
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 103 ---GNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLE 156
G+ + W I+ E LG S D L P+D + I R++L+
Sbjct: 66 KYYGSYLKDTKLW--------IIMEYLGGGSALDLLEPG-----PLDETQIATILREILK 112
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
+ ++H IH D+K NVLL +K+ D+ +
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------------------------ 148
Query: 217 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266
G T + +N V T + APEVI + DIWS+G +EL GE
Sbjct: 149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 75/340 (22%), Positives = 134/340 (39%), Gaps = 87/340 (25%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 106
+G+G FG+V C R +M A K + + IKK + +M E ++L+++
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-----NSRFV 62
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + ++ ++ +C+V + G L + F A ++ + +H
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+++ DLKPEN+LL +I++ D ++H P+ + R
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--------------------- 161
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
V T Y APEV+ +T+ D W++GC+L E+ G++ FQ +
Sbjct: 162 ----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK------------ 205
Query: 286 GPLPQHMLKRVDR-HAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
K++ R E+ V+ E + + S P ++L
Sbjct: 206 --------KKIKREEVERLVKEV----QEEYSEKFS-------PDARSLCKM-------- 238
Query: 345 LTHLLQGLLRYDPTDRL-----TAREALRHPFFTRDHLRR 379
LL DP +RL ARE HP F + + +R
Sbjct: 239 -------LLCKDPKERLGCQGGGAREVKEHPLFKQINFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 75/280 (26%), Positives = 109/280 (38%), Gaps = 84/280 (30%)
Query: 120 CIVFEKLGSSLYDFLRKNNYRSFPIDL--VREIARQLLECIAFMHDLCMIHTDLKPENVL 177
C+V K S LY +L R P+ L V +ARQLL I ++H +IH D+K ENVL
Sbjct: 236 CLVLPKYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVL 292
Query: 178 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER-----PDQNYIVST 232
++ P+D I + DFG+ + R P I T
Sbjct: 293 ---------------VNGPED------------ICLGDFGAACFARGSWSTPFHYGIAGT 325
Query: 233 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA-LFQTHENLEHLAMMERVLGPLPQH 291
APEV+ G +T DIWS G ++ E A LF E ++L
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL------ 379
Query: 292 MLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG-------- 343
R+ R A+ +V ++P+ A SR L+ Q+ +A
Sbjct: 380 ---RIIRQAQVHVD----EFPQHAGSR--------------LVSQYRHRAARNRRPAYTR 418
Query: 344 -----------DLTHLLQGLLRYDPTDRLTAREALRHPFF 372
D+ +L+ L +D R +A E LR P F
Sbjct: 419 PAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458
|
Length = 461 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 38/226 (16%)
Query: 49 SKMGEGTFGQV-LECWDRER---KEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKG 102
++GEG FG+V L +D E VA+K + G +++R EIE+L+ L H+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN- 67
Query: 103 GNRCVQIRNWFD--YRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
V+ + + + ++ E L S SL D+L+++ + L+ + Q+ + +
Sbjct: 68 ---IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL-FSSQICKGMD 123
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDFGS 218
++ IH DL N+L+ S + +K+ D+ + P+D Y+ + P S I
Sbjct: 124 YLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF------ 177
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264
+ APE + ++ D+WS G L EL T
Sbjct: 178 ----------------WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 40/226 (17%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDK 101
KI K+G+G F V + +VA+K V+ K R+ + EI++L+QL H
Sbjct: 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPN 63
Query: 102 GGNRCVQIRNWFDYRNHICIVFE-----KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 156
++ F N + IV E L + F K R P + + QL
Sbjct: 64 ----VIKYLASFIENNELNIVLELADAGDLSRMIKHF--KKQKRLIPERTIWKYFVQLCS 117
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
+ MH ++H D+KP NV + ++ +K+ D R F
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLG-----------LGRF----------F 156
Query: 217 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262
S T + +V T +Y +PE I G+ + DIWS+GC+L E+
Sbjct: 157 SSKTTA---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 63/272 (23%), Positives = 103/272 (37%), Gaps = 61/272 (22%)
Query: 113 FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 171
F ++C+V + G L+ L++ + ++ R A ++L + ++H L +++ DL
Sbjct: 70 FQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDL 129
Query: 172 KPENVLLVSSEYIKVPDYKSSLHTP-------KDSSYFKRMPKSSAIKVIDFGSTTYERP 224
KPEN+LL S +I + D+ S + K R ++I F R
Sbjct: 130 KPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR- 188
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
N V T Y APEVI G G D W++G +L E+ G F+
Sbjct: 189 -SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK-------------- 233
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
G+ E+ +++K S+
Sbjct: 234 -----------------------------GSNRDETFSNILKKEV---TFPGSPPVSS-S 260
Query: 345 LTHLLQGLLRYDPTDRL----TAREALRHPFF 372
L++ LL DP+ RL A E +HPFF
Sbjct: 261 ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 19/147 (12%)
Query: 142 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD------------- 188
F DL R +L I +H + IH D+KP+N+L+ +IK+ D
Sbjct: 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 189 --YKSSLHTPKDS-SYFKRM--PKSSAIKVID-FGSTTYERPDQNYIVSTRHYRAPEVIL 242
Y+ H +DS + +K ++ ++R + +V T +Y APEV+L
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 243 GLGWTYPCDIWSVGCILVELCTGEALF 269
G+T CD WSVG IL E+ G+ F
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 74/327 (22%), Positives = 130/327 (39%), Gaps = 84/327 (25%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
K+GEG+ G V D+ VA+K + K+ R + V+ + +H V++
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN----IVEM 81
Query: 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
+ + + + +V E L G +L D + + + + +L+ ++F+H +IH
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIATVCLAVLKALSFLHAQGVIH 138
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STTYERPD 225
D+K +++LL S +K+ DFG + E P
Sbjct: 139 RDIKSDSILLTSD---------------------------GRVKLSDFGFCAQVSKEVPR 171
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
+ +V T ++ APEVI L + DIWS+G +++E+ GE + N L M+R+
Sbjct: 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP---PYFNEPPLQAMKRIR 228
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
LP + ++ K PRL++ + +
Sbjct: 229 DNLPPKL-----KNLHKVS-----------------------PRLRSFLDR--------- 251
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFF 372
+L DP R TA E L HPF
Sbjct: 252 ------MLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 76/335 (22%), Positives = 125/335 (37%), Gaps = 94/335 (28%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR----C 106
+G+GTFG+V+ ++ + A+KI++ +E + + EV L + N
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILK-----KEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
++ F ++ +C V E + G L+ L + R F D R +++ + ++H
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK 115
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+++ DLK EN++L +IK+ D+ D++ K
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF-------------------- 155
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 283
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 156 ----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+ K PR +
Sbjct: 212 I-----------------------------------------KFPRTL----------SA 220
Query: 344 DLTHLLQGLLRYDPTDRL-----TAREALRHPFFT 373
D LL GLL DP RL A+E +RH FFT
Sbjct: 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 61/248 (24%), Positives = 106/248 (42%), Gaps = 38/248 (15%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
+G G FG V C + +++V IK + + K R AA E +VL+ L+ + +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN-----II 62
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+ F + IV E G +L ++++K D + Q+L + +H +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI 122
Query: 167 IHTDLKPENVLLVSSEYI-KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+H DLK +N+LL + + K+ D+ S K++ S Y
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGIS-------------------KILSSKSKAYT--- 160
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM--MER 283
+V T Y +PE+ G + DIW++GC+L EL + + F+ NL L + M
Sbjct: 161 ---VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKIMSG 216
Query: 284 VLGPLPQH 291
P+
Sbjct: 217 TFAPISDR 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 76/339 (22%), Positives = 124/339 (36%), Gaps = 107/339 (31%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 106
+G G+FG+V + E AIK ++ + K + E +L +L+
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH-----PFI 80
Query: 107 VQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + F N + + E +G L+ LRK FP D+ + +L+ ++H
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+I+ DLKPEN+LL + ++KV D+ + K++ PD
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDF----------GFAKKV------------------PD 170
Query: 226 QNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG------EALFQTHENLEHL 278
+ + + T Y APEVI G D W++G +L E G + F+ +E
Sbjct: 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK---- 226
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
+ GRL +P
Sbjct: 227 -------------------------ILAGRLKFP-----------------------NWF 238
Query: 339 DHSAGDLTHLLQGLLRYDPTDRLTA-----REALRHPFF 372
D A D L++GLL+ D T RL + HP+F
Sbjct: 239 DGRARD---LVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 67/249 (26%), Positives = 114/249 (45%), Gaps = 35/249 (14%)
Query: 46 KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
++ K+G+G FG+V + W+ K VAIK ++ EA + E +++++L +HDK
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVP 65
Query: 105 RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
+ I IV E +G SL DFL++ + + + + ++A Q+ + +A++
Sbjct: 66 LYAVVS-----EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ IH DL+ N+L+ + K+ D+ + +D+ Y R IK
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLA-RLIEDNEYTARQGAKFPIK----------- 168
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 282
+ APE L +T D+WS G +L EL T G + N E L +E
Sbjct: 169 -----------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
Query: 283 R-VLGPLPQ 290
R P PQ
Sbjct: 218 RGYRMPCPQ 226
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 73/326 (22%), Positives = 130/326 (39%), Gaps = 78/326 (23%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
K+GEG+ G V + ++VA+K + K+ R + V+ + +H+ V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN----VVEM 82
Query: 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
N + + + +V E L G +L D + + + + +L+ ++ +H +IH
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLKALSVLHAQGVIH 139
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 228
D+K +++LL +K+ D+ K E P +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSK------------------------EVPRRKS 175
Query: 229 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 288
+V T ++ APE+I L + DIWS+G +++E+ GE + L+ + M+
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------- 228
Query: 289 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348
R + P P+L+NL V S L
Sbjct: 229 -------------------RDNLP---------------PKLKNL--HKVSPS---LKGF 249
Query: 349 LQGLLRYDPTDRLTAREALRHPFFTR 374
L LL DP R TA E L+HPF +
Sbjct: 250 LDRLLVRDPAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 65/249 (26%), Positives = 116/249 (46%), Gaps = 36/249 (14%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAM-IEIEVLQQLAKHDKGGNRC 106
K+G G FG+V + +E K + RG+K+ ++ + IE+ V+++L KH
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYI 78
Query: 107 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPI------DLVREIARQLLECIAF 160
+ N + + +I + F G L +N + + + + +I RQLL +A+
Sbjct: 79 DRFLNKANQKLYILMEFCDAGD-----LSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133
Query: 161 MHDLC-------MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 213
H+L ++H DLKP+N+ L S I+ H K ++ + K+
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFL--STGIR--------HIGKITAQANNLNGRPIAKI 183
Query: 214 IDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALF 269
DFG + + + V T +Y +PE++L +Y D+W++GCI+ ELC+G+ F
Sbjct: 184 GDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
Query: 270 QTHENLEHL 278
N L
Sbjct: 244 HKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 34/237 (14%)
Query: 50 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108
K+G G FG+V + W+ K VA+K ++ E+ + E +++++L +HDK VQ
Sbjct: 13 KLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKL-RHDK----LVQ 65
Query: 109 IRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
+ I IV E + SL DFL+ R+ + + ++A Q+ +A++ + I
Sbjct: 66 LYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 227
H DL+ N+L+ K+ D+ + +D+ Y R IK
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLA-RLIEDNEYTARQGAKFPIK--------------- 168
Query: 228 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 283
+ APE L +T D+WS G +L EL T G + N E L +ER
Sbjct: 169 -------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 79/335 (23%), Positives = 131/335 (39%), Gaps = 96/335 (28%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAA--MIEIEVLQQLAKHDKGGNRC 106
+G+G+FG+VL + + A+K++ + I K +E M E VL + KH
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP----FL 58
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + F + + V + + G L+ L++ RSFP R A ++ + ++H L
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN 116
Query: 166 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
+I+ DLKPEN+LL S ++ + D+ K + K +S F P+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE--------------- 161
Query: 223 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282
Y APEV+ + D W +G +L E+ G F + + E M +
Sbjct: 162 ------------YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYD 206
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH-VDHS 341
+L + L ++ + S
Sbjct: 207 NILN--------------------------------------------KPLRLKPNISVS 222
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALR----HPFF 372
A HLL+GLL+ D T RL A++ H FF
Sbjct: 223 A---RHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 74/338 (21%), Positives = 126/338 (37%), Gaps = 101/338 (29%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-------EAAMIEIEVLQQLAKHDKGG 103
+G+G+FG+VL + E+ A+K++ KK E M E VL KH
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVL---KKDVILQDDDVECTMTEKRVLALAGKHP--- 56
Query: 104 NRCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
Q+ + F ++ + V E + G ++ R F R A +++ + F+
Sbjct: 57 -FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFL 112
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H+ +I+ DLK +NVLL S +IK+ D+ M K I G TT
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKIADFG--------------MCKEG----ILGGVTT- 153
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLA 279
+ T Y APE++ + D W++G +L E+ G++ F + L
Sbjct: 154 -----STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339
+ + V P+ + S+E+
Sbjct: 209 LEDEVR--YPRWL------------------------SKEAKS----------------- 225
Query: 340 HSAGDLTHLLQGLLRYDPTDRL----TAREALR-HPFF 372
+L+ L +P RL T + ++ HPFF
Sbjct: 226 --------ILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 84/347 (24%), Positives = 134/347 (38%), Gaps = 108/347 (31%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 106
+G+G+FG+V++ R+ + + A+K +R + + E VL Q+ C
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV--------NC 52
Query: 107 ---VQIRNWFDYRNHICIVFEKL-GSSLYDFLRK----NNYRSFPIDLVREIARQLLECI 158
V ++ F + +V + G L+ L++ + R+ R +LL +
Sbjct: 53 PFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA------RFYTAELLCAL 106
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
+H +I+ DLKPEN+LL DY+ I + DFG
Sbjct: 107 ENLHKFNVIYRDLKPENILL---------DYQGH------------------IALCDFGL 139
Query: 219 TTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275
D N T Y APE++LG G+T D W++G +L E+ TG
Sbjct: 140 CKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG---------- 189
Query: 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335
LP + V+ K ++ L +P+G
Sbjct: 190 ------------LPPFYDENVNEMYRKILQE-PLRFPDG--------------------- 215
Query: 336 QHVDHSAGDLTHLLQGLLRYDPTDRL---TAREALRHPFFTRDHLRR 379
D A D LL GLL DPT RL A+E HPFF++ ++
Sbjct: 216 --FDRDAKD---LLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKK 257
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 57/236 (24%), Positives = 102/236 (43%), Gaps = 58/236 (24%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110
+G GT+GQV + + ++ AIK++ + E +EI +L++ + H R
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHH----------R 73
Query: 111 NWFDY------------RNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLEC 157
N Y + + +V E G+ S+ D ++ + D + I R++L
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+A +H +IH D+K +NVLL +++ +K++DFG
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLT---------------------------ENAEVKLVDFG 166
Query: 218 -STTYERP--DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTG 265
S +R +N + T ++ APEVI + Y DIWS+G +E+ G
Sbjct: 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 4e-11
Identities = 54/235 (22%), Positives = 92/235 (39%), Gaps = 54/235 (22%)
Query: 50 KMGEGTFGQVLEC-WDR--ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGN 104
K+GEG FG+V + + VA+K ++ ++ R+ + E V+++L H
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPN--- 57
Query: 105 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN-NYRSFPI-------DLVREIARQL 154
V++ + +V E + G L D+LRK+ P DL+ A Q+
Sbjct: 58 -VVRLLGVCTEEEPLYLVLEYMEGGD-LLDYLRKSRPVFPSPEKSTLSLKDLLS-FAIQI 114
Query: 155 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 214
+ + ++ +H DL N L V + + +K+
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCL-VGEDLV--------------------------VKIS 147
Query: 215 DFGSTTYERPDQNYIVSTR---HYR--APEVILGLGWTYPCDIWSVGCILVELCT 264
DFG + D Y T R APE + +T D+WS G +L E+ T
Sbjct: 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 78/339 (23%), Positives = 131/339 (38%), Gaps = 85/339 (25%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 106
+G+G FG+V C R +M A K + + IKK + +M E ++L+++
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-----NSQFV 62
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + ++ ++ +C+V + G L + F + A ++L + +H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
++ DLKPEN+LL +I++ D ++ P+ S R
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR--------------------- 161
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
V T Y APEV+ +T D W +GC++ E+ G++ F+ E+V
Sbjct: 162 ----VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR--------GRKEKV- 208
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
+ + +RV E Y A E KS+ K+
Sbjct: 209 --KREEVDRRVLETEEVY----------SAKFSEEAKSICKM------------------ 238
Query: 346 THLLQGLLRYDPTDRL-----TAREALRHPFFTRDHLRR 379
LL DP RL A E RHPFF + +R
Sbjct: 239 ------LLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 62/242 (25%), Positives = 106/242 (43%), Gaps = 46/242 (19%)
Query: 48 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRC 106
+ K+G+G G V D + VAIK + K+ ++ +I EI V+++L +
Sbjct: 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN------ 77
Query: 107 VQIRNWFDYR---NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
I N+ D + + +V E L G SL D + + I V R+ L+ + F+H
Sbjct: 78 --IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLH 132
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---ST 219
+IH D+K +NVLL ++K+ DFG
Sbjct: 133 ANQVIHRDIKSDNVLL---------------------------GMDGSVKLTDFGFCAQI 165
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
T E+ ++ +V T ++ APEV+ + DIWS+G + +E+ GE + L L
Sbjct: 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225
Query: 280 MM 281
++
Sbjct: 226 LI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 68/329 (20%), Positives = 128/329 (38%), Gaps = 88/329 (26%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQ 108
+G G +G V +VA+KI+ + + I E+ +L QL + + N
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQL-RQSQPPN---I 64
Query: 109 IRNWFDYRN--HICIVFEKL-GSSLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHD 163
+ + Y + I+ E G S+ ++ PI + I R++L + ++H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHK 119
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ +IH D+K N+L+ ++ +K+ D+ + ++SS KR +T+
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KR--------------STF-- 161
Query: 224 PDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282
V T ++ APEVI G + DIWS+G + E+ TG + +
Sbjct: 162 ------VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------- 208
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342
R + +P+ K PRL++ + +
Sbjct: 209 RAMMLIPKS----------------------------------KPPRLED------NGYS 228
Query: 343 GDLTHLLQGLLRYDPTDRLTAREALRHPF 371
L + L +P +RL+A E L+ +
Sbjct: 229 KLLREFVAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 57/228 (25%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
++G G+FG V D E+VAIK K + E Q + K + +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIK------KMSYSGKQSNEKWQDIIKEVRFLQQLRH- 74
Query: 110 RNWFDY-----RNHIC-IVFEK-LGSS--LYDFLRKNNYRSFPIDLVREIA---RQLLEC 157
N +Y R H +V E LGS+ + + +K P+ V EIA L+
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK------PLQEV-EIAAICHGALQG 127
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+A++H IH D+K N+LL + +K+ DFG
Sbjct: 128 LAYLHSHERIHRDIKAGNILLT---------------------------EPGTVKLADFG 160
Query: 218 STTYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 262
S + P ++ V T ++ APEVIL + + D+WS+G +EL
Sbjct: 161 SASLVSPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 43/220 (19%)
Query: 50 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108
++G G FG V L W +RK VAIK +R E + E +V+ +L+ + VQ
Sbjct: 11 EIGSGQFGLVWLGYWLEKRK--VAIKTIREGAMSEEDFIEEAQVMMKLSH-----PKLVQ 63
Query: 109 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
+ R+ IC+VFE + L D+LR F + + + + E +A++ +I
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVI 122
Query: 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 227
H DL N L+ ++ +KV DFG T + DQ
Sbjct: 123 HRDLAARNCLV---------------------------GENQVVKVSDFGMTRFVLDDQ- 154
Query: 228 YIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVEL 262
Y ST + +PEV ++ D+WS G ++ E+
Sbjct: 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 23/151 (15%)
Query: 142 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK--SSLHTPKDS 199
FP L R +L I +H + IH D+KP+N+L+ +IK+ D+ + +S
Sbjct: 98 FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157
Query: 200 SYFKR--------MPKS------SAIKVIDFGSTTYERPDQNY-------IVSTRHYRAP 238
Y+++ M S S + D T +R + + +V T +Y AP
Sbjct: 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAP 217
Query: 239 EVILGLGWTYPCDIWSVGCILVELCTGEALF 269
EV+L G+T CD WSVG IL E+ G+ F
Sbjct: 218 EVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 79/341 (23%), Positives = 135/341 (39%), Gaps = 53/341 (15%)
Query: 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 98
V ++ + + G+ G+V + + V +KI G K +IE +LQ +
Sbjct: 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI--GQKG---TTLIEAMLLQNV-N 115
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
H +++++ C+V S LY +L K + R PID I +Q+LE +
Sbjct: 116 HPS----VIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGL 170
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
++H +IH D+K EN+ + + + + D ++ + P V+
Sbjct: 171 RYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAA-----------QFP------VVA--- 210
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
P + T APEV+ + DIWS G +L E+ A T
Sbjct: 211 -----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML---AYPSTIFEDPPS 262
Query: 279 AMMERVLGPLPQHMLKRVDR---HAEKYVRRGRLDWPEGAASRESIK--SVMKLPRLQNL 333
E V H+LK + H E++ R P R I+ S+ + P +
Sbjct: 263 TPEEYVKSC-HSHLLKIISTLKVHPEEFPRD-----PGSRLVRGFIEYASLERQPYTRYP 316
Query: 334 IMQHVD-HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
Q V+ G+ L+ +L +D R +A E L +P F
Sbjct: 317 CFQRVNLPIDGEF--LVHKMLTFDAAMRPSAEEILNYPMFA 355
|
Length = 357 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 64/252 (25%), Positives = 106/252 (42%), Gaps = 56/252 (22%)
Query: 38 IVFSAFAD-----KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV 92
I+F +F D +I +G+GT+G+V + +++ A+KI+ I E E +
Sbjct: 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI 67
Query: 93 LQQLAKHDKGGNRCVQIRNWF---DYRN--HICIVFEKL-GSSLYD----FLRKNNYRSF 142
L+ L+ H V+ + D +N + +V E G S+ D FL++
Sbjct: 68 LKALSDHPN----VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEE 123
Query: 143 PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202
PI + I + L + +H IH D+K N+LL +
Sbjct: 124 PI--IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT---------------------- 159
Query: 203 KRMPKSSAIKVIDFGST---TYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWS 254
+K++DFG + T R +N V T + APEVI L + CD+WS
Sbjct: 160 -----EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS 214
Query: 255 VGCILVELCTGE 266
+G +EL G+
Sbjct: 215 LGITAIELGDGD 226
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 46/225 (20%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA-----KHDKGG 103
S++GEG G V +C + + A+K + ++ ++L++L K
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSCKSP--- 59
Query: 104 NRCVQIRNWF--DYRNHICIVFEKLGS----SLYDFLRKNNYRSFPIDLVREIARQLLEC 157
V+ F + + I I E S+Y ++K R L + IA +L+
Sbjct: 60 -YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK-IAESVLKG 117
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
++++H +IH D+KP N+LL +K+ D+ S ++++
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG------------------ELVNSL 159
Query: 218 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262
+ T+ T Y APE I G ++ D+WS+G L+E+
Sbjct: 160 AGTF--------TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 68/257 (26%), Positives = 105/257 (40%), Gaps = 54/257 (21%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110
+G+G+FG+V +VR I + ++VL++ + R R
Sbjct: 4 LGQGSFGKVF--------------LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMER 49
Query: 111 NWFDYRNHICIV-----FEKLGSSLY---DFLRKNNYRS-------FPIDLVREIARQLL 155
+ NH IV F+ G LY DFLR + + F + V+ +L
Sbjct: 50 DILAEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 108
Query: 156 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 215
+ +H L +I+ DLKPEN+LL +IK+ D+ S K+S ID
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS----KES--------------ID 150
Query: 216 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275
Y T Y APEV+ G T D WS G ++ E+ TG FQ +
Sbjct: 151 HEKKAYS------FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK 204
Query: 276 EHLAMMERVLGPLPQHM 292
E + M+ + +PQ +
Sbjct: 205 ETMTMILKAKLGMPQFL 221
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 63/261 (24%), Positives = 108/261 (41%), Gaps = 54/261 (20%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ-- 108
+G+GTFG+V+ ++ A+KI++ +E + + EV L + NR +Q
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILK-----KEVIVAKDEVAHTLTE-----NRVLQNS 52
Query: 109 -------IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
++ F + +C V E G L+ L + R F D R +++ + +
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDY 110
Query: 161 MH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
+H + +++ DLK EN++L +IK+ D+ KD + K
Sbjct: 111 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-------------- 156
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEH 277
T Y APEV+ + D W +G ++ E+ G F Q HE L
Sbjct: 157 ----------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 206
Query: 278 LAMME-----RVLGPLPQHML 293
L +ME R L P + +L
Sbjct: 207 LILMEEIRFPRTLSPEAKSLL 227
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 7e-10
Identities = 60/240 (25%), Positives = 105/240 (43%), Gaps = 46/240 (19%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQ 108
K+G+G G V D + VAIK + ++ ++ +I EI V+++ N+
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE--------NKNPN 77
Query: 109 IRNWFDYR---NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
I N+ D + + +V E L G SL D + + I V R+ L+ + F+H
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALDFLHSN 134
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STTY 221
+IH D+K +N+LL ++K+ DFG T
Sbjct: 135 QVIHRDIKSDNILL---------------------------GMDGSVKLTDFGFCAQITP 167
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
E+ ++ +V T ++ APEV+ + DIWS+G + +E+ GE + L L ++
Sbjct: 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 41/228 (17%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 106
+G+G+FG+VL + + E A+K ++ I E M+E VL ++
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENP----FL 58
Query: 107 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREI--ARQLLECIAFMH 162
+ F + H+ V E L G ++ K + DL R A +++ + F+H
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-----DLYRATFYAAEIVCGLQFLH 113
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
+I+ DLK +NV+L +IK+ D+ M K + D ++T+
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFG--------------MCKENVFG--DNRASTF- 156
Query: 223 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270
T Y APE++ GL +T+ D WS G +L E+ G++ F
Sbjct: 157 -------CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 8e-10
Identities = 52/227 (22%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGG 103
+ S +G G G V + ++A K+V R+ + E++++ H+
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM-----HECRS 62
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
V F N+IC+ E + D + K P++++ +IA ++E + ++++
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 164 -LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
++H D+KP N+L+ S IK+ D+ S ++I+ + T+
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG------------------ELINSIADTF- 162
Query: 223 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269
V T Y +PE I G +T D+WS+G ++EL G+ F
Sbjct: 163 -------VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 8e-10
Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 35/228 (15%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREA-AMIEIEVLQQLAKHDKGGNRC 106
+G+G FG+V + +M A K + R KK E A++E E+L+++
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP-----FI 55
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + F+ + H+C+V + G L + R ++ V + Q+ I +H +
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+++ D+KPENVLL ++ D ++ G T +R
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD-------------------GKTITQR-- 154
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273
T Y APE++ ++YP D +++GC + E+ G F+ H+
Sbjct: 155 ----AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 50/234 (21%)
Query: 46 KIHSKMGEGTFGQV-LECWDRERK---EMVAIKIVRG--IKKYREAAMIEIEVLQQLAKH 99
K +GEG FG+V L C+D EMVA+K ++ ++ EI +L+ L
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 100 D---------KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 150
+ + G + +Q+ + + LGS L D+L K+ + L
Sbjct: 67 NIVKYKGCCSEQGGKGLQL----------IMEYVPLGS-LRDYLPKHKLNLAQLLL---F 112
Query: 151 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 210
A+Q+ E +A++H IH DL NVLL + +K+ D+ + P+ Y+
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-------- 164
Query: 211 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264
+V + G S + A E + ++Y D+WS G L EL T
Sbjct: 165 -RVREDGD------------SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 49/248 (19%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL-AKHD----KGGNR 105
+G G FG+V ++ + A+KI+R +A M+E E + + A+ D G
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILR------KADMLEKEQVAHIRAERDILVEADGAW 62
Query: 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL-----LECIA 159
V++ F + ++ ++ E L G + L K D + E A Q + I
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-------DTLSEEATQFYIAETVLAID 115
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPD---------------YKSSLHTPKDSSYFKR 204
+H L IH D+KP+N+LL + ++K+ D Y++ H P F+
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 205 MPKSSAIKVIDFGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 261
M + T+++ + V T Y APEV + G+ CD WS+G I+ E
Sbjct: 176 MNSKRK-------AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 262 LCTGEALF 269
+ G F
Sbjct: 229 MLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 76/339 (22%), Positives = 131/339 (38%), Gaps = 85/339 (25%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 106
+G+G FG+V C R +M A K + + IKK + AM E ++L+++
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-----NSRFV 62
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + ++ ++ +C+V + G L + F + A ++ + +H
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+++ DLKPEN+LL +I++ D ++ P+ G T R
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPE-------------------GETIRGR-- 161
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
V T Y APEV+ +T+ D W +GC++ E+ G++ F+ + +ER
Sbjct: 162 ----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-- 215
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
RV E+Y + + E A S
Sbjct: 216 ---------RVKEDQEEYSEK----FSEAARS---------------------------- 234
Query: 346 THLLQGLLRYDPTDRL-----TAREALRHPFFTRDHLRR 379
+ + LL DP RL A E HPFF + +R
Sbjct: 235 --ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 46 KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
++ K+G+G FG+V + W+ + VAIK ++ EA + E +V+++L +H+K
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 62
Query: 105 RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
VQ+ I IV E + SL DFL+ + + + ++A Q+ +A++
Sbjct: 63 -LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ +H DL+ N+L+ + KV D+ + +D+ Y R IK
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 168
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 282
+ APE L +T D+WS G +L EL T G + N E L +E
Sbjct: 169 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217
Query: 283 R 283
R
Sbjct: 218 R 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 59/240 (24%), Positives = 105/240 (43%), Gaps = 46/240 (19%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQ 108
K+G+G G V D + VAI+ + ++ ++ +I EI V+++ N+
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE--------NKNPN 78
Query: 109 IRNWFDYR---NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
I N+ D + + +V E L G SL D + + I V R+ L+ + F+H
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSN 135
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STTY 221
+IH D+K +N+LL ++K+ DFG T
Sbjct: 136 QVIHRDIKSDNILL---------------------------GMDGSVKLTDFGFCAQITP 168
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
E+ ++ +V T ++ APEV+ + DIWS+G + +E+ GE + L L ++
Sbjct: 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 58/240 (24%), Positives = 101/240 (42%), Gaps = 52/240 (21%)
Query: 47 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRC 106
+ S +G G FG+V ++ ++ A+K+ +KK + ++ E + +
Sbjct: 5 VKSLVGRGHFGEVQVVREKATGDIYAMKV---MKK---SVLLAQETVSFFEEE----RDI 54
Query: 107 VQIRN--W-------FDYRNHICIVFEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQLL 155
+ I N W F ++++ +V E G L L N Y F D+ + +L+
Sbjct: 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELV 112
Query: 156 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 215
I +H + +H D+KPENVL+ + +IK+ D+ S+ + ++P
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP--------- 163
Query: 216 FGSTTYERPDQNYIVSTRHYRAPEVILGL----GWTY--PCDIWSVGCILVELCTGEALF 269
V T Y APEV+ + TY CD WS+G I E+ G + F
Sbjct: 164 --------------VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 75/332 (22%), Positives = 129/332 (38%), Gaps = 86/332 (25%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 106
+G+GTFGQV + ++ + + A+K++ + I +E A E +L + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE--SPFI 58
Query: 107 VQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V ++ F + + +V + G L+ L+K F D + +L+ + +H
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD 116
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+++ DLKPEN+LL ++ +I + D+ S D+ TT
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDN------------------KTT----- 153
Query: 226 QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
N T Y APEV+L G+T D WS+G ++ E+C G + F
Sbjct: 154 -NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF--------------- 197
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
Q M + + G++ +P+ S E
Sbjct: 198 YAEDTQQMYRN--------IAFGKVRFPKNVLSDEG------------------------ 225
Query: 345 LTHLLQGLLRYDPTDRL----TAREALRHPFF 372
++GLL +P RL A E HPFF
Sbjct: 226 -RQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 40/283 (14%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
+G+G++G+V R + IK + ++ R+AA E ++L QL KH N
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHP---NIVA 63
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+W + IV G LY L++ + P + V E Q+ + ++H+ +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
+H DLK +NV L + IKV D R+ ++ D ST
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLG-----------IARVLENQC----DMAST------- 161
Query: 227 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL- 285
++ T +Y +PE+ + Y D+W++GC + E+ T + F + +++ R++
Sbjct: 162 --LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK---DMNSLVYRIIE 216
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328
G LP M K + + PE R S+KS+++ P
Sbjct: 217 GKLPP-MPKDYSPELGELIATMLSKRPE---KRPSVKSILRQP 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 60/289 (20%), Positives = 123/289 (42%), Gaps = 43/289 (14%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI- 109
+G GT+GQV + + ++ AIK++ E EI +L++ + H
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 110 -RNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
+N + + +V E G+ S+ D ++ + + + I R++L ++ +H +I
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 133
Query: 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP-- 224
H D+K +NVLL +++ +K++DFG S +R
Sbjct: 134 HRDIKGQNVLLT---------------------------ENAEVKLVDFGVSAQLDRTVG 166
Query: 225 DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
+N + T ++ APEVI + + D+WS+G +E+ G + L
Sbjct: 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 226
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328
++ R P P+ K+ + + ++ + + + R + + +MK P
Sbjct: 227 LIPR--NPAPRLKSKKWSKKFQSFIESCLV---KNHSQRPTTEQLMKHP 270
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 38/232 (16%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDK 101
+I K+G G F +V ++ VA+K V+ + K R+ + EI++L+QL +
Sbjct: 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN- 63
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKLG----SSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
++ + F N + IV E S + + +K R P V + QL
Sbjct: 64 ----VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQK-RLIPERTVWKYFVQLCSA 118
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+ MH ++H D+KP NV + ++ +K+ D R F
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-----------LGRF----------FS 157
Query: 218 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269
S T + +V T +Y +PE I G+ + DIWS+GC+L E+ ++ F
Sbjct: 158 SKTTA---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 68/324 (20%), Positives = 124/324 (38%), Gaps = 78/324 (24%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
K+GEG+ G V ++ VA+K++ K+ R + V+ + +H V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH----QNVVEM 83
Query: 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
+ + ++ E L G +L D + + I V E +L+ + ++H +IH
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCE---SVLQALCYLHSQGVIH 140
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 228
D+K +++LL +K+ D+ KD P +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDV------------------------PKRKS 176
Query: 229 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 288
+V T ++ APEVI + DIWS+G +++E+ GE + +
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--------------- 221
Query: 289 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348
P +KR+ R P + I V++
Sbjct: 222 PVQAMKRL-----------RDSPPPKLKNAHKISPVLR--------------------DF 250
Query: 349 LQGLLRYDPTDRLTAREALRHPFF 372
L+ +L +P +R TA+E L HPF
Sbjct: 251 LERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 59/245 (24%), Positives = 102/245 (41%), Gaps = 38/245 (15%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 106
+G+G+FG+VL + + A+K+++ +K ++ M E VL + KH
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHP----FL 58
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + F + V + + G L+ L++ RSFP R A ++ + ++H +
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN 116
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+++ DLKPEN+LL S ++ + D+ I D +T
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLC---------------KEGIAQSDTTTT------ 155
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF---QTHENLEHLAMME 282
T Y APEVI + D W +G +L E+ G F E +++
Sbjct: 156 ---FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212
Query: 283 RVLGP 287
VL P
Sbjct: 213 LVLRP 217
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 76/335 (22%), Positives = 121/335 (36%), Gaps = 94/335 (28%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMI-EIEVLQQLAKHDKGGNRC 106
+G+GTFG+V+ ++ A+KI+R I K A + E VLQ +H
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP----FL 57
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
++ F + +C V E G L+ L + R F + R +++ + ++H
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 115
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+++ D+K EN++L +IK+ D+ D + K
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-------------------- 155
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 283
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 156 ----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+ P R PE +
Sbjct: 212 IRFP--------------------RTLSPEAKS--------------------------- 224
Query: 344 DLTHLLQGLLRYDPTDRL-----TAREALRHPFFT 373
LL GLL+ DP RL A+E + H FF
Sbjct: 225 ----LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 35/236 (14%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRC 106
K+GEG+FG++ + E IK + K K +EA+ E+ +L ++ KH
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPN----I 61
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V F + IV E G L + + F D + Q+ + +HD
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121
Query: 166 MIHTDLKPENVLLVSSEYI-KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
++H D+K +N+ L + + K+ D+ + DS
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIA-RQLNDSMELAYT------------------- 161
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
V T +Y +PE+ + DIWS+GC+L ELCT + F+ + NL L +
Sbjct: 162 ----CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 46/225 (20%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQ 108
K+G+G G V D + VAIK + ++ ++ +I EI V+++ N+
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE--------NKHPN 77
Query: 109 IRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
I N+ D + + +V E L G SL D + + I V R+ L+ + F+H
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSN 134
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+IH D+K +N+LL ++K+ DFG P
Sbjct: 135 QVIHRDIKSDNILL---------------------------GMDGSVKLTDFGFCAQITP 167
Query: 225 DQN---YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266
+Q+ +V T ++ APEV+ + DIWS+G + +E+ GE
Sbjct: 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 52/226 (23%)
Query: 54 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113
G G C D + E V IK + R E +L+ + H +Q++ F
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAI-NHPS----IIQLKGTF 152
Query: 114 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 173
Y C++ + + LY +L R+ I + I R +L I ++H+ +IH D+K
Sbjct: 153 TYNKFTCLILPRYKTDLYCYL--AAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKA 210
Query: 174 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR 233
EN+ + + P D + + DFG+ + I + +
Sbjct: 211 ENIFI---------------NHPGD------------VCLGDFGAACFPVD----INANK 239
Query: 234 HY--------RAPEVILGLGWTYPCDIWSVGCILVELCTGE-ALFQ 270
+Y APE++ + DIWS G +L E+ T +LF+
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285
|
Length = 391 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 52/230 (22%), Positives = 94/230 (40%), Gaps = 59/230 (25%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKI--VRGIKKYREAAMI--EIEVLQQL---------- 96
+G GTFG+V DR + A+K+ + + + ++ + E VL+++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 97 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLL 155
+HD+ + ++ E + G L+ +LR N F A +++
Sbjct: 69 TEHDQ---------------RFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLFYASEIV 111
Query: 156 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 215
+ ++H +++ DLKPEN+LL +IK+ D+ A K+ D
Sbjct: 112 CALEYLHSKEIVYRDLKPENILLDKEGHIKLTDF------------------GFAKKLRD 153
Query: 216 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265
T + T Y APEVI G D W++G ++ E+ G
Sbjct: 154 RTWT---------LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 37/229 (16%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 106
+G+G FG+V C R +M A K + + IKK + AM E +L+++
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-----NSRFV 62
Query: 107 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI--ARQLLECIAFMHDL 164
V + ++ ++ +C+V + F N + D R I A +L + +
Sbjct: 63 VSLAYAYETKDALCLVLTIMNGGDLKF-HIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+++ DLKPEN+LL +I++ D ++ P+ G T R
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE-------------------GETVRGR- 161
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273
V T Y APEVI +T+ D W +GC++ E+ G++ F+ +
Sbjct: 162 -----VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIV----RGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++G G+FG V + E+VA+K + + + + + E++ LQQL KH
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPN---- 82
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
++ + + + +V E S D L + +++ I L+ +A++H
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHSHN 141
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
MIH D+K N+LL + +K+ DFGS + P
Sbjct: 142 MIHRDIKAGNILLT---------------------------EPGQVKLADFGSASKSSP- 173
Query: 226 QNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 262
N V T ++ APEVIL + + D+WS+G +EL
Sbjct: 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 63/255 (24%), Positives = 101/255 (39%), Gaps = 70/255 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+I +G+GT+G+V + +++ + A+KI+ I E E +LQ L H
Sbjct: 25 EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN---- 80
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC-------- 157
V+ F Y+ + G L+ L N S V E+ + LL C
Sbjct: 81 VVKFYGMF-YKADKLV-----GGQLWLVLELCNGGS-----VTELVKGLLICGQRLDEAM 129
Query: 158 IAF-----------MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 206
I++ +H+ +IH D+K N+LL +
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT-------------------------- 163
Query: 207 KSSAIKVIDFGST---TYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVGCI 258
+K++DFG + T R +N V T + APEVI + CD+WS+G
Sbjct: 164 -EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT 222
Query: 259 LVELCTGE-ALFQTH 272
+EL G+ LF H
Sbjct: 223 AIELGDGDPPLFDMH 237
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 65/319 (20%), Positives = 129/319 (40%), Gaps = 77/319 (24%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110
+G G++ +VL ++ ++ A+K+V+ + + + ++ + + + V +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 111 NWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
+ F + + +V E + G ++ R+ R P + R A ++ + F+H+ +I+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERGIIY 119
Query: 169 TDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
DLK +NVLL + +IK+ DY K L +S F P
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP------------------- 160
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
NYI APE++ G + + D W++G ++ E+ G + F
Sbjct: 161 -NYI-------APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI-------------- 198
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
+ D + E Y+ + L+ P +++PR ++ HV
Sbjct: 199 ------ITDNPDMNTEDYLFQVILEKP------------IRIPRFLSVKASHV------- 233
Query: 346 THLLQGLLRYDPTDRLTAR 364
L+G L DP +RL +
Sbjct: 234 ---LKGFLNKDPKERLGCQ 249
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 64/241 (26%), Positives = 111/241 (46%), Gaps = 34/241 (14%)
Query: 46 KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
K+ K+G G FG+V + +++ K VA+K ++ EA + E V++ L +HDK
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTL-QHDK--- 62
Query: 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
V++ + + I I+ E + SL DFL+ + P+ + + + Q+ E +AF+
Sbjct: 63 -LVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
IH DL+ N+L+ +S K+ D+ + +D+ Y R IK
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIK----------- 168
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 282
+ APE I +T D+WS G +L+E+ T G + N E + +E
Sbjct: 169 -----------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 217
Query: 283 R 283
R
Sbjct: 218 R 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 35/241 (14%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL-AKHD----KGGNR 105
+G G FG+V ++ + A+KI+R +A M+E E + + A+ D
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILR------KADMLEKEQVGHIRAERDILVEADSLW 62
Query: 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL-----LECIA 159
V++ F + ++ ++ E L G + L K D + E Q + I
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLAID 115
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYK--SSLHTPKDSSYFKRMPKS--SAIKVID 215
+H L IH D+KP+N+LL S ++K+ D+ + L + +++ + S S +
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 216 FGST----TYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 268
S T++R + V T Y APEV + G+ CD WS+G I+ E+ G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 269 F 269
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 59/222 (26%), Positives = 90/222 (40%), Gaps = 45/222 (20%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
++G G+FG V D E+VAIK K + E Q + K K R ++
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIK------KMSYSGKQSNEKWQDIIKEVKFLQR-IKH 84
Query: 110 RNWFDY-----RNHIC-IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
N +Y R H +V E S D L + +++ I L+ +A++H
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHS 143
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
MIH D+K N+LL + +K+ DFGS +
Sbjct: 144 HNMIHRDIKAGNILLT---------------------------EPGQVKLADFGSASIAS 176
Query: 224 PDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 262
P N V T ++ APEVIL + + D+WS+G +EL
Sbjct: 177 P-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 36/231 (15%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDK 101
+I K+G G F +V VA+K V+ K R + EI++L+QL +
Sbjct: 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN- 63
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLLECI 158
++ F N + IV E L ++ K R P V + QL +
Sbjct: 64 ----VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
MH ++H D+KP NV + ++ +K+ D +F K++A
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSS--KTTA-------- 162
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269
+ +V T +Y +PE I G+ + DIWS+GC+L E+ ++ F
Sbjct: 163 -------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 37/232 (15%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 106
+G+G+FG+V + + AIK ++ + E M+E VL +H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP----FL 58
Query: 107 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI--ARQLLECIAFMHDL 164
+ F + ++ V E L F ++ ++ DL R A +++ + F+H
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSK 115
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+++ DLK +N+LL + +IK+ D+ M K + + D + T+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFG--------------MCKENMLG--DAKTCTF--- 156
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276
T Y APE++LG + D WS G +L E+ G++ F H+ E
Sbjct: 157 -----CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 41/234 (17%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAA--MIEIEVLQQLAKHDKGGNRC 106
+G+G+FG+VL + ++ A+K++ + I K +E M E VL + KH
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP----FL 58
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + F + + V + + G L+ L++ R F R A ++ + ++H L
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN 116
Query: 166 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
+++ DLKPEN+LL S +I + D+ K ++ +S F P+
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE--------------- 161
Query: 223 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276
Y APEV+ + D W +G +L E+ G F + E
Sbjct: 162 ------------YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 57/248 (22%), Positives = 97/248 (39%), Gaps = 57/248 (22%)
Query: 51 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIE------IEVLQQLAKHDKGG 103
+G G FG V L W + VAIK++R E AM E +V+ +L+ H
Sbjct: 12 LGSGQFGVVHLGKWRGKID--VAIKMIR------EGAMSEDDFIEEAKVMMKLS-HPN-- 60
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
VQ+ + I IV E + + L ++LR+ + + + ++ + E + ++
Sbjct: 61 --LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLE 117
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
IH DL N LV + + +KV DFG Y
Sbjct: 118 SNGFIHRDLAARNC-LVGEDNV--------------------------VKVSDFGLARYV 150
Query: 223 RPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277
DQ Y S + PEV ++ D+WS G ++ E+ + + +E +
Sbjct: 151 LDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM--PYERFSN 207
Query: 278 LAMMERVL 285
++E V
Sbjct: 208 SEVVESVS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 46 KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
K+ K+G G FG+V + ++ K VAIK ++ EA + E +++QL +H
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHTK--VAIKSLKQGSMSPEAFLAEANLMKQL-QH----P 61
Query: 105 RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
R V++ + I I+ E + + SL DFL+ I+ + ++A Q+ E +AF+
Sbjct: 62 RLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
IH DL+ N+L+ + K+ D+ + +D+ Y R IK
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLA-RLIEDNEYTAREGAKFPIK----------- 168
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 282
+ APE I +T D+WS G +L E+ T G + N E + +E
Sbjct: 169 -----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE 217
Query: 283 R 283
R
Sbjct: 218 R 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 34/153 (22%)
Query: 117 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPE 174
I I E + G SL L+K P +++ +I+ +L + ++ + ++H D+KP
Sbjct: 72 GEISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPS 129
Query: 175 NVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVST 232
N+L+ S IK+ D+ S L DS N V T
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLI---DSM-------------------------ANSFVGT 161
Query: 233 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265
R Y +PE + G +T DIWS+G LVE+ G
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 52/229 (22%), Positives = 97/229 (42%), Gaps = 39/229 (17%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMI-EIEVLQQLAKHDKGGNRCV 107
G+G FG+V R+ K+M A+K + ++K ++ E +LQ+L H V
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NH----PFLV 63
Query: 108 QIRNWFDYRNHICIVFE-KLGSSL-YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
+ F ++ +V + LG L Y +K F + V+ +++ + ++H
Sbjct: 64 NLWYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+IH D+KP+N+LL ++ + D+ + D+ +T+
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-----------------TTST---- 159
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274
T Y APEV+ G++ D WS+G E G+ ++ H
Sbjct: 160 ----SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 30/170 (17%)
Query: 113 FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 171
F N++ +V + +G L L K R P D+ R +++ I +H L +H D+
Sbjct: 70 FQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQLHYVHRDI 128
Query: 172 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS 231
KP+NVLL + +I++ D+ S L +D + +SS V
Sbjct: 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTV-----QSSV------------------AVG 165
Query: 232 TRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALFQTHENLE 276
T Y +PE++ G+G P CD WS+G + E+ GE F +E
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 9e-08
Identities = 57/242 (23%), Positives = 99/242 (40%), Gaps = 41/242 (16%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 106
+G+G+FG+V+ + E AIK ++ E M+E VL +H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP----FL 58
Query: 107 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+ F + H+ V E L F +++ R F R A +++ + F+H +
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKKGI 117
Query: 167 IHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
I+ DLK +NVLL +IK+ D+ K +++ +S F
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF--------------------- 156
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMM 281
T Y APE++ G + D WS G +L E+ G++ F + + L +
Sbjct: 157 ------CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
Query: 282 ER 283
+R
Sbjct: 211 DR 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 33/162 (20%)
Query: 136 KNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194
K + F + + I Q++ + ++H + ++H DL P N++L +
Sbjct: 104 KEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD------------ 151
Query: 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDI 252
+ + DFG ++P+ +V T Y PE++ + D+
Sbjct: 152 ---------------KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADV 196
Query: 253 WSVGCILVELCTGEALFQTHENLEHLAM--MERVLGPLPQHM 292
W+ GCIL ++CT + F + N+ LA +E V PLP+ M
Sbjct: 197 WAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 43/228 (18%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIE--VLQQLAKHD--KGGN 104
+G G++ +VL ++ + + A+K+V+ + + ++ E V +Q + H G +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 105 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
C Q + R I + G ++ R+ R P + R + ++ + ++H+
Sbjct: 63 SCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER 115
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
+I+ DLK +NVLL S +IK+ DY K L +S F P
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP--------------- 160
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269
NYI APE++ G + + D W++G ++ E+ G + F
Sbjct: 161 -----NYI-------APEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 57/237 (24%), Positives = 101/237 (42%), Gaps = 41/237 (17%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHDKGGNRC 106
+G G FG+V + ++ A+KI+ + + A E +VL G N+
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN------GDNQW 62
Query: 107 VQIRNW-FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+ ++ F N++ +V + +G L L K R P D+ R +++ I +H L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQL 121
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+H D+KP+N+L+ + +I++ D+ S L +D +
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV----------------------- 158
Query: 225 DQNYIVSTRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALFQTHENLE 276
+ V T Y +PE++ G G P CD WS+G + E+ GE F +E
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 45/243 (18%)
Query: 50 KMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108
K+G G FG+V W+ K VA+K ++ EA + E +++++L +HDK VQ
Sbjct: 13 KLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKL-RHDK----LVQ 65
Query: 109 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
+ I IV E + SL DFL+ + + + ++A Q+ E +A++ I
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYI 125
Query: 168 HTDLKPENVLLVSSEYIKVPDY------KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H DL N+L+ + K+ D+ + +T ++ + + P IK
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA---KFP----IK--------- 169
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM 280
+ APE +T D+WS G +L E+ T G + N E L
Sbjct: 170 -------------WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216
Query: 281 MER 283
+ER
Sbjct: 217 VER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 35/242 (14%)
Query: 46 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
++ K+G G FG+V E W+ VA+K ++ + + E +++++L +H K
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKL-RHPK--- 62
Query: 105 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
+Q+ I IV E K GS L ++L+ R+ + + ++A Q+ +A++
Sbjct: 63 -LIQLYAVCTLEEPIYIVTELMKYGS-LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
IH DL NVL+ + KV D+ + K+ Y R IK
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLA-RVIKEDIYEAREGAKFPIK---------- 169
Query: 223 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 281
+ APE L ++ D+WS G +L E+ T G + N E L +
Sbjct: 170 ------------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
Query: 282 ER 283
++
Sbjct: 218 DQ 219
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 58/262 (22%), Positives = 102/262 (38%), Gaps = 65/262 (24%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD--KGGNRCVQ 108
+G G FG V + + ++A+K +R + E E + L D + C
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRST-------VDEKEQKRLLMDLDVVMRSSDCPY 64
Query: 109 IRNWFDYRNH-----IC-----IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
I ++ IC I +K +Y+ L+ P +++ +IA ++ +
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV----IPEEILGKIAVATVKAL 120
Query: 159 AFM-HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
++ +L +IH D+KP N+LL ++ IK+ DFG
Sbjct: 121 NYLKEELKIIHRDVKPSNILL---------------------------DRNGNIKLCDFG 153
Query: 218 STTYERPDQNYIVSTRH-----YRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALF 269
+ + I TR Y APE I G+ D+WS+G L E+ TG+ +
Sbjct: 154 ISGQL---VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210
Query: 270 QTHENL-EHLAMMERVLGPLPQ 290
++ + L + V G P
Sbjct: 211 PKWNSVFDQLTQV--VKGDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 47/186 (25%)
Query: 130 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 189
L+D L+K V++I RQL+E + +H +IH D+K ENVL
Sbjct: 96 LFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL------------ 141
Query: 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFG-------STTYERPDQNYIVSTRHYRAPEVIL 242
Y + + I + D+G + Y+ T Y +PE I
Sbjct: 142 -----------YDRAKDR---IYLCDYGLCKIIGTPSCYDG--------TLDYFSPEKIK 179
Query: 243 GLGWTYPCDIWSVGCILVELCTGEALFQTH--ENLEHLAMMERVLGPLPQHMLKRVDRHA 300
G + D W+VG + EL TG+ F+ E L+ ++++R LP +K V ++A
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP--FIKNVSKNA 237
Query: 301 EKYVRR 306
+V+
Sbjct: 238 NDFVQS 243
|
Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 43/227 (18%)
Query: 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIV----RGIKKYREAAMIEIEVLQQLAK 98
F+D ++G G+FG V D E+VAIK + + + + + E+ LQ+L +
Sbjct: 17 FSDL--REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-R 73
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
H +Q R + + +V E S D L + +++ + L+ +
Sbjct: 74 HPN----TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGL 128
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
A++H MIH D+K N+LL + +K+ DFGS
Sbjct: 129 AYLHSHNMIHRDVKAGNILLS---------------------------EPGLVKLGDFGS 161
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 262
+ P N V T ++ APEVIL + + D+WS+G +EL
Sbjct: 162 ASIMAP-ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 73/345 (21%), Positives = 139/345 (40%), Gaps = 77/345 (22%)
Query: 47 IHSKMGEGTFGQVLEC--WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
I S + G+ G+V C E+++ V +K V G K EI++L+ + +
Sbjct: 96 ILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR----EIDILKTI-------S 144
Query: 105 RCVQIR--NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
I + + +++ +C+V K L+ ++ ++ P++ I R+LLE +A++H
Sbjct: 145 HRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLH 202
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKS------SLHTPKDSSYFKRMPKSSAIKVIDF 216
+IH D+K EN+ L E + D+ + TP+ +
Sbjct: 203 GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW--------------- 247
Query: 217 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE-ALF--QTHE 273
T +PE++ + DIWS G +L E+ LF Q
Sbjct: 248 -------------SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
Query: 274 NLEHLAMMERVLG--PL--PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 329
+ L + R + PL PQ+ + +H ++Y R + ++ + R
Sbjct: 295 SSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPY-----------TIPPVIR 343
Query: 330 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
+ M D+ +L+ +L +D R +A++ L P FT+
Sbjct: 344 KYGMHM--------DVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380
|
Length = 392 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 59/241 (24%), Positives = 100/241 (41%), Gaps = 47/241 (19%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 106
+G+G+FG+VL + A+K+++ KK + M E VL + KH
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHP----FL 58
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + F + V + + G L+ L++ R F R A ++ I ++H L
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 166 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
+I+ DLKPEN+LL S ++ + D+ K + + +S F P+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPE--------------- 161
Query: 223 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF------QTHENLE 276
Y APEV+ + D W +G +L E+ G F Q ++N+
Sbjct: 162 ------------YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209
Query: 277 H 277
H
Sbjct: 210 H 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 40/218 (18%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108
+G G G V + + + ++A+K++ + ++ M E+E+L + +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-----PYIIG 63
Query: 109 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
F N I I E + G SL + YR P ++ IA +++ + ++ L ++
Sbjct: 64 FYGAFFVENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGLTYLWSLKIL 117
Query: 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 227
H D+KP N+L+ + +K+ D+ S ++++ + TY
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVS------------------TQLVNSIAKTY------ 153
Query: 228 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265
V T Y APE I G + D+WS+G +EL G
Sbjct: 154 --VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 73/334 (21%), Positives = 135/334 (40%), Gaps = 83/334 (24%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIE--VLQQLAKHD--KGGN 104
+G G++ +VL ++ + + A+K+++ + + ++ E V + + H G +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 105 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
C Q + R I F G ++ R+ R P + R + ++ + F+H+
Sbjct: 63 SCFQTES----RLFFVIEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER 115
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+I+ DLK +NVLL + +IK+ DY M K I+ D ST P
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYG--------------MCK-EGIRPGDTTSTFCGTP 160
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
NYI APE++ G + + D W++G ++ E+ G + F ++
Sbjct: 161 --NYI-------APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN------- 204
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
D++ E Y+ + L+ +++PR ++ V
Sbjct: 205 -----------PDQNTEDYLFQVILEKQ------------IRIPRSLSVKASSV------ 235
Query: 345 LTHLLQGLLRYDPTDRLTA------REALRHPFF 372
L+G L DP +RL R+ HPFF
Sbjct: 236 ----LKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 56/259 (21%), Positives = 95/259 (36%), Gaps = 83/259 (32%)
Query: 146 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205
+++ I RQ+L + +H ++H D+KP+N++
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF--------------------------S 289
Query: 206 PKSSAIKVIDFGSTT------------------YERPDQNYIVSTRHYRAPEVILGLG-- 245
S + K+ID G+ Y P+Q YI+ST+ AP +
Sbjct: 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQ-YIMSTQTPSAPSAPVATALS 348
Query: 246 ---WTYPC----DIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDR 298
W DI+S G I +++ F + +L R LKR D
Sbjct: 349 PVLWQLNLPDRFDIYSAGLIFLQMA-----FPNLRSDSNLIQFNR--------QLKRNDY 395
Query: 299 HAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358
+ R ++ R + V+ L D AG LL+ ++R+
Sbjct: 396 DLVAW--RKLVEPRASPDLRRGFE-VLDL-----------DGGAG--WELLKSMMRFKGR 439
Query: 359 DRLTAREALRHPFFTRDHL 377
R++A+ AL HP+F R+ L
Sbjct: 440 QRISAKAALAHPYFDREGL 458
|
Length = 566 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 37/221 (16%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQQLAKHDKGGNRC 106
S++G G G V + + ++A K++ IK R + E++VL H+
Sbjct: 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPYI 65
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V F I I E + G SL L++ + P +++ +++ +L +A++ +
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 166 MI-HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
I H D+KP N+L+ S IK+ D+ S ++ID + ++
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------QLIDSMANSF--- 162
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265
V TR Y +PE + G ++ DIWS+G LVEL G
Sbjct: 163 -----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 50/228 (21%)
Query: 51 MGEGTFGQVLEC----WDRERKEM-VAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGG 103
+G G FG+V+E + M VA+K+++ REA M E++++ L H+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE--- 99
Query: 104 NRCVQIRNWFDYRNH---ICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
I N I ++ E L +FLR+ ++ + + Q+ + +A
Sbjct: 100 ----NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
F+ IH DL NVLL + +K+ DFG
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGK---------------------------IVKICDFGLA 188
Query: 220 TYERPDQNYIV--STR---HYRAPEVILGLGWTYPCDIWSVGCILVEL 262
D NY+V + R + APE I +T+ D+WS G +L E+
Sbjct: 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 68/329 (20%), Positives = 132/329 (40%), Gaps = 84/329 (25%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
++G GT+G V + + E+ AIK+++ ++ + A+++ E++ + K K N
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIK-LEPGEDFAVVQQEII--MMKDCKHSNIVAYF 72
Query: 110 RNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDLCM 166
++ R+ + I E G SL D + + P+ + ++R+ L+ + ++H
Sbjct: 73 GSYLR-RDKLWICMEFCGGGSLQDIY----HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
+H D+K N+LL + ++K+ D+ S +T +R
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQ---------------------ITATIAKRKS- 165
Query: 227 NYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGE-ALFQTHENLEHLAMME 282
+ T ++ APEV G+ CDIW+VG +EL + +F H + L +M
Sbjct: 166 --FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP-MRALFLM- 221
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342
KS + P+L++ + +
Sbjct: 222 --------------------------------------TKSNFQPPKLKDKMKW-----S 238
Query: 343 GDLTHLLQGLLRYDPTDRLTAREALRHPF 371
H ++ L +P R TA + L+HPF
Sbjct: 239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 64/304 (21%), Positives = 110/304 (36%), Gaps = 94/304 (30%)
Query: 75 IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF 133
I++G++K E + + ++ + V + + + + +V + G L+
Sbjct: 22 ILKGLRKSSEYSRERLTIIPHCVPN------MVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75
Query: 134 LRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193
+ K + + P + V+ A +++ + +H ++ DL P N+LL +I++
Sbjct: 76 ISK--FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL------- 126
Query: 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIW 253
+YF R S + D + Y APEV T CD W
Sbjct: 127 ------TYFSRW------------SEVEDSCDGEAV--ENMYCAPEVGGISEETEACDWW 166
Query: 254 SVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE 313
S+G IL EL TG+ L + H P
Sbjct: 167 SLGAILFELLTGKTLVECH---------------------------------------PS 187
Query: 314 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA-----LR 368
G + ++ I + V A LLQ LL+++PT+RL A A
Sbjct: 188 GINTHTTLN-----------IPEWVSEEARS---LLQQLLQFNPTERLGAGVAGVEDIKS 233
Query: 369 HPFF 372
HPFF
Sbjct: 234 HPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 44/242 (18%)
Query: 50 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108
++G G FG V L W + K VAIK + E + E +V+ +L+ H K VQ
Sbjct: 11 ELGSGQFGVVHLGKWRAQIK--VAIKAINEGAMSEEDFIEEAKVMMKLS-HPK----LVQ 63
Query: 109 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
+ + + IV E + L ++LR+ D++ + + + E + ++ I
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 227
H DL N LVSS + +KV DFG T Y D+
Sbjct: 123 HRDLAARNC-LVSSTGV--------------------------VKVSDFGMTRYVLDDE- 154
Query: 228 YIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 281
Y S+ + PEV ++ D+WS G ++ E+ T G+ F+ N E + M+
Sbjct: 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214
Query: 282 ER 283
R
Sbjct: 215 SR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 59/241 (24%), Positives = 107/241 (44%), Gaps = 33/241 (13%)
Query: 46 KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
K+ K+G G FG+V + ++ K VA+K ++ +A + E +++ L +HDK
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTL-QHDK--- 62
Query: 105 RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
V++ I I+ E + SL DFL+ + + + + + Q+ E +A++
Sbjct: 63 -LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
IH DL+ NVL+ S K+ D+ + +D+ Y R IK
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGAKFPIK----------- 169
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 282
+ APE I +T D+WS G +L E+ T G+ + N + ++ ++
Sbjct: 170 -----------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218
Query: 283 R 283
R
Sbjct: 219 R 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 38/227 (16%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
+G G FG+V + +++ A+K++ IK+ A E + A V
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN----SPWVV 106
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
Q+ F ++ +V E + G L + + +NY P R +++ + +H +
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY-DVPEKWARFYTAEVVLALDAIHSMGF 163
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
IH D+KP+N+LL S ++K+ D+ + + +M K ++
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCM----------KMNKEGMVRC------------- 200
Query: 227 NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALF 269
+ V T Y +PEV+ G + CD WSVG L E+ G+ F
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 27/121 (22%)
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
+++ + +H + IH D+KP+N+LL S ++K+ D+ + + +M + ++
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------KMDANGMVR 199
Query: 213 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEAL 268
T PD Y +PEV+ G + CD WSVG L E+ G+
Sbjct: 200 C----DTAVGTPD---------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
Query: 269 F 269
F
Sbjct: 247 F 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 51/227 (22%), Positives = 98/227 (43%), Gaps = 38/227 (16%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
+G G FG+V + +++ A+K++ IK+ A E + A V
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN----SPWVV 106
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
Q+ F ++ +V E + G L + + +NY P + +++ + +H + +
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY-DVPEKWAKFYTAEVVLALDAIHSMGL 163
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
IH D+KP+N+LL ++K+ D+ + + +M ++ ++
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCM----------KMDETGMVRC------------- 200
Query: 227 NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALF 269
+ V T Y +PEV+ G + CD WSVG L E+ G+ F
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 106
+G G FG+V C + +M A+K + +K+ A+ E +L ++ D C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
+ F + +C + + + G L+ L ++ F +R A +++ + MH+
Sbjct: 62 MTYA--FHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRF 117
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+++ DLKP N+LL ++++ D + + K+ P +S
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS---------------- 155
Query: 226 QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHE 273
V T Y APEV+ G + D +S+GC+L +L G + F+ H+
Sbjct: 156 ----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 32/152 (21%)
Query: 121 IVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVL 177
I E + +SL F +K + + P D++ +IA +++ + ++H L +IH D+KP NVL
Sbjct: 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL 136
Query: 178 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRA 237
+ + +K+ D+ S + S K ID G + Y A
Sbjct: 137 INRNGQVKLCDFGISGYL-----------VDSVAKTIDAGC--------------KPYMA 171
Query: 238 PEVILG----LGWTYPCDIWSVGCILVELCTG 265
PE I G+ D+WS+G ++EL TG
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 49 SKMGEGTFGQV-LECWD---RERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGG 103
++G+G FG V L +D E+VA+K ++ ++ EIE+L+ L +HD
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDN-- 66
Query: 104 NRCVQIRN--WFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
V+ + + R ++ +V E L SL D+L+K+ R L+ A Q+ + + +
Sbjct: 67 --IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYASQICKGMEY 123
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDFGST 219
+ +H DL N+L+ S +K+ D+ + P+D Y+K R P S I
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI-------- 175
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264
+ APE + ++ D+WS G +L EL T
Sbjct: 176 --------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 61/255 (23%), Positives = 99/255 (38%), Gaps = 68/255 (26%)
Query: 51 MGEGTFGQVLECWDRERKEM---VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 105
+G G FG V++ + VA+K ++ I ++ + E V+ QL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL--------- 53
Query: 106 CVQIRNWFDYRNHICIV----------------FEKLGSSLYDFLRKNNYRSFPIDLVRE 149
+H CIV LG L +L+K R P+ ++E
Sbjct: 54 -----------DHPCIVRLIGVCKGEPLMLVMELAPLGP-LLKYLKKR--REIPVSDLKE 99
Query: 150 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 209
+A Q+ +A++ +H DL NVLLV+ K+ D+ S S Y++
Sbjct: 100 LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR------ 153
Query: 210 AIKVIDFGSTTYER-PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 267
+TT R P + Y APE I ++ D+WS G L E + G
Sbjct: 154 --------ATTAGRWPLKWY--------APECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197
Query: 268 LFQTHENLEHLAMME 282
+ + E +AM+E
Sbjct: 198 PYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 56/241 (23%)
Query: 53 EGTFGQVLECWDR------ERKEMVAI------KIVRGIKKY-----REAAMIEIEVLQ- 94
G FG++ C R E + V K R I K R A +E E+L
Sbjct: 158 AGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILAL 217
Query: 95 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKN--NYRSFP-IDLVREIA 151
H+ ++I + ++ +K LY F+ +++ P + R I
Sbjct: 218 GRLNHEN----ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIM 273
Query: 152 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 211
+QLL + ++HD +IH D+K EN+ L D K L
Sbjct: 274 KQLLCAVEYIHDKKLIHRDIKLENIFLNC-------DGKIVLG----------------- 309
Query: 212 KVIDFGS-TTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 267
DFG+ +E+ + + V T +PE++ G G+ DIWS G IL+++ + +
Sbjct: 310 ---DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
Query: 268 L 268
Sbjct: 367 C 367
|
Length = 501 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 46/246 (18%)
Query: 50 KMGEGTFGQVLECWDRERK--EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
++G G FG V + + +K + VA+KI +K ++ E+L + N
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKI---LKNDNNDPALKDELL-------REANVMQ 51
Query: 108 QIRNWFDYRN-HIC------IVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
Q+ N + R IC +V E +LG L FL+KN + + E+ Q+ +
Sbjct: 52 QLDNPYIVRMIGICEAESWMLVMELAELGP-LNKFLQKN--KHVTEKNITELVHQVSMGM 108
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
++ + +H DL NVLLV+ Y K+ D+ S D +Y+K
Sbjct: 109 KYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-------------AK 155
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEH 277
T + P + Y APE + ++ D+WS G ++ E G+ ++ + E
Sbjct: 156 THGKWPVKWY--------APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV 207
Query: 278 LAMMER 283
M+E
Sbjct: 208 TQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 57/245 (23%), Positives = 108/245 (44%), Gaps = 41/245 (16%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYR--EAAMIEIEVLQQLAKHDKGGNRC 106
+G+G FG+V C R ++ A K + + +KK + E AM+E +L ++ H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSR---FI 55
Query: 107 VQIRNWFDYRNHICIVFEKLGSS-----LYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
V + F + +C+V + +Y+ +N FP Q++ + +
Sbjct: 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP--GFPEPRACFYTAQIISGLEHL 113
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H +I+ DLKPENVLL + +++ D A+++ D S T
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDL------------------GLAVELKDGQSKT- 154
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAM 280
+ Y T + APE++ G + + D +++G L E+ F+ E +E+ +
Sbjct: 155 ----KGY-AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 209
Query: 281 MERVL 285
+R+L
Sbjct: 210 KQRIL 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 39/226 (17%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 106
+G+G+FG+V+ + E+ AIKI++ + E M+E VL K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP----FL 63
Query: 107 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHD 163
Q+ + F + + V E + G +Y + ++ + EI+ L F+H
Sbjct: 64 TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF----FLHR 119
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+I+ DLK +NV+L S +IK+ D+ M K + G TT
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFG--------------MCKEHMVD----GVTT--- 158
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269
T Y APE+I + D W+ G +L E+ G+ F
Sbjct: 159 ---RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 42/236 (17%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 106
+G+G+FG+V+ +E + A+K+++ + E M E +L H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP----FL 58
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
Q+ F + + V E + G L ++K+ R F R A ++ + F+HD
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG 116
Query: 166 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
+I+ DLK +NVLL + K+ D+ K + K +S F
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF-------------------- 156
Query: 223 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
T Y APE++ + + D W++G +L E+ G A F+ EN + L
Sbjct: 157 -------CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 41/230 (17%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMI--EIEVLQQLAKHDKGGNRC 106
+G G FG+V + ++ A+KI+ + K E A E +VL G R
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLV------NGDRRW 62
Query: 107 V-QIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+ + F N++ +V + +G L L K R P D+ R +++ I +H L
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVHQL 121
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+H D+KP+NVLL + +I++ D+ S L D +
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV----------------------- 158
Query: 225 DQNYIVSTRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALF 269
N V T Y +PE++ G G P CD WS+G + E+ GE F
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
++G GT+G V + + E+ A+KI++ ++ + ++I+ E+ + K K N
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIK-LEPGDDFSLIQQEIF--MVKECKHCNIVAYF 72
Query: 110 RNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDLCM 166
++ R + I E G SL D + + P+ + + R+ L+ +A++H
Sbjct: 73 GSYLS-REKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
+H D+K N+LL + +K+ D+ A K+ +T +R
Sbjct: 128 MHRDIKGANILLTDNGDVKLADF------------------GVAAKIT---ATIAKRKS- 165
Query: 227 NYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVEL 262
+ T ++ APEV G+ CDIW+VG +EL
Sbjct: 166 --FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 49/205 (23%), Positives = 81/205 (39%), Gaps = 57/205 (27%)
Query: 129 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 188
SL D LRK+ F I + + A Q+ + ++ IH DL N+LL S + +K+ D
Sbjct: 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGD 140
Query: 189 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------APEVIL 242
+ + +P++ + +Y V H + APE +
Sbjct: 141 FGLM----------RALPQN----------------EDHY-VMEEHLKVPFAWCAPESLR 173
Query: 243 GLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAE 301
+++ D+W G L E+ T GE E G +LK++D+ E
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGE---------------EPWAGLSGSQILKKIDKEGE 218
Query: 302 KYVRRGRLDWPEGAASRESIKSVMK 326
RL+ PE A + I +VM
Sbjct: 219 ------RLERPE--ACPQDIYNVML 235
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 37/221 (16%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQQLAKHDKGGNRC 106
S++G G G V + + ++A K++ IK R + E++VL H+
Sbjct: 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPYI 65
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V F I I E + G SL L+K P ++ +++ +++ + ++ +
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH 123
Query: 166 MI-HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
I H D+KP N+L+ S IK+ D+ S ++ID + ++
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------QLIDSMANSF--- 162
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265
V TR Y +PE + G ++ DIWS+G LVE+ G
Sbjct: 163 -----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 56/245 (22%), Positives = 106/245 (43%), Gaps = 37/245 (15%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 106
+G+G+FG+V+ + E+ AIK+++ + + M E +L AKH
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP----FL 58
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
+ F ++ + V E + G L ++++ R F R A ++ + F+H
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+I+ DLK +N+LL + + K+ D+ M K + G TT
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFG--------------MCKEGILN----GVTT----- 153
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT--HENLEHLAMMER 283
T Y APE++ L + D W++G ++ E+ G+ F+ ++L + +
Sbjct: 154 -TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD 212
Query: 284 VLGPL 288
VL P+
Sbjct: 213 VLYPV 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 56/239 (23%), Positives = 99/239 (41%), Gaps = 32/239 (13%)
Query: 50 KMGEGTFGQVLECWDRERKEM--VAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++G G FG V + + RK+ VAIK+++ K R+ M E E++ QL
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN-----PY 56
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V++ + + ++ G L FL + V E+ Q+ + ++
Sbjct: 57 IVRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+H DL NVLLV+ Y K+ D+ S D SY+K + + P
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK-------------ARSAGKWPL 162
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMER 283
+ Y APE I ++ D+WS G + E G+ ++ + E ++ +E+
Sbjct: 163 KWY--------APECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 51/232 (21%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIEVLQQLAKHDKGG 103
+G+G+FG+V+ + E+ AIKI +KK E M+E VL K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKI---LKKDVIIQDDDVECTMVEKRVLALPGK----P 60
Query: 104 NRCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAF 160
Q+ + F + + V E + G +Y + ++ + EIA L F
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF----F 116
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+H +I+ DLK +NV+L + +IK+ D+ K ++ K + F P
Sbjct: 117 LHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP----------- 165
Query: 218 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269
+YI APE+I + D W+ G +L E+ G+ F
Sbjct: 166 ---------DYI-------APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 106
+G G FG+V C + +M A+K + +K+ A+ E +L ++ D C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
+ F + + + + + G L+ L ++ F +R A +++ + MH+
Sbjct: 62 MSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEAEMRFYAAEIILGLEHMHNRF 117
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+++ DLKP N+LL ++++ D + + K+ P +S
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS---------------- 155
Query: 226 QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHE 273
V T Y APEV+ G+ + D +S+GC+L +L G + F+ H+
Sbjct: 156 ----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 52/246 (21%), Positives = 92/246 (37%), Gaps = 61/246 (24%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA--------MIEIEVLQQLAKHD-- 100
+GEG FG+V++ K V +K +E A + E +L+Q+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTV-AVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 101 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKN----------------------N 138
K C Q D + + + K GS L FLR++ +
Sbjct: 67 KLYGACSQ-----DGPLLLIVEYAKYGS-LRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 139 YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198
R+ + + A Q+ + ++ ++ ++H DL NVL+ +K+ D+ S ++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 258
SY KR +K + A E + +T D+WS G +
Sbjct: 181 DSYVKRSKGRIPVK----------------------WMAIESLFDHIYTTQSDVWSFGVL 218
Query: 259 LVELCT 264
L E+ T
Sbjct: 219 LWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 64/252 (25%), Positives = 106/252 (42%), Gaps = 41/252 (16%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 106
+G+G+FG+V+ + E+ AIKI++ + E M+E VL K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP----FL 63
Query: 107 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHD 163
Q+ + F + + V E + G +Y + ++ + EIA L F+H
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF----FLHS 119
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+I+ DLK +NV+L S +IK+ D+ M K + G TT
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFG--------------MCKENMWD----GVTT--- 158
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL-AMME 282
T Y APE+I + D W+ G +L E+ G+A F+ + E ++ME
Sbjct: 159 ---KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
Query: 283 RVLGPLPQHMLK 294
+ P+ M K
Sbjct: 216 HNVA-YPKSMSK 226
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 39/251 (15%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+ ++G GT GQV + ++ ++A+K +R E I +++ L HD
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHD----- 72
Query: 106 C---VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
C V+ +F + + I E + + L D L K P D++ ++ +++ + ++
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELMSTCL-DKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 163 DL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
+ +IH D+KP N+LL +S +K+ D+ S R+ S A K G Y
Sbjct: 132 EKHGVIHRDVKPSNILLDASGNVKLCDFGIS----------GRLVDSKA-KTRSAGCAAY 180
Query: 222 ---ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
ER D RA D+WS+G LVEL TG+ F
Sbjct: 181 MAPERIDPPDPNPKYDIRA-------------DVWSLGISLVELATGQ--FPYKNCKTEF 225
Query: 279 AMMERVLGPLP 289
++ ++L P
Sbjct: 226 EVLTKILQEEP 236
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 43/185 (23%), Positives = 75/185 (40%), Gaps = 43/185 (23%)
Query: 127 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 186
G ++ L + + F D VR + +++ + +H L +++ D+K EN+LL S ++ +
Sbjct: 89 GGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVL 146
Query: 187 PDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG 243
D+ K L K+ +Y F T Y APE+I G
Sbjct: 147 TDFGLSKEFLSEEKERTY-------------SFCGTI-------------EYMAPEIIRG 180
Query: 244 -LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER-----------VLGPLPQH 291
G D WS+G ++ EL TG + F + + R +GP Q
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240
Query: 292 MLKRV 296
+L ++
Sbjct: 241 LLHKL 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 51/226 (22%), Positives = 93/226 (41%), Gaps = 34/226 (15%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ-----LAKHDKGG 103
+ +G G FG+VL ++ E+ AIK +KK A E+E L + +
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELYAIKA---LKKGDIIARDEVESLMCEKRIFETANSERH 61
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
V + F +H+C V E D + + F A ++ + ++H+
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGG--DLMMHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+++ DLK +N+LL + ++K+ D+ + K + FG T
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFG--------------LCKEG----MGFGDRT--- 158
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269
+ T + APEV+ +T D W +G ++ E+ GE+ F
Sbjct: 159 ---STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 33/117 (28%), Positives = 53/117 (45%), Gaps = 31/117 (26%)
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+H +I+ DLKPEN+LL + ++K+ D+ K S+H G
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE---------------------G 154
Query: 218 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274
+ T+ T Y APE+++ G D WS+G ++ ++ TG F T EN
Sbjct: 155 TVTHT------FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF-TAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 37/138 (26%), Positives = 57/138 (41%), Gaps = 29/138 (21%)
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+H L +I+ D+K EN+LL S+ ++ + D+ S +F
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK---------------------EFHEDE 159
Query: 221 YERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEH 277
ER T Y AP+++ G G D WS+G ++ EL TG + F E
Sbjct: 160 VERAYS--FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217
Query: 278 LAMMERVLG---PLPQHM 292
+ R+L P PQ M
Sbjct: 218 AEISRRILKSEPPYPQEM 235
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 33/140 (23%), Positives = 59/140 (42%), Gaps = 26/140 (18%)
Query: 129 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 188
SL FLR+N+ + LV + R + + ++ ++ +H DL N+L+ S+ KV D
Sbjct: 91 SLDKFLRENDGKFTVGQLVG-MLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSD 149
Query: 189 YKSSLHT-PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWT 247
+ S +++Y + K + APE I +T
Sbjct: 150 FGLSRRLEDSEATYTTKGGKIPI-----------------------RWTAPEAIAYRKFT 186
Query: 248 YPCDIWSVGCILVELCT-GE 266
D+WS G ++ E+ + GE
Sbjct: 187 SASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 34/125 (27%), Positives = 53/125 (42%), Gaps = 25/125 (20%)
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+H M+H DLK N+ L+ + IK+ D+ S S +D S+
Sbjct: 185 VHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS-------------LDVASS- 230
Query: 221 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
T +Y APE+ ++ D+WS+G IL EL T F+ E +
Sbjct: 231 --------FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---I 279
Query: 281 MERVL 285
M++VL
Sbjct: 280 MQQVL 284
|
Length = 478 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 46 KIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAK 98
KI +G G FG+V C R +R+ VAIK ++ +K R + E ++ Q
Sbjct: 7 KIEKVIGAGEFGEV--CSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
+ + + + IV E + SL FLRK++ + I LV + R +
Sbjct: 65 PN-----IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV-GMLRGIASG 118
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVID 215
+ ++ D+ +H DL N+L+ S+ KV D+ S L +++Y R K
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK-------- 170
Query: 216 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262
+ R + APE I +T D+WS G ++ E+
Sbjct: 171 --------------IPIR-WTAPEAIAYRKFTSASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 61/254 (24%), Positives = 108/254 (42%), Gaps = 57/254 (22%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK------HDKGG 103
++G G FG V++ + VAIK+++ E +M E E +++ AK H+K
Sbjct: 11 ELGTGQFG-VVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEE-AKVMMKLSHEK-- 60
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
VQ+ + I IV E + + L ++LR++ R P L+ E+ + + E +A++
Sbjct: 61 --LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-EMCKDVCEGMAYLE 117
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
IH DL N L+ +KV DFG + Y
Sbjct: 118 SKQFIHRDLAARNCLVDD---------------------------QGCVKVSDFGLSRYV 150
Query: 223 RPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA---LFQTHE 273
D+ Y S + PEV+L ++ D+W+ G ++ E+ + G+ F E
Sbjct: 151 LDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209
Query: 274 NLEHLAMMERVLGP 287
+E ++ R+ P
Sbjct: 210 TVEKVSQGLRLYRP 223
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 36/132 (27%), Positives = 54/132 (40%), Gaps = 25/132 (18%)
Query: 142 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201
F VR +++ + +H L +I+ D+K EN+LL S ++ + D+ S
Sbjct: 102 FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK-------- 153
Query: 202 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCIL 259
+F + ER T Y APEVI G G D WS+G +
Sbjct: 154 -------------EFLAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198
Query: 260 VELCTGEALFQT 271
EL TG + F
Sbjct: 199 FELLTGASPFTV 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 40/225 (17%)
Query: 51 MGEGTFGQVLEC-WDRE---RKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD--KG 102
+GEG FG+V C +D E E VA+K ++ A + EIE+L+ L + K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 103 GNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREI--ARQLLECIA 159
C + D N I ++ E L S SL ++L +N + I+L +++ A Q+ + +
Sbjct: 72 KGICTE-----DGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMD 123
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
++ +H DL NVL+ S +K+ D+ + D Y+ T
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----------------T 167
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264
+ D S + APE ++ + D+WS G L EL T
Sbjct: 168 VKDDLD-----SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 61/254 (24%), Positives = 101/254 (39%), Gaps = 40/254 (15%)
Query: 47 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA--KHDKGGN 104
+ K+G G +G+V E ++ VA+K ++ E M E L++ A K K N
Sbjct: 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPN 63
Query: 105 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
VQ+ I+ E + +L D+LR+ N + ++ +A Q+ + ++
Sbjct: 64 -LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
IH DL N L+ + +KV D+ S +Y IK
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK----------- 170
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLE 276
+ APE + ++ D+W+ G +L E+ T G L Q +E LE
Sbjct: 171 -----------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219
Query: 277 HLAMMERVLGPLPQ 290
MER G P+
Sbjct: 220 KGYRMERPEGCPPK 233
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 41/141 (29%), Positives = 64/141 (45%), Gaps = 29/141 (20%)
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
Q+L + +H MIH D+K N+LL S+ +K+ D+ F +M +A
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG-----------FSKM--YAATV 197
Query: 213 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272
D G T T +Y APE+ ++ D++S+G +L EL T + F
Sbjct: 198 SDDVGRT---------FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG- 247
Query: 273 ENLEHLAMMERVLG----PLP 289
EN+E + M + L PLP
Sbjct: 248 ENMEEV--MHKTLAGRYDPLP 266
|
Length = 496 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 37/221 (16%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCV 107
++G G G V + R + A+K++ G + R EIE+L+ H V
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD-VNHPN----VV 135
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+ + FD+ I ++ E + G SL F D+ ARQ+L IA++H +
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEG--THIADEQFLADV----ARQILSGIAYLHRRHI 189
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+H D+KP N+L+ S++ +K+ D+ S L D P +S++ I + S
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-------PCNSSVGTIAYMSPERINT 242
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265
D N+ G Y DIWS+G ++E G
Sbjct: 243 DLNH--------------GAYDGYAGDIWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 51/239 (21%)
Query: 47 IHSKMGEGTFGQVL--ECWD---RERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHD 100
+ ++GEG FG+V EC++ + K +VA+K ++ R+ E E+L L +H+
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHE 67
Query: 101 ---KGGNRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSF-------PIDLVR- 148
K CV+ + + +VFE + L FLR + + P +L +
Sbjct: 68 HIVKFYGVCVE-------GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 149 ---EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205
IA+Q+ + ++ +H DL N L+ + +K+ D+ S
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR------------ 168
Query: 206 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264
D ST Y R + ++ R + PE I+ +T D+WS+G +L E+ T
Sbjct: 169 ---------DVYSTDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 42/176 (23%), Positives = 69/176 (39%), Gaps = 46/176 (26%)
Query: 143 PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202
+ R + Q+L+ +A H+ ++H DLKP+N+++ +
Sbjct: 78 AGETGRLML-QVLDALACAHNQGIVHRDLKPQNIMVSQTG-------------------- 116
Query: 203 KRMPKSSAIKVIDFGSTT----YERPDQNYI------VSTRHYRAPEVILGLGWTYPCDI 252
KV+DFG T D + + T Y APE + G T D+
Sbjct: 117 ----VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 253 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGP----LPQ----HMLKRVDRHA 300
++ G I +E TG+ + Q E ++ + L P LP H L +V R A
Sbjct: 173 YAWGLIFLECLTGQRVVQGASVAE---ILYQQLSPVDVSLPPWIAGHPLGQVLRKA 225
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 46 KIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAK 98
KI +G G FG+V C R +R+ VAIK ++ +K R + E ++ Q
Sbjct: 7 KIEEVIGAGEFGEV--CRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
+ + + + I+ E + +L FLR+N+ + I LV + R +
Sbjct: 65 PN-----IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLV-GMLRGIAAG 118
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+ ++ ++ +H DL N+L+ S+ KV D+ S D+S
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS----------------- 161
Query: 218 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262
TY I + APE I +T D+WS G ++ E+
Sbjct: 162 DPTYTSSLGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 50/226 (22%)
Query: 50 KMGEGTFGQVLE-CWDRERKEMVAIKIV-RGIKKYREAAMIEIEVLQQLAKHDK------ 101
K+G G FG+V E W + VAIKI+ ++ E++ L++L +H
Sbjct: 13 KLGSGYFGEVWEGLWKNRVR--VAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFA 69
Query: 102 --GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
V I I + EK SL FLR + P+ + ++A Q+ E +A
Sbjct: 70 VCSVGEPVYI---------ITELMEK--GSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYI-KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
++ + IH DL N+ LV + + KV D+ + K+ Y + I
Sbjct: 119 YLEEQNSIHRDLAARNI-LVGEDLVCKVADFGLA-RLIKEDVY---LSSDKKIPY----- 168
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264
+ APE ++ D+WS G +L E+ T
Sbjct: 169 ---------------KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 9e-04
Identities = 50/230 (21%), Positives = 94/230 (40%), Gaps = 48/230 (20%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 106
++G+G +G V + R +A+K +R K+ + M E+++L H
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDIL-----HKAVSPYI 61
Query: 107 VQIRNWFDYRN--HICIVFEKLGS--SLYDFLRKNNYRSFPIDLVREIARQLLECIAFM- 161
V F ++C+ + GS LY P D++R I +++ + F+
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYA--GGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
+ +IH D+KP NVL+ + +K+ D+ S + + K++
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN------------ 161
Query: 222 ERPDQNYIVSTRHYRAPEVILGLG------WTYPCDIWSVGCILVELCTG 265
+ + Y APE I G +T D+WS+G ++E+ G
Sbjct: 162 --------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 54/234 (23%), Positives = 98/234 (41%), Gaps = 36/234 (15%)
Query: 51 MGEGTFGQVLECWDRE--RKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 105
+G G FG+V + RKE+ VAIK ++ +K R+ + E ++ Q + H+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN----- 67
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYD-FLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+++ I+ E + + D +LR ++ LV + R + + ++ D+
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLV-GMLRGIAAGMKYLSDM 126
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI-DFGSTTYER 223
+H DL N+L+ S+ KV D+ S +V+ D TY
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLS-------------------RVLEDDPEGTYTT 167
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 276
+ + APE I +T D+WS G ++ E+ + GE + N E
Sbjct: 168 SGGKIPI---RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 66/268 (24%), Positives = 103/268 (38%), Gaps = 58/268 (21%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108
+ +G+G FG V+ R +K VA+K ++ +A + E V+ L +H VQ
Sbjct: 12 ATIGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQAFLAEASVMTTL-RHPN----LVQ 64
Query: 109 IRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
+ N + IV E + SL D+LR + A + E + ++ + +
Sbjct: 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFV 124
Query: 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 227
H DL NV LVS + + KV DFG Q+
Sbjct: 125 HRDLAARNV-LVSEDLVA--------------------------KVSDFGLAKEASQGQD 157
Query: 228 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 287
+ APE + ++ D+WS G +L E+ + RV P
Sbjct: 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS----------------FGRV--P 199
Query: 288 LPQHMLKRVDRHAEK-YVRRGRLDWPEG 314
P+ LK V H EK Y R++ PEG
Sbjct: 200 YPRIPLKDVVPHVEKGY----RMEAPEG 223
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS--SAIKVID 215
I ++H ++H DLKP+N+LL + + D+ +++ FK++ + I V +
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI--------FKKLEEEDLLDIDVDE 177
Query: 216 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264
IV T Y APE +LG+ + DI+++G IL ++ T
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 14/50 (28%), Positives = 34/50 (68%)
Query: 144 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193
I++++ + RQ+L + +H + ++H D+KPEN+L+ +K+ D+ +++
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAV 357
|
Length = 507 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 34/142 (23%), Positives = 67/142 (47%), Gaps = 14/142 (9%)
Query: 54 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL-AKHD----KGGNRCVQ 108
G FG+V + ++ A+K+V+ +A MI ++ Q+ A+ D V
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVK------KADMINKNMVHQVQAERDALALSKSPFIVH 68
Query: 109 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
+ N++ +V E L G + L Y F ++ + ++ + ++H +I
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHGII 126
Query: 168 HTDLKPENVLLVSSEYIKVPDY 189
H DLKP+N+L+ + +IK+ D+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 37/219 (16%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
K+ +G+G FG V+ R K VA+K ++ +A + E V+ QL +H
Sbjct: 9 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSN---- 60
Query: 106 CVQIRNWF-DYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
VQ+ + + + IV E + SL D+LR D + + + + E + ++
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+H DL NV LVS + + KV DFG T
Sbjct: 121 NNFVHRDLAARNV-LVSEDNVA--------------------------KVSDFGLTKEAS 153
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262
Q+ + APE + ++ D+WS G +L E+
Sbjct: 154 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 32/137 (23%), Positives = 58/137 (42%), Gaps = 25/137 (18%)
Query: 129 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 188
SL D +R++ P + Q+ + + ++ + M+H +L N+LL S +++ D
Sbjct: 94 SLLDHVRQHRDSLDP-QRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIAD 152
Query: 189 YK-SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWT 247
+ + L P D YF K+ IK + A E IL +T
Sbjct: 153 FGVADLLYPDDKKYFYSEHKTP-IK----------------------WMALESILFGRYT 189
Query: 248 YPCDIWSVGCILVELCT 264
+ D+WS G + E+ +
Sbjct: 190 HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 36/161 (22%), Positives = 69/161 (42%), Gaps = 19/161 (11%)
Query: 145 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 204
D+++ +A ++ + ++H IH+DL N L + +K+ DY +L + Y +
Sbjct: 100 DVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159
Query: 205 MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264
+ ++ + P+ +V R +L T +IWS+G + EL T
Sbjct: 160 DCHAVPLRWLA--------PE---LVEIRGQD----LLPKDQTKKSNIWSLGVTMWELFT 204
Query: 265 -GEALFQTHENLEHLA--MMERVLG-PLPQHMLKRVDRHAE 301
+ + + + L + E+ + P PQ LK DR E
Sbjct: 205 AADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE 245
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 379 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.59 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.8 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.57 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.46 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.35 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.35 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.24 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.22 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.21 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.0 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.98 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.89 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.86 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.82 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.6 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.57 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.54 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.46 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.42 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.31 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.29 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.24 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.11 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.05 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.73 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.64 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.56 | |
| PLN02236 | 344 | choline kinase | 96.49 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.18 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.11 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.8 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.72 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 95.61 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.59 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.2 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.83 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.69 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.64 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.61 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.51 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.42 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.06 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.56 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.3 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.18 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 91.98 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-56 Score=398.27 Aligned_cols=258 Identities=29% Similarity=0.468 Sum_probs=216.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch--------hhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
-.|-+.+.||+|+||.|-+|..+.||+.||||++++... ......+|+++|+++ +||+|++++++|+
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-----~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-----SHPNIVRIKDFFE 246 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-----CCCCEEEEeeeee
Confidence 357788999999999999999999999999999974211 123346899999999 8899999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
.++..|+||||+ ||+|.+.+-.++ .+.+.....++.|++.||.|||++||+||||||+|||+..+
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~------------ 312 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSND------------ 312 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccC------------
Confidence 999999999999 999999998765 68888999999999999999999999999999999999543
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCC---CCCccchHhHHHHHHHHHhCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~~l~~g~~p 268 (379)
..+..+||+|||+|+..+..+ .+.+||+.|.|||++.+.. +..++|+|||||++|.+++|.+|
T Consensus 313 ------------~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 313 ------------AEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred ------------CcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 356889999999999875443 6789999999999998755 33588999999999999999999
Q ss_pred CCCCchHH-HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 269 FQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 269 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
|....... ..+++.+...+.- ...|...+.++.+
T Consensus 381 FS~~~~~~sl~eQI~~G~y~f~---------------------------------------------p~~w~~Iseea~d 415 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYAFG---------------------------------------------PLQWDRISEEALD 415 (475)
T ss_pred cccccCCccHHHHHhcCccccc---------------------------------------------ChhhhhhhHHHHH
Confidence 97643322 3334433222211 1234568889999
Q ss_pred HHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 348 LLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
||.+||+.||++|||++|+|+||||+...
T Consensus 416 lI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 416 LINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 99999999999999999999999999654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-54 Score=383.07 Aligned_cols=324 Identities=60% Similarity=1.013 Sum_probs=289.4
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCC-CCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-GGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~i~~~~~~~~~~~~~~ 120 (379)
...|+|++.+|+|.||.|-.++|..++..||||++++-.+.++.+..|+++++++...++ +...++.+.+||+..++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 568999999999999999999999999999999999888889999999999999988774 4456999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
||+|.+|-|+.+++..+...+++...++.+..|+++++++||+.+++|-||||+||++.+....+..+.+.. .
T Consensus 168 ivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~-------~ 240 (415)
T KOG0671|consen 168 IVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK-------V 240 (415)
T ss_pred EEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc-------c
Confidence 999999999999999988788999999999999999999999999999999999999987766655544432 2
Q ss_pred ccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
++....++..++++|||.|..........+.|..|.|||++.+-+++.++||||+||||+|+.+|...|++.++.|....
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM 320 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM 320 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence 22334667889999999999888888888999999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+++++|++|..+..+.. ..++..++.++|++...... .+.+...+......+...+.....+.|||++||.+||.+|
T Consensus 321 MerIlGp~P~~mi~r~~--~~Kyf~~~rldw~e~~~~~~-~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTR--KEKYFRRGRLDWPEVSSKGK-SKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHhhCCCcHHHhhhhh--hHhhhhcccccCcccccccc-chhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 99999999999987755 77888888999998877665 5666666777777777777888889999999999999999
Q ss_pred cCHHHHhcCCCCCCC
Q 017021 361 LTAREALRHPFFTRD 375 (379)
Q Consensus 361 pta~e~l~hp~f~~~ 375 (379)
+|+.|+|.||||+.-
T Consensus 398 iTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 398 ITLREALSHPFFARL 412 (415)
T ss_pred ccHHHHhcCHHhhcC
Confidence 999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-53 Score=398.92 Aligned_cols=249 Identities=32% Similarity=0.516 Sum_probs=227.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeec----cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
..|+..+.||+|||+.||.+++..+|+.||+|++.+ ....+....+|+++.+.+ .|+|||+++++|++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-----~HpnIV~f~~~FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-----KHPNIVQFYHFFEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-----CCCcEEeeeeEeecCCc
Confidence 679999999999999999999999999999999975 566788888999999998 88999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+|+|.|+| .++|..++++.. .+++.+++.++.||+.||.|||+.+|+|||||..|+++
T Consensus 93 VYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL------------------- 151 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL------------------- 151 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee-------------------
Confidence 99999999 899999998554 79999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
+.+..+||+|||+|.....+ ..+.+|||-|+|||++.....++.+||||+||++|.|+.|++||...+-
T Consensus 152 --------~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v 223 (592)
T KOG0575|consen 152 --------NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV 223 (592)
T ss_pred --------cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH
Confidence 67788999999999876633 4678999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.++...|.......|. ..+.++++||++||+
T Consensus 224 kety~~Ik~~~Y~~P~-------------------------------------------------~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 224 KETYNKIKLNEYSMPS-------------------------------------------------HLSAEAKDLIRKLLR 254 (592)
T ss_pred HHHHHHHHhcCccccc-------------------------------------------------ccCHHHHHHHHHHhc
Confidence 8888777776555553 367899999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~ 374 (379)
.||.+|||+++||.|+||+.
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred CCcccCCCHHHHhcCHhhhC
Confidence 99999999999999999954
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-53 Score=399.22 Aligned_cols=310 Identities=39% Similarity=0.689 Sum_probs=255.7
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCC-CCeeEEecceeeecceEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG-GNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~-~~~i~~~~~~~~~~~~~~l 121 (379)
+.|.|.+.||+|+||.|-+|++..|++.||||++++....-.....|+.+|..+..++.. ..|+++++++|...+|.||
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 377899999999999999999999999999999998888888889999999999865543 4689999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|+|+.+.+|.++++......++...++.++.||+.||.+||+.||||+||||+|||+..
T Consensus 266 VfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~--------------------- 324 (586)
T KOG0667|consen 266 VFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD--------------------- 324 (586)
T ss_pred eehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc---------------------
Confidence 99999999999999987778999999999999999999999999999999999999965
Q ss_pred cccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~ 281 (379)
.....+|++|||.|......--....+..|.|||++.+.+|+.+.||||||||++||++|.+.|.+.++.+++..|
T Consensus 325 ----~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I 400 (586)
T KOG0667|consen 325 ----PKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI 400 (586)
T ss_pred ----CCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence 3445899999999987666666678899999999999999999999999999999999999999999999999999
Q ss_pred HHHcCCCChhHHHhhhhhhhhhhc-cCCCCCCCCCCch------h--hh----hhhccch-hhHHHHHHhhccchhHHHH
Q 017021 282 ERVLGPLPQHMLKRVDRHAEKYVR-RGRLDWPEGAASR------E--SI----KSVMKLP-RLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~------~--~~----~~~~~~~-~~~~~~~~~~~~~~~~~~~ 347 (379)
.+.+|.+|..+++.......-+.. .+.+......... + .. ......| .............-..+.|
T Consensus 401 ~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~d 480 (586)
T KOG0667|consen 401 IEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFID 480 (586)
T ss_pred HHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHH
Confidence 999999999998887666433333 2222211111100 0 00 0011122 1122222222244567899
Q ss_pred HHhhccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 348 LLQGLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
||.+||++||.+|+|+.|+|+||||..-.+
T Consensus 481 flk~~L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 481 FLKRCLEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHHhccCchhcCCHHHHhcCcccccccc
Confidence 999999999999999999999999995443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=382.45 Aligned_cols=287 Identities=30% Similarity=0.503 Sum_probs=239.0
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-hh-HhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YR-EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~-~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
+++-..+|.+.++||.|.||.||+|+.+++++.||||.++..-. +. -.-++|+..+.++ +.|+||+++.+.+.+
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kl----n~hpniikL~Evi~d 80 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKL----NPHPNIIKLKEVIRD 80 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhc----CCCCcchhhHHHhhc
Confidence 44556789999999999999999999999999999999985322 22 2234688888888 348999999999998
Q ss_pred cc-eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RN-HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~-~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+ .+|+|||||..+|.++++.. ++.++++.++.|+.||++||+|+|++|+.|||+||+|||+
T Consensus 81 ~~~~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---------------- 143 (538)
T KOG0661|consen 81 NDRILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---------------- 143 (538)
T ss_pred cCceEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe----------------
Confidence 87 99999999999999999887 5789999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCCCc--ccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~--~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
.+...+||+|||+|+......+. ++.|..|.|||++.. .-|+.+.|+||+|||++|+.+-++.|.+
T Consensus 144 -----------~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG 212 (538)
T KOG0661|consen 144 -----------SGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG 212 (538)
T ss_pred -----------cccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC
Confidence 55778999999999976666543 578999999999865 4588999999999999999999999999
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.++.+....|-+++|.+..+.|...-..+.. -.+.+|.-.. ..+..+....+.++.++|.+
T Consensus 213 ~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~----mnf~~P~~~~---------------~~l~~L~p~~s~~~~~li~~ 273 (538)
T KOG0661|consen 213 ASEIDQIYKICEVLGTPDKDSWPEGYNLASA----MNFRFPQVKP---------------SPLKDLLPNASSEAASLIER 273 (538)
T ss_pred CcHHHHHHHHHHHhCCCccccchhHHHHHHH----hccCCCcCCC---------------CChHHhCcccCHHHHHHHHH
Confidence 9999999999999999988777664222211 1222222111 11222334578899999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
||.+||++||||+|+|+||||+.-
T Consensus 274 ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 274 LLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HhcCCCccCccHHHHhcCcccccc
Confidence 999999999999999999999753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=372.36 Aligned_cols=254 Identities=27% Similarity=0.468 Sum_probs=213.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEee--ccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce-EE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH-IC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~-~~ 120 (379)
..+.+..||+|..|+||++.++.|++.+|+|++. .+......+.+|++++... ++++||.+++.|..++. ++
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-----~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-----QSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-----CCCCeeeEeEEEEeCCceEE
Confidence 4456689999999999999999999999999994 3455567788899988887 88999999999999984 99
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+|||| +|||.+++...+ .+++..+..++.++++||.|||. .+||||||||+|||+
T Consensus 155 I~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv-------------------- 212 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV-------------------- 212 (364)
T ss_pred eehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee--------------------
Confidence 999999 999999998765 69999999999999999999995 999999999999999
Q ss_pred CcccccCCCCCCeEEeecCccccc-CCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC--chH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYE-RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH--ENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~--~~~ 275 (379)
...+.+||||||.+... +....+.+||..|||||.+.+..|+.++||||||+.++|+++|+.||... ...
T Consensus 213 -------NskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~ 285 (364)
T KOG0581|consen 213 -------NSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL 285 (364)
T ss_pred -------ccCCCEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC
Confidence 55667888888887643 33346789999999999999999999999999999999999999999874 122
Q ss_pred HHHHHHHHHcC-CCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 276 EHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 276 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
..+..+..+.- ++|. .|+ ..+++++++||..||+
T Consensus 286 ~~~~Ll~~Iv~~ppP~--------------------lP~-------------------------~~fS~ef~~FV~~CL~ 320 (364)
T KOG0581|consen 286 DIFELLCAIVDEPPPR--------------------LPE-------------------------GEFSPEFRSFVSCCLR 320 (364)
T ss_pred CHHHHHHHHhcCCCCC--------------------CCc-------------------------ccCCHHHHHHHHHHhc
Confidence 33333333322 2221 111 1388999999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+||.+|||+.|+++|||++.-+
T Consensus 321 Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 321 KDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCcccCCCHHHHhcCHHHhhcc
Confidence 9999999999999999998543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-52 Score=369.19 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=224.0
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.....|++++.||+|+||.||+++.+.|++.+|+|++++. .+.......|..++..+ .||.++.++..|++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-----~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-----KHPFIVKLIYSFQT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-----CCCcEeeeEEeccc
Confidence 4456788999999999999999999999999999999753 23456667899999997 88999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
+..+|+|+||+ ||.|...+++.+ .+++..++-++.+|+.||.|||+.||+||||||+|||+
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---------------- 158 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---------------- 158 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee----------------
Confidence 99999999999 999999999876 79999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+..+.++|+|||+++..... ..+.+||+.|+|||++.+.+|+..+|+||||+++|+|++|.+||.+
T Consensus 159 -----------d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 159 -----------DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred -----------cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence 67788999999998743333 3557999999999999999999999999999999999999999999
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+.......+.+...+.++ ...+.++++++++
T Consensus 228 ~~~~~~~~~I~~~k~~~~p------------------------------------------------~~ls~~ardll~~ 259 (357)
T KOG0598|consen 228 EDVKKMYDKILKGKLPLPP------------------------------------------------GYLSEEARDLLKK 259 (357)
T ss_pred ccHHHHHHHHhcCcCCCCC------------------------------------------------ccCCHHHHHHHHH
Confidence 8877776666554422221 1256799999999
Q ss_pred ccccCCCCCc----CHHHHhcCCCCCCCCc
Q 017021 352 LLRYDPTDRL----TAREALRHPFFTRDHL 377 (379)
Q Consensus 352 ~L~~dP~~Rp----ta~e~l~hp~f~~~~~ 377 (379)
+|+.||++|. ++.++-+||||.+.+.
T Consensus 260 LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 260 LLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred HhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 9999999996 7999999999998763
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=379.93 Aligned_cols=272 Identities=26% Similarity=0.393 Sum_probs=226.3
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.....|++++.||+|+|++|++|+++.+++.||||++.+. +........|...|.++. +||.|++++.-|++
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~----~hPgivkLy~TFQD 145 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS----GHPGIVKLYFTFQD 145 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh----CCCCeEEEEEEeec
Confidence 3445678889999999999999999999999999999742 233455667888888884 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
+..+|+|+||+ +|+|.++|.+.+ .+.+.-++.++.+|+.||+|||+.|||||||||+|||++.++.++|.|||.+.-
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999 999999999987 799999999999999999999999999999999999996655555555555544
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
++...... . .+-.......+..+++||..|++||++.....++.+|+|+|||++|+|+.|.+||.+.++
T Consensus 224 l~~~~~~~----~-------~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 224 LSPSQKSQ----E-------NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred CChhhccc----c-------CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 33322110 0 000000011112457999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.-+++.|......+|+ ..++.++|||.++|.
T Consensus 293 yliFqkI~~l~y~fp~-------------------------------------------------~fp~~a~dLv~KLLv 323 (604)
T KOG0592|consen 293 YLIFQKIQALDYEFPE-------------------------------------------------GFPEDARDLIKKLLV 323 (604)
T ss_pred HHHHHHHHHhcccCCC-------------------------------------------------CCCHHHHHHHHHHHc
Confidence 9999999998777764 366789999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCCCCc
Q 017021 355 YDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
.||.+|+|+.|+-+||||...+.
T Consensus 324 ~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 324 RDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred cCccccccHHHHhhCcccccCCh
Confidence 99999999999999999998764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=354.43 Aligned_cols=280 Identities=31% Similarity=0.558 Sum_probs=233.1
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|+.+.++|+|+||.||+|+++.||+.||||++... .....-+++|+..+.++ .|+|+|.+++.|.-.+..+
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-----kH~NLVnLiEVFrrkrklh 77 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-----KHENLVNLIEVFRRKRKLH 77 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-----ccchHHHHHHHHHhcceeE
Confidence 478889999999999999999999999999999633 23456778999999999 7899999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|+|||..++.+-+.... ..++.+.+..+++|++.|+.|+|+++++||||||+||++
T Consensus 78 LVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---------------------- 134 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---------------------- 134 (396)
T ss_pred EEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE----------------------
Confidence 999999888888888865 358999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC-C--cccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ-N--YIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~-~--~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
..++.+||||||+|+....+. . -++.|..|.|||.+.+ .+|+.++||||+||++.||++|.+.|.+.++.+
T Consensus 135 -----t~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD 209 (396)
T KOG0593|consen 135 -----TQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID 209 (396)
T ss_pred -----ecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence 677889999999998666433 2 2578999999999987 789999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
+...|.+.+|.+++...+...+.. +...-.++.|+.. +++. .-....+..+.||+.+||+.|
T Consensus 210 QLy~I~ktLG~L~prhq~iF~~N~--~F~Gv~lP~~~~~---------------epLe-~k~p~~s~~~ld~~k~cL~~d 271 (396)
T KOG0593|consen 210 QLYLIRKTLGNLIPRHQSIFSSNP--FFHGVRLPEPEHP---------------EPLE-RKYPKISNVLLDLLKKCLKMD 271 (396)
T ss_pred HHHHHHHHHcccCHHHHHHhccCC--ceeeeecCCCCCc---------------cchh-hhcccchHHHHHHHHHHhcCC
Confidence 999999999999887655432211 1111112222211 1111 122345668999999999999
Q ss_pred CCCCcCHHHHhcCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTR 374 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~ 374 (379)
|++|++.+|+|.||||.+
T Consensus 272 P~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 272 PDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred ccccccHHHHhcChHHHH
Confidence 999999999999999943
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=341.32 Aligned_cols=278 Identities=28% Similarity=0.477 Sum_probs=236.8
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.+|...++||+|.||.||+|++..||+.||||+++.. +.....+.+|+..++.+ +|+||+.+.+.|-..+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-----~h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-----KHPNIIELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-----cCcchhhhhhhccCCCce
Confidence 4688899999999999999999999999999999743 33367888999999998 789999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 120 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 120 ~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
.+|+||+..+|...+..+. ..++...+..++.++++||+|||+..|+|||+||.|+|+
T Consensus 77 ~lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi--------------------- 134 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI--------------------- 134 (318)
T ss_pred EEEEEeccccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---------------------
Confidence 9999999999999997754 468999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCCC---cccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQN---YIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+.++.+||+|||+|+...+... ..+.|.-|.|||.+.+. .|+..+|+||.|||+.||+-|.+.|.+.++.
T Consensus 135 ------s~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi 208 (318)
T KOG0659|consen 135 ------SSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI 208 (318)
T ss_pred ------cCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH
Confidence 5667788888888876665542 23678899999999874 5999999999999999999999999999999
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
++...+.+.+|.+.++.|+.+.+..+... -...+.+. .. ......++++.||+.+||.+
T Consensus 209 dQL~~If~~LGTP~~~~WP~~~~lpdY~~-~~~~P~~~----------------~~----~lf~aas~d~ldLl~~m~~y 267 (318)
T KOG0659|consen 209 DQLSKIFRALGTPTPDQWPEMTSLPDYVK-IQQFPKPP----------------LN----NLFPAASSDALDLLSKMLTY 267 (318)
T ss_pred HHHHHHHHHcCCCCcccCccccccccHHH-HhcCCCCc----------------cc----cccccccHHHHHHHHhhhcc
Confidence 99999999999999998887665443322 11121111 00 12334677889999999999
Q ss_pred CCCCCcCHHHHhcCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~ 374 (379)
||.+|+||.|+|+|+||+.
T Consensus 268 nP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 268 NPKKRITASQALKHPYFKS 286 (318)
T ss_pred CchhcccHHHHhcchhhhc
Confidence 9999999999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=365.44 Aligned_cols=286 Identities=28% Similarity=0.446 Sum_probs=237.7
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeec---cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
.......|+.+++||+|.||.||+|++..||+.||+|++.. .......+.+|+.+|+++ +|+||+++.+...
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-----~HpNIikL~eivt 186 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-----DHPNIIKLEEIVT 186 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-----CCCcccceeeEEE
Confidence 44556678999999999999999999999999999999973 245667788999999999 8999999999988
Q ss_pred ec--ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 115 YR--NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 115 ~~--~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
+. ..+|+|+|||..+|.-++...+ -.+++.++..++.||+.||+|||++||+|||||.+|||+
T Consensus 187 ~~~~~siYlVFeYMdhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi-------------- 251 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI-------------- 251 (560)
T ss_pred ecCCceEEEEEecccchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE--------------
Confidence 76 6899999999999999987754 359999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
+.++.+||+|||+|+...... ...+-|.-|.|||++.+. .|+.++|+||+|||+.||+.|++
T Consensus 252 -------------dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 252 -------------DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred -------------cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence 566778888888887555443 234678999999999875 59999999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
.|.+.++.++...|.+..|.+.++.|+. ........-.. .......+.+.....++.+.+
T Consensus 319 I~~G~tEveQl~kIfklcGSP~e~~W~~-~kLP~~~~~kp-------------------~~~y~r~l~E~~~~~~~~~l~ 378 (560)
T KOG0600|consen 319 ILQGRTEVEQLHKIFKLCGSPTEDYWPV-SKLPHATIFKP-------------------QQPYKRRLRETFKDFPASALD 378 (560)
T ss_pred CcCCccHHHHHHHHHHHhCCCChhcccc-ccCCcccccCC-------------------CCcccchHHHHhccCCHHHHH
Confidence 9999999999999999999999988872 21110000000 001112223335567889999
Q ss_pred HHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 348 LLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
|+..||..||++|.||.++|+|+||+.+-
T Consensus 379 Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 379 LLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred HHHHHhccCccccccHHHHhcCcccccCC
Confidence 99999999999999999999999996553
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=368.72 Aligned_cols=282 Identities=27% Similarity=0.407 Sum_probs=227.9
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
++.-.|+++++||+|+||.||+|+-+.||+.+|+|++++.. .+......|..+|... +++.+|+++..|++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-----ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-----DSPWVVKLYYSFQD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-----CCCcEEEEEEEecC
Confidence 35667889999999999999999999999999999998643 3344555677777765 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
..++||||||. ||++..+|.+.+ .|++..++.++.+++.|++.+|+.|+|||||||+|+|++..|.+|+.||||+..
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccch
Confidence 99999999999 999999999887 799999999999999999999999999999999999999999999999999965
Q ss_pred CCCCCcccc------cCCCCCCeEEeecCcc--cccCCC---------------CCcccccCCccchhhhhCCCCCCccc
Q 017021 195 TPKDSSYFK------RMPKSSAIKVIDFGST--TYERPD---------------QNYIVSTRHYRAPEVILGLGWTYPCD 251 (379)
Q Consensus 195 ~~~~~~~~~------~~~~~~~~~l~Dfg~~--~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~sD 251 (379)
..+...... ........+-.||... ...... ..+.+|||.|+|||++.+.+|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 444322210 0000011122223210 000000 02368999999999999999999999
Q ss_pred hHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHc--CCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchh
Q 017021 252 IWSVGCILVELCTGEALFQTHENLEHLAMMERVL--GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 329 (379)
Q Consensus 252 vwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (379)
+||||||+|||+.|.+||.+.++.++...|.... ...|++
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~-------------------------------------- 412 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE-------------------------------------- 412 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------------------------------
Confidence 9999999999999999999999988888777643 222221
Q ss_pred hHHHHHHhhccchhHHHHHHhhccccCCCCCc---CHHHHhcCCCCCCCC
Q 017021 330 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL---TAREALRHPFFTRDH 376 (379)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---ta~e~l~hp~f~~~~ 376 (379)
...+.+++|||.+||. ||++|. +++||-+||||++.+
T Consensus 413 ---------~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 413 ---------VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred ---------CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 2356899999999999 999999 499999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=354.80 Aligned_cols=262 Identities=28% Similarity=0.484 Sum_probs=223.1
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
..|.+.++||+|+||+||+|+++.++..||||.+... .+..+....|+.++..+ .|+||+.++++.+.++++
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-----~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-----KHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-----CCcceeeEEEEEecCCeE
Confidence 4567778899999999999999999999999999643 44566778899999999 689999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||| ||+|.+++.+++ .+++..++.++.||+.||++||+.+||||||||+|||+.....
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~--------------- 147 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTAR--------------- 147 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCC---------------
Confidence 9999999 999999999986 7999999999999999999999999999999999999965310
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.+....+||+|||+|+...+.. .+.+|++.|||||++..+.|+.|+|+||+|+++|++++|+.||...+..|
T Consensus 148 ------~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 148 ------NDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred ------CCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 0112679999999999777654 55799999999999999999999999999999999999999999988888
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
.+..+++...-.|. .....++...+++...|+.|
T Consensus 222 L~~~~~k~~~~~~~----------------------------------------------~~~~~s~~~~~Ll~~ll~~~ 255 (429)
T KOG0595|consen 222 LLLYIKKGNEIVPV----------------------------------------------LPAELSNPLRELLISLLQRN 255 (429)
T ss_pred HHHHHhccccccCc----------------------------------------------hhhhccCchhhhhhHHHhcC
Confidence 87755553322211 01134566778999999999
Q ss_pred CCCCcCHHHHhcCCCCCCCCcC
Q 017021 357 PTDRLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~~~~ 378 (379)
|.+|.+..+-+.|++...+..+
T Consensus 256 ~~~~~~~~~~~~~~~l~~~p~~ 277 (429)
T KOG0595|consen 256 PKDRISFEDFFDHPFLAANPQD 277 (429)
T ss_pred ccccCchHHhhhhhhcccCccc
Confidence 9999999999999998876543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=345.78 Aligned_cols=281 Identities=27% Similarity=0.435 Sum_probs=235.3
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeec---cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee--c
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--R 116 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~--~ 116 (379)
...|+.+.+|++|.||.||+|+|+.|++.||+|+++- .........+|+.++.++ +|+|||.+.+...- -
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-----~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-----RHPNIVEVKEVVVGSNM 149 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-----CCCCeeeeEEEEecccc
Confidence 4568899999999999999999999999999999973 244567778999999998 78999999888763 3
Q ss_pred ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 117 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 117 ~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
+.+|+|||||..+|..+++... .++...++..++.|++.||+|||...|+||||||+|+|+
T Consensus 150 d~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm------------------ 210 (419)
T KOG0663|consen 150 DKIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL------------------ 210 (419)
T ss_pred ceeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee------------------
Confidence 5699999999999999999876 479999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCC-CCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
...+.+||+|||+|+..+.+. ...+-|.-|.|||++.+.+ |+.+.|+||+|||+.|++++++.|.+.
T Consensus 211 ---------~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 211 ---------SHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred ---------ccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 556678888999988766653 3356799999999998754 899999999999999999999999999
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhh-hhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc--chhHHHHHH
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEK-YVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH--SAGDLTHLL 349 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li 349 (379)
++.++..+|.+.+|.+.+..|+-+...... .+.. +. ...+....-... .+....+|+
T Consensus 282 sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f-----~~---------------~pyn~lr~kF~~~~lse~g~~Ll 341 (419)
T KOG0663|consen 282 SEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTF-----SE---------------HPYNNLRKKFGALSLSEQGFDLL 341 (419)
T ss_pred chHHHHHHHHHHhCCCccccCCCccccchhhcccc-----CC---------------CCchhhhhhccccccchhHHHHH
Confidence 999999999999999999988875544322 1111 11 111111111112 457899999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+.+|.+||.+|.||+|.|+|.||.+.
T Consensus 342 n~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 342 NKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred HHHhccCccccccHHHhhcccccccC
Confidence 99999999999999999999999984
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=349.89 Aligned_cols=277 Identities=29% Similarity=0.507 Sum_probs=233.0
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeec---cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-----c
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-----R 116 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~-----~ 116 (379)
|...+.||.|+||.|+.|.++.||+.||||++.. +.....+..+|+..+..+ .|+||+.+.+.+.. -
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-----~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-----RHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-----cCCCcceEEeeccccccccc
Confidence 3446999999999999999999999999999872 344567778899998888 67899999988875 3
Q ss_pred ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 117 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 117 ~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
+-+|+|+|+|+.+|.++++++. .++...+..+++||+.||.|+|+.+++||||||.|+++
T Consensus 99 ~DvYiV~elMetDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~------------------ 158 (359)
T KOG0660|consen 99 NDVYLVFELMETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL------------------ 158 (359)
T ss_pred ceeEEehhHHhhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheee------------------
Confidence 4699999999999999998875 59999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhh-CCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+.++.+||||||+|+..... ....+.|..|.|||++. ...|+.+.||||+|||+.||++|++.|.
T Consensus 159 ---------n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp 229 (359)
T KOG0660|consen 159 ---------NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP 229 (359)
T ss_pred ---------ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence 67778899999999876432 23457899999999875 4679999999999999999999999999
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhh-hhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
+.+..++...+.+..|.++++.+..+. +.++.++.+- ...|. ..........++.+.||+
T Consensus 230 G~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~sl-p~~p~------------------~~f~~~fp~a~p~AidLl 290 (359)
T KOG0660|consen 230 GKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSL-PQIPK------------------QPFSSIFPNANPLAIDLL 290 (359)
T ss_pred CCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhC-CCCCC------------------CCHHHHcCCCCHHHHHHH
Confidence 999999999999999999999888865 4445555431 11111 011223346788999999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
.+||+.||.+|+||+|+|+|||++.
T Consensus 291 ekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 291 EKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHhccCccccCCHHHHhcChhhhh
Confidence 9999999999999999999999974
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=340.56 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=227.1
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
..-..|++.+.||.|+||.|.+++.+.+|..+|+|+++..+ ++.+....|..+++.+ .||+++++.+.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-----~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-----SHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-----cCceeEEEEEeecc
Confidence 45567788899999999999999999999999999998532 3456667789999888 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+++|+||||. ||.|..++.+.+ ++++..++.++.||+.||+|||+.+|++||+||+|||+
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---------------- 177 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---------------- 177 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee----------------
Confidence 99999999999 999999998876 79999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
++++.+||+|||+|+......-+.+|||.|+|||++...++..++|.||||+++|||+.|.+||...+.
T Consensus 178 -----------D~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 178 -----------DQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred -----------ccCCcEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 778889999999999887777778999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
..+.+.|.+.--.+|. ..+++++|||.++|+
T Consensus 247 ~~iY~KI~~~~v~fP~-------------------------------------------------~fs~~~kdLl~~LL~ 277 (355)
T KOG0616|consen 247 IQIYEKILEGKVKFPS-------------------------------------------------YFSSDAKDLLKKLLQ 277 (355)
T ss_pred HHHHHHHHhCcccCCc-------------------------------------------------ccCHHHHHHHHHHHh
Confidence 7777666554333332 467899999999999
Q ss_pred cCCCCCc-----CHHHHhcCCCCCCCC
Q 017021 355 YDPTDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 355 ~dP~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
.|-.+|. ...++..||||++..
T Consensus 278 vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 278 VDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred hhhHhhhcCcCCCccccccCccccccc
Confidence 9999994 688999999999764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=337.75 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=220.0
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
...|++.+.||+|+|+.|+++.++.||+.+|+|+++.. ...-+...+|+.+.+.+ .||||+++++.+.+..+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-----qHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLHDSIQEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-----CCCcEeehhhhhcccce
Confidence 34689999999999999999999999999999999732 12234455667776666 88999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+|+|++ |++|..-+-+.- -.++..+..++.||+.||+|+|..||+|||+||.|+++-+
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLAS----------------- 145 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLAS----------------- 145 (355)
T ss_pred eEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeee-----------------
Confidence 99999999 888876554432 4788899999999999999999999999999999999943
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
.++...+||+|||.|...+... ....|||.|+|||++...+|+.++|||+.||++|-|+.|.+||.+.+..
T Consensus 146 -------K~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~ 218 (355)
T KOG0033|consen 146 -------KAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 218 (355)
T ss_pred -------ccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH
Confidence 2677889999999998766443 3468999999999999999999999999999999999999999987777
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
...++|.+.....|+ ..|++.++++++||++||..
T Consensus 219 rlye~I~~g~yd~~~---------------------------------------------~~w~~is~~Ak~LvrrML~~ 253 (355)
T KOG0033|consen 219 RLYEQIKAGAYDYPS---------------------------------------------PEWDTVTPEAKSLIRRMLTV 253 (355)
T ss_pred HHHHHHhccccCCCC---------------------------------------------cccCcCCHHHHHHHHHHhcc
Confidence 777777665433332 13567889999999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~~ 376 (379)
||.+|+||.|+|+|||+.+.+
T Consensus 254 dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 254 NPKKRITADEALKHPWICNRE 274 (355)
T ss_pred ChhhhccHHHHhCCchhcchH
Confidence 999999999999999998764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=362.75 Aligned_cols=252 Identities=30% Similarity=0.477 Sum_probs=214.8
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----c--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----K--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
..-.|++.+.||+|+||+|+.|++..+++.||+|+++.. . .......+|+.++..+. +||||+++++++.
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~----~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLR----SHPNIIRLLEVFA 90 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhc----cCCCEeEEEEEEe
Confidence 345789999999999999999999999999999987643 1 23444557888888882 3789999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
....+|+||||+ ||+|.+.+...+ .+.+..+..++.|++.|++|||+.||+||||||+||++
T Consensus 91 t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill--------------- 153 (370)
T KOG0583|consen 91 TPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL--------------- 153 (370)
T ss_pred cCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---------------
Confidence 999999999999 899999998854 79999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCC-CCeEEeecCcccccC---CCCCcccccCCccchhhhhCCC-CC-CccchHhHHHHHHHHHhCCC
Q 017021 194 HTPKDSSYFKRMPKS-SAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLG-WT-YPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~-~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlG~il~~l~~g~~ 267 (379)
+.+ +.+||+|||++.... ....+.+||+.|+|||++.+.. |+ .++||||+|+++|.|++|..
T Consensus 154 ------------d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~ 221 (370)
T KOG0583|consen 154 ------------DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRL 221 (370)
T ss_pred ------------cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCC
Confidence 555 789999999988662 2336679999999999999988 86 89999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccc-hhHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS-AGDLT 346 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 346 (379)
||...+...+...+.+..-..| . .. +.+++
T Consensus 222 PF~d~~~~~l~~ki~~~~~~~p-----------------------~--------------------------~~~S~~~~ 252 (370)
T KOG0583|consen 222 PFDDSNVPNLYRKIRKGEFKIP-----------------------S--------------------------YLLSPEAR 252 (370)
T ss_pred CCCCccHHHHHHHHhcCCccCC-----------------------C--------------------------CcCCHHHH
Confidence 9998665555544333322222 2 23 78999
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
+|+.+||+.||.+|+|+.++++||||+.
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=339.81 Aligned_cols=243 Identities=29% Similarity=0.437 Sum_probs=210.9
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeec---cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecc-eeeec
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN-WFDYR 116 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~-~~~~~ 116 (379)
.-..|+|+++||.|.||+||++.+..+|..||+|.++- +.+.++....|+.++.++ +||||+++++ .|..+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-----~HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-----NHPNIVQYYAHSFIED 91 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-----CCchHHHHHHHhhhcc
Confidence 44569999999999999999999999999999999973 345667788899999999 8899999988 55555
Q ss_pred c-eEEEEEeCC-CCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH--cC--CcccCCCCCcEEEecccccccCC
Q 017021 117 N-HICIVFEKL-GSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD--LC--MIHTDLKPENVLLVSSEYIKVPD 188 (379)
Q Consensus 117 ~-~~~lv~e~~-~~sL~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~--iiH~dlkp~Nili~~~~~~~~~~ 188 (379)
+ .++||||+| +|+|.++++. +..+.+++..++.++.|++.||.++|+ .. |+||||||.||++
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---------- 161 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---------- 161 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE----------
Confidence 4 499999999 9999999964 344679999999999999999999998 44 9999999999999
Q ss_pred CccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhC
Q 017021 189 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g 265 (379)
+.++.+||.|||+++...... .+.+|||.||+||.+.+.+|+++|||||+||++|||+.-
T Consensus 162 -----------------~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL 224 (375)
T KOG0591|consen 162 -----------------TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCAL 224 (375)
T ss_pred -----------------cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhc
Confidence 666778888888887655543 356899999999999999999999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHc-CCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 266 EALFQTHENLEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
++||.+.+-.+....|.+.. .+.|++ ++|.+
T Consensus 225 ~~PF~g~n~~~L~~KI~qgd~~~~p~~------------------------------------------------~YS~~ 256 (375)
T KOG0591|consen 225 QSPFYGDNLLSLCKKIEQGDYPPLPDE------------------------------------------------HYSTD 256 (375)
T ss_pred CCCcccccHHHHHHHHHcCCCCCCcHH------------------------------------------------HhhhH
Confidence 99999998888888887753 334433 57889
Q ss_pred HHHHHhhccccCCCCCcCH
Q 017021 345 LTHLLQGLLRYDPTDRLTA 363 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta 363 (379)
+..+|..|+..||+.||+.
T Consensus 257 l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHccCCcccCCCc
Confidence 9999999999999999985
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=346.09 Aligned_cols=289 Identities=26% Similarity=0.353 Sum_probs=234.1
Q ss_pred eeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 36 TYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 36 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
+...+.-..+++++.||.|.-|+||+|+.+.++..+|+|++.+. .+...++..|.+||+.+ +||.++.++.
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-----DHPFlPTLYa 144 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-----DHPFLPTLYA 144 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-----CCCccchhhh
Confidence 34455666789999999999999999999999999999999743 23345566688888888 8999999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
.|+.+++.|+||||| ||+|..+.+++.++.+++..++.++.+++.||+|||-.|||.|||||+|||+.++|.+-+.||.
T Consensus 145 ~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 145 SFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred eeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecc
Confidence 999999999999999 9999999999998999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCccccc-----CCCCCCeE---E----------------eecCc--------ccccCCCCCcccccCCccch
Q 017021 191 SSLHTPKDSSYFKR-----MPKSSAIK---V----------------IDFGS--------TTYERPDQNYIVSTRHYRAP 238 (379)
Q Consensus 191 ~~~~~~~~~~~~~~-----~~~~~~~~---l----------------~Dfg~--------~~~~~~~~~~~~gt~~y~aP 238 (379)
|++.......-... ......+. . .|.+. |...+..+.+++||-+|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 98654221110000 00000000 0 11111 11222334668999999999
Q ss_pred hhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCch
Q 017021 239 EVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR 318 (379)
Q Consensus 239 E~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (379)
|++.+...+.++|+|+||+++|||+.|..||.+.+..+++..+......+|+.
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~--------------------------- 357 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE--------------------------- 357 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC---------------------------
Confidence 99999999999999999999999999999999998888776554433333321
Q ss_pred hhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcC----HHHHhcCCCCCCCC
Q 017021 319 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT----AREALRHPFFTRDH 376 (379)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----a~e~l~hp~f~~~~ 376 (379)
...+..++|||+++|.+||.+|.. |+||-+||||+..+
T Consensus 358 --------------------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 358 --------------------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN 399 (459)
T ss_pred --------------------CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence 136689999999999999999998 99999999999865
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=367.62 Aligned_cols=247 Identities=30% Similarity=0.550 Sum_probs=217.8
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
|++.+.||.|+-|.|-+|++.+||+++|||++... ......+.+|+.+|.-+ .|||++++++.++...++|
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-----~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-----EHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-----cCCCeeeeeeeeccCceEE
Confidence 78999999999999999999999999999999743 34566777899999988 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+|.||+ ||.|.+++-.++ .+++.++.+++.||+.|+.|+|..+|+|||+||+|+|+
T Consensus 89 lvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL--------------------- 145 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL--------------------- 145 (786)
T ss_pred EEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---------------------
Confidence 999999 999999999887 79999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCC-CccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+....+||+|||+|....+.+ .+.||+++|.|||++.+.+|. .++||||+|||+|.|++|+.||+..+-..
T Consensus 146 ------d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~ 219 (786)
T KOG0588|consen 146 ------DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV 219 (786)
T ss_pred ------hcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH
Confidence 455559999999998655554 457999999999999999986 99999999999999999999999766555
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+++ |.+.+|. ..++++.+||++||..|
T Consensus 220 LLlKV~~-----------------------G~f~MPs--------------------------~Is~eaQdLLr~ml~VD 250 (786)
T KOG0588|consen 220 LLLKVQR-----------------------GVFEMPS--------------------------NISSEAQDLLRRMLDVD 250 (786)
T ss_pred HHHHHHc-----------------------CcccCCC--------------------------cCCHHHHHHHHHHhccC
Confidence 5544443 3333332 47889999999999999
Q ss_pred CCCCcCHHHHhcCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTR 374 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~ 374 (379)
|++|+|.+|+++|||+..
T Consensus 251 p~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 251 PSTRITTEEILKHPFLSG 268 (786)
T ss_pred ccccccHHHHhhCchhhc
Confidence 999999999999999864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=338.91 Aligned_cols=285 Identities=31% Similarity=0.506 Sum_probs=235.0
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch---hhHhHHHHHHHHHHHHhcCCCCCe-eEEecceeeecc
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNR-CVQIRNWFDYRN 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~-i~~~~~~~~~~~ 117 (379)
-..|..+++||+|+||+||+|+++.+|+.||+|++..... ......+|+.++..+ .|.| ++.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-----~~~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-----SHANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-----CCCcceEEEEeeeeecc
Confidence 4568888999999999999999999999999999975433 566778999999999 4555 999999998876
Q ss_pred ------eEEEEEeCCCCCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCC
Q 017021 118 ------HICIVFEKLGSSLYDFLRKNNY--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 118 ------~~~lv~e~~~~sL~~~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
..++|+||...+|..+++.... ..++...+..++.||+.||+|||+++|+||||||+||++
T Consensus 85 ~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi----------- 153 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI----------- 153 (323)
T ss_pred cccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE-----------
Confidence 8999999999999999988652 257788999999999999999999999999999999999
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhC
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g 265 (379)
+..+.+||+|||+|+...-+. ...++|..|.|||++.+. .|+...||||+|||++||+++
T Consensus 154 ----------------~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~ 217 (323)
T KOG0594|consen 154 ----------------SSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTR 217 (323)
T ss_pred ----------------CCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhC
Confidence 566778888888887555333 234688999999999886 689999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
+..|.+.++.++...|.+.+|.+.+..|+.+....+.-.. ...++... ......+....+.
T Consensus 218 ~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~--f~~~~~~~-----------------~l~~~~~~~~~~~ 278 (323)
T KOG0594|consen 218 RPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAP--FPKWPGPK-----------------DLSSILPKLDPDG 278 (323)
T ss_pred CCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccccccccc--CcCCCCcc-----------------chHHhccccCccH
Confidence 9999999999999999999999999888876654433321 11111100 0111112233689
Q ss_pred HHHHhhccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 346 THLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
.+++.+||+.+|.+|.||+.+|.||||.+...
T Consensus 279 ~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 279 IELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred HHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 99999999999999999999999999998754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=360.19 Aligned_cols=257 Identities=27% Similarity=0.393 Sum_probs=220.6
Q ss_pred eeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 37 YIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 37 ~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
........|.-.++||+|+.|.||.|....+++.||+|++.... ..++-...|+.++... +|+|+|.+++.|-.
T Consensus 267 ~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-----~H~NiVnfl~Sylv 341 (550)
T KOG0578|consen 267 SQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-----HHPNIVNFLDSYLV 341 (550)
T ss_pred cCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-----cchHHHHHHHHhcc
Confidence 34556677888899999999999999999999999999997433 3355667899998887 88999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+.+|+||||+ ||+|.+++.... +++.++..++.++++||+|||.+||+|||||.+|||+
T Consensus 342 ~deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---------------- 402 (550)
T KOG0578|consen 342 GDELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---------------- 402 (550)
T ss_pred cceeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe----------------
Confidence 99999999999 999999998754 9999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
..++.+||+|||+|....... .+.+||+.|||||+.....|++++||||||+++.||+.|.+||-.
T Consensus 403 -----------~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 403 -----------TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred -----------ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 566779999999987554443 567899999999999999999999999999999999999999987
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.++....+.|...-.+ ... ..+..++.++||+.+
T Consensus 472 E~PlrAlyLIa~ng~P----------------------~lk------------------------~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 472 ENPLRALYLIATNGTP----------------------KLK------------------------NPEKLSPELKDFLDR 505 (550)
T ss_pred CChHHHHHHHhhcCCC----------------------CcC------------------------CccccCHHHHHHHHH
Confidence 7766555544432211 111 124678999999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
||+.||.+|++|.|+|+||||+-
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhhh
Confidence 99999999999999999999953
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=347.49 Aligned_cols=277 Identities=29% Similarity=0.489 Sum_probs=220.1
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.++||.|+||.||+|+++.+++.||+|+++... .......+|+.++..+ .|+|++++++++..++..++
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-----KHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-----CCCCEeeEEEEEcCCCeEEE
Confidence 4888899999999999999999999999999986432 2234566799998888 78999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
||||+.++|.+++.... ..++...+..++.||+.||+|||++||+||||||+||+++
T Consensus 81 v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---------------------- 137 (288)
T cd07871 81 VFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN---------------------- 137 (288)
T ss_pred EEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----------------------
Confidence 99999779999987654 3578999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
.++.++|+|||.+....... ....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 138 -----~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~ 212 (288)
T cd07871 138 -----EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212 (288)
T ss_pred -----CCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 44567777777765432211 23467899999999865 5688999999999999999999999998888888
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+..+.++...|+.+....... . ...+.. .... ........+.++.+||.+||++||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~--------------~~~~-~~~~~~~~~~~~~dll~~mL~~dp 273 (288)
T cd07871 213 LHLIFRLLGTPTEETWPGITSNEEFR-S---YLFPQY--------------RAQP-LINHAPRLDTDGIDLLSSLLLYET 273 (288)
T ss_pred HHHHHHHhCCCChHHhhccccchhhh-c---cccCcc--------------CCCc-hHHhCCCCCHHHHHHHHHhcCcCc
Confidence 88888888888888776543321110 0 000000 0000 011123456789999999999999
Q ss_pred CCCcCHHHHhcCCCC
Q 017021 358 TDRLTAREALRHPFF 372 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f 372 (379)
.+||||+|+++||||
T Consensus 274 ~~R~t~~~~l~hp~f 288 (288)
T cd07871 274 KSRISAEAALRHSYF 288 (288)
T ss_pred ccCCCHHHHhcCCCC
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=345.66 Aligned_cols=279 Identities=24% Similarity=0.339 Sum_probs=223.7
Q ss_pred eeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 35 ITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
...++.....|++.+.||.|.-++||+|+..-+++.||||+++.... .-....+|++.+..+ +||||+.++..
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-----~HPNIv~~~~s 92 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-----DHPNIVTYHCS 92 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-----CCCCcceEEEE
Confidence 44567778889999999999999999999999999999999974322 235677888888887 89999999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
|..+..+|+||+|| +||+.+++.......+.+..+..++.+++.||.|||.+|.||||||+.|||++.+|.+|++|||.
T Consensus 93 Fvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 93 FVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence 99999999999999 99999999987666799999999999999999999999999999999999998887777777776
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC--CCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.++..+. .-...+| .+.+||++|+|||++.. ..|++|+||||||++..||++|+.||
T Consensus 173 sa~l~~~G----------~R~~~rf----------~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 173 SASLFDSG----------DRQVTRF----------NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred eeeecccC----------ceeeEee----------ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 64432211 0111111 35689999999999643 46999999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
....+...+ +.+.-+.+|..... ....+..+.++..++++|
T Consensus 233 ~k~pPmkvL--l~tLqn~pp~~~t~-------------------------------------~~~~d~~k~~~ksf~e~i 273 (516)
T KOG0582|consen 233 SKYPPMKVL--LLTLQNDPPTLLTS-------------------------------------GLDKDEDKKFSKSFREMI 273 (516)
T ss_pred ccCChHHHH--HHHhcCCCCCcccc-------------------------------------cCChHHhhhhcHHHHHHH
Confidence 876665544 33344444421100 000112234667999999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
..||+.||.+||||+++|+|+||+....
T Consensus 274 ~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 274 ALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred HHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 9999999999999999999999997654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=366.61 Aligned_cols=312 Identities=39% Similarity=0.690 Sum_probs=233.0
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCC-CCCeeEEecceeeec-ce
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-GGNRCVQIRNWFDYR-NH 118 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~i~~~~~~~~~~-~~ 118 (379)
....|++.++||+|+||+||+|++..+++.||||+++...........|+.++..+.+... ++.+++.+.+++..+ .+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 3457999999999999999999999999999999997544445556678888888765432 345688888888754 58
Q ss_pred EEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+||++++++|.+++.+.+ .+++..+..++.||+.||.|||+ .||+||||||+|||++..+....... ..
T Consensus 207 ~~iv~~~~g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~--~~---- 278 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT--NR---- 278 (467)
T ss_pred EEEEEeccCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc--cc----
Confidence 99999999999999987764 68999999999999999999998 59999999999999976543211110 00
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
........+||+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 279 -----~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 279 -----ALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred -----ccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 001234569999999887655555567899999999999999999999999999999999999999999888888
Q ss_pred HHHHHHHcCCCChhHHHhhhh-hhhhhhcc-CCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 278 LAMMERVLGPLPQHMLKRVDR-HAEKYVRR-GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
...+.+..+.+|..+...... ..+.+... +.+. +. .....+........... ....+.+.|||.+||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~------~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLR-PC--TDPKHLARIARARPVRE------VIRDDLLCDLIYGLLHY 424 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhccccc-cc--CCHHHHHhhhcccchhh------hhchHHHHHHHHHhCCc
Confidence 888999999999887664321 11111111 1110 00 00000100000000000 11246789999999999
Q ss_pred CCCCCcCHHHHhcCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~ 374 (379)
||.+||||+|+|+||||..
T Consensus 425 dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 425 DRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred ChhhCCCHHHHhcCccccc
Confidence 9999999999999999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=356.38 Aligned_cols=249 Identities=29% Similarity=0.492 Sum_probs=217.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
+|-+.+.||+|.||.||+|+.+.|.+.||+|.+.+.. +.-....+|++++..+ .|+||+.++++|+...++|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-----kHpniv~m~esfEt~~~~~ 77 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-----KHPNIVEMLESFETSAHLW 77 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-----CCcchhhHHHhhcccceEE
Confidence 5778899999999999999999999999999997533 3345577899999998 7899999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|+|||.|+|..++...+ .++++.+..++.+++.||.|||+.+|+|||+||+||++
T Consensus 78 vVte~a~g~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---------------------- 133 (808)
T KOG0597|consen 78 VVTEYAVGDLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---------------------- 133 (808)
T ss_pred EEehhhhhhHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee----------------------
Confidence 999999669999998866 79999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
.+++.+|+||||+|+...... ....|||.|||||+..+.+|+..+|+|||||++||+.+|++||...+-.+.
T Consensus 134 -----~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~L 208 (808)
T KOG0597|consen 134 -----EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQL 208 (808)
T ss_pred -----cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHH
Confidence 788899999999998776654 346799999999999999999999999999999999999999986554444
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...|......+| .+.+..+.+|++.+|.+||
T Consensus 209 v~~I~~d~v~~p-------------------------------------------------~~~S~~f~nfl~gLL~kdP 239 (808)
T KOG0597|consen 209 VKSILKDPVKPP-------------------------------------------------STASSSFVNFLQGLLIKDP 239 (808)
T ss_pred HHHHhcCCCCCc-------------------------------------------------ccccHHHHHHHHHHhhcCh
Confidence 444433222222 1357789999999999999
Q ss_pred CCCcCHHHHhcCCCCCCC
Q 017021 358 TDRLTAREALRHPFFTRD 375 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f~~~ 375 (379)
.+|.|..+++.|||.+..
T Consensus 240 ~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 240 AQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hhcccHHHHhcChHHhhh
Confidence 999999999999998753
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=345.61 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=209.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ .|+|++++++.+.+....
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~ 76 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-----SHPFIIRLFWTEHDQRFL 76 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-----CCCcHhhhHhhhccCCeE
Confidence 4788899999999999999999999999999997432 2334566788888887 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli-------------------- 134 (291)
T cd05612 77 YMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL-------------------- 134 (291)
T ss_pred EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE--------------------
Confidence 9999999 899999998764 68999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
+.++.++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 135 -------~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~ 207 (291)
T cd05612 135 -------DKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207 (291)
T ss_pred -------CCCCCEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4556788888888876554444567999999999999988999999999999999999999999876655544
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+...... ++ ...+..++++|++||+.||.
T Consensus 208 ~~i~~~~~~-----------------------~~--------------------------~~~~~~~~~li~~~l~~dp~ 238 (291)
T cd05612 208 EKILAGKLE-----------------------FP--------------------------RHLDLYAKDLIKKLLVVDRT 238 (291)
T ss_pred HHHHhCCcC-----------------------CC--------------------------ccCCHHHHHHHHHHcCCCHH
Confidence 333221111 11 13466899999999999999
Q ss_pred CCcC-----HHHHhcCCCCCCC
Q 017021 359 DRLT-----AREALRHPFFTRD 375 (379)
Q Consensus 359 ~Rpt-----a~e~l~hp~f~~~ 375 (379)
+||+ ++|+++||||+..
T Consensus 239 ~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 239 RRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HccCCccCCHHHHhcCccccCC
Confidence 9995 9999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=340.56 Aligned_cols=279 Identities=32% Similarity=0.586 Sum_probs=218.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.+.||+|+||.||+|+++.+++.||+|++.... .......+|+.++..+ .|+|++++++.+...+..|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 76 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-----KQENIVELKEAFRRRGKLY 76 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-----CCccccchhhhEecCCEEE
Confidence 4788899999999999999999999999999997432 2344566788888887 7799999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||||+.+++.+.+.... ..+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 77 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---------------------- 133 (287)
T cd07848 77 LVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---------------------- 133 (287)
T ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----------------------
Confidence 999999444445554432 358999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+
T Consensus 134 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~ 208 (287)
T cd07848 134 -----SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID 208 (287)
T ss_pred -----cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 455567778888776433221 23468999999999998889999999999999999999999999888777
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+..+++|...++......... ...++... .............+.++.+||++||+.|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-------------~~~~~~~~~~~~~s~~~~dll~~~L~~~ 271 (287)
T cd07848 209 QLFTIQKVLGPLPAEQMKLFYSNPRFH----GLRFPAVN-------------HPQSLERRYLGILSGVLLDLMKNLLKLN 271 (287)
T ss_pred HHHHHHHhhCCCCHHHHHhhhccchhc----ccccCccc-------------CcccHHHhhhcccCHHHHHHHHHHccCC
Confidence 777888888888877665432211100 01111000 0001111223456788999999999999
Q ss_pred CCCCcCHHHHhcCCCC
Q 017021 357 PTDRLTAREALRHPFF 372 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f 372 (379)
|++|||++|+++||||
T Consensus 272 P~~R~s~~~~l~hp~f 287 (287)
T cd07848 272 PTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccCCCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=350.84 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=211.9
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.....|++.+.||+|+||.||+|+++.+++.||+|++.... .....+..|+.++..+ .|+|++++++.+..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-----SHPFIVNMMCSFQD 89 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCCCcEEEEEEc
Confidence 33456788899999999999999999999999999997432 2234566788888887 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
++..|+||||+ +++|.+.+.... .+++..+..++.||+.||+|||+.||+||||||+||++
T Consensus 90 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---------------- 151 (329)
T PTZ00263 90 ENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---------------- 151 (329)
T ss_pred CCEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----------------
Confidence 99999999999 899999998764 68899999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
+.++.++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 152 -----------~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 220 (329)
T PTZ00263 152 -----------DNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220 (329)
T ss_pred -----------CCCCCEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH
Confidence 556678888998887655555556799999999999998899999999999999999999999987655
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+.+.. ..+| ...+..+.+||.+||+
T Consensus 221 ~~~~~~i~~~~-----------------------~~~p--------------------------~~~~~~~~~li~~~L~ 251 (329)
T PTZ00263 221 FRIYEKILAGR-----------------------LKFP--------------------------NWFDGRARDLVKGLLQ 251 (329)
T ss_pred HHHHHHHhcCC-----------------------cCCC--------------------------CCCCHHHHHHHHHHhh
Confidence 44433322211 1111 1245678999999999
Q ss_pred cCCCCCcC-----HHHHhcCCCCCCCC
Q 017021 355 YDPTDRLT-----AREALRHPFFTRDH 376 (379)
Q Consensus 355 ~dP~~Rpt-----a~e~l~hp~f~~~~ 376 (379)
.||.+||+ ++++++||||++..
T Consensus 252 ~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 252 TDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred cCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 99999997 79999999998753
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=349.25 Aligned_cols=264 Identities=32% Similarity=0.516 Sum_probs=227.3
Q ss_pred eeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 37 YIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 37 ~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
........|++.+.||.|.||.||++..+.||+.+|+|.+.+... ......+|+.+++++. .|+|++.+.+.
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~----~hpniv~l~~~ 104 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLS----GHPNIVQLKDA 104 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhcc----CCCCEEEEEEE
Confidence 344455678999999999999999999999999999999974322 3457788999999983 38999999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
|++...+++|||+| ||.|.+.+... .+++..+..++.|++.|+.|||+.|++|||+||+|+|+....
T Consensus 105 ~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~--------- 172 (382)
T KOG0032|consen 105 FEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKD--------- 172 (382)
T ss_pred EEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeecccc---------
Confidence 99999999999999 99999999886 299999999999999999999999999999999999995431
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
.....++++|||++....... ...+||+.|+|||++....|+..+||||+|+++|.|++|.+||
T Consensus 173 --------------~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF 238 (382)
T KOG0032|consen 173 --------------EGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPF 238 (382)
T ss_pred --------------CCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCC
Confidence 234689999999998777732 5578999999999999999999999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
.+.+..+....+.+....++. ..|+..+..++++|
T Consensus 239 ~~~~~~~~~~~i~~~~~~f~~---------------------------------------------~~w~~is~~akd~i 273 (382)
T KOG0032|consen 239 WGETEFEIFLAILRGDFDFTS---------------------------------------------EPWDDISESAKDFI 273 (382)
T ss_pred cCCChhHHHHHHHcCCCCCCC---------------------------------------------CCccccCHHHHHHH
Confidence 998877766655443333222 23456788999999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+.||..||.+|+||.++|+|||+++.
T Consensus 274 ~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 274 RKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999975
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=339.47 Aligned_cols=256 Identities=31% Similarity=0.468 Sum_probs=205.3
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchh-hHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc--e
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--H 118 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~--~ 118 (379)
..++...+.||+|+||.||++.++.+|...|+|.+...... .....+|+.++.++ .|++||++++...... .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-----~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-----NHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-----CCCCEEeeCCccccccCee
Confidence 45678889999999999999999999999999998754211 34567899999998 5899999999855444 7
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
++++|||+ +|+|.+++...++ .+++..++.+..||+.||+|||++|++||||||+|||++.
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~----------------- 152 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDP----------------- 152 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeC-----------------
Confidence 99999999 9999999999876 7999999999999999999999999999999999999943
Q ss_pred CCcccccCCCCCCeEEeecCcccccCC---C---CCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERP---D---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~---~---~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
.++.+||+|||.+..... . .....||+.|+|||++... ..++++|||||||++.||+||+.||.
T Consensus 153 ---------~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 153 ---------SNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred ---------CCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence 146778888887765442 1 1346899999999999852 33469999999999999999999997
Q ss_pred CC-chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 271 TH-ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 271 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
.. ...+....+... ...| ..+...+.++++||
T Consensus 224 ~~~~~~~~~~~ig~~-~~~P----------------------------------------------~ip~~ls~~a~~Fl 256 (313)
T KOG0198|consen 224 EFFEEAEALLLIGRE-DSLP----------------------------------------------EIPDSLSDEAKDFL 256 (313)
T ss_pred hhcchHHHHHHHhcc-CCCC----------------------------------------------CCCcccCHHHHHHH
Confidence 63 222211111110 0111 11234678999999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
.+||+.||.+||||+++|.|||...++
T Consensus 257 ~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 257 RKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHhhcCcccCcCHHHHhhChhhhccc
Confidence 999999999999999999999997754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=356.55 Aligned_cols=255 Identities=25% Similarity=0.392 Sum_probs=218.5
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
.+....|+++++||+|.||+|++|..+.+++.+|||.+++. +...+..+.|..++... ..||.++.++..|+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la----~~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELA----NRHPFLVNLFSCFQ 439 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHh----ccCCeEeecccccc
Confidence 55566788999999999999999999999999999999863 33455666777777666 36899999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
+..++|+||||+ ||++..+.+. +.+++..++-|+.+|+.||+|||+.|||+||||.+|||+
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL--------------- 501 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL--------------- 501 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---------------
Confidence 999999999999 8884333332 369999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccC---CCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+..+.+||+|||+++..- ....+++||+.|+|||++.+..|+.++|+|||||+||+|+.|.+||.
T Consensus 502 ------------D~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~ 569 (694)
T KOG0694|consen 502 ------------DTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP 569 (694)
T ss_pred ------------cccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC
Confidence 677788888888887422 23367899999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
+.++.+.+..|.......|. -.+.++.++++
T Consensus 570 gddEee~FdsI~~d~~~yP~-------------------------------------------------~ls~ea~~il~ 600 (694)
T KOG0694|consen 570 GDDEEEVFDSIVNDEVRYPR-------------------------------------------------FLSKEAIAIMR 600 (694)
T ss_pred CCCHHHHHHHHhcCCCCCCC-------------------------------------------------cccHHHHHHHH
Confidence 99999988877664433332 35678999999
Q ss_pred hccccCCCCCcC-----HHHHhcCCCCCCCC
Q 017021 351 GLLRYDPTDRLT-----AREALRHPFFTRDH 376 (379)
Q Consensus 351 ~~L~~dP~~Rpt-----a~e~l~hp~f~~~~ 376 (379)
++|++||++|.. +.+|.+||||...+
T Consensus 601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 601 RLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred HHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 999999999995 68999999999765
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=340.93 Aligned_cols=284 Identities=25% Similarity=0.409 Sum_probs=212.5
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
..|++.++||+|+||.||+|+++.+++.||+|+++... .......+|+.+++.+ .|+|++.+++++.++...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-----KHANIVLLHDIIHTKETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-----CCCCcCeEEEEEecCCeEE
Confidence 45889999999999999999999999999999987432 2234566788888888 7899999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||||++++|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+||+++
T Consensus 80 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~--------------------- 137 (303)
T cd07869 80 LVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--------------------- 137 (303)
T ss_pred EEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---------------------
Confidence 999999889998887653 3588999999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCch-H
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN-L 275 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~-~ 275 (379)
.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .
T Consensus 138 ------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 211 (303)
T cd07869 138 ------DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211 (303)
T ss_pred ------CCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence 44557777777665322211 23467899999999865 4578999999999999999999999987543 3
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+....+.++...|+...... .+.... ... .......... .....+..+.+||++||+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~-------------~~~~~~~~~~--~~~~~~~~~~dli~~mL~~ 274 (303)
T cd07869 212 DQLERIFLVLGTPNEDTWPGVHSLP-HFKPER-FTL-------------YSPKNLRQAW--NKLSYVNHAEDLASKLLQC 274 (303)
T ss_pred HHHHHHHHHhCCCChhhccchhhcc-cccccc-ccc-------------cCCccHHHHh--hccCCChHHHHHHHHHhcc
Confidence 4444555555655554444322110 000000 000 0000000000 0112457899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~~ 376 (379)
||.+|||+.|+++||||++..
T Consensus 275 dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 275 FPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred CchhccCHHHHhcCcccccCC
Confidence 999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=344.91 Aligned_cols=279 Identities=31% Similarity=0.494 Sum_probs=216.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec----
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---- 116 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~---- 116 (379)
.|++.++||+|+||.||+|.++.+++.||+|++... ......+.+|+.++..+ .|+|++++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-----RHPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-----CCCCEeeecceEeccCCCC
Confidence 478899999999999999999999999999998632 22234567799888888 789999999887543
Q ss_pred -ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 117 -NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 117 -~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
...|+||||++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++
T Consensus 76 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---------------- 137 (338)
T cd07859 76 FKDIYVVFELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN---------------- 137 (338)
T ss_pred CceEEEEEecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----------------
Confidence 3589999999889999987754 589999999999999999999999999999999999994
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhC--CCCCCccchHhHHHHHHHHHhCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus 138 -----------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~ 206 (338)
T cd07859 138 -----------ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206 (338)
T ss_pred -----------CCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence 45566777777665322111 22468999999999865 578899999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhh-hhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
||.+.+.......+....+.++......+.... ..+...-... ...+ ........++.+.
T Consensus 207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~--------------~~~~-----~~~~~~~~~~~~~ 267 (338)
T cd07859 207 LFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKK--------------QPVP-----FSQKFPNADPLAL 267 (338)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhccc--------------CCCc-----hHHhcCCCChHHH
Confidence 999888777777777778887777666543221 1111100000 0000 0011223567889
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
++|.+||+.||++|||++|+++||||++.
T Consensus 268 ~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 268 RLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 99999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=334.44 Aligned_cols=278 Identities=29% Similarity=0.495 Sum_probs=224.0
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec--c---
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--N--- 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--~--- 117 (379)
.+|.-.+.+|.|+||.||+|...++++.||||++-.+.. ...+|+++++.+ .|+||+++..+|... +
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l-----~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKL-----DHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhc-----CCcCeeeEEEEEEecCCCchh
Confidence 445566999999999999999999999999999865543 334599999977 889999998887642 2
Q ss_pred eEEEEEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 118 HICIVFEKLGSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 118 ~~~lv~e~~~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
...+||||+..+|.+.++.. .+..++...+.-+.+||+.||.|||+.||+||||||+|+|++.
T Consensus 96 ~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~--------------- 160 (364)
T KOG0658|consen 96 YLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP--------------- 160 (364)
T ss_pred HHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC---------------
Confidence 56799999999999999842 2346889999999999999999999999999999999999963
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
..+.+||||||.|+...... .+..-|..|.|||.+.+. .|+.+.||||+||++.||+-|++.|.+.
T Consensus 161 -----------~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 161 -----------DTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred -----------CCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 45788999999998655444 344568899999999874 5999999999999999999999999999
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..++...+.+.+|.++.+..+.+..... +.....+. ..+.. .-.....++++.+|+.++
T Consensus 230 s~~dQL~eIik~lG~Pt~e~I~~mn~~y~---~~~~p~ik-------------~~~~~----~~~~~~~~~d~~dll~~~ 289 (364)
T KOG0658|consen 230 SSVDQLVEIIKVLGTPTREDIKSMNPNYT---EFKFPQIK-------------AHPWH----KVFFKRLPPDALDLLSKL 289 (364)
T ss_pred CHHHHHHHHHHHhCCCCHHHHhhcCcccc---cccCcccc-------------cccce----eecccCCCHHHHHHHHHH
Confidence 99999999999999999876655433221 11111110 01100 012345778999999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
|+++|.+|.+|.|+++||||.+
T Consensus 290 L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 290 LQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred hccChhhcCCHHHHhcchhhHH
Confidence 9999999999999999999975
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=336.55 Aligned_cols=278 Identities=28% Similarity=0.467 Sum_probs=212.8
Q ss_pred hhhhhhccccccceeEEEEEecC-CCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee-----
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD----- 114 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~-~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~----- 114 (379)
.|++.+.||+|+||.||+|++.. +++.||+|+++... .......+|+.++..+.. ..|+|++++++++.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET--FEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcc--cCCCCcceEEEEEecccCC
Confidence 58899999999999999999854 57889999986422 223445567777766633 25799999998874
Q ss_pred ecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 115 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 115 ~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.....++||||++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 80 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---------------- 143 (290)
T cd07862 80 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---------------- 143 (290)
T ss_pred CCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE----------------
Confidence 3457999999998899999987655568999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++|+|||.+...... .....||+.|+|||.+.+..++.++|||||||++|+|++|++||.+.
T Consensus 144 -----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 144 -----------TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred -----------cCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 45556788888877543322 23356899999999998888999999999999999999999999988
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+....+.++...++........... +.............+..+.++|.+|
T Consensus 213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~li~~~ 270 (290)
T cd07862 213 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH----------------------SKSAQPIEKFVTDIDELGKDLLLKC 270 (290)
T ss_pred CHHHHHHHHHHHhCCCChhhchhhhcccchhcc----------------------CCCCCCHHHHccCCCHHHHHHHHHH
Confidence 887777777776665544333221111000000 0000111122234677899999999
Q ss_pred cccCCCCCcCHHHHhcCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f 372 (379)
|+.||++|||+.|+|+||||
T Consensus 271 l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 271 LTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hccCchhcCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=339.38 Aligned_cols=258 Identities=23% Similarity=0.367 Sum_probs=207.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ .|++++.+.+.+.+++..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~iv~~~~~~~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-----NSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-----CCCcEEEEEEEEccCCeE
Confidence 4778899999999999999999999999999986432 2223456788888887 778999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++||||+ +++|.+.+.......+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill-------------------- 135 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL-------------------- 135 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE--------------------
Confidence 9999999 8999988865544468999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.++|+|||.+....... ....||..|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 136 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~ 208 (285)
T cd05631 136 -------DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV 208 (285)
T ss_pred -------CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch
Confidence 455668888888776532221 23468999999999999899999999999999999999999998654322
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+....... . .......+.++.+||++||+.|
T Consensus 209 ~~~~~~~~~~~~-------------------~--------------------------~~~~~~~s~~~~~li~~~l~~~ 243 (285)
T cd05631 209 KREEVDRRVKED-------------------Q--------------------------EEYSEKFSEDAKSICRMLLTKN 243 (285)
T ss_pred hHHHHHHHhhcc-------------------c--------------------------ccCCccCCHHHHHHHHHHhhcC
Confidence 221111111000 0 0112346778999999999999
Q ss_pred CCCCcC-----HHHHhcCCCCCCCCcC
Q 017021 357 PTDRLT-----AREALRHPFFTRDHLR 378 (379)
Q Consensus 357 P~~Rpt-----a~e~l~hp~f~~~~~~ 378 (379)
|.+||+ ++++++||||++.+.+
T Consensus 244 P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 244 PKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred HHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 999997 9999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=343.54 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=201.0
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|+++.+|+.||+|+++... ........|+.++..+ .|++++.+.+.+..++..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~i~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-----RHPFLTALKYSFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-----CCCCCCCEEEEEEcCCEEEEEEe
Confidence 46899999999999999999999999997432 2234456688888777 77999999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|.+.+.... .+++..+..++.||+.||+|||+.||+||||||+||++
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll------------------------- 128 (323)
T cd05571 76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML------------------------- 128 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE-------------------------
Confidence 99 899999987754 68999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+.++.++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......
T Consensus 129 --~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~ 206 (323)
T cd05571 129 --DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (323)
T ss_pred --CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH
Confidence 4556678888887764221 12345799999999999998999999999999999999999999987655443332
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+...... + ....+.++.+||.+||+.||++|
T Consensus 207 ~~~~~~~-----------------------~--------------------------p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 207 ILMEEIR-----------------------F--------------------------PRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred HHcCCCC-----------------------C--------------------------CCCCCHHHHHHHHHHccCCHHHc
Confidence 2211111 1 12356789999999999999999
Q ss_pred c-----CHHHHhcCCCCCCC
Q 017021 361 L-----TAREALRHPFFTRD 375 (379)
Q Consensus 361 p-----ta~e~l~hp~f~~~ 375 (379)
| ++.++++||||...
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=344.78 Aligned_cols=281 Identities=27% Similarity=0.468 Sum_probs=221.6
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc----
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---- 117 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~---- 117 (379)
|++.++||+|+||.||+|.+..+++.||+|++... ......+.+|+.++..+ .|+|++.+++++....
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~ 76 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-----KHDNVLSALDILQPPHIDPF 76 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-----CCCCcCCHhheecCCCcccc
Confidence 67889999999999999999999999999998642 12234567788888887 7899999999998776
Q ss_pred -eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 -HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 -~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..|+|+||++++|.+.+.... .++...+..++.||+.||.|||+.|++||||||+||++
T Consensus 77 ~~~~lv~e~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili------------------ 136 (372)
T cd07853 77 EEIYVVTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV------------------ 136 (372)
T ss_pred ceEEEEeeccccCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE------------------
Confidence 899999999888988886654 68999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+....... ....+|..|+|||.+.+. .++.++|||||||++|+|++|+.||.+
T Consensus 137 ---------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 207 (372)
T cd07853 137 ---------NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207 (372)
T ss_pred ---------CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence 445567777777665432221 223578899999998774 478999999999999999999999999
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+..+....+.+..+.++...+..................+. ...........+.++.+||.+
T Consensus 208 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~ 270 (372)
T cd07853 208 QSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPS-----------------LPVLYTLSSQATHEAVHLLCR 270 (372)
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCc-----------------hHHhcccCCCCCHHHHHHHHH
Confidence 888888888888888777665555444443333222111110 000011223457789999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
||+.||.+|||+.|+++||||.+..
T Consensus 271 mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 271 MLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred hCCCChhhCcCHHHHhcCHhhCCCc
Confidence 9999999999999999999998854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=343.54 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=209.7
Q ss_pred echhhhhhhhccccccceeEEEEEecCCC-ceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~-~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
.....|++.+.||+|+||.||+|.++.++ ..||+|++.... .....+..|+.++..+ .|+||+++++++.
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-----NHPFCVNLYGSFK 101 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCCcceEEEEE
Confidence 34456888899999999999999877655 689999986432 2334556788888877 7899999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
+++..|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl--------------- 164 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL--------------- 164 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---------------
Confidence 999999999999 999999998764 68999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+...........||+.|+|||++.+..++.++|+|||||++|+|++|..||...+
T Consensus 165 ------------~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 165 ------------DKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred ------------CCCCCEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 55567888888888765544455679999999999998889999999999999999999999998766
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
.......+.+.....| ...+..+.++|++||
T Consensus 233 ~~~~~~~i~~~~~~~p-------------------------------------------------~~~~~~~~~li~~~l 263 (340)
T PTZ00426 233 PLLIYQKILEGIIYFP-------------------------------------------------KFLDNNCKHLMKKLL 263 (340)
T ss_pred HHHHHHHHhcCCCCCC-------------------------------------------------CCCCHHHHHHHHHHc
Confidence 5444433322111111 134567899999999
Q ss_pred ccCCCCCc-----CHHHHhcCCCCCCC
Q 017021 354 RYDPTDRL-----TAREALRHPFFTRD 375 (379)
Q Consensus 354 ~~dP~~Rp-----ta~e~l~hp~f~~~ 375 (379)
+.||.+|+ |++++++||||.+.
T Consensus 264 ~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 264 SHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred ccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999995 89999999999864
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=331.26 Aligned_cols=278 Identities=28% Similarity=0.493 Sum_probs=212.4
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-----
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----- 115 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----- 115 (379)
.|++.+.||+|+||.||+|+++.+++.||+|.++... .......+|+.++..+.+ ..|+|++++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA--FDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhh--cCCCCeeeeeeeeccccCCC
Confidence 4788899999999999999999999999999987422 122345567777777643 257999999988764
Q ss_pred cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 116 RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 116 ~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
....+++||++.++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 79 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili----------------- 141 (288)
T cd07863 79 ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV----------------- 141 (288)
T ss_pred CceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-----------------
Confidence 356899999997799999887554568999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+....... ....||..|+|||++.+..++.++|||||||++|+|++|++||.+..
T Consensus 142 ----------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 142 ----------TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred ----------CCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 445567777777776443222 23467899999999988889999999999999999999999998877
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+....+.+....|+......... . .+.............+..+.++|.+||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~---------------~~~~~~~~~~~~~~~~~~~~~li~~~L 269 (288)
T cd07863 212 EADQLGKIFDLIGLPPEDDWPRDVTLPRGA-------F---------------SPRGPRPVQSVVPEIEESGAQLLLEML 269 (288)
T ss_pred HHHHHHHHHHHhCCCChhhCcccccccccc-------c---------------CCCCCCchHHhCcCcCHHHHHHHHHHh
Confidence 766666666666554433322110000000 0 000001112223356678999999999
Q ss_pred ccCCCCCcCHHHHhcCCCC
Q 017021 354 RYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f 372 (379)
+.||++|||+.|++.||||
T Consensus 270 ~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 270 TFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccCcccCCCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=342.39 Aligned_cols=258 Identities=25% Similarity=0.372 Sum_probs=211.9
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.++||+|+||.||+|++..+++.||+|+++... .....+..|+.++..+ .|++++++++.+..++..
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~iv~~~~~~~~~~~~ 76 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-----KSEWLVKLLYAFQDDEYL 76 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-----CCCCCccEEEEEEcCCEE
Confidence 4788999999999999999999999999999997432 2234456677777777 689999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~-------------------- 134 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI-------------------- 134 (333)
T ss_pred EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--------------------
Confidence 9999999 999999998764 68999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
+.++.++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+..
T Consensus 135 -------~~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 207 (333)
T cd05600 135 -------DASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW 207 (333)
T ss_pred -------CCCCCEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH
Confidence 5566788999998876555555667999999999999889999999999999999999999999876665544
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+........ .+... . .....+.++.++|.+||+.+|.
T Consensus 208 ~~i~~~~~~~~---------------------~~~~~-----------~---------~~~~~s~~~~~li~~~l~~~~~ 246 (333)
T cd05600 208 ENLKYWKETLQ---------------------RPVYD-----------D---------PRFNLSDEAWDLITKLINDPSR 246 (333)
T ss_pred HHHHhcccccc---------------------CCCCC-----------c---------cccccCHHHHHHHHHHhhChhh
Confidence 43332111000 00000 0 0013567899999999999999
Q ss_pred CCcCHHHHhcCCCCCCCC
Q 017021 359 DRLTAREALRHPFFTRDH 376 (379)
Q Consensus 359 ~Rpta~e~l~hp~f~~~~ 376 (379)
+||+++++++||||++..
T Consensus 247 rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 247 RFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred hcCCHHHHHhCcccCCCC
Confidence 999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=351.77 Aligned_cols=280 Identities=27% Similarity=0.503 Sum_probs=216.4
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-----
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----- 115 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----- 115 (379)
....|++.++||+|+||.||+|.+..+++.||+|++.... ....+|+.++..+ .|+|++++.+++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l-----~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNL-----NHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhc-----CCCCCcceeeeEeeccccc
Confidence 3456899999999999999999999999999999986432 2234688888888 78999998877642
Q ss_pred ---cceEEEEEeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 116 ---RNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 116 ---~~~~~lv~e~~~~sL~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
..++++||||++++|.+++.. .....+++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus 136 ~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~---------- 205 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP---------- 205 (440)
T ss_pred CCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC----------
Confidence 235789999998888888754 22346899999999999999999999999999999999999942
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCC
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
....++|+|||.+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+
T Consensus 206 ----------------~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~ 269 (440)
T PTZ00036 206 ----------------NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269 (440)
T ss_pred ----------------CCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 2245888888888644322 2345689999999998764 68999999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||.+.+..+....+.+..+.++.+.+......... ..++.. ........+....+.++.+
T Consensus 270 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~------~~~~~~--------------~~~~l~~~~p~~~~~~~~~ 329 (440)
T PTZ00036 270 IFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD------IKFPDV--------------KPKDLKKVFPKGTPDDAIN 329 (440)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc------ccCCcc--------------CchhHHHHhccCCCHHHHH
Confidence 99998888888888888887776655433221100 011110 0001111223346778999
Q ss_pred HHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 348 LLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
||.+||++||.+||||.|+++||||.+
T Consensus 330 li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 330 FISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 999999999999999999999999975
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=317.21 Aligned_cols=251 Identities=30% Similarity=0.496 Sum_probs=213.2
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeec---------cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---------IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
|.-.+.||.|..++|-++..+.||+.+|+|++.- .....+...+|+.++.++ .+||+|+.+.+++++
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv----~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQV----MGHPYIIDLQDVYES 94 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHh----cCCCcEEEeeeeccC
Confidence 4556889999999999999999999999999852 122345556799999998 478999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
+.++++|+|.| .|.|.|++.+.- .+++...+.++.|++.|++|||..+|+||||||+|||+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---------------- 156 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---------------- 156 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee----------------
Confidence 99999999999 999999998875 69999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC------CCCCCccchHhHHHHHHHHHhCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
+.+..++|+|||++....+.. ...+|||+|+|||.+.. ..|+..+|+||+|+|+|.|+.|.
T Consensus 157 -----------ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 157 -----------DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred -----------ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 677789999999998766654 45799999999999853 45889999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
+||.-....-....|++.-..+.+. .|+..+...+
T Consensus 226 pPFwHRkQmlMLR~ImeGkyqF~sp---------------------------------------------eWadis~~~K 260 (411)
T KOG0599|consen 226 PPFWHRKQMLMLRMIMEGKYQFRSP---------------------------------------------EWADISATVK 260 (411)
T ss_pred CchhHHHHHHHHHHHHhcccccCCc---------------------------------------------chhhccccHH
Confidence 9997655544444444433333222 2445788999
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~ 373 (379)
|||.+||+.||.+|.|++|+|+||||.
T Consensus 261 dLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 261 DLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred HHHHHHHeeCchhcccHHHHhcChHHH
Confidence 999999999999999999999999994
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=335.17 Aligned_cols=282 Identities=25% Similarity=0.442 Sum_probs=222.7
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
..|++.++||+|+||.||+|+++.+++.||+|.++... .......+|+.++..+ .|+|++++++++..++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-----KHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-----CCCCcceEEEEEeeCCeEE
Confidence 35788899999999999999999999999999987432 2234566788888887 7799999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||||+.++|.+.+.... ..++...+..++.||+.||.|||+.||+||||||+||++
T Consensus 81 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---------------------- 137 (309)
T cd07872 81 LVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---------------------- 137 (309)
T ss_pred EEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----------------------
Confidence 999999779998887654 357899999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.++|+|||.+....... ....+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 138 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 212 (309)
T cd07872 138 -----NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212 (309)
T ss_pred -----CCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 445567777777765432221 23457889999999865 457899999999999999999999999888888
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+..+.++...|+.+......... ..+.... . .........+.++.++|.+||+.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~----------~-----~~~~~~~~~~~~~~~li~~~L~~d 273 (309)
T cd07872 213 ELHLIFRLLGTPTEETWPGISSNDEFKNY----NFPKYKP----------Q-----PLINHAPRLDTEGIELLTKFLQYE 273 (309)
T ss_pred HHHHHHHHhCCCCHHHHhhhcchhhhhhh----hcCccCC----------C-----chhhhccCCCHHHHHHHHHhccCC
Confidence 88888888888888777665433221110 0110000 0 000112245678999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~~ 376 (379)
|.+|||++|+++||||....
T Consensus 274 p~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 274 SKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhCCCHHHHhcChhhhhcc
Confidence 99999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=341.50 Aligned_cols=289 Identities=27% Similarity=0.436 Sum_probs=223.2
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec--
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-- 116 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~-- 116 (379)
...|++.+.||+|+||.||+|.+..+|+.||+|++... ......+.+|+.++..+ .|+|++++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-----NHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-----CCCCEeeeeeeeccCCC
Confidence 35688899999999999999999999999999998632 23345566788888887 789999999988654
Q ss_pred ----ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 117 ----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 117 ----~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
...|+||||++++|.+.+.. .++...+..++.|++.||.|||+.||+||||||+||++
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~-------------- 156 (359)
T cd07876 95 LEEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-------------- 156 (359)
T ss_pred ccccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--------------
Confidence 35799999997788877643 47889999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+.++.++|+|||.+....... ....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.
T Consensus 157 -------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 157 -------------KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred -------------CCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 455667888888776433222 23468999999999999899999999999999999999999999
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
+.+..+....+.+..+.++...+.........+.... ..++... ..+....... ..........+..+++||.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~ 296 (359)
T cd07876 224 GTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENR-PQYPGIS-FEELFPDWIF-----PSESERDKLKTSQARDLLS 296 (359)
T ss_pred CCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhC-CCCCCcc-hhhhcccccc-----ccccccccccchhHHHHHH
Confidence 8888777778888888888887777666555554332 1111110 0010000000 0000112234678999999
Q ss_pred hccccCCCCCcCHHHHhcCCCCC
Q 017021 351 GLLRYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f~ 373 (379)
+||+.||++|||++|+|+||||.
T Consensus 297 ~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 297 KMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHhccCcccCCCHHHHhcCchhh
Confidence 99999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.95 Aligned_cols=243 Identities=31% Similarity=0.498 Sum_probs=200.2
Q ss_pred cccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 51 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 51 Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
||+|+||.||+|+++.+++.||+|+++.. .........|+.++.++ +|++++.+++.+..++..|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-----NCPFIVPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCcEeceeeEEecCCeEEEEEcCC
Confidence 69999999999999999999999998742 22334556688888777 7899999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 127 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 127 -~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
+++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 76 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili--------------------------- 126 (312)
T cd05585 76 NGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL--------------------------- 126 (312)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---------------------------
Confidence 999999997754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 017021 206 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~ 282 (379)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.
T Consensus 127 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~ 206 (312)
T cd05585 127 DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206 (312)
T ss_pred CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence 45566888888877642221 233568999999999999899999999999999999999999998765544333222
Q ss_pred HHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCc-
Q 017021 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 361 (379)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp- 361 (379)
+.... + ....+..+.++|.+||+.||.+||
T Consensus 207 ~~~~~-----------------------~--------------------------~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 207 QEPLR-----------------------F--------------------------PDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCCC-----------------------C--------------------------CCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 11101 1 123567899999999999999997
Q ss_pred --CHHHHhcCCCCCCCC
Q 017021 362 --TAREALRHPFFTRDH 376 (379)
Q Consensus 362 --ta~e~l~hp~f~~~~ 376 (379)
+|.|++.||||.+..
T Consensus 238 ~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 238 YNGAQEIKNHPFFSQLS 254 (312)
T ss_pred CCCHHHHHcCCCcCCCC
Confidence 589999999999754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=338.92 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=203.6
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||.||+|.++.+++.||+|++.... ........|..++..+ .++++++.+++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~~~~i~~~~~~~~~~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP----GKPPFLTQLHSCFQTMDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc----CCCCceeeeEEEEEcCCEE
Confidence 3788899999999999999999999999999997432 2234455566666555 2446788999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+.+.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill-------------------- 134 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML-------------------- 134 (324)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE--------------------
Confidence 9999999 999999987754 58999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+.++.++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 135 -------~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (324)
T cd05587 135 -------DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 207 (324)
T ss_pred -------cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 4556678888887653211 123356899999999999989999999999999999999999999876655
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.+.....| ...+.++.+++.+||+.
T Consensus 208 ~~~~~i~~~~~~~~-------------------------------------------------~~~~~~~~~li~~~l~~ 238 (324)
T cd05587 208 ELFQSIMEHNVSYP-------------------------------------------------KSLSKEAVSICKGLLTK 238 (324)
T ss_pred HHHHHHHcCCCCCC-------------------------------------------------CCCCHHHHHHHHHHhhc
Confidence 54443332211111 13567889999999999
Q ss_pred CCCCCcCH-----HHHhcCCCCCCCC
Q 017021 356 DPTDRLTA-----REALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rpta-----~e~l~hp~f~~~~ 376 (379)
||.+|+++ +++++||||+..+
T Consensus 239 ~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 239 HPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999986 8999999998754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=347.04 Aligned_cols=278 Identities=22% Similarity=0.360 Sum_probs=210.5
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
....|++.+.||+|+||.||+|.+..+++.||+|... .....+|+.++..+ .|+||+++++++..+...+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAI-----NHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhC-----CCCCCCCEeEEEEECCeeE
Confidence 3456999999999999999999999999999999764 23456799999988 7899999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|+|+++++|..++.... .+++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 160 lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---------------------- 215 (391)
T PHA03212 160 LILPRYKTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---------------------- 215 (391)
T ss_pred EEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE----------------------
Confidence 999999889999887654 58999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCC----CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc---
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE--- 273 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~--- 273 (379)
+..+.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 216 -----~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~ 290 (391)
T PHA03212 216 -----NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLD 290 (391)
T ss_pred -----cCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccc
Confidence 45566788888877532211 123479999999999998889999999999999999999998875422
Q ss_pred ----hHHHHHHHHHHcCCCChhHHHhhhhhhhh----hhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 274 ----NLEHLAMMERVLGPLPQHMLKRVDRHAEK----YVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 274 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
.......+.+..+..|.+........... ..... ...+. ..+...+ ....+.++
T Consensus 291 ~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~------------~~~~~~~-----~~~~~~~l 352 (391)
T PHA03212 291 GDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKS-SRKPG------------SRPLWTN-----LYELPIDL 352 (391)
T ss_pred ccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhcc-CCCCC------------CCCCHHH-----HhhhhhhH
Confidence 22334445555565554321111111110 00000 00000 0000000 01245678
Q ss_pred HHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 346 THLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.+||.+||++||.+||||+|+|+||||.+.
T Consensus 353 ~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 353 EYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 999999999999999999999999999874
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=338.95 Aligned_cols=279 Identities=27% Similarity=0.489 Sum_probs=219.0
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--- 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--- 116 (379)
..|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++..+ .|+|++++++++...
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-----KHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-----CCCchhhhhhhhcccccc
Confidence 46889999999999999999999999999999987432 2234556788888888 778999999887543
Q ss_pred ---ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 117 ---NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 117 ---~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
...|+++++++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~--------------- 151 (343)
T cd07878 90 ENFNEVYLVTNLMGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV--------------- 151 (343)
T ss_pred cccCcEEEEeecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---------------
Confidence 457999999999999888653 49999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++|+|||.+...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 152 ------------~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 152 ------------NEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ------------CCCCCEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 45566788888887765555455678999999999876 46889999999999999999999999888
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhh-hhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
+..+....+.+..+..+......+.... ..+... ....+. ..........++.+.+||.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~------------------~~~~~~~~~~~~~~~~li~~ 280 (343)
T cd07878 220 DYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQS-LPHMPQ------------------QDLKKIFRGANPLAIDLLEK 280 (343)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhc-cccccc------------------hhHHHhccCCCHHHHHHHHH
Confidence 7777777777777777666555433222 111111 000000 00111222355678999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
||+.||.+|||+.|+++||||...
T Consensus 281 mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 281 MLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HcCCChhhCCCHHHHhcCcchhcc
Confidence 999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=335.35 Aligned_cols=252 Identities=26% Similarity=0.455 Sum_probs=226.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
-|.+.+.||+|.|+.|-+|++..||++||||++.+. ........+|+..+.-+ +|||||++++..+.+..+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-----QHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-----QHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-----cCcCeeeeeehhcccceEE
Confidence 378889999999999999999999999999999753 23345667899988888 8899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+|+|+- +|+|.+++-++. ..+.+..+..++.||+.|+.|+|+..++||||||+|+.+.
T Consensus 94 LiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF-------------------- 152 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF-------------------- 152 (864)
T ss_pred EEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--------------------
Confidence 999999 899999998865 4699999999999999999999999999999999999985
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCC-CccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.+-+.+||+|||++..+.+.. .+.+|+..|.|||++.+..|+ +++||||||||+|.|++|.+||+..++.|
T Consensus 153 ------EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 153 ------EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred ------eecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 466889999999998777655 567999999999999999998 88899999999999999999999999999
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
++-+|.......|+ +.+.+.+|||..||+.|
T Consensus 227 TLTmImDCKYtvPs-------------------------------------------------hvS~eCrdLI~sMLvRd 257 (864)
T KOG4717|consen 227 TLTMIMDCKYTVPS-------------------------------------------------HVSKECRDLIQSMLVRD 257 (864)
T ss_pred hhhhhhcccccCch-------------------------------------------------hhhHHHHHHHHHHHhcC
Confidence 88888776666654 46789999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~~ 376 (379)
|.+|.|.+++..|+|++...
T Consensus 258 PkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 258 PKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred chhhccHHHHhccccccCCC
Confidence 99999999999999998754
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=341.03 Aligned_cols=289 Identities=27% Similarity=0.429 Sum_probs=224.4
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec--
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-- 116 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~-- 116 (379)
...|++.+.||+|+||.||+|.+..+++.||+|++... ........+|+.++..+ .|+|++.+++.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIIGLLNVFTPQKS 97 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-----CCCCccccceeeccccc
Confidence 34688899999999999999999999999999998642 23345566788888777 778999998877543
Q ss_pred ----ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 117 ----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 117 ----~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..+|+||||++++|.+.+.. .++...+..++.|++.||.|||+.||+||||||+||++
T Consensus 98 ~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll-------------- 159 (364)
T cd07875 98 LEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-------------- 159 (364)
T ss_pred ccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE--------------
Confidence 46899999998888888754 37888999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+.++.++|+|||.+....... ....||..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 160 -------------~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 160 -------------KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred -------------CCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 455678888888876544322 23468999999999999899999999999999999999999999
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhh-hhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRES-IKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
+.+..+....+.+..+.++...++.+......+..+.. ..... ..+. ..... ...........+..+++||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~-----~~~~~~~~~~~~~~~~dll 298 (364)
T cd07875 227 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRP-KYAGY--SFEKLFPDVL-----FPADSEHNKLKASQARDLL 298 (364)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCC-CcCCC--ChHhhCcccc-----ccccccccccccHHHHHHH
Confidence 98888888888888888877777777666655544321 11100 0000 00000 0000111223456899999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
.+||+.||.+|||++|+|+||||..
T Consensus 299 ~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 299 SKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHhcCcCcccCCCHHHHhcCccccc
Confidence 9999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=332.83 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=203.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch---------------hhHhHHHHHHHHHHHHhcCCCCCeeEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------------YREAAMIEIEVLQQLAKHDKGGNRCVQ 108 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~~~~~~i~~ 108 (379)
+|++.+.||+|.||.|-+|++..+++.||||++.+... ..+...+|+.++.++ +|+|||+
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-----~H~nVV~ 172 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-----HHPNVVK 172 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-----CCcCeeE
Confidence 68999999999999999999999999999999964221 124667899999998 8899999
Q ss_pred ecceeeec--ceEEEEEeCC-CCCHHHHHHhCCCCC-CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccc
Q 017021 109 IRNWFDYR--NHICIVFEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 184 (379)
Q Consensus 109 ~~~~~~~~--~~~~lv~e~~-~~sL~~~l~~~~~~~-l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 184 (379)
+++..++. +.+|+|+||| .|.+. .....+. +++.+++.++.+++.||+|||.+||+||||||+|+|++.+|.+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~---w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVK---WCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccc---cCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 99999875 5799999999 66543 3333334 8999999999999999999999999999999999999555544
Q ss_pred ccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC---CCC-CCccchHhHHHHHH
Q 017021 185 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG---LGW-TYPCDIWSVGCILV 260 (379)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~-~~~sDvwSlG~il~ 260 (379)
||+|||.+...+..++. + ....-...+|||.|+|||...+ ..+ +.+.||||+||+||
T Consensus 250 KIsDFGVs~~~~~~~~~------~-------------~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLY 310 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDE------G-------------SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLY 310 (576)
T ss_pred EeeccceeeecccCCcc------c-------------cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHH
Confidence 44444443322221100 0 0000023689999999999866 223 48899999999999
Q ss_pred HHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc
Q 017021 261 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 261 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (379)
+|+.|+.||-+....++...|....-.+|+. +.
T Consensus 311 CllfG~~PF~~~~~~~l~~KIvn~pL~fP~~-----------------------------------------------pe 343 (576)
T KOG0585|consen 311 CLLFGQLPFFDDFELELFDKIVNDPLEFPEN-----------------------------------------------PE 343 (576)
T ss_pred HhhhccCCcccchHHHHHHHHhcCcccCCCc-----------------------------------------------cc
Confidence 9999999999988888887776654444421 13
Q ss_pred chhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
....++|||.+||++||++|++..++..|||..++
T Consensus 344 ~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 344 INEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 56789999999999999999999999999999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=339.09 Aligned_cols=251 Identities=28% Similarity=0.515 Sum_probs=225.7
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeec---cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce-
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH- 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~- 118 (379)
..|.+++++|+|+||.+++++++..+..+|+|++.- ....+..+.+|+.++.++ .||+|+.+.+.|..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-----~hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-----LHPNIVEYKDSFEEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-----cCCCeeeeccchhcCCce
Confidence 368899999999999999999999999999999963 345566888999999998 78999999999999888
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
++|||+|| ||++.+.+..+.+..++++.+..|+.|++.||.|||+..|+|||||+.||++
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl------------------- 139 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL------------------- 139 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc-------------------
Confidence 99999999 9999999988766689999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
.++..++|.|||+|+..++.. .+.+||+.|++||++.+.+|+.++|||||||++|||++-+++|.+.+.
T Consensus 140 --------tk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 140 --------TKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred --------cccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 677778999999998777764 457899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHc-CCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 275 LEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 275 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
......+.+.. .|.| ..++.+++.+|..||
T Consensus 212 ~~Li~ki~~~~~~Plp-------------------------------------------------~~ys~el~~lv~~~l 242 (426)
T KOG0589|consen 212 SELILKINRGLYSPLP-------------------------------------------------SMYSSELRSLVKSML 242 (426)
T ss_pred HHHHHHHhhccCCCCC-------------------------------------------------ccccHHHHHHHHHHh
Confidence 88887777755 3333 247889999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~ 374 (379)
+.+|..||+|.++|.+|....
T Consensus 243 ~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 243 RKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred hcCCccCCCHHHHhhChhhhh
Confidence 999999999999999987653
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=309.28 Aligned_cols=255 Identities=24% Similarity=0.430 Sum_probs=221.5
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.....|.|.+.||+|-||.||+|+.+.++..||+|++.+.+ .......+|+++-..+ .||||.+++++|.+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-----~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-----RHPNILRLYGYFHD 93 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-----CCccHHhhhhheec
Confidence 34456788999999999999999999999999999987432 1223344566665555 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
...+|+++||+ +|++...+.....+.+++..+..++.|++.||.|+|..+++|||+||+|+|+
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---------------- 157 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---------------- 157 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc----------------
Confidence 99999999999 8999999987666689999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCC-CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
...+.++++|||.+..... ...+.+||..|.+||...+...+..+|+|++|++.||++.|.+||.+..
T Consensus 158 -----------g~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 158 -----------GSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred -----------CCCCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 6677889999998876543 3456799999999999999999999999999999999999999999988
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..++..+|.+..-..|+ ..+..+.|+|.+||
T Consensus 227 ~~etYkrI~k~~~~~p~-------------------------------------------------~is~~a~dlI~~ll 257 (281)
T KOG0580|consen 227 HSETYKRIRKVDLKFPS-------------------------------------------------TISGGAADLISRLL 257 (281)
T ss_pred hHHHHHHHHHccccCCc-------------------------------------------------ccChhHHHHHHHHh
Confidence 88888887776554442 46789999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
..+|.+|.+..|++.|||+...
T Consensus 258 ~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 258 VKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ccCccccccHHHHhhhHHHHhc
Confidence 9999999999999999998753
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=335.63 Aligned_cols=245 Identities=26% Similarity=0.397 Sum_probs=199.2
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|+++.+++.||+|+++... ........|..++..+ ..|++++.+++++...+.+|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~h~~iv~~~~~~~~~~~~~iv~E 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA----RNHPFLTQLYCCFQTPDRLFFVME 76 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc----cCCCchhceeeEEEcCCEEEEEEc
Confidence 46899999999999999999999999987432 2233444566665544 367999999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|.+.+.... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 77 y~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli------------------------- 129 (320)
T cd05590 77 FVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL------------------------- 129 (320)
T ss_pred CCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE-------------------------
Confidence 99 899999887754 68999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+.++.++|+|||.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....
T Consensus 130 --~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 207 (320)
T cd05590 130 --DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 207 (320)
T ss_pred --CCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 4555677888887654221 12335689999999999988899999999999999999999999987766555443
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+.+.....| ...+.++.++|.+||+.||.+|
T Consensus 208 i~~~~~~~~-------------------------------------------------~~~~~~~~~li~~~L~~dP~~R 238 (320)
T cd05590 208 ILNDEVVYP-------------------------------------------------TWLSQDAVDILKAFMTKNPTMR 238 (320)
T ss_pred HhcCCCCCC-------------------------------------------------CCCCHHHHHHHHHHcccCHHHC
Confidence 332111111 1245788999999999999999
Q ss_pred cCH------HHHhcCCCCCCC
Q 017021 361 LTA------REALRHPFFTRD 375 (379)
Q Consensus 361 pta------~e~l~hp~f~~~ 375 (379)
|++ +++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 239 LGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCCHHHHHcCCCcCCC
Confidence 998 999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=341.36 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=210.4
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
....|...+.||+|.||.||+|.+..|++.||+|++... ......+.+|+.++.+. .+++|..+++.+-.+..
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-----~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-----DSPNITEYYGSYLKGTK 85 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-----CcchHHhhhhheeeccc
Confidence 344566779999999999999999999999999999742 33446677899999888 66899999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
++++|||| ||++.+.+.... .+.+..+..++.+++.||.|||+++.+|||||+.||++
T Consensus 86 LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~------------------- 144 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL------------------- 144 (467)
T ss_pred HHHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeE-------------------
Confidence 99999999 999999998865 55888999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
...+.++|+|||.+...... ..+++||+.|||||++.+..|+.++||||||++.+||++|.+|+....+
T Consensus 145 --------s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 145 --------SESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred --------eccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 44567888888877543332 2567899999999999998999999999999999999999999976554
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
......|-+ .. ...+...+++.+++||..||+
T Consensus 217 mrvlflIpk---~~---------------------------------------------PP~L~~~~S~~~kEFV~~CL~ 248 (467)
T KOG0201|consen 217 MRVLFLIPK---SA---------------------------------------------PPRLDGDFSPPFKEFVEACLD 248 (467)
T ss_pred ceEEEeccC---CC---------------------------------------------CCccccccCHHHHHHHHHHhh
Confidence 222111111 00 111223578899999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~ 374 (379)
+||+.||||.++|+|+|++.
T Consensus 249 k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 249 KNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred cCcccCcCHHHHhhhHHHHh
Confidence 99999999999999999986
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=334.80 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=202.8
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||.||+|+++.+++.||+|+++.... .......|..++... .+|++++.+++++...+..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~~~~i~~~~~~~~~~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS----GKPPFLTQLHSCFQTMDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc----cCCCeEeeEEEEEecCCEE
Confidence 36788999999999999999999999999999974321 122334455554443 3578899999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+.+.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill-------------------- 134 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML-------------------- 134 (323)
T ss_pred EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE--------------------
Confidence 9999999 899999987754 58999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+.++.++|+|||.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 135 -------~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~ 207 (323)
T cd05616 135 -------DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207 (323)
T ss_pred -------CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH
Confidence 4556678888887754321 123356899999999999999999999999999999999999999877665
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.......| ...+.++.+++.+||+.
T Consensus 208 ~~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~~li~~~l~~ 238 (323)
T cd05616 208 ELFQSIMEHNVAYP-------------------------------------------------KSMSKEAVAICKGLMTK 238 (323)
T ss_pred HHHHHHHhCCCCCC-------------------------------------------------CcCCHHHHHHHHHHccc
Confidence 55544433221111 13567899999999999
Q ss_pred CCCCCcC-----HHHHhcCCCCCCCC
Q 017021 356 DPTDRLT-----AREALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rpt-----a~e~l~hp~f~~~~ 376 (379)
||++|++ ..++++||||+...
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 239 HPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred CHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999998 48999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=340.83 Aligned_cols=280 Identities=22% Similarity=0.278 Sum_probs=205.8
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||+||+|.++.+++.||+|++.... .....+..|+.++..+ +|++++++++.+.+...+
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-----~~~~iv~~~~~~~~~~~~ 76 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-----DSLWVVKMFYSFQDKLNL 76 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-----CCCCcceEEEEEecCCeE
Confidence 4788899999999999999999999999999997432 2234455677777776 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred EEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999 999999998764 6899999999999999999999999999999999999988777778888776533211
Q ss_pred CcccccCCCCCCeEEeecCcccc-----c-------CCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCC
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTY-----E-------RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~-----~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
...... .........|+..... . .......+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 155 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 155 HRTEFY-RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccc-ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 100000 0000000011110000 0 00012347999999999999989999999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||.+.+..+....+....... .+|+ ....+++++
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~~---------------------~~p~------------------------~~~~s~~~~ 268 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKETL---------------------IFPP------------------------EVPISEKAK 268 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcCcc---------------------cCCC------------------------cCCCCHHHH
Confidence 9998776655544443211110 0110 012567889
Q ss_pred HHHhhccc--cCCCCCcCHHHHhcCCCCCCCC
Q 017021 347 HLLQGLLR--YDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 347 ~li~~~L~--~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
++|.+|+. .++..||+++|+++||||++..
T Consensus 269 ~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 269 DLILRFCCEWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred HHHHHHcCChhhcCCCCCHHHHhCCCCCCCCC
Confidence 99998665 2334568999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=336.10 Aligned_cols=245 Identities=27% Similarity=0.443 Sum_probs=199.9
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+++++.+++.||+|++.... ........|+.++..+ .|++++.+.+.+...+..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-----RHPFLTSLKYSFQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceEEEEEcCCEEEEEEe
Confidence 36899999999999999999999999997432 2234556677777776 77999999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|.+.+.... .+++..+..++.||+.||+|||+.||+||||||+||++
T Consensus 76 y~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll------------------------- 128 (328)
T cd05593 76 YVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML------------------------- 128 (328)
T ss_pred CCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE-------------------------
Confidence 99 899998887654 68999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+.++.++|+|||.+...... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....
T Consensus 129 --~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~ 206 (328)
T cd05593 129 --DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (328)
T ss_pred --CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH
Confidence 45566788888877542221 1234689999999999988899999999999999999999999987655443322
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+...... + ....+.++.++|++||+.||++|
T Consensus 207 ~~~~~~~-----------------------~--------------------------p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 207 ILMEDIK-----------------------F--------------------------PRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred hccCCcc-----------------------C--------------------------CCCCCHHHHHHHHHHcCCCHHHc
Confidence 2111111 1 12356789999999999999999
Q ss_pred c-----CHHHHhcCCCCCCCC
Q 017021 361 L-----TAREALRHPFFTRDH 376 (379)
Q Consensus 361 p-----ta~e~l~hp~f~~~~ 376 (379)
+ ++.|+++||||....
T Consensus 238 ~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred CCCCCCCHHHHhcCCCcCCCC
Confidence 7 899999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=333.39 Aligned_cols=246 Identities=27% Similarity=0.419 Sum_probs=196.9
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|+++.+|+.||+|+++... ........|..++... .+|++++++++.+.+.+++|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~~~~i~~~~~~~~~~~~~~lv~E 76 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA----WENPFLTHLYCTFQTKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc----cCCCCccCeeEEEEeCCEEEEEEC
Confidence 46899999999999999999999999997432 2223344455555433 367899999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|.+.+.... .+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 77 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~------------------------- 129 (316)
T cd05620 77 FLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML------------------------- 129 (316)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE-------------------------
Confidence 99 899999987754 68999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccC---CCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+.++.++|+|||.+.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 130 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~ 207 (316)
T cd05620 130 --DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES 207 (316)
T ss_pred --CCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 445567777777665321 112345689999999999998999999999999999999999999987665544433
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+.......| ...+.+++++|++||+.||++|
T Consensus 208 ~~~~~~~~~-------------------------------------------------~~~~~~~~~li~~~l~~dP~~R 238 (316)
T cd05620 208 IRVDTPHYP-------------------------------------------------RWITKESKDILEKLFERDPTRR 238 (316)
T ss_pred HHhCCCCCC-------------------------------------------------CCCCHHHHHHHHHHccCCHHHc
Confidence 322111111 1245688999999999999999
Q ss_pred cCH-HHHhcCCCCCCCC
Q 017021 361 LTA-REALRHPFFTRDH 376 (379)
Q Consensus 361 pta-~e~l~hp~f~~~~ 376 (379)
|++ +++++||||+...
T Consensus 239 ~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 239 LGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CCChHHHHcCCCcCCCC
Confidence 998 5888999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=338.24 Aligned_cols=288 Identities=26% Similarity=0.423 Sum_probs=221.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--- 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--- 116 (379)
..|++.+.||+|+||.||+|.+..+++.||+|++... ........+|+.++..+ .|+|++.+++.+...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-----CCCchhceeeeeeccccc
Confidence 4678889999999999999999999999999998642 22345566788888887 779999999887643
Q ss_pred ---ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 117 ---NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 117 ---~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
...|+||||+.+++.+.+.. .++...+..++.|++.||.|||+.|++||||||+||++
T Consensus 92 ~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill--------------- 152 (355)
T cd07874 92 EEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--------------- 152 (355)
T ss_pred cccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---------------
Confidence 35799999997788887754 47889999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+....... ....||..|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 153 ------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 153 ------------KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred ------------CCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 455668888888876543322 334689999999999998899999999999999999999999998
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+..+....+.+..+.+..+.+..+......+..+.. .+..... ...... .............+..+++||.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~ 293 (355)
T cd07874 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP-KYAGLTF-PKLFPD-----SLFPADSEHNKLKASQARDLLSK 293 (355)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCC-ccccccc-hhhccc-----cccccccccccccchHHHHHHHH
Confidence 8877777777777777777777766655555443321 1110000 000000 00000011122345678999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~ 373 (379)
||+.||++|||+.|+|+||||.
T Consensus 294 mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 294 MLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred HhcCCchhcCCHHHHhcCcchh
Confidence 9999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=340.93 Aligned_cols=280 Identities=26% Similarity=0.394 Sum_probs=208.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||.||+|++..+++.||+|+++... .....+..|..++..+ .|++++++++.+.++++.
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~ 76 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-----DSPWIVKLYYSFQDEEHL 76 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-----CCCCccchhhheecCCeE
Confidence 4788999999999999999999999999999997432 2334566788888777 689999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.... .+++..+..++.||+.||+|||+.|++||||||+||+++.++.+++.|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999 899999998763 6899999999999999999999999999999999999977777777777665433222
Q ss_pred CcccccCCCCCC-eEEeec----CcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 199 SSYFKRMPKSSA-IKVIDF----GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 199 ~~~~~~~~~~~~-~~l~Df----g~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
............ ...... ..............||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 100000000000 000000 000000001123468999999999999899999999999999999999999998766
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+....... ..|. ....++++.++|.+||
T Consensus 235 ~~~~~~~i~~~~~~~---------------------~~p~------------------------~~~~~~~~~~li~~ll 269 (350)
T cd05573 235 LQETYNKIINWKESL---------------------RFPP------------------------DPPVSPEAIDLICRLL 269 (350)
T ss_pred HHHHHHHHhccCCcc---------------------cCCC------------------------CCCCCHHHHHHHHHHc
Confidence 554443333211110 0000 0124678999999999
Q ss_pred ccCCCCCcC-HHHHhcCCCCCCCC
Q 017021 354 RYDPTDRLT-AREALRHPFFTRDH 376 (379)
Q Consensus 354 ~~dP~~Rpt-a~e~l~hp~f~~~~ 376 (379)
+ ||.+||+ ++|+++||||+...
T Consensus 270 ~-dp~~R~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 270 C-DPEDRLGSFEEIKSHPFFKGID 292 (350)
T ss_pred c-ChhhcCCCHHHHhcCCCcCCCC
Confidence 8 9999999 99999999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=335.43 Aligned_cols=245 Identities=25% Similarity=0.419 Sum_probs=199.4
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+++++.+|+.||+|++.... ........|+.++..+ .|++++.+++.+...+..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~i~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-----CCCCCcceeeEEecCCEEEEEEe
Confidence 46899999999999999999999999997431 2233445677777777 77999999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|...+.... .+++..+..++.||+.||.|||+.|++||||||+||+++
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~------------------------ 129 (323)
T cd05595 76 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD------------------------ 129 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc------------------------
Confidence 99 899998887654 689999999999999999999999999999999999994
Q ss_pred cCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....
T Consensus 130 ---~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~ 206 (323)
T cd05595 130 ---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206 (323)
T ss_pred ---CCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 4556777777766532211 1234689999999999888899999999999999999999999987655444332
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+....... ....++++.++|.+||+.||++|
T Consensus 207 ~~~~~~~~-------------------------------------------------p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 207 ILMEEIRF-------------------------------------------------PRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred HhcCCCCC-------------------------------------------------CCCCCHHHHHHHHHHccCCHHHh
Confidence 22111111 12356789999999999999999
Q ss_pred c-----CHHHHhcCCCCCCCC
Q 017021 361 L-----TAREALRHPFFTRDH 376 (379)
Q Consensus 361 p-----ta~e~l~hp~f~~~~ 376 (379)
+ ++.++++||||...+
T Consensus 238 ~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCCC
Confidence 8 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=334.51 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=201.7
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
|++.+.||+|+||.||+|.++.+++.||+|+++... ........|..++..+.. ..|+|++++++++...+..|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~--l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS--ERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccc--cCCCChhceeeEEEcCCEEE
Confidence 678899999999999999999999999999997432 122344455555544322 36899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|...+... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 79 lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill--------------------- 134 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL--------------------- 134 (324)
T ss_pred EEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---------------------
Confidence 999999 89998887653 58999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.++|+|||.+..... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 135 ------~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~ 208 (324)
T cd05589 135 ------DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208 (324)
T ss_pred ------CCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH
Confidence 4555677777777653221 1234568999999999999889999999999999999999999998766554
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.......| ...+..+.++|.+||+.|
T Consensus 209 ~~~~i~~~~~~~p-------------------------------------------------~~~~~~~~~li~~~L~~d 239 (324)
T cd05589 209 VFDSIVNDEVRYP-------------------------------------------------RFLSREAISIMRRLLRRN 239 (324)
T ss_pred HHHHHHhCCCCCC-------------------------------------------------CCCCHHHHHHHHHHhhcC
Confidence 4433322111111 135678899999999999
Q ss_pred CCCCc-----CHHHHhcCCCCCCCC
Q 017021 357 PTDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 357 P~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
|++|| ++.++++||||+..+
T Consensus 240 P~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 240 PERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 99999 799999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=333.59 Aligned_cols=299 Identities=22% Similarity=0.326 Sum_probs=211.4
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
..-.|++.++||+|+||.||++.++.++..||+|++... ......+.+|++++..+ +|+|++++++++..++.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDGE 77 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-----CCCCCCeEEEEEEECCE
Confidence 345688999999999999999999999999999998743 23345677889988888 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
.++||||+ +++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~----------------- 138 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN----------------- 138 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc-----------------
Confidence 99999999 899999997754 589999999999999999999986 699999999999994
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCC-CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
.++.++|+|||.+...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 139 ----------~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 139 ----------SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred ----------CCCcEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4455777777776533222 23356899999999999888999999999999999999999999876654
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhh----hhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHA----EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
+....+................... ......+....+. ....+........+. .......++.++.+||.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~ 283 (331)
T cd06649 209 ELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPA-MAIFELLDYIVNEPP----PKLPNGVFTPDFQEFVNK 283 (331)
T ss_pred HHHHHhcccccccccCCccccCcccccccccccccccccccc-hhHHHHHHHHHhCCC----cCCCCccccHHHHHHHHH
Confidence 4332221111000000000000000 0000000000000 000000000000000 000012356789999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCCCcC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~~~~ 378 (379)
||++||++|||++|+++||||+....+
T Consensus 284 ~L~~~P~~Rpt~~ell~h~~~~~~~~~ 310 (331)
T cd06649 284 CLIKNPAERADLKMLMNHTFIKRSEVE 310 (331)
T ss_pred HccCCcccCCCHHHHhcChHHhhcccc
Confidence 999999999999999999999876543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=333.18 Aligned_cols=246 Identities=27% Similarity=0.388 Sum_probs=197.2
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|++..+++.||+|+++... ........|..++... .+|++++++++.+..++..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~hp~i~~~~~~~~~~~~~~lv~e 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA----WEHPFLTHLFCTFQTKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhc----cCCCCccceeeEEEcCCEEEEEEc
Confidence 46899999999999999999999999997432 1222333444444332 378999999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 77 ~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill------------------------- 129 (316)
T cd05592 77 YLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL------------------------- 129 (316)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE-------------------------
Confidence 99 999999987754 68999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+.++.++|+|||.+..... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 130 --~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~ 207 (316)
T cd05592 130 --DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS 207 (316)
T ss_pred --CCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 4556678888887754221 12345789999999999988899999999999999999999999987766554433
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+....... ....+.++.++|.+||+.||++|
T Consensus 208 i~~~~~~~-------------------------------------------------~~~~~~~~~~ll~~~l~~~P~~R 238 (316)
T cd05592 208 ILNDRPHF-------------------------------------------------PRWISKEAKDCLSKLFERDPTKR 238 (316)
T ss_pred HHcCCCCC-------------------------------------------------CCCCCHHHHHHHHHHccCCHHHc
Confidence 32211111 11355688999999999999999
Q ss_pred cCH-HHHhcCCCCCCCC
Q 017021 361 LTA-REALRHPFFTRDH 376 (379)
Q Consensus 361 pta-~e~l~hp~f~~~~ 376 (379)
|++ .+++.||||...+
T Consensus 239 ~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 239 LGVDGDIRQHPFFRGID 255 (316)
T ss_pred CCChHHHHcCcccCCCC
Confidence 986 5888999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=332.84 Aligned_cols=245 Identities=22% Similarity=0.359 Sum_probs=199.5
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|+++.+++.||+|+++... ........|..++..+ .+|++++.+++.+..++..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~----~~hp~i~~~~~~~~~~~~~~lv~E 76 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA----AKHPFLTALHCCFQTKDRLFFVME 76 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhc----cCCCCccceeeEEEcCCeEEEEEe
Confidence 46899999999999999999999999997432 2223445566665543 367899999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|...+.... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 77 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill------------------------- 129 (321)
T cd05591 77 YVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL------------------------- 129 (321)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE-------------------------
Confidence 99 899998887654 68999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....
T Consensus 130 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~ 207 (321)
T cd05591 130 --DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES 207 (321)
T ss_pred --CCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 45567888888877542221 2334689999999999988999999999999999999999999988766555443
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+.......| ...+.++.++|.+||+.||++|
T Consensus 208 i~~~~~~~p-------------------------------------------------~~~~~~~~~ll~~~L~~dp~~R 238 (321)
T cd05591 208 ILHDDVLYP-------------------------------------------------VWLSKEAVSILKAFMTKNPNKR 238 (321)
T ss_pred HHcCCCCCC-------------------------------------------------CCCCHHHHHHHHHHhccCHHHc
Confidence 322111111 1245688999999999999999
Q ss_pred c-------CHHHHhcCCCCCCC
Q 017021 361 L-------TAREALRHPFFTRD 375 (379)
Q Consensus 361 p-------ta~e~l~hp~f~~~ 375 (379)
| +++++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 239 LGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred CCCCCCCCCHHHHhcCCccCCC
Confidence 9 99999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=329.97 Aligned_cols=285 Identities=26% Similarity=0.474 Sum_probs=207.9
Q ss_pred hhccccccceeEEEEEec--CCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee--cceEEEEE
Q 017021 48 HSKMGEGTFGQVLECWDR--ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVF 123 (379)
Q Consensus 48 ~~~Lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~~lv~ 123 (379)
..+||+|+||.||+|+++ .+++.||+|.+... .......+|+.++..+ .|+|++++++.+.. +..+|++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-GISMSACREIALLREL-----KHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC-CCcHHHHHHHHHHHhc-----CCCCCcceeeeEecCCCcEEEEEE
Confidence 368999999999999965 46789999998743 3345567899999888 78999999998854 56789999
Q ss_pred eCCCCCHHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 124 EKLGSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 124 e~~~~sL~~~l~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
||++++|.+++.... ...+++..+..++.||+.||.|||+.||+||||||+||++....
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~-------------- 145 (317)
T cd07868 80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG-------------- 145 (317)
T ss_pred eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCC--------------
Confidence 999889998886421 12488999999999999999999999999999999999995321
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+..+.++|+|||.+....... ....||+.|+|||++.+. .++.++||||+||++|+|++|++||
T Consensus 146 ---------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f 216 (317)
T cd07868 146 ---------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ---------CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCc
Confidence 345678999999886543321 235689999999998764 5889999999999999999999999
Q ss_pred CCCch---------HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc
Q 017021 270 QTHEN---------LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 270 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (379)
.+... ......+.+..+.++...|+.................. .................
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~ 285 (317)
T cd07868 217 HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRN-----------TYTNCSLIKYMEKHKVK 285 (317)
T ss_pred cCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhcc-----------ccCcccccchHHhcCCC
Confidence 75432 24445566667777766665543221110000000000 00000000111111223
Q ss_pred chhHHHHHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
.+..+.+||.+||++||.+||||+|+|+||||
T Consensus 286 ~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 286 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 45678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=341.64 Aligned_cols=281 Identities=24% Similarity=0.354 Sum_probs=207.4
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|+++++||+|+||+||+|+++.+++.||+|++.... .....+..|+.++..+ .|++++++++.+.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~l~~~~~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-----DNEWVVKLYYSFQDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-----CCCCeeeeEEEEecCCEE
Confidence 4778899999999999999999999999999997432 2334566788888777 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++++|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999 999999997754 6899999999999999999999999999999999999988888888888876432110
Q ss_pred --Cccccc------CCC-----CCCeEEeecCccc-------cc---CCCCCcccccCCccchhhhhCCCCCCccchHhH
Q 017021 199 --SSYFKR------MPK-----SSAIKVIDFGSTT-------YE---RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSV 255 (379)
Q Consensus 199 --~~~~~~------~~~-----~~~~~l~Dfg~~~-------~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 255 (379)
...... ... ......+.++... .. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 000000 000 0000001111000 00 000123579999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHH
Q 017021 256 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335 (379)
Q Consensus 256 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (379)
||++|+|++|..||...+..+....+....... .++.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------~~~~---------------------- 271 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTL---------------------HIPP---------------------- 271 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------------------CCCC----------------------
Confidence 999999999999998766544433322111100 0110
Q ss_pred HhhccchhHHHHHHhhcc--ccCCCCCcCHHHHhcCCCCCCCC
Q 017021 336 QHVDHSAGDLTHLLQGLL--RYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 336 ~~~~~~~~~~~~li~~~L--~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
....++++.+||.+|+ ..+|..|++++|+++||||++..
T Consensus 272 --~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 272 --QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred --CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 1135678999999855 55666699999999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=340.93 Aligned_cols=280 Identities=25% Similarity=0.368 Sum_probs=208.9
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||.||+|++..+++.||+|++.... .....+..|+.++..+ +|++++.+++.+.++.+.
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~~~~~~~~~~~~ 76 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-----DNPWVVKLYYSFQDENYL 76 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceEEEEEcCCeE
Confidence 4788899999999999999999999999999997432 2234455688888877 689999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++++|||++......
T Consensus 77 ~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred EEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999 899999997754 6899999999999999999999999999999999999988888888888877543221
Q ss_pred Cccc--ccCCCCCCeEEeecCccccc------------CCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh
Q 017021 199 SSYF--KRMPKSSAIKVIDFGSTTYE------------RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 199 ~~~~--~~~~~~~~~~l~Dfg~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~ 264 (379)
.... .........-.+++...... .......+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1100 00000000000000000000 000112469999999999998899999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||...+..+....+...... +..+. ....+++
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~~~------------------------~~~~s~~ 269 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKET---------------------LQFPD------------------------EVPLSPE 269 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCc---------------------cCCCC------------------------CCCCCHH
Confidence 99999876655443332211100 00110 0135678
Q ss_pred HHHHHhhccccCCCCCcC---HHHHhcCCCCCCCC
Q 017021 345 LTHLLQGLLRYDPTDRLT---AREALRHPFFTRDH 376 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpt---a~e~l~hp~f~~~~ 376 (379)
+.++|++||. +|.+|++ ++|+++||||+...
T Consensus 270 ~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 270 AKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred HHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 9999999997 9999998 99999999998753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=323.60 Aligned_cols=248 Identities=26% Similarity=0.449 Sum_probs=216.3
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
.-.|+|.+.||+|.||.|-+|+....|+.||||.++++ +..--.+.+|++++..+ +||||+.+++.|+..+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-----NHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-----NHPHIIQIYEVFENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-----CCCceeehhhhhcCCc
Confidence 45799999999999999999999999999999999743 22334556799999998 8899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
.+.|||||. +|.|++++...+ .+++.+++.++.||++|+.|+|+.+++|||||.+|||+
T Consensus 127 KIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL------------------ 186 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL------------------ 186 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheee------------------
Confidence 999999999 999999999876 79999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCC-CccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.+||+|||++..+.... .+++|++.|.+||++++.+|. +.+|.||||+++|.|+.|..||++.+
T Consensus 187 ---------D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 187 ---------DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred ---------cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 777888999999987665554 457999999999999999986 89999999999999999999999987
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..-...+|.+. -+..| +.+.++..||++||
T Consensus 258 hk~lvrQIs~G-----------------------aYrEP---------------------------~~PSdA~gLIRwmL 287 (668)
T KOG0611|consen 258 HKRLVRQISRG-----------------------AYREP---------------------------ETPSDASGLIRWML 287 (668)
T ss_pred HHHHHHHhhcc-----------------------cccCC---------------------------CCCchHHHHHHHHH
Confidence 65555444332 22222 24567899999999
Q ss_pred ccCCCCCcCHHHHhcCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~ 373 (379)
..||++|.|+.++-.|=|++
T Consensus 288 mVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 288 MVNPERRATIEDIASHWWVN 307 (668)
T ss_pred hcCcccchhHHHHhhhheee
Confidence 99999999999999998875
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=326.96 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=207.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+|++.+.||+|+||.||++.+..+++.||+|++.... .....+..|+.++..+ +|++++.+++.+..++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-----NSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-----CCCCEeeeeeeecCCCeE
Confidence 4788899999999999999999999999999986432 1223456688888887 779999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++||||+ +++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~-------------------- 135 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL-------------------- 135 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE--------------------
Confidence 9999999 8999988876544468999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.++|+|||.+....... ....|+..|+|||.+.+..++.++||||+||++|++++|..||.+.+...
T Consensus 136 -------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~ 208 (285)
T cd05605 136 -------DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208 (285)
T ss_pred -------CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence 455667888888776433222 23468899999999988889999999999999999999999998654432
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.......+ . ......+..+.+||.+||+.|
T Consensus 209 ~~~~~~~~~~~~~-------------------~--------------------------~~~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05605 209 KREEVERRVKEDQ-------------------E--------------------------EYSEKFSEAARSICRQLLTKD 243 (285)
T ss_pred HHHHHHHHhhhcc-------------------c--------------------------ccCcccCHHHHHHHHHHccCC
Confidence 2222211110000 0 011235678999999999999
Q ss_pred CCCCc-----CHHHHhcCCCCCCCCcC
Q 017021 357 PTDRL-----TAREALRHPFFTRDHLR 378 (379)
Q Consensus 357 P~~Rp-----ta~e~l~hp~f~~~~~~ 378 (379)
|++|| +++++++||||.....+
T Consensus 244 P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 244 PGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred HHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 99999 99999999999986544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=329.59 Aligned_cols=246 Identities=25% Similarity=0.397 Sum_probs=197.8
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|++..+++.||+|+++... ........|..++... ..|++++++++++.+.+..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~hp~iv~~~~~~~~~~~~~lv~e 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA----WEHPFLTHLYCTFQTKENLFFVME 76 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc----cCCCcCcceEEEEEeCCEEEEEEe
Confidence 46899999999999999999999999997432 2223344455555443 378999999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 77 y~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~------------------------- 129 (316)
T cd05619 77 YLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL------------------------- 129 (316)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE-------------------------
Confidence 99 899999997754 58899999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccC---CCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+.++.++|+|||.+.... .......||..|+|||++.+..++.++|||||||++|+|++|..||...+..+....
T Consensus 130 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (316)
T cd05619 130 --DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207 (316)
T ss_pred --CCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 455567788888765321 112335689999999999988899999999999999999999999987665544433
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+.......| ...+.++.++|.+||+.||++|
T Consensus 208 i~~~~~~~~-------------------------------------------------~~~~~~~~~li~~~l~~~P~~R 238 (316)
T cd05619 208 IRMDNPCYP-------------------------------------------------RWLTREAKDILVKLFVREPERR 238 (316)
T ss_pred HHhCCCCCC-------------------------------------------------ccCCHHHHHHHHHHhccCHhhc
Confidence 322111111 1245678999999999999999
Q ss_pred cCHH-HHhcCCCCCCCC
Q 017021 361 LTAR-EALRHPFFTRDH 376 (379)
Q Consensus 361 pta~-e~l~hp~f~~~~ 376 (379)
|++. ++++||||++..
T Consensus 239 ~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 239 LGVKGDIRQHPFFREID 255 (316)
T ss_pred CCChHHHHcCcccCCCC
Confidence 9996 899999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=338.78 Aligned_cols=259 Identities=24% Similarity=0.396 Sum_probs=208.3
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.......|++.+.||+|+||.||+|+++.+++.||+|+++... .....+..|+.++..+ +|++++.+++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-----~h~~iv~~~~~~ 112 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-----NSEWIVQLHYAF 112 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCcceEEEEE
Confidence 3455668899999999999999999999999999999997422 2233455678877776 789999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
.+++..|+||||+ +++|.+++... .+++..+..++.||+.||+|||+.||+||||||+||++
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl-------------- 175 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL-------------- 175 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE--------------
Confidence 9999999999999 99999998764 48899999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCC----CCCCccchHhHHHHHHHHHh
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL----GWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~~l~~ 264 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 176 -------------~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt 242 (370)
T cd05596 176 -------------DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242 (370)
T ss_pred -------------cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh
Confidence 555678888888776543321 235689999999998653 37899999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|+.||.+.+.......+...... ..+|. ....+.+
T Consensus 243 G~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~~~------------------------~~~~s~~ 277 (370)
T cd05596 243 GDTPFYADSLVGTYSKIMDHKNS---------------------LTFPD------------------------DIEISKQ 277 (370)
T ss_pred CCCCcCCCCHHHHHHHHHcCCCc---------------------CCCCC------------------------cCCCCHH
Confidence 99999876654443333221100 11111 1135778
Q ss_pred HHHHHhhccccCCCC--CcCHHHHhcCCCCCCCC
Q 017021 345 LTHLLQGLLRYDPTD--RLTAREALRHPFFTRDH 376 (379)
Q Consensus 345 ~~~li~~~L~~dP~~--Rpta~e~l~hp~f~~~~ 376 (379)
+.+||++||+.+|.+ |+|++|+++||||+...
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 999999999999998 99999999999998743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=326.24 Aligned_cols=281 Identities=27% Similarity=0.457 Sum_probs=219.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.++||+|+||.||+|+++.+++.||+|.+... .........|+.++..+ .|+|++++++++..++..++
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-----KHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-----CCCCcceEEEEEecCCeEEE
Confidence 578889999999999999999999999999998633 22234566788888888 78999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
||||+.++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus 82 v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~---------------------- 138 (301)
T cd07873 82 VFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN---------------------- 138 (301)
T ss_pred EEeccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC----------------------
Confidence 99999889999887653 3588999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
.++.++|+|||.+....... ....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+.
T Consensus 139 -----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~ 213 (301)
T cd07873 139 -----ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213 (301)
T ss_pred -----CCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 44567777777665432221 22356889999999865 3578899999999999999999999998877777
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+....+.++...|+.+...... .....+.. ............++.+.+||.+||+.||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~ml~~dp 274 (301)
T cd07873 214 LHFIFRILGTPTEETWPGILSNEEF----KSYNYPKY---------------RADCLHNHAPRLDSDGAELLSKLLQFEG 274 (301)
T ss_pred HHHHHHHcCCCChhhchhhhccccc----cccccCcc---------------ccccHHhhcCCCCHHHHHHHHHHhcCCc
Confidence 7777777777776666543221110 00111110 0001112223467789999999999999
Q ss_pred CCCcCHHHHhcCCCCCCCC
Q 017021 358 TDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f~~~~ 376 (379)
.+|||++|+++||||..-.
T Consensus 275 ~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 275 RKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccCcCHHHHhcCccccccc
Confidence 9999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=340.67 Aligned_cols=279 Identities=27% Similarity=0.409 Sum_probs=208.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|+++++||+|+||.||+|+++.+++.||+|++.... .....+..|+.++.++ +|++++++++.+.+++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-----~h~~iv~~~~~~~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-----DNEWVVRLYYSFQDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-----CCCcCCeEEEEEEeCCEE
Confidence 4778899999999999999999999999999997432 2334566788888887 779999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.+.. .+++..+..++.||+.||+|||+.||+||||||+|||++.++.++++|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999 899999987754 6899999999999999999999999999999999999988888888888876432111
Q ss_pred Cc--ccccCCCCCCeEEeecC---------------------cccc-cCCCCCcccccCCccchhhhhCCCCCCccchHh
Q 017021 199 SS--YFKRMPKSSAIKVIDFG---------------------STTY-ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWS 254 (379)
Q Consensus 199 ~~--~~~~~~~~~~~~l~Dfg---------------------~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 254 (379)
.. .....+ .......+|. .... .........||+.|+|||++.+..++.++||||
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 155 HDSKYYQSGD-HVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccc-ccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 000000 0000000000 0000 000012347999999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHH
Q 017021 255 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334 (379)
Q Consensus 255 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (379)
|||++|+|++|+.||.+.+..+....+....... ..|.
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------~~p~--------------------- 271 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL---------------------HIPP--------------------- 271 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---------------------CCCC---------------------
Confidence 9999999999999998776654443332211110 0000
Q ss_pred HHhhccchhHHHHHHhhccccCCCCCcC---HHHHhcCCCCCCCC
Q 017021 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTRDH 376 (379)
Q Consensus 335 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~e~l~hp~f~~~~ 376 (379)
....++++.++|.+|+ .||.+|++ ++++++||||+...
T Consensus 272 ---~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 272 ---QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred ---cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 1235678999999976 59999997 99999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=330.33 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=202.0
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
|++.+.||+|+||.||+|.++.+|+.||+|+++... ........|..++..+ .++++++.+++++.+.+.+|
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ----DKPPFLTQLHSCFQTVDRLY 77 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc----cCCCchhheeeEEecCCEEE
Confidence 567799999999999999999999999999997432 1223345566665554 35577888999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 78 lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill--------------------- 134 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML--------------------- 134 (323)
T ss_pred EEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---------------------
Confidence 999999 899999987754 68999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+...
T Consensus 135 ------~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~ 208 (323)
T cd05615 135 ------DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208 (323)
T ss_pred ------CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 45566788888877543222 233468999999999998889999999999999999999999998766554
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.......| ...+.++.+++.+||+.|
T Consensus 209 ~~~~i~~~~~~~p-------------------------------------------------~~~~~~~~~li~~~l~~~ 239 (323)
T cd05615 209 LFQSIMEHNVSYP-------------------------------------------------KSLSKEAVSICKGLMTKH 239 (323)
T ss_pred HHHHHHhCCCCCC-------------------------------------------------ccCCHHHHHHHHHHcccC
Confidence 4443332211111 124568899999999999
Q ss_pred CCCCcC-----HHHHhcCCCCCCCC
Q 017021 357 PTDRLT-----AREALRHPFFTRDH 376 (379)
Q Consensus 357 P~~Rpt-----a~e~l~hp~f~~~~ 376 (379)
|.+|++ ..++++||||....
T Consensus 240 p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 240 PSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred HhhCCCCCCCCHHHHhcCcccCCCC
Confidence 999997 57999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=329.23 Aligned_cols=245 Identities=24% Similarity=0.382 Sum_probs=198.4
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|+++.+++.||+|+++... ........|..++..+ ..|++++++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~----~~h~~i~~~~~~~~~~~~~~lv~e 76 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA----GKHPFLTQLHSCFQTKDRLFFVME 76 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhc----cCCCCccceeeEEEcCCEEEEEEc
Confidence 46899999999999999999999999997432 2233445566666554 267899999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|...+.... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 77 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill------------------------- 129 (318)
T cd05570 77 YVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL------------------------- 129 (318)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE-------------------------
Confidence 99 899999887764 68999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+.++.++|+|||.+..... ......||..|+|||++.+..++.++|+|||||++|+|++|..||...+..+....
T Consensus 130 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~ 207 (318)
T cd05570 130 --DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS 207 (318)
T ss_pred --CCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 4555677777777653211 12334689999999999998999999999999999999999999987665443332
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+..... .+ ....+..+.+||++||+.||++|
T Consensus 208 i~~~~~-----------------------~~--------------------------~~~~~~~~~~li~~~l~~dP~~R 238 (318)
T cd05570 208 ILEDEV-----------------------RY--------------------------PRWLSKEAKSILKSFLTKNPEKR 238 (318)
T ss_pred HHcCCC-----------------------CC--------------------------CCcCCHHHHHHHHHHccCCHHHc
Confidence 221100 01 11356789999999999999999
Q ss_pred cCH-----HHHhcCCCCCCC
Q 017021 361 LTA-----REALRHPFFTRD 375 (379)
Q Consensus 361 pta-----~e~l~hp~f~~~ 375 (379)
||+ .++++||||+..
T Consensus 239 ~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 239 LGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 999 999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=340.08 Aligned_cols=277 Identities=24% Similarity=0.360 Sum_probs=206.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.++||+|+||.||+|.++.+++.||+|++.... .....+..|+.++..+ .|++++++++++.++.++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~iv~~~~~~~~~~~~ 76 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-----DSPWVVSLYYSFQDAQYL 76 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEcCCee
Confidence 4788899999999999999999999999999986432 1223455677777776 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999 999999997654 6899999999999999999999999999999999999998888889999887432111
Q ss_pred Ccc--c----------ccCCCCCC-------------eEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchH
Q 017021 199 SSY--F----------KRMPKSSA-------------IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIW 253 (379)
Q Consensus 199 ~~~--~----------~~~~~~~~-------------~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw 253 (379)
... . ........ ..+.+++..... ......||+.|+|||++.+..++.++|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL--MAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccc--cccccCCCccccCHHHHccCCCCCceeeE
Confidence 000 0 00000000 001111111000 00124699999999999988999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHH
Q 017021 254 SVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 333 (379)
Q Consensus 254 SlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (379)
||||++|+|++|..||...+..+....+...... +.+|+
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~p~-------------------- 271 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETYRKIINWRET---------------------LYFPD-------------------- 271 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc---------------------cCCCC--------------------
Confidence 9999999999999999876654444333221100 11111
Q ss_pred HHHhhccchhHHHHHHhhccccCCCCC---cCHHHHhcCCCCCCC
Q 017021 334 IMQHVDHSAGDLTHLLQGLLRYDPTDR---LTAREALRHPFFTRD 375 (379)
Q Consensus 334 ~~~~~~~~~~~~~~li~~~L~~dP~~R---pta~e~l~hp~f~~~ 375 (379)
....+.++.+||.+||+ +|.+| +|+.|+++||||++.
T Consensus 272 ----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 272 ----DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred ----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 01356789999999998 67665 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=333.47 Aligned_cols=244 Identities=26% Similarity=0.427 Sum_probs=198.0
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||++++..+++.||+|++.... ........|..++..+ .|++++.+.+.+..++..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-----~hp~i~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-----RHPFLTALKYSFQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCCceEEEEEcCCEEEEEEe
Confidence 46899999999999999999999999997432 1223445566666665 77999999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
|+ +++|.+.+.... .+++..+..++.||+.||.|||+ .||+||||||+||++
T Consensus 76 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll------------------------ 129 (325)
T cd05594 76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML------------------------ 129 (325)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE------------------------
Confidence 99 899998887654 68999999999999999999997 799999999999999
Q ss_pred ccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus 130 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~ 206 (325)
T cd05594 130 ---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 206 (325)
T ss_pred ---CCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH
Confidence 45566788888877532221 123468999999999998889999999999999999999999998765544333
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.+...... . ....++++.++|.+||+.||++
T Consensus 207 ~i~~~~~~-----------------------~--------------------------p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 207 LILMEEIR-----------------------F--------------------------PRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred HHhcCCCC-----------------------C--------------------------CCCCCHHHHHHHHHHhhcCHHH
Confidence 22111111 1 1235678999999999999999
Q ss_pred Cc-----CHHHHhcCCCCCCC
Q 017021 360 RL-----TAREALRHPFFTRD 375 (379)
Q Consensus 360 Rp-----ta~e~l~hp~f~~~ 375 (379)
|+ ++.++++||||...
T Consensus 238 R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCCC
Confidence 97 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=335.78 Aligned_cols=259 Identities=23% Similarity=0.400 Sum_probs=206.9
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.......|++.+.||+|+||.||+|+++.+++.||+|++.... .....+.+|+.++..+ .|++++++++.+
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-----~hp~iv~~~~~~ 112 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFCAF 112 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCEeeEEEEE
Confidence 3445567899999999999999999999999999999986421 2233455677777776 789999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..+...|+||||+ +++|.+++... .+++..+..++.||+.||+|||+.||+||||||+||++
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl-------------- 175 (370)
T cd05621 113 QDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL-------------- 175 (370)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE--------------
Confidence 9999999999999 99999999764 48899999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCC----CCCccchHhHHHHHHHHHh
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~~l~~ 264 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+.. ++.++|+|||||++|+|++
T Consensus 176 -------------~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~ 242 (370)
T cd05621 176 -------------DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV 242 (370)
T ss_pred -------------CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh
Confidence 555678888888876543222 2456999999999997643 7789999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||.+.+.......+...... +.+|. ....+..
T Consensus 243 G~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~p~------------------------~~~~s~~ 277 (370)
T cd05621 243 GDTPFYADSLVGTYSKIMDHKNS---------------------LNFPE------------------------DVEISKH 277 (370)
T ss_pred CCCCCCCCCHHHHHHHHHhCCcc---------------------cCCCC------------------------cccCCHH
Confidence 99999876655444333221111 11111 0125678
Q ss_pred HHHHHhhccccCCCC--CcCHHHHhcCCCCCCCC
Q 017021 345 LTHLLQGLLRYDPTD--RLTAREALRHPFFTRDH 376 (379)
Q Consensus 345 ~~~li~~~L~~dP~~--Rpta~e~l~hp~f~~~~ 376 (379)
++++|.+||+.+|.+ |+|++|+++||||+...
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 999999999866654 89999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=341.12 Aligned_cols=280 Identities=25% Similarity=0.374 Sum_probs=206.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.++||+|+||.||+|+++.+++.||+|++.... .....+..|+.++..+ .|++++++++.+.+++.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~~~~~~~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-----DNEWVVKLYYSFQDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-----CCCCcceEEEEEEcCCEE
Confidence 4788999999999999999999999999999986432 2234556788888887 779999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++++|||++......
T Consensus 77 ~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999 999999997764 6889999999999999999999999999999999999988888888888876322100
Q ss_pred --Cccccc-----CCC-CCCeEEeecC--------ccc---ccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHH
Q 017021 199 --SSYFKR-----MPK-SSAIKVIDFG--------STT---YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 259 (379)
Q Consensus 199 --~~~~~~-----~~~-~~~~~l~Dfg--------~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il 259 (379)
...... .+. .......+.. ... ..........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 000000 000 0000000000 000 000001234799999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhc
Q 017021 260 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339 (379)
Q Consensus 260 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (379)
|+|++|+.||.+.+..+....+....... ..+ ...
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------~~~------------------------~~~ 269 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETTL---------------------HIP------------------------SQA 269 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCccc---------------------cCC------------------------CCC
Confidence 99999999998766554433222111000 000 011
Q ss_pred cchhHHHHHHhhccccCCCCCc---CHHHHhcCCCCCCCC
Q 017021 340 HSAGDLTHLLQGLLRYDPTDRL---TAREALRHPFFTRDH 376 (379)
Q Consensus 340 ~~~~~~~~li~~~L~~dP~~Rp---ta~e~l~hp~f~~~~ 376 (379)
..+.++.++|.+|+ .+|.+|+ |+.|+++||||+..+
T Consensus 270 ~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 270 KLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 35678899999976 5999999 999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=329.14 Aligned_cols=254 Identities=22% Similarity=0.393 Sum_probs=194.6
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|+++.+++.||+|+++... .....+..|..++..+ .+|++++.+++++.+.+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~----~~hp~Iv~~~~~~~~~~~~~lv~e 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA----SNHPFLVGLHSCFQTESRLFFVIE 76 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc----cCCCCCCceEEEEEcCCEEEEEEe
Confidence 46899999999999999999999999997432 1223345566666655 367899999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 77 ~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili------------------------- 129 (329)
T cd05588 77 FVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL------------------------- 129 (329)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE-------------------------
Confidence 99 899999887654 69999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccC---CCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+.++.++|+|||.+.... .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||......+.
T Consensus 130 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--- 204 (329)
T cd05588 130 --DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN--- 204 (329)
T ss_pred --CCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccc---
Confidence 445567777877765321 112345789999999999998999999999999999999999999964221000
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+.. .........+..+.... ....+..+.++|++||+.||.+|
T Consensus 205 --------~~~---~~~~~~~~~~~~~~~~~--------------------------p~~~~~~~~~li~~~L~~dP~~R 247 (329)
T cd05588 205 --------PDQ---NTEDYLFQVILEKQIRI--------------------------PRSLSVKASSVLKGFLNKDPKER 247 (329)
T ss_pred --------ccc---cchHHHHHHHHcCCCCC--------------------------CCCCCHHHHHHHHHHhccCHHHc
Confidence 000 00000000001111111 12356789999999999999999
Q ss_pred cC------HHHHhcCCCCCCC
Q 017021 361 LT------AREALRHPFFTRD 375 (379)
Q Consensus 361 pt------a~e~l~hp~f~~~ 375 (379)
+| ++|+++||||...
T Consensus 248 ~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 248 LGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred CCCCCCCCHHHHhcCCCCCCC
Confidence 97 7899999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=328.69 Aligned_cols=244 Identities=24% Similarity=0.417 Sum_probs=198.7
Q ss_pred hccccccceeEEEEEec---CCCceEEEEEeeccc-----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 49 SKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
++||+|+||.||++++. .+++.||+|+++... ........|+.++..+ .|+||+++++.+..++..|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~iv~~~~~~~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-----KHPFIVDLIYAFQTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-----CCCchhceeeEEecCCeEE
Confidence 68999999999999864 578999999987422 2234456788888887 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+.+...+ .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 77 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~--------------------- 133 (323)
T cd05584 77 LILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL--------------------- 133 (323)
T ss_pred EEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---------------------
Confidence 999999 899999997765 68889999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 134 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~ 207 (323)
T cd05584 134 ------DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK 207 (323)
T ss_pred ------CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH
Confidence 45566788888876532221 223468999999999988889999999999999999999999998765544
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+...... .+ ...+..+.++|.+||+.|
T Consensus 208 ~~~~~~~~~~~-----------------------~~--------------------------~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 208 TIDKILKGKLN-----------------------LP--------------------------PYLTPEARDLLKKLLKRN 238 (323)
T ss_pred HHHHHHcCCCC-----------------------CC--------------------------CCCCHHHHHHHHHHcccC
Confidence 33332221111 11 124578899999999999
Q ss_pred CCCCc-----CHHHHhcCCCCCCC
Q 017021 357 PTDRL-----TAREALRHPFFTRD 375 (379)
Q Consensus 357 P~~Rp-----ta~e~l~hp~f~~~ 375 (379)
|++|| ++.++++||||...
T Consensus 239 p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=330.38 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=197.6
Q ss_pred hhhhhhccccccceeEEEEEec---CCCceEEEEEeeccc-----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 44 ADKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.|++.++||+|+||.||++++. .+++.||+|++.... ........|..++..+ .+|++++.+++.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l----~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV----RQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhc----cCCCCcccEEEEEec
Confidence 3788899999999999999864 578999999987421 1223445677777665 357889999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
++..++||||+ +++|.+.+.... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---------------- 138 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---------------- 138 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE----------------
Confidence 99999999999 899999987654 68999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.++.++|+|||.+....... ....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||
T Consensus 139 -----------~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf 207 (332)
T cd05614 139 -----------DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207 (332)
T ss_pred -----------CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCC
Confidence 455667888888776432221 234689999999999765 4789999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
...........+.+.. ...... .....+..+.++|
T Consensus 208 ~~~~~~~~~~~~~~~~-------------------~~~~~~--------------------------~~~~~~~~~~~li 242 (332)
T cd05614 208 TLEGERNTQSEVSRRI-------------------LKCDPP--------------------------FPSFIGPEAQDLL 242 (332)
T ss_pred CCCCCCCCHHHHHHHH-------------------hcCCCC--------------------------CCCCCCHHHHHHH
Confidence 6432211111111000 000000 1123567899999
Q ss_pred hhccccCCCCCc-----CHHHHhcCCCCCCCC
Q 017021 350 QGLLRYDPTDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 350 ~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
.+||+.||++|| +++++++||||++..
T Consensus 243 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 243 HKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred HHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999 889999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=319.34 Aligned_cols=277 Identities=30% Similarity=0.481 Sum_probs=213.4
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.+.||+|++|.||+|+++.+++.||+|+++... ........|+.++..+ .|++++++++.+..++..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-----QHPNIVCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-----CCCCEeeeEEEEeeCCeEE
Confidence 3778899999999999999999999999999986432 2234566788888888 6899999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKLGSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+.++|.+++.... ...+++..+..++.||+.||.|||+.|++||||+|+||+++
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~-------------------- 135 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID-------------------- 135 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc--------------------
Confidence 999999778988886532 24689999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
.++.++|+|||.+....... ....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+....
T Consensus 136 -------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~ 208 (285)
T cd07861 136 -------NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI 208 (285)
T ss_pred -------CCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 44556667777665332221 123567889999988654 4789999999999999999999999987776
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.+..+......|+........... ...+ ............+.++.++|++||+.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~------------------~~~~~~~~~~~~~~~~~~li~~~l~~ 268 (285)
T cd07861 209 DQLFRIFRILGTPTEDVWPGVTSLPDYKNT--FPKW------------------KKGSLRSAVKNLDEDGLDLLEKMLIY 268 (285)
T ss_pred HHHHHHHHHhCCCChhhhhcchhhHHHHhh--cccc------------------CcchhHHhcCCCCHHHHHHHHHHhcC
Confidence 666666666666666655543322111000 0000 00111122334778999999999999
Q ss_pred CCCCCcCHHHHhcCCCC
Q 017021 356 DPTDRLTAREALRHPFF 372 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f 372 (379)
||++|||+.++++||||
T Consensus 269 dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 269 DPAKRISAKKALNHPYF 285 (285)
T ss_pred ChhhCCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=327.96 Aligned_cols=244 Identities=27% Similarity=0.410 Sum_probs=194.3
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHH-HHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVL-QQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l-~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
+.||+|+||+||+|+++.+|+.||+|++..... .......|...+ ..+ .|++++.+++.+...+..|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-----~hp~iv~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-----KHPFLVGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-----CCCCCCCeeEEEEeCCEEEEEE
Confidence 468999999999999999999999999974321 112223333322 233 7899999999999999999999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
||+ +++|..++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 76 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll------------------------ 129 (323)
T cd05575 76 DYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL------------------------ 129 (323)
T ss_pred cCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE------------------------
Confidence 999 899999987754 68999999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus 130 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 206 (323)
T cd05575 130 ---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206 (323)
T ss_pred ---CCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 45566788888877532211 233468999999999999889999999999999999999999998765544433
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.+...... .....+..+.++|.+||+.||.+
T Consensus 207 ~i~~~~~~-------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 207 NILNKPLR-------------------------------------------------LKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred HHHcCCCC-------------------------------------------------CCCCCCHHHHHHHHHHhhcCHHh
Confidence 32211100 01134678999999999999999
Q ss_pred CcCH----HHHhcCCCCCCC
Q 017021 360 RLTA----REALRHPFFTRD 375 (379)
Q Consensus 360 Rpta----~e~l~hp~f~~~ 375 (379)
||++ .++++||||...
T Consensus 238 R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9998 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=327.00 Aligned_cols=254 Identities=21% Similarity=0.387 Sum_probs=194.3
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|+++.+++.||+|+++... ........|..++.++ .+|++++.+++++..++..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~----~~hp~iv~~~~~~~~~~~~~lv~E 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFLVGLHSCFQTESRLFFVIE 76 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhc----CCCCcCCceeeEEEeCCEEEEEEe
Confidence 46899999999999999999999999997432 1223344566555544 367999999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|...+.... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 77 ~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili------------------------- 129 (329)
T cd05618 77 YVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL------------------------- 129 (329)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE-------------------------
Confidence 99 899998887654 68999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+.++.++|+|||.+..... ......||..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 130 --~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--- 204 (329)
T cd05618 130 --DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN--- 204 (329)
T ss_pred --CCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCC---
Confidence 5556788888887754221 12345789999999999998999999999999999999999999953211000
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+.. .........+....... +...+..+.++|.+||+.||++|
T Consensus 205 --------~~~---~~~~~~~~~i~~~~~~~--------------------------p~~~~~~~~~ll~~~L~~dP~~R 247 (329)
T cd05618 205 --------PDQ---NTEDYLFQVILEKQIRI--------------------------PRSLSVKAASVLKSFLNKDPKER 247 (329)
T ss_pred --------ccc---ccHHHHHHHHhcCCCCC--------------------------CCCCCHHHHHHHHHHhcCCHHHc
Confidence 000 00000000000111111 12356789999999999999999
Q ss_pred cC------HHHHhcCCCCCCC
Q 017021 361 LT------AREALRHPFFTRD 375 (379)
Q Consensus 361 pt------a~e~l~hp~f~~~ 375 (379)
|| ++++++||||+..
T Consensus 248 ~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 248 LGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred CCCCCCCCHHHHhcCCCCCCC
Confidence 98 4899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=332.49 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=201.9
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||.||+|+++.+++.||+|+++.... ....+..|+.++..+ +|++++.+++.+.+.+..
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-----~~~~i~~~~~~~~~~~~~ 76 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-----NSPWIPQLQYAFQDKDNL 76 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceeeEEecCCeE
Confidence 47888999999999999999999999999999974322 334455666666665 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll-------------------- 135 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI-------------------- 135 (330)
T ss_pred EEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE--------------------
Confidence 9999999 999999998753 368999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhh------CCCCCCccchHhHHHHHHHHHhCCCC
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVIL------GLGWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
+..+.++|+|||.+....... ....||+.|+|||++. ...++.++|||||||++|+|++|..|
T Consensus 136 -------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~P 208 (330)
T cd05601 136 -------DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208 (330)
T ss_pred -------CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCC
Confidence 455667777777775433322 2236899999999986 45678999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|...+..+....+..... ...++. ....+.++.+|
T Consensus 209 f~~~~~~~~~~~i~~~~~---------------------~~~~~~------------------------~~~~~~~~~~l 243 (330)
T cd05601 209 FHEGTSAKTYNNIMNFQR---------------------FLKFPE------------------------DPKVSSDFLDL 243 (330)
T ss_pred CCCCCHHHHHHHHHcCCC---------------------ccCCCC------------------------CCCCCHHHHHH
Confidence 987655444333222100 000110 01356789999
Q ss_pred HhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
|++||+ ||.+|||++++++||||+..
T Consensus 244 i~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 244 IQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=322.73 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=204.5
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+|++.+.||+|+||.||++.+..+++.||+|.+.... ........|+.++..+ .|++++.+.+.+.+.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-----NSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-----CCCCeeeeeEEEecCCEE
Confidence 3677799999999999999999999999999986432 1223455688888887 678999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~-------------------- 135 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL-------------------- 135 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE--------------------
Confidence 9999999 8999999876554468999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+..+.++|+|||.+....... ....||..|+|||.+.+..++.++|+||+||++|+|++|+.||.......
T Consensus 136 -------~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~ 208 (285)
T cd05630 136 -------DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 208 (285)
T ss_pred -------CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc
Confidence 455567888888775433221 23468999999999998889999999999999999999999997643211
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
............+ .......++++.+|+++||+.|
T Consensus 209 ~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05630 209 KREEVERLVKEVQ---------------------------------------------EEYSEKFSPDARSLCKMLLCKD 243 (285)
T ss_pred hHHHHHhhhhhhh---------------------------------------------hhcCccCCHHHHHHHHHHhhcC
Confidence 1111111000000 0112245678999999999999
Q ss_pred CCCCcC-----HHHHhcCCCCCCCCcC
Q 017021 357 PTDRLT-----AREALRHPFFTRDHLR 378 (379)
Q Consensus 357 P~~Rpt-----a~e~l~hp~f~~~~~~ 378 (379)
|++||| ++|+++||||++.++.
T Consensus 244 p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 244 PKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred HHHccCCCCCchHHHHcChhhhccCHH
Confidence 999999 9999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=319.06 Aligned_cols=276 Identities=29% Similarity=0.465 Sum_probs=211.5
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.+.||+|++|.||+|.++.+|+.||+|+++... ........|+.++..+ .|++++++++++.+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-----CCCCeeeHHHHhccCCceE
Confidence 4788899999999999999999999999999986422 2234556788888888 7799999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+++||++++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||+++
T Consensus 76 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~--------------------- 133 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN--------------------- 133 (284)
T ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc---------------------
Confidence 999999888988887643 3589999999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCC-CCCchH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF-QTHENL 275 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf-~~~~~~ 275 (379)
.++.++|+|||.+....... ....++..|+|||.+.+. .++.++|||||||++|+|++|..|+ .+.+..
T Consensus 134 ------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~ 207 (284)
T cd07839 134 ------KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207 (284)
T ss_pred ------CCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH
Confidence 44556777777665433221 123567889999998764 4689999999999999999988885 444555
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.+..+..+...|+.+........ ....+. ...........+.+++++|++||+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~ 267 (284)
T cd07839 208 DQLKRIFRLLGTPTEESWPGVSKLPDYKP---YPMYPA-----------------TTSLVNVVPKLNSTGRDLLQNLLVC 267 (284)
T ss_pred HHHHHHHHHhCCCChHHhHHhhhcccccc---cCCCCC-----------------cchhhhhcccCCHHHHHHHHHHhcC
Confidence 55666666777766665554332221100 000000 0001112234678899999999999
Q ss_pred CCCCCcCHHHHhcCCCC
Q 017021 356 DPTDRLTAREALRHPFF 372 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f 372 (379)
||.+|||++|+++||||
T Consensus 268 ~P~~R~t~~~il~h~~f 284 (284)
T cd07839 268 NPVQRISAEEALQHPYF 284 (284)
T ss_pred ChhhcCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=333.82 Aligned_cols=278 Identities=23% Similarity=0.345 Sum_probs=206.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||.||+|.++.+++.||+|++.... .....+..|+.++..+ .|++++++++.+.+.+..
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~iv~~~~~~~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-----DGAWVVKMFYSFQDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCEE
Confidence 4678899999999999999999999999999997432 2234455677777776 779999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.+.. .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++++|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred EEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999 899999997754 6899999999999999999999999999999999999988888888888876533221
Q ss_pred Ccccc-cCCCCCCeEEeecCccc-----c-------cCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhC
Q 017021 199 SSYFK-RMPKSSAIKVIDFGSTT-----Y-------ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 199 ~~~~~-~~~~~~~~~l~Dfg~~~-----~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g 265 (379)
..... ........ .++.... . ........+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 155 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 155 HRTEFYRNLTHNPP--SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccCCc--ccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 10000 00000000 0000000 0 00001234799999999999999999999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
+.||...+..+....+...... ..+|. ....+.++
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~p~------------------------~~~~s~~~ 267 (360)
T cd05627 233 YPPFCSETPQETYRKVMNWKET---------------------LVFPP------------------------EVPISEKA 267 (360)
T ss_pred CCCCCCCCHHHHHHHHHcCCCc---------------------eecCC------------------------CCCCCHHH
Confidence 9999876665544433221100 00110 01256789
Q ss_pred HHHHhhccccCCCCCc---CHHHHhcCCCCCCCC
Q 017021 346 THLLQGLLRYDPTDRL---TAREALRHPFFTRDH 376 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rp---ta~e~l~hp~f~~~~ 376 (379)
+++|.+|+. ||.+|+ +++|+++||||++.+
T Consensus 268 ~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 268 KDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred HHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCC
Confidence 999999774 999998 489999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=322.78 Aligned_cols=283 Identities=27% Similarity=0.494 Sum_probs=205.6
Q ss_pred hccccccceeEEEEEecC--CCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee--ecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRE--RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--YRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~--~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~--~~~~~~lv~e 124 (379)
.+||+|+||.||+|+++. ++..||+|.+... .......+|+.++..+ .|+|++++++++. .+...++++|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-GISMSACREIALLREL-----KHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC-CCcHHHHHHHHHHHhC-----CCCCeeeEEEEEeccCCCeEEEEEe
Confidence 589999999999998654 5688999998743 2344567799998888 7799999999885 4567899999
Q ss_pred CCCCCHHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 125 KLGSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 125 ~~~~sL~~~l~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
|++++|.+++.... ...+++..+..++.||+.||.|||+.|++||||||+||++...+
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~--------------- 145 (317)
T cd07867 81 YAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG--------------- 145 (317)
T ss_pred eeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCC---------------
Confidence 99889988875321 12478889999999999999999999999999999999994322
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+..+.++|+|||.+....... ....||..|+|||.+.+ ..++.++|||||||++|+|++|++||.
T Consensus 146 --------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 146 --------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred --------CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 345678899999886543321 23468899999999876 457899999999999999999999997
Q ss_pred CCch---------HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhh-hhhccchhhHHHHHHhhcc
Q 017021 271 THEN---------LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI-KSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 271 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 340 (379)
.... ......+....+.+....|+.+......... .... ......+............
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~ 285 (317)
T cd07867 218 CRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTL------------QKDFRRTTYANSSLIKYMEKHKVK 285 (317)
T ss_pred cccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhh------------hhhhcccccCCchhhhhhhcccCC
Confidence 5332 2334445555666666655543322110000 0000 0001111111122222234
Q ss_pred chhHHHHHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
.+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 286 ~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 286 PDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 45679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=318.34 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=195.9
Q ss_pred cccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 51 Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
||+|+||+||++.++.+++.||+|.+..... ....+..|+.+++.+ +|++++.+.+.+..+...|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-----HSRFIVSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-----CCCcEeeeeEEEcCCCeEEEEEeCC
Confidence 6999999999999999999999999864321 223455688888877 7799999999999999999999999
Q ss_pred -CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 127 -GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 127 -~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
+++|.+.+... ....+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili------------------------- 130 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL------------------------- 130 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE-------------------------
Confidence 89998887542 22368999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+.++.++|+|||.+...... .....||+.|+|||.+.+..++.++|+|||||++|+|++|+.||...........
T Consensus 131 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 208 (280)
T cd05608 131 --DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 208 (280)
T ss_pred --CCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 44556788888877543222 1234689999999999998999999999999999999999999976432111111
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+.......+ . ......+..+.+++.+||+.||++|
T Consensus 209 ~~~~~~~~~-------------------~--------------------------~~~~~~~~~~~~li~~~l~~~P~~R 243 (280)
T cd05608 209 LKQRILNDS-------------------V--------------------------TYPDKFSPASKSFCEALLAKDPEKR 243 (280)
T ss_pred HHHhhcccC-------------------C--------------------------CCcccCCHHHHHHHHHHhcCCHHHh
Confidence 111000000 0 0112367789999999999999999
Q ss_pred c-----CHHHHhcCCCCCCC
Q 017021 361 L-----TAREALRHPFFTRD 375 (379)
Q Consensus 361 p-----ta~e~l~hp~f~~~ 375 (379)
| +++++++||||++.
T Consensus 244 ~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 244 LGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred cCCCCCCHHHHhcChhhhcC
Confidence 9 89999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=323.23 Aligned_cols=249 Identities=27% Similarity=0.355 Sum_probs=201.4
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch---hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
+......+.+.||+|+||+||++.++.+.. ||+|++...+. ....+.+|+.++.++ .||||+.+++++..+
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~~~~f~~E~~il~~l-----~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDESRKAFRREASLLSRL-----RHPNIVQFYGACTSP 111 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEcCC
Confidence 334444566789999999999998765332 99999975332 255888999999998 889999999999988
Q ss_pred c-eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-CcccCCCCCcEEEecccccccCCCccCC
Q 017021 117 N-HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC-MIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 117 ~-~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
. ..++||||+ +|+|.+++.......++...+..++.||+.|++|||+++ ||||||||+|||+
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv--------------- 176 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV--------------- 176 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---------------
Confidence 8 799999999 999999998843357999999999999999999999999 9999999999999
Q ss_pred CCCCCCcccccCCCCC-CeEEeecCcccccCC---CCCcccccCCccchhhhh--CCCCCCccchHhHHHHHHHHHhCCC
Q 017021 194 HTPKDSSYFKRMPKSS-AIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVIL--GLGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~-~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
+.+. .+||+|||+++.... ......||..|+|||++. ...|+.++||||||+++|||+||+.
T Consensus 177 ------------~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~ 244 (362)
T KOG0192|consen 177 ------------DLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI 244 (362)
T ss_pred ------------cCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence 4554 788888888865443 223368999999999999 5689999999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||...........+.... . +..+| ..+.+.+..
T Consensus 245 Pf~~~~~~~~~~~v~~~~-~--------------------Rp~~p--------------------------~~~~~~l~~ 277 (362)
T KOG0192|consen 245 PFEDLAPVQVASAVVVGG-L--------------------RPPIP--------------------------KECPPHLSS 277 (362)
T ss_pred CCCCCCHHHHHHHHHhcC-C--------------------CCCCC--------------------------ccCCHHHHH
Confidence 999877644433322111 1 11111 135678999
Q ss_pred HHhhccccCCCCCcCHHHHhc
Q 017021 348 LLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~ 368 (379)
+|..||..||.+||+..+++.
T Consensus 278 l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 278 LMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHhCCCCCCcCCCHHHHHH
Confidence 999999999999999998863
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=307.62 Aligned_cols=268 Identities=26% Similarity=0.475 Sum_probs=216.1
Q ss_pred eeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 35 ITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
.++.....|...- ++||-|-.|.|-.+.++.||+++|+|++....+ +.+|++.--.. ..|+|||.+++.|+
T Consensus 55 k~~~itedY~is~-qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~----s~h~~iV~IidVye 125 (400)
T KOG0604|consen 55 KEYSITEDYSISW-QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMA----SGHPHIVSIIDVYE 125 (400)
T ss_pred hcccchhhheehh-hhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhh----cCCCceEEeehhhh
Confidence 4444444444433 689999999999999999999999999874333 33344432222 37899999999886
Q ss_pred e----cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCC
Q 017021 115 Y----RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 115 ~----~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
. .+.+.+|||.+ ||.|.+.++.++...+++.++..++.||..|+.|||+.+|.||||||+|+|+...
T Consensus 126 Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t-------- 197 (400)
T KOG0604|consen 126 NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTT-------- 197 (400)
T ss_pred hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecC--------
Confidence 4 46788999999 9999999999988889999999999999999999999999999999999999543
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCC
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
..+..+||+|||+|+....+. .+.+-|+.|.|||++..++|+..+|+||+||++|-|++|.+
T Consensus 198 ----------------~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyP 261 (400)
T KOG0604|consen 198 ----------------SPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_pred ----------------CCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCC
Confidence 678889999999998766433 45678999999999999999999999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||++..... .+..+ +.-+..|.+.+|+ +.|+..|.+++|
T Consensus 262 PFYS~hg~a-----------ispgM--------k~rI~~gqy~FP~----------------------pEWs~VSe~aKd 300 (400)
T KOG0604|consen 262 PFYSNHGLA-----------ISPGM--------KRRIRTGQYEFPE----------------------PEWSCVSEAAKD 300 (400)
T ss_pred cccccCCcc-----------CChhH--------HhHhhccCccCCC----------------------hhHhHHHHHHHH
Confidence 998754321 12221 1223334444443 346678899999
Q ss_pred HHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 348 LLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+|+.+|..+|.+|.|+.|++.|||+.+.+
T Consensus 301 lIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 301 LIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred HHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 99999999999999999999999998754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=326.80 Aligned_cols=295 Identities=21% Similarity=0.318 Sum_probs=209.6
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
....|++.++||+|+||.||++.++.++..+|+|++... ......+..|++++..+ +|+|++.+++++..++.
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDGE 77 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-----CCCcccceeEEEEECCE
Confidence 445789999999999999999999999999999998743 22345677899998888 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
.++||||+ +++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~----------------- 138 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----------------- 138 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc-----------------
Confidence 99999999 899999997754 588999999999999999999975 799999999999994
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCC-CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
.++.++|+|||.+...... .....||..|+|||.+.+..++.++|+|||||++|+|++|+.||......
T Consensus 139 ----------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 139 ----------SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred ----------CCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 4456788888877543222 23346899999999999888999999999999999999999999865543
Q ss_pred HHHHHHHHHc-CCCChhHHHhhhhhhhhhhccCCCCCCCCCC---chhh-hhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 276 EHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA---SRES-IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 276 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
+....+.... +........ .... ........+..... .... .......+. ........+.++.+||.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~ 280 (333)
T cd06650 209 ELELMFGCPVEGDPAESETS---PRPR-PPGRPLSSYGPDSRPPMAIFELLDYIVNEPP----PKLPSGVFGAEFQDFVN 280 (333)
T ss_pred HHHHHhcCcccCCccccccC---cccC-CccchhhhhcccccccccHHHHHHHHhcCCC----ccCCCCCcCHHHHHHHH
Confidence 3222111111 111000000 0000 00000000000000 0000 000000000 00001135678999999
Q ss_pred hccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 351 GLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
+||+.||++|||++|++.||||+....
T Consensus 281 ~~L~~~P~~Rpt~~ell~h~~~~~~~~ 307 (333)
T cd06650 281 KCLIKNPAERADLKQLMVHAFIKRSEA 307 (333)
T ss_pred HhccCCcccCcCHHHHhhCHHHhcCcc
Confidence 999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=331.05 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=207.0
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.......|++.+.||+|+||.||+|+++.+++.||+|++.... .....+.+|..++..+ +|++++++++.+
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-----~hp~iv~~~~~~ 112 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFYAF 112 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-----CCCCCCeEEEEE
Confidence 4556678999999999999999999999999999999986422 2233455677777766 789999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..++..|+||||+ +++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll-------------- 175 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL-------------- 175 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE--------------
Confidence 9999999999999 89999998764 48899999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCC----CCCccchHhHHHHHHHHHh
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~~l~~ 264 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 176 -------------~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~ 242 (371)
T cd05622 176 -------------DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242 (371)
T ss_pred -------------CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh
Confidence 455678888888876543321 2456999999999987643 7899999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||.+.+.......+....... .++. ....+..
T Consensus 243 G~~Pf~~~~~~~~~~~i~~~~~~~---------------------~~~~------------------------~~~~s~~ 277 (371)
T cd05622 243 GDTPFYADSLVGTYSKIMNHKNSL---------------------TFPD------------------------DNDISKE 277 (371)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCcc---------------------cCCC------------------------cCCCCHH
Confidence 999998776654444333211111 1110 1236778
Q ss_pred HHHHHhhccccCCCC--CcCHHHHhcCCCCCCCC
Q 017021 345 LTHLLQGLLRYDPTD--RLTAREALRHPFFTRDH 376 (379)
Q Consensus 345 ~~~li~~~L~~dP~~--Rpta~e~l~hp~f~~~~ 376 (379)
++++|..||+.++.+ |++++|+++||||++..
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 999999999844443 78999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=327.07 Aligned_cols=244 Identities=28% Similarity=0.479 Sum_probs=199.8
Q ss_pred hccccccceeEEEEEe---cCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 49 SKMGEGTFGQVLECWD---RERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~---~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
+.||+|+||.||++++ +.+|+.||+|++.... ........|+.++.++ .|+||+++++.+..++..|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-----NHPFIVKLHYAFQTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-----CCCCcccEEEEEEcCCEEEEE
Confidence 6799999999999986 3678999999997432 1233455688888877 789999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|||+ +++|.+.+.+.. .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 77 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~----------------------- 131 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL----------------------- 131 (318)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE-----------------------
Confidence 9999 899999997654 68999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
+.++.++|+|||.+...... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus 132 ----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 207 (318)
T cd05582 132 ----DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM 207 (318)
T ss_pred ----CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH
Confidence 45566888888877643332 12356899999999999888999999999999999999999999876654444
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+.+.....| ...+..+.++|++||+.||+
T Consensus 208 ~~i~~~~~~~p-------------------------------------------------~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 208 TMILKAKLGMP-------------------------------------------------QFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred HHHHcCCCCCC-------------------------------------------------CCCCHHHHHHHHHHhhcCHh
Confidence 33322111111 12467889999999999999
Q ss_pred CCcC-----HHHHhcCCCCCCC
Q 017021 359 DRLT-----AREALRHPFFTRD 375 (379)
Q Consensus 359 ~Rpt-----a~e~l~hp~f~~~ 375 (379)
+||| +.+++.||||...
T Consensus 239 ~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 239 NRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HcCCCCCCCHHHHhCCCCcCCC
Confidence 9999 7789999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=325.79 Aligned_cols=245 Identities=26% Similarity=0.368 Sum_probs=194.6
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|+++.+|+.||+|++.... ........|...+.+ ...|+|++++++.+...+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~----~~~hp~iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLK----NVKHPFLVGLHYSFQTTEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHH----hCCCCCCccEEEEEecCCEEEEEEc
Confidence 46899999999999999999999999997432 122233334333222 1378999999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|...+.... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 77 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll------------------------- 129 (325)
T cd05604 77 FVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL------------------------- 129 (325)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE-------------------------
Confidence 99 899998887654 68999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+.++.++|+|||.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....
T Consensus 130 --~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (325)
T cd05604 130 --DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN 207 (325)
T ss_pred --CCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHH
Confidence 4556778888887754221 12345689999999999998899999999999999999999999987665444333
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+...... .....+..+.++|++||+.||.+|
T Consensus 208 ~~~~~~~-------------------------------------------------~~~~~~~~~~~ll~~ll~~~p~~R 238 (325)
T cd05604 208 ILHKPLV-------------------------------------------------LRPGASLTAWSILEELLEKDRQRR 238 (325)
T ss_pred HHcCCcc-------------------------------------------------CCCCCCHHHHHHHHHHhccCHHhc
Confidence 2221000 011356678899999999999999
Q ss_pred cCH----HHHhcCCCCCCC
Q 017021 361 LTA----REALRHPFFTRD 375 (379)
Q Consensus 361 pta----~e~l~hp~f~~~ 375 (379)
|++ .++++||||+..
T Consensus 239 ~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 239 LGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred CCCCCCHHHHhcCCCcCCC
Confidence 977 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=328.73 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=196.1
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
-..|++.++||+|+||.||+|++..+++.||+|++... ......+.+|+.++..+ .|+||+++++++..++.+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-----NHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-----CCCCcceeeeEeccCCeE
Confidence 34578889999999999999999999999999998643 23345677899988887 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++||||+ +++|.+. ....+..+..++.||+.||.|||+.|++||||||+||++
T Consensus 148 ~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll-------------------- 201 (353)
T PLN00034 148 QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI-------------------- 201 (353)
T ss_pred EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE--------------------
Confidence 9999999 8887542 235677888999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-----CCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+.++.++|+|||.+....... ....||..|+|||.+.. ...+.++|||||||++|+|++|+.||.
T Consensus 202 -------~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 202 -------NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred -------cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 455567777777775433221 23578999999998743 234578999999999999999999997
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
.....+....+.......+ .......+.++.+||.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~l~~li~ 309 (353)
T PLN00034 275 VGRQGDWASLMCAICMSQP---------------------------------------------PEAPATASREFRHFIS 309 (353)
T ss_pred CCCCccHHHHHHHHhccCC---------------------------------------------CCCCCccCHHHHHHHH
Confidence 4322111111111000000 0001235678999999
Q ss_pred hccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 351 GLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
+||+.||++|||+.|+++||||.....
T Consensus 310 ~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 310 CCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred HHccCChhhCcCHHHHhcCcccccCCc
Confidence 999999999999999999999998753
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=316.84 Aligned_cols=252 Identities=35% Similarity=0.581 Sum_probs=202.5
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHh---HHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA---AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~---~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
|++.++||+|+||+||++.++.+++.||+|++......... ...|+..+..+ .|++++++.+++......++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-----RHPNIVQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-----TBTTBCHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-----cccccccccccccccccccc
Confidence 78889999999999999999999999999999855433322 23488888888 67899999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||++ +++|.+++.... .++...+..++.|++.||.+||+.|++|+||||+||++
T Consensus 76 v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---------------------- 131 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---------------------- 131 (260)
T ss_dssp EEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE----------------------
T ss_pred cccccccccccccccccc--cccccccccccccccccccccccccccccccccccccc----------------------
Confidence 99999 669999998443 68999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCccccc---CCCCCcccccCCccchhhhh-CCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYE---RPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.++|+|||.+... ........+|..|.|||.+. +..++.++|+||||+++|+|++|..||......+
T Consensus 132 -----~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~ 206 (260)
T PF00069_consen 132 -----DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD 206 (260)
T ss_dssp -----STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence 55667788888887642 22223456889999999998 7788999999999999999999999998764333
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+......... ..........+.++|.+||+.|
T Consensus 207 ~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~l~~li~~~l~~~ 244 (260)
T PF00069_consen 207 QLEIIEKILKRPLPSS------------------------------------------SQQSREKSEELRDLIKKMLSKD 244 (260)
T ss_dssp HHHHHHHHHHTHHHHH------------------------------------------TTSHTTSHHHHHHHHHHHSSSS
T ss_pred hhhhhhhccccccccc------------------------------------------ccccchhHHHHHHHHHHHccCC
Confidence 3333332221110000 0000112378999999999999
Q ss_pred CCCCcCHHHHhcCCCC
Q 017021 357 PTDRLTAREALRHPFF 372 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f 372 (379)
|++|||+.++++||||
T Consensus 245 p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 245 PEQRPSAEELLKHPWF 260 (260)
T ss_dssp GGGSTTHHHHHTSGGG
T ss_pred hhHCcCHHHHhcCCCC
Confidence 9999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=322.35 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=195.0
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|+++.+++.||+|+++... .....+..|..++.++ .+|++++.+++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~----~~~~~i~~~~~~~~~~~~~~lv~e 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQA----SSNPFLVGLHSCFQTTSRLFLVIE 76 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhh----cCCCCEeeEEEEEEeCCEEEEEEe
Confidence 46899999999999999999999999997432 2223445666666655 357899999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|...+.... .+++..+..++.||+.||+|||+.|++||||||+||++
T Consensus 77 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili------------------------- 129 (327)
T cd05617 77 YVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL------------------------- 129 (327)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE-------------------------
Confidence 99 999998887654 69999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccC---CCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH---H
Q 017021 204 RMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE---H 277 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~---~ 277 (379)
+.++.++|+|||.+.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 130 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~ 207 (327)
T cd05617 130 --DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT 207 (327)
T ss_pred --eCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc
Confidence 445567888888775321 11234578999999999999899999999999999999999999996422110 0
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+. +....... ....+..+.++|.+||+.||
T Consensus 208 ~~~~~~~-------------------~~~~~~~~--------------------------p~~~~~~~~~li~~~L~~dP 242 (327)
T cd05617 208 EDYLFQV-------------------ILEKPIRI--------------------------PRFLSVKASHVLKGFLNKDP 242 (327)
T ss_pred HHHHHHH-------------------HHhCCCCC--------------------------CCCCCHHHHHHHHHHhccCH
Confidence 0000000 00000011 12356788999999999999
Q ss_pred CCCcC------HHHHhcCCCCCCCC
Q 017021 358 TDRLT------AREALRHPFFTRDH 376 (379)
Q Consensus 358 ~~Rpt------a~e~l~hp~f~~~~ 376 (379)
++|++ +.++++||||+...
T Consensus 243 ~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 243 KERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 99998 47999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=315.91 Aligned_cols=329 Identities=33% Similarity=0.592 Sum_probs=246.8
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCC---CeeEEecceee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG---NRCVQIRNWFD 114 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~---~~i~~~~~~~~ 114 (379)
-+|..-+|-+.++||=|.|++||+|+|..+.+.||+|+.+......+.++.|+.++++++.++.++ ..||++++.|.
T Consensus 73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 356667889999999999999999999999999999999988888899999999999999888544 46999999998
Q ss_pred e----cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCcccCCCCCcEEEecc--------
Q 017021 115 Y----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSS-------- 181 (379)
Q Consensus 115 ~----~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~iiH~dlkp~Nili~~~-------- 181 (379)
. +.|+|+|+|+.|.+|..++.....+.++...+..|+.||+.||.||| ++||||.||||+|||+-..
T Consensus 153 hsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred ecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence 4 46999999999999999999888788999999999999999999999 6899999999999998542
Q ss_pred ---c--ccccC--------CCc-c---------C----------------------------------------CCCCCC
Q 017021 182 ---E--YIKVP--------DYK-S---------S----------------------------------------LHTPKD 198 (379)
Q Consensus 182 ---~--~~~~~--------~~~-~---------~----------------------------------------~~~~~~ 198 (379)
+ ....+ +-+ . + ...+..
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence 1 00000 000 0 0 000000
Q ss_pred -----------------------Cc------c---------------------cc------------------cCCCCCC
Q 017021 199 -----------------------SS------Y---------------------FK------------------RMPKSSA 210 (379)
Q Consensus 199 -----------------------~~------~---------------------~~------------------~~~~~~~ 210 (379)
.+ + .. ....+..
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 00 0 00 0112245
Q ss_pred eEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC------chHHHHHHHHHH
Q 017021 211 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH------ENLEHLAMMERV 284 (379)
Q Consensus 211 ~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~------~~~~~~~~~~~~ 284 (379)
+||+|||.|......-..-..|..|.|||++.+.+|+..+||||++|++|||+||.+.|... .+.+...++.+.
T Consensus 393 vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~EL 472 (590)
T KOG1290|consen 393 VKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMEL 472 (590)
T ss_pred EEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHH
Confidence 89999999987776665567899999999999999999999999999999999999999643 356677889999
Q ss_pred cCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHH--hhccchhHHHHHHhhccccCCCCCcC
Q 017021 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ--HVDHSAGDLTHLLQGLLRYDPTDRLT 362 (379)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt 362 (379)
+|..|..+.-.-.-+-+-+..+|.+..-.... .-|...-+.+. .......++.+|+.-||+.+|++|||
T Consensus 473 LG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK---------~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 473 LGKIPRKIALGGKYSRDFFNRRGELRHIRRLK---------PWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HhhccHHHHhcCcchHhhhccccceecccccC---------CCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 99999876544333222233333222111110 00111111111 11345577999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 017021 363 AREALRHPFFTRD 375 (379)
Q Consensus 363 a~e~l~hp~f~~~ 375 (379)
|.++|+|||+...
T Consensus 544 A~~cl~hPwLn~~ 556 (590)
T KOG1290|consen 544 AAQCLKHPWLNPV 556 (590)
T ss_pred HHHHhcCccccCC
Confidence 9999999999843
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=327.35 Aligned_cols=246 Identities=26% Similarity=0.447 Sum_probs=193.1
Q ss_pred cccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 51 Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
||+|+||+||+|+++.+++.||+|++..... .......|..++.... ...|++++.+++.+......|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL--LDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhc--cCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 7999999999999999999999999964321 1122333444444432 126799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 127 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 127 -~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
+++|.+.+.... .+++..+..++.||+.||+|||+.||+||||||+||++
T Consensus 79 ~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili--------------------------- 129 (330)
T cd05586 79 SGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL--------------------------- 129 (330)
T ss_pred CCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---------------------------
Confidence 899999887654 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHH
Q 017021 206 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~ 281 (379)
+.++.++|+|||.+..... ......||..|+|||.+.+. .++.++|||||||++|+|++|..||...+..+....+
T Consensus 130 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i 209 (330)
T cd05586 130 DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209 (330)
T ss_pred CCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence 4555678888887754222 12345689999999998764 4789999999999999999999999876554433322
Q ss_pred HHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCc
Q 017021 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 361 (379)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 361 (379)
....... +. ...+.++.++|.+||+.||.+||
T Consensus 210 ~~~~~~~-----------------------~~-------------------------~~~~~~~~~li~~~L~~~P~~R~ 241 (330)
T cd05586 210 AFGKVRF-----------------------PK-------------------------NVLSDEGRQFVKGLLNRNPQHRL 241 (330)
T ss_pred HcCCCCC-----------------------CC-------------------------ccCCHHHHHHHHHHcCCCHHHCC
Confidence 2111111 10 12467889999999999999998
Q ss_pred ----CHHHHhcCCCCCCC
Q 017021 362 ----TAREALRHPFFTRD 375 (379)
Q Consensus 362 ----ta~e~l~hp~f~~~ 375 (379)
++.++++||||++.
T Consensus 242 ~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 242 GAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCCHHHHhcCccccCC
Confidence 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=323.48 Aligned_cols=244 Identities=26% Similarity=0.409 Sum_probs=194.1
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHH-HHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEV-LQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~-l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
+.||+|+||.||+|+++.+++.||+|++..... .......|... +..+ .|++++++++.+...+..|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-----~h~~Iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-----KHPFLVGLHFSFQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-----CCCCCCceeEEEEcCCeEEEEE
Confidence 468999999999999999999999999974321 11222233322 2233 7899999999999999999999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 76 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili------------------------ 129 (325)
T cd05602 76 DYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL------------------------ 129 (325)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE------------------------
Confidence 999 899999997754 58889999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
+.++.++|+|||.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus 130 ---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (325)
T cd05602 130 ---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206 (325)
T ss_pred ---CCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH
Confidence 4555678888887753221 1234568999999999999899999999999999999999999998766554443
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.+...... .....+..+.++|.+||+.||.+
T Consensus 207 ~i~~~~~~-------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 207 NILNKPLQ-------------------------------------------------LKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred HHHhCCcC-------------------------------------------------CCCCCCHHHHHHHHHHcccCHHH
Confidence 33221100 11235678999999999999999
Q ss_pred CcCHH----HHhcCCCCCCC
Q 017021 360 RLTAR----EALRHPFFTRD 375 (379)
Q Consensus 360 Rpta~----e~l~hp~f~~~ 375 (379)
|+++. ++++|+||...
T Consensus 238 R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred CCCCCCCHHHHhcCcccCCC
Confidence 99876 89999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=315.16 Aligned_cols=251 Identities=23% Similarity=0.412 Sum_probs=196.7
Q ss_pred cccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 51 Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
||+|+||.||+++++.+|+.||+|.+.... ........|++++..+ +|++++.+.+.++.+.+.|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-----NSPFIVNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-----CCCcEEEEEEEEecCCeEEEEEecC
Confidence 699999999999999999999999986321 1233445688888887 7799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 127 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 127 -~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
+++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili--------------------------- 128 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL--------------------------- 128 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---------------------------
Confidence 8999988876554568899999999999999999999999999999999999
Q ss_pred CCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHH
Q 017021 206 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~ 283 (379)
+.+..++|+|||.+....... ....||..|+|||++.+..++.++|+|||||++|+|++|+.||...........+.+
T Consensus 129 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05607 129 DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208 (277)
T ss_pred cCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH
Confidence 445567788888765433222 234688999999999888899999999999999999999999975432111111111
Q ss_pred HcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCH
Q 017021 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 363 (379)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta 363 (379)
.... ..... .....+.+++++|++||+.||.+||++
T Consensus 209 ~~~~-------------------~~~~~-------------------------~~~~~~~~~~~li~~~L~~~P~~R~~~ 244 (277)
T cd05607 209 RTLE-------------------DEVKF-------------------------EHQNFTEESKDICRLFLAKKPEDRLGS 244 (277)
T ss_pred Hhhc-------------------ccccc-------------------------ccccCCHHHHHHHHHHhccCHhhCCCC
Confidence 0000 00000 011356789999999999999999999
Q ss_pred ----HHHhcCCCCCCCCc
Q 017021 364 ----REALRHPFFTRDHL 377 (379)
Q Consensus 364 ----~e~l~hp~f~~~~~ 377 (379)
++++.||||+..+.
T Consensus 245 ~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 245 REKNDDPRKHEFFKTINF 262 (277)
T ss_pred ccchhhhhcChhhcCCCH
Confidence 77889999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=313.98 Aligned_cols=277 Identities=32% Similarity=0.512 Sum_probs=216.6
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
+|++.+.||.|++|.||+|+++.+++.||+|++.... .....+..|++++.++ .|+|++++++++.+++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHPNIVKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-----CCCCCcchhhhcccCCcEE
Confidence 3788899999999999999999999999999986432 1234567789988888 7799999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||||+.++|.+++.......+++..+..++.|++.||+|||+.|++||||+|+||+++
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~--------------------- 134 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN--------------------- 134 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---------------------
Confidence 99999977899998775545789999999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCC-CCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.++.++|+|||.+....... ....++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||.+.+..+
T Consensus 135 ------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 208 (284)
T cd07860 135 ------TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208 (284)
T ss_pred ------CCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 45567777777665332221 2234678899999876644 5889999999999999999999999888777
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
...++.+..+.++...++.+............ +. ...........+.+++++|.+||+.|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~------------------~~~~~~~~~~~~~~~~~li~~~l~~~ 268 (284)
T cd07860 209 QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK--WA------------------RQDFSKVVPPLDEDGRDLLSQMLHYD 268 (284)
T ss_pred HHHHHHHHhCCCChhhhhhhhHHHHHHhhccc--cc------------------ccCHHHHcccCCHHHHHHHHHhcCCC
Confidence 77777777777776666543332111111000 00 00011112345678999999999999
Q ss_pred CCCCcCHHHHhcCCCC
Q 017021 357 PTDRLTAREALRHPFF 372 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f 372 (379)
|++|||++++++||||
T Consensus 269 P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 269 PNKRISAKAALAHPFF 284 (284)
T ss_pred cccCCCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=321.47 Aligned_cols=260 Identities=26% Similarity=0.435 Sum_probs=206.2
Q ss_pred eeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEee---ccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 36 TYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 36 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~---~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
..+...+..|+++++||+||.+.||++.... .+.||+|.+. .+......+..|+..|.++. ++.+|+.++++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLk----g~~~IIqL~DY 428 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLK----GHDKIIQLYDY 428 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhc----CCceEEEEeee
Confidence 4566788899999999999999999998544 4567777764 34445567788999999994 55789999999
Q ss_pred eeecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 113 FDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 113 ~~~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
...++.+|+|||+-..+|..++.++.. .++.-.++.+..|++.|+.++|.+||||.||||.|+++
T Consensus 429 Ev~d~~lYmvmE~Gd~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-------------- 493 (677)
T KOG0596|consen 429 EVTDGYLYMVMECGDIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-------------- 493 (677)
T ss_pred eccCceEEEEeecccccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE--------------
Confidence 999999999999999999999998762 34444888999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCC-----------CCCCccchHhHH
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGL-----------GWTYPCDIWSVG 256 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlG 256 (379)
..+.+||+|||.|....+.. ...+||+.||+||.+... +.+.++||||||
T Consensus 494 --------------VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG 559 (677)
T KOG0596|consen 494 --------------VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLG 559 (677)
T ss_pred --------------EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhh
Confidence 45789999999998766665 346899999999998532 267899999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHH
Q 017021 257 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336 (379)
Q Consensus 257 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (379)
||||+|+.|+.||..... ....+..+..|.. .+.+|..
T Consensus 560 CILYqMvYgktPf~~~~n--~~aKl~aI~~P~~------------------~Iefp~~---------------------- 597 (677)
T KOG0596|consen 560 CILYQMVYGKTPFGQIIN--QIAKLHAITDPNH------------------EIEFPDI---------------------- 597 (677)
T ss_pred hHHHHHHhcCCchHHHHH--HHHHHHhhcCCCc------------------cccccCC----------------------
Confidence 999999999999964221 1222222222211 1111110
Q ss_pred hhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 337 ~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
....++.+++..||++||.+|||+.++|+|||++-
T Consensus 598 ---~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 598 ---PENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ---CCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 11233999999999999999999999999999875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=305.53 Aligned_cols=272 Identities=26% Similarity=0.461 Sum_probs=213.9
Q ss_pred hhhh-hccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 45 DKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 45 y~i~-~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
|++. +.||+|+|+.|-.+.+..||..||+|++.+. ...+.+..+|++.+.+. .+|+||+.++++|+++..+|+|
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~C----qgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQC----QGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHh----cCCccHHHHHHHhcccceEEEE
Confidence 4543 5899999999999999999999999999754 34567788899988776 4789999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
||-+ ||+|.+.+.++. .+++.++..++.+|+.||.|||.+||.|||+||+|||.-..
T Consensus 155 fEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~p-------------------- 212 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESP-------------------- 212 (463)
T ss_pred EecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCC--------------------
Confidence 9999 999999998765 59999999999999999999999999999999999999432
Q ss_pred cccCCCCCCeEEeecCcccc----------cCCCCCcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHhCC
Q 017021 202 FKRMPKSSAIKVIDFGSTTY----------ERPDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~----------~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
+.-..+|||||.+..- ..++-.+.+|+..|||||+.. ...|+.++|.||||+|+|-|++|.
T Consensus 213 ----n~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY 288 (463)
T KOG0607|consen 213 ----NKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY 288 (463)
T ss_pred ----CCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence 4556789999876531 111224568999999999874 235899999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
+||.+.-..+ -|=.-.+.....+.-+-.-++.|++.+|+ +-|.+.+.+++
T Consensus 289 pPFvG~Cg~d--------CGWdrGe~Cr~CQ~~LFesIQEGkYeFPd----------------------kdWahIS~eak 338 (463)
T KOG0607|consen 289 PPFVGHCGAD--------CGWDRGEVCRVCQNKLFESIQEGKYEFPD----------------------KDWAHISSEAK 338 (463)
T ss_pred CCccCccCCc--------CCccCCCccHHHHHHHHHHHhccCCcCCh----------------------hhhHHhhHHHH
Confidence 9997642200 00000111111222233334455555543 34667899999
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
|+|+.+|..|+.+|.+|.++++|||+.+-.
T Consensus 339 dlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 339 DLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 999999999999999999999999998753
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=321.96 Aligned_cols=244 Identities=26% Similarity=0.366 Sum_probs=192.8
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHH-HHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEV-LQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~-l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
+.||+|+||.||+|+++.+++.||+|++..... ....+..|... +..+ .|+|++++++.+...+..|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-----~h~~iv~~~~~~~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-----KHPFLVGLHYSFQTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-----CCCCccceeeEEEcCCEEEEEE
Confidence 468999999999999999999999999874321 12223333332 3333 7899999999999999999999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
||+ +++|...+.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll------------------------ 129 (321)
T cd05603 76 DYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL------------------------ 129 (321)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE------------------------
Confidence 999 899988887654 68899999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
+.++.++|+|||.+..... ......||+.|+|||.+.+..++.++|||||||++|+|++|..||...+......
T Consensus 130 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (321)
T cd05603 130 ---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206 (321)
T ss_pred ---CCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 4556678888887654211 1233468999999999998889999999999999999999999998765444333
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.+...... .....+..+.++|.+||+.||.+
T Consensus 207 ~i~~~~~~-------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 207 NILHKPLQ-------------------------------------------------LPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred HHhcCCCC-------------------------------------------------CCCCCCHHHHHHHHHHccCCHhh
Confidence 22211101 11235668999999999999999
Q ss_pred CcCH----HHHhcCCCCCCC
Q 017021 360 RLTA----REALRHPFFTRD 375 (379)
Q Consensus 360 Rpta----~e~l~hp~f~~~ 375 (379)
||++ .++++||||...
T Consensus 238 R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred cCCCCCCHHHHhCCCCcCCC
Confidence 9976 499999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=330.19 Aligned_cols=278 Identities=23% Similarity=0.408 Sum_probs=206.7
Q ss_pred hhhhhhhhccccccceeEEEEEec--CCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDR--ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
...|++.+.||+|+||.||+|... .++..||+|.+.... ...+|+.++..+ .|++++++++.+......
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l-----~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTI-----SHRAIINLIHAYRWKSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhc-----CCCCccceeeeEeeCCEE
Confidence 446999999999999999999754 456889999986432 335689999888 789999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 120 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 120 ~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
|++||+++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 162 ~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill--------------------- 218 (392)
T PHA03207 162 CMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL--------------------- 218 (392)
T ss_pred EEEehhcCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---------------------
Confidence 9999999889999985543 68999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
+..+.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 219 ------~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 219 ------DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred ------cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 455567777777765433221 234689999999999988899999999999999999999999976532
Q ss_pred ---HHHHHHHHHHcCCCChhHH----HhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 275 ---LEHLAMMERVLGPLPQHML----KRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 275 ---~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
......+.+..+..+.... ..+......+.......++ .+. . ......+.++.+
T Consensus 293 ~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~---~--~~~~~~~~~~~~ 353 (392)
T PHA03207 293 KSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYT--------------IPP---V--IRKYGMHMDVEY 353 (392)
T ss_pred CCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCcc--------------ccc---h--hhccCcchhHHH
Confidence 2333334443333322111 1111111111111111000 000 0 001134567899
Q ss_pred HHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 348 LLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+|.+||+.||++||||.|+|+||||....
T Consensus 354 li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 354 LIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 99999999999999999999999998653
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=329.11 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=223.1
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.+...|.=++.||.|+||.||-|++..+.+.||||+++...+ .-..+.+|+..++++ .|||.+.+.++|-.
T Consensus 23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-----~HPntieYkgCyLr 97 (948)
T KOG0577|consen 23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-----RHPNTIEYKGCYLR 97 (948)
T ss_pred CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-----cCCCcccccceeec
Confidence 345566677999999999999999999999999999974322 235678899999999 78999999999999
Q ss_pred cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 116 RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 116 ~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
+...|+|||||-||..|++.-.. +++.+..+..|+.+.++||+|||+.+.||||||..|||+
T Consensus 98 e~TaWLVMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL----------------- 159 (948)
T KOG0577|consen 98 EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL----------------- 159 (948)
T ss_pred cchHHHHHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe-----------------
Confidence 99999999999888888887654 468999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC---CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
...+.+||+|||.|....+- ++++|||.|||||++.. ..|+-++||||||+++.+|+.+++|+-..
T Consensus 160 ----------se~g~VKLaDFGSAsi~~PA-nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 160 ----------SEPGLVKLADFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred ----------cCCCeeeeccccchhhcCch-hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence 66778899999988765543 56789999999999864 45999999999999999999999999999
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+.++.|.+...|.-. ..+++..++.||..|
T Consensus 229 NAMSALYHIAQNesPtLq-----------------------------------------------s~eWS~~F~~Fvd~C 261 (948)
T KOG0577|consen 229 NAMSALYHIAQNESPTLQ-----------------------------------------------SNEWSDYFRNFVDSC 261 (948)
T ss_pred hHHHHHHHHHhcCCCCCC-----------------------------------------------CchhHHHHHHHHHHH
Confidence 999999988887655421 135788999999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
|++=|.+|||++++|+|+|+.++.
T Consensus 262 LqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 262 LQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HhhCcccCCcHHHHhhcchhccCC
Confidence 999999999999999999998753
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=315.97 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=206.1
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+|++.+.||+|+||+||+|.+..+++.||+|++.... ........|+.++..+ .|++++.+.+.+..++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-----NSQFVVNLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-----CCcCceeEEEEEecCCEE
Confidence 3667789999999999999999999999999986432 2223456788888887 678999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+++|||+ +++|.+.+.......+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili-------------------- 135 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL-------------------- 135 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE--------------------
Confidence 9999999 8899988876544469999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.+..++|+|||.+....... ....|+..|+|||.+.+..++.++|+|||||++|+|++|..||.......
T Consensus 136 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~ 208 (285)
T cd05632 136 -------DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208 (285)
T ss_pred -------CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 445568888888775432211 23468999999999988889999999999999999999999998655433
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+........ . ......+.++.+|+..||+.|
T Consensus 209 ~~~~~~~~~~~~~-------------------~--------------------------~~~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05632 209 KREEVDRRVLETE-------------------E--------------------------VYSAKFSEEAKSICKMLLTKD 243 (285)
T ss_pred HHHHHHHhhhccc-------------------c--------------------------ccCccCCHHHHHHHHHHccCC
Confidence 3222221111000 0 011235678899999999999
Q ss_pred CCCCcC-----HHHHhcCCCCCCCCcC
Q 017021 357 PTDRLT-----AREALRHPFFTRDHLR 378 (379)
Q Consensus 357 P~~Rpt-----a~e~l~hp~f~~~~~~ 378 (379)
|++||+ +++++.||||....++
T Consensus 244 P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 244 PKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HhHcCCCcccChHHHHcChhhhcCCHH
Confidence 999999 8999999999886543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=321.06 Aligned_cols=252 Identities=24% Similarity=0.307 Sum_probs=211.1
Q ss_pred eeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 35 ITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
.....+....++++++||+|.||.||.|++..+ ..||+|.++...-....+.+|++++.++ .|++++++++++.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L-----~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKL-----RHEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhC-----cccCeEEEEEEEe
Confidence 445677888899999999999999999988654 3699999986666667888999999999 8899999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
.++-+||||||+ .|+|.+++....+..+...+.+.++.||++|++||+++++|||||-.+|||++
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~-------------- 337 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD-------------- 337 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec--------------
Confidence 988999999999 99999999986666899999999999999999999999999999999999995
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCCC-cc---cccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN-YI---VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 268 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~-~~---~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~p 268 (379)
.+..+||+|||+|+....+.- .. .-...|.|||.+....++.+|||||||++||||+| |+.|
T Consensus 338 -------------~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~p 404 (468)
T KOG0197|consen 338 -------------EDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVP 404 (468)
T ss_pred -------------cCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCC
Confidence 445566666666663222211 01 11346999999999999999999999999999998 9999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|.+.+..+....+.+...-+ - ++.+++++.++
T Consensus 405 y~~msn~ev~~~le~GyRlp----------------------~--------------------------P~~CP~~vY~l 436 (468)
T KOG0197|consen 405 YPGMSNEEVLELLERGYRLP----------------------R--------------------------PEGCPDEVYEL 436 (468)
T ss_pred CCCCCHHHHHHHHhccCcCC----------------------C--------------------------CCCCCHHHHHH
Confidence 99998888887776643211 1 12478899999
Q ss_pred HhhccccCCCCCcCHHHHh
Q 017021 349 LQGLLRYDPTDRLTAREAL 367 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l 367 (379)
+..||..+|++|||.+.+.
T Consensus 437 M~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 437 MKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHhhCCcccCCCHHHHH
Confidence 9999999999999998665
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=326.93 Aligned_cols=279 Identities=23% Similarity=0.368 Sum_probs=200.8
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
...|++.+.||+|+||.||+|++..+++.||+|+.... ....|..++.++ .|+|++++++++......++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNV-----NHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhC-----CCCCCcChhheEEeCCeeEE
Confidence 34689999999999999999999999999999986532 234588888887 78999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|+|++.++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 135 v~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill----------------------- 190 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI----------------------- 190 (357)
T ss_pred EEEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE-----------------------
Confidence 99999889999887643 368999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCC-CCCCch----
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL-FQTHEN---- 274 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~p-f~~~~~---- 274 (379)
+....++|+|||.+...... .....||..|+|||++.+..++.++|||||||++|+|+++..| |.....
T Consensus 191 ----~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~ 266 (357)
T PHA03209 191 ----NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266 (357)
T ss_pred ----CCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHH
Confidence 45566788888877643222 2335689999999999988899999999999999999985444 443211
Q ss_pred -----HHHHHHHHHHcCCCChhHHHh-hhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 275 -----LEHLAMMERVLGPLPQHMLKR-VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 275 -----~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
......+....+..|...... .......+.... .....+.... ........+.++.+|
T Consensus 267 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~-~~~~~~~~~~~~~~l 330 (357)
T PHA03209 267 YVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYA---------------SLERQPYTRY-PCFQRVNLPIDGEFL 330 (357)
T ss_pred HHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhc---------------ccCCCccccc-HHHhccCCCchHHHH
Confidence 111112222223222211100 000000000000 0000000000 000011345678899
Q ss_pred HhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
|.+||+.||.+||||.|+|+||||++
T Consensus 331 i~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 331 VHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHcCCcccCcCHHHHhcCchhcc
Confidence 99999999999999999999999985
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.72 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=199.2
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee------
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------ 115 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~------ 115 (379)
.-.|++.+.||+|+||.||+|.++.+++.||+|++.........+..|+..+..+ .+|+|++++.+.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~----~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKY----SHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHh----cCCCCeeeEeeEEeecCCCCC
Confidence 3468889999999999999999999999999999976555556677788887776 257899999998864
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
....|++|||+ +++|.+++.......+++..+..++.|++.||+|||+.+++|+|++|+||+++
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~--------------- 145 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT--------------- 145 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC---------------
Confidence 34689999999 88999999875545689999999999999999999999999999999999994
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHhCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
.+..++|+|||.+..... ......|+..|+|||++. +..++.++|+|||||++|+|++|.
T Consensus 146 ------------~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~ 213 (272)
T cd06637 146 ------------ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 213 (272)
T ss_pred ------------CCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 445677777777654322 123356888999999986 335788999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||...........+... . .... .....+.++.
T Consensus 214 ~p~~~~~~~~~~~~~~~~--~--------------------~~~~-------------------------~~~~~~~~~~ 246 (272)
T cd06637 214 PPLCDMHPMRALFLIPRN--P--------------------APRL-------------------------KSKKWSKKFQ 246 (272)
T ss_pred CCccccCHHHHHHHHhcC--C--------------------CCCC-------------------------CCCCcCHHHH
Confidence 999654332221111100 0 0000 0113456899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
+|+.+||..||.+|||+.|++.||||
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 247 SFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=313.64 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=213.5
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
...+..-|.|+++||+|+||.||+|.++++|+.+|||.+.- +..-+++.+|+.++++. ..+.+|++++.+-...
T Consensus 28 ~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC-----~S~yVVKYYGSYFK~s 101 (502)
T KOG0574|consen 28 NKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQC-----KSKYVVKYYGSYFKHS 101 (502)
T ss_pred cCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHc-----CCchhhhhhhhhccCC
Confidence 34567789999999999999999999999999999999973 45567888999999997 7799999999999889
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
.+|+||||| .|++.+++.... +++++.++..++..-++||+|||...=+|||||..|||++
T Consensus 102 DLWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN----------------- 163 (502)
T KOG0574|consen 102 DLWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN----------------- 163 (502)
T ss_pred ceEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc-----------------
Confidence 999999999 799999998765 5799999999999999999999999999999999999995
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
.++..||+|||.|...... .++..||+.|+|||++....|..++||||||++..||+.|++||..-.
T Consensus 164 ----------T~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 164 ----------TDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred ----------ccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 4555666666666543322 356789999999999999999999999999999999999999996543
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
+.-.. .-..-.+|+.+. -++.++.++.|||++||
T Consensus 234 PMRAI---FMIPT~PPPTF~-------------------------------------------KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 234 PMRAI---FMIPTKPPPTFK-------------------------------------------KPEEWSSEFNDFIRSCL 267 (502)
T ss_pred cccee---EeccCCCCCCCC-------------------------------------------ChHhhhhHHHHHHHHHh
Confidence 32111 111111111110 01347889999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.++|++|.||-++++|||++..
T Consensus 268 iK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 268 IKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred cCCHHHHHHHHHHhhhhhhcCC
Confidence 9999999999999999999864
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=320.89 Aligned_cols=255 Identities=26% Similarity=0.394 Sum_probs=199.4
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||.||+++++.+++.||+|++.... .....+..|..++..+ +|++++.+++.+.+++++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~ 76 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-----DRRWITNLHYAFQDENNL 76 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCCCceEEEEecCCeE
Confidence 5788999999999999999999999999999997422 1223355677766665 778999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.+.. ..+++..+..++.||+.||+|||+.|++||||||+||++
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill-------------------- 135 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL-------------------- 135 (331)
T ss_pred EEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE--------------------
Confidence 9999999 999999997643 358999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhC-----CCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
..++.++|+|||.+....... ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||
T Consensus 136 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf 208 (331)
T cd05597 136 -------DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208 (331)
T ss_pred -------CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCC
Confidence 455678888888875433222 22468999999999863 34788999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
...+..+....+...... ...+. .....+..++++|
T Consensus 209 ~~~~~~~~~~~i~~~~~~---------------------~~~~~-----------------------~~~~~~~~~~~li 244 (331)
T cd05597 209 YAESLVETYGKIMNHKEH---------------------FQFPP-----------------------DVTDVSEEAKDLI 244 (331)
T ss_pred CCCCHHHHHHHHHcCCCc---------------------ccCCC-----------------------ccCCCCHHHHHHH
Confidence 876554443332211100 00000 0112567899999
Q ss_pred hhccccCCCC--CcCHHHHhcCCCCCCC
Q 017021 350 QGLLRYDPTD--RLTAREALRHPFFTRD 375 (379)
Q Consensus 350 ~~~L~~dP~~--Rpta~e~l~hp~f~~~ 375 (379)
++||..++.+ |+++.++++||||.+.
T Consensus 245 ~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 245 RRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 9988664444 8899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=320.72 Aligned_cols=264 Identities=25% Similarity=0.393 Sum_probs=221.9
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeec----cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
+...-.|+..++||+||||.||-+.-+.||+.+|.|.+.+ ......-++.|.+++..+ +.+.||.+-..|+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-----~s~FiVslaYAfe 255 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-----SSPFIVSLAYAFE 255 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-----ccCcEEEEeeeec
Confidence 3344455666999999999999999999999999999853 234556677899999998 6678999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
+.+.+|+|+..| ||+|.-.+.+.++..+++..++.++.+|+.||++||..+|+.||+||+|||+
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL--------------- 320 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL--------------- 320 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---------------
Confidence 999999999999 9999999998887789999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+..+.++|.|+|+|....... ...+||.+|||||++.+..|+...|.|||||+||+|+.|+.||..
T Consensus 321 ------------Dd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 321 ------------DDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred ------------ccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 666778888888886443333 345899999999999999999999999999999999999999976
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.......+.+.+-.. +...++.+..|++++++++.
T Consensus 389 ~KeKvk~eEvdrr~~---------------------------------------------~~~~ey~~kFS~eakslc~~ 423 (591)
T KOG0986|consen 389 RKEKVKREEVDRRTL---------------------------------------------EDPEEYSDKFSEEAKSLCEG 423 (591)
T ss_pred hhhhhhHHHHHHHHh---------------------------------------------cchhhcccccCHHHHHHHHH
Confidence 544333323322211 22234456789999999999
Q ss_pred ccccCCCCCc-----CHHHHhcCCCCCCCCcCC
Q 017021 352 LLRYDPTDRL-----TAREALRHPFFTRDHLRR 379 (379)
Q Consensus 352 ~L~~dP~~Rp-----ta~e~l~hp~f~~~~~~~ 379 (379)
+|++||.+|. +++++-+||||+..+.||
T Consensus 424 LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 424 LLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred HHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 9999999998 688999999999998876
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=322.08 Aligned_cols=289 Identities=26% Similarity=0.432 Sum_probs=221.4
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--- 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--- 116 (379)
..|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.++..+ .|+|++++++++...
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-----NHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-----CCCCCcceeeeeccCCCc
Confidence 4588889999999999999999999999999998632 22334556788888887 779999999887543
Q ss_pred ---ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 117 ---NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 117 ---~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
...|+||||+.++|.+.+.. .++...+..++.|++.||+|||+.|++||||||+||++
T Consensus 91 ~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~--------------- 151 (353)
T cd07850 91 EEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--------------- 151 (353)
T ss_pred cccCcEEEEEeccCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---------------
Confidence 35799999998899988865 28889999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 152 ------------~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 152 ------------KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred ------------CCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 455567777887776543322 234578899999999998999999999999999999999999998
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+.......+....+.++.++...+......+....... ... ...+......... .........+..+.++|.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~ 293 (353)
T cd07850 220 TDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKY-AGY-SFEELFPDVLFPP----DSESHNKLKASQARDLLSK 293 (353)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCC-CCc-chhhhCcccccCc----ccccccccchhHHHHHHHH
Confidence 887777778888888888888777666555554332110 000 0000000000000 0000022356778999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~ 373 (379)
||+.||++|||+.|+|.||||+
T Consensus 294 ~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 294 MLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HcCCChhhCcCHHHHhcChhHh
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.10 Aligned_cols=278 Identities=35% Similarity=0.578 Sum_probs=217.4
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.+.||+|++|.||+|.+..+|+.||+|++.... .....+..|+.+++++ .|++++++++++..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-----QHPYVVKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-----CCCCCcceeeEEecCCeeE
Confidence 4788999999999999999999999999999987432 2345667788888877 5799999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|+||++++|.+++.... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++
T Consensus 76 ~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~--------------------- 133 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS--------------------- 133 (286)
T ss_pred EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---------------------
Confidence 999999999999987654 4689999999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
.++.++|+|||.+....... ....|+..|+|||.+.+. .++.++|||||||++|+|++|.+||.+....
T Consensus 134 ------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~ 207 (286)
T cd07832 134 ------ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI 207 (286)
T ss_pred ------CCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH
Confidence 45567778887766443322 234678899999988654 4689999999999999999999999887777
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+....+.+....|+...+..+. +...++... + ..........+.++.++|++||+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~------------~---~~~~~~~~~~~~~~~~li~~~l~~ 268 (286)
T cd07832 208 EQLAIVFRTLGTPNEETWPGLTSLPDY----NKITFPESK------------P---IPLEEIFPDASPEALDLLKGLLVY 268 (286)
T ss_pred HHHHHHHHHcCCCChHHHhhccCcchh----hcccCCCCC------------c---chHHHhCCCccHHHHHHHHHHhcc
Confidence 777777776666665555443221111 001111000 0 001122234568899999999999
Q ss_pred CCCCCcCHHHHhcCCCCC
Q 017021 356 DPTDRLTAREALRHPFFT 373 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~ 373 (379)
||.+|||++++++||||.
T Consensus 269 ~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 269 DPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ChhhCCCHHHHhhCcCcC
Confidence 999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=348.27 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=220.5
Q ss_pred eeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeec----cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 37 YIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 37 ~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
-.-.....|.|++.||+|+||.|.+++.+.|++.||+|++++ .......+..|..++..- +...|+.++..
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-----ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-----NSEWIVQLHYA 143 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-----CcHHHHHHHHH
Confidence 344567789999999999999999999999999999999975 233456777888887765 67889999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
|.+++++|+||||+ ||+|..++.+.. .+++..++.|+.+|+.||.-||+.|+|||||||+|||+
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl------------- 208 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL------------- 208 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe-------------
Confidence 99999999999999 999999999876 79999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhC-----CCCCCccchHhHHHHHHHH
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~~l 262 (379)
+..++++|+|||.+...+.++ ...+|||.|++||++.. ..|+..+|+||+||++|||
T Consensus 209 --------------d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEM 274 (1317)
T KOG0612|consen 209 --------------DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEM 274 (1317)
T ss_pred --------------cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHH
Confidence 778888999999887766554 45689999999999963 3589999999999999999
Q ss_pred HhCCCCCCCCchHHHHHHHHHH--cCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc
Q 017021 263 CTGEALFQTHENLEHLAMMERV--LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 263 ~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (379)
+.|..||+..+-.++...|... .-.+|++ ..
T Consensus 275 lyG~TPFYadslveTY~KIm~hk~~l~FP~~-----------------------------------------------~~ 307 (1317)
T KOG0612|consen 275 LYGETPFYADSLVETYGKIMNHKESLSFPDE-----------------------------------------------TD 307 (1317)
T ss_pred HcCCCcchHHHHHHHHHHHhchhhhcCCCcc-----------------------------------------------cc
Confidence 9999999988887777766654 2222211 23
Q ss_pred chhHHHHHHhhccccCCCCCcC---HHHHhcCCCCCCCC
Q 017021 341 SAGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTRDH 376 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rpt---a~e~l~hp~f~~~~ 376 (379)
+|.++++||++.+ -+|+.|.. ++++-.||||.+.+
T Consensus 308 VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 308 VSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred cCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCC
Confidence 7889999999855 57888887 99999999999865
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=319.16 Aligned_cols=303 Identities=18% Similarity=0.250 Sum_probs=201.9
Q ss_pred hhhhccccc--cceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 46 KIHSKMGEG--TFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 46 ~i~~~Lg~G--~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
+++++||+| +|++||++.++.+|+.||+|+++.. .........|+.+++.+ +|+||+++++++..++..+
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~hpniv~~~~~~~~~~~~~ 75 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-----NHPNIVPYRATFIADNELW 75 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEEECCEEE
Confidence 367899999 7899999999999999999999743 22334555688877777 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.+++.||+.....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~---- 151 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM---- 151 (327)
T ss_pred EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcc----
Confidence 999999 899999997654446899999999999999999999999999999999999977766666666533211
Q ss_pred cccccCCCCCCeEEeecCcccc-cCCCCCcccccCCccchhhhhC--CCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTY-ERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+++|.... .........++..|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 152 --------------~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 217 (327)
T cd08227 152 --------------INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217 (327)
T ss_pred --------------ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 11111110 0001122346778999999876 458899999999999999999999997654433
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccC-CCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
.... ...+..+... .......+...... ............... ..................++.+.+||++||+.
T Consensus 218 ~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 293 (327)
T cd08227 218 MLLE--KLNGTVPCLL-DTTTIPAEELTMKPSRSGANSGLGESTTVS-TPRPSNGESSSHPYNRTFSPHFHHFVEQCLQR 293 (327)
T ss_pred HHHH--HhcCCccccc-cccchhhhhcccCCcccCCcCCCCcccccC-CcCccccCCcccccccccCHHHHHHHHHHHhh
Confidence 2211 1112221110 00000000000000 000000000000000 00000000111112334577899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~ 375 (379)
||++|||++|+++||||++.
T Consensus 294 dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 294 NPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred CchhcCCHHHHhcChhhhhc
Confidence 99999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=310.20 Aligned_cols=277 Identities=27% Similarity=0.461 Sum_probs=210.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.+.||+|++|.||+|.++.+++.||+|.+..... ......+|+.++..+ .|++++++++++.+.+..++
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-----KHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-----CCcceeeEEEEEecCCeEEE
Confidence 57788999999999999999999999999999864321 223456789999888 67999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
||||++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 81 v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~---------------------- 137 (291)
T cd07844 81 VFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS---------------------- 137 (291)
T ss_pred EEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc----------------------
Confidence 99999779999887654 2588999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCc-hHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE-NLE 276 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~-~~~ 276 (379)
.++.++|+|||.+....... ....++..|+|||.+.+ ..++.++||||+||++|+|++|..||.... ..+
T Consensus 138 -----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~ 212 (291)
T cd07844 138 -----ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED 212 (291)
T ss_pred -----CCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 44556777777664332211 12246788999999865 457899999999999999999999997655 455
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccch--hHHHHHHhhccc
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA--GDLTHLLQGLLR 354 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~ 354 (379)
....+.+..+.+.+..+..+............. . .... ......... ..+.+++.+||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~----~~~~-------------~~~~~~~~~~~~~~~~li~~~L~ 273 (291)
T cd07844 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPF--Y----PPRP-------------LINHAPRLDRIPHGEELALKFLQ 273 (291)
T ss_pred HHHHHHHhcCCCChhhhhhhhhccccccccccc--c----CChh-------------HHHhCcCCCCchhHHHHHHHHhc
Confidence 555566667766666655544322111111000 0 0000 011111223 678999999999
Q ss_pred cCCCCCcCHHHHhcCCCC
Q 017021 355 YDPTDRLTAREALRHPFF 372 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f 372 (379)
.||++|||++++++||||
T Consensus 274 ~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 274 YEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cCcccccCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=315.49 Aligned_cols=282 Identities=29% Similarity=0.437 Sum_probs=216.6
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch---hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec--c
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--N 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--~ 117 (379)
..|++.+.||.|+||.||+|.++.+|+.||+|++..... ......+|+.++.++ .|++++++++++... +
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-----RHPNIVELKEVVVGKHLD 81 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-----CCCCCcceEEEEecCCCC
Confidence 467888999999999999999999999999999874321 223445688888887 678999999988654 5
Q ss_pred eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 118 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 118 ~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
..++||||++++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~------------------ 142 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT------------------ 142 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC------------------
Confidence 689999999889999987643 3689999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
..+.++|+|||.+....... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+
T Consensus 143 ---------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 143 ---------DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred ---------CCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 44556777777665433221 22245778999999865 457899999999999999999999999888
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+....+..+..+|+.+...... +....+.... +.........+.++.++|.+||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~ml 274 (309)
T cd07845 214 EIEQLDLIIQLLGTPNESIWPGFSDLPLV----GKFTLPKQPY---------------NNLKHKFPWLSEAGLRLLNFLL 274 (309)
T ss_pred HHHHHHHHHHhcCCCChhhchhhhccccc----ccccccCCCC---------------CchHHhccccCHHHHHHHHHHh
Confidence 88888888888777776666554332110 0011100000 0001111234678899999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+.||++|||+.|+++||||.+..
T Consensus 275 ~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 275 MYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred cCChhhCcCHHHHhcChhhccCC
Confidence 99999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=312.62 Aligned_cols=279 Identities=28% Similarity=0.449 Sum_probs=213.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch------hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
.|++.+.||+|++|.||+|.+..+++.||+|++..... ....+..|+.++..+ .|++++++++++.+++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-----KHPNIIGLLDVFGHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-----CCCCChhhhheeecCC
Confidence 36778999999999999999999999999999974322 234455688888777 6799999999999999
Q ss_pred eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 118 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 118 ~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
..++||||++++|.+++.... ..+++..+..++.||+.||.|||+.|++||||+|+||+++
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~------------------ 136 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA------------------ 136 (298)
T ss_pred EEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc------------------
Confidence 999999999889999997654 3689999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
.++.++|+|||.+....... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+
T Consensus 137 ---------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 137 ---------SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred ---------CCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 44556667777665433221 22346778999998865 457899999999999999999988888777
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.+..+.+....+................. ..........+..+.++|.+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~li~~~l 266 (298)
T cd07841 208 DIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPP---------------------TPLKQIFPAASDDALDLLQRLL 266 (298)
T ss_pred cHHHHHHHHHHcCCCchhhhhhcccccccccccccCC---------------------cchhhhcccccHHHHHHHHHHh
Confidence 7666666666666555554443222111110000000 0011122345678999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+.||++|||++|++.||||++..
T Consensus 267 ~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 267 TLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cCCcccCcCHHHHhhCccccCCC
Confidence 99999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=276.49 Aligned_cols=278 Identities=29% Similarity=0.484 Sum_probs=228.8
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|.-.++||+|.||+||+|++++|++.||+|++..+ +.....+.+|+-++..+ .|.||+++++...+++.+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-----khknivrl~dvlhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLHDVLHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-----hhcceeehhhhhccCceeE
Confidence 456679999999999999999999999999999743 34567888999999998 6789999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|+|||.-+|..++++..+ .+..+.++.++.|++.||.|+|++++.|||+||+|.++
T Consensus 78 lvfe~cdqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---------------------- 134 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---------------------- 134 (292)
T ss_pred EeHHHhhHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe----------------------
Confidence 9999999999999988653 58999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCCCC---cccccCCccchhhhhCCC-CCCccchHhHHHHHHHHHh-CCCCCCCCchH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQN---YIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCT-GEALFQTHENL 275 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~ 275 (379)
..++.+|++|||+++-++-+-. .-+.|..|.+|.++.+.+ |+...|+||.|||+.|+.. |.+.|.+.+..
T Consensus 135 -----n~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd 209 (292)
T KOG0662|consen 135 -----NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_pred -----ccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence 5666777888887775554432 235688899999998865 7788999999999999986 88889999999
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
++..++.+.+|.+.++.|+.+....+.-. ...+|...++.+. .+..+..-+|+++++|.-
T Consensus 210 dqlkrif~~lg~p~ed~wps~t~lpdyk~---yp~ypattswsqi-----------------vp~lns~grdllqkll~c 269 (292)
T KOG0662|consen 210 DQLKRIFRLLGTPTEDQWPSMTKLPDYKP---YPIYPATTSWSQI-----------------VPKLNSTGRDLLQKLLKC 269 (292)
T ss_pred HHHHHHHHHhCCCccccCCccccCCCCcc---cCCccccchHHHH-----------------hhhhcchhHHHHHHHhcc
Confidence 99999999999999998886554332210 0111111111111 123456678999999999
Q ss_pred CCCCCcCHHHHhcCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~ 374 (379)
+|.+|++|+.+++||||.+
T Consensus 270 np~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 270 NPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CcccccCHHHHhcCccccc
Confidence 9999999999999999986
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=308.03 Aligned_cols=275 Identities=32% Similarity=0.533 Sum_probs=212.1
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec--ceEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHIC 120 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--~~~~ 120 (379)
|++.++||+|+||.||+|.+..+++.||+|+++.... .......|+..+.++ .+|+|++++++++.++ +..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l----~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRL----SPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhc----CCCCCccceEEEEecCCCCcEE
Confidence 6788999999999999999999999999999874321 222334566666665 2478999999999887 8999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||||+.++|.+.+.... ..+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 77 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---------------------- 133 (282)
T cd07831 77 LVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---------------------- 133 (282)
T ss_pred EEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE----------------------
Confidence 999999778888887643 368999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
+. +.++|+|||.+....... ....++..|+|||.+.. ..++.++|+|||||++|+|++|..||.+.+..+.
T Consensus 134 -----~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~ 207 (282)
T cd07831 134 -----KD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207 (282)
T ss_pred -----cC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH
Confidence 34 668888888776443222 23457889999997654 4578999999999999999999999998888887
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+....+..++.+......... ....++.. ............+.++.++|.+||+.||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~l~~~P 267 (282)
T cd07831 208 IAKIHDVLGTPDAEVLKKFRKSRH-----MNYNFPSK---------------KGTGLRKLLPNASAEGLDLLKKLLAYDP 267 (282)
T ss_pred HHHHHHHcCCCCHHHHHhhccccc-----ccccCccc---------------ccccHHHHcccccHHHHHHHHHHhccCc
Confidence 777878788777765332211100 00111110 0011122223467899999999999999
Q ss_pred CCCcCHHHHhcCCCC
Q 017021 358 TDRLTAREALRHPFF 372 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f 372 (379)
++|||++++++||||
T Consensus 268 ~~R~~~~~~l~~~~~ 282 (282)
T cd07831 268 DERITAKQALRHPYF 282 (282)
T ss_pred ccccCHHHHhhCCCC
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=311.34 Aligned_cols=250 Identities=28% Similarity=0.453 Sum_probs=208.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|++|.||++.+..+++.||+|++.... ........|++++.++ +|+|++++++.+..++..
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 76 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-----RHPFLVNLYGSFQDDSNL 76 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCccceeeEEEcCCeE
Confidence 4788899999999999999999999999999987432 2345566788888887 689999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.... .++...+..++.|++.||.|||+.|++||||+|+||++
T Consensus 77 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili-------------------- 134 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL-------------------- 134 (290)
T ss_pred EEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE--------------------
Confidence 9999999 999999998764 68999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
+.++.++|+|||.+...........|++.|+|||.+.+...+.++|+||||+++|+|++|..||...+..+..
T Consensus 135 -------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 207 (290)
T cd05580 135 -------DSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY 207 (290)
T ss_pred -------CCCCCEEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4556688888888776555444557889999999998888889999999999999999999999876543333
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+.....+.| ...+..+.++|.+||+.||.
T Consensus 208 ~~~~~~~~~~~-------------------------------------------------~~~~~~l~~li~~~l~~~p~ 238 (290)
T cd05580 208 EKILEGKVRFP-------------------------------------------------SFFSPDAKDLIRNLLQVDLT 238 (290)
T ss_pred HHHhcCCccCC-------------------------------------------------ccCCHHHHHHHHHHccCCHH
Confidence 22221111111 12457889999999999999
Q ss_pred CCc-----CHHHHhcCCCCCCCC
Q 017021 359 DRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 359 ~Rp-----ta~e~l~hp~f~~~~ 376 (379)
+|+ +++|+++||||....
T Consensus 239 ~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 239 KRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HccCcccCCHHHHHcCcccccCC
Confidence 999 999999999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=308.15 Aligned_cols=258 Identities=24% Similarity=0.429 Sum_probs=203.9
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
...|++.+.||+|+||.||++.+..++..+|+|.+... ......+..|+.++..+ .|+|++.+++.+..++..+
T Consensus 4 ~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~ii~~~~~~~~~~~~~ 78 (282)
T cd06643 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-----DHPNIVKLLDAFYYENNLW 78 (282)
T ss_pred HHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-----CCCCeeeEEEEEeeCCEEE
Confidence 34589999999999999999999999999999998643 23345566788888877 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+|+||+ +++|..++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 79 ~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~-------------------- 137 (282)
T cd06643 79 ILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT-------------------- 137 (282)
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc--------------------
Confidence 999999 889988876533 3689999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
.++.++|+|||.+...... .....++..|+|||.+. +..++.++|+|||||++|+|++|+.||..
T Consensus 138 -------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 138 -------LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred -------cCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 4455666777666432211 12346888999999974 34577899999999999999999999987
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+..+....+.....+.. .....++.++.++|.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~ 244 (282)
T cd06643 211 LNPMRVLLKIAKSEPPTL----------------------------------------------AQPSRWSSEFKDFLKK 244 (282)
T ss_pred cCHHHHHHHHhhcCCCCC----------------------------------------------CCccccCHHHHHHHHH
Confidence 665443333222111100 0012356789999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCCCcC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~~~~ 378 (379)
||+.||.+|||++++++||||+....+
T Consensus 245 ~l~~~p~~Rp~~~~il~~~~~~~~~~~ 271 (282)
T cd06643 245 CLEKNVDARWTTTQLLQHPFVTVNSNK 271 (282)
T ss_pred HccCChhhCcCHHHHhcCCCEeccCCC
Confidence 999999999999999999999876543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.13 Aligned_cols=256 Identities=24% Similarity=0.384 Sum_probs=199.6
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.++||+|+||.||+++++.+++.||+|++.... .....+..|..++..+ +|++++.+++.+.+.+..
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~ 76 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-----DNQWITTLHYAFQDENNL 76 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-----CCCCEeeEEEEEecCCEE
Confidence 5788899999999999999999999999999986422 1122344566665554 778999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili-------------------- 135 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM-------------------- 135 (332)
T ss_pred EEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE--------------------
Confidence 9999999 999999997643 258999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.++.++|+|||.+....... ....||+.|+|||++. ...++.++|||||||++|+|++|+.||
T Consensus 136 -------~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf 208 (332)
T cd05623 136 -------DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208 (332)
T ss_pred -------CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCC
Confidence 455667888888775432211 2346899999999986 345789999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
...+..+....+...... ..+|. .....+.++.+||
T Consensus 209 ~~~~~~~~~~~i~~~~~~---------------------~~~p~-----------------------~~~~~s~~~~~li 244 (332)
T cd05623 209 YAESLVETYGKIMNHKER---------------------FQFPA-----------------------QVTDVSEDAKDLI 244 (332)
T ss_pred CCCCHHHHHHHHhCCCcc---------------------ccCCC-----------------------ccccCCHHHHHHH
Confidence 876655544333221100 00110 0123567899999
Q ss_pred hhccccCCCC--CcCHHHHhcCCCCCCCC
Q 017021 350 QGLLRYDPTD--RLTAREALRHPFFTRDH 376 (379)
Q Consensus 350 ~~~L~~dP~~--Rpta~e~l~hp~f~~~~ 376 (379)
++||..+|.+ |++++|+++||||.+..
T Consensus 245 ~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 245 RRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred HHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 9999765555 78999999999998753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=307.66 Aligned_cols=277 Identities=31% Similarity=0.582 Sum_probs=208.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.+.||+|++|.||+|.++.+++.||+|++.... .....+..|+.++.++ .|+|++.+++.+......+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~ 76 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-----KHPNLVNLIEVFRRKRKLH 76 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-----CCCCEeeeeeEEeeCCEEE
Confidence 4788899999999999999999999999999986432 2234566788888887 6799999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|..++.... .+++..+..++.|++.||+|||+.|++||||||+||+++
T Consensus 77 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~-------------------- 134 (286)
T cd07847 77 LVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT-------------------- 134 (286)
T ss_pred EEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc--------------------
Confidence 999999 666666655433 589999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
.++.++|+|||.+....... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+....
T Consensus 135 -------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~ 207 (286)
T cd07847 135 -------KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV 207 (286)
T ss_pred -------CCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 44556777777665433322 22357788999999876 45789999999999999999999999987776
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.+..+............. .+... ...+. +.............+..+.+||.+||+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~ 269 (286)
T cd07847 208 DQLYLIRKTLGDLIPRHQQIFSTN--QFFKG--LSIPE--------------PETREPLESKFPNISSPALSFLKGCLQM 269 (286)
T ss_pred HHHHHHHHHhCCCChHHhhhcccc--ccccc--ccCCC--------------cccccCHHHHhccCCHHHHHHHHHHhcC
Confidence 766666666655543322111000 00000 00000 0000011122334578899999999999
Q ss_pred CCCCCcCHHHHhcCCCC
Q 017021 356 DPTDRLTAREALRHPFF 372 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f 372 (379)
||++|||+.|++.||||
T Consensus 270 ~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 270 DPTERLSCEELLEHPYF 286 (286)
T ss_pred CccccCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=328.38 Aligned_cols=278 Identities=27% Similarity=0.361 Sum_probs=200.2
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
....|++.+.||+|+||.||+|.+..+++.||+|.... ....+|+.++.++ .|+||+++++++..++..+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L-----~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRL-----SHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHC-----CCCCCCcEEEEEEECCEEE
Confidence 45568899999999999999999999999999996432 2345799999988 7899999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||+++.++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 237 lv~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~--------------------- 294 (461)
T PHA03211 237 LVLPKYRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN--------------------- 294 (461)
T ss_pred EEEEccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC---------------------
Confidence 999999889999887643 3689999999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc--
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE-- 273 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~-- 273 (379)
.+..++|+|||++....... ....||..|+|||++.+..++.++|||||||++|+|++|..|+....
T Consensus 295 ------~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~ 368 (461)
T PHA03211 295 ------GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRG 368 (461)
T ss_pred ------CCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcc
Confidence 44556777777665332211 12468999999999999899999999999999999999876553321
Q ss_pred ------hHHHHHHHHHHcC---CCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 274 ------NLEHLAMMERVLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 274 ------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
.......+.+... ..+......+................ ..+... .....+.+
T Consensus 369 ~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-------------~~~~~~-----~~~~~~~~ 430 (461)
T PHA03211 369 DERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAY-------------TRPAWT-----RYYKLDLD 430 (461)
T ss_pred cccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCcc-------------CCcchh-----hhccccch
Confidence 1112222222111 11111000000000000000000000 000000 01134567
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 431 ~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 431 VEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 999999999999999999999999999975
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.61 Aligned_cols=252 Identities=22% Similarity=0.222 Sum_probs=204.2
Q ss_pred hhhhhhhccccccceeEEEEEecCC-CceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~-~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
..|++.+.||+|++|.||+|.+..+ ++.||+|.+.... .....+..|+.++..+ +|+||+++++.+..+++.|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-----~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-----DHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEEECCEEE
Confidence 3488999999999999999998877 7889999875432 2334556688888877 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+||||+ +++|.+.+... ....+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll------------------- 202 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL------------------- 202 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE-------------------
Confidence 999999 99999888642 22358899999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+..+.++|+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 203 --------~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 203 --------MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred --------CCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 45566788888877654322 13346899999999999888999999999999999999999999876
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+......+ .....+.++.++|.+|
T Consensus 275 ~~~~~~~~~~~~~~~~------------------------------------------------~~~~~s~~~~~li~~~ 306 (478)
T PTZ00267 275 SQREIMQQVLYGKYDP------------------------------------------------FPCPVSSGMKALLDPL 306 (478)
T ss_pred CHHHHHHHHHhCCCCC------------------------------------------------CCccCCHHHHHHHHHH
Confidence 6544443322211000 0113567899999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
|+.||++|||+++++.|||++.
T Consensus 307 L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 307 LSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred hccChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999999853
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=318.84 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=200.4
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.++||+|+||.||+++++.+++.||+|++.... .....+..|..++..+ .|++++.+++.+..++..
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~l~~~~~~~~~~ 76 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-----DCQWITTLHYAFQDENYL 76 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCEE
Confidence 4788999999999999999999999999999987422 1223345566666555 779999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill-------------------- 135 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL-------------------- 135 (331)
T ss_pred EEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE--------------------
Confidence 9999999 999999997743 258999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhC-----CCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||
T Consensus 136 -------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf 208 (331)
T cd05624 136 -------DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208 (331)
T ss_pred -------cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCc
Confidence 455668888888776443322 22468999999999875 45788999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
...+..+....+...... .+++. .....+..++++|
T Consensus 209 ~~~~~~~~~~~i~~~~~~---------------------~~~p~-----------------------~~~~~~~~~~~li 244 (331)
T cd05624 209 YAESLVETYGKIMNHEER---------------------FQFPS-----------------------HITDVSEEAKDLI 244 (331)
T ss_pred cCCCHHHHHHHHHcCCCc---------------------ccCCC-----------------------ccccCCHHHHHHH
Confidence 876654443332221100 00110 0123567899999
Q ss_pred hhccccCCCC--CcCHHHHhcCCCCCCCC
Q 017021 350 QGLLRYDPTD--RLTAREALRHPFFTRDH 376 (379)
Q Consensus 350 ~~~L~~dP~~--Rpta~e~l~hp~f~~~~ 376 (379)
.+||..++.+ |++++++++||||+..+
T Consensus 245 ~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 245 QRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred HHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 9999876655 56999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=305.43 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=199.9
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch------hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
.|++.+.||+|++|.||.|.+..+++.||+|.+..... ....+..|+.++.++ .|+++++++++++.+.
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~ 77 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-----QHERIVQYYGCLRDDE 77 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-----CCCCeeeeEEEEccCC
Confidence 57889999999999999999999999999999863221 223456677777777 7899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..++++||+ +++|.+.+.... .++...+..++.|++.||.|||+.|++||||+|+||++
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv------------------ 137 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR------------------ 137 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE------------------
Confidence 999999999 899999998754 58899999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+.++.++|+|||.+....... ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.
T Consensus 138 ---------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 208 (263)
T cd06625 138 ---------DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA 208 (263)
T ss_pred ---------cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 445567777777765332211 22357788999999998889999999999999999999999997
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
..+..+............ ......+..+.++|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~li~ 241 (263)
T cd06625 209 EFEAMAAIFKIATQPTNP-----------------------------------------------QLPSHVSPDARNFLR 241 (263)
T ss_pred ccchHHHHHHHhccCCCC-----------------------------------------------CCCccCCHHHHHHHH
Confidence 654433322211110000 011235678999999
Q ss_pred hccccCCCCCcCHHHHhcCCCC
Q 017021 351 GLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f 372 (379)
+||..||.+|||+.|+++||||
T Consensus 242 ~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 242 RTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=307.93 Aligned_cols=279 Identities=28% Similarity=0.451 Sum_probs=216.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec--c
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--N 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--~ 117 (379)
..|++.+.||+|+||.||+|.++.+++.+|+|.++... .....+.+|+.++.++ .|+|++.+.+++... +
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-----QHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-----CCCCEEEEEEEEEecCCC
Confidence 36889999999999999999999999999999997432 2223456788888888 679999999998877 8
Q ss_pred eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 118 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 118 ~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
..|+|+||++++|.+++.... ..+++..+..++.||+.||+|||+.|++||||+|+||++
T Consensus 80 ~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili------------------- 139 (293)
T cd07843 80 KIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL------------------- 139 (293)
T ss_pred cEEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE-------------------
Confidence 999999999779999987754 258999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCC-CCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+....... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||....
T Consensus 140 --------~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 140 --------NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred --------CCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 445567778887766433321 2245788899999987644 6899999999999999999999999888
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc-chhHHHHHHhhc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGL 352 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~ 352 (379)
..+....+....+.++...|..+........ ....... .......+... .+..+.++|++|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----------------~~~~~~~~~~~~~~~~~~~li~~~ 273 (293)
T cd07843 212 EIDQLNKIFKLLGTPTEKIWPGFSELPGAKK--KTFTKYP----------------YNQLRKKFPALSLSDNGFDLLNRL 273 (293)
T ss_pred hHHHHHHHHHHhCCCchHHHHHhhccchhcc--ccccccc----------------chhhhccccccCCChHHHHHHHHH
Confidence 7777777777777777766665432111100 0000000 00000011111 467899999999
Q ss_pred cccCCCCCcCHHHHhcCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f 372 (379)
|+.||++|||++|++.||||
T Consensus 274 l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 274 LTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hccCccccCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=307.59 Aligned_cols=253 Identities=25% Similarity=0.421 Sum_probs=199.0
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee------e
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD------Y 115 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~------~ 115 (379)
.-.|++.+.||+|+||.||+|.+..+++.+|+|++............|+.++.++ .+|+|++++++++. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~----~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKY----SHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHh----cCCCcEEEEeeehhcccccCC
Confidence 3468889999999999999999999999999999876544445566677777776 25789999998885 2
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
....|++|||+ +++|.+++.......+++..+..++.||+.||+|||+.|++|+|++|+||++
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---------------- 154 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---------------- 154 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----------------
Confidence 46899999999 7899999987554568899999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHhCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
+.++.++|+|||.+..... ......|+..|+|||.+. ...++.++|+|||||++|+|++|.
T Consensus 155 -----------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~ 223 (282)
T cd06636 155 -----------TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223 (282)
T ss_pred -----------CCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC
Confidence 4455678888887754322 123356889999999875 345788999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||......+....+.+. ..+ .. ....++..+.
T Consensus 224 ~p~~~~~~~~~~~~~~~~--~~~--------------------~~-------------------------~~~~~~~~~~ 256 (282)
T cd06636 224 PPLCDMHPMRALFLIPRN--PPP--------------------KL-------------------------KSKKWSKKFI 256 (282)
T ss_pred CCccccCHHhhhhhHhhC--CCC--------------------CC-------------------------cccccCHHHH
Confidence 999754432222111110 000 00 0013567899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
++|++||+.||.+|||+.|+++||||
T Consensus 257 ~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 257 DFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=333.35 Aligned_cols=256 Identities=22% Similarity=0.236 Sum_probs=202.0
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
......|++.+.||+|+||+||+|++..+++.||+|++.... .....+..|+..+..+ .|+++++++..+..
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-----~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-----DFFSIVKCHEDFAK 102 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-----CCCcEEEeecceec
Confidence 344568999999999999999999999999999999986432 2234455666666655 77889988877653
Q ss_pred cc--------eEEEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccc
Q 017021 116 RN--------HICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 184 (379)
Q Consensus 116 ~~--------~~~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 184 (379)
.. .+++||||+ +++|.+++... ....+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl------ 176 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL------ 176 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE------
Confidence 22 478999999 89999998653 23468999999999999999999999999999999999999
Q ss_pred ccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCCCCccchHhHHHHH
Q 017021 185 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 259 (379)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il 259 (379)
+.++.++|+|||+++..... .....||+.|+|||++.+..++.++|||||||++
T Consensus 177 ---------------------~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvil 235 (496)
T PTZ00283 177 ---------------------CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLL 235 (496)
T ss_pred ---------------------eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHH
Confidence 45566888888877543221 2345789999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhc
Q 017021 260 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339 (379)
Q Consensus 260 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (379)
|+|++|+.||...+..+....+...... ....
T Consensus 236 yeLltG~~Pf~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~ 267 (496)
T PTZ00283 236 YELLTLKRPFDGENMEEVMHKTLAGRYD------------------------------------------------PLPP 267 (496)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHhcCCCC------------------------------------------------CCCC
Confidence 9999999999876554433322111000 0112
Q ss_pred cchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 340 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
..++++.+++.+||+.||.+||++.++++|||++.
T Consensus 268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 35678999999999999999999999999999763
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=302.16 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=198.8
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-cceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~-~~~~ 119 (379)
.|++.+.||+|++|.||++.++.+++.||+|.+.... .....+..|+.++.++ .|++++.+.+.+.. ...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-----KHPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeecCCCCEE
Confidence 3788999999999999999999999999999986432 2234556677777776 67889999888764 4578
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|++|||+ +++|.+++.......+++.++..++.+++.||++||+.|++||||+|+||+++
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~------------------- 136 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT------------------- 136 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe-------------------
Confidence 9999999 89999999775445689999999999999999999999999999999999994
Q ss_pred CcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
....++|+|||.+...... .....+++.|+|||.+.+..++.++|+|||||++++|++|+.||...+..
T Consensus 137 --------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~ 208 (257)
T cd08223 137 --------RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN 208 (257)
T ss_pred --------cCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH
Confidence 4556777777766543221 12346788999999999888999999999999999999999999865543
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
.....+... ..+. .....+..+.+++.+||+.
T Consensus 209 ~~~~~~~~~--~~~~----------------------------------------------~~~~~~~~~~~li~~~l~~ 240 (257)
T cd08223 209 SLVYRIIEG--KLPP----------------------------------------------MPKDYSPELGELIATMLSK 240 (257)
T ss_pred HHHHHHHhc--CCCC----------------------------------------------CccccCHHHHHHHHHHhcc
Confidence 333222211 1100 0113567899999999999
Q ss_pred CCCCCcCHHHHhcCCCC
Q 017021 356 DPTDRLTAREALRHPFF 372 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f 372 (379)
||++|||+.++++||||
T Consensus 241 ~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 241 RPEKRPSVKSILRQPYI 257 (257)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=308.76 Aligned_cols=279 Identities=32% Similarity=0.502 Sum_probs=210.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce--
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH-- 118 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~-- 118 (379)
.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++..+. +|++++++++.+.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~----~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS----ESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHcc----CCCCccceeeeEeecCCCC
Confidence 4788899999999999999999999999999986432 12345667888888872 45789999988876655
Q ss_pred ---EEEEEeCCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 119 ---ICIVFEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 119 ---~~lv~e~~~~sL~~~l~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
.|++|||+.++|.+++.... ...+++..+..++.||+.||.|||+.|++||||+|+||+++.
T Consensus 78 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~------------ 145 (295)
T cd07837 78 KPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK------------ 145 (295)
T ss_pred CceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec------------
Confidence 89999999778999886542 235799999999999999999999999999999999999943
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
.++.++|+|||.+....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..|
T Consensus 146 --------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 146 --------------QKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred --------------CCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 15567888888776433221 22356788999998865 4578999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|.+.+..+....+.+..+.++...++.+......... +. ..........+..+.++.++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---------------~~~~~~~~~~~~~~~~~~~~ 270 (295)
T cd07837 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEF------PQ---------------WKPQDLSRAVPDLSPEGLDL 270 (295)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhc------Cc---------------ccchhHHHhccccCHHHHHH
Confidence 9887776666666665555554443322221110000 00 00011112223467889999
Q ss_pred HhhccccCCCCCcCHHHHhcCCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f~ 373 (379)
|.+||+.||.+|||++|++.||||+
T Consensus 271 i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 271 LQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHHHccCChhhcCCHHHHhcCCCcC
Confidence 9999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=305.67 Aligned_cols=277 Identities=30% Similarity=0.494 Sum_probs=215.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.++||.|++|.||+|++..+|+.||+|+++... .....+..|+.+++.+ .|+|++++++.+...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-----KHENIVRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-----cCCCEeeeeeeEeeCCcEEE
Confidence 4788899999999999999999999999999987432 2234566788888888 67999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKLGSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
||||+.++|.+++.... ...+++..+..++.|++.||.|||+.|++||||+|+||+++
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~--------------------- 134 (284)
T cd07836 76 VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN--------------------- 134 (284)
T ss_pred EEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---------------------
Confidence 99999779999887643 23589999999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.++.++|+|||.+....... ....++..|++||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+
T Consensus 135 ------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~ 208 (284)
T cd07836 135 ------KRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208 (284)
T ss_pred ------CCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 44567777777665332221 223568889999988654 46899999999999999999999999887777
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+....+.+..++.+.... .+. ...+... ........+..+..++++|.+||+.|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~---------------~~~~~~~~~~~~~~~~~~i~~~l~~~ 268 (284)
T cd07836 209 QLLKIFRIMGTPTESTWPGISQLP-EYK----PTFPRYP---------------PQDLQQLFPHADPLGIDLLHRLLQLN 268 (284)
T ss_pred HHHHHHHHhCCCChhhHHHHhcCc-hhc----ccccCCC---------------hHHHHHHhhhcCcHHHHHHHHHhcCC
Confidence 777777766666666555433111 110 0011000 01112223345788999999999999
Q ss_pred CCCCcCHHHHhcCCCC
Q 017021 357 PTDRLTAREALRHPFF 372 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f 372 (379)
|++||+++|+++||||
T Consensus 269 p~~R~~~~~~l~~~~f 284 (284)
T cd07836 269 PELRISAHDALQHPWF 284 (284)
T ss_pred cccCCCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=301.47 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=202.1
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
|.+.+.||+|++|.||+|.++.+++.||+|.+... ......+..|+.++..+ .|++++++++.+...+..|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-----DSSYIIRYYESFLDKGKLNI 76 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-----CCCCeehheeeeccCCEEEE
Confidence 66778999999999999999999999999998632 33455666788887777 78999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
||||+ +++|.+++.......++...+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~--------------------- 135 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD--------------------- 135 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---------------------
Confidence 99999 89999999876445789999999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
.++.++|+|||.+....... ....|++.|+|||+..+..++.++|+|||||++|+|++|+.||...+..+.
T Consensus 136 ------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 209 (256)
T cd08529 136 ------AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209 (256)
T ss_pred ------CCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 44567777777665433322 234578899999999988899999999999999999999999987664333
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+...+. .....+.++.++|++||+.||
T Consensus 210 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~i~~~l~~~p 241 (256)
T cd08529 210 ILKIIRGVFPP------------------------------------------------VSQMYSQQLAQLIDQCLTKDY 241 (256)
T ss_pred HHHHHcCCCCC------------------------------------------------CccccCHHHHHHHHHHccCCc
Confidence 32221111000 001245689999999999999
Q ss_pred CCCcCHHHHhcCCCC
Q 017021 358 TDRLTAREALRHPFF 372 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f 372 (379)
++||++.++++|||+
T Consensus 242 ~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 242 RQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCcCHHHHhhCCCC
Confidence 999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=306.56 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=203.7
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.-.|+|.++||.|+||.||++.+..+++.+|+|.+.... .....+..|+.+++.+ .|++++++++.+..+...|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-----KHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-----CCCceeEEEEEEecCCeEE
Confidence 456999999999999999999999899999999987432 2334566788888887 6899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~-------------------- 137 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT-------------------- 137 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC--------------------
Confidence 999999 889999987643 3589999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
.++.++|+|||.+...... .....++..|+|||.+. ...++.++|+|||||++|+|++|+.||..
T Consensus 138 -------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 138 -------LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred -------CCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 4556777777765432221 12346888999999975 34477899999999999999999999976
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+.......+... ..+. . .....++.++.++|.+
T Consensus 211 ~~~~~~~~~~~~~--~~~~------------------~--------------------------~~~~~~~~~~~~li~~ 244 (280)
T cd06611 211 LNPMRVLLKILKS--EPPT------------------L--------------------------DQPSKWSSSFNDFLKS 244 (280)
T ss_pred CCHHHHHHHHhcC--CCCC------------------c--------------------------CCcccCCHHHHHHHHH
Confidence 5543333222111 1000 0 0012356688999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
||+.||++||++.++++||||....
T Consensus 245 ~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 245 CLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HhccChhhCcCHHHHhcChhhcccc
Confidence 9999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=326.81 Aligned_cols=257 Identities=25% Similarity=0.449 Sum_probs=212.7
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeec-cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.+.-.+.|...||.|+||.||+|.+++++-..|.|++.. ....-..++-|++++... .||+|+.+++.|-.++.
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-----dHP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-----DHPVIVKLLSAYYFENK 103 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-----CChHHHHHHHHHhccCc
Confidence 345568899999999999999999999999999999863 344456677799998886 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+||+.||| ||-...++-..+ +.+++.++..+++|++.||.|||+++|||||||..|||+
T Consensus 104 LwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~------------------- 163 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL------------------- 163 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE-------------------
Confidence 99999999 777766665544 579999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
.-++.++|+|||.+..... ...++.|||+|||||+.. ..+|+.++||||||+++.+|+.+.+|-
T Consensus 164 --------TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH 235 (1187)
T KOG0579|consen 164 --------TLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH 235 (1187)
T ss_pred --------EecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc
Confidence 5566788888887754322 225678999999999874 468999999999999999999999998
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
...+..-....+.+. .|+.+ ..+.+++..+.||+
T Consensus 236 helnpMRVllKiaKS---ePPTL-------------------------------------------lqPS~Ws~~F~DfL 269 (1187)
T KOG0579|consen 236 HELNPMRVLLKIAKS---EPPTL-------------------------------------------LQPSHWSRSFSDFL 269 (1187)
T ss_pred cccchHHHHHHHhhc---CCCcc-------------------------------------------cCcchhhhHHHHHH
Confidence 766665554444332 22211 01235788999999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
..||..||..||+|+|+|+||||...
T Consensus 270 k~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 270 KRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHhcCCccCCCHHHHhhCcccccC
Confidence 99999999999999999999999854
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=310.49 Aligned_cols=287 Identities=25% Similarity=0.374 Sum_probs=204.4
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.+.||+|+||.||++.+..++..+|+|.+... ......+..|++++.++ .|+|++++++.+..++.+++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-----NSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEeeCCEEEE
Confidence 478889999999999999999999999999998643 22334567788888887 77999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
||||+ +++|.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||||+||+++.
T Consensus 77 v~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~------------------- 135 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS------------------- 135 (308)
T ss_pred EeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec-------------------
Confidence 99999 899999998764 68999999999999999999997 69999999999999944
Q ss_pred cccccCCCCCCeEEeecCcccccCCC-CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
++.++|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.....
T Consensus 136 --------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 207 (308)
T cd06615 136 --------RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207 (308)
T ss_pred --------CCcEEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH
Confidence 445677777766432221 23346889999999998888999999999999999999999999765533222
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+.......+... .. ........+.+......+........... ......++.++.++|.+||..||+
T Consensus 208 ~~~~~~~~~~~~~~----~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~ 276 (308)
T cd06615 208 AMFGRPVSEGEAKE----SH---RPVSGHPPDSPRPMAIFELLDYIVNEPPP----KLPSGAFSDEFQDFVDKCLKKNPK 276 (308)
T ss_pred HhhcCccccccccC----Cc---ccccCCCCCccchhhHHHHHHHHhcCCCc----cCcCcccCHHHHHHHHHHccCChh
Confidence 11111110000000 00 00000000000000000001110000000 000012567899999999999999
Q ss_pred CCcCHHHHhcCCCCCCC
Q 017021 359 DRLTAREALRHPFFTRD 375 (379)
Q Consensus 359 ~Rpta~e~l~hp~f~~~ 375 (379)
+|||+.|+++||||.+.
T Consensus 277 ~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 277 ERADLKELTKHPFIKRA 293 (308)
T ss_pred hCcCHHHHhcChhhhhc
Confidence 99999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=304.86 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=204.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.+.||.|++|.||+|.+..+++.||+|++.... .....+..|+.+++.+ .|+|++.+.+.+..+...|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-----RSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-----CCCCeeeeeEEEEECCeEEE
Confidence 5788999999999999999999999999999987432 2234556788888877 67999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
|+||+ +++|.+++... .+++..+..++.|++.||.|||+.+++||||+|+||++
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---------------------- 131 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---------------------- 131 (274)
T ss_pred EEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----------------------
Confidence 99999 88999998765 58999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
+.++.++|+|||.+...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+....
T Consensus 132 -----~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~ 206 (274)
T cd06609 132 -----SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV 206 (274)
T ss_pred -----CCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH
Confidence 44556777777776543322 2334678899999999888899999999999999999999999976554333
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc-chhHHHHHHhhccccC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLLRYD 356 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~d 356 (379)
...+.....+.. ... ++..+.+++.+||..|
T Consensus 207 ~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~l~~~l~~~ 238 (274)
T cd06609 207 LFLIPKNNPPSL------------------------------------------------EGNKFSKPFKDFVSLCLNKD 238 (274)
T ss_pred HHHhhhcCCCCC------------------------------------------------cccccCHHHHHHHHHHhhCC
Confidence 322222111100 011 4567999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCCCc
Q 017021 357 PTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~~~ 377 (379)
|++|||++++++||||++...
T Consensus 239 p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 239 PKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred hhhCcCHHHHhhChhhcCCCc
Confidence 999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=314.98 Aligned_cols=279 Identities=29% Similarity=0.508 Sum_probs=210.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec----
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---- 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~---- 116 (379)
..|++.+.||+|+||.||+|.+..+|+.||+|+++.. .........|+.++..+ .|+|++++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-----KHENIIGILDIIRPPSFES 79 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-----CCCCcCchhheeecccccc
Confidence 4688999999999999999999999999999998632 23345566788888888 678999998876543
Q ss_pred -ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 117 -NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 117 -~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
...|+++||++++|.+.+... .+++..+..++.|++.||+|||+.|++||||||+||+++.+
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~-------------- 142 (336)
T cd07849 80 FNDVYIVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-------------- 142 (336)
T ss_pred cceEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC--------------
Confidence 468999999988998888654 48999999999999999999999999999999999999544
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
+.++|+|||.+....... ....||..|+|||.+.+ ..++.++|||||||++|+|++|+.|
T Consensus 143 -------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~ 209 (336)
T cd07849 143 -------------CDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209 (336)
T ss_pred -------------CCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 445556666554322111 12457889999998754 4688999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhh-hhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
|...+.......+....+.++.+.+....... ..+... ..... ...........+.++.+
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-----------------~~~~~~~~~~~~~~~~~ 270 (336)
T cd07849 210 FPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKS--LPFKP-----------------KVPWNKLFPNADPKALD 270 (336)
T ss_pred CCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhh--cCcCC-----------------cccHHHHhcccCcHHHH
Confidence 98877777777777777766655544332211 111110 00000 00000112235778999
Q ss_pred HHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 348 LLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+|.+||+.||++|||+.|+++||||+.-
T Consensus 271 li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 271 LLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 9999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=307.04 Aligned_cols=280 Identities=26% Similarity=0.399 Sum_probs=207.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
..|++.+.||+|+||.||+|.++.+++.||+|++.... .......+|+..+..+ .|+|++++++++..+...|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-----KHANIVLLHDIIHTKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-----CCCCEeEEEEEEecCCeEE
Confidence 35788899999999999999999999999999986432 2223556788888887 6789999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|+||+++++.+.+.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus 80 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~--------------------- 137 (291)
T cd07870 80 FVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS--------------------- 137 (291)
T ss_pred EEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc---------------------
Confidence 999999888888776543 3578888999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCch-H
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN-L 275 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~-~ 275 (379)
.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+. .
T Consensus 138 ------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~ 211 (291)
T cd07870 138 ------YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF 211 (291)
T ss_pred ------CCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH
Confidence 4456777777766532221 122356889999999865 3578899999999999999999999976543 3
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+....+.+++..+..+...............+. ..... .. ....+..+.+++.+||+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~-~~-~~~~~~~~~~ll~~~l~~ 274 (291)
T cd07870 212 EQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQ---------------QLRVV-WK-RLSRPPKAEDLASQMLMM 274 (291)
T ss_pred HHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCc---------------chhhh-cc-ccCCChHHHHHHHHHhCc
Confidence 44445555566665555444332111110000000000 00000 00 001356789999999999
Q ss_pred CCCCCcCHHHHhcCCCC
Q 017021 356 DPTDRLTAREALRHPFF 372 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f 372 (379)
||.+|||++|++.||||
T Consensus 275 dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 275 FPKDRISAQDALLHPYF 291 (291)
T ss_pred CcccCcCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=296.86 Aligned_cols=294 Identities=28% Similarity=0.485 Sum_probs=229.0
Q ss_pred hhhhhhhccccccceeEEEEEecCCC----ceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~----~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
+.|++...||+|.||.||+|..+.++ ..+|||.++.. ......+.+|+..+..+ .|+|++.+...|-+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-----~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-----KHPNVISLVKVFLS 98 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-----cCCcchhHHHHHhc
Confidence 46888999999999999999766553 37899999854 24457788899999998 78999999998876
Q ss_pred -cceEEEEEeCCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 116 -RNHICIVFEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 116 -~~~~~lv~e~~~~sL~~~l~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
+..+++++||+..+|.+++.-+. .+.++...+.+++.||+.|+.|||+.=|+||||||.|||+.-+|
T Consensus 99 ~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg--------- 169 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG--------- 169 (438)
T ss_pred cCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC---------
Confidence 88999999999999999997432 24688999999999999999999999999999999999996544
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHh
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~ 264 (379)
...+.+||+|+|+++....+- ...+.|.-|.|||.+.+. .|+.+.||||.|||+.||++
T Consensus 170 --------------perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 170 --------------PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred --------------CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 567899999999998665543 235678999999999875 58999999999999999999
Q ss_pred CCCCCCCCc---------hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccch-hhHHHH
Q 017021 265 GEALFQTHE---------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP-RLQNLI 334 (379)
Q Consensus 265 g~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 334 (379)
-++.|.+.. ..+...+|.+++|.+.+..|+.+....+....- ..+....-++ .+-+..
T Consensus 236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~l------------s~f~~~~~~n~sL~~~~ 303 (438)
T KOG0666|consen 236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLL------------SDFRRHYYDNVSLHKYY 303 (438)
T ss_pred cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHH------------HHhHHhhcCcchHHHHH
Confidence 999997632 245667888899999988887655433321110 1111000000 011111
Q ss_pred HHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 335 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
..+..-++.+.+|+.+||++||-+|.||+|+++|+||.++.+
T Consensus 304 -~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~l 345 (438)
T KOG0666|consen 304 -HKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPL 345 (438)
T ss_pred -HHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCC
Confidence 112334456999999999999999999999999999998864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=312.73 Aligned_cols=280 Identities=24% Similarity=0.360 Sum_probs=210.5
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|++|.||+|.+..+++.||+|.+..... ....+..|++.+..+ .|++++++++.+......
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-----DHPFLPTLYASFQTETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-----CCCCchhheeeeecCCEE
Confidence 47788999999999999999999999999999974322 334566788888777 679999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|++|||+ +++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.+++.|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999 899999998765457899999999999999999999999999999999999988888888888876543222
Q ss_pred CcccccCCCCCC-----eE-EeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 199 SSYFKRMPKSSA-----IK-VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 199 ~~~~~~~~~~~~-----~~-l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
............ .+ .... .............||..|+|||.+.+..++.++||||||+++|+|++|+.||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSET-FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred ccccccccccccccccccccchhh-hcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 111000000000 00 0000 0000111123356899999999999888999999999999999999999999876
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+.......+ . ....+..+.++|.+|
T Consensus 236 ~~~~~~~~~~~~~~~~~-----------------------~------------------------~~~~~~~~~~li~~~ 268 (316)
T cd05574 236 NRDETFSNILKKEVTFP-----------------------G------------------------SPPVSSSARDLIRKL 268 (316)
T ss_pred chHHHHHHHhcCCccCC-----------------------C------------------------ccccCHHHHHHHHHH
Confidence 65443332221110100 0 011467899999999
Q ss_pred cccCCCCCcC----HHHHhcCCCCCCCC
Q 017021 353 LRYDPTDRLT----AREALRHPFFTRDH 376 (379)
Q Consensus 353 L~~dP~~Rpt----a~e~l~hp~f~~~~ 376 (379)
|+.||++||| ++|+++||||+...
T Consensus 269 l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 269 LVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred ccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 9999999999 99999999998753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=306.74 Aligned_cols=281 Identities=30% Similarity=0.471 Sum_probs=216.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.++||+|++|.||+|.++.+++.||+|++.... .....+..|+.++..+ .|++++++++++..+...|
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 77 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-----QHGNIVRLQDVVHSEKRLY 77 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-----cCCCEeeEEEEEecCCeEE
Confidence 4788899999999999999999999999999986432 2234566788888887 6799999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||||++++|.+.+.......+++..+..++.||+.||+|||+.|++|+||+|+||+++.
T Consensus 78 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~-------------------- 137 (294)
T PLN00009 78 LVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-------------------- 137 (294)
T ss_pred EEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--------------------
Confidence 999999778988887655445688899999999999999999999999999999999952
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.+..++|+|||.+....... ....+++.|+|||.+.+. .++.++|||||||++|+|++|..||......+
T Consensus 138 ------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~ 211 (294)
T PLN00009 138 ------RTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID 211 (294)
T ss_pred ------CCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 23457888888776433221 223568899999988664 57899999999999999999999998877666
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+....+.+....|............. ..++ ...........+..+.++|.+||+.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~------------------~~~~~~~~~~~~~~~~~~i~~~l~~~ 271 (294)
T PLN00009 212 ELFKIFRILGTPNEETWPGVTSLPDYKSAF--PKWP------------------PKDLATVVPTLEPAGVDLLSKMLRLD 271 (294)
T ss_pred HHHHHHHHhCCCChhhccccccchhhhhhc--ccCC------------------CCCHHHhCcCCChHHHHHHHHHccCC
Confidence 666666666666655554322211110000 0000 00111122346778999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~ 375 (379)
|++||++.++++||||.+.
T Consensus 272 P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 272 PSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhCcCHHHHhcCchHhHH
Confidence 9999999999999999864
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=304.57 Aligned_cols=276 Identities=31% Similarity=0.510 Sum_probs=214.1
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
|++.++||.|++|.||+|.++.+|..||+|++.... .....+..|+..+..+ .|++++++++++..++..|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-----~~~~iv~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-----NHPNIVRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-----CCCCccCHhheeccCCeEEE
Confidence 678899999999999999999999999999987432 2234566788888888 68999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
+|||++++|.+++.......+++..+..++.|++.||+|||+.+++||||+|+||+++
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---------------------- 133 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---------------------- 133 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----------------------
Confidence 9999988999999776544689999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
.++.++|+|||.+....... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+....
T Consensus 134 -----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 208 (283)
T cd07835 134 -----REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ 208 (283)
T ss_pred -----CCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 45567777777765432221 223467889999987654 468999999999999999999999988777666
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+..+.+.+..|..+....+-..... .++ ...........+..+.++|.+||+.||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~------------------~~~~~~~~~~~~~~~~~li~~~l~~~P 268 (283)
T cd07835 209 LFRIFRTLGTPDEDVWPGVTSLPDYKPTFP--KWA------------------RQDLSKVVPNLDEDGLDLLSKMLVYDP 268 (283)
T ss_pred HHHHHHHhCCCChHHhhhhhhchhhhhhcc--ccc------------------ccchhhhcCCCCHHHHHHHHHHhcCCh
Confidence 666666666666655544322211110000 000 000111233466789999999999999
Q ss_pred CCCcCHHHHhcCCCC
Q 017021 358 TDRLTAREALRHPFF 372 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f 372 (379)
++|||++|++.||||
T Consensus 269 ~~Rpt~~~il~~~~~ 283 (283)
T cd07835 269 AKRISAKAALQHPYF 283 (283)
T ss_pred hhCcCHHHHhcCCCC
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=309.34 Aligned_cols=279 Identities=27% Similarity=0.486 Sum_probs=208.9
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec----
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---- 116 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~---- 116 (379)
.|++.++||+|+||.||+|.+..+++.||+|++.... ........|+.+++++ .|++++++++++...
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKATPY 87 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-----CCCCccceEEEEecccccc
Confidence 5788899999999999999999999999999986322 2233445688888888 678999999887654
Q ss_pred ----ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 117 ----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 117 ----~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
...++||||++++|.+.+.... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.+
T Consensus 88 ~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~----------- 155 (310)
T cd07865 88 NRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD----------- 155 (310)
T ss_pred cCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-----------
Confidence 3569999999889988887653 358999999999999999999999999999999999999544
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHh
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~ 264 (379)
+.++|+|||.+....... ....++..|+|||.+.+. .++.++|+||||+++|+|++
T Consensus 156 ----------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t 219 (310)
T cd07865 156 ----------------GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219 (310)
T ss_pred ----------------CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHh
Confidence 455666666554322111 123567889999988664 46889999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||.+.+.......+.+..+..+..+++....... ... ...+.... ..... .-.....+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~--~~~~~-----------~l~~~~~~~~ 282 (310)
T cd07865 220 RSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLEL-FKK---MELPQGQK--RKVKE-----------RLKPYVKDPH 282 (310)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhh-hhh---ccCCCccc--hhhHH-----------hcccccCCHH
Confidence 9999998887777777888888887776654422111 000 11111000 00000 0001124567
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
+.++|.+||..||++|||++|+++||||
T Consensus 283 ~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 283 ALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 8999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.84 Aligned_cols=298 Identities=25% Similarity=0.419 Sum_probs=216.3
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhh---------------HhHHHHHHHHHHHHhcCCCCCee
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR---------------EAAMIEIEVLQQLAKHDKGGNRC 106 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~---------------~~~~~e~~~l~~l~~~~~~~~~i 106 (379)
...+.+.+.||+|+||.||+|.++.+++.||+|+++...... ..+.+|+.++..+ .|+++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i 82 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-----KHENI 82 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-----CCcce
Confidence 334456688999999999999999999999999986432211 1356788888887 67999
Q ss_pred EEecceeeecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccccc
Q 017021 107 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 186 (379)
Q Consensus 107 ~~~~~~~~~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~ 186 (379)
+.+++++..++..+++|||+.++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+++
T Consensus 83 v~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 83 MGLVDVYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred eeeeEEEecCCcEEEEEeccccCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEE
Confidence 99999999999999999999889999997654 5899999999999999999999999999999999999977776666
Q ss_pred CCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhC
Q 017021 187 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g 265 (379)
.|||.+.....+..... ... +... ..........++..|+|||.+.+. .++.++|+|||||++|+|++|
T Consensus 161 ~dfg~~~~~~~~~~~~~--~~~------~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDT--LSK------DETM--QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred CCccceeeccccccccc--ccc------cccc--cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 66665543321110000 000 0000 000111223467889999998764 468999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
..||.+.+..+....+....+.++...|+........ .. +.. . .. ..........+..+
T Consensus 231 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~-----~~~--~---------~~----~~~~~~~~~~~~~~ 289 (335)
T PTZ00024 231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLY-TE-----FTP--R---------KP----KDLKTIFPNASDDA 289 (335)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccc-cc-----cCc--C---------Cc----ccHHHhCcCCChHH
Confidence 9999988877777777777666655443321110000 00 000 0 00 00111123456789
Q ss_pred HHHHhhccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 346 THLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
.++|.+||+.||++|||++|++.||||.+..+
T Consensus 290 ~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 290 IDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 99999999999999999999999999998765
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=319.09 Aligned_cols=253 Identities=25% Similarity=0.439 Sum_probs=217.0
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeec---cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 125 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 125 (379)
+.||+|.||+||-|.++.+|+.||||++.+ ..+.......|+.+++.+ +||.|+.+...|++.+.+|+|||-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-----~HPGiV~le~M~ET~ervFVVMEK 644 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-----HHPGIVNLECMFETPERVFVVMEK 644 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-----CCCCeeEEEEeecCCceEEEEehh
Confidence 689999999999999999999999999964 345567788899999999 889999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 126 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 126 ~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
+.|+..+++-+.....+++.....++.||+.||.|||-++|+|+||||+|||+...
T Consensus 645 l~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~------------------------ 700 (888)
T KOG4236|consen 645 LHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA------------------------ 700 (888)
T ss_pred hcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC------------------------
Confidence 98888888766554579999999999999999999999999999999999999432
Q ss_pred CCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHH
Q 017021 206 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~ 283 (379)
+....+||||||+|+.....+ ++.+||+.|+|||++.+..|...-|+||+|||+|.-++|..||....+.. .+|++
T Consensus 701 ~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQN 778 (888)
T KOG4236|consen 701 SPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQN 778 (888)
T ss_pred CCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhc
Confidence 566789999999999877665 56799999999999999999999999999999999999999997544322 22222
Q ss_pred HcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCH
Q 017021 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 363 (379)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta 363 (379)
..+.+|. .-|.+.++.+.|||+.+|+..=.+|.|.
T Consensus 779 -----------------------AaFMyPp----------------------~PW~eis~~AidlIn~LLqVkm~kRysv 813 (888)
T KOG4236|consen 779 -----------------------AAFMYPP----------------------NPWSEISPEAIDLINNLLQVKMRKRYSV 813 (888)
T ss_pred -----------------------cccccCC----------------------CchhhcCHHHHHHHHHHHHHHHHHhcch
Confidence 2222221 1144678899999999999999999999
Q ss_pred HHHhcCCCCCCCCc
Q 017021 364 REALRHPFFTRDHL 377 (379)
Q Consensus 364 ~e~l~hp~f~~~~~ 377 (379)
+..|.|||+++-++
T Consensus 814 dk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 814 DKSLSHPWLQDYQT 827 (888)
T ss_pred HhhccchhhhcchH
Confidence 99999999998654
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=305.94 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=202.3
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.....|+++++||+|+||.||+|++..+++.||+|.+.... .....+..|+.++..+ .|++++++++.+..++.
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-----NHPYIVKLLGAFYWDGK 83 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCcEeeeEEEEEeCCe
Confidence 34467999999999999999999999999999999987432 2345566788887777 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+||||+ +++|..++.+.. ..+++..+..++.|++.||.|||+.|++|||+||+||++
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili------------------- 143 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL------------------- 143 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE-------------------
Confidence 99999999 888988876543 358999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.++.++|+|||.+...... .....++..|+|||.+. ...++.++|+|||||++|+|++|..||
T Consensus 144 --------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 215 (292)
T cd06644 144 --------TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 215 (292)
T ss_pred --------cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCC
Confidence 44556777777766532221 12345788999999884 344678999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
...+..+....+.+. ..+. . .....++.++.++|
T Consensus 216 ~~~~~~~~~~~~~~~--~~~~--------------------~------------------------~~~~~~~~~~~~li 249 (292)
T cd06644 216 HELNPMRVLLKIAKS--EPPT--------------------L------------------------SQPSKWSMEFRDFL 249 (292)
T ss_pred ccccHHHHHHHHhcC--CCcc--------------------C------------------------CCCcccCHHHHHHH
Confidence 765543332222111 0000 0 00123556889999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.+||+.||++||+++|+++||||...
T Consensus 250 ~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 250 KTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHhcCCcccCcCHHHHhcCcccccc
Confidence 99999999999999999999999853
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=314.95 Aligned_cols=279 Identities=26% Similarity=0.487 Sum_probs=218.9
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce--
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH-- 118 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~-- 118 (379)
.|++.+.||+|++|.||+|++..+++.||+|++... .........|+.+++.+ .|++++.+.+.+...+.
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-----DHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-----cCCCHHHHHHHhhcccccc
Confidence 578889999999999999999999999999998642 22334556788888887 67899998887766544
Q ss_pred ----EEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 119 ----ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 119 ----~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.++|+||++++|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 91 ~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---------------- 151 (343)
T cd07851 91 DFQDVYLVTHLMGADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---------------- 151 (343)
T ss_pred ccccEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----------------
Confidence 8999999999999998764 48999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+...........++..|+|||.+.+ ..++.++|||||||++|++++|+.||...+
T Consensus 152 -----------~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 152 -----------NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred -----------CCCCCEEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 44566888888887765544445568889999999865 367899999999999999999999998877
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhh-hhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
..+....+.+..+.+++.++..+.... ..+...... . .. ..........+..+.++|++|
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--------------~~----~~~~~~~~~~s~~l~dli~~~ 281 (343)
T cd07851 221 HIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQ-M--------------PK----KDFKEVFSGANPLAIDLLEKM 281 (343)
T ss_pred hHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccc-c--------------CC----CCHHHHhccCCHHHHHHHHHh
Confidence 777777777777777776665543221 111110000 0 00 001111224578899999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
|+.||++|||+.++++||||.+-.
T Consensus 282 l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 282 LVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred CCCChhhCCCHHHHhcCCCccccC
Confidence 999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.34 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=197.4
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
...|++.++||+|+||.||+|.+..+++.||+|+++.... ......+|+.++..+ .|++++++++.+...+..|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-----~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-----KHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEeCCEEE
Confidence 3478999999999999999999999999999999874432 223455677777776 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
++|||+ +++|.+++...+ .+++..+..++.|++.||.|||+.|++|+||||+||++
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili--------------------- 139 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL--------------------- 139 (267)
T ss_pred EEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---------------------
Confidence 999999 889999987755 68999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhh---CCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+..+.++|+|||.+...... .....|+..|+|||.+. ...++.++|+|||||++|+|++|..||....
T Consensus 140 ------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 140 ------TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred ------CCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 44556777777776533222 13346889999999974 4457899999999999999999999986544
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
........... ...+.. .. ....++..+.++|.+||
T Consensus 214 ~~~~~~~~~~~-~~~~~~-------------------~~------------------------~~~~~~~~~~~li~~~l 249 (267)
T cd06645 214 PMRALFLMTKS-NFQPPK-------------------LK------------------------DKMKWSNSFHHFVKMAL 249 (267)
T ss_pred chhhHHhhhcc-CCCCCc-------------------cc------------------------ccCCCCHHHHHHHHHHc
Confidence 32221111110 000000 00 00124567899999999
Q ss_pred ccCCCCCcCHHHHhcCCC
Q 017021 354 RYDPTDRLTAREALRHPF 371 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~ 371 (379)
+.||++|||++++++|||
T Consensus 250 ~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 250 TKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred cCCchhCcCHHHHhcCCC
Confidence 999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=307.15 Aligned_cols=254 Identities=25% Similarity=0.393 Sum_probs=202.6
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
....|++.+.||+|++|.||+|.+..+++.||+|.+.... .....+..|+.++..+ .|+|++.+.+.+..+.+.
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-----CCCCEeeEEEEEEeCCEE
Confidence 3357888899999999999999999999999999987432 2234566788887776 779999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++... .++..++..++.|++.||.|||+.|++||||||+||+++
T Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~------------------- 150 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG------------------- 150 (296)
T ss_pred EEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc-------------------
Confidence 9999999 89999998654 478999999999999999999999999999999999994
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
.++.++|+|||.+....... ....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 151 --------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~ 222 (296)
T cd06654 151 --------MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (296)
T ss_pred --------CCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 44567777777665432221 2346888999999998888899999999999999999999999765543
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
......... +..+ .+ .....+..+.++|.+||+.
T Consensus 223 ~~~~~~~~~-~~~~---------------------~~------------------------~~~~~~~~l~~li~~~l~~ 256 (296)
T cd06654 223 RALYLIATN-GTPE---------------------LQ------------------------NPEKLSAIFRDFLNRCLDM 256 (296)
T ss_pred HhHHHHhcC-CCCC---------------------CC------------------------CccccCHHHHHHHHHHCcC
Confidence 322111110 0000 00 0113456789999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~ 375 (379)
||++|||+.++++||||...
T Consensus 257 ~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 257 DVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred CcccCcCHHHHhhChhhhcc
Confidence 99999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=312.85 Aligned_cols=279 Identities=27% Similarity=0.478 Sum_probs=217.8
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc---
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--- 117 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~--- 117 (379)
.|++.+.||+|+||.||+|.+..++..||+|++... ......+..|+.++..+ .|++++.+.+.+....
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-----KHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-----CCCCccceeeeecCCcccc
Confidence 578889999999999999999999999999998532 22234566788888888 7789999999887543
Q ss_pred ---eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 118 ---HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 118 ---~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
..++||++++++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---------------- 151 (343)
T cd07880 91 RFHDFYLVMPFMGTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---------------- 151 (343)
T ss_pred ccceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----------------
Confidence 46999999998999888653 58999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
..++.++|+|||.+...........++..|+|||.+.+ ..++.++|+|||||++|++++|+.||...+
T Consensus 152 -----------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 152 -----------NEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred -----------cCCCCEEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 44566888888888765544444567889999999876 457899999999999999999999999877
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
.......+.+..+..+..+...+............ .... ...........+..+.++|.+||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~-~~~~~~~~~~~~~~~~~li~~~l 282 (343)
T cd07880 221 HLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKL-----------------PRFR-KKDFRSLLPNANPLAVNVLEKML 282 (343)
T ss_pred HHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhc-----------------cccC-cchHHHhccCCChHHHHHHHHHc
Confidence 76666666676677776665554322111000000 0000 01112233456788999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+.||++|||+.+++.||||+.-
T Consensus 283 ~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 283 VLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred CCChhhCCCHHHHhcCccHhhh
Confidence 9999999999999999999763
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=313.02 Aligned_cols=279 Identities=29% Similarity=0.504 Sum_probs=213.9
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec----
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---- 116 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~---- 116 (379)
.|++.+.||+|+||.||+|.+..+++.||+|.+... .........|+.++..+ +|+|++++++++...
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-----DHENVIAIKDIMPPPHREA 80 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-----CCCCccchHHheecccccc
Confidence 588889999999999999999999999999998642 22234556788888877 679999999987654
Q ss_pred -ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 117 -NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 117 -~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
...|+++||++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~---------------- 142 (337)
T cd07858 81 FNDVYIVYELMDTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---------------- 142 (337)
T ss_pred cCcEEEEEeCCCCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----------------
Confidence 3589999999889999987654 699999999999999999999999999999999999994
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+
T Consensus 143 -----------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 143 -----------ANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred -----------CCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 4455677777766543322 123457889999998865 4588999999999999999999999988
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhh-hhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
.+..+....+....+.++...+.... .....+... ....+. .......+..+..+.++|+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~--~~~~~~~~~~~~~~~~li~ 272 (337)
T cd07858 212 KDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRS-----------------LPYTPR--QSFARLFPHANPLAIDLLE 272 (337)
T ss_pred CChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHh-----------------cCcccc--cCHHHHcccCCHHHHHHHH
Confidence 87777777777777777665543211 111111110 000000 0011122356788999999
Q ss_pred hccccCCCCCcCHHHHhcCCCCCCC
Q 017021 351 GLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+||+.||++|||++|+++||||...
T Consensus 273 ~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 273 KMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHhcCChhhccCHHHHHcCcchhhh
Confidence 9999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=298.71 Aligned_cols=250 Identities=27% Similarity=0.451 Sum_probs=202.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
..|++.++||+|++|.||+|.+..+++.+|+|.++.... ...+.+|+.+++.+ .|++++++.+.+..+...|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC-----DSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC-----CCCcEeeeeeeeecCCcEEEE
Confidence 468899999999999999999998899999999975433 56777888888887 789999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
+||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++|||++|+||+++
T Consensus 77 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~---------------------- 133 (256)
T cd06612 77 MEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---------------------- 133 (256)
T ss_pred EecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC----------------------
Confidence 9999 889999987644 3689999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
.++.++|+|||.+....... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.........
T Consensus 134 -----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~ 208 (256)
T cd06612 134 -----EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208 (256)
T ss_pred -----CCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence 44567777777765433221 2345788999999999888999999999999999999999999764432211
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+.. ...+ .. .....++..+.++|.+||+.||+
T Consensus 209 ~~~~~--~~~~------------------~~--------------------------~~~~~~~~~~~~~i~~~l~~~P~ 242 (256)
T cd06612 209 FMIPN--KPPP------------------TL--------------------------SDPEKWSPEFNDFVKKCLVKDPE 242 (256)
T ss_pred hhhcc--CCCC------------------CC--------------------------CchhhcCHHHHHHHHHHHhcChh
Confidence 11000 0000 00 00112456899999999999999
Q ss_pred CCcCHHHHhcCCCC
Q 017021 359 DRLTAREALRHPFF 372 (379)
Q Consensus 359 ~Rpta~e~l~hp~f 372 (379)
+|||+.|+++||||
T Consensus 243 ~Rps~~~il~~~~~ 256 (256)
T cd06612 243 ERPSAIQLLQHPFI 256 (256)
T ss_pred hCcCHHHHhcCCCC
Confidence 99999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=299.65 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=203.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.+.||+|+||.||++.+..+++.||+|.+... ......+..|+.+++.+ .|++++.+.+.+...++.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-----KHPNIVQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-----CCCCeeeeEeeecCCCeEE
Confidence 378889999999999999999999999999998632 23344667788888887 6799999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+|+||+ +++|.+.+.......+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~--------------------- 134 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL--------------------- 134 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---------------------
Confidence 999999 8899999977544457899999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.+..++|+|||.+....... ....|+..|+|||.+.+..++.++|+|||||++++|++|+.||...+..+
T Consensus 135 ------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08218 135 ------TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208 (256)
T ss_pred ------cCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH
Confidence 445567888888775433321 22457888999999988888999999999999999999999997655443
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.. +..+. .....+.++.++|.+||+.+
T Consensus 209 ~~~~~~~--~~~~~----------------------------------------------~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08218 209 LVLKIIR--GSYPP----------------------------------------------VSSHYSYDLRNLVSQLFKRN 240 (256)
T ss_pred HHHHHhc--CCCCC----------------------------------------------CcccCCHHHHHHHHHHhhCC
Confidence 3322211 11100 01235678999999999999
Q ss_pred CCCCcCHHHHhcCCCC
Q 017021 357 PTDRLTAREALRHPFF 372 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f 372 (379)
|++||++.++++||||
T Consensus 241 p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 241 PRDRPSVNSILEKNFI 256 (256)
T ss_pred hhhCcCHHHHhhCcCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=309.18 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=202.3
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.....|++.++||+|++|.||++.+..+++.||+|.+.... .....+..|+.+++.+ .|++++.+++.+..++.
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDE 90 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCE
Confidence 34467889999999999999999999999999999997432 2334556677777776 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+||||+ +++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~------------------ 149 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG------------------ 149 (297)
T ss_pred EEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC------------------
Confidence 99999999 99999998764 488999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
.++.++|+|||.+....... ....+++.|+|||.+.+..++.++|+|||||++|++++|..||...+.
T Consensus 150 ---------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 150 ---------MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred ---------CCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 44567777777665432221 234678899999999988899999999999999999999999976443
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
......+... +.++ . ......+..+.+++.+||+
T Consensus 221 ~~~~~~~~~~-~~~~---------------------~------------------------~~~~~~~~~~~~li~~~l~ 254 (297)
T cd06656 221 LRALYLIATN-GTPE---------------------L------------------------QNPERLSAVFRDFLNRCLE 254 (297)
T ss_pred chheeeeccC-CCCC---------------------C------------------------CCccccCHHHHHHHHHHcc
Confidence 2211110000 0000 0 0011245678999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.||++||+++++++||||...
T Consensus 255 ~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 255 MDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred CChhhCcCHHHHhcCchhccc
Confidence 999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=313.85 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=190.5
Q ss_pred echhhhhhhhccccccceeEEEEEe-----cCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
++...|++.++||+|+||.||+|.+ ..+++.||+|+++... .....+..|+.++..+. +|+||+.++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~~~~ 79 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG----NHLNVVNLLGA 79 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc----cCcceeeEEeE
Confidence 4556789999999999999999975 3446789999997432 23355777888888773 57899999998
Q ss_pred eeec-ceEEEEEeCC-CCCHHHHHHhCC----------------------------------------------------
Q 017021 113 FDYR-NHICIVFEKL-GSSLYDFLRKNN---------------------------------------------------- 138 (379)
Q Consensus 113 ~~~~-~~~~lv~e~~-~~sL~~~l~~~~---------------------------------------------------- 138 (379)
+... ..++++|||+ +|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 7654 4689999999 999999987532
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCC
Q 017021 139 --------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 210 (379)
Q Consensus 139 --------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (379)
...+++..+..++.||+.||.|||+.||+||||||+||+++ .++.
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~---------------------------~~~~ 212 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---------------------------ENNV 212 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---------------------------CCCc
Confidence 12477888899999999999999999999999999999994 4456
Q ss_pred eEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHH
Q 017021 211 IKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 284 (379)
Q Consensus 211 ~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 284 (379)
++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||......+........
T Consensus 213 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 292 (338)
T cd05102 213 VKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD 292 (338)
T ss_pred EEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc
Confidence 7777777765432211 12345678999999998889999999999999999997 99999764432221111000
Q ss_pred cCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHH
Q 017021 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 364 (379)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 364 (379)
+.. .. .....++++.+++.+||+.||++|||+.
T Consensus 293 -~~~--------------------~~--------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~ 325 (338)
T cd05102 293 -GTR--------------------MR--------------------------APENATPEIYRIMLACWQGDPKERPTFS 325 (338)
T ss_pred -CCC--------------------CC--------------------------CCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 000 00 0123566899999999999999999999
Q ss_pred HHhc
Q 017021 365 EALR 368 (379)
Q Consensus 365 e~l~ 368 (379)
|+++
T Consensus 326 el~~ 329 (338)
T cd05102 326 ALVE 329 (338)
T ss_pred HHHH
Confidence 9985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=307.33 Aligned_cols=253 Identities=28% Similarity=0.417 Sum_probs=204.3
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
....|++.++||.|++|.||++.+..+++.||+|.+.... .....+..|+..++.+ .|+|++.+++.+..++..
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-----KNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-----CCCceeeeeeeEecCceE
Confidence 3456888899999999999999999999999999986432 2345566788888777 779999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+|+||+ +++|.+++... .+++.++..++.|++.||.|||+.|++||||+|+||+++
T Consensus 92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~------------------- 149 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG------------------- 149 (296)
T ss_pred EEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-------------------
Confidence 9999999 99999988764 489999999999999999999999999999999999994
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
.++.++|+|||.+....... ....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 150 --------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~ 221 (296)
T cd06655 150 --------MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (296)
T ss_pred --------CCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 45567777777665433221 2346788999999998888999999999999999999999999876654
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.....+.. ......++.+.++|++||+.
T Consensus 222 ~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~ 255 (296)
T cd06655 222 RALYLIATNGTPEL----------------------------------------------QNPEKLSPIFRDFLNRCLEM 255 (296)
T ss_pred HHHHHHHhcCCccc----------------------------------------------CCcccCCHHHHHHHHHHhhc
Confidence 43322211110000 00123567899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~ 374 (379)
||.+|||+.+++.||||+.
T Consensus 256 dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 256 DVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred ChhhCCCHHHHhhChHhhh
Confidence 9999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=307.87 Aligned_cols=285 Identities=29% Similarity=0.499 Sum_probs=209.3
Q ss_pred hhhhhccccccceeEEEEEecC--CCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec--
Q 017021 45 DKIHSKMGEGTFGQVLECWDRE--RKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-- 116 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~--~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~-- 116 (379)
|++.++||+|++|.||+|.++. +++.||+|.+... .........|+.++..+ .|++++++++++...
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 76 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-----KHENVVSLVEVFLEHAD 76 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-----CCCCccceEEEEeCCCC
Confidence 7788999999999999999988 8999999999752 23345566788888887 779999999999888
Q ss_pred ceEEEEEeCCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 117 NHICIVFEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 117 ~~~~lv~e~~~~sL~~~l~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
...++||||+++++.+++.... ...+++..+..++.|++.||+|||+.|++||||||+||+++.++
T Consensus 77 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~----------- 145 (316)
T cd07842 77 KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEG----------- 145 (316)
T ss_pred ceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCC-----------
Confidence 8899999999878888875432 12588999999999999999999999999999999999996521
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~ 266 (379)
+..+.++|+|||.+....... ....+|..|+|||.+.+. .++.++|||||||++|+|++|+
T Consensus 146 ------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~ 213 (316)
T cd07842 146 ------------PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213 (316)
T ss_pred ------------CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcC
Confidence 235667777777765432221 234578889999988764 5789999999999999999999
Q ss_pred CCCCCCchH---------HHHHHHHHHcCCCChhHHHhhhhhhhhhh---ccCCCCCCCCCCchhhhhhhccchhhHHHH
Q 017021 267 ALFQTHENL---------EHLAMMERVLGPLPQHMLKRVDRHAEKYV---RRGRLDWPEGAASRESIKSVMKLPRLQNLI 334 (379)
Q Consensus 267 ~pf~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (379)
.||.+.... .....+...++.+....+....+..+... ......++ ........
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~ 279 (316)
T cd07842 214 PIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYP--------------SNSLAKWM 279 (316)
T ss_pred CCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCC--------------CccHHHHH
Confidence 999764432 22334444455555554443322211110 00000000 00000100
Q ss_pred HHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 335 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
......+..+.+++.+||+.||++|||+.|++.||||
T Consensus 280 -~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 280 -EKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred -HhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 1113567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=300.70 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=196.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
.|++.+.||+|+||.||+|.+ .+++.+|+|+++... .....+..|++++..+ .|+|++++.+++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-----KHVNIVQYLGTCLDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-----CCCCEeeEeeEeecC
Confidence 378889999999999999986 578899999986322 1224456688888777 678999999999999
Q ss_pred ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 117 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
+..++++||+ +++|.+++.+.. .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~------------- 139 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG------------- 139 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-------------
Confidence 9999999999 899999997754 588999999999999999999999999999999999995544
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCC---------CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERP---------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
.++|+|||.+..... ......|+..|+|||.+.+..++.++|+|||||++|+|++|.
T Consensus 140 --------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~ 205 (265)
T cd06631 140 --------------IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205 (265)
T ss_pred --------------eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCC
Confidence 455555554432110 112245788999999999888999999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||...+..+....+....+..+. ..+.++.++.
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~ 239 (265)
T cd06631 206 PPLASMDRLAAMFYIGAHRGLMPR----------------------------------------------LPDSFSAAAI 239 (265)
T ss_pred CccccCChHHHHHHhhhccCCCCC----------------------------------------------CCCCCCHHHH
Confidence 999765544333222221111110 1124567899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
++|++||+.||++||++.|+++||||
T Consensus 240 ~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 240 DFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=303.83 Aligned_cols=256 Identities=23% Similarity=0.387 Sum_probs=198.1
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.+.||+|+||.||+|.+..+++.||+|.+... ......+..|+.++.++ +|++++++++.+...+..++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-----DSPYIIGFYGAFFVENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEECCEEEE
Confidence 467889999999999999999999999999998643 22345567788888887 78999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
||||+ +++|..+. .+++..+..++.|++.||.|||+.|++|+||||+||++
T Consensus 77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---------------------- 128 (279)
T cd06619 77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---------------------- 128 (279)
T ss_pred EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE----------------------
Confidence 99999 78875431 47888999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCC-CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
+.++.++|+|||.+...... .....||..|+|||.+.+..++.++|+|||||++|+|++|+.||......+..
T Consensus 129 -----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~- 202 (279)
T cd06619 129 -----NTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS- 202 (279)
T ss_pred -----CCCCCEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-
Confidence 45566788888877543322 23457899999999998888999999999999999999999999653211100
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
..+......+ ........ .....+.++.++|.+||+.||++
T Consensus 203 -------~~~~~~~~~~-------~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~P~~ 243 (279)
T cd06619 203 -------LMPLQLLQCI-------VDEDPPVL-------------------------PVGQFSEKFVHFITQCMRKQPKE 243 (279)
T ss_pred -------cchHHHHHHH-------hccCCCCC-------------------------CCCcCCHHHHHHHHHHhhCChhh
Confidence 0000000000 00000000 01134568999999999999999
Q ss_pred CcCHHHHhcCCCCCCCCc
Q 017021 360 RLTAREALRHPFFTRDHL 377 (379)
Q Consensus 360 Rpta~e~l~hp~f~~~~~ 377 (379)
||+++|++.||||...+.
T Consensus 244 Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 244 RPAPENLMDHPFIVQYND 261 (279)
T ss_pred CCCHHHHhcCcccccccC
Confidence 999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=299.70 Aligned_cols=249 Identities=25% Similarity=0.442 Sum_probs=193.8
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhh----HhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|.+..+++.||+|++....... .....|...+ .....|++++++++.+..++..|+++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~----~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM----MIQGESPYVAKLYYSFQSKDYLYLVME 77 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHH----hhcCCCCCeeeeeeeEEcCCeEEEEEe
Confidence 67999999999999999999999999986432211 1122232222 222377999999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 78 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~------------------------- 130 (260)
T cd05611 78 YLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI------------------------- 130 (260)
T ss_pred ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE-------------------------
Confidence 99 999999998754 58999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~ 283 (379)
+.+..++|+|||.+..... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..
T Consensus 131 --~~~~~~~l~dfg~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 207 (260)
T cd05611 131 --DQTGHLKLTDFGLSRNGLE-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207 (260)
T ss_pred --CCCCcEEEeecccceeccc-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 4455678888887754332 2334678899999999888889999999999999999999999987655443332221
Q ss_pred HcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCH
Q 017021 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 363 (379)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta 363 (379)
... .++. ......+..+.++|.+||+.||++|||+
T Consensus 208 ~~~-----------------------~~~~----------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 242 (260)
T cd05611 208 RRI-----------------------NWPE----------------------EVKEFCSPEAVDLINRLLCMDPAKRLGA 242 (260)
T ss_pred ccc-----------------------CCCC----------------------cccccCCHHHHHHHHHHccCCHHHccCC
Confidence 110 0100 0011356789999999999999999955
Q ss_pred ---HHHhcCCCCCCCC
Q 017021 364 ---REALRHPFFTRDH 376 (379)
Q Consensus 364 ---~e~l~hp~f~~~~ 376 (379)
+|++.||||++.+
T Consensus 243 ~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 243 NGYQEIKSHPFFKSIN 258 (260)
T ss_pred CcHHHHHcChHhhcCC
Confidence 7999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.78 Aligned_cols=281 Identities=27% Similarity=0.487 Sum_probs=215.9
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee----
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---- 115 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~---- 115 (379)
..|++.+.||+|++|.||+|.++.+++.||+|++.... .....+..|+.++..+ .|++++++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~ 79 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-----KHDNIIAIRDILRPPGAD 79 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-----CCCCccCHHHhccccCCC
Confidence 56888899999999999999999999999999987432 2334556788888887 67999999888763
Q ss_pred cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 116 RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 116 ~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
....++||||++++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~--------------- 142 (334)
T cd07855 80 FKDVYVVMDLMESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE--------------- 142 (334)
T ss_pred CceEEEEEehhhhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC---------------
Confidence 45789999999889999987654 5899999999999999999999999999999999999944
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
++.++|+|||.+....... ....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.
T Consensus 143 ------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~ 210 (334)
T cd07855 143 ------------DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210 (334)
T ss_pred ------------CCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCC
Confidence 4556666666654322111 12367889999999865 457899999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhh-hhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDR-HAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
||...+.......+....+.++...+..+.. ......... +.... ..........+.++.
T Consensus 211 pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~---------------~~~~~~~~~~~~~~~ 271 (334)
T cd07855 211 LFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNL----PRKQP---------------VPWSKIFPKASPEAL 271 (334)
T ss_pred ccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhc----ccCCC---------------CCHHHHcccCCHHHH
Confidence 9998877777777777788877776654322 111111110 00000 000112234578899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
++|++||+.||++|||+++++.||||....
T Consensus 272 ~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 272 DLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred HHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=302.22 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=202.9
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
...|++.++||.|+||.||+|.+..+++.||+|.+.... .....+..|+.++..+ .|++++++++.+.++...
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEECCEE
Confidence 356888999999999999999999999999999987432 2334556677777776 779999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++... .+++..+..++.|++.||+|||+.+++|+||+|+||+++
T Consensus 78 ~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~------------------- 135 (277)
T cd06640 78 WIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS------------------- 135 (277)
T ss_pred EEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc-------------------
Confidence 9999999 88999998754 488999999999999999999999999999999999994
Q ss_pred CcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
.++.++|+|||.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||......
T Consensus 136 --------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 207 (277)
T cd06640 136 --------EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM 207 (277)
T ss_pred --------CCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH
Confidence 4455677777766433221 12345788899999998888999999999999999999999999765443
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
.....+... ..+ ......+..+.+++.+||+.
T Consensus 208 ~~~~~~~~~--~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06640 208 RVLFLIPKN--NPP----------------------------------------------TLTGEFSKPFKEFIDACLNK 239 (277)
T ss_pred hHhhhhhcC--CCC----------------------------------------------CCchhhhHHHHHHHHHHccc
Confidence 222111100 000 00112456788999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCCCcC
Q 017021 356 DPTDRLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~~~~ 378 (379)
||++||++.++++||||.....|
T Consensus 240 ~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 240 DPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred CcccCcCHHHHHhChHhhhcchh
Confidence 99999999999999999887654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=303.89 Aligned_cols=279 Identities=33% Similarity=0.614 Sum_probs=214.6
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.+.||+|++|.||+|.++.+++.||+|+++.. ......+..|++++..+ .|++++.+.+.+..++..+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 76 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-----RHENIVNLKEAFRRKGRLY 76 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-----CCCCeeehhheEEECCEEE
Confidence 478889999999999999999999999999998642 23345677889988888 6799999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
++|||+++++.+.+..+. ..++...+..++.||+.||.|||+.|++|+|++|+||++
T Consensus 77 iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---------------------- 133 (288)
T cd07833 77 LVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---------------------- 133 (288)
T ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----------------------
Confidence 999999545544444332 258999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+.++.++|+|||.+....... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..
T Consensus 134 -----~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~ 208 (288)
T cd07833 134 -----SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI 208 (288)
T ss_pred -----CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 455667888888776443332 234578889999999887 7889999999999999999999999887777
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+....+..+............... ...++ ...............+.++.++|++||..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 271 (288)
T cd07833 209 DQLYLIQKCLGPLPPSHQELFSSNPRFAG----VAFPE-------------PSQPESLERRYPGKVSSPALDFLKACLRM 271 (288)
T ss_pred HHHHHHHHHhCCCCHHHhhhcccCccccc----cccCC-------------CCCcHHHHHhcCCccchHHHHHHHHHhcc
Confidence 77777777777776654443221110000 00000 00011111112233578899999999999
Q ss_pred CCCCCcCHHHHhcCCCC
Q 017021 356 DPTDRLTAREALRHPFF 372 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f 372 (379)
||++|||++++++||||
T Consensus 272 ~p~~Rps~~~il~~~~f 288 (288)
T cd07833 272 DPKERLTCDELLQHPYF 288 (288)
T ss_pred CchhcccHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=300.45 Aligned_cols=247 Identities=28% Similarity=0.437 Sum_probs=196.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch----------hhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.|.+...||+|++|.||+|.+..+++.||+|.+..... ....+..|+.++.++ .|++++++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-----QHENIVQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEE
Confidence 36778999999999999999999999999998863211 123456678888887 779999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
......++++||+ +++|.+++.... .++...+..++.|++.||+|||+.|++||||+|+||+++.++
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~---------- 143 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG---------- 143 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC----------
Confidence 9999999999999 889999998754 688999999999999999999999999999999999995444
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCC---------CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHH
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 263 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~ 263 (379)
.++|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|+
T Consensus 144 -----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~ 206 (267)
T cd06628 144 -----------------GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206 (267)
T ss_pred -----------------CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHh
Confidence 4555555554432211 12235788999999998888899999999999999999
Q ss_pred hCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchh
Q 017021 264 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343 (379)
Q Consensus 264 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (379)
+|+.||...+.......+.... .+ ......+.
T Consensus 207 ~g~~p~~~~~~~~~~~~~~~~~--~~----------------------------------------------~~~~~~~~ 238 (267)
T cd06628 207 TGKHPFPDCTQLQAIFKIGENA--SP----------------------------------------------EIPSNISS 238 (267)
T ss_pred hCCCCCCCccHHHHHHHHhccC--CC----------------------------------------------cCCcccCH
Confidence 9999998654433222111110 00 00123567
Q ss_pred HHHHHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 344 DLTHLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 344 ~~~~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
.+.++|++||+.||.+||++.|+++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 88999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=301.33 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=200.2
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec----
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---- 116 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~---- 116 (379)
..-.|++.+.||+|++|.||+|.++.+++.+|+|++.........+..|+.++.++ ..|++++++++++...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~----~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKY----SNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHh----cCCCChheEEEEEEecCCCC
Confidence 34578899999999999999999999999999999986655556677888888876 2578999999998654
Q ss_pred --ceEEEEEeCC-CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 117 --NHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 117 --~~~~lv~e~~-~~sL~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
...++||||+ +++|.+++.... ...+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~------------- 146 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL------------- 146 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE-------------
Confidence 4589999999 889999987532 3468999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhC-----CCCCCccchHhHHHHHHHHH
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELC 263 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~~l~ 263 (379)
+.++.++|+|||.+...... .....|+..|+|||.+.. ..++.++|||||||++|+|+
T Consensus 147 --------------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~ 212 (275)
T cd06608 147 --------------TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212 (275)
T ss_pred --------------ccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence 44556777777776533221 133468889999998753 34678999999999999999
Q ss_pred hCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchh
Q 017021 264 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343 (379)
Q Consensus 264 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (379)
+|+.||...........+... ..+ . +. ....++.
T Consensus 213 ~g~~p~~~~~~~~~~~~~~~~--~~~-~-------------------~~------------------------~~~~~~~ 246 (275)
T cd06608 213 DGKPPLCDMHPMRALFKIPRN--PPP-T-------------------LK------------------------SPENWSK 246 (275)
T ss_pred hCCCCccccchHHHHHHhhcc--CCC-C-------------------CC------------------------chhhcCH
Confidence 999999754433322221110 000 0 00 0112567
Q ss_pred HHHHHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 344 DLTHLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 344 ~~~~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
.+.++|++||..||++|||+.|+++|||+
T Consensus 247 ~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 247 KFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 89999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=311.54 Aligned_cols=279 Identities=26% Similarity=0.468 Sum_probs=215.6
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--- 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--- 116 (379)
..|.+.+.||+|+||.||+|.+..+++.||+|++.... .......+|+.++.++ .|+|++++.+.+...
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-----KHENVIGLLDVFTPARSL 91 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-----CCCcccceeeeeeecccc
Confidence 35778899999999999999999999999999986432 2234566788888887 779999998887543
Q ss_pred ---ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 117 ---NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 117 ---~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
...|+++++++++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 92 ~~~~~~~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll--------------- 153 (345)
T cd07877 92 EEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--------------- 153 (345)
T ss_pred cccccEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---------------
Confidence 457899999999999888654 48999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++|+|||.+...........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus 154 ------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 154 ------------NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred ------------cCCCCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 45566888888887655444444578889999999866 46789999999999999999999999887
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhh-hhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
+.......+.+..+..+..+...+..... .+... ....+. ..........++.+.++|.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~------------------~~~~~~~~~~~~~~~~li~~ 282 (345)
T cd07877 222 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQS-LTQMPK------------------MNFANVFIGANPLAVDLLEK 282 (345)
T ss_pred CHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHH-hcccCC------------------cchhhhcCCCCHHHHHHHHH
Confidence 77676677777777777666555433221 11110 000000 00011112356789999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
||+.||.+|||+.++++||||++-
T Consensus 283 ~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 283 MLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HcCCChhhcCCHHHHhcChhhhhc
Confidence 999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=302.90 Aligned_cols=276 Identities=33% Similarity=0.583 Sum_probs=217.7
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccch---hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
|++.+.||+|++|.||+|.+..+++.+|+|++..... .......|+.+++.+ .|++++++++.+..+...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-----NHPNIIKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-----cCCCcchHHHhhccCCCEEE
Confidence 5778999999999999999999999999999864322 345666788888888 67899999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
++||+.++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 76 v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili----------------------- 131 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI----------------------- 131 (283)
T ss_pred EEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE-----------------------
Confidence 99999779999887753 368999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
+.++.++|+|||.+....... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+.
T Consensus 132 ----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~ 207 (283)
T cd05118 132 ----NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ 207 (283)
T ss_pred ----CCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 455668888888776444332 224577889999998776 688999999999999999999999988777777
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+..+.+....+............ +.+.... .......+..+.+++++|.+||+.||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~---------------~~~~~~~~~~~~~~~~~i~~~l~~~P 268 (283)
T cd05118 208 LFKIFRTLGTPDPEVWPKFTSLARNYKF----SFPKKAG---------------MPLPKLFPNASPQALDLLSQMLHYDP 268 (283)
T ss_pred HHHHHHHcCCCchHhcccchhhhhhhhh----hhccccc---------------cCHHHhhhhhCHHHHHHHHHHhccCc
Confidence 6666666666655555554442222111 1111000 00011223467889999999999999
Q ss_pred CCCcCHHHHhcCCCC
Q 017021 358 TDRLTAREALRHPFF 372 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f 372 (379)
.+||++.+++.||||
T Consensus 269 ~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 269 HKRITAEQALAHPYF 283 (283)
T ss_pred ccCcCHHHHhhCCCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=311.64 Aligned_cols=278 Identities=28% Similarity=0.487 Sum_probs=214.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec----
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---- 116 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~---- 116 (379)
.|.+.+.||+|+||.||+|.+..+|+.||+|++... ......+..|+.++..+ .|+|++++.+++...
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-----QHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-----CCCCccchhheecccccCC
Confidence 567779999999999999999999999999998642 22234566788888887 779999999988754
Q ss_pred --ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 117 --NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 117 --~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
...++|+||+..+|.+++. ..+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---------------- 150 (342)
T cd07879 91 EFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---------------- 150 (342)
T ss_pred CCceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----------------
Confidence 3469999999778877653 258899999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+...........++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+
T Consensus 151 -----------~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 151 -----------NEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred -----------CCCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 45567888888887655444444567889999999866 457899999999999999999999999877
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
.......+....+..+..+.+.+...............+ ...........+..+.++|++||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~li~~~l 281 (342)
T cd07879 220 YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYP------------------RKDFSTLFPKASPQAVDLLEKML 281 (342)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcc------------------cchHHHHhcCCCHHHHHHHHHHc
Confidence 777777777777777666655543322111110000000 00011112345678999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+.||++||++++++.||||...
T Consensus 282 ~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 282 ELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred CCChhhCcCHHHHhcCcchhhc
Confidence 9999999999999999999764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=304.80 Aligned_cols=256 Identities=21% Similarity=0.354 Sum_probs=202.9
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.+.||+|+||.||++.+..+++.||+|.+... ......+.+|+.++.++ .|+|++++++.+..++..++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-----VSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-----CCCcHHhhhhheecCCeEEE
Confidence 588999999999999999999999999999988642 22335667788888877 77999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 122 VFEKL-GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
||||+ +++|.+++.... ...+++..+..++.|++.||.|||+ .|++||||||+||++
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~-------------------- 136 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV-------------------- 136 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE--------------------
Confidence 99999 889999887631 2358999999999999999999996 599999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCC-CCCcccccCCccchhhhhCC------CCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGL------GWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+..... ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..
T Consensus 137 -------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 137 -------NGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred -------CCCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 4456678888887754322 22334578899999998543 357899999999999999999999976
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.........+.......+. .....++.++.++|.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~li~~ 244 (286)
T cd06622 210 ETYANIFAQLSAIVDGDPP---------------------------------------------TLPSGYSDDAQDFVAK 244 (286)
T ss_pred cchhhHHHHHHHHhhcCCC---------------------------------------------CCCcccCHHHHHHHHH
Confidence 5443333333222211110 0112356789999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
||+.||++||++++++.||||....
T Consensus 245 ~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 245 CLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HcccCcccCCCHHHHhcChhhhhcc
Confidence 9999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=299.24 Aligned_cols=250 Identities=28% Similarity=0.465 Sum_probs=213.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|..++.||+|.||.|-+++.+.+|+.+|+|++++. .........|-.+++.. .||.+..+..+|+..+++
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-----~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-----RHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-----cCcHHHHhhhhhccCceE
Confidence 456779999999999999999999999999999742 23334445577777765 778899999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ ||.|.-.+++.. .+++..++.+-.+|+.||.|||+.+|+.||+|.+|.|+
T Consensus 244 CFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL-------------------- 301 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL-------------------- 301 (516)
T ss_pred EEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee--------------------
Confidence 9999999 999988887754 69999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccC---CCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
++++.+||+|||+++..- ....+.+|||.|+|||++....|+.++|.|.+||++|||++|+.||+..+..
T Consensus 302 -------DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 302 -------DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred -------ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 788889999999987433 3336689999999999999999999999999999999999999999987766
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
..+..|.-..-.+| ...+++++.|+..+|.+
T Consensus 375 kLFeLIl~ed~kFP-------------------------------------------------r~ls~eAktLLsGLL~k 405 (516)
T KOG0690|consen 375 KLFELILMEDLKFP-------------------------------------------------RTLSPEAKTLLSGLLKK 405 (516)
T ss_pred HHHHHHHhhhccCC-------------------------------------------------ccCCHHHHHHHHHHhhc
Confidence 66554433222222 24678999999999999
Q ss_pred CCCCCc-----CHHHHhcCCCCCCCC
Q 017021 356 DPTDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
||.+|. .|.|+.+|+||+..+
T Consensus 406 dP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 406 DPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred ChHhhcCCCchhHHHHHhhhhhccCC
Confidence 999998 599999999998764
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=303.67 Aligned_cols=277 Identities=31% Similarity=0.503 Sum_probs=209.8
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch---hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.++||+|+||.||+|.++.+++.||+|++..... ....+..|+.++..+ .|++++++++++..++..|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 76 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-----RHENLVNLIEVFRRKKRLY 76 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-----CCcchhhHHHhcccCCeEE
Confidence 47788999999999999999999999999999863221 234566788888887 6799999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+|+||+ +++|..+..... .+++..+..++.|++.||.|||+.|++|||++|+||++
T Consensus 77 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~--------------------- 133 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV--------------------- 133 (286)
T ss_pred EEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---------------------
Confidence 999999 777776655443 48999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+.++.++|+|||.+....... ....++..|+|||.+.+. .++.++||||||+++|+|++|++||......
T Consensus 134 ------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~ 207 (286)
T cd07846 134 ------SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI 207 (286)
T ss_pred ------CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH
Confidence 455667888888765432221 224578899999998753 4678999999999999999999999887777
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+....+.+++...+...... .... ...+... ............+..+.+++.+||+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~ 269 (286)
T cd07846 208 DQLYHIIKCLGNLIPRHQEIFQKNP--LFAG--MRLPEVK--------------EIEPLEKRFPKLSGLVLDLAKQCLRI 269 (286)
T ss_pred HHHHHHHHHhCCCchhhHHHhccch--Hhhc--ccccccc--------------CcchHHHhCCCcCHHHHHHHHHHhcC
Confidence 7666666666655433222111000 0000 0000000 00011122345678899999999999
Q ss_pred CCCCCcCHHHHhcCCCC
Q 017021 356 DPTDRLTAREALRHPFF 372 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f 372 (379)
||++||+++++++||||
T Consensus 270 ~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 270 DPDDRPSSSQLLHHEFF 286 (286)
T ss_pred CcccchhHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=301.55 Aligned_cols=251 Identities=26% Similarity=0.431 Sum_probs=190.6
Q ss_pred ccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeC
Q 017021 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 125 (379)
Q Consensus 50 ~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 125 (379)
.||+|+||.||++.+..+++.+|+|.+.... ........|...+..+.. .+|++++.+++.+..++..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhh--CCCCcEeEEEEEEecCCeEEEEEec
Confidence 4899999999999999999999999986432 112223334433333321 3678999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccccc
Q 017021 126 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 204 (379)
Q Consensus 126 ~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (379)
+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 79 ~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~------------------------- 131 (279)
T cd05633 79 MNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD------------------------- 131 (279)
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC-------------------------
Confidence 9 899999887654 689999999999999999999999999999999999994
Q ss_pred CCCCCCeEEeecCcccccCCC-CCcccccCCccchhhhh-CCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 017021 205 MPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282 (379)
Q Consensus 205 ~~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~ 282 (379)
.++.++|+|||.+...... .....||..|+|||... +..++.++|+||+||++|+|++|..||........ ..+.
T Consensus 132 --~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~ 208 (279)
T cd05633 132 --EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEID 208 (279)
T ss_pred --CCCCEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHH
Confidence 4456777777766533222 12346899999999986 45688999999999999999999999975322110 0111
Q ss_pred HHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCc-
Q 017021 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 361 (379)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp- 361 (379)
+.....+ ....+..+.++.++|++||+.||++||
T Consensus 209 ~~~~~~~---------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 209 RMTLTVN---------------------------------------------VELPDSFSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred HHhhcCC---------------------------------------------cCCccccCHHHHHHHHHHhcCCHHHhcC
Confidence 1000000 001123567899999999999999999
Q ss_pred ----CHHHHhcCCCCCCCCc
Q 017021 362 ----TAREALRHPFFTRDHL 377 (379)
Q Consensus 362 ----ta~e~l~hp~f~~~~~ 377 (379)
|++++++||||++.+.
T Consensus 244 ~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 244 CLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred CCCCCHHHHHhCccccCCCH
Confidence 6999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=301.36 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=202.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.++||.|+||.||+|.+..+++.||+|++.... .....+..|++++.++ +|+|++.+++.+..+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-----NHPFLVNLWYSFQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-----CCCChHHHHHhhcCCCeE
Confidence 4788899999999999999999999999999997432 2345667788888877 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++|+||+ +++|.+.+.... .+++..+..++.||+.||.|||+.|++|+||+|+||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~-------------------- 133 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL-------------------- 133 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE--------------------
Confidence 9999999 999999998763 68999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.++|+|||.+...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+...
T Consensus 134 -------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 206 (258)
T cd05578 134 -------DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI 206 (258)
T ss_pred -------cCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH
Confidence 45556778888777654333 233467889999999988889999999999999999999999998655321
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
............+ ......+..+.++|++||+.|
T Consensus 207 ~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~i~~~l~~~ 240 (258)
T cd05578 207 RDQIRAKQETADV----------------------------------------------LYPATWSTEAIDAINKLLERD 240 (258)
T ss_pred HHHHHHHhccccc----------------------------------------------cCcccCcHHHHHHHHHHccCC
Confidence 1111111000000 011234578999999999999
Q ss_pred CCCCcCH--HHHhcCCCC
Q 017021 357 PTDRLTA--REALRHPFF 372 (379)
Q Consensus 357 P~~Rpta--~e~l~hp~f 372 (379)
|.+||++ +|+++||||
T Consensus 241 p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 241 PQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred hhHcCCccHHHHhcCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=302.01 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=198.5
Q ss_pred cccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 51 Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
||+|+||+||+|.+..+|+.||+|++.... .....+..|+.++..+ .|++++.+++.++..+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-----SSRFIVSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-----CCCCEeeeeeEEecCCeEEEEEecC
Confidence 699999999999999999999999986421 2234446688888887 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 127 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 127 -~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
+++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~--------------------------- 128 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL--------------------------- 128 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---------------------------
Confidence 8999999977654568999999999999999999999999999999999999
Q ss_pred CCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHH
Q 017021 206 PKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~ 283 (379)
+.++.++|+|||.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.+
T Consensus 129 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05577 129 DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208 (277)
T ss_pred CCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh
Confidence 44556777777766543221 1234577889999999888889999999999999999999999976443111111111
Q ss_pred HcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCc--
Q 017021 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL-- 361 (379)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-- 361 (379)
..... .....+..++.+.++|.+||+.||++||
T Consensus 209 ~~~~~---------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 243 (277)
T cd05577 209 RTLEM---------------------------------------------AVEYPDKFSPEAKDLCEALLQKDPEKRLGC 243 (277)
T ss_pred ccccc---------------------------------------------cccCCccCCHHHHHHHHHHccCChhHccCC
Confidence 00000 0001123567899999999999999999
Q ss_pred ---CHHHHhcCCCCCCCCcC
Q 017021 362 ---TAREALRHPFFTRDHLR 378 (379)
Q Consensus 362 ---ta~e~l~hp~f~~~~~~ 378 (379)
++.++++||||++-+.+
T Consensus 244 ~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 244 RGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred CcccHHHHHhChhhhcCChh
Confidence 99999999999887664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.61 Aligned_cols=269 Identities=24% Similarity=0.420 Sum_probs=205.5
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee--cc
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RN 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~--~~ 117 (379)
-.|+++++||+|+||+||+|+++.++..||+|++... ......+..|+.++..+ .|++|+.++++|.. ..
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-----~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-----KHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-----CCCCcCeEEEEEEecCCC
Confidence 3688999999999999999999999999999998742 23345677899999988 77999999998854 46
Q ss_pred eEEEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHc-------CCcccCCCCCcEEEecccccccC
Q 017021 118 HICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDL-------CMIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-------~iiH~dlkp~Nili~~~~~~~~~ 187 (379)
.+|+||||+ +++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||+...... +.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~-lg 166 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH-IG 166 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc-cc
Confidence 799999999 89999998753 123689999999999999999999984 49999999999999643210 00
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC--CCCCCccchHhHHHHHHHHH
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELC 263 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~~l~ 263 (379)
+.... ....+....++|+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 167 ~i~~~---------~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 167 KITAQ---------ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred ccccc---------ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 00000 0011344569999999987544332 34578999999999864 34789999999999999999
Q ss_pred hCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchh
Q 017021 264 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343 (379)
Q Consensus 264 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (379)
+|..||...+..............+| ....+.
T Consensus 238 TGk~PF~~~~~~~qli~~lk~~p~lp------------------------------------------------i~~~S~ 269 (1021)
T PTZ00266 238 SGKTPFHKANNFSQLISELKRGPDLP------------------------------------------------IKGKSK 269 (1021)
T ss_pred HCCCCCCcCCcHHHHHHHHhcCCCCC------------------------------------------------cCCCCH
Confidence 99999976554332221111100000 012467
Q ss_pred HHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 344 DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 344 ~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
++.+||..||+.+|.+||++.|+|.|||++.
T Consensus 270 eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 270 ELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 8999999999999999999999999999974
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=297.03 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=203.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.+.||+|++|.||+|.+..+++.+|+|.+... ......+..|+.+++++ .|++++.+++.+..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-----SHPNIIEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-----CCCchhheeeeEecCCEEE
Confidence 478889999999999999999999999999998643 22345566788888887 6789999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.......+++..+..++.+++.||.|||++|++||||+|+||+++.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~------------------- 136 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK------------------- 136 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-------------------
Confidence 999999 889999998765456899999999999999999999999999999999999942
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
.+..++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+....
T Consensus 137 -------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 209 (256)
T cd08220 137 -------HKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL 209 (256)
T ss_pred -------CCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH
Confidence 23457888888776443322 234678899999999888889999999999999999999999976554333
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+...... . ..+..+..+.+++.+||+.||
T Consensus 210 ~~~~~~~~~~----------------------~--------------------------~~~~~~~~l~~li~~~l~~~p 241 (256)
T cd08220 210 VLKIMSGTFA----------------------P--------------------------ISDRYSPDLRQLILSMLNLDP 241 (256)
T ss_pred HHHHHhcCCC----------------------C--------------------------CCCCcCHHHHHHHHHHccCCh
Confidence 2222111000 0 012356789999999999999
Q ss_pred CCCcCHHHHhcCCCC
Q 017021 358 TDRLTAREALRHPFF 372 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f 372 (379)
++|||+.|+++||||
T Consensus 242 ~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 242 SKRPQLSQIMAQPIC 256 (256)
T ss_pred hhCCCHHHHhhCCCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=299.26 Aligned_cols=253 Identities=25% Similarity=0.459 Sum_probs=200.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
.|++.+.||+|++|.||++.+..+++.||+|++.... .....+..|+..++.+ .|++++++++.+.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-----NHPHIIRMLGATCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-----CCCceehhhceeccC
Confidence 3778899999999999999999999999999986322 1235667788888887 779999999999999
Q ss_pred ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 117 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
++.++|+||+ +++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.+
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~-------------- 139 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST-------------- 139 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--------------
Confidence 9999999999 899999997754 68899999999999999999999999999999999999432
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCC-------CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
+..++|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus 140 ------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 207 (268)
T cd06630 140 ------------GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207 (268)
T ss_pred ------------CCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 234777888776543322 1224578899999999888889999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|...........+.+.... .... ...+..+..+.++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~------------------~~~~--------------------------~~~~~~~~~~~~~ 243 (268)
T cd06630 208 WNAEKHSNHLALIFKIASA------------------TTAP--------------------------SIPEHLSPGLRDV 243 (268)
T ss_pred CCCCCCcchHHHHHHHhcc------------------CCCC--------------------------CCchhhCHHHHHH
Confidence 9654322211111111000 0000 0112356789999
Q ss_pred HhhccccCCCCCcCHHHHhcCCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f~ 373 (379)
+.+||+.||++|||+.++++||||.
T Consensus 244 i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 244 TLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=300.35 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=196.5
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
...|++.+.||+|+||.||+|++..+++.||+|++.... .....+..|+.++.++ .|++++.+++.+..+...+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-----KHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-----CCCCeeeeeEEEEeCCEEE
Confidence 346899999999999999999999999999999987432 2234456788888777 7799999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++|||++|+||+++
T Consensus 83 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~-------------------- 140 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT-------------------- 140 (267)
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC--------------------
Confidence 999999 889999987654 689999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhh---CCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
.++.++|+|||.+...... .....|+..|+|||.+. ...++.++|+|||||++|+|++|..||....
T Consensus 141 -------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 141 -------DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred -------CCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 4455777777776543221 12346788999999884 3447789999999999999999999986433
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.... ...+. . .....++..+.++|++||
T Consensus 214 ~~~~~~~~~~~~-----------------------~~~~~----------------~-----~~~~~~~~~~~~li~~~l 249 (267)
T cd06646 214 PMRALFLMSKSN-----------------------FQPPK----------------L-----KDKTKWSSTFHNFVKISL 249 (267)
T ss_pred hhhhheeeecCC-----------------------CCCCC----------------C-----ccccccCHHHHHHHHHHh
Confidence 222111000000 00000 0 001135678999999999
Q ss_pred ccCCCCCcCHHHHhcCCC
Q 017021 354 RYDPTDRLTAREALRHPF 371 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~ 371 (379)
+.||++|||++++++|+|
T Consensus 250 ~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 250 TKNPKKRPTAERLLTHLF 267 (267)
T ss_pred hCChhhCcCHHHHhcCCC
Confidence 999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=310.76 Aligned_cols=279 Identities=28% Similarity=0.493 Sum_probs=218.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc---
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--- 117 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~--- 117 (379)
.|++.+.||.|++|.||+|.+..+++.||+|++... ......+..|+.+++.+ .|++++.+.+++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-----RHENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-----CCcchhhhhhhhcccCccc
Confidence 478889999999999999999999999999998743 22345667788888888 6799999999988765
Q ss_pred --eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 118 --HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 118 --~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
..|++|||++++|.+++.... .+++..+..++.||+.||++||+.|++||||||+||+++
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~---------------- 137 (330)
T cd07834 76 FNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN---------------- 137 (330)
T ss_pred ccceEEEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----------------
Confidence 799999999878999987654 689999999999999999999999999999999999994
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
.++.++|+|||.+....... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus 138 -----------~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~p 206 (330)
T cd07834 138 -----------SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL 206 (330)
T ss_pred -----------CCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCC
Confidence 44566677776665433221 234578899999999877 788999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhh-hhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
|.+.+..+....+....+.+++..+.... .....+..... ..............+..+.+
T Consensus 207 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~ 267 (330)
T cd07834 207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLP-------------------KKPKKPLSKLFPGASPEAID 267 (330)
T ss_pred cCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcc-------------------cCCcchhHHhcccCCHHHHH
Confidence 99988888887787777777765544211 11111111100 00001111122346788999
Q ss_pred HHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 348 LLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+|++||+.||++|||++++++||||++.
T Consensus 268 li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 268 LLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred HHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 9999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=300.97 Aligned_cols=276 Identities=29% Similarity=0.469 Sum_probs=212.3
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec--ceE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHI 119 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--~~~ 119 (379)
|++.++||+|++|.||+|.+..+++.+|+|++... ......+..|+.++..+ .|++++.+++.+... +..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-----RHPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-----cCCCeeeheeeEecCCCCcE
Confidence 67789999999999999999999999999999754 23345566788888888 679999999999888 899
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 120 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 120 ~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
++|+||++++|.+++.... ..+++..+..++.||+.||+|||+.|++|+||+|+||+++
T Consensus 76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~-------------------- 134 (287)
T cd07840 76 YMVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN-------------------- 134 (287)
T ss_pred EEEeccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc--------------------
Confidence 9999999779998887653 3689999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
.++.++|+|||.+....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.
T Consensus 135 -------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 135 -------NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred -------CCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 44556777777665433322 22356778999997764 4578999999999999999999999998877
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhc-cchhHHHHHHhhcc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD-HSAGDLTHLLQGLL 353 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L 353 (379)
......+.+..+.++...|..+....... . .. .............. .++..+.+++++||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--------------~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 268 (287)
T cd07840 208 LEQLEKIFELCGSPTDENWPGVSKLPWFE--N--------------LK---PKKPYKRRLREFFKHLIDPSALDLLDKLL 268 (287)
T ss_pred HHHHHHHHHHhCCCchhhccccccchhhh--h--------------cc---ccccchhHHHHHhcccCCHHHHHHHHHHc
Confidence 77777777766666555444332220000 0 00 00000011111112 24789999999999
Q ss_pred ccCCCCCcCHHHHhcCCCC
Q 017021 354 RYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f 372 (379)
+.||.+||++.++++||||
T Consensus 269 ~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 269 TLDPKKRISADQALQHEYF 287 (287)
T ss_pred CCChhhCcCHHHHhhCcCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=300.39 Aligned_cols=237 Identities=16% Similarity=0.162 Sum_probs=190.9
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchh----hHhHHHHHHHHHHHHhcCCCCCeeEEecceeee----cceEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHIC 120 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----~~~~~ 120 (379)
..||+|++|.||+|.+ +|+.||+|.++..... ...+.+|+.++.++ .|+|++++++++.+ ....+
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-----DSNNILKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-----CCCCEEEEeeeEEecccCCCceE
Confidence 6789999999999976 6889999999754332 24556899999988 77899999998876 45789
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+||||+ +++|.+++.... .+++.....++.+++.||.|||+ .+++||||||+||++
T Consensus 99 lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill-------------------- 156 (283)
T PHA02988 99 LILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV-------------------- 156 (283)
T ss_pred EEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE--------------------
Confidence 999999 899999998754 68899999999999999999998 599999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC--CCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.++|+|||.+...........||..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+
T Consensus 157 -------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~ 229 (283)
T PHA02988 157 -------TENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE 229 (283)
T ss_pred -------CCCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH
Confidence 55566788888877654433334568899999999976 678999999999999999999999998766554
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+......++ . ....+..+.++|.+||+.|
T Consensus 230 ~~~~i~~~~~~~~---------------------~--------------------------~~~~~~~l~~li~~cl~~d 262 (283)
T PHA02988 230 IYDLIINKNNSLK---------------------L--------------------------PLDCPLEIKCIVEACTSHD 262 (283)
T ss_pred HHHHHHhcCCCCC---------------------C--------------------------CCcCcHHHHHHHHHHhcCC
Confidence 4433322111110 0 1135678999999999999
Q ss_pred CCCCcCHHHHhc
Q 017021 357 PTDRLTAREALR 368 (379)
Q Consensus 357 P~~Rpta~e~l~ 368 (379)
|++|||++|+++
T Consensus 263 p~~Rps~~ell~ 274 (283)
T PHA02988 263 SIKRPNIKEILY 274 (283)
T ss_pred cccCcCHHHHHH
Confidence 999999999984
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=285.15 Aligned_cols=258 Identities=22% Similarity=0.270 Sum_probs=205.9
Q ss_pred eeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 35 ITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
...+.+++.+|+|.+.||+|||+-||+++...+++.||+|++.... .....+++|++...++ +++|++++.+..
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-----~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-----NSPNVLRLVDHQ 87 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-----CCcchHHHHHHH
Confidence 4457788999999999999999999999999999999999998654 5677888999999988 779999888776
Q ss_pred eec-----ceEEEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCcEEEecccc
Q 017021 114 DYR-----NHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEY 183 (379)
Q Consensus 114 ~~~-----~~~~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiH~dlkp~Nili~~~~~ 183 (379)
..+ ...|++++|. .|+|.+.+... .+..+++.+++.|+.+|+.||.+||+.. ++||||||.||++.
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---- 163 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---- 163 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec----
Confidence 432 3599999999 99999998753 2335899999999999999999999998 99999999999994
Q ss_pred cccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCC------------cccccCCccchhhhhC---CCCCC
Q 017021 184 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN------------YIVSTRHYRAPEVILG---LGWTY 248 (379)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~------------~~~gt~~y~aPE~~~~---~~~~~ 248 (379)
..+.++|.|||.+....-.-. .-.-|..|.|||.+.- .-.+.
T Consensus 164 -----------------------~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~e 220 (302)
T KOG2345|consen 164 -----------------------DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITE 220 (302)
T ss_pred -----------------------CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCccccc
Confidence 445667777776653322211 1123788999999864 34789
Q ss_pred ccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccch
Q 017021 249 PCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328 (379)
Q Consensus 249 ~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (379)
++|||||||++|.|+.|..||...- +.- .++.-.+.++.+.+|+..
T Consensus 221 rtDIWSLGCtLYa~mf~~sPfe~~~---------~~G------------gSlaLAv~n~q~s~P~~~------------- 266 (302)
T KOG2345|consen 221 RTDIWSLGCTLYAMMFGESPFERIY---------QQG------------GSLALAVQNAQISIPNSS------------- 266 (302)
T ss_pred ccchhhhhHHHHHHHHcCCcchHHh---------hcC------------CeEEEeeeccccccCCCC-------------
Confidence 9999999999999999999996311 000 112234566677777632
Q ss_pred hhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 329 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.++..+.++|..||+.||.+||++.+++.+
T Consensus 267 -----------~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 267 -----------RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred -----------CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 377889999999999999999999999864
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=328.68 Aligned_cols=286 Identities=23% Similarity=0.302 Sum_probs=196.4
Q ss_pred hhhhhhhccccccceeEEEEEecCCC-ceEEE------------------EEeeccchhhHhHHHHHHHHHHHHhcCCCC
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERK-EMVAI------------------KIVRGIKKYREAAMIEIEVLQQLAKHDKGG 103 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~-~~vAi------------------K~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 103 (379)
..|++.++||+|+||+||+|..+... ...+. |.+.........+.+|+.++.++ .|
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-----~H 222 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-----NH 222 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-----CC
Confidence 46899999999999999998765332 22222 22222223344566788888888 78
Q ss_pred CeeEEecceeeecceEEEEEeCCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEec
Q 017021 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 180 (379)
Q Consensus 104 ~~i~~~~~~~~~~~~~~lv~e~~~~sL~~~l~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~ 180 (379)
+||+++++++...+..|+++++++++|.+++.... ........+..++.||+.||.|||+.||+||||||+|||+
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl-- 300 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL-- 300 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--
Confidence 99999999999999999999999888888875432 1123456788899999999999999999999999999999
Q ss_pred ccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHH
Q 017021 181 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVG 256 (379)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 256 (379)
+.++.++|+|||++....... ....||..|+|||++.+..++.++||||||
T Consensus 301 -------------------------~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 355 (501)
T PHA03210 301 -------------------------NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCG 355 (501)
T ss_pred -------------------------CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHH
Confidence 455668888888886543322 234689999999999998999999999999
Q ss_pred HHHHHHHhCCCC-CCCC--chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHH
Q 017021 257 CILVELCTGEAL-FQTH--ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 333 (379)
Q Consensus 257 ~il~~l~~g~~p-f~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (379)
|++|+|++|..+ +... ........+....+....++ +.....+..++....+... . . .....
T Consensus 356 vil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~i~~~~~~~~--~---~---------~~~~~ 420 (501)
T PHA03210 356 LILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEF-PDPPCKLFDYIDSAEIDHA--G---H---------SVPPL 420 (501)
T ss_pred HHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhc-CCcHHHHHHHhhhhhcccC--c---c---------chhhH
Confidence 999999998754 4322 22222333333222222111 0000011111111100000 0 0 00001
Q ss_pred HHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 334 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 334 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
.. ....+.++.++|.+||++||.+||||.|+|+||||.....
T Consensus 421 ~~--~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~ 462 (501)
T PHA03210 421 IR--NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE 462 (501)
T ss_pred HH--hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence 10 1124567889999999999999999999999999987653
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=294.62 Aligned_cols=249 Identities=28% Similarity=0.441 Sum_probs=203.5
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.+.||.|+||.||.+++..+++.+|+|.+... ......+.+|+.+++++ +|++++++++++.+.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-----QHPNIIAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-----CCCCeeEEEeEEecCCeEE
Confidence 478889999999999999999999999999998632 33445667888888887 7799999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
++|||+ +++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~-------------------- 135 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT-------------------- 135 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe--------------------
Confidence 999999 89999999876444689999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.++.++|+|||.+....... ....|++.|.|||.+.+..++.++|+||||+++|+|++|..||...+..+
T Consensus 136 -------~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08221 136 -------KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN 208 (256)
T ss_pred -------CCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 44456777777665332222 33468899999999988888999999999999999999999997755544
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.. +..+. .....+.++.++|.+||..|
T Consensus 209 ~~~~~~~--~~~~~----------------------------------------------~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08221 209 LVVKIVQ--GNYTP----------------------------------------------VVSVYSSELISLVHSLLQQD 240 (256)
T ss_pred HHHHHHc--CCCCC----------------------------------------------CccccCHHHHHHHHHHcccC
Confidence 4333221 11110 00235678999999999999
Q ss_pred CCCCcCHHHHhcCCCC
Q 017021 357 PTDRLTAREALRHPFF 372 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f 372 (379)
|++||++.++++|||+
T Consensus 241 p~~R~s~~~ll~~~~l 256 (256)
T cd08221 241 PEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCCCHHHHhhCcCC
Confidence 9999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=300.85 Aligned_cols=257 Identities=23% Similarity=0.427 Sum_probs=196.8
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.+.||+|+||.||+|.++.+|+.||+|+++... ........|...+.+. .+|+|++++++++..++.+|+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~----~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS----VDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHH----cCCCCeeeeeEEEecCCcEEE
Confidence 4778899999999999999999999999999987432 2233444455543332 377999999999999999999
Q ss_pred EEeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 122 VFEKLGSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+|||+.++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~-------------------- 137 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI-------------------- 137 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE--------------------
Confidence 9999988998888652 223689999999999999999999997 99999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC----CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG----LGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++|+|||.+....... ....|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...
T Consensus 138 -------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 138 -------NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred -------CCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 455567777877765432221 22457889999998864 45689999999999999999999999642
Q ss_pred c-hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 273 E-NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 273 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
. ..+....... +..+ ..+ .+.++.++.++|.+
T Consensus 211 ~~~~~~~~~~~~--~~~~--------------------~~~-------------------------~~~~~~~l~~li~~ 243 (283)
T cd06617 211 KTPFQQLKQVVE--EPSP--------------------QLP-------------------------AEKFSPEFQDFVNK 243 (283)
T ss_pred ccCHHHHHHHHh--cCCC--------------------CCC-------------------------ccccCHHHHHHHHH
Confidence 2 2221111111 0000 000 01256789999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCCCcC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~~~~ 378 (379)
||..||++||+++|+++||||.....+
T Consensus 244 ~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 244 CLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred HccCChhhCcCHHHHhcCchhhhcccc
Confidence 999999999999999999999987644
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=313.14 Aligned_cols=305 Identities=30% Similarity=0.566 Sum_probs=243.8
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCC-CCeeEEecceeeecce
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG-GNRCVQIRNWFDYRNH 118 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~-~~~i~~~~~~~~~~~~ 118 (379)
.-.-.|.|..-.|+|-|++|..|.+...|+.||||++.+++.....-+.|+++|.++...+.. ..+|++++..|...+|
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 344568888899999999999999999999999999999888888889999999999776643 3579999999999999
Q ss_pred EEEEEeCCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKLGSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~~~sL~~~l~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+|+|+|....+|.+++.+.+ +-.|...++..++.|+..||..|-.+||+|.||||+|||++
T Consensus 509 LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN------------------ 570 (752)
T KOG0670|consen 509 LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN------------------ 570 (752)
T ss_pred eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec------------------
Confidence 99999999999999998854 23588999999999999999999999999999999999996
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCCCc-ccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.+...+||||||.|.....+..+ +..+..|.|||++.+.+|+.+-|+||+||+||||.||+..|.+.+...
T Consensus 571 --------E~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 571 --------ESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred --------cCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence 35677999999999876666543 456778999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCC---------------CCCCCCCchhhhhhhccchhhHHHHHHhhccc
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRL---------------DWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (379)
.+...+.+-|++|..++.+-+=.-..+..+-.+ .++.-..+.+-...++..+.... -....
T Consensus 643 MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~d----eq~~~ 718 (752)
T KOG0670|consen 643 MLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPD----EQPKI 718 (752)
T ss_pred HHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCc----hhHHH
Confidence 999999999999998876633211111111000 01111111111111221111100 01124
Q ss_pred hhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 342 ~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
...+++|+.+||..||++|.|..|+|+||||+.
T Consensus 719 ~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 719 VQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 567999999999999999999999999999985
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.93 Aligned_cols=281 Identities=27% Similarity=0.453 Sum_probs=212.8
Q ss_pred hhhhhhccccccceeEEEEEecCC--CceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee---
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRER--KEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--- 115 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~--~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~--- 115 (379)
.|++.+.||+|+||.||++.+..+ +..||+|++... ......+..|+.++.++ .+|++++++++....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l----~~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHF----RGHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHh----cCCCChheeeeeeeeccc
Confidence 377889999999999999999888 899999998642 12234566788888776 257889998876432
Q ss_pred -cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 -RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 -~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
....++++++++++|.+.+.... .+++..+..++.||+.||.|||+.|++||||||+||+++.+
T Consensus 77 ~~~~~~~~~e~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~------------- 141 (332)
T cd07857 77 NFNELYLYEELMEADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD------------- 141 (332)
T ss_pred cCCcEEEEEecccCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC-------------
Confidence 35688999999889999987644 68999999999999999999999999999999999999544
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC-------CCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
+.++|+|||.+...... .....||..|+|||.+.+ ..++.++|+||+||++|+|++|+
T Consensus 142 --------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~ 207 (332)
T cd07857 142 --------------CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207 (332)
T ss_pred --------------CCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 45566666655432211 122468899999998765 56889999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||...+..+....+....+.++...+..+...............+. ..........+..+.
T Consensus 208 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~ 269 (332)
T cd07857 208 PVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPK------------------KPFESIFPNANPLAL 269 (332)
T ss_pred cCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCC------------------cchHhhCCCCCHHHH
Confidence 99998888888888888888887766555433221111110000000 000111233567899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+++.+||+.||.+|||+.|++.||||.+-
T Consensus 270 ~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 270 DLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 99999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=305.04 Aligned_cols=281 Identities=27% Similarity=0.478 Sum_probs=220.0
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-cc
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RN 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~-~~ 117 (379)
.-.|++.+.||.|+||.||+|.++.+++.||+|++... ......+..|+.++..+ .|+|++++.+++.. ..
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-----RHENIISLSDIFISPLE 83 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-----CCCCeeeEeeeEecCCC
Confidence 34588899999999999999999999999999987532 22345566788888888 67999999998865 56
Q ss_pred eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 118 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 118 ~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
..++++||++++|.+++... .++...+..++.|++.||.|||+.|++||||+|+||++
T Consensus 84 ~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili------------------- 141 (328)
T cd07856 84 DIYFVTELLGTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI------------------- 141 (328)
T ss_pred cEEEEeehhccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE-------------------
Confidence 78999999988999888653 47888899999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+..+.++|+|||.+...........++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.......
T Consensus 142 --------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~ 213 (328)
T cd07856 142 --------NENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213 (328)
T ss_pred --------CCCCCEEeCccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 44556788888877655444444567889999998765 568899999999999999999999998877777
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhh-hhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
....+.+..+.+|+++...+.... ..+........ + ..........+..+.++|++||+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~---~~~~~~~~~~~~~~~~li~~~l~~ 274 (328)
T cd07856 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKRE----------------P---VPFSEKFKNADPSAIDLLEKMLVF 274 (328)
T ss_pred HHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccC----------------C---CcHHHHcCCCCHHHHHHHHHHcCC
Confidence 777788888888887766532211 11111000000 0 000011234567899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~~ 376 (379)
||++|||+++++.||||...+
T Consensus 275 ~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 275 DPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred ChhhCCCHHHHhcCCcccccc
Confidence 999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=297.44 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=199.8
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.+.||.|++|+||+|.+..++..+|+|++.... .....+..|+..+..+ .|++++.+++.+......++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-----NHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-----CCCCEEEEEEEEeeCCEEEE
Confidence 5788999999999999999999899999999986432 2345667788877777 67899999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 122 VFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
++|++ +++|.+++..... ..+++..+..++.|++.||.+||+.|++||||+|+||+++
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~-------------------- 136 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-------------------- 136 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc--------------------
Confidence 99999 8999999976432 3589999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
.++.++|+|||.+....... ....|+..|+|||.+... .++.++|+|||||++|+|++|+.||..
T Consensus 137 -------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 209 (267)
T cd06610 137 -------EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209 (267)
T ss_pred -------CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence 44556777777654322221 223688899999998776 688999999999999999999999976
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+.........+. .+.. .+. .......+..+.+++.+
T Consensus 210 ~~~~~~~~~~~~~---~~~~-------------------~~~---------------------~~~~~~~~~~~~~li~~ 246 (267)
T cd06610 210 YPPMKVLMLTLQN---DPPS-------------------LET---------------------GADYKKYSKSFRKMISL 246 (267)
T ss_pred cChhhhHHHHhcC---CCCC-------------------cCC---------------------ccccccccHHHHHHHHH
Confidence 5443322221111 0000 000 00012356789999999
Q ss_pred ccccCCCCCcCHHHHhcCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f 372 (379)
||+.||++|||+.|+++||||
T Consensus 247 ~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 247 CLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HcCCChhhCcCHHHHhhCCCC
Confidence 999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=299.89 Aligned_cols=260 Identities=23% Similarity=0.383 Sum_probs=199.5
Q ss_pred eeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee-
Q 017021 36 TYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD- 114 (379)
Q Consensus 36 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~- 114 (379)
........+|++.+.||+|+||.||+|.++.+++.+|+|+++........+..|..++..+. .|+|++++++.+.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~ 86 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS----DHPNVVKFYGMYYK 86 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHh----cCCCeeeeeeeeee
Confidence 34445667889999999999999999999999999999998754444455667888887773 4789999998763
Q ss_pred ----ecceEEEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccC
Q 017021 115 ----YRNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 115 ----~~~~~~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~ 187 (379)
.+...++||||+ +++|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~-------- 158 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT-------- 158 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC--------
Confidence 456799999999 99999987642 223588899999999999999999999999999999999994
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhC-----CCCCCccchHhHHHHH
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCIL 259 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il 259 (379)
.++.++|+|||.+...... .....|+..|+|||++.. ..++.++|||||||++
T Consensus 159 -------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~ 219 (286)
T cd06638 159 -------------------TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITA 219 (286)
T ss_pred -------------------CCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHH
Confidence 4455777777776543221 123468899999998753 3478899999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhc
Q 017021 260 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339 (379)
Q Consensus 260 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (379)
|+|++|+.||............... ..+. . ....
T Consensus 220 ~el~~g~~p~~~~~~~~~~~~~~~~--~~~~--------------------~------------------------~~~~ 253 (286)
T cd06638 220 IELGDGDPPLADLHPMRALFKIPRN--PPPT--------------------L------------------------HQPE 253 (286)
T ss_pred HHHhcCCCCCCCCchhHHHhhcccc--CCCc--------------------c------------------------cCCC
Confidence 9999999999765432221111000 0000 0 0011
Q ss_pred cchhHHHHHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 340 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
.++..+.++|.+||+.||++|||+.|+++|+||
T Consensus 254 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 245679999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=300.25 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=198.3
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec-----
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR----- 116 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~----- 116 (379)
...|.+.+.||+|+||.||+|.++.+++.+|+|++............|+.++..+ ..|+|++++++.+...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l----~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL----PNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHh----cCCCCeEEEEEEEEeccccCC
Confidence 4568888999999999999999999999999999975444455666788777776 2578999999988643
Q ss_pred ceEEEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 117 NHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
...|+||||+ +++|.+++... ....+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili--------------- 161 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL--------------- 161 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---------------
Confidence 4689999999 88999988642 22468999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCC-----CCCCccchHhHHHHHHHHHhC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~~l~~g 265 (379)
+.++.++|+|||.+...... .....|+..|+|||.+... .++.++|+|||||++|+|++|
T Consensus 162 ------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g 229 (291)
T cd06639 162 ------------TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229 (291)
T ss_pred ------------cCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhC
Confidence 44556788888876543321 2334678899999997543 267899999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
+.||......+....+.+ +..+. .. ..+..+..+
T Consensus 230 ~~p~~~~~~~~~~~~~~~--~~~~~--------------------~~------------------------~~~~~~~~l 263 (291)
T cd06639 230 DPPLFDMHPVKTLFKIPR--NPPPT--------------------LL------------------------HPEKWCRSF 263 (291)
T ss_pred CCCCCCCcHHHHHHHHhc--CCCCC--------------------CC------------------------cccccCHHH
Confidence 999976544332221111 11000 00 011245679
Q ss_pred HHHHhhccccCCCCCcCHHHHhcCCCCC
Q 017021 346 THLLQGLLRYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~hp~f~ 373 (379)
.++|.+||+.||++||++.|+++||||+
T Consensus 264 ~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 264 NHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 9999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=324.58 Aligned_cols=258 Identities=27% Similarity=0.371 Sum_probs=209.8
Q ss_pred ceeeeeeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeec-cchhhHhHHHHHHHHHHHHhcCCCCCeeEE
Q 017021 30 NMFNLITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108 (379)
Q Consensus 30 ~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~ 108 (379)
........+......++|.+.|.+|||+.||+|.+...|..||+|++-. ++.......+|+++++.+ .+|+|||.
T Consensus 24 ~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L----~gh~nIV~ 99 (738)
T KOG1989|consen 24 ENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLL----SGHKNIVS 99 (738)
T ss_pred ccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHh----cCCCceee
Confidence 3445567888999999999999999999999999998889999999864 444556777899999998 57899999
Q ss_pred ecceee-e------cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCcEEE
Q 017021 109 IRNWFD-Y------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLL 178 (379)
Q Consensus 109 ~~~~~~-~------~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiH~dlkp~Nili 178 (379)
+++... . .-.+.|+|||| |++|-++|.......|++.+++.|+.+++.|+.+||.+. |||||||-+|||+
T Consensus 100 yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl 179 (738)
T KOG1989|consen 100 YIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL 179 (738)
T ss_pred EeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE
Confidence 999432 1 13578999999 799999998765556999999999999999999999887 9999999999999
Q ss_pred ecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC------------CcccccCCccchhhhh---C
Q 017021 179 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------------NYIVSTRHYRAPEVIL---G 243 (379)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------------~~~~gt~~y~aPE~~~---~ 243 (379)
..++..||||||.+.-.-... -...-|+.|+|||.+. +
T Consensus 180 ---------------------------s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg 232 (738)
T KOG1989|consen 180 ---------------------------SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSG 232 (738)
T ss_pred ---------------------------cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcC
Confidence 555677778888764221111 1134689999999984 6
Q ss_pred CCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhh
Q 017021 244 LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 323 (379)
Q Consensus 244 ~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (379)
.+.+.|+|||+|||+||-|+....||...... .+.++.+.+|..
T Consensus 233 ~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------------------------aIlng~Y~~P~~--------- 276 (738)
T KOG1989|consen 233 LPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------------------------AILNGNYSFPPF--------- 276 (738)
T ss_pred CCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------------------------eEEeccccCCCC---------
Confidence 67899999999999999999999999754322 244555555542
Q ss_pred hccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 324 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+.++..+.+||+.||+.||++||++.|++.+
T Consensus 277 ---------------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 277 ---------------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ---------------ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 3578899999999999999999999999864
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=297.84 Aligned_cols=277 Identities=29% Similarity=0.482 Sum_probs=207.4
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce---
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH--- 118 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~--- 118 (379)
|++.+.||+|+||.||+|+++.+++.||+|.+.... ........|+.++.++.. ..|++++++++.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES--FEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhc--cCCCCcceEEEEEeeccCCCC
Confidence 677899999999999999999899999999997322 223345567777766632 257899999999987766
Q ss_pred --EEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 119 --ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 119 --~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
.+++||++.++|.+++.......+++..+..++.|++.||.|||+.|++|+|++|+||++
T Consensus 79 ~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili------------------ 140 (287)
T cd07838 79 LKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV------------------ 140 (287)
T ss_pred ceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE------------------
Confidence 999999997789998877544468999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
+.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++|.+||...+.
T Consensus 141 ---------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 141 ---------TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred ---------ccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 445667788888775443322 233578889999999988899999999999999999999999988777
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+.+..+......+........ ..... .............+..+.++|.+||+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~ 269 (287)
T cd07838 212 ADQLDKIFDVIGLPSEEEWPRNVSLPR-----------------SSFPS-----YTPRSFKSFVPEICEEGLDLLKKMLT 269 (287)
T ss_pred HHHHHHHHHHcCCCChHhcCCCcccch-----------------hhccc-----ccccchhhhhhhhhHHHHHHHHHHhc
Confidence 666655555443322211110000000 00000 00000111122356788999999999
Q ss_pred cCCCCCcCHHHHhcCCCC
Q 017021 355 YDPTDRLTAREALRHPFF 372 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f 372 (379)
.||++||+++|+++||||
T Consensus 270 ~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 270 FNPHKRISAFEALQHPYF 287 (287)
T ss_pred cCCccCCCHHHHhcCcCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=298.57 Aligned_cols=278 Identities=31% Similarity=0.552 Sum_probs=212.9
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
|++.+.||+|++|+||+|.+..+++.||+|.+..... ......+|+..+..+ ..|++++.+++.+..++..++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~----~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKL----NEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhc----cCCCCchhHHHHhhcCCcEEEE
Confidence 6778999999999999999999999999999864322 122334566666666 2378999999999999999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 123 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 123 ~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
|||++++|.+.+.......+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i------------------------ 132 (283)
T cd07830 77 FEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV------------------------ 132 (283)
T ss_pred EecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE------------------------
Confidence 99998899999877654468999999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
+.++.++|+|||.+....... ....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...+..+...
T Consensus 133 ---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 133 ---SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred ---cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 445667777777775443322 23457888999998744 457899999999999999999999998888777777
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.+....+.++...|.......... ...++... . ..........+..+.++|++||+.||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----------~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~ 270 (283)
T cd07830 210 KICSVLGTPTKQDWPEGYKLASKL----GFRFPQFA----------P-----TSLHQLIPNASPEAIDLIKDMLRWDPKK 270 (283)
T ss_pred HHHHhcCCCChhhhhhHhhhhccc----cccccccc----------c-----ccHHHHcccCCHHHHHHHHHhcccCccc
Confidence 777777777766554322211111 00111000 0 0001112233678999999999999999
Q ss_pred CcCHHHHhcCCCC
Q 017021 360 RLTAREALRHPFF 372 (379)
Q Consensus 360 Rpta~e~l~hp~f 372 (379)
|||+.|++.||||
T Consensus 271 Rpt~~ei~~~~~~ 283 (283)
T cd07830 271 RPTASQALQHPYF 283 (283)
T ss_pred CCCHHHHhhCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=297.61 Aligned_cols=275 Identities=30% Similarity=0.526 Sum_probs=217.1
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
|++.++||+|++|.||+|.+..+++.||+|++... .........|+.+++.+ .|++++++++++.+.+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-----KHPNIVKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-----CCCCHHHHHhhhhcCCceEE
Confidence 56778999999999999999999999999999753 23345566788888877 67999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|+|+++++|.+++.+.. ..+++..+..++.|++.||.+||+.|++||||+|+||++
T Consensus 76 v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~----------------------- 131 (282)
T cd07829 76 VFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI----------------------- 131 (282)
T ss_pred EecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE-----------------------
Confidence 99999779999998763 258999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
+.++.++|+|||.+....... ....++..|+|||.+.+. .++.++|+|||||++|++++|..||.+.+..+.
T Consensus 132 ----~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 207 (282)
T cd07829 132 ----NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ 207 (282)
T ss_pred ----cCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 445667778887765433322 223456789999998766 788999999999999999999999998887777
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+..+.+.+..|..+..... .......+.. ..........+..+.++|++||+.||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~i~~~l~~~P 267 (282)
T cd07829 208 LFKIFQILGTPTEESWPGVTKLPD--YKPTFPKFPP------------------KDLEKVLPRLDPEGIDLLSKMLQYNP 267 (282)
T ss_pred HHHHHHHhCCCcHHHHHhhccccc--ccccccccCc------------------cchHHhcccccHHHHHHHHHhhccCc
Confidence 777888777777776665433220 0000000000 00011122346789999999999999
Q ss_pred CCCcCHHHHhcCCCC
Q 017021 358 TDRLTAREALRHPFF 372 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f 372 (379)
++||++.+++.||||
T Consensus 268 ~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 268 AKRISAKEALKHPYF 282 (282)
T ss_pred ccCCCHHHHhhCcCC
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=302.16 Aligned_cols=269 Identities=25% Similarity=0.373 Sum_probs=199.9
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||.||++.++.+++.||+|.+.... .....+..|+.++..+ .|++++++++.+..++..
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-----ENPFVVSMFCSFETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-----CCCCeeeeEEEEecCCEE
Confidence 4778899999999999999999999999999987432 2234455677777766 679999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++..+.+++.|||++.....+
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999 899999997754 6899999999999999999999999999999999999966665555555544221100
Q ss_pred CcccccCCCCCCeEEeecCcccccC-CCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYER-PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
... .+.+........ .......++..|+|||.+.+..++.++|+|||||++|++++|..||.+....+.
T Consensus 155 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~ 224 (305)
T cd05609 155 LTT----------NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 224 (305)
T ss_pred ccc----------cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 000 000000000000 000123577889999999888899999999999999999999999986554443
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...........|.. ....+..+.++|.+||+.||
T Consensus 225 ~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~li~~~l~~~P 258 (305)
T cd05609 225 FGQVISDDIEWPEG----------------------------------------------DEALPADAQDLISRLLRQNP 258 (305)
T ss_pred HHHHHhcccCCCCc----------------------------------------------cccCCHHHHHHHHHHhccCh
Confidence 33222211111100 01356778999999999999
Q ss_pred CCCcC---HHHHhcCCCCCCC
Q 017021 358 TDRLT---AREALRHPFFTRD 375 (379)
Q Consensus 358 ~~Rpt---a~e~l~hp~f~~~ 375 (379)
++||+ +.++++||||...
T Consensus 259 ~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 259 LERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred hhccCccCHHHHHhCccccCC
Confidence 99997 8999999999654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=295.92 Aligned_cols=244 Identities=27% Similarity=0.457 Sum_probs=197.0
Q ss_pred cccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 51 Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
||.|++|.||+|++..+++.||+|++.... .....+..|+.++..+ .|++++++.+.+.++...++++||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-----NHPFIVKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-----CCCCEeeeeeeEEcCCccEEEEecC
Confidence 699999999999999999999999986432 2345566788887777 7899999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 127 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 127 -~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
+++|.+++.+.. .++...+..++.||+.||.|||+.|++|+||+|+||++
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv--------------------------- 126 (262)
T cd05572 76 LGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL--------------------------- 126 (262)
T ss_pred CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---------------------------
Confidence 899999998754 58999999999999999999999999999999999999
Q ss_pred CCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc--hHHHHHHH
Q 017021 206 PKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE--NLEHLAMM 281 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~--~~~~~~~~ 281 (379)
+.++.++|+|||.+...... .....|+..|++||.+.+..++.++|+||||+++|+|++|..||.... ..+....+
T Consensus 127 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 206 (262)
T cd05572 127 DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206 (262)
T ss_pred cCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence 44566788888877644332 223467889999999988889999999999999999999999997655 22222111
Q ss_pred HHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCc
Q 017021 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 361 (379)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 361 (379)
.... .....| ...+.++.++|.+||+.||++||
T Consensus 207 ~~~~---------------------~~~~~~--------------------------~~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 207 LKGN---------------------GKLEFP--------------------------NYIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred hccC---------------------CCCCCC--------------------------cccCHHHHHHHHHHccCChhhCc
Confidence 1000 000111 12356899999999999999999
Q ss_pred C-----HHHHhcCCCCCCC
Q 017021 362 T-----AREALRHPFFTRD 375 (379)
Q Consensus 362 t-----a~e~l~hp~f~~~ 375 (379)
+ ++|+++||||++-
T Consensus 240 ~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 240 GNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CCcccCHHHHhcChhhhCC
Confidence 9 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=303.29 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=201.1
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
...|.....||+|+||.||++.+..++..||+|.+.... .....+..|+..+..+ .|+|++.+++.+..++..|
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-----HHENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-----CCCcHHHHHHheecCCeEE
Confidence 345666788999999999999999999999999986422 2344566788877776 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++... .+++..+..++.||+.||.|||+.|++||||||+||+++
T Consensus 96 lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~-------------------- 152 (292)
T cd06658 96 VVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT-------------------- 152 (292)
T ss_pred EEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--------------------
Confidence 999999 88999888553 488999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.++.++|+|||.+...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus 153 -------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 225 (292)
T cd06658 153 -------SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ 225 (292)
T ss_pred -------CCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4456777777766432211 123468889999999988889999999999999999999999998655544
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.....+... .....+..+.+++.+||+.|
T Consensus 226 ~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~li~~~l~~~ 259 (292)
T cd06658 226 AMRRIRDNLPPRVK----------------------------------------------DSHKVSSVLRGFLDLMLVRE 259 (292)
T ss_pred HHHHHHhcCCCccc----------------------------------------------cccccCHHHHHHHHHHccCC
Confidence 33222221111000 00124567899999999999
Q ss_pred CCCCcCHHHHhcCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~ 375 (379)
|.+|||++|+++||||...
T Consensus 260 P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 260 PSQRATAQELLQHPFLKLA 278 (292)
T ss_pred hhHCcCHHHHhhChhhhcc
Confidence 9999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=307.85 Aligned_cols=279 Identities=25% Similarity=0.416 Sum_probs=204.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec-----
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR----- 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~----- 116 (379)
..|++.+.||.|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|++++++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-----~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-----DHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-----CCCcchhhHhhhcccccccc
Confidence 46888999999999999999999999999999986433 2334566788888888 678999988766543
Q ss_pred ---------ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccC
Q 017021 117 ---------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 117 ---------~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~ 187 (379)
...|+||||++++|.+++... .+++..+..++.||+.||+|||+.|++||||||+||+++.
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~------- 149 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT------- 149 (342)
T ss_pred cccccccccceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC-------
Confidence 368999999988998888653 4899999999999999999999999999999999999942
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhC-CCCCCccchHhHHHHHH
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILV 260 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ 260 (379)
.+..++|+|||.+...+... ....++..|+|||.+.+ ..++.++|||||||++|
T Consensus 150 -------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 210 (342)
T cd07854 150 -------------------EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 210 (342)
T ss_pred -------------------CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHH
Confidence 23456777777665432211 12356888999998754 55789999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc
Q 017021 261 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 261 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (379)
+|++|..||...+..+....+.......................... .. ............
T Consensus 211 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-----------------~~~~~~~~~~~~ 271 (342)
T cd07854 211 EMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRND--GG-----------------EPRRPLRDLLPG 271 (342)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhc--cc-----------------ccCCCHHHHccC
Confidence 99999999988776665554444333222222221111111110000 00 000001112234
Q ss_pred chhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
.+.++.+||++||+.||.+|||+.|+++||||+.
T Consensus 272 ~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 272 VNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred CCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 6678999999999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=288.73 Aligned_cols=288 Identities=27% Similarity=0.477 Sum_probs=227.2
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEee---ccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY- 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~---~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~- 115 (379)
...-.|.-..+||+|.||.||+|+.+.+|++||+|++- ..+.......+|+.+++.+ .|+|++.+++.+..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-----kHenv~nliEic~tk 88 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTK 88 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-----cchhHHHHHHHHhhc
Confidence 33445777789999999999999999999999999863 2355678889999999998 66888888877653
Q ss_pred -------cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCC
Q 017021 116 -------RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 188 (379)
Q Consensus 116 -------~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~ 188 (379)
...+|+||++|..+|.-++.... -.++...+..++.+++.||.|+|...|+|||+||+|+||
T Consensus 89 ~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---------- 157 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---------- 157 (376)
T ss_pred cCCcccccceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE----------
Confidence 24599999999999999987653 358999999999999999999999999999999999999
Q ss_pred CccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCC-------cccccCCccchhhhhC-CCCCCccchHhHHHHHH
Q 017021 189 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN-------YIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILV 260 (379)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~-------~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ 260 (379)
++++.++|+|||+++......+ ..+.|..|.+||.+.+ ..|+++.|||+.|||+.
T Consensus 158 -----------------t~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCima 220 (376)
T KOG0669|consen 158 -----------------TKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMA 220 (376)
T ss_pred -----------------cCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHH
Confidence 6777888888888864433321 1345889999999877 45899999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhh-hccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhc
Q 017021 261 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKY-VRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339 (379)
Q Consensus 261 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (379)
+|++|.+.+++.++......|....|....++|+.++...-.. ++.. +.+.. ....+...+ ..+
T Consensus 221 eMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~e--Pl~~~--~~rkv~n~~---------kp~-- 285 (376)
T KOG0669|consen 221 EMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELE--PLPKG--QKRKVKNRL---------KPY-- 285 (376)
T ss_pred HHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCC--CCCcc--hhhhhhhhc---------ccc--
Confidence 9999999999999999999999999999999999876543221 1111 01110 000010000 000
Q ss_pred cchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 340 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.-.+++.||+.+||..||.+|++++|++.|.||+.+
T Consensus 286 ~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 286 VKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred cCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 113579999999999999999999999999999865
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=297.61 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=196.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-----------hhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
.|.+.+.||.|++|.||+|.+..+++.||+|.++.... ....+..|+.++..+ .|+++++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-----DHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-----CCCCcceEEEE
Confidence 57888999999999999999999999999999853211 112445677777777 67999999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
+...+..++||||+ +++|.+++.... .++...+..++.|++.||.|||+.|++||||+|+||+++
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~------------ 142 (272)
T cd06629 77 ETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD------------ 142 (272)
T ss_pred eccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc------------
Confidence 99999999999999 999999997764 689999999999999999999999999999999999994
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCC--CCCccchHhHHHHHHHHHh
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~~l~~ 264 (379)
.++.++|+|||.+...... .....|+..|+|||.+.... ++.++|+||||+++|++++
T Consensus 143 ---------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~ 207 (272)
T cd06629 143 ---------------ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA 207 (272)
T ss_pred ---------------CCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh
Confidence 4456777777766543221 12245788999999987654 7899999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||...+..+....+..... ....+. ......+..
T Consensus 208 g~~p~~~~~~~~~~~~~~~~~~---------------------~~~~~~----------------------~~~~~~~~~ 244 (272)
T cd06629 208 GRRPWSDEEAIAAMFKLGNKRS---------------------APPIPP----------------------DVSMNLSPV 244 (272)
T ss_pred CCCCCcCcchHHHHHHhhcccc---------------------CCcCCc----------------------cccccCCHH
Confidence 9999975443322211110000 000000 011235678
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
+.++|.+||..||++|||++|+++||||
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 245 ALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=295.32 Aligned_cols=248 Identities=28% Similarity=0.442 Sum_probs=192.9
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee--
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-- 115 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~-- 115 (379)
.|++.+.||+|+||.||+|.+..++..||+|++.... .....+..|+.+++.+ .|++++.+++++..
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 77 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-----QHERIVQYYGCLRDRA 77 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-----CCCCeeeEEEEEEcCC
Confidence 5788899999999999999999999999999986321 2234556688888887 67999999998865
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
+...++++||+ +++|.+++.... .++......++.|++.||.|||+.|++||||+|+||+++.
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~-------------- 141 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS-------------- 141 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC--------------
Confidence 46789999999 889999997754 5889999999999999999999999999999999999944
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC------CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
+..++|+|||.+...... .....++..|+|||.+.+..++.++|+||+||++|+|++|+.|
T Consensus 142 -------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~p 208 (266)
T cd06651 142 -------------AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208 (266)
T ss_pred -------------CCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCC
Confidence 445666777665432211 1223578899999999888899999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|......+....+... ...| ......+..+.++
T Consensus 209 f~~~~~~~~~~~~~~~-~~~~----------------------------------------------~~~~~~~~~~~~l 241 (266)
T cd06651 209 WAEYEAMAAIFKIATQ-PTNP----------------------------------------------QLPSHISEHARDF 241 (266)
T ss_pred ccccchHHHHHHHhcC-CCCC----------------------------------------------CCchhcCHHHHHH
Confidence 9765433222111110 0000 0011245677888
Q ss_pred HhhccccCCCCCcCHHHHhcCCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f~ 373 (379)
+ +||..||++||+++|+++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 8 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=301.86 Aligned_cols=292 Identities=25% Similarity=0.397 Sum_probs=209.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee----
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---- 115 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~---- 115 (379)
..|++.++||+|++|.||+|.++.+++.+|+|++.... .......+|++++..+ .|++++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-----KHPNVVPLIDMAVERPDK 82 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-----CCCCccchhhheeccccc
Confidence 46888999999999999999999999999999986322 1223456788888887 67899999887743
Q ss_pred ----cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 116 ----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 116 ----~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
...+++|+||+.+++...+.... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+++.|||+
T Consensus 83 ~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 83 SKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred ccccCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 33579999999888888876543 3699999999999999999999999999999999999997666666666655
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+........... . +.. ..........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.
T Consensus 162 ~~~~~~~~~~~~----~--------~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 162 ARPYDGPPPNPK----G--------GGG-GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred chhccCCCcccc----c--------CCc-ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 532211110000 0 000 000001223568889999987653 57899999999999999999999999
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
+.+.......+....+.+++..+..+............... ..............+.++|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~i~ 289 (311)
T cd07866 229 GKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNY-------------------PRTLEERFGKLGPEGLDLLS 289 (311)
T ss_pred CCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCC-------------------CccHHHHcccCChhHHHHHH
Confidence 88877777777776666655544432221111000000000 00111122345578999999
Q ss_pred hccccCCCCCcCHHHHhcCCCC
Q 017021 351 GLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f 372 (379)
+||+.||++|||+.|++.||||
T Consensus 290 ~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 290 KLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHcccCcccCcCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=296.10 Aligned_cols=247 Identities=21% Similarity=0.305 Sum_probs=197.6
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
...|.+.++||+|++|.||+|.++.+++.||+|++.........+..|+..+..+ .|++++++++++..++..++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-----CCCChhheEEEEcCCCCcEE
Confidence 3456778999999999999999999999999999986554456677888888887 67899999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|||+ +++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~-------------------- 139 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE-------------------- 139 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC--------------------
Confidence 99999 899999997755456899999999999999999999999999999999999954
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 275 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~ 275 (379)
++.++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus 140 -------~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 140 -------NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred -------CCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 4456666666654332221 11123567999999988889999999999999999998 99999775544
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+...... . .....+.++.++|.+||+.
T Consensus 213 ~~~~~~~~~~~~----------------------~--------------------------~~~~~~~~~~~li~~cl~~ 244 (263)
T cd05052 213 QVYELLEKGYRM----------------------E--------------------------RPEGCPPKVYELMRACWQW 244 (263)
T ss_pred HHHHHHHCCCCC----------------------C--------------------------CCCCCCHHHHHHHHHHccC
Confidence 433322211000 0 0123567899999999999
Q ss_pred CCCCCcCHHHHhc
Q 017021 356 DPTDRLTAREALR 368 (379)
Q Consensus 356 dP~~Rpta~e~l~ 368 (379)
||++|||+.++++
T Consensus 245 ~p~~Rp~~~~l~~ 257 (263)
T cd05052 245 NPSDRPSFAEIHQ 257 (263)
T ss_pred CcccCCCHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=300.69 Aligned_cols=250 Identities=30% Similarity=0.431 Sum_probs=198.6
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
...|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+..+..+ .|++++++++.+..++..
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-----CCCccHhhhcccccCCce
Confidence 346888999999999999999999999999999987332 2334566788877776 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||++..
T Consensus 78 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~------------------ 136 (277)
T cd06642 78 WIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE------------------ 136 (277)
T ss_pred EEEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC------------------
Confidence 9999999 88999988653 4889999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
++.++|+|||.+....... ....|+..|+|||.+.+..++.++|+|||||++|+|++|..||......
T Consensus 137 ---------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 207 (277)
T cd06642 137 ---------QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM 207 (277)
T ss_pred ---------CCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh
Confidence 4456677777665332221 2235788899999998888999999999999999999999998754332
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
.....+... ..+ ......+..+.++|.+||+.
T Consensus 208 ~~~~~~~~~--~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06642 208 RVLFLIPKN--SPP----------------------------------------------TLEGQYSKPFKEFVEACLNK 239 (277)
T ss_pred hHHhhhhcC--CCC----------------------------------------------CCCcccCHHHHHHHHHHccC
Confidence 222111000 000 00112456789999999999
Q ss_pred CCCCCcCHHHHhcCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~ 374 (379)
+|++|||+.++++||||..
T Consensus 240 ~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 240 DPRFRPTAKELLKHKFITR 258 (277)
T ss_pred CcccCcCHHHHHHhHHHHH
Confidence 9999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=296.90 Aligned_cols=265 Identities=24% Similarity=0.357 Sum_probs=203.2
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
..-.|++.+.||+|+||+||++.+..+++.||+|++... ......+..|++++..+ .|++++++++.+...+.
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-----RSPYIVSFYGAFLNENN 77 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-----CCCCcceEeeeEecCCE
Confidence 345789999999999999999999999999999998643 23345667788888877 77999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
.++||||+ +++|.+++...+ .+++..+..++.+++.||.|||+ .+++||||+|+||+++
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----------------- 138 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN----------------- 138 (284)
T ss_pred EEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC-----------------
Confidence 99999999 889999887754 68999999999999999999996 6899999999999994
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCC-CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
.++.++|+|||.+..... ......|+..|+|||.+.+..++.++|+|||||++|++++|..||......
T Consensus 139 ----------~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 208 (284)
T cd06620 139 ----------SRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208 (284)
T ss_pred ----------CCCcEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchh
Confidence 445677777776643221 123346889999999998888899999999999999999999999865432
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+... ..+.... ......+.......+ ....+.++.+|+.+||+.
T Consensus 209 ~~~~-------~~~~~~~----~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~ 252 (284)
T cd06620 209 DDGQ-------DDPMGIL----DLLQQIVQEPPPRLP-------------------------SSDFPEDLRDFVDACLLK 252 (284)
T ss_pred hhhh-------hhhhHHH----HHHHHHhhccCCCCC-------------------------chhcCHHHHHHHHHHhcC
Confidence 1100 0000000 000000000000000 011456789999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~ 375 (379)
||++|||++|+++||||.+.
T Consensus 253 dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 253 DPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CcccCcCHHHHhcCcccccc
Confidence 99999999999999999664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=299.71 Aligned_cols=278 Identities=29% Similarity=0.475 Sum_probs=209.9
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc--
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-- 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~-- 117 (379)
..|++.+.||+|++|.||+|.++.+++.||+|+++... ........|+.++..+ .|+|++++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-----NHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-----CCCCeeeeeheecCcchh
Confidence 46788899999999999999999999999999997432 2234555688888877 6799999998887654
Q ss_pred --------eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCC
Q 017021 118 --------HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 118 --------~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
..++++||+++++.+.+.... ..+++..+..++.|++.||.|||+.|++||||+|+||+++
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---------- 150 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDHDLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---------- 150 (302)
T ss_pred hhccccCCcEEEEEcccCccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----------
Confidence 899999999778888877643 3589999999999999999999999999999999999994
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHh
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~ 264 (379)
.++.++|+|||.+....... ....++..|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 151 -----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~ 213 (302)
T cd07864 151 -----------------NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213 (302)
T ss_pred -----------------CCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHh
Confidence 44556677777665332221 11245778999998865 346899999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|++||...+..+....+.+..+..+...++.+............. .............+..
T Consensus 214 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~ 274 (302)
T cd07864 214 KKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKK-------------------QYRRRLREEFSFIPTP 274 (302)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCChhhccccccccccccccccc-------------------ccccchhhhcCCCCHH
Confidence 999999887777777777776666555544332211100000000 0000111122235678
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
+.++|.+||+.||++|||+++++.||||
T Consensus 275 ~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 275 ALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=293.61 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=200.8
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
..|++.+.||.|++|.||+|.+..+++.+|+|++.... .....+..|+.++..+ +|++++++++.+...+..|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-----RHPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-----CCCChhceEEEEEeCCEEEE
Confidence 46788899999999999999999999999999987532 2345667788888887 78999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||+++
T Consensus 78 ~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~--------------------- 135 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT--------------------- 135 (262)
T ss_pred EEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC---------------------
Confidence 99999 889999987752 2689999999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCC---CCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
.++.++|+|||.+...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.
T Consensus 136 ------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~ 209 (262)
T cd06613 136 ------EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP 209 (262)
T ss_pred ------CCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 4556777777766543322 1234678889999998776 788999999999999999999999976554
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+.......+. . ......+.++.+++++||.
T Consensus 210 ~~~~~~~~~~~~~~~~---------------------------------------~-----~~~~~~~~~~~~li~~~l~ 245 (262)
T cd06613 210 MRALFLISKSNFPPPK---------------------------------------L-----KDKEKWSPVFHDFIKKCLT 245 (262)
T ss_pred HHHHHHHHhccCCCcc---------------------------------------c-----cchhhhhHHHHHHHHHHcC
Confidence 4333222211000000 0 0011245678999999999
Q ss_pred cCCCCCcCHHHHhcCCC
Q 017021 355 YDPTDRLTAREALRHPF 371 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~ 371 (379)
.||..|||+.+++.|||
T Consensus 246 ~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 246 KDPKKRPTATKLLQHPF 262 (262)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 99999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=301.34 Aligned_cols=252 Identities=23% Similarity=0.418 Sum_probs=201.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
..|.....||+|+||.||+|.+..+++.||+|.+... ......+..|+.++..+ .|++++++++.+..++..|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-----QHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-----CCCchhhhhhheeeCCeEEE
Confidence 3344557899999999999999999999999998632 22344566777777776 78999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
++||+ +++|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 96 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---------------------- 150 (297)
T cd06659 96 LMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---------------------- 150 (297)
T ss_pred EEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE----------------------
Confidence 99999 88999887653 48999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
+.++.++|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||......+.
T Consensus 151 -----~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 225 (297)
T cd06659 151 -----TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 225 (297)
T ss_pred -----ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 45566788888876533222 2335688999999999888899999999999999999999999986555443
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.....+.. ......+..+.++|++||+.||
T Consensus 226 ~~~~~~~~~~~~----------------------------------------------~~~~~~~~~l~~~i~~~l~~~P 259 (297)
T cd06659 226 MKRLRDSPPPKL----------------------------------------------KNAHKISPVLRDFLERMLTREP 259 (297)
T ss_pred HHHHhccCCCCc----------------------------------------------cccCCCCHHHHHHHHHHhcCCc
Confidence 332211100000 0011245678999999999999
Q ss_pred CCCcCHHHHhcCCCCCCC
Q 017021 358 TDRLTAREALRHPFFTRD 375 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f~~~ 375 (379)
++||+++++++||||..-
T Consensus 260 ~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 260 QERATAQELLDHPFLLQT 277 (297)
T ss_pred ccCcCHHHHhhChhhccC
Confidence 999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=293.84 Aligned_cols=246 Identities=25% Similarity=0.371 Sum_probs=198.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.++||.|+||.||++.++.+++.+|+|.++.. .........|..++..+ .|+|++++++.+..++.+|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-----KHPNIVAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEECCEEEE
Confidence 377889999999999999999999999999998632 23345566777877777 77999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|||+ +++|.+++.......+++..+..++.|++.||.+||+.|++|+||||+||+++
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~--------------------- 134 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT--------------------- 134 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC---------------------
Confidence 99999 89999998765545689999999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
.++.++++|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+....
T Consensus 135 ------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 208 (255)
T cd08219 135 ------QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208 (255)
T ss_pred ------CCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence 45567777777765433221 234688899999999888899999999999999999999999986554333
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+..... .....+..+.++|.+||+.||
T Consensus 209 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~li~~~l~~~P 240 (255)
T cd08219 209 ILKVCQGSYKP------------------------------------------------LPSHYSYELRSLIKQMFKRNP 240 (255)
T ss_pred HHHHhcCCCCC------------------------------------------------CCcccCHHHHHHHHHHHhCCc
Confidence 32222111000 011245678999999999999
Q ss_pred CCCcCHHHHhcC
Q 017021 358 TDRLTAREALRH 369 (379)
Q Consensus 358 ~~Rpta~e~l~h 369 (379)
++|||+.++++-
T Consensus 241 ~~Rp~~~~il~~ 252 (255)
T cd08219 241 RSRPSATTILSR 252 (255)
T ss_pred ccCCCHHHHhhc
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=296.69 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=203.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.+.||+|++|.||+|.++.+++.||+|++... ......+..|++.++.+ .|++++.+++.+...+..++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-----NSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-----CCCchhhhheeeecCCEEEE
Confidence 467889999999999999999999999999998743 23345567788888777 58999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
++||+ +++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||+|+||++
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~--------------------- 134 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV--------------------- 134 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---------------------
Confidence 99999 799999998753 368999999999999999999999 999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch--HH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN--LE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~--~~ 276 (379)
+.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..
T Consensus 135 ------~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 208 (265)
T cd06605 135 ------NSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208 (265)
T ss_pred ------CCCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc
Confidence 455668888888775432221 125678899999999888899999999999999999999999975421 11
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.......+ ...+ ....+..+.++|.+||..|
T Consensus 209 ~~~~~~~~~~~~~-------------------~~~~-------------------------~~~~~~~~~~li~~~l~~~ 244 (265)
T cd06605 209 IFELLQYIVNEPP-------------------PRLP-------------------------SGKFSPDFQDFVNLCLIKD 244 (265)
T ss_pred HHHHHHHHhcCCC-------------------CCCC-------------------------hhhcCHHHHHHHHHHcCCC
Confidence 1111111111100 0000 0015678999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~~ 376 (379)
|++|||+.|++.||||++-+
T Consensus 245 p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 245 PRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred chhCcCHHHHhhCchhhccc
Confidence 99999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=292.20 Aligned_cols=248 Identities=29% Similarity=0.449 Sum_probs=198.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
+|+..+.||+|++|.||+|.+..+++.||+|.+.... .....+..|+..+..+ .|++++++++++..+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-----QHPNIVQYLGTEREED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-----CCCCchheeeeEecCC
Confidence 3677899999999999999999899999999986432 2335566788887777 7799999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..++++||+ +++|.+++.+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~----------------- 136 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD----------------- 136 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-----------------
Confidence 999999999 889999997754 588999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCC-CCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
.+..++|+|||.+....... ....|+..|++||.+.... ++.++|+|||||++|+|++|+.||....
T Consensus 137 ----------~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 137 ----------TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred ----------CCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 45567777777665432222 3346788999999987766 8899999999999999999999997654
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+... ...+ ......+..+.+++++||
T Consensus 207 ~~~~~~~~~~~-~~~~----------------------------------------------~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 207 GVAAVFKIGRS-KELP----------------------------------------------PIPDHLSDEAKDFILKCL 239 (258)
T ss_pred HHHHHHHHHhc-ccCC----------------------------------------------CcCCCcCHHHHHHHHHHh
Confidence 33322221110 0000 011235678899999999
Q ss_pred ccCCCCCcCHHHHhcCCCC
Q 017021 354 RYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f 372 (379)
+.||++||++.+++.|||+
T Consensus 240 ~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 240 QRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hcCcccCcCHHHHhcCCCC
Confidence 9999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=295.38 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=190.7
Q ss_pred ccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeC
Q 017021 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 125 (379)
Q Consensus 50 ~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 125 (379)
.||+|+||.||+|.+..+++.||+|++.... ........|...+..+.. .+|++++.+.+.+...+..++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHh--CCCCcEeeeeeeeecCCEEEEEEec
Confidence 4799999999999999999999999986421 112223334444333322 3678999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccccc
Q 017021 126 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 204 (379)
Q Consensus 126 ~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (379)
+ |++|.+++.... .+++..+..++.|++.||.|||+.+++||||||+||+++
T Consensus 79 ~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~------------------------- 131 (278)
T cd05606 79 MNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD------------------------- 131 (278)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC-------------------------
Confidence 9 999999887654 689999999999999999999999999999999999994
Q ss_pred CCCCCCeEEeecCcccccCC-CCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 017021 205 MPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282 (379)
Q Consensus 205 ~~~~~~~~l~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~ 282 (379)
.++.++|+|||.+..... ......|+..|+|||.+.+ ..++.++|+||+||++|+|++|+.||.............
T Consensus 132 --~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~ 209 (278)
T cd05606 132 --EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209 (278)
T ss_pred --CCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence 445677777776653322 1233468999999999874 468899999999999999999999997642211110000
Q ss_pred HHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCc-
Q 017021 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 361 (379)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp- 361 (379)
..... ... .....+.++.+++.+||..||.+||
T Consensus 210 ~~~~~--------------------~~~--------------------------~~~~~s~~~~~li~~~l~~~p~~R~~ 243 (278)
T cd05606 210 MTLTM--------------------AVE--------------------------LPDSFSPELRSLLEGLLQRDVNRRLG 243 (278)
T ss_pred Hhhcc--------------------CCC--------------------------CCCcCCHHHHHHHHHHhhcCHHhccC
Confidence 00000 000 1123567899999999999999999
Q ss_pred ----CHHHHhcCCCCCCCC
Q 017021 362 ----TAREALRHPFFTRDH 376 (379)
Q Consensus 362 ----ta~e~l~hp~f~~~~ 376 (379)
++.++++||||++.+
T Consensus 244 ~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 244 CLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred CCCCCHHHHHhCccccCCC
Confidence 999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=295.21 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=190.9
Q ss_pred hhhhhcc--ccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 45 DKIHSKM--GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 45 y~i~~~L--g~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
|++.+.+ |+|+||.||++.++.+++.+|+|.+........ |......+ ..|++++++++.+..++..|+|
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~----~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLM----KDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHh----hcCCCEEEEEEEEecCCeeEEE
Confidence 4444554 999999999999999999999999874322111 22222222 2578999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||++..++
T Consensus 88 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~------------------- 146 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK------------------- 146 (267)
T ss_pred EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-------------------
Confidence 9999 899999998764 689999999999999999999999999999999999995322
Q ss_pred cccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH-HH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL-AM 280 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~-~~ 280 (379)
..++|+|||.+...... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||......+.. ..
T Consensus 147 -------~~~~l~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~ 218 (267)
T PHA03390 147 -------DRIYLCDYGLCKIIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES 218 (267)
T ss_pred -------CeEEEecCccceecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHH
Confidence 26788888877644322 2346788999999998888999999999999999999999999754332210 11
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+....... ....+..+..+.++|.+||+.||.+|
T Consensus 219 ~~~~~~~~----------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R 252 (267)
T PHA03390 219 LLKRQQKK----------------------------------------------LPFIKNVSKNANDFVQSMLKYNINYR 252 (267)
T ss_pred HHHhhccc----------------------------------------------CCcccccCHHHHHHHHHHhccChhhC
Confidence 10000000 00112467889999999999999999
Q ss_pred cC-HHHHhcCCCCCC
Q 017021 361 LT-AREALRHPFFTR 374 (379)
Q Consensus 361 pt-a~e~l~hp~f~~ 374 (379)
|+ ++|+|+||||+.
T Consensus 253 ~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 253 LTNYNEIIKHPFLKI 267 (267)
T ss_pred CchHHHHhcCCcccC
Confidence 96 599999999973
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=300.12 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=203.0
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
..|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ .|+|++++.+++...+.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~~~~~~~~~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-----RHPNTIEYKGCYLREHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEEeCCe
Confidence 45889999999999999999999999999999986322 2234566788888877 78999999999999999
Q ss_pred EEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 119 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 119 ~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
.|+|+||+.+++.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 90 ~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~-------------------- 148 (307)
T cd06607 90 AWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL-------------------- 148 (307)
T ss_pred EEEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE--------------------
Confidence 99999999888888886543 358999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhh---CCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+.++.++|+|||.+...... ....++..|+|||.+. ...++.++||||||+++|+|++|..||...+..
T Consensus 149 -------~~~~~~kL~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~ 220 (307)
T cd06607 149 -------TEPGTVKLADFGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220 (307)
T ss_pred -------CCCCCEEEeecCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH
Confidence 55567888888877644332 3346788999999874 345789999999999999999999999766544
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
.....+... ..+. .+ ...++..+.++|.+||+.
T Consensus 221 ~~~~~~~~~--~~~~--------------------~~-------------------------~~~~~~~~~~li~~~l~~ 253 (307)
T cd06607 221 SALYHIAQN--DSPT--------------------LS-------------------------SNDWSDYFRNFVDSCLQK 253 (307)
T ss_pred HHHHHHhcC--CCCC--------------------CC-------------------------chhhCHHHHHHHHHHhcC
Confidence 432222111 0000 00 012456799999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~~ 376 (379)
||++||++.+++.||||....
T Consensus 254 ~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 254 IPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred ChhhCcCHHHHhcChhhcccC
Confidence 999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=298.73 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=198.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|+..+.||+|+||.||++.+..+++.||+|++.... .....+..|+..+.++ ..|++++++++++..++..++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~----~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS----SDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHh----cCCCCEeeeeeEEecCCcEEE
Confidence 5667799999999999999999999999999986432 2344556777777776 247899999999999999999
Q ss_pred EEeCCCCCHHHHHH---hCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 122 VFEKLGSSLYDFLR---KNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 122 v~e~~~~sL~~~l~---~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+|||++.++.++.. ......+++..+..++.|++.||+|||+ .+++||||||+||++
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~------------------- 141 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL------------------- 141 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE-------------------
Confidence 99999777666543 2223468999999999999999999997 499999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCC---CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+..+.++|+|||.+...... .....|+..|+|||.+.+. .++.++|||||||++|+|++|+.||...
T Consensus 142 --------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 142 --------DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred --------ccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 44556788888877543222 1234678899999998765 6889999999999999999999999754
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
. +....+.+.....+.. .+ ......++.++.+||.+|
T Consensus 214 ~--~~~~~~~~~~~~~~~~-------------------~~----------------------~~~~~~~~~~l~~li~~~ 250 (288)
T cd06616 214 N--SVFDQLTQVVKGDPPI-------------------LS----------------------NSEEREFSPSFVNFINLC 250 (288)
T ss_pred c--hHHHHHhhhcCCCCCc-------------------CC----------------------CcCCCccCHHHHHHHHHH
Confidence 3 2222222222111100 00 000123567899999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 353 LRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
|+.||++|||++++++||||.....
T Consensus 251 l~~~p~~Rpt~~~i~~~~~~~~~~~ 275 (288)
T cd06616 251 LIKDESKRPKYKELLEHPFIKDYEE 275 (288)
T ss_pred ccCChhhCcCHHHHhcChhhhchhh
Confidence 9999999999999999999987554
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=296.27 Aligned_cols=247 Identities=20% Similarity=0.261 Sum_probs=191.8
Q ss_pred chhhhhhhhccccccceeEEEEEec---CCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
....|++.+.||+|+||.||+|+++ ..+..||+|.++... .....+..|+..+.++ .|+|++++++++..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~ 77 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-----DHSNIVRLEGVITR 77 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEEec
Confidence 4567889999999999999999865 456789999987542 2334566788877776 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
++..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~------------ 144 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL------------ 144 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC------------
Confidence 99999999999 889999987653 3689999999999999999999999999999999999995544
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 269 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf 269 (379)
.++++|||.+....... ....++..|+|||.+.+..++.++|||||||++|++++ |..||
T Consensus 145 ---------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~ 209 (266)
T cd05064 145 ---------------VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY 209 (266)
T ss_pred ---------------cEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCc
Confidence 45555555443221111 11234568999999988899999999999999999775 99999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
...+..+....+.+....+ . ...++..+.+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~----------------------~--------------------------~~~~~~~~~~li 241 (266)
T cd05064 210 WDMSGQDVIKAVEDGFRLP----------------------A--------------------------PRNCPNLLHQLM 241 (266)
T ss_pred CcCCHHHHHHHHHCCCCCC----------------------C--------------------------CCCCCHHHHHHH
Confidence 8765544433332211100 0 113556799999
Q ss_pred hhccccCCCCCcCHHHHhc
Q 017021 350 QGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~ 368 (379)
.+||+.||++|||++|+++
T Consensus 242 ~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 242 LDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHcCCCchhCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=292.37 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=200.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|.+.+.||+|+||.||++.++.+|..+|+|.+... ......+..|+.+++.+ .|++++++++.+......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-----~h~~i~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-----KHPNIVTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-----CCCChhhhhheeccCCeEE
Confidence 367889999999999999999999999999998643 12344566788888887 6789999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+++||+ +++|.+++.......+++..+..++.|++.||.|||+.+++|+|++|+||+++.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~------------------ 137 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN------------------ 137 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC------------------
Confidence 999999 8999999977554457999999999999999999999999999999999999532
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+..++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|++++|..||...+..+
T Consensus 138 --------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 209 (257)
T cd08225 138 --------GMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209 (257)
T ss_pred --------CCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 2345777777765443322 22357889999999988888999999999999999999999997654433
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.. +..+ ......+.++.++|.+||+.+
T Consensus 210 ~~~~~~~--~~~~----------------------------------------------~~~~~~~~~~~~~i~~~l~~~ 241 (257)
T cd08225 210 LVLKICQ--GYFA----------------------------------------------PISPNFSRDLRSLISQLFKVS 241 (257)
T ss_pred HHHHHhc--ccCC----------------------------------------------CCCCCCCHHHHHHHHHHhccC
Confidence 2221111 0000 001134568999999999999
Q ss_pred CCCCcCHHHHhcCCCC
Q 017021 357 PTDRLTAREALRHPFF 372 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f 372 (379)
|++|||+.|+++||||
T Consensus 242 p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 242 PRDRPSITSILKRPFL 257 (257)
T ss_pred hhhCcCHHHHhhCCCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=292.91 Aligned_cols=248 Identities=27% Similarity=0.442 Sum_probs=193.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee--
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-- 115 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~-- 115 (379)
.|++.+.||+|+||.||++.+..++..||+|.+.... .....+..|+.++..+ .|++++.+++.+.+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-----LHERIVQYYGCLRDPM 77 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-----CCCCeeeEEeEeccCC
Confidence 4778899999999999999999999999999985321 1234556688888887 77999999998865
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
...++++|||+ +++|.+++.+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~------------- 142 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV------------- 142 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC-------------
Confidence 35788999999 889999988754 58889999999999999999999999999999999999544
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCC------CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERP------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
+.++|+|||.+..... ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.|
T Consensus 143 --------------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 208 (265)
T cd06652 143 --------------GNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208 (265)
T ss_pred --------------CCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCC
Confidence 4556666665543211 11224578899999999888899999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|...........+ ...... . ......+..+.++
T Consensus 209 ~~~~~~~~~~~~~---~~~~~~------------------~--------------------------~~~~~~~~~~~~~ 241 (265)
T cd06652 209 WAEFEAMAAIFKI---ATQPTN------------------P--------------------------VLPPHVSDHCRDF 241 (265)
T ss_pred CCccchHHHHHHH---hcCCCC------------------C--------------------------CCchhhCHHHHHH
Confidence 9765433322211 111000 0 0011245678899
Q ss_pred HhhccccCCCCCcCHHHHhcCCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f~ 373 (379)
|++||. +|++||+++|+++|||+.
T Consensus 242 i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 242 LKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHhc-ChhhCCCHHHHhcCcccC
Confidence 999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=294.97 Aligned_cols=254 Identities=21% Similarity=0.364 Sum_probs=200.5
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.+.||+|+||.||+|.+..+++.||+|.++.. ......+..|+.+++.+.. ..|++++++++.+..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ--SQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc--CCCCCeeeEeeeeeeCCEEEE
Confidence 478889999999999999999999999999998642 2334556678888888743 247999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|||+ +++|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||+++
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~--------------------- 135 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT--------------------- 135 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---------------------
Confidence 99999 89999998654 589999999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
..+.++|+|||.+....... ....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.......
T Consensus 136 ------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 136 ------NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred ------CCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 45567777777765433221 23468889999998865 457899999999999999999999997644322
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+... .++ ..+ ....+.++.+++.+||+.|
T Consensus 210 ~~~~~~~~--~~~--------------------~~~-------------------------~~~~~~~~~~~i~~~l~~~ 242 (277)
T cd06917 210 AMMLIPKS--KPP--------------------RLE-------------------------DNGYSKLLREFVAACLDEE 242 (277)
T ss_pred hhhccccC--CCC--------------------CCC-------------------------cccCCHHHHHHHHHHcCCC
Confidence 11110000 000 000 0124568999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~~ 376 (379)
|++||++.|+++||||++..
T Consensus 243 p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 243 PKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred cccCcCHHHHhhChHhhccc
Confidence 99999999999999997754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=299.20 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=191.1
Q ss_pred chhhhhhhhccccccceeEEEEEecC----------------CCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCC
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRE----------------RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKG 102 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~----------------~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~ 102 (379)
....|++.++||+|+||.||+|.+.. ++..||+|++... ......+.+|+.++..+ .
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~ 77 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-----K 77 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-----C
Confidence 44568889999999999999997532 3457999998743 22345677898888887 6
Q ss_pred CCeeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHc
Q 017021 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY-----------------RSFPIDLVREIARQLLECIAFMHDL 164 (379)
Q Consensus 103 ~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~-----------------~~l~~~~~~~~~~qi~~aL~~LH~~ 164 (379)
|+|++++++++.+.+..+++|||+ +++|.+++..... ..+++..+..++.||+.||.|||+.
T Consensus 78 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 78 DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 799999999999999999999999 8999999865321 1357788999999999999999999
Q ss_pred CCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchh
Q 017021 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPE 239 (379)
Q Consensus 165 ~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE 239 (379)
|++||||||+||+++ .++.++|+|||.+....... ....++..|+|||
T Consensus 158 ~ivH~dlkp~Nill~---------------------------~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (304)
T cd05096 158 NFVHRDLATRNCLVG---------------------------ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE 210 (304)
T ss_pred CccccCcchhheEEc---------------------------CCccEEECCCccceecccCceeEecCcCCCCccccCHH
Confidence 999999999999994 44566777777665332221 1224567899999
Q ss_pred hhhCCCCCCccchHhHHHHHHHHHh--CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCc
Q 017021 240 VILGLGWTYPCDIWSVGCILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS 317 (379)
Q Consensus 240 ~~~~~~~~~~sDvwSlG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (379)
.+.+..++.++|||||||++|+|++ +..||...+..+............... . .
T Consensus 211 ~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----------------~-~------ 266 (304)
T cd05096 211 CILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQ-----------------V-Y------ 266 (304)
T ss_pred HHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcccc-----------------c-c------
Confidence 9988889999999999999999986 567887655444333222211000000 0 0
Q ss_pred hhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHh
Q 017021 318 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 367 (379)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l 367 (379)
......++..+.+++.+||+.||.+|||+.|+.
T Consensus 267 -----------------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 267 -----------------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred -----------------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 000123567899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=304.50 Aligned_cols=301 Identities=17% Similarity=0.216 Sum_probs=195.0
Q ss_pred hhhccccc--cceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 47 IHSKMGEG--TFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 47 i~~~Lg~G--~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
+...||.| +||+||+|++..+|+.||+|++.... ...+.+..|+.++..+ +|+|++++++++..++..++
T Consensus 2 ~~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-----~h~niv~~~~~~~~~~~~~~ 76 (328)
T cd08226 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-----RHPNIMTSWTVFTTGSWLWV 76 (328)
T ss_pred hHHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCcceEeeeEecCCceEE
Confidence 34667777 99999999999999999999987432 2234455666666655 78999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
|+||+ +++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||++..++.+++.+|+.+........
T Consensus 77 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 77 ISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred EEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 99999 88999999876544689999999999999999999999999999999999997666555555542211110000
Q ss_pred ccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCC--CCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
.............++..|+|||++.+. .++.++|||||||++|+|++|+.||......+..
T Consensus 157 -----------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 219 (328)
T cd08226 157 -----------------KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219 (328)
T ss_pred -----------------cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH
Confidence 000000000112345679999998763 4789999999999999999999999865543322
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhh----hccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS----VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
..........|... ...........++...+... ........ .+.... ........++..+.+||++||+
T Consensus 220 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~ 293 (328)
T cd08226 220 LQKLKGPPYSPLDI--TTFPCEESRMKNSQSGVDSG-IGESVVAAGMTQTMTSER---LRTPSSKTFSPAFQNLVELCLQ 293 (328)
T ss_pred HHHhcCCCCCCccc--cccchhhhhhccchhhhhcc-cccchhcccccccccccc---ccchhhhhhhHHHHHHHHHHcc
Confidence 22111111111000 00000000000000000000 00000000 000000 0011123467889999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.||++|||++|+++||||...
T Consensus 294 ~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 294 QDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred CCcccCCCHHHHhhCHHHHHH
Confidence 999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=296.51 Aligned_cols=270 Identities=27% Similarity=0.397 Sum_probs=206.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|.+.+.||+|++|.||+|.+..+++.||+|++... .........|..++.++. .|++++++++.+...+..
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~----~~~~i~~~~~~~~~~~~~ 77 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN----GHPGIIKLYYTFQDEENL 77 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc----cCCCchhHHHHhcCCceE
Confidence 478889999999999999999999999999998642 222345566777777762 389999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+++||++ +++|.+++.+.. .+++..+..++.|++.||.+||+.|++|+|++|+||++..++.+++.|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999 999999998765 6999999999999999999999999999999999999987777777777766443222
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
..... .......++..............++..|+|||...+..++.++|+||||++++++++|..||...+.....
T Consensus 156 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 231 (280)
T cd05581 156 SSPES----NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231 (280)
T ss_pred ccccc----CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 11100 00000011111111111223345788999999998888899999999999999999999999876644433
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+.......| ...+..+.++|++||+.||+
T Consensus 232 ~~~~~~~~~~~-------------------------------------------------~~~~~~~~~li~~~l~~~p~ 262 (280)
T cd05581 232 QKILKLEYSFP-------------------------------------------------PNFPPDAKDLIEKLLVLDPQ 262 (280)
T ss_pred HHHHhcCCCCC-------------------------------------------------CccCHHHHHHHHHHhcCCHh
Confidence 33322111111 12456889999999999999
Q ss_pred CCcCH----HHHhcCCCC
Q 017021 359 DRLTA----REALRHPFF 372 (379)
Q Consensus 359 ~Rpta----~e~l~hp~f 372 (379)
+|||+ .|+++||||
T Consensus 263 ~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 263 DRLGVNEGYDELKAHPFF 280 (280)
T ss_pred hCCCcccCHHHHhcCCCC
Confidence 99999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=295.30 Aligned_cols=251 Identities=28% Similarity=0.411 Sum_probs=201.0
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
...|++.++||+|+||.||+|.+..+++.||+|++.... .....+.+|+..+..+ .|++++++++.+..+...
T Consensus 3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~ 77 (277)
T cd06641 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKDTKL 77 (277)
T ss_pred HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-----CCCCEeEEEEEEEeCCeE
Confidence 346888999999999999999999999999999986332 2334566788887777 779999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++... .++...+..++.|++.|+.+||+.|++|+||+|+||++
T Consensus 78 ~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i-------------------- 134 (277)
T cd06641 78 WIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL-------------------- 134 (277)
T ss_pred EEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE--------------------
Confidence 9999999 88999988753 48999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+.++.++|+|||.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||......
T Consensus 135 -------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 207 (277)
T cd06641 135 -------SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM 207 (277)
T ss_pred -------CCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH
Confidence 44456777777766533222 12345788899999998888899999999999999999999999764433
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
.....+... ..+ ......+.++.+++.+||+.
T Consensus 208 ~~~~~~~~~--~~~----------------------------------------------~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 208 KVLFLIPKN--NPP----------------------------------------------TLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred HHHHHHhcC--CCC----------------------------------------------CCCcccCHHHHHHHHHHccC
Confidence 322211110 000 00113456789999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~ 375 (379)
||++||++.++++||||.+.
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=283.60 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=200.4
Q ss_pred hhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 46 ~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
+++..||+|..|.||+++.+.+|...|||.+... .....+++..+.+...- .+.+.||+++++|..+..+++.|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s----~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKS----HDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhc----cCCCeeeeeeeEEeeCchHHHHH
Confidence 4678999999999999999999999999999743 33345555566655442 25799999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
|.|+.-+..++..-. +++++..+-.+...++.||.||. ++||+|||+||+|||+
T Consensus 171 elMs~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl------------------------ 225 (391)
T KOG0983|consen 171 ELMSTCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL------------------------ 225 (391)
T ss_pred HHHHHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE------------------------
Confidence 999766777776644 36999999999999999999997 7889999999999999
Q ss_pred ccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC---CCCCCccchHhHHHHHHHHHhCCCCCCCCc-hHH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTHE-NLE 276 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~~l~~g~~pf~~~~-~~~ 276 (379)
+..+.+||||||.+...-... ....|.+.|+|||.+.- ..|+.++||||||++++||+||..||.+.+ +.+
T Consensus 226 ---De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe 302 (391)
T KOG0983|consen 226 ---DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE 302 (391)
T ss_pred ---ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH
Confidence 555667888888776543333 23478999999999853 468999999999999999999999999854 444
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
..-.+.+...|.-. ....+++.+++|+..||++|
T Consensus 303 ~ltkvln~ePP~L~----------------------------------------------~~~gFSp~F~~fv~~CL~kd 336 (391)
T KOG0983|consen 303 VLTKVLNEEPPLLP----------------------------------------------GHMGFSPDFQSFVKDCLTKD 336 (391)
T ss_pred HHHHHHhcCCCCCC----------------------------------------------cccCcCHHHHHHHHHHhhcC
Confidence 44444332211100 01237899999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~ 375 (379)
+.+||.-.++|+|||+..=
T Consensus 337 ~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 337 HRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred cccCcchHHHhcCcceeec
Confidence 9999999999999998753
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=294.98 Aligned_cols=263 Identities=23% Similarity=0.357 Sum_probs=198.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee--cceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~ 119 (379)
.|++.++||.|++|.||++.+..+++.+|+|++.... .....+.+|++++..+ .|+|++.+++++.. ++.+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-----KSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-----CCCCeeeeeeEEEccCCCeE
Confidence 3567789999999999999999999999999987432 2445677888888887 78999999998754 4578
Q ss_pred EEEEeCC-CCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
|+||||+ +++|.+++.. .....++...+..++.||+.||.|||+.|++|+||+|+||+++
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~----------------- 139 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT----------------- 139 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe-----------------
Confidence 9999999 8999988764 2223588999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch-
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN- 274 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~- 274 (379)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus 140 ----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (287)
T cd06621 140 ----------RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209 (287)
T ss_pred ----------cCCeEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence 44557777777765432221 234567889999999888899999999999999999999999975421
Q ss_pred -HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 275 -LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 275 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..............+. ..+.. .......++.+.++|.+||
T Consensus 210 ~~~~~~~~~~~~~~~~~-------------------~~~~~--------------------~~~~~~~~~~~~~li~~~l 250 (287)
T cd06621 210 PLGPIELLSYIVNMPNP-------------------ELKDE--------------------PGNGIKWSEEFKDFIKQCL 250 (287)
T ss_pred CCChHHHHHHHhcCCch-------------------hhccC--------------------CCCCCchHHHHHHHHHHHc
Confidence 0000000000000000 00000 0000124567899999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 354 RYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
+.||++|||+.|+++||||+...-
T Consensus 251 ~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 251 EKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCCcccCCCHHHHHhCcccccccc
Confidence 999999999999999999966543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=294.56 Aligned_cols=251 Identities=26% Similarity=0.438 Sum_probs=200.4
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
.|.-.+.||+|++|.||++.+..+++.+|+|++.... .....+.+|+.++..+ .|++++++++.+..++..+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-----~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-----CCCChheEEEEEEcCCeEEEE
Confidence 4455579999999999999999999999999986432 2334566788887777 779999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
+||+ +++|.+++... .++...+..++.|++.||+|||+.|++||||+|+||++
T Consensus 95 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~----------------------- 148 (285)
T cd06648 95 MEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL----------------------- 148 (285)
T ss_pred EeccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE-----------------------
Confidence 9999 89999998773 58999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
+.++.++|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+..+..
T Consensus 149 ----~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~ 224 (285)
T cd06648 149 ----TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM 224 (285)
T ss_pred ----cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence 44556777777765432221 12345888999999998888999999999999999999999999765554443
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+.....+... .....+..+.++|++||+.||+
T Consensus 225 ~~~~~~~~~~~~----------------------------------------------~~~~~~~~l~~li~~~l~~~p~ 258 (285)
T cd06648 225 KRIRDNLPPKLK----------------------------------------------NLHKVSPRLRSFLDRMLVRDPA 258 (285)
T ss_pred HHHHhcCCCCCc----------------------------------------------ccccCCHHHHHHHHHHcccChh
Confidence 332221100000 0012456899999999999999
Q ss_pred CCcCHHHHhcCCCCCCC
Q 017021 359 DRLTAREALRHPFFTRD 375 (379)
Q Consensus 359 ~Rpta~e~l~hp~f~~~ 375 (379)
+|||+.++++||||+..
T Consensus 259 ~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 259 QRATAAELLNHPFLAKA 275 (285)
T ss_pred hCcCHHHHccCcccccC
Confidence 99999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=291.65 Aligned_cols=245 Identities=29% Similarity=0.512 Sum_probs=197.0
Q ss_pred cccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 51 Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
||.|+||.||++++..+++.+|+|++.... .....+..|+..+..+ .|+|++++++.+..++..|+++|++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-----QSPYVVKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-----CCcchhHHHHheecCcEEEEEEecC
Confidence 689999999999999999999999986432 2344566677777777 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 127 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 127 -~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
+++|.+++.+.. .+++..+..++.|++.||+|||+.|++||||+|+||+++
T Consensus 76 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~-------------------------- 127 (265)
T cd05579 76 PGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID-------------------------- 127 (265)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc--------------------------
Confidence 889999998765 689999999999999999999999999999999999994
Q ss_pred CCCCCeEEeecCcccccCCC-----------CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 206 PKSSAIKVIDFGSTTYERPD-----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
.++.++|+|||.+...... .....++..|+|||.......+.++|+||||+++|++++|..||.....
T Consensus 128 -~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 206 (265)
T cd05579 128 -SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206 (265)
T ss_pred -CCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 4455666677665432221 1234578889999999888889999999999999999999999987665
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+.... ..++.. ...+..+.+++.+||+
T Consensus 207 ~~~~~~~~~~~-----------------------~~~~~~------------------------~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 207 EEIFQNILNGK-----------------------IEWPED------------------------VEVSDEAIDLISKLLV 239 (265)
T ss_pred HHHHHHHhcCC-----------------------cCCCcc------------------------ccCCHHHHHHHHHHhc
Confidence 44443332211 111110 0135788999999999
Q ss_pred cCCCCCcCH---HHHhcCCCCCCCC
Q 017021 355 YDPTDRLTA---REALRHPFFTRDH 376 (379)
Q Consensus 355 ~dP~~Rpta---~e~l~hp~f~~~~ 376 (379)
.||++|||+ .++++||||++..
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccCCC
Confidence 999999999 9999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=299.47 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=201.2
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
...|++.+.||+|+||.||++.+..++..||+|.+... ......+..|+.++..+ .|++++.+++.+......|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-----KHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-----CCCCeeehhheeeeCCcEE
Confidence 45788999999999999999999989999999998632 23345566788777776 6799999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+|+||+ +++|.+++.+. .++...+..++.|++.||.|||+.|++|+||+|+||++.
T Consensus 93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~-------------------- 149 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-------------------- 149 (293)
T ss_pred EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc--------------------
Confidence 999999 89999998764 378999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.++.++|+|||.+....... ....|++.|+|||.+.+..++.++|+|||||++|++++|..||...+..+
T Consensus 150 -------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~ 222 (293)
T cd06647 150 -------MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (293)
T ss_pred -------CCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 44567777777654332221 23457888999999988888999999999999999999999997654432
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.. +..+ .+ ...+..+..+.++|++||+.|
T Consensus 223 ~~~~~~~--~~~~--------------------~~------------------------~~~~~~~~~l~~li~~~l~~~ 256 (293)
T cd06647 223 ALYLIAT--NGTP--------------------EL------------------------QNPEKLSAIFRDFLNRCLEMD 256 (293)
T ss_pred heeehhc--CCCC--------------------CC------------------------CCccccCHHHHHHHHHHccCC
Confidence 2111100 0000 00 001124567899999999999
Q ss_pred CCCCcCHHHHhcCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~ 375 (379)
|++||++++++.||||+.-
T Consensus 257 p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 257 VEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred hhhCcCHHHHhcCHHHhcC
Confidence 9999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=294.75 Aligned_cols=247 Identities=23% Similarity=0.291 Sum_probs=195.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCC-----ceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERK-----EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~-----~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
..|++.+.||+|+||.||+|.+...+ ..||+|.+.... .....+.+|+..+..+ .|++++.+++++..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i~~~~~~~~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-----QHPNIVCLLGVCTK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-----CCcccceEEEEEcC
Confidence 46889999999999999999876554 789999986432 2344567788888877 77999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEec
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 180 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~--------------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~ 180 (379)
....|++|||+ +++|.+++..... ..++...+..++.|++.||.|||+.|++||||||+||+++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~- 158 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG- 158 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc-
Confidence 89999999999 8999999976421 3578889999999999999999999999999999999994
Q ss_pred ccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhH
Q 017021 181 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSV 255 (379)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 255 (379)
.+..++|+|||.+....... ....+++.|+|||.+.+..++.++|||||
T Consensus 159 --------------------------~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl 212 (283)
T cd05048 159 --------------------------EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212 (283)
T ss_pred --------------------------CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence 44556777777665322211 12345778999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHH
Q 017021 256 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334 (379)
Q Consensus 256 G~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (379)
||++|+|++ |..||.+.+..+....+.+...+.
T Consensus 213 G~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~---------------------------------------------- 246 (283)
T cd05048 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP---------------------------------------------- 246 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC----------------------------------------------
Confidence 999999998 999998766544433322211000
Q ss_pred HHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 335 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.....+.++.+|+.+||+.||.+||+++|++++
T Consensus 247 --~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 247 --CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred --CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012366789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=300.53 Aligned_cols=281 Identities=32% Similarity=0.480 Sum_probs=211.8
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeec---cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee--cc
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RN 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~--~~ 117 (379)
..|.+.+.||+|+||.||+|.+..+++.+|+|.+.. ..........|+.++.++ .+|+|++++++++.. ..
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l----~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQEL----GDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHh----cCCCCccceeeeeccCCCc
Confidence 468899999999999999999999999999998853 122334456688877776 356899999998764 34
Q ss_pred eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 118 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 118 ~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
..|+||||++++|.+++... .+++.....++.|++.||.|||+.|++||||+|+||+++.
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~----------------- 142 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS----------------- 142 (337)
T ss_pred eEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-----------------
Confidence 78999999987999988764 5788899999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCC--------CCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPD--------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
++.++|+|||.+...... .....||..|+|||.+.+ ..++.++|+||||+++|+|++|+.|
T Consensus 143 ----------~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~p 212 (337)
T cd07852 143 ----------DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212 (337)
T ss_pred ----------CCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCC
Confidence 445666666655432211 122457889999998754 4578999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|.+....+....+....+..+...+..+........... ....... ......+..+.++.++
T Consensus 213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~-~~~~~~~~~~~~l~~l 274 (337)
T cd07852 213 FPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDS-----------------LPSRPRK-PLDELLPKASDDALDL 274 (337)
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhh-----------------ccccccc-chhhhccCCCHHHHHH
Confidence 988877777777777777776665554433222111110 0000000 0111223367889999
Q ss_pred HhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
|.+||+.||++|||+.++++||||..-
T Consensus 275 i~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 275 LKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHhccCCcccccCHHHHhhChhhhhh
Confidence 999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=306.14 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=192.3
Q ss_pred eechhhhhhhhccccccceeEEEEEe-----cCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.++...|++.++||+|+||.||+|.+ ..++..||+|+++... .....+.+|+.++..+. .|+||+++++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~----~HpnIv~l~~ 106 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG----NHINIVNLLG 106 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc----CCcceeeeee
Confidence 44555799999999999999999964 3567789999986432 23445677888888772 5789999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCC----------------------------------------------------
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNN---------------------------------------------------- 138 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~---------------------------------------------------- 138 (379)
++..++..++||||+ +|+|.+++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 999999999999999 999999986532
Q ss_pred ---------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 139 ---------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 139 ---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
...+++..+..++.||+.||.|||+.|++||||||+||+++.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~----------------- 249 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH----------------- 249 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC-----------------
Confidence 113678889999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCCC-----cccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 271 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~ 271 (379)
+..++|+|||.+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus 250 ----------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 250 ----------GRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred ----------CCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 44566777776654332211 1234567999999999899999999999999999998 8899976
Q ss_pred CchHHHHHH-HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 272 HENLEHLAM-MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 272 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
......... +...... .. ....+.++.++|.
T Consensus 320 ~~~~~~~~~~~~~~~~~----------------------~~--------------------------~~~~~~~l~~li~ 351 (375)
T cd05104 320 MPVDSKFYKMIKEGYRM----------------------LS--------------------------PECAPSEMYDIMK 351 (375)
T ss_pred CCchHHHHHHHHhCccC----------------------CC--------------------------CCCCCHHHHHHHH
Confidence 433221111 1110000 00 0123467999999
Q ss_pred hccccCCCCCcCHHHHhcC
Q 017021 351 GLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~h 369 (379)
+||+.||++|||++|+++.
T Consensus 352 ~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 352 SCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHccCChhHCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=314.03 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=205.5
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeec-cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 126 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~- 126 (379)
-+||+|.||+||-|+|..|+...|||.+.. .....+..++|+..-.++ .|.|||++.+++..++++-|.||-.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-----rHkNIVrYLGs~senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-----RHKNIVRYLGSVSENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-----hhHhHHHHhhccCCCCeEEEEeecCC
Confidence 589999999999999999999999999863 344556677888888888 6689999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccccc
Q 017021 127 GSSLYDFLRKNNYRSF--PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 204 (379)
Q Consensus 127 ~~sL~~~l~~~~~~~l--~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (379)
||+|.+++..+.+ ++ .+...-.+..||++||.|||...|+|||||-+|+|++
T Consensus 656 GGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN------------------------- 709 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN------------------------- 709 (1226)
T ss_pred CCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe-------------------------
Confidence 9999999998763 56 6788999999999999999999999999999999996
Q ss_pred CCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCC--CCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH-
Q 017021 205 MPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENLEHL- 278 (379)
Q Consensus 205 ~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~- 278 (379)
.-.+.+||.|||-+++.... ..++.||..|||||++... .|+.++|||||||++.||+||++||.........
T Consensus 710 -TySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM 788 (1226)
T KOG4279|consen 710 -TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM 788 (1226)
T ss_pred -eccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh
Confidence 34467888888877653332 3457899999999999753 5899999999999999999999999754332211
Q ss_pred --HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 279 --AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 279 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
..+.+...+.| +..+.+++.||.+|+.+|
T Consensus 789 FkVGmyKvHP~iP-------------------------------------------------eelsaeak~FilrcFepd 819 (1226)
T KOG4279|consen 789 FKVGMYKVHPPIP-------------------------------------------------EELSAEAKNFILRCFEPD 819 (1226)
T ss_pred hhhcceecCCCCc-------------------------------------------------HHHHHHHHHHHHHHcCCC
Confidence 01111122222 246788999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCCCcC
Q 017021 357 PTDRLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~~~~ 378 (379)
|.+||+|.++|.-||++..+.|
T Consensus 820 ~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 820 PCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred cccCccHHHhccCcccccCCCC
Confidence 9999999999999999987544
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=290.07 Aligned_cols=249 Identities=23% Similarity=0.403 Sum_probs=198.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee--ecce
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--YRNH 118 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~--~~~~ 118 (379)
.|++.+.||.|+||.||+|.+..+++.||+|++... ......+..|+.++..+ .|++++++++.+. .+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-----KHPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-----CCCccceeeeeeecCCCCE
Confidence 377889999999999999999999999999998642 22344566788888887 7789999988765 3457
Q ss_pred EEEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HcCCcccCCCCCcEEEecccccccCCCc
Q 017021 119 ICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMH-----DLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH-----~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
.+++|||+ +++|.+++... ....+++..+..++.||+.||.||| +.+++|+||+|+||+++
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~----------- 144 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD----------- 144 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe-----------
Confidence 89999999 89999999763 2246899999999999999999999 89999999999999994
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCC
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus 145 ----------------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 208 (265)
T cd08217 145 ----------------ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208 (265)
T ss_pred ----------------cCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 45567777777766443322 23467889999999988888999999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||...+..+....+.... .+ . .....+..+.+
T Consensus 209 p~~~~~~~~~~~~~~~~~--~~--------------------~--------------------------~~~~~~~~~~~ 240 (265)
T cd08217 209 PFTARNQLQLASKIKEGK--FR--------------------R--------------------------IPYRYSSELNE 240 (265)
T ss_pred cccCcCHHHHHHHHhcCC--CC--------------------C--------------------------CccccCHHHHH
Confidence 998765333222221110 00 0 11235678999
Q ss_pred HHhhccccCCCCCcCHHHHhcCCCC
Q 017021 348 LLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
++.+||+.||++|||+.++++|||+
T Consensus 241 l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 241 VIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=290.93 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=196.3
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+....|++.++||+|++|.||+|.+. ++..||+|.+.........+..|+.++..+ .|++++++++.+...+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTL-----QHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhC-----CCCCeeeEEEEEcCCCCc
Confidence 34567899999999999999999865 456799999875555556777899998887 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+++|||+ +++|.+++.......++...+..++.|++.||+|||+.|++||||||+||+++.+
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~----------------- 139 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES----------------- 139 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-----------------
Confidence 9999999 8999999977554568899999999999999999999999999999999999544
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 273 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~ 273 (379)
+.++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||....
T Consensus 140 ----------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 209 (261)
T cd05072 140 ----------LMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209 (261)
T ss_pred ----------CcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC
Confidence 445666666654332211 11234667999999988888999999999999999998 999997655
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.+.... + .....+.++.+++.+||
T Consensus 210 ~~~~~~~~~~~~~~-~-----------------------------------------------~~~~~~~~~~~li~~~l 241 (261)
T cd05072 210 NSDVMSALQRGYRM-P-----------------------------------------------RMENCPDELYDIMKTCW 241 (261)
T ss_pred HHHHHHHHHcCCCC-C-----------------------------------------------CCCCCCHHHHHHHHHHc
Confidence 44433332221100 0 01135568899999999
Q ss_pred ccCCCCCcCHHHHhc
Q 017021 354 RYDPTDRLTAREALR 368 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~ 368 (379)
..||++|||++++++
T Consensus 242 ~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 242 KEKAEERPTFDYLQS 256 (261)
T ss_pred cCCcccCcCHHHHHH
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=293.31 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=195.1
Q ss_pred chhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
....|.+.+.||+|+||.||+|.+. .+++.||+|+++.... ....+.+|++++..+ .|++++.+++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~ 77 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-----QHENIVKFYGVC 77 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-----CCCCchheeeEE
Confidence 3457889999999999999999874 3468899999874332 345677898888887 678999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEec
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNN------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 180 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~ 180 (379)
......+++|||+ +++|.+++...+ ...+++..+..++.|++.||.+||+.|++||||||+||+++.
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 9999999999999 999999997643 124788899999999999999999999999999999999954
Q ss_pred ccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCCCCccchHhH
Q 017021 181 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSV 255 (379)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 255 (379)
++.++|+|||.+...... .....++..|+|||.+.+..++.++|||||
T Consensus 158 ---------------------------~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (280)
T cd05049 158 ---------------------------DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 210 (280)
T ss_pred ---------------------------CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHH
Confidence 455666666655432111 112245678999999998899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHH
Q 017021 256 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334 (379)
Q Consensus 256 G~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (379)
||++|+|++ |..||...+..+....+.+.....
T Consensus 211 G~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------------------------- 244 (280)
T cd05049 211 GVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ---------------------------------------------- 244 (280)
T ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC----------------------------------------------
Confidence 999999998 999997665544333222111000
Q ss_pred HHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 335 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.....+..+.+++++||+.||++|||+.|+++
T Consensus 245 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 245 --RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 01135678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=290.23 Aligned_cols=253 Identities=27% Similarity=0.459 Sum_probs=203.9
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.+.||+|++|.||+|.+..+++.||+|++.... .....+..|+..+..+ .|++++++++.+...+..++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-----ESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEccCCeEEE
Confidence 4678899999999999999999999999999987543 3456677788888887 57899999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
++||+ +++|.+++.... .+++..+..++.|++.||+|||+ .|++||||+|+||++
T Consensus 77 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~--------------------- 133 (264)
T cd06623 77 VLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI--------------------- 133 (264)
T ss_pred EEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---------------------
Confidence 99999 899999998753 68999999999999999999999 999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 134 ------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 207 (264)
T cd06623 134 ------NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207 (264)
T ss_pred ------CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC
Confidence 455667777777765443322 13467889999999988888999999999999999999999997654211
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc-chhHHHHHHhhcccc
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLLRY 355 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~ 355 (379)
............. ... ... .+..+.++|++||..
T Consensus 208 ~~~~~~~~~~~~~-------------------~~~--------------------------~~~~~~~~l~~li~~~l~~ 242 (264)
T cd06623 208 FFELMQAICDGPP-------------------PSL--------------------------PAEEFSPEFRDFISACLQK 242 (264)
T ss_pred HHHHHHHHhcCCC-------------------CCC--------------------------CcccCCHHHHHHHHHHccC
Confidence 1111111111000 000 112 567899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~ 375 (379)
+|++|||+.|+++||||+.-
T Consensus 243 ~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 243 DPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.06 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=201.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|...++||+|+||+||+|.+..+++.||+|++.... .....+..|+.+++.+ .|++++.+++++.+....
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-----KHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-----CCCCCccEEEEEEeCCEE
Confidence 3666688999999999999999999999999986322 2224556788888877 679999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 120 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 120 ~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
|+||||+.+++.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 97 ~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili--------------------- 154 (313)
T cd06633 97 WLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL--------------------- 154 (313)
T ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---------------------
Confidence 9999999778888886643 358999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhh---CCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
..++.++|+|||.+..... .....|+..|+|||.+. ...++.++|+|||||++|+|++|..||...+...
T Consensus 155 ------~~~~~~kL~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~ 227 (313)
T cd06633 155 ------TEPGQVKLADFGSASKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 227 (313)
T ss_pred ------CCCCCEEEeecCCCcccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4455678888887654322 23456888999999974 3457889999999999999999999997765544
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.... .+.. ....++..+.+|+.+||+.+
T Consensus 228 ~~~~~~~~~--~~~~---------------------------------------------~~~~~~~~l~~li~~~l~~~ 260 (313)
T cd06633 228 ALYHIAQND--SPTL---------------------------------------------QSNEWTDSFRGFVDYCLQKI 260 (313)
T ss_pred HHHHHHhcC--CCCC---------------------------------------------CccccCHHHHHHHHHHccCC
Confidence 333222111 1100 01124567899999999999
Q ss_pred CCCCcCHHHHhcCCCCCCCCc
Q 017021 357 PTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~~~ 377 (379)
|.+||++.+++.||||.....
T Consensus 261 P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 261 PQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred hhhCcCHHHHhcCcccCCCch
Confidence 999999999999999987554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=289.63 Aligned_cols=249 Identities=29% Similarity=0.459 Sum_probs=196.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch---hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
+|++.+.||+|++|.||++.+..+++.||+|.++.... ....+..|+.++..+ .|++++++++.+...+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-----KHPNLVKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-----CCCChhheeeeEecCCEEE
Confidence 47888999999999999999998999999999975433 456677788888887 6789999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+|+||+ +++|.+++.... .+++..+..++.+++.||.|||+.|++|+||+|+||+++.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~------------------ 135 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN------------------ 135 (264)
T ss_pred EEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC------------------
Confidence 999999 899999998754 57899999999999999999999999999999999999544
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhCCC---CCCccchHhHHHHHHHHHhCCCCC
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.++|+|||.+....... ....++..|+|||.+.+.. ++.++||||||+++|++++|..||
T Consensus 136 ---------~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf 206 (264)
T cd06626 136 ---------GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206 (264)
T ss_pred ---------CCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence 455666666554332221 1235678999999987765 789999999999999999999999
Q ss_pred CCCch-HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 270 QTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 270 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
..... ......+.. +..+ ..|. ....+..+.++
T Consensus 207 ~~~~~~~~~~~~~~~--~~~~--------------------~~~~------------------------~~~~~~~~~~l 240 (264)
T cd06626 207 SELDNEFQIMFHVGA--GHKP--------------------PIPD------------------------SLQLSPEGKDF 240 (264)
T ss_pred cCCcchHHHHHHHhc--CCCC--------------------CCCc------------------------ccccCHHHHHH
Confidence 75432 111111111 1111 0000 01235678899
Q ss_pred HhhccccCCCCCcCHHHHhcCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
|.+||+.||++|||+.|++.|||+
T Consensus 241 i~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 241 LDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=306.56 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=190.8
Q ss_pred echhhhhhhhccccccceeEEEEEecCC-----CceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
+....|++.+.||+|+||.||+|.+..+ +..||+|.++... .....+..|+.+++.+ ..|+||+++++.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l----~~h~nIv~~~~~ 110 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHL----GQHKNIVNLLGA 110 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhh----ccCCceeeEeeE
Confidence 4556789999999999999999986544 3579999997432 2234566788888776 257899999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCC-----------------------------------------------------
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNN----------------------------------------------------- 138 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~----------------------------------------------------- 138 (379)
+...+..++||||+ +++|.+++....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 99999999999999 999999986431
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 139 ---------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 139 ---------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
...+++..+..++.||+.||.|||+.|++||||||+||+++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~----------------------- 247 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD----------------------- 247 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC-----------------------
Confidence 124678889999999999999999999999999999999954
Q ss_pred cCCCCCCeEEeecCcccccCCCCC-----cccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHH
Q 017021 204 RMPKSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 277 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~ 277 (379)
+..++|+|||.+........ ...++..|+|||++.+..++.++|||||||++|+|++ |+.||........
T Consensus 248 ----~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~ 323 (374)
T cd05106 248 ----GRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK 323 (374)
T ss_pred ----CCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH
Confidence 44566777776653322211 1234567999999988889999999999999999997 9999976433222
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
........... . .....+.++.++|.+||+.||
T Consensus 324 ~~~~~~~~~~~---------------------~--------------------------~~~~~~~~l~~li~~cl~~dp 356 (374)
T cd05106 324 FYKMVKRGYQM---------------------S--------------------------RPDFAPPEIYSIMKMCWNLEP 356 (374)
T ss_pred HHHHHHcccCc---------------------c--------------------------CCCCCCHHHHHHHHHHcCCCh
Confidence 11111100000 0 001245789999999999999
Q ss_pred CCCcCHHHHhc
Q 017021 358 TDRLTAREALR 368 (379)
Q Consensus 358 ~~Rpta~e~l~ 368 (379)
++|||+.++++
T Consensus 357 ~~RPs~~~l~~ 367 (374)
T cd05106 357 TERPTFSQISQ 367 (374)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=292.63 Aligned_cols=256 Identities=28% Similarity=0.440 Sum_probs=205.6
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
....|++...||+|++|.||++.+..++..||+|++.........+..|++.+..+ .|+|++++++.+..+...|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-----KHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-----CCCCeeEEEEEEEECCEEE
Confidence 45568888999999999999999998899999999986544455677788888877 6789999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+++||+ +++|.+++.... ..++...+..++.|++.||.|||+.|++|+|++|+||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~-------------------- 150 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS-------------------- 150 (286)
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc--------------------
Confidence 999999 799999998754 3589999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.++.++|+|||.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+...
T Consensus 151 -------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~ 223 (286)
T cd06614 151 -------KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223 (286)
T ss_pred -------CCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4455666777655432221 123357788999999988889999999999999999999999997655443
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+... ..+. .. ....++..+.++|++||+.+
T Consensus 224 ~~~~~~~~--~~~~--------------------~~------------------------~~~~~~~~l~~li~~~l~~~ 257 (286)
T cd06614 224 ALFLITTK--GIPP--------------------LK------------------------NPEKWSPEFKDFLNKCLVKD 257 (286)
T ss_pred HHHHHHhc--CCCC--------------------Cc------------------------chhhCCHHHHHHHHHHhccC
Confidence 33222111 0000 00 00124567899999999999
Q ss_pred CCCCcCHHHHhcCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~ 375 (379)
|.+|||+.++++||||+..
T Consensus 258 p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 258 PEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred hhhCcCHHHHhhChHhhcc
Confidence 9999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=290.15 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=197.3
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+...|++.++||.|+||.||+|.++. ++.+|+|++..... ....+..|+.++..+ .|++++++++++......
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-----RHKHLISLFAVCSVGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-----CCcchhheeeeEecCCCe
Confidence 34568999999999999999999887 88899999875443 345566788887777 679999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+++|||+ +++|.+++.......++...+..++.||+.||.|||+.|++||||+|+||+++.
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~------------------ 139 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE------------------ 139 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcC------------------
Confidence 9999999 889999998765557899999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCch
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 274 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~ 274 (379)
+..++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+.
T Consensus 140 ---------~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~ 210 (261)
T cd05148 140 ---------DLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210 (261)
T ss_pred ---------CceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 4456666666654332211 11234567999999988889999999999999999998 8999987665
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+...... + .....+..+.++|.+||+
T Consensus 211 ~~~~~~~~~~~~~-~-----------------------------------------------~~~~~~~~~~~~i~~~l~ 242 (261)
T cd05148 211 HEVYDQITAGYRM-P-----------------------------------------------CPAKCPQEIYKIMLECWA 242 (261)
T ss_pred HHHHHHHHhCCcC-C-----------------------------------------------CCCCCCHHHHHHHHHHcC
Confidence 4444433321110 0 012356789999999999
Q ss_pred cCCCCCcCHHHHhc
Q 017021 355 YDPTDRLTAREALR 368 (379)
Q Consensus 355 ~dP~~Rpta~e~l~ 368 (379)
.||++|||++++++
T Consensus 243 ~~p~~Rpt~~~l~~ 256 (261)
T cd05148 243 AEPEDRPSFKALRE 256 (261)
T ss_pred CCchhCcCHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=289.71 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=191.5
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 126 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~- 126 (379)
..||+|+||.||+|.+..++..||+|.+.... .....+.+|+.++..+ .|++++++++++..++..++++||+
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-----KHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-----CCCCeeeeeeeeccCCEEEEEEecCC
Confidence 57999999999999999999999999986432 2344667788888877 7799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccccc
Q 017021 127 GSSLYDFLRKNNYRSF--PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 204 (379)
Q Consensus 127 ~~sL~~~l~~~~~~~l--~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (379)
+++|.+++.... ..+ +...+..++.||+.||.|||+.|++||||||+||+++.
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~------------------------ 143 (268)
T cd06624 89 GGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT------------------------ 143 (268)
T ss_pred CCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC------------------------
Confidence 899999997653 134 78888999999999999999999999999999999942
Q ss_pred CCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCC--CCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 205 MPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 205 ~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
....++|+|||.+...... .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..||..........
T Consensus 144 --~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~ 221 (268)
T cd06624 144 --YSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221 (268)
T ss_pred --CCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH
Confidence 2346788888877543221 1234578899999998654 37899999999999999999999996432211110
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
......... . ......+.++.+++++||+.+|++
T Consensus 222 ~~~~~~~~~--------------------~--------------------------~~~~~~~~~~~~li~~~l~~~p~~ 255 (268)
T cd06624 222 FKVGMFKIH--------------------P--------------------------EIPESLSAEAKNFILRCFEPDPDK 255 (268)
T ss_pred hhhhhhccC--------------------C--------------------------CCCcccCHHHHHHHHHHcCCCchh
Confidence 000000000 0 011235567999999999999999
Q ss_pred CcCHHHHhcCCCC
Q 017021 360 RLTAREALRHPFF 372 (379)
Q Consensus 360 Rpta~e~l~hp~f 372 (379)
|||+.|++.||||
T Consensus 256 Rpt~~~ll~~~~~ 268 (268)
T cd06624 256 RASAHDLLQDPFL 268 (268)
T ss_pred CCCHHHHHhCCCC
Confidence 9999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=288.45 Aligned_cols=244 Identities=25% Similarity=0.342 Sum_probs=193.5
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
..|++.+.||+|+||.||++.++. +..+|+|.+.........+..|+.+++.+ +|++++++++++......+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKL-----SHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHC-----CCCCceeEEEEEccCCCEEEE
Confidence 346778999999999999998765 45799999875555556778899999888 779999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~--------------------- 135 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS--------------------- 135 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC---------------------
Confidence 9999 899999987643 25889999999999999999999999999999999999944
Q ss_pred cccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 276 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~ 276 (379)
+..++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+
T Consensus 136 ------~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05114 136 ------TGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209 (256)
T ss_pred ------CCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 4456666666654322111 11234567999999988889999999999999999999 899998766555
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+..... . ....+..+.+++.+||+.|
T Consensus 210 ~~~~i~~~~~~~----------------------~--------------------------~~~~~~~~~~li~~c~~~~ 241 (256)
T cd05114 210 VVEMISRGFRLY----------------------R--------------------------PKLASMTVYEVMYSCWHEK 241 (256)
T ss_pred HHHHHHCCCCCC----------------------C--------------------------CCCCCHHHHHHHHHHccCC
Confidence 444332211100 0 0123457899999999999
Q ss_pred CCCCcCHHHHhc
Q 017021 357 PTDRLTAREALR 368 (379)
Q Consensus 357 P~~Rpta~e~l~ 368 (379)
|++|||++++++
T Consensus 242 p~~Rps~~~l~~ 253 (256)
T cd05114 242 PEGRPTFAELLR 253 (256)
T ss_pred cccCcCHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=284.67 Aligned_cols=248 Identities=29% Similarity=0.496 Sum_probs=203.4
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccch-hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
|.+.+.||+|++|.||++.+..+++.+++|++..... ....+..|+..+..+ .|++++.+.+.+......++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-----KHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-----CCCCEeEEEEEEecCCeEEEEE
Confidence 6777999999999999999998999999999975432 456677788888887 5789999999999999999999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
||+ +++|.+++.... ..+++..+..++.|++.||.+||+.|++||||+|+||++
T Consensus 77 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i------------------------ 131 (253)
T cd05122 77 EFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL------------------------ 131 (253)
T ss_pred ecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE------------------------
Confidence 999 799999987753 368999999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....
T Consensus 132 ---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 208 (253)
T cd05122 132 ---TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208 (253)
T ss_pred ---ccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 455678888888876555443 445688899999999888889999999999999999999999986544333222
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
... ...+. .+. ...++..+.++|.+||+.||++|
T Consensus 209 ~~~--~~~~~--------------------~~~------------------------~~~~~~~~~~~i~~~l~~~p~~R 242 (253)
T cd05122 209 IAT--NGPPG--------------------LRN------------------------PEKWSDEFKDFLKKCLQKNPEKR 242 (253)
T ss_pred HHh--cCCCC--------------------cCc------------------------ccccCHHHHHHHHHHccCChhhC
Confidence 211 00000 000 00135689999999999999999
Q ss_pred cCHHHHhcCCC
Q 017021 361 LTAREALRHPF 371 (379)
Q Consensus 361 pta~e~l~hp~ 371 (379)
||+.|+++|||
T Consensus 243 ~t~~~~l~~~~ 253 (253)
T cd05122 243 PTAEQLLKHPF 253 (253)
T ss_pred CCHHHHhcCCC
Confidence 99999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=293.75 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=202.0
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
....|+..+.||+|+||.||++++..++..||+|.+.... .....+..|+.++..+ .|++++.+++++..+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~ 97 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-----KHPNSIEYKGCYLRE 97 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEeeC
Confidence 3455788899999999999999999999999999986432 2233566788888777 779999999999999
Q ss_pred ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 117 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 117 ~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
...++||||+.++|.+.+.... ..+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 98 ~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~------------------ 158 (317)
T cd06635 98 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL------------------ 158 (317)
T ss_pred CeEEEEEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE------------------
Confidence 9999999999778888876543 358999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhh---CCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+..... .....|+..|+|||.+. ...++.++|+|||||++|+|++|..||...+
T Consensus 159 ---------~~~~~~kl~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 159 ---------TEPGQVKLADFGSASIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred ---------CCCCCEEEecCCCccccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 4455677788877654332 22346788999999974 3457899999999999999999999997655
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.....+... ...++..+.++|.+||
T Consensus 229 ~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~l~~li~~~l 261 (317)
T cd06635 229 AMSALYHIAQNESPTLQ-----------------------------------------------SNEWSDYFRNFVDSCL 261 (317)
T ss_pred HHHHHHHHHhccCCCCC-----------------------------------------------CccccHHHHHHHHHHc
Confidence 44433332221111000 0124567899999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+.+|.+||++.++++|||+....
T Consensus 262 ~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 262 QKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred cCCcccCcCHHHHHhChhhhccC
Confidence 99999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=288.14 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=193.4
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
..|++.+.||+|+||.||++.+.. +..+|+|.+.........+..|+..+..+ +|++++++++++......+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKL-----SHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcC-----CCCCeeeEEEEEccCCCcEEE
Confidence 457888999999999999998754 44599999875544456677888888887 789999999999988899999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|||+ +++|.+++..... .+++..+..++.||+.||.|||+.|++|+||||+||+++
T Consensus 78 ~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~---------------------- 134 (256)
T cd05113 78 TEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD---------------------- 134 (256)
T ss_pred EEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----------------------
Confidence 9999 8899999976542 589999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 276 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~ 276 (379)
.++.++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 135 -----~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~ 209 (256)
T cd05113 135 -----DQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209 (256)
T ss_pred -----CCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 44456666666654322211 11234567999999988889999999999999999998 999997655544
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+...... ....+..+.+++.+||+.|
T Consensus 210 ~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05113 210 TVEKVSQGLRLYR------------------------------------------------PHLASEKVYAIMYSCWHEK 241 (256)
T ss_pred HHHHHhcCCCCCC------------------------------------------------CCCCCHHHHHHHHHHcCCC
Confidence 3333222111100 0124568999999999999
Q ss_pred CCCCcCHHHHhcC
Q 017021 357 PTDRLTAREALRH 369 (379)
Q Consensus 357 P~~Rpta~e~l~h 369 (379)
|.+|||+.+++++
T Consensus 242 p~~Rp~~~~ll~~ 254 (256)
T cd05113 242 AEERPTFQQLLSS 254 (256)
T ss_pred cccCCCHHHHHHh
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=288.86 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=197.2
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+....|++.+.||+|++|.||+|.+.. ++.||+|.++........+.+|+.++.++ .|++++++++++...+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKL-----RHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHC-----CCCCccceeEEEecCCCe
Confidence 345568889999999999999998754 56799999975554456677888888888 679999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+++|||+ +++|.+++.......+++..+..++.|++.||.+||+.|++||||||+||+++
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~------------------- 137 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG------------------- 137 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc-------------------
Confidence 9999999 99999999775545689999999999999999999999999999999999994
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC-Ccc---cccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYI---VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 273 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~---~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~ 273 (379)
.++.++|+|||.+....... ... ..+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+
T Consensus 138 --------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 138 --------ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred --------CCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 44556777777665433221 111 12357999999988889999999999999999999 999998765
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
.......+.+.... + . ....+..+.+++.+||
T Consensus 210 ~~~~~~~~~~~~~~-~---------------------~--------------------------~~~~~~~~~~li~~~l 241 (261)
T cd05068 210 NAEVLQQVDQGYRM-P---------------------C--------------------------PPGCPKELYDIMLDCW 241 (261)
T ss_pred HHHHHHHHHcCCCC-C---------------------C--------------------------CCcCCHHHHHHHHHHh
Confidence 54443333221100 0 0 0124568999999999
Q ss_pred ccCCCCCcCHHHHhc
Q 017021 354 RYDPTDRLTAREALR 368 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~ 368 (379)
+.||++||+++++++
T Consensus 242 ~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 242 KEDPDDRPTFETLQW 256 (261)
T ss_pred hcCcccCCCHHHHHH
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=286.62 Aligned_cols=248 Identities=27% Similarity=0.507 Sum_probs=201.6
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.+.||.|++|.||++.+..+++.||+|++.... .....+..|++++..+ .|++++.+.+.+......+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~~~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-----NHPNIIKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-----CCCChhheEEEEecCCEEE
Confidence 4778899999999999999999999999999997432 3445667788888877 5789999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+++|++ +++|.+.+.... ...+++..+..++.+++.||.+||+.|++|+||+|+||+++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~------------------ 137 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT------------------ 137 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc------------------
Confidence 999999 889999997742 24689999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
.+..++|+|||.+....... ....|++.|+|||...+..++.++|+||+|+++++|++|+.||...+.
T Consensus 138 ---------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 208 (258)
T cd08215 138 ---------SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL 208 (258)
T ss_pred ---------CCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH
Confidence 44556777777665433321 234678899999999888899999999999999999999999976554
Q ss_pred HHHHHHHHHHc-CCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 275 LEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 275 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
.+......+.. .+. ....+..+.+++++||
T Consensus 209 ~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~i~~~l 239 (258)
T cd08215 209 LELALKILKGQYPPI-------------------------------------------------PSQYSSELRNLVSSLL 239 (258)
T ss_pred HHHHHHHhcCCCCCC-------------------------------------------------CCCCCHHHHHHHHHHc
Confidence 33332221110 000 1135678999999999
Q ss_pred ccCCCCCcCHHHHhcCCCC
Q 017021 354 RYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f 372 (379)
..||++|||+.++++||||
T Consensus 240 ~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 240 QKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=307.85 Aligned_cols=258 Identities=22% Similarity=0.363 Sum_probs=211.5
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEee-----ccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~-----~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
....+..-+...+||+|+|-+||+|.|..+|..||.-.++ .......++..|+..|..| .|+||++++++
T Consensus 35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-----~H~NIirfy~S 109 (632)
T KOG0584|consen 35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-----KHPNIIRFYDS 109 (632)
T ss_pred cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-----CCCceeeeeeh
Confidence 3444455567789999999999999999999999987765 2344457888999999998 88999999999
Q ss_pred eeecc--eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCcEEEecccccccC
Q 017021 113 FDYRN--HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 113 ~~~~~--~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~~~ 187 (379)
|.+.. .+.+|+|++ .|+|..+..+.+ .+....+..|+.||+.||.|||++. |+|||||.+||++.
T Consensus 110 W~d~~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin-------- 179 (632)
T KOG0584|consen 110 WVDTDNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN-------- 179 (632)
T ss_pred eecCCCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--------
Confidence 98765 489999999 999999998876 6999999999999999999999875 99999999999994
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCC
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
...+.+||.|+|+|....... .+..|||.|||||... ..|+..+||||||.++.||+|+.
T Consensus 180 ------------------G~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~e 240 (632)
T KOG0584|consen 180 ------------------GNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSE 240 (632)
T ss_pred ------------------CCcCceeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhcc
Confidence 344779999999987655543 4468999999999987 58999999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
+||.-....... ..++.+..++..+. .-..++++
T Consensus 241 YPYsEC~n~AQI--YKKV~SGiKP~sl~--------------------------------------------kV~dPevr 274 (632)
T KOG0584|consen 241 YPYSECTNPAQI--YKKVTSGIKPAALS--------------------------------------------KVKDPEVR 274 (632)
T ss_pred CChhhhCCHHHH--HHHHHcCCCHHHhh--------------------------------------------ccCCHHHH
Confidence 999765543222 23333333222221 12346899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+||.+||.. .+.|+||.|+|.||||..+.
T Consensus 275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 275 EFIEKCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred HHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence 999999999 99999999999999999873
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=284.59 Aligned_cols=247 Identities=29% Similarity=0.444 Sum_probs=201.4
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.+.||+|++|.||++.+..+++.||+|.+.... .....+..|++.+.++ .|++++.+.+++...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-----KHPNIVKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-----CCCCccEEEEEEEeCCEEE
Confidence 4778899999999999999999999999999997543 2445667788888777 6788999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
++||++ +++|.+++.... .+++..+..++.|++.||.+||+.|++||||+|+||++
T Consensus 76 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i--------------------- 132 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT--------------------- 132 (254)
T ss_pred EEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---------------------
Confidence 999999 889999998764 68999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.++|+|||.+....... ....++..|+|||...+..++.++|+||||+++|+|++|..||...+...
T Consensus 133 ------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~ 206 (254)
T cd06627 133 ------TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA 206 (254)
T ss_pred ------CCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 445567777777776443332 23467889999999988778899999999999999999999997655433
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....... .. ... .....+..+.+++.+||+.|
T Consensus 207 ~~~~~~~--~~--------------------~~~--------------------------~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 207 ALFRIVQ--DD--------------------HPP--------------------------LPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred HHHHHhc--cC--------------------CCC--------------------------CCCCCCHHHHHHHHHHHhCC
Confidence 2221111 00 000 11234578999999999999
Q ss_pred CCCCcCHHHHhcCCCC
Q 017021 357 PTDRLTAREALRHPFF 372 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f 372 (379)
|++|||+.|++.||||
T Consensus 239 p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 239 PNLRPTAKQLLKHPWI 254 (254)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=292.96 Aligned_cols=251 Identities=26% Similarity=0.441 Sum_probs=198.4
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
.|.-..+||+|+||.||++.++.+++.||+|++.... .....+..|+.++..+ .|++++++++.+..++..+++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-----CCcchhheeeEEEeCCEEEEE
Confidence 3444578999999999999999999999999986322 2344566788877777 678999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|||+ +++|.+++... .+++..+..++.|++.||+|||+.|++||||+|+||+++
T Consensus 96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~---------------------- 150 (292)
T cd06657 96 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT---------------------- 150 (292)
T ss_pred EecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----------------------
Confidence 9999 88999887543 488999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
.++.++|+|||.+...... .....|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.+....+..
T Consensus 151 -----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~ 225 (292)
T cd06657 151 -----HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 225 (292)
T ss_pred -----CCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4455677777765432211 12346788999999998888899999999999999999999999876554433
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+........ ......+..+.+++.+||+.||.
T Consensus 226 ~~~~~~~~~~~----------------------------------------------~~~~~~~~~l~~li~~~l~~~P~ 259 (292)
T cd06657 226 KMIRDNLPPKL----------------------------------------------KNLHKVSPSLKGFLDRLLVRDPA 259 (292)
T ss_pred HHHHhhCCccc----------------------------------------------CCcccCCHHHHHHHHHHHhCCcc
Confidence 32222111000 00112456788999999999999
Q ss_pred CCcCHHHHhcCCCCCCC
Q 017021 359 DRLTAREALRHPFFTRD 375 (379)
Q Consensus 359 ~Rpta~e~l~hp~f~~~ 375 (379)
+||++.++++||||...
T Consensus 260 ~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 260 QRATAAELLKHPFLAKA 276 (292)
T ss_pred cCcCHHHHhcChHHhcc
Confidence 99999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=286.65 Aligned_cols=246 Identities=22% Similarity=0.307 Sum_probs=194.5
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
...|++.+.||+|+||.||++.++ ++..+|+|++.........+..|+.++..+ .|++++++++++...+..|+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-----SHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-----CCCCEEEEEEEEcCCCceEE
Confidence 345788999999999999999876 466799999875544455677888888887 67999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 77 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~--------------------- 134 (256)
T cd05059 77 VTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG--------------------- 134 (256)
T ss_pred EEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC---------------------
Confidence 99999 899999997654 2589999999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCCC----cccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQN----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 275 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~ 275 (379)
.++.++|+|||.+........ ...++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..
T Consensus 135 ------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 208 (256)
T cd05059 135 ------EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS 208 (256)
T ss_pred ------CCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH
Confidence 445567777776653322111 1123457999999988889999999999999999998 89999765554
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+...... . .....+.++.+++.+||..
T Consensus 209 ~~~~~~~~~~~~----------------------~--------------------------~~~~~~~~~~~li~~cl~~ 240 (256)
T cd05059 209 EVVESVSAGYRL----------------------Y--------------------------RPKLAPTEVYTIMYSCWHE 240 (256)
T ss_pred HHHHHHHcCCcC----------------------C--------------------------CCCCCCHHHHHHHHHHhcC
Confidence 433322211100 0 0123567899999999999
Q ss_pred CCCCCcCHHHHhcC
Q 017021 356 DPTDRLTAREALRH 369 (379)
Q Consensus 356 dP~~Rpta~e~l~h 369 (379)
+|++|||+.|+++.
T Consensus 241 ~p~~Rpt~~~~l~~ 254 (256)
T cd05059 241 KPEDRPAFKKLLSQ 254 (256)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=286.11 Aligned_cols=244 Identities=25% Similarity=0.340 Sum_probs=192.3
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
...|++.++||+|+||.||+|.+. ++..+|+|.+.........+..|+.++.++ .|++++++++++. ....++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-----~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-----RHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-----CCCceEEEEeEEC-CCCcEE
Confidence 456899999999999999999865 456799999986555556778899998888 6789999998875 456899
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|||+ +++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~-------------------- 137 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD-------------------- 137 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC--------------------
Confidence 99999 899999997755456899999999999999999999999999999999999954
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 275 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~ 275 (379)
+..++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus 138 -------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 138 -------GLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred -------CceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 4456666666664332221 11234567999999988889999999999999999999 89999776554
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+...... + .....+..+.+++.+||+.
T Consensus 211 ~~~~~~~~~~~~----------------------~--------------------------~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05070 211 EVLEQVERGYRM----------------------P--------------------------CPQDCPISLHELMLQCWKK 242 (260)
T ss_pred HHHHHHHcCCCC----------------------C--------------------------CCCcCCHHHHHHHHHHccc
Confidence 443332211000 0 0123456899999999999
Q ss_pred CCCCCcCHHHHh
Q 017021 356 DPTDRLTAREAL 367 (379)
Q Consensus 356 dP~~Rpta~e~l 367 (379)
||++|||+++++
T Consensus 243 ~p~~Rpt~~~l~ 254 (260)
T cd05070 243 DPEERPTFEYLQ 254 (260)
T ss_pred CcccCcCHHHHH
Confidence 999999999987
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=286.69 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=196.0
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+....|++.++||+|+||.||+|.++ +++.||+|.+.........+..|+.++..+ +|++++++++++. .+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQL-----QHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhc-----CCcCeeeEEEEEc-cCCc
Confidence 45667899999999999999999865 467899999986555566778899988888 6789999998764 4568
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+++|||+ +++|.+++.......++...+..++.|++.||+|||+.|++||||||+||+++
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~------------------- 136 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS------------------- 136 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc-------------------
Confidence 9999999 89999998776555789999999999999999999999999999999999994
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 273 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~ 273 (379)
.+..++|+|||.+....... ....++..|+|||.+....++.++|+||||+++|++++ |+.||...+
T Consensus 137 --------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 137 --------ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred --------CCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 44556777777665433211 12235678999999988888999999999999999998 999998765
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.+..... .....+.++.+++.+||
T Consensus 209 ~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~li~~~l 240 (260)
T cd05067 209 NPEVIQNLERGYRMP------------------------------------------------RPDNCPEELYELMRLCW 240 (260)
T ss_pred hHHHHHHHHcCCCCC------------------------------------------------CCCCCCHHHHHHHHHHc
Confidence 544433322211100 01124568999999999
Q ss_pred ccCCCCCcCHHHHhc
Q 017021 354 RYDPTDRLTAREALR 368 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~ 368 (379)
+.||++|||++++++
T Consensus 241 ~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 241 KEKPEERPTFEYLRS 255 (260)
T ss_pred cCChhhCCCHHHHHH
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=284.51 Aligned_cols=248 Identities=29% Similarity=0.450 Sum_probs=201.2
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec--ceE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHI 119 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--~~~ 119 (379)
|++.+.||+|++|.||+|.+..+++.|++|++.... .....+..|+..++++ .|++++.+++.+... ...
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~ 76 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-----QHPNIVRYYGSERDEEKNTL 76 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-----CCCCEeeEEEEEecCCCCeE
Confidence 677799999999999999999999999999987543 3456677788888888 689999999999888 899
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++++|++ +++|.+++.+.. .+++..+..++.|++.||.|||+.|++|+|++|+||++
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i-------------------- 134 (260)
T cd06606 77 NIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV-------------------- 134 (260)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--------------------
Confidence 9999999 999999998765 68999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
..++.++|+|||.+...... .....++..|.|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 135 -------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 135 -------DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred -------cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 44566777777776544333 233467889999999988888999999999999999999999997654
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
.... .+...... .... ......+..+.++|.+||
T Consensus 208 ~~~~--~~~~~~~~------------------~~~~--------------------------~~~~~~~~~l~~~i~~~l 241 (260)
T cd06606 208 NPMA--ALYKIGSS------------------GEPP--------------------------EIPEHLSEEAKDFLRKCL 241 (260)
T ss_pred chHH--HHHhcccc------------------CCCc--------------------------CCCcccCHHHHHHHHHhC
Confidence 1111 11110000 0000 011234678999999999
Q ss_pred ccCCCCCcCHHHHhcCCCC
Q 017021 354 RYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f 372 (379)
+.||++||++.|++.||||
T Consensus 242 ~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 242 RRDPKKRPTADELLQHPFL 260 (260)
T ss_pred cCChhhCCCHHHHhhCCCC
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=287.57 Aligned_cols=246 Identities=26% Similarity=0.348 Sum_probs=191.6
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
....|++.++||+|+||.||+|.+..++ .||+|+++........+..|++++..+ +|++++++++.+. ....+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l-----~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhC-----CCCCcceEEEEEC-CCCcE
Confidence 4456899999999999999999887654 599999985444455677888888887 6789999988774 45689
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~-------------------- 136 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-------------------- 136 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc--------------------
Confidence 999999 88999999875444688999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCch
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 274 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~ 274 (379)
.++.++|+|||.+....... ....++..|+|||...+..++.++|+|||||++|+|++ |..||.....
T Consensus 137 -------~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 137 -------ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred -------CCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 44556777777665432221 12235667999999988889999999999999999999 8889976554
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+.... ..+ .....+..+.+++.+||+
T Consensus 210 ~~~~~~~~~~~-~~~-----------------------------------------------~~~~~~~~l~~li~~~l~ 241 (262)
T cd05071 210 REVLDQVERGY-RMP-----------------------------------------------CPPECPESLHDLMCQCWR 241 (262)
T ss_pred HHHHHHHhcCC-CCC-----------------------------------------------CccccCHHHHHHHHHHcc
Confidence 43332221100 000 011245678999999999
Q ss_pred cCCCCCcCHHHHhc
Q 017021 355 YDPTDRLTAREALR 368 (379)
Q Consensus 355 ~dP~~Rpta~e~l~ 368 (379)
.||++|||++++++
T Consensus 242 ~~p~~Rp~~~~~~~ 255 (262)
T cd05071 242 KEPEERPTFEYLQA 255 (262)
T ss_pred CCcccCCCHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=306.48 Aligned_cols=257 Identities=25% Similarity=0.360 Sum_probs=217.9
Q ss_pred eeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 37 YIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 37 ~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.....-..|.|.+.||+|.|+.|.+|++..|+..||||++.+. ........+|++++..+ .||||++++...
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-----~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-----NHPNIVKLFSVI 124 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-----CCcceeeeeeee
Confidence 3344556788999999999999999999999999999999753 23345577899999998 889999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
+....+|+||||+ ++.+.+++.+.+ .+.+..+..++.|++.|++|||+++|+|||||.+|+++
T Consensus 125 ~t~~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL-------------- 188 (596)
T KOG0586|consen 125 ETEATLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL-------------- 188 (596)
T ss_pred eecceeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc--------------
Confidence 9999999999999 999999999987 67789999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCC-CccchHhHHHHHHHHHhCCCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.+..++|+|||++....... .+.+|++.|.|||+..+.+|. +.+|+||+|+++|.|+.|..||
T Consensus 189 -------------~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPF 255 (596)
T KOG0586|consen 189 -------------DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPF 255 (596)
T ss_pred -------------ccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccccc
Confidence 677779999999987655443 567999999999999998875 9999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
++.+-.+..... -.+++.+|. -.+.+..++|
T Consensus 256 DG~~lk~Lr~rv-----------------------l~gk~rIp~--------------------------~ms~dce~lL 286 (596)
T KOG0586|consen 256 DGQNLKELRPRV-----------------------LRGKYRIPF--------------------------YMSCDCEDLL 286 (596)
T ss_pred CCcccccccchh-----------------------eeeeecccc--------------------------eeechhHHHH
Confidence 986654433221 112222221 2567899999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+++|..||.+|++.+++..|.|...-+
T Consensus 287 rk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 287 RKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred HHhhccCccccCCHHHhhhhcccchhh
Confidence 999999999999999999999986543
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=286.34 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=193.9
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee-eecceE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHI 119 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~-~~~~~~ 119 (379)
....|++.+.||+|+||.||++... |..||+|.++.. .....+..|+.++..+ .|++++++++++ ..+...
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-chHHHHHHHHHHHHhC-----CCCCeeeEEEEEEcCCCce
Confidence 3456888899999999999999754 778999998743 3355677888888887 678999999865 456679
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++++||+ +++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~-------------------- 135 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV-------------------- 135 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE--------------------
Confidence 9999999 8899999987654468899999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 277 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~ 277 (379)
+.++.++|+|||.+...........++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+.
T Consensus 136 -------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~ 208 (256)
T cd05082 136 -------SEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208 (256)
T ss_pred -------cCCCcEEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 44556777777776644433333445668999999988889999999999999999997 9999976554333
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+...+ ...+..+..+.+++.+||+.||
T Consensus 209 ~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~li~~~l~~~p 240 (256)
T cd05082 209 VPRVEKGYKM------------------------------------------------DAPDGCPPVVYDVMKQCWHLDA 240 (256)
T ss_pred HHHHhcCCCC------------------------------------------------CCCCCCCHHHHHHHHHHhcCCh
Confidence 3322211000 0012356789999999999999
Q ss_pred CCCcCHHHHhc
Q 017021 358 TDRLTAREALR 368 (379)
Q Consensus 358 ~~Rpta~e~l~ 368 (379)
++|||++++++
T Consensus 241 ~~Rpt~~~l~~ 251 (256)
T cd05082 241 ATRPSFLQLRE 251 (256)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=289.61 Aligned_cols=252 Identities=22% Similarity=0.289 Sum_probs=197.3
Q ss_pred chhhhhhhhccccccceeEEEEEecC-----CCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
....|++.+.||+|++|.||+|.+.. ++..||+|.+.... .....+..|+.++..+ .|++++++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~ 78 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-----NHQNIVRLIGVS 78 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEE
Confidence 44568899999999999999999987 78899999986432 2234567788888877 778999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~ 187 (379)
.+....++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+.+++||||||+||+++.++
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~----- 153 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG----- 153 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC-----
Confidence 8888999999999 9999999976531 2478999999999999999999999999999999999996432
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHH
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l 262 (379)
....++|+|||.+....... .....+..|+|||++.+..++.++|||||||++|+|
T Consensus 154 -------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el 214 (277)
T cd05036 154 -------------------PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214 (277)
T ss_pred -------------------CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHH
Confidence 23457888888776542211 112234679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccc
Q 017021 263 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341 (379)
Q Consensus 263 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (379)
++ |..||...+..+....+.... .... ....
T Consensus 215 ~~~g~~pf~~~~~~~~~~~~~~~~----------------------~~~~--------------------------~~~~ 246 (277)
T cd05036 215 FSLGYMPYPGRTNQEVMEFVTGGG----------------------RLDP--------------------------PKGC 246 (277)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCC----------------------cCCC--------------------------CCCC
Confidence 97 999998755443332221110 0000 1134
Q ss_pred hhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 342 AGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 342 ~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+..+.+++++||+.||++|||+.++++|
T Consensus 247 ~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 247 PGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5688999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=284.96 Aligned_cols=246 Identities=22% Similarity=0.312 Sum_probs=197.7
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
+...|++.+.||.|+||.||+|.+. |+.||+|.+.........+..|+.++..+ .|++++++++++.+....+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTL-----RHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhc-----CCcceeeeEEEEcCCCCeE
Confidence 4557889999999999999999764 78899999986554456777888888887 6789999999999899999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~-------------------- 136 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS-------------------- 136 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe--------------------
Confidence 999999 78999999876544689999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 278 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~ 278 (379)
.++.++|+|||.+...........++..|+|||.+....++.++|+||||+++|++++ |..||......+..
T Consensus 137 -------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 209 (256)
T cd05039 137 -------EDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209 (256)
T ss_pred -------CCCCEEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 4556777777777654332222334567999999988888999999999999999997 99999765544333
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+..... . ...+..++.+.++|++||..||+
T Consensus 210 ~~~~~~~~----------------------~--------------------------~~~~~~~~~~~~li~~~l~~~p~ 241 (256)
T cd05039 210 PHVEKGYR----------------------M--------------------------EAPEGCPPEVYKVMKDCWELDPA 241 (256)
T ss_pred HHHhcCCC----------------------C--------------------------CCccCCCHHHHHHHHHHhccChh
Confidence 22211100 0 00123567899999999999999
Q ss_pred CCcCHHHHhc
Q 017021 359 DRLTAREALR 368 (379)
Q Consensus 359 ~Rpta~e~l~ 368 (379)
+|||++++++
T Consensus 242 ~Rp~~~~l~~ 251 (256)
T cd05039 242 KRPTFKQLRE 251 (256)
T ss_pred hCcCHHHHHH
Confidence 9999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=306.29 Aligned_cols=245 Identities=27% Similarity=0.418 Sum_probs=200.2
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
...|.+...+|.|+|+.|-.+.+..+++..++|++... .....+|..++... .+|+|++...+.+.++.+.|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~----~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLV----RDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhh----cCCCcceeecceecCCceeee
Confidence 45677888899999999999999999999999999754 22233355555554 377999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
|||++ |+-+.+.+..+. .+. ..+..|+.+|+.|+.|||++|++|||+||+|||+.
T Consensus 394 v~e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--------------------- 449 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--------------------- 449 (612)
T ss_pred eehhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec---------------------
Confidence 99999 776666666654 233 77888999999999999999999999999999993
Q ss_pred ccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
...+.++|||||.+...+....+.+-|..|.|||++....|+.++|+||||+++|+|++|..||...... ..
T Consensus 450 -----~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~e 521 (612)
T KOG0603|consen 450 -----GSAGHLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IE 521 (612)
T ss_pred -----CCCCcEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HH
Confidence 2456789999999887666644556788999999999999999999999999999999999999875443 11
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+.+-++.++ +....|.++++||++||+.||.+|
T Consensus 522 i~~~i~~~~-----------------------------------------------~s~~vS~~AKdLl~~LL~~dP~~R 554 (612)
T KOG0603|consen 522 IHTRIQMPK-----------------------------------------------FSECVSDEAKDLLQQLLQVDPALR 554 (612)
T ss_pred HHHhhcCCc-----------------------------------------------cccccCHHHHHHHHHhccCChhhC
Confidence 222222211 113578899999999999999999
Q ss_pred cCHHHHhcCCCC
Q 017021 361 LTAREALRHPFF 372 (379)
Q Consensus 361 pta~e~l~hp~f 372 (379)
+++++++.||||
T Consensus 555 l~~~~i~~h~w~ 566 (612)
T KOG0603|consen 555 LGADEIGAHPWF 566 (612)
T ss_pred cChhhhccCcch
Confidence 999999999999
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=291.80 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=200.5
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
....|.+.+.||+|++|.||+|.++.+++.+|+|.+... ......+..|+.++..+ +|++++.+.+++...
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-----RHPNTIQYRGCYLRE 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-----CCCCcccEEEEEEcC
Confidence 455688889999999999999999999999999998632 12234556788888877 678999999999999
Q ss_pred ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 117 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 117 ~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
...++||||+.+++.+.+.... ..+++..+..++.|++.||.|||+.|++||||+|+||+++
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~----------------- 149 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----------------- 149 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC-----------------
Confidence 9999999999778888876543 3589999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhh---CCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
.++.++|+|||.+...... ....++..|+|||.+. ...++.++|||||||++|+|++|..||...+
T Consensus 150 ----------~~~~~kl~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 150 ----------EPGLVKLGDFGSASIMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred ----------CCCcEEECCcccceeecCc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 4456777777776543322 2346788999999975 3457889999999999999999999997654
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.+...+.. ....++..+.++|.+||
T Consensus 219 ~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~li~~cl 251 (308)
T cd06634 219 AMSALYHIAQNESPAL-----------------------------------------------QSGHWSEYFRNFVDSCL 251 (308)
T ss_pred HHHHHHHHhhcCCCCc-----------------------------------------------CcccccHHHHHHHHHHh
Confidence 4333322222111000 01135677899999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+.+|++||+++++++|||+...
T Consensus 252 ~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 252 QKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred hCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=290.47 Aligned_cols=247 Identities=20% Similarity=0.305 Sum_probs=192.4
Q ss_pred hhhhhhhccccccceeEEEEEe----cCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 43 FADKIHSKMGEGTFGQVLECWD----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~----~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
..|++.++||+|+||.||+|.+ ..++..||+|.+.... .....+.+|+.++..+ .|+|++++++++..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-----HHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-----CCCCeeeEEEEEecC
Confidence 3567889999999999999985 3456889999997422 2224566788888887 779999999999999
Q ss_pred ceEEEEEeCC-CCCHHHHHHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEec
Q 017021 117 NHICIVFEKL-GSSLYDFLRKNN---------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 180 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~~---------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~ 180 (379)
...|++|||+ +++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~- 158 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG- 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc-
Confidence 9999999999 889999985321 12478889999999999999999999999999999999994
Q ss_pred ccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhH
Q 017021 181 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSV 255 (379)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 255 (379)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||
T Consensus 159 --------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05090 159 --------------------------EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212 (283)
T ss_pred --------------------------CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHH
Confidence 44556777777765432211 22345667999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHH
Q 017021 256 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334 (379)
Q Consensus 256 G~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (379)
||++|+|++ |..||.+.+..+....+..... + +
T Consensus 213 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~---------------------~------------------------ 246 (283)
T cd05090 213 GVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL-L---------------------P------------------------ 246 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-C---------------------C------------------------
Confidence 999999998 9999987655443333222110 0 0
Q ss_pred HHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 335 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.....+..+.+++.+||+.||++||++.+++++
T Consensus 247 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 247 --CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred --CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 011345788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=286.76 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=194.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeec----cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||.||+|+++.+++.||+|.++. .......+..|+.++..+ .|++++++++.+...+..
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 77 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-----NHPNVIKYLDSFIEDNEL 77 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-----CCcceeeeeeeEEECCeE
Confidence 57888999999999999999999999999998753 223334567788888887 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
++++||+ +++|.+++... ....+++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~----------------- 140 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT----------------- 140 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc-----------------
Confidence 9999999 88999988642 223578999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
.++.++|+|||.+....... ....|+..|+|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 141 ----------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 141 ----------ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ----------CCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 44557777777665433222 23457889999999988888999999999999999999999996543
Q ss_pred h--HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 274 N--LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 274 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
. .+....+.. .+.++. .....+..+.++|.+
T Consensus 211 ~~~~~~~~~~~~-~~~~~~----------------------------------------------~~~~~~~~~~~li~~ 243 (267)
T cd08228 211 MNLFSLCQKIEQ-CDYPPL----------------------------------------------PTEHYSEKLRELVSM 243 (267)
T ss_pred ccHHHHHHHHhc-CCCCCC----------------------------------------------ChhhcCHHHHHHHHH
Confidence 2 121111111 011100 011245679999999
Q ss_pred ccccCCCCCcCHHHHhcC
Q 017021 352 LLRYDPTDRLTAREALRH 369 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~h 369 (379)
||+.||++|||+.++++.
T Consensus 244 cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 244 CIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HCCCCcccCcCHHHHHHH
Confidence 999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=289.16 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=195.0
Q ss_pred chhhhhhhhccccccceeEEEEEecC-----CCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
....|++.++||+|+||.||+|.++. .+..||+|.++... .....+..|...+..+ +|++++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~ 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-----TCHHVVRLLGVV 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEE
Confidence 45678999999999999999997652 35689999986433 2233456677777777 678999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccc
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 184 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 184 (379)
.++...|+||||+ +++|.+++.... ...++...+..++.|++.||.|||+.|++||||||+||+++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~----- 153 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA----- 153 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc-----
Confidence 9999999999999 899999997532 12346678889999999999999999999999999999994
Q ss_pred ccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHH
Q 017021 185 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 259 (379)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il 259 (379)
.+..++|+|||.++...... ....++..|+|||.+.+..++.++|+|||||++
T Consensus 154 ----------------------~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l 211 (288)
T cd05061 154 ----------------------HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211 (288)
T ss_pred ----------------------CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHH
Confidence 44556777777665322111 112345679999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhh
Q 017021 260 VELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338 (379)
Q Consensus 260 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (379)
|+|++ |..||.+....+....+.. +.. ... .
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~~--~~~--------------------~~~--------------------------~ 243 (288)
T cd05061 212 WEITSLAEQPYQGLSNEQVLKFVMD--GGY--------------------LDQ--------------------------P 243 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHc--CCC--------------------CCC--------------------------C
Confidence 99998 7889976544332221111 000 000 0
Q ss_pred ccchhHHHHHHhhccccCCCCCcCHHHHhc------CCCCCCCC
Q 017021 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALR------HPFFTRDH 376 (379)
Q Consensus 339 ~~~~~~~~~li~~~L~~dP~~Rpta~e~l~------hp~f~~~~ 376 (379)
...+..+.+++.+||+.||++|||+.++++ ||||.+..
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 124568999999999999999999999987 99998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=284.86 Aligned_cols=239 Identities=21% Similarity=0.353 Sum_probs=185.8
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
+.||+|+||.||+|.++.+++.||+|.+... ......+.+|+.++..+ .|++++++++++......++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-----SHPNIVRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEcCCCCeEEEEeec
Confidence 4789999999999999999999999987632 23345677888888887 7899999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 127 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 127 -~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
+++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++
T Consensus 76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~----------------------- 131 (252)
T cd05084 76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN----------------------- 131 (252)
T ss_pred cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-----------------------
Confidence 899999987643 3588999999999999999999999999999999999995444
Q ss_pred CCCCCeEEeecCcccccCCCCC-----cccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHHHH
Q 017021 206 PKSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 279 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~ 279 (379)
.++|+|||.+........ ....+..|+|||.+.+..++.++|+|||||++|+|++ |..||......+...
T Consensus 132 ----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~ 207 (252)
T cd05084 132 ----VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE 207 (252)
T ss_pred ----cEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH
Confidence 456666665543221110 1112356999999988889999999999999999997 888886544333222
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.+..... .. .....+..+.+++.+||+.||++
T Consensus 208 ~~~~~~~----------------------~~--------------------------~~~~~~~~~~~li~~~l~~~p~~ 239 (252)
T cd05084 208 AIEQGVR----------------------LP--------------------------CPELCPDAVYRLMERCWEYDPGQ 239 (252)
T ss_pred HHHcCCC----------------------CC--------------------------CcccCCHHHHHHHHHHcCCChhh
Confidence 2211100 00 01234678999999999999999
Q ss_pred CcCHHHHhc
Q 017021 360 RLTAREALR 368 (379)
Q Consensus 360 Rpta~e~l~ 368 (379)
|||++++++
T Consensus 240 Rps~~~~~~ 248 (252)
T cd05084 240 RPSFSTVHQ 248 (252)
T ss_pred CcCHHHHHH
Confidence 999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=289.99 Aligned_cols=248 Identities=22% Similarity=0.330 Sum_probs=193.4
Q ss_pred chhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
..-.|.+.+.||+|+||.||++.+. .++..+|+|.+... ......+..|+.++..+ .|++++++++++.
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~ 77 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-----QHEHIVKFYGVCV 77 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEe
Confidence 4456888999999999999999852 34567999998643 23345677888888887 7799999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccc
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNY-----------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 182 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~ 182 (379)
..+..+++|||+ +++|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+||+++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~-- 155 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE-- 155 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc--
Confidence 999999999999 8999999975431 24899999999999999999999999999999999999944
Q ss_pred ccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHH
Q 017021 183 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 257 (379)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ 257 (379)
++.++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||
T Consensus 156 -------------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~ 210 (288)
T cd05093 156 -------------------------NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 210 (288)
T ss_pred -------------------------CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHH
Confidence 4456666666665332211 1223567899999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHH
Q 017021 258 ILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336 (379)
Q Consensus 258 il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (379)
++|+|++ |..||......+....+.+. ..+ .
T Consensus 211 il~~l~t~g~~p~~~~~~~~~~~~i~~~--~~~--------------------~-------------------------- 242 (288)
T cd05093 211 VLWEIFTYGKQPWYQLSNNEVIECITQG--RVL--------------------Q-------------------------- 242 (288)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcC--CcC--------------------C--------------------------
Confidence 9999998 99999776554433322211 000 0
Q ss_pred hhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 337 ~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.....+.++.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 243 RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01235678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=296.48 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=189.9
Q ss_pred echhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
++...|++.+.||+|+||.||+|.+. .+++.||+|+++... .....+..|+.++.++ .+|+|+++++++
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l----~~h~niv~~~~~ 79 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHI----GHHLNVVNLLGA 79 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhh----ccCcchhheeee
Confidence 45568999999999999999999753 345789999987432 2234556688877776 256899999987
Q ss_pred eee-cceEEEEEeCC-CCCHHHHHHhCCC---------------------------------------------------
Q 017021 113 FDY-RNHICIVFEKL-GSSLYDFLRKNNY--------------------------------------------------- 139 (379)
Q Consensus 113 ~~~-~~~~~lv~e~~-~~sL~~~l~~~~~--------------------------------------------------- 139 (379)
+.. +..+++++||+ +++|.+++.....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 754 46789999999 8999999865321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCe
Q 017021 140 --------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 211 (379)
Q Consensus 140 --------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (379)
..+++..+..++.||+.||.|||+.||+||||||+||+++ .++.+
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---------------------------~~~~v 212 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---------------------------ENNVV 212 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---------------------------CCCcE
Confidence 2578899999999999999999999999999999999994 44557
Q ss_pred EEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHc
Q 017021 212 KVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVL 285 (379)
Q Consensus 212 ~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 285 (379)
+|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+......+
T Consensus 213 kL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~-- 290 (337)
T cd05054 213 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK-- 290 (337)
T ss_pred EEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh--
Confidence 777777775432211 12345678999999999999999999999999999998 9999975433221111000
Q ss_pred CCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHH
Q 017021 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 365 (379)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 365 (379)
.+... ......+.++.+++.+||+.+|++||++.|
T Consensus 291 --------------------~~~~~-------------------------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~e 325 (337)
T cd05054 291 --------------------EGTRM-------------------------RAPEYATPEIYSIMLDCWHNNPEDRPTFSE 325 (337)
T ss_pred --------------------ccCCC-------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 00000 001134578999999999999999999999
Q ss_pred HhcC
Q 017021 366 ALRH 369 (379)
Q Consensus 366 ~l~h 369 (379)
+++|
T Consensus 326 ll~~ 329 (337)
T cd05054 326 LVEI 329 (337)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=288.55 Aligned_cols=249 Identities=19% Similarity=0.239 Sum_probs=191.8
Q ss_pred chhhhhhhhccccccceeEEEEEecC-----CCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
....|++.++||+|+||.||+|.+.. +++.||+|+++.... ....+..|..++..+ .|++++++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~iv~~~~~~ 77 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-----QHPNIVCLLGVV 77 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEE
Confidence 34568999999999999999998754 357899999974322 234456677777766 789999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEE
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLL 178 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili 178 (379)
......++++||+ +++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 78 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 9999999999999 899999985321 1247888899999999999999999999999999999999
Q ss_pred ecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchH
Q 017021 179 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIW 253 (379)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvw 253 (379)
.. +..++|+|||.+....... ....+++.|+|||.+.+..++.++|||
T Consensus 158 ~~---------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 210 (283)
T cd05091 158 FD---------------------------KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIW 210 (283)
T ss_pred cC---------------------------CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHH
Confidence 44 4456667777655322211 122456789999999888899999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHH
Q 017021 254 SVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 332 (379)
Q Consensus 254 SlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (379)
||||++|+|++ |..||.+....+....+.+.... .
T Consensus 211 slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----------------------~---------------------- 246 (283)
T cd05091 211 SYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL----------------------P---------------------- 246 (283)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC----------------------C----------------------
Confidence 99999999998 88898776554443332221100 0
Q ss_pred HHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 333 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 333 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.....+..+.+++.+||+.||++||+++++++.
T Consensus 247 ----~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 247 ----CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred ----CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 012356778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=283.96 Aligned_cols=247 Identities=27% Similarity=0.425 Sum_probs=193.8
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc------chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec-
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR- 116 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~- 116 (379)
.|++.+.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++++ .|++++.+++.+.+.
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-----RHDRIVQYYGCLRDPE 77 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-----CCCCcceEEEEEEcCC
Confidence 578889999999999999999999999999997522 12234566788888888 678999999988653
Q ss_pred -ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 117 -NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 117 -~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
+..++++||+ +++|.+.+.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~------------- 142 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA------------- 142 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-------------
Confidence 5689999999 889999987754 58899999999999999999999999999999999999544
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC------CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
+.++|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|+.|
T Consensus 143 --------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 208 (264)
T cd06653 143 --------------GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208 (264)
T ss_pred --------------CCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 44566666655432211 1224578899999999888889999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|......+...++ ....+. ...++..+..+.++
T Consensus 209 ~~~~~~~~~~~~~---~~~~~~--------------------------------------------~~~p~~~~~~~~~~ 241 (264)
T cd06653 209 WAEYEAMAAIFKI---ATQPTK--------------------------------------------PMLPDGVSDACRDF 241 (264)
T ss_pred CCccCHHHHHHHH---HcCCCC--------------------------------------------CCCCcccCHHHHHH
Confidence 9765443322211 111100 00122466789999
Q ss_pred HhhccccCCCCCcCHHHHhcCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
|++||+ +|.+|||+.+++.|||+
T Consensus 242 i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 242 LKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHhc-CcccCccHHHHhcCCCC
Confidence 999999 57999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=282.14 Aligned_cols=239 Identities=31% Similarity=0.552 Sum_probs=196.6
Q ss_pred cccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 51 Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
||.|+||.||++.+..+++.+|+|++..... ....+..|+.++..+ .|++++.+++.++.++..+++||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-----NHPFIVKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-----CCCcHHHHHHHeecCCeeEEEEecC
Confidence 6999999999999998899999999874322 334667788888877 6789999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 127 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 127 -~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
+++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||++
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~--------------------------- 126 (250)
T cd05123 76 PGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL--------------------------- 126 (250)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---------------------------
Confidence 999999998764 58999999999999999999999999999999999999
Q ss_pred CCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 017021 206 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~ 282 (379)
+..+.++|+|||.+...... .....++..|++||...+...+.++|+||||+++|++++|..||...+..+....+.
T Consensus 127 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 206 (250)
T cd05123 127 DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL 206 (250)
T ss_pred cCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 44556788888877654332 234567889999999988888899999999999999999999997655433322222
Q ss_pred HHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcC
Q 017021 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 362 (379)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 362 (379)
+.. ..++ ...+..+.++|++||..||++||+
T Consensus 207 ~~~-----------------------~~~~--------------------------~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 207 KDP-----------------------LRFP--------------------------EFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred cCC-----------------------CCCC--------------------------CCCCHHHHHHHHHHhcCCHhhCCC
Confidence 211 1111 123568899999999999999999
Q ss_pred H---HHHhcCCCC
Q 017021 363 A---REALRHPFF 372 (379)
Q Consensus 363 a---~e~l~hp~f 372 (379)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=293.83 Aligned_cols=255 Identities=27% Similarity=0.384 Sum_probs=215.8
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
+....|..+.+||+|+||.|.+|+.+.|.+.+|||+++++ +...+..+.|..+|+-- ...|.++.++..|++
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~----~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP----GKPPFLVQLHSCFQT 421 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecC----CCCchHHHHHHHhhh
Confidence 3344456679999999999999999999999999999753 22334445566655443 234678999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
-+++|+||||+ ||+|--.+++-+ .+.+..+..++.+|+-||-|||++||+.||||.+|||+
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---------------- 483 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---------------- 483 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe----------------
Confidence 99999999999 999988888876 68899999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+..+.+||+|||+++..-.. ..+.+||+.|+|||++..++|+..+|+||+||++|||+.|.+||.+
T Consensus 484 -----------d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 484 -----------DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred -----------ccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 77888999999998743332 3567999999999999999999999999999999999999999999
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.++.+.++.|.+.-...| +..|.++.+++..
T Consensus 553 eDE~elF~aI~ehnvsyP-------------------------------------------------KslSkEAv~ickg 583 (683)
T KOG0696|consen 553 EDEDELFQAIMEHNVSYP-------------------------------------------------KSLSKEAVAICKG 583 (683)
T ss_pred CCHHHHHHHHHHccCcCc-------------------------------------------------ccccHHHHHHHHH
Confidence 999999988776544433 2467889999999
Q ss_pred ccccCCCCCcC-----HHHHhcCCCCCCCC
Q 017021 352 LLRYDPTDRLT-----AREALRHPFFTRDH 376 (379)
Q Consensus 352 ~L~~dP~~Rpt-----a~e~l~hp~f~~~~ 376 (379)
.|...|.+|.. -.++-.||||....
T Consensus 584 ~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 584 LLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred HhhcCCccccCCCCccccchhhCcchhhcc
Confidence 99999999984 47899999998753
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=294.78 Aligned_cols=248 Identities=21% Similarity=0.259 Sum_probs=191.3
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCce----EEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEM----VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~----vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
+....|++.+.||+|+||.||+|.+..+++. ||+|.++.. ......+..|+.++..+ .|+|++++++++
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~g~~ 78 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGIC 78 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEE
Confidence 4456789999999999999999988766554 899998643 23345667788888877 789999999988
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
... ..+++++|+ +++|.+++.... ..++...+..++.||+.||+|||+.|++||||||+||+++
T Consensus 79 ~~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~------------- 143 (316)
T cd05108 79 LTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK------------- 143 (316)
T ss_pred cCC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec-------------
Confidence 765 467899999 999999998754 3588899999999999999999999999999999999994
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCCC-----cccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 266 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~ 266 (379)
.+..++|+|||.+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 144 --------------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~ 209 (316)
T cd05108 144 --------------TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 209 (316)
T ss_pred --------------CCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCC
Confidence 445567777777654332221 1223567999999998889999999999999999997 99
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||.+....+....+... ..+| . ...++.++.
T Consensus 210 ~p~~~~~~~~~~~~~~~~-~~~~---------------------~--------------------------~~~~~~~~~ 241 (316)
T cd05108 210 KPYDGIPASEISSILEKG-ERLP---------------------Q--------------------------PPICTIDVY 241 (316)
T ss_pred CCCCCCCHHHHHHHHhCC-CCCC---------------------C--------------------------CCCCCHHHH
Confidence 999765443322211110 0000 0 012456788
Q ss_pred HHHhhccccCCCCCcCHHHHhcC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+++.+||+.||++|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=283.97 Aligned_cols=245 Identities=26% Similarity=0.356 Sum_probs=192.1
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
...|++.++||+|++|.||+|.+..++ .+|+|++.........+..|+.++..+ .|++++.+++++. .+..++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKL-----RHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhC-----CCCCeeeEEEEEc-CCCcEE
Confidence 456889999999999999999876654 599999875555556677899988887 6788999988775 456899
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|||+ +++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~--------------------- 136 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG--------------------- 136 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---------------------
Confidence 99999 78999999875544588999999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 275 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~ 275 (379)
.+..++|+|||.+....... ....++..|+|||...+..++.++|+||||+++|+|++ |..||.+....
T Consensus 137 ------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 210 (260)
T cd05069 137 ------DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210 (260)
T ss_pred ------CCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 44556777777665332221 12235667999999988889999999999999999999 99999875554
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+...... + .....+..+.+++++||+.
T Consensus 211 ~~~~~~~~~~~~-~-----------------------------------------------~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05069 211 EVLEQVERGYRM-P-----------------------------------------------CPQGCPESLHELMKLCWKK 242 (260)
T ss_pred HHHHHHHcCCCC-C-----------------------------------------------CCcccCHHHHHHHHHHccC
Confidence 433322221100 0 0112456899999999999
Q ss_pred CCCCCcCHHHHhc
Q 017021 356 DPTDRLTAREALR 368 (379)
Q Consensus 356 dP~~Rpta~e~l~ 368 (379)
||++||+++++++
T Consensus 243 ~p~~Rp~~~~i~~ 255 (260)
T cd05069 243 DPDERPTFEYIQS 255 (260)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=292.08 Aligned_cols=247 Identities=21% Similarity=0.272 Sum_probs=189.5
Q ss_pred hhhhhhccccccceeEEEEEecCCCce--EEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEM--VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~--vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||.||+|.++.++.. +|+|.++.. ......+.+|+.++.++. +|++++++++++...+..
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~----~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRGYL 83 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc----CCCCcceEEEEECCCCCc
Confidence 567789999999999999998877754 577776532 223345667888887772 568999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccc
Q 017021 120 CIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 184 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 184 (379)
|+||||+ +++|.+++.... ...+++..+..++.|++.||+|||+.|++||||||+||+++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~----- 158 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----- 158 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec-----
Confidence 9999999 899999997542 12478999999999999999999999999999999999994
Q ss_pred ccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHH
Q 017021 185 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l 262 (379)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|
T Consensus 159 ----------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 216 (303)
T cd05088 159 ----------------------ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216 (303)
T ss_pred ----------------------CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHH
Confidence 45567777777664322111 112235679999999888889999999999999999
Q ss_pred Hh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccc
Q 017021 263 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341 (379)
Q Consensus 263 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (379)
++ |..||...+..+....+.... .+ . .....
T Consensus 217 lt~g~~p~~~~~~~~~~~~~~~~~--~~--------------------~--------------------------~~~~~ 248 (303)
T cd05088 217 VSLGGTPYCGMTCAELYEKLPQGY--RL--------------------E--------------------------KPLNC 248 (303)
T ss_pred HhcCCCCcccCChHHHHHHHhcCC--cC--------------------C--------------------------CCCCC
Confidence 98 999997655443332211100 00 0 00124
Q ss_pred hhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 342 AGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 342 ~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+.++.+++.+||+.||++||++++++++
T Consensus 249 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 249 DDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=282.91 Aligned_cols=248 Identities=26% Similarity=0.336 Sum_probs=197.5
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+....|++.++||+|+||.||+|.+.. ++.||+|.+.........+..|+..++.+ .|++++++++++......
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKL-----RHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhC-----CCCCEeeeeeeeecCCce
Confidence 445678899999999999999999764 57799999986555566778899988887 679999999999998999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+++|||+ +++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~------------------- 137 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG------------------- 137 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc-------------------
Confidence 9999999 89999999876545689999999999999999999999999999999999994
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 273 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~ 273 (379)
.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|++++ |+.||.+.+
T Consensus 138 --------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 138 --------ENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred --------CCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 44566777777665433211 11223567999999998889999999999999999998 999997655
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+...... + . ....+.++.+++.+||
T Consensus 210 ~~~~~~~~~~~~~~-~---------------------~--------------------------~~~~~~~~~~~i~~~l 241 (261)
T cd05034 210 NREVLEQVERGYRM-P---------------------R--------------------------PPNCPEELYDLMLQCW 241 (261)
T ss_pred HHHHHHHHHcCCCC-C---------------------C--------------------------CCCCCHHHHHHHHHHc
Confidence 44433332221100 0 0 0123567899999999
Q ss_pred ccCCCCCcCHHHHhc
Q 017021 354 RYDPTDRLTAREALR 368 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~ 368 (379)
+.||++||+++++++
T Consensus 242 ~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 242 DKDPEERPTFEYLQS 256 (261)
T ss_pred ccCcccCCCHHHHHH
Confidence 999999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=285.69 Aligned_cols=248 Identities=28% Similarity=0.454 Sum_probs=194.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc------chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
.|.+.++||+|+||.||++.+..++..+++|+++.. ......+..|..++..+ +|+|++++++++....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-----DHPAIVKFHASFLERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-----CCCcHHHHHHHHhcCC
Confidence 478889999999999999999888877877776531 12233445677777666 7899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
..++++||+ +++|.+++.. .....+++..+..++.|++.||.|||+.|++|+|++|+||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-------------- 141 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-------------- 141 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec--------------
Confidence 999999999 8899988864 22246899999999999999999999999999999999999932
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
..++|+|||.+....... ....|+..|+|||...+..++.++|+||||+++|+|++|..||..
T Consensus 142 --------------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 142 --------------NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred --------------CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 237777777665432221 234578899999999888889999999999999999999999976
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
....+....+.. +..+. ....++.++.++|.+
T Consensus 208 ~~~~~~~~~~~~--~~~~~----------------------------------------------~~~~~~~~~~~li~~ 239 (260)
T cd08222 208 QNFLSVVLRIVE--GPTPS----------------------------------------------LPETYSRQLNSIMQS 239 (260)
T ss_pred ccHHHHHHHHHc--CCCCC----------------------------------------------CcchhcHHHHHHHHH
Confidence 544333222211 11110 012356788999999
Q ss_pred ccccCCCCCcCHHHHhcCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f 372 (379)
||+.||++||++.|+++||||
T Consensus 240 ~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 240 MLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=281.80 Aligned_cols=249 Identities=28% Similarity=0.417 Sum_probs=199.6
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.++||.|++|.||++.++.+++.+|+|.+.... ........|+..++.+ .|++++.+.+.+......+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-----NHPNIISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-----CCCCchhhhhhhccCCEEE
Confidence 3778899999999999999999999999999987432 2334555677777777 6789999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+|+||+ +++|.+++... ....+++..+..++.|++.||+|||+.|++|+||+|+||++.
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~------------------ 137 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV------------------ 137 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe------------------
Confidence 999999 89999998662 223688999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCC-CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.+..++|+|||.+...... .....++..|++||.+.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus 138 ---------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~ 208 (256)
T cd08530 138 ---------ANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD 208 (256)
T ss_pred ---------cCCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 3455777777776543332 123457889999999988889999999999999999999999998766544
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.... .+. .....+.++.+++.+||+.|
T Consensus 209 ~~~~~~~~~--~~~----------------------------------------------~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08530 209 LRYKVQRGK--YPP----------------------------------------------IPPIYSQDLQNFIRSMLQVK 240 (256)
T ss_pred HHHHHhcCC--CCC----------------------------------------------CchhhCHHHHHHHHHHcCCC
Confidence 332221111 000 01134567999999999999
Q ss_pred CCCCcCHHHHhcCCCC
Q 017021 357 PTDRLTAREALRHPFF 372 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f 372 (379)
|++|||+.|+++||++
T Consensus 241 p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 241 PKLRPNCDKILASPAV 256 (256)
T ss_pred cccCCCHHHHhcCCCC
Confidence 9999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=281.66 Aligned_cols=241 Identities=25% Similarity=0.376 Sum_probs=193.7
Q ss_pred hccccccceeEEEEEecCC---CceEEEEEeeccchh--hHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 49 SKMGEGTFGQVLECWDRER---KEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
+.||+|+||.||+|.+... +..||+|++...... ...+..|+..+..+ .|++++++++++......+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-----GHPNVVRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-----CCCChheeeeeecCCCceEEEE
Confidence 4689999999999998866 899999999754332 45667788888877 5799999999999999999999
Q ss_pred eCC-CCCHHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 124 EKL-GSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
||+ +++|.+++.... ...+++..+..++.|++.||+|||+.|++||||+|+||+++
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~---------------- 139 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG---------------- 139 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC----------------
Confidence 999 999999998751 24689999999999999999999999999999999999994
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 269 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf 269 (379)
.++.++|+|||.+...... .....++..|+|||.+....++.++|||||||++|+|++ |..||
T Consensus 140 -----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 208 (262)
T cd00192 140 -----------EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY 208 (262)
T ss_pred -----------CCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCC
Confidence 4456777777776544332 123456788999999988889999999999999999998 69999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
......+....+... . .... ....+.++.+++
T Consensus 209 ~~~~~~~~~~~~~~~--~--------------------~~~~--------------------------~~~~~~~~~~li 240 (262)
T cd00192 209 PGLSNEEVLEYLRKG--Y--------------------RLPK--------------------------PEYCPDELYELM 240 (262)
T ss_pred CCCCHHHHHHHHHcC--C--------------------CCCC--------------------------CccCChHHHHHH
Confidence 876544433322220 0 0000 123467899999
Q ss_pred hhccccCCCCCcCHHHHhcC
Q 017021 350 QGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~h 369 (379)
.+||+.||++|||+.|+++|
T Consensus 241 ~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 241 LSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHccCCcccCcCHHHHHHh
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=283.54 Aligned_cols=246 Identities=22% Similarity=0.308 Sum_probs=192.0
Q ss_pred hhhhhhhccccccceeEEEEEecCC---CceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
..|++.+.||+|+||.||+|.++.+ ...||+|.++.. ......+..|+.++..+ .|++++++++++..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-----DHPNIIRLEGVVTKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-----CCCCcceEeEEEecCC
Confidence 4578889999999999999988654 467999998643 22344566788888877 6799999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..+++|||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~---------------- 141 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS---------------- 141 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC----------------
Confidence 999999999 889999997754 25899999999999999999999999999999999999944
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ 270 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~ 270 (379)
+..++|+|||.+....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 142 -----------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 142 -----------NLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred -----------CCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 4456666666665433111 11124567999999988889999999999999999998 999996
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
.....+....+.+.... + . ....+..+.+++.
T Consensus 211 ~~~~~~~~~~~~~~~~~-~---------------------~--------------------------~~~~~~~l~~li~ 242 (266)
T cd05033 211 DMSNQDVIKAVEDGYRL-P---------------------P--------------------------PMDCPSALYQLML 242 (266)
T ss_pred CCCHHHHHHHHHcCCCC-C---------------------C--------------------------CCCCCHHHHHHHH
Confidence 55443333222211100 0 0 0124568899999
Q ss_pred hccccCCCCCcCHHHHhcC
Q 017021 351 GLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~h 369 (379)
+||+.||++||++.|++++
T Consensus 243 ~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 243 DCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHcCCCcccCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=285.74 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=190.2
Q ss_pred chhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
....|++.+.||+|+||.||+|.++ .++..||+|.++... .....+..|+.++..+ .|+|++++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~iv~~~~~~ 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLLGVV 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEE
Confidence 3456889999999999999999864 345779999986432 2334566788777776 779999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccc
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNY--------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 184 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 184 (379)
..+...++||||+ +++|.+++..... ..++...+..++.|++.||.|||+.|++||||||+||+++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~----- 153 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----- 153 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc-----
Confidence 9999999999999 8999999875321 1356788899999999999999999999999999999994
Q ss_pred ccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHH
Q 017021 185 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 259 (379)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il 259 (379)
.++.++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++
T Consensus 154 ----------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 211 (277)
T cd05062 154 ----------------------EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211 (277)
T ss_pred ----------------------CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHH
Confidence 44556667777654322111 112346789999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhh
Q 017021 260 VELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338 (379)
Q Consensus 260 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (379)
|+|++ |..||...+..+....+.... .... .
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~~~~----------------------~~~~--------------------------~ 243 (277)
T cd05062 212 WEIATLAEQPYQGMSNEQVLRFVMEGG----------------------LLDK--------------------------P 243 (277)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCC----------------------cCCC--------------------------C
Confidence 99998 788997655433332221110 0000 1
Q ss_pred ccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 339 ~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
...+..+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 244 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1345679999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=285.51 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=192.7
Q ss_pred chhhhhhhhccccccceeEEEEEecCC-----CceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
....|++.+.||+|+||.||+|.++.. +..||+|.+.... .....+..|+.++..+ .|++++++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~ 78 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-----NCHHVVRLLGVV 78 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-----CCCceeEEEEEE
Confidence 445678889999999999999987643 4889999986432 2334566777877776 778999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccc
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 184 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 184 (379)
......++||||+ +++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~----- 153 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA----- 153 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc-----
Confidence 9999999999999 899999997532 12367889999999999999999999999999999999994
Q ss_pred ccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHH
Q 017021 185 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 259 (379)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il 259 (379)
.++.++|+|||.++...... ....++..|+|||.+.+..++.++|||||||++
T Consensus 154 ----------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (277)
T cd05032 154 ----------------------EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVL 211 (277)
T ss_pred ----------------------CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHH
Confidence 44556677777664322211 223457789999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhh
Q 017021 260 VELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338 (379)
Q Consensus 260 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (379)
|++++ |..||...+..+....+.. +. .... .
T Consensus 212 ~el~t~g~~p~~~~~~~~~~~~~~~--~~--------------------~~~~--------------------------~ 243 (277)
T cd05032 212 WEMATLAEQPYQGLSNEEVLKFVID--GG--------------------HLDL--------------------------P 243 (277)
T ss_pred HHhhccCCCCCccCCHHHHHHHHhc--CC--------------------CCCC--------------------------C
Confidence 99998 9999976555443332221 00 0111 1
Q ss_pred ccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 339 ~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
...+..+.+++.+||+.+|++|||+.++++
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 244 ENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 124578999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=290.16 Aligned_cols=292 Identities=19% Similarity=0.217 Sum_probs=194.1
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
|+|.+.+|.|++ ||.+++..+++.||+|+++.. ......+..|+..+..+ .|+|++.+++.+...+..++
T Consensus 4 ~~i~~~~~~~~~--v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~~i~~~~~~~~~~~~~~~ 76 (314)
T cd08216 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-----QHPNILPYVTSFIVDSELYV 76 (314)
T ss_pred hhhhHhhcCCce--EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-----CCcchhhhhheeecCCeEEE
Confidence 455555555544 555555678999999998743 23345677788888887 67999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|||+ +++|.+++.......+++..+..++.|++.||+|||+.||+||||||+||+++.++.+++.||+.+........
T Consensus 77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence 99999 89999999875444689999999999999999999999999999999999997666666665554432211000
Q ss_pred ccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC--CCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
. . ...........++..|+|||.+.. ..++.++|+||+||++|+|++|+.||.........
T Consensus 157 ~--------~---------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~ 219 (314)
T cd08216 157 R--------Q---------RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML 219 (314)
T ss_pred c--------c---------cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0 0 000001122346778999999876 35789999999999999999999999865433221
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
+.+..+..+...-...... ......... ....................+.++.+++++||+.||+
T Consensus 220 --~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 284 (314)
T cd08216 220 --LEKVRGTVPCLLDKSTYPL-----YEDSMSQSR--------SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284 (314)
T ss_pred --HHHHhccCccccccCchhh-----hcCCcCccc--------ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCC
Confidence 2222222221100000000 000000000 0000000000011111223567899999999999999
Q ss_pred CCcCHHHHhcCCCCCCC
Q 017021 359 DRLTAREALRHPFFTRD 375 (379)
Q Consensus 359 ~Rpta~e~l~hp~f~~~ 375 (379)
+|||++|+|+||||+..
T Consensus 285 ~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 285 SRPSASQLLNHSFFKQC 301 (314)
T ss_pred cCcCHHHHhcCchHhhh
Confidence 99999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=281.09 Aligned_cols=286 Identities=27% Similarity=0.460 Sum_probs=232.6
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc---
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--- 117 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~--- 117 (379)
+|.=+..+|.|.- .|..|.|..+++.||+|.+... .....++.+|...+..+ .|+|++.++.+|....
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-----~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-----NHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-----cccceeeeeeccCccccHH
Confidence 3455578899988 8899999999999999998632 33456777899998888 8899999999997543
Q ss_pred ---eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 118 ---HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 118 ---~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+|+|||++..+|.+.+.. .+.-+.+..+++|++.|++|||+.||+||||||+||++
T Consensus 92 ~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---------------- 151 (369)
T KOG0665|consen 92 EFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---------------- 151 (369)
T ss_pred HHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee----------------
Confidence 5899999999999999874 36778899999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC-C-CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-Q-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
..++.+|+.|||.|+..++. . ...+.|..|.|||++.+..+...+||||+||++.||++|+..|.+.
T Consensus 152 -----------~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 152 -----------NSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred -----------cchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 66778888899988877766 2 3457899999999999999999999999999999999999999999
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+...++.+.+|.+-+..++++.+..+.+..+. +..-. -.+..+..+..... ..+.....+..++|++.+|
T Consensus 221 d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~----~~y~~--~~f~~~fpD~~f~~-~~e~~~~~~~~ardll~~M 293 (369)
T KOG0665|consen 221 DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENR----PQYQA--ISFSELFPDSLFPV-VLEGSKLDCSLARDLLSKM 293 (369)
T ss_pred hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcC----hHhhc--cchhhhCCcccccc-cccCCccchHHHHHHHHHh
Confidence 99999999999999999999999999998887731 11110 01111111111111 0111124557799999999
Q ss_pred cccCCCCCcCHHHHhcCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~ 373 (379)
|..||++|.|++++|+||||+
T Consensus 294 Lvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 294 LVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hccChhhcccHHHHhcCCeee
Confidence 999999999999999999996
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=319.00 Aligned_cols=268 Identities=20% Similarity=0.258 Sum_probs=194.6
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.++||+|+||.||+|.+..+++.||+|++... ......+.+|+.++..+ .|+|++++++.+.+++..
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-----~HPNIVkl~~v~~d~~~l 77 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-----IHPGIVPVYSICSDGDPV 77 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-----CCcCcCeEEEEEeeCCEE
Confidence 578899999999999999999999999999998642 23345677889888888 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNN---------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~---------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
|++|||+ |++|.+++.... ...++...+..++.||+.||+|||+.||+||||||+||+++..+.++++||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEec
Confidence 9999999 999999986421 123456778899999999999999999999999999999977776667777
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
|++.......+.. ........+.............||+.|+|||.+.+..++.++|||||||++|+|++|..||
T Consensus 158 GLAk~i~~~~~~~------~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 158 GAAIFKKLEEEDL------LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred Ccceecccccccc------cccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 6664431111000 0000000000000011112346999999999999989999999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
......+.... ..... |... ......++.+.+++
T Consensus 232 ~~~~~~ki~~~--~~i~~-P~~~-------------------------------------------~p~~~iP~~L~~LI 265 (932)
T PRK13184 232 RRKKGRKISYR--DVILS-PIEV-------------------------------------------APYREIPPFLSQIA 265 (932)
T ss_pred CCcchhhhhhh--hhccC-hhhc-------------------------------------------cccccCCHHHHHHH
Confidence 76433221110 00000 0000 00113567789999
Q ss_pred hhccccCCCCCcCHHHHhc
Q 017021 350 QGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~ 368 (379)
.+||+.||++|+++.+.+.
T Consensus 266 ~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 266 MKALAVDPAERYSSVQELK 284 (932)
T ss_pred HHHccCChhhCcCHHHHHH
Confidence 9999999999988766553
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=283.06 Aligned_cols=246 Identities=26% Similarity=0.384 Sum_probs=192.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|++|.||+|.+..+++.+|+|.+... ......+..|+.++..+ .|+|++++++.+..++..
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~ 77 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-----NHPNVIKYYASFIEDNEL 77 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-----cCCchhhhhheeEeCCeE
Confidence 578899999999999999999999999999988632 22334666788888887 779999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
+++|||+ +++|.+++... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----------------- 140 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----------------- 140 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc-----------------
Confidence 9999999 88999998642 223588999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
.++.++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+..
T Consensus 141 ----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 141 ----------ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ----------CCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 44556777777665332221 23467889999999988889999999999999999999999996533
Q ss_pred hH--HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 274 NL--EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 274 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.. +....+.....+ + . .....+..+.+++.+
T Consensus 211 ~~~~~~~~~~~~~~~~-~---------------------~-------------------------~~~~~~~~~~~li~~ 243 (267)
T cd08229 211 MNLYSLCKKIEQCDYP-P---------------------L-------------------------PSDHYSEELRQLVNM 243 (267)
T ss_pred chHHHHhhhhhcCCCC-C---------------------C-------------------------CcccccHHHHHHHHH
Confidence 21 111111110000 0 0 011356789999999
Q ss_pred ccccCCCCCcCHHHHhc
Q 017021 352 LLRYDPTDRLTAREALR 368 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~ 368 (379)
||+.||++|||+.++++
T Consensus 244 ~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 244 CINPDPEKRPDITYVYD 260 (267)
T ss_pred hcCCCcccCCCHHHHHH
Confidence 99999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=299.47 Aligned_cols=255 Identities=20% Similarity=0.248 Sum_probs=194.7
Q ss_pred eeeeechhhhhhhhccccccceeEEEEEecCC-----CceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEE
Q 017021 36 TYIVFSAFADKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108 (379)
Q Consensus 36 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~ 108 (379)
+...++...|++.+.||+|+||.||+|.+... +..||+|+++.. ......+..|+.++..+ ..|+||++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l----~~HpnIv~ 105 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHL----GPHLNIVN 105 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhc----CCCCCeee
Confidence 34556677899999999999999999987433 357999999643 22345677888888887 24799999
Q ss_pred ecceeeecceEEEEEeCC-CCCHHHHHHhCC-------------------------------------------------
Q 017021 109 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNN------------------------------------------------- 138 (379)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~------------------------------------------------- 138 (379)
+++++......|+||||+ +++|.+++....
T Consensus 106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 999999999999999999 999999886531
Q ss_pred ---------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Q 017021 139 ---------------------------------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 173 (379)
Q Consensus 139 ---------------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp 173 (379)
...+++..+..++.|++.||+|||+.|++||||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp 265 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA 265 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 12367788889999999999999999999999999
Q ss_pred CcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCC
Q 017021 174 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTY 248 (379)
Q Consensus 174 ~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~ 248 (379)
+||+++ .+..++|+|||.+....... ....++..|+|||.+.+..++.
T Consensus 266 ~Nill~---------------------------~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 318 (400)
T cd05105 266 RNVLLA---------------------------QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318 (400)
T ss_pred HhEEEe---------------------------CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc
Confidence 999994 44557777777765432211 2234667899999998888999
Q ss_pred ccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccc
Q 017021 249 PCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 327 (379)
Q Consensus 249 ~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (379)
++|||||||++|+|++ |..||......+...........+ .
T Consensus 319 ~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~---------------------~----------------- 360 (400)
T cd05105 319 LSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM---------------------A----------------- 360 (400)
T ss_pred hhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC---------------------C-----------------
Confidence 9999999999999997 899987543222211111100000 0
Q ss_pred hhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 328 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.....+..+.+++.+||+.||++|||+.++.+
T Consensus 361 ---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 361 ---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred ---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 01235678999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=286.12 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=191.9
Q ss_pred chhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
...+|++.++||+|+||.||++... .++..+|+|.+... ......+..|+.++..+ .|+|++++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~ 77 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-----QHQHIVRFYGVCT 77 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-----CCCCCceEEEEEe
Confidence 4567788899999999999999743 35678999988643 23345667788888877 7789999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEec
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNY-------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 180 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~ 180 (379)
.....+++|||+ +++|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+||+++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 999999999999 8999999976431 24788999999999999999999999999999999999944
Q ss_pred ccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhH
Q 017021 181 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSV 255 (379)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 255 (379)
+..++|+|||.+....... ....+++.|+|||.+.+..++.++|||||
T Consensus 158 ---------------------------~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (280)
T cd05092 158 ---------------------------GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF 210 (280)
T ss_pred ---------------------------CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHH
Confidence 4456666666654322211 12234678999999998889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHH
Q 017021 256 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334 (379)
Q Consensus 256 G~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (379)
||++|+|++ |..||......+....+.+....
T Consensus 211 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------------------------- 243 (280)
T cd05092 211 GVVLWEIFTYGKQPWYQLSNTEAIECITQGREL----------------------------------------------- 243 (280)
T ss_pred HHHHHHHHcCCCCCCccCCHHHHHHHHHcCccC-----------------------------------------------
Confidence 999999998 99999765544333222111000
Q ss_pred HHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 335 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
......++.+.++|.+||+.||.+||+++++++
T Consensus 244 -~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 244 -ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 001135678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=288.79 Aligned_cols=247 Identities=22% Similarity=0.272 Sum_probs=189.6
Q ss_pred hhhhhhccccccceeEEEEEecCCCc--eEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKE--MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~--~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||.||+|.++.++. .+|+|.++.. ......+..|+.++.++. +|++++++++.+...+..
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG----HHPNIINLLGACENRGYL 78 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc----CCCchhheEEEEccCCcc
Confidence 46788999999999999999877764 4688888632 223345677888887772 478999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccc
Q 017021 120 CIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 184 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 184 (379)
++++||+ +++|.+++.... ...+++..+..++.|++.||+|||+.|++||||||+||+++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~----- 153 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG----- 153 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC-----
Confidence 9999999 899999997532 12478899999999999999999999999999999999994
Q ss_pred ccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCc--ccccCCccchhhhhCCCCCCccchHhHHHHHHHH
Q 017021 185 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l 262 (379)
.+..++|+|||.+......... ...+..|+|||.+.+..++.++|||||||++|+|
T Consensus 154 ----------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 154 ----------------------ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred ----------------------CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 4455677777766432211111 1224569999999888899999999999999999
Q ss_pred Hh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccc
Q 017021 263 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341 (379)
Q Consensus 263 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (379)
++ |..||......+....+.+..... ....+
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~ 243 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQGYRME------------------------------------------------KPRNC 243 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCCCCC------------------------------------------------CCCCC
Confidence 97 999998765544333221111000 01235
Q ss_pred hhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 342 AGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 342 ~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+.++.+|+.+||+.||.+|||++++++.
T Consensus 244 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 244 DDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6789999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=281.96 Aligned_cols=243 Identities=21% Similarity=0.290 Sum_probs=191.7
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
...|++.+.||+|+||.||++. .+++.||+|+++... ....+..|+..+..+ .|++++++++.+..+. .++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~-~~~ 75 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-TAQAFLEETAVMTKL-----HHKNLVRLLGVILHNG-LYI 75 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-hHHHHHHHHHHHHhC-----CCCCcCeEEEEEcCCC-cEE
Confidence 3568899999999999999985 567889999997533 345677788888877 7789999998886554 799
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|||+ +++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~--------------------- 134 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS--------------------- 134 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---------------------
Confidence 99999 89999999876545689999999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 279 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~ 279 (379)
.++.++|+|||.+............+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..+...
T Consensus 135 ------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 208 (254)
T cd05083 135 ------EDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE 208 (254)
T ss_pred ------CCCcEEECCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 4456777777776543332222334567999999988889999999999999999997 999997655444332
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.+.+.....+ .+..+..+.+++.+||+.+|+.
T Consensus 209 ~~~~~~~~~~------------------------------------------------~~~~~~~~~~li~~~l~~~p~~ 240 (254)
T cd05083 209 CVEKGYRMEP------------------------------------------------PEGCPADVYVLMTSCWETEPKK 240 (254)
T ss_pred HHhCCCCCCC------------------------------------------------CCcCCHHHHHHHHHHcCCChhh
Confidence 2221110000 1135678899999999999999
Q ss_pred CcCHHHHhc
Q 017021 360 RLTAREALR 368 (379)
Q Consensus 360 Rpta~e~l~ 368 (379)
||++++++.
T Consensus 241 Rp~~~~l~~ 249 (254)
T cd05083 241 RPSFHKLRE 249 (254)
T ss_pred CcCHHHHHH
Confidence 999999974
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=281.68 Aligned_cols=236 Identities=22% Similarity=0.324 Sum_probs=183.9
Q ss_pred ccccccceeEEEEEe--cCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 50 KMGEGTFGQVLECWD--RERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 50 ~Lg~G~~g~V~~~~~--~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+||+|+||.||+|.+ +.++..+|+|+++... .....+..|+.++..+ .|+++++++++++ ....++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~-~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-----DNPYIVRMIGICE-AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEc-CCCcEEEEe
Confidence 689999999999964 4667899999986432 2345566788888877 7799999998875 446789999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
|+ +++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~----------------------- 130 (257)
T cd05116 76 LAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT----------------------- 130 (257)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcC-----------------------
Confidence 99 789999997654 5899999999999999999999999999999999999944
Q ss_pred cCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHH
Q 017021 204 RMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 276 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~ 276 (379)
+..++|+|||.+....... ....++..|+|||.+....++.++|+|||||++|+|++ |..||...+..+
T Consensus 131 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 206 (257)
T cd05116 131 ----QHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206 (257)
T ss_pred ----CCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 4456666766665432221 11123568999999988888999999999999999998 999998766555
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+...+ +. ....+.++.++|.+||+.|
T Consensus 207 ~~~~i~~~~~~----------------------~~--------------------------~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 207 VTQMIESGERM----------------------EC--------------------------PQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred HHHHHHCCCCC----------------------CC--------------------------CCCCCHHHHHHHHHHhccC
Confidence 44433321110 01 1135678999999999999
Q ss_pred CCCCcCHHHHhc
Q 017021 357 PTDRLTAREALR 368 (379)
Q Consensus 357 P~~Rpta~e~l~ 368 (379)
|++||++++|..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=289.33 Aligned_cols=260 Identities=23% Similarity=0.388 Sum_probs=195.8
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
....|++.+.||+|++|.||+|.+..+++.||+|+++... ........|+..+... ..|++++.+++++.....
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~----~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS----HDCPYIVKCYGYFITDSD 88 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhc----cCCCchHhhheeeecCCe
Confidence 3456788899999999999999999999999999997432 2233344455544443 257899999999999999
Q ss_pred EEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|++|||+++++.+++.... ..+++..+..++.|++.||+|||+ .|++||||+|+||+++
T Consensus 89 ~~~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~------------------ 149 (296)
T cd06618 89 VFICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD------------------ 149 (296)
T ss_pred EEEEeeccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc------------------
Confidence 99999999888888877643 368999999999999999999997 6999999999999994
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCC----CCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
.++.++|+|||.+....... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||..
T Consensus 150 ---------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 150 ---------ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred ---------CCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 44567777777665332211 2234678899999986543 78899999999999999999999965
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.... ...+.+...... ..++. ...++.++.+|+.+
T Consensus 221 ~~~~--~~~~~~~~~~~~-------------------~~~~~------------------------~~~~~~~l~~li~~ 255 (296)
T cd06618 221 CKTE--FEVLTKILQEEP-------------------PSLPP------------------------NEGFSPDFCSFVDL 255 (296)
T ss_pred chhH--HHHHHHHhcCCC-------------------CCCCC------------------------CCCCCHHHHHHHHH
Confidence 3221 111111111000 00000 01245689999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
||..||++||+++++++||||.....
T Consensus 256 ~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 256 CLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HccCChhhCCCHHHHhcChhhhccch
Confidence 99999999999999999999987553
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=287.17 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=193.7
Q ss_pred eechhhhhhhhccccccceeEEEEEe-----cCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.+....|.+.+.||+|+||.||++.+ ..++..||+|.++... .....+..|+.++.++ .+|+|++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~h~~iv~~~~ 106 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL----GNHENIVNLLG 106 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhc----cCCCCcceEEE
Confidence 34555788899999999999999975 3446689999987432 2234567788888877 24789999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
.+...+..+++|||+ +++|.+++.......+++.++..++.|++.||.|||+.+++|+||||+||+++.
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---------- 176 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH---------- 176 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcC----------
Confidence 999999999999999 899999997654345899999999999999999999999999999999999954
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT- 264 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~- 264 (379)
+..++|+|||.+....... ....++..|+|||.+.+..++.++||||+||++|+|++
T Consensus 177 -----------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~ 239 (302)
T cd05055 177 -----------------GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239 (302)
T ss_pred -----------------CCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhC
Confidence 4456666666654322211 11235678999999988889999999999999999998
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||......+............ . .....+..
T Consensus 240 g~~p~~~~~~~~~~~~~~~~~~~~---------------------~--------------------------~~~~~~~~ 272 (302)
T cd05055 240 GSNPYPGMPVDSKFYKLIKEGYRM---------------------A--------------------------QPEHAPAE 272 (302)
T ss_pred CCCCcCCCCchHHHHHHHHcCCcC---------------------C--------------------------CCCCCCHH
Confidence 999997655433322211100000 0 01124568
Q ss_pred HHHHHhhccccCCCCCcCHHHHhc
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
+.+++.+||..+|++|||+.|+++
T Consensus 273 ~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 273 IYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=285.52 Aligned_cols=255 Identities=23% Similarity=0.334 Sum_probs=193.5
Q ss_pred chhhhhhhhccccccceeEEEEEecCCC----------------ceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCC
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERK----------------EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKG 102 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~----------------~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~ 102 (379)
....|++.++||+|+||.||+|.+..++ ..||+|.+.... .....+..|+.+++++ .
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-----~ 77 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-----S 77 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-----C
Confidence 4457899999999999999999876543 568999987432 3455677789999888 6
Q ss_pred CCeeEEecceeeecceEEEEEeCC-CCCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Q 017021 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNN---------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLK 172 (379)
Q Consensus 103 ~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~---------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlk 172 (379)
|++++++++++..+...+++||++ +++|.+++.... ...+++..+..++.|++.||+|||+.|++|||||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 789999999999999999999999 899999987643 1258899999999999999999999999999999
Q ss_pred CCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCCC
Q 017021 173 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWT 247 (379)
Q Consensus 173 p~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~ 247 (379)
|+||+++. +..++|+|||.+...... .....++..|+|||.+.+..++
T Consensus 158 p~Nili~~---------------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 210 (296)
T cd05051 158 TRNCLVGK---------------------------NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT 210 (296)
T ss_pred hhceeecC---------------------------CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC
Confidence 99999954 455666666665432211 1123456789999999888899
Q ss_pred CccchHhHHHHHHHHHh--CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhc
Q 017021 248 YPCDIWSVGCILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 325 (379)
Q Consensus 248 ~~sDvwSlG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (379)
.++|||||||++|+|++ +..||...+..+....+........ ....
T Consensus 211 ~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------~~~~-------------- 258 (296)
T cd05051 211 TKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDG------------------RQIY-------------- 258 (296)
T ss_pred ccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccc------------------cccc--------------
Confidence 99999999999999998 7788876554443332222110000 0000
Q ss_pred cchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 326 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.......+.++.+++.+||+.||++|||+.|+++
T Consensus 259 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 259 ---------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ---------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 0001134578999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=286.38 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=196.2
Q ss_pred hhhhhhccccccceeEEEEEec---CCCceEEEEEeeccc-----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 44 ADKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.|++.+.||+|+||.||.|++. .+|+.||+|++.... ........|+.++.++. +|++++.+++.++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----QSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc----cCCChhceeeEeec
Confidence 3788899999999999999875 478999999987422 22345566778777762 56899999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
+...|+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---------------- 138 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---------------- 138 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE----------------
Confidence 99999999999 899999997754 58899999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCC--CCCCccchHhHHHHHHHHHhCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
+.++.++|+|||.+....... ....|+..|+|||.+.+. .++.++||||||+++|+|++|..|
T Consensus 139 -----------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p 207 (290)
T cd05613 139 -----------DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207 (290)
T ss_pred -----------CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCC
Confidence 445567777877765433221 224578899999998653 467899999999999999999999
Q ss_pred CCCCchHHHHHHHHH-HcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 269 FQTHENLEHLAMMER-VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 269 f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
|...........+.+ ..... .. ..+..+..+.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~--------------------~~--------------------------~~~~~~~~~~~ 241 (290)
T cd05613 208 FTVDGEKNSQAEISRRILKSE--------------------PP--------------------------YPQEMSALAKD 241 (290)
T ss_pred CCcCCccccHHHHHHHhhccC--------------------CC--------------------------CCccCCHHHHH
Confidence 964322111111111 00000 00 01235567899
Q ss_pred HHhhccccCCCCCc-----CHHHHhcCCCCCCCC
Q 017021 348 LLQGLLRYDPTDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 348 li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
++++||+.||++|| ++++++.||||....
T Consensus 242 ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 242 IIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 99999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=280.05 Aligned_cols=246 Identities=27% Similarity=0.420 Sum_probs=193.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|++|.||+|.+..+|+.||+|.++.. ......+..|+.++.++ .|++++.+++.+...+..
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-----~~~~i~~~~~~~~~~~~~ 77 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-----DHPNVIKYLASFIENNEL 77 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-----CCCCeeeeeeeeecCCeE
Confidence 578889999999999999999999999999988631 22345667788888887 678999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
+++|||+ +++|.+++... ....++...+..++.+++.||.|||+.|++||||+|+||+++
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~----------------- 140 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT----------------- 140 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC-----------------
Confidence 9999999 88999998652 223588999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
.++.++|+|||.+...... .....++..|.|||.+.+..++.++|+|||||++|+|++|..||....
T Consensus 141 ----------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 141 ----------ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ----------CCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 4455677777766533221 123457888999999988889999999999999999999999996533
Q ss_pred h--HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 274 N--LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 274 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
. .+....+.. +..+ ..+ ....+..+.++|.+
T Consensus 211 ~~~~~~~~~~~~--~~~~--------------------~~~-------------------------~~~~~~~~~~~i~~ 243 (267)
T cd08224 211 MNLYSLCKKIEK--CDYP--------------------PLP-------------------------ADHYSEELRDLVSR 243 (267)
T ss_pred ccHHHHHhhhhc--CCCC--------------------CCC-------------------------hhhcCHHHHHHHHH
Confidence 1 111111110 0000 000 01345688999999
Q ss_pred ccccCCCCCcCHHHHhc
Q 017021 352 LLRYDPTDRLTAREALR 368 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~ 368 (379)
||..+|++|||+.++++
T Consensus 244 cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 244 CINPDPEKRPDISYVLQ 260 (267)
T ss_pred HcCCCcccCCCHHHHHH
Confidence 99999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=300.23 Aligned_cols=239 Identities=24% Similarity=0.349 Sum_probs=193.4
Q ss_pred hhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-
Q 017021 48 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 126 (379)
Q Consensus 48 ~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~- 126 (379)
++=||+|+.|.||+|+ ..++.||||+++.-+ ..++.-|.++ .|+||+.+.+.+.....+|||||||
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~elk------ETdIKHLRkL-----kH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVRELK------ETDIKHLRKL-----KHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhhhh------hhhHHHHHhc-----cCcceeeEeeeecCCceeEEeeeccc
Confidence 3679999999999996 446889999886321 1145556666 7899999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCC
Q 017021 127 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 206 (379)
Q Consensus 127 ~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (379)
.|-|..++.... .++...+..|..+|+.|+.|||.+.|||||||.=|||| .
T Consensus 196 ~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI---------------------------s 246 (904)
T KOG4721|consen 196 QGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI---------------------------S 246 (904)
T ss_pred cccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe---------------------------e
Confidence 999999998865 78999999999999999999999999999999999999 5
Q ss_pred CCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHH
Q 017021 207 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284 (379)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 284 (379)
.+..+||+|||-++.....+ -.+.||..|||||++.+++.+.|+|||||||+||||+||..||...+...+...+...
T Consensus 247 ~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN 326 (904)
T KOG4721|consen 247 YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN 326 (904)
T ss_pred ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC
Confidence 66678888888776444332 3468999999999999999999999999999999999999999754443222111111
Q ss_pred cCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHH
Q 017021 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 364 (379)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 364 (379)
.. .+++| ..++.-++-||++||+-.|..||++.
T Consensus 327 sL---------------------~LpvP--------------------------stcP~GfklL~Kqcw~sKpRNRPSFr 359 (904)
T KOG4721|consen 327 SL---------------------HLPVP--------------------------STCPDGFKLLLKQCWNSKPRNRPSFR 359 (904)
T ss_pred cc---------------------cccCc--------------------------ccCchHHHHHHHHHHhcCCCCCccHH
Confidence 00 11122 24677888899999999999999999
Q ss_pred HHhcCCCCCCC
Q 017021 365 EALRHPFFTRD 375 (379)
Q Consensus 365 e~l~hp~f~~~ 375 (379)
|+|.|-=+...
T Consensus 360 qil~HldIa~p 370 (904)
T KOG4721|consen 360 QILLHLDIASP 370 (904)
T ss_pred HHHHHHhhcCH
Confidence 99999654443
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=282.58 Aligned_cols=245 Identities=20% Similarity=0.267 Sum_probs=186.3
Q ss_pred hhhhhccccccceeEEEEEecC---CCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc-
Q 017021 45 DKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN- 117 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~---~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~- 117 (379)
|++.+.||+|+||.||+|.+.. ++..||+|+++... .....+..|+..+..+ +|++++++++.+....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~ 75 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-----DHPNVMKLIGVCFEASS 75 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEeeeccCCc
Confidence 5788999999999999998765 34789999987432 2234566788877777 7899999998776544
Q ss_pred -----eEEEEEeCC-CCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccC
Q 017021 118 -----HICIVFEKL-GSSLYDFLRKNN----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 118 -----~~~lv~e~~-~~sL~~~l~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~ 187 (379)
..++++||+ +++|..++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++.
T Consensus 76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~------- 148 (273)
T cd05035 76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE------- 148 (273)
T ss_pred cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECC-------
Confidence 489999999 899999985431 125889999999999999999999999999999999999944
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHH
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l 262 (379)
+..++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|
T Consensus 149 --------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el 208 (273)
T cd05035 149 --------------------DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208 (273)
T ss_pred --------------------CCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHH
Confidence 4456666666654322211 112345679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccc
Q 017021 263 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341 (379)
Q Consensus 263 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (379)
++ |..||...+..+....+... . .... ....
T Consensus 209 ~~~g~~p~~~~~~~~~~~~~~~~--~--------------------~~~~--------------------------~~~~ 240 (273)
T cd05035 209 ATRGQTPYPGVENHEIYDYLRHG--N--------------------RLKQ--------------------------PEDC 240 (273)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcC--C--------------------CCCC--------------------------CcCC
Confidence 99 89999765544332222110 0 0000 1235
Q ss_pred hhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 342 AGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 342 ~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+..+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 241 LDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=286.23 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=193.0
Q ss_pred eechhhhhhhhccccccceeEEEEEecCC-----CceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.+....|++.+.||+|+||.||++.++.. ...+|+|.+.... .....+..|+.++..+ ..|++++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l----~~h~~i~~~~~ 83 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI----GKHKNIINLLG 83 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhh----cCCCCeeeEEE
Confidence 34556788889999999999999987644 3789999987432 2234566788777776 25689999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcE
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKN--------------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV 176 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~--------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Ni 176 (379)
++...+..+++|||+ +++|.+++... ....+++..+..++.|++.||+|||+.|++||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999 89999999652 223588999999999999999999999999999999999
Q ss_pred EEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccc
Q 017021 177 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCD 251 (379)
Q Consensus 177 li~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sD 251 (379)
+++. ++.++|+|||.+....... ....++..|+|||.+.+..++.++|
T Consensus 164 l~~~---------------------------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 216 (293)
T cd05053 164 LVTE---------------------------DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSD 216 (293)
T ss_pred EEcC---------------------------CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccc
Confidence 9944 4556666776665332211 1112456799999998888999999
Q ss_pred hHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhh
Q 017021 252 IWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 330 (379)
Q Consensus 252 vwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (379)
||||||++|++++ |..||......+....+..... ...
T Consensus 217 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------~~~------------------- 255 (293)
T cd05053 217 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR----------------------MEK------------------- 255 (293)
T ss_pred eeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc----------------------CCC-------------------
Confidence 9999999999997 9999976554443332211100 000
Q ss_pred HHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 331 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 331 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
....+..+.+|+.+||+.||++|||+.|++++
T Consensus 256 -------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 256 -------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred -------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 11245689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=284.25 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=191.7
Q ss_pred chhhhhhhhccccccceeEEEEEe----cCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWD----RERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~----~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
....|++.+.||+|+||.||+|.. +.++..||+|.++.. ......+.+|+.+++.+ .|+|++++.+++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~ 76 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-----YHENIVKYKGICT 76 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-----CCCCeeeeeeEEe
Confidence 456899999999999999999974 467889999998633 23345677888888887 7799999999887
Q ss_pred ec--ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 115 YR--NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 115 ~~--~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
.. ...++||||+ +++|.+++.+.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~--------- 146 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--------- 146 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC---------
Confidence 65 5789999999 999999997653 2589999999999999999999999999999999999995444
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhC
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g 265 (379)
.++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|+++
T Consensus 147 ------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~ 208 (284)
T cd05079 147 ------------------QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTY 208 (284)
T ss_pred ------------------CEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcC
Confidence 45566666554322211 123456789999999888899999999999999999998
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
..|....... ..+..++.+...... ............+ ....++..+
T Consensus 209 ~~~~~~~~~~-----~~~~~~~~~~~~~~~--~~~~~~~~~~~~~--------------------------~~~~~~~~~ 255 (284)
T cd05079 209 CDSESSPMTL-----FLKMIGPTHGQMTVT--RLVRVLEEGKRLP--------------------------RPPNCPEEV 255 (284)
T ss_pred CCCCccccch-----hhhhcccccccccHH--HHHHHHHcCccCC--------------------------CCCCCCHHH
Confidence 7765432110 111122221111000 0000000000000 112456789
Q ss_pred HHHHhhccccCCCCCcCHHHHhcC
Q 017021 346 THLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.+|+.+||+.||++|||+++++++
T Consensus 256 ~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 256 YQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=283.98 Aligned_cols=247 Identities=22% Similarity=0.262 Sum_probs=188.7
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCc----eEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~----~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
+....|++.++||+|+||+||+|.+..+++ .||+|+++.. ......+..|..++..+ +|++++.+++++
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~ 78 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-----GSPYVCRLLGIC 78 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-----CCCCCceEEEEE
Confidence 445678888999999999999999877765 4899998643 22344556677776666 678999998887
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
.. ...+++++|+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++.
T Consensus 79 ~~-~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~------------- 143 (279)
T cd05109 79 LT-STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK------------- 143 (279)
T ss_pred cC-CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc-------------
Confidence 65 4577899999 899999987643 3589999999999999999999999999999999999994
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCCC-----cccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 266 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~ 266 (379)
.+..++|+|||.+........ ...++..|+|||...+..++.++|||||||++|+|++ |.
T Consensus 144 --------------~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~ 209 (279)
T cd05109 144 --------------SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGA 209 (279)
T ss_pred --------------CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCC
Confidence 344567777777654332211 1234567999999988889999999999999999998 89
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||......+....+...... + .....+.++.
T Consensus 210 ~p~~~~~~~~~~~~~~~~~~~-~-----------------------------------------------~~~~~~~~~~ 241 (279)
T cd05109 210 KPYDGIPAREIPDLLEKGERL-P-----------------------------------------------QPPICTIDVY 241 (279)
T ss_pred CCCCCCCHHHHHHHHHCCCcC-C-----------------------------------------------CCccCCHHHH
Confidence 999765543333222211100 0 0012456789
Q ss_pred HHHhhccccCCCCCcCHHHHhc
Q 017021 347 HLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~ 368 (379)
+++.+||+.||++||++.+++.
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=317.10 Aligned_cols=144 Identities=22% Similarity=0.333 Sum_probs=127.1
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
..|++.++||.|+||.||+|++..+++.||+|+++... .....+..|+.++..+ .|++|+.++..+....+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~~~~~~~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-----KSPFIVHLYYSLQSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-----CCCCcCeEEEEEEECCE
Confidence 35788899999999999999999999999999997432 2234556677777766 77999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+..++.++|+|||++.
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999 999999997654 58899999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=278.90 Aligned_cols=237 Identities=24% Similarity=0.358 Sum_probs=184.3
Q ss_pred hccccccceeEEEEEecCCC---ceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 49 SKMGEGTFGQVLECWDRERK---EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~---~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
++||+|+||.||+|.+..++ ..+|+|.+..... ....+..|+.++..+ .|++++++++++. ....++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~-~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-----DHPCIVRLIGVCK-GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEc-CCceEEEE
Confidence 47999999999999876554 7899999875433 455677788888887 6789999998775 45689999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
||+ +++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.+
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~--------------------- 131 (257)
T cd05060 75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR--------------------- 131 (257)
T ss_pred EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC---------------------
Confidence 999 889999998765 68999999999999999999999999999999999999544
Q ss_pred ccCCCCCCeEEeecCcccccCCCCCc------ccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPDQNY------IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 275 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~ 275 (379)
+.++|+|||.+......... ..++..|+|||.+.+..++.++|||||||++|++++ |..||...+..
T Consensus 132 ------~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~ 205 (257)
T cd05060 132 ------HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205 (257)
T ss_pred ------CcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 45566666655433222211 123457999999988889999999999999999998 99999765544
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.+... .. .....+..+.++|.+||..
T Consensus 206 ~~~~~~~~~~~----------------------~~--------------------------~~~~~~~~l~~li~~cl~~ 237 (257)
T cd05060 206 EVIAMLESGER----------------------LP--------------------------RPEECPQEIYSIMLSCWKY 237 (257)
T ss_pred HHHHHHHcCCc----------------------CC--------------------------CCCCCCHHHHHHHHHHhcC
Confidence 33322221100 00 0123567899999999999
Q ss_pred CCCCCcCHHHHhc
Q 017021 356 DPTDRLTAREALR 368 (379)
Q Consensus 356 dP~~Rpta~e~l~ 368 (379)
||++|||+.++++
T Consensus 238 ~p~~Rp~~~~l~~ 250 (257)
T cd05060 238 RPEDRPTFSELES 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=285.76 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=190.9
Q ss_pred hhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeeccch-hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
...|.+.+.||+|+||.||+|.+. .++..+|+|.+..... ....+.+|+..+..+ .|++++++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~ 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-----QHEHIVKFYGVCGD 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-----CCCCcceEEEEEcc
Confidence 345778899999999999999854 3456799999874332 234566788888877 77999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEec
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 180 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~ 180 (379)
....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+.|++||||||+||+++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 99999999999 999999997642 124788999999999999999999999999999999999954
Q ss_pred ccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhH
Q 017021 181 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSV 255 (379)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 255 (379)
+..++|+|||.+....... ....++..|+|||.+.+..++.++|||||
T Consensus 159 ---------------------------~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (291)
T cd05094 159 ---------------------------NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211 (291)
T ss_pred ---------------------------CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHH
Confidence 4456666666654322211 22345778999999998889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHH
Q 017021 256 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334 (379)
Q Consensus 256 G~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (379)
||++|+|++ |..||...+..+....+... ..+ .
T Consensus 212 G~il~el~t~g~~p~~~~~~~~~~~~~~~~--~~~--------------------~------------------------ 245 (291)
T cd05094 212 GVILWEIFTYGKQPWFQLSNTEVIECITQG--RVL--------------------E------------------------ 245 (291)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhCC--CCC--------------------C------------------------
Confidence 999999998 99999765544332221110 000 0
Q ss_pred HHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 335 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.....+..+.+++.+||+.||++|||++++++
T Consensus 246 --~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 246 --RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred --CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 01124567999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=279.81 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=192.2
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+....|++.++||+|+||.||++.+. .+..+|+|.+.........+.+|+.+++.+ +|++++++++.+.. ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-----QHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhc-----CCCCcceEEEEEcC-CCe
Confidence 34567889999999999999999865 456699999875554456677898888887 67899999988877 778
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+++|||+ +++|.+++.......++...+..++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~------------------ 137 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA------------------ 137 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC------------------
Confidence 9999999 889999998765456888899999999999999999999999999999999944
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 273 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~ 273 (379)
...++|+|||.+....... ....++..|+|||.+....++.++|+|||||++|++++ |+.||...+
T Consensus 138 ---------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 138 ---------SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred ---------CCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 4456666666554322111 11234567999999988888999999999999999998 999997655
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
.......+.+.... ...+..+.++.+++.+||
T Consensus 209 ~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~i~~~l 240 (260)
T cd05073 209 NPEVIRALERGYRM------------------------------------------------PRPENCPEELYNIMMRCW 240 (260)
T ss_pred HHHHHHHHhCCCCC------------------------------------------------CCcccCCHHHHHHHHHHc
Confidence 43333222111000 001235568999999999
Q ss_pred ccCCCCCcCHHHHhc
Q 017021 354 RYDPTDRLTAREALR 368 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~ 368 (379)
+.||++||++.++++
T Consensus 241 ~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 241 KNRPEERPTFEYIQS 255 (260)
T ss_pred ccCcccCcCHHHHHH
Confidence 999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=279.94 Aligned_cols=228 Identities=26% Similarity=0.381 Sum_probs=181.4
Q ss_pred ccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-CCCHHH
Q 017021 54 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYD 132 (379)
Q Consensus 54 G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~ 132 (379)
|.+|.||+++++.+++.||+|.+...... ..|...+... .|++++.+++.+......+++|||+ +++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~----~~~~~~~~~~-----~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY----SRERLTIIPH-----CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh----hhHHHHHHhc-----CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 89999999999999999999999754321 1233222222 5789999999999999999999999 899999
Q ss_pred HHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeE
Q 017021 133 FLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212 (379)
Q Consensus 133 ~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (379)
++.+.. .+++..+..++.|++.||.|||+.|++||||||+||++ +.++.++
T Consensus 75 ~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---------------------------~~~~~~~ 125 (237)
T cd05576 75 HISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---------------------------DDRGHIQ 125 (237)
T ss_pred HHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---------------------------cCCCCEE
Confidence 987754 58999999999999999999999999999999999999 4556678
Q ss_pred EeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhH
Q 017021 213 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHM 292 (379)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 292 (379)
++|||.+...........++..|+|||...+..++.++|+||+|+++|+|++|..|+....... . .
T Consensus 126 l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-~--------~----- 191 (237)
T cd05576 126 LTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-N--------T----- 191 (237)
T ss_pred EecccchhccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-c--------c-----
Confidence 8888876655444444456778999999988888999999999999999999998774311100 0 0
Q ss_pred HHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCH-----HHHh
Q 017021 293 LKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA-----REAL 367 (379)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~e~l 367 (379)
..... ..+..+..++++|.+||+.||++|||+ +|++
T Consensus 192 -------------~~~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~ 232 (237)
T cd05576 192 -------------HTTLN--------------------------IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIK 232 (237)
T ss_pred -------------ccccC--------------------------CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHH
Confidence 00000 112356789999999999999999996 9999
Q ss_pred cCCCC
Q 017021 368 RHPFF 372 (379)
Q Consensus 368 ~hp~f 372 (379)
+||||
T Consensus 233 ~h~~~ 237 (237)
T cd05576 233 SHPFF 237 (237)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=281.73 Aligned_cols=244 Identities=18% Similarity=0.255 Sum_probs=184.2
Q ss_pred hhhhccccccceeEEEEEecCCCc--eEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-----
Q 017021 46 KIHSKMGEGTFGQVLECWDRERKE--MVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----- 115 (379)
Q Consensus 46 ~i~~~Lg~G~~g~V~~~~~~~~~~--~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----- 115 (379)
.|.+.||+|+||.||+|.+..++. .||+|.++.. ......+..|..++..+ .|+|++++++.+..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 76 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-----DHPNVMRLIGVCLQTVESE 76 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEccCCccc
Confidence 467899999999999999877765 6999998643 23345566788888877 77899999876532
Q ss_pred -cceEEEEEeCC-CCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCC
Q 017021 116 -RNHICIVFEKL-GSSLYDFLRKN----NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 116 -~~~~~lv~e~~-~~sL~~~l~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
....+++|||+ +++|.+++... ....+++..+..++.|++.||+|||+.|++||||||+||+++
T Consensus 77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---------- 146 (272)
T cd05075 77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN---------- 146 (272)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc----------
Confidence 23578999999 89999887432 123478999999999999999999999999999999999994
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~ 264 (379)
.+..++|+|||.+....... ....+++.|+|||.+.+..++.++|||||||++|+|++
T Consensus 147 -----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~ 209 (272)
T cd05075 147 -----------------ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209 (272)
T ss_pred -----------------CCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHc
Confidence 44556666666665432211 12235678999999998889999999999999999999
Q ss_pred -CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchh
Q 017021 265 -GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343 (379)
Q Consensus 265 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (379)
|..||.+....+....+.+... + . .....+.
T Consensus 210 ~g~~p~~~~~~~~~~~~~~~~~~--~--------------------~--------------------------~~~~~~~ 241 (272)
T cd05075 210 RGQTPYPGVENSEIYDYLRQGNR--L--------------------K--------------------------QPPDCLD 241 (272)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCC--C--------------------C--------------------------CCCCCCH
Confidence 8999976554433322221100 0 0 0113456
Q ss_pred HHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 344 DLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 344 ~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.+.++|.+||+.||++|||+.+++++
T Consensus 242 ~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 242 GLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 78999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=286.43 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=191.5
Q ss_pred echhhhhhhhccccccceeEEEEEecCCC--------------ceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCC
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERK--------------EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGG 103 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~--------------~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~ 103 (379)
++...|++.++||+|+||.||+|++..++ ..||+|.++.. ......+.+|++++.++ .|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-----~h 76 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-----KN 76 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CC
Confidence 34567899999999999999999875432 35999998743 22334567799988888 77
Q ss_pred CeeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Q 017021 104 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY----------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLK 172 (379)
Q Consensus 104 ~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlk 172 (379)
++++++++++...+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+.|++|||||
T Consensus 77 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk 156 (295)
T cd05097 77 PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156 (295)
T ss_pred CCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence 99999999999999999999999 8999999865321 136788899999999999999999999999999
Q ss_pred CCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCC
Q 017021 173 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWT 247 (379)
Q Consensus 173 p~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~ 247 (379)
|+||+++. +..++|+|||.+....... ....++..|+|||.+.+..++
T Consensus 157 p~Nill~~---------------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 209 (295)
T cd05097 157 TRNCLVGN---------------------------HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT 209 (295)
T ss_pred hhhEEEcC---------------------------CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcC
Confidence 99999954 4456666666654322111 112346789999999888899
Q ss_pred CccchHhHHHHHHHHHh--CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhc
Q 017021 248 YPCDIWSVGCILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 325 (379)
Q Consensus 248 ~~sDvwSlG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (379)
.++|+|||||++|+|++ +..||...+..+....+.+..... +.....
T Consensus 210 ~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~------------------~~~~~~------------- 258 (295)
T cd05097 210 TASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQ------------------GRQIYL------------- 258 (295)
T ss_pred chhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhc------------------cccccC-------------
Confidence 99999999999999988 677887655444333222211000 000000
Q ss_pred cchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 326 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
......+..+.+++.+||+.||++|||++++++
T Consensus 259 ----------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 259 ----------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 001124578999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=286.67 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=190.7
Q ss_pred chhhhhhhhccccccceeEEEEEecC-------CCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
..-.|.+.+.||+|+||.||+|.+.. ++..+|+|.++... .....+..|+.++..+ ..|++++++++
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l----~~h~~i~~~~~ 91 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI----GKHKNIINLLG 91 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHh----cCCCCEeeEEE
Confidence 34578999999999999999998643 23579999997432 2234566677777776 24689999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcE
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV 176 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Ni 176 (379)
.+...+..|+||||+ +++|.+++.... ...++..+++.++.|++.||+|||+.|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 999999999999999 889999997642 12478899999999999999999999999999999999
Q ss_pred EEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccc
Q 017021 177 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCD 251 (379)
Q Consensus 177 li~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sD 251 (379)
+++. ++.++|+|||.+....... ....++..|+|||.+.+..++.++|
T Consensus 172 ll~~---------------------------~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 224 (307)
T cd05098 172 LVTE---------------------------DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224 (307)
T ss_pred EEcC---------------------------CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHH
Confidence 9944 4456667776664332111 1112346799999998888999999
Q ss_pred hHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhh
Q 017021 252 IWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 330 (379)
Q Consensus 252 vwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (379)
+|||||++|+|++ |..||......+....+..... .+.
T Consensus 225 vwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------~~~------------------- 263 (307)
T cd05098 225 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR----------------------MDK------------------- 263 (307)
T ss_pred HHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCC----------------------CCC-------------------
Confidence 9999999999998 8899876544333322211100 000
Q ss_pred HHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 331 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 331 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
....+.++.+++.+||..+|++|||+.+++++
T Consensus 264 -------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 264 -------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred -------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 11356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=278.76 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=192.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
.|++.+.||+|+||.||++.+.. +..+|+|++.........+..|+.++.++ .|++++++++.+......+++|
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKL-----SHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhC-----CCCCeeeEEEEEccCCceEEEE
Confidence 56778999999999999998754 67899999875544456677899988887 6789999999999999999999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
||+ +++|.+++.... ..++++.+..++.|++.||++||+.|++|+||||+||+++
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~----------------------- 134 (256)
T cd05112 79 EFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG----------------------- 134 (256)
T ss_pred EcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc-----------------------
Confidence 999 899999987653 2578999999999999999999999999999999999994
Q ss_pred ccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 277 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~ 277 (379)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.
T Consensus 135 ----~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05112 135 ----ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210 (256)
T ss_pred ----CCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 44556777777665322211 11234568999999988889999999999999999998 9999976554443
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+...... ....+..+.+++.+||+.||
T Consensus 211 ~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~l~~~~l~~~p 242 (256)
T cd05112 211 VETINAGFRLYK------------------------------------------------PRLASQSVYELMQHCWKERP 242 (256)
T ss_pred HHHHhCCCCCCC------------------------------------------------CCCCCHHHHHHHHHHcccCh
Confidence 332221100000 01245679999999999999
Q ss_pred CCCcCHHHHhcC
Q 017021 358 TDRLTAREALRH 369 (379)
Q Consensus 358 ~~Rpta~e~l~h 369 (379)
++|||+.+++++
T Consensus 243 ~~Rp~~~~~l~~ 254 (256)
T cd05112 243 EDRPSFSLLLHQ 254 (256)
T ss_pred hhCCCHHHHHHh
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=284.11 Aligned_cols=242 Identities=27% Similarity=0.402 Sum_probs=187.8
Q ss_pred hhhccccccceeEEEEEec----CCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 47 IHSKMGEGTFGQVLECWDR----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 47 i~~~Lg~G~~g~V~~~~~~----~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
+.+.||.|.||.||+|.+. ..+..|+||.++.. ......+.+|++.+.++ .|+|++++++++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-----RHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-----SBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-----ccccccccccccccccccc
Confidence 4588999999999999887 45688999999642 22357778899888888 7799999999999888899
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+|+||+ +++|.+++.......++......++.||+.||.|||+.+++||+|+++||+++
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~-------------------- 137 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD-------------------- 137 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE--------------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------------------
Confidence 999999 78999999987445799999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCc
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 273 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~ 273 (379)
.+..+||+|||.+....... ....+...|+|||.+.+..++.++||||||+++||+++ |+.||...+
T Consensus 138 -------~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~ 210 (259)
T PF07714_consen 138 -------SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD 210 (259)
T ss_dssp -------TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred -------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 45567777777665442211 12345678999999988889999999999999999999 789998766
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.+..... ....++..+.++|.+||
T Consensus 211 ~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~li~~C~ 242 (259)
T PF07714_consen 211 NEEIIEKLKQGQRLP------------------------------------------------IPDNCPKDIYSLIQQCW 242 (259)
T ss_dssp HHHHHHHHHTTEETT------------------------------------------------SBTTSBHHHHHHHHHHT
T ss_pred cccccccccccccce------------------------------------------------eccchhHHHHHHHHHHc
Confidence 655444442221110 11235678999999999
Q ss_pred ccCCCCCcCHHHHhc
Q 017021 354 RYDPTDRLTAREALR 368 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~ 368 (379)
..||++|||+.++++
T Consensus 243 ~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 243 SHDPEKRPSFQEILQ 257 (259)
T ss_dssp -SSGGGS--HHHHHH
T ss_pred CCChhhCcCHHHHHh
Confidence 999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=277.69 Aligned_cols=243 Identities=25% Similarity=0.345 Sum_probs=192.6
Q ss_pred hhhhccccccceeEEEEEecCCC----ceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 46 KIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 46 ~i~~~Lg~G~~g~V~~~~~~~~~----~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
++.+.||.|+||.||++.+..++ ..||+|++..... ....+..|+..+..+ +|++++++++.+.+.+..
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-----DHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-----CCCchheEEEEEcCCCee
Confidence 56789999999999999998766 8999999975433 455677788888877 678999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+++||++ +++|.+++.......+++..+..++.|++.||++||+.|++|+||+|+||+++.
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~------------------ 138 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE------------------ 138 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEcc------------------
Confidence 9999999 899999998755333899999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCCC----cccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQN----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 273 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~ 273 (379)
++.++|+|||.+........ ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+
T Consensus 139 ---------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~ 209 (258)
T smart00219 139 ---------NLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS 209 (258)
T ss_pred ---------CCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 44566666666653332211 1125678999999988888999999999999999998 888887655
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
.......+.+.... .. ....+.++.+++.+||
T Consensus 210 ~~~~~~~~~~~~~~----------------------~~--------------------------~~~~~~~~~~~i~~~l 241 (258)
T smart00219 210 NEEVLEYLKKGYRL----------------------PK--------------------------PENCPPEIYKLMLQCW 241 (258)
T ss_pred HHHHHHHHhcCCCC----------------------CC--------------------------CCcCCHHHHHHHHHHC
Confidence 44433322221100 00 0124678999999999
Q ss_pred ccCCCCCcCHHHHhc
Q 017021 354 RYDPTDRLTAREALR 368 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~ 368 (379)
..||++|||+.|+++
T Consensus 242 ~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 242 AEDPEDRPTFSELVE 256 (258)
T ss_pred cCChhhCcCHHHHHh
Confidence 999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=282.42 Aligned_cols=245 Identities=24% Similarity=0.332 Sum_probs=187.3
Q ss_pred hccccccceeEEEEEecCCCc-------eEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 49 SKMGEGTFGQVLECWDRERKE-------MVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~-------~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
+.||+|+||.||+|.++.++. .+|+|.+.... .....+..|..++..+ .|+|++++++++..+...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-----~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-----SHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-----CCCChhheeeEEEeCCCcE
Confidence 468999999999998866544 48899886432 2234556677777766 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.... ..+++..+..++.||+.||+|||+.|++||||||+||+++.++..++.+
T Consensus 76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~----------- 143 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGN----------- 143 (258)
T ss_pred EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCC-----------
Confidence 999999 899999997654 2588999999999999999999999999999999999997765443322
Q ss_pred cccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCC-CCCCCCchHHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGE-ALFQTHENLEH 277 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~-~pf~~~~~~~~ 277 (379)
...++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|+|++|. .||...+....
T Consensus 144 --------~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~ 214 (258)
T cd05078 144 --------PPFIKLSDPGISITVLPK-EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214 (258)
T ss_pred --------CceEEecccccccccCCc-hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence 234789999988654432 23467889999999876 45789999999999999999984 66654333221
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
.. ........ ....+.++.++|.+||+.||
T Consensus 215 ~~-~~~~~~~~-------------------------------------------------~~~~~~~~~~li~~~l~~~p 244 (258)
T cd05078 215 LQ-FYEDRHQL-------------------------------------------------PAPKWTELANLINQCMDYEP 244 (258)
T ss_pred HH-HHHccccC-------------------------------------------------CCCCcHHHHHHHHHHhccCh
Confidence 11 11000000 11234678999999999999
Q ss_pred CCCcCHHHHhcC
Q 017021 358 TDRLTAREALRH 369 (379)
Q Consensus 358 ~~Rpta~e~l~h 369 (379)
++|||++++++.
T Consensus 245 ~~Rps~~~il~~ 256 (258)
T cd05078 245 DFRPSFRAIIRD 256 (258)
T ss_pred hhCCCHHHHHHh
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=283.52 Aligned_cols=254 Identities=24% Similarity=0.405 Sum_probs=193.5
Q ss_pred hhhhhccccccceeEEEEEec---CCCceEEEEEeeccc-----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 45 DKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
|++.+.||+|++|.||++++. .+++.||+|+++... .....+..|+.++.++ .+|++++.+++.+..+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~----~~~~~i~~~~~~~~~~ 77 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV----RRCPFLVTLHYAFQTD 77 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhc----cCCcchhhhheeeecC
Confidence 678899999999999999864 467889999987422 2234455677777776 3578999999999999
Q ss_pred ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 117 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
...++||||+ +++|.+.+.... .+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~----------------- 138 (288)
T cd05583 78 TKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL----------------- 138 (288)
T ss_pred CEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE-----------------
Confidence 9999999999 889999987654 58899999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCC--CCCccchHhHHHHHHHHHhCCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.++.++|+|||.+....... ....|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||
T Consensus 139 ----------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 208 (288)
T cd05583 139 ----------DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208 (288)
T ss_pred ----------CCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCc
Confidence 445567788888765433222 1235788999999987654 678999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
...........+.+. ......+. ....+..+.++|
T Consensus 209 ~~~~~~~~~~~~~~~-------------------~~~~~~~~--------------------------~~~~~~~l~~li 243 (288)
T cd05583 209 TVDGEQNSQSEISRR-------------------ILKSKPPF--------------------------PKTMSAEARDFI 243 (288)
T ss_pred ccCcccchHHHHHHH-------------------HHccCCCC--------------------------CcccCHHHHHHH
Confidence 643221111111000 00000000 112456789999
Q ss_pred hhccccCCCCCcC---HHHHhcCCCCCCCC
Q 017021 350 QGLLRYDPTDRLT---AREALRHPFFTRDH 376 (379)
Q Consensus 350 ~~~L~~dP~~Rpt---a~e~l~hp~f~~~~ 376 (379)
.+||+.||++||| +.++++||||+..+
T Consensus 244 ~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 244 QKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 9999999999998 56779999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=279.69 Aligned_cols=245 Identities=21% Similarity=0.304 Sum_probs=189.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCc---eEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~---~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
..|...+.||+|+||.||+|.++.+++ .+|+|.+... ......+..|+.++..+ .|++++++.+++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-----SHHNIIRLEGVVTKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-----CCCCeeEEEEEEccCC
Confidence 356677999999999999999876654 7999998643 23345566777777766 6789999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.|++|||+||+||+++.+
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~--------------- 143 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN--------------- 143 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC---------------
Confidence 999999999 889999987653 358999999999999999999999999999999999999544
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCCC------cccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 269 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf 269 (379)
..++|+|||.+........ ....+..|+|||.+.+..++.++|||||||++|++++ |+.||
T Consensus 144 ------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~ 211 (268)
T cd05063 144 ------------LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211 (268)
T ss_pred ------------CcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCC
Confidence 4456666665543222111 0112356999999988889999999999999999997 99999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
...+..+....+.+.. ..|. ....+.++.+++
T Consensus 212 ~~~~~~~~~~~i~~~~-~~~~-----------------------------------------------~~~~~~~~~~li 243 (268)
T cd05063 212 WDMSNHEVMKAINDGF-RLPA-----------------------------------------------PMDCPSAVYQLM 243 (268)
T ss_pred CcCCHHHHHHHHhcCC-CCCC-----------------------------------------------CCCCCHHHHHHH
Confidence 7655544433332211 1110 012456789999
Q ss_pred hhccccCCCCCcCHHHHhc
Q 017021 350 QGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~ 368 (379)
.+||+.||++||++.++++
T Consensus 244 ~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 244 LQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHcCCCcccCcCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=290.04 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=188.9
Q ss_pred echhhhhhhhccccccceeEEEEEe-----cCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
+....|++.+.||+|+||.||+|.+ ..+++.||+|+++... .....+.+|+.++.++. +|+|+++++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~~~~ 79 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGA 79 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc----CCccHhhhcce
Confidence 4556799999999999999999984 3567899999997432 23345677888888872 56889999987
Q ss_pred eee-cceEEEEEeCC-CCCHHHHHHhCCC---------------------------------------------------
Q 017021 113 FDY-RNHICIVFEKL-GSSLYDFLRKNNY--------------------------------------------------- 139 (379)
Q Consensus 113 ~~~-~~~~~lv~e~~-~~sL~~~l~~~~~--------------------------------------------------- 139 (379)
+.. +...+++|||+ +++|.+++.....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 754 45689999999 9999999865321
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 140 --------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 140 --------------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
..++...+..++.|++.||.|||+.|++||||||+||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~-------------------------- 213 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-------------------------- 213 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc--------------------------
Confidence 1357778889999999999999999999999999999994
Q ss_pred CCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHHHH
Q 017021 206 PKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 279 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~ 279 (379)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+...
T Consensus 214 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 292 (343)
T cd05103 214 -ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292 (343)
T ss_pred -CCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH
Confidence 45567777777765432211 11234567999999988889999999999999999997 999987543221111
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.... .......+ ...++++.+++..||+.||++
T Consensus 293 ~~~~---------------------~~~~~~~~--------------------------~~~~~~~~~~~~~cl~~~p~~ 325 (343)
T cd05103 293 RRLK---------------------EGTRMRAP--------------------------DYTTPEMYQTMLDCWHGEPSQ 325 (343)
T ss_pred HHHh---------------------ccCCCCCC--------------------------CCCCHHHHHHHHHHccCChhh
Confidence 1000 00000000 113457889999999999999
Q ss_pred CcCHHHHhcC
Q 017021 360 RLTAREALRH 369 (379)
Q Consensus 360 Rpta~e~l~h 369 (379)
|||+.|+++|
T Consensus 326 Rps~~eil~~ 335 (343)
T cd05103 326 RPTFSELVEH 335 (343)
T ss_pred CcCHHHHHHH
Confidence 9999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=282.46 Aligned_cols=244 Identities=19% Similarity=0.310 Sum_probs=188.6
Q ss_pred hhhhhccccccceeEEEEEecC-----CCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 45 DKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
|++.+.||+|+||.||+|.+.. ....+|+|.+.... .....+..|+.++..+ .|+|++++++.+...+
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-----NHPHVIKLYGACSQDG 76 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-----CCCCEeeEEEEEecCC
Confidence 6788999999999999998753 23579999886432 2234566788888887 7899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNN----------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPE 174 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~ 174 (379)
..++++||+ +++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 999999999 899999986421 124778899999999999999999999999999999
Q ss_pred cEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCc
Q 017021 175 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYP 249 (379)
Q Consensus 175 Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~ 249 (379)
||++. .+..++|+|||.+....... ....++..|+|||.+.+..++.+
T Consensus 157 nill~---------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~ 209 (290)
T cd05045 157 NVLVA---------------------------EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ 209 (290)
T ss_pred eEEEc---------------------------CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH
Confidence 99994 44556777777665322211 12235668999999988889999
Q ss_pred cchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccch
Q 017021 250 CDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328 (379)
Q Consensus 250 sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (379)
+||||||+++|+|++ |..||.+....+....+.+.... +
T Consensus 210 ~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------~------------------ 249 (290)
T cd05045 210 SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM----------------------E------------------ 249 (290)
T ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC----------------------C------------------
Confidence 999999999999998 99999765543333222111000 0
Q ss_pred hhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 329 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.....+.++.+++.+||+.||++||+++++++
T Consensus 250 --------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 250 --------RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred --------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 01235578999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=295.50 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=199.3
Q ss_pred eeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeec---cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 36 TYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 36 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
++-.+......+.++||+|.||+||+|++-. .||||+++- .+..-+.+..|+.++.+- -|.||+-+.++
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-----RH~NIlLFMG~ 456 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-----RHENILLFMGA 456 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhc-----chhhheeeehh
Confidence 4556666677899999999999999998754 399999973 344667788899999887 56899999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
+..+.. .||+.+| |.+|+.++.... ..+.....+.|+.|+++|+.|||.++|||||||..||++
T Consensus 457 ~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl------------- 521 (678)
T KOG0193|consen 457 CMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL------------- 521 (678)
T ss_pred hcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE-------------
Confidence 999888 9999999 889999998755 358899999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhC---CCCCCccchHhHHHHHHHHH
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELC 263 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~~l~ 263 (379)
..++.++|+|||++....... ....|...|+|||++.. .+|++++||||||+++|||+
T Consensus 522 --------------~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELl 587 (678)
T KOG0193|consen 522 --------------HEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELL 587 (678)
T ss_pred --------------ccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHH
Confidence 555778888888775433222 23467889999999864 46999999999999999999
Q ss_pred hCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchh
Q 017021 264 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343 (379)
Q Consensus 264 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (379)
+|..||...+......++-+ |.+..+. -.....+..
T Consensus 588 tg~lPysi~~~dqIifmVGr--G~l~pd~------------------------------------------s~~~s~~pk 623 (678)
T KOG0193|consen 588 TGELPYSIQNRDQIIFMVGR--GYLMPDL------------------------------------------SKIRSNCPK 623 (678)
T ss_pred hCcCCcCCCChhheEEEecc--cccCccc------------------------------------------hhhhccCHH
Confidence 99999985444333222211 1111110 011123566
Q ss_pred HHHHHHhhccccCCCCCcCHHHHhc
Q 017021 344 DLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 344 ~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
++++|+..||.+++++||...++|.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 8999999999999999999999886
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=280.59 Aligned_cols=246 Identities=20% Similarity=0.208 Sum_probs=183.6
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCc----eEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~----~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
....|++.+.||+|+||.||+|.+..+++ .+|+|.+..... ....+..|+..+..+ .|+|++++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-----~h~~iv~~~~~~~ 79 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-----DHAYIVRLLGICP 79 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-----CCCCcceEEEEEC
Confidence 34567888999999999999999877766 477787753211 122334444455444 7899999999875
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
. ...++++||+ +++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||+++
T Consensus 80 ~-~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~-------------- 143 (279)
T cd05111 80 G-ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK-------------- 143 (279)
T ss_pred C-CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc--------------
Confidence 4 4578899999 899999997654 3589999999999999999999999999999999999994
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 267 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~ 267 (379)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|++++ |..
T Consensus 144 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~ 210 (279)
T cd05111 144 -------------SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAE 210 (279)
T ss_pred -------------CCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCC
Confidence 44556677777665332211 12345678999999988889999999999999999998 999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||.+....+....+.+. ..+ .. ....+.++.+
T Consensus 211 p~~~~~~~~~~~~~~~~--~~~--------------------~~--------------------------~~~~~~~~~~ 242 (279)
T cd05111 211 PYAGMRPHEVPDLLEKG--ERL--------------------AQ--------------------------PQICTIDVYM 242 (279)
T ss_pred CCCCCCHHHHHHHHHCC--CcC--------------------CC--------------------------CCCCCHHHHH
Confidence 99875543332222111 000 00 0123456788
Q ss_pred HHhhccccCCCCCcCHHHHhc
Q 017021 348 LLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~ 368 (379)
++.+||..||++|||+.|+++
T Consensus 243 li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 243 VMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=292.59 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=193.5
Q ss_pred eeechhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
..+....|.+.++||+|+||.||+|++. .+++.||+|+++... .....+..|+.++..+. .|+|+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~----~H~niv~~~ 107 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG----PHLNIVNLL 107 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC----CCCCeEEEE
Confidence 3445567888999999999999999864 345789999997432 22345677889888872 378999999
Q ss_pred ceeeecceEEEEEeCC-CCCHHHHHHhCCC--------------------------------------------------
Q 017021 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNNY-------------------------------------------------- 139 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~-------------------------------------------------- 139 (379)
+.+..++..++||||+ +++|.+++.....
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 9999999999999999 9999999965321
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Q 017021 140 ----------------------------------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 173 (379)
Q Consensus 140 ----------------------------------------------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp 173 (379)
..+++..+..++.||+.||+|||+.+++||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 1356677889999999999999999999999999
Q ss_pred CcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCCCC
Q 017021 174 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTY 248 (379)
Q Consensus 174 ~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ 248 (379)
+||+++ ....++|+|||.+...... .....++..|+|||.+.+..++.
T Consensus 268 ~NiLl~---------------------------~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 320 (401)
T cd05107 268 RNVLIC---------------------------EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320 (401)
T ss_pred ceEEEe---------------------------CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc
Confidence 999994 4455777777776532211 12235678899999998888999
Q ss_pred ccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccc
Q 017021 249 PCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 327 (379)
Q Consensus 249 ~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (379)
++|||||||++|+|++ |..||......+........ +.. ..
T Consensus 321 ~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~-~~~--------------------~~----------------- 362 (401)
T cd05107 321 LSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR-GYR--------------------MA----------------- 362 (401)
T ss_pred HhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc-CCC--------------------CC-----------------
Confidence 9999999999999998 88998754433222111100 000 00
Q ss_pred hhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 328 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.....+.++.+++.+||..+|.+||+++|+++.
T Consensus 363 ---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 363 ---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 012356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=275.34 Aligned_cols=284 Identities=29% Similarity=0.477 Sum_probs=234.4
Q ss_pred hhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc-----
Q 017021 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----- 117 (379)
Q Consensus 46 ~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~----- 117 (379)
+--+.||.|+||.||.+.|..+|+.||+|++.+- -.......+|+..+..+ .|.|+....+......
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-----kHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-----RHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-----ccccHHHHHHhcCCCCchHHH
Confidence 3447899999999999999999999999998632 22346677899988888 5678888887776543
Q ss_pred eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 118 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 118 ~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.+|+++|++..+|..++-+.. .++...+..+++||+.||.|||+.+|+||||||.|.++
T Consensus 131 EiYV~TELmQSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV------------------- 189 (449)
T KOG0664|consen 131 ELYVLTELMQSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV------------------- 189 (449)
T ss_pred HHHHHHHHHHhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe-------------------
Confidence 478899999889998887654 68899999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCCCc----ccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNY----IVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~----~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
.+++.+||||||+++..+..... -+.|..|.|||++.+. .|+.+.||||.|||+.||+.++..|+..
T Consensus 190 --------NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 190 --------NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred --------ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 77888999999999876665432 3568899999999774 5999999999999999999999999999
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
++.+..+.|...+|.++-+.+...++-++..+-++...-|+..- + .... ..++-..+..+++.+|
T Consensus 262 ~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~v----L---Ytls--------S~~~~~heav~~~~~~ 326 (449)
T KOG0664|consen 262 GPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQR----L---YKIA--------SPDDKNHEAVDLLQKL 326 (449)
T ss_pred ChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccc----e---eeec--------CCcccchHHHHHHHHH
Confidence 99999999999999999999999888888888877655554221 0 0000 0112345788899999
Q ss_pred cccCCCCCcCHHHHhcCCCCCCCCcC
Q 017021 353 LRYDPTDRLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~~~~~ 378 (379)
|..||++|.+.++++.|++..+-.+|
T Consensus 327 l~~d~dkris~~~A~~~~~~~e~R~r 352 (449)
T KOG0664|consen 327 LHFDPDKRISVEEALQHRYLEEGRLR 352 (449)
T ss_pred hCCCCcccccHhhhccccccccccee
Confidence 99999999999999999998776554
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=279.23 Aligned_cols=246 Identities=24% Similarity=0.331 Sum_probs=190.8
Q ss_pred hhhhhhhhccccccceeEEEEEecCCC---ceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERK---EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~---~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
...|++.+.||+|+||.||+|.++.++ ..+|+|.++.. ......+..|+.++.++ .|+|++++++++..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-----DHPNIIHLEGVVTKS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEecC
Confidence 356788999999999999999887554 37999998643 23345667788888777 789999999999999
Q ss_pred ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 117 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
+..|++|||+ +++|.+++.... ..++...+..++.|++.||++||+.|++||||||+||+++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~--------------- 141 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS--------------- 141 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC---------------
Confidence 9999999999 889999998754 35789999999999999999999999999999999999954
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCCC------cccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 268 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~p 268 (379)
+..++|+|||.+........ ...++..|+|||.+.+..++.++|+|||||++|++++ |..|
T Consensus 142 ------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p 209 (267)
T cd05066 142 ------------NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209 (267)
T ss_pred ------------CCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCC
Confidence 44566666665543322111 1123457999999988889999999999999999886 9999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|......+....+.+... .| . ....+..+.++
T Consensus 210 ~~~~~~~~~~~~~~~~~~-~~---------------------~--------------------------~~~~~~~~~~l 241 (267)
T cd05066 210 YWEMSNQDVIKAIEEGYR-LP---------------------A--------------------------PMDCPAALHQL 241 (267)
T ss_pred cccCCHHHHHHHHhCCCc-CC---------------------C--------------------------CCCCCHHHHHH
Confidence 976554433332222110 00 0 01245678999
Q ss_pred HhhccccCCCCCcCHHHHhc
Q 017021 349 LQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~ 368 (379)
+.+||+.+|.+||++.++++
T Consensus 242 i~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 242 MLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHcccCchhCCCHHHHHH
Confidence 99999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=279.78 Aligned_cols=245 Identities=23% Similarity=0.349 Sum_probs=190.6
Q ss_pred hhhhhhhccccccceeEEEEEecCCCc---eEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~---~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
..|++.+.||+|+||.||+|.++.+++ .||+|.++.. ......+..|+.++..+ .|+|++++.+++..+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-----DHPNIIHLEGVVTKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCcCcceEEEEECCCC
Confidence 347888999999999999999887664 6999998743 33345677788888877 7899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..++||||+ +++|.+++.... ..++...+..++.|++.||.|||+.|++|+||||+||+++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~---------------- 141 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS---------------- 141 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcC----------------
Confidence 999999999 889999987654 35899999999999999999999999999999999999944
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCCC------ccc--ccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQN------YIV--STRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 267 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~------~~~--gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~ 267 (379)
+..++|+|||.+........ ... .+..|+|||.+.+..++.++|||||||++|++++ |..
T Consensus 142 -----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~ 210 (269)
T cd05065 142 -----------NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210 (269)
T ss_pred -----------CCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCC
Confidence 44566666665543221110 011 1346999999988889999999999999999886 999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||...+..+....+..... .| . ....+..+.+
T Consensus 211 p~~~~~~~~~~~~i~~~~~-~~---------------------~--------------------------~~~~~~~~~~ 242 (269)
T cd05065 211 PYWDMSNQDVINAIEQDYR-LP---------------------P--------------------------PMDCPTALHQ 242 (269)
T ss_pred CCCCCCHHHHHHHHHcCCc-CC---------------------C--------------------------cccCCHHHHH
Confidence 9976555443333321110 00 0 0124567899
Q ss_pred HHhhccccCCCCCcCHHHHhc
Q 017021 348 LLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~ 368 (379)
++.+||+.||++||+++++++
T Consensus 243 li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 243 LMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=281.30 Aligned_cols=259 Identities=24% Similarity=0.284 Sum_probs=187.9
Q ss_pred hhhhhhhhccccccceeEEEEE----ecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 42 AFADKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~----~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
+..|++.+.||+|+||+||++. ...++..||+|.+.... .....+.+|++++..+ .|++++++.+++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~ 77 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-----YHENIVKYKGCCSE 77 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEec
Confidence 3456899999999999998864 34568899999987432 2345667788888887 77999999998765
Q ss_pred --cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 116 --RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 116 --~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
....+++|||+ +++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~------------- 141 (283)
T cd05080 78 QGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD------------- 141 (283)
T ss_pred CCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc-------------
Confidence 34689999999 89999999764 489999999999999999999999999999999999994
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 142 --------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~ 207 (283)
T cd05080 142 --------------NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207 (283)
T ss_pred --------------CCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCC
Confidence 44556777777665432211 1123456799999998888999999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.|+......- ...+....+...... .......+ .. .......+..+.
T Consensus 208 ~p~~~~~~~~-~~~~~~~~~~~~~~~-------~~~~~~~~-----------------~~--------~~~~~~~~~~~~ 254 (283)
T cd05080 208 DSKQSPPKKF-EEMIGPKQGQMTVVR-------LIELLERG-----------------MR--------LPCPKNCPQEVY 254 (283)
T ss_pred CCCCCCcchh-hhhhcccccccchhh-------hhhhhhcC-----------------CC--------CCCCCCCCHHHH
Confidence 9986533210 000000000000000 00000000 00 001123567899
Q ss_pred HHHhhccccCCCCCcCHHHHhc
Q 017021 347 HLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~ 368 (379)
+++.+||+.||++|||++++++
T Consensus 255 ~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 255 ILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=275.39 Aligned_cols=240 Identities=23% Similarity=0.297 Sum_probs=186.4
Q ss_pred hccccccceeEEEEEecC-CC--ceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 49 SKMGEGTFGQVLECWDRE-RK--EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~-~~--~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
++||+|++|.||+|.+.. .+ ..||+|.+..... ....+..|+..+.++ .|++++++++.+.. ...++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-----DHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-----CCCCccceeEEEcC-CeEEEEE
Confidence 468999999999998765 33 3699999975433 345667788888887 77999999999888 8899999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
||+ +++|.+.+.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-------------------- 134 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-------------------- 134 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC--------------------
Confidence 999 89999999775434689999999999999999999999999999999999995544
Q ss_pred ccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 275 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~ 275 (379)
.++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..
T Consensus 135 -------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 207 (257)
T cd05040 135 -------KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS 207 (257)
T ss_pred -------EEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 45555555544322211 12346678999999988889999999999999999998 99999766554
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.......+ . ....+..+.+++.+||+.
T Consensus 208 ~~~~~~~~~~~~~~---------------------~--------------------------~~~~~~~~~~li~~~l~~ 240 (257)
T cd05040 208 QILKKIDKEGERLE---------------------R--------------------------PEACPQDIYNVMLQCWAH 240 (257)
T ss_pred HHHHHHHhcCCcCC---------------------C--------------------------CccCCHHHHHHHHHHCCC
Confidence 44333322110000 0 112456889999999999
Q ss_pred CCCCCcCHHHHhc
Q 017021 356 DPTDRLTAREALR 368 (379)
Q Consensus 356 dP~~Rpta~e~l~ 368 (379)
+|++|||++++++
T Consensus 241 ~p~~Rps~~~~~~ 253 (257)
T cd05040 241 NPADRPTFAALRE 253 (257)
T ss_pred CcccCCCHHHHHH
Confidence 9999999999984
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=283.28 Aligned_cols=250 Identities=20% Similarity=0.308 Sum_probs=190.8
Q ss_pred echhhhhhhhccccccceeEEEEEec-------CCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~-------~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
+....|.+.++||+|+||.||+|.+. .....+|+|.++... .....+..|+.++..+ .+|+++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l----~~h~~iv~~~ 84 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLI----GKHKNIINLL 84 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhc----cCCCCeeeEE
Confidence 44567889999999999999999763 234579999987432 2234556677777666 2478999999
Q ss_pred ceeeecceEEEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCc
Q 017021 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPEN 175 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~N 175 (379)
+++...+..+++|||+ +++|.+++.... ...++...+..++.|++.||.|||+.|++||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 9999999999999999 899999997632 1347888999999999999999999999999999999
Q ss_pred EEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCcc
Q 017021 176 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPC 250 (379)
Q Consensus 176 ili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~s 250 (379)
|++. .++.++|+|||.++...... ....++..|+|||.+.+..++.++
T Consensus 165 ill~---------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 217 (314)
T cd05099 165 VLVT---------------------------EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 217 (314)
T ss_pred EEEc---------------------------CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccc
Confidence 9994 44456777777665332211 111234579999999888899999
Q ss_pred chHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchh
Q 017021 251 DIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 329 (379)
Q Consensus 251 DvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (379)
|||||||++|+|++ |..||......+....+..... ..
T Consensus 218 DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------~~------------------- 256 (314)
T cd05099 218 DVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR----------------------MD------------------- 256 (314)
T ss_pred hhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------CC-------------------
Confidence 99999999999998 8999976554444332221100 00
Q ss_pred hHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 330 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.....+.++.+++.+||+.||++|||+.|+++
T Consensus 257 -------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 257 -------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01134568899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=313.36 Aligned_cols=269 Identities=25% Similarity=0.353 Sum_probs=197.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee------
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------ 115 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~------ 115 (379)
.|+.++.||+||||.||+++++.+|+.||||++... +.....+.+|+..++++ +||||++++..|.+
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-----nHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-----NHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-----CCcceeeeehhhhccCCccc
Confidence 456788999999999999999999999999999754 55567788899999999 88999998875421
Q ss_pred --------------------------------------------------------------------------------
Q 017021 116 -------------------------------------------------------------------------------- 115 (379)
Q Consensus 116 -------------------------------------------------------------------------------- 115 (379)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------c--------ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH
Q 017021 116 -------------------------R--------NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161 (379)
Q Consensus 116 -------------------------~--------~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~L 161 (379)
+ ..+||-|||| ...+.++++.+.. .-.....+.++.+|+.||.|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-NSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-chhhHHHHHHHHHHHHHHHHH
Confidence 0 1368999999 6677777776541 114778999999999999999
Q ss_pred HHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccC-CCCCcccccCCccchhh
Q 017021 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER-PDQNYIVSTRHYRAPEV 240 (379)
Q Consensus 162 H~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~-~~~~~~~gt~~y~aPE~ 240 (379)
|++|||||||||.||+++.+..+||+|||++.-.-... ........+.+.....+ ......+||.-|+|||+
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~-------~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENL-------ESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhh-------hhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 99999999999999999988888888888874311000 00111111111111111 12245689999999999
Q ss_pred hhCCC---CCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHc-CCCChhHHHhhhhhhhhhhccCCCCCCCCCC
Q 017021 241 ILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA 316 (379)
Q Consensus 241 ~~~~~---~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (379)
+.+.. |+.|+|+||||++++||+ .||.. .+|-...+.+.. |..|.+
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~T--sMERa~iL~~LR~g~iP~~------------------------- 836 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEML---YPFGT--SMERASILTNLRKGSIPEP------------------------- 836 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHh---ccCCc--hHHHHHHHHhcccCCCCCC-------------------------
Confidence 97654 999999999999999999 45753 333333333322 222221
Q ss_pred chhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCC
Q 017021 317 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~ 373 (379)
..++.+.-+.-..+|++||+.||++||||.|+|++.||.
T Consensus 837 ------------------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 837 ------------------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ------------------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 011223345667899999999999999999999999997
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=282.25 Aligned_cols=256 Identities=22% Similarity=0.332 Sum_probs=190.7
Q ss_pred echhhhhhhhccccccceeEEEEEecC----------------CCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCC
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRE----------------RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 101 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~----------------~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~ 101 (379)
|....|++.++||+|+||.||++.+.. ++..||+|.+... ......+..|+.++..+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l----- 76 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL----- 76 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-----
Confidence 345568999999999999999986432 3457999998743 22345677888888887
Q ss_pred CCCeeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCC
Q 017021 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY---------RSFPIDLVREIARQLLECIAFMHDLCMIHTDL 171 (379)
Q Consensus 102 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dl 171 (379)
.|++++++++++...+..+++|||+ +++|.+++..... ..+++..+..++.|++.||+|||+.|++||||
T Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl 156 (296)
T cd05095 77 KDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL 156 (296)
T ss_pred CCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence 6799999999999999999999999 8999999876431 13667889999999999999999999999999
Q ss_pred CCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCC
Q 017021 172 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGW 246 (379)
Q Consensus 172 kp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~ 246 (379)
||+||+++ .+..++|+|||.+....... ....++..|+|||...+..+
T Consensus 157 kp~Nili~---------------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 209 (296)
T cd05095 157 ATRNCLVG---------------------------KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF 209 (296)
T ss_pred ChheEEEc---------------------------CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc
Confidence 99999994 44556777777665322211 11234568999999888889
Q ss_pred CCccchHhHHHHHHHHHh--CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhh
Q 017021 247 TYPCDIWSVGCILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 324 (379)
Q Consensus 247 ~~~sDvwSlG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (379)
+.++|+|||||++|+|++ |..||...+..+......+... ........ +
T Consensus 210 ~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~---------------~~~~~~~~--~------------ 260 (296)
T cd05095 210 TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFR---------------DQGRQVYL--P------------ 260 (296)
T ss_pred cchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHh---------------hccccccC--C------------
Confidence 999999999999999998 7788876544333221111000 00000000 0
Q ss_pred ccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 325 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
....++..+.+++.+||+.||.+|||+.++++
T Consensus 261 ------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 261 ------------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 01134578899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=275.04 Aligned_cols=237 Identities=24% Similarity=0.345 Sum_probs=181.7
Q ss_pred ccccccceeEEEEEec--CCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeC
Q 017021 50 KMGEGTFGQVLECWDR--ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 125 (379)
Q Consensus 50 ~Lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 125 (379)
.||+|+||.||+|.+. .++..||+|++.... .....+.+|+.+++++ .|++++++++.++. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~ii~~~~~~~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-----DNPYIVRMIGVCEA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEcC-CCeEEEEEe
Confidence 4899999999999765 445679999987432 2234567888888887 77999999998764 578999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccccc
Q 017021 126 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 204 (379)
Q Consensus 126 ~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (379)
+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.
T Consensus 76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~------------------------ 130 (257)
T cd05115 76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN------------------------ 130 (257)
T ss_pred CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcC------------------------
Confidence 9 899999987543 36899999999999999999999999999999999999944
Q ss_pred CCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHH
Q 017021 205 MPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 277 (379)
Q Consensus 205 ~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~ 277 (379)
+..++|+|||.+....... ....++..|+|||.+....++.++|||||||++|++++ |..||......+.
T Consensus 131 ---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 207 (257)
T cd05115 131 ---QHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV 207 (257)
T ss_pred ---CCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 4456666666654322211 11123567999999988889999999999999999996 9999986554433
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+... .. .....+.++.++|.+||+.||
T Consensus 208 ~~~~~~~~~----------------------~~--------------------------~~~~~~~~l~~li~~c~~~~~ 239 (257)
T cd05115 208 MSFIEQGKR----------------------LD--------------------------CPAECPPEMYALMKDCWIYKW 239 (257)
T ss_pred HHHHHCCCC----------------------CC--------------------------CCCCCCHHHHHHHHHHcCCCh
Confidence 322211100 00 012356789999999999999
Q ss_pred CCCcCHHHHhc
Q 017021 358 TDRLTAREALR 368 (379)
Q Consensus 358 ~~Rpta~e~l~ 368 (379)
++||++.++.+
T Consensus 240 ~~Rp~~~~i~~ 250 (257)
T cd05115 240 EDRPNFAKVEE 250 (257)
T ss_pred hhCcCHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=282.82 Aligned_cols=252 Identities=19% Similarity=0.292 Sum_probs=192.7
Q ss_pred eechhhhhhhhccccccceeEEEEEec-------CCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEe
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~-------~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~ 109 (379)
......|.+.+.||+|+||.||+|.+. .++..||+|.+... ......+..|+.++..+ ..|+|++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l----~~h~~i~~~ 86 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI----GKHKNIINL 86 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhh----ccCCCchhe
Confidence 356777889999999999999999752 23457999998643 22335566788877776 257899999
Q ss_pred cceeeecceEEEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCC
Q 017021 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPE 174 (379)
Q Consensus 110 ~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~ 174 (379)
++++......+++|||+ +++|.+++.... ...++...+..++.||+.||.|||+.|++||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999 889999997642 124678889999999999999999999999999999
Q ss_pred cEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCc
Q 017021 175 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYP 249 (379)
Q Consensus 175 Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~ 249 (379)
||+++. ++.++|+|||.+....... ....++..|+|||.+.+..++.+
T Consensus 167 Nili~~---------------------------~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 219 (304)
T cd05101 167 NVLVTE---------------------------NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 219 (304)
T ss_pred eEEEcC---------------------------CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch
Confidence 999944 4456666666665332211 11234567999999988889999
Q ss_pred cchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccch
Q 017021 250 CDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328 (379)
Q Consensus 250 sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (379)
+||||||+++|++++ |..||...+..+....+..... ..
T Consensus 220 ~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------~~------------------ 259 (304)
T cd05101 220 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR----------------------MD------------------ 259 (304)
T ss_pred hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc----------------------CC------------------
Confidence 999999999999998 8888876554443332211100 00
Q ss_pred hhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 329 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.....+.++.+++.+||+.+|++|||+.|+++.
T Consensus 260 --------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 260 --------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred --------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 011356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=280.24 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=190.0
Q ss_pred hhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
...|++.+.||+|+||.||+|.+. .++..||+|++.... .....+..|+.++..+ .|++++++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~iv~~~~~~~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DHPNIVKLLGVCA 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-----CCCchheEEEEEc
Confidence 456888899999999999999875 367889999987432 2345567788888887 7799999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNN--------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 173 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~--------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp 173 (379)
.+...++++||+ +++|.+++.... ...+++..+..++.|++.||+|||+.|++||||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 999999999999 889999997431 12367888999999999999999999999999999
Q ss_pred CcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCC
Q 017021 174 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTY 248 (379)
Q Consensus 174 ~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~ 248 (379)
+||+++. ++.++|+|||.+....... ....++..|+|||.+.+..++.
T Consensus 159 ~nil~~~---------------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 211 (288)
T cd05050 159 RNCLVGE---------------------------NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTT 211 (288)
T ss_pred hheEecC---------------------------CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCc
Confidence 9999944 4456666666654322111 1123456799999998888999
Q ss_pred ccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccc
Q 017021 249 PCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 327 (379)
Q Consensus 249 ~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (379)
++|||||||++|+|++ |..||.+....+....+... .. ...
T Consensus 212 ~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~--~~--------------------~~~---------------- 253 (288)
T cd05050 212 ESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG--NV--------------------LSC---------------- 253 (288)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--CC--------------------CCC----------------
Confidence 9999999999999997 88888765544333222110 00 000
Q ss_pred hhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 328 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
....+.++.++|.+||+.||++|||+.|+++
T Consensus 254 ----------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 254 ----------PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred ----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1124568999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=278.28 Aligned_cols=243 Identities=23% Similarity=0.330 Sum_probs=182.3
Q ss_pred ccccccceeEEEEEecCC------------------------CceEEEEEeeccch-hhHhHHHHHHHHHHHHhcCCCCC
Q 017021 50 KMGEGTFGQVLECWDRER------------------------KEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGN 104 (379)
Q Consensus 50 ~Lg~G~~g~V~~~~~~~~------------------------~~~vAiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~ 104 (379)
.||+|+||.||+|....+ ...||+|++..... ....+.+|..+++.+ .|+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-----~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-----SHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-----CCC
Confidence 689999999999975322 24589998864322 234455666666666 789
Q ss_pred eeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccc
Q 017021 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 183 (379)
Q Consensus 105 ~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 183 (379)
|++++++++..+...++||||+ +++|..++.... ..+++..+..++.||+.||+|||+.|++||||||+||+++..+.
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 9999999999999999999999 889988886543 35889999999999999999999999999999999999965431
Q ss_pred cccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHH
Q 017021 184 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l 262 (379)
.. .....++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|++
T Consensus 156 ~~--------------------~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el 214 (274)
T cd05076 156 AE--------------------GTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214 (274)
T ss_pred cc--------------------CccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence 10 22345889999987543222 22357788999998865 5688999999999999998
Q ss_pred H-hCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccc
Q 017021 263 C-TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341 (379)
Q Consensus 263 ~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (379)
+ +|..||......+....... ....| ...
T Consensus 215 ~~~g~~p~~~~~~~~~~~~~~~-~~~~~-------------------------------------------------~~~ 244 (274)
T cd05076 215 CFDGEVPLKERTPSEKERFYEK-KHRLP-------------------------------------------------EPS 244 (274)
T ss_pred HhCCCCCccccChHHHHHHHHh-ccCCC-------------------------------------------------CCC
Confidence 5 69999976544332111111 00000 113
Q ss_pred hhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 342 AGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 342 ~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
...+.++|.+||+.||++|||+.+++++
T Consensus 245 ~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 245 CKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred ChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 3578899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=286.04 Aligned_cols=253 Identities=19% Similarity=0.272 Sum_probs=192.9
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCC-------CceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEE
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRER-------KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~-------~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~ 108 (379)
..+....|+|.+.||+|+||.||+|.+... +..||+|.++.. ......+..|+.++.++ ..|+|+++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l----~~h~~iv~ 82 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMI----GKHKNIIN 82 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhh----cCCCCeee
Confidence 445667899999999999999999986432 246899988743 22345667788887776 24689999
Q ss_pred ecceeeecceEEEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Q 017021 109 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 173 (379)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp 173 (379)
+++.+..++..++++||+ +++|.+++.... ...++...+..++.|++.||+|||+.|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 999999999999999999 889999997632 12467888999999999999999999999999999
Q ss_pred CcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCC
Q 017021 174 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTY 248 (379)
Q Consensus 174 ~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~ 248 (379)
+||+++. +..++|+|||.++...... ....++..|+|||.+.+..++.
T Consensus 163 ~Nill~~---------------------------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (334)
T cd05100 163 RNVLVTE---------------------------DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 215 (334)
T ss_pred ceEEEcC---------------------------CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc
Confidence 9999944 4456666766665332211 1112346799999999888999
Q ss_pred ccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccc
Q 017021 249 PCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 327 (379)
Q Consensus 249 ~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (379)
++|||||||++|+|++ |..||...+..+....+..... .+.
T Consensus 216 ~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------~~~---------------- 257 (334)
T cd05100 216 QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR----------------------MDK---------------- 257 (334)
T ss_pred hhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------------CCC----------------
Confidence 9999999999999998 8899976554443332211100 000
Q ss_pred hhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 328 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
....+..+.+++.+||+.+|++|||+.|++++
T Consensus 258 ----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 258 ----------PANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred ----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 11345688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=273.05 Aligned_cols=238 Identities=24% Similarity=0.354 Sum_probs=187.8
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
++||+|++|.||++.+.. ++.||+|++..... ....+..|+.++.++ .|++++.+++++......++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-----DHPNIVKLIGVCVQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCeEEEEEEEecCCCeEEEEEcC
Confidence 478999999999999877 89999999874332 345667788888877 7789999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 127 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 127 -~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
+++|.+++.... ..++...+..++.+++.||.|||+.|++||||+|+||++
T Consensus 75 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili--------------------------- 126 (251)
T cd05041 75 PGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV--------------------------- 126 (251)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---------------------------
Confidence 899999987643 257899999999999999999999999999999999999
Q ss_pred CCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHHHH
Q 017021 206 PKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 279 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~ 279 (379)
+.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||..........
T Consensus 127 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~ 206 (251)
T cd05041 127 GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE 206 (251)
T ss_pred cCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH
Confidence 445567777777765433111 11223557999999988889999999999999999998 889987655433322
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.+...... . ..+..+..+.+++.+||+.||++
T Consensus 207 ~~~~~~~~----------------------~--------------------------~~~~~~~~~~~li~~~l~~~p~~ 238 (251)
T cd05041 207 RIESGYRM----------------------P--------------------------APQLCPEEIYRLMLQCWAYDPEN 238 (251)
T ss_pred HHhcCCCC----------------------C--------------------------CCccCCHHHHHHHHHHhccChhh
Confidence 22111000 0 01134568999999999999999
Q ss_pred CcCHHHHhc
Q 017021 360 RLTAREALR 368 (379)
Q Consensus 360 Rpta~e~l~ 368 (379)
|||+.|+++
T Consensus 239 Rp~~~ell~ 247 (251)
T cd05041 239 RPSFSEIYN 247 (251)
T ss_pred CcCHHHHHH
Confidence 999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=275.31 Aligned_cols=244 Identities=20% Similarity=0.254 Sum_probs=182.8
Q ss_pred hccccccceeEEEEEecC------------CCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 49 SKMGEGTFGQVLECWDRE------------RKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~------------~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
+.||+|+||.||+|.... ....||+|.+.... .....+.+|+.++..+ .|+|++++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-----~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-----SHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-----CCCCEeeEEEEEec
Confidence 468999999999997532 23468999876432 2233455666777666 78999999999998
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
....+++|||+ +++|..++.... ..+++..+..++.||+.||+|||+.|++||||||+||++..++..+
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~--------- 145 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDG--------- 145 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccC---------
Confidence 88999999999 888888876543 3589999999999999999999999999999999999996543210
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhh-CCCCCCccchHhHHHHHHHHH-hCCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELC-TGEALFQTH 272 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~~l~-~g~~pf~~~ 272 (379)
.....++++|||.+...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||...
T Consensus 146 -----------~~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 146 -----------ECGPFIKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred -----------CCCceeEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 22344889999987644322 2345788899999886 456889999999999999997 588888654
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
...+... ... +. .. ...+.+.++.++|.+|
T Consensus 214 ~~~~~~~-~~~--~~---------------------~~--------------------------~~~~~~~~~~~li~~c 243 (262)
T cd05077 214 TLAEKER-FYE--GQ---------------------CM--------------------------LVTPSCKELADLMTHC 243 (262)
T ss_pred chhHHHH-HHh--cC---------------------cc--------------------------CCCCChHHHHHHHHHH
Confidence 3322111 000 00 00 0012345789999999
Q ss_pred cccCCCCCcCHHHHhcC
Q 017021 353 LRYDPTDRLTAREALRH 369 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~h 369 (379)
|+.||.+||++.+++++
T Consensus 244 l~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 244 MNYDPNQRPFFRAIMRD 260 (262)
T ss_pred cCCChhhCcCHHHHHHh
Confidence 99999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=276.83 Aligned_cols=248 Identities=23% Similarity=0.291 Sum_probs=190.8
Q ss_pred echhhhhhhhccccccceeEEEEEecCC---CceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
.....|.+.++||+|+||.||+|.+..+ ...||+|..... ......+..|+.++..+ .|++++++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~ 77 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-----DHPHIVKLIGVIT 77 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-----CCCchhceeEEEc
Confidence 3455688889999999999999987544 456999998743 23445677788888887 6789999999887
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
. ...++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++.
T Consensus 78 ~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~------------- 142 (270)
T cd05056 78 E-NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS------------- 142 (270)
T ss_pred C-CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEec-------------
Confidence 5 4578999999 899999997654 35899999999999999999999999999999999999944
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 268 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~p 268 (379)
.+.++|+|||.+....... ....++..|+|||.+....++.++||||||+++|++++ |..|
T Consensus 143 --------------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 208 (270)
T cd05056 143 --------------PDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208 (270)
T ss_pred --------------CCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCC
Confidence 4456666776654332221 11123467999999988889999999999999999986 9999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|......+....+.+.... .. ....+..+.++
T Consensus 209 f~~~~~~~~~~~~~~~~~~----------------------~~--------------------------~~~~~~~~~~l 240 (270)
T cd05056 209 FQGVKNNDVIGRIENGERL----------------------PM--------------------------PPNCPPTLYSL 240 (270)
T ss_pred CCCCCHHHHHHHHHcCCcC----------------------CC--------------------------CCCCCHHHHHH
Confidence 9876554443322211100 00 11345789999
Q ss_pred HhhccccCCCCCcCHHHHhcC
Q 017021 349 LQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~h 369 (379)
|.+||..+|++|||+.+++..
T Consensus 241 i~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 241 MTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=276.52 Aligned_cols=241 Identities=22% Similarity=0.293 Sum_probs=183.4
Q ss_pred hccccccceeEEEEEecCCCc--eEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRERKE--MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~--~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|.++.++. .+|+|.++.. ......+..|+.++..+. +|++++++++.+...+..+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc----cCCCeeeEEEEEecCCCceEEEE
Confidence 368999999999999988775 4688888632 233456667888888773 56899999999999999999999
Q ss_pred CC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCC
Q 017021 125 KL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
|+ +++|.+++.... ...+++..+..++.|++.||+|||+.|++||||||+||+++
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~---------- 146 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---------- 146 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc----------
Confidence 99 899999987532 12478899999999999999999999999999999999994
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CC
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 266 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~ 266 (379)
.+..++|+|||++....... .....+..|+|||++....++.++|+|||||++|+|++ |.
T Consensus 147 -----------------~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~ 209 (270)
T cd05047 147 -----------------ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 209 (270)
T ss_pred -----------------CCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 44556667777654221111 11123557999999988889999999999999999997 99
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||...+..+....+.... ... .....+.++.
T Consensus 210 ~pf~~~~~~~~~~~~~~~~----------------------~~~--------------------------~~~~~~~~~~ 241 (270)
T cd05047 210 TPYCGMTCAELYEKLPQGY----------------------RLE--------------------------KPLNCDDEVY 241 (270)
T ss_pred CCccccCHHHHHHHHhCCC----------------------CCC--------------------------CCCcCCHHHH
Confidence 9997654433222211100 000 0012456789
Q ss_pred HHHhhccccCCCCCcCHHHHhc
Q 017021 347 HLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~ 368 (379)
+++.+||+.||.+|||+.++++
T Consensus 242 ~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 242 DLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHcccChhhCCCHHHHHH
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=276.90 Aligned_cols=250 Identities=19% Similarity=0.297 Sum_probs=192.2
Q ss_pred chhhhhhhhccccccceeEEEEEecC-----CCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
+...|++.+.||+|+||.||+|+.+. +.+.||+|.+..... ....+..|+.++.++ .|++++++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~ 77 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-----SHKNVVRLLGLC 77 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-----CCcceeeeEEEE
Confidence 34567888999999999999999754 356799999864332 245677889998888 678999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccc
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYR-------SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 185 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 185 (379)
......++||||+ +++|.+++...... .+++..+..++.|++.||.|||+.|++||||||+||++..+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~---- 153 (275)
T cd05046 78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ---- 153 (275)
T ss_pred CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC----
Confidence 9989999999999 89999999765411 58999999999999999999999999999999999999544
Q ss_pred cCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC----CCcccccCCccchhhhhCCCCCCccchHhHHHHHHH
Q 017021 186 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 261 (379)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~ 261 (379)
+.++++|||.+...... .....++..|+|||.+.+..++.++||||||+++|+
T Consensus 154 -----------------------~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~ 210 (275)
T cd05046 154 -----------------------REVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210 (275)
T ss_pred -----------------------CcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHH
Confidence 44555666655422111 122345678999999988788899999999999999
Q ss_pred HHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc
Q 017021 262 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 262 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (379)
+++ |..||...........+.. +...++ ....
T Consensus 211 l~~~~~~p~~~~~~~~~~~~~~~-----------------------~~~~~~------------------------~~~~ 243 (275)
T cd05046 211 VFTQGELPFYGLSDEEVLNRLQA-----------------------GKLELP------------------------VPEG 243 (275)
T ss_pred HHhCCCCCccccchHHHHHHHHc-----------------------CCcCCC------------------------CCCC
Confidence 998 8889865443332222111 001110 0123
Q ss_pred chhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 341 SAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.+..+.+++.+||+.||.+|||+.|++++
T Consensus 244 ~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 244 CPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 56789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=302.51 Aligned_cols=274 Identities=22% Similarity=0.324 Sum_probs=176.8
Q ss_pred chhhhhhhhccccccceeEEEEEecCC----CceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecce----
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRER----KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW---- 112 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~----~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~---- 112 (379)
....|++.++||+|+||.||+|++..+ +..||+|++...... |......+.+. .+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~------e~~~~e~l~~~--~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV------EIWMNERVRRA--CPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh------HHHHHHHHHhh--chhhHHHHHHhhhcc
Confidence 445788999999999999999999988 999999998632211 11111122111 11111111111
Q ss_pred --eeecceEEEEEeCC-CCCHHHHHHhCCCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCC
Q 017021 113 --FDYRNHICIVFEKL-GSSLYDFLRKNNYR------------------SFPIDLVREIARQLLECIAFMHDLCMIHTDL 171 (379)
Q Consensus 113 --~~~~~~~~lv~e~~-~~sL~~~l~~~~~~------------------~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dl 171 (379)
...+...++|+||+ +++|.+++...... ......+..++.||+.||.|||+.||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 23556799999999 88999998754311 0123346689999999999999999999999
Q ss_pred CCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC----CCcccccCCccchhhhhCCC--
Q 017021 172 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLG-- 245 (379)
Q Consensus 172 kp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-- 245 (379)
||+|||++. ....++|+|||++...... .....+|+.|+|||.+....
T Consensus 282 KP~NILl~~--------------------------~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~ 335 (566)
T PLN03225 282 KPQNIIFSE--------------------------GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQT 335 (566)
T ss_pred CHHHEEEeC--------------------------CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCC
Confidence 999999942 2456888888888643221 23457899999999764321
Q ss_pred --------------------CCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhc
Q 017021 246 --------------------WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR 305 (379)
Q Consensus 246 --------------------~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (379)
++.++|||||||++|+|+++..++. +....+.......+.....+.......
T Consensus 336 ~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~------ 407 (566)
T PLN03225 336 PSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPR------ 407 (566)
T ss_pred CCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccc------
Confidence 3345699999999999998665543 222222222222222222221111100
Q ss_pred cCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 306 RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
..+.... .....+.....+.+||.+||+.||.+|||++|+|+||||.+...
T Consensus 408 --------------------~~~~~~~-~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 408 --------------------ASPDLRR-GFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred --------------------cchhhhh-hhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 0000000 00112234456789999999999999999999999999987653
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=276.79 Aligned_cols=245 Identities=21% Similarity=0.330 Sum_probs=188.5
Q ss_pred hccccccceeEEEEEecCCC------ceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 49 SKMGEGTFGQVLECWDRERK------EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~------~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
+.||+|+||.||+|+++... +.+|+|.+.... .....+.+|+.++..+ .|++++++++++...+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-----NHPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-----CCCCeeeEeeeecCCCCeE
Confidence 36899999999999876544 789999886432 3345667788888877 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNN-----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
++|||+ +++|.+++.... ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~----------- 144 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGY----------- 144 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCC-----------
Confidence 999999 899999997532 124788999999999999999999999999999999999965430
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 268 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~p 268 (379)
+....++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |+.|
T Consensus 145 -----------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 145 -----------DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred -----------CCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 122367777887765332211 12234678999999988889999999999999999998 9999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|...+..+....+.... ... .....+..+.++
T Consensus 214 ~~~~~~~~~~~~~~~~~----------------------~~~--------------------------~~~~~~~~~~~l 245 (269)
T cd05044 214 YPALNNQEVLQHVTAGG----------------------RLQ--------------------------KPENCPDKIYQL 245 (269)
T ss_pred CcccCHHHHHHHHhcCC----------------------ccC--------------------------CcccchHHHHHH
Confidence 97665544333221100 000 012345688999
Q ss_pred HhhccccCCCCCcCHHHHhc
Q 017021 349 LQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~ 368 (379)
|.+||+.+|++||+++++++
T Consensus 246 i~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 246 MTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.82 Aligned_cols=253 Identities=22% Similarity=0.346 Sum_probs=209.7
Q ss_pred eeeeeechhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeE
Q 017021 35 ITYIVFSAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCV 107 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~ 107 (379)
.....+...+.+..+.||+|+||.||+|+-. .....||||.++.. .....++.+|++.+..+ +|+|||
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-----~H~nIV 552 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-----QHPNIV 552 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-----cCCCeE
Confidence 3345566666777899999999999999753 33578999999843 33678899999999999 899999
Q ss_pred EecceeeecceEEEEEeCC-CCCHHHHHHhCC--------CCC----CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCC
Q 017021 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNN--------YRS----FPIDLVREIARQLLECIAFMHDLCMIHTDLKPE 174 (379)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~--------~~~----l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~ 174 (379)
++++.+..++-.|+|+||| .|||.++|.... +.. ++..+.+.++.||+.|+.||-++.++||||-.+
T Consensus 553 rLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATR 632 (774)
T KOG1026|consen 553 RLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATR 632 (774)
T ss_pred EEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhh
Confidence 9999999999999999999 999999997532 112 788999999999999999999999999999999
Q ss_pred cEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcc-----cccCCccchhhhhCCCCCCc
Q 017021 175 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI-----VSTRHYRAPEVILGLGWTYP 249 (379)
Q Consensus 175 Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~ 249 (379)
|+|+ ..+..+||.|||+++......-+. .-..+||+||.+...+|+.+
T Consensus 633 NCLV---------------------------ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte 685 (774)
T KOG1026|consen 633 NCLV---------------------------GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE 685 (774)
T ss_pred hcee---------------------------ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch
Confidence 9999 566778888888887544333222 22468999999999999999
Q ss_pred cchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccch
Q 017021 250 CDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328 (379)
Q Consensus 250 sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (379)
|||||+||++||+++ |+.||.+....|..+.+.+--- +
T Consensus 686 SDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L---------------------------------------- 724 (774)
T KOG1026|consen 686 SDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-L---------------------------------------- 724 (774)
T ss_pred hhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-c----------------------------------------
Confidence 999999999999998 9999999988887766554211 1
Q ss_pred hhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHh
Q 017021 329 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 367 (379)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l 367 (379)
..++.++.++.+|+..||+.+|.+||+++|+-
T Consensus 725 -------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 725 -------SCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred -------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 12245788999999999999999999999973
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=302.54 Aligned_cols=263 Identities=23% Similarity=0.381 Sum_probs=217.2
Q ss_pred eeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 35 ITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
+..++.+.-++.|.+.||.|.+|.||+++.+.+++..|+||+........++..|.+++..+ ++|+|++.+++++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~----~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKY----SHHPNVATFYGAFI 86 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhc----cCCCCcceEEEEEE
Confidence 44566777888999999999999999999999999999999987766677666677776665 68899999999886
Q ss_pred e-----cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCC
Q 017021 115 Y-----RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 188 (379)
Q Consensus 115 ~-----~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~ 188 (379)
. ++.+|+||||| |||..|+++...+..+.+..+..|++.++.||.+||...++|||+|-.|||+
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---------- 156 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---------- 156 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE----------
Confidence 4 46899999999 9999999988656789999999999999999999999999999999999999
Q ss_pred CccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCC-----CCCCccchHhHHHHHH
Q 017021 189 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILV 260 (379)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~ 260 (379)
..++.+||+|||.+...... .++..||+.|||||++... .|+..+|+||||++..
T Consensus 157 -----------------T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaI 219 (953)
T KOG0587|consen 157 -----------------TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAI 219 (953)
T ss_pred -----------------eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceee
Confidence 67778889999988654433 3567899999999998643 3778999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc
Q 017021 261 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 261 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (379)
||..|.+|+-...+.-. +......+|..+ ..++.
T Consensus 220 EladG~PPl~DmHPmra---LF~IpRNPPPkL-------------------------------------------krp~k 253 (953)
T KOG0587|consen 220 EMAEGAPPLCDMHPMRA---LFLIPRNPPPKL-------------------------------------------KRPKK 253 (953)
T ss_pred hhcCCCCCccCcchhhh---hccCCCCCCccc-------------------------------------------cchhh
Confidence 99999999964433221 222222222211 12346
Q ss_pred chhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
++.++.+||..||..|-.+||+..++|.|||+++
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 8889999999999999999999999999999983
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=258.31 Aligned_cols=284 Identities=26% Similarity=0.494 Sum_probs=213.5
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec--ce
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NH 118 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--~~ 118 (379)
..-.|+|.+++|+|.|+.||.|.+..++++++||+++.- ....+.+|+.+++.+ .+++||+.+.+...++ ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL----~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNL----RGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhc----cCCCCeeehhhhhcCccccC
Confidence 345789999999999999999999999999999999843 346778899999998 3679999999999875 46
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
..+++||. ..+...+.. .++...++.++.+++.||.|+|+.||+|||+||.|+|++
T Consensus 110 paLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId------------------ 166 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID------------------ 166 (338)
T ss_pred chhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec------------------
Confidence 78999999 555554432 488889999999999999999999999999999999996
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCC-CCCCc
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL-FQTHE 273 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~p-f~~~~ 273 (379)
.....++|+|||+|-...+.. +..+.+..|-.||.+-. +.|+..-|+|||||++..|+-.+.| |.+.+
T Consensus 167 --------h~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 167 --------HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred --------hhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 355679999999997666654 34567788899999865 5588999999999999999887666 56778
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc-chhHHHHHHhhc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGL 352 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~ 352 (379)
..++...+.+++|.- +.. ..+.++.-. .++ ..+.+-..-.......++..-+.+ .++++.||+.++
T Consensus 239 N~DQLVkIakVLGt~--el~----~Yl~KY~i~----Ldp---~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldkl 305 (338)
T KOG0668|consen 239 NYDQLVKIAKVLGTD--ELY----AYLNKYQID----LDP---QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKL 305 (338)
T ss_pred CHHHHHHHHHHhChH--HHH----HHHHHHccC----CCh---hHhhHhhccccccHHHhCCccccccCChHHHHHHHHH
Confidence 888888888888752 221 112111110 000 000000001111111222222222 348999999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
|..|-.+|+||.|++.||||..
T Consensus 306 LrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 306 LRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HhhccccccchHHHhcCchHHH
Confidence 9999999999999999999964
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=277.72 Aligned_cols=249 Identities=18% Similarity=0.239 Sum_probs=191.4
Q ss_pred echhhhhhhhccccccceeEEEEEecC----CCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRE----RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~----~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
+....|++.+.||+|+||.||+|.+.. ++..||+|++... ......+..|..++..+ .|+|++++++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~ 77 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-----SHQNILPILHVC 77 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEE
Confidence 456678889999999999999999876 3688999998743 23345566788877777 789999999876
Q ss_pred ee-cceEEEEEeCC-CCCHHHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccc
Q 017021 114 DY-RNHICIVFEKL-GSSLYDFLRKNNY------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 185 (379)
Q Consensus 114 ~~-~~~~~lv~e~~-~~sL~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 185 (379)
.. +...+++++|+ +++|.+++..... ..+++..+..++.|++.||+|||+.+++||||||+||++..
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~----- 152 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE----- 152 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcC-----
Confidence 55 57789999999 8999999876421 35889999999999999999999999999999999999944
Q ss_pred cCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHH
Q 017021 186 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 260 (379)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ 260 (379)
+..++|+|||.++...... ....++..|+|||.+.+..++.++|||||||++|
T Consensus 153 ----------------------~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~ 210 (280)
T cd05043 153 ----------------------ELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLW 210 (280)
T ss_pred ----------------------CCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHH
Confidence 4556666666654322211 1123566799999998888999999999999999
Q ss_pred HHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhc
Q 017021 261 ELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339 (379)
Q Consensus 261 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (379)
++++ |+.||...+..+....+..... + .. ..
T Consensus 211 el~~~g~~p~~~~~~~~~~~~~~~~~~-~---------------------~~--------------------------~~ 242 (280)
T cd05043 211 ELMTLGQTPYVEIDPFEMAAYLKDGYR-L---------------------AQ--------------------------PI 242 (280)
T ss_pred HHhcCCCCCcCcCCHHHHHHHHHcCCC-C---------------------CC--------------------------CC
Confidence 9998 9999987655443322211100 0 00 01
Q ss_pred cchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 340 HSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 340 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
..++++.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 243 NCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 24567899999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=289.08 Aligned_cols=191 Identities=27% Similarity=0.383 Sum_probs=162.0
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchh-hHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc-eEEEEEeCC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-HICIVFEKL 126 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~ 126 (379)
..||+|+||.||+|....+ ..||||++...... ..++..|+.++.++ .|+|++++++++.+.+ ..++|+||+
T Consensus 81 ~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-----~H~Nlv~LlGyC~e~~~~~~LVYEym 154 (361)
T KOG1187|consen 81 NLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRL-----RHPNLVKLLGYCLEGGEHRLLVYEYM 154 (361)
T ss_pred cceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcC-----CCcCcccEEEEEecCCceEEEEEEcc
Confidence 6999999999999986554 88999998865444 56699999999999 7899999999999988 599999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 127 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC---MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 127 -~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
.|+|.+.+.......++|.....|+.+++.||+|||... |+||||||+|||+
T Consensus 155 ~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL------------------------ 210 (361)
T KOG1187|consen 155 PNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL------------------------ 210 (361)
T ss_pred CCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE------------------------
Confidence 889999998765326899999999999999999999744 9999999999999
Q ss_pred ccCCCCCCeEEeecCcccccCC-CCCc--c-cccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 203 KRMPKSSAIKVIDFGSTTYERP-DQNY--I-VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~-~~~~--~-~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.+...||+|||+|+.... .... . .||.+|+|||+......+.++||||||+++.||++|+.+.+..
T Consensus 211 ---D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 211 ---DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ---CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 5566677777777743332 2211 1 6899999999998888999999999999999999999888643
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=270.97 Aligned_cols=238 Identities=23% Similarity=0.333 Sum_probs=184.6
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
+.||+|+||.||+|... ++..+|+|.+.... .....+..|+.++..+ .|+|++++++++...+..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQY-----DHPNIVKLIGVCTQRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-----CCCCcCeEEEEEecCCccEEEEECC
Confidence 46899999999999864 57889999986432 2234566788888777 7899999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 127 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 127 -~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
+++|.+++.... ..+++..+..++.|++.||.|+|+.|++||||+|+||+++.+
T Consensus 75 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~------------------------ 129 (250)
T cd05085 75 PGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN------------------------ 129 (250)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC------------------------
Confidence 899999987643 357899999999999999999999999999999999999544
Q ss_pred CCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHHHHH
Q 017021 206 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM 280 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~ 280 (379)
..++|+|||.+....... ....++..|+|||++.+..++.++|+||||+++|++++ |..||...........
T Consensus 130 ---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~ 206 (250)
T cd05085 130 ---NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ 206 (250)
T ss_pred ---CeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 445666666554322111 11233567999999988888999999999999999998 9999976554433322
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+...... . .....+..+.+++.+||+.||++|
T Consensus 207 ~~~~~~~----------------------~--------------------------~~~~~~~~~~~li~~~l~~~p~~R 238 (250)
T cd05085 207 VEKGYRM----------------------S--------------------------CPQKCPDDVYKVMQRCWDYKPENR 238 (250)
T ss_pred HHcCCCC----------------------C--------------------------CCCCCCHHHHHHHHHHcccCcccC
Confidence 2211000 0 011345789999999999999999
Q ss_pred cCHHHHhc
Q 017021 361 LTAREALR 368 (379)
Q Consensus 361 pta~e~l~ 368 (379)
||+.|+++
T Consensus 239 p~~~~l~~ 246 (250)
T cd05085 239 PKFSELQK 246 (250)
T ss_pred CCHHHHHH
Confidence 99999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=273.84 Aligned_cols=248 Identities=20% Similarity=0.367 Sum_probs=190.7
Q ss_pred hhhhhhccccccceeEEEEEecC-CCceEEEEEeeccc-----------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGIK-----------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~-~~~~vAiK~~~~~~-----------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.|++.+.||+|+||.||++.++. +++.+|+|.+.... ........|+.++... ..|+|++.+++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~----~~h~~i~~~~~ 76 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ----LRHPNIVRYYK 76 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc----CCCCCeeeEEe
Confidence 37889999999999999999887 68899999985221 1112233454444332 26799999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccC
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~ 187 (379)
.+..++..+++|||+ +++|.+++... ....+++..++.++.|++.||.|||+ .|++|+||+|+||++
T Consensus 77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~--------- 147 (269)
T cd08528 77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML--------- 147 (269)
T ss_pred eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---------
Confidence 999999999999999 88999988542 22358899999999999999999996 789999999999999
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhC
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g 265 (379)
..++.++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 148 ------------------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g 209 (269)
T cd08528 148 ------------------GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTL 209 (269)
T ss_pred ------------------CCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhC
Confidence 455567778888776543332 234578899999999888899999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
+.||...+.......+......+. .....+..+
T Consensus 210 ~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~l 242 (269)
T cd08528 210 QPPFYSTNMLSLATKIVEAVYEPL-----------------------------------------------PEGMYSEDV 242 (269)
T ss_pred CCcccccCHHHHHHHHhhccCCcC-----------------------------------------------CcccCCHHH
Confidence 999976554333322222111100 001345789
Q ss_pred HHHHhhccccCCCCCcCHHHHhcC
Q 017021 346 THLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.++|++||+.||++||++.|+.++
T Consensus 243 ~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 243 TDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=275.61 Aligned_cols=247 Identities=21% Similarity=0.273 Sum_probs=192.0
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCc----eEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~----~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
+....|++.+.||+|+||.||+|.++.+|+ .+|+|...... .....+.+|+..++.+ .|+|++++++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~ 78 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-----DHPHVVRLLGIC 78 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEE
Confidence 445678899999999999999999876664 58999886443 2335566788888887 779999999988
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
.. ...++++||+ +++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++
T Consensus 79 ~~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~------------- 143 (279)
T cd05057 79 LS-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK------------- 143 (279)
T ss_pred ec-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc-------------
Confidence 77 7899999999 899999997754 2489999999999999999999999999999999999994
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCCCc-----ccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-----IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 266 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~ 266 (379)
.++.++|+|||.+......... ..++..|+|||.+....++.++|+|||||++|++++ |+
T Consensus 144 --------------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~ 209 (279)
T cd05057 144 --------------TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGA 209 (279)
T ss_pred --------------CCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCC
Confidence 4445667777766543322211 123567999999988889999999999999999998 99
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||.+....+....+.... ..+ . ....+..+.
T Consensus 210 ~p~~~~~~~~~~~~~~~~~-~~~---------------------~--------------------------~~~~~~~~~ 241 (279)
T cd05057 210 KPYEGIPAVEIPDLLEKGE-RLP---------------------Q--------------------------PPICTIDVY 241 (279)
T ss_pred CCCCCCCHHHHHHHHhCCC-CCC---------------------C--------------------------CCCCCHHHH
Confidence 9998766544333222211 000 0 012456788
Q ss_pred HHHhhccccCCCCCcCHHHHhc
Q 017021 347 HLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~ 368 (379)
+++.+||..||..|||+.++++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=274.09 Aligned_cols=242 Identities=23% Similarity=0.313 Sum_probs=185.4
Q ss_pred hccccccceeEEEEEecCCC----------ceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 49 SKMGEGTFGQVLECWDRERK----------EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~----------~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
+.||+|+||.||+|.++.++ ..+++|++.........+.+|+.++..+ .|++++.+++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-----SHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-----CCcchhheeeEEec-CC
Confidence 46899999999999998776 4588898775444356667788887777 77999999998877 77
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.++||||+ +++|.+++..... .++...+..++.||+.||+|||+.|++||||||+||+++.++..
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~------------- 140 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLN------------- 140 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccc-------------
Confidence 89999999 8999999987542 58899999999999999999999999999999999999654310
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCC--CCCCccchHhHHHHHHHHHh-CCCCCCCCch
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCT-GEALFQTHEN 274 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~ 274 (379)
......++|+|||.+..... .....++..|+|||++.+. .++.++|+|||||++|+|++ |..||...+.
T Consensus 141 -------~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 141 -------EGYVPFIKLSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred -------cCCceeEEeCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 01223689999998875443 2234567789999998876 68899999999999999999 5777765432
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+...... .....+ ......+.++|.+||.
T Consensus 213 ~~~~~~~~----------------------~~~~~~----------------------------~~~~~~~~~li~~~l~ 242 (259)
T cd05037 213 SEKERFYQ----------------------DQHRLP----------------------------MPDCAELANLINQCWT 242 (259)
T ss_pred hhHHHHHh----------------------cCCCCC----------------------------CCCchHHHHHHHHHhc
Confidence 21111000 000000 0122578899999999
Q ss_pred cCCCCCcCHHHHhc
Q 017021 355 YDPTDRLTAREALR 368 (379)
Q Consensus 355 ~dP~~Rpta~e~l~ 368 (379)
.||++|||+.++++
T Consensus 243 ~~p~~Rpt~~~il~ 256 (259)
T cd05037 243 YDPTKRPSFRAILR 256 (259)
T ss_pred cChhhCCCHHHHHH
Confidence 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=276.19 Aligned_cols=261 Identities=23% Similarity=0.313 Sum_probs=186.1
Q ss_pred chhhhhhhhccccccceeEEEEE----ecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~----~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
....|++.+.||+|+||.||++. +..+++.||+|.+.... .....+..|++++.++ .|+|++++.+++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~ 76 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-----QHDNIVKYKGVCYS 76 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCCeeEEEEEEcc
Confidence 34578899999999999999997 44678899999986433 2334567788888887 78999999887643
Q ss_pred --cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 116 --RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 116 --~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
....++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~----------- 144 (284)
T cd05081 77 AGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE----------- 144 (284)
T ss_pred CCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC-----------
Confidence 35789999999 899999997643 258999999999999999999999999999999999999544
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCCC------cccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
+.++|+|||.+........ ...++..|+|||.+.+..++.++|+|||||++|+|++|.
T Consensus 145 ----------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 208 (284)
T cd05081 145 ----------------NRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYS 208 (284)
T ss_pred ----------------CeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcC
Confidence 4455566655543221111 112334589999998888999999999999999999987
Q ss_pred CCCCCCchHHHHHHHHHHcCCCC--hhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLP--QHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
.|+..... ... +..+... ...... .......+. .. ......+..
T Consensus 209 ~~~~~~~~-~~~----~~~~~~~~~~~~~~~----~~~~~~~~~-~~------------------------~~~~~~~~~ 254 (284)
T cd05081 209 DKSCSPPA-EFM----RMMGNDKQGQMIVYH----LIELLKNNG-RL------------------------PAPPGCPAE 254 (284)
T ss_pred CcCCCcch-hhh----hhcccccccccchHH----HHHHHhcCC-cC------------------------CCCCCCCHH
Confidence 76643221 111 1111100 000000 000000000 00 011235678
Q ss_pred HHHHHhhccccCCCCCcCHHHHhc
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 255 IYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.92 Aligned_cols=250 Identities=30% Similarity=0.436 Sum_probs=199.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
++++-...||.|.||.||.|.+..||+..|+|.++-. .+.-..+.+|..++..+ .|||++++++.-.+...+
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-----nHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-----NHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-----cCccccccCceeecHHHH
Confidence 3445557899999999999999999999999998632 22334455688888888 889999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+|.|||| +|+|.+++...+ ..++.....+..|++.|++|||++|||||||||+||+++.+|
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g---------------- 1371 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG---------------- 1371 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC----------------
Confidence 9999999 999999998754 678888899999999999999999999999999999995554
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhCC---CCCCccchHhHHHHHHHHHhCCCC
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
.+|+.|||.|....+.. ....||+.|||||++.+. +-..++|||||||+..||+||+.|
T Consensus 1372 -----------~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrP 1440 (1509)
T KOG4645|consen 1372 -----------LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRP 1440 (1509)
T ss_pred -----------cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCc
Confidence 45555555554322221 245799999999999764 356889999999999999999999
Q ss_pred CCCC-chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 269 FQTH-ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 269 f~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
|... ++.....++.. |.-| .+| +..+++.+|
T Consensus 1441 W~~~dne~aIMy~V~~--gh~P--------------------q~P--------------------------~~ls~~g~d 1472 (1509)
T KOG4645|consen 1441 WAELDNEWAIMYHVAA--GHKP--------------------QIP--------------------------ERLSSEGRD 1472 (1509)
T ss_pred hhhccchhHHHhHHhc--cCCC--------------------CCc--------------------------hhhhHhHHH
Confidence 9753 33333333322 2211 111 236789999
Q ss_pred HHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 348 LLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
||.+||+.||.+|++|.|+++|.|-+.
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 999999999999999999999999764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=290.05 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=198.7
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCc---e-EEEEEeec----cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKE---M-VAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~---~-vAiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
.-.+..+.++||+|+||.||+|+.+..+. . ||+|..+. ......++++|.+++.++ +|+||++++++
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-----~H~NVVr~yGV 229 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-----NHPNVVRFYGV 229 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-----CCCCEEEEEEE
Confidence 33344566899999999999998876432 3 89999884 245567888899999998 88999999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
.....-+++|||+| ||+|.++|.+... .++..+...++.+.+.||+|||+.+++||||-.+|+|+..
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~----------- 297 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK----------- 297 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC-----------
Confidence 99999999999999 9999999998763 5999999999999999999999999999999999999944
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--C-cccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCC
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--N-YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 267 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~ 267 (379)
+..+||+|||++....... . ...-...|+|||.+....|+.++||||+||++||+++ |..
T Consensus 298 ----------------~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~ 361 (474)
T KOG0194|consen 298 ----------------KGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAE 361 (474)
T ss_pred ----------------CCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCC
Confidence 4446666666655332110 0 1123468999999998899999999999999999998 888
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||.+....+....+.......+. ....+..+..
T Consensus 362 Py~g~~~~~v~~kI~~~~~r~~~-----------------------------------------------~~~~p~~~~~ 394 (474)
T KOG0194|consen 362 PYPGMKNYEVKAKIVKNGYRMPI-----------------------------------------------PSKTPKELAK 394 (474)
T ss_pred CCCCCCHHHHHHHHHhcCccCCC-----------------------------------------------CCCCHHHHHH
Confidence 99998887777666332211110 1134567888
Q ss_pred HHhhccccCCCCCcCHHHHhc
Q 017021 348 LLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~ 368 (379)
++.+|+..||++|||+.++.+
T Consensus 395 ~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 395 VMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHhccCChhhccCHHHHHH
Confidence 999999999999999998863
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=277.08 Aligned_cols=257 Identities=15% Similarity=0.215 Sum_probs=180.4
Q ss_pred eechhhhhhhhccccccceeEEEEEecCC---CceEEEEEeeccchhh-Hh--H------HHHHHHHHHHHhcCCCCCee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGIKKYR-EA--A------MIEIEVLQQLAKHDKGGNRC 106 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~-~~--~------~~e~~~l~~l~~~~~~~~~i 106 (379)
......|+|.+.||+|+||.||+|.+..+ +..+|+|+........ .. . ..++..+..+ ....|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~--~~~~h~~i 85 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI--HNIDHLGI 85 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHh--ccCCCCCC
Confidence 34556799999999999999999998877 6778888754221110 00 0 0111111111 22367788
Q ss_pred EEecceeeecc----eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccc
Q 017021 107 VQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 182 (379)
Q Consensus 107 ~~~~~~~~~~~----~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~ 182 (379)
+.+++...... ..+++++++..++.+.+.... ..++..+..++.|++.||+|||+.+++||||||+||+++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~--- 160 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD--- 160 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---
Confidence 88887655432 457889988778888876643 467888999999999999999999999999999999994
Q ss_pred ccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCC----------CCCcccccCCccchhhhhCCCCCCccch
Q 017021 183 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP----------DQNYIVSTRHYRAPEVILGLGWTYPCDI 252 (379)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~sDv 252 (379)
.+..++|+|||++..... ......||+.|+|||+..+..++.++||
T Consensus 161 ------------------------~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~Di 216 (294)
T PHA02882 161 ------------------------GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDL 216 (294)
T ss_pred ------------------------CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHH
Confidence 445677777777654321 1122468999999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCchHH-HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhH
Q 017021 253 WSVGCILVELCTGEALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 331 (379)
Q Consensus 253 wSlG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (379)
|||||++|+|++|..||....... ....... +..+. +..+...
T Consensus 217 wSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~-------~~~~~--------~~~~~~~--------------------- 260 (294)
T PHA02882 217 ESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC-------DFIKR--------LHEGKIK--------------------- 260 (294)
T ss_pred HHHHHHHHHHHhCCCCCCccccchHHHHHhHH-------HHHHH--------hhhhhhc---------------------
Confidence 999999999999999998763222 1111110 00000 0000000
Q ss_pred HHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 332 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 332 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
....+..+.++++.|++.+|++||+.+++++
T Consensus 261 ------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 261 ------IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1124577999999999999999999999874
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=272.41 Aligned_cols=244 Identities=23% Similarity=0.286 Sum_probs=178.4
Q ss_pred hccccccceeEEEEEec--CCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDR--ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
++||+|+||.||+|... .....+|+|.+.... .....+.+|+..+..+ .|+|++++++.+......++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-----NHPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-----CCCCcceEEEEECCCCceEEEEE
Confidence 36899999999999643 345678999876332 2234556788777766 78999999999999999999999
Q ss_pred CC-CCCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 125 KL-GSSLYDFLRKNNY---RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
|+ +++|.+++..... ...++..+..++.||+.||+|||+.|++||||||+||+++
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~--------------------- 134 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT--------------------- 134 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec---------------------
Confidence 99 8999999976431 2346778899999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhC-------CCCCCccchHhHHHHHHHHHh-CCC
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGCILVELCT-GEA 267 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~~l~~-g~~ 267 (379)
.++.++|+|||.+....... ....++..|+|||+... ..++.++|||||||++|+|++ |..
T Consensus 135 ------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~ 208 (269)
T cd05042 135 ------ADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ 208 (269)
T ss_pred ------CCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCC
Confidence 45566777777664322211 12245677999999743 346789999999999999998 788
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||......+.......... .+.+. + ......+..+.+
T Consensus 209 p~~~~~~~~~~~~~~~~~~----------------------~~~~~--------------~-------~~~~~~~~~~~~ 245 (269)
T cd05042 209 PYPDLSDEQVLKQVVREQD----------------------IKLPK--------------P-------QLDLKYSDRWYE 245 (269)
T ss_pred CCCcCCHHHHHHHHhhccC----------------------ccCCC--------------C-------cccccCCHHHHH
Confidence 8876554443322211110 00000 0 011235567788
Q ss_pred HHhhccccCCCCCcCHHHHhc
Q 017021 348 LLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~ 368 (379)
++..|+ .||++|||++||++
T Consensus 246 ~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 246 VMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHh-cCcccccCHHHHHH
Confidence 999998 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=291.00 Aligned_cols=278 Identities=25% Similarity=0.394 Sum_probs=211.1
Q ss_pred hhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 47 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 47 i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
.++.||-|+||.|.+++...|..+||+|.+.+.+ .+......|.++|+.. +.+.||+++..|.+.+.+|+|
T Consensus 633 kik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-----Dn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 633 KIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-----DNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred EEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-----CCcceEEEEEEeccCCceEEE
Confidence 3478999999999999988999999999997533 2334445688888776 778999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC--CCCCC
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH--TPKDS 199 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~--~~~~~ 199 (379)
|||+ ||++-.+|-+.+ .+++..++.++.++..|+++.|+.|+|||||||+||||+.+|.+|+.||||... |--++
T Consensus 708 MdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999 999999998877 799999999999999999999999999999999999999999999999999742 22222
Q ss_pred cccc---------------cCCCCCCeEEeecCcccccCCC-CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHH
Q 017021 200 SYFK---------------RMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 263 (379)
Q Consensus 200 ~~~~---------------~~~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~ 263 (379)
+++. +.+....+++..+......... ..+.+||+.|+|||++....|+.-+|+||.|||||+|+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 2221 1111111222221111100000 12358999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchh
Q 017021 264 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343 (379)
Q Consensus 264 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (379)
.|..||......++...+...... +..+.. ...+.
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~-------------------------------------l~~~~~--------~~ls~ 900 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNF-------------------------------------LHIPYQ--------GNLSK 900 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhc-------------------------------------cccccc--------cccCH
Confidence 999999877766655444332111 011111 23577
Q ss_pred HHHHHHhhccccCCCCCc---CHHHHhcCCCCCCCCc
Q 017021 344 DLTHLLQGLLRYDPTDRL---TAREALRHPFFTRDHL 377 (379)
Q Consensus 344 ~~~~li~~~L~~dP~~Rp---ta~e~l~hp~f~~~~~ 377 (379)
++.++|.+ |.-+++.|. .++||..||||+...+
T Consensus 901 e~~~li~k-Lc~sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 901 EALDLIQK-LCCSADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred HHHHHHHH-HhcChhhhhcccchhhhhcCccccccch
Confidence 88899887 556788888 5888999999998764
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=270.85 Aligned_cols=244 Identities=20% Similarity=0.243 Sum_probs=178.3
Q ss_pred hccccccceeEEEEEec--CCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDR--ERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.||+|+||.||+|.+. .++..+|+|.++.... ....+.+|+..+.++ .|+|++++++.+.+....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-----QHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEcCCCCcEEEEE
Confidence 36899999999999754 4567899999874332 234566788888887 78999999999999899999999
Q ss_pred CC-CCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 125 KL-GSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
|+ +++|.+++.... ....+...+..++.|++.||.|||+.|++|+||||+||+++.
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~-------------------- 135 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA-------------------- 135 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC--------------------
Confidence 99 899999997532 123566788889999999999999999999999999999954
Q ss_pred ccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCC-------CCCCccchHhHHHHHHHHHh-CCC
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGL-------GWTYPCDIWSVGCILVELCT-GEA 267 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlG~il~~l~~-g~~ 267 (379)
+..++|+|||.+...... .....++..|+|||++.+. .++.++|+|||||++|+|++ |..
T Consensus 136 -------~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~ 208 (269)
T cd05087 136 -------DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQ 208 (269)
T ss_pred -------CCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCC
Confidence 445666666665432211 1123467789999998642 35789999999999999996 999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||......+......... ....+. + ......+..+.+
T Consensus 209 p~~~~~~~~~~~~~~~~~----------------------~~~~~~--------------~-------~~~~~~~~~~~~ 245 (269)
T cd05087 209 PYRHLSDEQVLTYTVREQ----------------------QLKLPK--------------P-------RLKLPLSDRWYE 245 (269)
T ss_pred CCCCCChHHHHHHHhhcc----------------------cCCCCC--------------C-------ccCCCCChHHHH
Confidence 997655433221111100 000000 0 001124567888
Q ss_pred HHhhccccCCCCCcCHHHHhc
Q 017021 348 LLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~ 368 (379)
+++.|+ .+|++|||++|++.
T Consensus 246 l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 246 VMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHHh-cCcccCCCHHHHHH
Confidence 999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=270.29 Aligned_cols=239 Identities=19% Similarity=0.229 Sum_probs=176.5
Q ss_pred hccccccceeEEEEEecC---CCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee-ecceEEEE
Q 017021 49 SKMGEGTFGQVLECWDRE---RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHICIV 122 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~---~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~-~~~~~~lv 122 (379)
+.||+|+||.||+|.+.. .+..||+|.+.... .....+..|..++..+ .|++++.+++++. .++..+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-----SHPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-----CCCCcceEEEEeecCCCCcEEE
Confidence 468999999999998653 34679999985322 2334566677777766 7899999998654 56678999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
+||+ +++|.+++.... ..++...+..++.|++.||+|||+.+++||||||+||+++.+
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-------------------- 134 (262)
T cd05058 76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-------------------- 134 (262)
T ss_pred EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC--------------------
Confidence 9999 899999997654 246777888999999999999999999999999999999544
Q ss_pred cccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCc
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 273 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~ 273 (379)
+.++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+
T Consensus 135 -------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 207 (262)
T cd05058 135 -------FTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207 (262)
T ss_pred -------CcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 445666666554321110 12235668999999988889999999999999999999 566676544
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+... .. ... ....+..+.+++.+||
T Consensus 208 ~~~~~~~~~~~--~~--------------------~~~--------------------------~~~~~~~~~~li~~cl 239 (262)
T cd05058 208 SFDITVYLLQG--RR--------------------LLQ--------------------------PEYCPDPLYEVMLSCW 239 (262)
T ss_pred HHHHHHHHhcC--CC--------------------CCC--------------------------CCcCCHHHHHHHHHHc
Confidence 33322211110 00 000 0123567899999999
Q ss_pred ccCCCCCcCHHHHhc
Q 017021 354 RYDPTDRLTAREALR 368 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~ 368 (379)
+.+|++||++.|+++
T Consensus 240 ~~~p~~Rp~~~~il~ 254 (262)
T cd05058 240 HPKPEMRPTFSELVS 254 (262)
T ss_pred CCChhhCCCHHHHHH
Confidence 999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=274.61 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=192.2
Q ss_pred chhhhhhhhccccccceeEEEEEec----CCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDR----ERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~----~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
....|++.+.||+|+||.||+|... .++..+|+|+++.... ....+..|+..+..+ .|++++++++++.
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-----~~~~i~~~~~~~~ 76 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-----DHENIVKYKGVCE 76 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-----CCCChheEEeeee
Confidence 3456888899999999999999864 3478999999975444 356777888888877 6789999999887
Q ss_pred e--cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 115 Y--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 115 ~--~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
. +...+++|||+ +++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+||++
T Consensus 77 ~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~------------- 142 (284)
T cd05038 77 KPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV------------- 142 (284)
T ss_pred cCCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE-------------
Confidence 7 56899999999 899999997754 258999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCCC------cccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhC
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g 265 (379)
+.+..++|+|||.+........ ...++..|+|||.+.+..++.++|+|||||++|+|++|
T Consensus 143 --------------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg 208 (284)
T cd05038 143 --------------ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY 208 (284)
T ss_pred --------------cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeecc
Confidence 4456677777777654432211 12344569999999888899999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCCh-hHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQ-HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
..|+....... ....++... .....+.... ....... ....++.+
T Consensus 209 ~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~---~~~~~~~--------------------------~~~~~~~~ 254 (284)
T cd05038 209 GDPSQSPPAEF-----LRMIGIAQGQMIVTRLLELL---KEGERLP--------------------------RPPSCPDE 254 (284)
T ss_pred CCCcccccchh-----ccccccccccccHHHHHHHH---HcCCcCC--------------------------CCccCCHH
Confidence 99886532211 001111000 0000000000 0000000 01134567
Q ss_pred HHHHHhhccccCCCCCcCHHHHhc
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 255 VYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=277.03 Aligned_cols=247 Identities=21% Similarity=0.245 Sum_probs=187.4
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCc----eEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~----~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
....|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....+..|+.++..+ .|+|++++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~h~niv~~~~~~~ 79 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-----DHPHLVRLLGVCL 79 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCcccEEEEEc
Confidence 34456788999999999999999887775 57899886432 2223556777777776 7899999999886
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
.. ..+++++|+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~-------------- 143 (303)
T cd05110 80 SP-TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK-------------- 143 (303)
T ss_pred CC-CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec--------------
Confidence 54 467899999 899999987653 3588999999999999999999999999999999999994
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 267 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~ 267 (379)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|++++ |..
T Consensus 144 -------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~ 210 (303)
T cd05110 144 -------------SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 210 (303)
T ss_pred -------------CCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 34456777777665432211 11234678999999988889999999999999999997 899
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||.+....+....+.... .++ . ....+..+.+
T Consensus 211 p~~~~~~~~~~~~~~~~~-~~~---------------------~--------------------------~~~~~~~~~~ 242 (303)
T cd05110 211 PYDGIPTREIPDLLEKGE-RLP---------------------Q--------------------------PPICTIDVYM 242 (303)
T ss_pred CCCCCCHHHHHHHHHCCC-CCC---------------------C--------------------------CCCCCHHHHH
Confidence 997654333222211100 000 0 0123457889
Q ss_pred HHhhccccCCCCCcCHHHHhcC
Q 017021 348 LLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~h 369 (379)
++..||..||++||+++++++.
T Consensus 243 li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 243 VMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=293.03 Aligned_cols=203 Identities=27% Similarity=0.418 Sum_probs=177.9
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeec--cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec----
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---- 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~---- 116 (379)
+.+...+.||+||||.||++++++||+.||+|.++. .....+.+.+|++++.++ .|+|||+++++-++.
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-----nh~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-----NHPNIVKLFDIEETKFLGL 87 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-----CchhhhhhcccCCccccCc
Confidence 555666899999999999999999999999999974 345678889999999999 689999999988754
Q ss_pred --ceEEEEEeCC-CCCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 117 --NHICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 117 --~~~~lv~e~~-~~sL~~~l~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
+...+||||| ||||...+++. +...+++.+++.++..+..||.|||+.||+||||||.||++....
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge---------- 157 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE---------- 157 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC----------
Confidence 3678999999 99999999873 334699999999999999999999999999999999999995432
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
++....||||||.|+....++ .+.+||..|.+||.... ..|+.-+|.|||||++|+.+||..||
T Consensus 158 -------------dgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF 224 (732)
T KOG4250|consen 158 -------------DGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPF 224 (732)
T ss_pred -------------CCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCC
Confidence 577789999999998766665 56789999999999985 77889999999999999999999999
Q ss_pred CCCc
Q 017021 270 QTHE 273 (379)
Q Consensus 270 ~~~~ 273 (379)
....
T Consensus 225 ~p~~ 228 (732)
T KOG4250|consen 225 IPFG 228 (732)
T ss_pred CcCC
Confidence 7643
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=287.64 Aligned_cols=251 Identities=26% Similarity=0.402 Sum_probs=211.5
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeec----cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
...+++..||-||||.|=++........+|+|++++ ..++.+....|..++... ..+.|++++.-|.+.++
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-----~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-----RSDFIVRLYRTFRDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-----CchHHHHHHHHhccchh
Confidence 345677999999999999998766555699999974 244556666788887776 57899999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+|++||-| ||.|..++...+ .+....++.++..+++|++|||++|||.|||||+|.+++.
T Consensus 495 vYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~----------------- 555 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDN----------------- 555 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeecc-----------------
Confidence 99999999 999999998876 6999999999999999999999999999999999999954
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
.+-+||.|||+|+...... -+++||+.|.|||++.+...+.++|.||||+++|||++|++||.+.++.
T Consensus 556 ----------~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm 625 (732)
T KOG0614|consen 556 ----------RGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM 625 (732)
T ss_pred ----------CCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence 4556777888877555444 3468999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
.+...|-+.+.. +. ++...+..+.+||+++-..
T Consensus 626 ktYn~ILkGid~---------------------i~--------------------------~Pr~I~k~a~~Lik~LCr~ 658 (732)
T KOG0614|consen 626 KTYNLILKGIDK---------------------IE--------------------------FPRRITKTATDLIKKLCRD 658 (732)
T ss_pred HHHHHHHhhhhh---------------------hh--------------------------cccccchhHHHHHHHHHhc
Confidence 777666553211 11 1124667899999999999
Q ss_pred CCCCCcC-----HHHHhcCCCCCC
Q 017021 356 DPTDRLT-----AREALRHPFFTR 374 (379)
Q Consensus 356 dP~~Rpt-----a~e~l~hp~f~~ 374 (379)
+|.+|.. +.|+-+|.||..
T Consensus 659 ~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 659 NPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred CcHhhhccccCChHHHHhhhhhhc
Confidence 9999995 999999999975
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=269.96 Aligned_cols=245 Identities=17% Similarity=0.217 Sum_probs=185.0
Q ss_pred hhhhhccccccceeEEEEEec---CCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc-
Q 017021 45 DKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN- 117 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~- 117 (379)
|++.+.||+|+||.||+|.++ .+++.||+|++... ......+..|+.++..+ .|++++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-----DHPNVIKLIGVSLRSRA 75 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-----CCCCcceEEEEEccCCC
Confidence 677899999999999999865 35789999998743 22344566788888877 7799999999875432
Q ss_pred -----eEEEEEeCC-CCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccC
Q 017021 118 -----HICIVFEKL-GSSLYDFLRKNN----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 118 -----~~~lv~e~~-~~sL~~~l~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~ 187 (379)
..+++++|+ +++|.+++.... ...++...+..++.|++.||+|||+.|++||||||+||+++
T Consensus 76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~-------- 147 (273)
T cd05074 76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN-------- 147 (273)
T ss_pred CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc--------
Confidence 357889999 899988875321 12478899999999999999999999999999999999994
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHH
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l 262 (379)
.+..++|+|||.+....... ....++..|++||.+.+..++.++|||||||++|+|
T Consensus 148 -------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el 208 (273)
T cd05074 148 -------------------ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEI 208 (273)
T ss_pred -------------------CCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHH
Confidence 44556677777665432211 122345679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccc
Q 017021 263 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341 (379)
Q Consensus 263 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (379)
++ |..||...+..+....+.... . ... ....
T Consensus 209 ~~~g~~p~~~~~~~~~~~~~~~~~-~---------------------~~~--------------------------~~~~ 240 (273)
T cd05074 209 MTRGQTPYAGVENSEIYNYLIKGN-R---------------------LKQ--------------------------PPDC 240 (273)
T ss_pred hhCCCCCCCCCCHHHHHHHHHcCC-c---------------------CCC--------------------------CCCC
Confidence 98 889997655443332222110 0 000 0124
Q ss_pred hhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 342 AGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 342 ~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+..+.+++.+||+.+|++|||+.+++++
T Consensus 241 ~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 241 LEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5689999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=301.30 Aligned_cols=251 Identities=22% Similarity=0.335 Sum_probs=205.3
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCc-----eEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKE-----MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~-----~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
..++..+-.+.+.||+|+||.||.|....-.. .||+|.++.. ......+++|..++..+ +|+||++++
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-----~HpNiv~li 761 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-----DHPNIVSLI 761 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-----CCcceeeEE
Confidence 34556677788999999999999998764433 3999998743 45567888899999888 889999999
Q ss_pred ceeeecceEEEEEeCC-CCCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccc
Q 017021 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNN-----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 184 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~-~~sL~~~l~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 184 (379)
+.+-+..-.+|++||| ||+|..++.... ...++....+.++.+|++|..||+++++|||||..+|+|+
T Consensus 762 Gv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL------ 835 (1025)
T KOG1095|consen 762 GVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL------ 835 (1025)
T ss_pred EeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee------
Confidence 9999999999999999 999999998751 2358899999999999999999999999999999999999
Q ss_pred ccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcc-----cccCCccchhhhhCCCCCCccchHhHHHHH
Q 017021 185 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI-----VSTRHYRAPEVILGLGWTYPCDIWSVGCIL 259 (379)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~sDvwSlG~il 259 (379)
+....+||+|||+|+......-+. .-...|||||.+....++.++|||||||++
T Consensus 836 ---------------------~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVll 894 (1025)
T KOG1095|consen 836 ---------------------DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLL 894 (1025)
T ss_pred ---------------------cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHH
Confidence 555778888888887333322111 123589999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhh
Q 017021 260 VELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338 (379)
Q Consensus 260 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (379)
||+++ |..||...+..+..... .+.|+++.|.
T Consensus 895 WEifslG~~PY~~~~n~~v~~~~----------------------~~ggRL~~P~------------------------- 927 (1025)
T KOG1095|consen 895 WEIFSLGATPYPSRSNFEVLLDV----------------------LEGGRLDPPS------------------------- 927 (1025)
T ss_pred HHHHhCCCCCCCCcchHHHHHHH----------------------HhCCccCCCC-------------------------
Confidence 99999 99999988876665422 2223333333
Q ss_pred ccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 339 ~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.++..+.++|.+||+.+|++||+...+++
T Consensus 928 -~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 928 -YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 46778999999999999999999999986
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=267.03 Aligned_cols=257 Identities=21% Similarity=0.371 Sum_probs=199.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.-+=+..||.|+||+|++..++.+|+..|+|++... .+...++..|.+...+- .+.++||++++..-.++--|+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks----~~cp~IVkfyGa~F~EGdcWi 140 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKS----SNCPNIVKFYGALFSEGDCWI 140 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhh----cCCcHHHHHhhhhhcCCceee
Confidence 334458999999999999999999999999999753 23445555566554332 367899999999888889999
Q ss_pred EEeCCCCCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 122 VFEKLGSSLYDFLRK---NNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 122 v~e~~~~sL~~~l~~---~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.||+|..||..+-.. -....+++..+-.+....+.||+||- ...|||||+||+|||+
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl------------------- 201 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL------------------- 201 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE-------------------
Confidence 999998887665432 12235889888899999999999997 5789999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC--CCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+..+.+||||||.+......- ..-.|...|+|||.+.. ..|+.+||+||||+++||++||..||.+-+
T Consensus 202 --------dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 202 --------DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred --------ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 566778888888876433221 22368899999999864 358999999999999999999999998754
Q ss_pred hHHHHHHHHHHc-CCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 274 NLEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 274 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+ .+.++.++. |.+|--.. + ...-+++..++.+|.-|
T Consensus 274 s--vfeql~~Vv~gdpp~l~~------------------~-----------------------~~~~~~s~~~~~fintC 310 (361)
T KOG1006|consen 274 S--VFEQLCQVVIGDPPILLF------------------D-----------------------KECVHYSFSMVRFINTC 310 (361)
T ss_pred H--HHHHHHHHHcCCCCeecC------------------c-----------------------ccccccCHHHHHHHHHH
Confidence 4 566666654 44332100 0 00124778999999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
|.+|-+.||..++++++||+..
T Consensus 311 l~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 311 LIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred hhcccccCcchhhhhcCchhhh
Confidence 9999999999999999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=298.49 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=192.7
Q ss_pred hcccccccee-EEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCCC
Q 017021 49 SKMGEGTFGQ-VLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 127 (379)
Q Consensus 49 ~~Lg~G~~g~-V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 127 (379)
+.+|.|+-|+ ||+|. ..|+.||+|++- ......+.+|+..++.- ..|+||+++++.-.++.+.||+.|+|.
T Consensus 515 eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll--~e~~~~A~rEi~lL~eS----D~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGV--YEGREVAVKRLL--EEFFDFAQREIQLLQES----DEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred HHcccCCCCcEEEEEe--eCCceehHHHHh--hHhHHHHHHHHHHHHhc----cCCCceEEEEeeccCCceEEEEehHhh
Confidence 7889999985 59996 457899999985 33345667788877654 478999999999999999999999999
Q ss_pred CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 128 SSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 128 ~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
.+|.+++... ..........+....|++.||++||+.+|+||||||+||||.... +
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~----------------------~ 644 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS----------------------A 644 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC----------------------C
Confidence 9999999884 111122256678899999999999999999999999999995321 1
Q ss_pred CCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHHH
Q 017021 206 PKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 278 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~ 278 (379)
.+...++|.|||+++...... ....||-+|+|||++....-+.++||+||||++|+.++ |+.||...-..+
T Consensus 645 ~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-- 722 (903)
T KOG1027|consen 645 DGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-- 722 (903)
T ss_pred CcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--
Confidence 455778999999988765554 23468999999999998888889999999999999888 599997432211
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..|.. +... +. .+. ..+++ ++.|||.+|+.+||.
T Consensus 723 ~NIl~--~~~~-------------------------------L~------~L~-----~~~d~--eA~dLI~~ml~~dP~ 756 (903)
T KOG1027|consen 723 ANILT--GNYT-------------------------------LV------HLE-----PLPDC--EAKDLISRMLNPDPQ 756 (903)
T ss_pred hhhhc--Cccc-------------------------------ee------eec-----cCchH--HHHHHHHHhcCCCcc
Confidence 11111 0000 00 000 00111 899999999999999
Q ss_pred CCcCHHHHhcCCCCCCCCcC
Q 017021 359 DRLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 359 ~Rpta~e~l~hp~f~~~~~~ 378 (379)
.||+|.+||.||||+..+.|
T Consensus 757 ~RPsa~~VL~HPlFW~~ekr 776 (903)
T KOG1027|consen 757 LRPSATDVLNHPLFWDSEKR 776 (903)
T ss_pred cCCCHHHHhCCCccCChHHH
Confidence 99999999999999987643
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=264.95 Aligned_cols=244 Identities=21% Similarity=0.238 Sum_probs=177.1
Q ss_pred hccccccceeEEEEEecCC--CceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRER--KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~--~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
++||+|+||.||++....+ ...+++|.++... .....+.+|...+..+ .|+|++++++.+......|+|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~iv~~~~~~~~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-----QHPNILQCLGQCVEAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-----CCcchhheEEEecCCCccEEEEe
Confidence 3689999999999975433 3456777765332 2345667777777766 78999999999999999999999
Q ss_pred CC-CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 125 KL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|+ +++|.+++.... ...++...+..++.||+.||+|||+.+++||||||+||+++
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~---------------------- 133 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT---------------------- 133 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc----------------------
Confidence 99 899999997642 22466778889999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeecCcccccCC-----CCCcccccCCccchhhhhC-------CCCCCccchHhHHHHHHHHHh-CCCC
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGCILVELCT-GEAL 268 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~~l~~-g~~p 268 (379)
.++.++|+|||.+..... ......++..|+|||++.. ..++.++|||||||++|+|++ |..|
T Consensus 134 -----~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 208 (268)
T cd05086 134 -----SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208 (268)
T ss_pred -----CCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCC
Confidence 445567777776542111 1123457889999998743 245789999999999999997 5778
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|...+..+....+.+.... ..+. + ......++.+.++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~----------------------~~~~--------------~-------~~~~~~~~~~~~l 245 (268)
T cd05086 209 YSHLSDREVLNHVIKDQQV----------------------KLFK--------------P-------QLELPYSERWYEV 245 (268)
T ss_pred CCCCCHHHHHHHHHhhccc----------------------ccCC--------------C-------ccCCCCcHHHHHH
Confidence 8765554433322211100 0000 0 0011245678889
Q ss_pred HhhccccCCCCCcCHHHHhc
Q 017021 349 LQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~ 368 (379)
+..|| .||++||+++|+++
T Consensus 246 ~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 246 LQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHh-hCcccCCCHHHHHH
Confidence 99999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=277.72 Aligned_cols=335 Identities=25% Similarity=0.357 Sum_probs=229.6
Q ss_pred cceeeeeeeeeechhhhhhhhccccccceeEEEEEecC---CCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCe
Q 017021 29 CNMFNLITYIVFSAFADKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105 (379)
Q Consensus 29 ~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~---~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~ 105 (379)
..+.+..++.++....|+++++||.|.|++||++.+.. .++.||+|.+... .....+..|++.+..+. ++.|
T Consensus 22 ee~~~l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-s~p~ri~~El~~L~~~g----G~~n 96 (418)
T KOG1167|consen 22 EEIEQLRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-SSPSRILNELEMLYRLG----GSDN 96 (418)
T ss_pred hHHHHHHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-cCchHHHHHHHHHHHhc----cchh
Confidence 45566677788888999999999999999999999887 7899999999743 34667888999999984 5578
Q ss_pred eEEecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecc-cc
Q 017021 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS-EY 183 (379)
Q Consensus 106 i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~-~~ 183 (379)
|+.+.+++..++.+.+|+||+ .....++... ++...+..+++.++.||.++|+.||+|||+||.|++++.. +.
T Consensus 97 i~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 97 IIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred hhcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCC
Confidence 999999999999999999999 6777777654 7788999999999999999999999999999999999765 66
Q ss_pred cccCCCccCCCCCCC-----Ccc---cccCC-CCCCeEEeec-------CcccccCCC----CCcccccCCccchhhhhC
Q 017021 184 IKVPDYKSSLHTPKD-----SSY---FKRMP-KSSAIKVIDF-------GSTTYERPD----QNYIVSTRHYRAPEVILG 243 (379)
Q Consensus 184 ~~~~~~~~~~~~~~~-----~~~---~~~~~-~~~~~~l~Df-------g~~~~~~~~----~~~~~gt~~y~aPE~~~~ 243 (379)
..+.|||++...... +.. ..... ....+-.... |.....+.. .....||++|.|||++..
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 678999999621110 000 00001 0101000000 000000011 123579999999999987
Q ss_pred CC-CCCccchHhHHHHHHHHHhCCCCCCC-CchHHHHHHHHHHcCCCChhHHHhhhhhhhh--hhcc-CCCCCCCCCCch
Q 017021 244 LG-WTYPCDIWSVGCILVELCTGEALFQT-HENLEHLAMMERVLGPLPQHMLKRVDRHAEK--YVRR-GRLDWPEGAASR 318 (379)
Q Consensus 244 ~~-~~~~sDvwSlG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~ 318 (379)
.+ .+.+.||||.|+|+..++++..||-. .++.+...++...+|.- ++.+ ....... ..+. .....++.....
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~--~mrk-~A~l~g~~~l~~ksn~~~~~e~~~~f 328 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSA--EMRK-CAALPGRILLWQKSNIPTIPELRVNF 328 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChH--HHHH-HhhcCCceeeeccccccccHHHHhch
Confidence 55 57899999999999999999999754 45556666666666542 2222 1111111 1110 011111111112
Q ss_pred hhhh--hhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 319 ESIK--SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 319 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+.+. .....+..........+..+..+.||+.+||..||.+|.||+++|+||||.+-+
T Consensus 329 ~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 329 ETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred hccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 2221 111111110122233345666899999999999999999999999999998644
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=262.28 Aligned_cols=271 Identities=21% Similarity=0.355 Sum_probs=209.6
Q ss_pred eeeeeeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCee
Q 017021 31 MFNLITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 106 (379)
Q Consensus 31 ~~~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i 106 (379)
|-........+-..|+++++||+|+|+.|.+++.+.|.+.+|+|++++. +..-.....|..+..+. .++|.+
T Consensus 238 m~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~a----sn~pfl 313 (593)
T KOG0695|consen 238 MDGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNNPFL 313 (593)
T ss_pred ccccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhc----cCCCeE
Confidence 3334445556667789999999999999999999999999999999742 22222333344444443 578999
Q ss_pred EEecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccc
Q 017021 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 185 (379)
Q Consensus 107 ~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 185 (379)
+-++..|.++..+++|.||. ||+|--.++++. .++++.++.+..+|+.||.|||++||+.||+|.+|+|+
T Consensus 314 vglhscfqtesrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvll------- 384 (593)
T KOG0695|consen 314 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL------- 384 (593)
T ss_pred EehhhhhcccceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE-------
Confidence 99999999999999999999 999887777765 79999999999999999999999999999999999999
Q ss_pred cCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHH
Q 017021 186 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l 262 (379)
+..+.+||+|+|+++..-.+ .++.+||+.|.|||++.+..|++.+|.|+||++++||
T Consensus 385 --------------------daeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfem 444 (593)
T KOG0695|consen 385 --------------------DAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 444 (593)
T ss_pred --------------------ccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHH
Confidence 77788899999988753333 3567999999999999999999999999999999999
Q ss_pred HhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccch
Q 017021 263 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342 (379)
Q Consensus 263 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (379)
+.|+.||.-.... .|+. ..++++-+.+-...+.+|. ..+
T Consensus 445 magrspfdivgm~------------n~d~---ntedylfqvilekqiripr--------------------------sls 483 (593)
T KOG0695|consen 445 MAGRSPFDIVGMD------------NPDM---NTEDYLFQVILEKQIRIPR--------------------------SLS 483 (593)
T ss_pred HcCCCCcceecCC------------Cccc---chhHHHHHHHhhhcccccc--------------------------eee
Confidence 9999999642110 0000 0111111111122222221 244
Q ss_pred hHHHHHHhhccccCCCCCc------CHHHHhcCCCCCCC
Q 017021 343 GDLTHLLQGLLRYDPTDRL------TAREALRHPFFTRD 375 (379)
Q Consensus 343 ~~~~~li~~~L~~dP~~Rp------ta~e~l~hp~f~~~ 375 (379)
-.+..++..-|.+||.+|. ..+++..||||...
T Consensus 484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 5677788999999999998 47899999999754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=276.75 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=207.9
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
.....++||-|.||.||.+.++.-.-.||||.++.+.-...++++|..++..+ .|+|+|++++.+..+.-+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-----kHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-----cCccHHHHhhhhccCCCeEEEE
Confidence 34456899999999999999999889999999997777778999999999999 8899999999999999999999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
||| .|+|.+++.......++.-.++.++.||..|++||.++++|||||-.+|+|+
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV------------------------ 398 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV------------------------ 398 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc------------------------
Confidence 999 9999999988766678888999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCcccccCCCCCc-ccc---cCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPDQNY-IVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 277 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~~~~-~~g---t~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~ 277 (379)
..+..+|++|||+++....+.-+ ..| .+.|.|||.+....++.++|||+|||+|||++| |..||.+-+....
T Consensus 399 ---gEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV 475 (1157)
T KOG4278|consen 399 ---GENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 475 (1157)
T ss_pred ---cccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH
Confidence 66778888888888766555422 122 457999999999999999999999999999998 9999998766555
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+++.. +++- .+.+++...+|++.||+++|
T Consensus 476 Y~LLEkgy----------------------RM~~--------------------------PeGCPpkVYeLMraCW~WsP 507 (1157)
T KOG4278|consen 476 YGLLEKGY----------------------RMDG--------------------------PEGCPPKVYELMRACWNWSP 507 (1157)
T ss_pred HHHHhccc----------------------cccC--------------------------CCCCCHHHHHHHHHHhcCCc
Confidence 44443321 1111 23578899999999999999
Q ss_pred CCCcCHHHHh
Q 017021 358 TDRLTAREAL 367 (379)
Q Consensus 358 ~~Rpta~e~l 367 (379)
++||+.+|+-
T Consensus 508 sDRPsFaeiH 517 (1157)
T KOG4278|consen 508 SDRPSFAEIH 517 (1157)
T ss_pred ccCccHHHHH
Confidence 9999998874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=266.40 Aligned_cols=258 Identities=23% Similarity=0.266 Sum_probs=191.4
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc----e
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----H 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~----~ 118 (379)
.+.++.+.||+|.||.||+|.++ |+.||||++... .+..+.+|.++.+..+. .|+||+.++..-..++ .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmL---RHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR--DERSWFRETEIYQTVML---RHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEeccc--chhhhhhHHHHHHHHHh---ccchhhhhhhccccCCCceEE
Confidence 34567899999999999999766 688999999743 36778889999999866 7789999888766443 6
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-----c---CCcccCCCCCcEEEecccccccCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-----L---CMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-----~---~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
+|+|++|. .|||.|++... .++.+..+++++.++.||+|||- + .|.|||||..|||++.++
T Consensus 284 LwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~------- 353 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG------- 353 (513)
T ss_pred EEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-------
Confidence 89999999 99999999985 59999999999999999999994 2 399999999999995555
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-------CCcccccCCccchhhhhCCC----CC--CccchHhHH
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLG----WT--YPCDIWSVG 256 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~----~~--~~sDvwSlG 256 (379)
.+.|+|+|+|...... .+..+||.+|||||++.... +. ..+||||||
T Consensus 354 --------------------~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafg 413 (513)
T KOG2052|consen 354 --------------------TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFG 413 (513)
T ss_pred --------------------cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHH
Confidence 4555555555432222 25568999999999997632 22 568999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHH
Q 017021 257 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336 (379)
Q Consensus 257 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (379)
+++||++.+-.-= + - ....+-+.+++.+...+.|.+..++...+.+..+..
T Consensus 414 LVlWEiarRc~~g-g-i---------------------------~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipn 464 (513)
T KOG2052|consen 414 LVLWEIARRCESG-G-I---------------------------VEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPN 464 (513)
T ss_pred HHHHHHHHHhhcC-C-E---------------------------ehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCc
Confidence 9999998642110 0 0 000111223444445556666666666666655555
Q ss_pred hhcc--chhHHHHHHhhccccCCCCCcCHHHH
Q 017021 337 HVDH--SAGDLTHLLQGLLRYDPTDRLTAREA 366 (379)
Q Consensus 337 ~~~~--~~~~~~~li~~~L~~dP~~Rpta~e~ 366 (379)
.|.. .-..+.++++.||..||..|.||=-+
T Consensus 465 rW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 465 RWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred ccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 5543 33568889999999999999987433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=287.12 Aligned_cols=243 Identities=23% Similarity=0.363 Sum_probs=210.0
Q ss_pred hhhhhccccccceeEEEEEecCCC---ceEEEEEeec--cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERK---EMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~---~~vAiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.+|.++||.|.||.|++|+.+..| ..||||.++. .++++..++.|..++.++ +||||+++.+.....+-+
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-----dHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-----DHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-----CCCcEEEEEEEEecCcee
Confidence 358899999999999999988665 6699999984 467788999999999998 899999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
.||+||| .|+|..+|..+.+ .++..++..+++.|+.|++||-+.+++||||-.+|||+
T Consensus 706 MIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV-------------------- 764 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV-------------------- 764 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee--------------------
Confidence 9999999 9999999998874 49999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCCCcc---c-c--cCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYI---V-S--TRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 271 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~---~-g--t~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~ 271 (379)
+.+..+|+.|||+++..+.+.... . | ..+|.|||.+..++++.+|||||+|++|||.++ |..||..
T Consensus 765 -------NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 765 -------NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred -------ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence 566677777777776544433211 1 2 258999999999999999999999999999886 9999998
Q ss_pred CchHHHHHHHHHHcC-CCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 272 HENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
.++.+....+++... |+|- .++..+..|+.
T Consensus 838 mSNQdVIkaIe~gyRLPpPm-------------------------------------------------DCP~aL~qLMl 868 (996)
T KOG0196|consen 838 MSNQDVIKAIEQGYRLPPPM-------------------------------------------------DCPAALYQLML 868 (996)
T ss_pred cchHHHHHHHHhccCCCCCC-------------------------------------------------CCcHHHHHHHH
Confidence 888888888888653 3331 37789999999
Q ss_pred hccccCCCCCcCHHHHhcC
Q 017021 351 GLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~h 369 (379)
.||++|-.+||..+|++++
T Consensus 869 dCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 869 DCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHhhcCCCHHHHHHH
Confidence 9999999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=276.54 Aligned_cols=272 Identities=22% Similarity=0.350 Sum_probs=180.8
Q ss_pred chhhhhhhhccccccceeEEEEEec----------------CCCceEEEEEeeccch-hh--------------HhHHHH
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDR----------------ERKEMVAIKIVRGIKK-YR--------------EAAMIE 89 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~----------------~~~~~vAiK~~~~~~~-~~--------------~~~~~e 89 (379)
....|++.++||+|+||.||+|.+. ..++.||||.+..... .. .....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4557889999999999999999752 3356799999864221 11 122335
Q ss_pred HHHHHHHHhcCCCCCeeEEecceeee--------cceEEEEEeCC-CCCHHHHHHhCCC---------------------
Q 017021 90 IEVLQQLAKHDKGGNRCVQIRNWFDY--------RNHICIVFEKL-GSSLYDFLRKNNY--------------------- 139 (379)
Q Consensus 90 ~~~l~~l~~~~~~~~~i~~~~~~~~~--------~~~~~lv~e~~-~~sL~~~l~~~~~--------------------- 139 (379)
...+.++.+....+.+++.+.+++.. .+..++||||+ +++|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 55666664443334456677766643 35689999999 8999999874311
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCc
Q 017021 140 -RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218 (379)
Q Consensus 140 -~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~ 218 (379)
..+++..+..++.|++.||.|||+.+++||||||+||++ +.+..++|+|||.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---------------------------~~~~~~kL~DFGl 355 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---------------------------TVDGQVKIIDFGA 355 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---------------------------CCCCcEEEEeCcC
Confidence 123566788999999999999999999999999999999 4455678888887
Q ss_pred ccccCCCC----CcccccCCccchhhhhCCC--------------------CC--CccchHhHHHHHHHHHhCCC-CCCC
Q 017021 219 TTYERPDQ----NYIVSTRHYRAPEVILGLG--------------------WT--YPCDIWSVGCILVELCTGEA-LFQT 271 (379)
Q Consensus 219 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~--------------------~~--~~sDvwSlG~il~~l~~g~~-pf~~ 271 (379)
+....... ....+|+.|+|||.+.... ++ .+.|+||+||++|+|+++.. ||..
T Consensus 356 a~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 356 AVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred ccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 75432221 1123478999999875322 12 34799999999999999875 6643
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
...... .+.+ ..... +.+. .......+++ .++..++.++||+.+
T Consensus 436 ~~~f~~--~~~~-~~~~~----~~~r-----~~~~~~~~~~------------------------~~d~~s~~~~dLi~~ 479 (507)
T PLN03224 436 IRLFNT--ELRQ-YDNDL----NRWR-----MYKGQKYDFS------------------------LLDRNKEAGWDLACK 479 (507)
T ss_pred hhhhhh--HHhh-ccchH----HHHH-----hhcccCCCcc------------------------cccccChHHHHHHHH
Confidence 211110 0000 00000 0000 0001111111 234567899999999
Q ss_pred ccccCC---CCCcCHHHHhcCCCCCCC
Q 017021 352 LLRYDP---TDRLTAREALRHPFFTRD 375 (379)
Q Consensus 352 ~L~~dP---~~Rpta~e~l~hp~f~~~ 375 (379)
||..+| .+|+||+|+|+||||..+
T Consensus 480 LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 480 LITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred HhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 999866 689999999999999753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=252.75 Aligned_cols=238 Identities=37% Similarity=0.607 Sum_probs=190.5
Q ss_pred cceeEEEEEecCCCceEEEEEeeccchh--hHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-CCCHH
Q 017021 55 TFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLY 131 (379)
Q Consensus 55 ~~g~V~~~~~~~~~~~vAiK~~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~ 131 (379)
+||.||+|.+..+++.+|+|++...... ...+..|+..++.+ .|++++++.+.+......++++|++ +++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-----KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-----CCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 5899999999989999999999743322 46777788888877 7789999999999999999999999 66999
Q ss_pred HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCe
Q 017021 132 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 211 (379)
Q Consensus 132 ~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (379)
+++.... .++...+..++.+++.++.+||+.+++|+|++|+||++ ..++.+
T Consensus 76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---------------------------~~~~~~ 126 (244)
T smart00220 76 DLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---------------------------DEDGHV 126 (244)
T ss_pred HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---------------------------CCCCcE
Confidence 9997754 38899999999999999999999999999999999999 445667
Q ss_pred EEeecCcccccCCC--CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC-chHHHHHHHHHHcCCC
Q 017021 212 KVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMMERVLGPL 288 (379)
Q Consensus 212 ~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~ 288 (379)
+|+|||.+...... .....++..|++||...+..++.++|+||||++++++++|..||... +.......+.......
T Consensus 127 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~ 206 (244)
T smart00220 127 KLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF 206 (244)
T ss_pred EEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC
Confidence 78888877654442 23456788999999998888899999999999999999999999763 3222222221111111
Q ss_pred ChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 289 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
+. .....+.++.+++.+||..||++||++.++++
T Consensus 207 ~~----------------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 207 PP----------------------------------------------PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cc----------------------------------------------ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00 00014568999999999999999999999999
Q ss_pred CCCC
Q 017021 369 HPFF 372 (379)
Q Consensus 369 hp~f 372 (379)
||||
T Consensus 241 ~~~~ 244 (244)
T smart00220 241 HPFF 244 (244)
T ss_pred CCCC
Confidence 9997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=273.44 Aligned_cols=247 Identities=22% Similarity=0.340 Sum_probs=200.7
Q ss_pred eechhhhhhhhccccccceeEEEEEecCC--C--ceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRER--K--EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~--~--~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
.+.+....+.++||.|-||.||.|..... | --||||..+.+ ....+.++.|..+++.+ +||||+++++.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-----dHphIikLIGv 459 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-----DHPHIIKLIGV 459 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-----CCcchhheeee
Confidence 34445556778999999999999976432 2 34899998753 34467888999999998 88999999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
+.+.. .|||||++ -|.|.++++... ..++......+++||+.||.|||+..++||||-.+|||+
T Consensus 460 ~~e~P-~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV------------- 524 (974)
T KOG4257|consen 460 CVEQP-MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV------------- 524 (974)
T ss_pred eeccc-eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee-------------
Confidence 97664 89999999 899999998765 369999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcc----cccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CC
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI----VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 266 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~----~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~ 266 (379)
.+...+||+|||+++....+.-.. .-...|+|||.++.+.++.+||||.|||++||++. |.
T Consensus 525 --------------sSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGv 590 (974)
T KOG4257|consen 525 --------------SSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGV 590 (974)
T ss_pred --------------cCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcC
Confidence 666778888888888766654221 12458999999999999999999999999999987 99
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||.+....+....+++.. +++.| +.+++.+.
T Consensus 591 kPfqgvkNsDVI~~iEnGe----------------------RlP~P--------------------------~nCPp~LY 622 (974)
T KOG4257|consen 591 KPFQGVKNSDVIGHIENGE----------------------RLPCP--------------------------PNCPPALY 622 (974)
T ss_pred CccccccccceEEEecCCC----------------------CCCCC--------------------------CCCChHHH
Confidence 9998866555443333321 22222 35788999
Q ss_pred HHHhhccccCCCCCcCHHHHh
Q 017021 347 HLLQGLLRYDPTDRLTAREAL 367 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l 367 (379)
.|+.+||++||.+||...++.
T Consensus 623 slmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHhccCcccCCcHHHHH
Confidence 999999999999999988765
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=265.61 Aligned_cols=262 Identities=23% Similarity=0.400 Sum_probs=199.8
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhh--------HhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--------EAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~--------~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
..-...|-++..||+|||+.||+|.|...++.||+|+-..+..|+ ..+.+|..+-..+ +|+.||+++
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-----DHpRIVKlY 533 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-----DHPRIVKLY 533 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-----Ccceeeeee
Confidence 344568999999999999999999999999999999976544443 3344566665555 889999999
Q ss_pred ceee-ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--cCCcccCCCCCcEEEeccccccc
Q 017021 111 NWFD-YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD--LCMIHTDLKPENVLLVSSEYIKV 186 (379)
Q Consensus 111 ~~~~-~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~iiH~dlkp~Nili~~~~~~~~ 186 (379)
++|. +.+.+|-|+||| |.+|.-++..+. .+++.+++.|+.||+.||.||.. ..|||=||||.|||+.+.
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G----- 606 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG----- 606 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC-----
Confidence 9997 456799999999 888877777654 79999999999999999999995 469999999999999542
Q ss_pred CCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCC----------cccccCCccchhhhhC----CCCCCccch
Q 017021 187 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN----------YIVSTRHYRAPEVILG----LGWTYPCDI 252 (379)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~----------~~~gt~~y~aPE~~~~----~~~~~~sDv 252 (379)
...+.+||+|||+++.....+. -..||-.|++||.+.- ...+.++||
T Consensus 607 -------------------tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDV 667 (775)
T KOG1151|consen 607 -------------------TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDV 667 (775)
T ss_pred -------------------cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceee
Confidence 3456677777777776555441 1358899999998743 237899999
Q ss_pred HhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHH
Q 017021 253 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 332 (379)
Q Consensus 253 wSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (379)
||+|||+|..+.|+.||.-.......-+-..++.. ....+|.
T Consensus 668 WSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA-------------------tEVqFP~------------------- 709 (775)
T KOG1151|consen 668 WSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA-------------------TEVQFPP------------------- 709 (775)
T ss_pred EeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc-------------------eeccCCC-------------------
Confidence 99999999999999999753321111110000100 0001111
Q ss_pred HHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 333 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 333 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
-+..++++.+||++||++--++|....|+-.||||--
T Consensus 710 -----KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 710 -----KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred -----CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 1246789999999999999999999999999999865
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=271.36 Aligned_cols=252 Identities=21% Similarity=0.265 Sum_probs=205.2
Q ss_pred eeeeeechhhhhhhhccccccceeEEEEEecCCC---ceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEe
Q 017021 35 ITYIVFSAFADKIHSKMGEGTFGQVLECWDRERK---EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQI 109 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~---~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~ 109 (379)
-..+++.+...++.++||+|.||.|++|.++..+ ..||||.+..... .-..+.+|+.++..+ .|++++++
T Consensus 102 ~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-----~H~hliRL 176 (1039)
T KOG0199|consen 102 DLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-----QHPHLIRL 176 (1039)
T ss_pred CcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-----cCcceeEE
Confidence 3457888999999999999999999999887443 5699999974322 357788999999998 88999999
Q ss_pred cceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCC
Q 017021 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 188 (379)
Q Consensus 110 ~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~ 188 (379)
++..-+ .-..+|||++ .|+|.+.+.+.....|....+..++.||+.|+.||.++++|||||-.+|+++..
T Consensus 177 yGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas-------- 247 (1039)
T KOG0199|consen 177 YGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS-------- 247 (1039)
T ss_pred eeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc--------
Confidence 999987 5678999999 999999998844457889999999999999999999999999999999999944
Q ss_pred CccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcc------cccCCccchhhhhCCCCCCccchHhHHHHHHHH
Q 017021 189 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI------VSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~------~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l 262 (379)
...+||+|||+.+........+ .-...|.|||.+....++.++|||++||+||||
T Consensus 248 -------------------prtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEM 308 (1039)
T KOG0199|consen 248 -------------------PRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEM 308 (1039)
T ss_pred -------------------cceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhh
Confidence 4556666666665444333221 123479999999999999999999999999999
Q ss_pred Hh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccc
Q 017021 263 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341 (379)
Q Consensus 263 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (379)
++ |..||.+.+...+++.+.+.. .+. ..+.+
T Consensus 309 FtyGEePW~G~~g~qIL~~iD~~e----------------------rLp--------------------------RPk~c 340 (1039)
T KOG0199|consen 309 FTYGEEPWVGCRGIQILKNIDAGE----------------------RLP--------------------------RPKYC 340 (1039)
T ss_pred hccCCCCCCCCCHHHHHHhccccc----------------------cCC--------------------------CCCCC
Confidence 98 899999988877776655211 011 11347
Q ss_pred hhHHHHHHhhccccCCCCCcCHHHHh
Q 017021 342 AGDLTHLLQGLLRYDPTDRLTAREAL 367 (379)
Q Consensus 342 ~~~~~~li~~~L~~dP~~Rpta~e~l 367 (379)
+.++.+++..||..+|++|||+..+.
T Consensus 341 sedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHH
Confidence 88999999999999999999998875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=266.57 Aligned_cols=259 Identities=23% Similarity=0.315 Sum_probs=208.1
Q ss_pred eeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeec--cchhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 36 TYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 36 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
....|.+..-.++++||+|-||.|.++.- +.+.+||+|+++. ....+..+.+|+.+|.++ .||||+.+.+.+
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-----khPNIveLvGVC 604 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRL-----KHPNIVELLGVC 604 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhcc-----CCCCeeEEEeee
Confidence 34566777778899999999999999984 4479999999974 344568899999999999 779999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..++-+++++||+ .|+|.+++.++.-..+.-....+++.||+.|++||.+.+++|||+.++|+|+
T Consensus 605 ~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv-------------- 670 (807)
T KOG1094|consen 605 VQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV-------------- 670 (807)
T ss_pred ecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee--------------
Confidence 9999999999999 9999999998743344556777899999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCCCc-----ccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh--C
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-----IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT--G 265 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~--g 265 (379)
+++..+||+|||+++........ .+-...|+|||.+...+++.+||+|+||+++||+++ .
T Consensus 671 -------------~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~ 737 (807)
T KOG1094|consen 671 -------------DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCR 737 (807)
T ss_pred -------------cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHh
Confidence 78888999999998744333322 233579999999999999999999999999999875 7
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
..||....+..........+...+.. ..+. .+.-++..+
T Consensus 738 e~Py~~lt~e~vven~~~~~~~~~~~-------------------------------~~l~----------~P~~cp~~l 776 (807)
T KOG1094|consen 738 EQPYSQLTDEQVVENAGEFFRDQGRQ-------------------------------VVLS----------RPPACPQGL 776 (807)
T ss_pred hCchhhhhHHHHHHhhhhhcCCCCcc-------------------------------eecc----------CCCcCcHHH
Confidence 89998766655544443333222111 0011 122466788
Q ss_pred HHHHhhccccCCCCCcCHHHHhc
Q 017021 346 THLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.++|..||..|-.+|||.+++..
T Consensus 777 yelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 777 YELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHHHhchhhhcCCCHHHHHH
Confidence 89999999999999999999853
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=260.26 Aligned_cols=261 Identities=22% Similarity=0.251 Sum_probs=187.1
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc----
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---- 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~---- 117 (379)
-...++.+.||+|.||.||+|. .+++.||||++.. ...+.+..|.++..... -.|+||+++++.-+-..
T Consensus 209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~---m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE--QEKQSFQNEKNIYSLPG---MKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhh--ccCceeEEEecCH--HHHHHHHhHHHHHhccC---ccchhHHHhhchhccCCcccc
Confidence 3445678999999999999995 5569999999973 34566677777776542 37899999998877544
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---------cCCcccCCCCCcEEEecccccccC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD---------LCMIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---------~~iiH~dlkp~Nili~~~~~~~~~ 187 (379)
.++||++|. .|+|.+++..+. .++....+++..++.||+|||+ ..|+|||||..|||++
T Consensus 282 eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-------- 350 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-------- 350 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc--------
Confidence 799999999 999999999874 9999999999999999999995 3599999999999994
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCC-C----C-CccchHhHH
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLG-W----T-YPCDIWSVG 256 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-~----~-~~sDvwSlG 256 (379)
.+....|+|||+|.+..+.. ...+||.+|||||++.+.. + . .+.||||+|
T Consensus 351 -------------------~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamg 411 (534)
T KOG3653|consen 351 -------------------NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMG 411 (534)
T ss_pred -------------------cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHH
Confidence 55566777777776544432 2368999999999997632 1 1 467999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHH
Q 017021 257 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336 (379)
Q Consensus 257 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (379)
.++||++++-.-++.....+..--.+...|.-| +.+.++.++-..+.+..+..
T Consensus 412 LVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP---------------------------t~e~mq~~VV~kK~RP~~p~ 464 (534)
T KOG3653|consen 412 LVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP---------------------------TLEEMQELVVRKKQRPKIPD 464 (534)
T ss_pred HHHHHHHhhcccccCCCCCcccCchhHHhcCCC---------------------------CHHHHHHHHHhhccCCCChh
Confidence 999999997655532111111111122223222 22223332222222222222
Q ss_pred hhc--cchhHHHHHHhhccccCCCCCcCHHHH
Q 017021 337 HVD--HSAGDLTHLLQGLLRYDPTDRLTAREA 366 (379)
Q Consensus 337 ~~~--~~~~~~~~li~~~L~~dP~~Rpta~e~ 366 (379)
.|. ....-+++.+..||+.||+.|.||.-+
T Consensus 465 ~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 465 AWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred hhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 222 234568999999999999999998644
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.07 Aligned_cols=185 Identities=19% Similarity=0.267 Sum_probs=151.1
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
++..+.||+|+||.||+|+++.++..||+|+++..... ...|+..+.++ .|+||+++++++.+++..|+|||
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l-----~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKL-----QHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhC-----CCCCcceEEEEEEcCCCCEEEEe
Confidence 45567899999999999999999999999998643221 22356667766 78999999999999999999999
Q ss_pred CC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 125 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH---DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 125 ~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
|+ +++|.+++.. +++.....++.|++.||+||| +.+++|||+||+||+++..
T Consensus 764 y~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~------------------- 819 (968)
T PLN00113 764 YIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK------------------- 819 (968)
T ss_pred CCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-------------------
Confidence 99 9999999953 788999999999999999999 6699999999999999543
Q ss_pred ccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
...++. ++........ ....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 820 --------~~~~~~-~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 820 --------DEPHLR-LSLPGLLCTD-TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred --------CceEEE-eccccccccC-CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 333332 3333222111 223678999999999988899999999999999999999999853
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=223.20 Aligned_cols=201 Identities=23% Similarity=0.434 Sum_probs=160.0
Q ss_pred hhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 47 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 47 i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
-...||+|++|.|=+.++..+|...|+|.+... .+...+.+.|+.+..+- ...|.++.+++..-....+++.||
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~----~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRT----VDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccC----CCCCeEEEeehhhhccccEEEeHH
Confidence 457899999999999999999999999998732 23334444555554332 367999999999888899999999
Q ss_pred CCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 125 KLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 125 ~~~~sL~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
.+..||..+-.. ..+..+++..+-+++..+++||.|||+ ..++|||+||+|||+
T Consensus 126 ~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI----------------------- 182 (282)
T KOG0984|consen 126 LMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI----------------------- 182 (282)
T ss_pred HhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE-----------------------
Confidence 999998877654 233478999999999999999999995 579999999999999
Q ss_pred cccCCCCCCeEEeecCcccccCCCC-Cc-ccccCCccchhhhhC----CCCCCccchHhHHHHHHHHHhCCCCCCCC-ch
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ-NY-IVSTRHYRAPEVILG----LGWTYPCDIWSVGCILVELCTGEALFQTH-EN 274 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~-~~-~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~~l~~g~~pf~~~-~~ 274 (379)
+..+.+|+||||.+......- .+ -.|...|+|||.+.. ..|+.+|||||||+++.||++++.||..- ++
T Consensus 183 ----n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 183 ----NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred ----ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 566678888888776544332 12 368889999999853 36999999999999999999999999763 34
Q ss_pred HHHH
Q 017021 275 LEHL 278 (379)
Q Consensus 275 ~~~~ 278 (379)
.+++
T Consensus 259 F~qL 262 (282)
T KOG0984|consen 259 FQQL 262 (282)
T ss_pred HHHH
Confidence 4433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=256.56 Aligned_cols=199 Identities=27% Similarity=0.443 Sum_probs=173.4
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhH---------HHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA---------MIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~---------~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
....|...+++|.|+||.|++|.+++....|+||-+.+..-....+ -.|+++|.++..+ .|+||+++++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~--sH~NIlKlLd 636 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH--SHENILKLLD 636 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc--Cccchhhhhh
Confidence 3345788899999999999999999999999999987542222222 2499999999664 5799999999
Q ss_pred eeeecceEEEEEeCC--CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCC
Q 017021 112 WFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~--~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
+|++++++||+||.. |.+|.+++..+. .+++..+..++.|++.|+++||++||+|||||-+|+++
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv----------- 703 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV----------- 703 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEE-----------
Confidence 999999999999998 789999999886 79999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccC-CCCCcccccCCccchhhhhCCCC-CCccchHhHHHHHHHHHhCCC
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER-PDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~~l~~g~~ 267 (379)
++++.++|+|||.+.... .+-..+.||..|.|||++.+.+| +.+.|||+||+++|.++....
T Consensus 704 ----------------d~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 704 ----------------DSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred ----------------ecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 788899999999886433 33356789999999999999887 588899999999999999999
Q ss_pred CCC
Q 017021 268 LFQ 270 (379)
Q Consensus 268 pf~ 270 (379)
||+
T Consensus 768 pyy 770 (772)
T KOG1152|consen 768 PYY 770 (772)
T ss_pred CCc
Confidence 886
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=259.58 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=198.6
Q ss_pred eeeechhhhhhhhccccccceeEEEEEec----C---CCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeE
Q 017021 37 YIVFSAFADKIHSKMGEGTFGQVLECWDR----E---RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCV 107 (379)
Q Consensus 37 ~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~----~---~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~ 107 (379)
...+....-++.+.||+|+||.|++|.-. . ....||+|..+.. ......+..|+.++..+. .|+|++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g----~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG----KHPNIV 365 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc----CCcchh
Confidence 34555555577789999999999999743 1 1456999998742 345677788999998883 578999
Q ss_pred EecceeeecceEEEEEeCC-CCCHHHHHHhCC------------C--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Q 017021 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNN------------Y--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLK 172 (379)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~------------~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlk 172 (379)
.+.+.+...+.+++|+||+ .|+|.+++.... . ..++......++.||+.|++||++.+++||||-
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLA 445 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLA 445 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhh
Confidence 9999999999999999999 999999998754 0 138899999999999999999999999999999
Q ss_pred CCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcc----cc--cCCccchhhhhCCCC
Q 017021 173 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI----VS--TRHYRAPEVILGLGW 246 (379)
Q Consensus 173 p~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~----~g--t~~y~aPE~~~~~~~ 246 (379)
.+|||+ ..+..+||+|||+|+......... .| ...|+|||.+....|
T Consensus 446 aRNVLi---------------------------~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f 498 (609)
T KOG0200|consen 446 ARNVLI---------------------------TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF 498 (609)
T ss_pred hhhEEe---------------------------cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc
Confidence 999999 667788999999988544443221 11 235999999999999
Q ss_pred CCccchHhHHHHHHHHHh-CCCCCCCCc-hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhh
Q 017021 247 TYPCDIWSVGCILVELCT-GEALFQTHE-NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 324 (379)
Q Consensus 247 ~~~sDvwSlG~il~~l~~-g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (379)
+.+|||||+|+++||+++ |..||.+.. ..+....+.+. .++..|
T Consensus 499 t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G----------------------~r~~~P------------ 544 (609)
T KOG0200|consen 499 TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEG----------------------NRMEQP------------ 544 (609)
T ss_pred cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcC----------------------CCCCCC------------
Confidence 999999999999999998 899997633 22222211111 112222
Q ss_pred ccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHh
Q 017021 325 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 367 (379)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l 367 (379)
..++.++.++++.||+.+|++||+..|+.
T Consensus 545 --------------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 545 --------------EHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred --------------CCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 35678899999999999999999999886
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=260.98 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=203.3
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchh-hHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+...|.++.++|+|.||.||+|+|+.++++.|+|+++..... .....+|+-++.. +.|+||+.+++.+-.....
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~d-----c~h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRD-----CRHPNIVAYFGSYLRRDKL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeec-----CCCcChHHHHhhhhhhcCc
Confidence 345688889999999999999999999999999999854322 2233345444433 4889999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|++|||| ||+|.++-.-.+ ++++.++...+.+.++||+|||++|=+|||||-.||++
T Consensus 88 wicMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanill-------------------- 145 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL-------------------- 145 (829)
T ss_pred EEEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceee--------------------
Confidence 9999999 889998876655 79999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhh---CCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
...+.++++|||.+...... ...+.||+.|+|||+.. ...|...+|+|++|++..|+..-++|.-..
T Consensus 146 -------td~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl 218 (829)
T KOG0576|consen 146 -------TDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL 218 (829)
T ss_pred -------cccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc
Confidence 56677888888877654433 34568999999999863 446889999999999999998877775332
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
.........-+ -++-|.. + +-...+++.+.+|++.+
T Consensus 219 hpmr~l~LmTk-S~~qpp~--------------------------------------l-----kDk~kws~~fh~fvK~a 254 (829)
T KOG0576|consen 219 HPMRALFLMTK-SGFQPPT--------------------------------------L-----KDKTKWSEFFHNFVKGA 254 (829)
T ss_pred chHHHHHHhhc-cCCCCCc--------------------------------------c-----cCCccchHHHHHHHHHH
Confidence 22221111111 1111110 0 01135788999999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCCCCcCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTRDHLRR 379 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~~~~~~ 379 (379)
|..||.+||||+-+|.|||+....-||
T Consensus 255 ltknpKkRptaeklL~h~fvs~~l~~r 281 (829)
T KOG0576|consen 255 LTKNPKKRPTAEKLLQHPFVSQTLSRR 281 (829)
T ss_pred hcCCCccCCChhhheeceeeccchhhH
Confidence 999999999999999999998775543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=279.19 Aligned_cols=200 Identities=19% Similarity=0.227 Sum_probs=154.0
Q ss_pred ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 117 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 117 ~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..++.++|+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+...+.+|+.|||++....
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred chhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 4578889999999999997643 468999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCC-------------------CCcccccCCccchhhhhCCCCCCccchHhHHH
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-------------------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 257 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ 257 (379)
. +.+..++++|||.++..... .....||+.|+|||++.+..++.++|||||||
T Consensus 132 ~--------~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGv 203 (793)
T PLN00181 132 S--------DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGV 203 (793)
T ss_pred c--------cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHH
Confidence 2 34567999999998642210 01135788999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHh
Q 017021 258 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 337 (379)
Q Consensus 258 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (379)
++|||++|..|+.... .....+... ..|...
T Consensus 204 iL~ELl~~~~~~~~~~--~~~~~~~~~--~~~~~~--------------------------------------------- 234 (793)
T PLN00181 204 LLFELFCPVSSREEKS--RTMSSLRHR--VLPPQI--------------------------------------------- 234 (793)
T ss_pred HHHHHhhCCCchhhHH--HHHHHHHHh--hcChhh---------------------------------------------
Confidence 9999999888764311 111111110 001000
Q ss_pred hccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 338 ~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
........+++.+||+.||.+||++.|+++||||.+.
T Consensus 235 -~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 235 -LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred -hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 0012345678899999999999999999999999763
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=254.01 Aligned_cols=254 Identities=21% Similarity=0.246 Sum_probs=205.3
Q ss_pred eeeeeeeechhhhhhhhccccccceeEEEEEecCCC----ceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCee
Q 017021 33 NLITYIVFSAFADKIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRC 106 (379)
Q Consensus 33 ~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~----~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i 106 (379)
|...+..+..-.-+..++||+|+||+||+|.+.-.| -+||+|++... .+...+++.|.-++..+ +|+|+
T Consensus 686 n~~~lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-----dHpnl 760 (1177)
T KOG1025|consen 686 NLALLRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-----DHPNL 760 (1177)
T ss_pred hhhheeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-----CCchH
Confidence 567777777888888899999999999999775444 56899998643 33467788899888888 88999
Q ss_pred EEecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccc
Q 017021 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 185 (379)
Q Consensus 107 ~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 185 (379)
+++++++.... +-||++|+ .|+|.++++.+. ..+.....+.|..||++|+.|||.++++||||-.+|||+
T Consensus 761 ~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV------- 831 (1177)
T KOG1025|consen 761 LRLLGVCMLST-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV------- 831 (1177)
T ss_pred HHHhhhcccch-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee-------
Confidence 99999987665 88999999 999999998865 468889999999999999999999999999999999999
Q ss_pred cCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcc-----cccCCccchhhhhCCCCCCccchHhHHHHHH
Q 017021 186 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI-----VSTRHYRAPEVILGLGWTYPCDIWSVGCILV 260 (379)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ 260 (379)
.+...+|++|||+++...+..... .-.+.|+|-|.+....|+.++||||+||++|
T Consensus 832 --------------------ksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiW 891 (1177)
T KOG1025|consen 832 --------------------KSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIW 891 (1177)
T ss_pred --------------------cCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHH
Confidence 566778888888887655554221 1235799999999999999999999999999
Q ss_pred HHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhc
Q 017021 261 ELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339 (379)
Q Consensus 261 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (379)
|++| |..|+.+....++-..++... +++. ++
T Consensus 892 ElmTFGa~Py~gi~~~eI~dlle~ge----------------------RLsq--------------------------Pp 923 (1177)
T KOG1025|consen 892 ELMTFGAKPYDGIPAEEIPDLLEKGE----------------------RLSQ--------------------------PP 923 (1177)
T ss_pred HHHhcCCCccCCCCHHHhhHHHhccc----------------------cCCC--------------------------CC
Confidence 9999 999998876655443332211 1111 12
Q ss_pred cchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 340 HSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 340 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.++-++.-++.+||..|++.||+++++.+
T Consensus 924 iCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 924 ICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred CccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 46677888999999999999999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-29 Score=214.96 Aligned_cols=208 Identities=39% Similarity=0.618 Sum_probs=177.4
Q ss_pred cccccceeEEEEEecCCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-C
Q 017021 51 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 127 (379)
Q Consensus 51 Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 127 (379)
||+|++|.||++.+..+++.+++|++..... ....+.+|+..+..+ .+++++.+++++......++++|++ +
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-----NHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-----CCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 6899999999999988899999999985433 246777888888888 5588999999999989999999999 6
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCC
Q 017021 128 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 207 (379)
Q Consensus 128 ~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (379)
++|.+++.... ..++...+..++.+++.+|.+||+.|++|+|++|.||++.. .
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~--------------------------~ 128 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS--------------------------D 128 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC--------------------------C
Confidence 99999998752 25889999999999999999999999999999999999943 1
Q ss_pred CCCeEEeecCcccccCCC---CCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHH
Q 017021 208 SSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283 (379)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~ 283 (379)
...++|+|||.+...... .....+...|.+||..... .++.++|+|++|++++++
T Consensus 129 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------- 187 (215)
T cd00180 129 NGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------- 187 (215)
T ss_pred CCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------
Confidence 567888888877654443 2334577889999999876 788999999999999998
Q ss_pred HcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCH
Q 017021 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 363 (379)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta 363 (379)
..+.+++.+||+.||++||++
T Consensus 188 -----------------------------------------------------------~~~~~~l~~~l~~~p~~R~~~ 208 (215)
T cd00180 188 -----------------------------------------------------------PELKDLIRKMLQKDPEKRPSA 208 (215)
T ss_pred -----------------------------------------------------------HHHHHHHHHHhhCCcccCcCH
Confidence 046679999999999999999
Q ss_pred HHHhcCC
Q 017021 364 REALRHP 370 (379)
Q Consensus 364 ~e~l~hp 370 (379)
+++++|+
T Consensus 209 ~~l~~~~ 215 (215)
T cd00180 209 KEILEHL 215 (215)
T ss_pred HHHhhCC
Confidence 9999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=220.51 Aligned_cols=198 Identities=25% Similarity=0.335 Sum_probs=163.4
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEE-ecceeeecceEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ-IRNWFDYRNHICI 121 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~-~~~~~~~~~~~~l 121 (379)
-.|.|.+.||+|.||.+-+++++.++..+|+|.+.........+.+|...-..+ ..|.||+. +...|++.+..++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~L----s~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFL----SPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceee----ccchhhhHHHHHHhhcCceEEE
Confidence 468899999999999999999999999999999987666667777777665555 34445544 4557888899999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
++||+ .|+|.+-+...+ +.+.....++.|+++|+.|+|+.+++|||||.+|||+..
T Consensus 100 ~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~-------------------- 156 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD-------------------- 156 (378)
T ss_pred eeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec--------------------
Confidence 99999 899998887755 889999999999999999999999999999999999954
Q ss_pred ccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCC---C--CCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL---G--WTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~---~--~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
.....+||||||.++..+..-...-.+..|.+||..... . ..+.+|+|.||+++|.+++|..||+..
T Consensus 157 -----~df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 157 -----ADFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred -----CCccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 334589999999998766554444456678899986432 2 457889999999999999999999853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=210.42 Aligned_cols=194 Identities=36% Similarity=0.594 Sum_probs=164.6
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
|.+.+.||.|++|.||++.+..+++.+|+|.+..... ....+..|+..+..+ .+++++++++++......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~i~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-----KHPNIVKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-----CCCChhhheeeeecCCceEEE
Confidence 5667899999999999999998899999999975432 356667788888777 668899999999988999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
+|++ +++|.+++..... .+++..+..++.+++.+|.+||+.+++|+|++|.||++
T Consensus 76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v----------------------- 131 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL----------------------- 131 (225)
T ss_pred EeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-----------------------
Confidence 9999 6799999987641 17899999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhh-hCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVI-LGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+....++|+|||.+....... ....++..|++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus 132 ----~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 132 ----GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 444677888888776544332 445678889999998 666788899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=201.83 Aligned_cols=168 Identities=23% Similarity=0.275 Sum_probs=122.7
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCC
Q 017021 128 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 207 (379)
Q Consensus 128 ~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (379)
|+|.+++...+ ..+++..++.++.|++.||.|||+.+ ||+||+++ .
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---------------------------~ 46 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---------------------------W 46 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---------------------------C
Confidence 68999998643 36999999999999999999999998 99999994 4
Q ss_pred CCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH-HHHHHHHHcC
Q 017021 208 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE-HLAMMERVLG 286 (379)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~ 286 (379)
++.+++ ||.+....... ..||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+.....
T Consensus 47 ~~~~~~--fG~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 122 (176)
T smart00750 47 DGLLKL--DGSVAFKTPEQ--SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP 122 (176)
T ss_pred ccceee--ccceEeecccc--CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc
Confidence 445555 66665433322 258899999999999999999999999999999999999996543211 1111111111
Q ss_pred CCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccch--hHHHHHHhhccccCCCCCcCHH
Q 017021 287 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA--GDLTHLLQGLLRYDPTDRLTAR 364 (379)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpta~ 364 (379)
+... .. .+. ....+ ..+.++|.+||+.||.+|||+.
T Consensus 123 ~~~~----------------------~~------------~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~ 160 (176)
T smart00750 123 ADDP----------------------RD------------RSN--------LESVSAARSFADFMRVCASRLPQRREAAN 160 (176)
T ss_pred cCCc----------------------cc------------ccc--------HHHHHhhhhHHHHHHHHHhcccccccCHH
Confidence 0000 00 000 00122 3689999999999999999999
Q ss_pred HHhcCCCCCCC
Q 017021 365 EALRHPFFTRD 375 (379)
Q Consensus 365 e~l~hp~f~~~ 375 (379)
|+++|+|+...
T Consensus 161 ~ll~~~~~~~~ 171 (176)
T smart00750 161 HYLAHCRALFA 171 (176)
T ss_pred HHHHHHHHHHH
Confidence 99999987643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=208.26 Aligned_cols=248 Identities=17% Similarity=0.203 Sum_probs=182.0
Q ss_pred chhhhhhhhccccccceeEEEEEecCC-----CceEEEEEeeccchh--hHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
..-++++...+-+|.||.||.|.+++. .+.|-+|.++..... ...+..|--.+.- -.|+|+..+.+..
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~-----~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYG-----ASHPNLLSVLGVS 356 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhc-----CcCCCccceeEEE
Confidence 344466778889999999999966543 345677777643322 1222223222222 2688888887765
Q ss_pred e-ecceEEEEEeCC-CCCHHHHHHh------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccc
Q 017021 114 D-YRNHICIVFEKL-GSSLYDFLRK------NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 185 (379)
Q Consensus 114 ~-~~~~~~lv~e~~-~~sL~~~l~~------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 185 (379)
. +....++++.+. -++|..++.. .+-+.++-.+...++.|++.|++|||+.|++|.||-.+|++|+
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId------ 430 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID------ 430 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh------
Confidence 4 456788999999 7899999982 2223467788999999999999999999999999999999994
Q ss_pred cCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccc-----cCCccchhhhhCCCCCCccchHhHHHHHH
Q 017021 186 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS-----TRHYRAPEVILGLGWTYPCDIWSVGCILV 260 (379)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~g-----t~~y~aPE~~~~~~~~~~sDvwSlG~il~ 260 (379)
....+||+|-.+++..-+..-...| ...|++||.+.+..|+.++|+||||+++|
T Consensus 431 ---------------------d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllW 489 (563)
T KOG1024|consen 431 ---------------------DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLW 489 (563)
T ss_pred ---------------------hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHH
Confidence 4466777777666543333222222 45799999999999999999999999999
Q ss_pred HHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhc
Q 017021 261 ELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339 (379)
Q Consensus 261 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (379)
||+| |+.|+..-++.|....+.... ++.. +-
T Consensus 490 ELmtlg~~PyaeIDPfEm~~ylkdGy----------------------RlaQ--------------------------P~ 521 (563)
T KOG1024|consen 490 ELMTLGKLPYAEIDPFEMEHYLKDGY----------------------RLAQ--------------------------PF 521 (563)
T ss_pred HHHhcCCCCccccCHHHHHHHHhccc----------------------eecC--------------------------CC
Confidence 9998 999998877776554443321 0111 12
Q ss_pred cchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 340 HSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 340 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.+++++..++-.||..+|++||+.+|+..
T Consensus 522 NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 522 NCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 47789999999999999999999999863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-25 Score=207.12 Aligned_cols=208 Identities=28% Similarity=0.351 Sum_probs=169.0
Q ss_pred hhhhhhccccccceeEEEEEecCCC-ceEEEEEeeccch-hhHhHHHHHHHHHHHHhcCCCCCeeEEeccee-eecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~-~~vAiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~-~~~~~~~ 120 (379)
.|++.++||+|+||.||.|.+..++ ..+|+|....... .......|..++..+.. .....+++.+++.. ..+.+.|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~-~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK-KNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh-hcCCCCCCEEEEeccCCCceeE
Confidence 7999999999999999999988774 6789998875322 12256678999888865 22335677777777 5788999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||+.+|.||.++........++...+..++.|++.+|++||+.|++||||||+|+++....
T Consensus 98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~------------------ 159 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSS------------------ 159 (322)
T ss_pred EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCC------------------
Confidence 99999999999998776656899999999999999999999999999999999999995421
Q ss_pred ccccCCCCCCeEEeecCccc--cc----C----CC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCC
Q 017021 201 YFKRMPKSSAIKVIDFGSTT--YE----R----PD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~--~~----~----~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
......+.|+|||+++ .. + +. .....||..|+++....+...+.+.|+||++.++.++..|..
T Consensus 160 ----~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~L 235 (322)
T KOG1164|consen 160 ----RSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSL 235 (322)
T ss_pred ----CcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCC
Confidence 0122568999999987 31 1 11 123459999999999999999999999999999999999999
Q ss_pred CCCCCch
Q 017021 268 LFQTHEN 274 (379)
Q Consensus 268 pf~~~~~ 274 (379)
||.....
T Consensus 236 PW~~~~~ 242 (322)
T KOG1164|consen 236 PWEALEM 242 (322)
T ss_pred CCccccc
Confidence 9976553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=190.83 Aligned_cols=210 Identities=27% Similarity=0.350 Sum_probs=171.3
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.+-.|+++++||+|+||.+|+|.....|+.||||.-++..... ....|..+...+. +...++.+..+..+..+-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-qL~yEskvY~iL~----~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-QLLYESKVYRILQ----GGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-chhHHHHHHHHhc----cCCCCchhhhhccccccce
Confidence 3446899999999999999999999999999999987544433 3445777777663 3355777888888889999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||++.|.||.+++.-.. +.++...++-++-|++.-++|+|.++++||||||+|+|+.-.
T Consensus 88 lVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlg------------------- 147 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLG------------------- 147 (341)
T ss_pred eeeeccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccc-------------------
Confidence 999999999999987543 469999999999999999999999999999999999999532
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC----------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
--...+.|+|||+|+..-... ....||..|.+-....+...+...|+=|+|.++...-.|..||+
T Consensus 148 -----rh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 148 -----RHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred -----cccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 234568999999987533322 34579999999988888888899999999999999999999999
Q ss_pred CCchHHHHHH
Q 017021 271 THENLEHLAM 280 (379)
Q Consensus 271 ~~~~~~~~~~ 280 (379)
+-......+.
T Consensus 223 glka~tk~QK 232 (341)
T KOG1163|consen 223 GLKAATKKQK 232 (341)
T ss_pred ccchhhHHHH
Confidence 8655444433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=195.93 Aligned_cols=212 Identities=24% Similarity=0.311 Sum_probs=178.6
Q ss_pred eeeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 34 LITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 34 ~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.-..+...+..|+|.++||+|+||.++.|++-.++++||||.-.. ....-....|-.....+. +.+.|+..+.+-
T Consensus 19 s~s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~----g~~GIP~vYYFG 93 (449)
T KOG1165|consen 19 SSSGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLG----GTEGIPQVYYFG 93 (449)
T ss_pred CCCCceEecccceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHc----CCCCCCceeeec
Confidence 334456778899999999999999999999999999999998653 222344555777777774 446688888888
Q ss_pred eecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 114 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 114 ~~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
.++.+-.+|+|+.|.||.|+++-.+ +.++...+.-++.|++.-++++|++.+|.|||||+|+||...+.
T Consensus 94 qeG~~NiLVidLLGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~---------- 162 (449)
T KOG1165|consen 94 QEGKYNILVIDLLGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGT---------- 162 (449)
T ss_pred cccchhhhhhhhhCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCC----------
Confidence 8888999999999999999998866 57999999999999999999999999999999999999976542
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC----------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHH
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 263 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~ 263 (379)
.....+.++|||+|+....+. .+..||..||+-....+...+.+.|+=|||.+++..+
T Consensus 163 ------------k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFL 230 (449)
T KOG1165|consen 163 ------------KDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 230 (449)
T ss_pred ------------CCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhc
Confidence 455779999999997543332 3357999999999999999999999999999999999
Q ss_pred hCCCCCCCCc
Q 017021 264 TGEALFQTHE 273 (379)
Q Consensus 264 ~g~~pf~~~~ 273 (379)
.|..||++-.
T Consensus 231 RGsLPWQGLK 240 (449)
T KOG1165|consen 231 RGSLPWQGLK 240 (449)
T ss_pred cCCCcccccc
Confidence 9999998743
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-26 Score=224.24 Aligned_cols=257 Identities=21% Similarity=0.272 Sum_probs=179.2
Q ss_pred hhhhccccccceeEEEEEecCCCceEEEEEee----ccchhhHh---HHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREA---AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 46 ~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~----~~~~~~~~---~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
+-...+|.|++|.|+.+......+.++.|.+. ........ ...|.-+-.. ..|++++.....+.+...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~-----l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSS-----LSHPNIIETLDIVQEIDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccc-----ccCCchhhhHHHHhhccc
Confidence 34578999999988888877666666666543 11111111 1112222222 266777666666555544
Q ss_pred EEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 119 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 119 ~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
..-.||||.++|..++...+ .++...+..++.|++.||+|+|+.|+.|||+||+|+++
T Consensus 396 ~~~~mE~~~~Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~-------------------- 453 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV-------------------- 453 (601)
T ss_pred chhhhhcccHHHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE--------------------
Confidence 44449999449999998763 58899999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhCCCCC-CccchHhHHHHHHHHHhCCCCCC
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
..++.+||||||.+....... ...+|+..|+|||.+.+..|+ ...||||.|+++..|.+|+.||.
T Consensus 454 -------~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 454 -------TENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred -------ecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence 455567777777765433322 335789999999999999988 67899999999999999999998
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
.....+.... .+....+... .......+...+..-+.+|.
T Consensus 527 ~a~~~~~~~~------------------------~~~~~~~~~~----------------~~~~~~~~~~lp~~~~~~~~ 566 (601)
T KOG0590|consen 527 VAKKSDNSFK------------------------TNNYSDQRNI----------------FEGPNRLLSLLPRETRIIIY 566 (601)
T ss_pred cccccccchh------------------------hhcccccccc----------------ccChHHHHHhchhhHHHHHH
Confidence 6543222110 0000000000 00001112234567788999
Q ss_pred hccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 351 GLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+||++||.+|.|++++++.+||++..
T Consensus 567 ~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 567 RMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHccCChhheecHHHHhhChHhhhcc
Confidence 99999999999999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-22 Score=185.34 Aligned_cols=255 Identities=32% Similarity=0.488 Sum_probs=190.8
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHHHHHHhcCCCCC-eeEEecceeeecceE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGN-RCVQIRNWFDYRNHI 119 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~-~i~~~~~~~~~~~~~ 119 (379)
|.+.+.||.|+||.||++.+. ..+|+|.+..... ....+.+|...+..+ .++ +++.+.+.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-----NHPPNIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-----cCCcceeeEEEEEecCCEE
Confidence 677889999999999999987 7789999874322 355667777777777 434 699999999878888
Q ss_pred EEEEeCC-CCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+++++++ ++++.+++..... ..++......++.|++.++.++|+.|++|||+||+||++.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~------------------ 135 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD------------------ 135 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec------------------
Confidence 9999999 8899877766431 1588999999999999999999999999999999999994
Q ss_pred CCcccccCCCCC-CeEEeecCcccccCCC---------CCcccccCCccchhhhhC---CCCCCccchHhHHHHHHHHHh
Q 017021 198 DSSYFKRMPKSS-AIKVIDFGSTTYERPD---------QNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 198 ~~~~~~~~~~~~-~~~l~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~~l~~ 264 (379)
... .++++|||.+...... .....||..|.+||.+.+ ..++...|+||+|++++++++
T Consensus 136 ---------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~ 206 (384)
T COG0515 136 ---------RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT 206 (384)
T ss_pred ---------CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHh
Confidence 334 5788888877533322 245679999999999987 567899999999999999999
Q ss_pred CCCCCCCCch----HHHHHHHHHHcCC-CChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhc
Q 017021 265 GEALFQTHEN----LEHLAMMERVLGP-LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339 (379)
Q Consensus 265 g~~pf~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (379)
|..||..... ......+.....+ .... ... ... .
T Consensus 207 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~------~~~----------------~ 245 (384)
T COG0515 207 GLPPFEGEKNSSATSQTLKIILELPTPSLASP-------------------LSP------SNP----------------E 245 (384)
T ss_pred CCCCCCCCCccccHHHHHHHHHhcCCcccccc-------------------cCc------ccc----------------c
Confidence 9999876553 2222222111111 0000 000 000 1
Q ss_pred cchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 340 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.....+.+++..|+..+|..|.++.+...+++....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 246 LISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred hhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 123578899999999999999999998888766543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=192.08 Aligned_cols=167 Identities=20% Similarity=0.181 Sum_probs=120.8
Q ss_pred hhhhhhhhccccccceeEEEEEecC-CCceEEEEEeecc------chhhHhHHHHHHHHHHHHhcCCCCCeeE-Eeccee
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCV-QIRNWF 113 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~-~~~~vAiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~i~-~~~~~~ 113 (379)
.-.|++.+.||+|+||+||+|.++. +++.||+|++... ......+.+|+.++..+ .|++++ .+++.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-----~h~~iv~~l~~~- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-----RGIGVVPQLLAT- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-----cCCCCCcEEEEc-
Confidence 3458899999999999999998876 6788899986522 22345678899999998 455554 34432
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCC-CCCcEEEecccccccCCCcc
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL-KPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dl-kp~Nili~~~~~~~~~~~~~ 191 (379)
+..|+||||+ |++|.. +.. .. ...++.+++.||.|||+.||+|||| ||+|||+
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv------------- 145 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM------------- 145 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE-------------
Confidence 4579999999 888862 211 11 1457889999999999999999999 9999999
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----------CcccccCCccchhhhhCCC------CCCccchH
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----------NYIVSTRHYRAPEVILGLG------WTYPCDIW 253 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~------~~~~sDvw 253 (379)
+.++.++|+|||+|....... ....+++.|.|||.+.... .+..+|-|
T Consensus 146 --------------~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 146 --------------GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred --------------cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 344567788888776443332 2245778899999885322 33446666
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=183.06 Aligned_cols=273 Identities=19% Similarity=0.235 Sum_probs=183.3
Q ss_pred HHHHhhcceeecceeeeeeeeeechhhhhhhhccccccceeEEEEEecCCCc----------------------------
Q 017021 18 LTMALRNRVLMCNMFNLITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKE---------------------------- 69 (379)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~---------------------------- 69 (379)
+....++..+.+..-+... ..|....|+|.+.||+|....||.|..+..|.
T Consensus 133 ~~~~~ks~~whDei~~r~d-skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~ 211 (598)
T KOG4158|consen 133 YNEDLKSTEWHDEIPNRID-SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVS 211 (598)
T ss_pred HHHhhhccCCCCcCcchhh-cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCccc
Confidence 3344555556554444333 55667779999999999999999887654211
Q ss_pred -------eEEEEEeecc--chhhHhHH----HHHHHH-----------------HHHHhcCCCCCeeEEecceeee----
Q 017021 70 -------MVAIKIVRGI--KKYREAAM----IEIEVL-----------------QQLAKHDKGGNRCVQIRNWFDY---- 115 (379)
Q Consensus 70 -------~vAiK~~~~~--~~~~~~~~----~e~~~l-----------------~~l~~~~~~~~~i~~~~~~~~~---- 115 (379)
+.|||.+-+- +.....+. +|+-=. ..-..+...||||+++..+|.+
T Consensus 212 ~p~~~aFPLAiKmMfN~~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~ 291 (598)
T KOG4158|consen 212 KPAQKAFPLAIKMMFNFEHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKV 291 (598)
T ss_pred CccccccchHHHHhcccccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhcc
Confidence 1344443210 11111111 111000 0001122368999999998864
Q ss_pred -----------------------cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Q 017021 116 -----------------------RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLK 172 (379)
Q Consensus 116 -----------------------~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlk 172 (379)
+...|+||..+..+|.+++..+. .+......++.|+++|+.|||++|+.|||+|
T Consensus 292 lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlK 368 (598)
T KOG4158|consen 292 LPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLK 368 (598)
T ss_pred CCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhccc
Confidence 24689999999999999998865 6777888899999999999999999999999
Q ss_pred CCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCC---------CCCcccccCCccchhhhhC
Q 017021 173 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP---------DQNYIVSTRHYRAPEVILG 243 (379)
Q Consensus 173 p~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~---------~~~~~~gt~~y~aPE~~~~ 243 (379)
.+||++--+. +.-..+.++|||.+.-... ......|....+|||+...
T Consensus 369 SDNiL~Eldd-----------------------D~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 369 SDNILLELDD-----------------------DEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred ccceEEEecC-----------------------CCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999994321 4556688889986642222 1122356778899999875
Q ss_pred CC-----C-CCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCc
Q 017021 244 LG-----W-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS 317 (379)
Q Consensus 244 ~~-----~-~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (379)
.+ . -.++|.|+.|.+.||+++...||++....... .+.|.+.+.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~---------------------~r~Yqe~qL--------- 475 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD---------------------TRTYQESQL--------- 475 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec---------------------hhhhhhhhC---------
Confidence 43 2 26889999999999999999999874331110 011111111
Q ss_pred hhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHH
Q 017021 318 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 364 (379)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 364 (379)
..+.+.+++.+++++..+|+.||++|++++
T Consensus 476 -----------------Palp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 476 -----------------PALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred -----------------CCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 122345778999999999999999999843
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-24 Score=203.48 Aligned_cols=238 Identities=25% Similarity=0.390 Sum_probs=187.4
Q ss_pred ccccccceeEEEEEe---cCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 50 KMGEGTFGQVLECWD---RERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 50 ~Lg~G~~g~V~~~~~---~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
.+|+|+||.|++++- ...|..+|+|..+... ........|..++... ..++.++.++..++.+...++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~----~~~~f~v~lhyafqt~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFV----HNTPFLVKLHYAFQTDGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhc----cCCCceeeeeeeeccccchhHhh
Confidence 379999999998753 3447889999986321 1111333456666555 35788999999999999999999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
++. |+.|...+.... .+.+.....+...++.+++++|+.|+++||+|++||++
T Consensus 77 d~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill------------------------ 130 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL------------------------ 130 (612)
T ss_pred hhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee------------------------
Confidence 999 888877766654 57788888999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~ 282 (379)
+..+.+++.|||.++..-..... +||..|+|||++. .....+|.||+|+++++|++|..||.+ +...+|.
T Consensus 131 ---d~~Ghi~~tdfglske~v~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il 200 (612)
T KOG0603|consen 131 ---LLEGHIKLTDFGLSKEAVKEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL 200 (612)
T ss_pred ---cccCccccCCchhhhHhHhhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh
Confidence 55666777777776643333322 8999999999998 567889999999999999999999987 5555555
Q ss_pred HHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcC
Q 017021 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 362 (379)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 362 (379)
+.....|.+ .+..+++++..++..+|..|..
T Consensus 201 ~~~~~~p~~-------------------------------------------------l~~~a~~~~~~l~~r~p~nrLg 231 (612)
T KOG0603|consen 201 KAELEMPRE-------------------------------------------------LSAEARSLFRQLFKRNPENRLG 231 (612)
T ss_pred hhccCCchh-------------------------------------------------hhHHHHHHHHHHHhhCHHHHhc
Confidence 544444443 4567899999999999999995
Q ss_pred -----HHHHhcCCCCCCCC
Q 017021 363 -----AREALRHPFFTRDH 376 (379)
Q Consensus 363 -----a~e~l~hp~f~~~~ 376 (379)
+.|+++|+||+..+
T Consensus 232 ~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 232 AGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred cCcchhHHHhccchheeee
Confidence 58999999998754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-23 Score=183.58 Aligned_cols=202 Identities=20% Similarity=0.281 Sum_probs=125.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhh----HhHHHHHHHHHHHHhcCC-----CCCe------eEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDK-----GGNR------CVQ 108 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~----~~~~~e~~~l~~l~~~~~-----~~~~------i~~ 108 (379)
+.+..+.||.|+++.||.+++.+||+.+|+|++....... +.+.+|......+....+ .+-. +++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455689999999999999999999999999986332211 122222211111000000 0001 222
Q ss_pred ecc---eeeec---c-----eEEEEEeCCCCCHHHHHHh---CCC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Q 017021 109 IRN---WFDYR---N-----HICIVFEKLGSSLYDFLRK---NNY--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLK 172 (379)
Q Consensus 109 ~~~---~~~~~---~-----~~~lv~e~~~~sL~~~l~~---~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlk 172 (379)
+.+ +++.. . ..+++|+-+.+||.+++.. ... ..+.......+..|+++.+++||+.|++|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 221 11111 1 3478899999999988653 111 123344556777899999999999999999999
Q ss_pred CCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCC--------
Q 017021 173 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-------- 244 (379)
Q Consensus 173 p~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-------- 244 (379)
|+|+++ +.++.+.|.||+.....+........+..|.+||.....
T Consensus 173 ~~nfll---------------------------~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~ 225 (288)
T PF14531_consen 173 PENFLL---------------------------DQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNA 225 (288)
T ss_dssp GGGEEE----------------------------TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEE
T ss_pred eeeEEE---------------------------cCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccc
Confidence 999999 566777888887665544433222345678999977432
Q ss_pred CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 245 GWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 245 ~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
.++.+.|.|+||+++|.|+++..||...
T Consensus 226 ~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 226 PYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp EE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred eeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 4788999999999999999999999754
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=208.40 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=175.6
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccc-h-hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-K-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~-~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
+...+-||++.|=.|.+|++.+ | .|++|++-+.+ . .-..+.+++.-.+.. ...+||++.+......++..|+|
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~---l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIKFA---LMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred eeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHHHH---hhcCCcccchHHHHHhhHHHHHH
Confidence 4455899999999999998765 3 39999985432 1 112222222222211 12679999999998899999999
Q ss_pred EeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC--CCCCCCc
Q 017021 123 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL--HTPKDSS 200 (379)
Q Consensus 123 ~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~--~~~~~~~ 200 (379)
=+|...+|.|.+.-.. -+...+...|+.||+.||..+|..||+|||||.+|||+..=..+.+.||...+ +.|.+.-
T Consensus 100 RqyvkhnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHhhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9999999999998765 47788999999999999999999999999999999999887788888887442 2222111
Q ss_pred ccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCC----------C-CCCccchHhHHHHHHHHHh-CCCC
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL----------G-WTYPCDIWSVGCILVELCT-GEAL 268 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlG~il~~l~~-g~~p 268 (379)
+||+.-..... .-.+|+|||.+... + .+++-||||+||+++||++ |.+|
T Consensus 178 -------------adf~fFFDTSr------RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~Pl 238 (1431)
T KOG1240|consen 178 -------------ADFTFFFDTSR------RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPL 238 (1431)
T ss_pred -------------ccceEEEecCC------ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCc
Confidence 24443221111 12379999998541 2 6688899999999999987 8888
Q ss_pred CCCCchHHHHHHHHHHc---CCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 269 FQTHENLEHLAMMERVL---GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
|.-.. +..+. ...++..+ +. .....+
T Consensus 239 F~LSQ-------L~aYr~~~~~~~e~~L-----------------------------e~---------------Ied~~~ 267 (1431)
T KOG1240|consen 239 FTLSQ-------LLAYRSGNADDPEQLL-----------------------------EK---------------IEDVSL 267 (1431)
T ss_pred ccHHH-------HHhHhccCccCHHHHH-----------------------------Hh---------------CcCccH
Confidence 85211 11111 11111111 11 123468
Q ss_pred HHHHhhccccCCCCCcCHHHHhcC
Q 017021 346 THLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+++|..|++.||++|.+|++.|+-
T Consensus 268 Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 268 RNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHHHccCchhccCHHHHHHh
Confidence 889999999999999999999964
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-23 Score=204.75 Aligned_cols=238 Identities=25% Similarity=0.358 Sum_probs=165.8
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.-.+..++.|..|+||.||.++++.|.+.+|+|+ +++....+. ++.. .+..+.
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilRn------ilt~--------------------a~npfv 134 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILRN------ILTF--------------------AGNPFV 134 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhhc------cccc--------------------cCCcce
Confidence 3445566889999999999999999999999954 322110000 1111 112222
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
| |+=...+...+ .++.. ++.+++|+|+-||+|||+||+|.+|..-|.+|+.|||++..-...-..
T Consensus 135 v-----gDc~tllk~~g--~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 135 V-----GDCATLLKNIG--PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred e-----chhhhhcccCC--CCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 2 44444444433 23332 277899999999999999999999988888888888877432221111
Q ss_pred cccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~ 281 (379)
. ...+.++- .++.+. ....+||+.|.|||++..+.|+.++|+|++|+|+|+.+-|..||.+....+.+.++
T Consensus 200 n---l~eg~I~k----~t~Ef~--dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v 270 (1205)
T KOG0606|consen 200 N---LKEGHIEK----DTHEFQ--DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 270 (1205)
T ss_pred h---hhhcchHH----HHHHhh--hccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh
Confidence 0 01111110 111111 12348999999999999999999999999999999999999999999888888776
Q ss_pred HHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCc
Q 017021 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 361 (379)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 361 (379)
.......|+. .+...++++++|.++|+.+|..|.
T Consensus 271 isd~i~wpE~----------------------------------------------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 271 ISDDIEWPEE----------------------------------------------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhcccccc----------------------------------------------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 6655544432 124668999999999999999997
Q ss_pred ---CHHHHhcCCCCCCCC
Q 017021 362 ---TAREALRHPFFTRDH 376 (379)
Q Consensus 362 ---ta~e~l~hp~f~~~~ 376 (379)
.+-++-+|+||..=.
T Consensus 305 gt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 305 GTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred ccchhhhhhhccceeecc
Confidence 688899999998643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=201.95 Aligned_cols=209 Identities=22% Similarity=0.303 Sum_probs=168.4
Q ss_pred eeeeeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 32 FNLITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 32 ~~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.+...-+...+..|.|.+.||+|+||+||.|.... |++||||+-+....|...+. .+++.+|. ..--+-++.+..
T Consensus 687 l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~--~q~~~RLk--~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 687 LNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC--LQVMERLK--PQMLPSIMHISS 761 (974)
T ss_pred cCccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh--HHHHHhhc--hhhhcchHHHHH
Confidence 44566778888899999999999999999999776 99999999887666654443 44444553 112244666667
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
.+...+..++|++|. .|+|.++++.. +.+++..+..++.|++..+++||.++||||||||+|+|+.....
T Consensus 762 a~~~~~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~------- 832 (974)
T KOG1166|consen 762 AHVFQNASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREIC------- 832 (974)
T ss_pred HHccCCcceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccC-------
Confidence 777788889999999 99999999843 47999999999999999999999999999999999999964321
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhC
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g 265 (379)
.......++|||||.+....... ....+|..+-|+|...|++++..+|.|.|+.++|.|+-|
T Consensus 833 -------------~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG 899 (974)
T KOG1166|consen 833 -------------ADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFG 899 (974)
T ss_pred -------------CCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHH
Confidence 01336779999999886533332 335688999999999999999999999999999999988
Q ss_pred CC
Q 017021 266 EA 267 (379)
Q Consensus 266 ~~ 267 (379)
++
T Consensus 900 ~y 901 (974)
T KOG1166|consen 900 KY 901 (974)
T ss_pred HH
Confidence 64
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=161.70 Aligned_cols=137 Identities=19% Similarity=0.203 Sum_probs=101.7
Q ss_pred hhccccccceeEEEEEecCCCceEEEEEeeccch---h------------------------hHhHHHHHHHHHHHHhcC
Q 017021 48 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---Y------------------------REAAMIEIEVLQQLAKHD 100 (379)
Q Consensus 48 ~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~------------------------~~~~~~e~~~l~~l~~~~ 100 (379)
...||+|++|.||+|.+. +|+.||+|+++.... . ......|...+..+.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 478999999999999987 899999999974311 0 012234888888886533
Q ss_pred CCCCeeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCCcccCCCCCcEEE
Q 017021 101 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM-HDLCMIHTDLKPENVLL 178 (379)
Q Consensus 101 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~L-H~~~iiH~dlkp~Nili 178 (379)
...|.+.. ... .++||||+ |+++....... ..++...+..++.|++.+|.++ |+.||+||||||+||++
T Consensus 81 v~~p~~~~------~~~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPIL------LKS-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEE------ecC-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 22333221 112 38999999 55555443332 2588999999999999999999 79999999999999999
Q ss_pred ecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCccccc
Q 017021 179 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222 (379)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~ 222 (379)
+ ++.++|+|||.|...
T Consensus 152 ~----------------------------~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H----------------------------DGKLYIIDVSQSVEH 167 (190)
T ss_pred E----------------------------CCcEEEEEccccccC
Confidence 3 246899999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=167.16 Aligned_cols=168 Identities=13% Similarity=0.142 Sum_probs=121.1
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHh----------HHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----------AMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~----------~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
...|++.+.||.|+||.||++.+ ++..+|+|++......... +.+|+..+.++.+ +++....+
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~-----~GI~~~~d 102 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRS-----EGLASLND 102 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHH-----CCCCcceE
Confidence 56789999999999999999765 4668999999633221111 4567778888844 45555555
Q ss_pred eeee--------cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccc
Q 017021 112 WFDY--------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 182 (379)
Q Consensus 112 ~~~~--------~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~ 182 (379)
++.. .+..+++|||+ |.+|.++.. +++ ....+++.+|..+|..|++|||+||+||++.
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~--- 169 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS--- 169 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---
Confidence 5432 34689999999 788987731 333 2355899999999999999999999999993
Q ss_pred ccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHH
Q 017021 183 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l 262 (379)
.++ ++|+|||......... ....+.....+..++|+||||+++...
T Consensus 170 ------------------------~~g-i~liDfg~~~~~~e~~---------a~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 170 ------------------------KNG-LRIIDLSGKRCTAQRK---------AKDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred ------------------------CCC-EEEEECCCcccccchh---------hHHHHHHHhHhcccccccceeEeehHH
Confidence 344 8999999775432211 112244556677899999999997654
Q ss_pred H
Q 017021 263 C 263 (379)
Q Consensus 263 ~ 263 (379)
.
T Consensus 216 ~ 216 (232)
T PRK10359 216 K 216 (232)
T ss_pred H
Confidence 4
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.4e-20 Score=158.36 Aligned_cols=138 Identities=17% Similarity=0.123 Sum_probs=100.7
Q ss_pred hhhccccccceeEEEEEecCCCceEEEEEeeccchh---------------------------hHhHHHHHHHHHHHHhc
Q 017021 47 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY---------------------------REAAMIEIEVLQQLAKH 99 (379)
Q Consensus 47 i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~---------------------------~~~~~~e~~~l~~l~~~ 99 (379)
|.+.||+|++|.||+|.+. +|+.||+|+++..... ......|...+.++.+.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999998743110 11123577888887553
Q ss_pred CCCCCeeEEecceeeecceEEEEEeCC-CCCHHHH-HHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcE
Q 017021 100 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF-LRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENV 176 (379)
Q Consensus 100 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~-l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Ni 176 (379)
....|. .+.. . ..|+||||+ |+++... +.. . .++...+..++.|++.+|.++|+ .|++||||||+||
T Consensus 80 ~i~~p~---~~~~--~--~~~lVmE~~~g~~~~~~~l~~-~--~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NI 149 (190)
T cd05145 80 GVPVPE---PILL--K--KNVLVMEFIGDDGSPAPRLKD-V--PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNI 149 (190)
T ss_pred CCCCce---EEEe--c--CCEEEEEEecCCCchhhhhhh-c--cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhE
Confidence 322222 2211 1 248999999 5544333 333 2 47888999999999999999999 9999999999999
Q ss_pred EEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccC
Q 017021 177 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223 (379)
Q Consensus 177 li~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~ 223 (379)
++ + ++.++|+|||.+....
T Consensus 150 ll---------------------------~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 150 LY---------------------------H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EE---------------------------E-CCCEEEEEcccceecC
Confidence 99 3 4568999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-19 Score=152.46 Aligned_cols=181 Identities=18% Similarity=0.171 Sum_probs=133.9
Q ss_pred hhhccccccceeEEEEEecCCCceEEEEEeeccchhhH-----hHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 47 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE-----AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 47 i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~-----~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
+...|++|+||+|+.+.. .+.+++.+.+.....+.. .+.+|++++.++.+ +++++.++++ +..++
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~----~~~vP~ll~~----~~~~l 75 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDG----LPRTPRLLHW----DGRHL 75 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCC----CCCCCEEEEE----cCEEE
Confidence 558899999999998864 678899888875554333 46789999999843 3456666654 34699
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCC-CCCcEEEecccccccCCCccCCCCCCCC
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL-KPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dl-kp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+|+|+ |.+|.+.... ....++.|++.+|.++|+.||+|||| ||+||++
T Consensus 76 vmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv--------------------- 125 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV--------------------- 125 (218)
T ss_pred EEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---------------------
Confidence 99999 8888654321 11346789999999999999999999 7999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCCCc----------------ccccCCccchhhhhCC-CCC-CccchHhHHHHHHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQNY----------------IVSTRHYRAPEVILGL-GWT-YPCDIWSVGCILVE 261 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~----------------~~gt~~y~aPE~~~~~-~~~-~~sDvwSlG~il~~ 261 (379)
+.++.++|+|||.+......... ...++.++.|+...-. ..+ ...+.++.|+-+|.
T Consensus 126 ------~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~ 199 (218)
T PRK12274 126 ------QEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYR 199 (218)
T ss_pred ------cCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHH
Confidence 44566888899888755544311 1246778888765332 334 66788999999999
Q ss_pred HHhCCCCCCCCc
Q 017021 262 LCTGEALFQTHE 273 (379)
Q Consensus 262 l~~g~~pf~~~~ 273 (379)
++|+..|..+.+
T Consensus 200 ~~~~~~~~~~~~ 211 (218)
T PRK12274 200 FVTRRVLHWEDN 211 (218)
T ss_pred HHhccCCccccC
Confidence 999999886644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.7e-19 Score=154.29 Aligned_cols=140 Identities=18% Similarity=0.181 Sum_probs=110.7
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc---eEE-EEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---HIC-IVF 123 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~---~~~-lv~ 123 (379)
+.||+|++|.||. ++.++.. +||++... ........+|+..+..+.+....|+||++++++++++. .++ +|+
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred ceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 7899999999995 6777766 69988643 23456788899999999776678899999999999873 434 789
Q ss_pred eCC---CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH-HHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 124 EKL---GSSLYDFLRKNNYRSFPIDLVREIARQLLECI-AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 124 e~~---~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL-~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
||. +++|.+++.+. .+++. ..++.+++.++ +|||+.+|+||||||+||+++..+
T Consensus 85 e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~----------------- 142 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRIS----------------- 142 (210)
T ss_pred cCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccC-----------------
Confidence 995 58999999663 35555 35677888788 999999999999999999996432
Q ss_pred cccccCCCCCCeEEeecCcc
Q 017021 200 SYFKRMPKSSAIKVIDFGST 219 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~ 219 (379)
+.+..++|+|++.+
T Consensus 143 ------~~~~~~~LiDg~G~ 156 (210)
T PRK10345 143 ------ESEVIPVVCDNIGE 156 (210)
T ss_pred ------CCCCcEEEEECCCC
Confidence 34568999995544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=155.05 Aligned_cols=144 Identities=21% Similarity=0.185 Sum_probs=107.8
Q ss_pred chhhhhhhhccccccceeEEEEE-ecCCCceEEEEEeeccch-------------------------hhHhHHHHHHHHH
Q 017021 41 SAFADKIHSKMGEGTFGQVLECW-DRERKEMVAIKIVRGIKK-------------------------YREAAMIEIEVLQ 94 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~-~~~~~~~vAiK~~~~~~~-------------------------~~~~~~~e~~~l~ 94 (379)
.+.-|+|.+.||+|++|.||+|. +..+|+.||+|++..... .......|...+.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 34468899999999999999999 677899999999874321 0122456888888
Q ss_pred HHHhcCCCCCeeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-CcccCCC
Q 017021 95 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC-MIHTDLK 172 (379)
Q Consensus 95 ~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-iiH~dlk 172 (379)
++.+. ...++..+.. ...++||||+ |.+|........ .+....+..++.|++.+|.+||+.| ++|||+|
T Consensus 106 ~L~~~---~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik 176 (237)
T smart00090 106 RLYEA---GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLS 176 (237)
T ss_pred HHHhc---CCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence 88542 2223333332 2348999999 667765543322 4566677899999999999999999 9999999
Q ss_pred CCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccc
Q 017021 173 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221 (379)
Q Consensus 173 p~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~ 221 (379)
|+||++ + +..++|+|||.+..
T Consensus 177 p~NIli---------------------------~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 177 EYNILV---------------------------H-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhhEEE---------------------------E-CCCEEEEEChhhhc
Confidence 999999 4 45689999998764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-19 Score=155.84 Aligned_cols=247 Identities=16% Similarity=0.153 Sum_probs=178.5
Q ss_pred eeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeec---cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 36 TYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 36 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
.|..+.-....+..+|.+...|..|++++.. ..++.|+++- ...-.+.+..|.-.+.-+ .||||..+++.
T Consensus 183 r~~gid~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrif-----shpnilpvlga 255 (448)
T KOG0195|consen 183 RYTGIDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIF-----SHPNILPVLGA 255 (448)
T ss_pred cccCcchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeee-----cCCchhhhhhh
Confidence 3444444445677899999999999998764 4577888752 223345555666666555 78999999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCcEEEecccccccCCC
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
+..+.++.++..|+ .++|..++.....--....++.+++.+++.|++|||+.. |.--.+...+++++.+-.
T Consensus 256 cnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlt------ 329 (448)
T KOG0195|consen 256 CNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLT------ 329 (448)
T ss_pred ccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhh------
Confidence 99999999999999 899999998876445677899999999999999999865 334478889999965322
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCC---CccchHhHHHHHHHHHhCC
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWT---YPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlG~il~~l~~g~ 266 (379)
..+..+|-.++.. .....-.+.|++||.+...+-+ .++|+|||++++|||.|+.
T Consensus 330 -------------------arismad~kfsfq----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~tre 386 (448)
T KOG0195|consen 330 -------------------ARISMADTKFSFQ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTRE 386 (448)
T ss_pred -------------------hheecccceeeee----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccc
Confidence 2233333322221 1122346789999999876533 6789999999999999999
Q ss_pred CCCCCCchHHHHHH--HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 267 ALFQTHENLEHLAM--MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 267 ~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
.||..-.+.|---. ++..... + ++..+..
T Consensus 387 vpfadlspmecgmkialeglrv~-----------------------i--------------------------ppgis~h 417 (448)
T KOG0195|consen 387 VPFADLSPMECGMKIALEGLRVH-----------------------I--------------------------PPGISRH 417 (448)
T ss_pred cccccCCchhhhhhhhhcccccc-----------------------C--------------------------CCCccHH
Confidence 99976555442211 1111111 1 1346788
Q ss_pred HHHHHhhccccCCCCCcCHHHHh
Q 017021 345 LTHLLQGLLRYDPTDRLTAREAL 367 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l 367 (379)
...|++-|+..||.+||..+.++
T Consensus 418 m~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999988775
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.7e-19 Score=163.68 Aligned_cols=183 Identities=27% Similarity=0.420 Sum_probs=132.0
Q ss_pred eEEEEEeCC-CCCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRK-NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
++||.|++| ..+|.+++.. ......+......++.|+..|++| +|.+|+|+||.||++..+.+.||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 689999999 8999999974 344456788999999999999999 99999999999999977777777777766544
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCch
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 274 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~ 274 (379)
....+. ..........+||..|++||.+.++.|+.++||||||++++|++. -...+.
T Consensus 407 ~~~~~~------------------~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---- 464 (516)
T KOG1033|consen 407 DKDETV------------------APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---- 464 (516)
T ss_pred ccCCcc------------------cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----
Confidence 332200 000011123479999999999999999999999999999999997 222222
Q ss_pred HHHHHHHHHH-cCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 275 LEHLAMMERV-LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 275 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
.......+ -|..|+..+. .-+.-.+|+++||
T Consensus 465 --r~~t~~d~r~g~ip~~~~~----------------------------------------------d~p~e~~ll~~ll 496 (516)
T KOG1033|consen 465 --RIATLTDIRDGIIPPEFLQ----------------------------------------------DYPEEYTLLQQLL 496 (516)
T ss_pred --HHHhhhhhhcCCCChHHhh----------------------------------------------cCcHHHHHHHHhc
Confidence 11111111 1233322111 1234567999999
Q ss_pred ccCCCCCcCHHHHhcCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~ 373 (379)
...|.+||++.+.--|+|.+
T Consensus 497 s~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 497 SPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred CCCcccCchHHHHhhhhhcC
Confidence 99999999999888888753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.6e-17 Score=140.78 Aligned_cols=132 Identities=22% Similarity=0.274 Sum_probs=100.8
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccch---------hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+.||+|++|.||+|.+ .|..+++|+...... .......|..++..+.+ ++++....++......
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~i~~p~~~~~~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARK-----AGVNVPAVYFVDPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHH-----CCCCCCeEEEEeCCCC
Confidence 6799999999999986 677899998653211 12345668888888754 2232222334455678
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+++|||+ |++|.+++.... . ....++.+++.+|.++|+.|++|||++|.||++
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~-------------------- 128 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL-------------------- 128 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE--------------------
Confidence 8999999 889999986532 2 778889999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTY 221 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~ 221 (379)
+ +..++++|||.+..
T Consensus 129 -------~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 129 -------S-GGKIYLIDFGLAEF 143 (211)
T ss_pred -------E-CCCEEEEECCcccC
Confidence 3 45688999998764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.9e-17 Score=152.80 Aligned_cols=196 Identities=20% Similarity=0.247 Sum_probs=141.4
Q ss_pred CCCeeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCC-cccCCCCCcEEEe
Q 017021 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM-IHTDLKPENVLLV 179 (379)
Q Consensus 102 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i-iH~dlkp~Nili~ 179 (379)
.|.|+.++.+...++...++|.+|| .|+|.+.+.... -.++......++.+|+.||.|+|...| .|+.+++.|++++
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd 83 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVD 83 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceee
Confidence 6788999999999999999999999 999999998843 357888999999999999999997665 9999999999995
Q ss_pred cccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCC-----CCCcccccCCccchhhhhCCC-------CC
Q 017021 180 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILGLG-------WT 247 (379)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~ 247 (379)
..+ .+||+|||+...... ......-...|.|||.+.+.. .+
T Consensus 84 ~~w---------------------------~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~ 136 (484)
T KOG1023|consen 84 SRW---------------------------VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALT 136 (484)
T ss_pred eeE---------------------------EEEechhhhcccccccccccccchhHHHHhccCHHHhccccccccccccc
Confidence 555 455555555443321 001112345789999997631 46
Q ss_pred CccchHhHHHHHHHHHhCCCCCCCCch----HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhh
Q 017021 248 YPCDIWSVGCILVELCTGEALFQTHEN----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 323 (379)
Q Consensus 248 ~~sDvwSlG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (379)
.+.|+||+|++++|+++.+.||..... .+....+.+ .+..+
T Consensus 137 ~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~---------------------------------- 181 (484)
T KOG1023|consen 137 QKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-GGSNP---------------------------------- 181 (484)
T ss_pred ccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-cCCCC----------------------------------
Confidence 789999999999999999999975322 233333332 01000
Q ss_pred hccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHh
Q 017021 324 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 367 (379)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l 367 (379)
..|..... . ...+++..++++||..+|..||+++++-
T Consensus 182 --~rP~i~~~----~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 182 --FRPSIELL----N-ELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred --cCcchhhh----h-hcchHHHHHHHHhcccChhhCccHHHHH
Confidence 00111100 0 2334788899999999999999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.9e-16 Score=135.30 Aligned_cols=137 Identities=24% Similarity=0.267 Sum_probs=100.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-----------------------hhHhHHHHHHHHHHHHhcC
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------------------YREAAMIEIEVLQQLAKHD 100 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----------------------~~~~~~~e~~~l~~l~~~~ 100 (379)
.|.+.+.||+|+||.||++... +|+.||+|++..... .......|...+..+.+..
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 5788899999999999999875 799999998763210 1112456777777774421
Q ss_pred CCCCeeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEe
Q 017021 101 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 179 (379)
Q Consensus 101 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~ 179 (379)
..++..++ ....+++|||+ |++|.++... .....++.+++.++.++|+.|++|||++|+||++
T Consensus 95 ---i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill- 158 (198)
T cd05144 95 ---FPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV- 158 (198)
T ss_pred ---CCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE-
Confidence 12333322 23458999999 7788655321 3355678899999999999999999999999999
Q ss_pred cccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccC
Q 017021 180 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223 (379)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~ 223 (379)
+.+..++|+|||.+....
T Consensus 159 --------------------------~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 --------------------------DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred --------------------------cCCCcEEEEECCccccCC
Confidence 556788999999886433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.9e-16 Score=134.23 Aligned_cols=128 Identities=21% Similarity=0.252 Sum_probs=95.8
Q ss_pred ccccccceeEEEEEecCCCceEEEEEeeccc----h-----hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIK----K-----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 50 ~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~-----~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.||+|++|.||++. .++..+++|...... . .......|..++..+.+.. .+++..+. ......+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~---i~~p~~~~--~~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAG---VNTPVVYD--VDPDNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCC---CCCCEEEE--EECCCCE
Confidence 37999999999998 456789999864211 0 1244557888888885532 12333332 3455678
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
++|||+ |++|.+++.... . .++.+++.+|.++|+.|++|||++|.||++
T Consensus 74 lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~--------------------- 123 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV--------------------- 123 (199)
T ss_pred EEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEE---------------------
Confidence 999999 899998875532 1 778899999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccc
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTY 221 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~ 221 (379)
+ +..++++|||.+..
T Consensus 124 ------~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 124 ------R-DDKLYLIDFGLGKY 138 (199)
T ss_pred ------E-CCcEEEEECCCCcC
Confidence 3 46688999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.6e-18 Score=168.30 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=186.2
Q ss_pred chhhhhhhhccccccceeEEEEEec-CCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDR-ERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~-~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
....|++.+.||+|+|+.|-.+.+. .+...+|.|.+.... .....+..|..+-..+ ..|.|++.+++.....
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~----s~h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKL----SKHSNTVHMIEPSSSP 93 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccc----cccccccccCCccCCC
Confidence 4667888899999999999888764 445667777775332 2222222344443333 2378999999999999
Q ss_pred ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCcccCCCCCcEEEeccc-ccccCCCccCC
Q 017021 117 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSE-YIKVPDYKSSL 193 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~iiH~dlkp~Nili~~~~-~~~~~~~~~~~ 193 (379)
...++++++. |+++.+.+........+...+..++.|+..++.|+| ..++.|+|+||+|.+++.++ .+++
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~------- 166 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKI------- 166 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccC-------
Confidence 9999999999 888888774322225777888899999999999999 99999999999999996655 4444
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCC-CC-----Ccccc-cCCccchhhhhCCCC-CCccchHhHHHHHHHHHhC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-DQ-----NYIVS-TRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~-~~-----~~~~g-t~~y~aPE~~~~~~~-~~~sDvwSlG~il~~l~~g 265 (379)
.|||.|..... .. ...+| ++.|.|||...+..+ .+..|+||+|+++..+++|
T Consensus 167 --------------------~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g 226 (601)
T KOG0590|consen 167 --------------------ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTG 226 (601)
T ss_pred --------------------CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccC
Confidence 45554433222 11 22467 899999999988654 5888999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
..|+......... ...|.+.. .......+...+..+
T Consensus 227 ~~p~~~~~~~~~~-----------------------------~~~~~~~~---------------~~~~~~~~~~~~~~~ 262 (601)
T KOG0590|consen 227 ELPWDFPSRKDGR-----------------------------YSSWKSNK---------------GRFTQLPWNSISDQA 262 (601)
T ss_pred CCCcccccccccc-----------------------------ceeecccc---------------cccccCccccCChhh
Confidence 9998754332100 00000000 000011234567788
Q ss_pred HHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 346 THLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
.+++.++|..+|+.|.+.+++-.+||+..
T Consensus 263 ~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 263 HDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred hhcccccccCCchhccccccccccccccc
Confidence 99999999999999999999999999987
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.9e-15 Score=128.52 Aligned_cols=135 Identities=22% Similarity=0.241 Sum_probs=91.6
Q ss_pred hhccccccceeEEEEEecCCCceEEEEEeeccchhh---Hh----------------------HHHHHHHHHHHHhcCCC
Q 017021 48 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR---EA----------------------AMIEIEVLQQLAKHDKG 102 (379)
Q Consensus 48 ~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~---~~----------------------~~~e~~~l~~l~~~~~~ 102 (379)
.+.||+|+||.||+|.+. +|+.||+|++....... .. ...|...+..+....
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-- 78 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG-- 78 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC--
Confidence 578999999999999976 79999999987432111 00 123555555554322
Q ss_pred CCeeEEecceeeecceEEEEEeCC-CCCHH-HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEe
Q 017021 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLY-DFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLV 179 (379)
Q Consensus 103 ~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~-~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~ 179 (379)
..++..+.. ...+++|||+ ++++. ..+.... .. ..+..++.+++.++.++|+ .|++|||+||+||++
T Consensus 79 -~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili- 148 (187)
T cd05119 79 -VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV- 148 (187)
T ss_pred -CCCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE-
Confidence 112222221 2358999999 53321 1122111 11 5678899999999999999 999999999999999
Q ss_pred cccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCccccc
Q 017021 180 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222 (379)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~ 222 (379)
+ ++.++|+|||.+...
T Consensus 149 --------------------------~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 --------------------------D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred --------------------------E-CCcEEEEECcccccc
Confidence 4 567889999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=4e-15 Score=148.02 Aligned_cols=133 Identities=22% Similarity=0.212 Sum_probs=98.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc----c-----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----K-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
.|...+.||+|+||+||++.+... .+++|+.... . ........|..++..+. +++++....+..
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~~~i~~p~~~~~ 406 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-----RAGVPTPVIYDV 406 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-----ccCCCeeEEEEE
Confidence 345678999999999999976543 3455443211 0 11245667888888883 344544444444
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
.....++||||+ +++|.+++. ....++.+++.+|.+||+.|++|||+||+||++.
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-------------- 462 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-------------- 462 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE--------------
Confidence 556678999999 899998875 2456889999999999999999999999999992
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccc
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTY 221 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~ 221 (379)
+..++|+|||.++.
T Consensus 463 --------------~~~~~liDFGla~~ 476 (535)
T PRK09605 463 --------------DDRLYLIDFGLGKY 476 (535)
T ss_pred --------------CCcEEEEeCccccc
Confidence 24688999998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-15 Score=145.57 Aligned_cols=267 Identities=20% Similarity=0.242 Sum_probs=185.9
Q ss_pred eeeeechhhhhhhhcccc--ccceeEEEEEe--cCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEE
Q 017021 36 TYIVFSAFADKIHSKMGE--GTFGQVLECWD--RERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108 (379)
Q Consensus 36 ~~~~~~~~~y~i~~~Lg~--G~~g~V~~~~~--~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~ 108 (379)
.+..+-.+.+.+.+.+|. |.+|.||.+.. .+++..+|+|.-+.. ......-++|......+ ..|.+.++
T Consensus 107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i----~~~~~~v~ 182 (524)
T KOG0601|consen 107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKI----DSHENPVR 182 (524)
T ss_pred CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhccccc----Cccccccc
Confidence 344455666778899999 99999999998 899999999984421 12223333444443333 35678888
Q ss_pred ecceeeecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHH----HHHHHHHcCCcccCCCCCcEEEecc-cc
Q 017021 109 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE----CIAFMHDLCMIHTDLKPENVLLVSS-EY 183 (379)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~----aL~~LH~~~iiH~dlkp~Nili~~~-~~ 183 (379)
.+..++..+..|+-+|+|+.+|.++..... ..++...++..+.+... ||.++|+.+++|-|+||+||+...+ ..
T Consensus 183 ~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 183 DSPAWEGSGILFIQTELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred cCcccccCCcceeeeccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccce
Confidence 899999999999999999999998887654 24788899999999999 9999999999999999999999655 44
Q ss_pred cccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHH
Q 017021 184 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 263 (379)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~ 263 (379)
+++.||++.... .+.+++...... ....|..-|++||...+ .++..+|++++|.++.+..
T Consensus 262 ~~~~df~~v~~i------------------~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~ 321 (524)
T KOG0601|consen 262 CKLTDFGLVSKI------------------SDGNFSSVFKVS-KRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAI 321 (524)
T ss_pred eecCCcceeEEc------------------cCCccccceeee-ecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhH
Confidence 555555433211 111111111100 00135566999999877 5689999999999999988
Q ss_pred hCCCCCCCC--chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccc
Q 017021 264 TGEALFQTH--ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341 (379)
Q Consensus 264 ~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (379)
++..+.... ..... +.+.. .| .++-..-
T Consensus 322 l~~~~~~~g~~~~W~~---~r~~~--ip---------------------------------------------~e~~~~~ 351 (524)
T KOG0601|consen 322 LGSHLPSVGKNSSWSQ---LRQGY--IP---------------------------------------------LEFCEGG 351 (524)
T ss_pred hhcccccCCCCCCccc---ccccc--Cc---------------------------------------------hhhhcCc
Confidence 876655432 11110 00000 11 0111234
Q ss_pred hhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 342 ~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
+.++...+.+|++.+|-.|++++.+++|+++....+
T Consensus 352 s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~ 387 (524)
T KOG0601|consen 352 SSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLF 387 (524)
T ss_pred chhhhhHHHHhcCcchhhhhHHHHHhccccccchhh
Confidence 455666899999999999999999999999876543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-16 Score=140.92 Aligned_cols=242 Identities=19% Similarity=0.248 Sum_probs=156.6
Q ss_pred eEEEEEecCCCceEEEEEeecc-----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec-----ceEEEEEeCC-
Q 017021 58 QVLECWDRERKEMVAIKIVRGI-----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKL- 126 (379)
Q Consensus 58 ~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~- 126 (379)
.||++.+.+.|.+|+.-.++.. .........-...+.++ .|.|+++++.++.+. ..+.+++||+
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllql-----vHsnlvkfH~yw~d~K~~e~~rviFiteyms 155 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQL-----VHSNLVKFHKYWTDKKYEEKPRVIFITEYMS 155 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHH-----HHHHHHHHHHhhcccccccccceEEEEeccc
Confidence 4677777888877776555321 11112222233334444 456799999998754 3588899999
Q ss_pred CCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 127 GSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 127 ~~sL~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
.+++.+++++ +....+....+.+|+.||+.||.|||+.. |+|+++..+-|++..+|.+|+..-...
T Consensus 156 sgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~---------- 225 (458)
T KOG1266|consen 156 SGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD---------- 225 (458)
T ss_pred chhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcc----------
Confidence 9999999976 33456889999999999999999999875 999999999999976665554211100
Q ss_pred ccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCC-CCCCchHHHHHHH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL-FQTHENLEHLAMM 281 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~p-f~~~~~~~~~~~~ 281 (379)
..+..+..+ .........+-++|.+||.-.-...+-++|||++|.+..+|..+..- -.+.+..+.-..+
T Consensus 226 ---s~h~s~~~~-------~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~i 295 (458)
T KOG1266|consen 226 ---STHPSVNST-------REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENI 295 (458)
T ss_pred ---ccchhhhhh-------hHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhh
Confidence 000000000 00011122356789999987666677899999999999999887542 2222221111111
Q ss_pred HHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCc
Q 017021 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 361 (379)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 361 (379)
.+..-. -...--++++.+||+-.|..||
T Consensus 296 a~~i~~----------------------------------------------------len~lqr~~i~kcl~~eP~~rp 323 (458)
T KOG1266|consen 296 ANVIIG----------------------------------------------------LENGLQRGSITKCLEGEPNGRP 323 (458)
T ss_pred hhheee----------------------------------------------------ccCccccCcCcccccCCCCCCc
Confidence 111000 0112345689999999999999
Q ss_pred CHHHHhcCCCCCCCC
Q 017021 362 TAREALRHPFFTRDH 376 (379)
Q Consensus 362 ta~e~l~hp~f~~~~ 376 (379)
+|.+++.||..-+.+
T Consensus 324 ~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 324 DARLLLFHPLLFEVH 338 (458)
T ss_pred chhhhhcCceeeecc
Confidence 999999999765543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=5e-14 Score=125.29 Aligned_cols=134 Identities=20% Similarity=0.192 Sum_probs=97.0
Q ss_pred hccc-cccceeEEEEEecCCCceEEEEEeecc--------------chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 49 SKMG-EGTFGQVLECWDRERKEMVAIKIVRGI--------------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 49 ~~Lg-~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
..|| .||.|+||.+... +..+|||.+... ......+.+|...+..+.+.. ..++..+...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~g---i~vP~pl~~~ 111 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAG---LPVPRPIAAR 111 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCC---CCCceeEeee
Confidence 4687 8999999999754 678999988521 122345677999999986533 2234444433
Q ss_pred ee-cc---eEEEEEeCC-C-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccC
Q 017021 114 DY-RN---HICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 114 ~~-~~---~~~lv~e~~-~-~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~ 187 (379)
.. .. ..++|||++ | .+|.+++... .++... +.+|+.+|.+||+.||+||||||.|||+
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv--------- 175 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL--------- 175 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE---------
Confidence 22 22 245999999 5 5898887653 355543 5689999999999999999999999999
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccc
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~ 221 (379)
+.++.++|+|||.+..
T Consensus 176 ------------------~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 176 ------------------DPDGKFWLIDFDRGEL 191 (239)
T ss_pred ------------------cCCCCEEEEECCCccc
Confidence 4455799999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.4e-14 Score=116.80 Aligned_cols=132 Identities=23% Similarity=0.302 Sum_probs=104.6
Q ss_pred hhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 47 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 47 i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
+++.||+|.++.||++.... ..+++|....... ...+..|...+..+.+. ...++.++.+....+..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~---~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARK---GLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHc---CCCCCeEEEEcCCCCccEEEEEec
Confidence 45789999999999998654 6799999875433 45677899999998664 245777777777778899999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 127 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL---CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 127 -~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
+.++..+ +......++.+++.+|..+|.. +++|+|++|.||++
T Consensus 76 ~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~------------------------ 122 (155)
T cd05120 76 EGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV------------------------ 122 (155)
T ss_pred CCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE------------------------
Confidence 6555433 4456667788999999999985 69999999999999
Q ss_pred ccCCCCCCeEEeecCccc
Q 017021 203 KRMPKSSAIKVIDFGSTT 220 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~ 220 (379)
+....++++|||.+.
T Consensus 123 ---~~~~~~~l~Df~~~~ 137 (155)
T cd05120 123 ---DDGKILGIIDWEYAG 137 (155)
T ss_pred ---ECCcEEEEEeccccc
Confidence 345678999998875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.3e-15 Score=148.35 Aligned_cols=280 Identities=21% Similarity=0.275 Sum_probs=191.6
Q ss_pred hhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeC
Q 017021 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 125 (379)
Q Consensus 46 ~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 125 (379)
.+.+.+-+|.++.++.+.-..+|...+.|.......-.....+++..-..+. ....+|.++.....+....-.+++++|
T Consensus 807 ~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~-i~p~~P~v~~~~~s~~~rsP~~L~~~~ 885 (1205)
T KOG0606|consen 807 EITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNIL-ITPRSPAVVRSFPSFPCRSPLPLVGHY 885 (1205)
T ss_pred eecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCcc-ccCCCCceecccCCCCCCCCcchhhHH
Confidence 4556888999999999987788877777766533222221111111111111 101334455444445556778999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc-cCCCCCCCCcccc
Q 017021 126 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK-SSLHTPKDSSYFK 203 (379)
Q Consensus 126 ~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~-~~~~~~~~~~~~~ 203 (379)
. +++|...+.+.+ ....+.++..+..+.+++++||+..+.|+|++|.|.+....+..++++|+ +...-.-......
T Consensus 886 ~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 886 LNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred hccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 9 889998888766 56777888889999999999999999999999999999999999999998 3322111111100
Q ss_pred -cCCCCCCeEEeecCcccc--cC-----CCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 204 -RMPKSSAIKVIDFGSTTY--ER-----PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 204 -~~~~~~~~~l~Dfg~~~~--~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
.....+... +++-... .. .......||+.|.+||.+.+...+..+|+|++|+++++.++|.+||......
T Consensus 964 sg~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 964 SGPSSSGTPR--RLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred ccccccCccc--cccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 001111111 1111111 00 1123357899999999999999999999999999999999999999876665
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
..+..+ -++.++||..+ ...+..+.+++...|..
T Consensus 1042 ~~f~ni-----------------------~~~~~~~p~g~-----------------------~~~s~~aq~~~~~ll~~ 1075 (1205)
T KOG0606|consen 1042 QIFENI-----------------------LNRDIPWPEGP-----------------------EEGSYEAQDLINRLLTE 1075 (1205)
T ss_pred hhhhcc-----------------------ccCCCCCCCCc-----------------------cccChhhhhhhhhhhcc
Confidence 544322 22334444321 23567899999999999
Q ss_pred CCCCCcCHH---HHhcCCCCCCCC
Q 017021 356 DPTDRLTAR---EALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rpta~---e~l~hp~f~~~~ 376 (379)
+|.+|..|. ++-.||||+...
T Consensus 1076 ~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1076 EPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred CchhccCcccccccccCCccCCCC
Confidence 999999888 999999998764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.6e-12 Score=125.44 Aligned_cols=143 Identities=18% Similarity=0.207 Sum_probs=94.3
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchh-----------------------------------------hHhHH
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-----------------------------------------REAAM 87 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-----------------------------------------~~~~~ 87 (379)
+.||+|++|.||+|+.+ +|+.||||+....-.. +-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999865 6899999998532100 01233
Q ss_pred HHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHH-HHHHHHHcC
Q 017021 88 IEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE-CIAFMHDLC 165 (379)
Q Consensus 88 ~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~-aL~~LH~~~ 165 (379)
.|...+.++.....+++.+..-.-+.+.....++||||+ |.+|.++...... .... ..++..++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~~---~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLDR---KALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCCH---HHHHHHHHHHHHHHHHhCC
Confidence 455555666554444443322222222334579999999 8899887654211 1222 234444444 467889999
Q ss_pred CcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccC
Q 017021 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223 (379)
Q Consensus 166 iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~ 223 (379)
++|+|+||.||++ ..++.++++|||.+....
T Consensus 278 ~~H~D~hPgNilv---------------------------~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFV---------------------------LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEE---------------------------CCCCcEEEEeCCCeeECC
Confidence 9999999999999 556678999999886543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.7e-12 Score=123.31 Aligned_cols=145 Identities=18% Similarity=0.263 Sum_probs=91.8
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccch-----------------------------------hh------HhHH
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------------------------------YR------EAAM 87 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----------------------------------~~------~~~~ 87 (379)
+.||+|++|.||+|+.+.+|+.||||+....-. .. -.+.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 689999999999999988899999999863210 01 1223
Q ss_pred HHHHHHHHHHhcCCCCCe--eEEecceeeecceEEEEEeCC-CCCHHHHH--HhCCCC--CCCHHHHHHHHHHHHHHHHH
Q 017021 88 IEIEVLQQLAKHDKGGNR--CVQIRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNYR--SFPIDLVREIARQLLECIAF 160 (379)
Q Consensus 88 ~e~~~l~~l~~~~~~~~~--i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l--~~~~~~--~l~~~~~~~~~~qi~~aL~~ 160 (379)
.|...+.++.....+.+. ++.++ .+.....++||||+ |+.+.++- ...+.. .+....+..++.|
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~--~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q------- 275 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVY--WDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ------- 275 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceee--cccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------
Confidence 455555555443322222 22222 22245578999999 88987753 332210 1233333333333
Q ss_pred HHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC
Q 017021 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225 (379)
Q Consensus 161 LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~ 225 (379)
+...|++|+|+||.||++..++ ...+.++++|||......+.
T Consensus 276 if~~GffHaDpHPGNIlv~~~g-----------------------~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 VFRDGFFHADMHPGNIFVSYDP-----------------------PENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHhCCeeeCCCChHHeEEecCC-----------------------CCCCeEEEEecceEEECCHH
Confidence 3469999999999999996543 23357889999988765443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=3e-11 Score=103.08 Aligned_cols=137 Identities=18% Similarity=0.222 Sum_probs=96.6
Q ss_pred hhccccccceeEEEEEecC------CCceEEEEEeecc-------------c----------hhh----HhHHHHHHHHH
Q 017021 48 HSKMGEGTFGQVLECWDRE------RKEMVAIKIVRGI-------------K----------KYR----EAAMIEIEVLQ 94 (379)
Q Consensus 48 ~~~Lg~G~~g~V~~~~~~~------~~~~vAiK~~~~~-------------~----------~~~----~~~~~e~~~l~ 94 (379)
..+||.|-=+.||.|.... .+..+|+|+++.. + .+. ..+.+|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4678999999999997543 3578999998521 0 011 12237899999
Q ss_pred HHHhcCCCCCeeEEecceeeecceEEEEEeCCCC-CHHH-HHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCCcccCC
Q 017021 95 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS-SLYD-FLRKNNYRSFPIDLVREIARQLLECIAFM-HDLCMIHTDL 171 (379)
Q Consensus 95 ~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~-sL~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~L-H~~~iiH~dl 171 (379)
++....-. ++..+.. ..-++||||+++ .+.. .+... .++...+..+..+++.+|..+ |+.|++|||+
T Consensus 82 rl~~~Gv~---vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL 151 (197)
T cd05146 82 RMQKAGIP---CPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECNLVHADL 151 (197)
T ss_pred HHHHcCCC---CCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 98775533 4444433 456789999954 2321 22221 355566777889999999998 8999999999
Q ss_pred CCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCccccc
Q 017021 172 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222 (379)
Q Consensus 172 kp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~ 222 (379)
++.||++. ++.+.++|||.+...
T Consensus 152 s~~NIL~~----------------------------~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH----------------------------DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE----------------------------CCcEEEEECCCceeC
Confidence 99999993 246899999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.7e-11 Score=103.26 Aligned_cols=126 Identities=17% Similarity=0.116 Sum_probs=89.9
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-C
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 127 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 127 (379)
+.|+.|..+.||++... ++.|++|+.............|...+..+.... .+++++.... ...++|||++ |
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~----~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAG----IGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhC----CCCceEEEeC--CCCeEEEEecCC
Confidence 67889999999999854 778999998644322344567888888875532 1334443332 2357999999 7
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCC-----cccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 128 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM-----IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 128 ~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i-----iH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
.++.+. . .. ...+..+++.+|..||+.++ +|||++|.||++
T Consensus 76 ~~l~~~----~--~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~------------------------ 121 (170)
T cd05151 76 SELLTE----D--FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL------------------------ 121 (170)
T ss_pred Cccccc----c--cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE------------------------
Confidence 666532 0 11 12345789999999999885 999999999999
Q ss_pred ccCCCCCCeEEeecCccc
Q 017021 203 KRMPKSSAIKVIDFGSTT 220 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~ 220 (379)
+ ++.++++||+.+.
T Consensus 122 ---~-~~~~~liDf~~a~ 135 (170)
T cd05151 122 ---D-DGRLWLIDWEYAG 135 (170)
T ss_pred ---E-CCeEEEEeccccc
Confidence 3 3458899999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.3e-12 Score=120.33 Aligned_cols=253 Identities=21% Similarity=0.158 Sum_probs=168.4
Q ss_pred eeechhhhhhhhccccccceeEEEEEec-CCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDR-ERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~-~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.....-.+..+..||.|.|+.|+..... .++-.|++|...+. .........|+.....+. .|.+++.....|
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~----~~~~~~g~~~~W 335 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILG----SHLPSVGKNSSW 335 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhh----cccccCCCCCCc
Confidence 3344455667799999999999987655 77888999987632 233444455666666663 445677777777
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecc-cccccCCCcc
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDYKS 191 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~-~~~~~~~~~~ 191 (379)
......|+--||| ++++.....-.. .+.+...+.+..|++.++.++|+..++|+|+||+||++.++ +..++.
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~~~--~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~---- 409 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVTSQ--MLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLG---- 409 (524)
T ss_pred cccccccCchhhhcCcchhhhhHHHH--hcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcc----
Confidence 7777788999999 776655543221 37788899999999999999999999999999999999764 333344
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCcc--chhhhhCCCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR--APEVILGLGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
|||......-......++..+. +++......+..++|++|||..+.+.+++...-
T Consensus 410 -----------------------~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 410 -----------------------DFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred -----------------------ccccccccceecccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 4443322111111112233333 555555667889999999999999999876433
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
....... .+.+..-+. .......+..+.
T Consensus 467 ~~~~~~~---~i~~~~~p~-------------------------------------------------~~~~~~~~q~~~ 494 (524)
T KOG0601|consen 467 ESGVQSL---TIRSGDTPN-------------------------------------------------LPGLKLQLQVLL 494 (524)
T ss_pred cccccce---eeecccccC-------------------------------------------------CCchHHhhhhhh
Confidence 2211110 001100000 001224566677
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
..|...++..|+.+.++..|.-|.+.
T Consensus 495 kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 495 KVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred hhhcCCccccchhhhhhcccchhhhh
Confidence 88999999999999999998876543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.1e-10 Score=111.25 Aligned_cols=189 Identities=16% Similarity=0.211 Sum_probs=130.9
Q ss_pred eeeeeechhhhhhhhccccccceeEE-EEEecCCCceEEEEEeeccch-hhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 35 ITYIVFSAFADKIHSKMGEGTFGQVL-ECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G~~g~V~-~~~~~~~~~~vAiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
++......+-|.| ....-++.+ +| .|..+.++.+|++..++.... +.....+-++.+..+ .||+|+++++.
T Consensus 5 f~~~~~~~fpY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-----RHP~Il~yL~t 77 (690)
T KOG1243|consen 5 FSRDSSSQFPYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-----RHPNILSYLDT 77 (690)
T ss_pred ecccccccCCccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-----cCchhhhhhhh
Confidence 3344455566777 444555555 45 577788899999999874333 234455566667777 67999999999
Q ss_pred eeecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 113 FDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 113 ~~~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
++..+..|+|+|-+.. |...++. +.......-+.||+.||.||| .++++|++|.-+.|+++..|..|+++|.+
T Consensus 78 ~e~~~~~ylvTErV~P-l~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~ 151 (690)
T KOG1243|consen 78 TEEEGTLYLVTERVRP-LETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLEL 151 (690)
T ss_pred hcccCceEEEeecccc-HHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEE
Confidence 9999999999999832 5566665 336667777899999999997 78899999999999997666666655543
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhC
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g 265 (379)
. ...... ......-..|..|+.+.... -..|.|.|||++++++.|
T Consensus 152 v---------------------------~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 152 V---------------------------SKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred E---------------------------eccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 3 211111 01111122355666543322 345999999999999998
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=6e-09 Score=86.05 Aligned_cols=144 Identities=23% Similarity=0.185 Sum_probs=103.5
Q ss_pred hhccccccceeEEEEEecCCCceEEEEEeec---------cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 48 HSKMGEGTFGQVLECWDRERKEMVAIKIVRG---------IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 48 ~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
...+-+|+=+.|+++. ..|+...||.-.. ..-...+..+|...+.+........| .++ +.+...
T Consensus 12 l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P---~l~--~~D~~~ 84 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAP---RLI--FIDTYG 84 (229)
T ss_pred ceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCc---eEE--EEecCC
Confidence 4677889999999985 4577777776421 12234566678888888766543333 332 444455
Q ss_pred EEEEEeCCCC--CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 119 ICIVFEKLGS--SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 119 ~~lv~e~~~~--sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
-.|.||+..| ++.+++.......-.......++..|-..+.-||..+++||||..+||++.+.
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~--------------- 149 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSD--------------- 149 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecC---------------
Confidence 5788999955 89999887654444444557888889999999999999999999999999654
Q ss_pred CCCcccccCCCCCCeEEeecCccccc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYE 222 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~ 222 (379)
.....+.++|||++...
T Consensus 150 ---------~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 150 ---------GNQITPILIDFGLSSVS 166 (229)
T ss_pred ---------CCcCceEEEeecchhcc
Confidence 34455789999998643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=7.4e-11 Score=114.73 Aligned_cols=165 Identities=20% Similarity=0.324 Sum_probs=109.5
Q ss_pred HHHHHHHHH-HcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCccccc
Q 017021 154 LLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVST 232 (379)
Q Consensus 154 i~~aL~~LH-~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt 232 (379)
++.|+.|+| +.++||++|.|++|.++..+.+|++.|+++.-...... .....-|+++. ......
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--------~p~~~yd~~lp-------~~~~~~ 172 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--------YPFSEYDPPLP-------LLLQPH 172 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--------cccccCCCCCC-------hhhccC
Confidence 448999999 67899999999999997777777776665533222110 11111122211 112234
Q ss_pred CCccchhhhhCCCCCCccchHhHHHHHHHHH-hCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCC
Q 017021 233 RHYRAPEVILGLGWTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW 311 (379)
Q Consensus 233 ~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (379)
..|.|||++.+...+.++|++|+||.+|.+. .|+..+...+...... ........+. .
T Consensus 173 ~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~~------------------~-- 231 (700)
T KOG2137|consen 173 LNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAGA------------------F-- 231 (700)
T ss_pred cccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhccccccc------------------c--
Confidence 6799999999988889999999999999998 5666555433221111 1111111000 0
Q ss_pred CCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCCcC
Q 017021 312 PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~ 378 (379)
......+.++++=+.++|..|+..||++.+++..|||.+.-++
T Consensus 232 ------------------------~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~ 274 (700)
T KOG2137|consen 232 ------------------------GYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLK 274 (700)
T ss_pred ------------------------cccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchhh
Confidence 0113466789999999999999999999999999999986543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.5e-09 Score=93.94 Aligned_cols=107 Identities=17% Similarity=0.142 Sum_probs=72.2
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---ceEEEEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---NHICIVF 123 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~---~~~~lv~ 123 (379)
+.|+.|..+.||++.... |+.+++|+...... .......|..++..+.... ..+++++.+.... +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~---~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTG---VPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCC---CCCCCEEEECCCCCccCCceEEE
Confidence 678999999999998643 57899999865432 3456778999988886532 2344444444433 3678999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH 162 (379)
|++ |.++.+.+.. ..++......++.+++.+|..||
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH 116 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALH 116 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHh
Confidence 999 7666654421 13556666666667777777776
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.8e-09 Score=85.13 Aligned_cols=129 Identities=20% Similarity=0.206 Sum_probs=92.4
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeecc---------chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGI---------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
..+++|+=+.|+.+.. -|..+++|.-... .-...+...|..++.++.... .+++.++++ +.+.-
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~G---V~~P~v~dv--D~~~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAG---VPVPIVYDV--DPDNG 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcC---CCCCeEEEE--cCCCC
Confidence 4578899999999854 3555777764311 122355567888888887654 344444443 35556
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
.|+|||. |..|.+.+... ...++..+-.-+.-||..||+|||+.++||++.
T Consensus 75 ~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~------------------- 126 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS------------------- 126 (204)
T ss_pred EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe-------------------
Confidence 7899999 77888888764 134566677778899999999999999999993
Q ss_pred CcccccCCCCCCeEEeecCcccc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTY 221 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~ 221 (379)
+..+.++|||++..
T Consensus 127 ---------~~~i~~IDfGLg~~ 140 (204)
T COG3642 127 ---------GGRIYFIDFGLGEF 140 (204)
T ss_pred ---------CCcEEEEECCcccc
Confidence 33489999999863
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.7e-08 Score=92.53 Aligned_cols=167 Identities=17% Similarity=0.223 Sum_probs=119.9
Q ss_pred cceeEEEEEecCCCceEEEEEeeccchhh-HhHHHHHHHHHHHHhcCCCCCeeEEecceeee----cceEEEEEeCC--C
Q 017021 55 TFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVFEKL--G 127 (379)
Q Consensus 55 ~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~--~ 127 (379)
-..+.|+++...+|..|++|++....... .....-++...++ .|.|++.+.+.|.. +..+++|++|. .
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-----~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-----CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-----ccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 34678999999999999999994221111 1222345566666 78999999999984 34689999999 5
Q ss_pred CCHHHHHHhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 128 SSLYDFLRKN-------------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 128 ~sL~~~l~~~-------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+|.+..... .+...+++.+|.++.|+..||.++|+.|+..+-|.|.+|++
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---------------- 426 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---------------- 426 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe----------------
Confidence 6888775421 12246789999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
.++..++|...|..-....+. . |.+.+ -.+-|.-.||.++..|++|..
T Consensus 427 -----------~G~~RIriS~C~i~Dvl~~d~---------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 427 -----------TGKMRIRISGCGIMDVLQEDP---------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred -----------eCcceEEEecccceeeecCCC---------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 455566666555443322221 0 11111 245699999999999999853
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.9e-08 Score=88.61 Aligned_cols=141 Identities=18% Similarity=0.063 Sum_probs=95.2
Q ss_pred eEEEEEecCCCceEEEEEeeccchh------------hHhHHHHHHHHHHHHhcCCCCCeeEEecceeee--cceEEEEE
Q 017021 58 QVLECWDRERKEMVAIKIVRGIKKY------------REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVF 123 (379)
Q Consensus 58 ~V~~~~~~~~~~~vAiK~~~~~~~~------------~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~~lv~ 123 (379)
.|.++. ..|+.|.+|........ ...+.+|...+..+.......|..+-+...-.. ....++||
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 355553 34678999987532210 114678999998887765444544333211111 23578999
Q ss_pred eCC-CC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 124 EKL-GS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 124 e~~-~~-sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|++ +. +|.+++........+......++.+++..+.-||..|++|||+++.|||++.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~------------------ 176 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFP------------------ 176 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEecccc------------------
Confidence 999 43 7999986432224566777889999999999999999999999999999953100
Q ss_pred cccCCCCCCeEEeecCccc
Q 017021 202 FKRMPKSSAIKVIDFGSTT 220 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~ 220 (379)
.......+.+|||+.+.
T Consensus 177 --~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 177 --GREEDLKLSVIDLHRAQ 193 (268)
T ss_pred --CCCCCceEEEEECCccc
Confidence 00235679999999774
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=9.5e-09 Score=87.43 Aligned_cols=127 Identities=26% Similarity=0.312 Sum_probs=76.0
Q ss_pred eEEEEEecCCCceEEEEEeecc--------------c-------------hhhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 58 QVLECWDRERKEMVAIKIVRGI--------------K-------------KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 58 ~V~~~~~~~~~~~vAiK~~~~~--------------~-------------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
.||.|.. ..|+.+|+|+.... . .......+|...|.++.... .+++..+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~G---v~vP~p~ 76 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAG---VPVPKPY 76 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT----SS--EE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCC---ccCCcEE
Confidence 4888885 45779999998521 0 01234456888888875533 3455554
Q ss_pred ceeeecceEEEEEeCCC--CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH-HHHcCCcccCCCCCcEEEecccccccC
Q 017021 111 NWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIARQLLECIAF-MHDLCMIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~~--~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~-LH~~~iiH~dlkp~Nili~~~~~~~~~ 187 (379)
.+. .-++||||++ |.....+.... ++......++.+++..+.. +|+.|++|||+.+.||++.
T Consensus 77 ~~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~-------- 141 (188)
T PF01163_consen 77 DYN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD-------- 141 (188)
T ss_dssp EEE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE--------
T ss_pred EEe----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee--------
Confidence 332 2469999995 53333333321 2234556667777775555 5899999999999999993
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccC
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~ 223 (379)
.+ .+.++|||.+....
T Consensus 142 -------------------~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 142 -------------------DG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp -------------------TT-CEEE--GTTEEETT
T ss_pred -------------------cc-eEEEEecCcceecC
Confidence 22 79999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.4e-07 Score=78.52 Aligned_cols=141 Identities=11% Similarity=0.105 Sum_probs=102.6
Q ss_pred ccccceeEEEEEecCCCceEEEEEeecc-------chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec--ceEEEE
Q 017021 52 GEGTFGQVLECWDRERKEMVAIKIVRGI-------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIV 122 (379)
Q Consensus 52 g~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--~~~~lv 122 (379)
|.||.+.|+..... |+.+-+|.-.+. ......+.+|...+.++.......|.++ +.+.-..+ -..+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56999999997633 446888886521 2356788899999999988665444333 22222122 247899
Q ss_pred EeCCC--CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 123 FEKLG--SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 123 ~e~~~--~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+|-++ .+|.+++....-...+......++.+++.++.-||+.|+.|+|+.+.||+++..
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~------------------- 164 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE------------------- 164 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-------------------
Confidence 99884 699998866543345777778999999999999999999999999999999532
Q ss_pred ccccCCCCCCeEEeecCccc
Q 017021 201 YFKRMPKSSAIKVIDFGSTT 220 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~ 220 (379)
+...+.++||.-++
T Consensus 165 ------g~~~v~lIDlEk~r 178 (216)
T PRK09902 165 ------GKAEAGFLDLEKSR 178 (216)
T ss_pred ------CCeeEEEEEhhccc
Confidence 22358999997654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=8e-07 Score=82.43 Aligned_cols=189 Identities=15% Similarity=0.202 Sum_probs=117.2
Q ss_pred hhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee-------eecceE
Q 017021 47 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-------DYRNHI 119 (379)
Q Consensus 47 i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~-------~~~~~~ 119 (379)
..+.||+|+-+.+|..-... . -+.|++......-. .+.+..+... ..++-+..-..|= ..+..+
T Consensus 15 ~gr~LgqGgea~ly~l~e~~--d-~VAKIYh~Pppa~~--aqk~a~la~~----p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR--D-QVAKIYHAPPPAAQ--AQKVAELAAT----PDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhh--c-hhheeecCCCchHH--HHHHHHhccC----CCCcchhhhhcccHHHhhCCCcccee
Confidence 45789999999999874322 2 35688764322111 1112222221 1222221101110 112347
Q ss_pred EEEEeCC-C-CCHHHHHHh----CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 120 CIVFEKL-G-SSLYDFLRK----NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 120 ~lv~e~~-~-~sL~~~l~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
.++|+.. | ..+..+.+. +......+..+++....++.+.+.||..|..-||++++|+|++.++
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~----------- 154 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS----------- 154 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-----------
Confidence 8889988 3 244444432 2222467889999999999999999999999999999999995544
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCC--CCCcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHhC-
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERP--DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTG- 265 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~g- 265 (379)
.+.|.|-..--.... .-...+|..+|++||.-. +-.-+...|.|.||+++++++.|
T Consensus 155 ----------------~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~gg 218 (637)
T COG4248 155 ----------------KVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGG 218 (637)
T ss_pred ----------------eEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcC
Confidence 344444321111111 112347889999999875 22345778999999999999875
Q ss_pred CCCCCC
Q 017021 266 EALFQT 271 (379)
Q Consensus 266 ~~pf~~ 271 (379)
+.||.+
T Consensus 219 rHPysG 224 (637)
T COG4248 219 RHPYSG 224 (637)
T ss_pred CCCCCc
Confidence 999976
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=9e-07 Score=77.00 Aligned_cols=113 Identities=26% Similarity=0.295 Sum_probs=82.8
Q ss_pred hHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-cceEEEEEeCC-C-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH
Q 017021 83 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159 (379)
Q Consensus 83 ~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~-~-~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~ 159 (379)
...+.+|...+..+......-|..+-+...-.. ....++|+|++ + .+|.+++.... ..+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence 456778999888887765444443333221111 13568999999 4 48999987743 2566778889999999999
Q ss_pred HHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccc
Q 017021 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221 (379)
Q Consensus 160 ~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~ 221 (379)
-||..|++|+|+++.|||+... .....+.++||+-+..
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~------------------------~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPD------------------------DGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCC------------------------CCceeEEEEcchhcee
Confidence 9999999999999999999543 2345799999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.3e-06 Score=76.95 Aligned_cols=138 Identities=28% Similarity=0.346 Sum_probs=95.9
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-----------------------chhhHhHHHHHHHHHHHHh
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-----------------------KKYREAAMIEIEVLQQLAK 98 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------------------~~~~~~~~~e~~~l~~l~~ 98 (379)
+.-+.|..+||-|-=+.||.|.+. .|.++|+|.=... ...+..+.+|.+.|+++..
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred ChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 345668889999999999999976 5889999984310 1123556678999988854
Q ss_pred cCCCCCeeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEE
Q 017021 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 177 (379)
Q Consensus 99 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nil 177 (379)
.. -.++.-+++ +...+|||+. |..|...- +..+....++..|+.-+.-+-..|++|||+++=||+
T Consensus 169 ~G---~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIl 234 (304)
T COG0478 169 EG---VKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNIL 234 (304)
T ss_pred cC---CCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEE
Confidence 32 123333322 4567899999 65554331 234455555566666666666899999999999999
Q ss_pred EecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccc
Q 017021 178 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221 (379)
Q Consensus 178 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~ 221 (379)
+ +.++.+.++||-.+..
T Consensus 235 V---------------------------~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 235 V---------------------------TEDGDIVVIDWPQAVP 251 (304)
T ss_pred E---------------------------ecCCCEEEEeCccccc
Confidence 9 5667789999977654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.2e-06 Score=85.64 Aligned_cols=144 Identities=17% Similarity=0.237 Sum_probs=94.8
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc-----------------------------------------hhhHhHH
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-----------------------------------------KYREAAM 87 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----------------------------------------~~~~~~~ 87 (379)
+.|+.++-|.||+|+.+. |+.||||+...+- ..+-.+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 678899999999999765 9999999975210 0112233
Q ss_pred HHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-CCCHHHH--HHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 017021 88 IEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF--LRKNNYRSFPIDLVREIARQLLECIAFMHDL 164 (379)
Q Consensus 88 ~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~--l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 164 (379)
+|...+.++.....+.+.+..=.-+++..+.-.++|||+ |..+.++ +...+ .+.+.+.....++ .+..+=..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d~k~ia~~~~~~--f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---IDRKELAELLVRA--FLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CCHHHHHHHHHHH--HHHHHHhc
Confidence 466666677666655554332222344455678999999 7777777 44433 5544443333322 13344458
Q ss_pred CCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC
Q 017021 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225 (379)
Q Consensus 165 ~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~ 225 (379)
|+.|.|.+|.||++ ..++.+.+.|||......+.
T Consensus 285 gffHaDpHpGNi~v---------------------------~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 GFFHADPHPGNILV---------------------------RSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred CccccCCCccceEE---------------------------ecCCcEEEEcCcceecCCHH
Confidence 99999999999999 55677888888887665554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.6e-06 Score=74.72 Aligned_cols=122 Identities=18% Similarity=0.192 Sum_probs=68.0
Q ss_pred hhhhccccccceeEEEEEecCCCceEEEEEeeccchhhH----------hHHHHHHHHHHHHhcCCCCC---eeEEecce
Q 017021 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----------AAMIEIEVLQQLAKHDKGGN---RCVQIRNW 112 (379)
Q Consensus 46 ~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~----------~~~~e~~~l~~l~~~~~~~~---~i~~~~~~ 112 (379)
++.+.+-......|.+. ...|+.+++|.........+ ...+.+.....+.......+ .++.....
T Consensus 34 ~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~ 111 (229)
T PF06176_consen 34 KIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKI 111 (229)
T ss_pred eEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeee
Confidence 33333333333333333 34567788888753221111 11223343444433221111 22222333
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEe
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 179 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~ 179 (379)
+......+++|||+ |..|.+... +++ .+.-.+.+++.-+|+.|+.|||++|.|+++.
T Consensus 112 ~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 112 FRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS 169 (229)
T ss_pred ccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE
Confidence 33345567999999 777766532 222 2334577789999999999999999999993
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.35 E-value=8.1e-06 Score=71.27 Aligned_cols=136 Identities=17% Similarity=0.171 Sum_probs=90.5
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccch-------------------------hhHhHHHHHHHHHHHHhcCCCC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------------------------YREAAMIEIEVLQQLAKHDKGG 103 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------------------------~~~~~~~e~~~l~~l~~~~~~~ 103 (379)
..|++|-=+.||+|.. .++..+|+|++..... ......+|...|.++.....
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV-- 130 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV-- 130 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC--
Confidence 4677888889999974 5588999999963210 11223457777777765432
Q ss_pred CeeEEecceeeecceEEEEEeCCCCCH--HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEec
Q 017021 104 NRCVQIRNWFDYRNHICIVFEKLGSSL--YDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVS 180 (379)
Q Consensus 104 ~~i~~~~~~~~~~~~~~lv~e~~~~sL--~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~ 180 (379)
.+++=+.+ ..-.+||||+|..- .-.|.. -.+....+..+..+++..+.-|-. .|++|+||+.=|||+
T Consensus 131 -rvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~-- 200 (268)
T COG1718 131 -RVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV-- 200 (268)
T ss_pred -CCCCceee----cCCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE--
Confidence 22222222 23469999995431 111111 123444678888889888888866 999999999999999
Q ss_pred ccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccC
Q 017021 181 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223 (379)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~ 223 (379)
. ++.+.+||+|.|....
T Consensus 201 -------------------------~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 201 -------------------------H-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -------------------------E-CCeEEEEECccccccC
Confidence 3 5678999999986543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.35 E-value=9.5e-06 Score=71.57 Aligned_cols=72 Identities=13% Similarity=0.169 Sum_probs=51.9
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-C
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 127 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 127 (379)
.+||+|..+.||+. .+..+++|..... .......+|.+++..+.... ..+++.+.+.+..+..+++||++ |
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~g---lpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLG---IPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcC---CCCCceEEEEecCCeeeeeeeecCC
Confidence 57899999999984 2456889998642 23455678999999886533 23555666666677788999999 5
Q ss_pred C
Q 017021 128 S 128 (379)
Q Consensus 128 ~ 128 (379)
.
T Consensus 79 ~ 79 (226)
T TIGR02172 79 K 79 (226)
T ss_pred c
Confidence 4
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.7e-05 Score=70.04 Aligned_cols=78 Identities=21% Similarity=0.254 Sum_probs=55.5
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee---eecceEEEEEeC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF---DYRNHICIVFEK 125 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~---~~~~~~~lv~e~ 125 (379)
+.|+.|..+.||++.... ..+++|..... ........|..++..+..... .++.++... ......+++|++
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~---pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGI---PVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTS---BS--EEEEEEETEETSEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCC---CCceEEeecccccccccceEEEEE
Confidence 678999999999998655 47999998754 456677789999988876543 344554422 334568999999
Q ss_pred C-CCCHHH
Q 017021 126 L-GSSLYD 132 (379)
Q Consensus 126 ~-~~sL~~ 132 (379)
+ |.++..
T Consensus 77 i~g~~~~~ 84 (239)
T PF01636_consen 77 IPGRPLDD 84 (239)
T ss_dssp ESSEEHHH
T ss_pred eccccccc
Confidence 9 666666
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=5.2e-07 Score=87.67 Aligned_cols=245 Identities=16% Similarity=0.100 Sum_probs=159.5
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCe-eEEecceeeecceEEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR-CVQIRNWFDYRNHICIV 122 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~-i~~~~~~~~~~~~~~lv 122 (379)
-|...+-+++|+++.+++.+...+...+ .+.+... .....+++.|.++ ++|| .+..++.++.+...++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~-----n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKV-----NNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHc-----cCCCCcccccccCCcccccchh
Confidence 3445567799999999999876655544 7776643 3334478888888 6677 77778888888999999
Q ss_pred EeCC-CC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 123 FEKL-GS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 123 ~e~~-~~-sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
++++ ++ +....+.... ..+..-+...+...-..+|+++|+.-=+|+| ||+..
T Consensus 313 ~~i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s--------------------- 366 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS--------------------- 366 (829)
T ss_pred hhhhcCCccccccCChhh-HhhhhhhhhhhhhhhcccccccccccccCcc----ccccc---------------------
Confidence 9999 44 2222221111 1244445666667778889999988778887 77663
Q ss_pred ccccCCCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
+...++.+|+........ .+...+|+.++|||+.....+....|.|++|.--.++.-|-+|-.++....
T Consensus 367 -------~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~-- 437 (829)
T KOG0576|consen 367 -------EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVL-- 437 (829)
T ss_pred -------ccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcccc--
Confidence 244566666665544443 455678999999999999899999999999987667776766554311000
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH-HHHhhccccCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT-HLLQGLLRYDP 357 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~li~~~L~~dP 357 (379)
-..|..| .. +.+... . .++.... ++...|+..-|
T Consensus 438 ----~~~g~~p---------------------------~s---------~~L~~~--~---aw~~~~~~~~~~~~~~g~P 472 (829)
T KOG0576|consen 438 ----PMIGNGP---------------------------NS---------PMLTDK--S---AWSPVFHRDFPAPCLNGLP 472 (829)
T ss_pred ----CCCCCCC---------------------------Cc---------cccchh--h---hcCcccccCCcccccCCCC
Confidence 0000000 00 000000 0 0111112 47788999999
Q ss_pred CCCcCHHHHhcCCCCCCCCcC
Q 017021 358 TDRLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f~~~~~~ 378 (379)
..|+.+..++.|.+|.+=.+|
T Consensus 473 ~~pkv~mgacfsKvfngCpl~ 493 (829)
T KOG0576|consen 473 PTPKVHMGACFSKVFNGCPLR 493 (829)
T ss_pred CCCcchhhHHHHHHhccCccc
Confidence 999999999999999876655
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.21 E-value=5.5e-05 Score=64.98 Aligned_cols=123 Identities=15% Similarity=0.261 Sum_probs=92.3
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc-----------------hhhHhHHHHHHHHHHHH-hcCCCCCeeEEec
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-----------------KYREAAMIEIEVLQQLA-KHDKGGNRCVQIR 110 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----------------~~~~~~~~e~~~l~~l~-~~~~~~~~i~~~~ 110 (379)
..||+|+.-.||.-- . +....||+..... .......+|+....++. .......++++++
T Consensus 7 ~~i~~G~~R~cy~HP--~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP--D-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC--C-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 678999999999763 3 2336889886443 23456677888888887 6666678899999
Q ss_pred ceeeecceEEEEEeCC-------CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecc
Q 017021 111 NWFDYRNHICIVFEKL-------GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS 181 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~-------~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~ 181 (379)
++.+++--..+|+|.+ ..+|.+++.... ++. .+...+.++ .++|-..+|+.+|++|.||++...
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~~f---~~~l~~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALDEF---KRYLLDHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHHHH---HHHHHHcCCeecCCCcccEEEEec
Confidence 9999998899999976 247888885543 555 444444444 567789999999999999999654
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.3e-05 Score=66.42 Aligned_cols=77 Identities=14% Similarity=0.086 Sum_probs=52.6
Q ss_pred hccccccc-eeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-
Q 017021 49 SKMGEGTF-GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 126 (379)
Q Consensus 49 ~~Lg~G~~-g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~- 126 (379)
..|-.|.. +.||++... +..+.+|+..... ......|..++..+... ..+++++.+...++..++||+++
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~----~~vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGK----LPVPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhc----CCCCeEEEEEecCCccEEEEEeeC
Confidence 34555655 788999643 4678999886432 33456789888888653 33666666666666789999999
Q ss_pred CCCHHHH
Q 017021 127 GSSLYDF 133 (379)
Q Consensus 127 ~~sL~~~ 133 (379)
|.++.+.
T Consensus 76 G~~l~~~ 82 (244)
T cd05150 76 GVPAAAL 82 (244)
T ss_pred CccHhHh
Confidence 7666543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.0001 Score=72.09 Aligned_cols=144 Identities=14% Similarity=0.136 Sum_probs=89.6
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeecc--------------------------------ch------hhHhHHHHH
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGI--------------------------------KK------YREAAMIEI 90 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------------------------~~------~~~~~~~e~ 90 (379)
+.||..+.|.||+|+.+. |+.||+|+-... +. .+-.+.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 688999999999999776 999999996421 00 112223344
Q ss_pred HHHHHHHhcCCCCC-----eeEEecceeeecceEEEEEeCC-CCCHH--HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 017021 91 EVLQQLAKHDKGGN-----RCVQIRNWFDYRNHICIVFEKL-GSSLY--DFLRKNNYRSFPIDLVREIARQLLECIAFMH 162 (379)
Q Consensus 91 ~~l~~l~~~~~~~~-----~i~~~~~~~~~~~~~~lv~e~~-~~sL~--~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH 162 (379)
+...+..+...+.. .|++++..+ .....++|||+ |..+. +.+++.+ ++...+..-+.+.. +.-+=
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~--~~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAY--LEQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHH--HHHHH
Confidence 44333333221111 244444333 44578999999 65444 4455544 66665544443332 23344
Q ss_pred HcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccC
Q 017021 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223 (379)
Q Consensus 163 ~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~ 223 (379)
..|++|+|-+|.||++..++ ..+..+.+-|||+.....
T Consensus 319 ~~GffHaDPHPGNilv~~~~-----------------------~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNP-----------------------EGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCC-----------------------CCCccEEEEccccccccc
Confidence 78899999999999996543 356788999999876433
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.89 E-value=7.6e-05 Score=63.71 Aligned_cols=125 Identities=18% Similarity=0.228 Sum_probs=85.1
Q ss_pred eeechhhhhhhhccccccc-eeEEEEEecCCCceEEEEEeec-----c----------c-------hhhHhHHHHHHHHH
Q 017021 38 IVFSAFADKIHSKMGEGTF-GQVLECWDRERKEMVAIKIVRG-----I----------K-------KYREAAMIEIEVLQ 94 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~-g~V~~~~~~~~~~~vAiK~~~~-----~----------~-------~~~~~~~~e~~~l~ 94 (379)
+......++.++.||.|.- |.||+++ ..|+.+|||++.. . . .....+..|.....
T Consensus 32 F~~h~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg 109 (207)
T PF13095_consen 32 FTHHGDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG 109 (207)
T ss_pred cCCCCCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence 3334567888899999999 9999996 4578999999421 0 0 12234556888888
Q ss_pred HHHhcCCCCCeeEEecceeeec------------------ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHH
Q 017021 95 QLAKHDKGGNRCVQIRNWFDYR------------------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 156 (379)
Q Consensus 95 ~l~~~~~~~~~i~~~~~~~~~~------------------~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~ 156 (379)
++......+..-+++++|..-. ....||.|+....- .+.... +.+|..
T Consensus 110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~ 175 (207)
T PF13095_consen 110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLR 175 (207)
T ss_pred HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHH
Confidence 8876554333358888887311 13567888772211 123333 345777
Q ss_pred HHHHHHHcCCcccCCCCCcEEE
Q 017021 157 CIAFMHDLCMIHTDLKPENVLL 178 (379)
Q Consensus 157 aL~~LH~~~iiH~dlkp~Nili 178 (379)
-+..+|+.||+-+|+++.|..=
T Consensus 176 dl~~~~k~gI~~~Dv~~~ny~~ 197 (207)
T PF13095_consen 176 DLKILHKLGIVPRDVKPRNYRG 197 (207)
T ss_pred HHHHHHHCCeeeccCccccccC
Confidence 7889999999999999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00014 Score=75.85 Aligned_cols=199 Identities=23% Similarity=0.302 Sum_probs=121.6
Q ss_pred HHHHHHHHHhcCCCCCeeEEecceeeecce----EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 017021 89 EIEVLQQLAKHDKGGNRCVQIRNWFDYRNH----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163 (379)
Q Consensus 89 e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~----~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 163 (379)
|+..+..+ .|.|++.++.+.-.... ..+..+++ +.++...+..-. ..+....+.+..++..||.++|+
T Consensus 232 e~~~l~k~-----~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 232 ELESLSKI-----AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHhh-----ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH
Confidence 44445555 55677766665543322 23445677 778888887765 68899999999999999999999
Q ss_pred cCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEe--ecCcccccCCCCC--cccccCCccchh
Q 017021 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI--DFGSTTYERPDQN--YIVSTRHYRAPE 239 (379)
Q Consensus 164 ~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--Dfg~~~~~~~~~~--~~~gt~~y~aPE 239 (379)
... .++.+...... ....++.+..... ||+.+........ ...-+..+.+||
T Consensus 305 ~~l-------~~v~L~~s~~~-----------------~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e 360 (1351)
T KOG1035|consen 305 LSL-------EHVVLSASSSK-----------------ESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADE 360 (1351)
T ss_pred hcc-------ceeEEeccccc-----------------ccccCccceeecchhhhcccccCCCcccchhhcCcccccccc
Confidence 833 34444221000 0001333444444 6666654333321 122344567787
Q ss_pred hhhCCCCC--CccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCc
Q 017021 240 VILGLGWT--YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS 317 (379)
Q Consensus 240 ~~~~~~~~--~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (379)
......+. ...|+|.+|.....+..|..+-...... ...+..
T Consensus 361 ~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~------~~~l~~------------------------------ 404 (1351)
T KOG1035|consen 361 DLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP------VSLLDV------------------------------ 404 (1351)
T ss_pred ccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch------hhhhcc------------------------------
Confidence 77665544 4479999999999888765433211100 000000
Q ss_pred hhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 318 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
.......+.+.+|+.-++++|+++.+++.|||.+...
T Consensus 405 ----------------------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 405 ----------------------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred ----------------------ccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 0111567788999999999999999999999987543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00031 Score=58.30 Aligned_cols=134 Identities=22% Similarity=0.217 Sum_probs=88.0
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
..+.-++.+.|++|.+|.||++.++ |..+|+|+-. .+..+.....|.+++..+.... .-+.++.+- ..+
T Consensus 20 ~~~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~----~~p~vy~yg----~~~ 88 (201)
T COG2112 20 GKYELRVEKELAKGTTSVVYLGEWR--GGEVALKVRR-RDSPRRNLEKEAKILEILAGEG----VTPEVYFYG----EDF 88 (201)
T ss_pred cchhhhhhhhhhcccccEEEEeecc--CceEEEEEec-CCcchhhHHHHHHHHHHhhhcC----CCceEEEec----hhh
Confidence 3444567889999999999999765 4689999877 4555778888999988874432 122333222 233
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCC-CCcEEEecccccccCCCccCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLK-PENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlk-p~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
+.|||+ |.+|.+..... +... +..++.+---|-..||-|+.+. |...++
T Consensus 89 i~me~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vl-------------------- 139 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVL-------------------- 139 (201)
T ss_pred hhhhhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEE--------------------
Confidence 559999 76887765421 1222 2345555444567899999886 444444
Q ss_pred CcccccCCCCCCeEEeecCcccc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTY 221 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~ 221 (379)
-.+..+.|+||.-|..
T Consensus 140 -------v~~~~~~iIDFd~At~ 155 (201)
T COG2112 140 -------VNDRDVYIIDFDSATF 155 (201)
T ss_pred -------ecCCcEEEEEccchhh
Confidence 2334789999998863
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.0002 Score=63.55 Aligned_cols=73 Identities=14% Similarity=0.086 Sum_probs=44.6
Q ss_pred hccccccce-eEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhc-CCCCCeeEEecceeee---cceEEEEE
Q 017021 49 SKMGEGTFG-QVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH-DKGGNRCVQIRNWFDY---RNHICIVF 123 (379)
Q Consensus 49 ~~Lg~G~~g-~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~-~~~~~~i~~~~~~~~~---~~~~~lv~ 123 (379)
+.|+.||.. .||+.. ..+++|.... .........|..++..+... ... ++..+...+. ....|++|
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~---vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLP---VPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCC---CCceeecCCCccCCCcceEEE
Confidence 567877776 589762 3477887653 22345677899999888653 222 3333333222 23458899
Q ss_pred eCC-CCCH
Q 017021 124 EKL-GSSL 130 (379)
Q Consensus 124 e~~-~~sL 130 (379)
+++ |.++
T Consensus 74 ~~i~G~~l 81 (235)
T cd05155 74 RWLEGETA 81 (235)
T ss_pred EeecCCCC
Confidence 998 6554
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0011 Score=61.39 Aligned_cols=139 Identities=20% Similarity=0.248 Sum_probs=93.9
Q ss_pred hhhhccccccceeEEEEEecCCCceEEEEEeecc--------------------------ch-hhHhHHHHHHHHHHHHh
Q 017021 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--------------------------KK-YREAAMIEIEVLQQLAK 98 (379)
Q Consensus 46 ~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------------------~~-~~~~~~~e~~~l~~l~~ 98 (379)
.|..+|..|-=+.||.|. ..+|..+|||+++.+ .+ ....+.+|+..|.++..
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 355788889999999998 566888999999621 00 12334568888888866
Q ss_pred cCCCCCeeEEecceeeecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCCcccCCCCCcEE
Q 017021 99 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM-HDLCMIHTDLKPENVL 177 (379)
Q Consensus 99 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~L-H~~~iiH~dlkp~Nil 177 (379)
.....|--+-+ ....|||+++|.+=...-.- ....++...+..+-.+++.-+.-| |.+++||.||.-=|+|
T Consensus 226 aGIP~PePIlL-------k~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L 297 (520)
T KOG2270|consen 226 AGIPCPEPILL-------KNHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL 297 (520)
T ss_pred cCCCCCCceee-------ecceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence 54333321111 33479999995331111001 112477777888888888777776 6889999999999999
Q ss_pred EecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccc
Q 017021 178 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221 (379)
Q Consensus 178 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~ 221 (379)
+ -++.+.+||-+.+..
T Consensus 298 y----------------------------hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 298 Y----------------------------HDGKLYIIDVSQSVE 313 (520)
T ss_pred E----------------------------ECCEEEEEEcccccc
Confidence 9 356789999988764
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00085 Score=70.62 Aligned_cols=78 Identities=17% Similarity=0.122 Sum_probs=51.5
Q ss_pred hccccccceeEEEEEecCCC--ceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---ceEEE
Q 017021 49 SKMGEGTFGQVLECWDRERK--EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---NHICI 121 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~--~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~---~~~~l 121 (379)
+.++.|.++.+|+......+ ..+++|+..... .......+|..++..+..+ ....+++.+.++.+. +..|+
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~--~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEH--TDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhc--CCCCCCcEEEEecCCCcCCCceE
Confidence 67788999999998765432 467888765322 1234567899999888532 123356666665543 46889
Q ss_pred EEeCC-CC
Q 017021 122 VFEKL-GS 128 (379)
Q Consensus 122 v~e~~-~~ 128 (379)
|||++ |.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99999 43
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0011 Score=58.79 Aligned_cols=74 Identities=15% Similarity=0.317 Sum_probs=45.7
Q ss_pred hccccccceeEEEEEecC-CCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-
Q 017021 49 SKMGEGTFGQVLECWDRE-RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 126 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~-~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~- 126 (379)
+.|..|-...+|++.... .++.|++|+.............|..++..+..... .++++.... + .++|||+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl----~P~v~~~~~-~---~~l~e~i~ 75 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGL----APKLYATFQ-N---GLIYEFIP 75 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCC----CCeEEEEeC-C---cEEEEeeC
Confidence 567778888999997543 35679999876432222333468888888765432 233333332 1 3799998
Q ss_pred CCCH
Q 017021 127 GSSL 130 (379)
Q Consensus 127 ~~sL 130 (379)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 6544
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0033 Score=60.00 Aligned_cols=74 Identities=23% Similarity=0.231 Sum_probs=50.4
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeec-----cc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRG-----IK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
+.||.|.+..||++.+...++.|+||.-.. .+ ....+...|.+.|..+..... ..+++++.+. ....+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p--~~VPkV~~~D--~~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVP--DLVPKVYHYD--EELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCC--CCCCeEEEEC--CCCCE
Confidence 678999999999999865446899998431 01 123455668888887754322 3466666553 35578
Q ss_pred EEEeCC
Q 017021 121 IVFEKL 126 (379)
Q Consensus 121 lv~e~~ 126 (379)
+|||++
T Consensus 108 lVME~L 113 (401)
T PRK09550 108 TVMEDL 113 (401)
T ss_pred EEEecC
Confidence 999998
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0013 Score=60.49 Aligned_cols=74 Identities=11% Similarity=0.040 Sum_probs=47.7
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecc------eeeecceEEEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN------WFDYRNHICIV 122 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~------~~~~~~~~~lv 122 (379)
+.|..|....+|+... .+..+++|+... ........|..++..+...... ++..+. +...++..+++
T Consensus 20 ~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~---vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 20 EGISAGIENTNYFVTT--DSGRYVLTLFEK--VSAEELPFFLALLDHLAERGLP---VPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred ecccCccccceEEEEe--CCCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCC---CCccccCCCCcEeeeeCCceEEE
Confidence 5677787789999863 345699999864 2345566788888888664322 333322 12334567899
Q ss_pred EeCC-CCC
Q 017021 123 FEKL-GSS 129 (379)
Q Consensus 123 ~e~~-~~s 129 (379)
++++ |..
T Consensus 93 ~~~i~G~~ 100 (296)
T cd05153 93 VEFLAGEH 100 (296)
T ss_pred EEeCCCCC
Confidence 9999 544
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0023 Score=57.62 Aligned_cols=71 Identities=13% Similarity=0.038 Sum_probs=43.4
Q ss_pred ccccccceeEEEEEecCCCceEEEEEeeccchh-hHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-C
Q 017021 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 127 (379)
Q Consensus 50 ~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 127 (379)
.+..|-.+.+|+.. .+++.+++|+....... ......|..++..+..... .|.++ ... + -++|+|++ |
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~-~P~~i---~~~--~--~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGL-APKPI---LVN--E--HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCC-CCceE---EEe--C--CEEEEEeccC
Confidence 45568888999986 44667899986533221 1234668888888865432 23332 222 1 26899998 5
Q ss_pred CCH
Q 017021 128 SSL 130 (379)
Q Consensus 128 ~sL 130 (379)
..+
T Consensus 73 ~~~ 75 (256)
T TIGR02721 73 EVI 75 (256)
T ss_pred ccc
Confidence 443
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0079 Score=55.97 Aligned_cols=76 Identities=13% Similarity=0.050 Sum_probs=44.5
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEec-c--eeeecceEEEEEeC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-N--WFDYRNHICIVFEK 125 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~-~--~~~~~~~~~lv~e~ 125 (379)
+.|+.|....+|..... +..+++|++.. ........|...+..+.......|.++... + +....+..++++++
T Consensus 28 ~~l~~G~~n~~y~v~t~--~g~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTT--QGEYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeC--CCcEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 45677777899998643 34689998752 123344456677777755433333332211 1 12235668899999
Q ss_pred C-CC
Q 017021 126 L-GS 128 (379)
Q Consensus 126 ~-~~ 128 (379)
. |.
T Consensus 104 l~G~ 107 (319)
T PRK05231 104 LEGK 107 (319)
T ss_pred cCCC
Confidence 8 54
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0014 Score=63.15 Aligned_cols=90 Identities=24% Similarity=0.266 Sum_probs=61.1
Q ss_pred CccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccc
Q 017021 248 YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 327 (379)
Q Consensus 248 ~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (379)
+++||||+|.++.++.-|...+......+....+.++.-. +.+.....++.
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~-d~~~~~~a~e~---------------------------- 160 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTD-DQELLSTAMEH---------------------------- 160 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccC-chhHHHHHHHH----------------------------
Confidence 5999999999999999998777665665655555554321 11111111110
Q ss_pred hhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 328 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
...-......+++..+|+-..|..||...++.+++-|++
T Consensus 161 --------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 161 --------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred --------HHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 111124456888999999999999999999999988764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.014 Score=53.98 Aligned_cols=75 Identities=12% Similarity=0.014 Sum_probs=44.0
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecc---eeeecceEEEEEeC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN---WFDYRNHICIVFEK 125 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~---~~~~~~~~~lv~e~ 125 (379)
+.++.|....+|++.. . +..+++|+..... .......|..++..+.......+.++...+ .....+..++++++
T Consensus 28 ~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTT-D-VGRYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEe-C-CCcEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 5667777789999863 3 3468899875421 233445677777777554322222222111 11234667899999
Q ss_pred C
Q 017021 126 L 126 (379)
Q Consensus 126 ~ 126 (379)
+
T Consensus 105 i 105 (307)
T TIGR00938 105 L 105 (307)
T ss_pred C
Confidence 8
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0052 Score=56.70 Aligned_cols=74 Identities=15% Similarity=0.128 Sum_probs=45.2
Q ss_pred hccccccceeEEEEEecC------CCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 49 SKMGEGTFGQVLECWDRE------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~------~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
+.|..|-...+|++.... +++.+++|+.............|..++..+..... .++++..+.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~----~P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNL----GPKLYGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCC----CCceEEEeCC----Cch
Confidence 345556677889887543 25789999976543333455678888888866442 2334433332 257
Q ss_pred EeCC-CCCH
Q 017021 123 FEKL-GSSL 130 (379)
Q Consensus 123 ~e~~-~~sL 130 (379)
++++ |..+
T Consensus 76 ~e~i~G~~l 84 (302)
T cd05156 76 EEFIPSRTL 84 (302)
T ss_pred hheeCCCcC
Confidence 7887 5443
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.023 Score=53.21 Aligned_cols=82 Identities=20% Similarity=0.182 Sum_probs=50.6
Q ss_pred ccccccceeEEEEEecCCCceEEEEEee----c-c---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 50 KMGEGTFGQVLECWDRERKEMVAIKIVR----G-I---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 50 ~Lg~G~~g~V~~~~~~~~~~~vAiK~~~----~-~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.||.|....||++.+...++.|+||.-. . . .....+...|...|.......+ ..+++++.+ ++....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P--~~vP~vy~~--D~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVP--HLVPRIFHF--DTEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCc--cccCeEEEE--cccccee
Confidence 5799999999999986544689999842 1 1 1223444567777776654332 245555433 3445568
Q ss_pred EEeCC--CCCHHHHHH
Q 017021 122 VFEKL--GSSLYDFLR 135 (379)
Q Consensus 122 v~e~~--~~sL~~~l~ 135 (379)
|||++ ...|...+-
T Consensus 78 vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 78 VMEDLSHHKIARKGLI 93 (370)
T ss_pred hHhhCccchHHHHHHH
Confidence 89988 344545443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.005 Score=56.20 Aligned_cols=125 Identities=18% Similarity=0.250 Sum_probs=81.4
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeec----------c---------c----hhhHhHHHHHHHHHHHHh
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----------I---------K----KYREAAMIEIEVLQQLAK 98 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~----------~---------~----~~~~~~~~e~~~l~~l~~ 98 (379)
+--+.+...||-|-=+.||.+-+.. |++.++|.=.. + . ..+..+.+|...+..+..
T Consensus 91 ~~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 91 GSVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred chhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 3355678899999999999998654 77888887321 0 0 123445567777777755
Q ss_pred cCCCCCeeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEE
Q 017021 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 177 (379)
Q Consensus 99 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nil 177 (379)
+.- .+++-++ .+..++|||+. |..|.+.-.-. . +..+...++.-+--|..+|+||||.+-=||+
T Consensus 170 ~gf---pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~-----d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNim 234 (465)
T KOG2268|consen 170 RGF---PVPKPID----HNRHCVVMELVDGYPLRQVRHVE-----D---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIM 234 (465)
T ss_pred cCC---CCCCccc----ccceeeHHHhhcccceeeeeecC-----C---hHHHHHHHHHHHHHHHHcCceecccchheeE
Confidence 332 2333332 34568899999 77776553222 2 2233344555566788999999999999999
Q ss_pred Eeccc
Q 017021 178 LVSSE 182 (379)
Q Consensus 178 i~~~~ 182 (379)
+..++
T Consensus 235 v~dd~ 239 (465)
T KOG2268|consen 235 VKDDD 239 (465)
T ss_pred EecCC
Confidence 95433
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.017 Score=53.20 Aligned_cols=73 Identities=11% Similarity=0.015 Sum_probs=41.0
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeec---cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc--eEEEEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--HICIVF 123 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~--~~~lv~ 123 (379)
+....|....+|...+. ++.+++. ... .........+|..++..+... ...++..+..+.++. ..|.||
T Consensus 31 ~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~---~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 31 EEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDV---DVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCC---CCCCcccccccccCCCCCceEEE
Confidence 33333444455665443 7788888 331 112223334466666665332 334566666666655 789999
Q ss_pred eCC-C
Q 017021 124 EKL-G 127 (379)
Q Consensus 124 e~~-~ 127 (379)
+++ |
T Consensus 105 ~~veG 109 (321)
T COG3173 105 EWVEG 109 (321)
T ss_pred EEecc
Confidence 999 5
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.031 Score=52.62 Aligned_cols=74 Identities=15% Similarity=0.091 Sum_probs=43.4
Q ss_pred hccccccceeEEEEEecC----CCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEe
Q 017021 49 SKMGEGTFGQVLECWDRE----RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 124 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~----~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e 124 (379)
+.|-.|-...+|++.... +++.|++|+.............|..++..+..... .| ++++.+..+ .|.+
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl-~P---~~~~~~~~g----~v~e 113 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQ-GP---RLLGRFPNG----RVEE 113 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCC-CC---ceEEEECCc----eEEE
Confidence 344457778899986432 34689999886433333333568888888866543 23 333444322 4677
Q ss_pred CC-CCCH
Q 017021 125 KL-GSSL 130 (379)
Q Consensus 125 ~~-~~sL 130 (379)
|+ +.++
T Consensus 114 fi~g~~l 120 (344)
T PLN02236 114 FIHARTL 120 (344)
T ss_pred eeCCCCC
Confidence 77 4443
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.053 Score=51.50 Aligned_cols=83 Identities=24% Similarity=0.312 Sum_probs=52.0
Q ss_pred hhccccccceeEEEEEecCCCceEEEEEee----cc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 48 HSKMGEGTFGQVLECWDRERKEMVAIKIVR----GI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 48 ~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~----~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.+.||.|.-..||++.+...++.|+||.-. .. .....+...|.+.|.......++ .+++++.+ ++....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~--~VP~vy~~--D~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPG--LVPKVYLF--DSVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCC--cCCeEEEE--CcHHhh
Confidence 378899999999999985445679999842 11 12235556688888877664432 35555533 344456
Q ss_pred EEEeCC--CCCHHHHH
Q 017021 121 IVFEKL--GSSLYDFL 134 (379)
Q Consensus 121 lv~e~~--~~sL~~~l 134 (379)
+|||++ ...|.+.+
T Consensus 110 ~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 110 CVMEDLSDHTILRTAL 125 (409)
T ss_pred HHHHhCcccHHHHHHH
Confidence 778887 23344443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.062 Score=50.29 Aligned_cols=73 Identities=12% Similarity=0.226 Sum_probs=42.0
Q ss_pred hccccccceeEEEEEecCC---CceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeC
Q 017021 49 SKMGEGTFGQVLECWDRER---KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 125 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 125 (379)
+.|..|-...+|++..... +..|++|+..........-..|..++..+...... ++++.++. ++ +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~----P~~l~~~~-~G---~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFG----AKLLGVFG-NG---MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCC----CceeEEeC-Cc---Eeehh
Confidence 3444477778898865432 34789998764333333445688888888665432 33333342 22 46777
Q ss_pred C-CCC
Q 017021 126 L-GSS 129 (379)
Q Consensus 126 ~-~~s 129 (379)
+ +..
T Consensus 92 i~g~~ 96 (330)
T PLN02421 92 INART 96 (330)
T ss_pred hcCCC
Confidence 7 443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.28 Score=45.75 Aligned_cols=71 Identities=14% Similarity=0.054 Sum_probs=42.0
Q ss_pred cceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecc--eeeecceEEEEEeCC
Q 017021 55 TFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN--WFDYRNHICIVFEKL 126 (379)
Q Consensus 55 ~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~--~~~~~~~~~lv~e~~ 126 (379)
.-..||++.. .++..+++|+.............|+..+..+.......+.-+..-+ ....++..+.+++++
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeee
Confidence 3456888863 4456799998864333455666788888888664322111111111 223356778899988
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.093 Score=48.33 Aligned_cols=104 Identities=15% Similarity=0.137 Sum_probs=70.7
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee---cceEEEEEeC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---RNHICIVFEK 125 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~---~~~~~lv~e~ 125 (379)
+.||.|..+.||..... +..+++|..+. ......+..|...+..+.... ...++++++.+.. .+..++|||+
T Consensus 20 ~~i~~G~~~~vy~~~~~--~~~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~--~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 20 ECISEQPYAALWALYDS--QGNPMPLMARS-FSTPGVAQQEAWKLSMLARSG--TVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eecCCccceeEEEEEcC--CCCEEEEEecc-cccchHHHHHHHHHHHHccCC--CCCcCcEEEEeccCCcCCCeEEEEec
Confidence 67899999999998632 23477787542 223456777999998885532 2346666665543 4678999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 017021 126 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164 (379)
Q Consensus 126 ~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 164 (379)
+ |.++.+. .........+..+++.+|..||+.
T Consensus 95 i~G~~~~~~-------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 95 LRGVSVEAP-------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred cCCEecCCC-------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9 7666541 123444556667888999999975
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.04 Score=47.02 Aligned_cols=84 Identities=24% Similarity=0.229 Sum_probs=59.3
Q ss_pred HHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-CCCHHHH---HHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-
Q 017021 89 EIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF---LRKNNYRSFPIDLVREIARQLLECIAFMHD- 163 (379)
Q Consensus 89 e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~---l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~- 163 (379)
|.-+++.+.. ..+++++++++ ++ +++.||. .+++... +.... ..++.....++.+++..+.+++.
T Consensus 9 E~lll~~l~~----~~~~pk~lG~C---G~-~~v~E~~~~~~~~~~~~~l~~~~--~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 9 EPLLLQLLQG----SEPFPKLLGSC---GR-FYVVEYVGAGSLYGIYRPLSQFL--QSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred HHHHHHHcCC----CCCCCCeeeEC---CC-EEEEEeecCcccccccccccccc--ccCHHHHHHHHHHHHHHHHHHhcC
Confidence 6666666632 24789999888 32 4688998 4554321 11111 36789999999999999999986
Q ss_pred --cCCcccCCCCCcEEEeccc
Q 017021 164 --LCMIHTDLKPENVLLVSSE 182 (379)
Q Consensus 164 --~~iiH~dlkp~Nili~~~~ 182 (379)
..+.-.|++|+|+-+..++
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~ 99 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDG 99 (188)
T ss_pred CCCcEEEeecchHHeEEeCCC
Confidence 3477889999999995443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.087 Score=47.94 Aligned_cols=45 Identities=27% Similarity=0.150 Sum_probs=28.1
Q ss_pred cccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhc
Q 017021 53 EGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH 99 (379)
Q Consensus 53 ~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~ 99 (379)
+|-...|+.+. ...|+.+++|.-.. ........+|..++..+...
T Consensus 21 ~g~~~~v~~i~-~~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~~ 65 (276)
T cd05152 21 SGLDFQVVFAK-DTDGVPWVLRIPRR-PDVSERAAAEKRVLALVRKH 65 (276)
T ss_pred CcceeEEEEEE-cCCCCeEEEEecCC-HHHHHHHHHHHHHHHHHHhc
Confidence 33344555553 34477888888753 22345567899999988653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.16 Score=48.55 Aligned_cols=73 Identities=15% Similarity=0.114 Sum_probs=47.2
Q ss_pred hhccccccceeEEEEEecCCCceEEEEEee-----ccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 48 HSKMGEGTFGQVLECWDRERKEMVAIKIVR-----GIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 48 ~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~-----~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.+.||.|....||++.+. ++.++||+-. ... ....+...|...|..+.... ..++++++.+.+ +..
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~--p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLC--PDHVPEVYHFDR--TMA 110 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcC--CCCCCeEEEECC--CCC
Confidence 378899999999999863 4568999854 111 12334445666666654322 135777776665 446
Q ss_pred EEEEeCC
Q 017021 120 CIVFEKL 126 (379)
Q Consensus 120 ~lv~e~~ 126 (379)
+++||++
T Consensus 111 vlvME~L 117 (418)
T PLN02756 111 LIGMRYL 117 (418)
T ss_pred EEEEeec
Confidence 7789999
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.0042 Score=67.06 Aligned_cols=141 Identities=13% Similarity=-0.001 Sum_probs=97.5
Q ss_pred CCeeEEecceeee--cceEEEEEeCC-CCCHHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHcC-----CcccCCC
Q 017021 103 GNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYR--SFPIDLVREIARQLLECIAFMHDLC-----MIHTDLK 172 (379)
Q Consensus 103 ~~~i~~~~~~~~~--~~~~~lv~e~~-~~sL~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~-----iiH~dlk 172 (379)
|+++.....-... ...-+..++++ +|.+.+++-+.-.+ .+...-+...-.+.+.+..-+|+.. .+|+++|
T Consensus 1288 h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lk 1367 (2724)
T KOG1826|consen 1288 HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLK 1367 (2724)
T ss_pred ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhh
Confidence 3444444333332 23467889999 99999998664322 2333334333333377777777532 6999999
Q ss_pred CCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCc
Q 017021 173 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYP 249 (379)
Q Consensus 173 p~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~ 249 (379)
+.|.++ ..+..+++.++|+.+..++.. ....+++.|+.|++.....++.+
T Consensus 1368 f~lpmI---------------------------Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r 1420 (2724)
T KOG1826|consen 1368 FTLPMI---------------------------VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR 1420 (2724)
T ss_pred hhccce---------------------------ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH
Confidence 999999 566777888888887444443 22356778899999988889988
Q ss_pred cchHhHHHHHHHHHhCCCCCC
Q 017021 250 CDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 250 sDvwSlG~il~~l~~g~~pf~ 270 (379)
+|+|..|+-+|....|..+|.
T Consensus 1421 sdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1421 SDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHHHHHHHhcccHHHH
Confidence 999999999999888877663
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.12 Score=47.24 Aligned_cols=72 Identities=18% Similarity=0.217 Sum_probs=47.6
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
+.++.|.-..+|+.. .+++.+.+|+-. ......+..|..-|..+... ....+++.+.+....+..|+++|+.
T Consensus 23 ~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~--~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEA--NPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp EEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHT--TTSBS--EEEEEE-SSCCEEEEE--
T ss_pred EecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhc--CCCCCCeEEEEEeecCCceEEEEee
Confidence 567878889999986 667889999876 33345566788888888543 2345777777777777779999998
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.63 Score=50.37 Aligned_cols=81 Identities=15% Similarity=0.094 Sum_probs=45.3
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcC--CCCCeeEEec-ce----eee-cc--e
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD--KGGNRCVQIR-NW----FDY-RN--H 118 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~--~~~~~i~~~~-~~----~~~-~~--~ 118 (379)
+.|+ |..-.+|++.. .+|..+++|+.+... .......|...+..+.... ...|.++... +- ... ++ +
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 45677888863 456679999997532 2334444666777665542 2223333222 11 111 12 5
Q ss_pred EEEEEeCC-CCCHHH
Q 017021 119 ICIVFEKL-GSSLYD 132 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~ 132 (379)
.+.+++|. |..+.+
T Consensus 108 ~vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 108 LLRLLSWLPGTPLAE 122 (1013)
T ss_pred EEEEEeccCCCcHHh
Confidence 77889999 655554
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.21 Score=43.47 Aligned_cols=108 Identities=13% Similarity=0.187 Sum_probs=61.7
Q ss_pred cccceeEEEEEecCCCceEEEEEeeccc-h-hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-CCC
Q 017021 53 EGTFGQVLECWDRERKEMVAIKIVRGIK-K-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 129 (379)
Q Consensus 53 ~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~-~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s 129 (379)
-|+.++.-.+..+. |. ..+|++...+ . ...-+..+..+++++ ..++++.. +.+-.+.++.|.| ...
T Consensus 72 ~~gNsTl~~~kt~i-G~-L~lKKi~slp~~~~~~~y~nky~v~Arm-------hGilrL~N--Dn~~~yGvIlE~Cy~~~ 140 (308)
T PF07387_consen 72 FNGNSTLLIGKTKI-GP-LFLKKIRSLPCCINDALYFNKYRVFARM-------HGILRLKN--DNNYKYGVILERCYKIK 140 (308)
T ss_pred cCCceEEEEecccc-ch-hhhhhccCCCcccchhhhhhhhhHHHHh-------hheeEeec--CCCceeEEEEeeccCcc
Confidence 35666666665333 43 4556554322 2 234445677888777 33666662 2344577999998 332
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HcCCcccCCCCCcEEEeccccccc
Q 017021 130 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKV 186 (379)
Q Consensus 130 L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~iiH~dlkp~Nili~~~~~~~~ 186 (379)
. .+. .++.-=+.+|.-.| +.+.+|||..|+|||.+..|.+|+
T Consensus 141 i-----------~~~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKl 184 (308)
T PF07387_consen 141 I-----------NFS----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKL 184 (308)
T ss_pred c-----------chh----HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEe
Confidence 1 001 01111145677788 356999999999999944444333
|
The function of this family is unknown. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.13 Score=47.24 Aligned_cols=75 Identities=11% Similarity=-0.071 Sum_probs=44.1
Q ss_pred ccccceeEEEEEecC----C----CceEEEEEeeccch------hhHhHHHHHHHHHHHHhcC--------CCCCeeEEe
Q 017021 52 GEGTFGQVLECWDRE----R----KEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHD--------KGGNRCVQI 109 (379)
Q Consensus 52 g~G~~g~V~~~~~~~----~----~~~vAiK~~~~~~~------~~~~~~~e~~~l~~l~~~~--------~~~~~i~~~ 109 (379)
|.|-.|.+|++.-.. + ...+.+|....+.. ....+.+|+.....+.... ......+++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 778888898876533 2 24588888762221 1234456777666553211 112345666
Q ss_pred cceeeecceEEEEEeCC
Q 017021 110 RNWFDYRNHICIVFEKL 126 (379)
Q Consensus 110 ~~~~~~~~~~~lv~e~~ 126 (379)
+.....+...+||||.+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 66665555678888876
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.58 Score=43.64 Aligned_cols=78 Identities=18% Similarity=0.112 Sum_probs=47.4
Q ss_pred ccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCC-eeEEecce--eeecc--eEEEEEe
Q 017021 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN-RCVQIRNW--FDYRN--HICIVFE 124 (379)
Q Consensus 50 ~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~-~i~~~~~~--~~~~~--~~~lv~e 124 (379)
.|.+ .-..+|+.... .|+ +++|+.... ........|+..++.+.......+ .+...-+- ..-.+ +.+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~-~g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTE-DGR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEec-CCC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 44568888643 344 499999865 566777789999998877553221 12222221 11234 7888999
Q ss_pred CC-CCCHH
Q 017021 125 KL-GSSLY 131 (379)
Q Consensus 125 ~~-~~sL~ 131 (379)
++ |..+.
T Consensus 109 ~l~G~~~~ 116 (331)
T COG2334 109 YLPGRPLE 116 (331)
T ss_pred ecCCcCcC
Confidence 99 55554
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.11 Score=45.07 Aligned_cols=33 Identities=18% Similarity=0.036 Sum_probs=23.5
Q ss_pred CceEEEEEeeccchhhHhHHHHHHHHHHHHhcC
Q 017021 68 KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD 100 (379)
Q Consensus 68 ~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~ 100 (379)
++.|++++.......-..-..|..++..+....
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g 34 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAG 34 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTT
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcC
Confidence 467899998765455556667888888886644
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.064 Score=49.51 Aligned_cols=97 Identities=16% Similarity=0.139 Sum_probs=54.1
Q ss_pred EEEEEeCCCCCHHHHH---HhCCCCCCCHHHHHHHHHHHHHHHHHHH------HcCCcccCCCCCcEEEecccccccCCC
Q 017021 119 ICIVFEKLGSSLYDFL---RKNNYRSFPIDLVREIARQLLECIAFMH------DLCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 119 ~~lv~e~~~~sL~~~l---~~~~~~~l~~~~~~~~~~qi~~aL~~LH------~~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
..+|++++.++...+- ....+-.--.+.++.++.|++ |-|+- ....+|-||||+|||+.++.......+
T Consensus 246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~ 323 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKF 323 (434)
T ss_pred cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEE
Confidence 4588998844433332 222211233467778888885 44422 345899999999999965433222222
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~ 226 (379)
+-... .=.+.-.++|.||.++...+-..
T Consensus 324 ~~~~~---------vF~Epi~~~LnDFDfSqv~~i~N 351 (434)
T PF05445_consen 324 GNRNY---------VFKEPIRCCLNDFDFSQVANIIN 351 (434)
T ss_pred CCeEE---------EecccceeeecccCHHHhcccch
Confidence 11000 00234557889999887655443
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.56 E-value=0.28 Score=45.84 Aligned_cols=105 Identities=13% Similarity=0.247 Sum_probs=67.2
Q ss_pred cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
..+.|++|++.|+++.-.- .-..+++..++.+.+.-+.-+.+ -..=|||+.-+||++
T Consensus 298 ~~y~yl~~kdhgt~is~ik------~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---------------- 355 (488)
T COG5072 298 TLYLYLHFKDHGTPISIIK------ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---------------- 355 (488)
T ss_pred ceEEEEEEecCCceeeeee------cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----------------
Confidence 4567899999988875332 23467888888887776666653 458899999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHH
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 257 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ 257 (379)
+ ++.+.||||.+++....+.. ..-..+--|-.+.|.. +.+-+||-+--
T Consensus 356 -----------d-~GnvtLIDfklsRl~~~q~~--isy~rldhp~lF~G~d-d~QFeIYrlMr 403 (488)
T COG5072 356 -----------D-EGNVTLIDFKLSRLSYSQGI--ISYNRLDHPDLFNGVD-DYQFEIYRLMR 403 (488)
T ss_pred -----------e-cCceEEEEeeeeecccCCce--eeccccCchhhhcCcc-ceeeeHHHHHH
Confidence 4 66788888888773322221 1111223455555433 55666666443
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.30 E-value=0.13 Score=47.33 Aligned_cols=98 Identities=16% Similarity=0.096 Sum_probs=53.3
Q ss_pred eEEEEEeCCCCCHHHHH----HhCCCCCCCHHHHHHHHHHHHHHHHHH-H---HcCCcccCCCCCcEEEecccccccCCC
Q 017021 118 HICIVFEKLGSSLYDFL----RKNNYRSFPIDLVREIARQLLECIAFM-H---DLCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 118 ~~~lv~e~~~~sL~~~l----~~~~~~~l~~~~~~~~~~qi~~aL~~L-H---~~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
-..+|++++.++...+- ...+ -.--.+.++.++.||+.-.-.+ . ....+|-||||+|||+..+.......+
T Consensus 249 GnIIIfPLArcSadkv~~~~~~e~G-F~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~ 327 (444)
T PHA03111 249 GNIIIFPLARCSADKVTEENAAELG-FKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITL 327 (444)
T ss_pred CcEEEEehhhcccccCCHHHHHHcC-CccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEE
Confidence 35688888743332221 1222 1223567788888886533223 1 345899999999999965432111111
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~ 225 (379)
+-... . =.+.-.++|.||.++...+-.
T Consensus 328 ~~~~~------v---F~Epi~~~LnDFDfSqv~~i~ 354 (444)
T PHA03111 328 KDATY------V---FNEPIKACLNDFDFSQVANII 354 (444)
T ss_pred CCeEE------E---eccchhhhhcccCHHHHccch
Confidence 10000 0 023455788888888765544
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.18 E-value=1.3 Score=42.22 Aligned_cols=73 Identities=18% Similarity=0.169 Sum_probs=39.6
Q ss_pred hccccccceeEEEEEecCCC------ceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 49 SKMGEGTFGQVLECWDRERK------EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~------~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
+.|..|-...+|++...... +.|.+++.......-..-..|..++..+.... .-+++++.+.. +++
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~g----lgP~l~~~f~~----g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNN----FGPKIIGRFGD----FTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCC----CCCeEEEecCC----EEE
Confidence 34555778889998644321 22555554322222233345788888875543 23444444432 478
Q ss_pred EeCC-CCC
Q 017021 123 FEKL-GSS 129 (379)
Q Consensus 123 ~e~~-~~s 129 (379)
.||+ |.+
T Consensus 128 ~efIeGr~ 135 (383)
T PTZ00384 128 QEWVEGNT 135 (383)
T ss_pred EEEecccc
Confidence 8888 544
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.98 E-value=0.98 Score=43.04 Aligned_cols=59 Identities=27% Similarity=0.369 Sum_probs=40.3
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCCcccCCCCCcEEEec
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM-HDLCMIHTDLKPENVLLVS 180 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~L-H~~~iiH~dlkp~Nili~~ 180 (379)
..++-+|. |.++..+++... .++.....++.-.+.|+--+ --.+++|.|++|.||++.-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 34555666 888888887654 55555555555455555443 3567999999999999964
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 379 | ||||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-84 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-79 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 7e-78 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 9e-78 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-77 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-77 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-64 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-47 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-47 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-46 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-46 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-45 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-45 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-40 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-40 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-39 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-36 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-36 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-27 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-27 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-27 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-27 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-27 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-27 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-27 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-26 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-26 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-26 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-26 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-26 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-26 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-26 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-26 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-26 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-26 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-26 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-26 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-26 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-26 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-26 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-26 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-26 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-26 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-26 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-26 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-26 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-26 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-26 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-26 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-26 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-26 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-26 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-26 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-25 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-25 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-24 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-24 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-24 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-24 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-24 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-24 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-22 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-22 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-22 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-22 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-22 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-22 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-21 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-21 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-21 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-21 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-21 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-21 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-21 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-21 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-21 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-21 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-21 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-21 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-21 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-21 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-21 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-21 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-21 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-21 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-21 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-21 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-21 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-21 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-21 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-21 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-21 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-21 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-21 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-21 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-21 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-21 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-21 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-21 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-21 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-21 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-21 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-21 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-21 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-21 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-21 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-21 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-21 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-21 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-21 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-21 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-21 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-21 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-21 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-21 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-21 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-21 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-21 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-21 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-21 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-21 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-21 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-21 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-21 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-21 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-21 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-21 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-21 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-21 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-21 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-21 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-21 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-21 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-21 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-21 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-21 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-20 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-20 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-20 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-20 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-20 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-20 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-20 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-20 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-20 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-20 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-20 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-20 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-20 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-20 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-20 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-20 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-20 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-20 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-20 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-19 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-19 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-19 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-19 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-19 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-19 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-19 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-19 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-19 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-19 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-19 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-19 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-19 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-19 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-19 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-18 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-17 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-16 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-16 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-15 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-15 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-15 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-15 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-15 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-15 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-15 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-15 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-15 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-15 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-15 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-14 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-14 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-14 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-14 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-14 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-14 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-14 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-14 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-14 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-14 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-14 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-14 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 8e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 5e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 5e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-05 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 1e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 2e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 7e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-04 |
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 379 | |||
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-173 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-170 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-165 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-139 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-133 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-129 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-110 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-54 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 4e-54 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-50 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 9e-50 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-48 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-48 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-48 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-47 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-47 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-47 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-46 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-46 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-46 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-45 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-45 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-45 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 9e-45 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 5e-44 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-43 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 4e-43 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 5e-42 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-41 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-41 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-41 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-41 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 7e-41 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-40 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-40 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-40 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 9e-40 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-39 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-39 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-39 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-39 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-39 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 7e-39 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 9e-39 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-38 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-38 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-38 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-38 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-38 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-38 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-38 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-38 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-37 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-37 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-37 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-37 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-37 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-37 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-37 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-37 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 4e-37 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 5e-37 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 5e-37 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-37 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-36 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-36 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-36 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-36 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-36 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-36 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-36 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-36 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-36 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 6e-36 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 8e-36 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 9e-36 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-35 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-35 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-35 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 5e-35 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 5e-35 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 8e-35 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-34 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-34 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 6e-34 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 8e-34 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 8e-34 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-33 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-33 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-33 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 4e-33 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 6e-33 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-32 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-32 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 6e-32 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 8e-32 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-31 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 6e-31 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-30 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-30 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 7e-30 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-30 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 9e-30 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-27 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-26 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-26 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 9e-26 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 7e-24 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 9e-24 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-23 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-23 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-23 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-23 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-23 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 6e-23 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-22 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-22 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-22 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 7e-22 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-21 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-21 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-21 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-21 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-20 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-20 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-20 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-20 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-20 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 6e-20 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 7e-20 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 8e-20 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 9e-20 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-19 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-19 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 4e-19 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 6e-19 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 6e-19 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-18 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-18 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-18 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-18 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 5e-18 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-18 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 5e-18 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 6e-18 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 6e-18 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 6e-18 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 7e-18 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 7e-18 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 9e-18 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-17 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-17 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-17 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-17 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-17 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 5e-17 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 5e-17 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 6e-17 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 6e-17 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 7e-17 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-16 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-16 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-16 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-16 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 3e-16 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-15 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-15 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-15 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-15 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-15 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-15 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-15 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-14 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-14 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-14 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-14 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-13 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-13 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 7e-13 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-12 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-12 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-12 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-12 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-12 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 7e-12 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 9e-12 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-11 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-11 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-11 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-11 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-11 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-11 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 8e-11 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 9e-11 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-10 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-10 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-10 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-10 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-10 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-10 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 9e-10 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-09 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-09 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 9e-09 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-08 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-08 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 6e-08 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 7e-08 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-07 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-07 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-07 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-07 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-06 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-06 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 6e-06 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 7e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-05 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-05 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-05 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-05 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-05 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 6e-05 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-04 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-04 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-04 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-04 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 5e-04 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 6e-04 |
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 485 bits (1251), Expect = e-173
Identities = 130/330 (39%), Positives = 192/330 (58%), Gaps = 11/330 (3%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+ KMG+GTFG+VL C + K+ A+K+VR IKKY +A IE ++L+++ D N
Sbjct: 38 LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNN 97
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V+ F Y +H+C++FE LG SLY+ + +NNY F I+ ++ ++L+ + ++ +
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS 157
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+ HTDLKPEN+LL + K + K KS+ IK+IDFG T++
Sbjct: 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI--YRTKSTGIKLIDFGCATFKSDY 215
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
I++TR YRAPEVIL LGW D+WS GC+L EL TG LF+THE++EHLAMME ++
Sbjct: 216 HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESII 275
Query: 286 GPLPQHMLKRVDR-HAEKYVRRG--RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342
P+P++ML + + KYV + +L WPE A+S SIK V K L +I +
Sbjct: 276 QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL---- 331
Query: 343 GDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
L +L+ DPT R + E L+H F
Sbjct: 332 --FCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 478 bits (1233), Expect = e-170
Identities = 149/331 (45%), Positives = 211/331 (63%), Gaps = 15/331 (4%)
Query: 46 KIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG- 103
+I +GEG FG+V+EC D + VA+KIV+ + +Y EAA EI+VL+ L D
Sbjct: 17 EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNST 76
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
RCVQ+ WF++ HICIVFE LG S YDF+++N + F +D +R++A Q+ + + F+H
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS 136
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ HTDLKPEN+L V S+Y + + K +R + IKV+DFGS TY+
Sbjct: 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRD--------ERTLINPDIKVVDFGSATYDD 188
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
+ +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E G +F TH++ EHLAMMER
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+LGPLP+HM+++ + KY RLDW E +++ + K P + ++ Q V+H
Sbjct: 249 ILGPLPKHMIQKTRKR--KYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHER- 304
Query: 344 DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L L+Q +L YDP R+T REAL+HPFF
Sbjct: 305 -LFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 464 bits (1197), Expect = e-165
Identities = 144/331 (43%), Positives = 209/331 (63%), Gaps = 15/331 (4%)
Query: 46 KIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG- 103
+I +GEGTFG+V+EC D R K VA+KI+R + KYREAA +EI VL+++ + DK
Sbjct: 22 EIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENK 81
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
CV + +WF++ H+CI FE LG + ++FL++NN++ +P+ VR +A QL + F+H+
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE 141
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ HTDLKPEN+L V+SE+ + + S ++ K+++I+V DFGS T++
Sbjct: 142 NQLTHTDLKPENILFVNSEFETLYNEHKSCE--------EKSVKNTSIRVADFGSATFDH 193
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
IV+TRHYR PEVIL LGW PCD+WS+GCIL E G LFQTHEN EHL MME+
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+LGP+P HM+ R + KY +G L W E ++ +K K P ++ ++H
Sbjct: 254 ILGPIPSHMIHRTRKQ--KYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHV-- 308
Query: 344 DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L L++ +L +DP R+T EAL HPFF
Sbjct: 309 QLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 401 bits (1031), Expect = e-139
Identities = 109/340 (32%), Positives = 162/340 (47%), Gaps = 36/340 (10%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-N 104
++ +G+G+FGQV++ +D + + VA+K+VR K++ A EI +L+ L K DK
Sbjct: 100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 105 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+ + F +RNHIC+ FE L +LY+ ++KN ++ F + LVR+ A +L+C+ +H
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+IH DLKPEN+LL S IKVIDFGS+ YE
Sbjct: 220 RIIHCDLKPENILLKQ-------------------------QGRSGIKVIDFGSSCYEHQ 254
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
+ +R YRAPEVILG + P D+WS+GCIL EL TG L + + LA M +
Sbjct: 255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEG----------AASRESIKSVMKLPRLQNLI 334
LG Q +L R +G + R + P +
Sbjct: 315 LGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWG 374
Query: 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L+ L +DP R+T +ALRHP+ R
Sbjct: 375 NALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-133
Identities = 111/347 (31%), Positives = 174/347 (50%), Gaps = 43/347 (12%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-N 104
+I S +G+G+FGQV++ +DR +E VAIKI++ K + A IE+ +L+ + KHD
Sbjct: 57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 105 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-- 162
V ++ F +RNH+C+VFE L +LYD LR N+R ++L R+ A+Q+ + F+
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
+L +IH DLKPEN+LL + PK SAIK++DFGS+
Sbjct: 177 ELSIIHCDLKPENILLCN-------------------------PKRSAIKIVDFGSSCQL 211
Query: 223 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282
+ +R YR+PEV+LG+ + D+WS+GCILVE+ TGE LF ++ + +
Sbjct: 212 GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR-LQNLIMQHVDHS 341
VLG P H+L + + + + + W + R L N++
Sbjct: 272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGP 331
Query: 342 AG--------------DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
G L+ +L YDP R+ AL+H FF +
Sbjct: 332 GGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 375 bits (965), Expect = e-129
Identities = 102/349 (29%), Positives = 166/349 (47%), Gaps = 51/349 (14%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK---- 101
+ K+G G F V D VA+KIVRG K Y EAA EI++LQ++ D
Sbjct: 22 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 102 --GGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 155
G N +++ + F+++ H+ +VFE LG +L ++K +R P+ V++I++QLL
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 156 ECIAFMHDLC-MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 214
+ +MH C +IHTD+KPENVL+ + + IK+
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPE---------------------NLIQIKIA 180
Query: 215 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE- 273
D G+ + + TR YR+PEV+LG W DIWS C++ EL TG+ LF+ E
Sbjct: 181 DLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 274 -----NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328
+ +H+A + +LG LP ++L+ + RG L S +K
Sbjct: 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN----------ISKLKFW 290
Query: 329 RLQNLIM---QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L++++ + A +++ L +L+ DP R A + HP+
Sbjct: 291 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 326 bits (836), Expect = e-110
Identities = 101/366 (27%), Positives = 170/366 (46%), Gaps = 49/366 (13%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK---G 102
+ K+G G F V WD + K+ VA+K+V+ + Y E A+ EI +L+ + D
Sbjct: 40 HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPN 99
Query: 103 GNRCVQIRNWFDYR----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
VQ+ + F HIC+VFE LG L ++ K+NY+ P+ V++I +Q+L+ +
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 159 AFMHDLC-MIHTDLKPENVLLVSSEY----------------------IKVPDYKSSLHT 195
++H C +IHTD+KPEN+LL +E V ++
Sbjct: 160 DYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSV 255
+ + + +K+ D G+ + + TR YR+ EV++G G+ P DIWS
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWST 279
Query: 256 GCILVELCTGEALFQTHENLE------HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRL 309
C+ EL TG+ LF+ H E H+A++ +LG +P+ ++ E + ++G L
Sbjct: 280 ACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339
Query: 310 DWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD---LTHLLQGLLRYDPTDRLTAREA 366
+K L ++++ + S + T L +L P R TA E
Sbjct: 340 KHITK----------LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389
Query: 367 LRHPFF 372
LRHP+
Sbjct: 390 LRHPWL 395
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-54
Identities = 95/343 (27%), Positives = 154/343 (44%), Gaps = 74/343 (21%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGNR 105
K+GEG++G V +C +R+ ++VAIK + A+ EI +L+QL KH N
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFL-ESEDDPVIKKIALREIRMLKQL-KHP---N- 63
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + F + + +VFE ++ L + R P LV+ I Q L+ + F H
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP 224
IH D+KPEN +L++ K S IK+ DFG + P
Sbjct: 123 CIHRDVKPEN-ILIT--------------------------KHSVIKLCDFGFARLLTGP 155
Query: 225 DQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
Y V+TR YR+PE+++G Y P D+W++GC+ EL +G L+ +++ L +
Sbjct: 156 SDYYDDEVATRWYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL 214
Query: 281 MERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL-----I 334
+ + LG +P+H S S +K+P +++
Sbjct: 215 IRKTLGDLIPRH-------------------QQVF--STNQYFSGVKIPDPEDMEPLELK 253
Query: 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377
++ + A L L+G L DPT+RLT + L HP+F
Sbjct: 254 FPNISYPALGL---LKGCLHMDPTERLTCEQLLHHPYFENIRE 293
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 4e-54
Identities = 87/345 (25%), Positives = 142/345 (41%), Gaps = 76/345 (22%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGG 103
+GEG++G V++C +++ +VAIK +KK AM EI++L+QL +H+
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK---IAMREIKLLKQL-RHE--- 84
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
N V + + +VFE + ++ D L +V++ Q++ I F H
Sbjct: 85 N-LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHS 142
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYE 222
+IH D+KPEN +LVS +S +K+ DFG + T
Sbjct: 143 HNIIHRDIKPEN-ILVS--------------------------QSGVVKLCDFGFARTLA 175
Query: 223 RPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHL 278
P + Y V+TR YRAPE+++G Y D+W++GC++ E+ GE LF +++ L
Sbjct: 176 APGEVYDDEVATRWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL----- 333
+ LG L + ++LP ++
Sbjct: 235 YHIMMCLGNLIPR------------------HQELFNKNPVFAG--VRLPEIKEREPLER 274
Query: 334 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 378
+ DL + L DP R E L H FF D
Sbjct: 275 RYPKLSEVVIDL---AKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-50
Identities = 86/346 (24%), Positives = 147/346 (42%), Gaps = 85/346 (24%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNR 105
K+GEGT+G+V + D E VAIK +R ++ E A+ E+ +L++L +H N
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKEL-QHR---N- 94
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
+++++ + + + ++FE + L ++ KN + +++ QL+ + F H
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAENDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP 224
+H DLKP+N LL+S ++ +K+ DFG + + P
Sbjct: 153 CLHRDLKPQN-LLLSVS---------------------DASETPVLKIGDFGLARAFGIP 190
Query: 225 DQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
+ + + T YR PE++LG Y DIWS+ CI E+ LF ++ L
Sbjct: 191 IRQFTHEIITLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249
Query: 281 MERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP----------- 328
+ VLG P WP V LP
Sbjct: 250 IFEVLGLPDDT-------------------TWPG----------VTALPDWKQSFPKFRG 280
Query: 329 -RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
L+ ++ +D D LL +L DP R++A+ AL HP+F+
Sbjct: 281 KTLKRVLGALLDDEGLD---LLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-48
Identities = 86/347 (24%), Positives = 148/347 (42%), Gaps = 81/347 (23%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCV 107
+G G+FG V + + E+VAIK V K++ RE ++++++L H N V
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE-----LQIMRKL-DHC---N-IV 110
Query: 108 QIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRS--FPIDLVREIARQLLECIA 159
++R +F ++ +V + + ++Y R + P+ V+ QL +A
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
++H + H D+KP+N+LL D P ++ +K+ DFGS
Sbjct: 171 YIHSFGICHRDIKPQNLLL-------------------D-------PDTAVLKLCDFGSA 204
Query: 220 TYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276
+ + + +R+YRAPE+I G +T D+WS GC+L EL G+ +F ++
Sbjct: 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
Query: 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR-----LQ 331
L + +VLG + ++ ++ + ++ K P+
Sbjct: 265 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 302
Query: 332 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 378
+ A L LL Y PT RLT EA H FF D LR
Sbjct: 303 KVFRPRTPPEAIAL---CSRLLEYTPTARLTPLEACAHSFF--DELR 344
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-48
Identities = 86/351 (24%), Positives = 143/351 (40%), Gaps = 88/351 (25%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQL--AKHDK 101
++G G +G V + D VA+K VR G + + E+ +L++L +H
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP- 74
Query: 102 GGN----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
N V + D + +VFE + L +L K P + ++++ RQ L
Sbjct: 75 --NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+ F+H C++H DLKPEN +LV+S +K+ DFG
Sbjct: 133 LDFLHANCIVHRDLKPEN-ILVTSG--------------------------GTVKLADFG 165
Query: 218 -STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274
+ Y +V T YRAPEV+L + P D+WSVGCI E+ + LF +
Sbjct: 166 LARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224
Query: 275 LEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL--- 330
+ L + ++G P DWP + LPR
Sbjct: 225 ADQLGKIFDLIGLPPED-------------------DWPR----------DVSLPRGAFP 255
Query: 331 ----QNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+ + ++ ++ S LL +L ++P R++A AL+H + +D
Sbjct: 256 PRGPRPVQSVVPEMEESGAQ---LLLEMLTFNPHKRISAFRALQHSYLHKD 303
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 4e-48
Identities = 94/349 (26%), Positives = 152/349 (43%), Gaps = 86/349 (24%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCV 107
+G G+FG V + E E VAIK V K++ RE +++++ + KH N V
Sbjct: 47 VIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE-----LQIMRIV-KHP---N-VV 95
Query: 108 QIRNWF------DYRNHICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIA 159
++ +F + +V E + ++Y R ++ P+ L++ QLL +A
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
++H + + H D+KP+N+LL P S +K+IDFGS
Sbjct: 156 YIHSIGICHRDIKPQNLLL--------------------------DPPSGVLKLIDFGSA 189
Query: 220 TYERPDQNYI--VSTRHYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTHEN 274
+ + + +R+YRAPE+I G T DIWS GC++ EL G+ LF
Sbjct: 190 KILIAGEPNVSYICSRYYRAPELIFG--ATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247
Query: 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR----- 329
++ L + +VLG + +K ++ + ++ K P+
Sbjct: 248 IDQLVEIIKVLGTPSREQIKTMNPNYMEH----------------------KFPQIRPHP 285
Query: 330 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 378
+ A DL + LL Y P+ RLTA EAL HPFF D LR
Sbjct: 286 FSKVFRPRTPPDAIDL---ISRLLEYTPSARLTAIEALCHPFF--DELR 329
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-47
Identities = 93/337 (27%), Positives = 149/337 (44%), Gaps = 71/337 (21%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNR 105
K+GEGT+G V + +RE E+VA+K VR + E +A+ EI +L++L KH N
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKEL-KHK---N- 62
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V++ + + +VFE L + N ++V+ QLL+ + F H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP 224
++H DLKP+N LL++ +K+ +FG + + P
Sbjct: 122 VLHRDLKPQN-LLINRN--------------------------GELKLANFGLARAFGIP 154
Query: 225 DQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCT-GEALFQTHENLEHLA 279
+ Y V T YR P+V+ G Y D+WS GCI EL G LF ++ + L
Sbjct: 155 VRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
Query: 280 MMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQ 336
+ R+LG P + WP K P +L ++
Sbjct: 214 RIFRLLGTPTEE-------------------QWP-SMTKLPDYKPYPMYPATTSLVNVVP 253
Query: 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
++ + DL LQ LL+ +P R++A EAL+HP+F+
Sbjct: 254 KLNATGRDL---LQNLLKCNPVQRISAEEALQHPYFS 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-47
Identities = 67/350 (19%), Positives = 128/350 (36%), Gaps = 99/350 (28%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKG 102
I ++G G +V + + + K++ AIK V + ++ EI L +L +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ--H 86
Query: 103 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
++ +++ ++ +I +V E L +L+K +S + + +LE + +H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 144
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
++H+DLKP N L+V +K+IDFG
Sbjct: 145 QHGIVHSDLKPANFLIVDGM----------------------------LKLIDFGIANQM 176
Query: 223 RPDQNYIVS-----TRHYRAPEVILGLGW-----------TYPCDIWSVGCILVELCTGE 266
+PD +V T +Y PE I + + D+WS+GCIL + G+
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 326
FQ N ++ + ++ P +++P+
Sbjct: 237 TPFQQIIN--QISKLHAIIDP------------------NHEIEFPD------------- 263
Query: 327 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+ D +L+ L+ DP R++ E L HP+
Sbjct: 264 ----------IPEKDLQD---VLKCCLKRDPKQRISIPELLAHPYVQIQT 300
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-47
Identities = 91/336 (27%), Positives = 141/336 (41%), Gaps = 71/336 (21%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNR 105
K+GEGT+G V + + E A+K +R ++K E + EI +L++L KH N
Sbjct: 9 KIGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKEL-KHS---N- 61
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V++ + + + +VFE L L L + QLL IA+ HD
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP 224
++H DLKP+N LL++ E +K+ DFG + + P
Sbjct: 121 VLHRDLKPQN-LLINRE--------------------------GELKIADFGLARAFGIP 153
Query: 225 DQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
+ Y + T YRAP+V++G Y DIWSVGCI E+ G LF + L
Sbjct: 154 VRKYTHEIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 281 MERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQH 337
+ R+LG P + +WP + ++
Sbjct: 213 IFRILGTPNSK-------------------NWP-NVTELPKYDPNFTVYEPLPWESFLKG 252
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
+D S D LL +L+ DP R+TA++AL H +F
Sbjct: 253 LDESGID---LLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-46
Identities = 68/350 (19%), Positives = 129/350 (36%), Gaps = 99/350 (28%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKG 102
I ++G G +V + + E+K++ AIK V + ++ EI L +L +
Sbjct: 12 SILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ--H 67
Query: 103 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
++ +++ ++ +I +V E L +L+K +S + + +LE + +H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 125
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
++H+DLKP N L+V +K+IDFG
Sbjct: 126 QHGIVHSDLKPANFLIVDGM----------------------------LKLIDFGIANQM 157
Query: 223 RPDQNYI-----VSTRHYRAPEVILGLG-----------WTYPCDIWSVGCILVELCTGE 266
+PD + V T +Y PE I + + D+WS+GCIL + G+
Sbjct: 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
Query: 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 326
FQ N ++ + ++ P +++P+
Sbjct: 218 TPFQQIIN--QISKLHAIIDP------------------NHEIEFPD------------- 244
Query: 327 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+ D +L+ L+ DP R++ E L HP+
Sbjct: 245 ----------IPEKDLQD---VLKCCLKRDPKQRISIPELLAHPYVQIQT 281
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-46
Identities = 90/336 (26%), Positives = 148/336 (44%), Gaps = 70/336 (20%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNR 105
K+GEGT+G V + D + +VA+K +R + E A+ EI +L++L H N
Sbjct: 28 KVGEGTYGVVYKAKDS-QGRIVALKRIR-LDAEDEGIPSTAIREISLLKEL-HHP---N- 80
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
V + + + +VFE + L L +N ++ QLL +A H
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP 224
++H DLKP+N LL++S+ A+K+ DFG + + P
Sbjct: 140 ILHRDLKPQN-LLINSD--------------------------GALKLADFGLARAFGIP 172
Query: 225 DQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
++Y V T YRAP+V++G Y DIWS+GCI E+ TG+ LF + + L
Sbjct: 173 VRSYTHEVVTLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK 231
Query: 281 MERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQH 337
+ +LG P P+ +WP+ + ++ + I+
Sbjct: 232 IFSILGTPNPR-------------------EWPQVQELPLWKQRTFQVFEKKPWSSIIPG 272
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
D LL +L +DP R++AR+A+ HP+F
Sbjct: 273 FCQEGID---LLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-46
Identities = 91/348 (26%), Positives = 146/348 (41%), Gaps = 88/348 (25%)
Query: 50 KMGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQL--AKHDKG 102
++GEG +G+V + D + VA+K VR ++ E + + E+ VL+ L +H
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLETFEHP-- 74
Query: 103 GN----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
N V + D + +VFE + L +L K P + ++++ QLL +
Sbjct: 75 -NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 217
F+H ++H DLKP+N +LV+S IK+ DFG
Sbjct: 134 DFLHSHRVVHRDLKPQN-ILVTSS--------------------------GQIKLADFGL 166
Query: 218 STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275
+ Y +V T YRAPEV+L + P D+WSVGCI E+ + LF+ ++
Sbjct: 167 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 225
Query: 276 EHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL---- 330
+ L + V+G P + DWP + LPR
Sbjct: 226 DQLGKILDVIGLPGEE-------------------DWPR----------DVALPRQAFHS 256
Query: 331 ---QNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
Q + + +D D LL L ++P R++A AL HP+F
Sbjct: 257 KSAQPIEKFVTDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYFQ 301
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-45
Identities = 78/340 (22%), Positives = 146/340 (42%), Gaps = 60/340 (17%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++ K+G G + +V E + E V +KI++ +KK + EI++L+ L N
Sbjct: 39 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGGP---N- 92
Query: 106 CVQIRNWF--DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
+ + + +VFE + ++ DF K Y++ +R ++L+ + + H
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHS 148
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ ++H D+KP NV++ D + K +++ID+G +
Sbjct: 149 MGIMHRDVKPHNVMI-------------------DHEHRK-------LRLIDWGLAEFYH 182
Query: 224 PDQNYI--VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG-EALFQTHENLEHLA 279
P Q Y V++R+++ PE+++ + Y D+WS+GC+L + E F H+N + L
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR--LQNLIMQH 337
+ +VLG Y+ + ++ + + R + +
Sbjct: 243 RIAKVLGT-ED---------LYDYIDKYNIELD-----PRFNDILGRHSRKRWERFVHSE 287
Query: 338 VDHSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
H L LLRYD RLTAREA+ HP+F
Sbjct: 288 NQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-45
Identities = 91/343 (26%), Positives = 150/343 (43%), Gaps = 75/343 (21%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLAKHDKGGN 104
K+G GT+ V + ++ VA+K V+ G A+ EI ++++L KH+ N
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS---TAIREISLMKEL-KHE---N 64
Query: 105 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNY----RSFPIDLVREIARQLLECIAF 160
V++ + N + +VFE + + L ++ R ++LV+ QLL+ +AF
Sbjct: 65 -IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-ST 219
H+ ++H DLKP+N LL++ K +K+ DFG +
Sbjct: 124 CHENKILHRDLKPQN-LLIN--------------------------KRGQLKLGDFGLAR 156
Query: 220 TYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENL 275
+ P + V T YRAP+V++G TY DIWS GCIL E+ TG+ LF +
Sbjct: 157 AFGIPVNTFSSEVVTLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE 215
Query: 276 EHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334
E L ++ ++G P WP ++ ++L
Sbjct: 216 EQLKLIFDIMGTPNES-------------------LWP-SVTKLPKYNPNIQQRPPRDLR 255
Query: 335 MQHVDHSAGDLT----HLLQGLLRYDPTDRLTAREALRHPFFT 373
H+ L L GLL+ +P RL+A++AL HP+F
Sbjct: 256 QVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-45
Identities = 88/335 (26%), Positives = 139/335 (41%), Gaps = 68/335 (20%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLAKHDKGGN 104
K+GEGT+ V + + +VA+K +R G A+ E+ +L+ L KH N
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC---TAIREVSLLKDL-KHA---N 61
Query: 105 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
V + + + +VFE L L +L + V+ QLL +A+ H
Sbjct: 62 -IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYER 223
++H DLKP+N LL++ + +K+ DFG +
Sbjct: 120 KVLHRDLKPQN-LLIN--------------------------ERGELKLADFGLARAKSI 152
Query: 224 PDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLA 279
P + Y V T YR P+++LG Y D+W VGCI E+ TG LF E L
Sbjct: 153 PTKTYDNEVVTLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH 211
Query: 280 MMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
+ R+LG P + WP ++ E R + L+ H
Sbjct: 212 FIFRILGTPTEE-------------------TWPGILSNEEFKTYNYPKYRAEALL-SHA 251
Query: 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
D LL LL+++ +R++A +A++HPFF
Sbjct: 252 PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-45
Identities = 69/350 (19%), Positives = 127/350 (36%), Gaps = 99/350 (28%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKG 102
I ++G G +V + + + K++ AIK V + ++ EI L +L +H
Sbjct: 59 SILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD- 116
Query: 103 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
+ +++ ++ +I +V E L +L+K +S + + +LE + +H
Sbjct: 117 --KIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 172
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
++H+DLKP N L+V +K+IDFG
Sbjct: 173 QHGIVHSDLKPANFLIVDGM----------------------------LKLIDFGIANQM 204
Query: 223 RPDQNYIVS-----TRHYRAPEVILGLGW-----------TYPCDIWSVGCILVELCTGE 266
+PD +V +Y PE I + + D+WS+GCIL + G+
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
Query: 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 326
FQ N ++ + ++ P +++P
Sbjct: 265 TPFQQIIN--QISKLHAIIDP------------------NHEIEFP-------------- 290
Query: 327 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
D DL +L+ L+ DP R++ E L HP+
Sbjct: 291 ------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-44
Identities = 82/343 (23%), Positives = 145/343 (42%), Gaps = 82/343 (23%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYRE----AAMIEIEVLQQLAKHDKGG 103
+GEG F V + D+ ++VAIK ++ + ++ A+ EI++LQ+L H
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHP--- 72
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
N + + + F ++++I +VF+ + + L + K+N ++ L+ + ++H
Sbjct: 73 N-IIGLLDAFGHKSNISLVFDFMETDLEVII-KDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYE 222
++H DLKP N LL+ +K+ DFG + ++
Sbjct: 131 HWILHRDLKPNN-LLLDEN--------------------------GVLKLADFGLAKSFG 163
Query: 223 RPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHL 278
P++ Y V TR YRAPE++ G Y D+W+VGCIL EL +L+ L
Sbjct: 164 SPNRAYTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 222
Query: 279 AMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL---- 333
+ LG P + WP+ + LP
Sbjct: 223 TRIFETLGTPTEE-------------------QWPD----------MCSLPDYVTFKSFP 253
Query: 334 ---IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
+ + DL L+QGL ++P R+TA +AL+ +F+
Sbjct: 254 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-43
Identities = 58/330 (17%), Positives = 101/330 (30%), Gaps = 88/330 (26%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 106
++G G++G+V + +E + A+K K R + E+ +++ +H C
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP----CC 119
Query: 107 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
V++ ++ + + E G SL S P V R L +A +H +
Sbjct: 120 VRLEQAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGL 178
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 225
+H D+KP N+ L K+ DFG
Sbjct: 179 VHLDVKPANIFL---------------------------GPRGRCKLGDFGLLVELGTAG 211
Query: 226 QNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
Y APE++ G + D++S+G ++E+ L E + L +
Sbjct: 212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-RQGYL 269
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
+ S E
Sbjct: 270 PPEFTAGL------------------------SSE------------------------- 280
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L +L +L DP R TA L P +
Sbjct: 281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-43
Identities = 91/348 (26%), Positives = 147/348 (42%), Gaps = 66/348 (18%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++ G+GTFG V ++ VAIK V ++ E++++Q L N
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDL-AVLHHPN- 80
Query: 106 CVQIRNWF-----DYRNHIC--IVFEKLGSSLYDFLRKNNYR--SFPIDLVREIARQLLE 156
VQ++++F R I +V E + +L+ R R + P L++ QL+
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 157 CIAFMHDLCM--IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 214
I +H + H D+KP NVL+ + +K+
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLV-------------------N-------EADGTLKLC 174
Query: 215 DFGSTTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 271
DFGS P + + + +R+YRAPE+I G +T DIWSVGCI E+ GE +F+
Sbjct: 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234
Query: 272 HENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 330
+ L + RVLG + +L++++ H + + K
Sbjct: 235 DNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYN------------------SKGIPW 276
Query: 331 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 378
N+ H A + LL LL+Y P +R+ EAL HP+F D L
Sbjct: 277 SNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF--DELH 322
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-42
Identities = 67/337 (19%), Positives = 119/337 (35%), Gaps = 76/337 (22%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD--------- 100
+G+G FGQV++ + AIK +R ++ + E+ +L L H
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAW 71
Query: 101 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
V+ ++ + I E +LYD + N + D + RQ+LE ++
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALS 130
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF---KRMPKSSAIKVIDF 216
++H +IH DLKP N+ + S +K+ D F K + +S I +D
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGD-------------FGLAKNVHRSLDILKLDS 177
Query: 217 GSTTYERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENL 275
+ + + T Y A EV+ G G D++S+G I E+ F T
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FSTGMER 234
Query: 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335
++ K +R +++P + + +I
Sbjct: 235 VNIL----------------------KKLRSVSIEFPPDFDDNKM-------KVEKKIIR 265
Query: 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
L+ +DP R AR L +
Sbjct: 266 L---------------LIDHDPNKRPGARTLLNSGWL 287
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-41
Identities = 79/328 (24%), Positives = 128/328 (39%), Gaps = 74/328 (22%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111
GEG+F +C ++ + A+KI+ K+ EI L+ H N V++
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKEITALKLCEGHP---N-IVKLHE 73
Query: 112 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 170
F + H +V E L G L++ R + F I R+L+ ++ MHD+ ++H D
Sbjct: 74 VFHDQLHTFLVMELLNGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 171 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-- 228
LKPEN+L + IK+IDFG + PD
Sbjct: 132 LKPENLLFTDEN------------------------DNLEIKIIDFGFARLKPPDNQPLK 167
Query: 229 -IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 287
T HY APE++ G+ CD+WS+G IL + +G+ FQ+H+ +
Sbjct: 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD--------RSLTCT 219
Query: 288 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347
++K+ +++G + A +V A D
Sbjct: 220 SAVEIMKK--------IKKGDFSFEGEAWK-------------------NVSQEAKD--- 249
Query: 348 LLQGLLRYDPTDRLTAREALRHPFFTRD 375
L+QGLL DP RL + +
Sbjct: 250 LIQGLLTVDPNKRLKMSGLRYNEWLQDG 277
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 67/353 (18%), Positives = 127/353 (35%), Gaps = 85/353 (24%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+G G+ G V+ + VA+K + + + A++EI++L + H
Sbjct: 18 VSEKILGYGSSGTVVFQ-GSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDH----PN 70
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE-----IARQLLECIAF 160
++ + I E +L D + N + L +E + RQ+ +A
Sbjct: 71 VIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+H L +IH DLKP+N+L+ +S + ++ + ++ I + DFG
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSS--------------RFTADQQTGAENLRILISDFGLCK 176
Query: 221 YERPDQNYIVSTRH-------YRAPEVILGLGW-------TYPCDIWSVGCIL-VELCTG 265
Q+ + + +RAPE++ T DI+S+GC+ L G
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 325
+ F + + I+ +
Sbjct: 237 KHPF-----------------------------------------GDKYSRESNIIRGIF 255
Query: 326 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 378
L ++ L + + A D L+ ++ +DP R TA + LRHP F +
Sbjct: 256 SLDEMKCLHDRSLIAEATD---LISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 69/334 (20%), Positives = 122/334 (36%), Gaps = 78/334 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++ +G G++ C + A+KI I K + EIE+L + +H N
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPTEEIEILLRYGQHP---N- 77
Query: 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+ +++ +D ++ +V E + G L D + + + F + + + + ++H
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ 135
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
++H DLKP N+L V +I++ DFG R
Sbjct: 136 GVVHRDLKPSNILYVDES-----------------------GNPESIRICDFGFAKQLRA 172
Query: 225 DQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
+ T ++ APEV+ G+ CDIWS+G +L + TG F + ++
Sbjct: 173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
R+ G+ G + V +
Sbjct: 233 ARIG--------------------SGKFSLSGGYWN-------------------SVSDT 253
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
A D L+ +L DP RLTA LRHP+
Sbjct: 254 AKD---LVSKMLHVDPHQRLTAALVLRHPWIVHW 284
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-41
Identities = 83/368 (22%), Positives = 151/368 (41%), Gaps = 83/368 (22%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--RE------------------- 84
+ +G G+FG V E +D E + A+K V +Y RE
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYF 69
Query: 85 ---------AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLR 135
+ + K++ N + ++ ++ E + +L+ L+
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129
Query: 136 --KNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193
+ RS P++L+ QL + F+H L + H D+KP+N+L+
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV--------------- 174
Query: 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPC 250
K + +K+ DFGS P + + + +R YRAPE++LG +T
Sbjct: 175 -----------NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI 223
Query: 251 DIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 310
D+WS+GC+ EL G+ LF +++ L + +++G + + R++ H
Sbjct: 224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH----------- 272
Query: 311 WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHP 370
+ ++ + ++ + A D LL+ +LRY+P R+ EA+ HP
Sbjct: 273 -----YTEVRFPTLKAKD-WRKILPEGTPSLAID---LLEQILRYEPDLRINPYEAMAHP 323
Query: 371 FFTRDHLR 378
FF DHLR
Sbjct: 324 FF--DHLR 329
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-41
Identities = 72/358 (20%), Positives = 130/358 (36%), Gaps = 85/358 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIK------IVRGIKKYREAAMIEIEVLQQLAKH 99
+G G G V D + + VAIK RE I+++++L H
Sbjct: 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE-----IKIIRRL-DH 67
Query: 100 D----------KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE 149
D G++ N + IV E + + L + L + + R
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE---EHARL 124
Query: 150 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 209
QLL + ++H ++H DLKP N+ + + +
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL-------------------------- 158
Query: 210 AIKVIDFG---STTYERPDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVEL 262
+K+ DFG + ++ + T+ YR+P ++L +T D+W+ GCI E+
Sbjct: 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
Query: 263 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR----RGRLDWPEGAASR 318
TG+ LF LE + ++ + + + + + Y+R +
Sbjct: 219 LTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQ----- 273
Query: 319 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
++ + A D L+ +L + P DRLTA EAL HP+ +
Sbjct: 274 ---------------LLPGISREAVD---FLEQILTFSPMDRLTAEEALSHPYMSIYS 313
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 85/343 (24%), Positives = 158/343 (46%), Gaps = 30/343 (8%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQLAKHDKG 102
++ K+G+G +G V + DR E+VA+K I + +A EI +L +L+ H+
Sbjct: 12 ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE-- 69
Query: 103 GNRCVQIRNWF--DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
N V + N D + +VF+ + + L+ +R N + + QL++ I +
Sbjct: 70 -N-IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEP---VHKQYVVYQLIKVIKY 124
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDY-----KSSLHTPKDSSYFKRMPKSSAIKVID 215
+H ++H D+KP N+LL + ++KV D+ ++ ++ +
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 216 FGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 274
T Y V+TR YRAPE++LG +T D+WS+GCIL E+ G+ +F
Sbjct: 185 PILTDY--------VATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236
Query: 275 LEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 333
+ L + V+ ++ + A+ + + +++ I + K L+
Sbjct: 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296
Query: 334 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+ A D LL LL+++P R++A +AL+HPF + H
Sbjct: 297 PKADCNEEALD---LLDKLLQFNPNKRISANDALKHPFVSIFH 336
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 62/339 (18%), Positives = 117/339 (34%), Gaps = 86/339 (25%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
+G G G ++ VA+K + + + A E+++L++ +H N ++
Sbjct: 31 VLGHGAEGTIV-YRGMFDNRDVAVKRI--LPECFSFADREVQLLRESDEHP---N-VIRY 83
Query: 110 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 169
R I E ++L +++ + ++ ++ + +Q +A +H L ++H
Sbjct: 84 FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE-PITLLQQTTSGLAHLHSLNIVHR 142
Query: 170 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY- 228
DLKP N+L+ P K + DFG ++
Sbjct: 143 DLKPHNILISM---------------PNAHGKIK-------AMISDFGLCKKLAVGRHSF 180
Query: 229 -----IVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLA 279
+ T + APE++ TY DI+S GC+ + G F
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG--------- 231
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339
K + R A + LD +H D
Sbjct: 232 --------------KSLQRQANILLGACSLDCLH--------------------PEKHED 257
Query: 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 378
A + L++ ++ DP R +A+ L+HPFF +
Sbjct: 258 VIARE---LIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 58/347 (16%), Positives = 111/347 (31%), Gaps = 66/347 (19%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGG 103
+ +G+G V ++ ++ AIK+ + + M E EVL++L H
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHK--- 67
Query: 104 NRCVQIRNWFDYRN--HICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQLLECIA 159
V++ + H ++ E SLY L + N P + R ++ +
Sbjct: 68 -NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
+ + ++H ++KP N++ V E S K+ DFG+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDFGAA 163
Query: 220 TYERPDQNY--IVSTRHYRAPEVILGLGWTYP--------CDIWSVGCILVELCTGEALF 269
D+ + + T Y P++ D+WS+G TG F
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
Query: 270 QTHENLEHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328
+ E +M +++ P + V + G +DW S+ ++
Sbjct: 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQK-----AENGPIDWSGDMPVSCSLSRGLQ-- 276
Query: 329 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
LT +L +L D +
Sbjct: 277 --------------VLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-40
Identities = 80/359 (22%), Positives = 139/359 (38%), Gaps = 97/359 (27%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGN- 104
K+G+GTFG+V + R+ + VA+K V ++ +E A+ EI++LQ L KH+ N
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLL-KHE---NV 78
Query: 105 ---RCV---QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
+ + + + I +VF+ L L + F + ++ + + LL +
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGL 137
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 217
++H ++H D+K NVL + + +K+ DFG
Sbjct: 138 YYIHRNKILHRDMKAANVL---------------------------ITRDGVLKLADFGL 170
Query: 218 ----STTYERPDQNY--IVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ 270
S Y V T YR PE++LG + P D+W GCI+ E+ T + Q
Sbjct: 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230
Query: 271 THENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP- 328
+ LA++ ++ G P+ WP V
Sbjct: 231 GNTEQHQLALISQLCGSITPE-------------------VWPN----------VDNYEL 261
Query: 329 ------------RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
++++ + +V L+ LL DP R+ + +AL H FF D
Sbjct: 262 YEKLELVKGQKRKVKDRLKAYVRDPYA--LDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 56/332 (16%), Positives = 109/332 (32%), Gaps = 71/332 (21%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 106
K+G G FG V +C R + AIK + + A+ E+ L +H +
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS---H-V 73
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHD 163
V+ + + +H+ I E G SL D + +N F ++++ Q+ + ++H
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+ ++H D+KP N+ + + + + K+ D G T
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN--------KVMFKIGDLGHVT-RI 184
Query: 224 PDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282
+ A EV+ DI+++ +V E L + + +
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ-- 242
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342
G LP+ +P +
Sbjct: 243 ---GRLPR------------------------------------IP----------QVLS 253
Query: 343 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
+ T LL+ ++ DP R +A ++H
Sbjct: 254 QEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 77/336 (22%), Positives = 138/336 (41%), Gaps = 83/336 (24%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI-EIEVLQQLAKHDKG 102
+ K+G G +G+VL C D+ AIKI+ + + ++ E+ VL+ L H
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHP-- 96
Query: 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
N +++ ++F+ + + +V E G L+D + F I +Q+L + ++
Sbjct: 97 -N-IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYL 152
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H ++H DLKPEN+LL S E K + IK++DFG +
Sbjct: 153 HKHNIVHRDLKPENLLLESKE------------------------KDALIKIVDFGLSAV 188
Query: 222 ERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
+ + T +Y APEV+ + CD+WS+G IL L G F + E
Sbjct: 189 FENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--- 244
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339
++ +V +G+ + ++V
Sbjct: 245 ILRKVE--------------------KGKYTFDSPE-------------------WKNVS 265
Query: 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
A D L++ +L++D R++A++AL HP+
Sbjct: 266 EGAKD---LIKQMLQFDSQRRISAQQALEHPWIKEM 298
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 82/337 (24%), Positives = 143/337 (42%), Gaps = 84/337 (24%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDK 101
K +G+G+FG+V+ C D+ + A+K++ K +E+ + E+++L+QL H
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHP- 86
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
N +++ +F+ + + +V E G L+D + F I RQ+L I +
Sbjct: 87 --N-IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITY 141
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
MH ++H DLKPEN+LL S K + I++IDFG +T
Sbjct: 142 MHKNKIVHRDLKPENLLLESKS------------------------KDANIRIIDFGLST 177
Query: 221 YERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
+ + + T +Y APEV+ G + CD+WS G IL L +G F +
Sbjct: 178 HFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-- 234
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
++++V +G+ + + V
Sbjct: 235 -ILKKVE--------------------KGKYTFELPQ-------------------WKKV 254
Query: 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
SA D L++ +L Y P+ R++AR+AL H +
Sbjct: 255 SESAKD---LIRKMLTYVPSMRISARDALDHEWIQTY 288
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-39
Identities = 64/334 (19%), Positives = 121/334 (36%), Gaps = 79/334 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
I +G G FG V C + K+ K V+ + EI +L +H
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RH----RN 62
Query: 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+ + F+ + ++FE + G +++ + + + + Q+ E + F+H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSH 121
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+ H D++PEN++ + +SS IK+I+FG +P
Sbjct: 122 NIGHFDIRPENIIYQT-------------------------RRSSTIKIIEFGQARQLKP 156
Query: 225 DQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282
N+ + + Y APEV + D+WS+G ++ L +G F N + ++E
Sbjct: 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIE 213
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342
++ + E A + + A
Sbjct: 214 NIM--------------------NAEYTFDEEA-------------------FKEISIEA 234
Query: 343 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
D + LL + R+TA EAL+HP+ +
Sbjct: 235 MD---FVDRLLVKERKSRMTASEALQHPWLKQKI 265
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-39
Identities = 71/336 (21%), Positives = 130/336 (38%), Gaps = 90/336 (26%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111
G G G+VL+ +++ +E A+K+++ K R E+E+ + ++ + V+I +
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCP---H-IVRIVD 122
Query: 112 WFD----YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ R + IV E L G L+ ++ ++F EI + + E I ++H + +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
H D+KPEN+L S ++ +K+ DFG
Sbjct: 183 AHRDVKPENLLYTSKR------------------------PNAILKLTDFGFAKETTSHN 218
Query: 227 NY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
+ T +Y APEV+ + CD+WS+G I+ L G F ++ L
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------- 269
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNLIMQHVD 339
+ M R +R G+ + W V
Sbjct: 270 --AISPGMKTR--------IRMGQYEFPNPEWS------------------------EVS 295
Query: 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
L++ LL+ +PT R+T E + HP+ +
Sbjct: 296 EEVKM---LIRNLLKTEPTQRMTITEFMNHPWIMQS 328
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-39
Identities = 84/369 (22%), Positives = 144/369 (39%), Gaps = 89/369 (24%)
Query: 45 DKIHSKMGEGTFGQVLECWDRERK--EMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHD 100
+ K+G GT+G V + ++ K + A+K + GI +A EI +L++L KH
Sbjct: 23 EYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLREL-KHP 78
Query: 101 KGGNRCVQIRNWFDYRNHICI--VFE-------KLGSSLYDFLRKNNYRSFPIDLVREIA 151
N + ++ F + +F+ + P +V+ +
Sbjct: 79 ---N-VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 152 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 211
Q+L+ I ++H ++H DLKP N +LV E P+ +
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPAN-ILVMGEG----------------------PERGRV 171
Query: 212 KVIDFG-STTYERPDQNY-----IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELC 263
K+ D G + + P + +V T YRAPE++LG Y DIW++GCI EL
Sbjct: 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELL 230
Query: 264 TGEALFQ---------THENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPE 313
T E +F + + L + V+G P + DW +
Sbjct: 231 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK-------------------DWED 271
Query: 314 -------GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 366
++ ++ L + +H HLLQ LL DP R+T+ +A
Sbjct: 272 IKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331
Query: 367 LRHPFFTRD 375
++ P+F D
Sbjct: 332 MQDPYFLED 340
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-39
Identities = 81/350 (23%), Positives = 138/350 (39%), Gaps = 70/350 (20%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLAKHDKG 102
+ +G G G V +D VAIK + R + A A E+ +++ + H
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHK-- 121
Query: 103 GNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 156
N + + N F + + +V E + ++L ++ + + + Q+L
Sbjct: 122 -N-IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLC 175
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
I +H +IH DLKP N+++ S +K++DF
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSD---------------------------CTLKILDF 208
Query: 217 GSTTYERPDQN---YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273
G Y V TR+YRAPEVILG+G+ DIWSVGCI+ E+ + LF +
Sbjct: 209 GLARTAGTSFMMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
Query: 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR----RGRLDWPE---GAASRESIKSVMK 326
++ + LG +K++ YV L +P+ +
Sbjct: 268 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS----------- 316
Query: 327 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
L + + A D LL +L DP R++ +AL+HP+ +
Sbjct: 317 LFPADSEHNKLKASQARD---LLSKMLVIDPAKRISVDDALQHPYINVWY 363
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 69/346 (19%), Positives = 120/346 (34%), Gaps = 87/346 (25%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110
GEG +V C + + A+KI+ R E+E+L Q H N +++
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR---N-VLELI 77
Query: 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 169
+F+ + +VFEK+ G S+ + K R F + + + + F+H+ + H
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 170 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY- 228
DLKPEN+L + S +K+ DF + + + +
Sbjct: 136 DLKPENILCEHPN------------------------QVSPVKICDFDLGSGIKLNGDCS 171
Query: 229 ---------IVSTRHYRAPEVILGLGWTY-----PCDIWSVGCILVELCTGEALFQTHEN 274
+ Y APEV+ CD+WS+G IL L +G F
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231
Query: 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPR 329
+ + + ++ G+ + W
Sbjct: 232 SDCGWDRGEACPACQNMLFES--------IQEGKYEFPDKDWA----------------- 266
Query: 330 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
H+ +A D L+ LL D RL+A + L+HP+
Sbjct: 267 -------HISCAAKD---LISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 82/336 (24%), Positives = 137/336 (40%), Gaps = 83/336 (24%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKG 102
I +G+G+FG+VL+C DR ++ A+K++ K + E+E+L++L H
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHP-- 81
Query: 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
N +++ + + IV E G L+D + K F I +Q+ I +M
Sbjct: 82 -N-IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYM 137
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H ++H DLKPEN+LL S E K IK+IDFG +T
Sbjct: 138 HKHNIVHRDLKPENILLESKE------------------------KDCDIKIIDFGLSTC 173
Query: 222 ERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
+ + + T +Y APEV+ G + CD+WS G IL L +G F +
Sbjct: 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--- 229
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339
+++RV G+ + + +
Sbjct: 230 ILKRVE--------------------TGKYAFDLPQ-------------------WRTIS 250
Query: 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
A D L++ +L + P+ R+TA + L HP+ +
Sbjct: 251 DDAKD---LIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 73/335 (21%), Positives = 130/335 (38%), Gaps = 80/335 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGN 104
I ++G G FG V C ++ + K + + EI ++ QL H
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHP---- 108
Query: 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
+ + + + F+ + + ++ E L G L+D + +Y V RQ E + MH+
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHE 167
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
++H D+KPEN++ + K+S++K+IDFG T
Sbjct: 168 HSIVHLDIKPENIMCET-------------------------KKASSVKIIDFGLATKLN 202
Query: 224 PDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
PD+ +T + APE++ + D+W++G + L +G + F ++LE +
Sbjct: 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TL 259
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
+ V R ++ E A V
Sbjct: 260 QNVK--------------------RCDWEFDEDA-------------------FSSVSPE 280
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
A D ++ LL+ +P RLT +AL HP+ DH
Sbjct: 281 AKD---FIKNLLQKEPRKRLTVHDALEHPWLKGDH 312
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 71/385 (18%), Positives = 125/385 (32%), Gaps = 129/385 (33%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKH 99
+ +G+G++G V + + + + AIKI+ K E E+ ++++L H
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HH 87
Query: 100 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR------------------ 140
++ ++ +IC+V E G L D L
Sbjct: 88 ----PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 141 --------------------SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 180
L+ I RQ+ + ++H+ + H D+KPEN L +
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 181 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQNY------IVSTR 233
++ S IK++DFG S + + + T
Sbjct: 204 NK-------------------------SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 234 HYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQH 291
++ APEV+ +Y CD WS G +L L G F N + +VL
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFP-GVN--DADTISQVL------ 289
Query: 292 MLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351
+L + + + A D LL
Sbjct: 290 --------------NKKLCFENPNYN-------------------VLSPLARD---LLSN 313
Query: 352 LLRYDPTDRLTAREALRHPFFTRDH 376
LL + +R A AL+HP+ ++
Sbjct: 314 LLNRNVDERFDAMRALQHPWISQFS 338
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 64/356 (17%), Positives = 104/356 (29%), Gaps = 101/356 (28%)
Query: 36 TYIVFSAFAD--KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVL 93
+ V F K +G G FGQV + R + IK +K E A E++ L
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKAL 58
Query: 94 QQLAKH------------DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR 140
+L H + + I E +L ++ K
Sbjct: 59 AKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 141 SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200
L E+ Q+ + + ++H +I+ DLKP N+ LV
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV--------------------- 156
Query: 201 YFKRMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCI 258
+ +K+ DFG T + D T Y +PE I + D++++G I
Sbjct: 157 ------DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210
Query: 259 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR 318
L EL + T R G + +
Sbjct: 211 LAELLH---VCDTAFETSKFFTDLR-DGIISDIF------------------------DK 242
Query: 319 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
+ + L+ + LL P DR E LR +
Sbjct: 243 K----------EKTLLQK---------------LLSKKPEDRPNTSEILRTLTVWK 273
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-38
Identities = 77/358 (21%), Positives = 124/358 (34%), Gaps = 119/358 (33%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR---------EAAMIEIEVLQQL 96
++ +G+G F V C +RE + A+KI + + E E + L
Sbjct: 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKI---VDVAKFTSSPGLSTEDLKREASICHML 83
Query: 97 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNYRSFPIDLVREIARQ 153
KH + V++ + + +VFE + G+ L + R + + + RQ
Sbjct: 84 -KHP---H-IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 213
+LE + + HD +IH D+KP VLL S E S+ +K+
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKE------------------------NSAPVKL 174
Query: 214 IDFG-STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC------ 263
FG + V T H+ APEV+ + P D+W G IL + L
Sbjct: 175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234
Query: 264 -TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAAS 317
T E LF+ + +G+ W
Sbjct: 235 GTKERLFEG--------------------------------IIKGKYKMNPRQWS----- 257
Query: 318 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
H+ SA D L++ +L DP +R+T EAL HP+
Sbjct: 258 -------------------HISESAKD---LVRRMLMLDPAERITVYEALNHPWLKER 293
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 72/347 (20%), Positives = 134/347 (38%), Gaps = 94/347 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--------------GIKKYREAAMIEIE 91
K+G G +G+VL C ++ AIK+++ I+K+ E EI
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 92 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 150
+L+ L H N +++ + F+ + + +V E G L++ + + F I
Sbjct: 99 LLKSL-DHP---N-IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANI 151
Query: 151 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 210
+Q+L I ++H ++H D+KPEN+LL +
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKN------------------------SLLN 187
Query: 211 IKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 268
IK++DFG +++ D + T +Y APEV+ + CD+WS G I+ L G
Sbjct: 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246
Query: 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328
F + + ++++V +G+ +
Sbjct: 247 FGGQNDQD---IIKKVE--------------------KGKYYFDFND------------- 270
Query: 329 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+++ A + L++ +L YD R TA EAL + +
Sbjct: 271 ------WKNISDEAKE---LIKLMLTYDYNKRCTAEEALNSRWIKKY 308
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-38
Identities = 66/329 (20%), Positives = 112/329 (34%), Gaps = 79/329 (24%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108
G G F V +C + + A K + R + R + EI VL+ R +
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP----RVIN 93
Query: 109 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
+ ++ + I ++ E G ++ + V + +Q+LE + ++H ++
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 227
H DLKP+N+LL S IK++DFG +
Sbjct: 154 HLDLKPQNILLSSIY------------------------PLGDIKIVDFGMSRKIGHACE 189
Query: 228 Y--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
I+ T Y APE++ T D+W++G I L T + F +N E +
Sbjct: 190 LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TYLNIS 246
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
+ +D+ E V A D
Sbjct: 247 --------------------QVNVDYSEET-------------------FSSVSQLATD- 266
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTR 374
+Q LL +P R TA L H + +
Sbjct: 267 --FIQSLLVKNPEKRPTAEICLSHSWLQQ 293
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 74/331 (22%), Positives = 126/331 (38%), Gaps = 81/331 (24%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111
G G G+VLEC+ R + A+K++ K R+ E++ Q + + V I +
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----EVDHHWQASGGP---H-IVCILD 89
Query: 112 WFD----YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ + + I+ E + G L+ +++ ++F EI R + I F+H +
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 225
H D+KPEN+L S E K + +K+ DFG + +
Sbjct: 150 AHRDVKPENLLYTSKE------------------------KDAVLKLTDFGFAKETTQNA 185
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT-HENLEHLAMMERV 284
T +Y APEV+ + CD+WS+G I+ L G F + M R
Sbjct: 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR- 244
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
+R G+ +P V A
Sbjct: 245 -------------------IRLGQYGFPNPE-------------------WSEVSEDAKQ 266
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
L++ LL+ DPT+RLT + + HP+ +
Sbjct: 267 ---LIRLLLKTDPTERLTITQFMNHPWINQS 294
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 82/344 (23%), Positives = 139/344 (40%), Gaps = 58/344 (16%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLAKHDKG 102
+ +G G G V +D + VAIK + R + A A E+ +++ + H
Sbjct: 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHK-- 84
Query: 103 GNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 156
N + + N F + + IV E + ++L ++ + + Q+L
Sbjct: 85 -N-IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER----MSYLLYQMLC 138
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
I +H +IH DLKP N+++ S +K+ D+ L +S+
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF--GLARTAGTSFM-------------- 182
Query: 217 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276
T Y V TR+YRAPEVILG+G+ DIWSVGCI+ E+ G LF ++++
Sbjct: 183 -MTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 233
Query: 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVR----RGRLDWPEGAASRESIKSVMKLPRLQN 332
+ LG +K++ YV + + L +
Sbjct: 234 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK--------LFPDVLFPADS 285
Query: 333 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+ A D LL +L D + R++ EAL+HP+ +
Sbjct: 286 EHNKLKASQARD---LLSKMLVIDASKRISVDEALQHPYINVWY 326
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 74/335 (22%), Positives = 124/335 (37%), Gaps = 80/335 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGN 104
IH ++G G FG V +R A K V + +E EI+ + L +H
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPT--- 215
Query: 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
V + + F+ N + +++E + G L++ + + D E RQ+ + + MH+
Sbjct: 216 -LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHE 273
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+H DLKPEN++ + +S+ +K+IDFG T +
Sbjct: 274 NNYVHLDLKPENIMFTT-------------------------KRSNELKLIDFGLTAHLD 308
Query: 224 PDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
P Q+ T + APEV G Y D+WSVG + L +G + F + E +
Sbjct: 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TL 365
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
V + + A +
Sbjct: 366 RNVK--------------------SCDWNMDDSA-------------------FSGISED 386
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
D ++ LL DP R+T +AL HP+ T +
Sbjct: 387 GKD---FIRKLLLADPNTRMTIHQALEHPWLTPGN 418
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 90/360 (25%), Positives = 151/360 (41%), Gaps = 61/360 (16%)
Query: 31 MFNLITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-- 88
M I Y + S F ++ S +GEG +G V + E+VAIK + K A
Sbjct: 1 MPKRIVYNISSDF--QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR 58
Query: 89 EIEVLQQLAKHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFP 143
EI++L+ KH+ N + I N + N + I+ E + + L+ +
Sbjct: 59 EIKILKHF-KHE---N-IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD-- 111
Query: 144 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203
D ++ Q L + +H +IH DLKP N+L+ S+ +KV D+ + + ++
Sbjct: 112 -DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 204 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVEL 262
+ + V+TR YRAPEV+L ++ D+WS GCIL EL
Sbjct: 171 EPTGQQSGM------VEF--------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
Query: 263 CTGEALFQTHENLEHLAMMERVLG-PLPQHMLKRVD-RHAEKYVR----RGRLDWPEGAA 316
+F + L ++ ++G P + L+ ++ A +Y++ +
Sbjct: 217 FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK--- 273
Query: 317 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
P V+ DL LQ +L +DP R+TA+EAL HP+ H
Sbjct: 274 ---------MFP--------RVNPKGIDL---LQRMLVFDPAKRITAKEALEHPYLQTYH 313
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 47/242 (19%), Positives = 92/242 (38%), Gaps = 28/242 (11%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+H +GEG F QV E + + + +K + A E + QL + K +
Sbjct: 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKF-VLKVQKPANPWEFYIGTQLMERLKPSMQ 126
Query: 106 --CVQIRNWFDYRNHICIVFEKL-GSSLYDFL---RKNNYRSFPIDLVREIARQLLECIA 159
++ + ++N +V E +L + + + + P LV A ++L I
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
+HD +IH D+KP+N +L + + + S + +ID G +
Sbjct: 187 QVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG----------------LALIDLGQS 230
Query: 220 TYER--PDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274
+ P + T ++ E++ W Y D + V + + G + +E
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 275 LE 276
E
Sbjct: 291 GE 292
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 66/338 (19%), Positives = 115/338 (34%), Gaps = 91/338 (26%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKG 102
K+GEG+FG+ + E IK + K RE + E+ VL + KH
Sbjct: 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHP-- 83
Query: 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
VQ R F+ + IV + G L+ + F D + + Q+ + +
Sbjct: 84 --NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
HD ++H D+K +N+ L K +++ DFG
Sbjct: 142 HDRKILHRDIKSQNIFL---------------------------TKDGTVQLGDFGIARV 174
Query: 222 ERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
+ T +Y +PE+ + DIW++GC+L ELCT + F+ ++++L
Sbjct: 175 LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNL 233
Query: 279 AM--MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336
+ + P+ H S +
Sbjct: 234 VLKIISGSFPPVSLHY------------------------SYD----------------- 252
Query: 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L L+ L + +P DR + L F +
Sbjct: 253 --------LRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 83/346 (23%), Positives = 142/346 (41%), Gaps = 74/346 (21%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLAKHDKG 102
+ +G G +G V D+ E VAIK + R + A A E+ +L+ + +H+
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHE-- 83
Query: 103 GNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 156
N + + + F +V + + L + F + ++ + Q+L+
Sbjct: 84 -N-VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK----FSEEKIQYLVYQMLK 137
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
+ ++H ++H DLKP N+ + +K++DF
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNED---------------------------CELKILDF 170
Query: 217 GSTTYERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENL 275
G + + V TR YRAPEVIL DIWSVGCI+ E+ TG+ LF+ + L
Sbjct: 171 GLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 230
Query: 276 EHLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRESIKSVMKLPRL 330
+ L + +V G ++++ D+ A+ Y++ R D+ +
Sbjct: 231 DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ----------------- 273
Query: 331 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+ A D LL+ +L D RLTA +AL HPFF
Sbjct: 274 ---LFPRASPQAAD---LLEKMLELDVDKRLTAAQALTHPFFEPFR 313
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 81/351 (23%), Positives = 149/351 (42%), Gaps = 83/351 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEIEVLQQLA 97
+ S +G G +G V +D + VA+K + + YRE + +L+ +
Sbjct: 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKHM- 85
Query: 98 KHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA 151
KH+ N + + + F + N + +V +G+ L + ++ D V+ +
Sbjct: 86 KHE---N-VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFLI 138
Query: 152 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 211
Q+L + ++H +IH DLKP N+ + +
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNED---------------------------CEL 171
Query: 212 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ 270
K++DFG + + V+TR YRAPE++L + DIWSVGCI+ EL TG LF
Sbjct: 172 KILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231
Query: 271 THENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRESIKSVM 325
++++ L ++ R++G +LK++ A Y++ ++++
Sbjct: 232 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN------------ 279
Query: 326 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+ + A D LL+ +L D R+TA +AL H +F + H
Sbjct: 280 --------VFIGANPLAVD---LLEKMLVLDSDKRITAAQALAHAYFAQYH 319
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-37
Identities = 66/340 (19%), Positives = 124/340 (36%), Gaps = 85/340 (25%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIEVLQQLAK 98
++ ++G G F V +C + + A K ++ + RE E+ +L+++ +
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-R 66
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
H + + + F+ + + ++ E + G L+DFL + D + +Q+L+
Sbjct: 67 HP----NIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDG 120
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+ ++H + H DLKPEN++L+ + + IK+IDFG
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLD-----------------------KNVPNPRIKLIDFG 157
Query: 218 STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275
+ I T + APE++ D+WS+G I L +G + F
Sbjct: 158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF------ 211
Query: 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335
LG Q L + D+ E
Sbjct: 212 ---------LGETKQETLTN--------ISAVNYDFDEEY-------------------F 235
Query: 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+ A D ++ LL DP R+T ++L H +
Sbjct: 236 SNTSELAKD---FIRRLLVKDPKRRMTIAQSLEHSWIKAI 272
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 72/340 (21%), Positives = 122/340 (35%), Gaps = 85/340 (25%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIEVLQQLAK 98
I ++G G F V +C ++ A K ++ + RE E+ +L+Q+
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-L 73
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
H + + + ++ R + ++ E + G L+DFL + + +Q+L+
Sbjct: 74 HH----NVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDG 127
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+ ++H + H DLKPEN++L+ IK+IDFG
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIPHIKLIDFG 164
Query: 218 STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275
+ I T + APE++ D+WS+G I L +G + F
Sbjct: 165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF------ 218
Query: 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335
LG Q L + D+ E
Sbjct: 219 ---------LGDTKQETLAN--------ITSVSYDFDEEF-------------------F 242
Query: 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
H A D ++ LL + RLT +EALRHP+ T
Sbjct: 243 SHTSELAKD---FIRKLLVKETRKRLTIQEALRHPWITPV 279
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 75/353 (21%), Positives = 130/353 (36%), Gaps = 75/353 (21%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI------------EIEVL 93
+ + G++G V D E VAIK V I EI +L
Sbjct: 25 TVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 94 QQLAKHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVR 148
H N + +R+ F + + +V E + + L + ++
Sbjct: 84 NHF-HHP---N-ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQ 137
Query: 149 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 208
+L + +H+ ++H DL P N +L++
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGN-ILLADN-------------------------- 170
Query: 209 SAIKVIDFGSTTYERPDQN---YIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 264
+ I + DF + D N Y V+ R YRAPE+++ G+T D+WS GC++ E+
Sbjct: 171 NDITICDFNLAREDTADANKTHY-VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229
Query: 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKS 323
+ALF+ L + V+G + A Y+R + P + +
Sbjct: 230 RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP-----ARAWTA 284
Query: 324 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
V +P D A D L+ +L ++P R++ +ALRHP+F
Sbjct: 285 V--VP--------TADPVALD---LIAKMLEFNPQRRISTEQALRHPYFESLF 324
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-37
Identities = 58/341 (17%), Positives = 111/341 (32%), Gaps = 66/341 (19%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGG 103
+ +G+G V ++ ++ AIK+ + + M E EVL++L H
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHK--- 67
Query: 104 NRCVQIRNWFDYRN--HICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQLLECIA 159
V++ + H ++ E SLY L + N P + R ++ +
Sbjct: 68 -NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
+ + ++H ++KP N++ V E S K+ DFG+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDFGAA 163
Query: 220 TYERPDQNY--IVSTRHYRAPEVILGLGWTYP--------CDIWSVGCILVELCTGEALF 269
D+ + + T Y P++ D+WS+G TG F
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
Query: 270 QTHENLEHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328
+ E +M +++ P + V + G +DW S+ ++
Sbjct: 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQK-----AENGPIDWSGDMPVSCSLSRGLQ-- 276
Query: 329 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369
LT +L +L D +
Sbjct: 277 --------------VLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 76/334 (22%), Positives = 121/334 (36%), Gaps = 83/334 (24%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGG 103
K+G G FG V +R IK + + E EIEVL+ L H
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHP--- 80
Query: 104 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNYRSFPIDLVREIARQLLECIAF 160
++I F+ +++ IV E G L + + + ++ V E+ +Q++ +A+
Sbjct: 81 -NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
H ++H DLKPEN+L + S IK+IDFG
Sbjct: 140 FHSQHVVHKDLKPENILFQDTS------------------------PHSPIKIIDFGLAE 175
Query: 221 YERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
+ D++ T Y APEV T+ CDIWS G ++ L TG F +LE +
Sbjct: 176 LFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFT-GTSLEEV 233
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
+ ++ + +
Sbjct: 234 Q----------------------QKATYKEPNYAVEC--------------------RPL 251
Query: 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
A D LL+ +L DP R +A + L H +F
Sbjct: 252 TPQAVD---LLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 40/355 (11%), Positives = 88/355 (24%), Gaps = 99/355 (27%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRG--------IKKYREAAMIEIEVLQQLAKHDKGG 103
G V D ER E A+K+ +++ EA +L + + +
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 104 NRCVQIRNWFDYRNH-----------------ICIVFEKLGSSLYDFLRKNNYRS----- 141
R + + ++ ++ L ++
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190
Query: 142 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201
I + + QL+ A + ++H P+N+ ++
Sbjct: 191 EGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---------------------- 228
Query: 202 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY--PCDIWSVGCIL 259
+ + D + Y E + T+ + W +G +
Sbjct: 229 -----PDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283
Query: 260 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 319
+ F G + + R + + L + +
Sbjct: 284 YRVWCLFLPF----------------GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD 327
Query: 320 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
+K+ L+ L +D RL EA+ P F +
Sbjct: 328 FVKT------------------------LIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 71/341 (20%), Positives = 121/341 (35%), Gaps = 85/341 (24%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAK 98
I ++G G F V +C ++ A K ++ + RE E+ +L+Q+
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-L 73
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
H + + + ++ R + ++ E + G L+DFL + + +Q+L+
Sbjct: 74 HP----NIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDG 127
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+ ++H + H DLKPEN++L+ IK+IDFG
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIPHIKLIDFG 164
Query: 218 STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275
+ I T + APE++ D+WS+G I L +G + F
Sbjct: 165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF------ 218
Query: 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335
LG Q L + D+ E
Sbjct: 219 ---------LGDTKQETLAN--------ITAVSYDFDEEF-------------------F 242
Query: 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
A D ++ LL + RLT +EALRHP+ T
Sbjct: 243 SQTSELAKD---FIRKLLVKETRKRLTIQEALRHPWITPVD 280
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 83/350 (23%), Positives = 142/350 (40%), Gaps = 77/350 (22%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGG 103
S +GEG +G V +D K VAIK + + EI++L + +H+
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHE--- 85
Query: 104 NRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
N + I + + + IV + + + LY L+ + D + Q+L +
Sbjct: 86 N-IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGL 141
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 217
++H ++H DLKP N LL+++ +K+ DFG
Sbjct: 142 KYIHSANVLHRDLKPSN-LLLNTT--------------------------CDLKICDFGL 174
Query: 218 --STTYERPDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 271
+ ++ V+TR YRAPE++L G+T DIWSVGCIL E+ + +F
Sbjct: 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234
Query: 272 HENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRESIKSVMK 326
L+ L + +LG Q L + + A Y+ + ++ W
Sbjct: 235 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR------------L 282
Query: 327 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
P + D A D LL +L ++P R+ +AL HP+ + +
Sbjct: 283 FP--------NADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 72/339 (21%), Positives = 130/339 (38%), Gaps = 91/339 (26%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGN 104
+G G F +V R ++ A+K ++ +R++++ EI VL+++ KH+ N
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHE---N 67
Query: 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
V + + ++ H +V + + G L+D + + + + +Q+L + ++H+
Sbjct: 68 -IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHE 124
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
++H DLKPEN+L ++ E ++S I + DFG + E+
Sbjct: 125 NGIVHRDLKPENLLYLTPE------------------------ENSKIMITDFGLSKMEQ 160
Query: 224 PDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELCTGEALFQTHENLEHLAMM 281
T Y APEV+ ++ D WS+G I + LC G F E L
Sbjct: 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC-GYPPFYE-ETESKL--F 216
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNLIMQ 336
E++ G + W
Sbjct: 217 EKIK--------------------EGYYEFESPFWD------------------------ 232
Query: 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+ SA D + LL DP +R T +AL HP+ +
Sbjct: 233 DISESAKD---FICHLLEKDPNERYTCEKALSHPWIDGN 268
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 82/349 (23%), Positives = 134/349 (38%), Gaps = 91/349 (26%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAAMI--EIEVLQQL 96
+ +G G G+V ++R+ + VAI+I+ ++ A + EIE+L++L
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 97 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLL 155
H ++I+N+FD IV E + G L+D + N + Q+L
Sbjct: 198 -NHP----CIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQML 249
Query: 156 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 215
+ ++H+ +IH DLKPENVLL S E + IK+ D
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCLIKITD 285
Query: 216 FGSTTYERPDQNY--IVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQ 270
FG + + T Y APEV++ + G+ D WS+G IL +G F
Sbjct: 286 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345
Query: 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 330
H + + + G+ ++
Sbjct: 346 EHRT--------------QVSLKDQ--------ITSGKYNFIP----------------- 366
Query: 331 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 379
+ V A D L++ LL DP R T EALRHP+ + ++R
Sbjct: 367 --EVWAEVSEKALD---LVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-36
Identities = 84/341 (24%), Positives = 135/341 (39%), Gaps = 93/341 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKG 102
I +G+G+FG+VL+C DR ++ A+K++ K + E+E+L++L H
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHP-- 81
Query: 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
N +++ + + IV E G L+D + K F I +Q+ I +M
Sbjct: 82 -N-IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYM 137
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H ++H DLKPEN+LL S E K IK+IDFG +T
Sbjct: 138 HKHNIVHRDLKPENILLESKE------------------------KDCDIKIIDFGLSTC 173
Query: 222 ERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
+ + + T +Y APEV+ G + CD+WS G IL L +G F +N +
Sbjct: 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDIL 231
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNLI 334
K V G+ W
Sbjct: 232 ----------------------KRVETGKYAFDLPQWR---------------------- 247
Query: 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+ A D L++ +L + P+ R+TA + L HP+ +
Sbjct: 248 --TISDDAKD---LIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 63/340 (18%), Positives = 120/340 (35%), Gaps = 85/340 (25%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIEVLQQLAK 98
++G G F V +C ++ A K ++ + RE E+ +L+++ +
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-Q 72
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
H + + ++ + + ++ E + G L+DFL + + E +Q+L
Sbjct: 73 HP----NVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNG 126
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+ ++H L + H DLKPEN++L+ IK+IDFG
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRN-----------------------VPKPRIKIIDFG 163
Query: 218 STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275
+ I T + APE++ D+WS+G I L +G + F
Sbjct: 164 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335
E + V ++ +
Sbjct: 224 E---TLANVS--------------------AVNYEFEDEY-------------------F 241
Query: 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+ A D ++ LL DP R+T +++L+HP+
Sbjct: 242 SNTSALAKD---FIRRLLVKDPKKRMTIQDSLQHPWIKPK 278
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-36
Identities = 70/342 (20%), Positives = 118/342 (34%), Gaps = 97/342 (28%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDK 101
+ + +G G++G+V + + A K I KY + EIE+++ L H
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMKSL-DH-- 65
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
+++ F+ I +V E G L++ + F I + +L +A+
Sbjct: 66 --PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAY 121
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
H L + H DLKPEN L ++ S +K+IDFG
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDS------------------------PDSPLKLIDFGLAA 157
Query: 221 YERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
+P + V T +Y +P+V+ G + CD WS G ++ L G F +
Sbjct: 158 RFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEV 215
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNL 333
+R G W
Sbjct: 216 M----------------------LKIREGTFTFPEKDWL--------------------- 232
Query: 334 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+V A L++ LL P R+T+ +AL H +F +
Sbjct: 233 ---NVSPQAES---LIRRLLTKSPKQRITSLQALEHEWFEKQ 268
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-36
Identities = 76/339 (22%), Positives = 130/339 (38%), Gaps = 95/339 (28%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGG 103
++ S++G G V C + ++ A+K+ +KK + ++ EI VL +L H
Sbjct: 56 EVESELGRGATSIVYRCKQKGTQKPYALKV---LKKTVDKKIVRTEIGVLLRL-SHP--- 108
Query: 104 NRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
N ++++ F+ I +V E G L+D + + Y + + +Q+LE +A++H
Sbjct: 109 N-IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLH 165
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
+ ++H DLKPEN+L + + +K+ DFG +
Sbjct: 166 ENGIVHRDLKPENLLYATPA------------------------PDAPLKIADFGLSKIV 201
Query: 223 RPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELCTGEALFQTHENLEHLA 279
+ T Y APE++ G + D+WSVG I + LC G F +
Sbjct: 202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC-GFEPFYDERGDQ--F 258
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNLI 334
M R+L W
Sbjct: 259 MFRRIL--------------------NCEYYFISPWWD---------------------- 276
Query: 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
V +A D L++ L+ DP RLT +AL+HP+ T
Sbjct: 277 --EVSLNAKD---LVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-36
Identities = 66/350 (18%), Positives = 119/350 (34%), Gaps = 110/350 (31%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKG 102
+ ++G+G F V C + A KI+ + + + E + ++L +H
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHP-- 88
Query: 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
N V++ + + +VF+ + G L++ + + + +Q+LE IA+
Sbjct: 89 -N-IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYC 144
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H ++H +LKPEN+LL S K +A+K+ DFG
Sbjct: 145 HSNGIVHRNLKPENLLLASKA------------------------KGAAVKLADFGLAIE 180
Query: 222 ERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC--------TGEALFQ 270
+ + T Y +PEV+ ++ P DIW+ G IL + L L+
Sbjct: 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 240
Query: 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVM 325
++ G D W
Sbjct: 241 Q--------------------------------IKAGAYDYPSPEWD------------- 255
Query: 326 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
V A L+ +L +P R+TA +AL+ P+
Sbjct: 256 -----------TVTPEAKS---LIDSMLTVNPKKRITADQALKVPWICNR 291
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-36
Identities = 86/383 (22%), Positives = 148/383 (38%), Gaps = 86/383 (22%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEIEVLQQLA 97
+I +G G++G V E +D+ K +VAIK + + + RE I +L +L
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE-----IAILNRL- 109
Query: 98 KHDKGGN----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 153
HD + + I + + + +V E S R Y + ++ +
Sbjct: 110 NHD---HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLT--ELHIKTLLYN 164
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 213
LL + ++H ++H DLKP N L+ +KV D+ + + ++P S
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 214 IDFGSTTYERPDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT----- 264
++ + + + + + V TR YRAPE+IL +T D+WS+GCI EL
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 265 ------GEALF--------------------QTHENLEHLAMMERVLGPLPQHMLKRV-D 297
LF T N + L ++ +LG + ++ +
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344
Query: 298 RHAEKYVR----RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353
A++Y+R R D E + P A L L+ +L
Sbjct: 345 EDAKRYIRIFPKREGTDLAE------------RFP--------ASSADAIHL---LKRML 381
Query: 354 RYDPTDRLTAREALRHPFFTRDH 376
++P R+T E L HPFF
Sbjct: 382 VFNPNKRITINECLAHPFFKEVR 404
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 86/346 (24%), Positives = 145/346 (41%), Gaps = 73/346 (21%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLAKHDKG 102
+ +G G +G V D VAIK + R + A A E+ +L+ + +H+
Sbjct: 28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHE-- 84
Query: 103 GNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 156
N + + + F D +V +G+ L ++ D ++ + Q+L+
Sbjct: 85 -N-VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE---DRIQFLVYQMLK 139
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
+ ++H +IH DLKP N+ + +K++DF
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNED---------------------------CELKILDF 172
Query: 217 GSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 275
G + V TR YRAPEVIL +T DIWSVGCI+ E+ TG+ LF+ ++L
Sbjct: 173 GLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 232
Query: 276 EHLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRESIKSVMKLPRL 330
+ L + +V G P ++R+ A+ Y++ + D+
Sbjct: 233 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS----------------- 275
Query: 331 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
I+ + A + LL+ +L D R+TA EAL HP+F H
Sbjct: 276 ---ILTNASPLAVN---LLEKMLVLDAEQRVTAGEALAHPYFESLH 315
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-35
Identities = 75/341 (21%), Positives = 125/341 (36%), Gaps = 105/341 (30%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 107
G+G F + E D + KE+ A KIV + K + + EI + + L H V
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH----QHVV 78
Query: 108 QIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+F+ + + +V E SL + ++ ++ R RQ++ ++H +
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRV 136
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 225
IH DLK N+ L + + K+ DFG +T E
Sbjct: 137 IHRDLKLGNLFL---------NEDLEV------------------KIGDFGLATKVEYDG 169
Query: 226 Q---------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276
+ NYI APEV+ G ++ D+WS+GCI+ L G+ F+T L
Sbjct: 170 ERKKVLCGTPNYI-------APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCL- 220
Query: 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336
+ R +++ P+
Sbjct: 221 -------------KETYLR--------IKKNEYSIPK----------------------- 236
Query: 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377
H++ A L+Q +L+ DPT R T E L FFT ++
Sbjct: 237 HINPVAAS---LIQKMLQTDPTARPTINELLNDEFFTSGYI 274
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 70/351 (19%), Positives = 123/351 (35%), Gaps = 111/351 (31%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKG 102
++ ++G+G F V C + A I+ + + + E + + L KH
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHP-- 70
Query: 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
N V++ + H ++F+ + G L++ + Y + +Q+LE +
Sbjct: 71 -N-IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHC 126
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STT 220
H + ++H +LKPEN+LL S K +A+K+ DFG +
Sbjct: 127 HQMGVVHRNLKPENLLLASKL------------------------KGAAVKLADFGLAIE 162
Query: 221 YERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC--------TGEALF 269
E Q + T Y +PEV+ + P D+W+ G IL + L L+
Sbjct: 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY 222
Query: 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSV 324
Q ++ G D W
Sbjct: 223 Q--------------------------------QIKAGAYDFPSPEWD------------ 238
Query: 325 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
V A D L+ +L +P+ R+TA EAL+HP+ +
Sbjct: 239 ------------TVTPEAKD---LINKMLTINPSKRITAAEALKHPWISHR 274
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-35
Identities = 66/350 (18%), Positives = 119/350 (34%), Gaps = 110/350 (31%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKG 102
+ ++G+G F V C + A KI+ + + + E + ++L +H
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHP-- 65
Query: 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
N V++ + + +VF+ + G L++ + + + +Q+LE IA+
Sbjct: 66 -N-IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYC 121
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H ++H +LKPEN+LL S K +A+K+ DFG
Sbjct: 122 HSNGIVHRNLKPENLLLASKA------------------------KGAAVKLADFGLAIE 157
Query: 222 ERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC--------TGEALFQ 270
+ + T Y +PEV+ ++ P DIW+ G IL + L L+
Sbjct: 158 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 217
Query: 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVM 325
++ G D W
Sbjct: 218 Q--------------------------------IKAGAYDYPSPEWD------------- 232
Query: 326 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
V A L+ +L +P R+TA +AL+ P+
Sbjct: 233 -----------TVTPEAKS---LIDSMLTVNPKKRITADQALKVPWICNR 268
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 75/341 (21%), Positives = 125/341 (36%), Gaps = 105/341 (30%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 107
G+G F + E D + KE+ A KIV + K + + EI + + L H V
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH----QHVV 104
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+F+ + + +V E SL + ++ ++ R RQ++ ++H +
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRV 162
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 225
IH DLK N+ L + +K+ DFG +T E
Sbjct: 163 IHRDLKLGNLFL---------NEDLE------------------VKIGDFGLATKVEYDG 195
Query: 226 Q---------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276
+ NYI APEV+ G ++ D+WS+GCI+ L G+ F+T L
Sbjct: 196 ERKKVLCGTPNYI-------APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCL- 246
Query: 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336
+ R +++ P+
Sbjct: 247 -------------KETYLR--------IKKNEYSIPK----------------------- 262
Query: 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377
H++ A L+Q +L+ DPT R T E L FFT ++
Sbjct: 263 HINPVA---ASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-35
Identities = 80/326 (24%), Positives = 128/326 (39%), Gaps = 80/326 (24%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110
G G FGQV +C + +A KI++ K +E EI V+ QL H +Q+
Sbjct: 98 GGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHA----NLIQLY 152
Query: 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 169
+ F+ +N I +V E + G L+D + +Y + +Q+ E I MH + ++H
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 170 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY- 228
DLKPEN+L V+ + IK+IDFG +P +
Sbjct: 212 DLKPENILCVN-------------------------RDAKQIKIIDFGLARRYKPREKLK 246
Query: 229 -IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 287
T + APEV+ ++P D+WSVG I L +G + F LG
Sbjct: 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF---------------LGD 291
Query: 288 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347
L + R D + Q + A +
Sbjct: 292 NDAETLNN--------ILACRWDLEDEE-------------------FQDISEEAKE--- 321
Query: 348 LLQGLLRYDPTDRLTAREALRHPFFT 373
+ LL + + R++A EAL+HP+ +
Sbjct: 322 FISKLLIKEKSWRISASEALKHPWLS 347
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 78/354 (22%), Positives = 125/354 (35%), Gaps = 107/354 (30%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV----------RGIKKYREAAMIEIEVLQQ 95
+ +G G V C + + A+KI+ +++ REA + E+++L++
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 96 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 154
++ H N +Q+++ ++ +VF+ + L+D+L + R+I R L
Sbjct: 80 VSGHP---N-IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRAL 133
Query: 155 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 214
LE I +H L ++H DLKPEN+LL IK+
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDD---------------------------DMNIKLT 166
Query: 215 DFGSTTYERPDQNY--IVSTRHYRAPEVILGL------GWTYPCDIWSVGCILVELCTGE 266
DFG + P + + T Y APE+I G+ D+WS G I+ L G
Sbjct: 167 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226
Query: 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESI 321
F H ML+ + G W
Sbjct: 227 PPF-WHRK--------------QMLMLRM--------IMSGNYQFGSPEWD--------- 254
Query: 322 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+ D L+ L P R TA EAL HPFF +
Sbjct: 255 ---------------DYSDTVKD---LVSRFLVVQPQKRYTAEEALAHPFFQQY 290
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 65/337 (19%), Positives = 103/337 (30%), Gaps = 92/337 (27%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
++G G+FG+V D++ A+K VR + E+ L R V +
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGL-SSP----RIVPL 115
Query: 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
+ I E L G SL +++ P D Q LE + ++H ++H
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--------STT 220
D+K +NVLL S + DFG
Sbjct: 174 GDVKADNVLL--------------------------SSDGSRAALCDFGHALCLQPDGLG 207
Query: 221 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
+YI T + APEV++G DIWS C+++ + G H
Sbjct: 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG----------CH--- 254
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
P Q+ +K+ I +
Sbjct: 255 ------PWTQY---------------------------FRGPLCLKIASEPPPIREIPPS 281
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377
A +Q LR +P R +A E R +
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-34
Identities = 66/340 (19%), Positives = 110/340 (32%), Gaps = 89/340 (26%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNR 105
K+G G F +V VA+K V+ K R + EI++L+QL H N
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP---N- 93
Query: 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAFMH 162
++ F N + IV E L ++ K R P V + QL + MH
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 221
++H D+KP NV + + +K+ D G +
Sbjct: 154 SRRVMHRDIKPANVFIT---------------------------ATGVVKLGDLGLGRFF 186
Query: 222 ERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
+ +V T +Y +PE I G+ + DIWS+GC+L E+ ++ F + + +
Sbjct: 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYS 245
Query: 280 MMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
+ +++ P P S E L+ L+
Sbjct: 246 LCKKIEQCDYPP--------------------LPSDHYSEE----------LRQLVNM-- 273
Query: 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 378
+ DP R
Sbjct: 274 -------------CINPDPEKRPDVTYVYDVAKRMHACTA 300
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-34
Identities = 85/355 (23%), Positives = 136/355 (38%), Gaps = 103/355 (29%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAAMI--EIEVLQQL 96
+ +G G G+V ++R+ + VAIKI+ ++ A + EIE+L++L
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 97 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLL 155
H ++I+N+FD ++ IV E + G L+D + N + Q+L
Sbjct: 73 -NHP----CIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR--LKEATCKLYFYQML 124
Query: 156 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 215
+ ++H+ +IH DLKPENVLL S E + IK+ D
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCLIKITD 160
Query: 216 FGSTTYERPDQNY--IVSTRHYRAPEVILGL---GWTYPCDIWSVGCIL-VELCTGEALF 269
FG + + T Y APEV++ + G+ D WS+G IL + L G F
Sbjct: 161 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPF 219
Query: 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSV 324
H + + + G+ + W
Sbjct: 220 SEHRT--------------QVSLKDQ--------ITSGKYNFIPEVWA------------ 245
Query: 325 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 379
V A D L++ LL DP R T EALRHP+ + ++R
Sbjct: 246 ------------EVSEKALD---LVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 285
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 69/339 (20%), Positives = 111/339 (32%), Gaps = 64/339 (18%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGG 103
++ ++G G FG VL ++ E VAIK R K RE +EI+++++L H
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP--- 72
Query: 104 N-----RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQLLE 156
N + + E G L +L + N +R + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
+ ++H+ +IH DLKPEN++L + K+ID
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGP------------------------QRLIHKIIDL 168
Query: 217 GSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274
G + V T Y APE++ +T D WS G + E TG
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF-------- 220
Query: 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334
P + + K + ++K LP +L
Sbjct: 221 -------------RPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLS 267
Query: 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
AG L LQ +L + R T + F
Sbjct: 268 GI----LAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 79/353 (22%), Positives = 127/353 (35%), Gaps = 108/353 (30%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIEIEVLQQL 96
+G G V C R A+KI+ +++ REA E +L+Q+
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 97 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLL 155
A H + + + ++ + + +VF+ + L+D+L + R I R LL
Sbjct: 157 AGH----PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLL 210
Query: 156 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 215
E ++F+H ++H DLKPEN+LL + I++ D
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDD---------------------------NMQIRLSD 243
Query: 216 FGSTTYERPDQNY--IVSTRHYRAPEVILGL------GWTYPCDIWSVGCIL-VELCTGE 266
FG + + P + + T Y APE++ G+ D+W+ G IL L G
Sbjct: 244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA-GS 302
Query: 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESI 321
F H ML+ + G+ W
Sbjct: 303 PPF-WHRR--------------QILMLRM--------IMEGQYQFSSPEWD--------- 330
Query: 322 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
+ D L+ LL+ DP RLTA +AL+HPFF R
Sbjct: 331 ---------------DRSSTVKD---LISRLLQVDPEARLTAEQALQHPFFER 365
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 69/340 (20%), Positives = 122/340 (35%), Gaps = 104/340 (30%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 107
G+G+F V VAIK++ + + K + E+++ QL KH +
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KH----PSIL 74
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ N+F+ N++ +V E + +L+ + F + R Q++ + ++H +
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGI 133
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 225
+H DL N+LL + IK+ DFG +T + P
Sbjct: 134 LHRDLTLSNLLL---------TRNMN------------------IKIADFGLATQLKMPH 166
Query: 226 Q---------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276
+ NYI +PE+ D+WS+GC+ L G F T + +
Sbjct: 167 EKHYTLCGTPNYI-------SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT-DTV- 217
Query: 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336
++ L + V + P
Sbjct: 218 -------------KNTLNK--------VVLADYEMPS----------------------- 233
Query: 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+ A D L+ LLR +P DRL+ L HPF +R+
Sbjct: 234 FLSIEAKD---LIHQLLRRNPADRLSLSSVLDHPFMSRNS 270
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 65/344 (18%), Positives = 108/344 (31%), Gaps = 83/344 (24%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
+G G FG V E ++ AIK +R + RE M E++ L +L +H
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHP---GIVR 67
Query: 108 QIRNWFD-----------YRNHICIVFEKL--GSSLYDFLRKNNYRSFP-IDLVREIARQ 153
W + + ++ I + L +L D++ + I Q
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQ-LCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 213
+ E + F+H ++H DLKP N+ + +KV D+ M + +
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV----------TAMDQDEEEQ- 175
Query: 214 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273
+ V T+ Y +PE I G +++ DI+S+G IL EL F T
Sbjct: 176 -TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP---FSTQM 231
Query: 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 333
VR K P L
Sbjct: 232 ERVRTLTD----------------------VRNL------------------KFPPLFTQ 251
Query: 334 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377
++Q +L P +R A + + F
Sbjct: 252 KYP-------CEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-33
Identities = 63/352 (17%), Positives = 112/352 (31%), Gaps = 101/352 (28%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 102
++ +G G++G+ + + +++ K + ++ + E+ +L++L KH
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP-- 65
Query: 103 GNRCVQIRNWFDYR--NHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLLEC 157
N V+ + R + IV E G L + + + V + QL
Sbjct: 66 -N-IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 158 IAFMHDLC-----MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
+ H ++H DLKP NV L +K
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLD---------------------------GKQNVK 156
Query: 213 VIDFGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269
+ DFG D ++ V T +Y +PE + + + DIWS+GC+L ELC F
Sbjct: 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216
Query: 270 QTHENLEHLAM--MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 327
+ + LA E +P S E
Sbjct: 217 TA-FSQKELAGKIREGKFRRIPYRY------------------------SDE-------- 243
Query: 328 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 379
L ++ +L R + E L +P +H
Sbjct: 244 -----------------LNEIITRMLNLKDYHRPSVEEILENPLI-LEHHHH 277
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 86/379 (22%), Positives = 143/379 (37%), Gaps = 86/379 (22%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQLAKHDKG 102
I +G G++G V +D+ ++ VAIK + R + + I EI +L +L K D
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSD-- 85
Query: 103 GNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
+++ + + + IV E S L + + + + ++ I LL
Sbjct: 86 -Y-IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT--EEHIKTILYNLLLG 141
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPD------YKSSLHTPKDSSYFKRMPKSSAI 211
F+H+ +IH DLKP N LL +KV D S T + +
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 212 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG----- 265
K + T++ V TR YRAPE+IL +T DIWS GCI EL
Sbjct: 202 KNLKKQLTSH--------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253
Query: 266 ------EALFQ-----------------THENLEHLAMMERVLGPLPQHMLKRV-DRHAE 301
LF N + L ++ ++G + LK +
Sbjct: 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVI 313
Query: 302 KYVR----RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357
KY++ R ++ + K P + +L L+ +L+++P
Sbjct: 314 KYIKLFPHRKPINLKQ------------KYP--------SISDDGINL---LESMLKFNP 350
Query: 358 TDRLTAREALRHPFFTRDH 376
R+T +AL HP+
Sbjct: 351 NKRITIDQALDHPYLKDVR 369
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 67/336 (19%), Positives = 123/336 (36%), Gaps = 107/336 (31%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
+G G G+VL+ +++ +E A+K+++ K R E+E+ + ++ V+I
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCP----HIVRI 76
Query: 110 RNWFD----YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+ ++ R + IV E L G L+ ++ ++F EI + + E I ++H +
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+ H D+KPEN+L S ++ +K+ DFG
Sbjct: 137 NIAHRDVKPENLLYTSKR------------------------PNAILKLTDFG------- 165
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
A E G + CD+WS+G I+ L G F ++
Sbjct: 166 -----------FAKET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---------- 203
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNLIMQHVD 339
+ M R +R G+ + W V
Sbjct: 204 -LAISPGMKTR--------IRMGQYEFPNPEWS------------------------EVS 230
Query: 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
L++ LL+ +PT R+T E + HP+ +
Sbjct: 231 EEVKM---LIRNLLKTEPTQRMTITEFMNHPWIMQS 263
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 64/342 (18%), Positives = 124/342 (36%), Gaps = 93/342 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKG 102
K ++G G+F V + D E VA ++ K R+ E E+L+ L +H
Sbjct: 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHP-- 85
Query: 103 GNRCVQ-IRNWFDY---RNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLEC 157
V+ +W + I +V E + S +L +L++ ++ I ++R RQ+L+
Sbjct: 86 --NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKG 141
Query: 158 IAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 215
+ F+H +IH DLK +N+ + + ++K+ D
Sbjct: 142 LQFLHTRTPPIIHRDLKCDNIFI--------------------------TGPTGSVKIGD 175
Query: 216 FG-STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274
G +T ++ T + APE+ + D+++ G ++E+ T E + +N
Sbjct: 176 LGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 234
Query: 275 LEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 333
+ RV G P K P ++ +
Sbjct: 235 AA--QIYRRVTSGVKPASFDKVAI------------------------------PEVKEI 262
Query: 334 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
I +R + +R + ++ L H FF +
Sbjct: 263 IEG---------------CIRQNKDERYSIKDLLNHAFFQEE 289
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 69/329 (20%), Positives = 124/329 (37%), Gaps = 87/329 (26%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 107
G+G FG V +++ K ++A+K++ ++K + E+E+ L +H +
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPN----IL 72
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ +F + ++ E ++Y L+K F +L +++ H +
Sbjct: 73 RLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRV 130
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
IH D+KPEN+LL S+ +K+ D+ S+H P +R D
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRT-------------DLCGTLD- 172
Query: 227 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 286
Y PE+I G D+WS+G + E G+ F+ +
Sbjct: 173 --------YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------------- 211
Query: 287 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346
Q KR + R +P+ V A D
Sbjct: 212 --YQETYKR--------ISRVEFTFPD-----------------------FVTEGARD-- 236
Query: 347 HLLQGLLRYDPTDRLTAREALRHPFFTRD 375
L+ LL+++P+ R RE L HP+ T +
Sbjct: 237 -LISRLLKHNPSQRPMLREVLEHPWITAN 264
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-32
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 41/224 (18%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110
G+GT+G V D + +AIK + +Y + EI + + L KH VQ
Sbjct: 31 GKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHK----NIVQYL 85
Query: 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDLCMI 167
F I I E++ G SL L ++ + + + +Q+LE + ++HD ++
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS---TTYERP 224
H D+K +NVL+ S +K+ DFG+ P
Sbjct: 145 HRDIKGDNVLI--------------------------NTYSGVLKISDFGTSKRLAGINP 178
Query: 225 DQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGE 266
T Y APE+I G+ DIWS+GC ++E+ TG+
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 68/329 (20%), Positives = 118/329 (35%), Gaps = 87/329 (26%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 107
G+G FG V +++ K ++A+K++ ++K + EIE+ L +H +
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPN----IL 77
Query: 108 QIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ N+F R I ++ E LY L+K+ F +L + + + H+ +
Sbjct: 78 RMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKV 135
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
IH D+KPEN+L+ +K+ D+ S+H P +R T D
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRR-------------TMCGTLD- 177
Query: 227 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 286
Y PE+I G D+W G + E G F + H R++
Sbjct: 178 --------YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP---SHTETHRRIV- 225
Query: 287 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346
L +P + + D
Sbjct: 226 -------------------NVDLKFPP-----------------------FLSDGSKD-- 241
Query: 347 HLLQGLLRYDPTDRLTAREALRHPFFTRD 375
L+ LLRY P RL + + HP+ +
Sbjct: 242 -LISKLLRYHPPQRLPLKGVMEHPWVKAN 269
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-31
Identities = 55/341 (16%), Positives = 103/341 (30%), Gaps = 79/341 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGN 104
K+GEG F V A+K + ++ RE A E ++ + H N
Sbjct: 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHP---N 87
Query: 105 RCVQIRNWF----DYRNHICIVFE-KLGSSLYDFL--RKNNYRSFPIDLVREIARQLLEC 157
+++ + ++ ++ +L++ + K+ D + + +
Sbjct: 88 -ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+ +H H DLKP N+LL + D S + A ++
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM---------------NQACIHVEGS 191
Query: 218 STTYERPDQNYIVSTRHYRAPEVI---LGLGWTYPCDIWSVGCILVELCTGEALFQ-THE 273
D T YRAPE+ D+WS+GC+L + GE + +
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251
Query: 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 333
+ +A+ + +L P+ R S L L
Sbjct: 252 KGDSVAL-----------------------AVQNQLSIPQS--PRHS-------SALWQL 279
Query: 334 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
+ ++ DP R L +
Sbjct: 280 L---------------NSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 68/346 (19%), Positives = 121/346 (34%), Gaps = 103/346 (29%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI-----EIEVLQQLAK 98
++ +G G FG V VAIK V I + E E+ +L+++
Sbjct: 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV-S 104
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSS--LYDFLRKNNYRSFPIDLVREIARQLLE 156
G +++ +WF+ + ++ E+ L+DF+ + + +L R Q+LE
Sbjct: 105 SGFSG--VIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLE 160
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
+ H+ ++H D+K EN+L+ D + + +K+IDF
Sbjct: 161 AVRHCHNCGVLHRDIKDENILI-------------------DLNRGE-------LKLIDF 194
Query: 217 GSTTYERPDQNYIVS--TRHYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQT 271
GS D Y TR Y PE I Y +WS+G +L ++ G+ F
Sbjct: 195 GSGALL-KDTVYTDFDGTRVYSPPEWIRYHR--YHGRSAAVWSLGILLYDMVCGDIPF-- 249
Query: 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 331
++ + RG++ +
Sbjct: 250 ---------------------------EHDEEIIRGQVFFR------------------- 263
Query: 332 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377
+ + HL++ L P+DR T E HP+ L
Sbjct: 264 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 61/345 (17%), Positives = 112/345 (32%), Gaps = 101/345 (29%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI-----EIEVLQQLAK 98
++ +G+G FG V + VAIK++ + + + E+ +L ++
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 156
+++ +WF+ + +V E L+D++ + R Q++
Sbjct: 94 GGGHPG-VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVA 150
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
I H ++H D+K EN+L+ D + K+IDF
Sbjct: 151 AIQHCHSRGVVHRDIKDENILI-------------------DL-------RRGCAKLIDF 184
Query: 217 GSTTYERPDQNYIVS--TRHYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQT 271
GS D+ Y TR Y PE I Y P +WS+G +L ++ G+ F
Sbjct: 185 GSGAL-LHDEPYTDFDGTRVYSPPEWISRHQ--YHALPATVWSLGILLYDMVCGDIPF-- 239
Query: 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 331
++ + L +P
Sbjct: 240 ---------------------------ERDQEILEAELHFPA------------------ 254
Query: 332 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
H + D L++ L P+ R + E L P+
Sbjct: 255 --------HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-30
Identities = 59/360 (16%), Positives = 122/360 (33%), Gaps = 94/360 (26%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--------------- 88
+I + +G F +++ C + + A+K ++K R+
Sbjct: 34 RIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91
Query: 89 -EIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY------R 140
E++++ + K++ C+ + + I++E + S+ F
Sbjct: 92 NELQIITDI-KNE---Y-CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 141 SFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199
PI +++ I + +L +++H+ + H D+KP N+L+ D
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---------DKNGR------- 190
Query: 200 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGWTY--PCDIWSV 255
+K+ DFG + Y D+ S T + PE DIWS+
Sbjct: 191 -----------VKLSDFGESEY-MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSL 238
Query: 256 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGA 315
G L + F +L + +R +++P
Sbjct: 239 GICLYVMFYNVVPFSLKISL--------------VELFNN--------IRTKNIEYPLDR 276
Query: 316 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+ K N + + D L+ LR +P +R+T+ +AL+H +
Sbjct: 277 NHFLYPLTNKKSTCSNN----FLSNEDID---FLKLFLRKNPAERITSEDALKHEWLADT 329
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 67/355 (18%), Positives = 109/355 (30%), Gaps = 110/355 (30%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGN 104
++ + EG F V E D A+K + ++ A + E+ +++L+ H N
Sbjct: 31 RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP---N 87
Query: 105 ------RCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLE 156
+ D ++ +L G + + + D V +I Q
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 157 CIAFMHDL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 214
+ MH +IH DLK EN+LL IK+
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLS---------------------------NQGTIKLC 180
Query: 215 DFGSTTYERPDQNYIVS-----------TRH----YRAPEVI---LGLGWTYPCDIWSVG 256
DFGS T +Y S TR+ YR PE+I DIW++G
Sbjct: 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG 240
Query: 257 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA 316
CIL LC + F+ L + G+ P
Sbjct: 241 CILYLLCFRQHPFEDGAKLR---------------------------IVNGKYSIP---- 269
Query: 317 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
H L++ +L+ +P +RL+ E +
Sbjct: 270 -------------------PHDTQYT-VFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 9e-30
Identities = 49/367 (13%), Positives = 108/367 (29%), Gaps = 127/367 (34%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAM------IEIEVLQQLAKHDKGGNR 105
G+ LE D+E E + + ++ A+ + L + K+ K
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 106 CVQIRNWFD--------------------YRNHICIVFEKLGSSLYDFL-----RKNNYR 140
++ FD + ++ ++ S+L F + ++
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 141 SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200
S ++ Q++ +A +H ++HT L+P +++L
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--------------------- 240
Query: 201 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGW-----------T 247
+ + + F D +VS +R + PE+ T
Sbjct: 241 ------QRGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMT 291
Query: 248 YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG 307
+ D W++G ++ + + T + + +++ R
Sbjct: 292 FSFDAWALGLVIYWIWCADLPI-TKDAALGGS----------------------EWIFRS 328
Query: 308 RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 367
+ P+ LL+G LRY DRL +A+
Sbjct: 329 CKNIPQPVR------------------------------ALLEGFLRYPKEDRLLPLQAM 358
Query: 368 RHPFFTR 374
P + +
Sbjct: 359 ETPEYEQ 365
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 4e-27
Identities = 52/370 (14%), Positives = 105/370 (28%), Gaps = 122/370 (32%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--------GIKKYREAAMIE------------IE 91
G+ LE D+E E + + IK+ +E +
Sbjct: 87 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146
Query: 92 VLQQLAKHD--KGGNRCVQIRNWFDYRNH----ICIVFEKLGSSLYDFL-----RKNNYR 140
L+ + D K + IR D R+ ++ ++ S+L F + ++
Sbjct: 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 206
Query: 141 SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200
S ++ Q++ +A +H ++HT L+P +++L
Sbjct: 207 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--------------------- 245
Query: 201 YFKRMPKSSAIKVIDFGSTTYE----RPDQNYIVSTRHYRAPEVILGLG-----WTYPCD 251
+ + + F + + A ++ T+ D
Sbjct: 246 ------QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFD 299
Query: 252 IWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW 311
W++G + + + T + L E + R +
Sbjct: 300 TWTLGLAIYWIWCADLPN-TDDAA--LGGSEWIF--------------------RSCKNI 336
Query: 312 PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
P+ + LL+G LRY DRL +A+ P
Sbjct: 337 PQPVRA------------------------------LLEGFLRYPKEDRLLPLQAMETPE 366
Query: 372 F--TRDHLRR 379
+ R L
Sbjct: 367 YEQLRTELSA 376
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 57/333 (17%), Positives = 109/333 (32%), Gaps = 75/333 (22%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+ + E + E D + + +A ++I + + + G
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFP-IDLVREIARQLLECIAFMHD 163
+ ++ I + +L D++ + + I Q+ E + F+H
Sbjct: 128 QP-----SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
++H DLKP N+ + +KV D+ + ++ + MP +
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA----------- 231
Query: 221 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
V T+ Y +PE I G +++ DI+S+G IL EL F T
Sbjct: 232 ----THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS---FSTQ-------- 276
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
MERV ++ VR + P K P+ ++
Sbjct: 277 MERV------RIITD--------VRNLKF--PLL--------FTQKYPQEHMMVQD---- 308
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
+L PT+R A + + + F
Sbjct: 309 -----------MLSPSPTERPEATDIIENAIFE 330
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 71/345 (20%), Positives = 123/345 (35%), Gaps = 105/345 (30%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----------EIEVLQQ 95
S +G G FG V D+E+ + V +K ++ +K E I EI +L +
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 96 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS--LYDFLRKNNYRSFPIDLVREIARQ 153
+ +H +++ + F+ + +V EK GS L+ F+ ++ L I RQ
Sbjct: 86 V-EHAN----IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQ 138
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 213
L+ + ++ +IH D+K EN+++ + IK+
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVI-------------------AEDF--------TIKL 171
Query: 214 IDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQ 270
IDFGS Y + + T Y APEV++G + P ++WS+G L L E
Sbjct: 172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE---- 227
Query: 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 330
P L+ + P
Sbjct: 228 -----------------NPFCELEE--------TVEAAIHPP------------------ 244
Query: 331 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+ +L L+ GLL+ P R T + + P+ T+
Sbjct: 245 --------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 64/334 (19%), Positives = 116/334 (34%), Gaps = 50/334 (14%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 106
S++G G G V + + ++A K++ K I E++VL +
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE--------CNS 90
Query: 107 VQIRNW---FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
I + F I I E + G SL L+K P ++ +++ +++ + ++
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLR 148
Query: 163 D-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STT 220
+ ++H D+KP N+L+ S IK+ DFG S
Sbjct: 149 EKHKIMHRDVKPSNILVNSR---------------------------GEIKLCDFGVSGQ 181
Query: 221 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
N V TR Y +PE + G ++ DIWS+G LVE+ G + E M
Sbjct: 182 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+ R R + + + + +
Sbjct: 242 FGCQVEGDAAETPPR----PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 297
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
S + + L +P +R ++ + H F R
Sbjct: 298 SL-EFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-24
Identities = 68/349 (19%), Positives = 124/349 (35%), Gaps = 115/349 (32%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQLAKHDKGGNRC 106
GEG++G+V E D E A+KI++ K R EI++L++L +H
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RH------- 65
Query: 107 VQIRN--------WFDYRNHICIVFE--KLGSS-LYDFLRKNNYRSFPIDLVREIARQLL 155
+N + + + + +V E G + D + + + FP+ QL+
Sbjct: 66 ---KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRFPVCQAHGYFCQLI 119
Query: 156 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 215
+ + ++H ++H D+KP N+LL + +K+
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLL---------TTGGT------------------LKISA 152
Query: 216 FG-STTYERPDQNYIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEA 267
G + + T ++ PE+ GL T+ DIWS G L + TG
Sbjct: 153 LGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD-TFSGFKVDIWSAGVTLYNITTGLY 211
Query: 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 327
F+ +N+ L + + +G P
Sbjct: 212 PFE-GDNIYKLF----------------------ENIGKGSYAIP--------------- 233
Query: 328 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
L+ LL+G+L Y+P R + R+ +H +F + H
Sbjct: 234 -----------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-23
Identities = 55/329 (16%), Positives = 109/329 (33%), Gaps = 31/329 (9%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108
G V + E V ++ + + E+ V + H N V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHP---N-IVP 90
Query: 109 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
R F N + +V + S D + + + I + +L+ + ++H + +
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV 150
Query: 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 227
H +K ++L+ + + +S+ S + +
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSN------LSMISHGQRQRVVHDF-----------PK 193
Query: 228 YIVSTRHYRAPEVI--LGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
Y V + +PEV+ G+ DI+SVG EL G F+ + ++E++
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLN 251
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
G +P + E + R G + + + H S
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP-HF 310
Query: 346 THLLQGLLRYDPTDRLTAREALRHPFFTR 374
H ++ L+ +P R +A L H FF +
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFFKQ 339
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 65/332 (19%), Positives = 112/332 (33%), Gaps = 90/332 (27%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV-RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQ 108
G+G F +V VAIKI+ + + E+ +++ L H V+
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHP----NIVK 78
Query: 109 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
+ + + ++ E G ++D+L + R RQ++ + + H ++
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 227
H DLK EN+LL D + IK+ DFG +
Sbjct: 137 HRDLKAENLLL---------DADMN------------------IKIADFGFSNEFTVGGK 169
Query: 228 YIVS--TRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
Y APE+ G + P D+WS+G IL L +G F +NL+ L
Sbjct: 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKEL------ 222
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
+ V RG+ P + + D
Sbjct: 223 ----------------RERVLRGKYRIPF--------------------------YMSTD 240
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+LL+ L +P R T + ++ + H
Sbjct: 241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 71/332 (21%), Positives = 123/332 (37%), Gaps = 90/332 (27%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 107
GEG+FG+V + ++ VA+K + + +KK + EI L+ L +H +
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHP----HII 72
Query: 108 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 167
++ + I +V E G L+D++ + + D R +Q++ I + H ++
Sbjct: 73 KLYDVITTPTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIV 130
Query: 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 227
H DLKPEN+LL D + +K+ DFG +
Sbjct: 131 HRDLKPENLLL---------DDNLN------------------VKIADFGLSNIMTDGNF 163
Query: 228 YIVS--TRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
S + +Y APEVI G + P D+WS G +L + G F E +
Sbjct: 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD-DEFI--------- 213
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
++ K+ V P D +
Sbjct: 214 -----PNLFKK--------VNSCVYVMP--------------------------DFLSPG 234
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
L++ ++ DP R+T +E R P+F +
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 66/332 (19%), Positives = 113/332 (34%), Gaps = 89/332 (26%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 107
GEG+F V+ + AIKI+ I K + E +V+ +L H V
Sbjct: 39 GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP----FFV 93
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ F + L ++RK SF R +++ + ++H +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
IH DLKPEN+LL +I++ D+ ++ K + +
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTA----------KVLSP------ESKQARANS---- 191
Query: 227 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 286
V T Y +PE++ D+W++GCI+ +L G F N + ++++
Sbjct: 192 --FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGN--EYLIFQKII- 245
Query: 287 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346
+ D+P + A D
Sbjct: 246 -------------------KLEYDFP-----------------------EKFFPKARD-- 261
Query: 347 HLLQGLLRYDPTDRLT------AREALRHPFF 372
L++ LL D T RL HPFF
Sbjct: 262 -LVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-23
Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 43/242 (17%)
Query: 46 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
++ +G G FG V + W R + VAIK + + R+A ++E+ L ++ H
Sbjct: 11 EVEEVVGRGAFGVVCKAKW---RAKDVAIKQIES-ESERKAFIVELRQLSRV-NHP---- 61
Query: 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMH 162
V++ N +C+V E G SLY+ L + Q + +A++H
Sbjct: 62 NIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 163 DLC---MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
+ +IH DLKP N+LLV+ + +K+ DFG+
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTV--------------------------LKICDFGTA 153
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
+ + + APEV G ++ CD++S G IL E+ T F
Sbjct: 154 CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI 213
Query: 280 MM 281
M
Sbjct: 214 MW 215
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-23
Identities = 59/256 (23%), Positives = 94/256 (36%), Gaps = 54/256 (21%)
Query: 46 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQLAKH 99
+ +G G FG+V W + VA+K R + I E ++ L KH
Sbjct: 10 TLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KH 65
Query: 100 D-----KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 153
+G C++ ++C+V E G L L + P D++ A Q
Sbjct: 66 PNIIALRGV--CLK-------EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQ 113
Query: 154 LLECIAFMHDLC---MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 210
+ + ++HD +IH DLK N+L+ +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILI-------------------LQKVENGDLSNKI 154
Query: 211 IKVIDFGSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269
+K+ DFG + APEVI ++ D+WS G +L EL TGE F
Sbjct: 155 LKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
Query: 270 QTHENLEHLAMMERVL 285
++ LA+ V
Sbjct: 215 ---RGIDGLAVAYGVA 227
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 69/328 (21%), Positives = 108/328 (32%), Gaps = 79/328 (24%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111
G G FG D+ KE+VA+K + E EI + L +H V+ +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHP----NIVRFKE 83
Query: 112 WFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 170
H+ I+ E G LY+ + F D R +QLL +++ H + + H D
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRD 141
Query: 171 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NY 228
LK EN LL D S R +K+ DFG +
Sbjct: 142 LKLENTLL-------------------DGSPAPR------LKICDFGYSKSSVLHSQPKS 176
Query: 229 IVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 287
V T Y APEV+L + D+WS G L + G F+
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPRDY-------- 227
Query: 288 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347
R + + + P+ + + H
Sbjct: 228 ----------RKTIQRILSVKYSIPDDI------------------------RISPECCH 253
Query: 348 LLQGLLRYDPTDRLTAREALRHPFFTRD 375
L+ + DP R++ E H +F ++
Sbjct: 254 LISRIFVADPATRISIPEIKTHSWFLKN 281
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-22
Identities = 75/334 (22%), Positives = 121/334 (36%), Gaps = 95/334 (28%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 107
G GTFG+V + VA+KI+ + I+ I EI+ L+ +H +
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHP----HII 74
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ +V E + G L+D++ K+ R + +Q+L + + H +
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHMV 132
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
+H DLKPENVLL D + K+ DFG + +
Sbjct: 133 VHRDLKPENVLL---------DAHMN------------------AKIADFGLSNMMSDGE 165
Query: 227 NYIVSTR----HYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
+ T +Y APEVI G + P DIWS G IL L G F E++
Sbjct: 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-DEHV------ 216
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
+ K+ +R G P ++
Sbjct: 217 --------PTLFKK--------IRGGVFYIP--------------------------EYL 234
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+ LL +L+ DP R T ++ H +F +D
Sbjct: 235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-22
Identities = 48/253 (18%), Positives = 82/253 (32%), Gaps = 56/253 (22%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--------EIEVLQQLA 97
+ ++G+G FG V + + K +VAIK + E MI E+ ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL- 80
Query: 98 KHD-----KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIA 151
H G +V E + LY L + +
Sbjct: 81 NHPNIVKLYGL--MHN---------PPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLM 128
Query: 152 RQLLECIAFMHDL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 209
+ I +M + ++H DL+ N+ L S +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD----------------------ENAPV 166
Query: 210 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEA 267
KV DFG + + ++ + APE I +Y D +S IL + TGE
Sbjct: 167 CAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
Query: 268 LFQTHENLEHLAM 280
F + + +
Sbjct: 227 PF---DEYSYGKI 236
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 72/332 (21%), Positives = 121/332 (36%), Gaps = 87/332 (26%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRCV 107
G+G FG+V C R +M A K + IKK + AM E +L++ V
Sbjct: 193 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK-VNS----RFVV 247
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+ ++ ++ +C+V + G L + FP A ++ + +H +
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
++ DLKPEN+LL +I++ D + + G T R
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLA-------------------VHVPEGQTIKGR--- 345
Query: 227 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMMERVL 285
V T Y APEV+ +T+ D W++GC+L E+ G++ FQ + ++ + V
Sbjct: 346 ---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
++ E S ++
Sbjct: 403 --------------------EVPEEYSER-FSPQAR------------------------ 417
Query: 346 THLLQGLLRYDPTDRL-----TAREALRHPFF 372
L LL DP +RL +ARE HP F
Sbjct: 418 -SLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 66/335 (19%), Positives = 118/335 (35%), Gaps = 93/335 (27%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRC- 106
G G FG+V C + +M A+K + IK + + E +L ++ D C
Sbjct: 198 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-----CP 252
Query: 107 --VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
V + F + + + + + G L+ L ++ F +R A +++ + MH+
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN 310
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+++ DLKP N+LL ++++ D + K +
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------------------KPHAS 350
Query: 224 PDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282
V T Y APEV+ G+ + D +S+GC+L +L G + F+ H+ + +
Sbjct: 351 ------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342
L ++ P
Sbjct: 405 MTL--------------------TMAVELP-----------------------DSFSPEL 421
Query: 343 GDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
LL+GLL+ D RL A+E PFF
Sbjct: 422 RS---LLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-21
Identities = 62/335 (18%), Positives = 115/335 (34%), Gaps = 93/335 (27%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQI 109
GEG +G+V +R +E VA+KIV + I EI + + L H+ V+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE----NVVKF 70
Query: 110 RNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
N + E G L+D + + P + QL+ + ++H + + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITH 128
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQN 227
D+KPEN+LL D +K+ DFG +T + ++
Sbjct: 129 RDIKPENLLL-------------------DERD--------NLKISDFGLATVFRYNNRE 161
Query: 228 YIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
+++ Y APE++ + P D+WS G +L + GE + +
Sbjct: 162 RLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPWDQPSD------ 213
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+ Y W + +D
Sbjct: 214 --------SCQEYSDWKE-KKTY----LNPW------------------------KKIDS 236
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+ LL +L +P+ R+T + + ++ +
Sbjct: 237 AP---LALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-21
Identities = 58/356 (16%), Positives = 112/356 (31%), Gaps = 112/356 (31%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV-- 107
G+G++G V ++ A+K++ + + + + A R
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 108 QIRN-------------------WFDY-RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDL 146
Q+ D +H+ +VFE + + + D
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQ 138
Query: 147 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 206
R + L++ I ++H +IH D+KP N+L+
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV-------------------GEDG----- 174
Query: 207 KSSAIKVIDFG-STTYERPDQNYIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCI 258
IK+ DFG S ++ D ++S + APE + + D+W++G
Sbjct: 175 ---HIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
Query: 259 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR 318
L G+ F E + + + ++ L++P+
Sbjct: 230 LYCFVFGQCPFM-DERI--------------MCLHSK--------IKSQALEFPD----- 261
Query: 319 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
D + DL L+ +L +P R+ E HP+ TR
Sbjct: 262 ------------------QPDIAE-DLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-21
Identities = 79/336 (23%), Positives = 123/336 (36%), Gaps = 91/336 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGG 103
K+G+G+FG+V + D +++VAIKI+ + E I EI VL Q
Sbjct: 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPY-- 81
Query: 104 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
+ + + I+ E L G S D L + I R++L+ + ++H
Sbjct: 82 --VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH 136
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---ST 219
IH D+K NVLL +K+ DFG
Sbjct: 137 SEKKIHRDIKAANVLLSE---------------------------HGEVKLADFGVAGQL 169
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA-LFQTHENLEHL 278
T + +N V T + APEVI + DIWS+G +EL GE + H
Sbjct: 170 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------ 223
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
M +VL +P++ P L+
Sbjct: 224 PM--KVLFLIPKN----------------------------------NPPTLEG------ 241
Query: 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
++S L ++ L +P+ R TA+E L+H F R
Sbjct: 242 NYSK-PLKEFVEACLNKEPSFRPTAKELLKHKFILR 276
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 49/240 (20%), Positives = 96/240 (40%), Gaps = 54/240 (22%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD----- 100
++ +G GT+GQV + + ++ AIK++ E EI +L++ + H
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 101 -----KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 154
K + + W +V E S+ D ++ + + + I R++
Sbjct: 87 YGAFIKKNPPGMDDQLW--------LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 155 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 214
L ++ +H +IH D+K +NVLL +++ +K++
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLT---------------------------ENAEVKLV 171
Query: 215 DFG---STTYERPDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 266
DFG +N + T ++ APEVI + + D+WS+G +E+ G
Sbjct: 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 62/336 (18%), Positives = 113/336 (33%), Gaps = 92/336 (27%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRCV 107
G G FG+V C + ++ A K + +KK + +E +L + V
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK-VHS----RFIV 248
Query: 108 QIRNWFDYRNHICIVFE-----KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
+ F+ + +C+V + +Y+ N F Q++ + +H
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--PGFQEPRAIFYTAQIVSGLEHLH 306
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
+I+ DLKPENVLL +++ D A+++ + T
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDL------------------GLAVELKAGQTKTKG 348
Query: 223 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMM 281
T + APE++LG + + D +++G L E+ F+ E +E+ +
Sbjct: 349 Y------AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
+RVL + +P+ S S
Sbjct: 403 QRVL--------------------EQAVTYPDK-FSPASK-------------------- 421
Query: 342 AGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
+ LL+ DP RL + HP F
Sbjct: 422 -----DFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 75/334 (22%), Positives = 121/334 (36%), Gaps = 95/334 (28%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 107
G GTFG+V VA+KI+ + I+ I EI+ L+ +H +
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHP----HII 79
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ + I +V E + G L+D++ KN R + +Q+L + + H +
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
+H DLKPENVLL D + K+ DFG + +
Sbjct: 138 VHRDLKPENVLL---------DAHMN------------------AKIADFGLSNMMSDGE 170
Query: 227 NYIVSTR----HYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
+ T +Y APEVI G + P DIWS G IL L G F +++
Sbjct: 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DDHV------ 221
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
+ K+ + G P +
Sbjct: 222 --------PTLFKK--------ICDGIFYTP--------------------------QYL 239
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+ LL+ +L+ DP R T ++ H +F +D
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 62/335 (18%), Positives = 115/335 (34%), Gaps = 93/335 (27%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQI 109
GEG +G+V +R +E VA+KIV + I EI + + L H+ V+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHEN----VVKF 70
Query: 110 RNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 168
N + E G L+D + + P + QL+ + ++H + + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITH 128
Query: 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQN 227
D+KPEN+LL D +K+ DFG +T + ++
Sbjct: 129 RDIKPENLLL-------------------DERD--------NLKISDFGLATVFRYNNRE 161
Query: 228 YIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
+++ Y APE++ + P D+WS G +L + GE + +
Sbjct: 162 RLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPWDQPSD------ 213
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+ Y W + +D
Sbjct: 214 --------SCQEYSDWKE-KKTY----LNPW------------------------KKIDS 236
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+ LL +L +P+ R+T + + ++ +
Sbjct: 237 AP---LALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 69/337 (20%), Positives = 122/337 (36%), Gaps = 92/337 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+ K+GEG++G V + +E ++VAIK V ++ + + EI ++QQ
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQC--------D 82
Query: 106 CVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
+ ++ + IV E S+ D +R N ++ D + I + L+ + ++
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYL 141
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST-- 219
H + IH D+K N+LL + K+ DFG
Sbjct: 142 HFMRKIHRDIKAGNILLNT---------------------------EGHAKLADFGVAGQ 174
Query: 220 -TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA-LFQTHENLEH 277
T +N ++ T + APEVI +G+ DIWS+G +E+ G+ H
Sbjct: 175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH----- 229
Query: 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 337
M R + +P P +
Sbjct: 230 -PM--RAIFMIPT----------------------------------NPPPTFRK----- 247
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
+ + + T ++ L P R TA + L+HPF
Sbjct: 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-20
Identities = 67/331 (20%), Positives = 119/331 (35%), Gaps = 93/331 (28%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 107
G G+FG+V+ +E A+KI+ + K ++ + E +LQ + V
Sbjct: 50 GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFP----FLV 104
Query: 108 QIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ F +++ +V E G ++ LR+ F R A Q++ ++H L +
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
I+ DLKPEN+L+ Y I+V DFG +
Sbjct: 163 IYRDLKPENLLIDQQGY---------------------------IQVTDFGFAKRVKGRT 195
Query: 227 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 286
+ T APE+IL G+ D W++G ++ E+ G F + + + E+++
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQ--PIQIYEKIV- 251
Query: 287 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346
G++ +P H D
Sbjct: 252 -------------------SGKVRFP-----------------------SHFSSDLKD-- 267
Query: 347 HLLQGLLRYDPTDRL-----TAREALRHPFF 372
LL+ LL+ D T R + H +F
Sbjct: 268 -LLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 8e-20
Identities = 48/225 (21%), Positives = 95/225 (42%), Gaps = 46/225 (20%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQ 108
K+GEG+ G V ++ VA+K++ K+ R + E+ +++ +H
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHF-------N 103
Query: 109 IRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+ + + ++ E L G +L D + + I + +L+ +A++H
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI---ATVCEAVLQALAYLHAQ 160
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STTY 221
+IH D+K +++LL +K+ DFG +
Sbjct: 161 GVIHRDIKSDSILLTL---------------------------DGRVKLSDFGFCAQISK 193
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266
+ P + +V T ++ APEVI + DIWS+G +++E+ GE
Sbjct: 194 DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-20
Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 46/225 (20%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQ 108
K+G+G G V D + VAI+ + ++ ++ +I EI V+++ K+
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP-------N 78
Query: 109 IRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
I N+ D + + +V E L G SL D + + I + R+ L+ + F+H
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI---AAVCRECLQALEFLHSN 135
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST---TY 221
+IH D+K +N+LL ++K+ DFG T
Sbjct: 136 QVIHRDIKSDNILLGM---------------------------DGSVKLTDFGFCAQITP 168
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266
E+ ++ +V T ++ APEV+ + DIWS+G + +E+ GE
Sbjct: 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 58/250 (23%), Positives = 96/250 (38%), Gaps = 49/250 (19%)
Query: 46 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDK 101
I K+G G+FG V W VA+KI+ + + E+ ++++L +H
Sbjct: 40 NIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHP- 94
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR-SFPIDLVREIARQLLECIA 159
N V ++ IV E L SLY L K+ R +A + + +
Sbjct: 95 --N-IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 160 FMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
++H + ++H +LK N+L+ D Y +KV DFG
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLV-------------------DKKY--------TVKVCDFG 184
Query: 218 STTYERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274
+ + S T + APEV+ D++S G IL EL T + + N
Sbjct: 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW---GN 241
Query: 275 LEHLAMMERV 284
L ++ V
Sbjct: 242 LNPAQVVAAV 251
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-19
Identities = 50/225 (22%), Positives = 94/225 (41%), Gaps = 38/225 (16%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
+MG GT GQV + R+ ++A+K +R G K+ + +++++V+ + V
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP----YIV 87
Query: 108 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCM 166
Q F + I E +G+ ++ P ++ ++ +++ + ++ + +
Sbjct: 88 QCFGTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGV 146
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
IH D+KP N+LL IK+ D+ S R+ A +
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGIS----------GRLVDDKA---------------K 181
Query: 227 NYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVGCILVELCTGE 266
+ Y APE I + D+WS+G LVEL TG+
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 62/336 (18%), Positives = 118/336 (35%), Gaps = 86/336 (25%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 106
++G G +G V + +++A+K +R +E + ++++ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP----FT 68
Query: 107 VQIRNWFDYRNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD- 163
V + I E + +SL F ++ + ++ P D++ +IA +++ + +H
Sbjct: 69 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
L +IH D+KP NVL+ + +K+ D+ S + A
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGIS----------GYLVDDVA-------KDID-- 169
Query: 224 PDQNYIVSTRHYRAPEVILG----LGWTYPCDIWSVGCILVELCTGEALFQTHEN-LEHL 278
+ Y APE I G++ DIWS+G ++EL + + + L
Sbjct: 170 ------AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
+ V P P +L P S E
Sbjct: 224 KQV--VEEPSP------------------QL--PADKFSAE------------------- 242
Query: 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
L+ + +R T E ++HPFFT
Sbjct: 243 ------FVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-19
Identities = 72/337 (21%), Positives = 117/337 (34%), Gaps = 98/337 (29%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNR 105
++G G+FG V D E+VAIK + G + + I E+ LQ+L R
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL--------R 112
Query: 106 CVQIRNWFD---YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
+ + +V E S D L + + + + L+ +A++H
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH 171
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 221
MIH D+K N+LL +K+ DFG ++
Sbjct: 172 SHNMIHRDVKAGNILLSE---------------------------PGLVKLGDFGSASIM 204
Query: 222 ERPDQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEA-LFQTHENLEH 277
N V T ++ APEVIL + + D+WS+G +EL + LF +
Sbjct: 205 AP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----- 257
Query: 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 337
AM L + Q+ + P LQ+
Sbjct: 258 -AM--SALYHIAQN----------------------------------ESPALQS----- 275
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
H + + + L+ P DR T+ L+H F R
Sbjct: 276 -GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 52/250 (20%), Positives = 94/250 (37%), Gaps = 63/250 (25%)
Query: 46 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 100
+ ++G G+FG V + W + VA+K++ + + E+ VL++ +H
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD----VAVKMLN-VTAPTPQQLQAFKNEVGVLRKT-RHV 80
Query: 101 K-----GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 154
G + IV + GSSLY L + F + + +IARQ
Sbjct: 81 NILLFMGY--STA--------PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQT 129
Query: 155 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 214
+ ++H +IH DLK N + + + +K+
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNN-IFLHEDNT--------------------------VKIG 162
Query: 215 DFG-----STTYERPDQNYIVSTRHYRAPEVILGLGW---TYPCDIWSVGCILVELCTGE 266
DFG S + + + APEVI ++ D+++ G +L EL TG+
Sbjct: 163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
Query: 267 ALFQTHENLE 276
+ N +
Sbjct: 223 LPYSNINNRD 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 69/335 (20%), Positives = 117/335 (34%), Gaps = 95/335 (28%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRC 106
+G+G+FG+V+ + E+ A+KI++ E M+E VL K
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP----FL 404
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
Q+ + F + + V E + G L F A ++ + F+
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+I+ DLK +NV+L S +IK+ D+ M K + I G TT
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFG--------------MCKEN----IWDGVTT----- 499
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
T Y APE+I + D W+ G +L E+ G+A F+ + E + + ++
Sbjct: 500 -KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIM 555
Query: 286 G---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342
P+ M S+E++
Sbjct: 556 EHNVAYPKSM------------------------SKEAV--------------------- 570
Query: 343 GDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
+ +GL+ P RL R+ H FF
Sbjct: 571 ----AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 72/346 (20%), Positives = 119/346 (34%), Gaps = 92/346 (26%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 107
G G F +V ++ ++ A+KI+ + K E + E +VL
Sbjct: 70 GRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDRR----WIT 124
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
Q+ F N++ +V E G L L K R P ++ R +++ I +H L
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSVHRLGY 183
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
+H D+KP+N+LL +I++ D+ S L K+ G+
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCL------------------KLRADGTVR-----S 220
Query: 227 NYIVSTRHYRAPEVILGLGWTY-------PCDIWSVGCILVELCTGEALFQTHENLEHLA 279
V T Y +PE++ +G CD W++G E+ G+ F ++
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTA--E 277
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339
+++ + L P + V
Sbjct: 278 TYGKIVH------------------YKEHLSLPLVD--------------------EGVP 299
Query: 340 HSAGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTR---DHLRR 379
A D +Q LL P RL A + HPFF D LR
Sbjct: 300 EEARD---FIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRD 341
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 65/333 (19%), Positives = 116/333 (34%), Gaps = 97/333 (29%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 107
G+G+FG+V ++ + AIK ++ + + M+E VL +H
Sbjct: 26 GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP----FLT 81
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+ F + ++ V E L G L + F + A +++ + F+H +
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE---R 223
++ DLK +N+LL +IK+ D+ M K + + + T
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFG--------------MCKEN----MLGDAKTNTFCGT 181
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
PD Y APE++LG + + D WS G +L E+ G++ F + E +
Sbjct: 182 PD---------YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHS 229
Query: 284 VLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+ P+ + +E+
Sbjct: 230 IRMDNPFYPRWL------------------------EKEAK------------------- 246
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALR-HPFF 372
LL L +P RL R +R HP F
Sbjct: 247 ------DLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 5e-18
Identities = 64/332 (19%), Positives = 125/332 (37%), Gaps = 81/332 (24%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
G G++ +VL ++ + A+K+V+ + + E V +Q + H V
Sbjct: 18 GRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH----PFLV 73
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+ + F + + V E + G L R P + R + ++ + ++H+ +
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 131
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
I+ DLK +NVLL S +IK+ DY M K + G TT
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYG--------------MCKEG----LRPGDTT------ 167
Query: 227 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 286
+ T +Y APE++ G + + D W++G ++ E+ G + F + ++
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE--- 224
Query: 287 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346
++ + + ++ +++PR + A
Sbjct: 225 ---DYLFQVI------------------------LEKQIRIPR-------SLSVKAAS-- 248
Query: 347 HLLQGLLRYDPTDRL------TAREALRHPFF 372
+L+ L DP +RL + HPFF
Sbjct: 249 -VLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-18
Identities = 40/134 (29%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++ K+G G+FG + D E VAIK+ K+ + + E ++ + + +GG
Sbjct: 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-ESKIYKMM----QGGVG 66
Query: 106 CVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
IR W ++ +V E LG SL D L R F + V +A Q++ I ++H
Sbjct: 67 IPTIR-WCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 165 CMIHTDLKPENVLL 178
IH D+KP+N L+
Sbjct: 125 NFIHRDVKPDNFLM 138
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 64/339 (18%), Positives = 114/339 (33%), Gaps = 88/339 (25%)
Query: 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 106
++G G +G V + + +++A+K +R +E + +++V+ + +
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP----YI 83
Query: 107 VQIRNWFDYRNHICIVFEKLGSSLYDFLRK---NNYRSFPIDLVREIARQLLECIAFMHD 163
VQ I E + +S F + P +++ +I ++ + + +
Sbjct: 84 VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 164 -LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY- 221
L +IH D+KP N+LL S IK+ DFG +
Sbjct: 144 NLKIIHRDIKPSNILLDR---------------------------SGNIKLCDFGISGQL 176
Query: 222 -ERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEA-LFQTHENL 275
+ + R Y APE I G+ D+WS+G L EL TG + +
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236
Query: 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335
+ L + V G PQ L + E S
Sbjct: 237 DQLTQV--VKGDPPQ--LS---------------NSEEREFSPS---------------- 261
Query: 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
+ + L D + R +E L+HPF
Sbjct: 262 ---------FINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 6e-18
Identities = 69/340 (20%), Positives = 115/340 (33%), Gaps = 111/340 (32%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 107
G G+FG+V R A+K+++ + + ++ E +L + H +
Sbjct: 15 GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP----FII 69
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ F I ++ + + G L+ LRK + FP + + A ++ + ++H +
Sbjct: 70 RMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG------STT 220
I+ DLKPEN+LL D H IK+ DFG T
Sbjct: 128 IYRDLKPENILL---------DKNG--H----------------IKITDFGFAKYVPDVT 160
Query: 221 YER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277
Y PD Y APEV+ + D WS G ++ E+ G F N
Sbjct: 161 YTLCGTPD---------YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSN--T 208
Query: 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 337
+ E++L L +P
Sbjct: 209 MKTYEKIL--------------------NAELRFP-----------------------PF 225
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
+ D LL L+ D + RL + HP+F
Sbjct: 226 FNEDVKD---LLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-18
Identities = 52/231 (22%), Positives = 98/231 (42%), Gaps = 43/231 (18%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGN 104
+I ++G+G FG+V + ++E + A K++ + I EIE+L H
Sbjct: 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPY--- 77
Query: 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
V++ + + + I+ E G ++ + + + R ++ + RQ+LE + F+H
Sbjct: 78 -IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHS 135
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST---T 220
+IH DLK NVL+ I++ DFG +
Sbjct: 136 KRIIHRDLKAGNVLMTL---------------------------EGDIRLADFGVSAKNL 168
Query: 221 YERPDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 266
++ + T ++ APEV++ + Y DIWS+G L+E+ E
Sbjct: 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-18
Identities = 52/260 (20%), Positives = 93/260 (35%), Gaps = 60/260 (23%)
Query: 46 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 101
+I +G+G FGQV W E VAI+++ + +A E+ +Q +H+
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQT-RHEN 90
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
V H+ I+ G +LY +R ++ R+IA+++++ + +
Sbjct: 91 ----VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGY 145
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+H ++H DLK +NV D + + DFG +
Sbjct: 146 LHAKGILHKDLKSKNVFY---------DNGK-------------------VVITDFGLFS 177
Query: 221 YERPDQNYIVS--------TRHYRAPEVILGLGWTYP---------CDIWSVGCILVELC 263
Q + APE+I L D++++G I EL
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237
Query: 264 TGEALFQTHENLEHLAMMER 283
E F+T + M
Sbjct: 238 AREWPFKTQPAEAIIWQMGT 257
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 63/332 (18%), Positives = 125/332 (37%), Gaps = 81/332 (24%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 107
G G++ +VL ++ + A+++V+ + + E V +Q + H V
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH----PFLV 116
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+ + F + + V E + G L R P + R + ++ + ++H+ +
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 174
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
I+ DLK +NVLL S +IK+ DY M K + G TT
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYG--------------MCKEG----LRPGDTT------ 210
Query: 227 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 286
+ T +Y APE++ G + + D W++G ++ E+ G + F + ++
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE--- 267
Query: 287 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346
++ + + ++ +++PR + A
Sbjct: 268 ---DYLFQVI------------------------LEKQIRIPR-------SLSVKAAS-- 291
Query: 347 HLLQGLLRYDPTDRL------TAREALRHPFF 372
+L+ L DP +RL + HPFF
Sbjct: 292 -VLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-18
Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 8/134 (5%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++ K+G G FG++ + E VAIK+ + +E +QL G+
Sbjct: 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-QLHLEYRFYKQL----GSGDG 66
Query: 106 CVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
Q+ +F + +V E LG SL D L R+F + V IA QL+ + ++H
Sbjct: 67 IPQVY-YFGPCGKYNAMVLELLGPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 165 CMIHTDLKPENVLL 178
+I+ D+KPEN L+
Sbjct: 125 NLIYRDVKPENFLI 138
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 8/134 (5%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++ K+G G+FG++ + + E VAIK+ K+ + E ++ + L +GG
Sbjct: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKIYRIL----QGGTG 64
Query: 106 CVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+R WF ++ +V + LG SL D L R + V +A Q++ + F+H
Sbjct: 65 IPNVR-WFGVEGDYNVLVMDLLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 165 CMIHTDLKPENVLL 178
+H D+KP+N L+
Sbjct: 123 SFLHRDIKPDNFLM 136
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 71/351 (20%), Positives = 122/351 (34%), Gaps = 97/351 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGG 103
++ +G G V + +KE VAIK + K + EI+ + Q H
Sbjct: 18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHP--- 73
Query: 104 NRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLV---REIA---RQ 153
I +++ ++ + +V + L G S+ D ++ + V IA R+
Sbjct: 74 ----NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 213
+LE + ++H IH D+K N+LL ++++
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGE---------------------------DGSVQI 162
Query: 214 IDFG-----STTYERPDQ---NYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCT 264
DFG +T + V T + APEV+ G+ + DIWS G +EL T
Sbjct: 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222
Query: 265 GEA-LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 323
G A + M +VL Q+ ++ + + +
Sbjct: 223 GAAPYHKYP------PM--KVLMLTLQNDPPSLETGVQDKEMLKKY-------GKS---- 263
Query: 324 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
++ L+ DP R TA E LRH FF +
Sbjct: 264 ---------------------FRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 69/337 (20%), Positives = 119/337 (35%), Gaps = 101/337 (29%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 107
G+G+FG+V+ + E+ A+KI++ + + + M+E VL K
Sbjct: 29 GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP----FLT 84
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
Q+ + F + + V E + G L F A ++ + F+ +
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE---R 223
I+ DLK +NV+L S +IK+ D+ M K + I G TT
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFG--------------MCKEN----IWDGVTTKTFCGT 184
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
PD Y APE+I + D W+ G +L E+ G+A F E+ + + +
Sbjct: 185 PD---------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDE--LFQS 232
Query: 284 VLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
++ P+ M S+E++
Sbjct: 233 IMEHNVAYPKSM------------------------SKEAV------------------- 249
Query: 341 SAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
+ +GL+ P RL R+ H FF
Sbjct: 250 ------AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 43/231 (18%), Positives = 91/231 (39%), Gaps = 34/231 (14%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDK--- 101
+G+G FGQ ++ RE E++ +K + + + + E++V++ L +H
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLK 71
Query: 102 --GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
G + + + E + G +L ++ + +P A+ + +
Sbjct: 72 FIGV--LYK-------DKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGM 121
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF---KRMPKSSAIKVID 215
A++H + +IH DL N L+ ++ + V D F + M
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVAD-------------FGLARLMVDEKTQPEGL 168
Query: 216 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266
+R + +V ++ APE+I G + D++S G +L E+
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 37/255 (14%), Positives = 77/255 (30%), Gaps = 60/255 (23%)
Query: 46 KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 100
+K+ E G++ + W + + +K+++ ++ + E L+ H
Sbjct: 13 NFLTKLNENHSGELWKGRW---QGNDIVVKVLK-VRDWSTRKSRDFNEECPRLRIF-SHP 67
Query: 101 -----KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 154
G C H ++ + SLY+ L + + A +
Sbjct: 68 NVLPVLGA--CQS-----PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 155 LECIAFMHDL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
+AF+H L + L +V++ D +
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMI-------------------DEDM--------TAR 153
Query: 213 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYP---CDIWSVGCILVELCTGEALF 269
+ + + APE + D+WS +L EL T E F
Sbjct: 154 ISMADVKFSF--QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211
Query: 270 QTHENLEHLAMMERV 284
+L ++ + +V
Sbjct: 212 ---ADLSNMEIGMKV 223
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 8/134 (5%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
K+ ++GEG+FG + E + + VAIK + E + L G
Sbjct: 13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-EYRTYKLL----AGCTG 67
Query: 106 CVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+ +F H +V + LG SL D L R F + V A+Q+L + +H+
Sbjct: 68 IPNVY-YFGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 165 CMIHTDLKPENVLL 178
+++ D+KP+N L+
Sbjct: 126 SLVYRDIKPDNFLI 139
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 55/333 (16%), Positives = 113/333 (33%), Gaps = 93/333 (27%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRC- 106
G+G+FG+V + K+M A+K + + E E++++Q L
Sbjct: 24 GKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL--------EHP 75
Query: 107 --VQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
V + F + +V + LG L L++N F + V+ +L+ + ++ +
Sbjct: 76 FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQN 133
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+IH D+KP+N+LL ++ + D+ + ++ +
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIA-------------------AMLPRETQITT- 173
Query: 224 PDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
+ T+ Y APE+ G G+++ D WS+G EL G + + +
Sbjct: 174 -----MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+ + +P +
Sbjct: 229 VHTFE--------------------TTVVTYPSAWSQ----------------------- 245
Query: 341 SAGDLTHLLQGLLRYDPTDRL-TAREALRHPFF 372
++ LL+ LL +P R + P+
Sbjct: 246 ---EMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 66/333 (19%), Positives = 119/333 (35%), Gaps = 89/333 (26%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 107
G G FG+V + +++ A+K++ + K ++A E +++ A V
Sbjct: 78 GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-ANSP----WVV 132
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
Q+ F ++ +V E + G L + + P R +++ + +H +
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGF 189
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
IH D+KP+N+LL S ++K+ D+ + +M K ++ T PD
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTC----------MKMNKEGMVRCDTAVGT----PD- 234
Query: 227 NYIVSTRHYRAPEVILGLGWTYP----CDIWSVGCILVELCTGEALFQTHENLEHLAMME 282
Y +PEV+ G CD WSVG L E+ G+ F ++L
Sbjct: 235 --------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLV--GTYS 283
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342
+++ + L +P+ + K+
Sbjct: 284 KIMN------------------HKNSLTFPDDNDISKEAKN------------------- 306
Query: 343 GDLTHLLQGLLRYDPTDRLT---AREALRHPFF 372
L+ L D RL E RH FF
Sbjct: 307 -----LICAFLT-DREVRLGRNGVEEIKRHLFF 333
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 69/335 (20%), Positives = 117/335 (34%), Gaps = 96/335 (28%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 107
G+G+FG+V+ +E ++ A+K+++ I + + M E +L H
Sbjct: 32 GKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP----FLT 87
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
Q+ F + + V E + G L R F R A +++ + F+HD +
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALMFLHDKGI 145
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
I+ DLK +NVLL + K+ D+ M K I G TT
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFG--------------MCKEG----ICNGVTT------ 181
Query: 227 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 286
T Y APE++ + + D W++G +L E+ G A F+ + + E +L
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAILN 238
Query: 287 ---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
P + ++
Sbjct: 239 DEVVYPTWL------------------------HEDAT---------------------- 252
Query: 344 DLTHLLQGLLRYDPTDRL------TAREALRHPFF 372
+L+ + +PT RL LRHPFF
Sbjct: 253 ---GILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 66/344 (19%), Positives = 124/344 (36%), Gaps = 90/344 (26%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 107
G G FG+V + ++ A+KI+ + K E A E +VL
Sbjct: 83 GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSK----WIT 137
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+ F N++ +V + G L L K R P ++ R +++ I +H L
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSVHQLHY 196
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
+H D+KP+N+L+ + +I++ D+ S ++ + ++ T PD
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSC----------LKLMEDGTVQSSVAVGT----PD- 241
Query: 227 NYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
Y +PE++ + + CD WS+G + E+ GE F E+L
Sbjct: 242 --------YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLV--ETY 290
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
+++ + R +P V
Sbjct: 291 GKIMN------------------HKERFQFP-----------------------TQVTDV 309
Query: 342 AGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTR---DHLRR 379
+ + L++ L+ RL + +HPFF+ D++R
Sbjct: 310 SENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFSGIDWDNIRN 352
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-17
Identities = 77/336 (22%), Positives = 122/336 (36%), Gaps = 100/336 (29%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRC- 106
G+GTFG+V+ ++ A+KI+R I E A + E VLQ R
Sbjct: 14 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT--------RHP 65
Query: 107 --VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
++ F + +C V E G L F + R F + R +++ + ++H
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+++ D+K EN++L +IK+ D+ + K I G+T
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDF--------------GLCKEG----ISDGATM--- 162
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMM 281
T Y APEV+ + D W +G ++ E+ G F Q HE L L +M
Sbjct: 163 ---KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
E + P+ + S E+
Sbjct: 220 EEI--RFPRTL------------------------SPEAK-------------------- 233
Query: 342 AGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
LL GLL+ DP RL A+E + H FF
Sbjct: 234 -----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 77/335 (22%), Positives = 126/335 (37%), Gaps = 95/335 (28%)
Query: 51 MGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRC 106
+G+GTFG+V+ ++ A+KI++ I E A + E VLQ ++H
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP----FL 210
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DL 164
++ F + +C V E G L F + R F D R +++ + ++H +
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+++ DLK EN++L +IK+ D+ + K I G+T
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDF--------------GLCKEG----IKDGATM---- 306
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMME 282
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 307 --KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342
+ P+ + E+
Sbjct: 365 EI--RFPRTL------------------------GPEAK--------------------- 377
Query: 343 GDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
LL GLL+ DP RL A+E ++H FF
Sbjct: 378 ----SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 77/333 (23%), Positives = 122/333 (36%), Gaps = 94/333 (28%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 107
G+G+FG+VL + + A+K+++ I K +E M E VL + KH V
Sbjct: 47 GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP----FLV 102
Query: 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
+ F + + V + + G L F R F R A ++ + ++H L +
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 160
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
++ DLKPEN+LL S +I + D+ + K + I+ STT
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFG--------------LCKEN----IEHNSTTST---- 198
Query: 227 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL- 285
T Y APEV+ + D W +G +L E+ G F + E M + +L
Sbjct: 199 --FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILN 253
Query: 286 GPL--PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
PL ++ + +
Sbjct: 254 KPLQLKPNI------------------------TNSAR---------------------- 267
Query: 344 DLTHLLQGLLRYDPTDRL----TAREALRHPFF 372
HLL+GLL+ D T RL E H FF
Sbjct: 268 ---HLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 51/248 (20%), Positives = 93/248 (37%), Gaps = 59/248 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHD 100
++ + G G + DR R V +K + G + + AM E + L ++ H
Sbjct: 83 EVKGCIAHGGLGWIYLALDRNVNGRP--VVLKGLVHSGDAEAQAMAMAERQFLAEV-VHP 139
Query: 101 KGGNRCVQIRNWFDYRNHIC-----IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 154
VQI N+ ++ + IV E + G SL + P+ ++
Sbjct: 140 ----SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEI 191
Query: 155 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 214
L ++++H + +++ DLKPEN++L + +K+I
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEEQ----------------------------LKLI 223
Query: 215 DFG---STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271
D G Y+ T ++APE++ G T DI++VG L L
Sbjct: 224 DLGAVSRIN----SFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTR-N 277
Query: 272 HENLEHLA 279
++ L
Sbjct: 278 GRYVDGLP 285
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 31/150 (20%), Positives = 61/150 (40%), Gaps = 22/150 (14%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+ K+G G FG + + + E A +V+ + E++ Q++AK D
Sbjct: 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKW 99
Query: 106 CVQIRN---------WF--------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVR 148
+ + YR +V E+LG L +N +F V
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYR---FMVMERLGIDLQKISGQN--GTFKKSTVL 154
Query: 149 EIARQLLECIAFMHDLCMIHTDLKPENVLL 178
++ ++L+ + ++H+ +H D+K N+LL
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLL 184
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 29/155 (18%), Positives = 57/155 (36%), Gaps = 29/155 (18%)
Query: 46 KIHSKMGEGTFGQV--------LECWDRERKEMVAIKI-------VRGIKKY-REAAMIE 89
K+ S G + L C +K+ ++K+ + R A ++
Sbjct: 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQ 104
Query: 90 IEVLQQLAKHDKGG-NRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFP 143
+ ++L C+ F YR +V LG SL L +
Sbjct: 105 VNKWKKLYSTPLLAIPTCM----GFGVHQDKYR---FLVLPSLGRSLQSALDVSPKHVLS 157
Query: 144 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLL 178
V ++A +LL+ + F+H+ +H ++ EN+ +
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 66/341 (19%), Positives = 127/341 (37%), Gaps = 106/341 (31%)
Query: 52 GEGTFGQVL---ECWDRERKEMVAIKIVRG---IKKYREAA--MIEIEVLQQLAKHDKGG 103
G+G +G+V + ++ A+K+++ ++ ++ A E +L+++
Sbjct: 26 GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV------- 78
Query: 104 NRC---VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
+ V + F + ++ E L G L F++ F D ++ +
Sbjct: 79 -KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALG 135
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
+H +I+ DLKPEN++L ++K+ D+ K+S I G+
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC----KES--------------IHDGTV 177
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
T+ T Y APE+++ G D WS+G ++ ++ TG F T EN +
Sbjct: 178 THT------FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRK--K 228
Query: 280 MMERVLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336
++++L LP ++ ++E+
Sbjct: 229 TIDKILKCKLNLPPYL------------------------TQEAR--------------- 249
Query: 337 HVDHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
LL+ LL+ + RL A E HPFF
Sbjct: 250 ----------DLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 66/285 (23%), Positives = 117/285 (41%), Gaps = 57/285 (20%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRE---RKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 100
K ++G+G FG V C +D E+VA+K ++ +++ EIE+L+ L +HD
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 71
Query: 101 KGGNRCVQIRN--WFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 156
V+ + + R ++ ++ E GS L D+L+K+ R I L+ + Q+ +
Sbjct: 72 N----IVKYKGVCYSAGRRNLKLIMEYLPYGS-LRDYLQKHKERIDHIKLL-QYTSQICK 125
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
+ ++ IH DL N+ LV +E +K+ DF
Sbjct: 126 GMEYLGTKRYIHRDLATRNI-LVENENR--------------------------VKIGDF 158
Query: 217 GSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270
G T D+ + APE + ++ D+WS G +L EL T
Sbjct: 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--- 215
Query: 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 314
++ A R++G Q + H + ++ RL P+G
Sbjct: 216 --KSKSPPAEFMRMIGNDKQGQMI--VFHLIELLKNNGRLPRPDG 256
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 67/285 (23%), Positives = 117/285 (41%), Gaps = 57/285 (20%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRE---RKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 100
K ++G+G FG V C +D E+VA+K ++ +++ EIE+L+ L +HD
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 102
Query: 101 KGGNRCVQIRN--WFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 156
V+ + + R ++ ++ E GS L D+L+K+ R I L+ + Q+ +
Sbjct: 103 N----IVKYKGVCYSAGRRNLKLIMEYLPYGS-LRDYLQKHKERIDHIKLL-QYTSQICK 156
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
+ ++ IH DL N+ LV +E +K+ DF
Sbjct: 157 GMEYLGTKRYIHRDLATRNI-LVENENR--------------------------VKIGDF 189
Query: 217 GSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270
G T D+ Y APE + ++ D+WS G +L EL T
Sbjct: 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--- 246
Query: 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 314
++ A R++G Q + H + ++ RL P+G
Sbjct: 247 --KSKSPPAEFMRMIGNDKQGQMI--VFHLIELLKNNGRLPRPDG 287
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 75/339 (22%), Positives = 125/339 (36%), Gaps = 104/339 (30%)
Query: 52 GEGTFGQVL---ECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNR 105
G+G+FG+V + + +++ A+K+++ + R +E ++L ++
Sbjct: 33 GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV--------N 84
Query: 106 C---VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
V++ F + ++ + L G L F R + F + V+ +L + +
Sbjct: 85 HPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H L +I+ DLKPEN+LL +IK+ D+ S K+S ID Y
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLS----KES--------------IDHEKKAY 184
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
T Y APEV+ G T D WS G ++ E+ TG FQ + E M
Sbjct: 185 S------FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TM 235
Query: 282 ERVLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
+L +PQ + S E+
Sbjct: 236 TMILKAKLGMPQFL------------------------SPEAQ----------------- 254
Query: 339 DHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
LL+ L + +P +RL E RH FF
Sbjct: 255 --------SLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 55/302 (18%), Positives = 109/302 (36%), Gaps = 57/302 (18%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
+ +G+G FG+V W R E VA+KI ++ EI L +H+ N
Sbjct: 45 VLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREERSWFREAEIYQTVML-RHE---N 97
Query: 105 ----RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
++ + +V + SL+D+L + + ++ + ++A +A
Sbjct: 98 ILGFIAADNKD-NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLA 153
Query: 160 FMHD--------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 211
+H + H DLK +N+L+ + + D ++ + P
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-- 211
Query: 212 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYP------CDIWSVGCILVELCTG 265
V T+ Y APEV+ DI+++G + E+
Sbjct: 212 ------------------VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
Query: 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 325
++ HE+ + P + M K V ++ R + P S E+++ +
Sbjct: 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV------CEQKLRPNIPNRWQSCEALRVMA 307
Query: 326 KL 327
K+
Sbjct: 308 KI 309
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 65/356 (18%), Positives = 111/356 (31%), Gaps = 104/356 (29%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD----- 100
++ G FG V + E VA+KI K E+ L + KH+
Sbjct: 27 QLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQF 83
Query: 101 -----KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 154
+G + V + ++ SL DFL+ N + + IA +
Sbjct: 84 IGAEKRGTSVDVDL----------WLITAFHEKGSLSDFLKAN---VVSWNELCHIAETM 130
Query: 155 LECIAFMHD----------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 204
+A++H+ + H D+K +NVLL ++
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL-------------------KNNLT-- 169
Query: 205 MPKSSAIKVIDFG-----STTYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWS 254
+ DFG D + V TR Y APEV+ D+++
Sbjct: 170 ------ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223
Query: 255 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLP--QHMLKRVDRHAEKYVRRGRLDWP 312
+G +L EL + E++ E +G P + M + V ++ R
Sbjct: 224 MGLVLWELASRCTAA-DGPVDEYMLPFEEEIGQHPSLEDMQEVVVH------KKKRPVLR 276
Query: 313 EGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368
+ + + L I + DH D RL+A
Sbjct: 277 ------DYWQKHAGMAMLCETIEECWDH---------------DAEARLSAGCVGE 311
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 48/264 (18%), Positives = 82/264 (31%), Gaps = 77/264 (29%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD---- 100
+ +G+G +G+V W + E VA+KI + E+ L +H+
Sbjct: 11 TLLECVGKGRYGEVWRGSW---QGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILG 66
Query: 101 ------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 153
+ Q+ ++ SLYD+L+ + I
Sbjct: 67 FIASDMTSRHSSTQL----------WLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLS 113
Query: 154 LLECIAFMHDL--------CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205
+ +A +H + H DLK +N+L+ K +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV-----------KKNGQ----------- 151
Query: 206 PKSSAIKVIDFG-------STTYERPDQNYIVSTRHYRAPEVILGLGWTYP------CDI 252
+ D G ST N V T+ Y APEV+ DI
Sbjct: 152 -----CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 253 WSVGCILVELCTGEALFQTHENLE 276
W+ G +L E+ E+ +
Sbjct: 207 WAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 29/153 (18%), Positives = 58/153 (37%), Gaps = 25/153 (16%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA---MIEIEVLQQLAKHDKG 102
K+ +G+G FG + D E V +K E++ Q+ AK ++
Sbjct: 38 KVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 103 GNRCVQIRN---------WF--------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 145
+ YR ++ ++ GS L N + F
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYR---FMIMDRFGSDLQKIYEANA-KRFSRK 152
Query: 146 LVREIARQLLECIAFMHDLCMIHTDLKPENVLL 178
V +++ ++L+ + ++H+ +H D+K N+LL
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLL 185
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 69/338 (20%), Positives = 121/338 (35%), Gaps = 92/338 (27%)
Query: 52 GEGTFGQVL---ECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLAKHDKGG 103
G G +G+V + + ++ A+K+++ K E E +VL+ + +
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP--- 119
Query: 104 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
V + F + ++ + + G L+ L + F V+ +++ + +H
Sbjct: 120 -FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH 176
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
L +I+ D+K EN+LL S+ ++ + D+ S K+ V D Y+
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLS----KEF-------------VADETERAYD 219
Query: 223 RPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQT-HENLEHLA 279
T Y AP+++ G G D WS+G ++ EL TG + F E
Sbjct: 220 ------FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339
+ R+L + +P Q +
Sbjct: 274 ISRRIL--------------------KSEPPYP-----------------------QEMS 290
Query: 340 HSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
A D L+Q LL DP RL A E H FF
Sbjct: 291 ALAKD---LIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 65/361 (18%), Positives = 114/361 (31%), Gaps = 114/361 (31%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD---- 100
++ ++G+G +G+V W R E VA+K+ ++ EI + +H+
Sbjct: 40 QMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTTEEASWFRETEIYQTVLM-RHENILG 95
Query: 101 ------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 153
KG Q+ ++ + SLYD+L+ + + ++A
Sbjct: 96 FIAADIKGTGSWTQL----------YLITDYHENGSLYDYLKST---TLDAKSMLKLAYS 142
Query: 154 LLECIAFMHDL--------CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205
+ + +H + H DLK +N+L+ K +
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV-----------KKNGT----------- 180
Query: 206 PKSSAIKVIDFG-------STTYERPDQNYIVSTRHYRAPEVILGLGWTYP------CDI 252
+ D G T N V T+ Y PEV+ D+
Sbjct: 181 -----CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235
Query: 253 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV-----RRG 307
+S G IL E+ E + LP H L D E ++
Sbjct: 236 YSFGLILWEVARRCVSGGIVEEYQ-----------LPYHDLVPSDPSYEDMREIVCIKKL 284
Query: 308 RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 367
R +P +S E L ++ L+ + H +P RLTA
Sbjct: 285 RPSFPNRWSSDEC------LRQMGKLMTECWAH---------------NPASRLTALRVK 323
Query: 368 R 368
+
Sbjct: 324 K 324
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 56/234 (23%), Positives = 95/234 (40%), Gaps = 49/234 (20%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRE---RKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHD 100
K S++G+G FG V C +D +VA+K ++ ++ EI++L+ L D
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSD 84
Query: 101 KGGNRCVQIRN--WFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 156
V+ R + R + +V E G L DFL+++ R L+ + Q+ +
Sbjct: 85 F----IVKYRGVSYGPGRQSLRLVMEYLPSG-CLRDFLQRHRARLDASRLL-LYSSQICK 138
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
+ ++ +H DL N+ LV SE +K+ DF
Sbjct: 139 GMEYLGSRRCVHRDLAARNI-LVESEAH--------------------------VKIADF 171
Query: 217 GSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT 264
G D++Y V + APE + ++ D+WS G +L EL T
Sbjct: 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 67/289 (23%), Positives = 109/289 (37%), Gaps = 65/289 (22%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRER---KEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 99
K +GEG FG+V C +D E E VA+K ++ + EIE+L+ L H
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YH 82
Query: 100 DK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 152
+ G C + D N I ++ E G SL ++L KN + + + A
Sbjct: 83 ENIVKYKG--ICTE-----DGGNGIKLIMEFLPSG-SLKEYLPKNKNKINLKQQL-KYAV 133
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
Q+ + + ++ +H DL NV LV SE+ +K
Sbjct: 134 QICKGMDYLGSRQYVHRDLAARNV-LVESEHQ--------------------------VK 166
Query: 213 VIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGE 266
+ DFG T D+ Y APE ++ + D+WS G L EL T
Sbjct: 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-- 224
Query: 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 314
+ ++ ++ + Q + R+ ++ G RL P
Sbjct: 225 --YCDSDSSPMALFLKMIGPTHGQMTVTRL----VNTLKEGKRLPCPPN 267
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 49/246 (19%), Positives = 97/246 (39%), Gaps = 42/246 (17%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK---- 101
+ K+G G +G+V E ++ VA+K ++ E + E V++++ KH
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQL 281
Query: 102 -GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
G C + I+ E G+ L D+LR+ N + ++ +A Q+ +
Sbjct: 282 LG--VCTR-------EPPFYIITEFMTYGN-LLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
++ IH +L N L+ + +KV D+ S +Y IK
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIK------ 384
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 277
+ APE + ++ D+W+ G +L E+ T G + + + +
Sbjct: 385 ----------------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 428
Query: 278 LAMMER 283
++E+
Sbjct: 429 YELLEK 434
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 35/153 (22%), Positives = 65/153 (42%), Gaps = 38/153 (24%)
Query: 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 179
+V E + G +L +++ + +D Q+L+ I HD+ ++H D+KP+N+L
Sbjct: 88 LVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNIL-- 143
Query: 180 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG------STTYERPDQNYIVSTR 233
+ + +K+ DFG T+ + N+++ T
Sbjct: 144 -------------------------IDSNKTLKIFDFGIAKALSETSLTQT--NHVLGTV 176
Query: 234 HYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266
Y +PE G DI+S+G +L E+ GE
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 35/153 (22%), Positives = 59/153 (38%), Gaps = 36/153 (23%)
Query: 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 179
IV E + G +L D + E+ + + F H +IH D+KP N++
Sbjct: 93 IVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM-- 148
Query: 180 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG------STTYERPDQNYIVSTR 233
+ ++A+KV+DFG + ++ T
Sbjct: 149 -------------------------ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 234 HYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266
Y +PE G D++S+GC+L E+ TGE
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 35/150 (23%), Positives = 51/150 (34%), Gaps = 37/150 (24%)
Query: 127 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 186
G L LR+ I RQ+ + H H D+KPEN+L+
Sbjct: 118 GVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV-------- 167
Query: 187 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG------STTYERPDQNYIVSTRHYRAPEV 240
+ D ++DFG + V T +Y APE
Sbjct: 168 --------SADD-----------FAYLVDFGIASATTDEKLTQL--GNTVGTLYYMAPER 206
Query: 241 ILGLGWTYPCDIWSVGCILVELCTGEALFQ 270
TY DI+++ C+L E TG +Q
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 65/349 (18%), Positives = 112/349 (32%), Gaps = 79/349 (22%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
K+ +G G +G V + + VA+K+ + I + + +HD N
Sbjct: 16 KLLELIGRGRYGAVYKGSL---DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHD---N 68
Query: 105 --RCV--QIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
R + R D R +V E GS L +L + + +A + +
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGS-LXKYLSLH---TSDWVSSCRLAHSVTRGL 124
Query: 159 AFMHD---------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 209
A++H + H DL NVL+ + + D+ S+ + ++
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 210 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-------GWTYPCDIWSVGCILVEL 262
A V T Y APEV+ G D++++G I E+
Sbjct: 185 A----------------ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
Query: 263 CTGEALFQTHENLEHLAM-MERVLGPLP--QHMLKRVDRHAEKYVRRGRLDWPEGAASRE 319
E++ M + +G P + M V R + R +PE
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR------EKQRPKFPEAWKENS 282
Query: 320 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368
+ + L+ I D D RLTA+ A
Sbjct: 283 -----LAVRSLKETIEDCWDQ---------------DAEARLTAQXAEE 311
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 53/251 (21%), Positives = 99/251 (39%), Gaps = 56/251 (22%)
Query: 50 KMGEGTFGQVLE-CWDRERKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 105
++G G FG V + + +K++ VAIK+++ K E M E +++ QL +
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPY---- 71
Query: 106 CVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
V++ + +V E G L+ FL ++ E+ Q+ +
Sbjct: 72 IVRL-----IGVCQAEALMLVMEMAGGGP-LHKFLVGKREEIPVSNVA-ELLHQVSMGMK 124
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
++ + +H DL NVLLV+ Y K+ DFG +
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKIS---------------------------DFGLS 157
Query: 220 TYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272
D +Y + + APE I ++ D+WS G + E + G+ ++
Sbjct: 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217
Query: 273 ENLEHLAMMER 283
+ E +A +E+
Sbjct: 218 KGPEVMAFIEQ 228
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 51/261 (19%), Positives = 96/261 (36%), Gaps = 61/261 (23%)
Query: 46 KIHSKMGEGTFGQVLE-------CWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLA 97
+ +G+GTF ++ + + + + V +K++ + Y E+ ++ +L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL- 69
Query: 98 KHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREI 150
H G CV + +V E K GS L +L+KN + + E+
Sbjct: 70 SHKHLVLNYG--VCVC-------GDENILVQEFVKFGS-LDTYLKKNKNCINILWKL-EV 118
Query: 151 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 210
A+QL + F+ + +IH ++ +N+LL+ E K +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN-------------------PPF 159
Query: 211 IKVIDFGSTTYERPDQNYIVSTRHYR------APEVIL-GLGWTYPCDIWSVGCILVELC 263
IK+ D G + ++ + PE I D WS G L E+C
Sbjct: 160 IKLSDPGIS---I----TVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212
Query: 264 T-GEALFQTHENLEHLAMMER 283
+ G+ ++ L E
Sbjct: 213 SGGDKPLSALDSQRKLQFYED 233
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 9e-12
Identities = 67/289 (23%), Positives = 107/289 (37%), Gaps = 67/289 (23%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRE---RKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 99
K +GEG FG+V +D EMVA+K ++ ++R EI++L+ L H
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YH 92
Query: 100 DK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 152
+ G C + +V E LG SL D+L +++ L+ A+
Sbjct: 93 EHIIKYKG--CCED-----AGAASLQLVMEYVPLG-SLRDYLPRHSIG--LAQLL-LFAQ 141
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
Q+ E +A++H IH DL NV L+ ++ + +K
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNV-LLDNDRL--------------------------VK 174
Query: 213 VIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGE 266
+ DFG Y APE + + Y D+WS G L EL T
Sbjct: 175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-- 232
Query: 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 314
+E + Q + R+ + + RG RL P+
Sbjct: 233 --HCDSSQSPPTKFLELIGIAQGQMTVLRL----TELLERGERLPRPDK 275
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 2e-11
Identities = 51/251 (20%), Positives = 78/251 (31%), Gaps = 62/251 (24%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVR---------GIKKYREAAMIEIEVLQQLAKHD 100
K+GEG FG+V + VAIKI+ +K E + EI + ++L+
Sbjct: 27 KIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84
Query: 101 KG------------GNRCVQ-------IRNWFDYRN-----------------HICIVFE 124
CVQ ++ W Y + I + FE
Sbjct: 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144
Query: 125 KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI-HTDLKPENVLLVSSEY 183
G L K + + + I QL +A H DL NVLL +
Sbjct: 145 FGGIDLEQMRTKLS----SLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSL 200
Query: 184 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG 243
K LH + + +ID+ + ER ++ G
Sbjct: 201 KK-------LHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDV--SMDEDLFTG 251
Query: 244 LGWTYPCDIWS 254
G Y DI+
Sbjct: 252 DG-DYQFDIYR 261
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 66/251 (26%), Positives = 104/251 (41%), Gaps = 54/251 (21%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
++ K+G+G FG+V W+ + VAIK ++ EA + E +V+++L +H+K
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 323
Query: 105 RCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
VQ+ Y I IV E GS L DFL+ + + + ++A Q+ +
Sbjct: 324 -LVQL-----YAVVSEEPIYIVTEYMSKGS-LLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
A++ + +H DL+ N+ LV + KV DFG
Sbjct: 377 AYVERMNYVHRDLRAANI-LVGENLV--------------------------CKVADFGL 409
Query: 219 TTYERPDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272
D Y + APE L +T D+WS G +L EL T G +
Sbjct: 410 ARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468
Query: 273 ENLEHLAMMER 283
N E L +ER
Sbjct: 469 VNREVLDQVER 479
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 3e-11
Identities = 51/251 (20%), Positives = 97/251 (38%), Gaps = 52/251 (20%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK---- 101
+ K+G G +G+V E ++ VA+K ++ E + E V++++ KH
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQL 74
Query: 102 -GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
G C + I+ E G +L D+LR+ N + ++ +A Q+ +
Sbjct: 75 LG--VCTR-------EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
++ IH DL N LV ++ +KV DFG
Sbjct: 125 EYLEKKNFIHRDLAARNC-LVGENHL--------------------------VKVADFGL 157
Query: 219 TTYERPDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272
+ D Y + APE + ++ D+W+ G +L E+ T G + +
Sbjct: 158 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216
Query: 273 ENLEHLAMMER 283
+ + ++E+
Sbjct: 217 DLSQVYELLEK 227
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 44/246 (17%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
++ K+G+G FG+V W+ + VAIK ++ EA + E +V+++L +H+K
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 240
Query: 105 RCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
VQ+ Y I IV E GS L DFL+ + + + ++A Q+ +
Sbjct: 241 -LVQL-----YAVVSEEPIYIVTEYMSKGS-LLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
A++ + +H DL+ N+L+ + KV D+ + +D+ Y R IK
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIK------ 346
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 277
+ APE L +T D+WS G +L EL T G + N E
Sbjct: 347 ----------------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 390
Query: 278 LAMMER 283
L +ER
Sbjct: 391 LDQVER 396
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 44/246 (17%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
K+ K+G G FG+V +++ K VA+K ++ EA + E V++ L +HD
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTL-QHD---- 243
Query: 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
+ V++ + I I+ E + SL DFL+ + P+ + + + Q+ E +AF+
Sbjct: 244 KLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
IH DL+ N+ LVS+ + K+ DFG
Sbjct: 303 RNYIHRDLRAANI-LVSASLV--------------------------CKIADFGLARVIE 335
Query: 224 PDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 277
D Y + APE I +T D+WS G +L+E+ T G + N E
Sbjct: 336 -DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 394
Query: 278 LAMMER 283
+ +ER
Sbjct: 395 IRALER 400
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 57/252 (22%), Positives = 104/252 (41%), Gaps = 58/252 (23%)
Query: 50 KMGEGTFGQVLE-CWDRERKEM-VAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGN 104
++G G FG V + + ++ VA+KI++ ++ + E V+QQL +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPY--- 79
Query: 105 RCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
V++ +V E +LG L +L++N R + E+ Q+ +
Sbjct: 80 -IVRM-----IGICEAESWMLVMEMAELGP-LNKYLQQN--RHVKDKNIIELVHQVSMGM 130
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
++ + +H DL NVLLV+ Y K+ DFG
Sbjct: 131 KYLEESNFVHRDLAARNVLLVTQHYAKIS---------------------------DFGL 163
Query: 219 TTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 271
+ R D+NY + H + APE I ++ D+WS G ++ E + G+ ++
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
Query: 272 HENLEHLAMMER 283
+ E AM+E+
Sbjct: 224 MKGSEVTAMLEK 235
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 8e-11
Identities = 55/265 (20%), Positives = 100/265 (37%), Gaps = 59/265 (22%)
Query: 46 KIHSKMGEGTFGQVLE-CWDRERKEM--VAIKIVR----GIKKYREAAMIEIEVLQQLAK 98
++ K+G+G+FG V WD + VA+K ++ + + + E+ + L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-D 79
Query: 99 HDKGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 152
H +++ Y + +V E LGS L D LRK+ L A
Sbjct: 80 HRN----LIRL-----YGVVLTPPMKMVTELAPLGS-LLDRLRKHQGHFLLGTLS-RYAV 128
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
Q+ E + ++ IH DL N+LL + + +K+
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG------------------------- 163
Query: 213 VIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-G 265
DFG + ++ V H + APE + +++ D W G L E+ T G
Sbjct: 164 --DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 221
Query: 266 EALFQTHENLEHLAMMERVLGPLPQ 290
+ + + L +++ LP+
Sbjct: 222 QEPWIGLNGSQILHKIDKEGERLPR 246
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 9e-11
Identities = 63/251 (25%), Positives = 105/251 (41%), Gaps = 54/251 (21%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
K+ ++G G FG+V ++ K VA+K ++ +A + E +++QL +H +
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQL-QHQR--- 69
Query: 105 RCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
V++ Y + I I+ E + GS L DFL+ + I+ + ++A Q+ E +
Sbjct: 70 -LVRL-----YAVVTQEPIYIITEYMENGS-LVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
AF+ + IH DL+ N+ LVS K+ DFG
Sbjct: 123 AFIEERNYIHRDLRAANI-LVSDTLS--------------------------CKIADFGL 155
Query: 219 TTYERPDQNYIVSTRH---YR--APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272
D Y + APE I +T D+WS G +L E+ T G +
Sbjct: 156 ARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
Query: 273 ENLEHLAMMER 283
N E + +ER
Sbjct: 215 TNPEVIQNLER 225
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 52/251 (20%), Positives = 99/251 (39%), Gaps = 56/251 (22%)
Query: 50 KMGEGTFGQVLE-CWDRERKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 105
++G G FG V + + +K++ VAIK+++ K E M E +++ QL +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPY---- 397
Query: 106 CVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
V++ + +V E G L+ FL ++ E+ Q+ +
Sbjct: 398 IVRL-----IGVCQAEALMLVMEMAGGGP-LHKFLVGKREEIPVSNVA-ELLHQVSMGMK 450
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
++ + +H +L NVLLV+ Y K+ DFG +
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKIS---------------------------DFGLS 483
Query: 220 TYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272
D +Y + + APE I ++ D+WS G + E + G+ ++
Sbjct: 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543
Query: 273 ENLEHLAMMER 283
+ E +A +E+
Sbjct: 544 KGPEVMAFIEQ 554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 57/257 (22%), Positives = 95/257 (36%), Gaps = 58/257 (22%)
Query: 46 KIHSKMGEGTFGQVLE-CW--DRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHD 100
I +G G G+V +R VAIK ++ ++ R + E ++ Q H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHP 110
Query: 101 K-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 153
G + IV E + GS L FLR ++ + + LV + R
Sbjct: 111 NIIRLEG--VVTR-------GRLAMIVTEYMENGS-LDTFLRTHDGQFTIMQLV-GMLRG 159
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 213
+ + ++ DL +H DL NV LV S + KV
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNV-LVDSNLV--------------------------CKV 192
Query: 214 IDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GE 266
DFG + D + +T + APE I ++ D+WS G ++ E+ GE
Sbjct: 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252
Query: 267 ALFQTHENLEHLAMMER 283
+ N + ++ +E
Sbjct: 253 RPYWNMTNRDVISSVEE 269
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 57/252 (22%), Positives = 100/252 (39%), Gaps = 48/252 (19%)
Query: 46 KIHSKMGEGTFGQVLE-CW--DRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHD 100
I +G G FG+V +++ VAIK ++ +K R + E ++ Q H
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHP 106
Query: 101 KGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
+++ + IV E + GS L FLRK++ + I LV + R + +
Sbjct: 107 N----IIRLEGVVTKSKPVMIVTEYMENGS-LDSFLRKHDAQFTVIQLV-GMLRGIASGM 160
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
++ D+ +H DL N+ L++S + KV DFG
Sbjct: 161 KYLSDMGYVHRDLAARNI-LINSNLV--------------------------CKVSDFGL 193
Query: 219 TTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 271
D +TR + +PE I +T D+WS G +L E+ + GE +
Sbjct: 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 272 HENLEHLAMMER 283
N + + ++
Sbjct: 254 MSNQDVIKAVDE 265
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 63/247 (25%), Positives = 99/247 (40%), Gaps = 46/247 (18%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
++G G FG V W + K VAIK +R E + E EV+ +L H K
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK--VAIKTIREGAMSEEDFIEEAEVMMKL-SHPK--- 64
Query: 105 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
VQ+ + IC+V E + G L D+LR L+ + + E +A++
Sbjct: 65 -LVQLYGVCLEQAPICLVTEFMEHGC-LSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLE 121
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
+ C+IH DL N LV + IKV DFG T +
Sbjct: 122 EACVIHRDLAARNC-LVGENQV--------------------------IKVSDFGMTRFV 154
Query: 223 RPDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 276
D Y ST + +PEV ++ D+WS G ++ E+ + G+ ++ N E
Sbjct: 155 -LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213
Query: 277 HLAMMER 283
+ +
Sbjct: 214 VVEDIST 220
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 3e-10
Identities = 56/247 (22%), Positives = 95/247 (38%), Gaps = 46/247 (18%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
+ ++G G FG V W + VA+K+++ + E + + +L H K
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYD--VAVKMIKEGSMSEDEFFQEAQTMMKL-SHPK--- 64
Query: 105 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
V+ I IV E G L ++LR + P L+ E+ + E +AF+
Sbjct: 65 -LVKFYGVCSKEYPIYIVTEYISNGC-LLNYLRSHGKGLEPSQLL-EMCYDVCEGMAFLE 121
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
IH DL N LV + +KV DFG T Y
Sbjct: 122 SHQFIHRDLAARNC-LVDRDLC--------------------------VKVSDFGMTRYV 154
Query: 223 RPDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 276
D Y+ S + APEV ++ D+W+ G ++ E+ + G+ + + N E
Sbjct: 155 L-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213
Query: 277 HLAMMER 283
+ + +
Sbjct: 214 VVLKVSQ 220
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 53/253 (20%), Positives = 91/253 (35%), Gaps = 54/253 (21%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGG 103
+ ++G G FG+V R +VA+K R + + E +L+Q H
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPN-- 173
Query: 104 NRCVQIRNWFDY-----RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
V++ + I IV E + G FLR R L+ ++
Sbjct: 174 --IVRL-----IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLL-QMVGDAAAG 225
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+ ++ C IH DL N LV+ + + +K+ DFG
Sbjct: 226 MEYLESKCCIHRDLAARNC-LVTEKNV--------------------------LKISDFG 258
Query: 218 STTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ 270
+ E D Y S + APE + ++ D+WS G +L E + G + +
Sbjct: 259 MSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYP 317
Query: 271 THENLEHLAMMER 283
N + +E+
Sbjct: 318 NLSNQQTREFVEK 330
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 49/255 (19%), Positives = 101/255 (39%), Gaps = 55/255 (21%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEM---VAIKIVRG--IKKYREAAMIEIEVLQQLAKH 99
K +G G FG V + W E +++ VAIK +R K + + E V+ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76
Query: 100 DKGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 153
++ + + ++ + G L D++R++ L+ Q
Sbjct: 77 PH----VCRL-----LGICLTSTVQLITQLMPFGC-LLDYVREHKDNIGSQYLL-NWCVQ 125
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK----RMPKSS 209
+ + + ++ D ++H DL NVL+ + +++K+ D+ + + + ++P
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--- 182
Query: 210 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 268
IK + A E IL +T+ D+WS G + EL T G
Sbjct: 183 -IK----------------------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 269 FQTHENLEHLAMMER 283
+ E +++E+
Sbjct: 220 YDGIPASEISSILEK 234
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 54/247 (21%), Positives = 101/247 (40%), Gaps = 46/247 (18%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104
++G G FG V W + VAIK+++ + + E +V+ L H+K
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNL-SHEK--- 80
Query: 105 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
VQ+ + I I+ E G L ++LR+ +R L+ E+ + + E + ++
Sbjct: 81 -LVQLYGVCTKQRPIFIITEYMANGC-LLNYLREMRHRFQTQQLL-EMCKDVCEAMEYLE 137
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
+H DL N LV+ + + +KV DFG + Y
Sbjct: 138 SKQFLHRDLAARNC-LVNDQGV--------------------------VKVSDFGLSRYV 170
Query: 223 RPDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 276
D+ Y S + PEV++ ++ DIW+ G ++ E+ + G+ ++ N E
Sbjct: 171 LDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
Query: 277 HLAMMER 283
+ +
Sbjct: 230 TAEHIAQ 236
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 54/258 (20%), Positives = 96/258 (37%), Gaps = 59/258 (22%)
Query: 46 KIHSKMGEGTFGQVLE-CW---DRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 99
+G G FG+V + +++ VAIK ++ +K R + E ++ Q H
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SH 105
Query: 100 DK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 152
G + + I+ E + G+ L FLR+ + + LV + R
Sbjct: 106 HNIIRLEG--VISK-------YKPMMIITEYMENGA-LDKFLREKDGEFSVLQLV-GMLR 154
Query: 153 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
+ + ++ ++ +H DL N+ LV+S + K
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNI-LVNSNLV--------------------------CK 187
Query: 213 VIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-G 265
V DFG + D +T + APE I +T D+WS G ++ E+ T G
Sbjct: 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 247
Query: 266 EALFQTHENLEHLAMMER 283
E + N E + +
Sbjct: 248 ERPYWELSNHEVMKAIND 265
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 53/255 (20%), Positives = 97/255 (38%), Gaps = 55/255 (21%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEM---VAIKIVRGI--KKYREAAMIEIEVLQQLAKH 99
+ +G G FG V + W E + + V IK++ ++ +A + + L H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DH 74
Query: 100 DKGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 153
V++ + + +V + LGS L D +R++ P L+ Q
Sbjct: 75 AH----IVRL-----LGLCPGSSLQLVTQYLPLGS-LLDHVRQHRGALGPQLLL-NWGVQ 123
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK----RMPKSS 209
+ + + ++ + M+H +L NVLL S ++V D+ + P D + P
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP--- 180
Query: 210 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 268
IK + A E I +T+ D+WS G + EL T G
Sbjct: 181 -IK----------------------WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
Query: 269 FQTHENLEHLAMMER 283
+ E ++E+
Sbjct: 218 YAGLRLAEVPDLLEK 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 59/250 (23%), Positives = 98/250 (39%), Gaps = 47/250 (18%)
Query: 46 KIHSKMGEGTFGQVLE-CWDRERKE--MVAIKIVRG--IKKYREAAMIEIEVLQQLAKHD 100
++ +GEG FG V + + VAIK + RE + E ++Q H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 76
Query: 101 KGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQL 154
V++ N + I+ E LG L FL+ Y L+ A QL
Sbjct: 77 H----IVKL-----IGVITENPVWIIMELCTLGE-LRSFLQVRKYSLDLASLI-LYAYQL 125
Query: 155 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 214
+A++ +H D+ NVL+ S++ +K+ D+ S + +DS+Y+K IK
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK-- 182
Query: 215 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 273
+ APE I +T D+W G + E+ G FQ +
Sbjct: 183 --------------------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222
Query: 274 NLEHLAMMER 283
N + + +E
Sbjct: 223 NNDVIGRIEN 232
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 49/255 (19%), Positives = 101/255 (39%), Gaps = 55/255 (21%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEM---VAIKIVRG--IKKYREAAMIEIEVLQQLAKH 99
K +G G FG V + W E +++ VAIK +R K + + E V+ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76
Query: 100 DKGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 153
++ + + ++ + G L D++R++ L+ Q
Sbjct: 77 PH----VCRL-----LGICLTSTVQLITQLMPFGC-LLDYVREHKDNIGSQYLL-NWCVQ 125
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK----RMPKSS 209
+ + + ++ D ++H DL NVL+ + +++K+ D+ + + + ++P
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--- 182
Query: 210 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 268
IK + A E IL +T+ D+WS G + EL T G
Sbjct: 183 -IK----------------------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 269 FQTHENLEHLAMMER 283
+ E +++E+
Sbjct: 220 YDGIPASEISSILEK 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 6e-08
Identities = 52/256 (20%), Positives = 97/256 (37%), Gaps = 59/256 (23%)
Query: 46 KIHSKMGEGTFGQVLE-CW--DRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHD 100
++ +GEG FG+V E + + K VA+K + +E M E +++ L H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHP 73
Query: 101 KGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQL 154
V++ I+ E G L +L +N + LV + Q+
Sbjct: 74 H----IVKL-----IGIIEEEPTWIIMELYPYGE-LGHYLERNKNSLKVLTLV-LYSLQI 122
Query: 155 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 214
+ +A++ + +H D+ N+ LV+S +K+
Sbjct: 123 CKAMAYLESINCVHRDIAVRNI-LVASPEC--------------------------VKLG 155
Query: 215 DFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEA 267
DFG + Y + Y R +PE I +T D+W + E+ + G+
Sbjct: 156 DFGLSRYIEDEDYY--KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
Query: 268 LFQTHENLEHLAMMER 283
F EN + + ++E+
Sbjct: 214 PFFWLENKDVIGVLEK 229
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 39/150 (26%), Positives = 63/150 (42%), Gaps = 20/150 (13%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK---- 101
K+ +G+G FG V+ R K VA+K ++ +A + E V+ QL +H
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQL 251
Query: 102 -GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
G V+ + + IV E GS L D+LR D + + + + E +
Sbjct: 252 LG--VIVE------EKGGLYIVTEYMAKGS-LVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPD 188
++ +H DL NVL+ KV D
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSD 332
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 49/251 (19%)
Query: 46 KIHSKMGEGTFGQVLE-CW--DRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHD 100
++ +GEG FG V + + VAIK + RE + E ++Q H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 451
Query: 101 K-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 153
G + N + I+ E LG L FL+ + L+ A Q
Sbjct: 452 HIVKLIG--VITE--------NPVWIIMELCTLGE-LRSFLQVRKFSLDLASLI-LYAYQ 499
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 213
L +A++ +H D+ NVL+ S++ +K+ D+ S + +DS+Y+K IK
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK- 557
Query: 214 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272
+ APE I +T D+W G + E+ G FQ
Sbjct: 558 ---------------------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596
Query: 273 ENLEHLAMMER 283
+N + + +E
Sbjct: 597 KNNDVIGRIEN 607
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 60/250 (24%), Positives = 88/250 (35%), Gaps = 72/250 (28%)
Query: 46 KIHSKMGEGTFGQVLEC-WDRERKEM-VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 101
K +GEG FGQVL+ ++ M AIK ++ K E+EVL +L H
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 102 -----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIA--- 151
G C R ++ + E G +L DFLRK+ +
Sbjct: 88 IINLLG--ACEH-------RGYLYLAIEYAPHG-NLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 152 ----RQLLEC---IA----FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200
+QLL +A ++ IH DL N+ LV Y+
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI-LVGENYV---------------- 180
Query: 201 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWS 254
K+ DFG + R Q V R A E + +T D+WS
Sbjct: 181 ----------AKIADFGLS---R-GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 226
Query: 255 VGCILVELCT 264
G +L E+ +
Sbjct: 227 YGVLLWEIVS 236
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 29/248 (11%), Positives = 51/248 (20%), Gaps = 65/248 (26%)
Query: 47 IHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKG 102
+ G Q + D VA+ V + + L ++
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KP-- 91
Query: 103 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
++ + R +V E + G SL + P+ +R + L
Sbjct: 92 --GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIR-AMQSLAAAADAA 145
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H + + P V + + +
Sbjct: 146 HRAGVALSIDHPSRVRVSI---------------------------DGDVVLAYPA---- 174
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
DI +G L L LA
Sbjct: 175 -------------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA 214
Query: 282 ERVLGPLP 289
ER P
Sbjct: 215 ERDTAGQP 222
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 54/251 (21%), Positives = 93/251 (37%), Gaps = 58/251 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK---- 101
K+ +G+G FG V+ R K VA+K ++ +A + E V+ QL +H
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQL 79
Query: 102 -GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
G + + + + IV E GS L D+LR D + + + + E +
Sbjct: 80 LG---VI-----VEEKGGLYIVTEYMAKGS-LVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
++ +H DL NV LVS + + KV DFG
Sbjct: 131 EYLEGNNFVHRDLAARNV-LVSEDNV--------------------------AKVSDFGL 163
Query: 219 TTYERPDQNYIVSTRH---YR--APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272
T + APE + ++ D+WS G +L E+ + G +
Sbjct: 164 TKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218
Query: 273 ENLEHLAMMER 283
+ + +E+
Sbjct: 219 PLKDVVPRVEK 229
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 53/254 (20%), Positives = 78/254 (30%), Gaps = 72/254 (28%)
Query: 46 KIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAK 98
+G G FG+V+E + VA+K+++ E M E++VL L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 99 HDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIA 151
H G C ++ E G L +FLR+ I
Sbjct: 86 HMNIVNLLG--ACTI-------GGPTLVITEYCCYG-DLLNFLRRKRDSFICSKTSPAIM 135
Query: 152 RQLLECIAFMHDLCM----------------IHTDLKPENVLLVSSEYIKVPDYKSSLHT 195
+ L IH DL N+ L++ I
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI-LLTHGRI----------- 183
Query: 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR-----APEVILGLGWTYPC 250
K+ DFG + D NY+V APE I +T+
Sbjct: 184 ---------------TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 228
Query: 251 DIWSVGCILVELCT 264
D+WS G L EL +
Sbjct: 229 DVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 61/300 (20%), Positives = 106/300 (35%), Gaps = 86/300 (28%)
Query: 46 KIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAK 98
+ +G G FG+V+E + VA+K+++ +EA M E++++ L +
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 99 HDKGGN---RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN--NYRSFPIDLVREIA 151
H+ N C + ++ E G L +FLR+ + P +
Sbjct: 109 HENIVNLLGACTH-------GGPVLVITEYCCYG-DLLNFLRRKSRVLETDPAFAIANST 160
Query: 152 RQLLECIAFMHDLC--M--------IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201
+ + F + M IH D+ NV L+++ ++
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV-LLTNGHV----------------- 202
Query: 202 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVG 256
K+ DFG D NYIV + APE I +T D+WS G
Sbjct: 203 ---------AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 253
Query: 257 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGA 315
+L E+ + L + P P + V+ K V+ G ++ P A
Sbjct: 254 ILLWEIFS-------------LGLN-----PYPGIL---VNSKFYKLVKDGYQMAQPAFA 292
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 6e-06
Identities = 27/164 (16%), Positives = 58/164 (35%), Gaps = 12/164 (7%)
Query: 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 102
A KI+ ++ F ++ E E ++ + +K E L++ +
Sbjct: 77 MAVKIY-RIETSEFDKMDEY--LYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA--- 130
Query: 103 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
G Q + Y ++ ++ L R V I ++E + ++
Sbjct: 131 GVSVPQP---YTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLY 187
Query: 163 DLC-MIHTDLKPENVLLVSS-EYIKVPDYKSSLHTPKDSSYFKR 204
++H DL N++ + +I + + H P SY +R
Sbjct: 188 QEAELVHADLSEYNIMYIDKVYFIDMGQAVTLRH-PMAESYLER 230
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 50/252 (19%), Positives = 85/252 (33%), Gaps = 69/252 (27%)
Query: 46 KIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAK 98
K+ +G G FGQV+E VA+K+++ + E M E+++L +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 99 HDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN----NYRSFPIDLV 147
H G + ++ E K G +L +LR + +
Sbjct: 90 HLNVVNLLG---AC-----TKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKVAPEDL 140
Query: 148 REIARQLLECIAFMHDLC--M--------IHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197
+ L I + + M IH DL N+ L+S + +
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI-LLSEKNV------------- 186
Query: 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR-----APEVILGLGWTYPCDI 252
+K+ DFG D +Y+ APE I +T D+
Sbjct: 187 -------------VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 253 WSVGCILVELCT 264
WS G +L E+ +
Sbjct: 234 WSFGVLLWEIFS 245
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 2e-05
Identities = 56/432 (12%), Positives = 114/432 (26%), Gaps = 120/432 (27%)
Query: 1 MRMRGSSGILMVDMY-----ILLTMALRNRVLMCNMFNLITYIVFSAFADKIHSKMGE-G 54
+ +R + +L+ + + + + C M I ++ +
Sbjct: 145 LELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL-----------NLKNCN 193
Query: 55 TFGQVLE-----CWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109
+ VLE + + IK + E+ L + + C+ +
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY----ENCLLV 249
Query: 110 -RN-W-------FDYRNHIC-IVFEKLGSSLYDFLRKNNYRSFPID-----LVREIARQL 154
N F+ C I+ + DFL +D L + + L
Sbjct: 250 LLNVQNAKAWNAFNLS---CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL 306
Query: 155 LECIAFMHDLCMIHTDLKPE----NVLLVS--SEYIKVPDYKSSLHTPKDSSYFKRMPKS 208
L L DL E N +S +E I+ +K +
Sbjct: 307 LLKY-----LDCRPQDLPREVLTTNPRRLSIIAESIR--------DGLATWDNWKHVNCD 353
Query: 209 SAIKVIDFGSTTYERPDQNYIVSTRHYRA----------PEVILGLGWTYPCDIWSVGCI 258
+I+ S P + + + P ++L L W V +
Sbjct: 354 KLTTIIE-SSLNVLEPAEYR----KMFDRLSVFPPSAHIPTILLSLIWFDVIKS-DVMVV 407
Query: 259 LVELCTGEALFQTHEN----LEHLAMMERVLGPLPQHMLKRVDRHA---EKYVRRGRLDW 311
+ +L + + + + + + + + H + Y D
Sbjct: 408 VNKLHKYSLVEKQPKESTISIPSIYLELK------VKLENEYALHRSIVDHYNIPKTFDS 461
Query: 312 PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
+ + P L H+ H HL + +R+ R F
Sbjct: 462 DD-----------LIPPYLDQYFYSHIGH------HLKNI----EHPERM---TLFRMVF 497
Query: 372 ----FTRDHLRR 379
F +R
Sbjct: 498 LDFRFLEQKIRH 509
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 58/339 (17%), Positives = 105/339 (30%), Gaps = 91/339 (26%)
Query: 46 KIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAK 98
K+ +G G FGQV+E VA+K+++ A M E+++L +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
H N + + ++ E +L +LR R+ + + AR
Sbjct: 85 HL---NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK--RNEFVPYKTKGARFR--- 136
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY--KSSLHTPKDSSYFKRMPKSSA----- 210
+ I DLK + SS+ + + SL ++ + + K
Sbjct: 137 -QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 211 ------------------------------------IKVIDFGSTTYERPDQNYIVSTRH 234
+K+ DFG D +Y+
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 235 YR-----APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 289
APE I +T D+WS G +L E+ + LG P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------------------LGASP 295
Query: 290 -QHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMK 326
+ ++D + ++ G R+ P+ + M
Sbjct: 296 YPGV--KIDEEFCRRLKEGTRMRAPDYT--TPEMYQTML 330
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 30/155 (19%), Positives = 54/155 (34%), Gaps = 23/155 (14%)
Query: 46 KIHSKMGEGTFGQVLEC---WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAKHD 100
+ +G G FG V + +K A+K + I E + + E +++ H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHP 86
Query: 101 K-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 153
G +V K G L +F+R + DL+ Q
Sbjct: 87 NVLSLLG---IC-----LRSEGSPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIG-FGLQ 136
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 188
+ + + ++ +H DL N +L +KV D
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 171
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 45/251 (17%), Positives = 84/251 (33%), Gaps = 58/251 (23%)
Query: 46 KIHSKMGEGTFGQVLE--CWDRERKEM-VAIKIVRGIKKYREAA--MIEIEVLQQLAKHD 100
+ +G G FG V D + K++ A+K + I E + + E +++ H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHP 150
Query: 101 K-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 153
G +V K G L +F+R + DL+ Q
Sbjct: 151 NVLSLLG---IC-----LRSEGSPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIG-FGLQ 200
Query: 154 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 213
+ + + F+ +H DL N ++ ++ +KV
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNC-MLDEKFT--------------------------VKV 233
Query: 214 IDFG-STTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-G 265
DFG + + + + + + A E + +T D+WS G +L EL T G
Sbjct: 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 293
Query: 266 EALFQTHENLE 276
+ +
Sbjct: 294 APPYPDVNTFD 304
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 31/121 (25%), Positives = 47/121 (38%), Gaps = 37/121 (30%)
Query: 150 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 209
A + F+H+ IH D+K N+LL D ++ K S
Sbjct: 142 AANGI----NFLHENHHIHRDIKSANILL-------------------DEAF---TAKIS 175
Query: 210 AIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT 264
DFG ++++R Y APE + G T DI+S G +L+E+ T
Sbjct: 176 -----DFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIIT 229
Query: 265 G 265
G
Sbjct: 230 G 230
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 50/254 (19%), Positives = 92/254 (36%), Gaps = 72/254 (28%)
Query: 46 KIHSKMGEGTFGQVLEC-------WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQL 96
+ +GEG FGQV+ R VA+K+++ ++ + + E+E+++ +
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 97 AKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN----NYRSFPID 145
KH G C Q + ++ E G +L ++L+ S+
Sbjct: 132 GKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLQARRPPGLEYSYNPS 181
Query: 146 LVREIARQLLECIAFMHDLC--M--------IHTDLKPENVLLVSSEYIKVPDYKSSLHT 195
E + ++ + + M IH DL NV LV+ + +
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV-LVTEDNV----------- 229
Query: 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPC 250
+K+ DFG Y +T + APE + +T+
Sbjct: 230 ---------------MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 274
Query: 251 DIWSVGCILVELCT 264
D+WS G +L E+ T
Sbjct: 275 DVWSFGVLLWEIFT 288
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 57/257 (22%), Positives = 90/257 (35%), Gaps = 83/257 (32%)
Query: 46 KIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKH 99
+ ++GEG FG+V + K +VA+K ++ + R+ E E+L L +H
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QH 102
Query: 100 DK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 152
G C + + +VFE + G L FLR + + + ++A
Sbjct: 103 QHIVRFFG--VCTE-------GRPLLMVFEYMRHG-DLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 153 QLLECIAFMH-------------DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199
L + L +H DL N LV +
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNC-LVGQGLV--------------- 196
Query: 200 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------------APEVILGLGWT 247
+K+ DFG + R I ST +YR PE IL +T
Sbjct: 197 -----------VKIGDFGMS---R----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238
Query: 248 YPCDIWSVGCILVELCT 264
D+WS G +L E+ T
Sbjct: 239 TESDVWSFGVVLWEIFT 255
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 44/255 (17%), Positives = 83/255 (32%), Gaps = 60/255 (23%)
Query: 50 KMGEGTFGQVLEC---WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAKHDK--- 101
+G+G FG V + + AIK + I + ++ + E +++ L H
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLA 86
Query: 102 --GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
G + ++ G L F+R DL+ Q+
Sbjct: 87 LIG---IM-----LPPEGLPHVLLPYMCHGD-LLQFIRSPQRNPTVKDLI-SFGLQVARG 136
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+ ++ + +H DL N ++ + +KV DFG
Sbjct: 137 MEYLAEQKFVHRDLAARNC-MLDESFT--------------------------VKVADFG 169
Query: 218 STTYERPDQNYIVSTRHYR--------APEVILGLGWTYPCDIWSVGCILVELCT-GEAL 268
D+ Y +H A E + +T D+WS G +L EL T G
Sbjct: 170 LARDIL-DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
Query: 269 FQTHENLEHLAMMER 283
++ + + + +
Sbjct: 229 YRHIDPFDLTHFLAQ 243
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 51/256 (19%), Positives = 92/256 (35%), Gaps = 76/256 (29%)
Query: 46 KIHSKMGEGTFGQVLEC-------WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQL 96
+ +GEG FGQV+ + VA+K+++ ++ + + E+E+++ +
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 97 AKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVRE 149
KH G C Q + ++ E G +L ++LR R ++ +
Sbjct: 98 GKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRAR--RPPGMEYSYD 145
Query: 150 IARQLLECIAFMHDLCM----------------IHTDLKPENVLLVSSEYIKVPDYKSSL 193
I R E + F + IH DL NV LV+ +
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV-LVTENNV--------- 195
Query: 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTY 248
+K+ DFG Y +T + APE + +T+
Sbjct: 196 -----------------MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 249 PCDIWSVGCILVELCT 264
D+WS G ++ E+ T
Sbjct: 239 QSDVWSFGVLMWEIFT 254
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 5e-04
Identities = 55/259 (21%), Positives = 89/259 (34%), Gaps = 77/259 (29%)
Query: 46 KIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAK 98
+ +G G FG+V+ VA+K+++ REA M E++++ QL
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 99 HDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIA 151
H+ G C I ++FE G L ++LR + ++ E
Sbjct: 108 HENIVNLLGA--CTL-------SGPIYLIFEYCCYG-DLLNYLRSKREKFSEDEIEYENQ 157
Query: 152 RQLLECIAF----MHDLCM-----------------IHTDLKPENVLLVSSEYIKVPDYK 190
++L E DL +H DL NV LV+ +
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV-LVTHGKV------ 210
Query: 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR-----APEVILGLG 245
+K+ DFG D NY+V APE +
Sbjct: 211 --------------------VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 250
Query: 246 WTYPCDIWSVGCILVELCT 264
+T D+WS G +L E+ +
Sbjct: 251 YTIKSDVWSYGILLWEIFS 269
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 51/254 (20%), Positives = 92/254 (36%), Gaps = 72/254 (28%)
Query: 46 KIHSKMGEGTFGQVLEC-------WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQL 96
+ +GEG FGQV+ + VA+K+++ ++ + + E+E+++ +
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 97 AKHDKGGN---RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIA 151
KH N C Q + ++ E G +L ++LR R ++ +I
Sbjct: 144 GKHKNIINLLGACTQ-------DGPLYVIVEYASKG-NLREYLRAR--RPPGMEYSYDIN 193
Query: 152 RQLLECIAFMHDLCM----------------IHTDLKPENVLLVSSEYIKVPDYKSSLHT 195
R E + F + IH DL NV LV+ +
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV-LVTENNV----------- 241
Query: 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPC 250
+K+ DFG Y +T + APE + +T+
Sbjct: 242 ---------------MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 286
Query: 251 DIWSVGCILVELCT 264
D+WS G ++ E+ T
Sbjct: 287 DVWSFGVLMWEIFT 300
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 57/259 (22%), Positives = 93/259 (35%), Gaps = 86/259 (33%)
Query: 46 KIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKH 99
+ ++GEG FG+V + K +VA+K ++ R+ E E+L L +H
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QH 76
Query: 100 DK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSF---------- 142
+ G C + + +VFE K G L FLR + +
Sbjct: 77 EHIVKFYG--VCGD-------GDPLIMVFEYMKHG-DLNKFLRAHGPDAMILVDGQPRQA 126
Query: 143 -----PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197
++ IA Q+ + ++ +H DL N LV + +
Sbjct: 127 KGELGLSQML-HIASQIASGMVYLASQHFVHRDLATRNC-LVGANLL------------- 171
Query: 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------------APEVILGLG 245
+K+ DFG + R + ST +YR PE I+
Sbjct: 172 -------------VKIGDFGMS---R----DVYSTDYYRVGGHTMLPIRWMPPESIMYRK 211
Query: 246 WTYPCDIWSVGCILVELCT 264
+T D+WS G IL E+ T
Sbjct: 212 FTTESDVWSFGVILWEIFT 230
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 379 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.03 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.92 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.61 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.02 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.02 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.87 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.7 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.45 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.42 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.18 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.16 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.15 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.07 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.95 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.94 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.43 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.14 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.1 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.02 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.72 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.43 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.09 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.85 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.7 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-60 Score=439.49 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=218.6
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
...|++.++||+|+||+||+|+++.+|+.||||+++.. ......+.+|+.++..+ .|+||+++++++.+++.+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-----~HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEE
Confidence 35689999999999999999999999999999999743 33455678899999998 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
|||||| ||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 148 ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl--------------------- 203 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL--------------------- 203 (346)
T ss_dssp EEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------
T ss_pred EEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---------------------
Confidence 999999 99999999874 49999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.+||+|||+|+..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+
T Consensus 204 ------~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 277 (346)
T 4fih_A 204 ------THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 277 (346)
T ss_dssp ------CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ------CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 55667888888888754333 245689999999999999999999999999999999999999999888777
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.....+... .+...++++++||.+||+.|
T Consensus 278 ~~~~i~~~~~~~~~----------------------------------------------~~~~~s~~~~dli~~~L~~d 311 (346)
T 4fih_A 278 AMKMIRDNLPPRLK----------------------------------------------NLHKVSPSLKGFLDRLLVRD 311 (346)
T ss_dssp HHHHHHHSSCCCCS----------------------------------------------CGGGSCHHHHHHHHHHSCSS
T ss_pred HHHHHHcCCCCCCC----------------------------------------------ccccCCHHHHHHHHHHcCCC
Confidence 66655543222111 11246789999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~ 375 (379)
|++||||+|+|+||||++.
T Consensus 312 P~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 312 PAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp TTTSCCHHHHTTCGGGGGC
T ss_pred hhHCcCHHHHhcCHhhcCC
Confidence 9999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-60 Score=434.31 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=218.7
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
...|++.+.||+|+||+||+|+++.+|+.||+|+++.. ......+.+|+.++..+ +||||+++++++++++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-----DHPFFVKLYFTFQDDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEeCC
Confidence 34699999999999999999999999999999999742 23345677899998887 7899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
.+|+||||| ||+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl------------------ 165 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL------------------ 165 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------------
T ss_pred EEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE------------------
Confidence 999999999 999999998765 69999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.+||+|||+|+..... ..+.+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+
T Consensus 166 ---------~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 236 (311)
T 4aw0_A 166 ---------NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236 (311)
T ss_dssp ---------CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---------cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 56677888888888754332 2346899999999999999999999999999999999999999998
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+..+....+.+....+| +..++++++||.+
T Consensus 237 ~~~~~~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~dli~~ 267 (311)
T 4aw0_A 237 GNEGLIFAKIIKLEYDFP-------------------------------------------------EKFFPKARDLVEK 267 (311)
T ss_dssp SSHHHHHHHHHHTCCCCC-------------------------------------------------TTCCHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCC-------------------------------------------------cccCHHHHHHHHH
Confidence 887777666554332222 1357789999999
Q ss_pred ccccCCCCCcCHHH------HhcCCCCCCCC
Q 017021 352 LLRYDPTDRLTARE------ALRHPFFTRDH 376 (379)
Q Consensus 352 ~L~~dP~~Rpta~e------~l~hp~f~~~~ 376 (379)
||+.||++|||++| +++||||++.+
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 99999999999988 58999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-60 Score=425.96 Aligned_cols=249 Identities=24% Similarity=0.422 Sum_probs=203.9
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.+.||+|+||+||+|+++.+|+.||+|+++.. ......+.+|+.+++.+ .||||+++++++++++.+
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-----RHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-----CCCCCCeEEEEEEECCEE
Confidence 589999999999999999999999999999999642 23345678899999998 789999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 120 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 120 ~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
|+||||++|+|.+.+.+.+ .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 89 ~ivmEy~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl--------------------- 145 (275)
T 3hyh_A 89 IMVIEYAGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL--------------------- 145 (275)
T ss_dssp EEEEECCCEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---------------------
T ss_pred EEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---------------------
Confidence 9999999999999998865 69999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCC-CCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.+||+|||+|+...... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+
T Consensus 146 ------~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~ 219 (275)
T 3hyh_A 146 ------DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV 219 (275)
T ss_dssp ------CTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------CCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 556678888888886543332 34689999999999998886 589999999999999999999999877666
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+...+.| ...++++++||.+||+.|
T Consensus 220 ~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~~li~~~L~~d 250 (275)
T 3hyh_A 220 LFKNISNGVYTLP-------------------------------------------------KFLSPGAAGLIKRMLIVN 250 (275)
T ss_dssp HHHHHHHTCCCCC-------------------------------------------------TTSCHHHHHHHHHHSCSS
T ss_pred HHHHHHcCCCCCC-------------------------------------------------CCCCHHHHHHHHHHccCC
Confidence 6555544322222 135678999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~ 375 (379)
|++|||++|+++||||+.+
T Consensus 251 P~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 251 PLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp GGGSCCHHHHHHCHHHHTT
T ss_pred hhHCcCHHHHHcCcccccC
Confidence 9999999999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-60 Score=440.56 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=213.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|+++++||+|+||+||+|+++.+|+.||||++... ......+.+|+.+++++ .|+||+++++++++++.+|
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-----KHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-----CCCCCCcEEEEEEECCEEE
Confidence 689999999999999999999999999999999743 33456778899999998 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||| ||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl--------------------- 158 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL--------------------- 158 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---------------------
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---------------------
Confidence 999999 9999999987665568999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.+||+|||+|+...... ...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+
T Consensus 159 ------~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~ 232 (350)
T 4b9d_A 159 ------TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232 (350)
T ss_dssp ------CTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ------CCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 566778889999887654332 23579999999999999999999999999999999999999999888777
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+...+. .+..+++++++||.+||+.|
T Consensus 233 ~~~~i~~~~~~~------------------------------------------------~~~~~s~~~~~li~~~L~~d 264 (350)
T 4b9d_A 233 LVLKIISGSFPP------------------------------------------------VSLHYSYDLRSLVSQLFKRN 264 (350)
T ss_dssp HHHHHHHTCCCC------------------------------------------------CCTTSCHHHHHHHHHHTCSS
T ss_pred HHHHHHcCCCCC------------------------------------------------CCccCCHHHHHHHHHHccCC
Confidence 666554432111 01246788999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~ 375 (379)
|++|||++|+|+||||++.
T Consensus 265 P~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 265 PRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp GGGSCCHHHHHTSHHHHTT
T ss_pred hhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=440.15 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=218.7
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
...|++.++||+|+||.||+|+++.+|+.||||++... ......+.+|+.++..+ .|+||+++++++.+++.+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-----~HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-----CCCCCCceEEEEEECCEEE
Confidence 35689999999999999999999999999999999743 33455678899999998 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
|||||| ||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 225 iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl--------------------- 280 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL--------------------- 280 (423)
T ss_dssp EEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---------------------
T ss_pred EEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---------------------
Confidence 999999 99999999765 49999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.+||+|||+|...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+
T Consensus 281 ------~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 354 (423)
T 4fie_A 281 ------THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 354 (423)
T ss_dssp ------CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ------cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 55667888888888754333 245689999999999999999999999999999999999999999888777
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.....+... .+...++++++||.+||+.|
T Consensus 355 ~~~~i~~~~~~~~~----------------------------------------------~~~~~s~~~~dli~~~L~~d 388 (423)
T 4fie_A 355 AMKMIRDNLPPRLK----------------------------------------------NLHKVSPSLKGFLDRLLVRD 388 (423)
T ss_dssp HHHHHHHSCCCCCS----------------------------------------------CTTSSCHHHHHHHHHHSCSS
T ss_pred HHHHHHcCCCCCCc----------------------------------------------ccccCCHHHHHHHHHHcCCC
Confidence 66655543221110 11246789999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~ 375 (379)
|++||||+|+|+||||++.
T Consensus 389 P~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 389 PAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp TTTSCCHHHHTTCGGGGGC
T ss_pred hhHCcCHHHHhcCHHhcCC
Confidence 9999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-58 Score=417.82 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=207.8
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
...+..|++.++||+|+||+||+|.++.+++.||+|++... ......+.+|+.++.++ .||||+++++++++
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~ 96 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWES 96 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEE
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEee
Confidence 33445568888999999999999999999999999999642 23345678899999988 78999999999875
Q ss_pred ----cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCcEEEecccccccCC
Q 017021 116 ----RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPD 188 (379)
Q Consensus 116 ----~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~~~~ 188 (379)
++.+|+||||| ||+|.+++.+.. .+++..+..++.||+.||+|||++| |+||||||+|||++
T Consensus 97 ~~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--------- 165 (290)
T 3fpq_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--------- 165 (290)
T ss_dssp EETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES---------
T ss_pred ccCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE---------
Confidence 45789999999 999999998765 6999999999999999999999998 99999999999993
Q ss_pred CccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCC
Q 017021 189 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
..++.+||+|||+|+...... ...+||+.|+|||++.+ .|+.++|||||||++|+|++|+.
T Consensus 166 -----------------~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~ 227 (290)
T 3fpq_A 166 -----------------GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp -----------------STTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -----------------CCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCC
Confidence 135678888888887543332 34689999999998865 69999999999999999999999
Q ss_pred CCCCCchHHHH-HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 268 LFQTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 268 pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
||...+..... ..+.. +..|. ..+...+++++
T Consensus 228 Pf~~~~~~~~~~~~i~~--~~~~~---------------------------------------------~~~~~~~~~~~ 260 (290)
T 3fpq_A 228 PYSECQNAAQIYRRVTS--GVKPA---------------------------------------------SFDKVAIPEVK 260 (290)
T ss_dssp TTTTCSSHHHHHHHHTT--TCCCG---------------------------------------------GGGGCCCHHHH
T ss_pred CCCCCCcHHHHHHHHHc--CCCCC---------------------------------------------CCCccCCHHHH
Confidence 99765443322 21111 11111 01224567899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+||.+||+.||++|||++|+|+||||++.
T Consensus 261 ~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=424.12 Aligned_cols=251 Identities=27% Similarity=0.440 Sum_probs=209.7
Q ss_pred hhhhhhhccccccceeEEEEEec---CCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 43 FADKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
..|++.+.||+|+||+||+|++. .+++.||+|+++.. ......+.+|+.++.++ +||||++++++++++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-----NHPFIVKLHYAFQTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-----CCTTEECEEEEEEET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-----CCCCCCeEEEEEEEC
Confidence 46999999999999999999874 56889999999742 22234566788877776 789999999999999
Q ss_pred ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 117 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
+.+|+||||| ||+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl----------------- 159 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL----------------- 159 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE-----------------
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE-----------------
Confidence 9999999999 999999998865 69999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.+||+|||+|+.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.
T Consensus 160 ----------~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 160 ----------DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp ----------CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 5667788899998865322 224568999999999999999999999999999999999999999988
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+.+...+.| ...++++++||.+|
T Consensus 230 ~~~~~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~~li~~~ 260 (304)
T 3ubd_A 230 DRKETMTMILKAKLGMP-------------------------------------------------QFLSPEAQSLLRML 260 (304)
T ss_dssp SHHHHHHHHHHCCCCCC-------------------------------------------------TTSCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCC-------------------------------------------------CcCCHHHHHHHHHH
Confidence 87777666654332222 13677899999999
Q ss_pred cccCCCCCcC-----HHHHhcCCCCCCCC
Q 017021 353 LRYDPTDRLT-----AREALRHPFFTRDH 376 (379)
Q Consensus 353 L~~dP~~Rpt-----a~e~l~hp~f~~~~ 376 (379)
|+.||++||| ++|+++||||++.+
T Consensus 261 L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 261 FKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp TCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred cccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 9999999998 47999999999754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-57 Score=427.82 Aligned_cols=279 Identities=27% Similarity=0.459 Sum_probs=223.6
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-----
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----- 115 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----- 115 (379)
.|+++++||+|+||+||+|+++.+|+.||||+++.. ......+.+|+.+++.+ .|+||+++++++..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-----KHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCSSCTT
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-----CCCCcceEeeeeecccccc
Confidence 589999999999999999999999999999999643 23345677899999998 78999999998753
Q ss_pred -cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 -RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 -~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+.+|+|||||+|+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 130 ~~~~~~ivmE~~~g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---------------- 191 (398)
T 4b99_A 130 EFKSVYVVLDLMESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---------------- 191 (398)
T ss_dssp TCCCEEEEEECCSEEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----------------
T ss_pred cCCEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc----------------
Confidence 46799999999888999997754 79999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCC-------CCCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERP-------DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~ 266 (379)
+.++.+||+|||+|+.... .....+||+.|+|||++.+. .++.++||||+||++|+|++|+
T Consensus 192 -----------~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~ 260 (398)
T 4b99_A 192 -----------NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260 (398)
T ss_dssp -----------CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTS
T ss_pred -----------CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCC
Confidence 4556677777777754322 12346899999999998875 4689999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhh-hhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
+||.+.+..+....+.+..+.++...+....... ..+... ...... ..........++++
T Consensus 261 ~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~------------------~~~~~~~~~~s~~~ 321 (398)
T 4b99_A 261 QLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQS-LPPRQP------------------VPWETVYPGADRQA 321 (398)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHS-SCCCCC------------------CCHHHHSTTCCHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhc-CCCcCC------------------CCHHHhCCCCCHHH
Confidence 9999999999999999999988876654432211 111111 000000 00112234567899
Q ss_pred HHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 346 THLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.|||.+||++||++||||+|+|+||||++-
T Consensus 322 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 322 LSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred HHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 999999999999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=420.59 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=207.4
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
..|++.++||+|+||.||+|+++.+|+.||||+++... ...+|+.+++.+ .||||+++++++++++.+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----~~~~E~~il~~l-----~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----FRVEELVACAGL-----SSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCTHHHHTTTTC-----CCTTBCCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH----hHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEE
Confidence 34778889999999999999999999999999997532 224588888777 789999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|||| ||+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 129 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---------------------- 184 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---------------------- 184 (336)
T ss_dssp ECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC----------------------
T ss_pred EeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe----------------------
Confidence 9999 999999998765 699999999999999999999999999999999999994
Q ss_pred cccCCCCC-CeEEeecCcccccCCCC--------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 202 FKRMPKSS-AIKVIDFGSTTYERPDQ--------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 202 ~~~~~~~~-~~~l~Dfg~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
.++ .+||+|||+|+...... ...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.
T Consensus 185 -----~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 259 (336)
T 4g3f_A 185 -----SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 259 (336)
T ss_dssp -----TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred -----CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 333 47888888886543321 2357999999999999999999999999999999999999999876
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+.....++ ...++.+++.+.+||.+|
T Consensus 260 ~~~~~~~~i~~~~~~~----------------------------------------------~~~~~~~s~~~~~li~~~ 293 (336)
T 4g3f_A 260 FRGPLCLKIASEPPPI----------------------------------------------REIPPSCAPLTAQAIQEG 293 (336)
T ss_dssp CCSCCHHHHHHSCCGG----------------------------------------------GGSCTTSCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCc----------------------------------------------hhcCccCCHHHHHHHHHH
Confidence 5544443333311100 012235778999999999
Q ss_pred cccCCCCCcCHHHH-------------hcCCCCCCCC
Q 017021 353 LRYDPTDRLTAREA-------------LRHPFFTRDH 376 (379)
Q Consensus 353 L~~dP~~Rpta~e~-------------l~hp~f~~~~ 376 (379)
|+.||++||||+|+ ++|||+.+-+
T Consensus 294 L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 294 LRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred ccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 99999999999997 6799998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=413.77 Aligned_cols=309 Identities=24% Similarity=0.354 Sum_probs=215.9
Q ss_pred hhhhhhhccccccceeEEEEEec---CCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
-.|++.++||+|+||+||+|+++ .+++.||+|++... .......+|++++..+ .+|+||+++++++++.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~----~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVA----GGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHT----CSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHh----cCCCCCceEEEEEEECCEE
Confidence 45899999999999999999875 46889999998743 3355677888888876 3578999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecc-cccccCCCccCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDYKSSLHTPK 197 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~-~~~~~~~~~~~~~~~~ 197 (379)
|+||||+ +++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|++|||++.....
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999 899999983 48999999999999999999999999999999999999765 6777777777654322
Q ss_pred CCcccccCCCCCCeEEeecCccc---------------ccCCCCCcccccCCccchhhhhCC-CCCCccchHhHHHHHHH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTT---------------YERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVE 261 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~---------------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~ 261 (379)
... .+.+|+.+. .........+||+.|+|||++.+. .|+.++||||+||++|+
T Consensus 171 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e 239 (361)
T 4f9c_A 171 TKI-----------ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239 (361)
T ss_dssp CSC-----------GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred ccc-----------cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence 111 001111000 001111335799999999999875 48899999999999999
Q ss_pred HHhCCCCCCC-CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhh----------ccchhh
Q 017021 262 LCTGEALFQT-HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV----------MKLPRL 330 (379)
Q Consensus 262 l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~ 330 (379)
|++|+.||.. .++.+....+.+..|..+...+... ......... ..+.. ..+...... ......
T Consensus 240 ll~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~--~~~~~~~~~--~~p~~-~~~~~~~~~~~~~~~~p~~~~~~~~ 314 (361)
T 4f9c_A 240 LLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKT--FGKSILCSK--EVPAQ-DLRKLCERLRGMDSSTPKLTSDIQG 314 (361)
T ss_dssp HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH--TTEEEEESS--CCCCC-CHHHHHHHHC---------------
T ss_pred HHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhh--ccccccccc--cCcch-hhhHHHHhhcccccccccccccccc
Confidence 9999999854 4567777888887775433222111 000000000 01100 000000000 000001
Q ss_pred HHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 331 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 331 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
.......+...++++.|||++||++||++||||+|+|+||||++.++
T Consensus 315 ~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~l 361 (361)
T 4f9c_A 315 HATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMSL 361 (361)
T ss_dssp -------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC--
T ss_pred ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 11122335567889999999999999999999999999999998654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=396.47 Aligned_cols=265 Identities=24% Similarity=0.287 Sum_probs=189.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc----
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---- 117 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~---- 117 (379)
.|++++.||+|+||.||+|+++.+|+.||+|+++.. ......+.+|+.+++++ .||||+++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-----EHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEEC----
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEecCcccc
Confidence 488999999999999999999999999999999643 23345677899998887 7899999999987543
Q ss_pred --------eEEEEEeCC-CCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccC
Q 017021 118 --------HICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 118 --------~~~lv~e~~-~~sL~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~ 187 (379)
++|+||||| +++|.+++..... ...+...++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEc
Confidence 479999999 9999999987541 124566788999999999999999999999999999999555544444
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCC
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
|||++.....+..... ... ...........+||+.|+|||++.+..|+.++|||||||++|+|++
T Consensus 161 DFGla~~~~~~~~~~~--------~~~----~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~--- 225 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQT--------VLT----PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--- 225 (299)
T ss_dssp CCCCC--------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---
T ss_pred cCccceecCCCccccc--------ccc----ccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---
Confidence 4444433221110000 000 0000001123479999999999999999999999999999999995
Q ss_pred CCCCCchHHHHHHHHHHc-CCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 268 LFQTHENLEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
||.+.. +....+.... ...|+. ....++.+.
T Consensus 226 Pf~~~~--~~~~~~~~~~~~~~p~~----------------------------------------------~~~~~~~~~ 257 (299)
T 4g31_A 226 PFSTQM--ERVRTLTDVRNLKFPPL----------------------------------------------FTQKYPCEY 257 (299)
T ss_dssp CCSSHH--HHHHHHHHHHTTCCCHH----------------------------------------------HHHHCHHHH
T ss_pred CCCCcc--HHHHHHHHHhcCCCCCC----------------------------------------------CcccCHHHH
Confidence 775422 2222222221 222211 112345678
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+||.+||+.||++|||+.|+++||||++-+
T Consensus 258 ~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 258 VMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=423.38 Aligned_cols=258 Identities=28% Similarity=0.434 Sum_probs=222.5
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
..|+|.+.||+|+||.||+|+++.+|+.||+|++... ......+.+|+.++..+ .|+||+++++++++++.+|+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-----RHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-----CCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECCEEEE
Confidence 3689999999999999999999999999999998743 33456677899999998 78999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
||||| ||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+..
T Consensus 232 v~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-------------------- 290 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-------------------- 290 (573)
T ss_dssp EEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS--------------------
T ss_pred EEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC--------------------
Confidence 99999 999999986543 26999999999999999999999999999999999999943
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
+..+.+||+|||+|....... ...+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+..
T Consensus 291 -----~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~ 365 (573)
T 3uto_A 291 -----KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 365 (573)
T ss_dssp -----SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred -----CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 234679999999998765544 3457999999999999999999999999999999999999999998887777
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+.+....++.. .+...+.++++||.+||+.||.
T Consensus 366 ~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~dli~~~L~~dp~ 400 (573)
T 3uto_A 366 RNVKSCDWNMDDS---------------------------------------------AFSGISEDGKDFIRKLLLADPN 400 (573)
T ss_dssp HHHHTTCCCCCSG---------------------------------------------GGTTSCHHHHHHHHTTSCSSGG
T ss_pred HHHHhCCCCCCcc---------------------------------------------cccCCCHHHHHHHHHHccCChh
Confidence 6665544333322 1234678899999999999999
Q ss_pred CCcCHHHHhcCCCCCCCC
Q 017021 359 DRLTAREALRHPFFTRDH 376 (379)
Q Consensus 359 ~Rpta~e~l~hp~f~~~~ 376 (379)
+|||++|+|+||||+..+
T Consensus 401 ~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 401 TRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp GSCCHHHHHHSTTTSCCC
T ss_pred HCcCHHHHhcCcCcCCCC
Confidence 999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=388.77 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=203.3
Q ss_pred echhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
+....|.+.++||+|+||+||+|++. .++..||||+++.. ......+.+|+.++.++ .||||+++++++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-----~HpnIV~l~g~~ 84 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-----QHEHIVKFYGVC 84 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEE
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-----CCCCCccEEEEE
Confidence 45567888999999999999999865 45789999999743 33456788899999888 789999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecc
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNN-----------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS 181 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~ 181 (379)
.+++..|+||||| +|+|.+++...+ ...+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl--- 161 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV--- 161 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---
Confidence 9999999999999 999999997642 2368999999999999999999999999999999999999
Q ss_pred cccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHH
Q 017021 182 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVG 256 (379)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 256 (379)
+.+..+||+|||+|+...... ....||+.|+|||++.+..|+.++||||||
T Consensus 162 ------------------------~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~G 217 (299)
T 4asz_A 162 ------------------------GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 217 (299)
T ss_dssp ------------------------CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred ------------------------CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHH
Confidence 455667788888776433221 234689999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHH
Q 017021 257 CILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335 (379)
Q Consensus 257 ~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (379)
|++|||+| |+.||.+.+..+....+.+...+ ..
T Consensus 218 vvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~----------------------~~------------------------ 251 (299)
T 4asz_A 218 VVLWEIFTYGKQPWYQLSNNEVIECITQGRVL----------------------QR------------------------ 251 (299)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC----------------------CC------------------------
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC----------------------CC------------------------
Confidence 99999998 89999987776666555442211 11
Q ss_pred HhhccchhHHHHHHhhccccCCCCCcCHHHHh
Q 017021 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 367 (379)
Q Consensus 336 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l 367 (379)
+..+++++.+||.+||+.||++|||++|++
T Consensus 252 --p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 252 --PRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred --CccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 123667899999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-53 Score=419.87 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=209.2
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
....-.|++.+.||+|+||.||+|+++.+|+.||+|++++.. ........|..++..+.. .+||||++++++|+
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~--~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFH 262 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSS--SCCTTBCCEEEEEE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhh--CCCCCEeEEEEEEE
Confidence 344456899999999999999999999999999999997421 223334445444444322 37899999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
+.+.+|+||||| ||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl--------------- 325 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--------------- 325 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---------------
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---------------
Confidence 999999999999 999999998865 69999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCC-CCcccccCCccchhhhh-CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.+||+|||+|...... ..+.+||+.|+|||++. +..|+.++|+|||||++|+|++|.+||.+
T Consensus 326 ------------d~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 326 ------------DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp ------------CTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred ------------eCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 56677888888888754433 34568999999999996 46799999999999999999999999976
Q ss_pred CchHH---HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 272 HENLE---HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 272 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
.+..+ ....+....... ++..++++++|
T Consensus 394 ~~~~~~~~i~~~i~~~~~~~-------------------------------------------------p~~~S~~a~dL 424 (689)
T 3v5w_A 394 HKTKDKHEIDRMTLTMAVEL-------------------------------------------------PDSFSPELRSL 424 (689)
T ss_dssp GGCCCHHHHHHHHHHCCCCC-------------------------------------------------CTTSCHHHHHH
T ss_pred CChHHHHHHHHhhcCCCCCC-------------------------------------------------CccCCHHHHHH
Confidence 43222 111111111111 12467899999
Q ss_pred HhhccccCCCCCcC-----HHHHhcCCCCCCCC
Q 017021 349 LQGLLRYDPTDRLT-----AREALRHPFFTRDH 376 (379)
Q Consensus 349 i~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~ 376 (379)
|.+||+.||.+|++ |+|+++||||++.+
T Consensus 425 I~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp HHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred HHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 99999999999998 89999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=389.78 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=201.2
Q ss_pred eechhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
.+....+.+.++||+|+||.||+|+++ .+++.||||+++.. ......+.+|+.++.++ .|+||++++++
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-----~HpnIV~l~g~ 111 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-----QHQHIVRFFGV 111 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEE
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEE
Confidence 345567788899999999999999865 46889999999743 33456788899999888 78999999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEE
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNN-------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLL 178 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~-------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili 178 (379)
+.+++.+|+||||| +|+|.+++.... ...+++.++..++.||+.||.|||+.+|+||||||+|||+
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 99999999999999 999999997642 1258999999999999999999999999999999999999
Q ss_pred ecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchH
Q 017021 179 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIW 253 (379)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvw 253 (379)
+ .+..+||+|||+|+...... ....||+.|+|||++.+..++.++|||
T Consensus 192 ~---------------------------~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvw 244 (329)
T 4aoj_A 192 G---------------------------QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVW 244 (329)
T ss_dssp E---------------------------TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHH
T ss_pred C---------------------------CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcccccc
Confidence 4 45566777777765432221 235689999999999999999999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHH
Q 017021 254 SVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 332 (379)
Q Consensus 254 SlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (379)
||||++|||+| |+.||...+..+....+.+...+ ..|
T Consensus 245 S~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~----------------------~~p-------------------- 282 (329)
T 4aoj_A 245 SFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL----------------------ERP-------------------- 282 (329)
T ss_dssp HHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCC----------------------CCC--------------------
T ss_pred chHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC----------------------CCc--------------------
Confidence 99999999999 89999987776665554432111 111
Q ss_pred HHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 333 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 333 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
..+++++.+||.+||+.||++|||++|++++
T Consensus 283 ------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 283 ------RACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp ------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred ------ccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 2366789999999999999999999999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=382.31 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=196.9
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.+....+++.++||+|+||+||+|+++. .||||+++.. ......+.+|+.++.++ .|+||+++++++..
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-----~HpNIV~l~g~~~~ 103 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-----RHVNILLFMGYMTK 103 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECS
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEC
Confidence 4555677889999999999999998643 4999998632 33446678899999888 78999999998764
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
+.+|+||||| +|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 104 -~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~-------------- 167 (307)
T 3omv_A 104 -DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHE-------------- 167 (307)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEET--------------
T ss_pred -CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECC--------------
Confidence 5689999999 999999997654 36999999999999999999999999999999999999954
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhC---CCCCCccchHhHHHHHHHHHhCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
++.+||+|||+|+..... ....+||+.|+|||++.+ .+|+.++|||||||++|||+||+
T Consensus 168 -------------~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~ 234 (307)
T 3omv_A 168 -------------GLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234 (307)
T ss_dssp -------------TEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred -------------CCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCC
Confidence 455666777766543221 133579999999999964 35899999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||...+..+....+.......|. . ...+..+++++.
T Consensus 235 ~Pf~~~~~~~~~~~~~~~~~~~p~--------------------~-----------------------~~~~~~~~~~l~ 271 (307)
T 3omv_A 235 LPYSHINNRDQIIFMVGRGYASPD--------------------L-----------------------SKLYKNCPKAMK 271 (307)
T ss_dssp CTTTTCCCHHHHHHHHHTTCCCCC--------------------S-----------------------TTSCTTSCHHHH
T ss_pred CCCCCCChHHHHHHHHhcCCCCCC--------------------c-----------------------ccccccchHHHH
Confidence 999876654433322221111110 0 011234678899
Q ss_pred HHHhhccccCCCCCcCHHHH------hcCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREA------LRHPFFT 373 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~------l~hp~f~ 373 (379)
+||.+||+.||++|||++|+ |+|++.+
T Consensus 272 ~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 272 RLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp HHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 99999999999999999976 5777754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=386.03 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=203.6
Q ss_pred eechhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.+....+++.++||+|+||+||+|+.. .+++.||||+++.. ......+.+|+.++.++ .||||+++++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-----~HpNIV~l~g 96 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-----QHPNVVCLLG 96 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-----CCCCCCCcce
Confidence 345566788899999999999999853 46789999999643 33456788999999998 8899999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcE
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV 176 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Ni 176 (379)
++.+++.+++||||| +|+|.+++.... ...+++..+..++.||+.||+|||+++|+||||||+||
T Consensus 97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NI 176 (308)
T 4gt4_A 97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 176 (308)
T ss_dssp EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccce
Confidence 999999999999999 999999996532 12589999999999999999999999999999999999
Q ss_pred EEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCCCCccc
Q 017021 177 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCD 251 (379)
Q Consensus 177 li~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sD 251 (379)
|++ .+..+||+|||+|+..... .....||+.|+|||++.+..|+.++|
T Consensus 177 Ll~---------------------------~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksD 229 (308)
T 4gt4_A 177 LVY---------------------------DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSD 229 (308)
T ss_dssp EEC---------------------------GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHH
T ss_pred EEC---------------------------CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccch
Confidence 994 4455677777776532221 13357899999999999999999999
Q ss_pred hHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhh
Q 017021 252 IWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 330 (379)
Q Consensus 252 vwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (379)
||||||++|||+| |..||.+.+..+....+.+... ++.
T Consensus 230 VwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~----------------------~~~------------------- 268 (308)
T 4gt4_A 230 IWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV----------------------LPC------------------- 268 (308)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCC----------------------CCC-------------------
T ss_pred hhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------CCC-------------------
Confidence 9999999999998 8999998777665554433211 111
Q ss_pred HHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 331 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 331 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
++.++..+.+|+.+||+.||++|||++||+++
T Consensus 269 -------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 269 -------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 12366789999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=389.46 Aligned_cols=310 Identities=35% Similarity=0.611 Sum_probs=248.2
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcC-CCCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~~i~~~~~~~~~~~~~~ 120 (379)
...|++.++||+|+||.||+|.+..+++.||+|+++........+..|+.++..+.+.. ..|+|++.+++.+...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 45699999999999999999999999999999999876666677788999999987654 35789999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||||++++|.+++.......+++..+..++.||+.||+|||+.||+||||||+||+++.++
T Consensus 176 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~------------------ 237 (429)
T 3kvw_A 176 MTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG------------------ 237 (429)
T ss_dssp EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT------------------
T ss_pred EEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC------------------
Confidence 99999988999999887655699999999999999999999999999999999999994321
Q ss_pred ccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
...++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 238 -------~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~ 310 (429)
T 3kvw_A 238 -------RSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310 (429)
T ss_dssp -------SCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred -------CcceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 2238999999997766666667899999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchh----------hhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE----------SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
+.+..+.++..++.............+...+.......+ ........+.............++.+.+||+
T Consensus 311 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~ 390 (429)
T 3kvw_A 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK 390 (429)
T ss_dssp HHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHH
T ss_pred HHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHH
Confidence 999999999988876655443333332222111000000 0000111122222333344456788999999
Q ss_pred hccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 351 GLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+||++||++||||+|+|+||||++..
T Consensus 391 ~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 391 QCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp HHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred HHCCCChhhCCCHHHHhCChhhccCC
Confidence 99999999999999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=380.46 Aligned_cols=324 Identities=40% Similarity=0.687 Sum_probs=250.0
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.-.|++.++||+|+||.||+|++..+++.||+|+++...........|..++..+......|+||+++++++...+..|+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 34789999999999999999999999999999999866666677778999999987655568999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
||||++++|.+++.......+++..+..++.||+.||.|||+.||+||||||+||+++.....+-. .... ........
T Consensus 114 v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~-~~~~-~~~~~~~~ 191 (360)
T 3llt_A 114 IFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL-ITVR-RVTDGKKI 191 (360)
T ss_dssp EECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE-EEEE-CTTTCCEE
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc-cchh-cccccccc
Confidence 999999999999988765569999999999999999999999999999999999999642210000 0000 00000000
Q ss_pred cccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~ 281 (379)
.........++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 271 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 00012367899999999987666666778999999999999999999999999999999999999999999988999999
Q ss_pred HHHcCCCChhHHHhhhhhhh-hhhcc--CCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 282 ERVLGPLPQHMLKRVDRHAE-KYVRR--GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
....++.|..++........ .+... ....|++............. .........++.+.+||.+||+.||+
T Consensus 272 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~L~~dP~ 345 (360)
T 3llt_A 272 ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK------CLPLYKIIKHELFCDFLYSILQIDPT 345 (360)
T ss_dssp HHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHT------CCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred HHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhh------cccccccchHHHHHHHHHHHhcCChh
Confidence 99999999887766443222 12111 12334443333322221111 01112233457899999999999999
Q ss_pred CCcCHHHHhcCCCCC
Q 017021 359 DRLTAREALRHPFFT 373 (379)
Q Consensus 359 ~Rpta~e~l~hp~f~ 373 (379)
+||||+|+|+||||+
T Consensus 346 ~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 346 LRPSPAELLKHKFLE 360 (360)
T ss_dssp GSCCHHHHTTSGGGC
T ss_pred hCCCHHHHhcCcccC
Confidence 999999999999996
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=382.55 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=201.0
Q ss_pred eechhhhhhhhccccccceeEEEEEecCC-----CceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.++...|++.++||+|+||.||+|.+..+ ++.||+|.++.. ......+.+|+.++.++ .+||||+++++
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l----~hhpnIV~l~g 135 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI----GHHLNVVNLLG 135 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEEE
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHc----CCCCcEEEEEE
Confidence 35567899999999999999999987654 468999999743 23345678899999998 34589999999
Q ss_pred eeee-cceEEEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCc
Q 017021 112 WFDY-RNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPEN 175 (379)
Q Consensus 112 ~~~~-~~~~~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~N 175 (379)
++.. ++.+|+||||| +|+|.+++.... ...+++..+..++.||+.||+|||+++|+||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 8865 46799999999 999999997632 2348899999999999999999999999999999999
Q ss_pred EEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCcc
Q 017021 176 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPC 250 (379)
Q Consensus 176 ili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~s 250 (379)
||++ .++.+||+|||+|+...... ....||+.|+|||++.+..|+.++
T Consensus 216 ILl~---------------------------~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ks 268 (353)
T 4ase_A 216 ILLS---------------------------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 268 (353)
T ss_dssp EEEC---------------------------GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred eeeC---------------------------CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcc
Confidence 9994 44566777777776433322 234689999999999999999999
Q ss_pred chHhHHHHHHHHHh-CCCCCCCCchHHH-HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccch
Q 017021 251 DIWSVGCILVELCT-GEALFQTHENLEH-LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328 (379)
Q Consensus 251 DvwSlG~il~~l~~-g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (379)
|||||||++|||+| |..||.+.+..+. ...+.+... +..|
T Consensus 269 DVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~----------------------~~~p---------------- 310 (353)
T 4ase_A 269 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR----------------------MRAP---------------- 310 (353)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC----------------------CCCC----------------
T ss_pred cEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC----------------------CCCC----------------
Confidence 99999999999998 9999987654332 222222111 1111
Q ss_pred hhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 329 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+.+++++.++|.+||+.||++|||++|+++|
T Consensus 311 ----------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 311 ----------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp ----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 2356789999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=369.03 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=213.5
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.-.|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.++..+ .|+||+++++++...+.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-----NHPNIVKLFEVIETEKT 88 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEECCE
Confidence 346899999999999999999999999999999997432 2345567899988888 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+||||+ +++|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll------------------- 147 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL------------------- 147 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-------------------
T ss_pred EEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE-------------------
Confidence 99999999 899999997765 69999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCC-CccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
+.++.++|+|||.+....... ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.
T Consensus 148 --------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 219 (328)
T 3fe3_A 148 --------DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219 (328)
T ss_dssp --------CTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --------cCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 566678888888886544332 345799999999999988775 789999999999999999999998776
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+.......| ...++++.+||++||+
T Consensus 220 ~~~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~~li~~~L~ 250 (328)
T 3fe3_A 220 KELRERVLRGKYRIP-------------------------------------------------FYMSTDCENLLKRFLV 250 (328)
T ss_dssp HHHHHHHHHCCCCCC-------------------------------------------------TTSCHHHHHHHHHHCC
T ss_pred HHHHHHHHhCCCCCC-------------------------------------------------CCCCHHHHHHHHHHCC
Confidence 665554444222222 1256789999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.||.+|||++|+++||||+..
T Consensus 251 ~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 251 LNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp SSTTTSCCHHHHTTCTTTTTT
T ss_pred CChhHCcCHHHHhcCHhhcCC
Confidence 999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=365.52 Aligned_cols=284 Identities=27% Similarity=0.490 Sum_probs=224.4
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
...|++.++||+|+||+||+|+++.+++.||+|++.... .......+|+.++..+... .|+|++++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~h~niv~~~~~~~~ 85 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF--EHPNVVRLMDVCAT 85 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHH--CCTTBCCEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhc--CCCCeEEeeeeeec
Confidence 346899999999999999999999999999999987322 1234566788888777432 47999999999876
Q ss_pred cc-----eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 116 RN-----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 116 ~~-----~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
.. ..++|||+++++|.+++.......+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~------------ 153 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV------------ 153 (308)
T ss_dssp CCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE------------
T ss_pred cCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE------------
Confidence 54 6899999998899999988765569999999999999999999999999999999999999
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCC
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 154 ---------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p 218 (308)
T 3g33_A 154 ---------------TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 218 (308)
T ss_dssp ---------------CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCS
T ss_pred ---------------cCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCC
Confidence 555678888888886544332 345789999999999998999999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|.+.+..+....+.+..+.++...|+......... ++ +.............+..+.+|
T Consensus 219 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~---------------~~~~~~~~~~~~~~~~~~~~l 276 (308)
T 3g33_A 219 FCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA-------FP---------------PRGPRPVQSVVPEMEESGAQL 276 (308)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGG-------SC---------------CCCCCCHHHHSCSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhccchhhccccc-------cC---------------CCCCCcHHHhCccccHHHHHH
Confidence 99988888888888888777665433211111000 00 000011123345678899999
Q ss_pred HhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
|.+||+.||++|||++|+|+||||++++
T Consensus 277 i~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 277 LLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp HHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred HHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 9999999999999999999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=373.52 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=218.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-------hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
-.|++.+.||+|+||.||+|.++.+|+.||+|+++.... ....+.+|+.++..+ .|+||+++++++.+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-----LHPNIITLHDVYEN 86 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-----CCTTBCCEEEEEEC
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-----CCcCCCcEEEEEEe
Confidence 358899999999999999999999999999999974322 235667888888877 68999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++...+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~------------ 152 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN------------ 152 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT------------
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCC------------
Confidence 99999999999 999999997654 699999999999999999999999999999999999995332
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
.....++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 153 -----------~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 153 -----------IPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp -----------SSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred -----------CCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 122368999999987544432 3457999999999999989999999999999999999999999988
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+.......+... +...+..+++||.+|
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~---------------------------------------------~~~~s~~~~~li~~~ 256 (361)
T 2yab_A 222 TKQETLANITAVSYDFDEEF---------------------------------------------FSQTSELAKDFIRKL 256 (361)
T ss_dssp SHHHHHHHHHTTCCCCCHHH---------------------------------------------HTTSCHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCchh---------------------------------------------ccCCCHHHHHHHHHH
Confidence 77766665554433333322 234678899999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
|+.||.+|||++|+++||||+..
T Consensus 257 L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 257 LVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp SCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCCChhHCcCHHHHhcCcCcCCC
Confidence 99999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=359.40 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=213.4
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
....|++.++||+|+||+||+|.+..+++.||+|++... ......+.+|+.++..+ .|+||+++++++..++..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-----CCCCCCeEeEEEEECCEE
Confidence 456799999999999999999999999999999998643 23345567788888887 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++... .+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~-------------------- 149 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL-------------------- 149 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--------------------
T ss_pred EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE--------------------
Confidence 9999999 99999999875 48999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 150 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 222 (297)
T 3fxz_A 150 -------GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (297)
T ss_dssp -------CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred -------CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 555678888888776544332 3457999999999999999999999999999999999999999887665
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
.....+.....+... .....+..+.+||.+||+.
T Consensus 223 ~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~li~~~l~~ 256 (297)
T 3fxz_A 223 RALYLIATNGTPELQ----------------------------------------------NPEKLSAIFRDFLNRCLEM 256 (297)
T ss_dssp HHHHHHHHHCSCCCS----------------------------------------------CGGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHhCCCCCCC----------------------------------------------CccccCHHHHHHHHHHccC
Confidence 544433332211100 0123567899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~ 375 (379)
||++|||++|+++||||+..
T Consensus 257 dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 257 DVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp STTTSCCHHHHTTCGGGGGC
T ss_pred ChhHCcCHHHHhhChhhccc
Confidence 99999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=363.14 Aligned_cols=281 Identities=28% Similarity=0.423 Sum_probs=222.9
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
..|++.++||+|+||+||+|++. +++.||+|++.... .....+.+|+.++..+ .|+||+++++++.+++..
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-----HHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-----CCTTBCCEEEEECCSSCE
T ss_pred hhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-----CCCCEeeeeeEEccCCEE
Confidence 46889999999999999999985 48999999997432 2335677899999888 789999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 120 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 120 ~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
++||||+.++|.+.+.... ..+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 95 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~--------------------- 152 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI--------------------- 152 (311)
T ss_dssp EEEEECCSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---------------------
T ss_pred EEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---------------------
Confidence 9999999779999887754 358999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....
T Consensus 153 ------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 153 ------NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp ------CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred ------CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence 555678888888886544322 33468999999999876 56899999999999999999999999988888
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+....+.++...|+.+.......... ....+. .......+..+.++.+||.+||+.
T Consensus 227 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-----------------~~~~~~~~~~~~~~~~li~~~L~~ 287 (311)
T 3niz_A 227 DQLPKIFSILGTPNPREWPQVQELPLWKQRT--FQVFEK-----------------KPWSSIIPGFCQEGIDLLSNMLCF 287 (311)
T ss_dssp THHHHHHHHHCCCCTTTSGGGTTSHHHHSCC--CCCCCC-----------------CCHHHHSTTCCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHHCCCChHHhhhhhccchhhhcc--cccccC-----------------CcHHHhCcccCHHHHHHHHHHcCC
Confidence 8888888877776655544433222111100 000000 001122345678899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~~ 376 (379)
||++|||++|+++||||++.+
T Consensus 288 dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 288 DPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CTTTSCCHHHHHTSGGGTTSC
T ss_pred ChhHCCCHHHHhcCcccccCC
Confidence 999999999999999999754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=382.83 Aligned_cols=290 Identities=25% Similarity=0.410 Sum_probs=227.7
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec--
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-- 116 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~-- 116 (379)
...|++.++||+|+||.||+|.+..+++.||+|++... ......+.+|+.++..+ .|+||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIISLLNVFTPQKT 135 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEccCCc
Confidence 35689999999999999999999999999999999742 33455667888888887 789999999998654
Q ss_pred ----ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 117 ----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 117 ----~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..+|+||||+.++|.+.+.. .+++..+..++.||+.||+|||+.||+||||||+||++
T Consensus 136 ~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll-------------- 197 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-------------- 197 (464)
T ss_dssp TTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--------------
T ss_pred cccCCeEEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE--------------
Confidence 46799999997778887753 48999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 198 -------------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 198 -------------KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp -------------CTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred -------------eCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 556678888888887554432 34579999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
+.+..+....+.+..|.++.+.++.+......+..+.. .+... ............ .........++++.+||.
T Consensus 265 g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~-----~~~~~~~~~s~~~~dLl~ 337 (464)
T 3ttj_A 265 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP-KYAGL-TFPKLFPDSLFP-----ADSEHNKLKASQARDLLS 337 (464)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSC-CCCCC-CHHHHSCGGGSC-----CSSHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhccc-ccCCC-ChHHhCcccccc-----cccccccccCHHHHHHHH
Confidence 99999999999999999999988888777766655421 11110 000000000000 000111223678999999
Q ss_pred hccccCCCCCcCHHHHhcCCCCCC
Q 017021 351 GLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
+||+.||++|||++|+|+||||+.
T Consensus 338 ~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 338 KMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHcCCChhhCCCHHHHhcChhhhh
Confidence 999999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=367.81 Aligned_cols=257 Identities=22% Similarity=0.379 Sum_probs=220.6
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
..|++.+.||+|+||.||+|.++.+++.||+|++.........+.+|+.++..+ .|+|++++++++.+.+..++|
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-----RHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-----CCTTBCCEEEEEEETTEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-----CCCCCCeEeEEEecCCEEEEE
Confidence 368899999999999999999999999999999986655566777899999887 789999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus 80 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~--------------------- 137 (321)
T 1tki_A 80 FEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT--------------------- 137 (321)
T ss_dssp ECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS---------------------
T ss_pred EEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc---------------------
Confidence 9999 889999997643 35899999999999999999999999999999999999943
Q ss_pred cccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
..++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus 138 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 213 (321)
T 1tki_A 138 ----RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE 213 (321)
T ss_dssp ----SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred ----CCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHH
Confidence 125678999999887654433 33578999999999998888999999999999999999999999887776666
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.+.+....++... +...+.++.+||.+||+.||.+
T Consensus 214 ~i~~~~~~~~~~~---------------------------------------------~~~~s~~~~~li~~~L~~dp~~ 248 (321)
T 1tki_A 214 NIMNAEYTFDEEA---------------------------------------------FKEISIEAMDFVDRLLVKERKS 248 (321)
T ss_dssp HHHHTCCCCCHHH---------------------------------------------HTTSCHHHHHHHHTTSCSSGGG
T ss_pred HHHcCCCCCChhh---------------------------------------------hccCCHHHHHHHHHHcCCChhH
Confidence 6555444433322 2346788999999999999999
Q ss_pred CcCHHHHhcCCCCCCC
Q 017021 360 RLTAREALRHPFFTRD 375 (379)
Q Consensus 360 Rpta~e~l~hp~f~~~ 375 (379)
|||+.|+|+||||++.
T Consensus 249 Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 249 RMTASEALQHPWLKQK 264 (321)
T ss_dssp SCCHHHHHHSHHHHSC
T ss_pred CcCHHHHhcChhhccC
Confidence 9999999999999765
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=365.57 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=212.1
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
...|++.+.||+|+||.||+|+++.+|+.||+|+++.. .........|..++..+ .|++++++++++.+.+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~l~~~~~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-----CCCcCcceEEEEEeCC
Confidence 34688999999999999999999999999999999743 22345566788877766 7899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll------------------ 138 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML------------------ 138 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE------------------
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE------------------
Confidence 999999999 899999998754 68999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||++...... ....+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+
T Consensus 139 ---------~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 139 ---------DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp ---------CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ---------CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 55567888888877643222 234679999999999999899999999999999999999999998876
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.......| ...++++.+||.+||
T Consensus 210 ~~~~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~~li~~lL 240 (337)
T 1o6l_A 210 HERLFELILMEEIRFP-------------------------------------------------RTLSPEAKSLLAGLL 240 (337)
T ss_dssp HHHHHHHHHHCCCCCC-------------------------------------------------TTSCHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCCCCC-------------------------------------------------CCCCHHHHHHHHHHh
Confidence 6555544433211111 135678999999999
Q ss_pred ccCCCCCc-----CHHHHhcCCCCCCCC
Q 017021 354 RYDPTDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 354 ~~dP~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
+.||.+|| +++|+++||||+..+
T Consensus 241 ~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 241 KKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred hcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 99999999 999999999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=363.55 Aligned_cols=322 Identities=46% Similarity=0.836 Sum_probs=247.6
Q ss_pred hhhhhhhhccccccceeEEEEEe-cCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcC-CCCCeeEEecceeeecceE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~-~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~~i~~~~~~~~~~~~~ 119 (379)
...|++.+.||+|+||.||+|.+ +.+++.||+|+++...........|+.++..+.+.. ..+++++.+++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 34789999999999999999998 568899999999866666677888999999987653 3456799999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 120 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 120 ~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
++||||++++|.+++.......+++..+..++.||+.||.|||+.||+||||||+||++...+.....+.+..
T Consensus 93 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~------- 165 (339)
T 1z57_A 93 CIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK------- 165 (339)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-----------
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc-------
Confidence 9999999999999998876556899999999999999999999999999999999999965332111100000
Q ss_pred cccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
.......+..++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus 166 -~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 166 -RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred -cccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 0000012567999999999876666666789999999999999899999999999999999999999999988888888
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.+.+..+++|..++...... .+......+|............... +. .......+..+.++.+||.+||+.||.+
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKR--KYFHHDRLDWDEHSSAGRYVSRACK-PL--KEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCG--GGEETTEECCCTTSHHHHHHHHHCC-CG--GGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhCCCCHHHHhhccch--hHHhhccccccccccccchhhhcCc-ch--hhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 89999999998887765432 2222233344432211111111100 00 0000112234678999999999999999
Q ss_pred CcCHHHHhcCCCCCCCC
Q 017021 360 RLTAREALRHPFFTRDH 376 (379)
Q Consensus 360 Rpta~e~l~hp~f~~~~ 376 (379)
|||++|+++||||++..
T Consensus 320 Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 320 RITLREALKHPFFDLLK 336 (339)
T ss_dssp SCCHHHHTTSGGGGGGG
T ss_pred ccCHHHHhcCHHHHHHh
Confidence 99999999999998643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=370.56 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=210.7
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
+....|++.+.||+|+||.||+|+++.+++.||+|+++.. .........|..++..+ ..|++|+++++++.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~----~~hp~Iv~l~~~~~~ 95 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA----RNHPFLTQLFCCFQT 95 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHT----TTCTTBCCEEEEEEC
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhc----cCCCceeeEEEEEEe
Confidence 3345688999999999999999999999999999999743 22334455677777665 267999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---------------- 157 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---------------- 157 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----------------
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE----------------
Confidence 99999999999 899999998764 69999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 158 -----------~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 226 (353)
T 3txo_A 158 -----------DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226 (353)
T ss_dssp -----------CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -----------CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence 55667888888887643222 2345799999999999988899999999999999999999999998
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+..+....+.......| ...+..+.+||++
T Consensus 227 ~~~~~~~~~i~~~~~~~p-------------------------------------------------~~~~~~~~~li~~ 257 (353)
T 3txo_A 227 ENEDDLFEAILNDEVVYP-------------------------------------------------TWLHEDATGILKS 257 (353)
T ss_dssp SSHHHHHHHHHHCCCCCC-------------------------------------------------TTSCHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCC-------------------------------------------------CCCCHHHHHHHHH
Confidence 887776665554332222 1256789999999
Q ss_pred ccccCCCCCcCH------HHHhcCCCCCCCC
Q 017021 352 LLRYDPTDRLTA------REALRHPFFTRDH 376 (379)
Q Consensus 352 ~L~~dP~~Rpta------~e~l~hp~f~~~~ 376 (379)
||+.||.+||++ +|+++||||++.+
T Consensus 258 lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 258 FMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp HTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred HhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 999999999998 9999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=363.15 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=215.9
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
....|++.+.||+|+||.||+|+++.+|+.||+|+++... ........|..++..+ .|++|+++++++.+.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-----THPFIIRMWGTFQDA 78 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CBTTBCCEEEEEECS
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-----CCCCCceEeEEEEeC
Confidence 3456889999999999999999999999999999997432 2334556677777766 789999999999999
Q ss_pred ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 117 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
...|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----------------- 139 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL----------------- 139 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE-----------------
T ss_pred CEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE-----------------
Confidence 9999999999 899999998765 68999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+.++.++|+|||.+...........||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..
T Consensus 140 ----------~~~g~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 209 (318)
T 1fot_A 140 ----------DKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 209 (318)
T ss_dssp ----------CTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ----------cCCCCEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 5566788888888876655555678999999999999999999999999999999999999999887766
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.+.....| ...+.++.++|.+||+.
T Consensus 210 ~~~~~i~~~~~~~p-------------------------------------------------~~~~~~~~~li~~lL~~ 240 (318)
T 1fot_A 210 KTYEKILNAELRFP-------------------------------------------------PFFNEDVKDLLSRLITR 240 (318)
T ss_dssp HHHHHHHHCCCCCC-------------------------------------------------TTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHhCCCCCC-------------------------------------------------CCCCHHHHHHHHHHhcc
Confidence 65554443222211 13567899999999999
Q ss_pred CCCCCc-----CHHHHhcCCCCCCCC
Q 017021 356 DPTDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
||++|| +++|+++||||++..
T Consensus 241 dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 241 DLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred CHHHcCCCcCCCHHHHhcCccccCCC
Confidence 999999 999999999998753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=372.76 Aligned_cols=326 Identities=30% Similarity=0.525 Sum_probs=238.9
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCC---CCCeeEEecceee----
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK---GGNRCVQIRNWFD---- 114 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~---~~~~i~~~~~~~~---- 114 (379)
...|++.++||+|+||.||+|++..+++.||+|+++........+.+|+.++..+.+... +|++++++++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 356899999999999999999999999999999998766667788899999999976442 3677999999887
Q ss_pred ecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
...+.|+||||++++|.+.+.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.....+++...
T Consensus 116 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~ 195 (397)
T 1wak_A 116 NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT 195 (397)
T ss_dssp TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence 56689999999988888888776545799999999999999999999998 99999999999999765421111100000
Q ss_pred CC------CCC-------------C---cccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccc
Q 017021 194 HT------PKD-------------S---SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCD 251 (379)
Q Consensus 194 ~~------~~~-------------~---~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD 251 (379)
.. +.. . ...........++|+|||.+...........||+.|+|||++.+..++.++|
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 275 (397)
T 1wak_A 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275 (397)
T ss_dssp ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHHH
T ss_pred HHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHHH
Confidence 00 000 0 0000001234799999999987666666678999999999999999999999
Q ss_pred hHhHHHHHHHHHhCCCCCCCCc------hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhc
Q 017021 252 IWSVGCILVELCTGEALFQTHE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 325 (379)
Q Consensus 252 vwSlG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (379)
||||||++|+|++|..||...+ ..+....+.+..+.+|..++.........+...+................+
T Consensus 276 iwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 354 (397)
T 1wak_A 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL- 354 (397)
T ss_dssp HHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH-
T ss_pred HHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh-
Confidence 9999999999999999997654 455667778888988887765433322222222211111110000000000
Q ss_pred cchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 326 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
..........+..+.+||.+||+.||++|||++|+|+||||++
T Consensus 355 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 355 ------VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp ------HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ------hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0000112345678999999999999999999999999999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=367.29 Aligned_cols=192 Identities=23% Similarity=0.275 Sum_probs=152.7
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc----e
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----H 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~----~ 118 (379)
..|.+.++||+|+||+||+|++ +|+.||||+++...........|+..+..+ .|+||+++++++.+++ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-----~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-----RHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-----CCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-----CCCCCCcEEEEEEecCCCceE
Confidence 3578889999999999999986 589999999975433222222233333333 7899999999987653 6
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCcccCCCCCcEEEecccccccCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL--------CMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
+|+||||| +|+|.+++... .+++.....++.|++.||+|||++ +|+||||||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl----------- 141 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV----------- 141 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE-----------
T ss_pred EEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE-----------
Confidence 89999999 99999999875 489999999999999999999987 89999999999999
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhCC------CCCCccchHhHH
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL------GWTYPCDIWSVG 256 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG 256 (379)
+.++.+||+|||+|+...... ...+||+.|+|||++.+. .++.++||||||
T Consensus 142 ----------------~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~G 205 (303)
T 3hmm_A 142 ----------------KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp ----------------CTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred ----------------CCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHH
Confidence 555667777777775433221 234799999999999764 366799999999
Q ss_pred HHHHHHHhCCCCCCC
Q 017021 257 CILVELCTGEALFQT 271 (379)
Q Consensus 257 ~il~~l~~g~~pf~~ 271 (379)
|++|||+||..||..
T Consensus 206 vvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 206 LVFWEIARRCSIGGI 220 (303)
T ss_dssp HHHHHHHHTBCBTTB
T ss_pred HHHHHHHHCCCCCCc
Confidence 999999999887754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=371.36 Aligned_cols=279 Identities=27% Similarity=0.491 Sum_probs=224.9
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--- 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--- 116 (379)
..|++.+.||+|+||.||+|.++.+|+.||+|++... ......+.+|+.++..+ .|+||+.+++++...
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-----RHENVIGLLDVFTPDETL 99 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-----CBTTBCCCSEEECSCSST
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-----CCcCCCCceeeEecCCcc
Confidence 4689999999999999999999999999999998532 23345677899999888 679999999998765
Q ss_pred ---ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 117 ---NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 117 ---~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
..+|+||||++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 100 ~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll--------------- 161 (367)
T 1cm8_A 100 DDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV--------------- 161 (367)
T ss_dssp TTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---------------
T ss_pred ccCceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---------------
Confidence 346999999999999999874 48999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++|+|||.+...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 162 ------------~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 162 ------------NEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp ------------CTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------cCCCCEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 55667888999988776655566789999999999887 67899999999999999999999999999
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhh-hhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
+..+....+.+..+.++.+.+..+.... ..+... ....+. ..........++.+.+||.+
T Consensus 230 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~------------------~~~~~~~~~~~~~~~~ll~~ 290 (367)
T 1cm8_A 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG-LPELEK------------------KDFASILTNASPLAVNLLEK 290 (367)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHH-SCCCCC------------------CCGGGTCTTCCHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHh-CCCCCC------------------CCHHHHCCCCCHHHHHHHHH
Confidence 9989999999999999988877654322 222211 000000 00011223467889999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
||+.||.+|||++|+|+||||++-
T Consensus 291 mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 291 MLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HccCChhHCCCHHHHhcChHHHhh
Confidence 999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=370.07 Aligned_cols=308 Identities=35% Similarity=0.647 Sum_probs=236.1
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCC-CCCeeEEecceeeecceEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-GGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~i~~~~~~~~~~~~~~l 121 (379)
..|++.+.||+|+||+||+|.++.+++.||+|+++...........|+.++..+.++.. .+++++.+.+.+...+..|+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 57899999999999999999999999999999998665556677778888888865432 33468999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
||||++++|.+++.......+++..+..++.|++.||.||| +.||+||||||+||++..
T Consensus 134 v~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~------------------- 194 (382)
T 2vx3_A 134 VFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN------------------- 194 (382)
T ss_dssp EEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-------------------
T ss_pred EEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-------------------
Confidence 99999889999998865456999999999999999999999 579999999999999943
Q ss_pred cccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
+..+.++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 195 ------~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 268 (382)
T 2vx3_A 195 ------PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 268 (382)
T ss_dssp ------TTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ------CCCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 23567899999999877666666789999999999999999999999999999999999999999999889888
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCC----------CCCchhhhhhhcc----chhhHH-HHHHhhccchhH
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE----------GAASRESIKSVMK----LPRLQN-LIMQHVDHSAGD 344 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~ 344 (379)
.+.+..+.+|..+++........+.......|.. .......+...+. .+.... ...........+
T Consensus 269 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (382)
T 2vx3_A 269 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348 (382)
T ss_dssp HHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHH
T ss_pred HHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHH
Confidence 9999899988887765433221111110000000 0000000100000 000000 000000112357
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+.+||.+||+.||++||||+|+|+||||++.
T Consensus 349 ~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 349 FKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=371.08 Aligned_cols=312 Identities=24% Similarity=0.417 Sum_probs=211.7
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec--c
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--N 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--~ 117 (379)
..|++.++||+|+||.||+|.++.+|+.||+|++... ........+|+.++..+ .+|+||+++++++... .
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l----~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL----SGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHT----TTCTTBCCEEEEEECTTSS
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhc----cCCCCCCeeeeEEecCCCC
Confidence 4688999999999999999999999999999998532 33345566788888877 2489999999998754 4
Q ss_pred eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 118 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 118 ~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.+|+||||++++|.+++... .++...+..++.||+.||.|||+.||+||||||+||+++.++.+|++|||++.....
T Consensus 85 ~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp CEEEEEECCSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEEEecccCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 79999999988999999874 489999999999999999999999999999999999996655555555555432211
Q ss_pred CCcccccCCCCCCeEEeecCcc-cccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGST-TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~-~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
...... ............ ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 162 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 162 IRRVTN----NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp CCCCCC----CGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccc----cccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 100000 000000000000 000011123579999999999976 67899999999999999999999999999999
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhh-hhhhcc----CCCCCCCCCCchhhhhhhccchhhHHHHH--HhhccchhHHHHH
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHA-EKYVRR----GRLDWPEGAASRESIKSVMKLPRLQNLIM--QHVDHSAGDLTHL 348 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 348 (379)
+....+....+.++.+.+..+.... ..+... ............ +....... ......++++.+|
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~dl 308 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIF---------TKWKNLLLKINPKADCNEEALDL 308 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCH---------HHHHHHHHHHCTTCCCCHHHHHH
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhC---------cchhhhcccccccccCCHHHHHH
Confidence 9999998888888877665432211 111100 000000000000 00011111 1122567899999
Q ss_pred HhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
|.+||+.||++|||++|+|+||||+.
T Consensus 309 l~~~L~~dP~~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 309 LDKLLQFNPNKRISANDALKHPFVSI 334 (388)
T ss_dssp HHHHCCSSGGGSCCHHHHTTSTTTTT
T ss_pred HHHhhccCcccCCCHHHHhCCHHHHH
Confidence 99999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=359.55 Aligned_cols=279 Identities=28% Similarity=0.473 Sum_probs=220.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.++||+|+||+||+|+++.+++.||+|++.... .....+.+|+.++.++ .|+|++++++++.+++..+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 77 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-----CCCCEeeEEeEEEeCCEEE
Confidence 5889999999999999999999999999999997432 2335666788888777 6899999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||||+++++.+.+.... ..+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 78 lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---------------------- 134 (292)
T 3o0g_A 78 LVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---------------------- 134 (292)
T ss_dssp EEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----------------------
T ss_pred EEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----------------------
Confidence 999999778888876643 369999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCC-CCCccchHhHHHHHHHHHhCCCC-CCCCchH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEAL-FQTHENL 275 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~~l~~g~~p-f~~~~~~ 275 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..
T Consensus 135 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~ 209 (292)
T 3o0g_A 135 -----NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_dssp -----CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred -----cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH
Confidence 556678888888886543222 3357899999999998765 79999999999999999987766 5666667
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.+..+.++...|+......... ..+.... ...........+..+++||++||+.
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~L~~ 269 (292)
T 3o0g_A 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYK------PYPMYPA--------------TTSLVNVVPKLNATGRDLLQNLLKC 269 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCC------CCCCCCT--------------TCCCTTTSTTCCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHhCCCChhhhhhhccccccc------ccccccC--------------CcchhhcccccChHHHHHHHHHhcc
Confidence 7777888878777766555433321110 0000000 0000112234678899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~ 375 (379)
||++|||++|+++||||++-
T Consensus 270 dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 270 NPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp SGGGSCCHHHHHTSGGGTTC
T ss_pred ChhhCCCHHHHhcCcccccC
Confidence 99999999999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=360.88 Aligned_cols=259 Identities=24% Similarity=0.435 Sum_probs=218.4
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-------hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
..|++.+.||+|+||.||+|.++.+|+.||+|+++.... ....+.+|+.++..+ .|+|++++++++.+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-----QHPNVITLHEVYEN 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEC
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-----CCCCCCcEEEEEEe
Confidence 468899999999999999999999999999999974321 245677899999888 68999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
....++||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++..++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~------------ 151 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN------------ 151 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS------------
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCC------------
Confidence 99999999999 899999997654 699999999999999999999999999999999999995432
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
.....++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 152 -----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 152 -----------VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp -----------SSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred -----------CCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 22347899999988755432 23457999999999999889999999999999999999999999887
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
...+....+.......+.. .+...+..+.+||.+|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~li~~~ 255 (326)
T 2y0a_A 221 TKQETLANVSAVNYEFEDE---------------------------------------------YFSNTSALAKDFIRRL 255 (326)
T ss_dssp SHHHHHHHHHHTCCCCCHH---------------------------------------------HHTTSCHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCcCcc---------------------------------------------ccccCCHHHHHHHHHH
Confidence 7766665554443333322 1234677899999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
|+.||.+|||++|+++||||+...
T Consensus 256 L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 256 LVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp SCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred ccCChhhCCCHHHHhcCCCccCCc
Confidence 999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=362.69 Aligned_cols=287 Identities=29% Similarity=0.467 Sum_probs=213.5
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
...|++.++||+|+||.||+|.++.+|+.||+|+++... .....+.+|+.++..+ .|+||+++++++..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-----KHENIVRLYDVIHTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-----CBTTBCCEEEEECCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-----CCCCcceEEEEEEECCeE
Confidence 346899999999999999999999999999999997432 2335667888888877 679999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 120 CIVFEKLGSSLYDFLRKNN----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 120 ~lv~e~~~~sL~~~l~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
|+||||+.++|.+++.... ...+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~----------------- 141 (317)
T 2pmi_A 79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI----------------- 141 (317)
T ss_dssp EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE-----------------
T ss_pred EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE-----------------
Confidence 9999999889999987532 1358999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 142 ----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 142 ----------NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp ----------CTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ----------cCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 55567888888887654332 233578999999999976 4689999999999999999999999999
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+..+....+.+..+.+++..|+.+........ ..+... ................+.++.+||.+
T Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~ 276 (317)
T 2pmi_A 212 TNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP-----NIQQRP----------PRDLRQVLQPHTKEPLDGNLMDFLHG 276 (317)
T ss_dssp SSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCT-----TCCCCC----------CCCSHHHHGGGCSSCCCHHHHHHHHH
T ss_pred CChHHHHHHHHHHhCCCChhHhhhhhhhhhccc-----cccccc----------chhHHHhhcccccccCCHHHHHHHHH
Confidence 888888888888888877766655433211100 000000 00000011111223567889999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
||+.||++|||++|+++||||++.
T Consensus 277 ~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 277 LLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp HSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HCCCCcccCCCHHHHhCChhhhcc
Confidence 999999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=374.75 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=217.1
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
..|++.+.||+|+||.||+|.++.+|+.||+|++.... .....+.+|+.++..+ .|+||+++++++.+++..
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-----KHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-----CBTTBCCEEEEEECSSEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCcCCCeEEEEEEECCEE
Confidence 46889999999999999999999999999999997432 2345567899998888 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+.+.... .+++..+..++.||+.||.|||+.||+||||||+||+++..
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~----------------- 146 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK----------------- 146 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBS-----------------
T ss_pred EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecc-----------------
Confidence 9999999 899999998765 69999999999999999999999999999999999999532
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
..++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 147 -------~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~ 219 (444)
T 3soa_A 147 -------LKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 219 (444)
T ss_dssp -------STTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred -------CCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH
Confidence 245679999999987654433 2357999999999999989999999999999999999999999988777
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.......+.. .++..++++.+||.+||+.
T Consensus 220 ~~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~ 254 (444)
T 3soa_A 220 RLYQQIKAGAYDFPSP---------------------------------------------EWDTVTPEAKDLINKMLTI 254 (444)
T ss_dssp HHHHHHHHTCCCCCTT---------------------------------------------TTTTSCHHHHHHHHHHSCS
T ss_pred HHHHHHHhCCCCCCcc---------------------------------------------ccccCCHHHHHHHHHHcCC
Confidence 7666665544333321 1234678899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~ 374 (379)
||++|||++|+|+||||+.
T Consensus 255 dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 255 NPSKRITAAEALKHPWISH 273 (444)
T ss_dssp STTTSCCHHHHHHSCTTHH
T ss_pred ChhHCCCHHHHhcCccccC
Confidence 9999999999999999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=357.16 Aligned_cols=279 Identities=29% Similarity=0.461 Sum_probs=217.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.+.||+|+||.||+|++ .+++.||+|++.... .....+.+|+.++..+ .|+|++++++++...+..+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 76 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-----KHSNIVKLYDVIHTKKRLV 76 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-----CCTTBCCEEEEEECSSCEE
T ss_pred cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-----CCCCEeeeeeEEccCCeEE
Confidence 588999999999999999998 678999999986432 2235566788888777 6899999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 77 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---------------------- 133 (288)
T 1ob3_A 77 LVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---------------------- 133 (288)
T ss_dssp EEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----------------------
T ss_pred EEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----------------------
Confidence 999999779999998753 358999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+
T Consensus 134 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 208 (288)
T 1ob3_A 134 -----NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208 (288)
T ss_dssp -----CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----cCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 556678888888876543221 334689999999999764 58999999999999999999999999988888
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+..+.++...|+.+....... . ...... ..+ ........+.++.+||.+||+.|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~------------~~~-----~~~~~~~~~~~~~~li~~~L~~d 268 (288)
T 1ob3_A 209 QLMRIFRILGTPNSKNWPNVTELPKYD-P--NFTVYE------------PLP-----WESFLKGLDESGIDLLSKMLKLD 268 (288)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCC-T--TCCCCC------------CCC-----GGGTCCSCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHCCCChhhchhhhcccccc-c--cccccc------------Ccc-----HHHHhhhcCHHHHHHHHHHcCCC
Confidence 877777777766655444322211100 0 000000 000 01122356788999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~~ 376 (379)
|++|||++|+++||||++.+
T Consensus 269 P~~Rpt~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 269 PNQRITAKQALEHAYFKENN 288 (288)
T ss_dssp TTTSCCHHHHHTSGGGGC--
T ss_pred cccCCCHHHHhcCcchhhcC
Confidence 99999999999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=365.57 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=213.0
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.....|++.+.||+|+||.||+|+++.+|+.||+|+++.. .........|..++..+ ..|++++++++++.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~----~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA----WEHPFLTHMFCTFQT 89 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH----TTCTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhc----CCCCCCCcEEEEEEe
Confidence 4456788999999999999999999999999999999743 22344556677777765 367999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..|+||||+ |++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---------------- 151 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---------------- 151 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----------------
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE----------------
Confidence 99999999999 999999998754 69999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+..... .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+
T Consensus 152 -----------~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 152 -----------DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp -----------CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -----------CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence 5556778888887764322 22446799999999999999999999999999999999999999998
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+..+....+.......| ...+.++.+||.+
T Consensus 221 ~~~~~~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~~li~~ 251 (345)
T 1xjd_A 221 QDEEELFHSIRMDNPFYP-------------------------------------------------RWLEKEAKDLLVK 251 (345)
T ss_dssp SSHHHHHHHHHHCCCCCC-------------------------------------------------TTSCHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCC-------------------------------------------------cccCHHHHHHHHH
Confidence 777666555443221111 1256789999999
Q ss_pred ccccCCCCCcCHH-HHhcCCCCCCCC
Q 017021 352 LLRYDPTDRLTAR-EALRHPFFTRDH 376 (379)
Q Consensus 352 ~L~~dP~~Rpta~-e~l~hp~f~~~~ 376 (379)
||+.||++||++. |+++||||++.+
T Consensus 252 lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 252 LFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HhcCCHhHcCCChHHHHcCccccCCC
Confidence 9999999999998 999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=366.15 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=217.7
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.....|++.+.||+|+||.||+|+++.+|+.||+|+++... .......+|+.++..+ .|++++++++++.+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEc
Confidence 34457889999999999999999999999999999997432 2334566777777766 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---------------- 174 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---------------- 174 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----------------
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE----------------
Confidence 99999999999 899999998765 59999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
+.++.++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 175 -----------~~~g~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 243 (350)
T 1rdq_E 175 -----------DQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp -----------CTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -----------CCCCCEEEcccccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH
Confidence 566678889999887666655667899999999999999999999999999999999999999998776
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+.......| ...+.++.++|.+||+
T Consensus 244 ~~~~~~i~~~~~~~p-------------------------------------------------~~~~~~~~~li~~lL~ 274 (350)
T 1rdq_E 244 IQIYEKIVSGKVRFP-------------------------------------------------SHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp HHHHHHHHHCCCCCC-------------------------------------------------TTCCHHHHHHHHHHSC
T ss_pred HHHHHHHHcCCCCCC-------------------------------------------------CCCCHHHHHHHHHHhh
Confidence 665555444222221 1356789999999999
Q ss_pred cCCCCCcC-----HHHHhcCCCCCCCC
Q 017021 355 YDPTDRLT-----AREALRHPFFTRDH 376 (379)
Q Consensus 355 ~dP~~Rpt-----a~e~l~hp~f~~~~ 376 (379)
.||.+||+ ++|+++||||+..+
T Consensus 275 ~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 275 VDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred cCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 99999998 99999999998753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=377.58 Aligned_cols=308 Identities=26% Similarity=0.425 Sum_probs=211.5
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee----
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---- 115 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~---- 115 (379)
..|++.+.||+|+||.||+|+++.+++.||||++... ......+.+|+.++..+ .|+||+++++++..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-----NHDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCSCTT
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-----CCCCCCceEEEEecCCcc
Confidence 4689999999999999999999999999999998642 23345677899999888 78999999999843
Q ss_pred -cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 -RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 -~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
...+|+||||++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 128 ~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 128 KFDELYVVLEIADSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp TCCCEEEEECCCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred cCceEEEEEeccccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 36799999999999999998754 699999999999999999999999999999999999998888888888887765
Q ss_pred CCCCCccc---ccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhh-hCCCCCCccchHhHHHHHHHHHh------
Q 017021 195 TPKDSSYF---KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVI-LGLGWTYPCDIWSVGCILVELCT------ 264 (379)
Q Consensus 195 ~~~~~~~~---~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~~l~~------ 264 (379)
........ ..........+++|+............+||+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 43221110 000111223344444333323333456789999999986 45669999999999999999998
Q ss_pred -----CCCCCCCCc--------------------hHHHHHHHHHHcCCCChhHHHhhhhhh-hhhhccCCCCCCCCCCch
Q 017021 265 -----GEALFQTHE--------------------NLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASR 318 (379)
Q Consensus 265 -----g~~pf~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 318 (379)
|+++|.+.+ ..+....+.+..|.++.+.+..+.... ..+... ......
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~----- 359 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI-FPKREG----- 359 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTT-SCCCCC-----
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHh-cCCCCC-----
Confidence 677776543 245667777888888888776654322 222111 000000
Q ss_pred hhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 319 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
..........++++.+||++||+.||++|||++|+|+||||++.+
T Consensus 360 -------------~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 360 -------------TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp -------------CCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred -------------CCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 001122334678899999999999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=363.73 Aligned_cols=292 Identities=26% Similarity=0.428 Sum_probs=222.3
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
.......|++.++||+|+||.||+|++..+++.||+|+++... .....+.+|+.++..+ .|+|++++++++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-----QHRNIIELKSVIH 103 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-----CCTTBCCEEEEEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-----CCCCcceEEEEEe
Confidence 3344557899999999999999999999999999999996432 2234556788888777 7899999999999
Q ss_pred ecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 115 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 115 ~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
+++..++||||+.++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++..++.
T Consensus 104 ~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~----------- 170 (329)
T 3gbz_A 104 HNHRLHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDA----------- 170 (329)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC--------------
T ss_pred cCCEEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCC-----------
Confidence 999999999999889999998865 5999999999999999999999999999999999999964321
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+....++|+|||.+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.
T Consensus 171 -----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 171 -----------SETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp -------------CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -----------CccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 34456999999988754432 2335689999999999874 48999999999999999999999999
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
+.+..+....+.+..+.++...++.......... .++.. .............+.++.+||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~--------------~~~~~~~~~~~~~~~~~~~li~ 300 (329)
T 3gbz_A 240 GDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQ-----SFPKF--------------RGKTLKRVLGALLDDEGLDLLT 300 (329)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-----TCCCC--------------CCCCHHHHHGGGSCHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhh-----hhhhh--------------ccccHhhhcccccCHHHHHHHH
Confidence 9888888888888777766554443222111100 00000 0001111223346788999999
Q ss_pred hccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 351 GLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
+||+.||.+|||++|+|+||||++...
T Consensus 301 ~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 301 AMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp HHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred HHccCChhhCCCHHHHhCCcccCCCCC
Confidence 999999999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=366.73 Aligned_cols=282 Identities=27% Similarity=0.461 Sum_probs=220.8
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.++||+|+||.||+|+++.+++.||+|++..... ....+.+|+.++..+ .|+|++++++++..++..++
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-----KHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-----CCTTBCCEEEEEECSSCEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-----CCCCCCeeeeEEeeCCEEEE
Confidence 58899999999999999999999999999999974322 122344688887777 68999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
||||++++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 78 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~----------------------- 133 (324)
T 3mtl_A 78 VFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI----------------------- 133 (324)
T ss_dssp EEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE-----------------------
T ss_pred EecccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE-----------------------
Confidence 99999889999998754 368999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 134 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 209 (324)
T 3mtl_A 134 ----NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ 209 (324)
T ss_dssp ----CTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ----CCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 455678888888876443322 23468999999999876 5689999999999999999999999999998888
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+..+.++...|+........... .++. .............++++.+||.+||+.||
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~----~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP 270 (324)
T 3mtl_A 210 LHFIFRILGTPTEETWPGILSNEEFKTY----NYPK---------------YRAEALLSHAPRLDSDGADLLTKLLQFEG 270 (324)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGCHHHHHT----CCCC---------------CCCCCHHHHCTTSCHHHHHHHHHHSCSSG
T ss_pred HHHHHHHhCCCChHhchhhhcchhhccc----cccc---------------ccchhhhhhcCCCCHHHHHHHHHHcCcCc
Confidence 8888888888776655543222111100 0110 00011122334577889999999999999
Q ss_pred CCCcCHHHHhcCCCCCCCCc
Q 017021 358 TDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f~~~~~ 377 (379)
.+|||++|+|+||||.+...
T Consensus 271 ~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 271 RNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp GGSCCHHHHTTSGGGGGGCS
T ss_pred ccCCCHHHHhcChhhhhccc
Confidence 99999999999999987643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=368.53 Aligned_cols=279 Identities=26% Similarity=0.470 Sum_probs=211.4
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--- 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--- 116 (379)
..|++.+.||+|+||.||+|.+..+|+.||+|++... ......+.+|+.++..+ .|+|++.+++++...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-----KHENVIGLLDVFTPARSL 103 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCSSG
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEecCCcc
Confidence 5689999999999999999999999999999998642 23345667899988888 689999999988654
Q ss_pred ---ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 117 ---NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 117 ---~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
...|+|+|+++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 104 ~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll--------------- 165 (367)
T 2fst_X 104 EEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--------------- 165 (367)
T ss_dssp GGCCCCEEEEECCCEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---------------
T ss_pred ccCCeEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---------------
Confidence 568999999999999998763 59999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++|+|||.+...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 166 ------------~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 166 ------------NEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp ------------CTTCCEEECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------CCCCCEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 55667888888888765555555689999999999877 67899999999999999999999999999
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhh-hhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
+..+....+.+..+.++.+.++.+.... ..+... ....+. ..........++.+.+||.+
T Consensus 234 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~------------------~~~~~~~~~~~~~~~dLl~~ 294 (367)
T 2fst_X 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQS-LTQMPK------------------MNFANVFIGANPLAVDLLEK 294 (367)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHT-SCCCCC------------------CCHHHHTTTCCHHHHHHHHH
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhc-cCCCCC------------------CCHHHHCCCCCHHHHHHHHH
Confidence 9989999999999998888776653322 222221 111110 00112223567889999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
||+.||++|||++|+|+||||++-
T Consensus 295 mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 295 MLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hCCCCcccCcCHHHHhcChhhhhc
Confidence 999999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=363.61 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=210.7
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
......|++.+.||+|+||.||+|+++.+++.||+|+++... ........|..++..+ ..|++++.+++++.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~----~~hp~iv~l~~~~~ 91 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP----GKPPFLTQLHSCFQ 91 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCT----TCCTTBCCEEEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhc----CCCCEEeeEEEEEE
Confidence 345567899999999999999999999999999999997532 2233445565555443 36799999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
+.+..|+||||+ |++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 92 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll--------------- 154 (353)
T 2i0e_A 92 TMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML--------------- 154 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---------------
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---------------
Confidence 999999999999 899999998754 69999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+.++.++|+|||++..... .....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.
T Consensus 155 ------------~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 222 (353)
T 2i0e_A 155 ------------DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222 (353)
T ss_dssp ------------CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ------------cCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCC
Confidence 5556788888887764322 2244679999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
+.+..+....+.......| ...+.++.+||.
T Consensus 223 ~~~~~~~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~~li~ 253 (353)
T 2i0e_A 223 GEDEDELFQSIMEHNVAYP-------------------------------------------------KSMSKEAVAICK 253 (353)
T ss_dssp CSSHHHHHHHHHHCCCCCC-------------------------------------------------TTSCHHHHHHHH
T ss_pred CCCHHHHHHHHHhCCCCCC-------------------------------------------------CCCCHHHHHHHH
Confidence 8777666655544222222 135678999999
Q ss_pred hccccCCCCCc-----CHHHHhcCCCCCCCC
Q 017021 351 GLLRYDPTDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 351 ~~L~~dP~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
+||+.||.+|| +++|+++||||+..+
T Consensus 254 ~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 254 GLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp HHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 99999999999 479999999998643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=366.01 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=216.7
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
..|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ .|+||+++++++.+++..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEeCCEE
Confidence 46899999999999999999999999999999997432 2335567899998888 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+.+.... .+++..+..++.||+.||.|||+.||+||||||+||+++..
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~----------------- 164 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK----------------- 164 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCS-----------------
T ss_pred EEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC-----------------
Confidence 9999999 889999987654 68999999999999999999999999999999999999543
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
..+..++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 165 -------~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 237 (362)
T 2bdw_A 165 -------AKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 237 (362)
T ss_dssp -------STTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------CCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 234568999999987655433 34579999999999999899999999999999999999999998877766
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.......+.. .++..++++.+||.+||+.|
T Consensus 238 ~~~~i~~~~~~~~~~---------------------------------------------~~~~~~~~~~~li~~~L~~d 272 (362)
T 2bdw_A 238 LYAQIKAGAYDYPSP---------------------------------------------EWDTVTPEAKSLIDSMLTVN 272 (362)
T ss_dssp HHHHHHHTCCCCCTT---------------------------------------------GGGGSCHHHHHHHHHHSCSS
T ss_pred HHHHHHhCCCCCCcc---------------------------------------------cccCCCHHHHHHHHHHcCCC
Confidence 665554433332211 12346788999999999999
Q ss_pred CCCCcCHHHHhcCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTR 374 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~ 374 (379)
|++|||++|+|+||||..
T Consensus 273 P~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 273 PKKRITADQALKVPWICN 290 (362)
T ss_dssp GGGSCCHHHHTTSHHHHT
T ss_pred hhhCcCHHHHhcCcccCC
Confidence 999999999999999964
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=366.16 Aligned_cols=265 Identities=20% Similarity=0.364 Sum_probs=208.5
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
.+....|++.++||+|+||.||+|+++.+++.||+|+++... ........|..++.++ ..|++|+++++++.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~----~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFLVGLHSCFQ 123 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHH----TTCTTBCCEEEEEE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhc----CCCCCcCeeEEEEE
Confidence 345567899999999999999999999999999999997432 2234456788887776 36799999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
+.+.+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl--------------- 186 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--------------- 186 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---------------
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---------------
Confidence 999999999999 899999998764 69999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+.++.++|+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 187 ------------~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~ 254 (396)
T 4dc2_A 187 ------------DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254 (396)
T ss_dssp ------------CTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred ------------CCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 5566788888888764222 2245689999999999999999999999999999999999999997
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
.....+... ..........+..+...+| ...+.++.+||+
T Consensus 255 ~~~~~~~~~--------------~~~~~~~~~~i~~~~~~~p--------------------------~~~s~~~~~li~ 294 (396)
T 4dc2_A 255 IVGSSDNPD--------------QNTEDYLFQVILEKQIRIP--------------------------RSLSVKAASVLK 294 (396)
T ss_dssp TTTC--------------------CCHHHHHHHHHHCCCCCC--------------------------TTSCHHHHHHHH
T ss_pred ccccccccc--------------hhhHHHHHHHHhccccCCC--------------------------CcCCHHHHHHHH
Confidence 532211000 0000000011111111121 236778999999
Q ss_pred hccccCCCCCcCH------HHHhcCCCCCCCC
Q 017021 351 GLLRYDPTDRLTA------REALRHPFFTRDH 376 (379)
Q Consensus 351 ~~L~~dP~~Rpta------~e~l~hp~f~~~~ 376 (379)
+||+.||.+||++ +|+++||||++.+
T Consensus 295 ~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 295 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp HHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred HHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 9999999999985 8999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=362.40 Aligned_cols=310 Identities=32% Similarity=0.525 Sum_probs=237.4
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCC------CCCeeEEecc
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK------GGNRCVQIRN 111 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~------~~~~i~~~~~ 111 (379)
..+....|++.+.||+|+||.||+|++..+++.||+|++............|+.++.++.+... .|+|++++++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 3456678999999999999999999999999999999998666566777889999998865321 2678999999
Q ss_pred eeeecc----eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCcEEEeccccccc
Q 017021 112 WFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKV 186 (379)
Q Consensus 112 ~~~~~~----~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~~ 186 (379)
++...+ ..++|||+++++|.+++.......+++..+..++.||+.||.|||+. ||+||||||+||++...+..
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~-- 171 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP-- 171 (373)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT--
T ss_pred HhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC--
Confidence 988654 89999999999999999886555699999999999999999999998 99999999999999643210
Q ss_pred CCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCC
Q 017021 187 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
+....++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 172 -------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 232 (373)
T 1q8y_A 172 -------------------ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232 (373)
T ss_dssp -------------------TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred -------------------cCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCC
Confidence 2345689999999987666556668999999999999999999999999999999999999
Q ss_pred CCCCCCc------hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc
Q 017021 267 ALFQTHE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 267 ~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (379)
.||...+ ..+....+.+..+.+|..++.........+...+............ . .............
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~~~ 305 (373)
T 1q8y_A 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP-L------EDVLTEKYKFSKD 305 (373)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC-H------HHHHHHTTCCCHH
T ss_pred CCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccc-h------hhhhhhcccCCcc
Confidence 9998654 4556677778889999887765443322222222111111000000 0 0000000112234
Q ss_pred chhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.+.++.+||.+||+.||++|||++|+|+||||++.
T Consensus 306 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 56789999999999999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=357.93 Aligned_cols=264 Identities=20% Similarity=0.367 Sum_probs=206.9
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
+....|++.+.||+|+||.||+|+++.+++.||+|+++... ........|..++..+ ..|++|+++++++.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~----~~hp~iv~l~~~~~~ 81 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFLVGLHSCFQT 81 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHT----TTCTTBCCEEEEEEC
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhc----CCCCccCeEEEEEEe
Confidence 34557899999999999999999999999999999997432 2234455677777665 367999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---------------- 143 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---------------- 143 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----------------
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE----------------
Confidence 99999999999 899999998754 69999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+..... .....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 144 -----------~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 144 -----------DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp -----------CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -----------CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 5566788888888764222 22345799999999999999999999999999999999999999975
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
........ ..........+..+...+| ...+.++.+||.+
T Consensus 213 ~~~~~~~~--------------~~~~~~~~~~i~~~~~~~p--------------------------~~~s~~~~~li~~ 252 (345)
T 3a8x_A 213 VGSSDNPD--------------QNTEDYLFQVILEKQIRIP--------------------------RSLSVKAASVLKS 252 (345)
T ss_dssp TTC---------------------CHHHHHHHHHHCCCCCC--------------------------TTSCHHHHHHHHH
T ss_pred cccccccc--------------cccHHHHHHHHHcCCCCCC--------------------------CCCCHHHHHHHHH
Confidence 32111000 0000000001111111111 2366789999999
Q ss_pred ccccCCCCCcCH------HHHhcCCCCCCCC
Q 017021 352 LLRYDPTDRLTA------REALRHPFFTRDH 376 (379)
Q Consensus 352 ~L~~dP~~Rpta------~e~l~hp~f~~~~ 376 (379)
||+.||.+||++ +|+++||||+..+
T Consensus 253 lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 253 FLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp HTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred HhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 999999999996 8999999998753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=358.00 Aligned_cols=321 Identities=44% Similarity=0.821 Sum_probs=246.0
Q ss_pred hhhhhhhhccccccceeEEEEEecCCC-ceEEEEEeeccchhhHhHHHHHHHHHHHHhcCC-CCCeeEEecceeeecceE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-GGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~-~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~i~~~~~~~~~~~~~ 119 (379)
...|++.+.||+|+||.||+|.+..++ +.||+|+++........+..|+.++..+.+... .+.+++.+.+++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 357899999999999999999998776 789999998666667778889999999876542 334588889999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 120 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 120 ~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
|+||||+++++.+.+.......+++..+..++.||+.||.|||+.||+||||||+||++...+...+.+.. .
T Consensus 98 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~--------~ 169 (355)
T 2eu9_A 98 CIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH--------K 169 (355)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC---------
T ss_pred EEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc--------c
Confidence 99999998888888877655579999999999999999999999999999999999999654322221111 0
Q ss_pred cccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
...........++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 00111245678999999999876666666789999999999999899999999999999999999999999988888888
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.+.+..++.|..++....... +...+...|+................. .........+..+.+||.+||+.||++
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQK--YFYKGGLVWDENSSDGRYVKENCKPLK---SYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGG--GEETTEECCCTTSHHHHHHHHHCCCGG---GGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHcCCCcHHHhhhccchh--hhcccccccccccchhccccccCCccc---ccccccchhHHHHHHHHHHHhcCChhh
Confidence 899999999998877643221 222222333332211111111110000 000011234568999999999999999
Q ss_pred CcCHHHHhcCCCCCCC
Q 017021 360 RLTAREALRHPFFTRD 375 (379)
Q Consensus 360 Rpta~e~l~hp~f~~~ 375 (379)
|||++|+++||||++.
T Consensus 325 Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 325 RITLAEALLHPFFAGL 340 (355)
T ss_dssp SCCHHHHTTSGGGGGC
T ss_pred CcCHHHHhcChhhcCC
Confidence 9999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=368.85 Aligned_cols=299 Identities=27% Similarity=0.406 Sum_probs=215.8
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--- 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--- 116 (379)
..|++.+.||+|+||.||+|+++.+++.||+|++... ......+.+|+.++..+ .|+||+.+++++...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-----KSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCSCTT
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-----CCCCcceEEEEEecCCCC
Confidence 4689999999999999999999999999999999742 23345677899999888 679999999998766
Q ss_pred --ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 117 --NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 117 --~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
...|+||||++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+|++|||++..
T Consensus 101 ~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 101 KFDELYIVLEIADSDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp TCCCEEEEEECCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cCCeEEEEEecCCcCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 5799999999889999998754 699999999999999999999999999999999999996555555555554432
Q ss_pred CCCCCcccccCCCCCCeEEeecCcc-------cccCCCCCcccccCCccchhhh-hCCCCCCccchHhHHHHHHHHHhC-
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGST-------TYERPDQNYIVSTRHYRAPEVI-LGLGWTYPCDIWSVGCILVELCTG- 265 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~-------~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~~l~~g- 265 (379)
........ ...+.... ..........+||+.|+|||++ .+..++.++|||||||++|+|++|
T Consensus 179 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 179 INSEKDTN---------IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp C----------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred cccccccc---------ccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 21111000 00000000 0000011345789999999986 456699999999999999999984
Q ss_pred ----------CCCCCCCc-----------------hHHHHHHHHHHcCCCChhHHHhhhh-hhhhhhccCCCCCCCCCCc
Q 017021 266 ----------EALFQTHE-----------------NLEHLAMMERVLGPLPQHMLKRVDR-HAEKYVRRGRLDWPEGAAS 317 (379)
Q Consensus 266 ----------~~pf~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 317 (379)
.++|.+.+ ..+....+.+..|.++.+.+..+.. .+..++.......+
T Consensus 250 ~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 324 (432)
T 3n9x_A 250 QSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP----- 324 (432)
T ss_dssp TTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCC-----
T ss_pred cccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCC-----
Confidence 44444432 3556677788889988887765432 22222221110000
Q ss_pred hhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 318 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
..........++++.+||.+||+.||++|||++|+|+||||++.+
T Consensus 325 --------------~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 325 --------------INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp --------------CCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred --------------CCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 001122345778999999999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=352.42 Aligned_cols=281 Identities=31% Similarity=0.535 Sum_probs=220.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.++||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.++..+ .|+|++++++++...+..+
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 78 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-----KHPNLVNLLEVFRRKRRLH 78 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-----CCCCccchhheeecCCeEE
Confidence 5889999999999999999999999999999986432 2245566788888888 6899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 79 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~--------------------- 135 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI--------------------- 135 (311)
T ss_dssp EEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------
T ss_pred EEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---------------------
Confidence 999999 777888776554 68999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..
T Consensus 136 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 209 (311)
T 4agu_A 136 ------TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV 209 (311)
T ss_dssp ------CTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ------cCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 556678888888886544322 33478999999999976 56899999999999999999999999998888
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.+..+..++.......... +......+.+... ..........+..+.+||.+||+.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~li~~~L~~ 271 (311)
T 4agu_A 210 DQLYLIRKTLGDLIPRHQQVFSTNQ--YFSGVKIPDPEDM----------------EPLELKFPNISYPALGLLKGCLHM 271 (311)
T ss_dssp HHHHHHHHHHCSCCHHHHHHHHTCG--GGTTCCCCCCSSC----------------CCHHHHCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHhccccccccccccccc--ccccCcCCCcccc----------------chhhhhcccccHHHHHHHHHHccC
Confidence 8888888888877765544322211 1111111111110 011112235778899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~~ 376 (379)
||++|||++|+++||||++..
T Consensus 272 dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 272 DPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp STTTSCCHHHHHTSGGGTTCC
T ss_pred ChhhcCCHHHHhcChHHHhcc
Confidence 999999999999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=362.86 Aligned_cols=278 Identities=27% Similarity=0.480 Sum_probs=223.7
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
..|++.+.||+|+||.||+|.++.+|+.||+|++... ......+.+|+.++..+ .|+|++.+++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-----QHENVIGLLDVFTPASSL 116 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCSSS
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-----CCCCchhhhhheeccCCc
Confidence 4688999999999999999999999999999999742 23345667888888888 689999999999877654
Q ss_pred ------EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 120 ------CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 120 ------~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
|+||||++++|.+.+.. .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 117 ~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll--------------- 177 (371)
T 4exu_A 117 RNFYDFYLVMPFMQTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV--------------- 177 (371)
T ss_dssp TTCCCCEEEEECCCEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---------------
T ss_pred ccceeEEEEEccccccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---------------
Confidence 99999998888887743 48999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++|+|||.+...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 178 ------------~~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 178 ------------NEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp ------------CTTCCEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------CCCCCEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 55667888999988776666666788999999999987 67899999999999999999999999999
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+.+..+.++.+++..+...............+ ...........++.+.+||.+|
T Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~li~~~ 307 (371)
T 4exu_A 246 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTP------------------RKDFTQLFPRASPQAADLLEKM 307 (371)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCC------------------CCCHHHHSTTSCHHHHHHHHHH
T ss_pred ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCc------------------chhHHHhccccChHHHHHHHHH
Confidence 9889999999999998888776654332211111000000 0011223345788999999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
|+.||++|||++|+|+||||+.
T Consensus 308 L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 308 LELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp SCSCTTTSCCHHHHHTSGGGTT
T ss_pred CCCChhhcCCHHHHhcCccccc
Confidence 9999999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=365.54 Aligned_cols=258 Identities=26% Similarity=0.459 Sum_probs=216.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
..|++.+.||+|+||.||+|.++.+|+.||+|++.... .....+.+|+.++..+ .|+||+++++++.+....++
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-----HHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-----CCcCCCeEEEEEEeCCEEEE
Confidence 36899999999999999999999999999999997532 2344567788888777 78999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus 126 v~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-------------------- 184 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-------------------- 184 (387)
T ss_dssp EEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS--------------------
T ss_pred EEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec--------------------
Confidence 99999 899999987643 35899999999999999999999999999999999999943
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
...+.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 185 -----~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~ 259 (387)
T 1kob_A 185 -----KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 259 (387)
T ss_dssp -----TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred -----CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH
Confidence 234568999999987655443 2357899999999999989999999999999999999999999987776665
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+.......+.. .+...++++.+||.+||+.||.
T Consensus 260 ~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~dP~ 294 (387)
T 1kob_A 260 QNVKRCDWEFDED---------------------------------------------AFSSVSPEAKDFIKNLLQKEPR 294 (387)
T ss_dssp HHHHHCCCCCCSS---------------------------------------------TTTTSCHHHHHHHHTTSCSSGG
T ss_pred HHHHhCCCCCCcc---------------------------------------------ccccCCHHHHHHHHHHcCCChh
Confidence 5544432222110 1124677899999999999999
Q ss_pred CCcCHHHHhcCCCCCCCC
Q 017021 359 DRLTAREALRHPFFTRDH 376 (379)
Q Consensus 359 ~Rpta~e~l~hp~f~~~~ 376 (379)
+|||++|+++||||+...
T Consensus 295 ~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 295 KRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp GSCCHHHHHTSTTTSSCC
T ss_pred HCcCHHHHhhCccccCCc
Confidence 999999999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=367.70 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=215.4
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.......|++.++||+|+||.||+|+++.+++.||+|+++... .....+..|..++..+ +|++|+++++++
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~ 138 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFYAF 138 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-----CCCCCCeEEEEE
Confidence 3455667899999999999999999999999999999997421 2234466788888887 789999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
.+++.+|+||||+ |++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 139 ~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl-------------- 201 (410)
T 3v8s_A 139 QDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL-------------- 201 (410)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--------------
T ss_pred EECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE--------------
Confidence 9999999999999 99999999775 48999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCC----CCCccchHhHHHHHHHHHh
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~~l~~ 264 (379)
+.++.++|+|||.+....... ...+||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 202 -------------~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~ 268 (410)
T 3v8s_A 202 -------------DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268 (410)
T ss_dssp -------------CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH
T ss_pred -------------CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh
Confidence 556678888888876544432 3467999999999998765 7899999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHc--CCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccch
Q 017021 265 GEALFQTHENLEHLAMMERVL--GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (379)
|..||.+.+..+....+.+.. ...|. ....+
T Consensus 269 G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-----------------------------------------------~~~~s 301 (410)
T 3v8s_A 269 GDTPFYADSLVGTYSKIMNHKNSLTFPD-----------------------------------------------DNDIS 301 (410)
T ss_dssp SSCTTCCSSHHHHHHHHHTHHHHCCCCT-----------------------------------------------TCCCC
T ss_pred CCCCCCCCChhhHHHHHHhccccccCCC-----------------------------------------------ccccc
Confidence 999999877766665554321 11110 12467
Q ss_pred hHHHHHHhhccccCCCC--CcCHHHHhcCCCCCCCC
Q 017021 343 GDLTHLLQGLLRYDPTD--RLTAREALRHPFFTRDH 376 (379)
Q Consensus 343 ~~~~~li~~~L~~dP~~--Rpta~e~l~hp~f~~~~ 376 (379)
.++++||.+||+.+|.+ ||+++|+++||||++.+
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 89999999999999999 99999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=362.32 Aligned_cols=260 Identities=26% Similarity=0.397 Sum_probs=202.3
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.....|++.++||+|+||.||+|+++.+++.||+|++...........+|+.++..+ .|+||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-----RHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-----CCCCCCcEEEEEeeCCEE
Confidence 345679999999999999999999999999999999986666667778899998888 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.+
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~----------------- 152 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS----------------- 152 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-----------------
T ss_pred EEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-----------------
Confidence 9999999 899999997754 69999999999999999999999999999999999999432
Q ss_pred CcccccCCCCCCeEEeecCcccccCC--CCCcccccCCccchhhhhCCCCCCc-cchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERP--DQNYIVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
....++|+|||.+..... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......
T Consensus 153 --------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 153 --------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp --------SSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred --------CCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence 233489999998863322 2244579999999999988887644 89999999999999999999864432
Q ss_pred HHHH-HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 276 EHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 276 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.... .+.+.... ....+. ....++.+.+||.+||+
T Consensus 225 ~~~~~~~~~~~~~--------------------~~~~~~------------------------~~~~s~~~~~li~~~L~ 260 (361)
T 3uc3_A 225 RDYRKTIQRILSV--------------------KYSIPD------------------------DIRISPECCHLISRIFV 260 (361)
T ss_dssp CCHHHHHHHHHTT--------------------CCCCCT------------------------TSCCCHHHHHHHHHHSC
T ss_pred HHHHHHHHHHhcC--------------------CCCCCC------------------------cCCCCHHHHHHHHHHcc
Confidence 1111 11111110 011110 11356789999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.||.+|||+.|+++||||...
T Consensus 261 ~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 261 ADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp SCTTTSCCHHHHHTSHHHHTT
T ss_pred CChhHCcCHHHHHhCcchhcC
Confidence 999999999999999999543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=366.55 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=205.6
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
-.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++..+ .|+||+++++++.+.+.
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-----RHPHIIKLYDVITTPTD 83 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEeCCE
Confidence 36889999999999999999999999999999997432 2234567788888777 78999999999999999
Q ss_pred EEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 119 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 119 ~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
.++||||++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 84 ~~lv~E~~~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll-------------------- 141 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL-------------------- 141 (336)
T ss_dssp EEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE--------------------
T ss_pred EEEEEECCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE--------------------
Confidence 99999999999999987764 69999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCC-CCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+.++.++|+|||.+....... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 142 -------~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~ 214 (336)
T 3h4j_B 142 -------DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214 (336)
T ss_dssp -------CTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST
T ss_pred -------cCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH
Confidence 556678888888876543332 34579999999999988776 68999999999999999999999753321
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+.. ..+..+.... .+..++.+.+||++||+.
T Consensus 215 ~~~-----------------------~~i~~~~~~~--------------------------p~~~s~~~~~li~~~L~~ 245 (336)
T 3h4j_B 215 NLF-----------------------KKVNSCVYVM--------------------------PDFLSPGAQSLIRRMIVA 245 (336)
T ss_dssp TCB-----------------------CCCCSSCCCC--------------------------CTTSCHHHHHHHHTTSCS
T ss_pred HHH-----------------------HHHHcCCCCC--------------------------cccCCHHHHHHHHHHcCC
Confidence 100 0011111111 123567899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~ 375 (379)
||.+|||++|+++||||+..
T Consensus 246 dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 246 DPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp SGGGSCCHHHHTTCHHHHTT
T ss_pred ChhHCcCHHHHHhChhhccC
Confidence 99999999999999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=351.23 Aligned_cols=259 Identities=26% Similarity=0.440 Sum_probs=216.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-------hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
-.|++.+.||+|+||.||+|+++.+|+.||+|++..... ....+.+|+.++..+ .|+|++++++++.+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-----LHHNVITLHDVYEN 86 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEC
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-----CCCCcceEEEEEec
Confidence 468899999999999999999999999999999974321 245677899999888 68999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..++||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++..++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~------------ 152 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN------------ 152 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT------------
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCC------------
Confidence 99999999999 899999998754 689999999999999999999999999999999999995432
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
.....++|+|||.+....... ....||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.
T Consensus 153 -----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 153 -----------IPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp -----------SSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred -----------CCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 112268999999887544332 3457899999999999989999999999999999999999999887
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+.......+.. .....+..+.+||.+|
T Consensus 222 ~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~~~~~~~li~~~ 256 (321)
T 2a2a_A 222 TKQETLANITSVSYDFDEE---------------------------------------------FFSHTSELAKDFIRKL 256 (321)
T ss_dssp SHHHHHHHHHTTCCCCCHH---------------------------------------------HHTTCCHHHHHHHHTT
T ss_pred CHHHHHHHHHhcccccChh---------------------------------------------hhcccCHHHHHHHHHH
Confidence 7666555444433232221 1234677899999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
|+.||++|||++|+++||||+...
T Consensus 257 l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 257 LVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp SCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred cCCChhhCcCHHHHhcCccccCCC
Confidence 999999999999999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=363.58 Aligned_cols=306 Identities=17% Similarity=0.209 Sum_probs=210.3
Q ss_pred eeeeeechhhhhhhhccccc--cceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEe
Q 017021 35 ITYIVFSAFADKIHSKMGEG--TFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQI 109 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G--~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~ 109 (379)
.+.+....-.|++.++||+| +||.||+|+++.+++.||+|++.... .....+.+|+.++..+ .|+||+++
T Consensus 17 ~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~ 91 (389)
T 3gni_B 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-----NHPNIVPY 91 (389)
T ss_dssp -CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-----CCTTBCCE
T ss_pred hhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-----CCCCCCcE
Confidence 34456677789999999999 99999999999999999999997432 3345566799988888 78999999
Q ss_pred cceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCC
Q 017021 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 188 (379)
Q Consensus 110 ~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~ 188 (379)
++++.+++..|+||||+ +++|.+++.......+++..+..++.||+.||.|||+.||+||||||+||+++.++
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~------ 165 (389)
T 3gni_B 92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG------ 165 (389)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC------
T ss_pred eEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC------
Confidence 99999999999999999 89999999886545799999999999999999999999999999999999995544
Q ss_pred CccCCCCCCCCcccccCCCCCCeEEeecCccccc----------CCCCCcccccCCccchhhhhC--CCCCCccchHhHH
Q 017021 189 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE----------RPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVG 256 (379)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~----------~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG 256 (379)
.++|+|||.+... ........||+.|+|||++.+ ..++.++||||||
T Consensus 166 ---------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 224 (389)
T 3gni_B 166 ---------------------KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 224 (389)
T ss_dssp ---------------------CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHH
T ss_pred ---------------------CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHH
Confidence 4555555544221 111233478999999999987 5789999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccc-hhhHHHHH
Q 017021 257 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL-PRLQNLIM 335 (379)
Q Consensus 257 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 335 (379)
|++|+|++|+.||.+.+..+....+.. +..+. ................... .......+........ ........
T Consensus 225 ~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (389)
T 3gni_B 225 ITACELANGHVPFKDMPATQMLLEKLN--GTVPC-LLDTSTIPAEELTMSPSRS-VANSGLSDSLTTSTPRPSNGDSPSH 300 (389)
T ss_dssp HHHHHHHHSSCTTTTCCSTTHHHHC-------------------------------------------------------
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCc-ccccccccccccccccccc-ccccccccccccCccccccCCCCCC
Confidence 999999999999987655443322211 11110 0000000000000000000 0000000000000000 00111122
Q ss_pred HhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 336 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
......++.+.+||++||+.||++|||++|+|+||||++..
T Consensus 301 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 301 PYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -----CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 23456788999999999999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=358.58 Aligned_cols=258 Identities=27% Similarity=0.383 Sum_probs=211.4
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
...|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ .|+||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-----KHPHIVELLETYSS 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-----CCCCCCcEEEEEEe
Confidence 346889999999999999999999999999999986321 1345677899999888 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
.+..|+||||+ +++|.+.+... ....+++..+..++.||+.||.|||+.||+||||||+||+++.+
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~----------- 166 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASK----------- 166 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSS-----------
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecC-----------
Confidence 99999999999 89998887643 22358999999999999999999999999999999999999543
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
.....++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 167 -------------~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 233 (351)
T 3c0i_A 167 -------------ENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233 (351)
T ss_dssp -------------STTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred -------------CCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCC
Confidence 233458999999887654432 3457999999999999989999999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
.+.. .+....+.+.....+.. .+...+.++.+||
T Consensus 234 ~~~~-~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li 267 (351)
T 3c0i_A 234 YGTK-ERLFEGIIKGKYKMNPR---------------------------------------------QWSHISESAKDLV 267 (351)
T ss_dssp CSSH-HHHHHHHHHTCCCCCHH---------------------------------------------HHTTSCHHHHHHH
T ss_pred CCcH-HHHHHHHHcCCCCCCcc---------------------------------------------ccccCCHHHHHHH
Confidence 8743 23333332222121111 1234678899999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
.+||+.||++|||+.|+++||||++
T Consensus 268 ~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 268 RRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHCCCChhHCcCHHHHhcChhhcC
Confidence 9999999999999999999999976
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=353.45 Aligned_cols=256 Identities=23% Similarity=0.383 Sum_probs=207.1
Q ss_pred eeechhhhhhhhccccccceeEEEEEec---CCCceEEEEEeeccc-----hhhHhHHHHHHHHHHHHhcCCCCCeeEEe
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQI 109 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~ 109 (379)
..+....|++.+.||+|+||.||+|++. .+++.||+|+++... .......+|+.++..+ .|+||+++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~ 86 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-----KHPFIVDL 86 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-----CCTTBCCE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-----CCCCccce
Confidence 3455678999999999999999999985 689999999997431 2334556788888887 68999999
Q ss_pred cceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCC
Q 017021 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 188 (379)
Q Consensus 110 ~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~ 188 (379)
++++...+..|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---------- 154 (327)
T 3a62_A 87 IYAFQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---------- 154 (327)
T ss_dssp EEEEECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE----------
T ss_pred eEEEEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE----------
Confidence 99999999999999999 899999998754 68999999999999999999999999999999999999
Q ss_pred CccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhC
Q 017021 189 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g 265 (379)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 155 -----------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 217 (327)
T 3a62_A 155 -----------------NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217 (327)
T ss_dssp -----------------CTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred -----------------CCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHC
Confidence 45567788888877643222 2345799999999999998899999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
..||.+.+..+....+.+.....| ...+..+
T Consensus 218 ~~pf~~~~~~~~~~~i~~~~~~~p-------------------------------------------------~~~~~~~ 248 (327)
T 3a62_A 218 APPFTGENRKKTIDKILKCKLNLP-------------------------------------------------PYLTQEA 248 (327)
T ss_dssp SCSCCCSSHHHHHHHHHHTCCCCC-------------------------------------------------TTSCHHH
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCC-------------------------------------------------CCCCHHH
Confidence 999998776665554444322222 1356789
Q ss_pred HHHHhhccccCCCCCc-----CHHHHhcCCCCCCCC
Q 017021 346 THLLQGLLRYDPTDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
.+||.+||+.||.+|| +++|+++||||+..+
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 9999999999999999 899999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=360.54 Aligned_cols=256 Identities=25% Similarity=0.420 Sum_probs=207.4
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
...|++.+.||+|+||.||+|.++.+++.||+|+++.... ...+|++++.++ ..|+||+++++++.+++..|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~----~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRY----GQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHH----TTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHh----cCCCCcCeEEEEEEcCCEEEE
Confidence 3468899999999999999999999999999999975432 344578887776 257999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
||||+ +++|.+.+.... .+++..+..++.||+.||.|||+.||+||||||+||++....
T Consensus 94 v~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~------------------ 153 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES------------------ 153 (342)
T ss_dssp EECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS------------------
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCC------------------
Confidence 99999 899999998764 699999999999999999999999999999999999984321
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc---h
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE---N 274 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~---~ 274 (379)
.....++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .
T Consensus 154 -----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 228 (342)
T 2qr7_A 154 -----GNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP 228 (342)
T ss_dssp -----CSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH
T ss_pred -----CCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH
Confidence 122458999999887543322 34578999999999988788999999999999999999999997632 2
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+.......+. ..+...+.++.+||++||+
T Consensus 229 ~~~~~~i~~~~~~~~~---------------------------------------------~~~~~~s~~~~~li~~~L~ 263 (342)
T 2qr7_A 229 EEILARIGSGKFSLSG---------------------------------------------GYWNSVSDTAKDLVSKMLH 263 (342)
T ss_dssp HHHHHHHHHCCCCCCS---------------------------------------------TTTTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHccCCcccCc---------------------------------------------cccccCCHHHHHHHHHHCC
Confidence 2333322221111110 1123467899999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~ 374 (379)
.||++|||++|+++||||.+
T Consensus 264 ~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 264 VDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp SSTTTSCCHHHHTTSHHHHT
T ss_pred CChhHCcCHHHHhcCCeecC
Confidence 99999999999999999954
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=361.42 Aligned_cols=289 Identities=27% Similarity=0.438 Sum_probs=221.1
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc-
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN- 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~- 117 (379)
...|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.++..+ .|+|++++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSCCS
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-----CCCCccceEEeeccccc
Confidence 35689999999999999999999999999999999742 23345667888888887 7899999999987654
Q ss_pred -----eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 118 -----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 118 -----~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..|+||||+.++|.+.+.. .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 99 ~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~-------------- 160 (371)
T 2xrw_A 99 LEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-------------- 160 (371)
T ss_dssp TTTCCEEEEEEECCSEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--------------
T ss_pred cccccceEEEEEcCCCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE--------------
Confidence 7899999998889988863 48999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 161 -------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 161 -------------KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp -------------CTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred -------------cCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 455678888888876544332 33578999999999999899999999999999999999999999
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhh-hhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRES-IKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
+.+..+....+.+..+.++.+.++.+......+..+.. .+... ..+. ...... +. ........+..+.+||
T Consensus 228 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~-~~----~~~~~~~~~~~~~~li 299 (371)
T 2xrw_A 228 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRP-KYAGY--SFEKLFPDVLF-PA----DSEHNKLKASQARDLL 299 (371)
T ss_dssp CSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSC-CCCCC--CHHHHSCGGGS-CC----SSHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCc-ccccc--chhhhcccccC-cc----cccccccccHHHHHHH
Confidence 98888888888888888888888777666655554421 11110 0010 000000 00 0011122467899999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
.+||+.||++|||++|+|+||||+.
T Consensus 300 ~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 300 SKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHCcCChhhCCCHHHHhCCcchhh
Confidence 9999999999999999999999964
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=356.16 Aligned_cols=286 Identities=26% Similarity=0.443 Sum_probs=222.3
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee---
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--- 115 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~--- 115 (379)
...|++.++||+|+||.||+|+++.+|+.||+|++... ......+.+|+.++..+ .|+|++++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-----CCTTBCCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-----cCCCcccHhheeecccc
Confidence 35789999999999999999999999999999998633 22344667899999888 68999999998876
Q ss_pred -----cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 116 -----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 116 -----~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
.+..|+||||+.++|.+.+.... ..+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 91 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~------------ 157 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI------------ 157 (351)
T ss_dssp ------CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------
T ss_pred ccccCCceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE------------
Confidence 45789999999878888887654 358999999999999999999999999999999999999
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-------CCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHH
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l 262 (379)
+.++.++|+|||.+...... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 158 ---------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 222 (351)
T 3mi9_A 158 ---------------TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222 (351)
T ss_dssp ---------------CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHH
T ss_pred ---------------cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHH
Confidence 45556777788777543311 123468999999999876 4579999999999999999
Q ss_pred HhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccch
Q 017021 263 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342 (379)
Q Consensus 263 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (379)
++|..||.+.+..+....+.+..+.++...++.+...... .......... ........ ....+
T Consensus 223 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-----------~~~~~~~~--~~~~~ 285 (351)
T 3mi9_A 223 WTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY----EKLELVKGQK-----------RKVKDRLK--AYVRD 285 (351)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGG----TSSCCCSSCC-----------CCHHHHHH--HHHCC
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhh----cccccccccc-----------cCHHHHhh--hccCC
Confidence 9999999999888888888888888887766544322110 0000000000 00000000 01235
Q ss_pred hHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 343 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 343 ~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
+.+.+||.+||+.||++|||++|+|+||||+....
T Consensus 286 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 286 PYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred hHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 77999999999999999999999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=354.50 Aligned_cols=251 Identities=29% Similarity=0.538 Sum_probs=187.3
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-C
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 127 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 127 (379)
+.||+|+||.||+|.++.+++.||+|++... ......+|+.++..+. +|+||+++++++.++...|+||||+ +
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~----~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCE----GHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhc----CCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 7899999999999999999999999999743 3456667888888772 4899999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCC
Q 017021 128 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 207 (379)
Q Consensus 128 ~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (379)
++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++..+ ..
T Consensus 91 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~------------------------~~ 144 (325)
T 3kn6_A 91 GELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE------------------------ND 144 (325)
T ss_dssp CBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC---------------------------
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecC------------------------CC
Confidence 89999998864 69999999999999999999999999999999999999543 22
Q ss_pred CCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH-------HH
Q 017021 208 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL-------EH 277 (379)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~-------~~ 277 (379)
...++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. +.
T Consensus 145 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 224 (325)
T 3kn6_A 145 NLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI 224 (325)
T ss_dssp -CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH
T ss_pred cccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH
Confidence 3468999999887543332 3456899999999999989999999999999999999999999764321 11
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.. +....+ ...+...++++.+||.+||+.||
T Consensus 225 ~~~i~~-----------------------~~~~~~----------------------~~~~~~~s~~~~~li~~~L~~dP 259 (325)
T 3kn6_A 225 MKKIKK-----------------------GDFSFE----------------------GEAWKNVSQEAKDLIQGLLTVDP 259 (325)
T ss_dssp HHHHTT-----------------------TCCCCC----------------------SHHHHTSCHHHHHHHHHHHCCCT
T ss_pred HHHHHc-----------------------CCCCCC----------------------cccccCCCHHHHHHHHHHCCCCh
Confidence 111111 111111 01123467899999999999999
Q ss_pred CCCcCHHHHhcCCCCCCCC
Q 017021 358 TDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f~~~~ 376 (379)
.+|||++|+++||||++..
T Consensus 260 ~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 260 NKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp TTCCCTTTSTTCGGGCTTC
T ss_pred hHCCCHHHHhcChhhccCc
Confidence 9999999999999998753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=357.28 Aligned_cols=280 Identities=28% Similarity=0.485 Sum_probs=225.1
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--- 116 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--- 116 (379)
+..|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.++..+ .|+|++.+++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-----RHENIIGINDIIRAPTIE 100 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-----CCTTBCCCCEEECCSSTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-----CCCCCccceeEEecCCcc
Confidence 45799999999999999999999999999999999732 23346677899999888 689999999988654
Q ss_pred --ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 117 --NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 117 --~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
...|+|||+++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---------------- 161 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---------------- 161 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----------------
T ss_pred ccceEEEEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE----------------
Confidence 478999999988999999875 49999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus 162 -----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 230 (364)
T 3qyz_A 162 -----------NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230 (364)
T ss_dssp -----------CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred -----------CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCC
Confidence 455667888888776443321 23478999999998754 458999999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhh-hhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
||.+.+..+....+....+.++.+.+..+..... .+.... ..+.. ..........+.++.
T Consensus 231 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-----------------~~~~~~~~~~~~~~~ 291 (364)
T 3qyz_A 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL--PHKNK-----------------VPWNRLFPNADSKAL 291 (364)
T ss_dssp SSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS--CCCCC-----------------CCHHHHCTTSCHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhc--CCccC-----------------CCHHHhCCCCCHHHH
Confidence 9999988888888999889888877665332221 111100 00000 001122335678899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+||.+||+.||++|||++|+|+||||++.
T Consensus 292 ~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 292 DLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 99999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=357.27 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=199.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
..|++.+.||+|+||.||+|+++.+++.||+|+++... ....+.+|+.++..+ .|+||+++++++...+..++|
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRL-----SHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHC-----CCTTBCCEEEEEECSSEEEEE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhC-----CCCCCcceeeeEecCCeEEEE
Confidence 45899999999999999999999999999999998533 345667799999888 689999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++...
T Consensus 127 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~-------------------- 184 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP-------------------- 184 (349)
T ss_dssp ECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSS--------------------
T ss_pred EEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecC--------------------
Confidence 9999 899999997754 68999999999999999999999999999999999999431
Q ss_pred cccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH-HH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE-HL 278 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~-~~ 278 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||......+ ..
T Consensus 185 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 260 (349)
T 2w4o_A 185 ----APDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF 260 (349)
T ss_dssp ----STTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH
T ss_pred ----CCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH
Confidence 236678999999887544332 34578999999999999899999999999999999999999997655433 22
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+.......+. ..++..+.++.+||.+||+.||+
T Consensus 261 ~~i~~~~~~~~~---------------------------------------------~~~~~~~~~~~~li~~~L~~dP~ 295 (349)
T 2w4o_A 261 RRILNCEYYFIS---------------------------------------------PWWDEVSLNAKDLVRKLIVLDPK 295 (349)
T ss_dssp HHHHTTCCCCCT---------------------------------------------TTTTTSCHHHHHHHHTTSCSSGG
T ss_pred HHHHhCCCccCC---------------------------------------------chhhhCCHHHHHHHHHHccCChh
Confidence 222221111110 01234677899999999999999
Q ss_pred CCcCHHHHhcCCCCCCCC
Q 017021 359 DRLTAREALRHPFFTRDH 376 (379)
Q Consensus 359 ~Rpta~e~l~hp~f~~~~ 376 (379)
+|||+.|+++||||++..
T Consensus 296 ~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 296 KRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp GSCCHHHHHHSTTTTSTT
T ss_pred hCcCHHHHhcCcccCCCc
Confidence 999999999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=357.48 Aligned_cols=280 Identities=26% Similarity=0.448 Sum_probs=219.0
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch------hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
...|++.+.||+|+||.||+|.++.+|+.||+|++..... ....+.+|+.++..+ .|+|++++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-----SHPNIIGLLDAFGH 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-----CCTTBCCEEEEECC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-----CCCCCCeEEEEEee
Confidence 4578999999999999999999999999999999874221 124567899999888 68999999999999
Q ss_pred cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 116 RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 116 ~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
.+..++||||+.++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~----------------- 145 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL----------------- 145 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-----------------
T ss_pred CCceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE-----------------
Confidence 99999999999779999887653 358889999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+
T Consensus 146 ----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~ 215 (346)
T 1ua2_A 146 ----------DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 215 (346)
T ss_dssp ----------CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ----------cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 455678888888876543322 345789999999999764 588999999999999999999999999
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+..+....+.+..+.++...|+......+......... . .........+.++.+||.+
T Consensus 216 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~-----~~~~~~~~~~~~~~~li~~ 274 (346)
T 1ua2_A 216 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG----------------I-----PLHHIFSAAGDDLLDLIQG 274 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCC----------------C-----CHHHHCTTCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCC----------------C-----ChHHhhccCCHHHHHHHHH
Confidence 888888888877777766554443322111110000000 0 0112234567899999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
||+.||++|||++|+++||||+..
T Consensus 275 ~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 275 LFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp HHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HhccChhhCCCHHHHhcChhhhcC
Confidence 999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=358.45 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=206.3
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchh----hHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.....|++.+.||+|+||.||+|+++.+++.||+|+++..... ......|..++ .....|++|+++++.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~l----l~~~~hp~Iv~l~~~~~~ 110 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL----LKNVKHPFLVGLHFSFQT 110 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CC----BCCCCCTTBCCEEEEEEC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHH----HHhCCCCCCCCEEEEEEe
Confidence 4456789999999999999999999999999999999754321 12222232221 122478999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..|+||||+ |++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||++
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---------------- 172 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---------------- 172 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----------------
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE----------------
Confidence 99999999999 899999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccC---CCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||++.... ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+
T Consensus 173 -----------~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 173 -----------DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp -----------CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred -----------CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 556678888888876422 223456899999999999999999999999999999999999999998
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+..+....+.......+ ...+..+.+||.+
T Consensus 242 ~~~~~~~~~i~~~~~~~~-------------------------------------------------~~~~~~~~~li~~ 272 (373)
T 2r5t_A 242 RNTAEMYDNILNKPLQLK-------------------------------------------------PNITNSARHLLEG 272 (373)
T ss_dssp SBHHHHHHHHHHSCCCCC-------------------------------------------------SSSCHHHHHHHHH
T ss_pred CCHHHHHHHHHhcccCCC-------------------------------------------------CCCCHHHHHHHHH
Confidence 777666554443211111 2356789999999
Q ss_pred ccccCCCCCcCH----HHHhcCCCCCCCC
Q 017021 352 LLRYDPTDRLTA----REALRHPFFTRDH 376 (379)
Q Consensus 352 ~L~~dP~~Rpta----~e~l~hp~f~~~~ 376 (379)
||+.||.+||++ .++++||||+..+
T Consensus 273 lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 273 LLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp HTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred HcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 999999999987 6999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=350.56 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=197.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch---hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
..|++.++||+|+||+||+|+++.+++.||+|++..... .......|+..+..+ ..|+|++++++++.+++..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~----~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV----GQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHH----CCCTTBCCEEEEEEETTEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHh----cCCCcEEEEEEEEEeCCEE
Confidence 568999999999999999999999999999999864322 223333444444443 2679999999999999999
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 120 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 120 ~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
|+||||++++|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++
T Consensus 133 ~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~-------------------- 191 (311)
T 3p1a_A 133 YLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG-------------------- 191 (311)
T ss_dssp EEEEECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--------------------
T ss_pred EEEEeccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC--------------------
Confidence 9999999999999987754 3699999999999999999999999999999999999994
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
.++.++|+|||.+....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..|+.......
T Consensus 192 -------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~- 262 (311)
T 3p1a_A 192 -------PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ- 262 (311)
T ss_dssp -------GGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH-
T ss_pred -------CCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-
Confidence 44567777777776543332 23468999999999876 78999999999999999999977665422211
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
.+.+ +..+. ......+.++.++|.+||+.||
T Consensus 263 --~~~~--~~~~~---------------------------------------------~~~~~~~~~l~~li~~~L~~dP 293 (311)
T 3p1a_A 263 --QLRQ--GYLPP---------------------------------------------EFTAGLSSELRSVLVMMLEPDP 293 (311)
T ss_dssp --HHTT--TCCCH---------------------------------------------HHHTTSCHHHHHHHHHHSCSST
T ss_pred --HHhc--cCCCc---------------------------------------------ccccCCCHHHHHHHHHHcCCCh
Confidence 1100 11111 1223467889999999999999
Q ss_pred CCCcCHHHHhcCCCCCCC
Q 017021 358 TDRLTAREALRHPFFTRD 375 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f~~~ 375 (379)
++|||++|+++||||+++
T Consensus 294 ~~Rpt~~ell~hp~~~~p 311 (311)
T 3p1a_A 294 KLRATAEALLALPVLRQP 311 (311)
T ss_dssp TTSCCHHHHHTSGGGSCC
T ss_pred hhCcCHHHHHhCccccCC
Confidence 999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=355.63 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=204.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
..|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ .|+||+++++++.+++..|
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-----CCCCCCeEEEEEecCCeEE
Confidence 46889999999999999999999999999999986432 2335667889888887 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll--------------------- 138 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL--------------------- 138 (323)
T ss_dssp EEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---------------------
T ss_pred EEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---------------------
Confidence 999999 889999887654 69999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCC-CCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 139 ------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 139 ------DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp ------CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred ------eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 55567888888887543221 134578999999999988775 688999999999999999999997654
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
................ ..+...+..+.+||.+||
T Consensus 213 ~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~L 246 (323)
T 3tki_A 213 DSCQEYSDWKEKKTYL----------------------------------------------NPWKKIDSAPLALLHKIL 246 (323)
T ss_dssp TTSHHHHHHHTTCTTS----------------------------------------------TTGGGSCHHHHHHHHHHS
T ss_pred hHHHHHHHHhcccccC----------------------------------------------CccccCCHHHHHHHHHHc
Confidence 3211111000000000 011346778999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+.||++|||++|+++||||+...
T Consensus 247 ~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 247 VENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp CSSTTTSCCHHHHTTCTTTTCCC
T ss_pred cCChhhCcCHHHHhhChhhcccc
Confidence 99999999999999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=364.69 Aligned_cols=259 Identities=23% Similarity=0.357 Sum_probs=213.7
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
.+....|++.++||+|+||.||+|+++.+++.||+|+++... .....+..|..++..+ .|++|+++++++.
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-----~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-----DSKWITTLHYAFQ 144 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-----CTTTBCCEEEEEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEe
Confidence 344567899999999999999999999999999999997422 2223366788888776 7899999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
+.+..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl--------------- 208 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM--------------- 208 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---------------
Confidence 999999999999 999999998743 369999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHh
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~ 264 (379)
+.++.+||+|||++....... ...+||+.|+|||++. ...++.++|||||||++|+|++
T Consensus 209 ------------~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ellt 276 (437)
T 4aw2_A 209 ------------DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276 (437)
T ss_dssp ------------CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHH
T ss_pred ------------cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHh
Confidence 556678888888776443332 2357999999999987 4568999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHc--CCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccch
Q 017021 265 GEALFQTHENLEHLAMMERVL--GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (379)
|+.||.+.+..+....+.... ...|. .....+
T Consensus 277 G~~Pf~~~~~~~~~~~i~~~~~~~~~p~----------------------------------------------~~~~~s 310 (437)
T 4aw2_A 277 GETPFYAESLVETYGKIMNHKERFQFPT----------------------------------------------QVTDVS 310 (437)
T ss_dssp SSCTTCCSSHHHHHHHHHTHHHHCCCCS----------------------------------------------SCCCSC
T ss_pred CCCCCCCCChhHHHHhhhhccccccCCc----------------------------------------------ccccCC
Confidence 999999887766665553311 11111 012367
Q ss_pred hHHHHHHhhccccCCCC--CcCHHHHhcCCCCCCCC
Q 017021 343 GDLTHLLQGLLRYDPTD--RLTAREALRHPFFTRDH 376 (379)
Q Consensus 343 ~~~~~li~~~L~~dP~~--Rpta~e~l~hp~f~~~~ 376 (379)
+++++||++||+.+|++ |++++|+++||||++.+
T Consensus 311 ~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 311 ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 88999999999999988 99999999999998754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=355.11 Aligned_cols=286 Identities=29% Similarity=0.451 Sum_probs=215.0
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc-----
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----- 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~----- 117 (379)
..|++.+.||+|+||.||+|+++.+++.||+|++............++..+..+ .|+|++++++++...+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-----~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-----HHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-----CCTTBCCEEEEEEEECSSCTT
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-----CCCCcccHHHhhhcccccccc
Confidence 468899999999999999999999999999999976555555666677777777 7899999999986533
Q ss_pred --eEEEEEeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH--HcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 118 --HICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 118 --~~~lv~e~~~~sL~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
..++||||+.++|.+.+.. .....+++..+..++.|++.||.||| +.||+||||||+||+++.
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~----------- 166 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE----------- 166 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET-----------
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC-----------
Confidence 3899999997777766653 23346899999999999999999999 999999999999999952
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCC-CCCccchHhHHHHHHHHHhCCCC
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~~l~~g~~p 268 (379)
.++.++|+|||.+....... ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.|
T Consensus 167 ---------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~p 231 (360)
T 3e3p_A 167 ---------------ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPI 231 (360)
T ss_dssp ---------------TTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ---------------CCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 25578888888886544332 3456899999999987654 89999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|.+.+..+....+.+..+.++.+.+..+.............. ..............+.++.+|
T Consensus 232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l 294 (360)
T 3e3p_A 232 FRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKG-----------------IPWSNVFSDHSLKDAKEAYDL 294 (360)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCC-----------------CCHHHHTTTCCCTTHHHHHHH
T ss_pred cCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhcccccccc-----------------CCcccccchhhccccHHHHHH
Confidence 999998888999999999999888776543322111100000 001111112223467889999
Q ss_pred HhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
|.+||+.||.+|||+.|+|+||||++..
T Consensus 295 i~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 295 LSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHHHhccCccccCCHHHHhcCccccccC
Confidence 9999999999999999999999998653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=362.57 Aligned_cols=281 Identities=28% Similarity=0.521 Sum_probs=221.4
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee----
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---- 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~---- 115 (379)
.....|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+|+.++..+ .|+||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l-----~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVL-----DHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTC-----CCTTBCCEEEEEEEC---
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHc-----CCCCccchhheeeecCcc
Confidence 345579999999999999999999999999999999875432 234688888777 78999999998843
Q ss_pred ----------------------------------cceEEEEEeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHH
Q 017021 116 ----------------------------------RNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIA 159 (379)
Q Consensus 116 ----------------------------------~~~~~lv~e~~~~sL~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~ 159 (379)
..+.++||||+.++|.+.+.. .....+++..+..++.||+.||.
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 345899999998888888764 23346999999999999999999
Q ss_pred HHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC--CCcccccCCccc
Q 017021 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRA 237 (379)
Q Consensus 160 ~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~a 237 (379)
|||+.||+||||||+||+++. .++.++|+|||.+...... .....||+.|+|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~--------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~a 209 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNS--------------------------KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRA 209 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEET--------------------------TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCC
T ss_pred HHHHCcCccCccCHHHEEEcC--------------------------CCCcEEEEECCCCcccCCCCCCcCcccCCCccC
Confidence 999999999999999999942 3457888888888754332 234578999999
Q ss_pred hhhhhCCC-CCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCC
Q 017021 238 PEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA 316 (379)
Q Consensus 238 PE~~~~~~-~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (379)
||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.+..+.++.+.+......... ..++....
T Consensus 210 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~------~~~~~~~~ 283 (383)
T 3eb0_A 210 PELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE------VRFPTLKA 283 (383)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--------CCCCCCCC
T ss_pred HHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc------ccCCccCc
Confidence 99987754 899999999999999999999999999999999999999998887766544322111 11111000
Q ss_pred chhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 317 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
...........+.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 284 --------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 284 --------------KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp --------------CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred --------------ccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 01111223456788999999999999999999999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=358.64 Aligned_cols=253 Identities=23% Similarity=0.414 Sum_probs=208.9
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
....|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ .|+||+.+++++.+.
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-----EHPFLVNLWYSFQDE 87 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECS
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEeC
Confidence 3456889999999999999999999999999999997432 2335666788888877 789999999999999
Q ss_pred ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 117 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
+..|+||||+ |++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll----------------- 148 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL----------------- 148 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE-----------------
T ss_pred CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE-----------------
Confidence 9999999999 999999998754 69999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC---CCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 149 ----------~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 149 ----------DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp ----------CTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ----------CCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 566678888888886543322 45679999999999864 458899999999999999999999997
Q ss_pred CCchH---HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 271 THENL---EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 271 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
..+.. +....+.......| ..++..+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~p-------------------------------------------------~~~s~~~~~ 249 (384)
T 4fr4_A 219 IRSSTSSKEIVHTFETTVVTYP-------------------------------------------------SAWSQEMVS 249 (384)
T ss_dssp CCTTSCHHHHHHHHHHCCCCCC-------------------------------------------------TTSCHHHHH
T ss_pred CCCCccHHHHHHHHhhcccCCC-------------------------------------------------CcCCHHHHH
Confidence 54322 22222211111111 235678999
Q ss_pred HHhhccccCCCCCcC-HHHHhcCCCCCCCC
Q 017021 348 LLQGLLRYDPTDRLT-AREALRHPFFTRDH 376 (379)
Q Consensus 348 li~~~L~~dP~~Rpt-a~e~l~hp~f~~~~ 376 (379)
||.+||+.||.+||+ ++++++||||++.+
T Consensus 250 li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 250 LLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp HHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred HHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 999999999999998 99999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=343.88 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=216.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
..|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ .|+|++++++++..++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-----CCCCcCeEEEEEEcCCEE
Confidence 46889999999999999999999999999999997432 2234566788888888 689999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++||||+ +++|.+.+.... .+++..+..++.|++.||.|||+.|++||||||+||+++.+
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~----------------- 141 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK----------------- 141 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSS-----------------
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecC-----------------
Confidence 9999999 889999887764 68999999999999999999999999999999999999543
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.....++|+|||.+....... ....||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+
T Consensus 142 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 214 (284)
T 3kk8_A 142 -------AKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214 (284)
T ss_dssp -------STTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------CCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH
Confidence 233558999999886554433 33578999999999999899999999999999999999999998877766
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.......+.. .+...++++.+||.+||+.|
T Consensus 215 ~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~li~~~l~~d 249 (284)
T 3kk8_A 215 LYAQIKAGAYDYPSP---------------------------------------------EWDTVTPEAKSLIDSMLTVN 249 (284)
T ss_dssp HHHHHHHTCCCCCTT---------------------------------------------TTTTSCHHHHHHHHHHSCSS
T ss_pred HHHHHHhccccCCch---------------------------------------------hhcccCHHHHHHHHHHcccC
Confidence 655554433322211 01235678999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~~ 376 (379)
|++|||++|+++||||++.+
T Consensus 250 p~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 250 PKKRITADQALKVPWICNRE 269 (284)
T ss_dssp TTTSCCHHHHTTSHHHHSCC
T ss_pred hhhCCCHHHHhcCccccCCh
Confidence 99999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=368.47 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=204.6
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
...|++.++||+|+||.||+|.++.+|+.||+|+++... ........|+.+++.+ .|+|++.+++++...+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-----RHPFLTALKYSFQTHD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-----SCTTSCCEEEEEEETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-----CCCeEeeEEEEEeeCC
Confidence 456899999999999999999999999999999997431 2223344565555554 6899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
.+|+||||+ +++|.+++.... .+++..+..++.||+.||+|||+ .||+||||||+|||+
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll----------------- 282 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML----------------- 282 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE-----------------
T ss_pred EEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE-----------------
Confidence 999999999 899999997754 68999999999999999999998 999999999999999
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 283 ----------~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 283 ----------DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp ----------CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 45567888888877643222 23467999999999999999999999999999999999999999887
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+.......| ...++++.+||.+|
T Consensus 353 ~~~~~~~~i~~~~~~~p-------------------------------------------------~~~~~~~~~li~~~ 383 (446)
T 4ejn_A 353 DHEKLFELILMEEIRFP-------------------------------------------------RTLGPEAKSLLSGL 383 (446)
T ss_dssp SHHHHHHHHHHCCCCCC-------------------------------------------------TTSCHHHHHHHHHH
T ss_pred CHHHHHHHHHhCCCCCC-------------------------------------------------ccCCHHHHHHHHHH
Confidence 76665554443222222 13567899999999
Q ss_pred cccCCCCCc-----CHHHHhcCCCCCCCC
Q 017021 353 LRYDPTDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 353 L~~dP~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
|+.||.+|| |++|+++||||++..
T Consensus 384 L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 384 LKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred cccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 999999999 999999999999754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=342.19 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=216.3
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
...|++.+.||+|+||.||+|.++.++..||+|++... ......+.+|+.++..+ .|+|++++++++.+.+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-----DHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCeEE
Confidence 34689999999999999999999999999999998743 23345677888888887 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++..+
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~------------------ 142 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD------------------ 142 (277)
T ss_dssp EEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS------------------
T ss_pred EEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC------------------
Confidence 999999 889999987754 68999999999999999999999999999999999999332
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
+.+..++|+|||.+....... ....||+.|+|||.+.+. ++.++||||||+++|+|++|..||...+..+.
T Consensus 143 ------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 215 (277)
T 3f3z_A 143 ------SPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV 215 (277)
T ss_dssp ------STTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ------CCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 355678999999886544332 345789999999998764 89999999999999999999999998777776
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+.....+...+ ...++.+.++|.+||+.||
T Consensus 216 ~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~li~~~l~~dp 250 (277)
T 3f3z_A 216 MLKIREGTFTFPEKDW---------------------------------------------LNVSPQAESLIRRLLTKSP 250 (277)
T ss_dssp HHHHHHCCCCCCHHHH---------------------------------------------TTSCHHHHHHHHHHTCSST
T ss_pred HHHHHhCCCCCCchhh---------------------------------------------hcCCHHHHHHHHHHccCCh
Confidence 6666554444443221 2356789999999999999
Q ss_pred CCCcCHHHHhcCCCCCC
Q 017021 358 TDRLTAREALRHPFFTR 374 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f~~ 374 (379)
.+|||+.|+++||||++
T Consensus 251 ~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 251 KQRITSLQALEHEWFEK 267 (277)
T ss_dssp TTSCCHHHHTTSHHHHH
T ss_pred hhCcCHHHHhcCHHHhc
Confidence 99999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=363.45 Aligned_cols=293 Identities=26% Similarity=0.469 Sum_probs=209.5
Q ss_pred hhh-hhccccccceeEEEEEec--CCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee--ecceE
Q 017021 45 DKI-HSKMGEGTFGQVLECWDR--ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--YRNHI 119 (379)
Q Consensus 45 y~i-~~~Lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~--~~~~~ 119 (379)
|++ .++||+|+||.||+|+++ .+++.||+|++... .....+.+|+.++..+ .|+||+++++++. .....
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLREL-----KHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHC-----CCTTBCCCCEEEEETTTTEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhc-----CCCCeeeEeeEEecCCCCeE
Confidence 444 458999999999999965 56899999999743 3345677899999998 6899999999995 47789
Q ss_pred EEEEeCCCCCHHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 120 CIVFEKLGSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 120 ~lv~e~~~~sL~~~l~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
|+||||++++|.+++.... ...+++..++.++.||+.||.|||+.||+||||||+||++...+
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~---------- 165 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG---------- 165 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS----------
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC----------
Confidence 9999999889998886321 12489999999999999999999999999999999999994321
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCC------CCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g 265 (379)
+..+.++|+|||.+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 166 -------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 232 (405)
T 3rgf_A 166 -------------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232 (405)
T ss_dssp -------------TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHS
T ss_pred -------------CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhC
Confidence 35567899999988754432 1335789999999999874 489999999999999999999
Q ss_pred CCCCCCCch---------HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHH
Q 017021 266 EALFQTHEN---------LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336 (379)
Q Consensus 266 ~~pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (379)
..||.+... .+....+.+.++.++...|..+............. ................
T Consensus 233 ~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~ 301 (405)
T 3rgf_A 233 EPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF-----------RRNTYTNCSLIKYMEK 301 (405)
T ss_dssp SCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHC-----------CGGGGTTCCHHHHHHT
T ss_pred CCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhc-----------cccCCCcchhhhhHhh
Confidence 999976543 36667777778877766655443221111000000 0000001111122222
Q ss_pred hhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 337 ~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
.....+..+.+||.+||+.||.+||||+|+|+||||++..+
T Consensus 302 ~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 302 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp TTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred cCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 33345778999999999999999999999999999987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=352.61 Aligned_cols=261 Identities=24% Similarity=0.365 Sum_probs=213.3
Q ss_pred hhhhh-hccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~-~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|.+. +.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ .+|++++++++++...+..
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l----~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELA----KSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHT----TTCTTBCCEEEEEECSSEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhc----cCCCCEEEEEEEEEeCCeE
Confidence 35555 88999999999999999999999999997432 2345667788888776 3568999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++||||+ +++|.+++.......+++..+..++.||+.||+|||+.|++||||||+||+++..
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~----------------- 167 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSI----------------- 167 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCB-----------------
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecC-----------------
Confidence 9999999 8899999866544579999999999999999999999999999999999999431
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
...+.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 168 -------~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 240 (327)
T 3lm5_A 168 -------YPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE 240 (327)
T ss_dssp -------TTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------CCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH
Confidence 125678999999887554432 34579999999999999899999999999999999999999999887776
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+.....+... ....+..+.++|.+||+.|
T Consensus 241 ~~~~i~~~~~~~~~~~---------------------------------------------~~~~~~~~~~li~~~L~~d 275 (327)
T 3lm5_A 241 TYLNISQVNVDYSEET---------------------------------------------FSSVSQLATDFIQSLLVKN 275 (327)
T ss_dssp HHHHHHHTCCCCCTTT---------------------------------------------TTTSCHHHHHHHHHHSCSS
T ss_pred HHHHHHhcccccCchh---------------------------------------------hcccCHHHHHHHHHHcCCC
Confidence 6665555443333211 1235678999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCCCc
Q 017021 357 PTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~~~ 377 (379)
|.+|||++|+|+||||++.+.
T Consensus 276 P~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 276 PEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp GGGSCCHHHHTTCGGGCCCCT
T ss_pred hhhCcCHHHHhCCHhhccccc
Confidence 999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=351.20 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=199.5
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch---------------------------hhHhHHHHHHHHHH
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------------------------YREAAMIEIEVLQQ 95 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------------------------~~~~~~~e~~~l~~ 95 (379)
..|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.++..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 468899999999999999999999999999999974321 12456778888888
Q ss_pred HHhcCCCCCeeEEecceeee--cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Q 017021 96 LAKHDKGGNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLK 172 (379)
Q Consensus 96 l~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlk 172 (379)
+ .|+|++++++++.+ .+..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.|++|||||
T Consensus 93 l-----~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 164 (298)
T 2zv2_A 93 L-----DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164 (298)
T ss_dssp C-----CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred C-----CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 7 78999999999986 57899999999 8888776433 359999999999999999999999999999999
Q ss_pred CCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCC---C
Q 017021 173 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG---W 246 (379)
Q Consensus 173 p~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~---~ 246 (379)
|+||++ +.++.++|+|||.+....... ....||+.|+|||.+.+.. +
T Consensus 165 p~Nil~---------------------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 217 (298)
T 2zv2_A 165 PSNLLV---------------------------GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFS 217 (298)
T ss_dssp GGGEEE---------------------------CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEE
T ss_pred HHHEEE---------------------------CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCC
Confidence 999999 455667888888776543322 3357899999999987655 3
Q ss_pred CCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhcc
Q 017021 247 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 326 (379)
Q Consensus 247 ~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (379)
+.++|||||||++|+|++|..||...+.......+.......| .
T Consensus 218 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------------~------------- 261 (298)
T 2zv2_A 218 GKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFP-----------------------D------------- 261 (298)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------------------S-------------
T ss_pred CchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCC-----------------------C-------------
Confidence 6789999999999999999999987665444433332211111 0
Q ss_pred chhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 327 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
....+..+.++|.+||+.||++|||++|+++||||++
T Consensus 262 -----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 262 -----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp -----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred -----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 1235678999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=360.76 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=211.3
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.....|++.+.||+|+||.||+|+++.+|+.||+|+++... .....+..|..++..+ .|++|+++++++.+
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-----~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-----DRRWITQLHFAFQD 132 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-----CTTTBCCEEEEEEC
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEee
Confidence 44567899999999999999999999999999999997422 2234456788888776 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..|+||||+ +++|.+++.+.+ ..+++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---------------- 195 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---------------- 195 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----------------
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee----------------
Confidence 99999999999 999999998753 258999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhh-------CCCCCCccchHhHHHHHHHHH
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVIL-------GLGWTYPCDIWSVGCILVELC 263 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlG~il~~l~ 263 (379)
+.++.++|+|||++....... ...+||+.|+|||++. ...++.++|||||||++|+|+
T Consensus 196 -----------d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell 264 (412)
T 2vd5_A 196 -----------DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264 (412)
T ss_dssp -----------CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH
T ss_pred -----------cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH
Confidence 556678888888876544332 2357999999999987 356899999999999999999
Q ss_pred hCCCCCCCCchHHHHHHHHHHc--CCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccc
Q 017021 264 TGEALFQTHENLEHLAMMERVL--GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341 (379)
Q Consensus 264 ~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (379)
+|+.||.+.+..+....+.... ...|. .....
T Consensus 265 tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~----------------------------------------------~~~~~ 298 (412)
T 2vd5_A 265 YGQTPFYADSTAETYGKIVHYKEHLSLPL----------------------------------------------VDEGV 298 (412)
T ss_dssp HSSCTTCCSSHHHHHHHHHTHHHHCCCC--------------------------------------------------CC
T ss_pred hCCCCCCCCCHHHHHHHHHhcccCcCCCc----------------------------------------------cccCC
Confidence 9999999877766655443311 11110 01246
Q ss_pred hhHHHHHHhhccccCCCCC---cCHHHHhcCCCCCCCC
Q 017021 342 AGDLTHLLQGLLRYDPTDR---LTAREALRHPFFTRDH 376 (379)
Q Consensus 342 ~~~~~~li~~~L~~dP~~R---pta~e~l~hp~f~~~~ 376 (379)
+.++++||++||+ +|.+| |+++|+++||||++.+
T Consensus 299 s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 7899999999999 99998 5999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=370.06 Aligned_cols=257 Identities=30% Similarity=0.497 Sum_probs=216.8
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
...|++.++||+|+||+||+|+++.+++.||+|++... ......+.+|+.++.++ .|+||+++++++.+.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-----DHPNIMKLFEILEDSSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-----CCCCcCeEEEEEEcCCE
Confidence 35689999999999999999999999999999998632 23456677899999998 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+||||+ +++|.+.+.... .+++..+..++.||+.||.|||+.||+||||||+||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~---------------- 157 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK---------------- 157 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSS----------------
T ss_pred EEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC----------------
Confidence 99999999 899999987754 69999999999999999999999999999999999999532
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
..+..++|+|||.+....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..
T Consensus 158 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 228 (486)
T 3mwu_A 158 --------EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (486)
T ss_dssp --------STTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------CCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 345679999999887554433 34579999999999877 5899999999999999999999999988777
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.......+.. .+...++++.+||.+||+.
T Consensus 229 ~~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~ 263 (486)
T 3mwu_A 229 DILKRVETGKYAFDLP---------------------------------------------QWRTISDDAKDLIRKMLTF 263 (486)
T ss_dssp HHHHHHHHTCCCSCSG---------------------------------------------GGGGSCHHHHHHHHHHTCS
T ss_pred HHHHHHHhCCCCCCCc---------------------------------------------ccCCCCHHHHHHHHHHcCC
Confidence 7666555533322211 1234678899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~ 375 (379)
||.+|||+.|+|+||||+..
T Consensus 264 dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 264 HPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp STTTSCCHHHHHHCHHHHHT
T ss_pred ChhhCcCHHHHhcCHhhccC
Confidence 99999999999999999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=348.83 Aligned_cols=254 Identities=25% Similarity=0.418 Sum_probs=209.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
..|+..++||+|+||.||+|+++.+|+.||+|++.... .....+.+|+.++..+ .|+|++++++++...+..++
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-----QHFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEEEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-----CCCCcceEEEEEEECCEEEE
Confidence 34666689999999999999999999999999997432 2345567788888777 78999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
||||+ +++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 120 v~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---------------------- 174 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---------------------- 174 (321)
T ss_dssp EECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----------------------
T ss_pred EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----------------------
Confidence 99999 89999998754 48999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.
T Consensus 175 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 175 -----TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp -----CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred -----CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 45566888888877654332 2345799999999999998899999999999999999999999987766554
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.....+... .....++.+.++|.+||+.||
T Consensus 250 ~~~~~~~~~~~~~----------------------------------------------~~~~~~~~l~~li~~~l~~dp 283 (321)
T 2c30_A 250 MKRLRDSPPPKLK----------------------------------------------NSHKVSPVLRDFLERMLVRDP 283 (321)
T ss_dssp HHHHHHSSCCCCT----------------------------------------------TGGGSCHHHHHHHHHHSCSST
T ss_pred HHHHhcCCCCCcC----------------------------------------------ccccCCHHHHHHHHHHccCCh
Confidence 4433332111100 012356789999999999999
Q ss_pred CCCcCHHHHhcCCCCCCCCc
Q 017021 358 TDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f~~~~~ 377 (379)
++|||++|+++||||.+...
T Consensus 284 ~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 284 QERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp TTSCCHHHHHTSGGGGGCCC
T ss_pred hhCcCHHHHhcChhhccCCC
Confidence 99999999999999987543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=346.15 Aligned_cols=273 Identities=24% Similarity=0.398 Sum_probs=200.8
Q ss_pred hhhhhh-hccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 43 FADKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 43 ~~y~i~-~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
..|++. +.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++.++ ..|+||+++++++.+++..|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~----~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC----QGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHT----CCCTTBCCEEEEEEETTEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHh----cCCCCeeeEEEEEeeCCEEE
Confidence 457774 78999999999999999999999999997432 3355677888888775 26899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++
T Consensus 88 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~----------------- 148 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN----------------- 148 (316)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSS-----------------
T ss_pred EEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCC-----------------
Confidence 999999 899999998754 689999999999999999999999999999999999995432
Q ss_pred cccccCCCCCCeEEeecCcccccCCC----------CCcccccCCccchhhhhC-----CCCCCccchHhHHHHHHHHHh
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~~l~~ 264 (379)
....++|+|||.+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 149 -------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~ 221 (316)
T 2ac3_A 149 -------QVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221 (316)
T ss_dssp -------SSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHH
T ss_pred -------CcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHH
Confidence 2234788888877543211 123458999999999875 457899999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||.+....+..... ...... ........+..+...++ ...+...+..
T Consensus 222 g~~pf~~~~~~~~~~~~----~~~~~~----~~~~~~~~i~~~~~~~~----------------------~~~~~~~~~~ 271 (316)
T 2ac3_A 222 GYPPFVGRCGSDCGWDR----GEACPA----CQNMLFESIQEGKYEFP----------------------DKDWAHISCA 271 (316)
T ss_dssp SSCSCCCCCCSCSCC--------CCHH----HHHHHHHHHHHCCCCCC----------------------HHHHTTSCHH
T ss_pred CCCCCcccccccccccc----cccchh----HHHHHHHHHhccCcccC----------------------chhcccCCHH
Confidence 99999764321100000 000000 00000001111111111 0112346788
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+.+||.+||+.||++|||++|+++||||++.
T Consensus 272 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 272 AKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 9999999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=359.51 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=207.7
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
+...+.||+|+||.||+|.+..+|+.||+|+++... .....+.+|+.++..+ .|+||+++++++...+..++||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-----DHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECCEEEEEE
Confidence 334678999999999999999999999999997532 3455677888888877 7899999999999999999999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++..
T Consensus 166 E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---------------------- 222 (373)
T 2x4f_A 166 EYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN---------------------- 222 (373)
T ss_dssp ECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE----------------------
T ss_pred eCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec----------------------
Confidence 999 899999887643 35899999999999999999999999999999999999953
Q ss_pred ccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+....++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 223 ---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 299 (373)
T 2x4f_A 223 ---RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN 299 (373)
T ss_dssp ---TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred ---CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 234568899999887554433 334699999999999988899999999999999999999999998877666655
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+......++.. .+...++++.+||.+||+.||.+|
T Consensus 300 i~~~~~~~~~~---------------------------------------------~~~~~~~~~~~li~~~L~~dp~~R 334 (373)
T 2x4f_A 300 ILACRWDLEDE---------------------------------------------EFQDISEEAKEFISKLLIKEKSWR 334 (373)
T ss_dssp HHHTCCCSCSG---------------------------------------------GGTTSCHHHHHHHHTTSCSSGGGS
T ss_pred HHhccCCCChh---------------------------------------------hhccCCHHHHHHHHHHcCCChhhC
Confidence 55433222211 112467789999999999999999
Q ss_pred cCHHHHhcCCCCCCC
Q 017021 361 LTAREALRHPFFTRD 375 (379)
Q Consensus 361 pta~e~l~hp~f~~~ 375 (379)
||++|+++||||++.
T Consensus 335 ps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 335 ISASEALKHPWLSDH 349 (373)
T ss_dssp CCHHHHHHSHHHHCH
T ss_pred CCHHHHhcCcCcCCC
Confidence 999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=351.54 Aligned_cols=283 Identities=27% Similarity=0.441 Sum_probs=220.8
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
...|++.+.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.++..+ .|+|++++++++...+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-----RHENLVNLLEVCKKKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-----CCCCEeeEEEEeecCCE
Confidence 456899999999999999999999999999999986432 2334566788888888 68999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+||||+ +++|.++..... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~------------------- 157 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV------------------- 157 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-------------------
T ss_pred EEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE-------------------
Confidence 99999999 667776655443 59999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+....... ....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+
T Consensus 158 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 158 --------SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp --------CTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --------cCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 555678888888876433322 335689999999999875 68899999999999999999999999988
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+....+..++.....+...... .....+.... ...........+..+.+||.+||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~L 291 (331)
T 4aaa_A 230 DIDQLYHIMMCLGNLIPRHQELFNKNPVF----AGVRLPEIKE--------------REPLERRYPKLSEVVIDLAKKCL 291 (331)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHHHHCGGG----TTCCCCCCSS--------------CCCHHHHSTTSCHHHHHHHHHHT
T ss_pred cHHHHHHHHHHhCCCChhhhhHhhhcccc----ccccCccccc--------------cchhhhcccchhHHHHHHHHHHh
Confidence 88888888888887776654443322110 0011111000 00111223456789999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+.||++|||++|+|+||||+...
T Consensus 292 ~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 292 HIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp CSSGGGSCCGGGGGGSHHHHGGG
T ss_pred ccCcccCCCHHHHhcCchhccCC
Confidence 99999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=371.25 Aligned_cols=256 Identities=30% Similarity=0.487 Sum_probs=217.6
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
...|++.+.||+|+||.||+|+++.+++.||+|++... ......+.+|+.++.++ .|+||+++++++.+.+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-----DHPNIMKLYEFFEDKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEeCC
Confidence 45789999999999999999999999999999998642 23456677899888887 7899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..|+||||+ +++|.+.+.... .+++..+..++.||+.||.|||+.||+||||||+||++...
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~--------------- 162 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK--------------- 162 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS---------------
T ss_pred EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecC---------------
Confidence 999999999 999999998765 69999999999999999999999999999999999999432
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
..++.++|+|||.+....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.
T Consensus 163 ---------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 232 (484)
T 3nyv_A 163 ---------SKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 232 (484)
T ss_dssp ---------STTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------CCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence 355779999999987655443 23579999999999977 689999999999999999999999998887
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+.+.....+.. .+...++.+.+||++||+
T Consensus 233 ~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~ 267 (484)
T 3nyv_A 233 YDILKKVEKGKYTFELP---------------------------------------------QWKKVSESAKDLIRKMLT 267 (484)
T ss_dssp HHHHHHHHHCCCCCCSG---------------------------------------------GGGGSCHHHHHHHHHHTC
T ss_pred HHHHHHHHcCCCCCCCc---------------------------------------------ccccCCHHHHHHHHHHCC
Confidence 77666655533222211 123467889999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~ 374 (379)
.||.+|||++|+|+||||+.
T Consensus 268 ~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 268 YVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp SSGGGSCCHHHHHTSHHHHH
T ss_pred CChhHCcCHHHHhhChhhcc
Confidence 99999999999999999964
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=342.56 Aligned_cols=254 Identities=24% Similarity=0.425 Sum_probs=209.9
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
+....|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++..+ .|+|++++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-----RHPNILRLYGYFHD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEEC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-----CCCCCcchhheEec
Confidence 34457889999999999999999999999999999986432 2234456677777666 68999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..++||||+ +++|.+.+.... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---------------- 142 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---------------- 142 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE----------------
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE----------------
Confidence 99999999999 889999998764 68999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+....... ....||+.|+|||.+.+..++.++||||||+++|+|++|..||...+
T Consensus 143 -----------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 143 -----------GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp -----------CTTSCEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----------cCCCCEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 555678888888775433332 34578999999999999889999999999999999999999998877
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.......| ...+..+.+||.+||
T Consensus 212 ~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~li~~~l 242 (279)
T 3fdn_A 212 YQETYKRISRVEFTFP-------------------------------------------------DFVTEGARDLISRLL 242 (279)
T ss_dssp HHHHHHHHHHTCCCCC-------------------------------------------------TTSCHHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCC-------------------------------------------------CcCCHHHHHHHHHHh
Confidence 6665555544333322 125678999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+.||.+|||++|+++||||+...
T Consensus 243 ~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 243 KHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp CSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ccChhhCCCHHHHhhCccccCCc
Confidence 99999999999999999997643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=370.56 Aligned_cols=255 Identities=28% Similarity=0.476 Sum_probs=212.1
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
..|++.++||+|+||+||+|+++.++..||+|++... ......+.+|+.++..+ .|+||+++++++.+.+..
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-----DHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEeCCEE
Confidence 4699999999999999999999999999999999743 22345667788888777 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +++|.+.+.... .+++..+..++.||+.||.|||+.||+||||||+||++...
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~----------------- 172 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK----------------- 172 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS-----------------
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCC-----------------
Confidence 9999999 899999887754 68999999999999999999999999999999999999532
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.....++|+|||.+....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+
T Consensus 173 -------~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 244 (494)
T 3lij_A 173 -------EKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244 (494)
T ss_dssp -------STTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------CCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 234568999999887544332 34579999999999864 68999999999999999999999999888777
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+.....+.. .+...++.+.+||.+||+.|
T Consensus 245 ~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~d 279 (494)
T 3lij_A 245 ILRKVEKGKYTFDSP---------------------------------------------EWKNVSEGAKDLIKQMLQFD 279 (494)
T ss_dssp HHHHHHHTCCCCCSG---------------------------------------------GGTTSCHHHHHHHHHHTCSS
T ss_pred HHHHHHhCCCCCCch---------------------------------------------hcccCCHHHHHHHHHHCCCC
Confidence 766665544333221 12346778999999999999
Q ss_pred CCCCcCHHHHhcCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTR 374 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~ 374 (379)
|.+|||+.|+|+||||++
T Consensus 280 p~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 280 SQRRISAQQALEHPWIKE 297 (494)
T ss_dssp TTTSCCHHHHHTCHHHHH
T ss_pred hhhCccHHHHhcCccccc
Confidence 999999999999999965
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=368.97 Aligned_cols=256 Identities=26% Similarity=0.436 Sum_probs=214.5
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--------------hhhHhHHHHHHHHHHHHhcCCCCCeeE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--------------KYREAAMIEIEVLQQLAKHDKGGNRCV 107 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------------~~~~~~~~e~~~l~~l~~~~~~~~~i~ 107 (379)
...|++.++||+|+||+||+|+++.+++.||+|++.... .....+.+|+.++..+ .|+||+
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv 109 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-----DHPNII 109 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-----CCTTBC
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-----CCCCCC
Confidence 457999999999999999999999999999999997432 2345677888888887 789999
Q ss_pred EecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccccc
Q 017021 108 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 186 (379)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~ 186 (379)
++++++.+....|+||||+ +++|.+.+.... .+++..+..++.||+.||.|||+.||+||||||+||++...
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~----- 182 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK----- 182 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESST-----
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecC-----
Confidence 9999999999999999999 899999987754 69999999999999999999999999999999999999543
Q ss_pred CCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh
Q 017021 187 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~ 264 (379)
.....++|+|||.+....... ....||+.|+|||++.+ .++.++|||||||++|+|++
T Consensus 183 -------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~ 242 (504)
T 3q5i_A 183 -------------------NSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLC 242 (504)
T ss_dssp -------------------TCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHH
T ss_pred -------------------CCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHh
Confidence 123468999999987554432 34579999999999875 68999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||.+.+..+....+.+.....+... +...+++
T Consensus 243 g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------------------------------------------~~~~s~~ 277 (504)
T 3q5i_A 243 GYPPFGGQNDQDIIKKVEKGKYYFDFND---------------------------------------------WKNISDE 277 (504)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCHHH---------------------------------------------HTTSCHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCccc---------------------------------------------cCCCCHH
Confidence 9999998887777666655433333221 2346788
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
+.+||++||+.||.+|||++|+|+||||++
T Consensus 278 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 278 AKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 999999999999999999999999999965
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=340.40 Aligned_cols=256 Identities=28% Similarity=0.403 Sum_probs=206.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
..|++.++||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ .|+|++++++++.+....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-----DHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-----CCchHHhHHHheecCCeEE
Confidence 46889999999999999999999999999999997543 2345677888888887 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+||||+ +++|.+.+... ....+++..+..++.||+.||.|||+.|++||||||+||++...
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~---------------- 160 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDT---------------- 160 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSS----------------
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecC----------------
Confidence 999999 88999998542 22469999999999999999999999999999999999999432
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+....++|+|||.+...... .....||+.|+|||.+.+ .++.++|||||||++|+|++|..||.+.+..
T Consensus 161 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~ 231 (285)
T 3is5_A 161 --------SPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE 231 (285)
T ss_dssp --------STTCCEEECCCCCCCC----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------CCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHH
Confidence 34567899999988654333 234578999999999864 6889999999999999999999999876655
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+............+. .....++.+.+||.+||+.
T Consensus 232 ~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~li~~~L~~ 265 (285)
T 3is5_A 232 EVQQKATYKEPNYAV----------------------------------------------ECRPLTPQAVDLLKQMLTK 265 (285)
T ss_dssp HHHHHHHHCCCCCCC------------------------------------------------CCCCHHHHHHHHHHTCS
T ss_pred HHHhhhccCCccccc----------------------------------------------ccCcCCHHHHHHHHHHccC
Confidence 544333221111110 0112567899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~ 374 (379)
||++|||++|+++||||++
T Consensus 266 dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 266 DPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CTTTSCCHHHHHTSGGGGC
T ss_pred ChhhCcCHHHHhcCHHhhc
Confidence 9999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=368.03 Aligned_cols=250 Identities=27% Similarity=0.389 Sum_probs=209.7
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
-.|++.+.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.++..+ .|+||+++++++...+.
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-----RHPHIIKLYQVISTPSD 90 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCE
Confidence 46889999999999999999999999999999997432 2234566788888776 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+||||+ +++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll------------------- 149 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL------------------- 149 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE-------------------
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE-------------------
Confidence 99999999 899999997654 69999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCC-CCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
+.++.++|+|||.+....... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.
T Consensus 150 --------~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 150 --------DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp --------CTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS
T ss_pred --------ecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH
Confidence 556678888888886544332 34579999999999988765 6899999999999999999999987666
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+.......| ...++++.+||.+||+
T Consensus 222 ~~~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~~Li~~~L~ 252 (476)
T 2y94_A 222 PTLFKKICDGIFYTP-------------------------------------------------QYLNPSVISLLKHMLQ 252 (476)
T ss_dssp HHHHHHHHTTCCCCC-------------------------------------------------TTCCHHHHHHHHHHTC
T ss_pred HHHHHHHhcCCcCCC-------------------------------------------------ccCCHHHHHHHHHHcC
Confidence 554443332211111 1256789999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.||.+|||++|+++||||++.
T Consensus 253 ~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 253 VDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp SSTTTSCCHHHHHTCHHHHTT
T ss_pred CCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=349.58 Aligned_cols=254 Identities=30% Similarity=0.509 Sum_probs=209.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---------hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
..|++.+.||+|+||.||+|.++.+|+.||||++.... .....+..|+.++..+. .|+|++.+++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~ 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA----GHPHIITLIDSY 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT----TCTTBCCEEEEE
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc----CCCCEeEEEEEE
Confidence 35888899999999999999999999999999986432 12345567888888872 578999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
...+..|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~-------------- 233 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL-------------- 233 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--------------
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--------------
Confidence 9999999999999 889999998754 69999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC------CCCCCccchHhHHHHHHHHHh
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~~l~~ 264 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 234 -------------~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~ 300 (365)
T 2y7j_A 234 -------------DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300 (365)
T ss_dssp -------------CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHH
T ss_pred -------------CCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHH
Confidence 555678888888776544332 34579999999999863 357899999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||...+.......+.......+.. .+...+..
T Consensus 301 g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~~~~ 335 (365)
T 2y7j_A 301 GSPPFWHRRQILMLRMIMEGQYQFSSP---------------------------------------------EWDDRSST 335 (365)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCHH---------------------------------------------HHSSSCHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCc---------------------------------------------ccccCCHH
Confidence 999998766655554444332222211 12346678
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
+.++|.+||+.||++|||++|+++||||++
T Consensus 336 ~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 336 VKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=353.26 Aligned_cols=278 Identities=28% Similarity=0.489 Sum_probs=220.4
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce-
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH- 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~- 118 (379)
..|++.+.||+|+||.||+|.++.+|+.||+|++... ......+.+|+.++..+ .|+|++++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-----QHENVIGLLDVFTPASSL 98 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCSSG
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-----CCCCcccHhheEeccccc
Confidence 4688999999999999999999999999999999642 22345667788888887 68999999999987653
Q ss_pred -----EEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 119 -----ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 119 -----~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
.|+||||+.++|.+++.. .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 99 ~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~--------------- 159 (353)
T 3coi_A 99 RNFYDFYLVMPFMQTDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV--------------- 159 (353)
T ss_dssp GGCCCCEEEEECCSEEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---------------
T ss_pred ccceeEEEEeccccCCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---------------
Confidence 599999998888877643 48999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++|+|||.+...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 160 ------------~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 160 ------------NEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp ------------CTTCCEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred ------------CCCCcEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 55567888888888765555555678999999999877 67899999999999999999999999998
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhh-hhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEK-YVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
+..+....+.+..+.++.+++..+...... +... ....+. ..........+..+.+||.+
T Consensus 228 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~------------------~~~~~~~~~~~~~~~~li~~ 288 (353)
T 3coi_A 228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQS-LPQTPR------------------KDFTQLFPRASPQAADLLEK 288 (353)
T ss_dssp CHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHT-SCBCSS------------------CCTTTTCTTSCHHHHHHHHH
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHh-CcCCCC------------------ccHHHhcCCcCHHHHHHHHH
Confidence 888888888888888888877665433221 1111 000000 00011123467899999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
||+.||++|||++|+++||||+.-
T Consensus 289 ~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 289 MLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HcCCCcccCCCHHHHhcCcchhhc
Confidence 999999999999999999999853
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=360.41 Aligned_cols=280 Identities=28% Similarity=0.487 Sum_probs=219.4
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-----
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----- 115 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----- 115 (379)
....|++.+.||+|+||.||+|+++.+|+.||||++.... ....+|++++..+ .|+||+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l-----~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKL-----DHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTC-----CCTTBCCEEEEEEEEETTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHc-----CCCCccceeeEEeccCCCC
Confidence 3457999999999999999999999999999999987543 2334688888887 78999999888743
Q ss_pred -cceEEEEEeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 116 -RNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 116 -~~~~~lv~e~~~~sL~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..++++||||+.+++.+.+.. .....+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus 124 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~------------ 191 (420)
T 1j1b_A 124 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP------------ 191 (420)
T ss_dssp TEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET------------
T ss_pred cceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC------------
Confidence 235789999997788877653 22346999999999999999999999999999999999999952
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
....+||+|||.++..... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus 192 --------------~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf 257 (420)
T 1j1b_A 192 --------------DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257 (420)
T ss_dssp --------------TTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred --------------CCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 2345788888888653322 2345789999999999764 6899999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
.+.+..+....+.+..+.++.+.+......... ..++... ..+ ....+....+.++.+||
T Consensus 258 ~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~------~~~p~~~----------~~~----~~~~~~~~~~~~~~~Li 317 (420)
T 1j1b_A 258 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE------FKFPQIK----------AHP----WTKVFRPRTPPEAIALC 317 (420)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC------CCCCCCC----------CCC----HHHHSCTTSCHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh------hccCccC----------CCC----HHHhcCCCCCHHHHHHH
Confidence 998888888888888888887666543221111 1111100 000 01112234578899999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
.+||+.||.+|||+.|+++||||++
T Consensus 318 ~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 318 SRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHhccCChhHCCCHHHHhCCHhhcc
Confidence 9999999999999999999999965
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=378.55 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=212.3
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
+....|++.+.||+|+||.||+|+++.+++.||+|+++... ........|..++..+ .+|++++.+++++++
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~----~~~~~i~~l~~~~~~ 413 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP----GKPPFLTQLHSCFQT 413 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCT----TCCTTBCCEEEECBC
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhc----cCCCeEEEEEEEEEe
Confidence 34456899999999999999999999999999999997432 2233445565555443 367899999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+.+|+||||+ +++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---------------- 475 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---------------- 475 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE----------------
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE----------------
Confidence 99999999999 999999998765 69999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCC---CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 476 -----------~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~ 544 (674)
T 3pfq_A 476 -----------DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544 (674)
T ss_dssp -----------CSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -----------cCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC
Confidence 5566788888888764222 22446799999999999999999999999999999999999999998
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+..+....+.+.....| ...+.++.+||++
T Consensus 545 ~~~~~~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~~li~~ 575 (674)
T 3pfq_A 545 EDEDELFQSIMEHNVAYP-------------------------------------------------KSMSKEAVAICKG 575 (674)
T ss_dssp SSHHHHHHHHHSSCCCCC-------------------------------------------------TTSCHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCC-------------------------------------------------ccCCHHHHHHHHH
Confidence 877766655544322222 1367789999999
Q ss_pred ccccCCCCCcCH-----HHHhcCCCCCCCC
Q 017021 352 LLRYDPTDRLTA-----REALRHPFFTRDH 376 (379)
Q Consensus 352 ~L~~dP~~Rpta-----~e~l~hp~f~~~~ 376 (379)
||+.||++||++ +|+++||||+..+
T Consensus 576 lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 576 LMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp HSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred HccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 999999999997 9999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=342.99 Aligned_cols=285 Identities=27% Similarity=0.444 Sum_probs=223.1
Q ss_pred chhhhhhhhccccccceeEEEEEec-CCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee--
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDR-ERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-- 114 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~-~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~-- 114 (379)
....|++.+.||+|+||.||+|++. .+++.||+|++.... .......+|+.++..+.. ..|+|++++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET--FEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHH--TCCTTBCCEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhc--cCCCCeEeeeeeeeec
Confidence 3467899999999999999999985 678999999987432 223455678888877743 25799999999887
Q ss_pred ---ecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 115 ---YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 115 ---~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
.....++||||+.++|.+++.......+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili------------- 153 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV------------- 153 (326)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-------------
T ss_pred ccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE-------------
Confidence 5678999999998899999988765569999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 154 --------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 219 (326)
T 1blx_A 154 --------------TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219 (326)
T ss_dssp --------------CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred --------------cCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence 455667888888776543222 3356899999999999888999999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
.+.+..+....+.+..+.++...|.......+..... . ............+..+.+||
T Consensus 220 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~-----~~~~~~~~~~~~~~~~~~li 277 (326)
T 1blx_A 220 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS-----------------K-----SAQPIEKFVTDIDELGKDLL 277 (326)
T ss_dssp CCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCC-----------------C-----CCCCGGGTCCSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcc-----------------c-----CcchhhhccccCCHHHHHHH
Confidence 9988877777777776665544332211100000000 0 00011223345778899999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
.+||+.||++|||+.|+++||||++.+
T Consensus 278 ~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 278 LKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHcCCCcccCCCHHHHhcCccccccc
Confidence 999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=369.49 Aligned_cols=256 Identities=26% Similarity=0.407 Sum_probs=212.8
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.....|++.+.||+|+||.||+|+++.+|+.||+|++... ......+..|+.++..+ .|++|+++++++.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-----NSRFVVSLAYAYET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-----CCCCEeeEEEEEee
Confidence 4556788999999999999999999999999999999742 22345567899998887 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..|+||||+ |++|.+++.......+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---------------- 319 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---------------- 319 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----------------
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE----------------
Confidence 99999999999 9999999987654569999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++|+|||++....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 320 -----------d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 320 -----------DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp -----------CTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred -----------eCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 556678888888876544332 3357999999999999988999999999999999999999999875
Q ss_pred ch----HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 273 EN----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 273 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
+. .+....+...... .....++++.+|
T Consensus 389 ~~~~~~~~i~~~i~~~~~~-------------------------------------------------~p~~~s~~~~dL 419 (576)
T 2acx_A 389 KKKIKREEVERLVKEVPEE-------------------------------------------------YSERFSPQARSL 419 (576)
T ss_dssp SSCCCHHHHHHHHHHCCCC-------------------------------------------------CCTTSCHHHHHH
T ss_pred ccchhHHHHHHHhhccccc-------------------------------------------------CCccCCHHHHHH
Confidence 32 1122111111111 112467899999
Q ss_pred HhhccccCCCCCc-----CHHHHhcCCCCCCCC
Q 017021 349 LQGLLRYDPTDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 349 i~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
|.+||+.||.+|| +++|+++||||+..+
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 9999999999999 899999999999754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=360.25 Aligned_cols=255 Identities=26% Similarity=0.470 Sum_probs=197.4
Q ss_pred hhhhh-hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee----cce
Q 017021 44 ADKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNH 118 (379)
Q Consensus 44 ~y~i~-~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----~~~ 118 (379)
.|.+. +.||+|+||+||+|.++.+++.||+|+++.. ....+|+.++.++ ..|+||+++++++.. ..+
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~----~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRA----SQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHH----TTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHh----cCCCCcceEeEEEeecccCCcE
Confidence 35554 6899999999999999999999999999743 3455677776555 267899999998875 678
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+|+||||+ +++|.+++.......+++..+..++.||+.||.|||+.||+||||||+||+++..
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~---------------- 197 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK---------------- 197 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS----------------
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecC----------------
Confidence 99999999 8899999987654569999999999999999999999999999999999999532
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
..++.++|+|||++....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 198 --------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 269 (400)
T 1nxk_A 198 --------RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_dssp --------STTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTC
T ss_pred --------CCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccc
Confidence 225778999999887544332 3457899999999998889999999999999999999999999765432
Q ss_pred H----HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 276 E----HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 276 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
+ ....+.. +....+. ..+...+.++.+||++
T Consensus 270 ~~~~~~~~~i~~-----------------------~~~~~~~----------------------~~~~~~s~~~~~li~~ 304 (400)
T 1nxk_A 270 AISPGMKTRIRM-----------------------GQYEFPN----------------------PEWSEVSEEVKMLIRN 304 (400)
T ss_dssp SSCCSHHHHHHH-----------------------TCCCCCT----------------------TTTTTSCHHHHHHHHT
T ss_pred cccHHHHHHHHc-----------------------CcccCCC----------------------cccccCCHHHHHHHHH
Confidence 1 1111111 1111110 0123467889999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
||+.||.+|||++|+++||||.+.
T Consensus 305 ~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 305 LLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HCCCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=340.43 Aligned_cols=258 Identities=24% Similarity=0.430 Sum_probs=212.6
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-------hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
-.|++.+.||+|+||.||+|.++.+++.||+|+++.... ....+.+|+.++..+ .|+|++++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-----RHPNIITLHDIFEN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEC
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-----CCCCeeehhheecC
Confidence 468899999999999999999999999999999874321 245677899999888 68999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~------------ 145 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN------------ 145 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS------------
T ss_pred CCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC------------
Confidence 99999999999 899999997754 689999999999999999999999999999999999995432
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
.....++|+|||.+....... ....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 146 -----------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 146 -----------VPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp -----------SSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred -----------CCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 233478999999887544332 3346899999999999889999999999999999999999999887
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+.......+.. .....+..+.++|.+|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~li~~~ 249 (283)
T 3bhy_A 215 TKQETLTNISAVNYDFDEE---------------------------------------------YFSNTSELAKDFIRRL 249 (283)
T ss_dssp SHHHHHHHHHTTCCCCCHH---------------------------------------------HHTTCCHHHHHHHHTT
T ss_pred chHHHHHHhHhcccCCcch---------------------------------------------hcccCCHHHHHHHHHH
Confidence 6655544443322222211 1234567899999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
|+.||++|||++|+++||||+..
T Consensus 250 l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 250 LVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp SCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ccCCHhHCcCHHHHHhCHHHHHH
Confidence 99999999999999999999764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=355.11 Aligned_cols=281 Identities=30% Similarity=0.496 Sum_probs=219.1
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--- 116 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--- 116 (379)
.....|++.+.||+|+||.||+|++..+++ ||+|++..... ...+|+.++..+ .|+||+++++++...
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~---~~~~E~~il~~l-----~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR---FKNRELQIMRIV-----KHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT---SCCHHHHHHHTC-----CCTTBCCEEEEEEEESSS
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc---hHHHHHHHHHhC-----CCCCcceEEEEEEecCCC
Confidence 345579999999999999999999888776 88888764332 223588888887 789999999998543
Q ss_pred ---ceEEEEEeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 117 ---NHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 117 ---~~~~lv~e~~~~sL~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
.+.++||||+.+++.+.+.. .....+++..+..++.||+.||.|||+.||+||||||+||+++
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~------------ 175 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD------------ 175 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE------------
T ss_pred CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc------------
Confidence 34899999997666665542 1224699999999999999999999999999999999999994
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCC--CCCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCC
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP--DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
..++.++|+|||.+..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 176 --------------~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 241 (394)
T 4e7w_A 176 --------------PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL 241 (394)
T ss_dssp --------------TTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred --------------CCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 1456788888888865332 22445789999999998765 589999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|.+.+..+....+.+..+.++.+.+....... .......... ...........++++.+|
T Consensus 242 f~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~---~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~l 301 (394)
T 4e7w_A 242 FPGESGIDQLVEIIKVLGTPSREQIKTMNPNY---MEHKFPQIRP-----------------HPFSKVFRPRTPPDAIDL 301 (394)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG---SSSCCCCCCC-----------------CCHHHHSCTTCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh---hhhccccccC-----------------CcHHHhccccCCHHHHHH
Confidence 99999989999999999988887666543221 1111111100 011112233467899999
Q ss_pred HhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
|.+||+.||.+|||+.|+++||||++-
T Consensus 302 i~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 302 ISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=348.20 Aligned_cols=281 Identities=24% Similarity=0.407 Sum_probs=216.5
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch------------hhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------------YREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
..|++.+.||+|+||.||+|.+.. |+.||+|++..... ....+.+|+.++.++ .|+|+++++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~ 95 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-----HHPNILGLR 95 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-----CCTTBCCCS
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-----CCcCcccee
Confidence 468889999999999999999865 89999999863211 125677899999888 689999999
Q ss_pred ceeee-----cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccc
Q 017021 111 NWFDY-----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 185 (379)
Q Consensus 111 ~~~~~-----~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 185 (379)
+++.. ....|+||||++++|.+.+.... ..+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~------- 167 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL------- 167 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-------
T ss_pred eeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE-------
Confidence 99843 34789999999889999987643 368999999999999999999999999999999999999
Q ss_pred cCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHH
Q 017021 186 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l 262 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 168 --------------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 227 (362)
T 3pg1_A 168 --------------------ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227 (362)
T ss_dssp --------------------CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHH
T ss_pred --------------------cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHH
Confidence 555678888888886433322 34578999999999877 6789999999999999999
Q ss_pred HhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhh-hhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccc
Q 017021 263 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341 (379)
Q Consensus 263 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (379)
++|+.||.+.+..+....+.+..+.++...+.... .....+........+.. .........
T Consensus 228 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~ 289 (362)
T 3pg1_A 228 FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPAR------------------AWTAVVPTA 289 (362)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCC------------------CHHHHSTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChh------------------hHHhhCCCC
Confidence 99999999998888888888888877765544322 22222222222222110 011223456
Q ss_pred hhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 342 ~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
++.+.+||.+||+.||.+|||++|+++||||++.
T Consensus 290 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 290 DPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 7889999999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=340.17 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=211.7
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
+....|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++..+ .|+|++++++++.+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-----RHPNILRMYNYFHD 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEEC
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-----CCCCEeeEEEEEEc
Confidence 34457889999999999999999999999999999996432 2234566788888777 68999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..++||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---------------- 147 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---------------- 147 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE----------------
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE----------------
Confidence 99999999999 889999998764 68999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC-CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+...... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...+
T Consensus 148 -----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 148 -----------GYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp -----------CTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----------cCCCCEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 45566888888877543332 234578999999999999889999999999999999999999998766
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.......| ...+..+.++|.+||
T Consensus 217 ~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~li~~~l 247 (284)
T 2vgo_A 217 HTETHRRIVNVDLKFP-------------------------------------------------PFLSDGSKDLISKLL 247 (284)
T ss_dssp HHHHHHHHHTTCCCCC-------------------------------------------------TTSCHHHHHHHHHHS
T ss_pred HhHHHHHHhccccCCC-------------------------------------------------CcCCHHHHHHHHHHh
Confidence 5554433322111111 135678999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 354 RYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
+.||.+|||++|+++||||+....
T Consensus 248 ~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 248 RYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp CSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred hcCHhhCCCHHHHhhCHHHHhhcc
Confidence 999999999999999999986543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=343.48 Aligned_cols=258 Identities=23% Similarity=0.389 Sum_probs=212.4
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
...|++.+.||+|+||.||+|+++.+|+.||+|+++.... ....+.+|+.++..+ .|+|++++++++.+.+..|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-----KHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-----CCCCeeehhhhcccCCEEE
Confidence 3468899999999999999999999999999999975432 334567789988888 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++...
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~------------------ 142 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP------------------ 142 (304)
T ss_dssp EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS------------------
T ss_pred EEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC------------------
Confidence 999999 889999987754 58999999999999999999999999999999999999321
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~ 278 (379)
+.+..++|+|||.+....... ....||+.|+|||.+.+..++.++|||||||++|+|++|..||......+..
T Consensus 143 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 216 (304)
T 2jam_A 143 ------EENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF 216 (304)
T ss_dssp ------STTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred ------CCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 345668888888876543322 2346899999999999888999999999999999999999999887666555
Q ss_pred HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCC
Q 017021 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 358 (379)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 358 (379)
..+.+.....+.. .+...+..+.++|.+||+.||+
T Consensus 217 ~~i~~~~~~~~~~---------------------------------------------~~~~~~~~~~~li~~~l~~dp~ 251 (304)
T 2jam_A 217 EKIKEGYYEFESP---------------------------------------------FWDDISESAKDFICHLLEKDPN 251 (304)
T ss_dssp HHHHHCCCCCCTT---------------------------------------------TTTTSCHHHHHHHHHHHCSSTT
T ss_pred HHHHcCCCCCCcc---------------------------------------------ccccCCHHHHHHHHHHcCCChh
Confidence 5444432222110 1124667899999999999999
Q ss_pred CCcCHHHHhcCCCCCCC
Q 017021 359 DRLTAREALRHPFFTRD 375 (379)
Q Consensus 359 ~Rpta~e~l~hp~f~~~ 375 (379)
+|||++|+++||||+..
T Consensus 252 ~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 252 ERYTCEKALSHPWIDGN 268 (304)
T ss_dssp TSCCHHHHHTSHHHHSS
T ss_pred HCcCHHHHhcCccccCC
Confidence 99999999999999765
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=363.79 Aligned_cols=256 Identities=22% Similarity=0.340 Sum_probs=211.0
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.....|++.+.||+|+||.||+|+++.+|+.||+|++.... .....+..|..++..+ +|++|+.+++++.+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-----HSRFIVSLAYAFET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-----CCCCEeeEEEEEee
Confidence 44567888899999999999999999999999999997432 2335567789988887 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
.+..|+||||+ |++|.+++.... ...+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl-------------- 322 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL-------------- 322 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--------------
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE--------------
Confidence 99999999999 899999997643 3468999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.++.++|+|||++....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 323 -------------~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF 389 (543)
T 3c4z_A 323 -------------DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389 (543)
T ss_dssp -------------CTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred -------------eCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCC
Confidence 556678888888886543332 2347999999999999999999999999999999999999999
Q ss_pred CCCch----HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 270 QTHEN----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 270 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
.+.+. .+....+....... ....+..+
T Consensus 390 ~~~~~~~~~~~~~~~i~~~~~~~-------------------------------------------------p~~~s~~~ 420 (543)
T 3c4z_A 390 RARGEKVENKELKQRVLEQAVTY-------------------------------------------------PDKFSPAS 420 (543)
T ss_dssp CCTTCCCCHHHHHHHHHHCCCCC-------------------------------------------------CTTSCHHH
T ss_pred CCCccchhHHHHHHHHhhcccCC-------------------------------------------------CcccCHHH
Confidence 86532 22222222111111 12367889
Q ss_pred HHHHhhccccCCCCCcC-----HHHHhcCCCCCCCC
Q 017021 346 THLLQGLLRYDPTDRLT-----AREALRHPFFTRDH 376 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~ 376 (379)
.+||++||+.||.+||+ ++++++||||++..
T Consensus 421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 99999999999999995 69999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=337.53 Aligned_cols=262 Identities=22% Similarity=0.373 Sum_probs=207.9
Q ss_pred eeeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 34 LITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 34 ~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
....+...+..|++.+.||+|+||.||+|.+..++..||+|++... ......+.+|+.++..+ .|+|+++++
T Consensus 17 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~ 91 (290)
T 1t4h_A 17 KAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFY 91 (290)
T ss_dssp -CCEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-----CCTTBCCEE
T ss_pred hhhhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-----CCCCeeeee
Confidence 3444566677799999999999999999999999999999998743 23345566788887777 789999999
Q ss_pred ceeee----cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCcEEEecccc
Q 017021 111 NWFDY----RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEY 183 (379)
Q Consensus 111 ~~~~~----~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiH~dlkp~Nili~~~~~ 183 (379)
+++.. ....++||||+ +++|.+++.... .+++..+..++.||+.||.|||+.| ++||||||+||+++
T Consensus 92 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---- 165 (290)
T 1t4h_A 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT---- 165 (290)
T ss_dssp EEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES----
T ss_pred eeeccccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE----
Confidence 98865 46799999999 889999998754 6899999999999999999999999 99999999999993
Q ss_pred cccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCCCCccchHhHHHHHHHH
Q 017021 184 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l 262 (379)
..++.++|+|||.+....... ....||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 166 ----------------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l 222 (290)
T 1t4h_A 166 ----------------------GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 222 (290)
T ss_dssp ----------------------STTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred ----------------------CCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHH
Confidence 145678888998886544433 33568999999998875 589999999999999999
Q ss_pred HhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccch
Q 017021 263 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342 (379)
Q Consensus 263 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (379)
++|+.||.............. .+..+. ......+
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~-~~~~~~---------------------------------------------~~~~~~~ 256 (290)
T 1t4h_A 223 ATSEYPYSECQNAAQIYRRVT-SGVKPA---------------------------------------------SFDKVAI 256 (290)
T ss_dssp HHSSCTTTTCSSHHHHHHHHT-TTCCCG---------------------------------------------GGGGCCC
T ss_pred HhCCCCCCCcCcHHHHHHHHh-ccCCcc---------------------------------------------ccCCCCC
Confidence 999999987544332211110 011110 1122355
Q ss_pred hHHHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 343 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 343 ~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+++.++|.+||+.||.+|||++|+++||||+++
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 789999999999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=348.68 Aligned_cols=255 Identities=26% Similarity=0.360 Sum_probs=209.0
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
....|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.++..+ .|+|++++++++..+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~ 126 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-----RHPNTIQYRGCYLRE 126 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEET
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEEC
Confidence 3456888999999999999999999999999999997432 2234567899998888 789999999999999
Q ss_pred ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 117 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 117 ~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
+..++||||+.++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----------------- 188 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----------------- 188 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE-----------------
T ss_pred CeEEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC-----------------
Confidence 9999999999888988886543 3689999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhh---CCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
.++.++|+|||.+...... ....||+.|+|||++. +..++.++|||||||++|+|++|+.||...+
T Consensus 189 ----------~~~~~kL~DfG~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 189 ----------EPGLVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp ----------TTTEEEECCCTTCBSSSSB-CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ----------CCCCEEEeeccCceecCCC-CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4556788888877654432 3457899999999985 4568899999999999999999999998776
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.+...+.. ....++..+.+||.+||
T Consensus 258 ~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~l~~li~~~l 290 (348)
T 1u5q_A 258 AMSALYHIAQNESPAL-----------------------------------------------QSGHWSEYFRNFVDSCL 290 (348)
T ss_dssp HHHHHHHHHHSCCCCC-----------------------------------------------CCTTSCHHHHHHHHHHT
T ss_pred hHHHHHHHHhcCCCCC-----------------------------------------------CCCCCCHHHHHHHHHHc
Confidence 6554443333211110 01135678999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+.||++|||++|+++||||....
T Consensus 291 ~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 291 QKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp CSSGGGSCCHHHHTTCHHHHSCC
T ss_pred ccChhhCcCHHHHhhChhhhccC
Confidence 99999999999999999997653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=339.51 Aligned_cols=252 Identities=24% Similarity=0.423 Sum_probs=183.9
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
..|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.++..+ .|+|++++++++.+.+.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-----KHPSILELYNYFEDSNY 85 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-----CCTTBCCEEEEEECSSE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-----CCCCeEeEEEEEccCCe
Confidence 468899999999999999999999999999999974321 234566788777776 68999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili------------------- 145 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL------------------- 145 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE-------------------
T ss_pred EEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE-------------------
Confidence 99999999 889999998753 368999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
+.++.++|+|||.+....... ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 146 --------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 146 --------TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp --------CTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred --------cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 455678888888776543222 235689999999999988899999999999999999999999976443
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+ . ...... ....+.++.++|.+||+
T Consensus 218 ~~~~~~~---~--------------------~~~~~~--------------------------~~~~~~~~~~li~~~l~ 248 (278)
T 3cok_A 218 KNTLNKV---V--------------------LADYEM--------------------------PSFLSIEAKDLIHQLLR 248 (278)
T ss_dssp C-----C---C--------------------SSCCCC--------------------------CTTSCHHHHHHHHHHSC
T ss_pred HHHHHHH---h--------------------hcccCC--------------------------ccccCHHHHHHHHHHcc
Confidence 2211100 0 000000 12356789999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
.||++|||++|+++||||.+..
T Consensus 249 ~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 249 RNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp SSGGGSCCHHHHTTSTTTC---
T ss_pred cCHhhCCCHHHHhcCccccCCC
Confidence 9999999999999999998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=361.97 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=201.1
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---------hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
..|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++.++ .|+|++++++++
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~ 209 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-----NHPCIIKIKNFF 209 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-----CCTTBCCCCEEE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-----CCCCEeeEEEEE
Confidence 46889999999999999999999999999999997432 1123466799999988 789999999998
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..+ ..|+||||+ +++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++..
T Consensus 210 ~~~-~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~----------- 275 (419)
T 3i6u_A 210 DAE-DYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ----------- 275 (419)
T ss_dssp ESS-EEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS-----------
T ss_pred ecC-ceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecC-----------
Confidence 654 579999999 889988886654 69999999999999999999999999999999999999532
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC---CCCCCccchHhHHHHHHHHHhCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
..+..++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 276 -------------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 276 -------------EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp -------------SSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred -------------CCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 234568999999987654433 34579999999999853 567889999999999999999999
Q ss_pred CCCCCchH-HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 268 LFQTHENL-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 268 pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
||...... .....+.......+ ...+...+..+.
T Consensus 343 pf~~~~~~~~~~~~i~~~~~~~~---------------------------------------------~~~~~~~~~~~~ 377 (419)
T 3i6u_A 343 PFSEHRTQVSLKDQITSGKYNFI---------------------------------------------PEVWAEVSEKAL 377 (419)
T ss_dssp SSCCCSSSCCHHHHHHTTCCCCC---------------------------------------------HHHHTTSCHHHH
T ss_pred CCCCCcchHHHHHHHhcCCCCCC---------------------------------------------chhhcccCHHHH
Confidence 99764332 11111111111111 112334678899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCCCCCcC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~ 378 (379)
+||.+||+.||.+|||++|+|+||||++.+.+
T Consensus 378 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 409 (419)
T 3i6u_A 378 DLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409 (419)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhCCcccCChhHH
Confidence 99999999999999999999999999986543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=336.29 Aligned_cols=257 Identities=29% Similarity=0.481 Sum_probs=211.6
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
...|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++.++. +|+|++++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~ 91 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS----GHPNIIQLKD 91 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT----TCTTBCCEEE
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc----CCCCEeeeee
Confidence 356889999999999999999999999999999996432 22355667888888872 4789999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
++...+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~------------ 157 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL------------ 157 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE------------
Confidence 999999999999999 889999998754 68999999999999999999999999999999999999
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhh------CCCCCCccchHhHHHHHHHH
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL------GLGWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~~l 262 (379)
+.++.++|+|||.+....... ....||+.|+|||++. ...++.++||||||+++|+|
T Consensus 158 ---------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l 222 (298)
T 1phk_A 158 ---------------DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 222 (298)
T ss_dssp ---------------CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred ---------------cCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHH
Confidence 455668888888776544332 3356899999999985 45678999999999999999
Q ss_pred HhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccch
Q 017021 263 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342 (379)
Q Consensus 263 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (379)
++|..||...+..+....+.......+.. .+...+
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~ 257 (298)
T 1phk_A 223 LAGSPPFWHRKQMLMLRMIMSGNYQFGSP---------------------------------------------EWDDYS 257 (298)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCTT---------------------------------------------TGGGSC
T ss_pred HHCCCCCcCccHHHHHHHHhcCCcccCcc---------------------------------------------cccccC
Confidence 99999998776655544443322221110 112466
Q ss_pred hHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 343 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 343 ~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
..+.++|.+||+.||.+|||++|+++||||++..
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 258 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 7899999999999999999999999999998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.59 Aligned_cols=281 Identities=25% Similarity=0.416 Sum_probs=214.6
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee-------
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD------- 114 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~------- 114 (379)
..|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++..+ .|+|++++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-----DHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECTTSCBCC
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-----CCCCeeEEEEeccccccccc
Confidence 46899999999999999999999999999999987432 3345667888888887 7899999988763
Q ss_pred -------ecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccC
Q 017021 115 -------YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 115 -------~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~ 187 (379)
.....|+||||++++|.+++... .+++..+..++.|++.||+|||+.|++||||||+||+++.
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~------- 155 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYMETDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT------- 155 (320)
T ss_dssp C----CCSCSEEEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET-------
T ss_pred cccccccccCceeEEeeccCCCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC-------
Confidence 44689999999988999998653 5899999999999999999999999999999999999952
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC------CCcccccCCccchhhhhC-CCCCCccchHhHHHHHH
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILV 260 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ 260 (379)
.+..++|+|||.+...... .....+|..|+|||.+.+ ..++.++|||||||++|
T Consensus 156 -------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 216 (320)
T 2i6l_A 156 -------------------EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 216 (320)
T ss_dssp -------------------TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHH
T ss_pred -------------------CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHH
Confidence 3356778888877654322 123457899999999876 67899999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc
Q 017021 261 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 261 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (379)
+|++|+.||.+.+..+....+.+..+......+.........+...... .+ ..........
T Consensus 217 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~------------------~~~~~~~~~~ 277 (320)
T 2i6l_A 217 EMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMT-EP------------------HKPLTQLLPG 277 (320)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTT-SC------------------CCCHHHHSTT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCccccccccc-CC------------------CCChhHhcch
Confidence 9999999999988888777777777666665554433322222111000 00 0001122345
Q ss_pred chhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
.+.++.+||.+||+.||++|||++|+++||||+...
T Consensus 278 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 278 ISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred hhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 788999999999999999999999999999998653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=350.03 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=209.2
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc------chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
-...|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.++..+ .|+||+++++++.
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~ 98 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-----HHPNIARLYEVYE 98 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-----CCTTBCCEEEEEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-----CCCCcceeehhhc
Confidence 345789999999999999999999999999999998642 23346677899999888 6899999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCC--------------------------------------CCCCCHHHHHHHHHHHH
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNN--------------------------------------YRSFPIDLVREIARQLL 155 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~--------------------------------------~~~l~~~~~~~~~~qi~ 155 (379)
+.+..++||||+ +++|.+++.... ...+++..+..++.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 999999999999 999999985210 11246778889999999
Q ss_pred HHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-------CCc
Q 017021 156 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNY 228 (379)
Q Consensus 156 ~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~ 228 (379)
.||+|||+.||+||||||+||+++.+ ....++|+|||.+...... ...
T Consensus 179 ~~l~~LH~~~ivH~Dlkp~NIll~~~-------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 233 (345)
T 3hko_A 179 SALHYLHNQGICHRDIKPENFLFSTN-------------------------KSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESCS-------------------------SSCCEEECCCTTCEEGGGTTCC-------
T ss_pred HHHHHHHHCCccccCCChhhEEEecC-------------------------CCceEEEeeccccccccccCccccccccc
Confidence 99999999999999999999999432 2236889999988643221 134
Q ss_pred ccccCCccchhhhhC--CCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhcc
Q 017021 229 IVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 306 (379)
Q Consensus 229 ~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (379)
..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+..
T Consensus 234 ~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------- 298 (345)
T 3hko_A 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP--------------- 298 (345)
T ss_dssp -CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG---------------
T ss_pred cCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc---------------
Confidence 568999999999975 678899999999999999999999998877766555444432222111
Q ss_pred CCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 307 GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
.....++.+.+||.+||+.||.+|||+.|+++||||++..
T Consensus 299 ------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 299 ------------------------------NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp ------------------------------GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred ------------------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 1123567899999999999999999999999999998653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=342.74 Aligned_cols=286 Identities=24% Similarity=0.473 Sum_probs=211.1
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee--cceE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHI 119 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~ 119 (379)
...|++.++||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.++..+. +|+|++.+++++.. ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~----~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR----GGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHT----TSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcC----CCCCEEEeeeeeccCCCCce
Confidence 45789999999999999999999999999999999743 3456778999999983 47899999999987 6789
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++||||+ +++|.+++.. +++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus 109 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~------------------ 165 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH------------------ 165 (330)
T ss_dssp EEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET------------------
T ss_pred EEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC------------------
Confidence 9999999 8899988743 889999999999999999999999999999999999953
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCCC-Cch
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT-HEN 274 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~~-~~~ 274 (379)
.+..++|+|||.+....... ....||..|+|||.+.+ ..++.++|||||||++|+|++|..||.. ...
T Consensus 166 --------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 237 (330)
T 3nsz_A 166 --------EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237 (330)
T ss_dssp --------TTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred --------CCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch
Confidence 22368888888886543322 34578999999999877 6689999999999999999999999954 344
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+.+..+.. .....+. ......... ..+......................++++.+||.+||+
T Consensus 238 ~~~l~~~~~~~~~~--~~~~~~~--------~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 305 (330)
T 3nsz_A 238 YDQLVRIAKVLGTE--DLYDYID--------KYNIELDPR--FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 305 (330)
T ss_dssp HHHHHHHHHHHCHH--HHHHHHH--------HTTCCCCTH--HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSC
T ss_pred HHHHHHHHHhcCCc--hhhhHHH--------Hhccccccc--hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhc
Confidence 44444444444421 1111111 000000000 00000000000000000011123367899999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
.||.+||||+|+|+||||++..
T Consensus 306 ~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 306 YDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp SSGGGSCCHHHHHTSGGGTTCC
T ss_pred CCcccCCCHHHHhcCccHhhhc
Confidence 9999999999999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=345.67 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=201.0
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
+.+.+..|++.+.||+|+||.||+|.+ .+++.||+|++.... .....+.+|+.++..+.+ ++++++++++++.
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ---HSDKIIRLYDYEI 79 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT---TCTTBCCEEEEEE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhh---cCCceEEEeeeEe
Confidence 456677899999999999999999997 458899999997432 233566789999999854 3488999999999
Q ss_pred ecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 115 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 115 ~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.++..|+|||+.+++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++.
T Consensus 80 ~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~--------------- 142 (343)
T 3dbq_A 80 TDQYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------------- 142 (343)
T ss_dssp CSSEEEEEECCCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---------------
T ss_pred eCCEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE---------------
Confidence 999999999977999999998865 689999999999999999999999999999999999993
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhC-----------CCCCCccchHhHHHH
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-----------LGWTYPCDIWSVGCI 258 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~i 258 (379)
++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||+
T Consensus 143 -------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~i 209 (343)
T 3dbq_A 143 -------------DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 209 (343)
T ss_dssp -------------TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHH
T ss_pred -------------CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHH
Confidence 2347888888876543332 23579999999999865 568899999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhh
Q 017021 259 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338 (379)
Q Consensus 259 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (379)
+|+|++|..||....... ..+.....+. ....++
T Consensus 210 l~ell~g~~pf~~~~~~~--~~~~~~~~~~------------------~~~~~~-------------------------- 243 (343)
T 3dbq_A 210 LYYMTYGKTPFQQIINQI--SKLHAIIDPN------------------HEIEFP-------------------------- 243 (343)
T ss_dssp HHHHHHSSCTTTTCCSHH--HHHHHHHCTT------------------SCCCCC--------------------------
T ss_pred HHHHHhCCCcchhhhhHH--HHHHHHhcCC------------------cccCCc--------------------------
Confidence 999999999997543211 1111111100 001111
Q ss_pred ccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 339 ~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
...+..+.+||.+||+.||.+|||++|+++||||+.
T Consensus 244 ~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 124467899999999999999999999999999964
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=341.46 Aligned_cols=249 Identities=26% Similarity=0.329 Sum_probs=193.0
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc---
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--- 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~--- 117 (379)
..|++.+.||+|+||.||+|+++.+|+.||+|+++.. ......+.+|+.++..+ .|+||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-----EHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-----CCTTBCCEEEEEEECCSCH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEEeccch
Confidence 3588899999999999999999999999999999732 33456677898888887 7899999999875432
Q ss_pred ------------------------------------------------------eEEEEEeCC-CCCHHHHHHhCCC-CC
Q 017021 118 ------------------------------------------------------HICIVFEKL-GSSLYDFLRKNNY-RS 141 (379)
Q Consensus 118 ------------------------------------------------------~~~lv~e~~-~~sL~~~l~~~~~-~~ 141 (379)
+.++||||+ +++|.+++..... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 489999999 8999999987542 13
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccc
Q 017021 142 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221 (379)
Q Consensus 142 l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~ 221 (379)
.+...+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||.+..
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---------------------------~~~~kL~DfG~a~~ 213 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM---------------------------DDVVKVGDFGLVTA 213 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---------------------------TCCEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeC---------------------------CCCEEEeecCcccc
Confidence 456678999999999999999999999999999999954 44566666666543
Q ss_pred cCCC---------------CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHH-c
Q 017021 222 ERPD---------------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV-L 285 (379)
Q Consensus 222 ~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~ 285 (379)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..|+. +....+... .
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~ 288 (332)
T 3qd2_B 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRN 288 (332)
T ss_dssp CSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHT
T ss_pred cccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhc
Confidence 3322 123468999999999999999999999999999999999866542 111111111 1
Q ss_pred CCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHH
Q 017021 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 365 (379)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 365 (379)
+..|.. ....++.+.+||.+||+.||.+|||++|
T Consensus 289 ~~~~~~----------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ 322 (332)
T 3qd2_B 289 LKFPLL----------------------------------------------FTQKYPQEHMMVQDMLSPSPTERPEATD 322 (332)
T ss_dssp TCCCHH----------------------------------------------HHHHCHHHHHHHHHHHCSSGGGSCCHHH
T ss_pred cCCCcc----------------------------------------------cccCChhHHHHHHHHccCCCCcCCCHHH
Confidence 111111 1124567899999999999999999999
Q ss_pred HhcCCCCCC
Q 017021 366 ALRHPFFTR 374 (379)
Q Consensus 366 ~l~hp~f~~ 374 (379)
+++||||++
T Consensus 323 ~l~~~~f~~ 331 (332)
T 3qd2_B 323 IIENAIFEN 331 (332)
T ss_dssp HHHSTTCCC
T ss_pred Hhhchhhhc
Confidence 999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=347.06 Aligned_cols=245 Identities=26% Similarity=0.430 Sum_probs=204.7
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch---------hhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
...|++.+.||+|+||.||+|+++.+++.||+|+++.... ....+.+|+.++..+ .|+||++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~Iv~~~~~ 97 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-----EHANIIKVLDI 97 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-----CCTTBCCEEEE
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-----CCCCEeeEEEE
Confidence 3478899999999999999999999999999999975321 234566799988887 78999999999
Q ss_pred eeecceEEEEEeCC-CC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 113 FDYRNHICIVFEKL-GS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~-sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
+.+.+..++||||+ ++ +|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 98 ~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll------------ 163 (335)
T 3dls_A 98 FENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI------------ 163 (335)
T ss_dssp EECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------
T ss_pred EeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE------------
Confidence 99999999999998 44 9999998765 69999999999999999999999999999999999999
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCC-CCccchHhHHHHHHHHHhCCC
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~~l~~g~~ 267 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+..+ +.++|||||||++|+|++|..
T Consensus 164 ---------------~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 228 (335)
T 3dls_A 164 ---------------AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228 (335)
T ss_dssp ---------------CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred ---------------cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCC
Confidence 556678888888887544433 34568999999999988776 789999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||....... ...... ....+.++.+
T Consensus 229 pf~~~~~~~-----------------------------~~~~~~--------------------------~~~~~~~l~~ 253 (335)
T 3dls_A 229 PFCELEETV-----------------------------EAAIHP--------------------------PYLVSKELMS 253 (335)
T ss_dssp SCSSGGGGT-----------------------------TTCCCC--------------------------SSCCCHHHHH
T ss_pred chhhHHHHH-----------------------------hhccCC--------------------------CcccCHHHHH
Confidence 996422100 000000 1135678999
Q ss_pred HHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 348 LLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
||.+||+.||.+|||++|+++||||++.
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHccCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=336.36 Aligned_cols=273 Identities=20% Similarity=0.255 Sum_probs=201.8
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
...|++.+.||+|+||.||+|.++.+++.||+|++... ........+|+..+..+ ..|+|++++++++.+.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l----~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL----GQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHS----CSCTTBCCEEEEEEETTE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHh----CCCCCeeeeeeeeecCCe
Confidence 34688999999999999999999999999999999743 23345556677666665 367899999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
.++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.||+||||||+||+++..+.....+.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~-- 163 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE-- 163 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc--
Confidence 99999999 889999997642 1358999999999999999999999999999999999999766544332222110
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
.........++|+|||.+....... ...||+.|+|||.+.+. .++.++|||||||++|+|++|.+|+.....
T Consensus 164 ------~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 164 ------DDWASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp ------------CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred ------ccccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 0111355679999999987655433 34689999999999775 456899999999999999999887754322
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.. .+.+ +.. .. .....+..+.++|.+||+
T Consensus 237 ~~---~~~~--~~~--------------------~~--------------------------~~~~~~~~~~~li~~~l~ 265 (289)
T 1x8b_A 237 WH---EIRQ--GRL--------------------PR--------------------------IPQVLSQEFTELLKVMIH 265 (289)
T ss_dssp HH---HHHT--TCC--------------------CC--------------------------CSSCCCHHHHHHHHHHTC
T ss_pred HH---HHHc--CCC--------------------CC--------------------------CCcccCHHHHHHHHHHhC
Confidence 11 1111 000 00 112356789999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCCCCcC
Q 017021 355 YDPTDRLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~~~~~ 378 (379)
.||++|||++|+++||||++...|
T Consensus 266 ~dp~~Rps~~~ll~h~~~~~~~~k 289 (289)
T 1x8b_A 266 PDPERRPSAMALVKHSVLLSASRK 289 (289)
T ss_dssp SSGGGSCCHHHHHTCTTC------
T ss_pred CCcccCCCHHHHhhChHhhhhccC
Confidence 999999999999999999986543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=337.65 Aligned_cols=253 Identities=29% Similarity=0.424 Sum_probs=210.5
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.....|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ .|+|++++++++.+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~ 86 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-----AHQHVVGFHGFFED 86 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEC
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-----CCCCEeeeeeeecc
Confidence 34567889999999999999999999999999999987432 2345566788888777 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..++||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---------------- 148 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---------------- 148 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----------------
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE----------------
Confidence 99999999999 899999987754 68999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+...... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 149 -----------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 149 -----------NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp -----------CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred -----------cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 45566788888877654322 2335689999999999988899999999999999999999999987
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
....+....+.......| ...+..+.++|.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~li~~ 248 (294)
T 2rku_A 218 SCLKETYLRIKKNEYSIP-------------------------------------------------KHINPVAASLIQK 248 (294)
T ss_dssp SSHHHHHHHHHTTCCCCC-------------------------------------------------TTSCHHHHHHHHH
T ss_pred CCHHHHHHHHhhccCCCc-------------------------------------------------cccCHHHHHHHHH
Confidence 665544433322111111 1355688999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
||+.||++|||++|+++||||++.
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HcccChhhCcCHHHHhhChheecC
Confidence 999999999999999999999765
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=344.06 Aligned_cols=253 Identities=29% Similarity=0.424 Sum_probs=211.9
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.....|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++..+ .|+|++++++++.+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 112 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-----AHQHVVGFHGFFED 112 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEC
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEec
Confidence 44567899999999999999999999999999999987432 3345666788888777 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---------------- 174 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---------------- 174 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----------------
T ss_pred CCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE----------------
Confidence 99999999999 899999987754 68999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 175 -----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 175 -----------NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp -----------CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred -----------cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 45566888888887654322 2335689999999999998899999999999999999999999987
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
....+....+.......| ...+..+.+||.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~li~~ 274 (335)
T 2owb_A 244 SCLKETYLRIKKNEYSIP-------------------------------------------------KHINPVAASLIQK 274 (335)
T ss_dssp SSHHHHHHHHHHTCCCCC-------------------------------------------------TTSCHHHHHHHHH
T ss_pred CCHHHHHHHHhcCCCCCC-------------------------------------------------ccCCHHHHHHHHH
Confidence 665554443333221111 1355688999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
||+.||++|||++|+++||||...
T Consensus 275 ~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HccCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=344.68 Aligned_cols=279 Identities=29% Similarity=0.457 Sum_probs=213.0
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec----
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---- 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~---- 116 (379)
..|++.+.||+|+||.||+|.+..+|+.||+|++... ......+.+|+.++..+ .|+|++++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-----KHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCSCSTT
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-----cCCCcCCeeeeecccccCc
Confidence 4688999999999999999999999999999999632 23345566899988888 689999999877654
Q ss_pred -ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 117 -NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 117 -~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
...|+||||++++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++.
T Consensus 86 ~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~--------------- 147 (353)
T 2b9h_A 86 FNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS--------------- 147 (353)
T ss_dssp CCCEEEEECCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT---------------
T ss_pred cceEEEEEeccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcC---------------
Confidence 679999999988999999874 4999999999999999999999999999999999999954
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCC-------------CCcccccCCccchhhhhC-CCCCCccchHhHHHHHHH
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVE 261 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~ 261 (379)
++.++|+|||.+...... .....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 148 ------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 215 (353)
T 2b9h_A 148 ------------NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215 (353)
T ss_dssp ------------TCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHH
T ss_pred ------------CCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHH
Confidence 445666666665433221 122468999999998765 678999999999999999
Q ss_pred HHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHh-hh-hhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhc
Q 017021 262 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKR-VD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339 (379)
Q Consensus 262 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (379)
|++|+.||.+.+..+....+....+.++...... .. .....+. ......+ .........
T Consensus 216 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~--~~~~~~~~~ 276 (353)
T 2b9h_A 216 LFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYI-----------------KSLPMYP--AAPLEKMFP 276 (353)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHH-----------------HTSCCCC--CCCHHHHST
T ss_pred HHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHh-----------------hcccCCC--Ccchhhhcc
Confidence 9999999999887777777777666554221100 00 0000000 0000000 001122334
Q ss_pred cchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 340 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
..++++.+||.+||+.||++|||++|+++||||+..
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 277 RVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred cCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 678899999999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=334.85 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=201.2
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
.-.|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+..+..+ .|+|++++++++...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-----RHPHIIKLYQVISTPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-----CCCCEeEEEEEEecCC
Confidence 346889999999999999999999999999999997432 2234566788887776 6899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..++||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~------------------ 144 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL------------------ 144 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE------------------
T ss_pred eEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE------------------
Confidence 999999999 889999998764 68999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCC-CCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+....... ....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||....
T Consensus 145 ---------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 145 ---------DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp ---------CTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ---------CCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 455668888888776544332 33468999999999988765 589999999999999999999998766
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.......| ...+..+.++|.+||
T Consensus 216 ~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~l~~li~~~l 246 (276)
T 2h6d_A 216 VPTLFKKIRGGVFYIP-------------------------------------------------EYLNRSVATLLMHML 246 (276)
T ss_dssp HHHHHHHHHHCCCCCC-------------------------------------------------TTSCHHHHHHHHHHT
T ss_pred HHHHHHHhhcCcccCc-------------------------------------------------hhcCHHHHHHHHHHc
Confidence 5544443333221111 124568899999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+.||++|||++|+++||||++.
T Consensus 247 ~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 247 QVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp CSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCChhhCCCHHHHHhChhhccC
Confidence 9999999999999999999865
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=341.63 Aligned_cols=258 Identities=22% Similarity=0.375 Sum_probs=206.0
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee----
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---- 115 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~---- 115 (379)
...-.|++.+.||+|+||.||+|++..+++.||+|++.........+.+|+.++..+ ..|+|++++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l----~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKY----SHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHH----CCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhc----cCCCCeeeeeeEEeeccCc
Confidence 345678999999999999999999999999999999986655667788899988887 257899999999876
Q ss_pred --cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 116 --RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 116 --~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
.+..++||||+ +++|.+++.......+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~-------------- 162 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL-------------- 162 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE--------------
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE--------------
Confidence 56899999999 7899999987644468999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHh
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~ 264 (379)
+.++.++|+|||.+...... .....||+.|+|||++. +..++.++|||||||++|+|++
T Consensus 163 -------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~ 229 (326)
T 2x7f_A 163 -------------TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229 (326)
T ss_dssp -------------CTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHH
T ss_pred -------------cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHh
Confidence 45566788888877654322 23456899999999986 4568899999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||...+.......+.+...+.. ....++..
T Consensus 230 g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~ 262 (326)
T 2x7f_A 230 GAPPLCDMHPMRALFLIPRNPAPRL-----------------------------------------------KSKKWSKK 262 (326)
T ss_dssp SSCTTTTSCHHHHHHHHHHSCCCCC-----------------------------------------------SCSCSCHH
T ss_pred CCCCCCCCcHHHHHHHhhcCccccC-----------------------------------------------CccccCHH
Confidence 9999987665544333222111100 01235678
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+.++|.+||+.||.+|||++|+++||||++.
T Consensus 263 l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 263 FQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 9999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=350.05 Aligned_cols=298 Identities=21% Similarity=0.308 Sum_probs=210.4
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
.+....|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.++..+ .|+|++++++++..+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-----CCTTBCCEEEEEEET
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-----CCCCEEEEeEEEEEC
Confidence 34456789999999999999999999999999999999743 23345566777777766 789999999999999
Q ss_pred ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 117 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
+..++||||+ +++|.+++.... .+++..+..++.|++.||.|||+. ||+||||||+||++
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---------------- 165 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---------------- 165 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE----------------
T ss_pred CEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE----------------
Confidence 9999999999 889999998765 689999999999999999999986 99999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCC-CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 166 -----------~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 166 -----------NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp -----------CTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred -----------CCCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5566788899988753221 2234578999999999999899999999999999999999999998876
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.......+.................+....+ .....+........+. ........+.++.+||++||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L 309 (360)
T 3eqc_A 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRP-PMAIFELLDYIVNEPP----PKLPSGVFSLEFQDFVNKCL 309 (360)
T ss_dssp HHHHHHHHC-------------------------------CCCHHHHHHHHHHSCC----CCCCTTTSCHHHHHHHHHHH
T ss_pred HHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCC-cccchhhhhHHhccCC----CCCCcccccHHHHHHHHHHh
Confidence 655433322211111110000000000000000000000 0000000000000000 00001235778999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+.||++|||++|+++||||++.
T Consensus 310 ~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 310 IKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp CSSTTTSCCHHHHHTSHHHHHH
T ss_pred hcChhhCCCHHHHhhChHhhcc
Confidence 9999999999999999999753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=349.57 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=202.9
Q ss_pred eeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 37 YIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 37 ~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.+......|++.+.||+|+||.||+|.+.. ++.||+|++... ......+.+|+.++..+.+ +|+||+++++++
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~---~~~~iv~~~~~~ 125 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ---HSDKIIRLYDYE 125 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT---TCTTBCCEEEEE
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHccc---CCCeEEEEEEEE
Confidence 345556679999999999999999999765 899999999643 2334567789999998854 468999999999
Q ss_pred eecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 114 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 114 ~~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
..++.+|+|||+.+++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++.
T Consensus 126 ~~~~~~~lv~E~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-------------- 189 (390)
T 2zmd_A 126 ITDQYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-------------- 189 (390)
T ss_dssp ECSSEEEEEEECCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES--------------
T ss_pred ecCCEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE--------------
Confidence 9999999999966999999998865 689999999999999999999999999999999999992
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhC-----------CCCCCccchHhHHH
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-----------LGWTYPCDIWSVGC 257 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~ 257 (379)
++.++|+|||++....... ....||+.|+|||++.+ ..++.++|||||||
T Consensus 190 --------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGv 255 (390)
T 2zmd_A 190 --------------DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 255 (390)
T ss_dssp --------------SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHH
T ss_pred --------------CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHH
Confidence 2457888888876543322 23579999999999875 35889999999999
Q ss_pred HHHHHHhCCCCCCCCchH-HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHH
Q 017021 258 ILVELCTGEALFQTHENL-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336 (379)
Q Consensus 258 il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (379)
++|+|++|..||...... ... .....+. ....++
T Consensus 256 il~ell~G~~Pf~~~~~~~~~~---~~~~~~~------------------~~~~~~------------------------ 290 (390)
T 2zmd_A 256 ILYYMTYGKTPFQQIINQISKL---HAIIDPN------------------HEIEFP------------------------ 290 (390)
T ss_dssp HHHHHHHSSCTTTTCCCHHHHH---HHHHCTT------------------SCCCCC------------------------
T ss_pred HHHHHHHCCCcchhhhHHHHHH---HHHhCcc------------------ccCCCC------------------------
Confidence 999999999999764321 111 1111110 001111
Q ss_pred hhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 337 ~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
...+.++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 291 --~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 291 --DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp --CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred --ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 123567899999999999999999999999999964
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=333.72 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=204.8
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
..|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ .|+|++++++++.+++..|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-----CCCCceeeeeEEEcCCEEE
Confidence 46889999999999999999999999999999997432 3345667788887776 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~--------------------- 138 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL--------------------- 138 (276)
T ss_dssp EEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---------------------
T ss_pred EEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---------------------
Confidence 999999 789999886543 68999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCC-CCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+...... .....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||....
T Consensus 139 ------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 139 ------DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp ------CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred ------ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 45566788888877543221 133568999999999987665 688999999999999999999998654
Q ss_pred hHHH-HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 274 NLEH-LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 274 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
.... ........... ..+...+..+.++|.+|
T Consensus 213 ~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~li~~~ 245 (276)
T 2yex_A 213 DSCQEYSDWKEKKTYL-----------------------------------------------NPWKKIDSAPLALLHKI 245 (276)
T ss_dssp TTSHHHHHHHTTCTTS-----------------------------------------------TTGGGSCHHHHHHHHHH
T ss_pred hHHHHHHHhhhccccc-----------------------------------------------CchhhcCHHHHHHHHHH
Confidence 3211 11110000000 01124667899999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCCCCcC
Q 017021 353 LRYDPTDRLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~~~~~ 378 (379)
|+.||++|||++|+++||||++...+
T Consensus 246 l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 246 LVENPSARITIPDIKKDRWYNKPLKK 271 (276)
T ss_dssp SCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred CCCCchhCCCHHHHhcCccccChhhc
Confidence 99999999999999999999987554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=335.28 Aligned_cols=259 Identities=23% Similarity=0.399 Sum_probs=190.5
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhh--HhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
.+....|++.+.||+|+||.||+|.+..+++.||+|++....... .....|...+ .....|+|++++++++.++
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~----~~~~~h~~iv~~~~~~~~~ 78 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS----MRTVDCPFTVTFYGALFRE 78 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHH----HTTCCCTTBCCEEEEEECS
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHH----HHhCCCCeEEEEeeeeecc
Confidence 345667899999999999999999999999999999997432222 1222222221 1223789999999999999
Q ss_pred ceEEEEEeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCcEEEecccccccCCCccCC
Q 017021 117 NHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 117 ~~~~lv~e~~~~sL~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
+..++||||+.++|.+++.. .....+++..+..++.|++.||.|||+. |++||||||+||++
T Consensus 79 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~--------------- 143 (290)
T 3fme_A 79 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI--------------- 143 (290)
T ss_dssp SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---------------
T ss_pred CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---------------
Confidence 99999999997799888764 1234699999999999999999999998 99999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhh----hCCCCCCccchHhHHHHHHHHHhCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
+.++.++|+|||.+....... ....||+.|+|||.+ .+..++.++|||||||++|+|++|..
T Consensus 144 ------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 211 (290)
T 3fme_A 144 ------------NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211 (290)
T ss_dssp ------------CTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSC
T ss_pred ------------CCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCC
Confidence 455567778888775433332 234689999999996 45568899999999999999999999
Q ss_pred CCCCCch-HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 268 LFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 268 pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
||..... ............+ ..+ ....+.++.
T Consensus 212 p~~~~~~~~~~~~~~~~~~~~----------------------~~~-------------------------~~~~~~~~~ 244 (290)
T 3fme_A 212 PYDSWGTPFQQLKQVVEEPSP----------------------QLP-------------------------ADKFSAEFV 244 (290)
T ss_dssp SSCCCSCHHHHHHHHHHSCCC----------------------CCC-------------------------TTTSCHHHH
T ss_pred CccccCchHHHHHHHhccCCC----------------------Ccc-------------------------cccCCHHHH
Confidence 9976332 2222211111100 000 123567899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
++|.+||+.||++|||++|+++||||+..
T Consensus 245 ~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 245 DFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 99999999999999999999999999754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=354.60 Aligned_cols=265 Identities=14% Similarity=0.093 Sum_probs=192.3
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEec----
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIR---- 110 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~---- 110 (379)
......|++.+.||+|+||.||+|+++.+++.||+|++.... .....+.+|+.++..+.. .|+|+++++
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~---~hp~iv~~~~~~~ 134 (371)
T 3q60_A 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG---ESPEEARDRRRLL 134 (371)
T ss_dssp TCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-------------CBC
T ss_pred CCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc---cChhhhhhceeEE
Confidence 334556899999999999999999999999999999998632 334555677777777754 578877654
Q ss_pred ---ceeeec-----------------ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHH------HHHHHHHHHHHHHHHHc
Q 017021 111 ---NWFDYR-----------------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLV------REIARQLLECIAFMHDL 164 (379)
Q Consensus 111 ---~~~~~~-----------------~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~------~~~~~qi~~aL~~LH~~ 164 (379)
+.+... ...|+||||+.++|.+++...+ ..++.... ..++.||+.||+|||++
T Consensus 135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~ 213 (371)
T 3q60_A 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK 213 (371)
T ss_dssp CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence 333222 4489999999999999998642 12444444 67779999999999999
Q ss_pred CCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-
Q 017021 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG- 243 (379)
Q Consensus 165 ~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~- 243 (379)
||+||||||+|||+ +.++.++|+|||.+...........+|+.|+|||++.+
T Consensus 214 ~ivHrDikp~NIll---------------------------~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~ 266 (371)
T 3q60_A 214 GLVHGHFTPDNLFI---------------------------MPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNAS 266 (371)
T ss_dssp TEEETTCSGGGEEE---------------------------CTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCS
T ss_pred CCccCcCCHHHEEE---------------------------CCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCC
Confidence 99999999999999 55667899999988766554435567899999999987
Q ss_pred -CCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhh
Q 017021 244 -LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 322 (379)
Q Consensus 244 -~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (379)
..++.++|||||||++|+|++|+.||......... .+..............++
T Consensus 267 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~---------- 320 (371)
T 3q60_A 267 TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG----------------SWKRPSLRVPGTDSLAFG---------- 320 (371)
T ss_dssp EEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT----------------CCCBCCTTSCCCCSCCCT----------
T ss_pred CCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc----------------chhhhhhhhccccccchh----------
Confidence 67999999999999999999999999764321000 000000000000000000
Q ss_pred hhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 323 SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
.....++.+.+||.+||+.||++|||++|+++||||++
T Consensus 321 --------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 321 --------------SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp --------------TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred --------------hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 11246788999999999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=341.53 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=204.5
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---------hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
..|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ .|+|++++++++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~ 84 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-----NHPCIIKIKNFF 84 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-----CCCCCceEeeEE
Confidence 46889999999999999999999999999999986421 1223466799998888 789999999998
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..+. .|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.+
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~----------- 150 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ----------- 150 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS-----------
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecC-----------
Confidence 7665 89999999 889999987654 68999999999999999999999999999999999999532
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhh---CCCCCCccchHhHHHHHHHHHhCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
.....++|+|||.+....... ....||+.|+|||++. ...++.++|||||||++|+|++|..
T Consensus 151 -------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 151 -------------EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217 (322)
T ss_dssp -------------SSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------CCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 233459999999987654432 2346899999999974 4568899999999999999999999
Q ss_pred CCCCCchH-HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 268 LFQTHENL-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 268 pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
||...... .....+........ ...+...+..+.
T Consensus 218 pf~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~ 252 (322)
T 2ycf_A 218 PFSEHRTQVSLKDQITSGKYNFI---------------------------------------------PEVWAEVSEKAL 252 (322)
T ss_dssp SSCSTTCSSCHHHHHHHTCCCCC---------------------------------------------HHHHTTSCHHHH
T ss_pred CCcccchHHHHHHHHHhCccccC---------------------------------------------chhhhhcCHHHH
Confidence 99764321 11222221111111 112234678899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
+||.+||+.||++|||++|+++||||++...
T Consensus 253 ~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 253 DLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283 (322)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred HHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence 9999999999999999999999999987543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=336.20 Aligned_cols=252 Identities=24% Similarity=0.446 Sum_probs=204.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-----hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee--eec
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF--DYR 116 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~--~~~ 116 (379)
.|++.+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+.++..+ .|+|++++++++ ...
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-----RHKNVIQLVDVLYNEEK 80 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEECC--
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-----CCCCeeEEEEEEEcCCC
Confidence 5889999999999999999999999999999997432 2345667788888777 689999999988 455
Q ss_pred ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 117 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 117 ~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
...|+||||+.++|.+++.......+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~------------------ 142 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL------------------ 142 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------------
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE------------------
Confidence 68999999996668888887655679999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCC--CCCccchHhHHHHHHHHHhCCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus 143 ---------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (305)
T 2wtk_C 143 ---------TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213 (305)
T ss_dssp ---------CTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ---------cCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 455667777887776443221 2346899999999997654 367999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
...+..+....+.+.....+ ...+..+.++|
T Consensus 214 ~~~~~~~~~~~i~~~~~~~~-------------------------------------------------~~~~~~l~~li 244 (305)
T 2wtk_C 214 EGDNIYKLFENIGKGSYAIP-------------------------------------------------GDCGPPLSDLL 244 (305)
T ss_dssp CCSSHHHHHHHHHHCCCCCC-------------------------------------------------SSSCHHHHHHH
T ss_pred CCchHHHHHHHHhcCCCCCC-------------------------------------------------CccCHHHHHHH
Confidence 88766555444433211111 13567899999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
.+||+.||.+|||++|+++||||++..
T Consensus 245 ~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 245 KGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHccCChhhCCCHHHHhcCcccccCC
Confidence 999999999999999999999997653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=332.69 Aligned_cols=256 Identities=30% Similarity=0.496 Sum_probs=211.5
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
..|++.+.||+|+||.||+|+++.+++.||+|++.... .....+.+|+.++.++ .|++++++++++...+..
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-----DHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-----cCCCccEEEEEEeCCCeE
Confidence 47889999999999999999999999999999986432 2345677888888887 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++|||++ +++|.+.+.... .+++..+..++.||+.||.|||+.|++||||||+||+++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~----------------- 157 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK----------------- 157 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS-----------------
T ss_pred EEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecC-----------------
Confidence 9999999 899999887654 68999999999999999999999999999999999999542
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
.....++|+|||.+....... ....||+.|+|||.+.+ .++.++||||||+++|+|++|..||...+..+
T Consensus 158 -------~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (287)
T 2wei_A 158 -------EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229 (287)
T ss_dssp -------STTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------CCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 234578999999887554433 33468999999999876 48899999999999999999999998877665
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.......+. ..+...+.++.++|++||+.|
T Consensus 230 ~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~li~~~l~~d 264 (287)
T 2wei_A 230 ILKRVETGKYAFDL---------------------------------------------PQWRTISDDAKDLIRKMLTFH 264 (287)
T ss_dssp HHHHHHHCCCCCCS---------------------------------------------GGGTTSCHHHHHHHHHHTCSS
T ss_pred HHHHHHcCCCCCCc---------------------------------------------hhhhhcCHHHHHHHHHHcccC
Confidence 55444332211110 011235678999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~ 375 (379)
|++|||++|+++||||++.
T Consensus 265 p~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 265 PSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp GGGSCCHHHHHHSHHHHHH
T ss_pred hhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=336.12 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=205.1
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
.......|++.+.||+|+||.||+|.++.+|+.||+|++... .....+.+|+.++..+ .|+|++++++++...+
T Consensus 24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-SDLQEIIKEISIMQQC-----DSPHVVKYYGSYFKNT 97 (314)
T ss_dssp ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-SCCHHHHHHHHHHHTC-----CCTTBCCEEEEEEETT
T ss_pred hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-HHHHHHHHHHHHHHhC-----CCCCCccEEEEEEeCC
Confidence 344566789999999999999999999999999999999753 3345677888888887 7899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..|+||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~------------------ 158 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL------------------ 158 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------------
T ss_pred EEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE------------------
Confidence 999999999 789999997533 368999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+...... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...+
T Consensus 159 ---------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 159 ---------NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp ---------CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---------CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 45566788888877543322 233568999999999999889999999999999999999999998766
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
.......+.....+.. . ....++..+.++|.+||
T Consensus 230 ~~~~~~~~~~~~~~~~----------------------~------------------------~~~~~~~~l~~li~~~l 263 (314)
T 3com_A 230 PMRAIFMIPTNPPPTF----------------------R------------------------KPELWSDNFTDFVKQCL 263 (314)
T ss_dssp HHHHHHHHHHSCCCCC----------------------S------------------------SGGGSCHHHHHHHHHHT
T ss_pred hHHHHHHHhcCCCccc----------------------C------------------------CcccCCHHHHHHHHHHc
Confidence 5443332222111000 0 01235678999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+.||.+|||++|+++||||+...
T Consensus 264 ~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 264 VKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp CSCTTTSCCHHHHTTSHHHHTCC
T ss_pred cCChhhCcCHHHHHhCHHHhcCC
Confidence 99999999999999999998753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=334.97 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=210.3
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
.....|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.++..+ .|++++++++++....
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKDT 93 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETT
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEecCC
Confidence 3456689999999999999999999999999999999743 23346677888888887 7799999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..++||||+ +++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~------------------ 152 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL------------------ 152 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------------
T ss_pred eEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE------------------
Confidence 999999999 78999998754 58999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+...... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 153 ---------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 153 ---------SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp ---------CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---------CCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 45566788888877543332 234568999999999999889999999999999999999999998766
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.+...+ .....++..+.++|.+||
T Consensus 224 ~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 224 PMKVLFLIPKNNPP------------------------------------------------TLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp HHHHHHHHHHSCCC------------------------------------------------CCCSSCCHHHHHHHHHHC
T ss_pred HHHHHHHhhcCCCC------------------------------------------------CCccccCHHHHHHHHHHc
Confidence 55443333221100 001235678999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+.||.+|||++|+++||||....
T Consensus 256 ~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp CSSGGGSCCHHHHTTCHHHHHHC
T ss_pred CCChhhCcCHHHHhhChhhhcCC
Confidence 99999999999999999996543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=334.50 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=206.5
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.....|++.+.||+|+||.||+|.++.+++.||+|++... ......+..|+.++..+ .|+|++++++++...+.
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-----DHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECC-C
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-----CCCCEeeeeeeeeeCCe
Confidence 4556799999999999999999999999999999998643 23345677788888887 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~------------------- 150 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM------------------- 150 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE-------------------
T ss_pred EEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE-------------------
Confidence 99999999 889999987643 358999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccC---CCCCcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.++.++|+|||.+.... .......||+.|+|||.+. +..++.++|||||||++|+|++|..||
T Consensus 151 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 222 (302)
T 2j7t_A 151 --------TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222 (302)
T ss_dssp --------CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTT
T ss_pred --------CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCC
Confidence 555678888888764211 1123346899999999984 567889999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
...+..+....+.....+.. .....++..+.++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~l~~li 256 (302)
T 2j7t_A 223 HELNPMRVLLKIAKSDPPTL----------------------------------------------LTPSKWSVEFRDFL 256 (302)
T ss_dssp TTSCHHHHHHHHHHSCCCCC----------------------------------------------SSGGGSCHHHHHHH
T ss_pred ccCCHHHHHHHHhccCCccc----------------------------------------------CCccccCHHHHHHH
Confidence 87766554433332211100 00123567899999
Q ss_pred hhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 350 QGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
.+||+.||.+|||++|+++||||++..
T Consensus 257 ~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 257 KIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHcccChhhCCCHHHHhcChHHhhhc
Confidence 999999999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=361.11 Aligned_cols=252 Identities=17% Similarity=0.232 Sum_probs=194.8
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEec-----
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIR----- 110 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~----- 110 (379)
.....|++.+.||+|+||.||+|+++.+|+.||+|++... ......+.+|+.++..+.. ..|+||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG--IKNQKQAKVHLRFIF 147 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTT--CCSHHHHHHHHCBCC
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccc--cCCHHHHHHHhhhhh
Confidence 3456799999999999999999999999999999999632 2334566678765555432 2689998887
Q ss_pred --ceeeecc-----------------eEEEEEeCCCCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 017021 111 --NWFDYRN-----------------HICIVFEKLGSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCM 166 (379)
Q Consensus 111 --~~~~~~~-----------------~~~lv~e~~~~sL~~~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~i 166 (379)
++++..+ ..|+||||++|+|.+++..... ..+++..+..++.||+.||+|||+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 5554442 3899999998899999986420 123347888899999999999999999
Q ss_pred cccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCC--
Q 017021 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-- 244 (379)
Q Consensus 167 iH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-- 244 (379)
+||||||+||++ +.++.+||+|||++...........| +.|+|||++.+.
T Consensus 228 vHrDikp~NIll---------------------------~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~ 279 (377)
T 3byv_A 228 VHTYLRPVDIVL---------------------------DQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRAT 279 (377)
T ss_dssp ECSCCCGGGEEE---------------------------CTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTS
T ss_pred ecCCCCHHHEEE---------------------------cCCCCEEEEechhheecCCcccCCCC-cCccChhhhccccc
Confidence 999999999999 55567888888888765554445567 999999999887
Q ss_pred ---------CCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCC
Q 017021 245 ---------GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGA 315 (379)
Q Consensus 245 ---------~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (379)
.++.++|||||||++|+|++|+.||...+..+... .
T Consensus 280 ~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~----------------------~------------- 324 (377)
T 3byv_A 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE----------------------W------------- 324 (377)
T ss_dssp THHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG----------------------G-------------
T ss_pred ccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh----------------------h-------------
Confidence 79999999999999999999999996533211000 0
Q ss_pred CchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 316 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
........++++.+||.+||+.||++|||+.|+++||||++
T Consensus 325 ------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 325 ------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp ------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred ------------------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 00001246778999999999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=341.04 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=203.9
Q ss_pred echhhhhhhhccccccceeEEEEEec---CCCceEEEEEeecc-----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGI-----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.....|++.+.||+|+||.||+|++. .+++.||+|+++.. ......+..|+.++..+. +|++++.+++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~ 126 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----QSPFLVTLHY 126 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH----TCTTBCCEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHcc----CCCceeEEEE
Confidence 34468999999999999999999984 58999999998642 223455667899988884 4688999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
++...+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll------------ 192 (355)
T 1vzo_A 127 AFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL------------ 192 (355)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------
T ss_pred EEeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE------------
Confidence 999999999999999 889999998754 68999999999999999999999999999999999999
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhC--CCCCCccchHhHHHHHHHHHh
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~~l~~ 264 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 193 ---------------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~ 257 (355)
T 1vzo_A 193 ---------------DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257 (355)
T ss_dssp ---------------CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred ---------------CCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH
Confidence 555678888888776433221 23579999999999985 347899999999999999999
Q ss_pred CCCCCCCCchH----HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc
Q 017021 265 GEALFQTHENL----EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 265 g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (379)
|..||...... +....+.....+. ...
T Consensus 258 g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~ 288 (355)
T 1vzo_A 258 GASPFTVDGEKNSQAEISRRILKSEPPY-------------------------------------------------PQE 288 (355)
T ss_dssp SSCTTSCTTSCCCHHHHHHHHHHCCCCC-------------------------------------------------CTT
T ss_pred CCCCCccCCccchHHHHHHHHhccCCCC-------------------------------------------------Ccc
Confidence 99999754321 1111111111111 123
Q ss_pred chhHHHHHHhhccccCCCCCc-----CHHHHhcCCCCCCCC
Q 017021 341 SAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
.+..+.+||.+||+.||.+|| |++|+++||||+..+
T Consensus 289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 567899999999999999999 999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=341.32 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=199.1
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
...|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.++..+ .|+||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-----NHPAIVAVYDTGEAET 85 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-----CCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-----CCCCcceEEEeeeccC
Confidence 3468999999999999999999999999999999975322 223445566655555 7899999999987654
Q ss_pred ----eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 118 ----HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 118 ----~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..|+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~------------- 150 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS------------- 150 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-------------
T ss_pred CCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc-------------
Confidence 459999999 899999998765 699999999999999999999999999999999999994
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 151 --------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~ 216 (311)
T 3ork_A 151 --------------ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216 (311)
T ss_dssp --------------TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred --------------CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence 44567777777775433221 2346899999999999999999999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||.+.+..+...........++. ......+.++.
T Consensus 217 ~pf~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~l~ 251 (311)
T 3ork_A 217 PPFTGDSPVSVAYQHVREDPIPPS---------------------------------------------ARHEGLSADLD 251 (311)
T ss_dssp CSCCCSSHHHHHHHHHHCCCCCHH---------------------------------------------HHSTTCCHHHH
T ss_pred CCCCCCChHHHHHHHhcCCCCCcc---------------------------------------------cccCCCCHHHH
Confidence 999887765554433332211111 11234678899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~ 373 (379)
++|.+||+.||.+||++.+++.|+|++
T Consensus 252 ~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 252 AVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 999999999999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=333.82 Aligned_cols=282 Identities=21% Similarity=0.326 Sum_probs=208.1
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
.....|++.+.||+|+||.||+|++..+++.||+|+++... .......+|+.++..+ .|+|++++++++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-----NHKNIVKLFAIEEETT 80 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECTT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-----CCCCcceEEEEeecCC
Confidence 34557899999999999999999999999999999997432 2345667899999888 6899999999987654
Q ss_pred --eEEEEEeCC-CCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 118 --HICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 118 --~~~lv~e~~-~~sL~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+.||+||||||+||++....
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~----------- 149 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE----------- 149 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECT-----------
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccC-----------
Confidence 889999999 8999999986432 2389999999999999999999999999999999999983321
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhh--------CCCCCCccchHhHHHHHHHHH
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL--------GLGWTYPCDIWSVGCILVELC 263 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlG~il~~l~ 263 (379)
+....++|+|||.+....... ....||+.|+|||++. +..++.++|||||||++|+|+
T Consensus 150 ------------~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~ 217 (319)
T 4euu_A 150 ------------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217 (319)
T ss_dssp ------------TSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHH
T ss_pred ------------CCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHH
Confidence 345668999999887654433 3457899999999986 467899999999999999999
Q ss_pred hCCCCCCCCch-HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccch
Q 017021 264 TGEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342 (379)
Q Consensus 264 ~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (379)
+|..||..... ......+.+.....|...+..+... .++...|.... +. ........+
T Consensus 218 ~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-----~~~~~~~~~~~------------~~----~~~~~~~~~ 276 (319)
T 4euu_A 218 TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKA-----ENGPIDWSGDM------------PV----SCSLSRGLQ 276 (319)
T ss_dssp HSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECS-----TTCCEEEESSC------------CT----TCSSCHHHH
T ss_pred hCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcc-----cCCccccCccC------------Cc----ccccchhHH
Confidence 99999975332 1112222222222222111111100 00011111000 00 001123456
Q ss_pred hHHHHHHhhccccCCCCCcCHHHHhcCC
Q 017021 343 GDLTHLLQGLLRYDPTDRLTAREALRHP 370 (379)
Q Consensus 343 ~~~~~li~~~L~~dP~~Rpta~e~l~hp 370 (379)
..+.++|++||+.||++|||++|+|+||
T Consensus 277 ~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 277 VLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 7899999999999999999999999997
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=328.98 Aligned_cols=256 Identities=22% Similarity=0.335 Sum_probs=208.5
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee--e
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--Y 115 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~--~ 115 (379)
....|++.+.||+|+||.||+|.++.+++.||+|++... ......+.+|+.++..+ .|+|++++++++. .
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-----KHPNIVRYYDRIIDRT 78 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEEGG
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-----CCCCCCeEEEEEecCC
Confidence 345789999999999999999999999999999999743 23445677888888888 6899999999774 4
Q ss_pred cceEEEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CcccCCCCCcEEEecccccccC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----iiH~dlkp~Nili~~~~~~~~~ 187 (379)
....|+||||+ +++|.+++... ....+++..++.++.|++.||.|||+.| ++||||||+||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~--------- 149 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--------- 149 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---------
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---------
Confidence 67899999999 78999999763 2234899999999999999999999999 9999999999999
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~ 264 (379)
+.++.++|+|||.+....... ....||+.|+|||.+.+..++.++||||||+++|+|++
T Consensus 150 ------------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 211 (279)
T 2w5a_A 150 ------------------DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211 (279)
T ss_dssp ------------------CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHH
T ss_pred ------------------cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHH
Confidence 556678899999886554432 23468999999999999889999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||...+..+....+.....+. ....++..
T Consensus 212 g~~p~~~~~~~~~~~~i~~~~~~~------------------------------------------------~~~~~~~~ 243 (279)
T 2w5a_A 212 LMPPFTAFSQKELAGKIREGKFRR------------------------------------------------IPYRYSDE 243 (279)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCC------------------------------------------------CCTTSCHH
T ss_pred CCCCCcccCHHHHHHHHhhccccc------------------------------------------------CCcccCHH
Confidence 999998776655444333321100 01135678
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+.++|.+||+.||.+|||++|+++|+|+.++.
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 99999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=331.52 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=198.9
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
..|++.+.||+|+||.||+|++..+++.||+|++... ......+.+|+.++..+ .|+|++++++++..++.
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-----SHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-----CBTTBCCEEEEEECSSE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-----CCCCCceEEEeeeeCCe
Confidence 4689999999999999999999999999999998532 22234566777777776 68999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~------------------- 144 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI------------------- 144 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-------------------
T ss_pred EEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE-------------------
Confidence 99999999 889999998765 69999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+....... ....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 145 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 145 --------DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp --------CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred --------CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 555678888888876543322 23568999999999999999999999999999999999999998876
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+...... ....+.. ........+..+.++|.+||
T Consensus 217 ~~~~~~~~~--~~~~~~~------------------------------------------~~~~~~~~~~~l~~li~~~l 252 (294)
T 4eqm_A 217 AVSIAIKHI--QDSVPNV------------------------------------------TTDVRKDIPQSLSNVILRAT 252 (294)
T ss_dssp HHHHHHHHH--SSCCCCH------------------------------------------HHHSCTTSCHHHHHHHHHHS
T ss_pred hHHHHHHHh--hccCCCc------------------------------------------chhcccCCCHHHHHHHHHHh
Confidence 544432221 1111110 01122346788999999999
Q ss_pred ccCCCCCcCHHHHhcCCC
Q 017021 354 RYDPTDRLTAREALRHPF 371 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~ 371 (379)
+.||.+||+..+.+.++|
T Consensus 253 ~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 253 EKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp CSSGGGSCSSHHHHHHHH
T ss_pred cCCHhHccccHHHHHHHH
Confidence 999999996555555554
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=330.07 Aligned_cols=270 Identities=23% Similarity=0.337 Sum_probs=191.5
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-------
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------- 115 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~------- 115 (379)
..|++.+.||+|+||.||+|++..+++.||+|++.........+.+|+.++..+ .|+|++++++.+..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-----NHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEECCCCCC-
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-----CchHHHHHHHHHHhhcchhhh
Confidence 468899999999999999999999999999999986655566777888888877 68999999887754
Q ss_pred ------cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCC
Q 017021 116 ------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 188 (379)
Q Consensus 116 ------~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~ 188 (379)
.+..|+||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++++|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 46789999999 889999998754 3578899999999999999999999999999999999995555444444
Q ss_pred CccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCC
Q 017021 189 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
||++........... + +-..............||+.|+|||.+.+. .++.++|||||||++|+|++
T Consensus 160 fg~~~~~~~~~~~~~---------~-~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~--- 226 (303)
T 1zy4_A 160 FGLAKNVHRSLDILK---------L-DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--- 226 (303)
T ss_dssp CCCCSCTTC-----------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---
T ss_pred Ccchhhcccccchhc---------c-ccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---
Confidence 444322211100000 0 000000000111234689999999999865 68899999999999999998
Q ss_pred CCCCCch-HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 268 LFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 268 pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
||..... .+....+.......| . ......+..+.
T Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~-----------------------~----------------------~~~~~~~~~~~ 261 (303)
T 1zy4_A 227 PFSTGMERVNILKKLRSVSIEFP-----------------------P----------------------DFDDNKMKVEK 261 (303)
T ss_dssp CCSSHHHHHHHHHHHHSTTCCCC-----------------------T----------------------TCCTTTSHHHH
T ss_pred ccCCchhHHHHHHhccccccccC-----------------------c----------------------cccccchHHHH
Confidence 5543221 122211111111111 0 01123456789
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
++|++||+.||.+|||++|+++||||+...
T Consensus 262 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 262 KIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=325.54 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=206.5
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.+....|++.+.||+|+||.||+|.+. +++.||+|++.........+.+|+.++.++ .|+|++++++++.+++.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-----SHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSS
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCc
Confidence 456678999999999999999999986 467799999986655567788899999888 68999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~------------------ 140 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG------------------ 140 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC------------------
T ss_pred eEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc------------------
Confidence 99999999 889999997654 3589999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~ 272 (379)
.++.++|+|||.+....... ....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 141 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 141 ---------ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp ---------GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ---------CCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 44567888888776443321 23356778999999998899999999999999999999 99999887
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
...+....+........ ....+..+.+++.+|
T Consensus 212 ~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~li~~~ 243 (269)
T 4hcu_A 212 SNSEVVEDISTGFRLYK------------------------------------------------PRLASTHVYQIMNHC 243 (269)
T ss_dssp CHHHHHHHHHTTCCCCC------------------------------------------------CTTSCHHHHHHHHHH
T ss_pred CHHHHHHHHhcCccCCC------------------------------------------------CCcCCHHHHHHHHHH
Confidence 76655544433211111 112467899999999
Q ss_pred cccCCCCCcCHHHHhcC
Q 017021 353 LRYDPTDRLTAREALRH 369 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~h 369 (379)
|+.||.+|||++|+++|
T Consensus 244 l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 244 WRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCcccCcCHHHHHHH
Confidence 99999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=342.58 Aligned_cols=260 Identities=28% Similarity=0.475 Sum_probs=179.8
Q ss_pred hhhhhhh-ccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee----cc
Q 017021 43 FADKIHS-KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RN 117 (379)
Q Consensus 43 ~~y~i~~-~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----~~ 117 (379)
-.|++.+ .||+|+||.||+|.++.+++.||+|++..... ...|+..+.+. ..|+|++.+++++.. ..
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~----~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQA----SGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHH----TTSTTBCCEEEEEEEEETTEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHh----cCCCChHHHHHHHhhccCCCc
Confidence 3567744 69999999999999999999999999975432 22333333332 267899999998876 55
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..++||||+ +++|.+++.......+++..++.++.||+.||.|||+.|++||||||+||+++.+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~--------------- 164 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSK--------------- 164 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS---------------
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEec---------------
Confidence 699999999 8899999988765679999999999999999999999999999999999999542
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
.....++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 165 ---------~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 165 ---------EKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp ---------STTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ---------CCCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 235569999999987544332 3457899999999998888899999999999999999999999765433
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
.......+.. ..+....+. ..+...+..+.+||.+||+.
T Consensus 236 ~~~~~~~~~~-------------------~~~~~~~~~----------------------~~~~~~~~~~~~li~~~L~~ 274 (336)
T 3fhr_A 236 AISPGMKRRI-------------------RLGQYGFPN----------------------PEWSEVSEDAKQLIRLLLKT 274 (336)
T ss_dssp ----------------------------------CCCT----------------------TTSTTCCHHHHHHHHHHSCS
T ss_pred hhhhhHHHhh-------------------hccccccCc----------------------hhhccCCHHHHHHHHHHCCC
Confidence 2211110000 000000000 01234678899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~ 375 (379)
||.+|||++|+++||||++.
T Consensus 275 dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 275 DPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp SGGGSCCHHHHHHSHHHHTG
T ss_pred ChhHCcCHHHHhcCcccccc
Confidence 99999999999999999764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=335.18 Aligned_cols=268 Identities=25% Similarity=0.382 Sum_probs=186.6
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
..+....|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++..+ .|+|++++++++..
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-----HHPNIVSYYTSFVV 84 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-----CCTTBCCEEEEEES
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-----CCCCEeeEEEEEee
Confidence 3455667899999999999999999999999999999986432 2234455566665555 68999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhC------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKN------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 188 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~ 188 (379)
.+..++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---------- 154 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---------- 154 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----------
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE----------
Confidence 99999999999 89999999741 22358999999999999999999999999999999999999
Q ss_pred CccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC--------CCcccccCCccchhhhhC-CCCCCccchHhHHHHH
Q 017021 189 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCIL 259 (379)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il 259 (379)
+.++.++|+|||.+...... .....||+.|+|||.+.+ ..++.++|||||||++
T Consensus 155 -----------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 217 (303)
T 2vwi_A 155 -----------------GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 217 (303)
T ss_dssp -----------------CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHH
T ss_pred -----------------cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHH
Confidence 44556777777766433221 123468999999999875 5689999999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhc
Q 017021 260 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339 (379)
Q Consensus 260 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (379)
|+|++|..||.................+.... .........
T Consensus 218 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~ 258 (303)
T 2vwi_A 218 IELATGAAPYHKYPPMKVLMLTLQNDPPSLET---------------------------------------GVQDKEMLK 258 (303)
T ss_dssp HHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--------------------------------------------CCCC
T ss_pred HHHHhCCCCCccCchhhHHHHHhccCCCcccc---------------------------------------ccccchhhh
Confidence 99999999998765443322111110000000 000011123
Q ss_pred cchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 340 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
.++..+.++|.+||+.||.+|||++|+++||||+...
T Consensus 259 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 259 KYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred hhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 4677899999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=328.39 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=197.3
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
..+....|++.++||+|+||.||+|++ +++.||+|++.... .....+.+|+.++.++ .|+|++++++++.
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~ 104 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-----RHPNIVLFMGAVT 104 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEE
Confidence 445667889999999999999999976 57889999987432 2334567899999888 6899999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCcEEEecccccccCCCc
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
..+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+.| |+||||||+||++
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll------------ 172 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV------------ 172 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE------------
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE------------
Confidence 999999999999 8899999986531 13899999999999999999999999 9999999999999
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCC
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 173 ---------------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 237 (309)
T 3p86_A 173 ---------------DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237 (309)
T ss_dssp ---------------CTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCC
T ss_pred ---------------eCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 55567888888877643332 234578999999999999999999999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||...+..+....+....... .. ....++.+.+
T Consensus 238 Pf~~~~~~~~~~~~~~~~~~~---------------------~~--------------------------~~~~~~~l~~ 270 (309)
T 3p86_A 238 PWGNLNPAQVVAAVGFKCKRL---------------------EI--------------------------PRNLNPQVAA 270 (309)
T ss_dssp TTTTSCHHHHHHHHHHSCCCC---------------------CC--------------------------CTTSCHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCC---------------------CC--------------------------CccCCHHHHH
Confidence 998776655443332211111 11 1235678999
Q ss_pred HHhhccccCCCCCcCHHHHhc
Q 017021 348 LLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~ 368 (379)
+|.+||+.||.+|||++|+++
T Consensus 271 li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 271 IIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=323.47 Aligned_cols=249 Identities=21% Similarity=0.288 Sum_probs=206.0
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.+....|++.+.||+|+||.||+|.++ ++..||+|+++........+.+|+.++..+ .|+|++++++++..++.
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-----SHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSS
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-----CCCCEeeEEEEEccCCc
Confidence 456678999999999999999999876 467799999986665667788899999988 67999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~------------------- 137 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV------------------- 137 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE-------------------
T ss_pred eEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE-------------------
Confidence 99999999 899999997753 358999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~ 272 (379)
+.++.++|+|||.+....... ....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 138 --------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 138 --------DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp --------CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred --------CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 455667888888776443332 22345678999999998889999999999999999999 99999877
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+........ ....++.+.++|.+|
T Consensus 210 ~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~l~~li~~~ 241 (268)
T 3sxs_A 210 TNSEVVLKVSQGHRLYR------------------------------------------------PHLASDTIYQIMYSC 241 (268)
T ss_dssp CHHHHHHHHHTTCCCCC------------------------------------------------CTTSCHHHHHHHHHT
T ss_pred ChHHHHHHHHcCCCCCC------------------------------------------------CCcChHHHHHHHHHH
Confidence 66554443332211111 012456899999999
Q ss_pred cccCCCCCcCHHHHhcC
Q 017021 353 LRYDPTDRLTAREALRH 369 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~h 369 (379)
|+.||++|||++|+++|
T Consensus 242 l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 242 WHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=330.37 Aligned_cols=255 Identities=21% Similarity=0.247 Sum_probs=202.4
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.+..|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|+.++..+. .|++++.+++++..++..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~----~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLG----SGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHC----SCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhh----CCCCCCEEEEEEecCCccE
Confidence 3467899999999999999999999999999999997432 3456778999998883 5688999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||||++++|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.
T Consensus 82 lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~----------------- 143 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGN----------------- 143 (330)
T ss_dssp EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGG-----------------
T ss_pred EEEEeCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCC-----------------
Confidence 999999999999998753 36999999999999999999999999999999999999965432
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC----------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
.....++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 144 -----~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~ 218 (330)
T 2izr_A 144 -----KTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218 (330)
T ss_dssp -----TCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -----CCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcc
Confidence 122338888888876432221 34579999999999999999999999999999999999999998
Q ss_pred CCchH---HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 271 THENL---EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 271 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
+.+.. +....+.....+.+. .......+ ++.+
T Consensus 219 ~~~~~~~~~~~~~i~~~~~~~~~--------------------------------------------~~~~~~~p-~~~~ 253 (330)
T 2izr_A 219 GLKADTLKERYQKIGDTKRATPI--------------------------------------------EVLCENFP-EMAT 253 (330)
T ss_dssp TCCCSSHHHHHHHHHHHHHHSCH--------------------------------------------HHHTTTCH-HHHH
T ss_pred ccccccHHHHHHHHHhhhccCCH--------------------------------------------HHHhccCh-HHHH
Confidence 74332 222222111111111 01112234 8999
Q ss_pred HHhhccccCCCCCcCHHHHhc
Q 017021 348 LLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~ 368 (379)
+|..||+.||.+||+++++++
T Consensus 254 li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 254 YLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHhCCCCCCCCHHHHHH
Confidence 999999999999999999876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=326.45 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=197.6
Q ss_pred hhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 48 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 48 ~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
...||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++..+ .|+|++++++++...+..++||||+
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-----KHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-----CCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 358999999999999999999999999987532 3345667788888877 7899999999999999999999999
Q ss_pred -CCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccccc
Q 017021 127 -GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 204 (379)
Q Consensus 127 -~~sL~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (379)
+++|.+++..... ..+++..+..++.|++.||.|||+.|++||||||+||+++.
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~------------------------ 157 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT------------------------ 157 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET------------------------
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC------------------------
Confidence 8999999987532 24678899999999999999999999999999999999953
Q ss_pred CCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhhCCC--CCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 205 MPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 205 ~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
.++.++|+|||.+...... .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||..........
T Consensus 158 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 235 (295)
T 2clq_A 158 --YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235 (295)
T ss_dssp --TTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH
T ss_pred --CCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH
Confidence 2456788888877654332 23456899999999987643 7899999999999999999999997543322111
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.........+ ......+..+.++|.+||+.||++
T Consensus 236 ~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~dp~~ 269 (295)
T 2clq_A 236 FKVGMFKVHP----------------------------------------------EIPESMSAEAKAFILKCFEPDPDK 269 (295)
T ss_dssp HHHHHHCCCC----------------------------------------------CCCTTSCHHHHHHHHHTTCSSTTT
T ss_pred Hhhccccccc----------------------------------------------cccccCCHHHHHHHHHHccCChhh
Confidence 0000000000 011235678999999999999999
Q ss_pred CcCHHHHhcCCCCCCCCcC
Q 017021 360 RLTAREALRHPFFTRDHLR 378 (379)
Q Consensus 360 Rpta~e~l~hp~f~~~~~~ 378 (379)
|||++|+++||||+....+
T Consensus 270 Rps~~~ll~~~~~~~~~~~ 288 (295)
T 2clq_A 270 RACANDLLVDEFLKVSSKK 288 (295)
T ss_dssp SCCHHHHHTSGGGCC----
T ss_pred CCCHHHHhcChhhhhcccc
Confidence 9999999999999876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=324.53 Aligned_cols=250 Identities=20% Similarity=0.299 Sum_probs=209.3
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.+....|++.++||+|+||.||+|.++.+++.||+|++.........+.+|+.++..+ .|+|++++++++.+++.
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPP 83 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSS
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEccCCC
Confidence 3456778999999999999999999999999999999987666667788899999998 68999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.++||||+ +++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~------------------ 145 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG------------------ 145 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC------------------
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc------------------
Confidence 99999999 79999999886656799999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~ 272 (379)
.++.++|+|||.+....... ....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 146 ---------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 146 ---------ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp ---------GGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ---------CCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 44567788888776544333 22356788999999998899999999999999999999 99999876
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+....... .....++.+.++|.+|
T Consensus 217 ~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~l~~li~~~ 248 (288)
T 3kfa_A 217 DLSQVYELLEKDYRME------------------------------------------------RPEGCPEKVYELMRAC 248 (288)
T ss_dssp CGGGHHHHHHTTCCCC------------------------------------------------CCTTCCHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCC------------------------------------------------CCCCCCHHHHHHHHHH
Confidence 6544433332211110 0123567899999999
Q ss_pred cccCCCCCcCHHHHhc
Q 017021 353 LRYDPTDRLTAREALR 368 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~ 368 (379)
|+.||.+|||++|+++
T Consensus 249 l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 249 WQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred hCCChhhCcCHHHHHH
Confidence 9999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=340.19 Aligned_cols=271 Identities=20% Similarity=0.359 Sum_probs=208.3
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhh------------------HhHHHHHHHHHHHHhcCCCC
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR------------------EAAMIEIEVLQQLAKHDKGG 103 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~------------------~~~~~e~~~l~~l~~~~~~~ 103 (379)
...|++.+.||+|+||.||+|.+ +++.||+|++....... ..+.+|+.++..+ .|
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h 102 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-----KN 102 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-----CC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-----CC
Confidence 34789999999999999999998 89999999997432211 6677888888887 68
Q ss_pred CeeEEecceeeecceEEEEEeCC-CCCHHHH------HHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCc
Q 017021 104 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDF------LRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPEN 175 (379)
Q Consensus 104 ~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~------l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~N 175 (379)
+|++++++++.+.+..++||||+ +++|.++ +.......+++..+..++.|++.||.|||+ .|++||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 99999999999999999999999 7899998 655434579999999999999999999999 999999999999
Q ss_pred EEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-CCcccccCCccchhhhhCC-CCCC-ccch
Q 017021 176 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGL-GWTY-PCDI 252 (379)
Q Consensus 176 ili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~-~sDv 252 (379)
|++ +.++.++|+|||.+...... .....||..|+|||.+.+. .++. ++||
T Consensus 183 il~---------------------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 235 (348)
T 2pml_X 183 ILM---------------------------DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235 (348)
T ss_dssp EEE---------------------------CTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHH
T ss_pred EEE---------------------------cCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhH
Confidence 999 55567888888887653322 2345789999999999877 5665 9999
Q ss_pred HhHHHHHHHHHhCCCCCCCCch-HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhH
Q 017021 253 WSVGCILVELCTGEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 331 (379)
Q Consensus 253 wSlG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (379)
|||||++|+|++|..||..... .+....+.......| ....... . +...
T Consensus 236 ~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~-----------------------~~~~~~~--~-----~~~~ 285 (348)
T 2pml_X 236 WSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP-----------------------LDRNHFL--Y-----PLTN 285 (348)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCC-----------------------CSSSSST--T-----TTCC
T ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCc-----------------------cchhhhh--c-----cccc
Confidence 9999999999999999987655 443333322211111 1000000 0 0000
Q ss_pred HHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 332 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 332 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
..........+..+.+||.+||+.||.+|||++|+++||||++..
T Consensus 286 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 286 KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp --------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 001112245778999999999999999999999999999999764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=323.42 Aligned_cols=256 Identities=20% Similarity=0.246 Sum_probs=204.0
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
....|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+|+..+..+. +|++++.+++++......+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~~~~l~----~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLA----GCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTT----TCTTCCCEEEEEEETTEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-CccHHHHHHHHHHHHHh----cCCCCCeEEeecCCCceeE
Confidence 345689999999999999999999999999999998743 33456677888888873 4577888889999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||||++++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.
T Consensus 83 lv~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~----------------- 144 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS----------------- 144 (298)
T ss_dssp EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS-----------------
T ss_pred EEEEecCCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC-----------------
Confidence 999999999999998754 35899999999999999999999999999999999999965431
Q ss_pred ccccCCCCCCeEEeecCcccccCCC----------CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
.....++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 145 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 219 (298)
T 1csn_A 145 -----KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 219 (298)
T ss_dssp -----TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred -----CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcc
Confidence 23345888888887643322 234568999999999999899999999999999999999999998
Q ss_pred CCch---HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 271 THEN---LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 271 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
..+. .+....+.......+ .......++.++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~l~~ 255 (298)
T 1csn_A 220 GLKAATNKQKYERIGEKKQSTP--------------------------------------------LRELCAGFPEEFYK 255 (298)
T ss_dssp SCCSCCHHHHHHHHHHHHHHSC--------------------------------------------HHHHTTTSCHHHHH
T ss_pred hhhccccHHHHHHHHhhccCcc--------------------------------------------HHHHHhhCcHHHHH
Confidence 7432 222222221111111 11122346789999
Q ss_pred HHhhccccCCCCCcCHHHHhc
Q 017021 348 LLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~ 368 (379)
+|.+||+.||++|||++++++
T Consensus 256 li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 256 YMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHhcCCcccCCCHHHHHH
Confidence 999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=328.42 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=202.7
Q ss_pred eeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 35 ITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.+.+.+....|++.+.||+|+||.||+|.+. +++.||+|++... ......+.+|+.++..+.+ ++++++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~~iv~~~~ 95 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ---HSDKIIRLYD 95 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGG---GCTTBCCEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccc---cCCceEEEEE
Confidence 3446677788999999999999999999985 4889999999643 2334566789999999854 3588999999
Q ss_pred eeeecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 112 WFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
++...+..++|||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.
T Consensus 96 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~----------- 162 (313)
T 3cek_A 96 YEITDQYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----------- 162 (313)
T ss_dssp EEECSSEEEEEECCCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-----------
T ss_pred EeecCCEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-----------
Confidence 999999999999977999999998764 6899999999999999999999999999999999999932
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhC-----------CCCCCccchHhH
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-----------LGWTYPCDIWSV 255 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSl 255 (379)
+.++|+|||.+....... ....||+.|+|||.+.+ ..++.++|||||
T Consensus 163 -----------------~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~sl 225 (313)
T 3cek_A 163 -----------------GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225 (313)
T ss_dssp -----------------TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHH
T ss_pred -----------------CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHH
Confidence 457777887776543322 23468999999999875 467889999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHH
Q 017021 256 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335 (379)
Q Consensus 256 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (379)
||++|+|++|..||........ .+.....+. .....
T Consensus 226 G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~------------------~~~~~------------------------ 261 (313)
T 3cek_A 226 GCILYYMTYGKTPFQQIINQIS--KLHAIIDPN------------------HEIEF------------------------ 261 (313)
T ss_dssp HHHHHHHHHSSCTTTTCCSHHH--HHHHHHCTT------------------SCCCC------------------------
T ss_pred HHHHHHHHhCCCchhhHHHHHH--HHHHHHhcc------------------cccCC------------------------
Confidence 9999999999999976432111 111111000 00011
Q ss_pred HhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 336 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
....+..+.++|.+||+.||.+|||++|+++||||+...
T Consensus 262 --~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 262 --PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp --CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred --cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 112456799999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=325.48 Aligned_cols=251 Identities=18% Similarity=0.254 Sum_probs=198.7
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeec-cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
.+....|++.++||+|+||.||+|.+..+++.||+|++.. .......+.+|+.++.++ .|+||+++++++.+++
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~ 80 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-----EHPNVLKFIGVLYKDK 80 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETT
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCcCcccEEEEEecCC
Confidence 3556678899999999999999999999999999998854 334456677888888877 6899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~--------------- 144 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN--------------- 144 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT---------------
T ss_pred eeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC---------------
Confidence 999999999 889999998753 368999999999999999999999999999999999999544
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC-----------------CcccccCCccchhhhhCCCCCCccchHhHHHHH
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----------------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 259 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il 259 (379)
+.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++
T Consensus 145 ------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l 212 (310)
T 3s95_A 145 ------------KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVL 212 (310)
T ss_dssp ------------SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred ------------CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHH
Confidence 445556665554322211 145789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhc
Q 017021 260 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339 (379)
Q Consensus 260 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (379)
|+|++|..|+......... .. .............
T Consensus 213 ~el~~g~~~~~~~~~~~~~---------~~-------------------------------------~~~~~~~~~~~~~ 246 (310)
T 3s95_A 213 CEIIGRVNADPDYLPRTMD---------FG-------------------------------------LNVRGFLDRYCPP 246 (310)
T ss_dssp HHHHHTCCSSTTTSCBCTT---------SS-------------------------------------BCHHHHHHHTCCT
T ss_pred HHHhcCCCCCcchhhhHHH---------Hh-------------------------------------hhhhccccccCCC
Confidence 9999999988642210000 00 0000000111123
Q ss_pred cchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 340 HSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 340 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.+++.+.++|.+||+.||++|||++|+++
T Consensus 247 ~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 247 NCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 56778999999999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=331.37 Aligned_cols=249 Identities=22% Similarity=0.266 Sum_probs=201.9
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCc---eEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~---~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.+....|++.+.||+|+||.||+|+++.+++ .||+|+++.. ......+.+|+.++..+ .|+||+++++++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~ 119 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-----DHPNIIRLEGVV 119 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEE
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEE
Confidence 4556789999999999999999999986654 4999999743 33445677888888877 789999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
.+++..|+||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll-------------- 184 (325)
T 3kul_A 120 TRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV-------------- 184 (325)
T ss_dssp CGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--------------
T ss_pred EeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE--------------
Confidence 9999999999999 889999997653 368999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-C
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-G 265 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g 265 (379)
+.++.++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 185 -------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g 251 (325)
T 3kul_A 185 -------------DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251 (325)
T ss_dssp -------------CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred -------------CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 455667888888776543322 11235678999999998889999999999999999999 9
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
..||......+....+....... . ...++..+
T Consensus 252 ~~p~~~~~~~~~~~~~~~~~~~~----------------------~--------------------------~~~~~~~l 283 (325)
T 3kul_A 252 ERPYWNMTNRDVISSVEEGYRLP----------------------A--------------------------PMGCPHAL 283 (325)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCCC----------------------C--------------------------CTTCCHHH
T ss_pred CCCcccCCHHHHHHHHHcCCCCC----------------------C--------------------------CCCcCHHH
Confidence 99998876665554433321111 0 12356789
Q ss_pred HHHHhhccccCCCCCcCHHHHhc
Q 017021 346 THLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.++|.+||+.||.+|||++|+++
T Consensus 284 ~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 284 HQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=323.72 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=204.5
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.+....|++.+.||+|+||.||+|.+. ++..||+|++.........+.+|+.++..+ .|+|++++++++.+.+.
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-----SHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSS
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-----CCCCEeeEEEEEecCCC
Confidence 456678999999999999999999876 577899999986655667788899998888 68999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili------------------- 153 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV------------------- 153 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE-------------------
T ss_pred eEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE-------------------
Confidence 99999999 899999997633 258999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~ 272 (379)
+.++.++|+|||.+....... ....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus 154 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 154 --------NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp --------CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred --------cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 555678888888876543321 22346778999999998889999999999999999998 99999887
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+.+...... ....++.+.++|.+|
T Consensus 226 ~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~l~~li~~~ 257 (283)
T 3gen_A 226 TNSETAEHIAQGLRLYR------------------------------------------------PHLASEKVYTIMYSC 257 (283)
T ss_dssp CHHHHHHHHHTTCCCCC------------------------------------------------CTTCCHHHHHHHHHT
T ss_pred ChhHHHHHHhcccCCCC------------------------------------------------CCcCCHHHHHHHHHH
Confidence 76655554443221111 012456899999999
Q ss_pred cccCCCCCcCHHHHhcC
Q 017021 353 LRYDPTDRLTAREALRH 369 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~h 369 (379)
|+.||++|||++|+++|
T Consensus 258 l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 258 WHEKADERPTFKILLSN 274 (283)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhHCcCHHHHHHH
Confidence 99999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=338.30 Aligned_cols=258 Identities=19% Similarity=0.253 Sum_probs=207.9
Q ss_pred eeechhhhhhhhccccccceeEEEEE-----ecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~-----~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
..+....|++.++||+|+||.||+|. +..+++.||+|+++.. ......+.+|+.++..+ .|+||++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~ 140 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-----NHQNIVRCI 140 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-----CCCCCCeEE
Confidence 34566789999999999999999999 4567889999998642 33445677788888887 789999999
Q ss_pred ceeeecceEEEEEeCC-CCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccc
Q 017021 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 184 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 184 (379)
+++......++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++
T Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-- 218 (367)
T 3l9p_A 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG-- 218 (367)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS--
T ss_pred EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC--
Confidence 9999999999999999 8899999986431 2488999999999999999999999999999999999995332
Q ss_pred ccCCCccCCCCCCCCcccccCCCCCCeEEeecCccccc-----CCCCCcccccCCccchhhhhCCCCCCccchHhHHHHH
Q 017021 185 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE-----RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 259 (379)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il 259 (379)
.+..++|+|||.+... ........||+.|+|||++.+..++.++|||||||++
T Consensus 219 ----------------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il 276 (367)
T 3l9p_A 219 ----------------------PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276 (367)
T ss_dssp ----------------------TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ----------------------CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHH
Confidence 3446899999988632 1222345678999999999988999999999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhh
Q 017021 260 VELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338 (379)
Q Consensus 260 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (379)
|+|++ |..||...+..+....+.......+ .
T Consensus 277 ~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~------------------------------------------------~ 308 (367)
T 3l9p_A 277 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP------------------------------------------------P 308 (367)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC------------------------------------------------C
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------------------------------------------------C
Confidence 99998 9999988776655544333221111 1
Q ss_pred ccchhHHHHHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 339 ~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
...+..+.+||.+||+.||.+|||++|+++|.++
T Consensus 309 ~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 309 KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2356789999999999999999999999988654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=333.67 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=206.0
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-------hhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
......|++.+.||+|+||.||+|.+..+++.||+|++..... ....+..|+.++..+.+ .|++++++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~~i~~~~~ 115 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---GFSGVIRLLD 115 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS---SSCSBCCEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc---CCCCceEEEE
Confidence 3445679999999999999999999999999999999974321 22456679999988843 4689999999
Q ss_pred eeeecceEEEEEeCC-C-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCC
Q 017021 112 WFDYRNHICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~-~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
++..++..++|+|++ + ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--------- 184 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--------- 184 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---------
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC---------
Confidence 999999999999999 4 89999998754 6899999999999999999999999999999999999951
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCC-CCccchHhHHHHHHHHHhCCC
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~~l~~g~~ 267 (379)
.++.++|+|||.+....... ....||+.|+|||++.+..+ +.++|||||||++|+|++|..
T Consensus 185 -----------------~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~ 247 (320)
T 3a99_A 185 -----------------NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247 (320)
T ss_dssp -----------------TTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred -----------------CCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCC
Confidence 34567888888776544332 33568999999999887665 688999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||..... +.. +. ... ....+.++.+
T Consensus 248 pf~~~~~------~~~--~~---------------------~~~--------------------------~~~~~~~~~~ 272 (320)
T 3a99_A 248 PFEHDEE------IIR--GQ---------------------VFF--------------------------RQRVSSECQH 272 (320)
T ss_dssp SCCSHHH------HHH--CC---------------------CCC--------------------------SSCCCHHHHH
T ss_pred CCCChhh------hhc--cc---------------------ccc--------------------------cccCCHHHHH
Confidence 9964221 000 00 000 1235678999
Q ss_pred HHhhccccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 348 LLQGLLRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
||.+||+.||++|||++|+++||||++...
T Consensus 273 li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 273 LIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 999999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=331.06 Aligned_cols=261 Identities=16% Similarity=0.214 Sum_probs=189.6
Q ss_pred eeeeeechhhhhhhhccccccceeEEEEEecCCCc---eEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEE
Q 017021 35 ITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQ 108 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~---~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~ 108 (379)
..-..+....|++.+.||+|+||.||+|+++.+++ .||+|+++.. ......+.+|+.++..+ .|+|+++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~ 89 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-----DHPHVAK 89 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-----CCTTBCC
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-----CCCceeh
Confidence 34455667789999999999999999999887775 8999999742 33445677788888777 7899999
Q ss_pred ecceeeecceE------EEEEeCC-CCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEE
Q 017021 109 IRNWFDYRNHI------CIVFEKL-GSSLYDFLRKNN----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 177 (379)
Q Consensus 109 ~~~~~~~~~~~------~lv~e~~-~~sL~~~l~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nil 177 (379)
+++++...... ++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.|++||||||+||+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIl 169 (323)
T 3qup_A 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169 (323)
T ss_dssp CCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred hhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEE
Confidence 99999876554 9999999 889999996532 114899999999999999999999999999999999999
Q ss_pred EecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccch
Q 017021 178 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI 252 (379)
Q Consensus 178 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDv 252 (379)
+ +.++.++|+|||.+....... ....+|+.|+|||.+.+..++.++||
T Consensus 170 i---------------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 222 (323)
T 3qup_A 170 L---------------------------AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDV 222 (323)
T ss_dssp E---------------------------CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHH
T ss_pred E---------------------------cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccch
Confidence 9 455667888888776433322 22346778999999999899999999
Q ss_pred HhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhH
Q 017021 253 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 331 (379)
Q Consensus 253 wSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (379)
|||||++|+|++ |..||.+.+..+....+...... ..
T Consensus 223 ~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~----------------------~~-------------------- 260 (323)
T 3qup_A 223 WAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL----------------------KQ-------------------- 260 (323)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----------------------CC--------------------
T ss_pred hhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC----------------------CC--------------------
Confidence 999999999999 99999876665544333221100 00
Q ss_pred HHHHHhhccchhHHHHHHhhccccCCCCCcC-------HHHHhcCCCCCCC
Q 017021 332 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT-------AREALRHPFFTRD 375 (379)
Q Consensus 332 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------a~e~l~hp~f~~~ 375 (379)
....+..+.++|.+||+.||.+||| ++++++|||+...
T Consensus 261 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 261 ------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp ------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred ------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 1235678999999999999999999 8899999999764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=333.98 Aligned_cols=252 Identities=19% Similarity=0.290 Sum_probs=201.8
Q ss_pred eechhhhhhhhccccccceeEEEEEec-------CCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEe
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~-------~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~ 109 (379)
.+....|++.+.||+|+||.||+|++. .++..||+|+++.. ......+.+|+.++..+ ..|+||+++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~hpnIv~~ 152 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI----GKHKNIINL 152 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHS----CCCTTBCCE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHh----cCCCCEeeE
Confidence 345567899999999999999999874 34568999999743 22345677888888887 257899999
Q ss_pred cceeeecceEEEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCC
Q 017021 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPE 174 (379)
Q Consensus 110 ~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~ 174 (379)
++++...+..|+||||+ +++|.+++.... ...++...+..++.||+.||.|||+.||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 99999999999999999 889999998753 124789999999999999999999999999999999
Q ss_pred cEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCc
Q 017021 175 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYP 249 (379)
Q Consensus 175 Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~ 249 (379)
||++ +.++.++|+|||.+....... ....+|+.|+|||++.+..++.+
T Consensus 233 NIll---------------------------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 285 (370)
T 2psq_A 233 NVLV---------------------------TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 285 (370)
T ss_dssp GEEE---------------------------CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH
T ss_pred hEEE---------------------------CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH
Confidence 9999 455667888888776433321 22356788999999999999999
Q ss_pred cchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccch
Q 017021 250 CDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328 (379)
Q Consensus 250 sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (379)
+|||||||++|+|++ |..||.+....+....+..... ...
T Consensus 286 ~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~----------------------~~~----------------- 326 (370)
T 2psq_A 286 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR----------------------MDK----------------- 326 (370)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------------------CCC-----------------
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----------------------CCC-----------------
Confidence 999999999999999 9999987655444333222110 000
Q ss_pred hhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 329 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
...++.++.++|.+||+.||++|||+.|++++
T Consensus 327 ---------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 327 ---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12356789999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=332.71 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=199.7
Q ss_pred eechhhhhhhhccccccceeEEEEE-----ecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~-----~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.+....|++.+.||+|+||.||+|+ +..+++.||+|+++... .....+.+|+.++.++ .+|+||+++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~hpniv~~~~ 93 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI----GHHLNVVNLLG 93 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhh----cCCcceeeeee
Confidence 4566789999999999999999998 56678999999997532 2345677899999888 35689999999
Q ss_pred eeeecc-eEEEEEeCC-CCCHHHHHHhCCC--------------------------------------------------
Q 017021 112 WFDYRN-HICIVFEKL-GSSLYDFLRKNNY-------------------------------------------------- 139 (379)
Q Consensus 112 ~~~~~~-~~~lv~e~~-~~sL~~~l~~~~~-------------------------------------------------- 139 (379)
++...+ ..++||||+ +++|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 987754 599999999 8899999987542
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccC
Q 017021 140 --------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 205 (379)
Q Consensus 140 --------------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (379)
..+++..+..++.||+.||+|||+.||+||||||+||+++.
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~------------------------- 228 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE------------------------- 228 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-------------------------
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC-------------------------
Confidence 12889999999999999999999999999999999999944
Q ss_pred CCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHHHH
Q 017021 206 PKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 279 (379)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~ 279 (379)
++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+...
T Consensus 229 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 306 (359)
T 3vhe_A 229 --KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306 (359)
T ss_dssp --GGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred --CCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH
Confidence 4456777777665432221 23467889999999999899999999999999999998 999998765433322
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
......... .. ....++++.++|.+||+.||++
T Consensus 307 ~~~~~~~~~---------------------~~--------------------------~~~~~~~l~~li~~~l~~dP~~ 339 (359)
T 3vhe_A 307 RRLKEGTRM---------------------RA--------------------------PDYTTPEMYQTMLDCWHGEPSQ 339 (359)
T ss_dssp HHHHHTCCC---------------------CC--------------------------CTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHcCCCC---------------------CC--------------------------CCCCCHHHHHHHHHHccCChhh
Confidence 221111100 00 1235678999999999999999
Q ss_pred CcCHHHHhcC
Q 017021 360 RLTAREALRH 369 (379)
Q Consensus 360 Rpta~e~l~h 369 (379)
|||++|+++|
T Consensus 340 Rps~~ell~~ 349 (359)
T 3vhe_A 340 RPTFSELVEH 349 (359)
T ss_dssp SCCHHHHHHH
T ss_pred CCCHHHHHHH
Confidence 9999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.35 Aligned_cols=265 Identities=20% Similarity=0.272 Sum_probs=197.6
Q ss_pred eeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 35 ITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
.....+....|++.+.||+|+||+|+. ....+++.||||++.... .....+|+.++..+ ..|+||+++++++.
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l----~~HpnIv~l~~~~~ 88 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--FSFADREVQLLRES----DEHPNVIRYFCTEK 88 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--EEECHHHHHHHHHS----CCCTTBCCEEEEEE
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhc----cCCCCcCeEEEEEe
Confidence 334566777899999999999999764 335678999999996432 23456788888776 26899999999999
Q ss_pred ecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 115 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 115 ~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
+....|+||||++++|.+++..... ......+..++.||+.||.|||+.||+||||||+||++...+.
T Consensus 89 ~~~~~~lv~E~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~----------- 156 (432)
T 3p23_A 89 DRQFQYIAIELCAATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNA----------- 156 (432)
T ss_dssp ETTEEEEEEECCSEEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBT-----------
T ss_pred cCCEEEEEEECCCCCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCC-----------
Confidence 9999999999998899999987542 3445566789999999999999999999999999999953221
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhh---CCCCCCccchHhHHHHHHHHHh-
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCT- 264 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~~l~~- 264 (379)
+....++|+|||.+....... ....||+.|+|||++. ...++.++|||||||++|+|++
T Consensus 157 -----------~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~ 225 (432)
T 3p23_A 157 -----------HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225 (432)
T ss_dssp -----------TTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTT
T ss_pred -----------CCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcC
Confidence 334567899999887544321 2356999999999997 3567789999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||.......... ..+.... .... .....+..
T Consensus 226 g~~pf~~~~~~~~~~----~~~~~~~-------------------~~~~-----------------------~~~~~~~~ 259 (432)
T 3p23_A 226 GSHPFGKSLQRQANI----LLGACSL-------------------DCLH-----------------------PEKHEDVI 259 (432)
T ss_dssp SCBTTBSTTTHHHHH----HTTCCCC-------------------TTSC-----------------------TTCHHHHH
T ss_pred CCCCcchhhHHHHHH----HhccCCc-------------------cccC-----------------------ccccccHH
Confidence 999996543322111 1111000 0000 00123456
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+.+||.+||+.||.+|||++|+++||||+..
T Consensus 260 ~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 260 ARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred HHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 8899999999999999999999999999863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=330.31 Aligned_cols=252 Identities=18% Similarity=0.250 Sum_probs=204.3
Q ss_pred eechhhhhhhhccccccceeEEEEEecCC-------CceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEe
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRER-------KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~-------~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~ 109 (379)
.+....|++.++||+|+||.||+|++..+ +..||+|+++.. ......+.+|+.++..+ ..|+||+++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~hpnIv~~ 140 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI----GKHKNIINL 140 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHh----cCCchhhhh
Confidence 45567899999999999999999997543 367999999753 23335677899988887 357899999
Q ss_pred cceeeecceEEEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCC
Q 017021 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPE 174 (379)
Q Consensus 110 ~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~ 174 (379)
++++..++..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 99999999999999999 889999998754 135899999999999999999999999999999999
Q ss_pred cEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCc
Q 017021 175 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYP 249 (379)
Q Consensus 175 Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~ 249 (379)
||++ +.++.++|+|||.+....... ....+|+.|+|||++.+..++.+
T Consensus 221 NIll---------------------------~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 273 (382)
T 3tt0_A 221 NVLV---------------------------TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 273 (382)
T ss_dssp GEEE---------------------------CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH
T ss_pred eEEE---------------------------cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch
Confidence 9999 455667888888776443321 23356789999999999999999
Q ss_pred cchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccch
Q 017021 250 CDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328 (379)
Q Consensus 250 sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (379)
+|||||||++|+|++ |..||...+..+....+.+..... .
T Consensus 274 ~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------~----------------- 314 (382)
T 3tt0_A 274 SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD----------------------K----------------- 314 (382)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC----------------------C-----------------
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------C-----------------
Confidence 999999999999999 999998776655444333221110 0
Q ss_pred hhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 329 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
...++.++.++|.+||+.||++|||++|++++
T Consensus 315 ---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 315 ---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp ---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12356789999999999999999999999865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=321.76 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=202.4
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCC-------ceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERK-------EMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~-------~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
.+....|++.+.||+|+||.||+|.++.++ ..||+|++... ......+.+|+.++..+ .|+|+++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~ 78 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-----SHKHLVLNY 78 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-----CCTTBCCEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-----CCCCEeEEE
Confidence 355678899999999999999999998877 46999998643 33456677888888887 689999999
Q ss_pred ceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCC
Q 017021 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
+++..++..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++..++.+
T Consensus 79 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~- 156 (289)
T 4fvq_A 79 GVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN- 156 (289)
T ss_dssp EEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTB-
T ss_pred EEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccc-
Confidence 9999999999999999 899999998754 2489999999999999999999999999999999999997765433322
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCC-C
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGE-A 267 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~-~ 267 (379)
...++|+|||.+...... ....||+.|+|||.+.+ ..++.++|||||||++|+|++|. +
T Consensus 157 ------------------~~~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 217 (289)
T 4fvq_A 157 ------------------PPFIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217 (289)
T ss_dssp ------------------CCEEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ------------------cceeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 234899999988654332 23468899999999987 66899999999999999999954 5
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||......... .........+ ...+.++.+
T Consensus 218 ~~~~~~~~~~~-~~~~~~~~~~-------------------------------------------------~~~~~~l~~ 247 (289)
T 4fvq_A 218 PLSALDSQRKL-QFYEDRHQLP-------------------------------------------------APKAAELAN 247 (289)
T ss_dssp TTTTSCHHHHH-HHHHTTCCCC-------------------------------------------------CCSSCTTHH
T ss_pred CccccchHHHH-HHhhccCCCC-------------------------------------------------CCCCHHHHH
Confidence 55443332222 1111111111 124567899
Q ss_pred HHhhccccCCCCCcCHHHHhcC
Q 017021 348 LLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~h 369 (379)
+|.+||+.||++|||++|+++|
T Consensus 248 li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 248 LINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=315.95 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=204.4
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.+....|++.+.||+|+||.||+|.+. +++.||+|++.........+.+|+.++..+ .|+|++++++++.+++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-----SHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSS
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-----CCCCEeeEEEEEccCCC
Confidence 355667899999999999999999986 577899999986655567788899988887 68999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~------------------ 138 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG------------------ 138 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC------------------
T ss_pred eEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC------------------
Confidence 99999999 889999998754 3589999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCC----CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~ 272 (379)
.++.++|+|||.+...... .....+|..|+|||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus 139 ---------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 139 ---------ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp ---------GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ---------CCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 4456777888777644322 123356778999999998889999999999999999999 89999876
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+........ ....+..+.++|.+|
T Consensus 210 ~~~~~~~~i~~~~~~~~------------------------------------------------~~~~~~~l~~li~~~ 241 (267)
T 3t9t_A 210 SNSEVVEDISTGFRLYK------------------------------------------------PRLASTHVYQIMNHC 241 (267)
T ss_dssp CHHHHHHHHHTTCCCCC------------------------------------------------CTTSCHHHHHHHHHH
T ss_pred CHHHHHHHHhcCCcCCC------------------------------------------------CccCcHHHHHHHHHH
Confidence 66554443322211100 012457899999999
Q ss_pred cccCCCCCcCHHHHhcC
Q 017021 353 LRYDPTDRLTAREALRH 369 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~h 369 (379)
|+.||++|||++|++++
T Consensus 242 l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 242 WRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=335.84 Aligned_cols=249 Identities=22% Similarity=0.375 Sum_probs=202.6
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
.+....|++.+.||+|+||.||+|.++.+++.||+|+++.. ......+.+|+.++..+ .|+|++++++++..+
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-----SHPNIVRLIGVCTQK 184 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-----CCTTBCCEEEEECSS
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEecC
Confidence 45667889999999999999999999999999999998743 22345677899988887 789999999999999
Q ss_pred ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 117 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
+..|+||||+ +++|.+++...+ ..++...+..++.|++.||+|||+.|++||||||+||++
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~----------------- 246 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV----------------- 246 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-----------------
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE-----------------
Confidence 9999999999 899999997653 358999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 269 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf 269 (379)
+.++.++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 247 ----------~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~ 316 (377)
T 3cbl_A 247 ----------TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316 (377)
T ss_dssp ----------CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ----------cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 445567777777765433221 12235778999999998889999999999999999998 99999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
...+..+....+.+.. .++.| ..++..+.++|
T Consensus 317 ~~~~~~~~~~~~~~~~----------------------~~~~~--------------------------~~~~~~l~~li 348 (377)
T 3cbl_A 317 PNLSNQQTREFVEKGG----------------------RLPCP--------------------------ELCPDAVFRLM 348 (377)
T ss_dssp TTSCHHHHHHHHHTTC----------------------CCCCC--------------------------TTCCHHHHHHH
T ss_pred CCCCHHHHHHHHHcCC----------------------CCCCC--------------------------CCCCHHHHHHH
Confidence 8766554443332211 01111 13567899999
Q ss_pred hhccccCCCCCcCHHHHhc
Q 017021 350 QGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~ 368 (379)
.+||+.||++|||++++++
T Consensus 349 ~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 349 EQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=317.29 Aligned_cols=255 Identities=24% Similarity=0.316 Sum_probs=194.6
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-----hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.+....|++.+.||+|+||.||+|.+. ++.||+|++.... .....+.+|+.++..+ .|+|++++++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~ 75 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-----KHPNIIALRGVC 75 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-----CCCCEeeEEEEE
Confidence 345567899999999999999999864 7889999986432 2235567788888887 689999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccCCCCCcEEEecccccccCCC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC---MIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
..++..++||||+ +++|.+++... .+++..+..++.|++.||.|||+.| ++||||||+||+++....
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~------ 146 (271)
T 3dtc_A 76 LKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE------ 146 (271)
T ss_dssp CCC--CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCS------
T ss_pred ecCCceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccc------
Confidence 9999999999999 89999998643 5999999999999999999999999 899999999999954211
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCC
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
.....++.++|+|||.+....... ....||+.|+|||.+.+..++.++||||||+++|+|++|+.|
T Consensus 147 -------------~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 213 (271)
T 3dtc_A 147 -------------NGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213 (271)
T ss_dssp -------------SSCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCT
T ss_pred -------------cccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 001246779999999987544332 345789999999999998899999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|.+.+.......+.......+ .....++.+.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~l 246 (271)
T 3dtc_A 214 FRGIDGLAVAYGVAMNKLALP-----------------------------------------------IPSTCPEPFAKL 246 (271)
T ss_dssp TTTSCHHHHHHHHHTSCCCCC-----------------------------------------------CCTTCCHHHHHH
T ss_pred CCCCCHHHHHHhhhcCCCCCC-----------------------------------------------CCcccCHHHHHH
Confidence 987665544332222111100 012356789999
Q ss_pred HhhccccCCCCCcCHHHHhcC
Q 017021 349 LQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~h 369 (379)
|.+||+.||.+|||++|+++|
T Consensus 247 i~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 247 MEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCcccCcCHHHHHHH
Confidence 999999999999999999865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=344.74 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=207.7
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
..+....|++.++||+|+||.||+|.++.++..||+|+++........+.+|+.++.++ .|+||+++++++...+
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREP 289 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-----CCCCEeeEEEEEecCC
Confidence 34566778999999999999999999999999999999986655667888999999998 7899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..|+||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----------------- 352 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG----------------- 352 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC-----------------
Confidence 999999999 89999999876555689999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 271 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~ 271 (379)
.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 353 ----------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~ 422 (495)
T 1opk_A 353 ----------ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422 (495)
T ss_dssp ----------GGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ----------CCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence 44556777777765443222 12345678999999998889999999999999999999 9999987
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+..+....+.+... +.. ...++..+.+||.+
T Consensus 423 ~~~~~~~~~~~~~~~----------------------~~~--------------------------~~~~~~~l~~li~~ 454 (495)
T 1opk_A 423 IDLSQVYELLEKDYR----------------------MER--------------------------PEGCPEKVYELMRA 454 (495)
T ss_dssp CCGGGHHHHHHTTCC----------------------CCC--------------------------CTTCCHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCC----------------------CCC--------------------------CCCCCHHHHHHHHH
Confidence 665444333222110 000 12356789999999
Q ss_pred ccccCCCCCcCHHHHhc
Q 017021 352 LLRYDPTDRLTAREALR 368 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~ 368 (379)
||+.||++|||++++++
T Consensus 455 cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 455 CWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcCcChhHCcCHHHHHH
Confidence 99999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=324.37 Aligned_cols=251 Identities=23% Similarity=0.433 Sum_probs=196.4
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-------hhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
...|++.+.||+|+||.||+|++..+++.||+|++..... .......|+.++.++.... .|+|++++++++.
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG-GHPGVIRLLDWFE 108 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSC-CCSSBCCEEEEC-
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccC-CCCCeeeEEEEEe
Confidence 3468999999999999999999999999999999964321 2344556888888885433 6799999999999
Q ss_pred ecceEEEEEeC-C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 115 YRNHICIVFEK-L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 115 ~~~~~~lv~e~-~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..+..++|+|+ + +++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~------------ 174 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL------------ 174 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET------------
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC------------
Confidence 99999999999 5 889999998754 6899999999999999999999999999999999999951
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCCC-CccchHhHHHHHHHHHhCCCCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
.++.++|+|||.+....... ....||..|+|||++.+..+. .++|||||||++|+|++|+.||.
T Consensus 175 --------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 175 --------------RRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp --------------TTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred --------------CCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 44567888888776544332 345689999999998776654 68999999999999999999997
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
.... +.... ..+ ....+..+.++|.
T Consensus 241 ~~~~------~~~~~-----------------------~~~--------------------------~~~~~~~~~~li~ 265 (312)
T 2iwi_A 241 RDQE------ILEAE-----------------------LHF--------------------------PAHVSPDCCALIR 265 (312)
T ss_dssp SHHH------HHHTC-----------------------CCC--------------------------CTTSCHHHHHHHH
T ss_pred ChHH------Hhhhc-----------------------cCC--------------------------cccCCHHHHHHHH
Confidence 4221 00100 001 1235678999999
Q ss_pred hccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 351 GLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+||+.||++|||++|+++||||+...
T Consensus 266 ~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 266 RCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHccCChhhCcCHHHHhcChhhcCch
Confidence 99999999999999999999998754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=323.02 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=185.3
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchh--hHhHHHHHHH-HHHHHhcCCCCCeeEEecceee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEV-LQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~--~~~~~~e~~~-l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
.......|++.+.||+|+||.||+|.++.+|+.||+|++...... ......|... +.. ..|+|++++++++.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~-----~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS-----HDCPYIVQCFGTFI 94 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHT-----TTCTTBCCEEEEEE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHh-----cCCCceeeEEEEEe
Confidence 344556788899999999999999999999999999999753221 1222223322 222 27899999999999
Q ss_pred ecceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
.++..++||||+++.+..+..... ..+++..+..++.|++.||.|||+. |++||||||+||++
T Consensus 95 ~~~~~~lv~e~~~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~--------------- 158 (318)
T 2dyl_A 95 TNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL--------------- 158 (318)
T ss_dssp CSSEEEEEECCCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---------------
T ss_pred cCCcEEEEEeccCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---------------
Confidence 999999999999777776665432 3689999999999999999999995 99999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHhCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
+.++.++|+|||.+....... ....||+.|+|||.+. ...++.++|||||||++|+|++|+
T Consensus 159 ------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (318)
T 2dyl_A 159 ------------DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226 (318)
T ss_dssp ------------CTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSS
T ss_pred ------------CCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCC
Confidence 455667888888775433322 2346899999999984 456889999999999999999999
Q ss_pred CCCCCCc-hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 267 ALFQTHE-NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 267 ~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
.||.... ..+....+.+...+. .+. ....+.++
T Consensus 227 ~pf~~~~~~~~~~~~~~~~~~~~----------------------~~~------------------------~~~~~~~l 260 (318)
T 2dyl_A 227 FPYKNCKTDFEVLTKVLQEEPPL----------------------LPG------------------------HMGFSGDF 260 (318)
T ss_dssp CTTTTCCSHHHHHHHHHHSCCCC----------------------CCS------------------------SSCCCHHH
T ss_pred CCCCCCCccHHHHHHHhccCCCC----------------------CCc------------------------cCCCCHHH
Confidence 9998643 333332222211110 000 11356789
Q ss_pred HHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 346 THLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
.++|.+||+.||.+|||++|+++||||++
T Consensus 261 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 261 QSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 99999999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=320.50 Aligned_cols=253 Identities=23% Similarity=0.264 Sum_probs=193.0
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
...|++.+.||+|+||.||+|++..+++.||+|++... .....+..|..++..+.+ ++++..+..++...+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~l~~l~~----~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-TKHPQLHIESKIYKMMQG----GVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTT----STTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc-ccchHHHHHHHHHHHhcC----CCCCCeeeeecCCCCceEE
Confidence 34689999999999999999999999999999997643 234457779999988832 3445555666678889999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
||||++++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||++...
T Consensus 83 v~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-------------------- 141 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG-------------------- 141 (296)
T ss_dssp EEECCCCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCG--------------------
T ss_pred EEEccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeecc--------------------
Confidence 99999999999998643 359999999999999999999999999999999999999321
Q ss_pred cccCCCCCCeEEeecCcccccCCC----------CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+...... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 142 ----~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 4hgt_A 142 ----KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp ----GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred ----CCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcc
Confidence 23455777777776543322 1245789999999999999999999999999999999999999976
Q ss_pred CchHH---HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 272 HENLE---HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 272 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
.+... ....+.......+ .......+++++.++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~l~~l 253 (296)
T 4hgt_A 218 LKAATKRQKYERISEKKMSTP--------------------------------------------IEVLCKGYPSEFATY 253 (296)
T ss_dssp CCCSSSSSHHHHHHHHHHHSC--------------------------------------------HHHHTTTSCHHHHHH
T ss_pred cchhhhhhhhhhhhcccccch--------------------------------------------hhhhhccCCHHHHHH
Confidence 43211 1111111000000 111223467889999
Q ss_pred HhhccccCCCCCcCHHHHhc
Q 017021 349 LQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~ 368 (379)
|.+||+.||++|||++++++
T Consensus 254 i~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 254 LNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHhcCCCCCCCHHHHHH
Confidence 99999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=317.11 Aligned_cols=253 Identities=23% Similarity=0.265 Sum_probs=195.9
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
...|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|+.++..+.+ ++++..+..+....+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~----~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQG----GVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTT----STTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhc----CCCCCccccccCCCCceEE
Confidence 457899999999999999999999999999999987433 34567789999998843 2334455555667888999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
||||++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++...
T Consensus 83 v~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-------------------- 141 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG-------------------- 141 (296)
T ss_dssp EEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG--------------------
T ss_pred EEEecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecC--------------------
Confidence 99999999999998543 369999999999999999999999999999999999999421
Q ss_pred cccCCCCCCeEEeecCcccccCCC----------CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+...... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 142 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 3uzp_A 142 ----KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp ----GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred ----CCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 23455777777776543322 1345789999999999998999999999999999999999999976
Q ss_pred Cch---HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 272 HEN---LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 272 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
.+. .+....+.......+ .......+++++.++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~l~~l 253 (296)
T 3uzp_A 218 LKAATKRQKYERISEKKMSTP--------------------------------------------IEVLCKGYPSEFATY 253 (296)
T ss_dssp CCCSSSSSHHHHHHHHHHHSC--------------------------------------------HHHHTTTSCHHHHHH
T ss_pred cCchhhhhhhhhhcccccCCc--------------------------------------------hHHHHhhCCHHHHHH
Confidence 332 111111111100000 111223467889999
Q ss_pred HhhccccCCCCCcCHHHHhc
Q 017021 349 LQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~ 368 (379)
|.+||+.||++|||++++++
T Consensus 254 i~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 254 LNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHhcCcCcCCCHHHHHH
Confidence 99999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=324.33 Aligned_cols=251 Identities=19% Similarity=0.302 Sum_probs=201.1
Q ss_pred eechhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.+....|++.+.||+|+||.||+|.+. .+++.||+|++... ......+.+|+.++..+ .|+|++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~ 93 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-----NHPHVIKLYG 93 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEE
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-----CCCceeeEEE
Confidence 455678999999999999999999873 45689999999743 23345667788888777 7899999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcc
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNNY----------------------RSFPIDLVREIARQLLECIAFMHDLCMIH 168 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~~----------------------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH 168 (379)
++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+.|++|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 999999999999999 8999999987532 24889999999999999999999999999
Q ss_pred cCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhC
Q 017021 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG 243 (379)
Q Consensus 169 ~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~ 243 (379)
|||||+||+++ .++.++|+|||.+....... ....+|+.|+|||.+.+
T Consensus 174 ~dikp~NIli~---------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 226 (314)
T 2ivs_A 174 RDLAARNILVA---------------------------EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD 226 (314)
T ss_dssp CCCSGGGEEEE---------------------------TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH
T ss_pred cccchheEEEc---------------------------CCCCEEEccccccccccccccceeccCCCCcccccChhhhcC
Confidence 99999999995 44557777777765433322 22356788999999998
Q ss_pred CCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhh
Q 017021 244 LGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 322 (379)
Q Consensus 244 ~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (379)
..++.++|||||||++|+|++ |..||.+....+....+...... .
T Consensus 227 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------~------------ 272 (314)
T 2ivs_A 227 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM----------------------E------------ 272 (314)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC----------------------C------------
T ss_pred CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcC----------------------C------------
Confidence 889999999999999999999 99999876554433322221100 0
Q ss_pred hhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 323 SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.....+..+.++|.+||+.||++|||++|++++
T Consensus 273 --------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 273 --------------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp --------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012356789999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=330.34 Aligned_cols=268 Identities=21% Similarity=0.226 Sum_probs=194.7
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
+.+....|++.++||+|+||.||+|++. ++.||+|++............|+.++..+ .|+||+++++++....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-----KHENILQFIGAEKRGT 91 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-----CCTTBCCEEEEEEEEC
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-----CCCCchhhcceeccCC
Confidence 4466778999999999999999999865 78999999986555555555566666665 7899999999998744
Q ss_pred ----eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc----------CCcccCCCCCcEEEeccc
Q 017021 118 ----HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL----------CMIHTDLKPENVLLVSSE 182 (379)
Q Consensus 118 ----~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----------~iiH~dlkp~Nili~~~~ 182 (379)
..++||||+ +++|.+++... .+++..+..++.|++.||+|||+. ||+||||||+||++
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---- 164 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---- 164 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE----
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE----
Confidence 479999999 88999999875 499999999999999999999999 99999999999999
Q ss_pred ccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCC-----CCCCccch
Q 017021 183 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGL-----GWTYPCDI 252 (379)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-----~~~~~sDv 252 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+. .++.++||
T Consensus 165 -----------------------~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di 221 (322)
T 3soc_A 165 -----------------------KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221 (322)
T ss_dssp -----------------------CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHH
T ss_pred -----------------------CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchh
Confidence 455678888888875433221 235789999999999863 45678899
Q ss_pred HhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHH
Q 017021 253 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 332 (379)
Q Consensus 253 wSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (379)
|||||++|+|++|+.||.+................+....+. .........+.. ..
T Consensus 222 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~------------------~~ 277 (322)
T 3soc_A 222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ------EVVVHKKKRPVL------------------RD 277 (322)
T ss_dssp HHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHH------HHHTTSCCCCCC------------------CG
T ss_pred HHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhh------hhhhcccCCCCc------------------cc
Confidence 999999999999999997643311110001111111110000 000000000000 00
Q ss_pred HHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 333 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 333 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
. ......+..+.+||.+||+.||++|||++|+++
T Consensus 278 ~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 278 Y--WQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp G--GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c--ccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 000123456999999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=337.07 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=201.1
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc-
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN- 117 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~- 117 (379)
.+....|++.+.||+|+||.||+|.+. ++.||+|+++... ....+.+|+.++.++ .|+|++++++++....
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTC-----CCTTBCCEEEEEECTTS
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhc-----cCCCEEEEEEEEEcCCC
Confidence 355667899999999999999999875 7799999998543 566788899999888 7899999999876654
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..|+||||+ +++|.+++.......++...+..++.||+.||+|||+.|++||||||+||++
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill------------------ 322 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV------------------ 322 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE------------------
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE------------------
Confidence 799999999 8899999988664457999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchH
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 275 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~ 275 (379)
+.++.+||+|||++...........++..|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 323 ---------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 393 (450)
T 1k9a_A 323 ---------SEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393 (450)
T ss_dssp ---------CTTSCEEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT
T ss_pred ---------CCCCCEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 55667888888888754444344467889999999999999999999999999999998 99999876554
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.+... +.. ...+++.+.++|.+||+.
T Consensus 394 ~~~~~i~~~~~----------------------~~~--------------------------p~~~~~~l~~li~~cl~~ 425 (450)
T 1k9a_A 394 DVVPRVEKGYK----------------------MDA--------------------------PDGCPPAVYDVMKNCWHL 425 (450)
T ss_dssp THHHHHHTTCC----------------------CCC--------------------------CTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHcCCC----------------------CCC--------------------------CCcCCHHHHHHHHHHcCC
Confidence 44333322110 111 124677899999999999
Q ss_pred CCCCCcCHHHHhc
Q 017021 356 DPTDRLTAREALR 368 (379)
Q Consensus 356 dP~~Rpta~e~l~ 368 (379)
||++|||+.++++
T Consensus 426 dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 426 DAATRPTFLQLRE 438 (450)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhHCcCHHHHHH
Confidence 9999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=317.97 Aligned_cols=253 Identities=20% Similarity=0.244 Sum_probs=200.2
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchh--------hHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--------REAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
.+....|++.+.||+|+||.||+|++..+++.||+|++...... ...+.+|+.++..+ .|+|+++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~ 89 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-----NHPNIVKLY 89 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-----CCTTBCCEE
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-----CCCCchhhh
Confidence 35566789999999999999999999999999999998643211 14566788888777 689999999
Q ss_pred ceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCcEEEecccccccC
Q 017021 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVP 187 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~~~ 187 (379)
+++.+.. ++||||+ +++|.+.+.... ..+++..+..++.|++.||.|||+.| ++||||||+||+++..+.
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~---- 162 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE---- 162 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT----
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC----
Confidence 9987665 6999999 899999887654 36899999999999999999999999 999999999999954321
Q ss_pred CCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhh--CCCCCCccchHhHHHHHHHHHhC
Q 017021 188 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL--GLGWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~il~~l~~g 265 (379)
.....++|+|||.+...........||+.|+|||.+. ...++.++|||||||++|+|++|
T Consensus 163 ------------------~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g 224 (287)
T 4f0f_A 163 ------------------NAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224 (287)
T ss_dssp ------------------TCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHS
T ss_pred ------------------CCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcC
Confidence 2233489999999886665555568999999999984 44578999999999999999999
Q ss_pred CCCCCCCchHHH--HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchh
Q 017021 266 EALFQTHENLEH--LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343 (379)
Q Consensus 266 ~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (379)
..||......+. ...+.. .+..+ . .....++
T Consensus 225 ~~pf~~~~~~~~~~~~~~~~-~~~~~--------------------~--------------------------~~~~~~~ 257 (287)
T 4f0f_A 225 EGPFDEYSYGKIKFINMIRE-EGLRP--------------------T--------------------------IPEDCPP 257 (287)
T ss_dssp SCTTTTCCCCHHHHHHHHHH-SCCCC--------------------C--------------------------CCTTSCH
T ss_pred CCCCccccccHHHHHHHHhc-cCCCC--------------------C--------------------------CCcccCH
Confidence 999976543222 111111 11100 0 1124567
Q ss_pred HHHHHHhhccccCCCCCcCHHHHhc
Q 017021 344 DLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 344 ~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.+.++|.+||+.||.+|||++|+++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 258 RLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 8999999999999999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=326.29 Aligned_cols=252 Identities=20% Similarity=0.286 Sum_probs=203.1
Q ss_pred eeechhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
..+....|++.+.||+|+||.||+|++. .+++.||+|+++.. ......+.+|+.++..+ .|+|+++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~ 116 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DNPNIVKLL 116 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEEEEE
Confidence 3556678899999999999999999987 45689999999743 23345677888888887 789999999
Q ss_pred ceeeecceEEEEEeCC-CCCHHHHHHhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCc
Q 017021 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNNY----------------------RSFPIDLVREIARQLLECIAFMHDLCMI 167 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~----------------------~~l~~~~~~~~~~qi~~aL~~LH~~~ii 167 (379)
+++..++..|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.||+
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv 196 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 196 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9999999999999999 8899999987421 3689999999999999999999999999
Q ss_pred ccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhh
Q 017021 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVIL 242 (379)
Q Consensus 168 H~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~ 242 (379)
||||||+||+++ .++.++|+|||.+...... .....+|+.|+|||.+.
T Consensus 197 H~Dlkp~NIl~~---------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 249 (343)
T 1luf_A 197 HRDLATRNCLVG---------------------------ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 249 (343)
T ss_dssp CSCCSGGGEEEC---------------------------GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH
T ss_pred cCCCCcceEEEC---------------------------CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc
Confidence 999999999994 4556778888877543221 12346788999999999
Q ss_pred CCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhh
Q 017021 243 GLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI 321 (379)
Q Consensus 243 ~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (379)
+..++.++|||||||++|+|++ |..||.+.+..+....+.+.... ..
T Consensus 250 ~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------~~---------- 297 (343)
T 1luf_A 250 YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL----------------------AC---------- 297 (343)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC----------------------CC----------
T ss_pred cCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC----------------------CC----------
Confidence 8889999999999999999999 99999876665544333221100 00
Q ss_pred hhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 322 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
...++..+.++|.+||+.||++|||+.+++++
T Consensus 298 ----------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 298 ----------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp ----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 12356789999999999999999999999853
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=325.71 Aligned_cols=264 Identities=19% Similarity=0.228 Sum_probs=207.2
Q ss_pred eeeeeeeeechhhhhhhhccccccceeEEEEE-----ecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCC
Q 017021 32 FNLITYIVFSAFADKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGN 104 (379)
Q Consensus 32 ~~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~-----~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~ 104 (379)
.+......+....|++.+.||+|+||.||+|+ +..+++.||+|++... ......+.+|+.++..+ .|+
T Consensus 19 ss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~ 93 (327)
T 2yfx_A 19 SSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-----NHQ 93 (327)
T ss_dssp ECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-----CCT
T ss_pred cchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-----CCC
Confidence 33344455677889999999999999999998 5567889999999632 33445677788888887 789
Q ss_pred eeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEE
Q 017021 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLL 178 (379)
Q Consensus 105 ~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili 178 (379)
|++++++++......|+||||+ +++|.+++..... ..+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 94 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli 173 (327)
T 2yfx_A 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 173 (327)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEE
Confidence 9999999999999999999999 8999999987532 248899999999999999999999999999999999999
Q ss_pred ecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCCCCccchH
Q 017021 179 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIW 253 (379)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvw 253 (379)
+.+ ..+..++|+|||.+...... .....||+.|+|||.+.+..++.++|||
T Consensus 174 ~~~------------------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 229 (327)
T 2yfx_A 174 TCP------------------------GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229 (327)
T ss_dssp SCS------------------------STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHH
T ss_pred ecC------------------------CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHH
Confidence 532 23456899999987633221 2334678899999999888899999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHH
Q 017021 254 SVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 332 (379)
Q Consensus 254 SlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (379)
||||++|+|++ |..||......+....+....... .
T Consensus 230 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------~--------------------- 266 (327)
T 2yfx_A 230 SFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD----------------------P--------------------- 266 (327)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC----------------------C---------------------
T ss_pred HHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC----------------------C---------------------
Confidence 99999999998 999998766554443332211110 0
Q ss_pred HHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 333 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 333 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
...++..+.++|.+||+.||.+|||++|+++|.|+
T Consensus 267 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 267 -----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 12356789999999999999999999999998764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=325.19 Aligned_cols=269 Identities=22% Similarity=0.322 Sum_probs=184.9
Q ss_pred eeeeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 33 NLITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 33 ~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
+......+....|++.+.||+|+||.||+|.++.+|+.||+|++..... .......|...+. ....|+|+++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~----~~~~h~niv~~~ 87 (327)
T 3aln_A 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVM----RSSDCPYIVQFY 87 (327)
T ss_dssp CCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHH----SSCCCTTBCCEE
T ss_pred ChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHH----HcCCCCcEeeee
Confidence 3445556777889999999999999999999999999999999975322 2223333433222 123789999999
Q ss_pred ceeeecceEEEEEeCCCCCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCcEEEeccccccc
Q 017021 111 NWFDYRNHICIVFEKLGSSLYDFLRK---NNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKV 186 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~~~sL~~~l~~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiH~dlkp~Nili~~~~~~~~ 186 (379)
+++..++..++||||+.++|.+++.. .....+++..+..++.|++.||.|||+. |++||||||+||+++
T Consensus 88 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~------- 160 (327)
T 3aln_A 88 GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD------- 160 (327)
T ss_dssp EEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE-------
T ss_pred eEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc-------
Confidence 99999999999999997788888864 2234689999999999999999999998 999999999999994
Q ss_pred CCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhh----hCCCCCCccchHhHHHHHH
Q 017021 187 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILV 260 (379)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~ 260 (379)
.++.++|+|||.+....... ....||+.|+|||++ .+..++.++|||||||++|
T Consensus 161 --------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 220 (327)
T 3aln_A 161 --------------------RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220 (327)
T ss_dssp --------------------TTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHH
T ss_pred --------------------CCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHH
Confidence 44567777777775433322 223689999999998 4556899999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc
Q 017021 261 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 261 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (379)
+|++|..||....... ..+.+.. .......+. .....
T Consensus 221 ~l~~g~~pf~~~~~~~--~~~~~~~-------------------~~~~~~~~~----------------------~~~~~ 257 (327)
T 3aln_A 221 ELATGRFPYPKWNSVF--DQLTQVV-------------------KGDPPQLSN----------------------SEERE 257 (327)
T ss_dssp HHHHSCCCSSCC---------CCCC-------------------CSCCCCCCC----------------------CSSCC
T ss_pred HHHHCCCCCCCcchHH--HHHHHHh-------------------cCCCCCCCC----------------------ccccc
Confidence 9999999997543211 0000000 000000000 01124
Q ss_pred chhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.+..+.+||.+||+.||++|||++|+++||||...
T Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 258 FSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 66789999999999999999999999999999653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=324.75 Aligned_cols=249 Identities=20% Similarity=0.241 Sum_probs=194.1
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCce----EEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEM----VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~----vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
.+....|++.++||+|+||.||+|++..+++. ||+|.+... ......+.+|+.++.++ .|+|+++++++
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~ 85 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGI 85 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-----CBTTBCCEEEE
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-----CCCCEeEEEEE
Confidence 35567789999999999999999998877765 588877532 23456778899999888 67999999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
+..+. .+++++++ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus 86 ~~~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~----------- 152 (327)
T 3poz_A 86 CLTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT----------- 152 (327)
T ss_dssp EESSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE-----------
T ss_pred EecCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECC-----------
Confidence 98765 77888998 999999998754 36899999999999999999999999999999999999954
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-C
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-G 265 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g 265 (379)
++.++|+|||.+....... ....+|..|+|||.+.+..++.++|||||||++|+|++ |
T Consensus 153 ----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 216 (327)
T 3poz_A 153 ----------------PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216 (327)
T ss_dssp ----------------TTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ----------------CCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcC
Confidence 4557777777775433322 12346779999999999999999999999999999999 9
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
..||.+.+..+....+....... . ...++..+
T Consensus 217 ~~p~~~~~~~~~~~~~~~~~~~~----------------------~--------------------------~~~~~~~~ 248 (327)
T 3poz_A 217 SKPYDGIPASEISSILEKGERLP----------------------Q--------------------------PPICTIDV 248 (327)
T ss_dssp CCTTTTCCGGGHHHHHHTTCCCC----------------------C--------------------------CTTBCHHH
T ss_pred CCCccCCCHHHHHHHHHcCCCCC----------------------C--------------------------CccCCHHH
Confidence 99998766544433332211110 0 12356789
Q ss_pred HHHHhhccccCCCCCcCHHHHhcC
Q 017021 346 THLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.+++.+||+.||.+|||+.|++++
T Consensus 249 ~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 249 YMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=318.89 Aligned_cols=254 Identities=23% Similarity=0.324 Sum_probs=202.0
Q ss_pred eeechhhhhhhhccccccceeEEEEEe-----cCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
..+..-.|++.+.||+|+||.||+|++ ..+++.||+|++.... .....+.+|+.++.++ ..|+|+++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~h~~i~~~~ 93 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL----GNHMNIVNLL 93 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhc----ccCCCeeeEE
Confidence 345667889999999999999999984 4678899999997432 2346677899988888 3578999999
Q ss_pred ceeeecceEEEEEeCC-CCCHHHHHHhCCCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Q 017021 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYR----------------SFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 173 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~----------------~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp 173 (379)
+++..++..++||||+ +++|.+++...... .+++..+..++.||+.||.|||+.|++||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 9999999999999999 88999999875421 489999999999999999999999999999999
Q ss_pred CcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCC
Q 017021 174 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTY 248 (379)
Q Consensus 174 ~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~ 248 (379)
+||+++. ++.++|+|||.+....... ....||+.|+|||.+.+..++.
T Consensus 174 ~Nil~~~---------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 226 (313)
T 1t46_A 174 RNILLTH---------------------------GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226 (313)
T ss_dssp GGEEEET---------------------------TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred ceEEEcC---------------------------CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCCh
Confidence 9999954 4556777777665443332 2235678899999999889999
Q ss_pred ccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccc
Q 017021 249 PCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 327 (379)
Q Consensus 249 ~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (379)
++|||||||++|+|++ |..||.+....+............+
T Consensus 227 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------------- 268 (313)
T 1t46_A 227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML-------------------------------------- 268 (313)
T ss_dssp HHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC--------------------------------------
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC--------------------------------------
Confidence 9999999999999998 9999987554333222211110000
Q ss_pred hhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 328 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.....+..+.++|.+||+.||.+|||++|++++
T Consensus 269 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 269 ---------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 012356789999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=325.29 Aligned_cols=248 Identities=22% Similarity=0.249 Sum_probs=196.3
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCce----EEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEM----VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~----vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
+....|++.+.||+|+||.||+|.+..+++. ||+|.+... ......+.+|+.++..+ .|+||+++++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~ 84 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-----DHAHIVRLLGLC 84 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-----CCTTBCCEEEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEE
Confidence 4556789999999999999999999888776 777776532 22234556788888777 789999999988
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
. ++..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 85 ~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~-------------- 148 (325)
T 3kex_A 85 P-GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL-------------- 148 (325)
T ss_dssp C-BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE--------------
T ss_pred c-CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE--------------
Confidence 6 45689999999 899999997653 368899999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 266 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~ 266 (379)
+.++.++|+|||.+....... ....||..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 149 -------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~ 215 (325)
T 3kex_A 149 -------------KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 215 (325)
T ss_dssp -------------SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred -------------CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCC
Confidence 455668888888876543332 23457789999999998899999999999999999999 99
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||.+....+....+....... . ....+.++.
T Consensus 216 ~p~~~~~~~~~~~~~~~~~~~~----------------------~--------------------------~~~~~~~~~ 247 (325)
T 3kex_A 216 EPYAGLRLAEVPDLLEKGERLA----------------------Q--------------------------PQICTIDVY 247 (325)
T ss_dssp CTTTTSCTTHHHHHHHTTCBCC----------------------C--------------------------CTTBCTTTT
T ss_pred CCccccCHHHHHHHHHcCCCCC----------------------C--------------------------CCcCcHHHH
Confidence 9998766554443332211100 0 112456788
Q ss_pred HHHhhccccCCCCCcCHHHHhcC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~h 369 (379)
++|.+||+.||.+|||++|+++|
T Consensus 248 ~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 248 MVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=339.29 Aligned_cols=270 Identities=24% Similarity=0.285 Sum_probs=195.5
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
-...|.+.+.||+|+||+||.+. ..+|+.||+|++... ......+|+.++..+ ..|+||+++++.+.+++..|
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l----~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID--FCDIALMEIKLLTES----DDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG--GHHHHHHHHHHHHHH----TTSTTBCCEEEEEECSSEEE
T ss_pred hhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH--HHHHHHHHHHHHHhc----cCCCCcCeEEEEEecCCeEE
Confidence 33446667899999999998754 567999999998743 234567788888776 26799999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCC-----CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 121 IVFEKLGSSLYDFLRKNNYRS-----FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
+||||++++|.+++....... .++..+..++.||+.||+|||+.||+||||||+||+++..+......
T Consensus 86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~------- 158 (434)
T 2rio_A 86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ------- 158 (434)
T ss_dssp EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC-------
T ss_pred EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc-------
Confidence 999999889999998754111 12234567999999999999999999999999999997543211000
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhC-------CCCCCccchHhHHHHHHH
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGCILVE 261 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~~ 261 (379)
........++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 159 -------~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~e 231 (434)
T 2rio_A 159 -------QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231 (434)
T ss_dssp -------TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHH
T ss_pred -------ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHH
Confidence 001345679999999987654432 23479999999999975 568899999999999999
Q ss_pred HHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc
Q 017021 262 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 262 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (379)
|++ |..||......+. .+.+.....+ ... . .....
T Consensus 232 llt~g~~Pf~~~~~~~~--~i~~~~~~~~-----------------------~~~-------------~------~~~~~ 267 (434)
T 2rio_A 232 ILSKGKHPFGDKYSRES--NIIRGIFSLD-----------------------EMK-------------C------LHDRS 267 (434)
T ss_dssp HHTTSCCTTCSTTTHHH--HHHHTCCCCC-----------------------CCT-------------T------CCCHH
T ss_pred HHhCCCCCCCCchhhHH--HHhcCCCCcc-----------------------ccc-------------c------ccccc
Confidence 998 9999976443221 1111111100 000 0 00112
Q ss_pred chhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.+.++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 268 ~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 268 LIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp HHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred chHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 45789999999999999999999999999999754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.40 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=192.9
Q ss_pred eechhhhhhhhccccccceeEEEEEec---CCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.+....|++.+.||+|+||.||+|+++ .++..||+|+++.. ......+.+|+.++.++ .|+||+++++++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~ 115 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-----DHPNIIRLEGVV 115 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEE
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEE
Confidence 345567899999999999999999887 56788999999743 33455677888888877 789999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
...+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-------------- 180 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI-------------- 180 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--------------
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE--------------
Confidence 9999999999999 899999998654 358999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-C
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-G 265 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g 265 (379)
+.++.++|+|||.+....... ....+|..|+|||++.+..++.++|||||||++|+|++ |
T Consensus 181 -------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g 247 (373)
T 2qol_A 181 -------------NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247 (373)
T ss_dssp -------------CTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC
T ss_pred -------------cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCC
Confidence 455567777777776443322 11234678999999999899999999999999999998 9
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
+.||...+..+....+.......+ ...++..+
T Consensus 248 ~~P~~~~~~~~~~~~i~~~~~~~~------------------------------------------------~~~~~~~l 279 (373)
T 2qol_A 248 ERPYWEMSNQDVIKAVDEGYRLPP------------------------------------------------PMDCPAAL 279 (373)
T ss_dssp -CTTTTCCHHHHHHHHHTTEECCC------------------------------------------------CTTCBHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCC------------------------------------------------CccccHHH
Confidence 999987666554433322211100 11356789
Q ss_pred HHHHhhccccCCCCCcCHHHHhc
Q 017021 346 THLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.++|.+||+.||.+|||++|+++
T Consensus 280 ~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=318.72 Aligned_cols=265 Identities=23% Similarity=0.305 Sum_probs=197.2
Q ss_pred eechhhhhhhhccccccceeEEEEE----ecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~----~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.+....|++.++||+|+||.||+|+ +..+++.||+|++.... .....+.+|+.++..+ .|+|++++++++
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~ 80 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-----QHDNIVKYKGVC 80 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEE
Confidence 4567789999999999999999998 66789999999997433 3345677899888888 689999999988
Q ss_pred ee--cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 114 DY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 114 ~~--~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
.. ....++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~--------- 150 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE--------- 150 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---------
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC---------
Confidence 54 45689999999 899999998754 258999999999999999999999999999999999999554
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~ 264 (379)
+.++|+|||.+....... ....+|..|+|||.+.+..++.++|||||||++|+|++
T Consensus 151 ------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 212 (295)
T 3ugc_A 151 ------------------NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212 (295)
T ss_dssp ------------------TEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH
T ss_pred ------------------CeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 456666666665433221 12346778999999999899999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..|+...... .....+..+..... .....+.......... ...++++
T Consensus 213 g~~~~~~~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--------------------------~~~~~~~ 260 (295)
T 3ugc_A 213 YIEKSKSPPAE-----FMRMIGNDKQGQMI-VFHLIELLKNNGRLPR--------------------------PDGCPDE 260 (295)
T ss_dssp TTCTTCSHHHH-----HHHHHCTTCCTHHH-HHHHHHHHHTTCCCCC--------------------------CTTCCHH
T ss_pred cccccCCChHH-----HHhhhcCccccchh-HHHHHHHHhccCcCCC--------------------------CcCcCHH
Confidence 99998753221 11111211111100 0011111111111111 1246788
Q ss_pred HHHHHhhccccCCCCCcCHHHHhc
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
+.++|.+||+.||++|||++|+++
T Consensus 261 l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 261 IYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=316.81 Aligned_cols=250 Identities=24% Similarity=0.287 Sum_probs=190.8
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCC---CceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
..+....|++.+.||+|+||.||+|.+..+ +..||+|++... ......+.+|+.++..+ .|+|+++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~ 84 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGV 84 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEE
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCccceEEEE
Confidence 345667899999999999999999998654 457999998642 23345667788888777 78999999998
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
+. ++..|+||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---------- 152 (281)
T 1mp8_A 85 IT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---------- 152 (281)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET----------
T ss_pred Ec-cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC----------
Confidence 84 46789999999 789999998654 358999999999999999999999999999999999999544
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CC
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 266 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~ 266 (379)
+.++|+|||.+....... ....+|+.|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 153 -----------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~ 215 (281)
T 1mp8_A 153 -----------------DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 215 (281)
T ss_dssp -----------------TEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred -----------------CCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCC
Confidence 456677777665433221 22346778999999998899999999999999999996 99
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||......+....+..... ... ....++.+.
T Consensus 216 ~pf~~~~~~~~~~~i~~~~~----------------------~~~--------------------------~~~~~~~l~ 247 (281)
T 1mp8_A 216 KPFQGVKNNDVIGRIENGER----------------------LPM--------------------------PPNCPPTLY 247 (281)
T ss_dssp CTTTTCCGGGHHHHHHTTCC----------------------CCC--------------------------CTTCCHHHH
T ss_pred CCCCcCCHHHHHHHHHcCCC----------------------CCC--------------------------CCCCCHHHH
Confidence 99987665444333322110 000 123567899
Q ss_pred HHHhhccccCCCCCcCHHHHhcC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~h 369 (379)
++|.+||+.||++|||+.|++++
T Consensus 248 ~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 248 SLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=323.87 Aligned_cols=254 Identities=20% Similarity=0.273 Sum_probs=199.3
Q ss_pred eechhhhhhhhccccccceeEEEEEe-----cCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~-----~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.+....|++.+.||+|+||.||+|.+ ..++..||+|++... ......+.+|+.++.++ ..|+||+++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~hp~iv~~~~ 116 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL----GSHENIVNLLG 116 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHH----CCCTTBCCEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhh----cCCCCeeeEEE
Confidence 34566889999999999999999997 346778999999742 23446677899998888 35789999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccc
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNNY---------------------RSFPIDLVREIARQLLECIAFMHDLCMIHT 169 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~~---------------------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~ 169 (379)
++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+.||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 999999999999999 8899999987542 237899999999999999999999999999
Q ss_pred CCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCC
Q 017021 170 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGL 244 (379)
Q Consensus 170 dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~ 244 (379)
||||+||+++ .++.++|+|||.+....... ....||+.|+|||.+.+.
T Consensus 197 Dikp~NIll~---------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 249 (344)
T 1rjb_A 197 DLAARNVLVT---------------------------HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 249 (344)
T ss_dssp TCSGGGEEEE---------------------------TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred CCChhhEEEc---------------------------CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC
Confidence 9999999994 44567777777765433222 234577899999999988
Q ss_pred CCCCccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhh
Q 017021 245 GWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 323 (379)
Q Consensus 245 ~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (379)
.++.++|||||||++|+|++ |..||.+....+........... ...
T Consensus 250 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~~------------ 296 (344)
T 1rjb_A 250 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK---------------------MDQ------------ 296 (344)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC---------------------CCC------------
T ss_pred CCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCC---------------------CCC------------
Confidence 99999999999999999998 99999876543332222111000 000
Q ss_pred hccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCC
Q 017021 324 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHP 370 (379)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 370 (379)
....+..+.++|.+||+.||.+|||+.|+++|.
T Consensus 297 --------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 297 --------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp --------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 113567899999999999999999999999763
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=337.35 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=204.5
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
..+....|++.++||+|+||.||+|.+.. +..||+|+++........+.+|+.++..+ .|+|++++++++. .+
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTL-----QHDKLVKLHAVVT-KE 255 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTC-----CCTTBCCEEEEEC-SS
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhC-----CCCCEeeEEEEEe-CC
Confidence 34566788999999999999999999754 67899999986655667888899998887 7899999999886 56
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..|+||||+ +++|.+++.......++...+..++.||+.||.|||+.||+||||||+|||+
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill------------------ 317 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV------------------ 317 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE------------------
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE------------------
Confidence 789999999 8999999976433358899999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 271 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~ 271 (379)
+.++.+||+|||++....... ....+|..|+|||++....++.++|||||||++|+|++ |..||.+
T Consensus 318 ---------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 318 ---------SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp ---------CTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ---------CCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 555678888888886543321 22345778999999998899999999999999999999 9999988
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+..+....+.+....+ . ...++..+.++|.+
T Consensus 389 ~~~~~~~~~i~~~~~~~----------------------~--------------------------~~~~~~~l~~li~~ 420 (454)
T 1qcf_A 389 MSNPEVIRALERGYRMP----------------------R--------------------------PENCPEELYNIMMR 420 (454)
T ss_dssp CCHHHHHHHHHHTCCCC----------------------C--------------------------CTTSCHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCC----------------------C--------------------------CCCCCHHHHHHHHH
Confidence 77666555444321111 0 11356789999999
Q ss_pred ccccCCCCCcCHHHHhc
Q 017021 352 LLRYDPTDRLTAREALR 368 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~ 368 (379)
||+.||++|||++++++
T Consensus 421 cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 421 CWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhHCcCHHHHHH
Confidence 99999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=326.44 Aligned_cols=258 Identities=16% Similarity=0.217 Sum_probs=190.4
Q ss_pred eechhhhhhhhccccccceeEEEEEecC---CCceEEEEEeeccchh------------hHhHHHHHHHHHHHHhcCCCC
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGIKKY------------REAAMIEIEVLQQLAKHDKGG 103 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~---~~~~vAiK~~~~~~~~------------~~~~~~e~~~l~~l~~~~~~~ 103 (379)
.+....|++.+.||+|+||.||+|.+.. ++..||+|++...... ...+.+|+..+..+ .|
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-----~h 107 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-----DY 107 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-----SC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-----cc
Confidence 3455679999999999999999999987 7899999998754221 11122333333333 78
Q ss_pred CeeEEecceeee----cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEe
Q 017021 104 NRCVQIRNWFDY----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 179 (379)
Q Consensus 104 ~~i~~~~~~~~~----~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~ 179 (379)
+|++++++++.. ....|+||||++++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++
T Consensus 108 ~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 108 LGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG 185 (345)
T ss_dssp CCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred cCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc
Confidence 999999999887 78999999999999999997755 699999999999999999999999999999999999996
Q ss_pred cccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC----------CCcccccCCccchhhhhCCCCCCc
Q 017021 180 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYP 249 (379)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~ 249 (379)
.++ ...++|+|||.+...... .....||+.|+|||++.+..++.+
T Consensus 186 ~~~-------------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 240 (345)
T 2v62_A 186 YKN-------------------------PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR 240 (345)
T ss_dssp SSS-------------------------TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH
T ss_pred cCC-------------------------CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch
Confidence 432 236788888877543221 123468999999999999899999
Q ss_pred cchHhHHHHHHHHHhCCCCCCCC--chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccc
Q 017021 250 CDIWSVGCILVELCTGEALFQTH--ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 327 (379)
Q Consensus 250 sDvwSlG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (379)
+|||||||++|+|++|..||... +...............|......
T Consensus 241 ~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------- 288 (345)
T 2v62_A 241 SDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKW-------------------------------- 288 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHH--------------------------------
T ss_pred hhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhh--------------------------------
Confidence 99999999999999999999642 22222222222222333221110
Q ss_pred hhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 328 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
......+.++.++|.+||+.||++|||++++++
T Consensus 289 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 289 --------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp --------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 000146778999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=326.13 Aligned_cols=259 Identities=15% Similarity=0.206 Sum_probs=194.6
Q ss_pred echhhhhhhhccccccceeEEEEEecCC-----CceEEEEEeeccchhhHhHHHHHHHHHHHHh----------cCCCCC
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGIKKYREAAMIEIEVLQQLAK----------HDKGGN 104 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~----------~~~~~~ 104 (379)
.....|++.++||+|+||.||+|.++.+ ++.||+|++.... .....|+.++..+.+ ....|+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence 3455799999999999999999998765 5889999987543 234445555555432 234689
Q ss_pred eeEEecceeeec----ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEec
Q 017021 105 RCVQIRNWFDYR----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 180 (379)
Q Consensus 105 ~i~~~~~~~~~~----~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~ 180 (379)
||+++++++... .+.|+||||++++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence 999999998764 5689999999999999998753 36999999999999999999999999999999999999952
Q ss_pred ccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC----------CCcccccCCccchhhhhCCCCCCcc
Q 017021 181 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPC 250 (379)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~s 250 (379)
..++.++|+|||.+...... .....||+.|+|||++.+..++.++
T Consensus 188 -------------------------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 242 (364)
T 3op5_A 188 -------------------------KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRG 242 (364)
T ss_dssp -------------------------SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHH
T ss_pred -------------------------CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchh
Confidence 14456777777777533221 1234599999999999998999999
Q ss_pred chHhHHHHHHHHHhCCCCCCCCchHHHH-HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchh
Q 017021 251 DIWSVGCILVELCTGEALFQTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 329 (379)
Q Consensus 251 DvwSlG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (379)
|||||||++|+|++|+.||.+....... ..........
T Consensus 243 Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----------------------------------------- 281 (364)
T 3op5_A 243 DLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYREN----------------------------------------- 281 (364)
T ss_dssp HHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHC-----------------------------------------
T ss_pred hHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhh-----------------------------------------
Confidence 9999999999999999999853222111 1111100000
Q ss_pred hHHHHHHhh--ccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 330 LQNLIMQHV--DHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 330 ~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
......... ...+.++.++|..||+.||.+||+++++++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 282 IASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 000111111 346788999999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=317.57 Aligned_cols=246 Identities=23% Similarity=0.322 Sum_probs=190.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
-.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.++..+ .|+|++++++++..++.
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-----QEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-----CCCCeeEEEEEEeeCCe
Confidence 468899999999999999999999999999999974322 235566777777766 77999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~------------------- 167 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV------------------- 167 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-------------------
T ss_pred EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE-------------------
Confidence 99999999 789999998764 68999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.++.++|+|||.+....... ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 168 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 168 --------SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp --------CTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred --------cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 455667788888775443322 23468999999999998889999999999999999999999998765
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
.......+.. ..+.+ .......+..+.++|.+||
T Consensus 240 ~~~~~~~~~~-~~~~~---------------------------------------------~~~~~~~~~~l~~li~~~l 273 (309)
T 2h34_A 240 LSVMGAHINQ-AIPRP---------------------------------------------STVRPGIPVAFDAVIARGM 273 (309)
T ss_dssp HHHHHHHHHS-CCCCG---------------------------------------------GGTSTTCCTHHHHHHHHHT
T ss_pred HHHHHHHhcc-CCCCc---------------------------------------------cccCCCCCHHHHHHHHHhc
Confidence 4322221111 11110 0112346778999999999
Q ss_pred ccCCCCCc-CHHHHhc
Q 017021 354 RYDPTDRL-TAREALR 368 (379)
Q Consensus 354 ~~dP~~Rp-ta~e~l~ 368 (379)
+.||++|| |++++++
T Consensus 274 ~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 274 AKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CSSGGGSCSSHHHHHH
T ss_pred cCCHHHHHHhHHHHHH
Confidence 99999999 8888763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=315.94 Aligned_cols=245 Identities=26% Similarity=0.319 Sum_probs=197.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-------
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------- 115 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~------- 115 (379)
..|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.++..+ .|+|++++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKL-----DHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHC-----CCTTBCCEEEEEEEEEEC---
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhC-----CCCCEEEEeeeEeccccCccc
Confidence 46889999999999999999999999999999997543 3566799998888 78999999988754
Q ss_pred ---------cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccc
Q 017021 116 ---------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 185 (379)
Q Consensus 116 ---------~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 185 (379)
....++||||+ +++|.+++.......+++..+..++.||+.||.|||+.|++||||||+||+++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~----- 157 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD----- 157 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE-----
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC-----
Confidence 45689999999 789999998764457999999999999999999999999999999999999954
Q ss_pred cCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHH
Q 017021 186 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 263 (379)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~ 263 (379)
++.++|+|||.+...... .....||+.|+|||.+.+..++.++||||||+++|+|+
T Consensus 158 ----------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 215 (284)
T 2a19_B 158 ----------------------TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215 (284)
T ss_dssp ----------------------TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHH
T ss_pred ----------------------CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHH
Confidence 445777777776543332 23346899999999999989999999999999999999
Q ss_pred hCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchh
Q 017021 264 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343 (379)
Q Consensus 264 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (379)
+|..|+.... .....+.. +. .....+.
T Consensus 216 ~~~~~~~~~~--~~~~~~~~--~~-------------------------------------------------~~~~~~~ 242 (284)
T 2a19_B 216 HVCDTAFETS--KFFTDLRD--GI-------------------------------------------------ISDIFDK 242 (284)
T ss_dssp SCCSSHHHHH--HHHHHHHT--TC-------------------------------------------------CCTTSCH
T ss_pred hcCCcchhHH--HHHHHhhc--cc-------------------------------------------------ccccCCH
Confidence 9988774211 11100000 00 0123567
Q ss_pred HHHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 344 DLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 344 ~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
.+.++|.+||+.||.+|||+.|+++|.+.-..
T Consensus 243 ~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 243 KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 78999999999999999999999999765443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=310.49 Aligned_cols=247 Identities=15% Similarity=0.120 Sum_probs=197.3
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
.+....|++.+.||+|+||.||+|++. ++.||+|++.... .....+.+|+.++.++ .|+|++++++++.+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-----SHPNVLPVLGACQS 78 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-----SCTTEECEEEEECT
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-----CCCchhheEEEEcc
Confidence 455667899999999999999999875 7889999997432 2334566677766665 68999999999987
Q ss_pred c--ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCcEEEecccccccCCCc
Q 017021 116 R--NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 116 ~--~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
. +..++||||+ +++|.+++.......+++..+..++.|++.||.|||+.| ++||||||+||++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~------------ 146 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI------------ 146 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE------------
T ss_pred CCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE------------
Confidence 7 7899999999 889999998866456899999999999999999999999 9999999999999
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCC---ccchHhHHHHHHHHHhCCC
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlG~il~~l~~g~~ 267 (379)
+.++.++|+|||++..... ....||+.|+|||.+.+..++. ++|||||||++|+|++|+.
T Consensus 147 ---------------~~~~~~~l~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 209 (271)
T 3kmu_A 147 ---------------DEDMTARISMADVKFSFQS--PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209 (271)
T ss_dssp ---------------CTTSCEEEEGGGSCCTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSC
T ss_pred ---------------cCCcceeEEeccceeeecc--cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 4555677777776543222 3346899999999998765544 7999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||...+..+....+......+ . .....++.+.+
T Consensus 210 p~~~~~~~~~~~~~~~~~~~~---------------------~--------------------------~~~~~~~~~~~ 242 (271)
T 3kmu_A 210 PFADLSNMEIGMKVALEGLRP---------------------T--------------------------IPPGISPHVSK 242 (271)
T ss_dssp TTTTSCHHHHHHHHHHSCCCC---------------------C--------------------------CCTTCCHHHHH
T ss_pred CccccChHHHHHHHHhcCCCC---------------------C--------------------------CCCCCCHHHHH
Confidence 998766655443332211110 0 01235678999
Q ss_pred HHhhccccCCCCCcCHHHHhc
Q 017021 348 LLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~ 368 (379)
+|.+||+.||++|||++|+++
T Consensus 243 li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 243 LMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=322.38 Aligned_cols=254 Identities=26% Similarity=0.355 Sum_probs=181.9
Q ss_pred eeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 35 ITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.+.+.+....|++.++||+|+||.||+|++..+++.||+|++... ......+.+|+.++.++. +|+|++++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----~h~~iv~~~~~~ 95 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS----GHPNIVQFCSAA 95 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT----TSTTBCCEEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc----cCCChhhccccc
Confidence 455677788999999999999999999999999999999998543 333456678888888882 478999999888
Q ss_pred --------eecceEEEEEeCCCCCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCcEEEeccc
Q 017021 114 --------DYRNHICIVFEKLGSSLYDFLRK-NNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSE 182 (379)
Q Consensus 114 --------~~~~~~~lv~e~~~~sL~~~l~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiH~dlkp~Nili~~~~ 182 (379)
......+++|||++++|.+++.. .....+++..+..++.||+.||.|||+.| ++||||||+||+++.++
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred cccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence 34556899999998899999865 22236999999999999999999999999 99999999999995555
Q ss_pred ccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC---------------CCcccccCCccchhhh---hCC
Q 017021 183 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---------------QNYIVSTRHYRAPEVI---LGL 244 (379)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~---------------~~~~~gt~~y~aPE~~---~~~ 244 (379)
. ++|+|||.+...... .....||+.|+|||++ .+.
T Consensus 176 ~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 228 (337)
T 3ll6_A 176 T---------------------------IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228 (337)
T ss_dssp C---------------------------EEBCCCTTCBCCSSCC-------------------------------CCTTS
T ss_pred C---------------------------EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccC
Confidence 4 555555554432221 1134689999999998 456
Q ss_pred CCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhh
Q 017021 245 GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 324 (379)
Q Consensus 245 ~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (379)
.++.++|||||||++|+|++|..||.......... .. ...+
T Consensus 229 ~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~~------------------------~~~~------------ 269 (337)
T 3ll6_A 229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN---GK------------------------YSIP------------ 269 (337)
T ss_dssp CSSHHHHHHHHHHHHHHHHHSSCCC---------------------------------------CCCC------------
T ss_pred CCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc---Cc------------------------ccCC------------
Confidence 68899999999999999999999996533221110 00 0000
Q ss_pred ccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCC
Q 017021 325 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHP 370 (379)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 370 (379)
.....+..+.+||.+||+.||.+|||++|+++|-
T Consensus 270 ------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 270 ------------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ------------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ------------cccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 0123456788999999999999999999999763
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=313.41 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=199.9
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.....|++.+.||+|+||.||+|.+. +++.||+|++.........+.+|+.++..+ .|+|++++++++.. +..
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-----QHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-----CCcCcceEEEEEcC-CCc
Confidence 34567899999999999999999975 567899999986655567788899999988 67999999998764 458
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++||||+ +++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~-------------------- 142 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV-------------------- 142 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--------------------
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE--------------------
Confidence 9999999 8999999875432358999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 273 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~ 273 (379)
+.++.++|+|||.+....... ....+|..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+
T Consensus 143 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 143 -------SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp -------CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred -------cCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 455667888888776543322 22346778999999988889999999999999999999 999998766
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.+..... .....+..+.++|.+||
T Consensus 216 ~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~l~~li~~~l 247 (279)
T 1qpc_A 216 NPEVIQNLERGYRMV------------------------------------------------RPDNCPEELYQLMRLCW 247 (279)
T ss_dssp HHHHHHHHHTTCCCC------------------------------------------------CCTTCCHHHHHHHHHHT
T ss_pred HHHHHHHHhcccCCC------------------------------------------------CcccccHHHHHHHHHHh
Confidence 655443332211100 01235678999999999
Q ss_pred ccCCCCCcCHHHHhc
Q 017021 354 RYDPTDRLTAREALR 368 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~ 368 (379)
+.||++|||++++++
T Consensus 248 ~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 248 KERPEDRPTFDYLRS 262 (279)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred ccChhhCCCHHHHHH
Confidence 999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=318.96 Aligned_cols=253 Identities=19% Similarity=0.267 Sum_probs=201.9
Q ss_pred eeechhhhhhhhccccccceeEEEEEec-------CCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEE
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQ 108 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~-------~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~ 108 (379)
..+....|++.+.||+|+||.||+|++. .++..||+|+++... .....+.+|+.++..+ ..|+||++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~hp~iv~ 105 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI----GKHKNIIN 105 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHH----CCCTTBCC
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHh----hcCCCEee
Confidence 3456678999999999999999999975 457789999997432 3345667888888887 35789999
Q ss_pred ecceeeecceEEEEEeCC-CCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Q 017021 109 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 173 (379)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~--------------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp 173 (379)
+++++...+..|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.|++||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 999999999999999999 8899999986531 2488999999999999999999999999999999
Q ss_pred CcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCC
Q 017021 174 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTY 248 (379)
Q Consensus 174 ~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~ 248 (379)
+||++ +.++.++|+|||.+....... ....+|+.|+|||++.+..++.
T Consensus 186 ~NIll---------------------------~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 238 (334)
T 2pvf_A 186 RNVLV---------------------------TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238 (334)
T ss_dssp GGEEE---------------------------CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH
T ss_pred ceEEE---------------------------cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh
Confidence 99999 455667778888776443322 2234678899999998888999
Q ss_pred ccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccc
Q 017021 249 PCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 327 (379)
Q Consensus 249 ~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (379)
++|||||||++|+|++ |..||.+....+....+....... .
T Consensus 239 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------~---------------- 280 (334)
T 2pvf_A 239 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD----------------------K---------------- 280 (334)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC----------------------C----------------
T ss_pred HHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCC----------------------C----------------
Confidence 9999999999999999 999998766655444333321110 0
Q ss_pred hhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 328 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
...++..+.++|.+||+.||.+|||++|++++
T Consensus 281 ----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 281 ----------PANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11356789999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=316.94 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=198.7
Q ss_pred eechhhhhhhhccccccceeEEEEEe-----cCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.+....|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+|+.++..+ .+|+|++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~hp~iv~~~~ 98 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI----GHHLNVVNLLG 98 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhc----ccCCCeeeEEE
Confidence 45667899999999999999999984 4677999999997532 2345677888888888 35689999999
Q ss_pred eeeec-ceEEEEEeCC-CCCHHHHHHhCCCC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCc
Q 017021 112 WFDYR-NHICIVFEKL-GSSLYDFLRKNNYR--------------SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPEN 175 (379)
Q Consensus 112 ~~~~~-~~~~lv~e~~-~~sL~~~l~~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~N 175 (379)
++... ...++||||+ +++|.+++...... .+++..+..++.|++.||.|||+.|++||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 98765 4599999999 88999999875421 28899999999999999999999999999999999
Q ss_pred EEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCcc
Q 017021 176 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPC 250 (379)
Q Consensus 176 ili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~s 250 (379)
|+++ .++.++|+|||.+....... ....||+.|+|||++.+..++.++
T Consensus 179 il~~---------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 231 (316)
T 2xir_A 179 ILLS---------------------------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 231 (316)
T ss_dssp EEEC---------------------------GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred EEEC---------------------------CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchh
Confidence 9994 44557777777765443322 234578899999999998999999
Q ss_pred chHhHHHHHHHHHh-CCCCCCCCchHHHH-HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccch
Q 017021 251 DIWSVGCILVELCT-GEALFQTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328 (379)
Q Consensus 251 DvwSlG~il~~l~~-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (379)
|||||||++|+|++ |..||.+....+.. ..+...... ..
T Consensus 232 Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------~~----------------- 272 (316)
T 2xir_A 232 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------------------RA----------------- 272 (316)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC----------------------CC-----------------
T ss_pred HHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccC----------------------CC-----------------
Confidence 99999999999998 99999875533222 222111100 00
Q ss_pred hhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 329 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
....++.+.++|.+||+.||.+|||++|+++|
T Consensus 273 ---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 273 ---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11356789999999999999999999999976
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=321.62 Aligned_cols=261 Identities=22% Similarity=0.266 Sum_probs=201.7
Q ss_pred ceeeeeeeeeechhhhhhhhccccccceeEEEEEecCCCceE--EEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCe
Q 017021 30 NMFNLITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMV--AIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNR 105 (379)
Q Consensus 30 ~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~v--AiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~ 105 (379)
+--+...|..+....|++.+.||+|+||.||+|+++.++..+ |+|.++.. ......+.+|+.++.++ ..|+|
T Consensus 12 ~~~~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l----~~hp~ 87 (327)
T 1fvr_A 12 NNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL----GHHPN 87 (327)
T ss_dssp ----CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTC----CCCTT
T ss_pred CCCCCcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhc----cCCCc
Confidence 333445566677778999999999999999999999888865 99998742 22344566777777665 36789
Q ss_pred eEEecceeeecceEEEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccC
Q 017021 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTD 170 (379)
Q Consensus 106 i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~d 170 (379)
++++++++.+.+..|+||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.|++|||
T Consensus 88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~d 167 (327)
T 1fvr_A 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 167 (327)
T ss_dssp BCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 999999999999999999999 889999997643 23689999999999999999999999999999
Q ss_pred CCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCCCCCC
Q 017021 171 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTY 248 (379)
Q Consensus 171 lkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ 248 (379)
|||+||+++ .++.++|+|||.+...... .....+|+.|+|||.+.+..++.
T Consensus 168 lkp~NIl~~---------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 220 (327)
T 1fvr_A 168 LAARNILVG---------------------------ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT 220 (327)
T ss_dssp CSGGGEEEC---------------------------GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH
T ss_pred CccceEEEc---------------------------CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCc
Confidence 999999994 4456777777776532221 12235678899999999888999
Q ss_pred ccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccc
Q 017021 249 PCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 327 (379)
Q Consensus 249 ~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (379)
++|||||||++|+|++ |..||.+.+..+....+..... ...
T Consensus 221 ~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~----------------------~~~---------------- 262 (327)
T 1fvr_A 221 NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR----------------------LEK---------------- 262 (327)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC----------------------CCC----------------
T ss_pred hhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC----------------------CCC----------------
Confidence 9999999999999998 9999987665444332211100 000
Q ss_pred hhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 328 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
....+..+.++|.+||+.||.+|||++|+++|
T Consensus 263 ----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 263 ----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp ----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11356789999999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=333.23 Aligned_cols=256 Identities=20% Similarity=0.275 Sum_probs=198.5
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
...|++.++||+|+||.||+|++..+++.||||++.... ....+..|..++..+.+ ++++..+..+....+..++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~----~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQG----GTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTT----STTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcC----CCCCCeEEEEEeeCCEEEE
Confidence 456899999999999999999999999999999987433 34456778998888743 3456666666778889999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
||||++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||+...
T Consensus 81 vme~~g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-------------------- 139 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-------------------- 139 (483)
T ss_dssp EEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG--------------------
T ss_pred EEECCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecC--------------------
Confidence 99999999999998643 369999999999999999999999999999999999999421
Q ss_pred cccCCCCCCeEEeecCcccccCCCC----------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+..+.++|+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 140 ----~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~ 215 (483)
T 3sv0_A 140 ----RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (483)
T ss_dssp ----GGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred ----CCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 244567777777775433222 245799999999999999999999999999999999999999987
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.........+.+... .............++.++.++|..
T Consensus 216 ~~~~~~~~~~~~i~~-----------------------------------------~~~~~~~~~l~~~~p~~l~~li~~ 254 (483)
T 3sv0_A 216 LKAGTKKQKYEKISE-----------------------------------------KKVATSIEALCRGYPTEFASYFHY 254 (483)
T ss_dssp CCCSSHHHHHHHHHH-----------------------------------------HHHHSCHHHHHTTSCHHHHHHHHH
T ss_pred ccchhHHHHHHHHhh-----------------------------------------ccccccHHHHhcCCcHHHHHHHHH
Confidence 443221111111000 000011122234567899999999
Q ss_pred ccccCCCCCcCHHHHhc
Q 017021 352 LLRYDPTDRLTAREALR 368 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~ 368 (379)
||+.||++||+++++++
T Consensus 255 cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 255 CRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHTCCTTCCCCHHHHHH
T ss_pred HhcCChhhCcCHHHHHH
Confidence 99999999999998864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=318.46 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=196.3
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCC----ceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~----~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
.+....|++.+.||+|+||.||+|.++.++ ..||+|++... ......+.+|+.++..+ .|+|+++++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~ 114 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-----SHHNIIRLEGV 114 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEE
Confidence 456677889999999999999999987654 45999999743 23345567788888877 78999999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
+...+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~------------- 180 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV------------- 180 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-------------
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE-------------
Confidence 99999999999999 889999998753 368999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT- 264 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~- 264 (379)
+.++.++|+|||.+....... ....+|..|+|||.+.+..++.++|||||||++|+|++
T Consensus 181 --------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 246 (333)
T 1mqb_A 181 --------------NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 246 (333)
T ss_dssp --------------CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --------------CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcC
Confidence 455667777777776443321 11235778999999999899999999999999999998
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||...+..+....+....... . ....+..
T Consensus 247 g~~pf~~~~~~~~~~~~~~~~~~~----------------------~--------------------------~~~~~~~ 278 (333)
T 1mqb_A 247 GERPYWELSNHEVMKAINDGFRLP----------------------T--------------------------PMDCPSA 278 (333)
T ss_dssp SCCTTTTCCHHHHHHHHHTTCCCC----------------------C--------------------------CTTCBHH
T ss_pred CCCCcccCCHHHHHHHHHCCCcCC----------------------C--------------------------cccCCHH
Confidence 999998766555443332211100 0 1135678
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+.++|.+||+.||++|||+++++++
T Consensus 279 l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 279 IYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=334.76 Aligned_cols=254 Identities=26% Similarity=0.336 Sum_probs=201.2
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.+....|++.++||+|+||.||+|.+.. +..||+|+++........+.+|+.++.++ .|+|++++++++.. +.
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SS
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhC-----CCCCEeeEEEEEcC-Cc
Confidence 4566778999999999999999999875 45699999986555567788999999998 78999999998876 67
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.++||||+ +++|.+++.......+++..+..++.||+.||+|||++|++||||||+||+++.
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~----------------- 315 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE----------------- 315 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-----------------
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECC-----------------
Confidence 89999999 899999997643345899999999999999999999999999999999999944
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~ 272 (379)
++.++|+|||.+....... ....+|..|+|||.+.+..++.++|||||||++|+|++ |..||.+.
T Consensus 316 ----------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 316 ----------NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp ----------GGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ----------CCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 4556777777665433221 12346778999999998899999999999999999999 99999887
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
...+....+.+.... +. ...++..+.++|.+|
T Consensus 386 ~~~~~~~~i~~~~~~----------------------~~--------------------------~~~~~~~l~~li~~c 417 (452)
T 1fmk_A 386 VNREVLDQVERGYRM----------------------PC--------------------------PPECPESLHDLMCQC 417 (452)
T ss_dssp CHHHHHHHHHTTCCC----------------------CC--------------------------CTTSCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCC----------------------CC--------------------------CCCCCHHHHHHHHHH
Confidence 665555443322111 00 123567899999999
Q ss_pred cccCCCCCcCHHHHhc--CCCCCC
Q 017021 353 LRYDPTDRLTAREALR--HPFFTR 374 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~--hp~f~~ 374 (379)
|+.||++|||++++++ ..++..
T Consensus 418 l~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 418 WRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ccCChhhCcCHHHHHHHHHHHhcc
Confidence 9999999999999986 345543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=312.88 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=197.3
Q ss_pred echhhhhhhh-ccccccceeEEEEEec--CCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 40 FSAFADKIHS-KMGEGTFGQVLECWDR--ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 40 ~~~~~y~i~~-~Lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
+....|.+.+ .||+|+||.||+|.++ .++..||+|+++.. ......+.+|+.++..+ .|+|++++++++
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~- 79 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPYIVRLIGVC- 79 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEE-
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-----CCCCEeEEEEEe-
Confidence 4455677776 9999999999999864 46788999999753 33456677899999888 689999999998
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
..+..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~------------ 146 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR------------ 146 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET------------
T ss_pred cCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC------------
Confidence 456699999999 889999997543 358999999999999999999999999999999999999544
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 266 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~ 266 (379)
+.++|+|||.+....... ....+|+.|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 147 ---------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 211 (287)
T 1u59_A 147 ---------------HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211 (287)
T ss_dssp ---------------TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred ---------------CCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 456666666665433221 12346788999999988889999999999999999998 99
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||...+..+....+.+... ... ....++.+.
T Consensus 212 ~p~~~~~~~~~~~~i~~~~~----------------------~~~--------------------------~~~~~~~l~ 243 (287)
T 1u59_A 212 KPYKKMKGPEVMAFIEQGKR----------------------MEC--------------------------PPECPPELY 243 (287)
T ss_dssp CTTTTCCTHHHHHHHHTTCC----------------------CCC--------------------------CTTCCHHHH
T ss_pred CCcccCCHHHHHHHHhcCCc----------------------CCC--------------------------CCCcCHHHH
Confidence 99987666554433322110 000 123567899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHP 370 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp 370 (379)
++|.+||+.||.+|||+.|+++|.
T Consensus 244 ~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 244 ALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHH
Confidence 999999999999999999999764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=315.24 Aligned_cols=247 Identities=22% Similarity=0.307 Sum_probs=191.2
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee-ecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRN 117 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~-~~~ 117 (379)
.+....|++.+.||+|+||.||+|.+. |+.||+|+++.. .....+.+|+.++..+ .|+|++++++++. ..+
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTC-----CCTTBCCEEEEECCC--
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-hHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCC
Confidence 455678899999999999999999864 789999999753 3456677888888877 6899999999864 445
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..++||||+ +++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~------------------ 150 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV------------------ 150 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------------
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE------------------
Confidence 799999999 7799999987542347899999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchH
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 275 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~ 275 (379)
+.++.++|+|||.+...........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus 151 ---------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 221 (278)
T 1byg_A 151 ---------SEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 221 (278)
T ss_dssp ---------CTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred ---------eCCCcEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 55567888888887765554445567889999999998899999999999999999998 99999865543
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.+... .. .....++.+.++|.+||+.
T Consensus 222 ~~~~~~~~~~~----------------------~~--------------------------~~~~~~~~l~~li~~~l~~ 253 (278)
T 1byg_A 222 DVVPRVEKGYK----------------------MD--------------------------APDGCPPAVYEVMKNCWHL 253 (278)
T ss_dssp GHHHHHTTTCC----------------------CC--------------------------CCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHhcCCC----------------------CC--------------------------CcccCCHHHHHHHHHHhcC
Confidence 33322211100 00 0123567899999999999
Q ss_pred CCCCCcCHHHHhc
Q 017021 356 DPTDRLTAREALR 368 (379)
Q Consensus 356 dP~~Rpta~e~l~ 368 (379)
||++|||+.|+++
T Consensus 254 ~p~~Rps~~~l~~ 266 (278)
T 1byg_A 254 DAAMRPSFLQLRE 266 (278)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=319.44 Aligned_cols=247 Identities=20% Similarity=0.241 Sum_probs=192.8
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceE----EEEEeec--cchhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMV----AIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~v----AiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
+....|++.++||+|+||.||+|++..+++.+ |+|.+.. .......+.+|+.++..+ .|+|++++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~ 86 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGIC 86 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-----CBTTBCCCCEEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-----CCCCeeEEEEEE
Confidence 45677899999999999999999998888765 6666642 233456677888888877 689999999999
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..+. .+++++++ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++.+
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~----------- 153 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP----------- 153 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-----------
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-----------
Confidence 8765 77888888 999999998754 358999999999999999999999999999999999999544
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 266 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~ 266 (379)
+.++|+|||.+....... ....+|+.|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 154 ----------------~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~ 217 (327)
T 3lzb_A 154 ----------------QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217 (327)
T ss_dssp ----------------TEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ----------------CCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCC
Confidence 456677777665433222 12346778999999999999999999999999999999 99
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||.+....+....+....... . ....+.++.
T Consensus 218 ~p~~~~~~~~~~~~~~~~~~~~----------------------~--------------------------~~~~~~~l~ 249 (327)
T 3lzb_A 218 KPYDGIPASEISSILEKGERLP----------------------Q--------------------------PPICTIDVY 249 (327)
T ss_dssp CTTTTCCGGGHHHHHHTTCCCC----------------------C--------------------------CTTBCHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCC----------------------C--------------------------CccCCHHHH
Confidence 9998766555443332221110 0 123567899
Q ss_pred HHHhhccccCCCCCcCHHHHhc
Q 017021 347 HLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~ 368 (379)
++|.+||+.||.+|||+.|+++
T Consensus 250 ~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 250 MIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=310.61 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=196.5
Q ss_pred eechhhhhhhhccccccceeEEEEEecC---CCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~---~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.+....|++.+.||+|+||.||+|.+.. ++..||+|++... ......+.+|+.++..+ .|+|++++++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~ 82 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-----DHPHIVKLIGII 82 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-----CCTTBCCEEEEE
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-----CCCCcceEEEEE
Confidence 4556788999999999999999998654 3456999998743 23456677899999998 689999999988
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..+ ..|+||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+
T Consensus 83 ~~~-~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~----------- 149 (281)
T 3cc6_A 83 EEE-PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP----------- 149 (281)
T ss_dssp CSS-SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-----------
T ss_pred cCC-CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-----------
Confidence 754 568999999 899999997754 358999999999999999999999999999999999999544
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 267 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~ 267 (379)
+.++|+|||.+....... ....+|+.|+|||.+.+..++.++|||||||++|+|++ |+.
T Consensus 150 ----------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~ 213 (281)
T 3cc6_A 150 ----------------ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213 (281)
T ss_dssp ----------------TEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----------------CcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCC
Confidence 456777777665433322 22346788999999998899999999999999999998 999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||......+....+....... . ....++.+.+
T Consensus 214 p~~~~~~~~~~~~~~~~~~~~----------------------~--------------------------~~~~~~~l~~ 245 (281)
T 3cc6_A 214 PFFWLENKDVIGVLEKGDRLP----------------------K--------------------------PDLCPPVLYT 245 (281)
T ss_dssp TTTTSCGGGHHHHHHHTCCCC----------------------C--------------------------CTTCCHHHHH
T ss_pred CcccCChHHHHHHHhcCCCCC----------------------C--------------------------CCCCCHHHHH
Confidence 998655544443332221110 0 1135678999
Q ss_pred HHhhccccCCCCCcCHHHHhcC
Q 017021 348 LLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~h 369 (379)
+|.+||+.||++|||++|++++
T Consensus 246 li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 246 LMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=319.82 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=201.3
Q ss_pred eechhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
......|++.+.||+|+||.||+|.++ .+++.||+|++.... .....+.+|+.++..+ .|+|++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~ 95 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLLG 95 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-----CCTTBCCEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-----CCCCEeeeEE
Confidence 455678999999999999999999876 467889999997432 2334566788877776 7899999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccc
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 182 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~ 182 (379)
++.+.+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---- 171 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---- 171 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE----
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE----
Confidence 999999999999999 889999997532 1246899999999999999999999999999999999999
Q ss_pred ccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHH
Q 017021 183 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 257 (379)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ 257 (379)
+.++.++|+|||.+....... ....+|+.|+|||.+.+..++.++|||||||
T Consensus 172 -----------------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 228 (322)
T 1p4o_A 172 -----------------------AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228 (322)
T ss_dssp -----------------------CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred -----------------------cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHH
Confidence 455667888888776433221 2235688899999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHH
Q 017021 258 ILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336 (379)
Q Consensus 258 il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (379)
++|+|++ |..||...+..+....+.+... ...
T Consensus 229 il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------~~~------------------------- 261 (322)
T 1p4o_A 229 VLWEIATLAEQPYQGLSNEQVLRFVMEGGL----------------------LDK------------------------- 261 (322)
T ss_dssp HHHHHHHTSCCTTTTSCHHHHHHHHHTTCC----------------------CCC-------------------------
T ss_pred HHHHHHhcCCCccccCCHHHHHHHHHcCCc----------------------CCC-------------------------
Confidence 9999999 8999987665444333222110 000
Q ss_pred hhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 337 ~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
....+..+.++|.+||+.||.+|||+.|+++|
T Consensus 262 -~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 262 -PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12356789999999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=312.77 Aligned_cols=248 Identities=22% Similarity=0.314 Sum_probs=196.1
Q ss_pred eeechhhhhhhh-ccccccceeEEEEE--ecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 38 IVFSAFADKIHS-KMGEGTFGQVLECW--DRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 38 ~~~~~~~y~i~~-~Lg~G~~g~V~~~~--~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
..+....|++.+ .||+|+||.||+|. +..+++.||+|+++... .....+.+|+.++..+ .|+|++++++
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~ 85 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-----DNPYIVRMIG 85 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-----CCTTBCCEEE
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-----CCCCEEEEEE
Confidence 345567788888 99999999999994 45678999999997432 2345677788888887 6899999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
++ ..+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.+
T Consensus 86 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~--------- 153 (291)
T 1xbb_A 86 IC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ--------- 153 (291)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---------
T ss_pred EE-CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC---------
Confidence 98 566789999999 899999998764 68999999999999999999999999999999999999544
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCC------cccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~ 264 (379)
+.++|+|||.+........ ...+|+.|+|||.+.+..++.++||||||+++|+|++
T Consensus 154 ------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 215 (291)
T 1xbb_A 154 ------------------HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215 (291)
T ss_dssp ------------------TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred ------------------CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHh
Confidence 4566666666654333221 1235678999999988888999999999999999999
Q ss_pred -CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchh
Q 017021 265 -GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343 (379)
Q Consensus 265 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (379)
|..||...+..+....+.....+ .. ...++.
T Consensus 216 ~g~~p~~~~~~~~~~~~~~~~~~~----------------------~~--------------------------~~~~~~ 247 (291)
T 1xbb_A 216 YGQKPYRGMKGSEVTAMLEKGERM----------------------GC--------------------------PAGCPR 247 (291)
T ss_dssp TTCCSSTTCCHHHHHHHHHTTCCC----------------------CC--------------------------CTTCCH
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCC----------------------CC--------------------------CCCCCH
Confidence 99999877665544333221100 00 123567
Q ss_pred HHHHHHhhccccCCCCCcCHHHHhc
Q 017021 344 DLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 344 ~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.+.++|.+||+.||.+|||+.++++
T Consensus 248 ~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 248 EMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8999999999999999999999974
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=334.96 Aligned_cols=279 Identities=20% Similarity=0.323 Sum_probs=204.5
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc-
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN- 117 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~- 117 (379)
.+..|++.++||+|+||.||+|+++.+++.||+|+++... .....+.+|+.++..+ .|+|++++++++...+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-----NHKNIVKLFAIEEETTT 81 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECTTT
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-----CCCCCCeEEEeeccCCC
Confidence 4567999999999999999999999999999999997432 2345667899999888 6899999999988654
Q ss_pred -eEEEEEeCC-CCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 118 -HICIVFEKL-GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 118 -~~~lv~e~~-~~sL~~~l~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.||+||||||+||++....
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~------------ 149 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE------------ 149 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECT------------
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecC------------
Confidence 789999999 899999997643 12389999999999999999999999999999999999983321
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC--------CCCCCccchHhHHHHHHHHHh
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG--------LGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG~il~~l~~ 264 (379)
+....++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 150 -----------~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t 218 (396)
T 4eut_A 150 -----------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218 (396)
T ss_dssp -----------TSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred -----------CCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHH
Confidence 345568999999887544432 34578999999999865 457789999999999999999
Q ss_pred CCCCCCCCch-HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchh
Q 017021 265 GEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343 (379)
Q Consensus 265 g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (379)
|+.||..... ......+.+.....|...+..+... .++...|...... ........+.
T Consensus 219 g~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-----~~~~~~~~~~~~~----------------~~~l~~~~~~ 277 (396)
T 4eut_A 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKA-----ENGPIDWSGDMPV----------------SCSLSRGLQV 277 (396)
T ss_dssp SSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECS-----TTCCEEEESSCCT----------------TCSSCHHHHH
T ss_pred CCCCCCCCCcccchHHHHHHHhcCCCcccchhheec-----cCCCcccCccCCc----------------ccccchHHHh
Confidence 9999975322 1111222222222222211111110 0111111110000 0011223567
Q ss_pred HHHHHHhhccccCCCCCcCHHHHhc
Q 017021 344 DLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 344 ~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.+.++|++||+.||++|||++|+++
T Consensus 278 ~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 278 LLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred hchHHHHHhhccChhhhccHHHHHH
Confidence 8999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=310.49 Aligned_cols=248 Identities=19% Similarity=0.250 Sum_probs=193.1
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCc---eEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~---~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
.....|++.++||+|+||.||+|.+..+++ .||+|++.... .....+.+|+.++..+ .|+|++++++++.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~ 92 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-----NHPNVLALIGIML 92 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEEC
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEe
Confidence 444566777999999999999999765544 79999987432 2345667788888887 7899999999998
Q ss_pred ecceE-EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 115 YRNHI-CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 115 ~~~~~-~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
+.+.. +++|||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 93 ~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili-------------- 157 (298)
T 3pls_A 93 PPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML-------------- 157 (298)
T ss_dssp CSSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--------------
T ss_pred cCCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE--------------
Confidence 66554 9999999 999999997743 468999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCC-------CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g 265 (379)
+.++.++|+|||.+..... ......+|+.|+|||.+.+..++.++|||||||++|+|++|
T Consensus 158 -------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 224 (298)
T 3pls_A 158 -------------DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224 (298)
T ss_dssp -------------CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHT
T ss_pred -------------cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhC
Confidence 4455677777777653322 12334678899999999998999999999999999999995
Q ss_pred -CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 266 -EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 266 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
.+||...+..+....+........ ....+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~ 256 (298)
T 3pls_A 225 GAPPYRHIDPFDLTHFLAQGRRLPQ------------------------------------------------PEYCPDS 256 (298)
T ss_dssp SCCTTTTSCGGGHHHHHHTTCCCCC------------------------------------------------CTTCCHH
T ss_pred CCCCCccCCHHHHHHHhhcCCCCCC------------------------------------------------CccchHH
Confidence 555555444443332222111100 1235678
Q ss_pred HHHHHhhccccCCCCCcCHHHHhc
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
+.++|.+||+.||.+|||++++++
T Consensus 257 l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 257 LYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=313.14 Aligned_cols=250 Identities=17% Similarity=0.211 Sum_probs=193.6
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCC---CceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
+......|++.+.||+|+||.||+|.+..+ +..+|+|.++.. ......+.+|+.++.++ .|+|+++++++
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~ 94 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-----SHPNVLSLLGI 94 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-----CCTTBCCCCEE
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-----CCCCEeeeeeE
Confidence 344566789999999999999999987544 346899998742 23345667788888877 68999999998
Q ss_pred -eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 113 -FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 113 -~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
+..++..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~------------ 161 (298)
T 3f66_A 95 CLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML------------ 161 (298)
T ss_dssp ECCSSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------
T ss_pred EEcCCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE------------
Confidence 45667899999999 889999997644 358999999999999999999999999999999999999
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-------CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHH
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 263 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~ 263 (379)
+.++.++|+|||.+...... .....+|+.|+|||.+.+..++.++|||||||++|+|+
T Consensus 162 ---------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 226 (298)
T 3f66_A 162 ---------------DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226 (298)
T ss_dssp ---------------CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ---------------CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 44556777777776543222 12245778899999999989999999999999999999
Q ss_pred h-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccch
Q 017021 264 T-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342 (379)
Q Consensus 264 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (379)
+ |.+||...+..+....+.+...... ....+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~ 258 (298)
T 3f66_A 227 TRGAPPYPDVNTFDITVYLLQGRRLLQ------------------------------------------------PEYCP 258 (298)
T ss_dssp TTSCCSSTTSCTTTHHHHHHTTCCCCC------------------------------------------------CTTCC
T ss_pred hCCCCCCccCCHHHHHHHHhcCCCCCC------------------------------------------------CccCC
Confidence 9 6677766554443333222111110 11356
Q ss_pred hHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 343 GDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 343 ~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
..+.++|.+||+.||.+|||++|+++
T Consensus 259 ~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 259 DPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78999999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=313.84 Aligned_cols=247 Identities=25% Similarity=0.376 Sum_probs=188.6
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+....|++.+.||+|+||.||+|.+. ++.||+|++.. ......+.+|+.++.++ .|+|++++++++.+ ..
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~--~~ 74 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-ESERKAFIVELRQLSRV-----NHPNIVKLYGACLN--PV 74 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-TTHHHHHHHHHHHHHHC-----CCTTBCCEEEBCTT--TT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-hhHHHHHHHHHHHHhcC-----CCCCcCeEEEEEcC--Cc
Confidence 34567889999999999999999864 68899999974 34456778899999888 78999999998864 47
Q ss_pred EEEEeCC-CCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHD---LCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
++||||+ +++|.+++..... ..++...+..++.|++.||.|||+ .|++||||||+||+++.++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~------------ 142 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG------------ 142 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT------------
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC------------
Confidence 9999999 8999999986531 136889999999999999999999 8999999999999995322
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
..++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 143 --------------~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 208 (307)
T 2eva_A 143 --------------TVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG 208 (307)
T ss_dssp --------------TEEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS
T ss_pred --------------CEEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc
Confidence 237888888887655544455799999999999998999999999999999999999999975432
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
...........+..+ . .....+..+.++|.+||+
T Consensus 209 ~~~~~~~~~~~~~~~--------------------~--------------------------~~~~~~~~l~~li~~~l~ 242 (307)
T 2eva_A 209 PAFRIMWAVHNGTRP--------------------P--------------------------LIKNLPKPIESLMTRCWS 242 (307)
T ss_dssp SHHHHHHHHHTTCCC--------------------C--------------------------CBTTCCHHHHHHHHHHTC
T ss_pred cHHHHHHHHhcCCCC--------------------C--------------------------cccccCHHHHHHHHHHhc
Confidence 211110000001100 0 012356789999999999
Q ss_pred cCCCCCcCHHHHhc
Q 017021 355 YDPTDRLTAREALR 368 (379)
Q Consensus 355 ~dP~~Rpta~e~l~ 368 (379)
.||++|||++|+++
T Consensus 243 ~dp~~Rps~~ell~ 256 (307)
T 2eva_A 243 KDPSQRPSMEEIVK 256 (307)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=315.11 Aligned_cols=267 Identities=24% Similarity=0.330 Sum_probs=200.1
Q ss_pred eeeeechhhhhhhhccccccceeEEEEE----ecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEe
Q 017021 36 TYIVFSAFADKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQI 109 (379)
Q Consensus 36 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~----~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~ 109 (379)
....+....|++.++||+|+||.||+|+ +..+++.||+|++.... .....+.+|+.++..+ .|+|++++
T Consensus 14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~ 88 (302)
T 4e5w_A 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-----YHENIVKY 88 (302)
T ss_dssp CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-----CCTTBCCE
T ss_pred ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-----CCCCeeee
Confidence 3344556779999999999999999998 67789999999997432 2345677888888887 68999999
Q ss_pred cceeeec--ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccccc
Q 017021 110 RNWFDYR--NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 186 (379)
Q Consensus 110 ~~~~~~~--~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~ 186 (379)
++++... ...++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.
T Consensus 89 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~------ 161 (302)
T 4e5w_A 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES------ 161 (302)
T ss_dssp EEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE------
T ss_pred eeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcC------
Confidence 9998876 6789999999 889999996643 35899999999999999999999999999999999999954
Q ss_pred CCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHH
Q 017021 187 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 260 (379)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ 260 (379)
++.++|+|||.+....... ....||..|+|||.+.+..++.++|||||||++|
T Consensus 162 ---------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 220 (302)
T 4e5w_A 162 ---------------------EHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220 (302)
T ss_dssp ---------------------TTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred ---------------------CCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHH
Confidence 4456777777765443322 2345788899999999888999999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc
Q 017021 261 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 261 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (379)
+|++|..|+.... .......++....... ............... ...
T Consensus 221 ~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~--------------------------~~~ 267 (302)
T 4e5w_A 221 ELLTYCDSDSSPM-----ALFLKMIGPTHGQMTV--TRLVNTLKEGKRLPC--------------------------PPN 267 (302)
T ss_dssp HHHTTTCGGGSHH-----HHHHHHHCSCCGGGHH--HHHHHHHHTTCCCCC--------------------------CTT
T ss_pred HHHHccCCCcchh-----hHHhhccCCcccccCH--HHHHHHHhccCCCCC--------------------------CCC
Confidence 9999999875321 1122222232222111 011111111111111 124
Q ss_pred chhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 341 SAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
+++.+.++|.+||+.||.+|||++|+++
T Consensus 268 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 268 CPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 6788999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=314.59 Aligned_cols=261 Identities=17% Similarity=0.220 Sum_probs=196.4
Q ss_pred cceeeeeeeeeechhhhhhhhccccccceeEEEEEecC---CCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCC
Q 017021 29 CNMFNLITYIVFSAFADKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKG 102 (379)
Q Consensus 29 ~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~---~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~ 102 (379)
.+..+......+....|++.+.||+|+||.||+|.+.. ++..||+|+++.. ......+.+|+.++..+ .
T Consensus 20 eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~ 94 (313)
T 3brb_A 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-----S 94 (313)
T ss_dssp ----CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-----C
T ss_pred HhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-----C
Confidence 44555566677788899999999999999999998765 5668999998743 22335567788888877 6
Q ss_pred CCeeEEecceeeecc-----eEEEEEeCC-CCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Q 017021 103 GNRCVQIRNWFDYRN-----HICIVFEKL-GSSLYDFLRKN----NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLK 172 (379)
Q Consensus 103 ~~~i~~~~~~~~~~~-----~~~lv~e~~-~~sL~~~l~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlk 172 (379)
|+|++++++++.... ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.|++|||||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dik 174 (313)
T 3brb_A 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLA 174 (313)
T ss_dssp CTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCS
T ss_pred CCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 899999999987654 469999999 88999998542 22468999999999999999999999999999999
Q ss_pred CCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCC
Q 017021 173 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWT 247 (379)
Q Consensus 173 p~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~ 247 (379)
|+||++ +.++.++|+|||.+....... ....+++.|+|||.+.+..++
T Consensus 175 p~NIli---------------------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 227 (313)
T 3brb_A 175 ARNCML---------------------------RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 227 (313)
T ss_dssp GGGEEE---------------------------CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCC
T ss_pred cceEEE---------------------------cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCcc
Confidence 999999 455567777777775433221 223567889999999999999
Q ss_pred CccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhcc
Q 017021 248 YPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 326 (379)
Q Consensus 248 ~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (379)
.++|||||||++|+|++ |..||......+....+...... ..
T Consensus 228 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------~~--------------- 270 (313)
T 3brb_A 228 SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL----------------------KQ--------------- 270 (313)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC----------------------CC---------------
T ss_pred chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC----------------------CC---------------
Confidence 99999999999999999 89999876654443322221100 00
Q ss_pred chhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 327 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
....+..+.++|.+||+.||.+|||+++++++
T Consensus 271 -----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 271 -----------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -----------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12356789999999999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=318.21 Aligned_cols=265 Identities=22% Similarity=0.241 Sum_probs=197.7
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
....|++.+.||+|+||.||+|+++ +++.||+|++.... .....+.+|+.++..+ .|+|++++++++...+..
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFC-----RHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-----CCTTBCCEEEECCCTTCC
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEcCCCeE
Confidence 3457899999999999999999964 68899999987432 2345566787777666 689999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNY--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
++||||+ +++|.+++..... ..+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~------------------ 172 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL------------------ 172 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE------------------
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE------------------
Confidence 9999999 8999999865432 248999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+...... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 173 ---------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~ 243 (321)
T 2qkw_B 173 ---------DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243 (321)
T ss_dssp ---------CTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred ---------CCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccc
Confidence 45567788888877543221 1234689999999999888899999999999999999999999976
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
....+...... ........+.+... +. +.. ........+..+.+++.+
T Consensus 244 ~~~~~~~~~~~----------------~~~~~~~~~~~~~~------------~~-~~~---~~~~~~~~~~~l~~li~~ 291 (321)
T 2qkw_B 244 SLPREMVNLAE----------------WAVESHNNGQLEQI------------VD-PNL---ADKIRPESLRKFGDTAVK 291 (321)
T ss_dssp SSSSSCCCHHH----------------HTHHHHTTTCCCSS------------SS-SSC---TTCSCHHHHHHHHHHHHH
T ss_pred cCcHHHHHHHH----------------HhhhccccccHHHh------------cC-hhh---ccccCHHHHHHHHHHHHH
Confidence 43211100000 00000000000000 00 000 000112356789999999
Q ss_pred ccccCCCCCcCHHHHhcCC
Q 017021 352 LLRYDPTDRLTAREALRHP 370 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp 370 (379)
||+.||++|||++|+++|.
T Consensus 292 ~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 292 CLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HTCSSGGGSCCHHHHHHHH
T ss_pred HcCCCcccCcCHHHHHHHH
Confidence 9999999999999999763
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=312.74 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=188.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
..|++.+.||+|+||.||+|.+..+|+.||+|++... ......+.+|+.++..+ .|+|++++++++...+.
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-----NHPNVIKYYASFIEDNE 106 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEETTE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCc
Confidence 4689999999999999999999999999999998742 23445667788888877 68999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
.++||||+ +++|.+++... ....+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~----------------- 169 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI----------------- 169 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-----------------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE-----------------
Confidence 99999999 88999998752 23468999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++|+|||.+....... ....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 170 ----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 170 ----------TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ----------CTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred ----------cCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 455667788888775433322 2346899999999999989999999999999999999999999754
Q ss_pred ch--HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 273 EN--LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 273 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
.. .+....+... ..+ ..+ ....+.++.++|.
T Consensus 240 ~~~~~~~~~~~~~~--~~~--------------------~~~-------------------------~~~~~~~l~~li~ 272 (310)
T 2wqm_A 240 KMNLYSLCKKIEQC--DYP--------------------PLP-------------------------SDHYSEELRQLVN 272 (310)
T ss_dssp -CCHHHHHHHHHTT--CSC--------------------CCC-------------------------TTTSCHHHHHHHH
T ss_pred chhHHHHHHHhhcc--cCC--------------------CCc-------------------------ccccCHHHHHHHH
Confidence 22 1111111110 000 000 1235678999999
Q ss_pred hccccCCCCCcCHHHHhcC
Q 017021 351 GLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~h 369 (379)
+||+.||++|||+++++++
T Consensus 273 ~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 273 MCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhhCCCHHHHHHH
Confidence 9999999999999999853
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=324.53 Aligned_cols=254 Identities=15% Similarity=0.136 Sum_probs=191.8
Q ss_pred chhhhhhhhccccccceeEEEEEecCC--------CceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEE----
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRER--------KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ---- 108 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~--------~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~---- 108 (379)
....|++.+.||+|+||.||+|++..+ ++.||+|++... ..+.+|+.++.++ .|+|+++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l-----~h~niv~~~~~ 110 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRA-----AKPLQVNKWKK 110 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHH-----CCHHHHHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHh-----cccchhhhhhh
Confidence 356899999999999999999999874 889999999743 3566789998888 4566655
Q ss_pred -----------ecceeee-cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcE
Q 017021 109 -----------IRNWFDY-RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV 176 (379)
Q Consensus 109 -----------~~~~~~~-~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Ni 176 (379)
+++++.. ++..|+||||++++|.+++.......+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred hccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 5566655 6789999999999999999876334699999999999999999999999999999999999
Q ss_pred EEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC----------CCcccccCCccchhhhhCCCC
Q 017021 177 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGW 246 (379)
Q Consensus 177 li~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~ 246 (379)
+++.++ ...++|+|||.+...... .....||+.|+|||++.+..+
T Consensus 191 l~~~~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 245 (352)
T 2jii_A 191 FVDPED-------------------------QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP 245 (352)
T ss_dssp EEETTE-------------------------EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC
T ss_pred EEcCCC-------------------------CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC
Confidence 996443 015666666666432221 123478999999999999899
Q ss_pred CCccchHhHHHHHHHHHhCCCCCCCCc--hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhh
Q 017021 247 TYPCDIWSVGCILVELCTGEALFQTHE--NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 324 (379)
Q Consensus 247 ~~~sDvwSlG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (379)
+.++|||||||++|+|++|..||.... ...............+.. ...
T Consensus 246 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~---------- 295 (352)
T 2jii_A 246 SRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPF--------------------VGP---------- 295 (352)
T ss_dssp CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCE--------------------ECT----------
T ss_pred CchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhh--------------------hhh----------
Confidence 999999999999999999999997643 222222211111111100 000
Q ss_pred ccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 325 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
...+...+..+.++|.+||+.||.+|||++++++
T Consensus 296 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 296 ----------CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp ----------TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ----------ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 0001235788999999999999999999999974
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=319.01 Aligned_cols=254 Identities=21% Similarity=0.281 Sum_probs=198.0
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCc-----eEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKE-----MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~-----~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
..+....|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+|+.++..+ ..|+|+++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~h~~iv~~~ 116 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL----GQHENIVNLL 116 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhh----cCCCCeeeEE
Confidence 44556678999999999999999999877664 79999997432 3345677899998888 2578999999
Q ss_pred ceeeecceEEEEEeCC-CCCHHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEE
Q 017021 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNN------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 177 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~-~~sL~~~l~~~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nil 177 (379)
+++..++..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.|++||||||+||+
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 9999999999999999 889999997532 235799999999999999999999999999999999999
Q ss_pred EecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccch
Q 017021 178 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI 252 (379)
Q Consensus 178 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDv 252 (379)
++.++. ++|+|||.+....... ....||+.|+|||.+.+..++.++||
T Consensus 197 ~~~~~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 249 (333)
T 2i1m_A 197 LTNGHV---------------------------AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249 (333)
T ss_dssp EEGGGE---------------------------EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHH
T ss_pred ECCCCe---------------------------EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHH
Confidence 966554 4555555554322111 22356788999999998899999999
Q ss_pred HhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhH
Q 017021 253 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 331 (379)
Q Consensus 253 wSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (379)
|||||++|+|++ |..||.+....+....+.......+ .
T Consensus 250 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------~-------------------- 288 (333)
T 2i1m_A 250 WSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA---------------------Q-------------------- 288 (333)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC---------------------C--------------------
T ss_pred HHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC---------------------C--------------------
Confidence 999999999998 9999987554333322222111100 0
Q ss_pred HHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 332 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 332 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
....+..+.++|.+||+.||.+|||++|++++
T Consensus 289 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 289 ------PAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 11245689999999999999999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=314.99 Aligned_cols=252 Identities=22% Similarity=0.278 Sum_probs=186.0
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee----cc
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RN 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----~~ 117 (379)
...|++.+.||+|+||.||+|++ +++.||+|++.... ......|.+++.... ..|+|++++++.+.. ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~---l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVM---LRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTC---CCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhh---ccCcCeeeEEEeeccccCCCc
Confidence 45788999999999999999986 68999999997432 344555666665532 278999999988543 45
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCcccCCCCCcEEEecccccccCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--------DLCMIHTDLKPENVLLVSSEYIKVPD 188 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH--------~~~iiH~dlkp~Nili~~~~~~~~~~ 188 (379)
..++||||+ +++|.+++... .+++..+..++.|++.||+||| +.|++||||||+||++
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---------- 146 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---------- 146 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE----------
T ss_pred eeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE----------
Confidence 689999999 88999999654 5999999999999999999999 9999999999999999
Q ss_pred CccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhCC------CCCCccchHhH
Q 017021 189 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL------GWTYPCDIWSV 255 (379)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~sDvwSl 255 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+. .++.++|||||
T Consensus 147 -----------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl 209 (301)
T 3q4u_A 147 -----------------KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209 (301)
T ss_dssp -----------------CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred -----------------cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence 455667778887775332222 224789999999999876 34578999999
Q ss_pred HHHHHHHHhC----------CCCCCCCchH-HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhh
Q 017021 256 GCILVELCTG----------EALFQTHENL-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 324 (379)
Q Consensus 256 G~il~~l~~g----------~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (379)
||++|+|++| ..||...... .....+.+.... .......+.
T Consensus 210 G~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~----------- 261 (301)
T 3q4u_A 210 GLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCV-----------------DQQRPNIPN----------- 261 (301)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT-----------------SCCCCCCCG-----------
T ss_pred HHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhc-----------------cCCCCCCCh-----------
Confidence 9999999999 7777542210 000111110000 000000000
Q ss_pred ccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 325 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.......+..+.++|.+||+.||++|||++|+++
T Consensus 262 ----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 262 ----------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp ----------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ----------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 0112235678999999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=313.87 Aligned_cols=240 Identities=26% Similarity=0.478 Sum_probs=185.6
Q ss_pred hhhhh-hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee----cce
Q 017021 44 ADKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNH 118 (379)
Q Consensus 44 ~y~i~-~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----~~~ 118 (379)
.|.+. +.||+|+||.||+|.++.+++.||+|+++.. ....+|+.++.+. ..|+|++++++++.. ...
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~----~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRA----SQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHH----TTSTTBCCEEEEEEEEETTEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHh----ccCCCchhHHhhhhhhcCCCce
Confidence 35555 7799999999999999999999999999743 3455677777554 267899999999887 778
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.++||||+ +++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---------------- 153 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK---------------- 153 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS----------------
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecC----------------
Confidence 99999999 8899999988765579999999999999999999999999999999999999432
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
..+..++|+|||.+.... +..++.++|||||||++|+|++|..||......+.
T Consensus 154 --------~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 206 (299)
T 3m2w_A 154 --------RPNAILKLTDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206 (299)
T ss_dssp --------STTCCEEECCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------
T ss_pred --------CCCCcEEEeccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh
Confidence 225779999999875322 23467899999999999999999999976443221
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+ ......+.... ....+...+.++.++|.+||+.||
T Consensus 207 ~~~~-------------------~~~~~~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~~dP 245 (299)
T 3m2w_A 207 SPGM-------------------KTRIRMGQYEF----------------------PNPEWSEVSEEVKMLIRNLLKTEP 245 (299)
T ss_dssp -CCS-------------------CCSSCTTCCSS----------------------CHHHHTTSCHHHHHHHHHHTCSST
T ss_pred hHHH-------------------HHHHhhccccC----------------------CchhcccCCHHHHHHHHHHcccCh
Confidence 1000 00000000000 011223567899999999999999
Q ss_pred CCCcCHHHHhcCCCCCCC
Q 017021 358 TDRLTAREALRHPFFTRD 375 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f~~~ 375 (379)
.+|||++|+++||||++.
T Consensus 246 ~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 246 TQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp TTSCCHHHHHTSHHHHTG
T ss_pred hhCCCHHHHhcChhhccc
Confidence 999999999999999765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=320.89 Aligned_cols=265 Identities=23% Similarity=0.278 Sum_probs=198.2
Q ss_pred eechhhhhhhhccccccceeEEEEE----ecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 113 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~----~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~ 113 (379)
.+....|++.+.||+|+||.||+|+ +..+++.||+|++.... .....+.+|+.++..+ .|+|++.+++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~ 93 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-----HSDFIVKYRGVS 93 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEE
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-----CCCceeEEEEEE
Confidence 4567788999999999999999998 57789999999997442 3345577899888887 779999999887
Q ss_pred e--ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 114 D--YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 114 ~--~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
. .....++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++.+
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~--------- 163 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE--------- 163 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---------
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC---------
Confidence 6 456799999999 999999997743 258999999999999999999999999999999999999544
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~ 264 (379)
+.++|+|||.+....... ....||..|+|||.+.+..++.++|||||||++|+|++
T Consensus 164 ------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~ 225 (327)
T 3lxl_A 164 ------------------AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225 (327)
T ss_dssp ------------------TEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred ------------------CCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHh
Confidence 456666776665433222 22357888999999998889999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|..||........... ......+. . ............... ...+++.
T Consensus 226 g~~p~~~~~~~~~~~~--~~~~~~~~--~---~~~~~~~~~~~~~~~--------------------------~~~~~~~ 272 (327)
T 3lxl_A 226 YCDKSCSPSAEFLRMM--GCERDVPA--L---SRLLELLEEGQRLPA--------------------------PPACPAE 272 (327)
T ss_dssp TTCGGGSHHHHHHHHC--C----CCH--H---HHHHHHHHTTCCCCC--------------------------CTTCCHH
T ss_pred CCCCCccccchhhhhc--cccccccc--H---HHHHHHhhcccCCCC--------------------------CCcccHH
Confidence 9999875332111100 00000000 0 000011111111111 1246788
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+.++|.+||+.||.+|||++|++++
T Consensus 273 l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 273 VHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=315.62 Aligned_cols=269 Identities=19% Similarity=0.201 Sum_probs=198.1
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch--hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
....-.|++.+.||+|+||.||+|++. +++.||+|++..... ....+.+|+.++..+ .|+|++++++++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMA-----VHRNLLRLRGFCMTP 99 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTC-----CCTTBCCCCEEECCS
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhc-----cCCCccceEEEEecC
Confidence 345567899999999999999999854 588999999874321 223566787777666 689999999999999
Q ss_pred ceEEEEEeCC-CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccCCCCCcEEEecccccccCCCc
Q 017021 117 NHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDL---CMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
+..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||+. |++||||||+||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~------------ 167 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL------------ 167 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE------------
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE------------
Confidence 9999999999 889999998653 22489999999999999999999999 99999999999999
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCC
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 168 ---------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 232 (326)
T 3uim_A 168 ---------------DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232 (326)
T ss_dssp ---------------CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCC
T ss_pred ---------------CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCC
Confidence 555678888888876543322 2245899999999998888999999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||...... ....... ................. . . ..........+..+.
T Consensus 233 ~pf~~~~~~----------~~~~~~~----~~~~~~~~~~~~~~~~~------------~-~---~~~~~~~~~~~~~l~ 282 (326)
T 3uim_A 233 RAFDLARLA----------NDDDVML----LDWVKGLLKEKKLEALV------------D-V---DLQGNYKDEEVEQLI 282 (326)
T ss_dssp CSBCHHHHT----------TTSCSBH----HHHHTTTTSSCCSTTSS------------C-T---TCTTSCCHHHHHHHH
T ss_pred Ccccccccc----------cccchhH----HHHHHHHhhchhhhhhc------------C-h---hhccccCHHHHHHHH
Confidence 999621100 0000000 00000000000000000 0 0 000011223567899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHP 370 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp 370 (379)
+++.+||+.||.+|||++|+++|-
T Consensus 283 ~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 283 QVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp HHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred HHHHHHhCcCCccCCCHHHHHHHh
Confidence 999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=313.69 Aligned_cols=261 Identities=19% Similarity=0.253 Sum_probs=200.4
Q ss_pred cceeeeeeeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeE
Q 017021 29 CNMFNLITYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCV 107 (379)
Q Consensus 29 ~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~ 107 (379)
.+.......+.+....|++.+.||+|+||.||+|++..+++.||+|++... ......+.+|+.++..+ .|+|++
T Consensus 15 ~~~~~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv 89 (317)
T 2buj_A 15 ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-----NHPNIL 89 (317)
T ss_dssp -CCSEEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-----CCTTBC
T ss_pred cceeecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-----CCCCee
Confidence 344455677778888999999999999999999999999999999998643 33455667788888877 789999
Q ss_pred Eecceee----ecceEEEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEec
Q 017021 108 QIRNWFD----YRNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 180 (379)
Q Consensus 108 ~~~~~~~----~~~~~~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~ 180 (379)
++++++. .....++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~-- 167 (317)
T 2buj_A 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL-- 167 (317)
T ss_dssp CCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--
T ss_pred eEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--
Confidence 9999886 345789999999 88999999762 22468999999999999999999999999999999999999
Q ss_pred ccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC------------CcccccCCccchhhhhCCC---
Q 017021 181 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------------NYIVSTRHYRAPEVILGLG--- 245 (379)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------------~~~~gt~~y~aPE~~~~~~--- 245 (379)
+.++.++|+|||.+....... ....||+.|+|||.+.+..
T Consensus 168 -------------------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 222 (317)
T 2buj_A 168 -------------------------GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222 (317)
T ss_dssp -------------------------CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEE
T ss_pred -------------------------cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcC
Confidence 455667888888765433211 1234689999999987654
Q ss_pred CCCccchHhHHHHHHHHHhCCCCCCCCchH--HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhh
Q 017021 246 WTYPCDIWSVGCILVELCTGEALFQTHENL--EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 323 (379)
Q Consensus 246 ~~~~sDvwSlG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (379)
++.++|||||||++|+|++|..||...... .....+. . ....+
T Consensus 223 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-----------------------~-~~~~~----------- 267 (317)
T 2buj_A 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-----------------------N-QLSIP----------- 267 (317)
T ss_dssp ECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH-----------------------C-C--CC-----------
T ss_pred CCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh-----------------------c-cCCCC-----------
Confidence 689999999999999999999999531100 0000000 0 00000
Q ss_pred hccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 324 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.....+..+.++|.+||+.||.+|||+++++++
T Consensus 268 -------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 268 -------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 012356789999999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=309.45 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=186.4
Q ss_pred eeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
..+..-.|++.++||+|+||.||+|++.. .||+|+++.. ......+.+|+.++..+ .|+|++.++++.
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~- 89 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-----RHVNILLFMGYS- 89 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEE-
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-----CCCcEEEEEeec-
Confidence 34566789999999999999999998643 4999998643 23345567788888777 789999999854
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
.....++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~------------- 155 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE------------- 155 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET-------------
T ss_pred cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC-------------
Confidence 556789999999 899999996543 36899999999999999999999999999999999999954
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhh---CCCCCCccchHhHHHHHHHHHhC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~~l~~g 265 (379)
++.++|+|||.+...... .....||+.|+|||.+. +..++.++|||||||++|+|++|
T Consensus 156 --------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 221 (289)
T 3og7_A 156 --------------DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221 (289)
T ss_dssp --------------TTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHS
T ss_pred --------------CCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHC
Confidence 455777777776533221 12346899999999986 55688899999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHH
Q 017021 266 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345 (379)
Q Consensus 266 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (379)
+.||......+............+. . ......++..+
T Consensus 222 ~~p~~~~~~~~~~~~~~~~~~~~~~--------------------~-----------------------~~~~~~~~~~l 258 (289)
T 3og7_A 222 QLPYSNINNRDQIIEMVGRGSLSPD--------------------L-----------------------SKVRSNCPKRM 258 (289)
T ss_dssp SCTTSSCCCHHHHHHHHHHTSCCCC--------------------T-----------------------TSSCTTSCHHH
T ss_pred CCCccccchHHHHHHHhcccccCcc--------------------h-----------------------hhccccCCHHH
Confidence 9999876554433322221111000 0 00112456789
Q ss_pred HHHHhhccccCCCCCcCHHHHhc
Q 017021 346 THLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 346 ~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.++|.+||+.||.+|||++|+++
T Consensus 259 ~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 259 KRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=345.50 Aligned_cols=278 Identities=24% Similarity=0.302 Sum_probs=204.1
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-----
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----- 115 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----- 115 (379)
..|++.++||+|+||.||+|.+..+|+.||+|++... ......+.+|+.++..+ .|+|++.+++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-----NHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-----CBTTBCCEEECCTTTCCCC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-----CCCCCCceeeeeccccccc
Confidence 4689999999999999999999999999999998642 33455677899999988 68999999888765
Q ss_pred -cceEEEEEeCC-CCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 116 -RNHICIVFEKL-GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 116 -~~~~~lv~e~~-~~sL~~~l~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
++..|+||||+ +++|.+++.... ...+++..+..++.|++.||.|||+.||+||||||+||+++.++
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g---------- 158 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP---------- 158 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS----------
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC----------
Confidence 67889999999 999999998743 23588999999999999999999999999999999999996432
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
....++|+|||.+....... ....||+.|+|||.+.+..++.++|||||||++|+|++|..||.
T Consensus 159 --------------~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 159 --------------QRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp --------------SSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------CceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 23458899999887654433 34578999999999998899999999999999999999999997
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
....... ........... .........+...+.... .. ........+..+.++|.
T Consensus 225 ~~~~~~~------~~~~i~~~~~~---~~~~~~~l~g~~~~~~~l----------p~------p~~l~~~ls~~L~dLI~ 279 (676)
T 3qa8_A 225 PNWQPVQ------WHGKVREKSNE---HIVVYDDLTGAVKFSSVL----------PT------PNHLSGILAGKLERWLQ 279 (676)
T ss_dssp SSCHHHH------SSTTCC---------CCSCCCCSSSCCCCSSS----------CC------SCCCCGGGHHHHHHHHH
T ss_pred cccchhh------hhhhhhcccch---hhhhhhhhcccccccccc----------CC------chhhchhhhHHHHHHHH
Confidence 6433211 00000000000 000000001111111100 00 01122346788999999
Q ss_pred hccccCCCCCcCHHHHhcCCCCCC
Q 017021 351 GLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
+||+.||++|||++|+++||||++
T Consensus 280 ~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 280 CMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp HHSCSSCC---CCTTCCCCTTHHH
T ss_pred HHccCCHhhCcCHHHHhcCHHHHH
Confidence 999999999999999999999964
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=314.29 Aligned_cols=266 Identities=26% Similarity=0.328 Sum_probs=199.3
Q ss_pred eeeeeeechhhhhhhhccccccceeEEEEE----ecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeE
Q 017021 34 LITYIVFSAFADKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCV 107 (379)
Q Consensus 34 ~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~----~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~ 107 (379)
+.....+....|++.++||+|+||.||++. +..+++.||+|+++... .....+.+|+.++..+ .|+|++
T Consensus 22 pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv 96 (318)
T 3lxp_A 22 PGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-----YHEHII 96 (318)
T ss_dssp --CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-----CCTTBC
T ss_pred CCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-----CCcchh
Confidence 344556777777999999999999997764 45678999999997532 3345677899999888 689999
Q ss_pred Eecceeee--cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccc
Q 017021 108 QIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 184 (379)
Q Consensus 108 ~~~~~~~~--~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 184 (379)
++++++.+ ...+++||||+ +++|.+++.... +++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~------ 167 (318)
T 3lxp_A 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL------ 167 (318)
T ss_dssp CEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------
T ss_pred hEEEEEecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE------
Confidence 99999987 46899999999 889999997754 8999999999999999999999999999999999999
Q ss_pred ccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHH
Q 017021 185 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 258 (379)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~i 258 (379)
+.++.++|+|||.+....... ....+|..|+|||.+.+..++.++|||||||+
T Consensus 168 ---------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 226 (318)
T 3lxp_A 168 ---------------------DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226 (318)
T ss_dssp ---------------------CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred ---------------------cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHH
Confidence 455667888888776544332 22357788999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccC-CCCCCCCCCchhhhhhhccchhhHHHHHHh
Q 017021 259 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQH 337 (379)
Q Consensus 259 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (379)
+|+|++|..||....... ....+...... .. .. .......+ ... .
T Consensus 227 l~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~-~~-~~-~~~~~~~~~~~~--------------------------~ 272 (318)
T 3lxp_A 227 LYELLTHCDSSQSPPTKF-----LELIGIAQGQM-TV-LR-LTELLERGERLP--------------------------R 272 (318)
T ss_dssp HHHHHTTTCGGGSHHHHH-----HHHHCSCCHHH-HH-HH-HHHHHHTTCCCC--------------------------C
T ss_pred HHHHHhCCCcccccchhh-----hhhhcccccch-hH-HH-HHHHHhcccCCC--------------------------C
Confidence 999999999997532211 00111111000 00 00 00011110 111 1
Q ss_pred hccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 338 ~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
...++..+.+||.+||+.||.+|||++|+++
T Consensus 273 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 273 PDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1246788999999999999999999999984
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=315.01 Aligned_cols=250 Identities=21% Similarity=0.271 Sum_probs=184.8
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec----c
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR----N 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~----~ 117 (379)
...|++.++||+|+||.||+|++. ++.||+|++.... ......|.+++... ...|+|++++++++... .
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~e~~~~~~~---~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE--EASWFRETEIYQTV---LMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG--HHHHHHHHHHHTST---TCCCTTBCCEEEEEEESCGGGC
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc--cchhhhHHHHHHHH---hhcCCCeeeEEEEEccCCCCCC
Confidence 357899999999999999999875 8999999997443 23334444444332 13789999999998876 7
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCcccCCCCCcEEEecccccccCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL--------CMIHTDLKPENVLLVSSEYIKVPD 188 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------~iiH~dlkp~Nili~~~~~~~~~~ 188 (379)
..++||||+ +++|.+++... .+++..+..++.|++.||+|||+. |++||||||+||++
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---------- 175 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---------- 175 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE----------
T ss_pred ceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE----------
Confidence 899999999 88999999775 499999999999999999999998 99999999999999
Q ss_pred CccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhCCCCCCc------cchHhH
Q 017021 189 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTYP------CDIWSV 255 (379)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~------sDvwSl 255 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+...+.. +|||||
T Consensus 176 -----------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 176 -----------------KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp -----------------CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred -----------------CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 455567777887775433222 23478999999999988776655 999999
Q ss_pred HHHHHHHHhC----------CCCCCCCch----HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhh
Q 017021 256 GCILVELCTG----------EALFQTHEN----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI 321 (379)
Q Consensus 256 G~il~~l~~g----------~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (379)
||++|+|++| ..||..... ............ .....+.
T Consensus 239 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~-------- 290 (337)
T 3mdy_A 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK--------------------LRPSFPN-------- 290 (337)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC--------------------CCCCCCG--------
T ss_pred HHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhc--------------------cCccccc--------
Confidence 9999999999 555543211 000000000000 0000000
Q ss_pred hhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 322 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
....+.++..+.++|.+||+.||++|||++|+++|
T Consensus 291 -------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 291 -------------RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp -------------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred -------------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 00112356789999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.23 Aligned_cols=254 Identities=26% Similarity=0.336 Sum_probs=204.7
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.+....|++.++||+|+||.||+|.+.. +..||||+++........+.+|+.++..+ .|+||+++++++.. +.
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SS
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhC-----CCCCEeeEEEEEee-cc
Confidence 4566788999999999999999999875 45699999986555567788999999998 78999999998876 67
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~------------------ 397 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG------------------ 397 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC------------------
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc------------------
Confidence 89999999 88999999764334589999999999999999999999999999999999994
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCC----CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 272 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~ 272 (379)
.+..+||+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 398 ---------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 398 ---------ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp ---------GGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred ---------CCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4456777777777644321 122346778999999998899999999999999999999 99999887
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
...+....+.+.... .. ...++..+.+||.+|
T Consensus 469 ~~~~~~~~i~~~~~~----------------------~~--------------------------~~~~~~~l~~li~~c 500 (535)
T 2h8h_A 469 VNREVLDQVERGYRM----------------------PC--------------------------PPECPESLHDLMCQC 500 (535)
T ss_dssp CHHHHHHHHHTTCCC----------------------CC--------------------------CTTCCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCC----------------------CC--------------------------CCCCCHHHHHHHHHH
Confidence 665554443322110 00 123567899999999
Q ss_pred cccCCCCCcCHHHHhcC--CCCCC
Q 017021 353 LRYDPTDRLTAREALRH--PFFTR 374 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~h--p~f~~ 374 (379)
|+.||++|||++++++. .+|..
T Consensus 501 l~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 501 WRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred cCCChhHCcCHHHHHHHHHHHhhc
Confidence 99999999999999864 45543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=310.26 Aligned_cols=257 Identities=24% Similarity=0.336 Sum_probs=194.4
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc-----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.|...++||+|+||.||+|.+ +++.||+|++... ......+.+|+.++..+ .|+|++++++++...+.
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 104 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-----QHENLVELLGFSSDGDD 104 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSS
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEecCCc
Confidence 455668999999999999985 5789999998642 23345677899998888 68999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
.++||||+ +++|.+++... ....+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili------------------ 166 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL------------------ 166 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE------------------
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE------------------
Confidence 99999999 99999999753 22358999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.++|+|||.+....... ....||+.|+|||.+.+ .++.++||||||+++|+|++|..||..
T Consensus 167 ---------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~ 236 (307)
T 2nru_A 167 ---------DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE 236 (307)
T ss_dssp ---------CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred ---------cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence 455667788888775433321 23468999999999876 478999999999999999999999986
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.........+.+........ ...+..... .......+..+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~ 282 (307)
T 2nru_A 237 HREPQLLLDIKEEIEDEEKT--------IEDYIDKKM--------------------------NDADSTSVEAMYSVASQ 282 (307)
T ss_dssp TBSSSBTTHHHHHHHTTSCC--------HHHHSCSSC--------------------------SCCCHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHhhhhhhh--------hhhhccccc--------------------------cccchHHHHHHHHHHHH
Confidence 54322221111111000000 000000000 00112345679999999
Q ss_pred ccccCCCCCcCHHHHhcC
Q 017021 352 LLRYDPTDRLTAREALRH 369 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~h 369 (379)
||+.||.+|||+++++++
T Consensus 283 cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 283 CLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HTCSSTTTSCCHHHHHHH
T ss_pred HcCCCcccCcCHHHHHHH
Confidence 999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=321.73 Aligned_cols=249 Identities=17% Similarity=0.197 Sum_probs=187.1
Q ss_pred echhhhhhhhccccccceeEEEEEecCC---CceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEeccee-
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF- 113 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~- 113 (379)
.....|++.+.||+|+||.||+|.+..+ +..||+|.++.. ......+.+|+.++.++ .|+|++++++++
T Consensus 86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~ 160 (373)
T 3c1x_A 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-----SHPNVLSLLGICL 160 (373)
T ss_dssp STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-----CCTTBCCCCEEEC
T ss_pred hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEE
Confidence 3445678889999999999999987543 346899998642 23345667788877776 789999999975
Q ss_pred eecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 114 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 114 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
..++..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll-------------- 225 (373)
T 3c1x_A 161 RSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML-------------- 225 (373)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--------------
T ss_pred cCCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE--------------
Confidence 4567889999999 889999997654 358899999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT- 264 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~- 264 (379)
+.++.++|+|||.+....... ....+|+.|+|||.+.+..++.++|||||||++|+|++
T Consensus 226 -------------~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~ 292 (373)
T 3c1x_A 226 -------------DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 292 (373)
T ss_dssp -------------CTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred -------------CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 445567777777765432221 22356788999999999899999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|.+||...+..+....+.+.... .. ...++..
T Consensus 293 ~~~p~~~~~~~~~~~~~~~~~~~----------------------~~--------------------------p~~~~~~ 324 (373)
T 3c1x_A 293 GAPPYPDVNTFDITVYLLQGRRL----------------------LQ--------------------------PEYCPDP 324 (373)
T ss_dssp SCCSCTTSCSSCHHHHHHTTCCC----------------------CC--------------------------CTTCCHH
T ss_pred cCCCCCCCCHHHHHHHHHcCCCC----------------------CC--------------------------CCCCCHH
Confidence 78888765543333222211100 00 1135678
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+.++|.+||+.||++|||++|++++
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=319.84 Aligned_cols=275 Identities=20% Similarity=0.211 Sum_probs=186.2
Q ss_pred eechhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee----
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD---- 114 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~---- 114 (379)
.+....|++.+.||+|+||.||+|++ +++.||+|++..... .....|.++... ....|+|++++++.+.
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~~---~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIYRV---PLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHHTS---TTCCCTTBCCEEEEEEEECT
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHHHH---HhccCcchhhheeccccccc
Confidence 45566789999999999999999975 689999999974432 233333333221 1237899999987443
Q ss_pred -ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCcccCCCCCcEEEecccc
Q 017021 115 -YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL---------CMIHTDLKPENVLLVSSEY 183 (379)
Q Consensus 115 -~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---------~iiH~dlkp~Nili~~~~~ 183 (379)
.....++||||+ +++|.+++.... .++..+..++.||+.||.|||+. ||+||||||+||+++
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~---- 154 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK---- 154 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC----
T ss_pred CCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc----
Confidence 334689999999 899999998764 68899999999999999999999 999999999999994
Q ss_pred cccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-----------CCcccccCCccchhhhhC-------CC
Q 017021 184 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----------QNYIVSTRHYRAPEVILG-------LG 245 (379)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-------~~ 245 (379)
.++.++|+|||.+...... .....||+.|+|||++.+ ..
T Consensus 155 -----------------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 211 (336)
T 3g2f_A 155 -----------------------NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES 211 (336)
T ss_dssp -----------------------TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHH
T ss_pred -----------------------CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccc
Confidence 4456777777776543221 123468999999999976 34
Q ss_pred CCCccchHhHHHHHHHHHhCCCCCCCCch-HHHHHHHHHHcCCCChh-HHHhhhhhhhhhhccCCCCCCCCCCchhhhhh
Q 017021 246 WTYPCDIWSVGCILVELCTGEALFQTHEN-LEHLAMMERVLGPLPQH-MLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 323 (379)
Q Consensus 246 ~~~~sDvwSlG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (379)
++.++|||||||++|+|++|..||..... .+.........+..|.. .... ... .......+++...
T Consensus 212 ~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--~~~~~~~~~~~~~------- 279 (336)
T 3g2f_A 212 ALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQV---LVS--REKQRPKFPEAWK------- 279 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHH---HHT--TSCCCCCCCTTCC-------
T ss_pred cccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHh---hhc--ccccCCCCCcccc-------
Confidence 66789999999999999999766643221 11111111111111111 0000 000 0001111111100
Q ss_pred hccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHH------hcCCCCCCC
Q 017021 324 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA------LRHPFFTRD 375 (379)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~------l~hp~f~~~ 375 (379)
.....+..+.+||.+||+.||++|||++|+ +.++|-+++
T Consensus 280 -------------~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 280 -------------ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp -------------CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred -------------cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 011245679999999999999999999999 556776654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=308.02 Aligned_cols=251 Identities=21% Similarity=0.261 Sum_probs=190.7
Q ss_pred eeechhhhhhhhccccccceeEEEEEecC-CC--ceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 38 IVFSAFADKIHSKMGEGTFGQVLECWDRE-RK--EMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 38 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~-~~--~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
..+....|++.+.||+|+||.||+|.+.. ++ ..||+|+++.. ......+.+|+.++..+ .|+|+++++
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~ 87 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-----DHRNLIRLY 87 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-----CCCCcccEE
Confidence 34566789999999999999999998643 33 36999998742 23445677888888887 689999999
Q ss_pred ceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCC
Q 017021 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
+++..+. .++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+
T Consensus 88 ~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-------- 157 (291)
T 1u46_A 88 GVVLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-------- 157 (291)
T ss_dssp EEECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET--------
T ss_pred EEEccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC--------
Confidence 9998765 88999999 899999997643 258999999999999999999999999999999999999544
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHH
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 263 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~ 263 (379)
+.++|+|||.+....... ....+|..|+|||.+.+..++.++||||||+++|+|+
T Consensus 158 -------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 218 (291)
T 1u46_A 158 -------------------DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218 (291)
T ss_dssp -------------------TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred -------------------CCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHH
Confidence 456667777665433322 1235677899999999888899999999999999999
Q ss_pred h-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccch
Q 017021 264 T-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342 (379)
Q Consensus 264 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (379)
+ |..||...+..+....+.......+ .....+
T Consensus 219 ~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~ 251 (291)
T 1u46_A 219 TYGQEPWIGLNGSQILHKIDKEGERLP-----------------------------------------------RPEDCP 251 (291)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTSCCCCC-----------------------------------------------CCTTCC
T ss_pred hCCCCCcccCCHHHHHHHHHccCCCCC-----------------------------------------------CCcCcC
Confidence 9 9999988766554443322111111 012356
Q ss_pred hHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 343 GDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 343 ~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
..+.++|.+||+.||++|||+++++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 789999999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=332.07 Aligned_cols=253 Identities=17% Similarity=0.184 Sum_probs=186.4
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCC-----------CCCe
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDK-----------GGNR 105 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~-----------~~~~ 105 (379)
....|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+|..++..+.+... ....
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3445778899999999999999999999999999987322 223455667776665533110 0001
Q ss_pred eEEe------cceeee-----cceEEEEEeCCCCCHHHHHHh-----CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCccc
Q 017021 106 CVQI------RNWFDY-----RNHICIVFEKLGSSLYDFLRK-----NNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 169 (379)
Q Consensus 106 i~~~------~~~~~~-----~~~~~lv~e~~~~sL~~~l~~-----~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~ 169 (379)
++.+ ...+.. ....+++|++++++|.+++.. .....+++..+..++.||+.||+|||+.||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111 111111 234788999999999999852 222357788999999999999999999999999
Q ss_pred CCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhh--------
Q 017021 170 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVI-------- 241 (379)
Q Consensus 170 dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~-------- 241 (379)
||||+|||+ +.++.+||+|||++...........| +.|+|||++
T Consensus 236 DiKp~NILl---------------------------~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~ 287 (413)
T 3dzo_A 236 YLRPVDIVL---------------------------DQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFG 287 (413)
T ss_dssp CCCGGGEEE---------------------------CTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTG
T ss_pred CcccceEEE---------------------------ecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccc
Confidence 999999999 55566888888888765555455677 999999999
Q ss_pred --hCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchh
Q 017021 242 --LGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 319 (379)
Q Consensus 242 --~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (379)
.+..++.++|||||||++|+|++|+.||...+..+... ..
T Consensus 288 ~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~----------------------~~---------------- 329 (413)
T 3dzo_A 288 QHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE----------------------WI---------------- 329 (413)
T ss_dssp GGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG----------------------GG----------------
T ss_pred cccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH----------------------HH----------------
Confidence 44457889999999999999999999997644311000 00
Q ss_pred hhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 320 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
.......+..+.+||.+||+.||++|||+.|+++||||++
T Consensus 330 ---------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 330 ---------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp ---------------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ---------------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 0001135678999999999999999999999999999964
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=320.78 Aligned_cols=217 Identities=21% Similarity=0.265 Sum_probs=172.9
Q ss_pred eeeeeechhhhhhhhccccccceeEEEE-----EecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEe
Q 017021 35 ITYIVFSAFADKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 109 (379)
Q Consensus 35 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~-----~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~ 109 (379)
..-+.+....|++.++||+|+||.||+| .+..+++.||+|+++.. ....+..|..++..+.. ..|++++.+
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~--~~~~~iv~~ 132 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKP--SMQHMFMKF 132 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCG--GGGGGBCCE
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhh--hhhhhhhhh
Confidence 3445667788999999999999999999 46778999999999744 34456778888887742 247899999
Q ss_pred cceeeecceEEEEEeCC-CCCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccc
Q 017021 110 RNWFDYRNHICIVFEKL-GSSLYDFLRKN---NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 185 (379)
Q Consensus 110 ~~~~~~~~~~~lv~e~~-~~sL~~~l~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~ 185 (379)
++.+...+..|+||||+ +++|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++......
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence 99999999999999999 89999999752 234699999999999999999999999999999999999995421000
Q ss_pred cCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCC-----CCCcccccCCccchhhhhCCCCCCccchHhHHHHHH
Q 017021 186 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 260 (379)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ 260 (379)
. ......+.++|+|||.+..... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 213 ------------~----~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 276 (365)
T 3e7e_A 213 ------------D----DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVY 276 (365)
T ss_dssp ----------------------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHH
T ss_pred ------------c----ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHH
Confidence 0 0013367899999999854321 113457999999999999999999999999999999
Q ss_pred HHHhCCCCCCC
Q 017021 261 ELCTGEALFQT 271 (379)
Q Consensus 261 ~l~~g~~pf~~ 271 (379)
+|++|+.||..
T Consensus 277 elltg~~pf~~ 287 (365)
T 3e7e_A 277 CMLFGTYMKVK 287 (365)
T ss_dssp HHHHSSCCCEE
T ss_pred HHHhCCCcccc
Confidence 99999999964
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=307.60 Aligned_cols=274 Identities=23% Similarity=0.298 Sum_probs=197.1
Q ss_pred cceeeeeeeeeechhhhhhhhccccccceeEEEEE----ecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCC
Q 017021 29 CNMFNLITYIVFSAFADKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGG 103 (379)
Q Consensus 29 ~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~----~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~ 103 (379)
...+.......+....|++.+.||+|+||.||+|+ +..+++.||+|++... ......+.+|+.++..+ .|
T Consensus 27 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h 101 (326)
T 2w1i_A 27 GSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-----QH 101 (326)
T ss_dssp ----------CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-----CC
T ss_pred HHHhcccCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CC
Confidence 33444445566778889999999999999999998 5678999999999743 23345677888888887 67
Q ss_pred CeeEEecceeeec--ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEec
Q 017021 104 NRCVQIRNWFDYR--NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 180 (379)
Q Consensus 104 ~~i~~~~~~~~~~--~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~ 180 (379)
+|++++++++... ...++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.
T Consensus 102 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~ 180 (326)
T 2w1i_A 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN 180 (326)
T ss_dssp TTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE
T ss_pred CCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcC
Confidence 9999999987654 3789999999 889999998764 35899999999999999999999999999999999999954
Q ss_pred ccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHh
Q 017021 181 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWS 254 (379)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwS 254 (379)
+ +.++|+|||.+....... ....++..|+|||.+.+..++.++||||
T Consensus 181 ~---------------------------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 233 (326)
T 2w1i_A 181 E---------------------------NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWS 233 (326)
T ss_dssp T---------------------------TEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHH
T ss_pred C---------------------------CcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHH
Confidence 4 456666666665433322 1234677899999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCCh-hHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHH
Q 017021 255 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ-HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 333 (379)
Q Consensus 255 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (379)
|||++|+|++|..|+..... + ..+..+..+. .... ....+........+.
T Consensus 234 lG~il~el~tg~~~~~~~~~-~----~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~---------------------- 284 (326)
T 2w1i_A 234 FGVVLYELFTYIEKSKSPPA-E----FMRMIGNDKQGQMIV--FHLIELLKNNGRLPR---------------------- 284 (326)
T ss_dssp HHHHHHHHHHTTCGGGSHHH-H----HHHHHCTTCCTHHHH--HHHHHHHHTTCCCCC----------------------
T ss_pred HHHHHHHHHhcCCCCCCCHH-H----HHHhhccccchhhhH--HHHHHHhhcCCCCCC----------------------
Confidence 99999999999998864211 1 1111111111 1100 000000111111111
Q ss_pred HHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 334 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 334 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
...++..+.++|.+||+.||++|||+.|+++
T Consensus 285 ----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 285 ----PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp ----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1246678999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=334.31 Aligned_cols=237 Identities=23% Similarity=0.325 Sum_probs=190.3
Q ss_pred hccccccceeEEEEEe--cCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 49 SKMGEGTFGQVLECWD--RERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~--~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
++||+|+||.||+|.+ +.+++.||+|+++... .....+.+|+.++..+ .|+||++++++++. +..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~-~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-----DNPYIVRMIGICEA-ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-----CCTTBCCEEEEEES-SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEec-CCEEEEE
Confidence 3799999999999954 4667899999997432 2346778899999998 78999999999865 4588999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus 449 E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~---------------------- 504 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT---------------------- 504 (635)
T ss_dssp ECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE----------------------
T ss_pred EccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeC----------------------
Confidence 999 899999998754 6899999999999999999999999999999999999954
Q ss_pred ccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 275 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~ 275 (379)
++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 505 -----~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 579 (635)
T 4fl3_A 505 -----QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 579 (635)
T ss_dssp -----TTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred -----CCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 4456777777765433221 12246788999999999899999999999999999998 99999987776
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.+..... . ...++.++.+||.+||+.
T Consensus 580 ~~~~~i~~~~~~~----------------------~--------------------------p~~~~~~l~~li~~cl~~ 611 (635)
T 4fl3_A 580 EVTAMLEKGERMG----------------------C--------------------------PAGCPREMYDLMNLCWTY 611 (635)
T ss_dssp HHHHHHHTTCCCC----------------------C--------------------------CTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHcCCCCC----------------------C--------------------------CCCCCHHHHHHHHHHcCC
Confidence 6555443321110 0 123567899999999999
Q ss_pred CCCCCcCHHHHhc
Q 017021 356 DPTDRLTAREALR 368 (379)
Q Consensus 356 dP~~Rpta~e~l~ 368 (379)
||++|||++++++
T Consensus 612 dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 612 DVENRPGFAAVEL 624 (635)
T ss_dssp STTTSCCHHHHHH
T ss_pred CHhHCcCHHHHHH
Confidence 9999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=331.14 Aligned_cols=244 Identities=24% Similarity=0.316 Sum_probs=191.0
Q ss_pred hhhhhhh-ccccccceeEEEEEec--CCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 43 FADKIHS-KMGEGTFGQVLECWDR--ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 43 ~~y~i~~-~Lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
..+.+.+ +||+|+||.||+|.++ .++..||||+++.. ......+.+|+.++..+ .|+||+++++++.. +
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-----~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPYIVRLIGVCQA-E 408 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-----CCTTBCCEEEEEES-S
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEecc-C
Confidence 3344445 7999999999999876 45677999999753 23456778899988887 78999999999876 5
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-------------- 473 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-------------- 473 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--------------
T ss_pred CeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC--------------
Confidence 699999999 899999997653 3689999999999999999999999999999999999995544
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 269 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf 269 (379)
.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 474 -------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf 540 (613)
T 2ozo_A 474 -------------YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540 (613)
T ss_dssp -------------EEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred -------------cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 56666666665432221 11235678999999998899999999999999999998 99999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 349 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 349 (379)
.+.+..+....+.+... +.. ...++.++.++|
T Consensus 541 ~~~~~~~~~~~i~~~~~----------------------~~~--------------------------p~~~~~~l~~li 572 (613)
T 2ozo_A 541 KKMKGPEVMAFIEQGKR----------------------MEC--------------------------PPECPPELYALM 572 (613)
T ss_dssp TTCCSHHHHHHHHTTCC----------------------CCC--------------------------CTTCCHHHHHHH
T ss_pred CCCCHHHHHHHHHcCCC----------------------CCC--------------------------CCcCCHHHHHHH
Confidence 88776655544333211 011 123667899999
Q ss_pred hhccccCCCCCcCHHHHhc
Q 017021 350 QGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 350 ~~~L~~dP~~Rpta~e~l~ 368 (379)
.+||+.||++|||++++++
T Consensus 573 ~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 573 SDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHTTCSSTTTSCCHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHH
Confidence 9999999999999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=317.54 Aligned_cols=271 Identities=19% Similarity=0.203 Sum_probs=190.5
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---------hhhHhHHHHHHHHHHHHhcCC----C-----
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDK----G----- 102 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~----~----- 102 (379)
....|++.++||+|+||.||+|++ +|+.||+|++.... .....+.+|+.++..+..... .
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 456799999999999999999987 68999999997432 122667889999998863211 1
Q ss_pred ------------CCeeEEecceeee-------------cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHH
Q 017021 103 ------------GNRCVQIRNWFDY-------------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 156 (379)
Q Consensus 103 ------------~~~i~~~~~~~~~-------------~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~ 156 (379)
|+||+++++++.+ .+..|+||||+ ++++.+.+.. ..+++..+..++.||+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence 5666666666665 78999999999 7766555543 25899999999999999
Q ss_pred HHHHHH-HcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCc
Q 017021 157 CIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHY 235 (379)
Q Consensus 157 aL~~LH-~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y 235 (379)
||+||| +.||+||||||+|||++.++... .++++. ............+||+|||+|+.... ....||+.|
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~-~~~~~~------~~~~~~~~~~~~vkL~DFG~a~~~~~--~~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKK-LHYTLN------GKSSTIPSCGLQVSIIDYTLSRLERD--GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSE-EEEEET------TEEEEEECTTEEEEECCCTTCBEEET--TEEECCCCT
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcc-eeeecc------CccccccCCCceEEEeeccccEecCC--CcEEEeecc
Confidence 999999 99999999999999997654110 000000 00000001234799999999976543 345899999
Q ss_pred cchhhhhCCCCCCccchHhHHHH-HHHHHhCCCCCCCCch-HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCC
Q 017021 236 RAPEVILGLGWTYPCDIWSVGCI-LVELCTGEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE 313 (379)
Q Consensus 236 ~aPE~~~~~~~~~~sDvwSlG~i-l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (379)
+|||++.+.. +.++||||||++ .+++++|..||..... ......+.+...... ..
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~ 300 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT----------------------KC 300 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS----------------------CC
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc----------------------cc
Confidence 9999998766 899999998777 6778889888842110 001111111000000 00
Q ss_pred CCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHh-cCCCCC
Q 017021 314 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL-RHPFFT 373 (379)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l-~hp~f~ 373 (379)
....+...++++.+||++||++| ||+|+| +||||+
T Consensus 301 --------------------~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 301 --------------------NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp --------------------CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred --------------------chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 00112346789999999999987 999999 999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=307.36 Aligned_cols=249 Identities=20% Similarity=0.251 Sum_probs=193.7
Q ss_pred eeeeechhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 36 TYIVFSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 36 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
+...+....|++.+.||+|+||.||+|.+.. .||+|+++.. ......+.+|+.++.++ .|+|+++++++
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~ 97 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-----RHENVVLFMGA 97 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-----CCTTBCCCCEE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-----CCCCEeEEEEE
Confidence 3345566778999999999999999998754 4999998632 22234455677777776 78999999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
+...+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||+++
T Consensus 98 ~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~------------ 164 (319)
T 2y4i_B 98 CMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD------------ 164 (319)
T ss_dssp EECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------------
T ss_pred EecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe------------
Confidence 99999999999999 899999997643 3589999999999999999999999999999999999994
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCC--------CCCcccccCCccchhhhhC---------CCCCCccchHh
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP--------DQNYIVSTRHYRAPEVILG---------LGWTYPCDIWS 254 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~--------~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwS 254 (379)
++.++|+|||.+..... ......||+.|+|||++.+ ..++.++||||
T Consensus 165 ----------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~s 228 (319)
T 2y4i_B 165 ----------------NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228 (319)
T ss_dssp ------------------CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHH
T ss_pred ----------------CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHH
Confidence 23567777776543221 1123458999999999864 34788999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHH
Q 017021 255 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334 (379)
Q Consensus 255 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (379)
|||++|+|++|..||......+....+.....+...
T Consensus 229 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------------------------- 264 (319)
T 2y4i_B 229 LGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS-------------------------------------------- 264 (319)
T ss_dssp HHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC--------------------------------------------
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC--------------------------------------------
Confidence 999999999999999876665544433222111100
Q ss_pred HHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 335 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
....+.++.++|.+||+.||.+|||++++++
T Consensus 265 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 265 ---QIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp ---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred ---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0135678999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=308.37 Aligned_cols=251 Identities=21% Similarity=0.272 Sum_probs=188.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc----e
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----H 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~----~ 118 (379)
..|++.+.||+|+||.||+|++ +++.||+|++... ....+..|.+++.... ..|+|++++++++.... .
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~---l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVM---LRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSC---CCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhh---cCCCcEEEEEeeecccCCccce
Confidence 5789999999999999999987 5899999999743 2445666777776632 27899999999998775 8
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCcccCCCCCcEEEecccccccCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--------DLCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH--------~~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
.++||||+ +++|.+++... .+++..+..++.|++.||.||| +.|++||||||+||++
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll----------- 180 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV----------- 180 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE-----------
T ss_pred eEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE-----------
Confidence 99999999 88999999875 4899999999999999999999 8999999999999999
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhCCC------CCCccchHhHH
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLG------WTYPCDIWSVG 256 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG 256 (379)
+.++.++|+|||.+....... ....||+.|+|||++.+.. ++.++||||||
T Consensus 181 ----------------~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 244 (342)
T 1b6c_B 181 ----------------KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244 (342)
T ss_dssp ----------------CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHH
T ss_pred ----------------CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHH
Confidence 455667888888775433322 3346899999999997753 33689999999
Q ss_pred HHHHHHHhC----------CCCCCCCchHH-HHHHHHHHcCCCChhHHHhhhhhhhhhhccC-CCCCCCCCCchhhhhhh
Q 017021 257 CILVELCTG----------EALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSV 324 (379)
Q Consensus 257 ~il~~l~~g----------~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 324 (379)
|++|+|++| ..||....... ....+.+.. .... ....+..
T Consensus 245 ~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~---------- 296 (342)
T 1b6c_B 245 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV------------------CEQKLRPNIPNR---------- 296 (342)
T ss_dssp HHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH------------------TTSCCCCCCCGG----------
T ss_pred HHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHH------------------HHHHhCCCCccc----------
Confidence 999999999 67775432100 000000000 0000 0000000
Q ss_pred ccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 325 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
......+..+.++|.+||+.||++|||+.|+++|
T Consensus 297 -----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 297 -----------WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp -----------GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred -----------ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 0012345679999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=327.32 Aligned_cols=247 Identities=23% Similarity=0.283 Sum_probs=195.8
Q ss_pred echhhhhhhhccccccceeEEEEEecCC---CceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
+....|++.+.||+|+||.||+|.+..+ +..||+|+++.. ......+.+|+.++..+ .|+||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVIT 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEe
Confidence 4456788999999999999999998654 467999998642 23346677899988888 7899999999885
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
++..|+||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~------------ 527 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN------------ 527 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET------------
T ss_pred -cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC------------
Confidence 45689999999 899999998654 358999999999999999999999999999999999999544
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 268 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~p 268 (379)
+.++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 528 ---------------~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~P 592 (656)
T 2j0j_A 528 ---------------DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592 (656)
T ss_dssp ---------------TEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ---------------CCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCC
Confidence 456666666665433222 12346778999999998899999999999999999997 9999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|.+.+..+....+...... +. ...+++.+.++
T Consensus 593 f~~~~~~~~~~~i~~~~~~----------------------~~--------------------------~~~~~~~l~~l 624 (656)
T 2j0j_A 593 FQGVKNNDVIGRIENGERL----------------------PM--------------------------PPNCPPTLYSL 624 (656)
T ss_dssp TTTCCHHHHHHHHHHTCCC----------------------CC--------------------------CTTCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCC----------------------CC--------------------------CccccHHHHHH
Confidence 9887766555444332111 01 12356789999
Q ss_pred HhhccccCCCCCcCHHHHhc
Q 017021 349 LQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~ 368 (379)
|.+||+.||++|||+.|+++
T Consensus 625 i~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 625 MTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=291.07 Aligned_cols=222 Identities=14% Similarity=0.006 Sum_probs=173.0
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch----hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
-.|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|...+..+ .|+|++++++++..++.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~~~~~~~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-----DKPGVARVLDVVHTRAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEETTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-----CCCCcceeeEEEEECCc
Confidence 468999999999999999999999999999999975422 235667788877666 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+||||+ |++|.+++... .....+..++.|++.||.|||++||+||||||+||+++
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~------------------ 163 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS------------------ 163 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE------------------
T ss_pred EEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc------------------
Confidence 99999999 88999998542 45567888999999999999999999999999999994
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
.++.++|++++ |++ +++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 164 ---------~~g~~kl~~~~-----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~ 210 (286)
T 3uqc_A 164 ---------IDGDVVLAYPA-----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG 210 (286)
T ss_dssp ---------TTSCEEECSCC-----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC
T ss_pred ---------CCCCEEEEecc-----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh
Confidence 44556665332 333 368999999999999999999999986443110
Q ss_pred HHHHHH-HcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 278 LAMMER-VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 278 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
.....+ ..+.. ..........+.++.++|.+||+.|
T Consensus 211 ~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~~l~~li~~~l~~d 247 (286)
T 3uqc_A 211 LAPAERDTAGQP-------------------------------------------IEPADIDRDIPFQISAVAARSVQGD 247 (286)
T ss_dssp SEECCBCTTSCB-------------------------------------------CCHHHHCTTSCHHHHHHHHHHHCTT
T ss_pred hHHHHHHhccCC-------------------------------------------CChhhcccCCCHHHHHHHHHHcccC
Confidence 000000 00000 0011223456788999999999999
Q ss_pred CCCCcCHHHHhc
Q 017021 357 PTDRLTAREALR 368 (379)
Q Consensus 357 P~~Rpta~e~l~ 368 (379)
|++| |++|+++
T Consensus 248 P~~R-s~~el~~ 258 (286)
T 3uqc_A 248 GGIR-SASTLLN 258 (286)
T ss_dssp SSCC-CHHHHHH
T ss_pred CccC-CHHHHHH
Confidence 9999 9999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=325.60 Aligned_cols=236 Identities=24% Similarity=0.341 Sum_probs=188.6
Q ss_pred hhhhhhhccccccceeEEEEEecC-CCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce-
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH- 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~-~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~- 118 (379)
-.|++.++||+|+||.||+|++.. +++.||||++... ......+..|+.++..+ .|+||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-----VHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-----CCTTBCCEEEEEEEECTT
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-----CCCCcCeEeeeEeecCCC
Confidence 579999999999999999999976 7899999998632 23344566788877776 78999999999987655
Q ss_pred ----EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 119 ----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 119 ----~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
.|+||||+ +++|.+++.. .+++..+..++.||+.||.|||+.||+||||||+||+++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~-------------- 216 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT-------------- 216 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--------------
T ss_pred CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe--------------
Confidence 79999999 8899887654 589999999999999999999999999999999999993
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
. ..++|+|||.+...... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+..
T Consensus 217 -------------~-~~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~ 280 (681)
T 2pzi_A 217 -------------E-EQLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY 280 (681)
T ss_dssp -------------S-SCEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEE
T ss_pred -------------C-CcEEEEecccchhcccC-CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccc
Confidence 3 26899999988765443 4557999999999987754 899999999999999999988886421
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
.. ..+.. .+ ....++.+.++|.+||
T Consensus 281 ~~-----------~~~~~-----------------------------------~~---------~~~~~~~l~~li~~~l 305 (681)
T 2pzi_A 281 VD-----------GLPED-----------------------------------DP---------VLKTYDSYGRLLRRAI 305 (681)
T ss_dssp CS-----------SCCTT-----------------------------------CH---------HHHHCHHHHHHHHHHT
T ss_pred cc-----------ccccc-----------------------------------cc---------ccccCHHHHHHHhhhc
Confidence 10 00000 00 0013467899999999
Q ss_pred ccCCCCCcCHHHHhcCCCC
Q 017021 354 RYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f 372 (379)
+.||.+||++.+.+.|+|+
T Consensus 306 ~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 306 DPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp CSSGGGSCSSHHHHHHHHH
T ss_pred cCChhhCCCHHHHHHHHHH
Confidence 9999999999888888775
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-31 Score=266.66 Aligned_cols=181 Identities=19% Similarity=0.119 Sum_probs=124.8
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeecc-----------chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGI-----------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
..++.|+.|....++....|+.||+|++... ......+.+|+++|.++ ..|+|++++++++++++
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~----~~~~~i~~~~~~~ed~~ 315 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQP----PAGFDAPAVLAHGENAQ 315 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSC----CTTCCCCCEEEEEECSS
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhc----CCCCCeeEEEEEEEECC
Confidence 3457788888888887888999999999632 12334566788887776 46789999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..||||||+ |++|.+++...+ .++.. .++.||+.||+|+|++||+||||||+|||+
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL------------------ 372 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV------------------ 372 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE------------------
T ss_pred EEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE------------------
Confidence 999999999 999999998765 56654 478999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
+.++.+||+|||+|+...... ...+||+.|+|||++.+. +..++|+||+|++++++.++.
T Consensus 373 ---------~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 373 ---------DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ---------CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred ---------CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 556678888888886544332 345799999999998774 567899999999988765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=222.17 Aligned_cols=176 Identities=19% Similarity=0.184 Sum_probs=137.4
Q ss_pred hhccccccceeEEEEEecCCCceEEEEEeeccc---------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 48 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 48 ~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
.+.||+|+||.||+| ...++.+|+|+..... .....+.+|+.++.++ .|+|++.+..+....+.
T Consensus 341 ~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~~~~~~~~~~~ 413 (540)
T 3en9_A 341 EHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-----KDFGIPAPYIFDVDLDN 413 (540)
T ss_dssp -------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-----GGGTCCCCCEEEEETTT
T ss_pred CCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-----CCCCcCceEEEEEeCCc
Confidence 468999999999999 4557889999864321 1134467899999998 66888855555556777
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+||||+ +++|.+++.. +..++.|++.||.|||++||+||||||+|||+
T Consensus 414 ~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl------------------- 464 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF------------------- 464 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE-------------------
T ss_pred cEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE-------------------
Confidence 89999999 8999999865 45889999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC----------CcccccCCccchhhhhC--CCCCCccchHhHHHHHHHHHhC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTG 265 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~~l~~g 265 (379)
+. .++|+|||+++...... ....||+.|+|||++.. ..|+..+|+||..+-..+-..+
T Consensus 465 --------~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~ 534 (540)
T 3en9_A 465 --------DK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVER 534 (540)
T ss_dssp --------SS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHT
T ss_pred --------CC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHh
Confidence 44 78999999998765532 24579999999999976 5678889999999888887777
Q ss_pred CCCC
Q 017021 266 EALF 269 (379)
Q Consensus 266 ~~pf 269 (379)
+.+|
T Consensus 535 r~rY 538 (540)
T 3en9_A 535 RARY 538 (540)
T ss_dssp CSCC
T ss_pred cccc
Confidence 6665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.8e-24 Score=191.79 Aligned_cols=154 Identities=24% Similarity=0.326 Sum_probs=117.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-------------------hhHhHHHHHHHHHHHHhcCCCCC
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------------------YREAAMIEIEVLQQLAKHDKGGN 104 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------------------~~~~~~~e~~~l~~l~~~~~~~~ 104 (379)
.|++.+.||+|+||.||+|.+ .+|+.||+|+++.... ....+.+|+.++..+.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~------- 162 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ------- 162 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-------
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-------
Confidence 445669999999999999999 8899999999963211 2445778999998883
Q ss_pred eeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccc
Q 017021 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 183 (379)
Q Consensus 105 ~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 183 (379)
| +.+.+.+.. +..|+||||+ |++|.+ +.. .....++.|++.||.|||+.||+||||||+|||+
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl----- 226 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV----- 226 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE-----
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE-----
Confidence 2 344444433 5569999999 889987 321 1244689999999999999999999999999999
Q ss_pred cccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC----------CCCCCccchH
Q 017021 184 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG----------LGWTYPCDIW 253 (379)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~sDvw 253 (379)
+ ++.++|+|||.+. .+..+.|||.+.. ..++..+|+|
T Consensus 227 ----------------------~-~~~vkl~DFG~a~----------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~ 273 (282)
T 1zar_A 227 ----------------------S-EEGIWIIDFPQSV----------EVGEEGWREILERDVRNIITYFSRTYRTEKDIN 273 (282)
T ss_dssp ----------------------E-TTEEEECCCTTCE----------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHH
T ss_pred ----------------------E-CCcEEEEECCCCe----------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChH
Confidence 4 5678999999885 3455789998853 3355555665
Q ss_pred h
Q 017021 254 S 254 (379)
Q Consensus 254 S 254 (379)
.
T Consensus 274 ~ 274 (282)
T 1zar_A 274 S 274 (282)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-20 Score=168.32 Aligned_cols=139 Identities=16% Similarity=0.163 Sum_probs=105.8
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCce--EEEEEeeccch-------------------------hhHhHHHHHHHHH
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEM--VAIKIVRGIKK-------------------------YREAAMIEIEVLQ 94 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~--vAiK~~~~~~~-------------------------~~~~~~~e~~~l~ 94 (379)
+..|++.+.||+|+||.||+|.+..+|+. ||||+++.... ....+.+|..++.
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 34467889999999999999998778999 99999753211 0125678999999
Q ss_pred HHHhcCCCCCeeEEecceeeecceEEEEEeCCC--C----CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCc
Q 017021 95 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--S----SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMI 167 (379)
Q Consensus 95 ~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~--~----sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ii 167 (379)
.+.+.....|.+.. . +..++||||++ + +|.++... .++..+..++.|++.||.+|| +.||+
T Consensus 126 ~l~~~~i~~p~~~~---~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~giv 193 (258)
T 1zth_A 126 RAKEAGVSVPQPYT---Y----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELV 193 (258)
T ss_dssp HHHHTTCCCCCEEE---E----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEE
T ss_pred HHHhCCCCCCeEEE---c----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 98765333333332 1 35689999994 3 77766432 234567789999999999999 99999
Q ss_pred ccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccc
Q 017021 168 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221 (379)
Q Consensus 168 H~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~ 221 (379)
||||||+|||+ +. .++|+|||.|..
T Consensus 194 HrDlkp~NILl---------------------------~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 194 HADLSEYNIMY---------------------------ID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSSCSTTSEEE---------------------------SS--SEEECCCTTCEE
T ss_pred eCCCCHHHEEE---------------------------cC--cEEEEECccccc
Confidence 99999999999 44 789999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=6.9e-17 Score=151.10 Aligned_cols=148 Identities=16% Similarity=0.149 Sum_probs=99.8
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccch-----------------------hhHhHHHHHHHHHHHH
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------------------YREAAMIEIEVLQQLA 97 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----------------------~~~~~~~e~~~l~~l~ 97 (379)
.+..|+|..+||+|++|.||+|.+. +|+.||||+++.... .+..+.+|...+.++.
T Consensus 93 rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 93 RKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 3445889999999999999999975 589999999752100 0112235677777775
Q ss_pred hcCCCCCeeEEecceeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcE
Q 017021 98 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV 176 (379)
Q Consensus 98 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Ni 176 (379)
..... ++..+. . ...++||||+ |.+|.++.. ......++.||+.+|.+||+.||+||||||.||
T Consensus 172 ~~gv~---vp~p~~---~-~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NI 236 (397)
T 4gyi_A 172 EEGFP---VPEPIA---Q-SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIHGDFNEFNI 236 (397)
T ss_dssp HTTCS---CCCEEE---E-ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred hcCCC---CCeeee---c-cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHE
Confidence 43221 222111 1 1237999999 777754321 123456789999999999999999999999999
Q ss_pred EEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccc
Q 017021 177 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221 (379)
Q Consensus 177 li~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~ 221 (379)
|+..++...-+ ......+.||||+.+..
T Consensus 237 Ll~~dgd~~d~-----------------~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 237 LIREEKDAEDP-----------------SSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEECSSCT-----------------TSEEEEEEECCCTTCEE
T ss_pred EEeCCCCcccc-----------------cccccceEEEEeCCccc
Confidence 99766521100 01122488999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=2.1e-11 Score=108.97 Aligned_cols=107 Identities=10% Similarity=0.048 Sum_probs=80.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
.|++...++.|+.+.||++... ++.+++|+..... .....+..|..++..+.. +..+++++++....+..|+|
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~----~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEG----KLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT----TSCCCCEEEEEEETTEEEEE
T ss_pred cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc----CCCCCeEEEEEecCCceEEE
Confidence 3667788888889999999743 6789999987421 223457789999988854 34577788888888899999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 163 (379)
||++ |.+|.+.+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp EECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHH
T ss_pred EEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhC
Confidence 9999 778876531 112234677889999999998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.03 E-value=4.8e-10 Score=99.57 Aligned_cols=97 Identities=13% Similarity=0.109 Sum_probs=65.5
Q ss_pred ccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-CCCH
Q 017021 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSL 130 (379)
Q Consensus 52 g~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL 130 (379)
+.|..+.||++.. .+|..+++|+.... .......|..++..+... ...+++++.+...++..++|||++ |.+|
T Consensus 29 ~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~---~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 29 IGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATT---GVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp CTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTT---TCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhC---CCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 3556699999964 45778999997643 234566799999888653 233666777777777899999999 7676
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 017021 131 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164 (379)
Q Consensus 131 ~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 164 (379)
. .. .... ..++.+++..|..||+.
T Consensus 103 ~--~~-----~~~~---~~~~~~l~~~l~~lh~~ 126 (264)
T 1nd4_A 103 L--SS-----HLAP---AEKVSIMADAMRRLHTL 126 (264)
T ss_dssp T--TS-----CCCH---HHHHHHHHHHHHHHTTS
T ss_pred C--cC-----cCCH---hHHHHHHHHHHHHHhCC
Confidence 3 11 1221 24556667777777754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.92 E-value=3.7e-09 Score=98.79 Aligned_cols=106 Identities=15% Similarity=0.136 Sum_probs=73.6
Q ss_pred hccccccceeEEEEEecCCCceEEEEEee--ccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---ceEEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVR--GIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---NHICI 121 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~--~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~---~~~~l 121 (379)
+.|+.|.++.||++... +..+++|+.. ... ........|..++..+... +..+++++..+.+. +..|+
T Consensus 44 ~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~---~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGT---DVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTS---SSCCCCEEEEECCTTTTSSCEE
T ss_pred EEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcC---CCCCCcEEEECCCCCccCCeEE
Confidence 67889999999999754 4678999876 322 1234667799999998652 34466676666655 45899
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 163 (379)
|||++ |..+.+.. ...++......++.+++.+|..||+
T Consensus 119 vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp EEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhC
Confidence 99999 65653311 1236788888899999999999997
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=3.4e-09 Score=96.73 Aligned_cols=103 Identities=16% Similarity=0.117 Sum_probs=69.0
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---ceEEEEEeC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---NHICIVFEK 125 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~---~~~~lv~e~ 125 (379)
+.++.|....||++. ..+++|+.... ........|..++..+.... ...++..+...... ...|+||++
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~--~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKL--PLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSS--SSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcC--CCCCCceEeecCCCCCCCcceEEEcc
Confidence 558899999999874 45899987533 33556778999988874421 11234443333322 246899999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 017021 126 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163 (379)
Q Consensus 126 ~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 163 (379)
+ |.++.+.... .++..+...++.+++..|..||+
T Consensus 98 i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~ 132 (304)
T 3sg8_A 98 IKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHS 132 (304)
T ss_dssp CCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHc
Confidence 9 7677643322 36777778888888888888885
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=3.7e-06 Score=76.55 Aligned_cols=102 Identities=18% Similarity=0.106 Sum_probs=63.4
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee-ecceEEEEEeCC-
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHICIVFEKL- 126 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~- 126 (379)
+.++.|....||+. +..+++|+.. ..........|..++..+..+.. ..++..+.+.. ..+..|++|+++
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~--v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVK--VNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCS--SBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCC--CCCCCeEeecccCCCceEEEEeccC
Confidence 45677888899988 4668999854 23345567789999999865321 23444444442 456688999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 017021 127 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162 (379)
Q Consensus 127 ~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH 162 (379)
|.++.+..-. .++......+..++...|..||
T Consensus 97 G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH 128 (306)
T 3tdw_A 97 GQILGEDGMA----VLPDDAKDRLALQLAEFMNELS 128 (306)
T ss_dssp SEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHH
T ss_pred CeECchhhhh----hCCHHHHHHHHHHHHHHHHHHh
Confidence 7677653211 2344444455555555555555
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.7e-06 Score=75.76 Aligned_cols=101 Identities=14% Similarity=0.182 Sum_probs=69.3
Q ss_pred cccccce-eEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-CC
Q 017021 51 MGEGTFG-QVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 128 (379)
Q Consensus 51 Lg~G~~g-~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 128 (379)
+..|..| .||+......+..+++|+-... ....+..|...+..+.. +..+++++.+..+++..|+|||++ |.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~----~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTA----FMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTT----TSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhcc----CCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 3445444 6899887777788999987633 23456678888888743 234777888888889999999999 77
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 017021 129 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163 (379)
Q Consensus 129 sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 163 (379)
++.+...... .....+..++...|..||+
T Consensus 106 ~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~ 134 (272)
T 4gkh_A 106 TAFQVLEEYP------DSGENIVDALAVFLRRLHS 134 (272)
T ss_dssp EHHHHHHHCG------GGHHHHHHHHHHHHHHHHT
T ss_pred cccccccCCH------HHHHHHHHHHHHHHHHhcC
Confidence 8777654421 1223455566677777774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=2.8e-05 Score=73.37 Aligned_cols=75 Identities=20% Similarity=0.235 Sum_probs=47.1
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccc--------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
+.||.|..+.||++....+++.+++|...... ........|..++..+.... ...++.++.+ +....+
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~--~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV--PHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTC--GGGSCCEEEE--ETTTTE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhC--CCCcCeEEEE--cCCccE
Confidence 67899999999999876667889999864211 11234567888888875432 1234444433 344568
Q ss_pred EEEeCCC
Q 017021 121 IVFEKLG 127 (379)
Q Consensus 121 lv~e~~~ 127 (379)
+|||++.
T Consensus 112 lvmE~l~ 118 (397)
T 2olc_A 112 TVMEDLS 118 (397)
T ss_dssp EEECCCT
T ss_pred EEEEeCC
Confidence 9999993
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.87 E-value=0.00024 Score=65.10 Aligned_cols=76 Identities=13% Similarity=0.184 Sum_probs=42.6
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEec-c--eeeecceEEEEEeC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-N--WFDYRNHICIVFEK 125 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~-~--~~~~~~~~~lv~e~ 125 (379)
+.|+.|..+.||++... +..+++|+.... ......|..++..+.......|.++... + +....+..+++|++
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 45666778899998743 345999998752 2233446677777765432223332211 1 12346778999999
Q ss_pred C-CCC
Q 017021 126 L-GSS 129 (379)
Q Consensus 126 ~-~~s 129 (379)
+ |.+
T Consensus 113 i~G~~ 117 (346)
T 2q83_A 113 IEGRP 117 (346)
T ss_dssp CCCBC
T ss_pred ecCcc
Confidence 9 543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=7e-05 Score=69.44 Aligned_cols=79 Identities=9% Similarity=0.068 Sum_probs=51.3
Q ss_pred hcc-ccccceeEEEEEec--C----CCceEEEEEeeccc---h-hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec-
Q 017021 49 SKM-GEGTFGQVLECWDR--E----RKEMVAIKIVRGIK---K-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR- 116 (379)
Q Consensus 49 ~~L-g~G~~g~V~~~~~~--~----~~~~vAiK~~~~~~---~-~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~- 116 (379)
+.| +.|....+|+.... . +++.+++|+..... . .......|..++..+.... ...+++++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~--~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELT--DVPVPRVRWIETTGD 103 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHC--CSCCCCEEEEECSST
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcC--CCCCCcEEEEccCCC
Confidence 567 77888999988643 1 15678999875432 1 1245677899998887651 12355555555444
Q ss_pred --ceEEEEEeCC-CCC
Q 017021 117 --NHICIVFEKL-GSS 129 (379)
Q Consensus 117 --~~~~lv~e~~-~~s 129 (379)
+..|+|||++ |.+
T Consensus 104 ~~g~~~~v~e~l~G~~ 119 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVV 119 (357)
T ss_dssp TTSSCEEEEECCCCBC
T ss_pred ccCCceEEEEecCCCC
Confidence 4578999999 544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.001 Score=59.97 Aligned_cols=69 Identities=12% Similarity=-0.036 Sum_probs=43.1
Q ss_pred hhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-
Q 017021 48 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 126 (379)
Q Consensus 48 ~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~- 126 (379)
.+.|+.|....+|++ +.+++|+.............|..++..+...... |.+ +... .+.-+++++++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~-P~~---~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVS-PEV---LHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSS-CCE---EEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCC-Cce---EEEE--CCCCEEEEeecC
Confidence 377888999999999 4589998864322222334588888888765433 333 3322 33346889998
Q ss_pred CC
Q 017021 127 GS 128 (379)
Q Consensus 127 ~~ 128 (379)
++
T Consensus 91 ~g 92 (301)
T 3dxq_A 91 GA 92 (301)
T ss_dssp TC
T ss_pred CC
Confidence 54
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0029 Score=57.39 Aligned_cols=75 Identities=23% Similarity=0.240 Sum_probs=56.0
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-C
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 127 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 127 (379)
+.|+.|....+|+... ++..+++|+.... ....+..|...+..+.... ...+++.+.+....+..|+|||++ |
T Consensus 42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~--~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTN--SINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTT--SSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhC--CCCcceEEEEeecCCceEEEEEeccC
Confidence 6788899999999974 4677899987633 2455677899998886631 245677777777778899999999 5
Q ss_pred CC
Q 017021 128 SS 129 (379)
Q Consensus 128 ~s 129 (379)
..
T Consensus 116 ~~ 117 (312)
T 3jr1_A 116 SK 117 (312)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0015 Score=61.96 Aligned_cols=74 Identities=16% Similarity=0.181 Sum_probs=43.1
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeec-----cch---hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRG-----IKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
+.||.|..+.||++.. +++.+++|.... ... .......|.+++..+.... ...+++++.+. .+..+
T Consensus 40 ~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~--~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 40 KEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLS--PDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHS--GGGSCCEEEEE--TTTTE
T ss_pred EEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhC--CCCCCeEEEEC--CCccE
Confidence 6788899999999963 467899994321 111 0122333555544443221 12345554443 46678
Q ss_pred EEEeCC-CC
Q 017021 121 IVFEKL-GS 128 (379)
Q Consensus 121 lv~e~~-~~ 128 (379)
+|||++ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 65
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0023 Score=54.31 Aligned_cols=98 Identities=13% Similarity=0.017 Sum_probs=59.0
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCC
Q 017021 128 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 206 (379)
Q Consensus 128 ~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (379)
.||.+++...+ .++++++++.++.|.+.+|.-+- ...-..+=+.|..|++..+|
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG------------------------ 87 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG------------------------ 87 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS------------------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC------------------------
Confidence 47999998866 47999999999999999887662 11112333456777774443
Q ss_pred CCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh
Q 017021 207 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~ 264 (379)
.+.+.+ ..+. .....+.|||... ...+.+.=|||||+++|..+-
T Consensus 88 ---~V~f~~-~~s~---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 88 ---AVTLAP-AADD---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---CEEECC-C---------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ceeccc-cccc---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 343321 1100 1123466787653 234567789999999999886
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0068 Score=55.07 Aligned_cols=74 Identities=15% Similarity=0.196 Sum_probs=47.0
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecce-----eeecceEEEEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW-----FDYRNHICIVF 123 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~-----~~~~~~~~lv~ 123 (379)
..|+ |....||++.. .+|+.+++|+.............|..++..+...... ++..+.. ...++..+++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~---vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVP---VAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCS---BCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCe---ecceeecCCcEEEEECCEEEEEE
Confidence 3456 77788998863 3456799999863322345566788888888764322 3333322 22356778999
Q ss_pred eCCC
Q 017021 124 EKLG 127 (379)
Q Consensus 124 e~~~ 127 (379)
+++.
T Consensus 107 ~~i~ 110 (328)
T 1zyl_A 107 PSVG 110 (328)
T ss_dssp ECCC
T ss_pred EecC
Confidence 9993
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0046 Score=56.46 Aligned_cols=78 Identities=9% Similarity=0.019 Sum_probs=39.5
Q ss_pred hcccccccee-EEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-
Q 017021 49 SKMGEGTFGQ-VLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 126 (379)
Q Consensus 49 ~~Lg~G~~g~-V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~- 126 (379)
+.|+.|+... +|+... .+++.+++|...... ......|..++..+.... ..+++++......+ +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g---~~vP~v~~~d~~~g--~ll~e~l~ 95 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLD---ISAPEIYAEEHARG--LLLIEDLG 95 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTT---CBCCCEEEEETTTT--EEEECCCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC--CccccHHHHHHHHHHhCC---CCCCceeeecCCCC--EEEEeeCC
Confidence 4555554443 667753 225667787654321 134456788888886643 23444444322333 6899998
Q ss_pred CCCHHHHH
Q 017021 127 GSSLYDFL 134 (379)
Q Consensus 127 ~~sL~~~l 134 (379)
+.++.+.+
T Consensus 96 ~~~l~~~l 103 (333)
T 3csv_A 96 DALFTEVI 103 (333)
T ss_dssp SCBHHHHH
T ss_pred CcchHHHh
Confidence 55665443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0066 Score=55.01 Aligned_cols=77 Identities=10% Similarity=0.067 Sum_probs=44.2
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEec-c--eeeecceEEEEEeC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-N--WFDYRNHICIVFEK 125 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~-~--~~~~~~~~~lv~e~ 125 (379)
+.|+.|....+|++... +..+++|+.... ........|..++..+.......|.++... + +....+..++++++
T Consensus 28 ~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTT--KDPLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEES--SCCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeC--CccEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 56677888899998743 336899998742 123345568888888876543223332211 1 11234667999999
Q ss_pred C-CC
Q 017021 126 L-GS 128 (379)
Q Consensus 126 ~-~~ 128 (379)
+ |.
T Consensus 105 l~G~ 108 (322)
T 2ppq_A 105 LEGM 108 (322)
T ss_dssp CCCB
T ss_pred CCCc
Confidence 9 53
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0063 Score=56.76 Aligned_cols=70 Identities=14% Similarity=0.171 Sum_probs=41.3
Q ss_pred hccccccceeEEEEEecC-------CCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 49 SKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
+.|..|-...+|++.... +++.+++|+.-..........+|..+++.+..... . ++++..+.. .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv-~---P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSL-G---PQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTS-S---CCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCC-C---CeEEEEcCC----cc
Confidence 456668888899998642 35789999974322234455579999988877553 2 344444433 28
Q ss_pred EEeCC
Q 017021 122 VFEKL 126 (379)
Q Consensus 122 v~e~~ 126 (379)
||||+
T Consensus 128 v~e~i 132 (379)
T 3feg_A 128 LEQYI 132 (379)
T ss_dssp EEECC
T ss_pred EEEEe
Confidence 99998
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.14 E-value=0.056 Score=49.41 Aligned_cols=70 Identities=13% Similarity=0.107 Sum_probs=43.2
Q ss_pred ccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecce------eeecceEEEEEeC
Q 017021 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW------FDYRNHICIVFEK 125 (379)
Q Consensus 52 g~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~------~~~~~~~~lv~e~ 125 (379)
|.|....||++... +| .+++|+..... ...|..++..+...... .++..+.. ....+..+++|++
T Consensus 32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~-----~~~E~~~l~~L~~~g~~--~vp~pi~~~~G~~~~~~~g~~~~l~~~ 102 (339)
T 3i1a_A 32 GADTNAFAYQADSE-SK-SYFIKLKYGYH-----DEINLSIIRLLHDSGIK--EIIFPIHTLEAKLFQQLKHFKIIAYPF 102 (339)
T ss_dssp TSCSSCEEEEEECS-SC-EEEEEEEECSS-----CCHHHHHHHHHHHTTCC--SSCCCCCCTTSCSSEECSSEEEEEEEC
T ss_pred cCccccceEEEEeC-CC-CEEEEEecCcc-----chHHHHHHHHHHhcCCc--ccccceecCCCCEEEEECCEEEEEEec
Confidence 44446789999743 34 89999876433 14577788877664322 13333321 2345788999999
Q ss_pred C-CCCH
Q 017021 126 L-GSSL 130 (379)
Q Consensus 126 ~-~~sL 130 (379)
+ |..+
T Consensus 103 i~G~~~ 108 (339)
T 3i1a_A 103 IHAPNG 108 (339)
T ss_dssp CCCCBT
T ss_pred cCCCcC
Confidence 9 5443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.10 E-value=0.015 Score=53.76 Aligned_cols=70 Identities=21% Similarity=0.137 Sum_probs=40.1
Q ss_pred hccccccceeEEEEEecC--------CCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 49 SKMGEGTFGQVLECWDRE--------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~--------~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
+.|+.|....+|++.... .++.+++|+.............|..++..+..... .| +++... . -+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~-~P---~~~~~~--~--~~ 110 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKI-AP---QLLNTF--N--GG 110 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTS-SC---CEEEEE--T--TE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCC-CC---ceEEec--C--Cc
Confidence 566778888999987543 13678999876432221223568888888866432 23 333322 2 26
Q ss_pred EEEeCC
Q 017021 121 IVFEKL 126 (379)
Q Consensus 121 lv~e~~ 126 (379)
+||+++
T Consensus 111 ~v~e~i 116 (369)
T 3c5i_A 111 RIEEWL 116 (369)
T ss_dssp EEEECC
T ss_pred EEEEEe
Confidence 899998
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.042 Score=48.87 Aligned_cols=71 Identities=13% Similarity=0.086 Sum_probs=47.1
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccch-hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
+.+|.|..+.||+++. .+|+.|++|+...... ....+..|...|..+.... ...+++.+.. +..++|||+.
T Consensus 21 ~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~--~vpvP~v~~~----~~~~lv~e~l 92 (288)
T 3f7w_A 21 AERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSF--GSPVPQVAGW----DDRTLAMEWV 92 (288)
T ss_dssp EEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCST--TCCSCCEEEE----ETTEEEEECC
T ss_pred EecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhC--CCCcceEEec----cCceEEEEee
Confidence 6789999999999984 5688999998753322 2234556889888885432 1223444332 2247889998
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.72 E-value=0.11 Score=49.61 Aligned_cols=70 Identities=11% Similarity=0.056 Sum_probs=42.7
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 126 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 126 (379)
+.|+.|-...+|++....++..+++|+.............|..++..+.... ..++++..+. + .+|++|+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~g----l~P~ll~~~~-~---G~v~e~I 183 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKN----IAKKIYVFFT-N---GRIEEFM 183 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSS----SBCCEEEEET-T---EEEEECC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcC----CCCCEEEEeC-C---eEEEEee
Confidence 5677788899999986554578999987532211112246888888885533 2344555442 2 2589998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.43 E-value=0.12 Score=48.86 Aligned_cols=69 Identities=14% Similarity=0.178 Sum_probs=44.5
Q ss_pred hccccccceeEEEEEecC-------CCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 49 SKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
+.|+.|....+|++.... +++.+++|+..... .......|..++..+..... . +++++.+.. .+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~li~E~~~l~~L~~~g~-~---P~l~~~~~~----g~ 149 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERHL-G---PKLYGIFSG----GR 149 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTTS-S---SCEEEEETT----EE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-cHHHHHHHHHHHHHHHhCCC-C---CcEEEEeCC----CE
Confidence 567778889999997643 25789999984321 11344578898888876542 2 333443332 37
Q ss_pred EEeCC
Q 017021 122 VFEKL 126 (379)
Q Consensus 122 v~e~~ 126 (379)
|++|+
T Consensus 150 v~e~l 154 (429)
T 1nw1_A 150 LEEYI 154 (429)
T ss_dssp EECCC
T ss_pred EEEEe
Confidence 88988
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.85 E-value=0.43 Score=44.95 Aligned_cols=73 Identities=14% Similarity=0.095 Sum_probs=44.8
Q ss_pred hccccccceeEEEEEecCC-------CceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 49 SKMGEGTFGQVLECWDRER-------KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~-------~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
+.+..|-...+|++..... ++.+++|+............+|..++..+..... .| ++++.+ .+ ++
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi-~P---~l~~~~--~~--~~ 147 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINI-AP---NIIADF--PE--GR 147 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTS-SC---CEEEEE--TT--EE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCC-CC---CEEEEc--CC--CE
Confidence 4566677888999876521 5779999975332222233568888888876543 23 333322 22 68
Q ss_pred EEeCC-CCC
Q 017021 122 VFEKL-GSS 129 (379)
Q Consensus 122 v~e~~-~~s 129 (379)
|++|+ |.+
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 89999 533
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.70 E-value=1.1 Score=41.83 Aligned_cols=34 Identities=24% Similarity=0.431 Sum_probs=25.1
Q ss_pred CcccCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCccc
Q 017021 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220 (379)
Q Consensus 166 iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~ 220 (379)
++|+|+.+.||++.+... .+....+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~---------------------~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRE---------------------NSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGG---------------------GCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcc---------------------cCcCCeEEEechHhcc
Confidence 689999999999954210 0345678999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 379 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-49 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-49 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-45 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-42 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-42 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-34 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-32 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-31 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-31 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-29 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-28 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-28 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-27 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-27 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-27 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-27 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-27 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-26 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-24 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-24 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-24 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-23 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-12 | |
| d1nw1a_ | 395 | d.144.1.8 (A:) Choline kinase {Caenorhabditis eleg | 3e-05 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-52
Identities = 66/334 (19%), Positives = 116/334 (34%), Gaps = 44/334 (13%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGG 103
+ S++G G G V + + ++A K++ R + E++VL +
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSP--- 64
Query: 104 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
V F I I E + G SL L+K P ++ +++ +++ + ++
Sbjct: 65 -YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR 121
Query: 163 DLC-MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STT 220
+ ++H D+KP N+L+ S IK+ DFG S
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQ 154
Query: 221 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
N V TR Y +PE + G ++ DIWS+G LVE+ G + E M
Sbjct: 155 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+ R G P A V + P
Sbjct: 215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK-----LPSGV 269
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
+ + + L +P +R ++ + H F R
Sbjct: 270 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 170 bits (432), Expect = 2e-50
Identities = 70/335 (20%), Positives = 127/335 (37%), Gaps = 80/335 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGN 104
I ++G G FG V C ++ + K + + EI ++ QL H
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHP---- 86
Query: 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
+ + + + F+ + + ++ E L G L+D + +Y+ V RQ E + MH+
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE 145
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
++H D+KPEN++ K+S++K+IDFG T
Sbjct: 146 HSIVHLDIKPENIMC-------------------------ETKKASSVKIIDFGLATKLN 180
Query: 224 PDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
PD+ +T + APE++ + D+W++G + L +G + F ++LE L +
Sbjct: 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 240
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
+R + V A+
Sbjct: 241 KRCDWEFDEDAFSSVSPEAK---------------------------------------- 260
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
++ LL+ +P RLT +AL HP+ DH
Sbjct: 261 -----DFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 167 bits (424), Expect = 3e-49
Identities = 74/336 (22%), Positives = 126/336 (37%), Gaps = 80/336 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGN 104
IH ++G G FG V +R A K V + +E EI+ + L +H
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHP---- 83
Query: 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
V + + F+ N + +++E + G L++ + + + D E RQ+ + + MH+
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHE 142
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+H DLKPEN++ + +S+ +K+IDFG T +
Sbjct: 143 NNYVHLDLKPENIMFTT-------------------------KRSNELKLIDFGLTAHLD 177
Query: 224 PDQNYIVST--RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
P Q+ V+T + APEV G Y D+WSVG + L +G + F + E L +
Sbjct: 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 237
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
+ + +
Sbjct: 238 KSCDWNMDDSAFSGISE------------------------------------------- 254
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377
D ++ LL DP R+T +AL HP+ T +
Sbjct: 255 --DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-49
Identities = 71/332 (21%), Positives = 132/332 (39%), Gaps = 80/332 (24%)
Query: 52 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111
G G G+VL+ +++ +E A+K+++ K R E+E+ + ++ V+I +
Sbjct: 21 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCP----HIVRIVD 72
Query: 112 WFDY----RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 166
++ R + IV E L G L+ ++ ++F EI + + E I ++H + +
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 132
Query: 167 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 226
H D+KPEN+L S ++ +K+ DFG
Sbjct: 133 AHRDVKPENLLYTS------------------------KRPNAILKLTDFGFAKETTSHN 168
Query: 227 NY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
+ T +Y APEV+ + CD+WS+G I+ L G F ++ L M+
Sbjct: 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT- 227
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
+R G+ ++P S S +
Sbjct: 228 ------------------RIRMGQYEFPNPEWSEVS----------------------EE 247
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+ L++ LL+ +PT R+T E + HP+ +
Sbjct: 248 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-48
Identities = 75/339 (22%), Positives = 144/339 (42%), Gaps = 45/339 (13%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKG 102
+ +K+G+GTFG+V + R+ + VA+K V + + A+ EI++LQ L +
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 103 GNRCV---QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
+ + + + I +VF+ L L N F + ++ + + LL +
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLY 131
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
++H ++H D+K NVL+ +K+ D+ + +
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLA-------------------RAFSLAKN 172
Query: 220 TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
+ N V T YR PE++LG + P D+W GCI+ E+ T + Q + L
Sbjct: 173 SQPNRYTNR-VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 231
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
A++ ++ G + + VD + + + L + ++ +K+ ++ P +LI +
Sbjct: 232 ALISQLCGSITPEVWPNVDNY--ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK-- 287
Query: 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377
LL DP R+ + +AL H FF D +
Sbjct: 288 -------------LLVLDPAQRIDSDDALNHDFFWSDPM 313
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (415), Expect = 7e-48
Identities = 101/345 (29%), Positives = 159/345 (46%), Gaps = 45/345 (13%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK---- 101
+ K+G G F V D VA+KIVRG K Y EAA EI++LQ++ D
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 102 --GGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 155
G N +++ + F+++ H+ +VFE LG +L ++K +R P+ V++I++QLL
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 156 ECIAFMHDLCMI-HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 214
+ +MH C I HTD+KPENVL+ + IK+
Sbjct: 136 LGLDYMHRRCGIIHTDIKPENVLMEIVDS---------------------PENLIQIKIA 174
Query: 215 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE- 273
D G+ + + TR YR+PEV+LG W DIWS C++ EL TG+ LF+ E
Sbjct: 175 DLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234
Query: 274 -----NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328
+ +H+A + +LG LP ++L+ + RG L S L
Sbjct: 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR-------NISKLKFWPLE 287
Query: 329 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
+ + A +++ L +L+ DP R A + HP+
Sbjct: 288 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-47
Identities = 82/334 (24%), Positives = 138/334 (41%), Gaps = 45/334 (13%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGG 103
S +GEG +G V +D K VAIK + + Y + + EI++L + + G
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 70
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
+ + + +V +G+ LY L+ + D + Q+L + ++H
Sbjct: 71 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHS 127
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
++H DLKP N+LL ++ +K+ D+ + D + +
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL------------------ 169
Query: 224 PDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282
V+TR YRAPE++L G+T DIWSVGCIL E+ + +F L+ L +
Sbjct: 170 ---TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342
+LG Q L + R L P K N + + D A
Sbjct: 227 GILGSPSQEDLNCIIN---LKARNYLLSLPH------------KNKVPWNRLFPNADSKA 271
Query: 343 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
D LL +L ++P R+ +AL HP+ + +
Sbjct: 272 LD---LLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 6e-47
Identities = 82/334 (24%), Positives = 138/334 (41%), Gaps = 54/334 (16%)
Query: 46 KIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDK 101
+ +++GEG +G+V + D + VA+K VR G + + + E+ VL+ L +
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 102 GGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
V + D + +VFE + L +L K P + ++++ QLL +
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
F+H ++H DLKP+N+L+ SS IK+ D
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSSGQIKLAD-------------------------FGLAR 164
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
+ +V T YRAPEV+L + P D+WSVGCI E+ + LF+ +++ L
Sbjct: 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
+ V+G + DWP A ++ + +
Sbjct: 225 GKILDVIGLPGEE------------------DWPRDVALPRQAFHSKSAQPIEKFV-TDI 265
Query: 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
D D LL L ++P R++A AL HP+F
Sbjct: 266 DELGKD---LLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 8e-47
Identities = 62/331 (18%), Positives = 120/331 (36%), Gaps = 79/331 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+I +G+G FG V +++ K ++A+K++ + + ++ ++ H + N
Sbjct: 9 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN- 67
Query: 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+++ +F + ++ E ++Y L+K F +L +++ H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK 125
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+IH D+KPEN+LL S+ +K+ D+ S+H P
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----------------------- 162
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
+ T Y PE+I G D+WS+G + E G+ F+ + E + RV
Sbjct: 163 ---TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
P + +
Sbjct: 220 EFTFPDFVTE-------------------------------------------------G 230
Query: 345 LTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
L+ LL+++P+ R RE L HP+ T +
Sbjct: 231 ARDLISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-46
Identities = 73/335 (21%), Positives = 138/335 (41%), Gaps = 58/335 (17%)
Query: 50 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGG 103
+GEG F V + D+ ++VAIK ++ + A+ EI++LQ+L H
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHP--- 60
Query: 104 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
+ + + F ++++I +VF+ + + L ++ N+ P ++ L+ + ++H
Sbjct: 61 -NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP-SHIKAYMLMTLQGLEYLHQ 118
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
++H DLKP N+LL + +K+ D+ + + +
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--------------------- 157
Query: 224 PDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282
+ V TR YRAPE++ G + D+W+VGCIL EL +L+ L +
Sbjct: 158 ---THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342
LG + WP+ + + + + I
Sbjct: 215 ETLGTPTEE------------------QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL 256
Query: 343 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 377
DL +QGL ++P R+TA +AL+ +F+
Sbjct: 257 LDL---IQGLFLFNPCARITATQALKMKYFSNRPG 288
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 3e-46
Identities = 89/331 (26%), Positives = 145/331 (43%), Gaps = 53/331 (16%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKG 102
+ K+GEGT+G V + ++ E+VA+K +R + A+ EI +L++L +
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-- 62
Query: 103 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
V++ + N + +VFE L L F+ + P+ L++ QLL+ +AF H
Sbjct: 63 ---IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
++H DLKP+N+L+ + IK+ D+ + +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-------------------- 159
Query: 223 RPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
+ V T YRAPE++LG ++ DIWS+GCI E+ T ALF ++ L +
Sbjct: 160 ----THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
R LG + + WP + + S K R + V
Sbjct: 216 FRTLGTPDEVV------------------WPGVTSMPDYKPSFPKWARQD--FSKVVPPL 255
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
D LL +L YDP R++A+ AL HPFF
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-46
Identities = 80/342 (23%), Positives = 145/342 (42%), Gaps = 65/342 (19%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+G G+FG V + + E+VAIK V K+++ E++++++L H
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-DHC----N 74
Query: 106 CVQIRNWF------DYRNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLEC 157
V++R +F ++ +V + + ++Y R ++ P+ V+ QL
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+A++H + H D+KP+N+LL P ++ +K+ DFG
Sbjct: 135 LAYIHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFG 168
Query: 218 STTYERPDQNY--IVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN 274
S + + +R+YRAPE+I G +T D+WS GC+L EL G+ +F
Sbjct: 169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228
Query: 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334
++ L + +VLG + ++ ++ + ++ +P+ +K +
Sbjct: 229 VDQLVEIIKVLGTPTREQIREMNPNYTEF------KFPQ-----------IKAHPWTKVF 271
Query: 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
A L LL Y PT RLT EA H FF
Sbjct: 272 RPRTPPEAIA---LCSRLLEYTPTARLTPLEACAHSFFDELR 310
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 156 bits (395), Expect = 9e-46
Identities = 68/340 (20%), Positives = 117/340 (34%), Gaps = 81/340 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----------GIKKYREAAMIEIEVLQQ 95
+ +G G V C + + A+KI+ +++ REA + E+++L++
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 96 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 154
++ H +Q+++ ++ +VF+ + L+D+L + + R+I R L
Sbjct: 66 VSGHP----NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRAL 119
Query: 155 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 214
LE I +H L ++H DLKPEN+LL IK+ D+ S +
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-------------------CQL 160
Query: 215 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274
D G E ++ G+ D+WS G I+ L G F +
Sbjct: 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220
Query: 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334
+ L M+
Sbjct: 221 MLMLRMIMSGNYQFGSPEWDDYSD------------------------------------ 244
Query: 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374
+ L+ L P R TA EAL HPFF +
Sbjct: 245 ---------TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-45
Identities = 58/336 (17%), Positives = 113/336 (33%), Gaps = 79/336 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
I +G G FG V C + K+ K V+ + EI +L +H
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHR----N 62
Query: 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+ + F+ + ++FE + G +++ + + + + Q+ E + F+H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSH 121
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+ H D++PEN++ + + K+I+FG +P
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTI-------------------------KIIEFGQARQLKP 156
Query: 225 DQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 282
N+ + + Y APEV + D+WS+G ++ L +G F N + + +
Sbjct: 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342
+ K +
Sbjct: 217 NAEYTFDEEAFKEISI-------------------------------------------- 232
Query: 343 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 378
+ + LL + R+TA EAL+HP+ + R
Sbjct: 233 -EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-45
Identities = 66/336 (19%), Positives = 122/336 (36%), Gaps = 81/336 (24%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGN 104
+I ++G+G FG+V + ++E + A K++ ++ E M+EI++L H
Sbjct: 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPN--- 70
Query: 105 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
V++ + F Y N++ I+ E D + R ++ + +Q L+ + ++HD
Sbjct: 71 -IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+IH DLK N+L IK+ D+ S +
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---------------------- 167
Query: 225 DQNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279
+ + T ++ APEV++ + Y D+WS+G L+E+ E + L
Sbjct: 168 --DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL 225
Query: 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 339
+ + P L P +S
Sbjct: 226 KIAKSEPP--------------------TLAQPSRWSS---------------------- 243
Query: 340 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
+ L+ L + R T + L+HPF T D
Sbjct: 244 ----NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 154 bits (390), Expect = 1e-44
Identities = 70/335 (20%), Positives = 137/335 (40%), Gaps = 56/335 (16%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++ K+G G + +V E + E V +KI++ ++ EI++L+ L
Sbjct: 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGP----N 91
Query: 106 CVQIRNWF--DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
+ + + +VFE + + + +R ++L+ + + H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCH 146
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
+ ++H D+KP NV++ + +++ID+G +
Sbjct: 147 SMGIMHRDVKPHNVMIDH--------------------------EHRKLRLIDWGLAEFY 180
Query: 223 RPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGE-ALFQTHENLEHL 278
P Q N V++R+++ PE+++ + Y D+WS+GC+L + + F H+N + L
Sbjct: 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
+ +VLG Y+ + ++ S + R + QH+
Sbjct: 241 VRIAKVLGT----------EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHL 290
Query: 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 373
+ L LLRYD RLTAREA+ HP+F
Sbjct: 291 VSP--EALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (381), Expect = 2e-43
Identities = 65/335 (19%), Positives = 120/335 (35%), Gaps = 81/335 (24%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGG 103
+G G F +V+ D+ +++VAIK + ++ + EI VL ++ KH
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHP--- 67
Query: 104 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
V + + ++ H+ ++ + + G L+D + + + + + Q+L+ + ++H
Sbjct: 68 -NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLH 124
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
DL ++H DLKPEN+L S + + S I + DFG + E
Sbjct: 125 DLGIVHRDLKPENLLYYS------------------------LDEDSKIMISDFGLSKME 160
Query: 223 RPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
P T Y APEV+ ++ D WS+G I L G F + +
Sbjct: 161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+ + +
Sbjct: 221 ILKAEYEFDSPYWDDISD------------------------------------------ 238
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
++ L+ DP R T +AL+HP+ D
Sbjct: 239 ---SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-42
Identities = 59/334 (17%), Positives = 112/334 (33%), Gaps = 79/334 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGG 103
+ +GEG +G+V +R +E VA+KIV E EI + + L H+
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE--- 63
Query: 104 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
V+ N + E G L+D + + P + QL+ + ++H
Sbjct: 64 -NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH 120
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
+ + H D+KPEN+LL + +K+ D+ + ++
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN----------------------R 158
Query: 223 RPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
N + T Y APE++ + P D+WS G +L + GE + +
Sbjct: 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS 217
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
+ + K++D
Sbjct: 218 DWKEKKTYLNPWKKIDSAPL---------------------------------------- 237
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375
LL +L +P+ R+T + + ++ +
Sbjct: 238 -----ALLHKILVENPSARITIPDIKKDRWYNKP 266
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-42
Identities = 81/336 (24%), Positives = 140/336 (41%), Gaps = 53/336 (15%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLA-KHDK 101
+ +G G +G V D VAIK + + + + A E+ +L+ + ++
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
G D +V +G+ L ++ D ++ + Q+L+ + ++
Sbjct: 81 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYI 137
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H +IH DLKP N+ + + +K++DFG
Sbjct: 138 HAAGIIHRDLKPGNLAV---------------------------NEDCELKILDFGLARQ 170
Query: 222 ERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
+ V TR YRAPEVIL + +T DIWSVGCI+ E+ TG+ LF+ ++L+ L
Sbjct: 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+ +V G P ++R+ K +G + + + I+ +
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS---------------ILTNASP 275
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
A + LL+ +L D R+TA EAL HP+F H
Sbjct: 276 LAVN---LLEKMLVLDAEQRVTAGEALAHPYFESLH 308
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-42
Identities = 73/335 (21%), Positives = 129/335 (38%), Gaps = 40/335 (11%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKG 102
+ +G G G V +D VAIK + + + + A E+ +++ + +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 103 GNR-CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
+ + + +V E + ++L ++ + + + Q+L I +
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHL 135
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H +IH DLKP N+++ S +K+ D T
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILD-------------------------FGLARTAG 170
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
V TR+YRAPEVILG+G+ DIWSVGCI+ E+ + LF + ++ +
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
LG +K++ YV P+ A L + +
Sbjct: 231 IEQLGTPCPEFMKKLQPTVRNYVEN----RPKYAGLTFPKLFPDSLFPADSEHNKLKASQ 286
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
A D LL +L DP R++ +AL+HP+ +
Sbjct: 287 ARD---LLSKMLVIDPAKRISVDDALQHPYINVWY 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-42
Identities = 75/336 (22%), Positives = 143/336 (42%), Gaps = 53/336 (15%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLA-KHDK 101
+ S +G G +G V +D + VA+K + + + E+ +L+ + ++
Sbjct: 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
G + N + +V +G+ L + ++ + D V+ + Q+L + ++
Sbjct: 81 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYI 137
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H +IH DLKP N+ + + +K++DFG +
Sbjct: 138 HSADIIHRDLKPSNLA---------------------------VNEDCELKILDFGLARH 170
Query: 222 ERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
+ V+TR YRAPE++L + DIWSVGCI+ EL TG LF ++++ L +
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+ R++G +LK++ + + + P+ + + +
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN---------------VFIGANP 275
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
A D LL+ +L D R+TA +AL H +F + H
Sbjct: 276 LAVD---LLEKMLVLDSDKRITAAQALAHAYFAQYH 308
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (373), Expect = 3e-42
Identities = 68/338 (20%), Positives = 115/338 (34%), Gaps = 88/338 (26%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDK 101
++G G+FG V D E+VAIK + + + + E+ LQ+L +H
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHP- 75
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
+Q R + + +V E S D L + + + + L+ +A++
Sbjct: 76 ---NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYL 131
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H MIH D+K N+LL +K+ DFGS +
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGL---------------------------VKLGDFGSASI 164
Query: 222 ERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
P ++ V T ++ APEVIL + + D+WS+G +EL + + L
Sbjct: 165 MAPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
+ + P Q W E
Sbjct: 224 YHIAQNESPALQSG-----------------HWSE------------------------- 241
Query: 339 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+ + L+ P DR T+ L+H F R+
Sbjct: 242 -----YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-42
Identities = 66/333 (19%), Positives = 115/333 (34%), Gaps = 80/333 (24%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGN 104
K+G+G G V D + VAI+ + + +E + EI V+++ K+
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP---- 77
Query: 105 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
V + + + + +V E L G SL D + + + + R+ L+ + F+H
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS 134
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+IH D+K +N+LL +K+ D+ + S M
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------------------ 176
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
V T ++ APEV+ + DIWS+G + +E+ GE + L L ++
Sbjct: 177 ------VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
P L PE ++
Sbjct: 231 NGTP--------------------ELQNPEKLSA-------------------------- 244
Query: 344 DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
L L D R +A+E L+H F
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 9e-41
Identities = 60/338 (17%), Positives = 123/338 (36%), Gaps = 91/338 (26%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKG 102
K ++G G+F V + D E VA ++ K R+ E E+L+ L +H
Sbjct: 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHP-- 68
Query: 103 GNRCVQIRNWF----DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
V+ + + + I +V E + +L +L++ + I ++R RQ+L+
Sbjct: 69 --NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKG 124
Query: 158 IAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 215
+ F+H +IH DLK +N+ + + ++K+ D
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITG--------------------------PTGSVKIGD 158
Query: 216 FGSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274
G T +R ++ T + APE+ + D+++ G ++E+ T E + +N
Sbjct: 159 LGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 217
Query: 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334
+ R V+ D
Sbjct: 218 AAQIY------------------RRVTSGVKPASFD------------------------ 235
Query: 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+ ++ +++G +R + +R + ++ L H FF
Sbjct: 236 ----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-40
Identities = 66/337 (19%), Positives = 119/337 (35%), Gaps = 85/337 (25%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAK 98
++G G F V +C ++ A K ++ + RE E+ +L+++ +
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-Q 71
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
H + + ++ + + ++ E + G L+DFL + S + E +Q+L
Sbjct: 72 HP----NVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNG 125
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+ ++H L + H DLKPEN++L+ R IK+IDFG
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLD-----------------------RNVPKPRIKIIDFG 162
Query: 218 STTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275
I T + APE++ D+WS+G I L +G + F
Sbjct: 163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222
Query: 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 335
E LA + V A+
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAK---------------------------------- 248
Query: 336 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
++ LL DP R+T +++L+HP+
Sbjct: 249 -----------DFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-39
Identities = 61/334 (18%), Positives = 109/334 (32%), Gaps = 81/334 (24%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
K +GEG+F V+ + AIKI+ +E + + + +
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF- 69
Query: 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
V++ F + L ++RK SF R +++ + ++H
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+IH DLKPEN+LL +I++ D+ ++ +S +
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-------------------- 167
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
N V T Y +PE++ D+W++GCI+ +L G F+ + ++
Sbjct: 168 --NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 225
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
P+ +P+
Sbjct: 226 EYDFPEKF------------------FPK------------------------------- 236
Query: 345 LTHLLQGLLRYDPTDRLTAREA------LRHPFF 372
L++ LL D T RL E HPFF
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 9e-39
Identities = 63/333 (18%), Positives = 112/333 (33%), Gaps = 85/333 (25%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDK 101
+H +G+G+FG+V ++ + AIK ++ + E M+E VL +H
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP- 63
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
+ F + ++ V E L G L ++ F + A +++ + F
Sbjct: 64 ---FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQF 118
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+H +++ DLK +N+LL +IK+ D+ +
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT------------------ 160
Query: 221 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
N T Y APE++LG + + D WS G +L E+ G++ F + E
Sbjct: 161 ------NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-- 212
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+R +P
Sbjct: 213 ---------------------HSIRMDNPFYPRWLEK----------------------- 228
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAR-EALRHPFF 372
+ LL L +P RL R + +HP F
Sbjct: 229 ---EAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (344), Expect = 3e-38
Identities = 79/331 (23%), Positives = 130/331 (39%), Gaps = 55/331 (16%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 102
K+GEGT+G V + + E A+K +R K + EI +L++L +
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSN-- 61
Query: 103 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
V++ + + + +VFE L L L + QLL IA+ H
Sbjct: 62 ---IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH 117
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
D ++H DLKP+N+L+ +K+ D+ + +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-------------------- 157
Query: 223 RPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
+ + T YRAP+V++G ++ DIWSVGCI E+ G LF + L +
Sbjct: 158 ----THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
R+LG V + + P ++ +D S
Sbjct: 214 FRILGTPNSKNWPNVTELP-----------------KYDPNFTVYEPLPWESFLKGLDES 256
Query: 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
DL L +L+ DP R+TA++AL H +F
Sbjct: 257 GIDL---LSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-38
Identities = 61/336 (18%), Positives = 112/336 (33%), Gaps = 93/336 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-------GIKKYREAAMIEIEVLQQLAK 98
++ +G G FG V VAIK V G +E+ +L++++
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
G +++ +WF+ + ++ E+ F + +L R Q+LE +
Sbjct: 67 GFSG---VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 217
H+ ++H D+K EN+L+ + +K+IDFG
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGE--------------------------LKLIDFGS 157
Query: 218 STTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLE 276
+ TR Y PE I +WS+G +L ++ G+ F+ E
Sbjct: 158 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-- 215
Query: 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336
+ RG++ + + +S
Sbjct: 216 ---------------------------IIRGQVFFRQRVSS------------------- 229
Query: 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 372
+ HL++ L P+DR T E HP+
Sbjct: 230 -------ECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 8e-38
Identities = 80/336 (23%), Positives = 141/336 (41%), Gaps = 55/336 (16%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKG 102
+ K+GEGT+G V + +RE E+VA+K VR + +A+ EI +L++L +
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN-- 62
Query: 103 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
V++ + + +VFE L + N P ++V+ QLL+ + F H
Sbjct: 63 ---IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGFCH 118
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 222
++H DLKP+N+L+ + +K+ ++ + +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-------------------- 158
Query: 223 RPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEA-LFQTHENLEHLAM 280
+ V T YR P+V+ G + D+WS GCI EL LF ++ + L
Sbjct: 159 ----SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+ R+LG + + + + K P +L+
Sbjct: 215 IFRLLGTPTEEQWPSMTKLPD-------------------YKPYPMYPATTSLVNVVPKL 255
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 376
+A LLQ LL+ +P R++A EAL+HP+F+
Sbjct: 256 NA-TGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 9e-38
Identities = 61/342 (17%), Positives = 110/342 (32%), Gaps = 96/342 (28%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKG 102
++ +G G++G+ + + +++ K + + ++ + E+ +L++L KH
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPN- 64
Query: 103 GNRCVQIRNWFDYR--NHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLEC 157
V+ + R + IV E G L + K + + V + QL
Sbjct: 65 ---IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 158 IAFMHDL-----CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 212
+ H ++H DLKP NV L + +K
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQN---------------------------VK 154
Query: 213 VIDFGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269
+ DFG D ++ V T +Y +PE + + + DIWS+GC+L ELC F
Sbjct: 155 LGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214
Query: 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 329
E +R G+ S E
Sbjct: 215 TAFSQKELAGK-----------------------IREGKFRRIPYRYSDE---------- 241
Query: 330 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 371
L ++ +L R + E L +P
Sbjct: 242 ---------------LNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (334), Expect = 1e-36
Identities = 58/334 (17%), Positives = 106/334 (31%), Gaps = 64/334 (19%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++ K+G G+FG + D E VAIK+ +K IE ++ + +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGG----VG 64
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
IR ++ +V E LG SL D + R F + V +A Q++ I ++H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
IH D+KP+N L+ + + D K+ + + I +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYII-------DFGLAKKYRDARTHQHIPYRENKN---- 172
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
+ T Y + LG+ + D+ S+G +L+ G +Q + ER
Sbjct: 173 ---LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER-- 227
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
+ ++ I +
Sbjct: 228 ---------------------------------------ISEKKMSTPIEVLCKGYPSEF 248
Query: 346 THLLQGLLRYDPTDRLTA---REALRHPFFTRDH 376
L D+ R+ R+ F +
Sbjct: 249 ATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (322), Expect = 7e-35
Identities = 62/336 (18%), Positives = 109/336 (32%), Gaps = 91/336 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDK 101
+I +G G+FG+V R A+K+++ K E E +L + H
Sbjct: 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP- 64
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
+++ F I ++ + + L + + R FP + + A ++ + ++
Sbjct: 65 ---FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYL 120
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H +I+ DLKPEN+LL + + IK+ DFG Y
Sbjct: 121 HSKDIIYRDLKPENILLDKNGH---------------------------IKITDFGFAKY 153
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
+ T Y APEV+ + D WS G ++ E+ G F
Sbjct: 154 VPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY----------- 202
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
++ + L +P
Sbjct: 203 ----DSNTMKTYEK--------ILNAELRFPPFFNE------------------------ 226
Query: 342 AGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
D+ LL L+ D + RL + HP+F
Sbjct: 227 --DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 126 bits (318), Expect = 1e-34
Identities = 49/250 (19%), Positives = 91/250 (36%), Gaps = 38/250 (15%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
K+ ++GEG+FG + E + + VAIK + E + LA
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGC----TG 62
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
+ + H +V + LG SL D L R F + V A+Q+L + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-------- 217
+++ D+KP+N L+ ++ I V+DFG
Sbjct: 122 LVYRDIKPDNFLIGR----------------------PNSKNANMIYVVDFGMVKFYRDP 159
Query: 218 --STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275
++ + T Y + LG + D+ ++G + + G +Q +
Sbjct: 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219
Query: 276 EHLAMMERVL 285
+ ER+
Sbjct: 220 TNKQKYERIG 229
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 128 bits (322), Expect = 2e-34
Identities = 67/339 (19%), Positives = 127/339 (37%), Gaps = 89/339 (26%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDK 101
+H +G G FG+V C + +M A+K + +K+ A+ E +L ++ D
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
V + F + + + + + G L+ L ++ F +R A +++ +
Sbjct: 67 --PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEH 122
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-ST 219
MH+ +++ DLKP N+LL + +++ D G +
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGH---------------------------VRISDLGLAC 155
Query: 220 TYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 278
+ + + V T Y APEV+ G+ + D +S+GC+L +L G + F+ H+ +
Sbjct: 156 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 215
Query: 279 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 338
+ L ++ P+ +
Sbjct: 216 EIDRMTLTM--------------------AVELPDSFSP--------------------- 234
Query: 339 DHSAGDLTHLLQGLLRYDPTDRLT-----AREALRHPFF 372
+L LL+GLL+ D RL A+E PFF
Sbjct: 235 -----ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 5e-34
Identities = 62/337 (18%), Positives = 112/337 (33%), Gaps = 90/337 (26%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDK 101
+G+GTFG+V+ ++ A+KI+R K + E VLQ +H
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RH-- 64
Query: 102 GGNRCVQIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
++ F + +C V E G L+ L + F + R +++ + +
Sbjct: 65 --PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEY 120
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+H +++ D+K EN++L +IK+ D+ D +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM------------------ 162
Query: 221 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
T Y APEV+ + D W +G ++ E+ G F ++ +
Sbjct: 163 ------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+ + +P +
Sbjct: 217 -----------------------ILMEEIRFPRTLSP----------------------- 230
Query: 341 SAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
+ LL GLL+ DP RL A+E + H FF
Sbjct: 231 ---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 2e-33
Identities = 57/326 (17%), Positives = 108/326 (33%), Gaps = 84/326 (25%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
K+ +G+G FG V+ R K VA+K ++ +A + E V+ QL +H
Sbjct: 10 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHS----N 61
Query: 106 CVQIRNWF-DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 163
VQ+ + + + IV E + SL D+LR D + + + + E + ++
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 164 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 223
+H DL NVL+ + + KV DFG T
Sbjct: 122 NNFVHRDLAARNVLV---------------------------SEDNVAKVSDFGLTKEAS 154
Query: 224 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 283
Q+ + APE + ++ D+WS G +L E+ + + L+ +
Sbjct: 155 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----- 209
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
+ + ++D P+G
Sbjct: 210 ----------------VPRVEKGYKMDAPDGCPP-------------------------- 227
Query: 344 DLTHLLQGLLRYDPTDRLTAREALRH 369
+ +++ D R + +
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (302), Expect = 9e-32
Identities = 66/336 (19%), Positives = 109/336 (32%), Gaps = 91/336 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDK 101
+G G+FG+V+ +E A+KI+ K K E + E +LQ +
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFP- 101
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 161
++ D N ++ G ++ LR+ F R A Q++ ++
Sbjct: 102 --FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 157
Query: 162 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 221
H L +I+ DLKPEN+L+ Y I+V DFG
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGY---------------------------IQVTDFGFAKR 190
Query: 222 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 281
+ + T APE+IL G+ D W++G ++ E+ G F + ++ +
Sbjct: 191 VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250
Query: 282 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 341
P H
Sbjct: 251 VSGKVRFPSHFSS----------------------------------------------- 263
Query: 342 AGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
DL LL+ LL+ D T R + H +F
Sbjct: 264 --DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-31
Identities = 62/333 (18%), Positives = 117/333 (35%), Gaps = 86/333 (25%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKG 102
+ ++G G+FG V + + VA+K++ + +A E+ VL++
Sbjct: 11 TVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT------ 61
Query: 103 GNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 159
R V I + Y + IV + GSSLY L + F + + +IARQ + +
Sbjct: 62 --RHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 160 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 219
++H +IH DLK N+ L +K+ D+ + + S +
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF--------------- 163
Query: 220 TYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLE 276
+ + + APEVI +++ D+++ G +L EL TG+ + N +
Sbjct: 164 -------EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216
Query: 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336
+ M V RG L + +
Sbjct: 217 QIIFM----------------------VGRGYLSPD---------------------LSK 233
Query: 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369
+ + L+ L+ +R + L
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (294), Expect = 3e-31
Identities = 48/270 (17%), Positives = 91/270 (33%), Gaps = 37/270 (13%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDK 101
++ +G G +V D VA+K++R + E + L H
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP- 67
Query: 102 GGNRCVQIRNWFDYRNH----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 156
V + + + IV E + G +L D + E+ +
Sbjct: 68 ---AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQ 122
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
+ F H +IH D+KP N+++ ++ +KV D+ + + +
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT----------- 171
Query: 217 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276
++ T Y +PE G D++S+GC+L E+ TGE F +
Sbjct: 172 ----------AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
Query: 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRR 306
R P + + + V +
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLK 251
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 7e-31
Identities = 62/331 (18%), Positives = 115/331 (34%), Gaps = 80/331 (24%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
K+ ++G G FG+V + + VA+K ++ +A + E +++QL +H R
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQ----R 69
Query: 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
V++ + I I+ E + SL DFL+ + I+ + ++A Q+ E +AF+ +
Sbjct: 70 LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
IH DL+ N+L+ + K+ D+ + + +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG------------------- 169
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
+ APE I +T D+WS G +L E+ T + +
Sbjct: 170 ----AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------ 219
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
+ R R+ P+ +
Sbjct: 220 ---------------IQNLERGYRMVRPDNCPE--------------------------E 238
Query: 345 LTHLLQGLLRYDPTDRLTAREALR--HPFFT 373
L L++ + P DR T FFT
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-30
Identities = 59/330 (17%), Positives = 109/330 (33%), Gaps = 78/330 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++ K+G+G FG+V VAIK ++ EA + E +V+++L +
Sbjct: 20 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHE-----K 73
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
VQ+ + SL DFL+ + + + ++A Q+ +A++ +
Sbjct: 74 LVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+H DL+ N+L+ + KV D+ + + ++
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-------------------- 173
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
+ APE L +T D+WS G +L EL T +
Sbjct: 174 ---AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----------- 219
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
+ +L +V+R R+ P L
Sbjct: 220 ---NREVLDQVERGY-------RMPCPPECPE--------------------------SL 243
Query: 346 THLLQGLLRYDPTDRLTAREALR--HPFFT 373
L+ R +P +R T +FT
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 9e-29
Identities = 60/332 (18%), Positives = 119/332 (35%), Gaps = 85/332 (25%)
Query: 50 KMGEGTFGQVLECWDRERK--EMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGN 104
++G G FG V + + + +K + VA+KI++ ++ + E V+QQL +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP---- 68
Query: 105 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
V++ + + + ++ L +L++N R + E+ Q+ + ++ +
Sbjct: 69 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES 126
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+H DL NVLLV+ Y K+ D+ S D +Y+K
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ------------------- 167
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMER 283
+ + APE I ++ D+WS G ++ E G+ ++ + E AM+E+
Sbjct: 168 --THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
R+ P G
Sbjct: 226 GE----------------------RMGCPAGCPR-------------------------- 237
Query: 344 DLTHLLQGLLRYDPTDRLTARE---ALRHPFF 372
++ L+ YD +R LR+ ++
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-28
Identities = 57/324 (17%), Positives = 104/324 (32%), Gaps = 76/324 (23%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++G G FG V + K+ VAIK +R E + E EV+ +L H +
Sbjct: 8 TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHP----K 61
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
VQ+ + IC+VFE + + F + + + + E +A++ + C
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+IH DL N L+ ++ IKV D+ + D
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-------------------- 161
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 285
+ +PEV ++ D+WS G ++ E+ + + + + +
Sbjct: 162 ---TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------- 211
Query: 286 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 345
E RL P A++ +
Sbjct: 212 --------------VEDISTGFRLYKPRLAST--------------------------HV 231
Query: 346 THLLQGLLRYDPTDRLTAREALRH 369
++ + P DR LR
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (274), Expect = 3e-28
Identities = 51/294 (17%), Positives = 110/294 (37%), Gaps = 31/294 (10%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
+ K+G G +G+V E ++ VA+K ++ E + E V++++ KH
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----N 74
Query: 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
VQ+ I+ E + +L D+LR+ N + ++ +A Q+ + ++
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
IH DL N L+ + +KV D+ S D+
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT----------------------- 171
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL--AMME 282
+ APE + ++ D+W+ G +L E+ T +L + + +
Sbjct: 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231
Query: 283 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336
P+ ++V + D P A ++ +++ + + + + +
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 8e-28
Identities = 57/343 (16%), Positives = 103/343 (30%), Gaps = 95/343 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRE--RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 101
K +GEG FGQVL+ ++ + AIK ++ K E+EVL +L H
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP- 71
Query: 102 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDL 146
+ + ++R ++ + E +L DFLRK+ +
Sbjct: 72 ---NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 147 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 206
+ A + + ++ IH DL N+L+ + K+ D+ S
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK------ 182
Query: 207 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266
+ + A E + +T D+WS G +L E+ +
Sbjct: 183 -------------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223
Query: 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 326
L EK + RL+ P
Sbjct: 224 GTPYCGMTCAEL---------------------YEKLPQGYRLEKPLNCDD--------- 253
Query: 327 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369
++ L++ R P +R + + L
Sbjct: 254 -----------------EVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-27
Identities = 57/355 (16%), Positives = 110/355 (30%), Gaps = 105/355 (29%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKE-----MVAIKIVR--GIKKYREAAMIEIEVLQQLAK 98
+ +G G FG+V+ + VA+K+++ REA M E++++ QL
Sbjct: 40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 99
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR----------------- 140
H+ V + I ++FE L ++LR +
Sbjct: 100 HE----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 141 ----SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196
+ + A Q+ + + F+ +H DL NVL+ + +K+ D+ +
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 256
DS+Y R + APE + +T D+WS G
Sbjct: 216 SDSNYVVRG----------------------NARLPVKWMAPESLFEGIYTIKSDVWSYG 253
Query: 257 CILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 314
+L E+ + G + + K ++ G ++D P
Sbjct: 254 ILLWEIFSLGVNPYPGIPVDANF----------------------YKLIQNGFKMDQPFY 291
Query: 315 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369
A ++ ++Q +D R +
Sbjct: 292 ATE--------------------------EIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (265), Expect = 6e-27
Identities = 49/250 (19%), Positives = 97/250 (38%), Gaps = 30/250 (12%)
Query: 46 KIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHD 100
KI +G G FG+V + +R+ VAIK ++ +K R + E ++ Q H
Sbjct: 29 KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHP 87
Query: 101 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
+ + + I+ E + + D + N F + + + R + + +
Sbjct: 88 N----VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+ D+ +H DL N+L+ S+ KV D+ S + ++ ++
Sbjct: 144 LADMNYVHRDLAARNILVNSNLVCKVSDFGLS-------------------RFLEDDTSD 184
Query: 221 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 279
+ APE I +T D+WS G ++ E+ + GE + N + +
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN 244
Query: 280 MMERVLGPLP 289
+E+ P
Sbjct: 245 AIEQDYRLPP 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 6e-27
Identities = 58/334 (17%), Positives = 111/334 (33%), Gaps = 62/334 (18%)
Query: 47 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRC 106
+ +G+G FG+V + R E VA+KI ++ EI L +H+
Sbjct: 7 LQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFI 63
Query: 107 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAF 160
+ +V + SL+D+L + + +A +E +
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+ H DLK +N+L+ + + D + V +T
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADL--------------------GLAVRHDSATD 163
Query: 221 YERPDQNYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVELCTGEALFQTHEN 274
N+ V T+ Y APEV+ DI+++G + E+ ++ HE+
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223
Query: 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334
+ P + M K V ++ R + P S E+++ + K
Sbjct: 224 YQLPYYDLVPSDPSVEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAK-------- 269
Query: 335 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368
+++ + RLTA +
Sbjct: 270 -------------IMRECWYANGAARLTALRIKK 290
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 7e-27
Identities = 66/333 (19%), Positives = 115/333 (34%), Gaps = 85/333 (25%)
Query: 50 KMGEGTFGQVLECWDRERKE--MVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++G G FG V + R RK+ VAIK+++ K E M E +++ QL +
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNP----Y 70
Query: 106 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
V++ + +V E G L+ FL P+ V E+ Q+ + ++ +
Sbjct: 71 IVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK 128
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+H DL NVLLV+ Y K+ D+ S D SY+
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR------------------- 169
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMER 283
+ + APE I ++ D+WS G + E L G+ ++ + E +A +E+
Sbjct: 170 --SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
Query: 284 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343
R++ P
Sbjct: 228 GK----------------------RMECPPECPP-------------------------- 239
Query: 344 DLTHLLQGLLRYDPTDRLTARE---ALRHPFFT 373
+L L+ Y DR +R +++
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 9e-27
Identities = 61/348 (17%), Positives = 114/348 (32%), Gaps = 98/348 (28%)
Query: 46 KIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAK 98
+G G FG+V+E + VA+K+++ REA M E++VL L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRK----------------NNYRS 141
H V + ++ E L +FLR+ ++ +
Sbjct: 86 HM----NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 142 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201
++ + + Q+ + +AF+ IH DL N+LL K+ D+ + DS+Y
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 202 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 261
+ + APE I +T+ D+WS G L E
Sbjct: 202 VV----------------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239
Query: 262 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRES 320
L + + ++ K ++ G R+ PE
Sbjct: 240 LFSLGSSPYPGMPVDSKFY---------------------KMIKEGFRMLSPE------- 271
Query: 321 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368
H+ ++ +++ DP R T ++ ++
Sbjct: 272 -------------------HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-26
Identities = 51/325 (15%), Positives = 104/325 (32%), Gaps = 78/325 (24%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 105
++G G FG V R + + VAIK+++ + + E +V+ L H+ +
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNL-SHE----K 60
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
VQ+ + I I+ E + + + F + E+ + + E + ++
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+H DL N L+ +KV D+ S + D
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-------------------- 160
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 284
+ PEV++ ++ DIW+ G ++ E+ + G+ ++ N E + +
Sbjct: 161 ---SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 217
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
L RL P A+
Sbjct: 218 L----------------------RLYRPHLASE--------------------------K 229
Query: 345 LTHLLQGLLRYDPTDRLTAREALRH 369
+ ++ +R T + L +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 4e-26
Identities = 62/343 (18%), Positives = 115/343 (33%), Gaps = 90/343 (26%)
Query: 46 KIHSKMGEGTFGQVLECWD---RERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLA 97
++ +G G +G+V + ++ A+K+++ K E E +VL+ +
Sbjct: 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86
Query: 98 KHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 156
+ V + F + ++ + G L+ L + F V+ +++
Sbjct: 87 QS----PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVL 140
Query: 157 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 216
+ +H L +I+ D+K EN+LL S+ ++ + D+ S
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF--------------------- 179
Query: 217 GSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHEN 274
E T Y AP+++ G G D WS+G ++ EL TG + F
Sbjct: 180 --VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237
Query: 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 334
A + R + + +P+ ++
Sbjct: 238 KNSQAEISR-------------------RILKSEPPYPQEMSA----------------- 261
Query: 335 MQHVDHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 372
L+Q LL DP RL A E H FF
Sbjct: 262 ---------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 7e-26
Identities = 44/253 (17%), Positives = 91/253 (35%), Gaps = 34/253 (13%)
Query: 52 GEGTFGQVLECWDR----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 105
G G FG+V + + +++ VAIK ++ +K R + E ++ Q + H
Sbjct: 16 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH-----N 70
Query: 106 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 165
+++ + I+ E + + D + F + + + R + + ++ ++
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 130
Query: 166 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 225
+H DL N+L+ S+ KV D+ S D
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT-------------------- 170
Query: 226 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL--AMMER 283
+ + APE I +T D+WS G ++ E+ T + + A+ +
Sbjct: 171 -SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229
Query: 284 VLGPLPQHMLKRV 296
P P +
Sbjct: 230 FRLPTPMDCPSAI 242
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 4e-25
Identities = 44/325 (13%), Positives = 83/325 (25%), Gaps = 76/325 (23%)
Query: 50 KMGEGTFGQVLECWDRE---RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGN 104
+G G FG V + +K A+K + I + E +++ H N
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHP---N 89
Query: 105 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 164
+ +V + +N + + + Q+ + + F+
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 165 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 224
+H DL N +L +KV D+ + +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA--------------- 194
Query: 225 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 284
+ A E + +T D+WS G +L EL T A N +
Sbjct: 195 -----KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------ 243
Query: 285 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344
++ RL PE +
Sbjct: 244 ---------------TVYLLQGRRLLQPE--------------------------YCPDP 262
Query: 345 LTHLLQGLLRYDPTDRLTAREALRH 369
L ++ R + E +
Sbjct: 263 LYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 5e-24
Identities = 53/348 (15%), Positives = 105/348 (30%), Gaps = 97/348 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQL 96
+ +GEG FGQV+ R VA+K+++ +K + E+E+++ +
Sbjct: 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75
Query: 97 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR--------------KNNYRS 141
KH + + + ++ E +L ++L+ N
Sbjct: 76 GKH----KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 142 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201
+ A Q+ + ++ IH DL NVL+ +K+ D+ + Y
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 202 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 261
K + APE + +T+ D+WS G +L E
Sbjct: 192 KKTT----------------------NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 229
Query: 262 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI 321
+ T +E L + R+D P +
Sbjct: 230 IFTLGGSPYPGVPVEEL---------------------FKLLKEGHRMDKPSNCTN---- 264
Query: 322 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369
+L +++ P+ R T ++ +
Sbjct: 265 ----------------------ELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.4 bits (244), Expect = 6e-24
Identities = 53/353 (15%), Positives = 99/353 (28%), Gaps = 104/353 (29%)
Query: 46 KIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAK 98
+ +GEG FG+V + E MVA+K+++ + E ++ +
Sbjct: 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS---------------- 141
V++ +C++FE + L +FLR + +
Sbjct: 76 P-----NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 142 ------FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195
IARQ+ +A++ + +H DL N L+ + +K+ D+ S +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSV 255
Y + PE I +T D+W+
Sbjct: 191 YSADYYKADGN----------------------DAIPIRWMPPESIFYNRYTTESDVWAY 228
Query: 256 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGA 315
G +L E+ + E + L PE
Sbjct: 229 GVVLWEIFSYGLQPYYGMAHEEV---------------------IYYVRDGNILACPENC 267
Query: 316 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368
+L +L++ P DR + R
Sbjct: 268 PL--------------------------ELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 7e-24
Identities = 55/349 (15%), Positives = 110/349 (31%), Gaps = 96/349 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAK 98
+ ++G+G+FG V E + E + VAIK V + R + E V+++
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS--------FPIDLVRE 149
H V++ ++ E + L +LR + + +
Sbjct: 83 H-----HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 150 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 209
+A ++ + +A+++ +H DL N ++ +K+ D+ + + Y K
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK--- 194
Query: 210 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269
+ + +PE + +T D+WS G +L E+ T
Sbjct: 195 -------------------GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235
Query: 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 329
+ E + + G LD P
Sbjct: 236 YQGLSNEQV---------------------LRFVMEGGLLDKP----------------- 257
Query: 330 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR------HPFF 372
D+ L L++ +Y+P R + E + P F
Sbjct: 258 ---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 2e-23
Identities = 42/253 (16%), Positives = 93/253 (36%), Gaps = 35/253 (13%)
Query: 46 KIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAK 98
++ K+G+G+FG V + VA+K ++ + + + E+ + L
Sbjct: 11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-D 69
Query: 99 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 158
H +++ + +V E + + F + + A Q+ E +
Sbjct: 70 HRN----LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 159 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 218
++ IH DL N+LL + + +K+ D+ P++ ++
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-------------- 170
Query: 219 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 277
Q + + APE + +++ D W G L E+ T G+ + +
Sbjct: 171 -------QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223
Query: 278 LAMMERVLGPLPQ 290
L +++ LP+
Sbjct: 224 LHKIDKEGERLPR 236
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 2e-23
Identities = 53/329 (16%), Positives = 91/329 (27%), Gaps = 81/329 (24%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHD 100
++ +GEG FG V + + VAIK + RE + E ++Q H
Sbjct: 10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 68
Query: 101 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 160
V++ N + I+ E + S + + A QL +A+
Sbjct: 69 ----HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 161 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 220
+ +H D+ NVL+ S++ +K+ D+ S + + Y
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--------------- 168
Query: 221 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280
+ APE I +T D+W G + E+ +
Sbjct: 169 --------GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-- 218
Query: 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340
+ RL P
Sbjct: 219 -------------------IGRIENGERLPMPPNCPP----------------------- 236
Query: 341 SAGDLTHLLQGLLRYDPTDRLTAREALRH 369
L L+ YDP+ R E
Sbjct: 237 ---TLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 3e-23
Identities = 50/332 (15%), Positives = 96/332 (28%), Gaps = 85/332 (25%)
Query: 46 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA--------MIEIEVLQQLA 97
K +G G FG V + E V I + IK+ REA + E V+ +
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA--IKELREATSPKANKEILDEAYVMASV- 68
Query: 98 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 157
+ ++ I L D++R++ + + Q+ +
Sbjct: 69 DNP----HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKG 123
Query: 158 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 217
+ ++ D ++H DL NVL+ + +++K+ D+ + + +
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------------- 170
Query: 218 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277
+ A E IL +T+ D+WS G + EL T +
Sbjct: 171 ---------EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
Query: 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 337
+ + + RL P
Sbjct: 222 I---------------------SSILEKGERLPQPPICTI-------------------- 240
Query: 338 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369
D+ ++ D R RE +
Sbjct: 241 ------DVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 2e-21
Identities = 55/347 (15%), Positives = 107/347 (30%), Gaps = 95/347 (27%)
Query: 46 KIHSKMGEGTFGQVLECWDRERK-----EMVAIKIVR--GIKKYREAAMIEIEVLQQLAK 98
K+ +G G FGQV+E VA+K+++ A M E+++L +
Sbjct: 16 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75
Query: 99 HDKGGNRCVQIRN-WFDYRNHICIVFEKL-GSSLYDFLRKNNY--------------RSF 142
H V + + ++ E +L +LR
Sbjct: 76 H----LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 143 PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202
++ + + Q+ + + F+ IH DL N+LL +K+ D+ + KD Y
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 203 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 262
++ + APE I +T D+WS G +L E+
Sbjct: 192 RK----------------------GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 229
Query: 263 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 322
+ A + + +R+
Sbjct: 230 FSLGASPYPGVK-------------IDEEFCRRLK------------------------- 251
Query: 323 SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369
+ M+ D++ ++ + +P+ R T E + H
Sbjct: 252 --------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.0 bits (155), Expect = 1e-12
Identities = 34/223 (15%), Positives = 64/223 (28%), Gaps = 39/223 (17%)
Query: 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGG 103
D I MGEG V C+ + E +K + G +++ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 104 NR-CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
R + + + + L + + ++ E+ +LE +A +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 221
++H DL NVL+ I +IDF S
Sbjct: 121 HRGIVHGDLSQYNVLVSEEG----------------------------IWIIDFPQSVEV 152
Query: 222 ERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVE 261
I+ R I+ + DI S +++
Sbjct: 153 GEEGWREIL----ERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} Length = 395 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Score = 43.3 bits (101), Expect = 3e-05
Identities = 24/175 (13%), Positives = 49/175 (28%), Gaps = 10/175 (5%)
Query: 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 102
K++ G + + E+ + + A + ++ +
Sbjct: 106 LGPKLYGIFSGGRLEEYIPSRPLSCHEISLAHMST-----KIAKRVAKVHQLEVPIWKEP 160
Query: 103 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 162
C ++ W + + N +DL RE+
Sbjct: 161 DYLCEALQRWLKQLTGTVDAEHRFDLPEECGVSSVNC----LDLARELEFLRAHISLSKS 216
Query: 163 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK-DSSYFKRMPKSSAIKVIDF 216
+ H DL+ N+LL + + S T +S P + +IDF
Sbjct: 217 PVTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDF 271
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 379 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.27 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.58 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.58 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.05 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.16 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.09 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=415.65 Aligned_cols=250 Identities=25% Similarity=0.426 Sum_probs=214.0
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
..|++.+.||+|+||+||+|+++.+++.||+|++... ......+.+|+.+++.+ .||||+++++++.+++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-----RHPNILRLYGYFHDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-----CCCCCCeEEEEEEECCE
Confidence 3588999999999999999999999999999998632 23345667899988887 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill------------------- 139 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL------------------- 139 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-------------------
T ss_pred EEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee-------------------
Confidence 99999999 899999998765 69999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.+||+|||.|....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 140 --------~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 211 (263)
T d2j4za1 140 --------GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211 (263)
T ss_dssp --------CTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred --------cCCCCEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH
Confidence 455667888888876544332 34579999999999999999999999999999999999999998877666
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+.....| +..++++++||.+||+.|
T Consensus 212 ~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~~li~~~L~~d 242 (263)
T d2j4za1 212 TYKRISRVEFTFP-------------------------------------------------DFVTEGARDLISRLLKHN 242 (263)
T ss_dssp HHHHHHTTCCCCC-------------------------------------------------TTSCHHHHHHHHHHTCSS
T ss_pred HHHHHHcCCCCCC-------------------------------------------------ccCCHHHHHHHHHHccCC
Confidence 5554433222222 135678999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~ 375 (379)
|++|||++|+|+||||+++
T Consensus 243 p~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 243 PSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp GGGSCCHHHHHTCHHHHHH
T ss_pred HhHCcCHHHHHcCcCcCCc
Confidence 9999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=413.96 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=214.7
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
...|++.++||+|+||+||+|.++.+|+.||+|+++.. ......+.+|+.+++++ .|+||+++++++.+++.+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-----CCCCEeeEeEEEEECCEEE
Confidence 35699999999999999999999999999999998743 23456678899999988 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ |++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl--------------------- 149 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL--------------------- 149 (293)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------
T ss_pred EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---------------------
Confidence 999999 99999988765 49999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.+||+|||+|....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 150 ------~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 223 (293)
T d1yhwa1 150 ------GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (293)
T ss_dssp ------CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ------CCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH
Confidence 555678888888887543322 34579999999999999999999999999999999999999998877665
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.....+... .+...++++++||.+||+.|
T Consensus 224 ~~~~~~~~~~~~~~----------------------------------------------~~~~~s~~~~~li~~~L~~d 257 (293)
T d1yhwa1 224 ALYLIATNGTPELQ----------------------------------------------NPEKLSAIFRDFLNRCLDMD 257 (293)
T ss_dssp HHHHHHHHCSCCCS----------------------------------------------SGGGSCHHHHHHHHHHTCSS
T ss_pred HHHHHHhCCCCCCC----------------------------------------------CcccCCHHHHHHHHHHccCC
Confidence 55444332211110 11246788999999999999
Q ss_pred CCCCcCHHHHhcCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTR 374 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~ 374 (379)
|.+|||++|+|+||||+.
T Consensus 258 P~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 258 VEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp TTTSCCHHHHTTCGGGGG
T ss_pred hhHCcCHHHHhcCHhhCC
Confidence 999999999999999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-58 Score=413.59 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=206.8
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
.|++.++||+|+||+||+|+++.+|+.||+|+++... .....+.+|+.+++++ .|+||+++++++.+++.+|+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-----CCTTBCCEEEEEEETTEEEE
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-----CCCCEeeEeeeeccCceeEE
Confidence 5899999999999999999999999999999986432 2345677899999888 78999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 81 vmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---------------------- 136 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---------------------- 136 (271)
T ss_dssp EEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----------------------
T ss_pred EEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE----------------------
Confidence 99999 889999986654 69999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCC-----CCcccccCCccchhhhhCCCC-CCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
+.++.+||+|||+|...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.
T Consensus 137 -----~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 137 -----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp -----CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred -----CCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 45566888888887643222 134579999999999988876 5789999999999999999999976543
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
..............+ ..+...++++.+||.+||+
T Consensus 212 ~~~~~~~~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~L~ 245 (271)
T d1nvra_ 212 SCQEYSDWKEKKTYL----------------------------------------------NPWKKIDSAPLALLHKILV 245 (271)
T ss_dssp TSHHHHHHHTTCTTS----------------------------------------------TTGGGSCHHHHHHHHHHSC
T ss_pred HHHHHHHHhcCCCCC----------------------------------------------CccccCCHHHHHHHHHHcC
Confidence 222211111111100 0123467889999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCCCCc
Q 017021 355 YDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
.||++|||++|+|+||||++...
T Consensus 246 ~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 246 ENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp SSTTTSCCHHHHTTCTTTTCCCC
T ss_pred CChhHCcCHHHHhcCHhhCcCCC
Confidence 99999999999999999986543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-57 Score=415.18 Aligned_cols=257 Identities=25% Similarity=0.430 Sum_probs=204.7
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
-.|++.+.||+|+||+||+|+++.+|+.||+|++.... .....+.+|+.++..+ .||||+++++++++++.+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-----KHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-----CCTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEE
Confidence 34899999999999999999999999999999997432 2345566799999887 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||| |++|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+||++...
T Consensus 84 lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~------------------ 143 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL------------------ 143 (307)
T ss_dssp EEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS------------------
T ss_pred EEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc------------------
Confidence 999999 899999998754 69999999999999999999999999999999999999432
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
+.++.+||+|||+|....... ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 144 ------~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 217 (307)
T d1a06a_ 144 ------DEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217 (307)
T ss_dssp ------STTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------CCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 356778999999987654433 346799999999999999999999999999999999999999998777666
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+....++.. .++..++++.+||.+||+.||
T Consensus 218 ~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~dP 252 (307)
T d1a06a_ 218 FEQILKAEYEFDSP---------------------------------------------YWDDISDSAKDFIRHLMEKDP 252 (307)
T ss_dssp HHHHHTTCCCCCTT---------------------------------------------TTTTSCHHHHHHHHHHSCSSG
T ss_pred HHHHhccCCCCCCc---------------------------------------------cccCCCHHHHHHHHHHccCCH
Confidence 55554432222211 123467889999999999999
Q ss_pred CCCcCHHHHhcCCCCCCC
Q 017021 358 TDRLTAREALRHPFFTRD 375 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f~~~ 375 (379)
++|||++|+++||||++.
T Consensus 253 ~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 253 EKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp GGSCCHHHHHHSTTTTSS
T ss_pred hHCcCHHHHhcCHhhCCC
Confidence 999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-57 Score=410.13 Aligned_cols=256 Identities=25% Similarity=0.435 Sum_probs=214.1
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.-.|++++.||+|+||+||+|+++.+|+.||+|+++.. ......+.+|+.+++++ .||||+++++++.+++..|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-----DHPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEeeCCeEE
Confidence 34689999999999999999999999999999999743 34456788899999998 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|.+++.+.. ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 86 lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll--------------------- 143 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF--------------------- 143 (288)
T ss_dssp EEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------
T ss_pred EEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---------------------
Confidence 999999 899999976643 369999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCC---CCcccccCCccchhhhh-----CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
+.++.+||+|||+|...... .....||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+
T Consensus 144 ------~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 144 ------TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp ------CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ------CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence 55667888888887543221 13457999999999984 45688999999999999999999999988
Q ss_pred CchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhh
Q 017021 272 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 351 (379)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 351 (379)
.+..+....+.+...+... .+...++++.+||.+
T Consensus 218 ~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~s~~~~~li~~ 251 (288)
T d2jfla1 218 LNPMRVLLKIAKSEPPTLA----------------------------------------------QPSRWSSNFKDFLKK 251 (288)
T ss_dssp SCGGGHHHHHHHSCCCCCS----------------------------------------------SGGGSCHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCC----------------------------------------------ccccCCHHHHHHHHH
Confidence 7766655544432211110 012467889999999
Q ss_pred ccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 352 LLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 352 ~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
||+.||++|||++|+++||||+.+.
T Consensus 252 ~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 252 CLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp HSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred HccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999998653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-57 Score=409.91 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=213.7
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
..|++.+.||+|+||+||+|+++.+|+.||+|+++.. ......+.+|+.++.++ .|+||+++++++.+++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-----DHPFFVKLYFTFQDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CSTTBCCEEEEEECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-----CCCCeeEEEEEEEECCE
Confidence 3589999999999999999999999999999999732 23345677899999888 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+|+||||+ +++|.+++...+ .+++..++.++.|++.||+|||+.||+||||||+|||+
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll------------------- 141 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL------------------- 141 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-------------------
T ss_pred EEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc-------------------
Confidence 99999999 899999988765 69999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++|+|||.|....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 142 --------~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 142 --------NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp --------CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --------CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 555678888888886543221 2357999999999999999999999999999999999999999987
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+.+.....| ...++++++||++|
T Consensus 214 ~~~~~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 214 NEYLIFQKIIKLEYDFP-------------------------------------------------EKFFPKARDLVEKL 244 (288)
T ss_dssp SHHHHHHHHHTTCCCCC-------------------------------------------------TTCCHHHHHHHHTT
T ss_pred CHHHHHHHHHcCCCCCC-------------------------------------------------ccCCHHHHHHHHHH
Confidence 77666555443222221 13567899999999
Q ss_pred cccCCCCCcCHHH------HhcCCCCCCCC
Q 017021 353 LRYDPTDRLTARE------ALRHPFFTRDH 376 (379)
Q Consensus 353 L~~dP~~Rpta~e------~l~hp~f~~~~ 376 (379)
|+.||++|||++| +++||||++.+
T Consensus 245 L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 245 LVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 9999999999998 58999998865
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-56 Score=407.72 Aligned_cols=260 Identities=24% Similarity=0.434 Sum_probs=220.6
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
-.|++.++||+|+||+||+|+++.+|+.||+|+++... .....+.+|+.+++++ .|+||+++++++++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-----QHPNVITLHEVYEN 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEC
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEE
Confidence 35899999999999999999999999999999986321 2345678899999998 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
++.+|+||||| +++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~------------ 150 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN------------ 150 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS------------
T ss_pred CCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCC------------
Confidence 99999999999 899999998765 699999999999999999999999999999999999996543
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
.....+||+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 151 -----------~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 151 -----------VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp -----------SSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------CcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 234569999999987654432 4467999999999999989999999999999999999999999988
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+.+.....+.. .+...+..+++||.+|
T Consensus 220 ~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~ 254 (293)
T d1jksa_ 220 TKQETLANVSAVNYEFEDE---------------------------------------------YFSNTSALAKDFIRRL 254 (293)
T ss_dssp SHHHHHHHHHTTCCCCCHH---------------------------------------------HHTTSCHHHHHHHHTT
T ss_pred CHHHHHHHHHhcCCCCCch---------------------------------------------hcCCCCHHHHHHHHHH
Confidence 7777666554443333322 1234678899999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCCCCc
Q 017021 353 LRYDPTDRLTAREALRHPFFTRDHL 377 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~~~~ 377 (379)
|+.||++|||++|+++||||+..+.
T Consensus 255 L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 255 LVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp SCSSGGGSCCHHHHHHSTTTCC---
T ss_pred ccCChhHCcCHHHHhcCcccCCCCh
Confidence 9999999999999999999987543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-56 Score=415.93 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=220.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc-chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
.|+|.+.||+|+||.||+|+++.+|+.||+|++... ......+.+|+.+++++ .|+||+++++++.+++.+|+|
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-----RHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-----CCTTBCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEE
Confidence 589999999999999999999999999999999743 23345677899999998 789999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|||| |++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+..
T Consensus 102 mE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~--------------------- 159 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT--------------------- 159 (350)
T ss_dssp ECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS---------------------
T ss_pred EEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc---------------------
Confidence 9999 999999986543 25999999999999999999999999999999999999943
Q ss_pred cccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 160 ----~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~ 235 (350)
T d1koaa2 160 ----KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 235 (350)
T ss_dssp ----TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ----CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 234679999999987655444 34679999999999999999999999999999999999999999888777776
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.+.......+.. .....++++++||.+||+.||++
T Consensus 236 ~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~dP~~ 270 (350)
T d1koaa2 236 NVKSCDWNMDDS---------------------------------------------AFSGISEDGKDFIRKLLLADPNT 270 (350)
T ss_dssp HHHHTCCCSCCG---------------------------------------------GGGGCCHHHHHHHHHHCCSSGGG
T ss_pred HHHhCCCCCCcc---------------------------------------------cccCCCHHHHHHHHHHccCChhH
Confidence 665544333221 11246778999999999999999
Q ss_pred CcCHHHHhcCCCCCCCC
Q 017021 360 RLTAREALRHPFFTRDH 376 (379)
Q Consensus 360 Rpta~e~l~hp~f~~~~ 376 (379)
|||++|+|+||||++.+
T Consensus 271 R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 271 RMTIHQALEHPWLTPGN 287 (350)
T ss_dssp SCCHHHHHHSTTTSCTT
T ss_pred CcCHHHHhcCcccCCCC
Confidence 99999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.9e-56 Score=416.08 Aligned_cols=257 Identities=26% Similarity=0.466 Sum_probs=220.5
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
.|++.++||+|+||.||+|+++.+|+.||+|+++... .....+.+|+.++.++ .|+||+++++++++++.+|+|
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-----HHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CSTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEE
Confidence 4899999999999999999999999999999997543 2345566799888887 789999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|||| |++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 105 mE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~--------------------- 162 (352)
T d1koba_ 105 LEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET--------------------- 162 (352)
T ss_dssp EECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS---------------------
T ss_pred EEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc---------------------
Confidence 9999 999998876543 35999999999999999999999999999999999999942
Q ss_pred cccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 279 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~ 279 (379)
...+.+||+|||+|....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 163 ----~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~ 238 (352)
T d1koba_ 163 ----KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 238 (352)
T ss_dssp ----TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred ----cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 245679999999998766544 33579999999999999999999999999999999999999999888877776
Q ss_pred HHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCC
Q 017021 280 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 359 (379)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 359 (379)
.+.+....++.. .+...++++.+||.+||+.||.+
T Consensus 239 ~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~dp~~ 273 (352)
T d1koba_ 239 NVKRCDWEFDED---------------------------------------------AFSSVSPEAKDFIKNLLQKEPRK 273 (352)
T ss_dssp HHHHCCCCCCSS---------------------------------------------TTTTSCHHHHHHHHTTSCSSGGG
T ss_pred HHHhCCCCCCcc---------------------------------------------cccCCCHHHHHHHHHHccCChhH
Confidence 666544443321 11246788999999999999999
Q ss_pred CcCHHHHhcCCCCCCCC
Q 017021 360 RLTAREALRHPFFTRDH 376 (379)
Q Consensus 360 Rpta~e~l~hp~f~~~~ 376 (379)
|||++|+|+||||++..
T Consensus 274 R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 274 RLTVHDALEHPWLKGDH 290 (352)
T ss_dssp SCCHHHHHTSTTTSSCC
T ss_pred CcCHHHHhcCHhhCCCc
Confidence 99999999999998653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-57 Score=416.78 Aligned_cols=295 Identities=22% Similarity=0.330 Sum_probs=211.4
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
+..-.|++.++||+|+||+||+|+++.+|+.||+|+++.. ......+.+|+.++.++ .||||+++++++.+++
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDG 77 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-----CCTTBCCEEEEEECSS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECC
Confidence 3455789999999999999999999999999999999743 33345677898888877 7899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
++|+||||+ +++|.+++.+.+ .+++..+..++.||+.||.|||+ .||+||||||+|||+
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl----------------- 138 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV----------------- 138 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE-----------------
T ss_pred EEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE-----------------
Confidence 999999999 899999998765 69999999999999999999997 599999999999999
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCC-CCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 274 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~ 274 (379)
+.++.+||+|||+|..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.
T Consensus 139 ----------~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 139 ----------NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp ----------CTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ----------CCCCCEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 5566788888888864322 23456899999999999999999999999999999999999999987665
Q ss_pred HHHHHHHHH-HcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 275 LEHLAMMER-VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 275 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
.+....... ..+...... .............. ..........+........+. ........+.++.|||.+||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~dli~~~L 282 (322)
T d1s9ja_ 209 KELELMFGCQVEGDAAETP-PRPRTPGRPLSSYG-MDSRPPMAIFELLDYIVNEPP----PKLPSGVFSLEFQDFVNKCL 282 (322)
T ss_dssp THHHHHC--------------------------------CCCCHHHHHHHHHTSCC----CCCCBTTBCHHHHHHHHHHT
T ss_pred HHHHHHHHHHhcCCcccCC-cccccccccccccc-cccccchhHHHHHhhhhccCC----ccCccccCCHHHHHHHHHHc
Confidence 443222111 111111100 00000000000000 000000000000000000000 00001235788999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~ 374 (379)
+.||.+||||+|+|+||||++
T Consensus 283 ~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 283 IKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp CSSTTTSCCHHHHHTSHHHHH
T ss_pred CCChhHCcCHHHHhhCHhhCc
Confidence 999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-56 Score=398.33 Aligned_cols=252 Identities=23% Similarity=0.406 Sum_probs=205.9
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee--
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-- 115 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~-- 115 (379)
.+..|++.++||+|+||+||+|+++.+++.||+|++... ......+.+|+++++++ +||||+++++++++
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWESTV 81 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEES
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEeecc
Confidence 444567888999999999999999999999999998743 23345667899988887 78999999999875
Q ss_pred --cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCcEEEecccccccCCCc
Q 017021 116 --RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 116 --~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
+..+|+||||+ +++|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~----------- 148 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT----------- 148 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES-----------
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee-----------
Confidence 45789999999 999999998764 6999999999999999999999998 99999999999993
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.++.+||+|||+|....... ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||
T Consensus 149 ---------------~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf 212 (270)
T d1t4ha_ 149 ---------------GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 212 (270)
T ss_dssp ---------------STTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ---------------CCCCCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCC
Confidence 235678999999887544433 34679999999999876 6999999999999999999999999
Q ss_pred CCCchHHHH-HHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 270 QTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 270 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
......+.. ..+.. +..|. ..+...++++.+|
T Consensus 213 ~~~~~~~~~~~~i~~--~~~~~---------------------------------------------~~~~~~~~~~~~l 245 (270)
T d1t4ha_ 213 SECQNAAQIYRRVTS--GVKPA---------------------------------------------SFDKVAIPEVKEI 245 (270)
T ss_dssp TTCSSHHHHHHHHTT--TCCCG---------------------------------------------GGGGCCCHHHHHH
T ss_pred CCcccHHHHHHHHHc--CCCCc---------------------------------------------ccCccCCHHHHHH
Confidence 765443322 22111 11111 1123466789999
Q ss_pred HhhccccCCCCCcCHHHHhcCCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFFT 373 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f~ 373 (379)
|.+||+.||++|||++|+|+||||+
T Consensus 246 i~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 246 IEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=408.17 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=216.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++++.||+|+||.||+|+++.+|+.||+|+++.. ......+.+|+.+++.+ .||||+++++++++++.+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CCTTBCCEEEEEECSSEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-----CCCCEEEEEeeecccccc
Confidence 588999999999999999999999999999999743 22345677888888887 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ ||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl-------------------- 138 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML-------------------- 138 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--------------------
T ss_pred ccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe--------------------
Confidence 9999999 999999998865 68999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+.++.+||+|||.|+...... ...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 139 -------~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~ 211 (337)
T d1o6la_ 139 -------DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211 (337)
T ss_dssp -------CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH
Confidence 566678888888887543322 3468999999999999999999999999999999999999999988877
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.......| ...++++++||++||++
T Consensus 212 ~~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~dli~~~L~~ 242 (337)
T d1o6la_ 212 RLFELILMEEIRFP-------------------------------------------------RTLSPEAKSLLAGLLKK 242 (337)
T ss_dssp HHHHHHHHCCCCCC-------------------------------------------------TTSCHHHHHHHHHHTCS
T ss_pred HHHHHHhcCCCCCC-------------------------------------------------ccCCHHHHHHHHhhccC
Confidence 66655544332222 23678899999999999
Q ss_pred CCCCCcC-----HHHHhcCCCCCCCC
Q 017021 356 DPTDRLT-----AREALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rpt-----a~e~l~hp~f~~~~ 376 (379)
||.+|++ ++|+++||||++.+
T Consensus 243 dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 243 DPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred CchhhcccccccHHHHHcCcccccCC
Confidence 9999994 99999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-55 Score=406.03 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=219.1
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
..|++.++||+|+||+||+|+++.+|+.||+|+++.. ......+.+|+.+++.+ .||||+++++++.+++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-----THPFIIRMWGTFQDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CBTTBCCEEEEEECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-----cCcChhheeeeEeeCCe
Confidence 4689999999999999999999999999999999742 23345667888888887 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.|+||||+ |++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl------------------- 137 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL------------------- 137 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE-------------------
T ss_pred eeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE-------------------
Confidence 99999999 899999988765 68899999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
+.++.+||+|||.|..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 138 --------~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 209 (316)
T d1fota_ 138 --------DKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209 (316)
T ss_dssp --------CTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred --------cCCCCEEEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH
Confidence 566778999999888766666677899999999999999999999999999999999999999998877776
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+.....| ...++++.++|.+||+.||
T Consensus 210 ~~~i~~~~~~~p-------------------------------------------------~~~s~~~~~li~~~L~~dp 240 (316)
T d1fota_ 210 YEKILNAELRFP-------------------------------------------------PFFNEDVKDLLSRLITRDL 240 (316)
T ss_dssp HHHHHHCCCCCC-------------------------------------------------TTSCHHHHHHHHHHTCSCT
T ss_pred HHHHHcCCCCCC-------------------------------------------------CCCCHHHHHHHHHHhhhCH
Confidence 665544332222 1356789999999999999
Q ss_pred CCCc-----CHHHHhcCCCCCCCC
Q 017021 358 TDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 358 ~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
.+|+ |++|+++||||++..
T Consensus 241 ~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 241 SQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp TTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HhccccchhhHHHHHcCcccccCC
Confidence 9996 999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=407.90 Aligned_cols=256 Identities=22% Similarity=0.386 Sum_probs=223.0
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
.|++.+.||+|+||+||+|.++.+|+.||+|+++........+.+|+.++..+ .|+||+++++++++++.+|+||
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-----RHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-----CCTTBCCEEEEEEETTEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECCEEEEEE
Confidence 48899999999999999999999999999999986665566778899999888 7899999999999999999999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
||| |++|.+++...+ ..+++..+..++.||+.||+|||+.||+||||||+|||++.
T Consensus 81 E~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~---------------------- 137 (321)
T d1tkia_ 81 EFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT---------------------- 137 (321)
T ss_dssp CCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS----------------------
T ss_pred ecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC----------------------
Confidence 999 899999997654 35899999999999999999999999999999999999953
Q ss_pred ccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHHHHH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 280 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~~~~ 280 (379)
+....++|+|||.+....... ....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....
T Consensus 138 ---~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~ 214 (321)
T d1tkia_ 138 ---RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN 214 (321)
T ss_dssp ---SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred ---CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 244578999999987654433 345789999999999999999999999999999999999999998888777777
Q ss_pred HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCC
Q 017021 281 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 360 (379)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 360 (379)
+.+....++... +...++++++||.+||+.||.+|
T Consensus 215 i~~~~~~~~~~~---------------------------------------------~~~~s~~~~~li~~~L~~dp~~R 249 (321)
T d1tkia_ 215 IMNAEYTFDEEA---------------------------------------------FKEISIEAMDFVDRLLVKERKSR 249 (321)
T ss_dssp HHHTCCCCCHHH---------------------------------------------HTTSCHHHHHHHHTTSCSSGGGS
T ss_pred HHhCCCCCChhh---------------------------------------------ccCCCHHHHHHHHHHccCChhHC
Confidence 666554444432 23467889999999999999999
Q ss_pred cCHHHHhcCCCCCCC
Q 017021 361 LTAREALRHPFFTRD 375 (379)
Q Consensus 361 pta~e~l~hp~f~~~ 375 (379)
||++|+++||||++.
T Consensus 250 ~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 250 MTASEALQHPWLKQK 264 (321)
T ss_dssp CCHHHHHHSHHHHSC
T ss_pred cCHHHHhcCHhhccC
Confidence 999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-56 Score=398.92 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=198.8
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee--cc
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RN 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~--~~ 117 (379)
..|++.+.||+|+||+||+|+++.+|+.||+|++... +.....+.+|+.++.++ .||||+++++++.+ ++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-----KHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-----CCTTBCCEEEEEEC----
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-----CCCCEeeEEEEEEeCCCC
Confidence 4689999999999999999999999999999998643 23345567788887777 78999999998854 56
Q ss_pred eEEEEEeCC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CcccCCCCCcEEEecccccccCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
.+|+||||| +|+|.+++.+. ....+++..++.++.||+.||.|||++| |+||||||+|||+
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll----------- 147 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL----------- 147 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE-----------
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc-----------
Confidence 789999999 89999998642 2246999999999999999999999977 9999999999999
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCC
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 266 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~ 266 (379)
+.++.+||+|||.|....... ....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 148 ----------------~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~ 211 (269)
T d2java1 148 ----------------DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 211 (269)
T ss_dssp ----------------CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ----------------CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCC
Confidence 556778888888887544332 3467999999999999999999999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||.+.+..+....+.....+. .+..+++++.
T Consensus 212 ~Pf~~~~~~~~~~~i~~~~~~~------------------------------------------------~~~~~s~~l~ 243 (269)
T d2java1 212 PPFTAFSQKELAGKIREGKFRR------------------------------------------------IPYRYSDELN 243 (269)
T ss_dssp CSCCCSSHHHHHHHHHHTCCCC------------------------------------------------CCTTSCHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCC------------------------------------------------CCcccCHHHH
Confidence 9998877666555443321110 0123677899
Q ss_pred HHHhhccccCCCCCcCHHHHhcCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREALRHPFF 372 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~l~hp~f 372 (379)
+||++||+.||.+|||++|+++|||+
T Consensus 244 ~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 244 EIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-55 Score=408.59 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=219.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
-.|+++++||+|+||.||+|+++.+|+.||||++... ......+.+|+.++..+ .|+||+++++++.+...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-----CCCcEeecccccccccc
Confidence 3689999999999999999999999999999999632 22345567888888877 78999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
.++||||+ +++|.+.+...+ .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl------------------- 174 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI------------------- 174 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE-------------------
T ss_pred cccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc-------------------
Confidence 99999999 999999998765 69999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
+.++.+||+|||+|+..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 175 --------~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 246 (350)
T d1rdqe_ 175 --------DQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp --------CTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred --------CCCCCEEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH
Confidence 566778999999988776666677899999999999999999999999999999999999999998777666
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.......| ...++++.+||++||+.||
T Consensus 247 ~~~i~~~~~~~p-------------------------------------------------~~~s~~~~~li~~~L~~dP 277 (350)
T d1rdqe_ 247 YEKIVSGKVRFP-------------------------------------------------SHFSSDLKDLLRNLLQVDL 277 (350)
T ss_dssp HHHHHHCCCCCC-------------------------------------------------TTCCHHHHHHHHHHSCSCT
T ss_pred HHHHhcCCCCCC-------------------------------------------------ccCCHHHHHHHHHHhhhCH
Confidence 665544332222 1367789999999999999
Q ss_pred CCCc-----CHHHHhcCCCCCCCC
Q 017021 358 TDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 358 ~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
.+|+ |++|+++||||+..+
T Consensus 278 ~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 278 TKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp TTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred HhccccccccHHHHHcCccccCCC
Confidence 9995 999999999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-55 Score=404.72 Aligned_cols=252 Identities=26% Similarity=0.356 Sum_probs=208.4
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 117 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~ 117 (379)
...|++.++||+|+||+||+|+++.+|+.||||+++... .....+.+|+.++.++ .|+||+++++++.+++
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-----RHPNTIQYRGCYLREH 88 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETT
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-----CCCCEeeEEEEEEECC
Confidence 456888999999999999999999999999999997432 2234567788888887 7899999999999999
Q ss_pred eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 ~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
.+|+||||| +++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----------------- 149 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----------------- 149 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE-----------------
T ss_pred EEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC-----------------
Confidence 999999999 777766655543 699999999999999999999999999999999999994
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhC---CCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
.++.+||+|||.|..... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+
T Consensus 150 ----------~~~~~Kl~DFG~a~~~~~-~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 150 ----------EPGLVKLGDFGSASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp ----------TTTEEEECCCTTCBSSSS-BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ----------CCCCEEEeecccccccCC-CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 455677888887765433 234579999999999864 358899999999999999999999998877
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.+...+.+. ...+++.+.+||++||
T Consensus 219 ~~~~~~~i~~~~~~~~~-----------------------------------------------~~~~s~~~~~li~~~L 251 (309)
T d1u5ra_ 219 AMSALYHIAQNESPALQ-----------------------------------------------SGHWSEYFRNFVDSCL 251 (309)
T ss_dssp HHHHHHHHHHSCCCCCS-----------------------------------------------CTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCC-----------------------------------------------CCCCCHHHHHHHHHHC
Confidence 66655444432211110 1236778999999999
Q ss_pred ccCCCCCcCHHHHhcCCCCCCC
Q 017021 354 RYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+.||.+|||++|+|+||||.+.
T Consensus 252 ~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 252 QKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp CSSGGGSCCHHHHTTCHHHHSC
T ss_pred cCChhHCcCHHHHHhCHHhcCC
Confidence 9999999999999999999764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-55 Score=398.39 Aligned_cols=281 Identities=32% Similarity=0.501 Sum_probs=226.3
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|+++++||+|+||+||+|+++.+|+.||+|+++... .....+.+|+.+++++ +|+||+++++++.+++.+|
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-----~Hp~Iv~~~~~~~~~~~~~ 77 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHPNIVKLLDVIHTENKLY 77 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-----CCCcEEEecccccccccee
Confidence 5889999999999999999999999999999996432 2356677899998887 7899999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
+||||+++++.+.+.......+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---------------------- 135 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---------------------- 135 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----------------------
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee----------------------
Confidence 9999997777777766655679999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCC-CCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.+..+||+|||.|....... ....||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+..+
T Consensus 136 -----~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~ 210 (298)
T d1gz8a_ 136 -----NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 210 (298)
T ss_dssp -----CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----cccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH
Confidence 566678888998886544332 3457999999999987766 4789999999999999999999999988888
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+..+.+.+..++.+....... ...+... ...........+.++.+||.+||+.|
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~---------------~~~~~~~~~~~s~~~~dll~~mL~~d 270 (298)
T d1gz8a_ 211 QLFRIFRTLGTPDEVVWPGVTSMPDYK-----PSFPKWA---------------RQDFSKVVPPLDEDGRSLLSQMLHYD 270 (298)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCC-----TTSCCCC---------------CCCHHHHSTTCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHhcCCCchhhccccccccccc-----ccccccc---------------ccchhhhccCCCHHHHHHHHHHccCC
Confidence 888888888777665544322211100 0011000 01111223457789999999999999
Q ss_pred CCCCcCHHHHhcCCCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~~~ 376 (379)
|++||||+|+|+||||++..
T Consensus 271 P~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 271 PNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TTTSCCHHHHHTSGGGTTCC
T ss_pred hhHCcCHHHHhCCHhhccCC
Confidence 99999999999999998643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=401.31 Aligned_cols=275 Identities=26% Similarity=0.469 Sum_probs=214.9
Q ss_pred hhccccccceeEEEEEecCCCceEEEEEeeccc------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 48 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 48 ~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+.+++++ .|+||+++++++.+++++|+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~~~~~~~~~~~~~i 77 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-----SHPNIIGLLDAFGHKSNISL 77 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-----CCTTBCCEEEEECCTTCCEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-----CCCCEeEEEeeeccCCceee
Confidence 478999999999999999999999999986332 1234577899999998 78999999999999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
||||+.+++...+.... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 78 vmE~~~~~~~~~~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli----------------------- 133 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL----------------------- 133 (299)
T ss_dssp EEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-----------------------
T ss_pred hhhhhcchHHhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe-----------------------
Confidence 99999444444443322 368999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchHHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 277 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~~ 277 (379)
+..+.+||+|||.+....... ...+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.
T Consensus 134 ----~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~ 209 (299)
T d1ua2a_ 134 ----DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 209 (299)
T ss_dssp ----CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ----cCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH
Confidence 566678888888886544332 345799999999998654 579999999999999999999999999999998
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+..+.++...+............ ...+ .. .........++++.+||.+||+.||
T Consensus 210 l~~i~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-------------~~-----~~~~~~~~~s~~~~dll~~~L~~dP 268 (299)
T d1ua2a_ 210 LTRIFETLGTPTEEQWPDMCSLPDYVTF---KSFP-------------GI-----PLHHIFSAAGDDLLDLIQGLFLFNP 268 (299)
T ss_dssp HHHHHHHHCCCCTTTSSSTTSSTTCCCC---CCCC-------------CC-----CHHHHCTTCCHHHHHHHHHHHCSST
T ss_pred HHHHHHhcCCCChhhccchhccchhhhh---ccCC-------------CC-----ChHHhcccCCHHHHHHHHHHccCCh
Confidence 8888888887776543322111100000 0000 00 0112234567899999999999999
Q ss_pred CCCcCHHHHhcCCCCCCCC
Q 017021 358 TDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 358 ~~Rpta~e~l~hp~f~~~~ 376 (379)
++||||+|+|+||||++..
T Consensus 269 ~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 269 CARITATQALKMKYFSNRP 287 (299)
T ss_dssp TTSCCHHHHHTSGGGTSSS
T ss_pred hhCcCHHHHhCCHhhCCCC
Confidence 9999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.4e-54 Score=390.43 Aligned_cols=254 Identities=29% Similarity=0.494 Sum_probs=213.4
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
..|++.+.||+|+||+||+|+++.+|+.||+|+++... .....+.+|+.+++++ ..|+||++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~~hpnIv~~~~~ 78 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV----SGHPNIIQLKDT 78 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHH----TTCTTBCCEEEE
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHh----cCCCCeEEEEee
Confidence 36889999999999999999999999999999986432 1234577899999998 237999999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCcc
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 191 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~ 191 (379)
+.+++.+|+||||+ +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 79 ~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill------------- 143 (277)
T d1phka_ 79 YETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL------------- 143 (277)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-------------
T ss_pred cccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE-------------
Confidence 99999999999999 899999998765 69999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhC------CCCCCccchHhHHHHHHHHH
Q 017021 192 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVELC 263 (379)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~~l~ 263 (379)
+.++.+||+|||.+....... ....||+.|+|||.+.+ ..++.++||||+||++|+|+
T Consensus 144 --------------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml 209 (277)
T d1phka_ 144 --------------DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 209 (277)
T ss_dssp --------------CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred --------------cCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhc
Confidence 566678888888887544432 34579999999999853 34788999999999999999
Q ss_pred hCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchh
Q 017021 264 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343 (379)
Q Consensus 264 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (379)
+|+.||.+.+..+....+.+....++.. .....++
T Consensus 210 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~ 244 (277)
T d1phka_ 210 AGSPPFWHRKQMLMLRMIMSGNYQFGSP---------------------------------------------EWDDYSD 244 (277)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTT---------------------------------------------TGGGSCH
T ss_pred cCCCCCCCCCHHHHHHHHHhCCCCCCCc---------------------------------------------ccccCCH
Confidence 9999999877766655554432221110 1224678
Q ss_pred HHHHHHhhccccCCCCCcCHHHHhcCCCCCC
Q 017021 344 DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 344 ~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
++++||.+||+.||++|||++|+|+||||++
T Consensus 245 ~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 245 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 9999999999999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-54 Score=394.42 Aligned_cols=284 Identities=27% Similarity=0.449 Sum_probs=221.8
Q ss_pred hhhhhhhhccccccceeEEEEEecCC-CceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee--
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-- 115 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~-~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~-- 115 (379)
...|+++++||+|+||+||+|++..+ ++.||||+++.. ........+|+.+++.+.. .+|+||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~--~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET--FEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHH--TCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhh--cCCCCcceeeeeecccc
Confidence 45799999999999999999999765 678999998642 2233456678888887754 267999999998853
Q ss_pred ---cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccC
Q 017021 116 ---RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 192 (379)
Q Consensus 116 ---~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~ 192 (379)
....+++||++.+++...........+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi-------------- 149 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV-------------- 149 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--------------
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE--------------
Confidence 457999999995555555555544579999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 193 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
+..+.++|+|||.+....... ....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.
T Consensus 150 -------------~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 150 -------------TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp -------------CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred -------------cCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence 455667777777765433222 34679999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
+.+..+....+.+..+.++...++............. .. ..........++.+.+||+
T Consensus 217 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~-----~~~~~~~~~~s~~~~dli~ 274 (305)
T d1blxa_ 217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK-----------------SA-----QPIEKFVTDIDELGKDLLL 274 (305)
T ss_dssp CSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCC-----------------CC-----CCGGGTCCSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHhhCCCchhcccccccchhhhhccc-----------------cc-----cchhhccccCCHHHHHHHH
Confidence 9998888888888888776654432211111110000 00 0112233456788999999
Q ss_pred hccccCCCCCcCHHHHhcCCCCCCCC
Q 017021 351 GLLRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+||++||++||||+|+|+||||++.+
T Consensus 275 ~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 275 KCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHCcCChhHCcCHHHHhcChhhcCch
Confidence 99999999999999999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=398.11 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=211.1
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.++||+|+||+||+|+++.+|+.||+|+++.. .........|..++.+. ..||||+++++++.+++.+
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~----~~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA----WEHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH----TTCTTBCCEEEEEECSSEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHh----CCCCcEEEEEEEEccCCce
Confidence 588999999999999999999999999999999742 22234455566655432 2789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 79 yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~-------------------- 136 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL-------------------- 136 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--------------------
T ss_pred eEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee--------------------
Confidence 9999999 999999998765 68999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
+..+.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 137 -------~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~ 209 (320)
T d1xjda_ 137 -------DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209 (320)
T ss_dssp -------CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 566677888888876443322 3357999999999999999999999999999999999999999988777
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.......| ...++++.+||++||+.
T Consensus 210 ~~~~~i~~~~~~~p-------------------------------------------------~~~s~~~~dli~~~L~~ 240 (320)
T d1xjda_ 210 ELFHSIRMDNPFYP-------------------------------------------------RWLEKEAKDLLVKLFVR 240 (320)
T ss_dssp HHHHHHHHCCCCCC-------------------------------------------------TTSCHHHHHHHHHHSCS
T ss_pred HHHHHHHcCCCCCC-------------------------------------------------ccCCHHHHHHHHHhccc
Confidence 76655544322222 13567899999999999
Q ss_pred CCCCCcCHH-HHhcCCCCCCCC
Q 017021 356 DPTDRLTAR-EALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rpta~-e~l~hp~f~~~~ 376 (379)
||++|||+. |+++||||++.+
T Consensus 241 dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 241 EPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp SGGGSBTTBSCGGGSGGGTTCC
T ss_pred CCCCCcCHHHHHHhCchhccCC
Confidence 999999995 899999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9e-54 Score=401.19 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=206.2
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc----hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
.|++.++||+|+||.||+|+++.+|+.||+|++.... .....+.+|...+..+.+ .+||||+++++++.+++.+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~--~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSS--SCCTTBCCEEEEEECSSEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhc--CCCCcEEEEEEEEEECCEE
Confidence 5889999999999999999999999999999986321 222334455554544422 2689999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ |++|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl-------------------- 140 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL-------------------- 140 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--------------------
T ss_pred EEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE--------------------
Confidence 9999999 899999998765 68999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCC-CCcccccCCccchhhhh-CCCCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.+||+|||+|...... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||...+..+
T Consensus 141 -------~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 213 (364)
T d1omwa3 141 -------DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213 (364)
T ss_dssp -------CSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred -------cCCCcEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence 55667888888888754433 34467999999999986 4568999999999999999999999998754433
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
............+ . .++..++++++||.+||+.|
T Consensus 214 ~~~~~~~~~~~~~--------------------~--------------------------~~~~~s~~~~~li~~~L~~d 247 (364)
T d1omwa3 214 KHEIDRMTLTMAV--------------------E--------------------------LPDSFSPELRSLLEGLLQRD 247 (364)
T ss_dssp HHHHHHHSSSCCC--------------------C--------------------------CCSSSCHHHHHHHHHHTCSS
T ss_pred HHHHHHhcccCCC--------------------C--------------------------CCCCCCHHHHHHHHHHcccC
Confidence 2222222111111 1 11246788999999999999
Q ss_pred CCCCcC-----HHHHhcCCCCCCCC
Q 017021 357 PTDRLT-----AREALRHPFFTRDH 376 (379)
Q Consensus 357 P~~Rpt-----a~e~l~hp~f~~~~ 376 (379)
|.+||| |+|+++||||++.+
T Consensus 248 P~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 248 VNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp TTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred HHHhCCCcccCHHHHHcCccccCCC
Confidence 999999 89999999998753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=399.00 Aligned_cols=279 Identities=28% Similarity=0.484 Sum_probs=226.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc--
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-- 117 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~-- 117 (379)
..|+++++||+|+||+||+|.++.+|+.||||+++.. ......+.+|+.++.++ .|+|++++++++...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-----RHENVIGLLDVFTPDETL 92 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-----CBTTBCCCSEEECSCSST
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-----CCCCeeEEEEEeccCccc
Confidence 4789999999999999999999999999999999742 23345677899999888 7899999999987654
Q ss_pred ----eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 118 ----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 118 ----~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
++|+||||++.+|..++... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 93 ~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~--------------- 154 (346)
T d1cm8a_ 93 DDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV--------------- 154 (346)
T ss_dssp TTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---------------
T ss_pred cccceEEEEEecccccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---------------
Confidence 57999999998998888764 49999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++++|||.|...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 155 ------------~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 155 ------------NEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp ------------CTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------ccccccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 666778899999988777776777899999999998764 5689999999999999999999999999
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+..+....+....+.+|...+.............+....... .........++.+.+||.+|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~s~~~~dli~~m 284 (346)
T d1cm8a_ 223 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK------------------DFASILTNASPLAVNLLEKM 284 (346)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCC------------------CGGGTCTTCCHHHHHHHHHH
T ss_pred ChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCccccc------------------chHHhccCCCHHHHHHHHHH
Confidence 988888899999999998877664433322222211111110 01112235678899999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
|+.||++||||+|+|+||||++
T Consensus 285 L~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 285 LVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp SCSSTTTSCCHHHHHHSGGGTT
T ss_pred CcCChhHCcCHHHHhcChhhCc
Confidence 9999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=401.60 Aligned_cols=260 Identities=27% Similarity=0.470 Sum_probs=207.6
Q ss_pred hhhhhh-ccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee----cce
Q 017021 44 ADKIHS-KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNH 118 (379)
Q Consensus 44 ~y~i~~-~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----~~~ 118 (379)
.|+|.. .||+|+||+||+|+++.+++.||||+++.. ....+|+.++.++ .+|+||++++++|++ ..+
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~----~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRA----SQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHH----TTSTTBCCEEEEEEEEETTEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHh----cCCCCCCeEEEEEeecccCCCE
Confidence 577765 599999999999999999999999999743 3455688877665 368999999999875 467
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 197 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~ 197 (379)
+|+||||| ||+|.+++...+...+++..++.++.||+.||+|||+.||+||||||+||+++..
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~---------------- 147 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK---------------- 147 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS----------------
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccc----------------
Confidence 99999999 8999999987665679999999999999999999999999999999999999532
Q ss_pred CCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCchH
Q 017021 198 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 275 (379)
Q Consensus 198 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~ 275 (379)
...+.+||+|||+|....... ....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 148 --------~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~ 219 (335)
T d2ozaa1 148 --------RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 219 (335)
T ss_dssp --------STTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred --------cccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH
Confidence 345679999999987544332 4567999999999999989999999999999999999999999875543
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+... +..+...+|. ..+...++++.+||++||+.
T Consensus 220 ~~~~~~~~~-------------------i~~~~~~~~~----------------------~~~~~~s~~~~~li~~~L~~ 258 (335)
T d2ozaa1 220 AISPGMKTR-------------------IRMGQYEFPN----------------------PEWSEVSEEVKMLIRNLLKT 258 (335)
T ss_dssp --------C-------------------CCSCSSSCCT----------------------THHHHSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHH-------------------HhcCCCCCCC----------------------cccccCCHHHHHHHHHHccC
Confidence 332222111 1111111111 11224678899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCCC
Q 017021 356 DPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 356 dP~~Rpta~e~l~hp~f~~~~ 376 (379)
||++|||++|+++||||.+..
T Consensus 259 dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 259 EPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp STTTSCCHHHHHHSHHHHTTT
T ss_pred ChhHCcCHHHHHcCHHhhCCC
Confidence 999999999999999997653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.6e-53 Score=384.84 Aligned_cols=277 Identities=28% Similarity=0.437 Sum_probs=218.7
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|++.++||+|+||+||+|+++ +|+.||+|+++.. ......+.+|+.++.++ +|+||+++++++..++..+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~~ 76 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-----KHSNIVKLYDVIHTKKRLV 76 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-----CCTTBCCEEEEEECSSCEE
T ss_pred CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-----CCCcEEeeeeecccCCcee
Confidence 5889999999999999999986 7899999999643 23346777899988887 7899999999999999999
Q ss_pred EEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 121 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 121 lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
++|+++++++...+.... ..+++..+..++.||+.||+|||+.||+||||||+|||+
T Consensus 77 i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---------------------- 133 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---------------------- 133 (286)
T ss_dssp EEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----------------------
T ss_pred EEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE----------------------
Confidence 999999655555554433 369999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCchHH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE 276 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~~~~ 276 (379)
+.++.+||+|||.+....... ....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+
T Consensus 134 -----~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~ 208 (286)
T d1ob3a_ 134 -----NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208 (286)
T ss_dssp -----CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----cCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH
Confidence 566778888888886544332 334689999999998765 46899999999999999999999999988888
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
...++.+..+.++...+.............. ... .. .........++++.|||++||+.|
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------------~~-----~~~~~~~~~s~~~~dli~~~L~~d 268 (286)
T d1ob3a_ 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFT---VYE------------PL-----PWESFLKGLDESGIDLLSKMLKLD 268 (286)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC---CCC------------CC-----CGGGTCCSCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHhhCCCChhhccchhhhhhcccccc---ccc------------Cc-----chhhhcccCCHHHHHHHHHHccCC
Confidence 8888888888777665544333221111000 000 00 011223456788999999999999
Q ss_pred CCCCcCHHHHhcCCCCCC
Q 017021 357 PTDRLTAREALRHPFFTR 374 (379)
Q Consensus 357 P~~Rpta~e~l~hp~f~~ 374 (379)
|++||||+|+|+||||++
T Consensus 269 P~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 269 PNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTTSCCHHHHHTSGGGGC
T ss_pred hhHCcCHHHHhcCcccCc
Confidence 999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=383.25 Aligned_cols=247 Identities=25% Similarity=0.456 Sum_probs=203.6
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc-------hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
.|+|.+.||+|+||+||+|+++.+|+.||+|+++... .....+.+|+.++.++.+ .|+||++++++++++
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~---~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---GFSGVIRLLDWFERP 81 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS---SSCSBCCEEEEEECS
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhcc---CCCCccEEEEEEeeC
Confidence 5899999999999999999999999999999986421 112345679999998843 478999999999999
Q ss_pred ceEEEEEeCC-C-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 117 NHICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 117 ~~~~lv~e~~-~-~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
+..|+||||+ + +++.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~-------------- 145 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-------------- 145 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--------------
T ss_pred CeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--------------
Confidence 9999999999 4 58888887654 6999999999999999999999999999999999999952
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC-CcccccCCccchhhhhCCCC-CCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
..+.++|+|||.|....... ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...
T Consensus 146 ------------~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 146 ------------NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp ------------TTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ------------CCCeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 23568888888886544333 44679999999999987665 57799999999999999999999752
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+. +.+ +...++ ...++++++||++|
T Consensus 214 ~~------i~~-----------------------~~~~~~--------------------------~~~s~~~~~li~~~ 238 (273)
T d1xwsa_ 214 EE------IIR-----------------------GQVFFR--------------------------QRVSSECQHLIRWC 238 (273)
T ss_dssp HH------HHH-----------------------CCCCCS--------------------------SCCCHHHHHHHHHH
T ss_pred hH------Hhh-----------------------cccCCC--------------------------CCCCHHHHHHHHHH
Confidence 21 111 011111 23678899999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
|+.||++|||++|+++||||++..
T Consensus 239 L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 239 LALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp TCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ccCCHhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999998754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=389.92 Aligned_cols=280 Identities=28% Similarity=0.479 Sum_probs=219.9
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee------
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------ 115 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~------ 115 (379)
...|+.+++||+|+||+||+|+++.+|+.||||++..... ...+|+.+++++ .|+|++++++++..
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l-----~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKL-----DHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHC-----CCTTBCCEEEEEEEC--CCS
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhc-----CCCCCCcEEEEEEecCccCC
Confidence 4478888999999999999999999999999999975432 334699999888 78999999998853
Q ss_pred cceEEEEEeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 116 RNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 116 ~~~~~lv~e~~~~sL~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
..++|+||||+++++.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~------------- 157 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP------------- 157 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-------------
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec-------------
Confidence 346899999996666555532 23346999999999999999999999999999999999999942
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhC-CCCCCccchHhHHHHHHHHHhCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ 270 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~~l~~g~~pf~ 270 (379)
....+||+|||.+...... .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.
T Consensus 158 -------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 158 -------------DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp -------------TTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred -------------CCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence 2246889999988654332 344679999999998875 468999999999999999999999999
Q ss_pred CCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHh
Q 017021 271 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 350 (379)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 350 (379)
..+..+....+.+..|.++.+.+........... .+.... . ..........++++.+||.
T Consensus 225 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~----------~----~~~~~~~~~~s~~~~dLl~ 284 (350)
T d1q5ka_ 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK------FPQIKA----------H----PWTKVFRPRTPPEAIALCS 284 (350)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC------CCCCCC----------C----CGGGTSCTTSCHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc------cccccc----------C----chhhhcccCCCHHHHHHHH
Confidence 9888888888889999988877665433221111 110000 0 0001112346778999999
Q ss_pred hccccCCCCCcCHHHHhcCCCCCCC
Q 017021 351 GLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 351 ~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+||++||++||||+|+|+||||++.
T Consensus 285 ~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 285 RLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHccCChhHCcCHHHHhcCHhhccc
Confidence 9999999999999999999999763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-52 Score=379.32 Aligned_cols=256 Identities=20% Similarity=0.292 Sum_probs=208.7
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+....|++.++||+|+||+||+|.++.+++.||+|+++.+....+.+.+|+.+++++ .|+||+++++++.+++..
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSC
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-----CCCCEecCCccEeeCCee
Confidence 455678889999999999999999999999999999987666677888999999998 789999999999999999
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++||||+ +|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~------------------- 149 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG------------------- 149 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-------------------
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC-------------------
Confidence 9999999 89999999876656799999999999999999999999999999999999994
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC-Cc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT-HE 273 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~-~~ 273 (379)
.++.+||+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.. .+
T Consensus 150 --------~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~ 221 (287)
T d1opja_ 150 --------ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221 (287)
T ss_dssp --------GGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred --------CCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch
Confidence 44556777777766543332 223578899999999999999999999999999999997666543 34
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.+... ... ++..++++.+||.+||
T Consensus 222 ~~~~~~~i~~~~~----------------------~~~--------------------------~~~~~~~l~~li~~cl 253 (287)
T d1opja_ 222 LSQVYELLEKDYR----------------------MER--------------------------PEGCPEKVYELMRACW 253 (287)
T ss_dssp HHHHHHHHHTTCC----------------------CCC--------------------------CTTCCHHHHHHHHHHT
T ss_pred HHHHHHHHhcCCC----------------------CCC--------------------------CccchHHHHHHHHHHc
Confidence 3333322221110 011 1246778999999999
Q ss_pred ccCCCCCcCHHHHhc--CCCCCCC
Q 017021 354 RYDPTDRLTAREALR--HPFFTRD 375 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~--hp~f~~~ 375 (379)
+.||++|||++|+++ ..++++.
T Consensus 254 ~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 254 QWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred CCCHhHCcCHHHHHHHHHHHHHhC
Confidence 999999999999986 3455544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=386.18 Aligned_cols=288 Identities=25% Similarity=0.400 Sum_probs=221.4
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-----
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----- 115 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~----- 115 (379)
.|+++++||+|+||+||+|+++.+|+.||||++... ......+.+|+.++.++ +|+||+++++++..
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCCSTT
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-----CCCCeeEEEEEEecccccc
Confidence 489999999999999999999999999999999743 23345677899998887 78999999999863
Q ss_pred -cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 -RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 -~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
..++|+||||+.+++.+.+.. .+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 93 ~~~~~~iv~Ey~~~~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---------------- 152 (355)
T d2b1pa1 93 EFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---------------- 152 (355)
T ss_dssp TCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----------------
T ss_pred cCceeEEEEeccchHHHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc----------------
Confidence 468999999996666666532 58999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
..++.++++|||.+....... ....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus 153 -----------~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 153 -----------KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp -----------CTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------ccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 555667778887765433332 3457899999999999999999999999999999999999999999
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+.......+....+.++.+.+.................... ........ .............++++.+||++|
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~----~~~~~~~~~~~~~s~~~~dll~~m 294 (355)
T d2b1pa1 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL---TFPKLFPD----SLFPADSEHNKLKASQARDLLSKM 294 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCC---CHHHHSCG----GGSCCSSHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccc---cccccccc----ccccccccccccCCHHHHHHHHHH
Confidence 88888888888888888888888777776665543211111 01110000 000001112234577899999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
|+.||++||||+|+|+||||++
T Consensus 295 L~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 295 LVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp SCSSTTTSCCHHHHHTSTTTGG
T ss_pred CcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=381.60 Aligned_cols=283 Identities=26% Similarity=0.427 Sum_probs=212.4
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee---
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--- 115 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~--- 115 (379)
.-.|+++++||+|+||+||+|+++.+|+.||||++... ......+.+|+.+++.+ .|+|++.+++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKAS 83 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-----CCTTBCCEEEEEEC---
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-----cCCCccceEeeeecccc
Confidence 35789999999999999999999999999999998532 33445677899999998 77899999888754
Q ss_pred -----cceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 116 -----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 116 -----~~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
+.++|+||||+++.+........ ..+++..++.++.||+.||.|||+.||+||||||+|||++
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~----------- 151 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----------- 151 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-----------
T ss_pred cccccCceEEEEEeccCCCccchhhhcc-cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec-----------
Confidence 45789999999655555544332 4689999999999999999999999999999999999994
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-------CCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHH
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVEL 262 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l 262 (379)
.++.++|+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 152 ----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el 215 (318)
T d3blha1 152 ----------------RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 215 (318)
T ss_dssp ----------------TTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred ----------------CCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeH
Confidence 4555666666666432221 1234699999999998765 689999999999999999
Q ss_pred HhCCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchh-hHHHHHHhhccc
Q 017021 263 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR-LQNLIMQHVDHS 341 (379)
Q Consensus 263 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 341 (379)
++|+.||.+.+..+....+.+..+.++...+.......... ........+. .... ......
T Consensus 216 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~--~~~~~~ 277 (318)
T d3blha1 216 WTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE----------------KLELVKGQKRKVKDR--LKAYVR 277 (318)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-----------------------CCSSCCBCHHHH--HHHHHC
T ss_pred hhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhh----------------hhcccccccccchhh--hccccC
Confidence 99999999989888888888888887765433322111000 0000000000 0000 011234
Q ss_pred hhHHHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 342 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 342 ~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
++.+.|||.+||++||++||||+|+|+||||+.+
T Consensus 278 ~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 278 DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 6788999999999999999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=370.17 Aligned_cols=246 Identities=25% Similarity=0.370 Sum_probs=196.4
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
...|++.++||+|+||+||+|+++ +++.||||+++........+.+|+.++.++ .|+||+++++++..++..++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-----SHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-----CCCCcccccceeccCCceEE
Confidence 345788899999999999999976 467899999987666677889999999998 78999999999999999999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+||+++
T Consensus 78 v~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~--------------------- 135 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG--------------------- 135 (263)
T ss_dssp EEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC---------------------
T ss_pred EEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec---------------------
Confidence 99999 999999987654 3688999999999999999999999999999999999995
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchH
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 275 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~ 275 (379)
.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..
T Consensus 136 ------~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~ 209 (263)
T d1sm2a_ 136 ------ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209 (263)
T ss_dssp ------GGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH
T ss_pred ------CCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH
Confidence 44556677777665433222 23468999999999999999999999999999999999 56667665555
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+....... . +...++++.+||.+||+.
T Consensus 210 ~~~~~i~~~~~~~----------------------~--------------------------p~~~~~~l~~li~~cl~~ 241 (263)
T d1sm2a_ 210 EVVEDISTGFRLY----------------------K--------------------------PRLASTHVYQIMNHCWKE 241 (263)
T ss_dssp HHHHHHHHTCCCC----------------------C--------------------------CTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHhcCCCC----------------------C--------------------------ccccCHHHHHHHHHHccC
Confidence 5554443322111 0 113567899999999999
Q ss_pred CCCCCcCHHHHhcC
Q 017021 356 DPTDRLTAREALRH 369 (379)
Q Consensus 356 dP~~Rpta~e~l~h 369 (379)
||++|||++|+++|
T Consensus 242 ~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 242 RPEDRPAFSRLLRQ 255 (263)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=384.26 Aligned_cols=279 Identities=26% Similarity=0.449 Sum_probs=221.8
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec---
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--- 116 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~--- 116 (379)
..|++.++||+|+||+||+|+++.+|+.||||+++.. ......+.+|+.+++++ .|+|++++++++...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-----KHENVIGLLDVFTPARSL 92 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCSST
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEeecccc
Confidence 3599999999999999999999999999999999743 22345677899999998 789999999988643
Q ss_pred ---ceEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 117 ---NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 117 ---~~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
...++++++.+++|.+++..+ .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi--------------- 154 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--------------- 154 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---------------
T ss_pred ccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---------------
Confidence 345555555599999998654 59999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCC-CCCccchHhHHHHHHHHHhCCCCCCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTH 272 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~~l~~g~~pf~~~ 272 (379)
+.++.++++|||.+...........||+.|+|||...+.. ++.++|||||||++|+|++|+.||.+.
T Consensus 155 ------------~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 155 ------------NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp ------------CTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------cccccccccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 5666788888888876666666678999999999877654 679999999999999999999999999
Q ss_pred chHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 273 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
+.......+.+..+..+.+....................+.. .........++++.|||.+|
T Consensus 223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~s~~~~dli~~m 284 (348)
T d2gfsa1 223 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM------------------NFANVFIGANPLAVDLLEKM 284 (348)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCC------------------CHHHHSTTCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCc------------------chhhhcCCCCHHHHHHHHHH
Confidence 998888888888888887766554333322222211111110 01112335678899999999
Q ss_pred cccCCCCCcCHHHHhcCCCCCC
Q 017021 353 LRYDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~hp~f~~ 374 (379)
|+.||.+||||+|+|+||||++
T Consensus 285 L~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 285 LVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp SCSSGGGSCCHHHHHTSGGGTT
T ss_pred CcCChhhCcCHHHHhcCHhhCC
Confidence 9999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=380.42 Aligned_cols=278 Identities=29% Similarity=0.522 Sum_probs=212.5
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc----
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---- 117 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~---- 117 (379)
.|+++++||+|+||+||+|+++.+|+.||||+++.. ......+.+|+.+++++ +|++++++++.+....
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-----~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-----RHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-----CCTTBCCCCEEECCSSTTTC
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-----CCCCCCcEEEEEeecccccc
Confidence 589999999999999999999999999999999743 23345678899999998 7899999999887543
Q ss_pred -eEEEEEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCC
Q 017021 118 -HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 196 (379)
Q Consensus 118 -~~~lv~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~ 196 (379)
..|+++++++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl------------------ 142 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL------------------ 142 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------------
T ss_pred ceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE------------------
Confidence 46777766699999999875 49999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCeEEeecCcccccCCC------CCcccccCCccchhhhh-CCCCCCccchHhHHHHHHHHHhCCCCC
Q 017021 197 KDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALF 269 (379)
Q Consensus 197 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~~l~~g~~pf 269 (379)
+.++.+||+|||++...... .....||+.|+|||++. +..++.++||||+||++|+|++|+.||
T Consensus 143 ---------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf 213 (345)
T d1pmea_ 143 ---------NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213 (345)
T ss_dssp ---------CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ---------CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC
Confidence 45566777777777543222 23356899999999984 456789999999999999999999999
Q ss_pred CCCchHHHHHHHHHHcCCCChhHHHhhhhh-hhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 270 QTHENLEHLAMMERVLGPLPQHMLKRVDRH-AEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
.+.+..+...........++.......... ....... .+... .. .........++++.+|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~----------~~-----~~~~~~~~~s~~~~~l 274 (345)
T d1pmea_ 214 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS----LPHKN----------KV-----PWNRLFPNADSKALDL 274 (345)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT----SCCCC----------CC-----CHHHHCTTSCHHHHHH
T ss_pred CCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhccccc----CCccC----------CC-----CHHHhCCCCCHHHHHH
Confidence 988887777777777666665443221111 1110000 00000 00 0112234567789999
Q ss_pred HhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 349 LQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
|.+||+.||.+||||+|+|+||||++.
T Consensus 275 i~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 275 LDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999999999853
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=375.94 Aligned_cols=253 Identities=26% Similarity=0.356 Sum_probs=204.6
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+....|++.++||+|+||.||+|+++ +++.||||+++........+.+|+.++.++ .|+||+++++++.+ +..
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~-~~~ 82 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-----QHQRLVRLYAVVTQ-EPI 82 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-----CCCCEeEEEeeecc-CCe
Confidence 34567899999999999999999975 578899999986666677889999999998 78999999998755 557
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++||||+ +|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll-------------------- 142 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV-------------------- 142 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--------------------
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee--------------------
Confidence 9999999 9999998765433358999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhC-CCCCCCCc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-EALFQTHE 273 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g-~~pf~~~~ 273 (379)
+.+..+||+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|||+|| .+|+...+
T Consensus 143 -------~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~ 215 (272)
T d1qpca_ 143 -------SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (272)
T ss_dssp -------CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred -------ecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC
Confidence 555667777888776543322 234688999999999988899999999999999999995 55555555
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.+...+. . ++..++++.+||.+||
T Consensus 216 ~~~~~~~i~~~~~~~----------------------~--------------------------p~~~~~~l~~li~~cl 247 (272)
T d1qpca_ 216 NPEVIQNLERGYRMV----------------------R--------------------------PDNCPEELYQLMRLCW 247 (272)
T ss_dssp HHHHHHHHHTTCCCC----------------------C--------------------------CTTCCHHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCCC----------------------C--------------------------cccChHHHHHHHHHHc
Confidence 544444333211111 1 1235678999999999
Q ss_pred ccCCCCCcCHHHHhc--CCCCCC
Q 017021 354 RYDPTDRLTAREALR--HPFFTR 374 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~--hp~f~~ 374 (379)
+.||++|||++|+++ |+||+.
T Consensus 248 ~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 248 KERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999998 788764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=365.14 Aligned_cols=245 Identities=21% Similarity=0.318 Sum_probs=206.0
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 122 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv 122 (379)
..|++.++||+|+||+||+|+++ +++.||||+++........+.+|+.++.++ .|+||+++++++.+++.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-----~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-----SHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTC-----CCTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhc-----CCCceeeEEEEEeeCCceEEE
Confidence 35788899999999999999975 678999999987666778889999999988 789999999999999999999
Q ss_pred EeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 123 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 123 ~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
|||+ +|+|.+++.... ..+++..+..++.|+++||+|||+.||+||||||+||++
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill----------------------- 133 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV----------------------- 133 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE-----------------------
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE-----------------------
Confidence 9999 899999876643 358899999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHH
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 276 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~ 276 (379)
+.+..+||+|||++....... ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+
T Consensus 134 ----~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 134 ----NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209 (258)
T ss_dssp ----CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred ----cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence 455667777777775433222 22468899999999999999999999999999999998 899999887776
Q ss_pred HHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccC
Q 017021 277 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 356 (379)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 356 (379)
....+.+...... +...++++.+||.+||+.|
T Consensus 210 ~~~~i~~~~~~~~------------------------------------------------p~~~~~~l~~li~~cl~~d 241 (258)
T d1k2pa_ 210 TAEHIAQGLRLYR------------------------------------------------PHLASEKVYTIMYSCWHEK 241 (258)
T ss_dssp HHHHHHTTCCCCC------------------------------------------------CTTCCHHHHHHHHHTTCSS
T ss_pred HHHHHHhCCCCCC------------------------------------------------cccccHHHHHHHHHHccCC
Confidence 6655543221111 1135678999999999999
Q ss_pred CCCCcCHHHHhcC
Q 017021 357 PTDRLTAREALRH 369 (379)
Q Consensus 357 P~~Rpta~e~l~h 369 (379)
|++|||++++++|
T Consensus 242 P~~RPt~~eil~~ 254 (258)
T d1k2pa_ 242 ADERPTFKILLSN 254 (258)
T ss_dssp GGGSCCHHHHHHH
T ss_pred HhHCcCHHHHHHH
Confidence 9999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-51 Score=371.54 Aligned_cols=277 Identities=27% Similarity=0.439 Sum_probs=217.8
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccc---hhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
.|+++++||+|+||+||+|+++.+|+.||||+++... .....+.+|+.+++.+ .|+||+++++++.+....+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~h~niv~~~~~~~~~~~~~ 77 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-----CcCCEEeecccccccccee
Confidence 5899999999999999999999999999999996432 3346677888888877 7899999999999999999
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
++++++ ++++..++.... .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 78 iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli--------------------- 134 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI--------------------- 134 (292)
T ss_dssp EEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------
T ss_pred EEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---------------------
Confidence 999999 777777666544 68999999999999999999999999999999999999
Q ss_pred cccccCCCCCCeEEeecCcccccCCCC---CcccccCCccchhhhhCCC-CCCccchHhHHHHHHHHHhCCCCC-CCCch
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALF-QTHEN 274 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~~l~~g~~pf-~~~~~ 274 (379)
+.+..++|+|||.+....... ....+++.|.|||.+.+.. ++.++|||||||++|+|++|+.|| .+.+.
T Consensus 135 ------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 208 (292)
T d1unla_ 135 ------NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_dssp ------CTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred ------ccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH
Confidence 556678888888887544433 2345778899999987765 689999999999999999998885 45566
Q ss_pred HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 275 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
.+....+....+.+++..++.......... ...... ...........++.+.+||++||+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~----------------~~~~~~~~~~~s~~~~dll~~mL~ 268 (292)
T d1unla_ 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKP----YPMYPA----------------TTSLVNVVPKLNATGRDLLQNLLK 268 (292)
T ss_dssp HHHHHHHHHHHCCCCTTTCTTGGGSTTCCC----CCCCCT----------------TCCCTTTSTTCCHHHHHHHHHHSC
T ss_pred HHHHHHHHhhcCCCChhhhhhhhhcccccc----cccccc----------------cchhhhccccCCHHHHHHHHHHcc
Confidence 667777777777776654443322211100 000000 001111223467789999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTR 374 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~ 374 (379)
.||.+||||+|+|+||||++
T Consensus 269 ~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 269 CNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp SSGGGSCCHHHHTTSGGGSS
T ss_pred CChhHCcCHHHHhcChhhcC
Confidence 99999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.4e-51 Score=377.38 Aligned_cols=284 Identities=24% Similarity=0.463 Sum_probs=210.3
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee--cceEE
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHIC 120 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~~ 120 (379)
-.|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+|+.++..+ .+|+||+++++++.. ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l----~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENL----RGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHH----TTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhc----cCCCCCcEEEEEEEecCCCcee
Confidence 35899999999999999999999999999999997433 45677899999888 247899999999874 45799
Q ss_pred EEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCC
Q 017021 121 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 199 (379)
Q Consensus 121 lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~ 199 (379)
+||||+ +++|..+. +.+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 109 ~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~------------------- 164 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH------------------- 164 (328)
T ss_dssp EEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-------------------
T ss_pred EEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC-------------------
Confidence 999999 78876542 35999999999999999999999999999999999999953
Q ss_pred cccccCCCCCCeEEeecCcccccCCC--CCcccccCCccchhhhhCC-CCCCccchHhHHHHHHHHHhCCCCCCCCc-hH
Q 017021 200 SYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHE-NL 275 (379)
Q Consensus 200 ~~~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~~l~~g~~pf~~~~-~~ 275 (379)
.+..++|+|||.|...... .....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.... ..
T Consensus 165 -------~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~ 237 (328)
T d3bqca1 165 -------EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237 (328)
T ss_dssp -------TTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred -------CCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH
Confidence 2345888999988754433 3455789999999998765 47899999999999999999999997654 44
Q ss_pred HHHHHHHHHcCCCChhHHHh-hhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccc
Q 017021 276 EHLAMMERVLGPLPQHMLKR-VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 354 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 354 (379)
+....+.+..+.+....+.. ............ ... .......... ........++++.|||++||+
T Consensus 238 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~--------~~~~~~~~s~~~~dli~~mL~ 304 (328)
T d3bqca1 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGR----HSRKRWERFV--------HSENQHLVSPEALDFLDKLLR 304 (328)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGT-CCC----CCCCCGGGGC--------CTTTGGGCCHHHHHHHHHHSC
T ss_pred HHHHHHHHHHCCchhhhhhhhcccccCcccchh-ccc----ccccchhhcc--------cccccccCCHHHHHHHHHHcc
Confidence 44555555555332221111 000000000000 000 0000000000 011123467889999999999
Q ss_pred cCCCCCcCHHHHhcCCCCCCCC
Q 017021 355 YDPTDRLTAREALRHPFFTRDH 376 (379)
Q Consensus 355 ~dP~~Rpta~e~l~hp~f~~~~ 376 (379)
+||.+||||+|+|+||||++..
T Consensus 305 ~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 305 YDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp SSGGGSCCHHHHHTSGGGTTSC
T ss_pred CChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-51 Score=371.20 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=194.7
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCc---eEEEEEeec--cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~---~vAiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
+....|++.+.||+|+||+||+|+++.+++ .||+|.+.. .......+.+|+.++.++ .|+||+++++++.
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~g~~~ 97 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-----DHPNVIHLEGVVT 97 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-----CCCCCccEEEEEe
Confidence 344568888999999999999999987765 589998863 233456778899998887 7899999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
.++.+++||||+ +|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 98 ~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl--------------- 161 (299)
T d1jpaa_ 98 KSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV--------------- 161 (299)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---------------
T ss_pred eCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---------------
Confidence 999999999999 899999887654 368999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC--------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT- 264 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~- 264 (379)
+.++.+||+|||+++...... ....||+.|+|||.+.+..++.++|||||||++|||+|
T Consensus 162 ------------~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~ 229 (299)
T d1jpaa_ 162 ------------NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229 (299)
T ss_dssp ------------CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ------------CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhC
Confidence 455567777777765433221 12357889999999999999999999999999999998
Q ss_pred CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhH
Q 017021 265 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 344 (379)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (379)
|+.||...+..+....+.+....++ +..++..
T Consensus 230 g~~Pf~~~~~~~~~~~i~~~~~~~~------------------------------------------------~~~~~~~ 261 (299)
T d1jpaa_ 230 GERPYWDMTNQDVINAIEQDYRLPP------------------------------------------------PMDCPSA 261 (299)
T ss_dssp SCCTTTTCCHHHHHHHHHTTCCCCC------------------------------------------------CTTCCHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCC------------------------------------------------CccchHH
Confidence 8999988777665554433221111 1135678
Q ss_pred HHHHHhhccccCCCCCcCHHHHhcC
Q 017021 345 LTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 345 ~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+.+||.+||+.||++|||++|++++
T Consensus 262 l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 262 LHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=375.24 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=200.6
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCc-----eEEEEEeec--cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKE-----MVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~-----~vAiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
++...|++.++||+|+||+||+|+++.+++ .||+|++.. .......+.+|+.++.++ .+|+||++++++
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~HpnIv~l~~~ 109 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL----GSHENIVNLLGA 109 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHH----CCCTTBCCEEEE
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHh----cCCCcEeEEEEE
Confidence 445678899999999999999999876553 699999853 233445677899988887 367999999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccC
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNNY---------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTD 170 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~~---------------------~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~d 170 (379)
+.+.+.+|+||||| +|+|.+++..... ..+++..++.++.||+.||+|||++||+|||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 99999999999999 9999999976431 2478999999999999999999999999999
Q ss_pred CCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCC
Q 017021 171 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLG 245 (379)
Q Consensus 171 lkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~ 245 (379)
|||+||+++ .++.+||+|||+|+...... ....||+.|+|||++.+..
T Consensus 190 lKp~Nill~---------------------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 242 (325)
T d1rjba_ 190 LAARNVLVT---------------------------HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 242 (325)
T ss_dssp CSGGGEEEE---------------------------TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred Cchhccccc---------------------------cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC
Confidence 999999994 45567777777776433332 2346799999999999999
Q ss_pred CCCccchHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhh
Q 017021 246 WTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 324 (379)
Q Consensus 246 ~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (379)
++.++|||||||++|||++ |..||.+.+..+....+.+.... ++.
T Consensus 243 ~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~---------------------~~~------------- 288 (325)
T d1rjba_ 243 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK---------------------MDQ------------- 288 (325)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC---------------------CCC-------------
T ss_pred CCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---------------------CCC-------------
Confidence 9999999999999999997 89999876554443332221111 111
Q ss_pred ccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 325 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
+...++++.+||.+||+.||++|||++|+++|
T Consensus 289 -------------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 289 -------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp -------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 12356789999999999999999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.8e-51 Score=369.11 Aligned_cols=249 Identities=23% Similarity=0.317 Sum_probs=195.5
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc--
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-- 117 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~-- 117 (379)
.|++.+.||+|+||+||+|+++.+|+.||+|+++.. ......+.+|+.++..+ +|+||+++++++...+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-----~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-----NHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEEECSS
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-----CCCCCCcccceeeeccCC
Confidence 489999999999999999999999999999999643 22344567888888877 8899999999987643
Q ss_pred --eEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 118 --HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 118 --~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+|+||||+ |++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||++..
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~-------------- 146 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA-------------- 146 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--------------
T ss_pred CceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc--------------
Confidence 489999999 899999987765 6999999999999999999999999999999999999954
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCC------CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
+...+++|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 147 -------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~P 213 (277)
T d1o6ya_ 147 -------------TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213 (277)
T ss_dssp -------------TSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred -------------cccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCC
Confidence 455666666655432221 2345799999999999999999999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|.+.+..+....+.+....++. ..++..++++.++
T Consensus 214 f~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~s~~l~~l 248 (277)
T d1o6ya_ 214 FTGDSPVSVAYQHVREDPIPPS---------------------------------------------ARHEGLSADLDAV 248 (277)
T ss_dssp CCCSSHHHHHHHHHHCCCCCGG---------------------------------------------GTSSSCCHHHHHH
T ss_pred CCCcCHHHHHHHHHhcCCCCCc---------------------------------------------hhccCCCHHHHHH
Confidence 9987776665544332222111 1123467899999
Q ss_pred HhhccccCCCCCc-CHHHHhcCCCC
Q 017021 349 LQGLLRYDPTDRL-TAREALRHPFF 372 (379)
Q Consensus 349 i~~~L~~dP~~Rp-ta~e~l~hp~f 372 (379)
|.+||+.||++|| ||+++ .|+|.
T Consensus 249 i~~~L~~dp~~R~~sa~~l-~~~l~ 272 (277)
T d1o6ya_ 249 VLKALAKNPENRYQTAAEM-RADLV 272 (277)
T ss_dssp HHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred HHHHccCCHhHCHhHHHHH-HHHHH
Confidence 9999999999999 55554 56654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=365.66 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=193.2
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeec
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 116 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~ 116 (379)
+..-.|++.++||+|+||+||+|+.+ ..||||+++.. ......+.+|+.++.++ .|+||+++++++..
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~~~~~~- 75 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-----RHVNILLFMGYSTA- 75 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEECS-
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeeeeEEEec-
Confidence 44556889999999999999999754 35999998632 33446677899988887 78999999987654
Q ss_pred ceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCC
Q 017021 117 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 195 (379)
Q Consensus 117 ~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~ 195 (379)
+.+++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---------------- 138 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---------------- 138 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----------------
T ss_pred cEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc----------------
Confidence 5689999999 899999997654 3589999999999999999999999999999999999994
Q ss_pred CCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhC---CCCCCccchHhHHHHHHHHHhCCC
Q 017021 196 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 196 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
.++.+||+|||+|....... ....||+.|+|||++.+ ..++.++|||||||++|||+||+.
T Consensus 139 -----------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~ 207 (276)
T d1uwha_ 139 -----------EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207 (276)
T ss_dssp -----------TTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred -----------CCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCC
Confidence 44566777777665433221 23578999999999864 348899999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
||.+.+...............|. .......+++++.+
T Consensus 208 Pf~~~~~~~~~~~~~~~~~~~p~-------------------------------------------~~~~~~~~~~~l~~ 244 (276)
T d1uwha_ 208 PYSNINNRDQIIFMVGRGYLSPD-------------------------------------------LSKVRSNCPKAMKR 244 (276)
T ss_dssp TTTTCCCHHHHHHHHHHTSCCCC-------------------------------------------GGGSCTTCCHHHHH
T ss_pred CCCCCChHHHHHHHHhcCCCCCc-------------------------------------------chhccccchHHHHH
Confidence 99876654433322221111110 00112346788999
Q ss_pred HHhhccccCCCCCcCHHHHhcC
Q 017021 348 LLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~h 369 (379)
||.+||+.||++|||++|+++|
T Consensus 245 li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 245 LMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=366.36 Aligned_cols=241 Identities=24% Similarity=0.373 Sum_probs=191.9
Q ss_pred hccccccceeEEEEEec--CCCceEEEEEeecc---chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 49 SKMGEGTFGQVLECWDR--ERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
++||+|+||+||+|.++ .+++.||+|+++.. ......+.+|+.++.++ .|+||++++++++.+ ..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~g~~~~~-~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-----DNPYIVRMIGICEAE-SWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEESS-SEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-----CCCCCceEEEEeccC-CEEEEE
Confidence 46999999999999764 45688999999632 23345678899999888 789999999998654 578999
Q ss_pred eCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCccc
Q 017021 124 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 202 (379)
Q Consensus 124 e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~ 202 (379)
||+ +|+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.+
T Consensus 87 E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~--------------------- 143 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ--------------------- 143 (277)
T ss_dssp ECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---------------------
T ss_pred EcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc---------------------
Confidence 999 899999998765 69999999999999999999999999999999999999554
Q ss_pred ccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchH
Q 017021 203 KRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 275 (379)
Q Consensus 203 ~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~ 275 (379)
+.++|+|||+++...... ....||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+.+..
T Consensus 144 ------~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~ 217 (277)
T d1xbba_ 144 ------HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217 (277)
T ss_dssp ------TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ------CcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence 455666666665433222 22468899999999999899999999999999999998 89999887766
Q ss_pred HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcccc
Q 017021 276 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 355 (379)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 355 (379)
+....+.+... ++.| ..+++++.+||.+||+.
T Consensus 218 ~~~~~i~~~~~----------------------~~~p--------------------------~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 218 EVTAMLEKGER----------------------MGCP--------------------------AGCPREMYDLMNLCWTY 249 (277)
T ss_dssp HHHHHHHTTCC----------------------CCCC--------------------------TTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHcCCC----------------------CCCC--------------------------cccCHHHHHHHHHHcCC
Confidence 55544433111 1111 23667899999999999
Q ss_pred CCCCCcCHHHH---hcCCCC
Q 017021 356 DPTDRLTAREA---LRHPFF 372 (379)
Q Consensus 356 dP~~Rpta~e~---l~hp~f 372 (379)
||++|||++++ |+|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 99999999998 456654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=366.08 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=198.1
Q ss_pred echhhhhhhh-ccccccceeEEEEEecCC--CceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 40 FSAFADKIHS-KMGEGTFGQVLECWDRER--KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 40 ~~~~~y~i~~-~Lg~G~~g~V~~~~~~~~--~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
+....+.+.+ +||+|+||.||+|.++.+ +..||||+++.. ......+.+|+.++.++ .|+||++++++++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~g~~~ 79 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPYIVRLIGVCQ 79 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-----CCCCEeeEeeeec
Confidence 3445666777 499999999999987644 557999999643 33456778899999998 7899999999987
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
++ .+|+||||+ +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 80 ~~-~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~----------- 146 (285)
T d1u59a_ 80 AE-ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----------- 146 (285)
T ss_dssp SS-SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-----------
T ss_pred cC-eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-----------
Confidence 54 589999999 899999986543 3699999999999999999999999999999999999995544
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 266 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~ 266 (379)
.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 147 ----------------~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~ 210 (285)
T d1u59a_ 147 ----------------YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210 (285)
T ss_dssp ----------------EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred ----------------ceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCC
Confidence 45666666665433221 23458899999999998899999999999999999998 99
Q ss_pred CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 267 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
.||...+..+....+.+... +.. ++.+++++.
T Consensus 211 ~Pf~~~~~~~~~~~i~~~~~----------------------~~~--------------------------p~~~~~~l~ 242 (285)
T d1u59a_ 211 KPYKKMKGPEVMAFIEQGKR----------------------MEC--------------------------PPECPPELY 242 (285)
T ss_dssp CTTTTCCTHHHHHHHHTTCC----------------------CCC--------------------------CTTCCHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCC----------------------CCC--------------------------CCcCCHHHH
Confidence 99988776665544433211 111 123667899
Q ss_pred HHHhhccccCCCCCcCHHHH---hcCCCC
Q 017021 347 HLLQGLLRYDPTDRLTAREA---LRHPFF 372 (379)
Q Consensus 347 ~li~~~L~~dP~~Rpta~e~---l~hp~f 372 (379)
+||.+||+.||++|||+.++ |+|+|+
T Consensus 243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999888 567765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=363.85 Aligned_cols=254 Identities=26% Similarity=0.326 Sum_probs=201.6
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceE
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 119 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~ 119 (379)
+....|++.+.||+|+||.||+|+++.+ +.||||+++........+.+|+.+++++ +|+||+++++++.+ +..
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-----ccCCEeEEEEEEec-CCe
Confidence 3456799999999999999999998765 5699999986666667888999999998 88999999999865 457
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
++||||+ +|+|.+++.......+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~------------------ 148 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE------------------ 148 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG------------------
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECC------------------
Confidence 8999999 899999986644346999999999999999999999999999999999999954
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCC-CCCCCCc
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE-ALFQTHE 273 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~-~pf~~~~ 273 (379)
++.+||+|||+++...... ....||+.|+|||++....++.++|||||||++|+|++|. +|+....
T Consensus 149 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~ 219 (285)
T d1fmka3 149 ---------NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 219 (285)
T ss_dssp ---------GGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ---------CCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC
Confidence 4556777777665432221 2346899999999999999999999999999999999955 4455555
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.+.... +. ....++++.+||.+||
T Consensus 220 ~~~~~~~i~~~~~~----------------------~~--------------------------~~~~~~~l~~li~~cl 251 (285)
T d1fmka3 220 NREVLDQVERGYRM----------------------PC--------------------------PPECPESLHDLMCQCW 251 (285)
T ss_dssp HHHHHHHHHTTCCC----------------------CC--------------------------CTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCC----------------------CC--------------------------CcccCHHHHHHHHHHc
Confidence 55554444332111 11 1235678999999999
Q ss_pred ccCCCCCcCHHHHhc--CCCCCCC
Q 017021 354 RYDPTDRLTAREALR--HPFFTRD 375 (379)
Q Consensus 354 ~~dP~~Rpta~e~l~--hp~f~~~ 375 (379)
+.||++|||+++|++ |+||+..
T Consensus 252 ~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 252 RKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999998 8999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=370.40 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=206.4
Q ss_pred hhhhhhhccccccceeEEEEEe---cCCCceEEEEEeecc-----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 43 FADKIHSKMGEGTFGQVLECWD---RERKEMVAIKIVRGI-----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~---~~~~~~vAiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
-.|++.++||+|+||+||+|++ +.+|+.||+|+++.. ......+.+|+.++.++. +++||++++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~----h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----QSPFLVTLHYAFQ 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH----TCTTBCCEEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhcc----CCCeEEEeeeeec
Confidence 4489999999999999999987 457899999998632 233456778999999994 3478999999999
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
+....+++|||+ +++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+||++
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill--------------- 162 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL--------------- 162 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---------------
T ss_pred cCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---------------
Confidence 999999999999 999999998765 57899999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCC--CCCCccchHhHHHHHHHHHhCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEA 267 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~~l~~g~~ 267 (379)
+.++.++|+|||.+....... ....||+.|+|||.+.+. .++.++|||||||++|+|++|+.
T Consensus 163 ------------~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~ 230 (322)
T d1vzoa_ 163 ------------DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230 (322)
T ss_dssp ------------CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------cCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCC
Confidence 556678888888876443322 345789999999999764 36789999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHc-CCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHH
Q 017021 268 LFQTHENLEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 346 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (379)
||.+.+..+....+.+.. ... ... ....++++.
T Consensus 231 PF~~~~~~~~~~~i~~~~~~~~--------------------~~~--------------------------~~~~s~~~~ 264 (322)
T d1vzoa_ 231 PFTVDGEKNSQAEISRRILKSE--------------------PPY--------------------------PQEMSALAK 264 (322)
T ss_dssp TTSCTTSCCCHHHHHHHHHHCC--------------------CCC--------------------------CTTSCHHHH
T ss_pred CCCCCCHHHHHHHHHHhcccCC--------------------CCC--------------------------cccCCHHHH
Confidence 998765433333222211 000 001 124678999
Q ss_pred HHHhhccccCCCCCc-----CHHHHhcCCCCCCCC
Q 017021 347 HLLQGLLRYDPTDRL-----TAREALRHPFFTRDH 376 (379)
Q Consensus 347 ~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~ 376 (379)
+||.+||++||++|| ||+|+++||||++.+
T Consensus 265 ~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 265 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp HHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 999999999999999 589999999998855
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=356.26 Aligned_cols=248 Identities=24% Similarity=0.295 Sum_probs=192.8
Q ss_pred echhhhhhhhccccccceeEEEEEecCCC---ceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERK---EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 114 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~---~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~ 114 (379)
+....|++.+.||+|+||.||+|++..++ ..||+|.++.. ......+.+|+.++.++ +||||+++++++.
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVIT 78 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEe
Confidence 45568999999999999999999986553 56899988632 33346677899988887 7899999999986
Q ss_pred ecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCC
Q 017021 115 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 193 (379)
Q Consensus 115 ~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~ 193 (379)
.+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+||+++.+
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~------------ 144 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN------------ 144 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET------------
T ss_pred -cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC------------
Confidence 46789999999 899999877654 368999999999999999999999999999999999999544
Q ss_pred CCCCCCcccccCCCCCCeEEeecCcccccCCCC----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCC
Q 017021 194 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 268 (379)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~p 268 (379)
+.+||+|||+|+...... ....||+.|+|||.+.+..++.++|||||||++|+|++ |.+|
T Consensus 145 ---------------~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P 209 (273)
T d1mp8a_ 145 ---------------DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 209 (273)
T ss_dssp ---------------TEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ---------------CcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCC
Confidence 456677777665433221 23467899999999999999999999999999999998 8999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|...+..+....+.+... .+. ++.+++++.+|
T Consensus 210 ~~~~~~~~~~~~i~~~~~----------------------~~~--------------------------~~~~~~~~~~l 241 (273)
T d1mp8a_ 210 FQGVKNNDVIGRIENGER----------------------LPM--------------------------PPNCPPTLYSL 241 (273)
T ss_dssp TTTCCGGGHHHHHHTTCC----------------------CCC--------------------------CTTCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCC----------------------CCC--------------------------CCCCCHHHHHH
Confidence 988776655544332111 111 12467789999
Q ss_pred HhhccccCCCCCcCHHHHhcC
Q 017021 349 LQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~h 369 (379)
|.+||+.||++|||++|+++|
T Consensus 242 i~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 242 MTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=353.25 Aligned_cols=246 Identities=20% Similarity=0.274 Sum_probs=190.6
Q ss_pred hhhhhhhhccccccceeEEEEEecCCC----ceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~----~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
...|++.+.||+|+||.||+|.++.++ ..||||+++.. ......+.+|+.++.++ .|+||+++++++.+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-----~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-----SHHNIIRLEGVISK 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-----CCCCEeeeeEEEec
Confidence 345778899999999999999987665 47999998643 33345677899998888 78999999999999
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
.+..++||||+ ++++.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---------------- 143 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---------------- 143 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----------------
T ss_pred CCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE----------------
Confidence 99999999999 888888877654 369999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCC-
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA- 267 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~- 267 (379)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||+++..
T Consensus 144 -----------~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~ 212 (283)
T d1mqba_ 144 -----------NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 212 (283)
T ss_dssp -----------CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred -----------CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCC
Confidence 555667777777776433221 12357899999999999999999999999999999999554
Q ss_pred CCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHH
Q 017021 268 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 347 (379)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (379)
|+...+..+....+..... .+. +...+..+.+
T Consensus 213 ~~~~~~~~~~~~~i~~~~~----------------------~~~--------------------------~~~~~~~l~~ 244 (283)
T d1mqba_ 213 PYWELSNHEVMKAINDGFR----------------------LPT--------------------------PMDCPSAIYQ 244 (283)
T ss_dssp TTTTCCHHHHHHHHHTTCC----------------------CCC--------------------------CTTCBHHHHH
T ss_pred ccccCCHHHHHHHHhccCC----------------------CCC--------------------------chhhHHHHHH
Confidence 4544444444333322111 111 1235678999
Q ss_pred HHhhccccCCCCCcCHHHHhc
Q 017021 348 LLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 348 li~~~L~~dP~~Rpta~e~l~ 368 (379)
||.+||+.||++|||++|+++
T Consensus 245 li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 245 LMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=354.54 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=193.1
Q ss_pred chhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceee-ecceE
Q 017021 41 SAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHI 119 (379)
Q Consensus 41 ~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~-~~~~~ 119 (379)
+-..|++.++||+|+||.||+|.+ +|..||+|+++. +...+.+.+|+.++.++ .|+||+++++++. ..+.+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~-~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-DATAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCC-CC--HHHHHTHHHHTTC-----CCTTBCCEEEEECCC--CC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECc-HHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEecCCcE
Confidence 344678889999999999999987 478899999974 34456788899988887 7899999999875 45678
Q ss_pred EEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCC
Q 017021 120 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 198 (379)
Q Consensus 120 ~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~ 198 (379)
|+||||+ +|+|.+++.......+++..++.++.||+.||.|||+.+|+||||||+||++
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~-------------------- 136 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV-------------------- 136 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--------------------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee--------------------
Confidence 9999999 9999999976543358999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCCCCCCchHHH
Q 017021 199 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 277 (379)
Q Consensus 199 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~pf~~~~~~~~ 277 (379)
+.++.++|+|||.++..........+|..|+|||++.+..++.++|||||||++|||++ |++||...+..+.
T Consensus 137 -------~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~ 209 (262)
T d1byga_ 137 -------SEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209 (262)
T ss_dssp -------CTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred -------cCCCCEeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 56677888899988876666666678999999999998899999999999999999998 7888877655444
Q ss_pred HHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhccccCC
Q 017021 278 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 357 (379)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 357 (379)
...+.+. ...+. +...++++.+||.+||+.||
T Consensus 210 ~~~i~~~----------------------~~~~~--------------------------~~~~~~~~~~li~~cl~~dP 241 (262)
T d1byga_ 210 VPRVEKG----------------------YKMDA--------------------------PDGCPPAVYEVMKNCWHLDA 241 (262)
T ss_dssp HHHHTTT----------------------CCCCC--------------------------CTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHcC----------------------CCCCC--------------------------CccCCHHHHHHHHHHcccCH
Confidence 4333221 11111 12356789999999999999
Q ss_pred CCCcCHHHHhcC
Q 017021 358 TDRLTAREALRH 369 (379)
Q Consensus 358 ~~Rpta~e~l~h 369 (379)
.+|||+.|++++
T Consensus 242 ~~Rps~~~l~~~ 253 (262)
T d1byga_ 242 AMRPSFLQLREQ 253 (262)
T ss_dssp GGSCCHHHHHHH
T ss_pred hHCcCHHHHHHH
Confidence 999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=355.66 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=188.2
Q ss_pred echhhhhhhhccccccceeEEEEEecC-----CCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
++...|++.++||+|+||.||+|++.. +++.||+|+++.. ......+..|...+.++ .+|++++.++++
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~----~~h~~iv~~~~~ 85 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI----GHHLNVVNLLGA 85 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHH----CCCTTBCCEEEE
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhh----cCCCeEEEeeee
Confidence 445678999999999999999998754 4578999998632 23344556677777776 356788888887
Q ss_pred eee-cceEEEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcE
Q 017021 113 FDY-RNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV 176 (379)
Q Consensus 113 ~~~-~~~~~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Ni 176 (379)
+.. +..+++||||| +|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 654 55789999999 999999997542 12488999999999999999999999999999999999
Q ss_pred EEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccc
Q 017021 177 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCD 251 (379)
Q Consensus 177 li~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sD 251 (379)
|++ .++.+||+|||+|+...... ....||+.|+|||++.+..++.++|
T Consensus 166 Ll~---------------------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD 218 (299)
T d1ywna1 166 LLS---------------------------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 218 (299)
T ss_dssp EEC---------------------------GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHH
T ss_pred eEC---------------------------CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccc
Confidence 994 44556667777665332221 2346899999999999999999999
Q ss_pred hHhHHHHHHHHHhC-CCCCCCCchHHHHHH-HHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchh
Q 017021 252 IWSVGCILVELCTG-EALFQTHENLEHLAM-MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 329 (379)
Q Consensus 252 vwSlG~il~~l~~g-~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (379)
||||||++|+|++| .+||.+.+..+.... +.+... +..
T Consensus 219 iwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~----------------------~~~------------------ 258 (299)
T d1ywna1 219 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR----------------------MRA------------------ 258 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC----------------------CCC------------------
T ss_pred eeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----------------------CCC------------------
Confidence 99999999999986 567876554333222 222110 111
Q ss_pred hHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 330 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
++..++++.++|.+||+.||++|||++|+++|
T Consensus 259 --------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 259 --------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 12356789999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-47 Score=359.91 Aligned_cols=308 Identities=31% Similarity=0.509 Sum_probs=229.1
Q ss_pred echhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCC------CCCeeEEeccee
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK------GGNRCVQIRNWF 113 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~------~~~~i~~~~~~~ 113 (379)
+.+-.|+|+++||+|+||+||+|+++.+|+.||||+++..........+|+.++..+.+... .|++++++++++
T Consensus 10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 44455999999999999999999999999999999998766666777889999998865432 357899999887
Q ss_pred eec--ceEEEEEeCC--CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCcEEEecccccccCC
Q 017021 114 DYR--NHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPD 188 (379)
Q Consensus 114 ~~~--~~~~lv~e~~--~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiH~dlkp~Nili~~~~~~~~~~ 188 (379)
... ...++++.++ +++............+++..+..++.||+.||.|||+ .||+||||||+|||++..+..
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~---- 165 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP---- 165 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT----
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc----
Confidence 653 4566666665 5555555555555678999999999999999999998 899999999999999654321
Q ss_pred CccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCC
Q 017021 189 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 268 (379)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~p 268 (379)
.....++++|||.+...........||+.|+|||++.+..++.++|+||+||++++|++|+.|
T Consensus 166 -----------------~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 228 (362)
T d1q8ya_ 166 -----------------ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228 (362)
T ss_dssp -----------------TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred -----------------cccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCC
Confidence 222458999999998777666777899999999999999999999999999999999999999
Q ss_pred CCCCc------hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccch
Q 017021 269 FQTHE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 342 (379)
Q Consensus 269 f~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (379)
|.... ..+........+|..|..++.............+............ . ..............+
T Consensus 229 F~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~~~~~ 301 (362)
T d1q8ya_ 229 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP-L------EDVLTEKYKFSKDEA 301 (362)
T ss_dssp C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC-H------HHHHHHTTCCCHHHH
T ss_pred CCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCc-h------hhhcccccccCcccC
Confidence 97542 3445566677788888887765544433332222111111100000 0 000001112233467
Q ss_pred hHHHHHHhhccccCCCCCcCHHHHhcCCCCCCC
Q 017021 343 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 375 (379)
Q Consensus 343 ~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 375 (379)
+++.|||.+||++||.+||||+|+|+||||++.
T Consensus 302 ~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 889999999999999999999999999999854
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=357.75 Aligned_cols=246 Identities=20% Similarity=0.236 Sum_probs=194.8
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCc----eEEEEEeec--cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 115 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~----~vAiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~ 115 (379)
...|++.++||+|+||+||+|.+..+|+ +||+|.++. .......+.+|+.++.++ .|+||+++++++.+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGICLT 82 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-----CCTTBCCEEEEEES
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEec
Confidence 3458999999999999999999988876 588888863 234456788999999998 78999999999987
Q ss_pred cceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCC
Q 017021 116 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 194 (379)
Q Consensus 116 ~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~ 194 (379)
+. .+++++++ +++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 83 ~~-~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~-------------- 146 (317)
T d1xkka_ 83 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT-------------- 146 (317)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--------------
T ss_pred CC-eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCC--------------
Confidence 65 56677777 999999887754 46899999999999999999999999999999999999954
Q ss_pred CCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh-CCCC
Q 017021 195 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 268 (379)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~-g~~p 268 (379)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||+| |..|
T Consensus 147 -------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p 213 (317)
T d1xkka_ 147 -------------PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213 (317)
T ss_dssp -------------TTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred -------------CCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCC
Confidence 4566777777765433322 12358999999999999999999999999999999998 8999
Q ss_pred CCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 269 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
|.+.+..+....+.+...+ +. ++.+++.+.+|
T Consensus 214 ~~~~~~~~~~~~i~~~~~~----------------------~~--------------------------p~~~~~~~~~l 245 (317)
T d1xkka_ 214 YDGIPASEISSILEKGERL----------------------PQ--------------------------PPICTIDVYMI 245 (317)
T ss_dssp TTTSCGGGHHHHHHHTCCC----------------------CC--------------------------CTTBCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCC----------------------CC--------------------------CcccCHHHHHH
Confidence 9876665554444332211 11 12366789999
Q ss_pred HhhccccCCCCCcCHHHHhcC
Q 017021 349 LQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l~h 369 (379)
|.+||+.||.+|||+.|+++|
T Consensus 246 i~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 246 MVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCChhhCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=348.38 Aligned_cols=250 Identities=20% Similarity=0.293 Sum_probs=195.0
Q ss_pred echhhhhhhhccccccceeEEEEEecCCC-------ceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEec
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDRERK-------EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 110 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~~~-------~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~ 110 (379)
++.-.|++.+.||+|+||.||+|++..++ ..||||+++... .....+..|...+.++ ..|+||++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~----~~HpnIv~~~ 85 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI----GKHKNIINLL 85 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHh----cCCCeEEecc
Confidence 45567889999999999999999976654 479999996432 2345566677777776 3689999999
Q ss_pred ceeeecceEEEEEeCC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCc
Q 017021 111 NWFDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPEN 175 (379)
Q Consensus 111 ~~~~~~~~~~lv~e~~-~~sL~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~N 175 (379)
+++.+++.+++||||+ +|+|.+++.... ...+++..++.++.||+.||+|||+.||+||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 9999999999999999 999999997543 2358999999999999999999999999999999999
Q ss_pred EEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCcc
Q 017021 176 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPC 250 (379)
Q Consensus 176 ili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~s 250 (379)
||+ +.++.+||+|||.+....... ....||+.|+|||.+.+..|+.++
T Consensus 166 iLl---------------------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~ 218 (299)
T d1fgka_ 166 VLV---------------------------TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 218 (299)
T ss_dssp EEE---------------------------CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHH
T ss_pred eee---------------------------cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchh
Confidence 999 455566777777665432221 235688999999999999999999
Q ss_pred chHhHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchh
Q 017021 251 DIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 329 (379)
Q Consensus 251 DvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (379)
|||||||++|+|++ |.+||...+..+....+.... .+..|
T Consensus 219 DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~----------------------~~~~p----------------- 259 (299)
T d1fgka_ 219 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH----------------------RMDKP----------------- 259 (299)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC----------------------CCCCC-----------------
T ss_pred hhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCC----------------------CCCCC-----------------
Confidence 99999999999998 789998766655443332211 11111
Q ss_pred hHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 330 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
...++++.+||.+||+.||++||||+|+++
T Consensus 260 ---------~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 260 ---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp ---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------ccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 246678999999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=347.43 Aligned_cols=249 Identities=21% Similarity=0.262 Sum_probs=190.8
Q ss_pred eechhhhhhhhccccccceeEEEEEecC-CC--ceEEEEEeecc----chhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRE-RK--EMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~-~~--~~vAiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.+....|++.+.||+|+||.||+|++.. ++ ..||||+++.. ......+.+|+.+++++ +|+||+++++
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~~~g 78 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-----DHRNLIRLYG 78 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-----CCCCEEEEEE
Confidence 3445678999999999999999998643 33 46899998642 33345678899999998 7899999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCc
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 190 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~ 190 (379)
++.++ ..++||||+ ++++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 79 ~~~~~-~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~--------- 147 (273)
T d1u46a_ 79 VVLTP-PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR--------- 147 (273)
T ss_dssp EECSS-SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET---------
T ss_pred EEeec-chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc---------
Confidence 99764 678999999 899998877643 359999999999999999999999999999999999999544
Q ss_pred cCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHh
Q 017021 191 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 264 (379)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~ 264 (379)
..+||+|||++....... ....||..|+|||.+.+..++.++|||||||++|||++
T Consensus 148 ------------------~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt 209 (273)
T d1u46a_ 148 ------------------DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209 (273)
T ss_dssp ------------------TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred ------------------cceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHh
Confidence 456666666665433322 12357789999999999999999999999999999998
Q ss_pred -CCCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchh
Q 017021 265 -GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 343 (379)
Q Consensus 265 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (379)
|+.||.+.+..+....+.+....++ . ...+++
T Consensus 210 ~G~~Pf~~~~~~~~~~~i~~~~~~~~---------------------~--------------------------~~~~~~ 242 (273)
T d1u46a_ 210 YGQEPWIGLNGSQILHKIDKEGERLP---------------------R--------------------------PEDCPQ 242 (273)
T ss_dssp TSCCTTTTCCHHHHHHHHHTSCCCCC---------------------C--------------------------CTTCCH
T ss_pred CCCCCCCCcCHHHHHHHHHhCCCCCC---------------------C--------------------------cccccH
Confidence 8999998877766554433211111 0 123567
Q ss_pred HHHHHHhhccccCCCCCcCHHHHhc
Q 017021 344 DLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 344 ~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
.+.+||.+||+.||++|||++|+++
T Consensus 243 ~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 243 DIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999999999999999863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-47 Score=348.11 Aligned_cols=258 Identities=24% Similarity=0.304 Sum_probs=199.5
Q ss_pred hhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 44 ADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 44 ~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
.|++.++||+|+||.||+|+++.+|+.||||++... .....+..|++++..+. ++++++.+..++.+++..++||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~E~~i~~~l~----~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-TKHPQLHIESKIYKMMQ----GGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC-TTSCCHHHHHHHHHHST----TSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh-ccCHHHHHHHHHHHHcc----CCCcccEEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999998743 33456777898888873 3455777777888899999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcccc
Q 017021 124 EKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 203 (379)
Q Consensus 124 e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (379)
||+++++.+.+.... ..+++..+..++.|++.||+|||++||+||||||+||++...
T Consensus 83 e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~---------------------- 139 (299)
T d1ckia_ 83 ELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG---------------------- 139 (299)
T ss_dssp ECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG----------------------
T ss_pred EEcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccccc----------------------
Confidence 999888888876644 469999999999999999999999999999999999998532
Q ss_pred cCCCCCCeEEeecCcccccCCC----------CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 204 RMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 204 ~~~~~~~~~l~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
+.+..++|+|||.|...... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||....
T Consensus 140 --~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 140 --KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp --GGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred --CCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 24456888888888653322 134579999999999999999999999999999999999999998755
Q ss_pred hHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhcc
Q 017021 274 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 353 (379)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 353 (379)
..+....+.+.... ..........+.+++++.++|..||
T Consensus 218 ~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~p~~~~~li~~cl 256 (299)
T d1ckia_ 218 AATKRQKYERISEK-----------------------------------------KMSTPIEVLCKGYPSEFATYLNFCR 256 (299)
T ss_dssp -------HHHHHHH-----------------------------------------HHHSCHHHHTTTSCHHHHHHHHHHH
T ss_pred hHHHHHHHHHhhcc-----------------------------------------cCCCChhHhccCCCHHHHHHHHHHc
Confidence 43332222111000 0000011223457788999999999
Q ss_pred ccCCCCCcCHH---HHhcCCCC
Q 017021 354 RYDPTDRLTAR---EALRHPFF 372 (379)
Q Consensus 354 ~~dP~~Rpta~---e~l~hp~f 372 (379)
+.||++||+++ ++|+|+|.
T Consensus 257 ~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 257 SLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HSCTTCCCCHHHHHHHHHHHHH
T ss_pred cCChhHCcCHHHHHHHHHHHHH
Confidence 99999999987 45677654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-47 Score=349.67 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=201.4
Q ss_pred eechhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.++.-.|++.++||+|+||+||+|+++ .+++.||||+++.. ......+.+|+.++.++ .|+|++.+++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-----~h~niv~~~~ 83 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DNPNIVKLLG 83 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEE
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-----CCCCccccee
Confidence 345567899999999999999999875 35688999999743 23356678899998887 7899999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcc
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNN----------------------YRSFPIDLVREIARQLLECIAFMHDLCMIH 168 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH 168 (379)
++...+..+++|||+ +++|.+++.... ...+++..+..++.|++.||+|||+.+++|
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH 163 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 163 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence 999999999999999 899999997532 123788899999999999999999999999
Q ss_pred cCCCCCcEEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhC
Q 017021 169 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG 243 (379)
Q Consensus 169 ~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~ 243 (379)
|||||+||++ +.+..+||+|||+|+...... ....||+.|+|||.+.+
T Consensus 164 rDlKp~NILl---------------------------d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (301)
T d1lufa_ 164 RDLATRNCLV---------------------------GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216 (301)
T ss_dssp SCCSGGGEEE---------------------------CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred eEEcccceEE---------------------------CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence 9999999999 445567788888775332221 23468899999999999
Q ss_pred CCCCCccchHhHHHHHHHHHhCC-CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhh
Q 017021 244 LGWTYPCDIWSVGCILVELCTGE-ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 322 (379)
Q Consensus 244 ~~~~~~sDvwSlG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (379)
..++.++|||||||++|||++|. +||...+..+....+.+.. .+ +.
T Consensus 217 ~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~--~~--------------------~~----------- 263 (301)
T d1lufa_ 217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN--IL--------------------AC----------- 263 (301)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--CC--------------------CC-----------
T ss_pred CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC--CC--------------------CC-----------
Confidence 99999999999999999999985 6788777666554433221 11 11
Q ss_pred hhccchhhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 323 SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
++..++++.+||.+||+.||++|||+.||++
T Consensus 264 ---------------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 264 ---------------PENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp ---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1245678999999999999999999999964
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=349.97 Aligned_cols=248 Identities=22% Similarity=0.263 Sum_probs=195.6
Q ss_pred hhhhhhhccccccceeEEEEEecCCCce--EEEEEeec--cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecce
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEM--VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~--vAiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~ 118 (379)
-.|++.++||+|+||.||+|+++.+|.. ||||+++. .......+.+|+.++.++ ..|+||+++++++.+++.
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l----~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL----GHHPNIINLLGACEHRGY 85 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTC----CCCTTBCCEEEEEEETTE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhc----cCCCCEeeEEEEEecCCe
Confidence 4667889999999999999999888764 67787753 223445677888888876 257999999999999999
Q ss_pred EEEEEeCC-CCCHHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccc
Q 017021 119 ICIVFEKL-GSSLYDFLRKN--------------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 183 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~--------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~ 183 (379)
.++||||+ +|+|.+++... ....+++..+..++.||+.||.|||+.|++||||||+|||+
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~----- 160 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV----- 160 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-----
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE-----
Confidence 99999999 99999999753 12468999999999999999999999999999999999999
Q ss_pred cccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC--CcccccCCccchhhhhCCCCCCccchHhHHHHHHH
Q 017021 184 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 261 (379)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~ 261 (379)
+.+..+||+|||++....... ....||..|+|||.+.+..++.++|||||||++|+
T Consensus 161 ----------------------~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~e 218 (309)
T d1fvra_ 161 ----------------------GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 218 (309)
T ss_dssp ----------------------CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred ----------------------cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHH
Confidence 455567778888775433322 23468999999999999999999999999999999
Q ss_pred HHhCC-CCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhcc
Q 017021 262 LCTGE-ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 340 (379)
Q Consensus 262 l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (379)
|++|. +||...+..+....+.+.. .+.. +..
T Consensus 219 ll~~~~~p~~~~~~~~~~~~i~~~~----------------------~~~~--------------------------~~~ 250 (309)
T d1fvra_ 219 IVSLGGTPYCGMTCAELYEKLPQGY----------------------RLEK--------------------------PLN 250 (309)
T ss_dssp HHTTSCCTTTTCCHHHHHHHGGGTC----------------------CCCC--------------------------CTT
T ss_pred HHhcCCCCCCCCCHHHHHHHHHhcC----------------------CCCC--------------------------Ccc
Confidence 99965 6787666555433322110 1111 123
Q ss_pred chhHHHHHHhhccccCCCCCcCHHHHhcC
Q 017021 341 SAGDLTHLLQGLLRYDPTDRLTAREALRH 369 (379)
Q Consensus 341 ~~~~~~~li~~~L~~dP~~Rpta~e~l~h 369 (379)
.++++.+||.+||+.||++|||++|+++|
T Consensus 251 ~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 251 CDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66789999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=343.17 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=198.9
Q ss_pred echhhhhhhhccccccceeEEEEEec-----CCCceEEEEEeecc--chhhHhHHHHHHHHHHHHhcCCCCCeeEEecce
Q 017021 40 FSAFADKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 112 (379)
Q Consensus 40 ~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~ 112 (379)
++...|++.++||+|+||.||+|+++ .+++.||+|+++.. ......+.+|+.++..+ .+|+||++++++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l----~~HpnIv~~~g~ 95 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL----GNHMNIVNLLGA 95 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEEEE
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhc----cCCCCEEEEEEE
Confidence 55567888999999999999999853 56789999999743 23445677888888887 368999999999
Q ss_pred eeecceEEEEEeCC-CCCHHHHHHhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCc
Q 017021 113 FDYRNHICIVFEKL-GSSLYDFLRKNN----------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPEN 175 (379)
Q Consensus 113 ~~~~~~~~lv~e~~-~~sL~~~l~~~~----------------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~N 175 (379)
+.+++..++||||| +++|.+++.... ...+++..+..++.||+.||+|||++|++||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 99999999999999 999999997643 1248899999999999999999999999999999999
Q ss_pred EEEecccccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCcc
Q 017021 176 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPC 250 (379)
Q Consensus 176 ili~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~s 250 (379)
|+++. ++.++++|||.+....... ....||+.|+|||.+.+..++.++
T Consensus 176 Il~~~---------------------------~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 228 (311)
T d1t46a_ 176 ILLTH---------------------------GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 228 (311)
T ss_dssp EEEET---------------------------TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred ccccc---------------------------cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcc
Confidence 99954 4556666666665433222 234789999999999998999999
Q ss_pred chHhHHHHHHHHHh-CCCCCCCCchHHHHHHHH-HHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccch
Q 017021 251 DIWSVGCILVELCT-GEALFQTHENLEHLAMME-RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 328 (379)
Q Consensus 251 DvwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (379)
|||||||++|+|++ |.+||.+.+..+....+. +...+..
T Consensus 229 DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~--------------------------------------- 269 (311)
T d1t46a_ 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS--------------------------------------- 269 (311)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCC---------------------------------------
T ss_pred cccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC---------------------------------------
Confidence 99999999999998 677776655544433322 2111110
Q ss_pred hhHHHHHHhhccchhHHHHHHhhccccCCCCCcCHHHHhc
Q 017021 329 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 368 (379)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 368 (379)
....+.++.+||.+||+.||.+|||++|+++
T Consensus 270 ---------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 270 ---------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1235678999999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5e-46 Score=338.97 Aligned_cols=254 Identities=20% Similarity=0.251 Sum_probs=200.5
Q ss_pred hhhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 42 AFADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 42 ~~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
+-.|+|.++||+|+||+||+|+++.+|+.||+|+++.. .....+.+|++.+..+. ++++++.+++++..+...++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~----~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLA----GCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTT----TCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhc----CCCCCCEEEEEeecCCccEE
Confidence 34689999999999999999999999999999998643 23445667888888873 34678888899999999999
Q ss_pred EEeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCcc
Q 017021 122 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 201 (379)
Q Consensus 122 v~e~~~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
||||++++|.+++.... ..++...+..++.|++.||.|||++||+||||||+||++.....
T Consensus 79 vme~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~------------------ 139 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS------------------ 139 (293)
T ss_dssp EEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS------------------
T ss_pred EEEecCCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccc------------------
Confidence 99999999999987754 46899999999999999999999999999999999999954210
Q ss_pred cccCCCCCCeEEeecCcccccCCC----------CCcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 017021 202 FKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 271 (379)
Q Consensus 202 ~~~~~~~~~~~l~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~ 271 (379)
...+.++|+|||.|+..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 140 ----~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~ 215 (293)
T d1csna_ 140 ----KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 215 (293)
T ss_dssp ----TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred ----ccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCC
Confidence 23567889999988643221 1335799999999999999999999999999999999999999976
Q ss_pred CchH---HHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHH
Q 017021 272 HENL---EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 348 (379)
Q Consensus 272 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 348 (379)
.... +....+.......+ ..+.....++++.++
T Consensus 216 ~~~~~~~~~~~~i~~~~~~~~--------------------------------------------~~~l~~~~p~~l~~i 251 (293)
T d1csna_ 216 LKAATNKQKYERIGEKKQSTP--------------------------------------------LRELCAGFPEEFYKY 251 (293)
T ss_dssp CCSCCHHHHHHHHHHHHHHSC--------------------------------------------HHHHTTTSCHHHHHH
T ss_pred ccchhHHHHHHHHHhccCCCC--------------------------------------------hHHhcCCCCHHHHHH
Confidence 4332 22211111100000 111223466789999
Q ss_pred HhhccccCCCCCcCHHHHh
Q 017021 349 LQGLLRYDPTDRLTAREAL 367 (379)
Q Consensus 349 i~~~L~~dP~~Rpta~e~l 367 (379)
+..|+..+|++||+.+.+.
T Consensus 252 i~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 252 MHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHHCCTTCCCCHHHHH
T ss_pred HHHHhcCCcccCcCHHHHH
Confidence 9999999999999876654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=345.31 Aligned_cols=256 Identities=22% Similarity=0.307 Sum_probs=204.6
Q ss_pred eechhhhhhhhccccccceeEEEEEecC-----CCceEEEEEeeccc--hhhHhHHHHHHHHHHHHhcCCCCCeeEEecc
Q 017021 39 VFSAFADKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 111 (379)
Q Consensus 39 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~ 111 (379)
.+..-.|++.++||+|+||+||+|.++. ++..||||+++... .....+.+|+.+++++ +|+||+++++
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~~~~ 90 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLLG 90 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-----CCTTBCCEEE
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-----CCCCEeeeee
Confidence 3555678899999999999999998753 46789999997432 2234567888888877 7899999999
Q ss_pred eeeecceEEEEEeCC-CCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccc
Q 017021 112 WFDYRNHICIVFEKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 182 (379)
Q Consensus 112 ~~~~~~~~~lv~e~~-~~sL~~~l~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~ 182 (379)
.+..+...++||||+ +|+|.+++.... ...++...+..++.|++.||.|||+++|+||||||+|||+
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---- 166 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---- 166 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE----
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee----
Confidence 999999999999999 999999986421 1246888999999999999999999999999999999999
Q ss_pred ccccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCC-----CcccccCCccchhhhhCCCCCCccchHhHHH
Q 017021 183 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 257 (379)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ 257 (379)
+.+..+||+|||+++...... ....||+.|+|||.+.+..++.++|||||||
T Consensus 167 -----------------------d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~ 223 (308)
T d1p4oa_ 167 -----------------------AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 223 (308)
T ss_dssp -----------------------CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred -----------------------cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHH
Confidence 556677777887776433222 2236899999999999999999999999999
Q ss_pred HHHHHHhC-CCCCCCCchHHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHH
Q 017021 258 ILVELCTG-EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 336 (379)
Q Consensus 258 il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (379)
++|+|++| ..||.+.+..+....+.+.. .++.|
T Consensus 224 il~El~t~~~~p~~~~~~~~~~~~i~~~~----------------------~~~~p------------------------ 257 (308)
T d1p4oa_ 224 VLWEIATLAEQPYQGLSNEQVLRFVMEGG----------------------LLDKP------------------------ 257 (308)
T ss_dssp HHHHHHHTSCCTTTTSCHHHHHHHHHTTC----------------------CCCCC------------------------
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHhCC----------------------CCCCc------------------------
Confidence 99999997 57887766665554433211 11111
Q ss_pred hhccchhHHHHHHhhccccCCCCCcCHHHHhc------CCCCCC
Q 017021 337 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALR------HPFFTR 374 (379)
Q Consensus 337 ~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~------hp~f~~ 374 (379)
+..++.+.++|.+||+.||++|||++|+++ +|+|++
T Consensus 258 --~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 258 --DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred --ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 235678999999999999999999999998 777654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=337.44 Aligned_cols=247 Identities=18% Similarity=0.203 Sum_probs=190.5
Q ss_pred hhccccccceeEEEEEecCCC---ceEEEEEeec--cchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeee-cceEEE
Q 017021 48 HSKMGEGTFGQVLECWDRERK---EMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICI 121 (379)
Q Consensus 48 ~~~Lg~G~~g~V~~~~~~~~~---~~vAiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~-~~~~~l 121 (379)
.++||+|+||+||+|++..++ ..||||+++. .......+.+|+.++.++ .|+||+++++++.. ++..++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-----SHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEEEETTTEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-----CCCCEeEEeEEEEecCCceEE
Confidence 478999999999999986653 3699999863 334456788999999888 78999999998765 568999
Q ss_pred EEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEecccccccCCCccCCCCCCCCc
Q 017021 122 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 200 (379)
Q Consensus 122 v~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~~~~~~~~~~~~~~~~~ 200 (379)
||||| +++|.+++.... ..++...+..++.|++.||.|||+.+|+||||||+|||++
T Consensus 107 v~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~--------------------- 164 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD--------------------- 164 (311)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---------------------
T ss_pred EEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC---------------------
Confidence 99999 899999887654 3578889999999999999999999999999999999994
Q ss_pred ccccCCCCCCeEEeecCcccccCCCC-------CcccccCCccchhhhhCCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 017021 201 YFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 273 (379)
Q Consensus 201 ~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~~l~~g~~pf~~~~ 273 (379)
.+..+||+|||+++...... ....||+.|+|||.+....++.++||||||+++|||++|..||....
T Consensus 165 ------~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 165 ------EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp ------TTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred ------CCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 45556666776665432221 22468899999999999899999999999999999999877776432
Q ss_pred h-HHHHHHHHHHcCCCChhHHHhhhhhhhhhhccCCCCCCCCCCchhhhhhhccchhhHHHHHHhhccchhHHHHHHhhc
Q 017021 274 N-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 352 (379)
Q Consensus 274 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 352 (379)
. .+....+.+ ...+..| +..++++.+||.+|
T Consensus 239 ~~~~~~~~i~~----------------------g~~~~~p--------------------------~~~~~~l~~li~~c 270 (311)
T d1r0pa_ 239 NTFDITVYLLQ----------------------GRRLLQP--------------------------EYCPDPLYEVMLKC 270 (311)
T ss_dssp ----CHHHHHT----------------------TCCCCCC--------------------------TTCCHHHHHHHHHH
T ss_pred CHHHHHHHHHc----------------------CCCCCCc--------------------------ccCcHHHHHHHHHH
Confidence 2 111111111 1111111 23567899999999
Q ss_pred cccCCCCCcCHHHHhcC------CCCCCC
Q 017021 353 LRYDPTDRLTAREALRH------PFFTRD 375 (379)
Q Consensus 353 L~~dP~~Rpta~e~l~h------p~f~~~ 375 (379)
|+.||++|||+.|+++| .|..++
T Consensus 271 l~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 271 WHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred cCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 99999999999999998 666654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=337.88 Aligned_cols=192 Identities=23% Similarity=0.294 Sum_probs=152.2
Q ss_pred hhhhhhhccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecc----e
Q 017021 43 FADKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----H 118 (379)
Q Consensus 43 ~~y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~----~ 118 (379)
..|.+.++||+|+||.||+|+. +|+.||||+++.... .....|.+++... ..+|+||+++++++...+ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~~---~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTV---MLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTST---TCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHHh---hCCCCcCcceEEEEEeCCCcceE
Confidence 4677889999999999999985 689999999975432 3334444433221 127899999999987643 6
Q ss_pred EEEEEeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------cCCcccCCCCCcEEEecccccccCCC
Q 017021 119 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD--------LCMIHTDLKPENVLLVSSEYIKVPDY 189 (379)
Q Consensus 119 ~~lv~e~~-~~sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--------~~iiH~dlkp~Nili~~~~~~~~~~~ 189 (379)
+|+||||+ +++|.+++.+. .+++.....++.|++.||.|+|+ .||+||||||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl----------- 141 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV----------- 141 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE-----------
T ss_pred EEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE-----------
Confidence 89999999 99999999875 48999999999999999999996 589999999999999
Q ss_pred ccCCCCCCCCcccccCCCCCCeEEeecCcccccCCC-------CCcccccCCccchhhhhCCC------CCCccchHhHH
Q 017021 190 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLG------WTYPCDIWSVG 256 (379)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG 256 (379)
+.++.+||+|||++...... .....||+.|+|||++.+.. ++.++||||||
T Consensus 142 ----------------~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~G 205 (303)
T d1vjya_ 142 ----------------KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp ----------------CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred ----------------cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhH
Confidence 45566777777766543222 12357999999999987642 56789999999
Q ss_pred HHHHHHHhCCCCCCC
Q 017021 257 CILVELCTGEALFQT 271 (379)
Q Consensus 257 ~il~~l~~g~~pf~~ 271 (379)
|++|||+||..||..
T Consensus 206 vvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 206 LVFWEIARRCSIGGI 220 (303)
T ss_dssp HHHHHHHHTBCBTTB
T ss_pred HHHHHHhhCCCCCCc
Confidence 999999999888754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=4.8e-24 Score=180.62 Aligned_cols=163 Identities=23% Similarity=0.282 Sum_probs=109.1
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccch-------------------hhHhHHHHHHHHHHHHhcCCCCCe
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------------------YREAAMIEIEVLQQLAKHDKGGNR 105 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------------------~~~~~~~e~~~l~~l~~~~~~~~~ 105 (379)
|-|.++||+|+||+||+|++. +|+.||||+++.... .......|...+.++ .+.+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~ 75 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-----QGLA 75 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-----TTSS
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-----cCCC
Confidence 346789999999999999975 689999998752110 112223455566555 4455
Q ss_pred eEEecceeeecceEEEEEeCCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCcEEEeccccc
Q 017021 106 CVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 184 (379)
Q Consensus 106 i~~~~~~~~~~~~~~lv~e~~~~-sL~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiH~dlkp~Nili~~~~~~ 184 (379)
++..++.. ..+++||++++ .+. .++...+..++.|++.+|+|||++||+||||||+|||+.+
T Consensus 76 v~~~~~~~----~~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~---- 138 (191)
T d1zara2 76 VPKVYAWE----GNAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE---- 138 (191)
T ss_dssp SCCEEEEE----TTEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET----
T ss_pred cceEEEec----CCEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC----
Confidence 55544332 23799999943 332 2444556788999999999999999999999999999943
Q ss_pred ccCCCccCCCCCCCCcccccCCCCCCeEEeecCcccccCCCCCcccccCCccch--h---hhhCCCCCCccchHhHHHHH
Q 017021 185 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAP--E---VILGLGWTYPCDIWSVGCIL 259 (379)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~sDvwSlG~il 259 (379)
..++|+|||.|.....+.. ..|... + ......|+.++|+||+.--+
T Consensus 139 ------------------------~~~~liDFG~a~~~~~~~~-----~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 139 ------------------------EGIWIIDFPQSVEVGEEGW-----REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ------------------------TEEEECCCTTCEETTSTTH-----HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ------------------------CCEEEEECCCcccCCCCCc-----HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 2378999998865443221 111111 0 01235688999999976433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.27 E-value=2e-06 Score=74.03 Aligned_cols=83 Identities=8% Similarity=-0.024 Sum_probs=55.2
Q ss_pred hhhhhccccccceeEEEEEecCCCceEEEEEeeccch-hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEE
Q 017021 45 DKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 123 (379)
Q Consensus 45 y~i~~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~ 123 (379)
|++.+..+.++.+.||+.. .+++.+++|+...... .......|...+..+.. +..+++++.+.+.++..++||
T Consensus 16 ~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~----~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 16 YRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG----KLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp SEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT----TSCCCCEEEEEEETTEEEEEE
T ss_pred eEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhc----cCCCCcEEEEEecCCceEEEE
Confidence 3444444444557899885 4566688998864322 23345678888877743 234677777778888999999
Q ss_pred eCC-CCCHHHH
Q 017021 124 EKL-GSSLYDF 133 (379)
Q Consensus 124 e~~-~~sL~~~ 133 (379)
++. |.++.+.
T Consensus 90 ~~l~G~~~~~~ 100 (263)
T d1j7la_ 90 SEADGVLCSEE 100 (263)
T ss_dssp ECCSSEEHHHH
T ss_pred Eeccccccccc
Confidence 999 6666544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.58 E-value=7.9e-05 Score=63.27 Aligned_cols=75 Identities=13% Similarity=0.103 Sum_probs=51.0
Q ss_pred cccccc-ceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEEEEeCC-C
Q 017021 50 KMGEGT-FGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 127 (379)
Q Consensus 50 ~Lg~G~-~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 127 (379)
.+..|. .+.||+... .++..+++|...... ......|...+..+.... ..+++++....+++..++||+++ |
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~g---vpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTG---VPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTT---CCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcC---CCCCceeeecccccceEEEEEeeec
Confidence 334444 367899874 446668999876432 334566888888876533 34677777777788899999999 5
Q ss_pred CCH
Q 017021 128 SSL 130 (379)
Q Consensus 128 ~sL 130 (379)
.++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.58 E-value=0.00013 Score=66.48 Aligned_cols=74 Identities=20% Similarity=0.240 Sum_probs=45.7
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeec-----cch---hhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEE
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRG-----IKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 120 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~ 120 (379)
+.||.|....||++.+..+++.|++|.-.. .+. ...+...|...+..+..... ..+++++.+ ++...+
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p--~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVP--HLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCG--GGSCCEEEE--ETTTTE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCC--CCcceEEEE--cCCCCE
Confidence 568999999999999888788999997431 111 12334568888877754321 235555533 344567
Q ss_pred EEEeCC
Q 017021 121 IVFEKL 126 (379)
Q Consensus 121 lv~e~~ 126 (379)
+|||++
T Consensus 108 lvmE~L 113 (392)
T d2pula1 108 TVMEDL 113 (392)
T ss_dssp EEECCC
T ss_pred EEEecc
Confidence 899999
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.05 E-value=0.0043 Score=54.38 Aligned_cols=69 Identities=16% Similarity=0.183 Sum_probs=46.5
Q ss_pred eeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEe--cceeeecceEEEEEeCC
Q 017021 57 GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI--RNWFDYRNHICIVFEKL 126 (379)
Q Consensus 57 g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~--~~~~~~~~~~~lv~e~~ 126 (379)
-.||+++. ++|+.|++|+..........+..|...+..+.......+..+.. -..+...+..+.++++.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence 47999974 56888999998754444566778999999987754322222222 12334567788899988
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.16 E-value=0.0084 Score=52.00 Aligned_cols=53 Identities=11% Similarity=0.093 Sum_probs=31.2
Q ss_pred hccccccceeEEEEEecCCCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCC
Q 017021 49 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 104 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 104 (379)
+.|..|---+.|+.+.. +..+++|++... ........|+..+..+.......|
T Consensus 24 ~~i~~G~~N~ny~v~t~--~g~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp 76 (316)
T d2ppqa1 24 KGIAEGVENSNFLLHTT--KDPLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCP 76 (316)
T ss_dssp EEECC---EEEEEEEES--SCCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred ecCCCCcccCeEEEEEC--CCcEEEEEcCCC-CCHHHHHHHHHHHHhhhhcccccc
Confidence 34456666788998743 345999998643 233445557888888877654433
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.09 E-value=0.0078 Score=54.18 Aligned_cols=69 Identities=13% Similarity=0.146 Sum_probs=45.1
Q ss_pred hccccccceeEEEEEecC-------CCceEEEEEeeccchhhHhHHHHHHHHHHHHhcCCCCCeeEEecceeeecceEEE
Q 017021 49 SKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 121 (379)
Q Consensus 49 ~~Lg~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l 121 (379)
++|+.|-.-.+|++.... ..+.|.+++.-. ........+|..+++.+..... .++++.++.. ++
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl----~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHL----GPKLYGIFSG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTS----SSCEEEEETT----EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCC----CCeEEEEcCC----ce
Confidence 567778888999998653 346688888753 2233445578888888866432 3445555532 57
Q ss_pred EEeCC
Q 017021 122 VFEKL 126 (379)
Q Consensus 122 v~e~~ 126 (379)
|++|+
T Consensus 119 I~efi 123 (395)
T d1nw1a_ 119 LEEYI 123 (395)
T ss_dssp EECCC
T ss_pred EEEEe
Confidence 88888
|